PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Todd, C; Ray, S; Madzimbamuto, F; Sanders, D				Todd, Charles; Ray, Sunanda; Madzimbamuto, Farai; Sanders, David			What is the way forward for health in Zimbabwe?	LANCET			English	Editorial Material							CARE; NEED		[Todd, Charles] Wendover Hlth Ctr, Aylesbury HP22 6LD, Bucks, England; [Ray, Sunanda; Madzimbamuto, Farai] ZADHR, Harare, Zimbabwe; [Ray, Sunanda] NHS Brighton & Hove City Teaching Primary Care Tr, Brighton, E Sussex, England; [Madzimbamuto, Farai] Haywards Heath, Brighton & Sussex Univ Hosp, Brighton, E Sussex, England; [Sanders, David] Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa	Brighton and Sussex University Hospitals NHS Trust; University of the Western Cape	Todd, C (corresponding author), Wendover Hlth Ctr, Aylesbury Rd, Aylesbury HP22 6LD, Bucks, England.	chas.todd@nhs.net		Madzimbamuto, Farai/0000-0002-2678-4048				[Anonymous], 2008, WORLD HLTH STAT 2008; Chambers K, 2009, LANCET, V373, P993, DOI 10.1016/S0140-6736(09)60591-2; CHIKANDA A, 2005, SO AFRICAN MIGRATION; CLEMENS M, 2005, COST CAUSES ZIMBABWE; *CSO ZIMB MACR INT, 2007, ZIMB DEM HLTH SURV 2; *FOR COMM OFF UK, 2009, COUNTR PROF ZIMB; Gilson L, 2005, BMJ-BRIT MED J, V331, P762, DOI 10.1136/bmj.331.7519.762; *GLOB FUND FIGHT A, TUB MAL PORTF GRANTS; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Human Rights Watch, 2008, BULL EACH YOU STAT S; Kapp C, 2005, LANCET, V366, P1151, DOI 10.1016/S0140-6736(05)67463-6; MBIZVO MT, 1993, SOC SCI MED, V36, P1197, DOI 10.1016/0277-9536(93)90240-5; *MIN HLTH CHILD WE, 2009, GETT ZIMB HLTH CAR S; *MIN HLTH CHILD WE, 2009, DAIL CHOL UPD AL; *MIN HLTH CHILD WE, 2009, MAT PER MORT STUD 20; Pereira C, 2007, BJOG-INT J OBSTET GY, V114, P1530, DOI 10.1111/j.1471-0528.2007.01489.x; Physicians for Human Rights, 2009, HLTH RUINS MAN MAD D; SHOKO B, 2009, ZIMBABWE STAKEHOLDER; THETARD R, 2004, S AFRICAN FAMILY PRA, V46, P32; THORNYCROFT P, 2009, SUNDAY INDEPEND 0208; Tibaijuka, 2005, REPORT FACT FINDING; United Nations Development Programme (UNDP), 2008, COMPR EC REC ZIMB DI; *WFP, MAJ FOOD APP ZIMB WF; *WHO, 2008, EP FACTSH HIV AIDS Z; *WHO, 2009, GLOB TUB CONTR 2008; World Bank, 2008, GROSS NAT INC PER CA; World Bank, 2008, WORLD DEV IND DAT	27	13	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 13	2010	375	9714					606	609		10.1016/S0140-6736(09)61498-7	http://dx.doi.org/10.1016/S0140-6736(09)61498-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	560YO	19828190				2022-12-28	WOS:000274941900034
J	Cohen, PA				Cohen, Pieter A.			American Roulette - Contaminated Dietary Supplements	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEPATIC-INJURY		[Cohen, Pieter A.] Cambridge Hlth Alliance, Somerville, MA USA; [Cohen, Pieter A.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Cambridge Health Alliance; Harvard University; Harvard Medical School	Cohen, PA (corresponding author), Cambridge Hlth Alliance, Somerville, MA USA.							Adachi M, 2003, ANN INTERN MED, V139, P488, DOI 10.7326/0003-4819-139-6-200309160-00012; Ashar BH, 2007, ARCH INTERN MED, V167, P966, DOI 10.1001/archinte.167.9.966; Cohen PA, 2009, J GEN INTERN MED, V24, P430, DOI 10.1007/s11606-008-0878-4; Lai V, 2006, BMJ-BRIT MED J, V332, P304, DOI 10.1136/bmj.332.7536.304-b; Poon W. T., 2007, Hong Kong Medical Journal, V13, P359	5	67	68	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2009	361	16					1523	1525		10.1056/NEJMp0904768	http://dx.doi.org/10.1056/NEJMp0904768			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	506LT	19812394	Green Published, Bronze			2022-12-28	WOS:000270777000002
J	Geschwind, DH; Konopka, G				Geschwind, Daniel H.; Konopka, Genevieve			Neuroscience in the era of functional genomics and systems biology	NATURE			English	Review							TRANSLATIONAL PROFILING APPROACH; GENE-COEXPRESSION NETWORK; COMPLEX TRAIT ANALYSIS; ADULT-MOUSE BRAIN; CNS CELL-TYPES; NERVOUS-SYSTEM; PROTEIN EXPRESSION; MOLECULAR CHARACTERIZATION; MICROARRAY ANALYSIS; ALZHEIMERS-DISEASE	Advances in genetics and genomics have fuelled a revolution in discovery-based, or hypothesis-generating, research that provides a powerful complement to the more directly hypothesis-driven molecular, cellular and systems neuroscience. Genetic and functional genomic studies have already yielded important insights into neuronal diversity and function, as well as disease. One of the most exciting and challenging frontiers in neuroscience involves harnessing the power of large-scale genetic, genomic and phenotypic data sets, and the development of tools for data integration and mining. Methods for network analysis and systems biology offer the promise of integrating these multiple levels of data, connecting molecular pathways to nervous system function.	[Geschwind, Daniel H.; Konopka, Genevieve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet & Neurobehav Genet, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.; Konopka, Genevieve] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Program Neurogenet & Neurobehav Genet, Los Angeles, CA 90095 USA.	dhg@ucla.edu		Konopka, Genevieve/0000-0002-3363-7302	US National Institutes of Health [NIMH R37 MH60233-06A1, NINDS U24 NS52108]; US National Institute on Aging; Dr Miriam & Sheldon G. Adelson Medical Research Foundation; A. P. Giannini Foundation Medical Research Foundation; NARSAD; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH090238, R37MH060233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS052108] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Dr Miriam & Sheldon G. Adelson Medical Research Foundation; A. P. Giannini Foundation Medical Research Foundation; NARSAD(NARSAD); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This Review would not have been possible without help from members of the Geschwind laboratory, especially G. Coppola, who helped with several figures and provided critical comments on the manuscript; M. Oldham, for his pioneering use of WGCNA in the brain; and D. Crandall of the Mental Retardation Research Centre media core at the University of California, Los Angeles, for assistance with Fig. 3. We are also grateful to our collaborators S. Horvath, S. Nelson and P. Mischel, for their generosity of time and expertise. We apologize to the authors of the many outstanding studies we were not able to cite owing to space limitations. We acknowledge support from the US National Institutes of Health (grants NIMH R37 MH60233- 06A1 and NINDS U24 NS52108), the US National Institute on Aging, and the Dr Miriam & Sheldon G. Adelson Medical Research Foundation programme on neural repair and rehabilitation for our work in functional genomics (D. H. G.); and the A. P. Giannini Foundation Medical Research Foundation and NARSAD (G. K.).	Anderson CNG, 2006, J PHYSIOL-LONDON, V575, P367, DOI 10.1113/jphysiol.2006.113795; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BILDER RM, 2009, NEUROSCIENCE    0120, DOI DOI 10.1016/J.NEUROSCIENCE.2009.01.027; Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Canterini S, 2009, MOL CELL NEUROSCI, V40, P249, DOI 10.1016/j.mcn.2008.10.013; Chatr-aryamontri A, 2008, METHODS MOL BIOL, V484, P305, DOI 10.1007/978-1-59745-398-1_20; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Coppola G, 2006, J PHYSIOL-LONDON, V575, P353, DOI 10.1113/jphysiol.2006.112623; Cowley MJ, 2009, MAMM GENOME, V20, P281, DOI 10.1007/s00335-009-9181-x; Croning MDR, 2009, NUCLEIC ACIDS RES, V37, pD846, DOI 10.1093/nar/gkn700; Day A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r112; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Emes RD, 2008, NAT NEUROSCI, V11, P799, DOI 10.1038/nn.2135; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Geschwind DH, 2000, P NATL ACAD SCI USA, V97, P10676, DOI 10.1073/pnas.97.20.10676; Geschwind DH, 2001, NAT REV NEUROSCI, V2, P435, DOI 10.1038/35077576; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635; Hovatta I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r25; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Iossifov I, 2008, GENOME RES, V18, P1150, DOI 10.1101/gr.075622.107; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; Karsten SL, 2006, NEURON, V51, P549, DOI 10.1016/j.neuron.2006.07.019; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474; Liu F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-153; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mathivanan S, 2008, NAT BIOTECHNOL, V26, P164, DOI 10.1038/nbt0208-164; Mathivanan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S19; McDowall MD, 2009, NUCLEIC ACIDS RES, V37, pD651, DOI 10.1093/nar/gkn870; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Mirnics K, 2000, NEURON, V28, P53, DOI 10.1016/S0896-6273(00)00085-4; Mirnics K, 2004, NAT NEUROSCI, V7, P434, DOI 10.1038/nn1230; Mischel PS, 2004, NAT REV NEUROSCI, V5, P782, DOI 10.1038/nrn1518; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Nadler JJ, 2006, GENETICS, V174, P1229, DOI 10.1534/genetics.106.061481; Nagasaka Y, 2005, P NATL ACAD SCI USA, V102, P14854, DOI 10.1073/pnas.0504178102; Nelson SB, 2006, CURR OPIN NEUROBIOL, V16, P571, DOI 10.1016/j.conb.2006.08.006; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Rilling JK, 2008, NAT NEUROSCI, V11, P426, DOI 10.1038/nn2072; Rodriguez-Esteban R, 2006, PLOS COMPUT BIOL, V2, P1031, DOI 10.1371/journal.pcbi.0020118; Rzhetsky A, 2004, J BIOMED INFORM, V37, P43, DOI 10.1016/j.jbi.2003.10.001; Rzhetsky A, 2007, P NATL ACAD SCI USA, V104, P11694, DOI 10.1073/pnas.0704820104; Sandberg R, 2000, P NATL ACAD SCI USA, V97, P11038, DOI 10.1073/pnas.97.20.11038; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tang Y, 2001, ANN NEUROL, V50, P699, DOI 10.1002/ana.10042; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Valor LM, 2007, P NATL ACAD SCI USA, V104, P4658, DOI 10.1073/pnas.0609071104; van der Zwaag B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005324; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	82	145	148	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					908	915		10.1038/nature08537	http://dx.doi.org/10.1038/nature08537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829370	Green Accepted			2022-12-28	WOS:000270817700035
J	Martens-Habbena, W; Berube, PM; Urakawa, H; de la Torre, JR; Stahl, DA				Martens-Habbena, Willm; Berube, Paul M.; Urakawa, Hidetoshi; de la Torre, Jose R.; Stahl, David A.			Ammonia oxidation kinetics determine niche separation of nitrifying Archaea and Bacteria	NATURE			English	Article							OXIDIZING BACTERIA; NITROSOMONAS-EUROPAEA; MARINE; NITROGEN; OCEAN; GROWTH; WATER; STARVATION; NUTRIENTS; PHYTOPLANKTON	The discovery of ammonia oxidation by mesophilic and thermophilic Crenarchaeota and the widespread distribution of these organisms in marine and terrestrial environments indicated an important role for them in the global nitrogen cycle(1-7). However, very little is known about their physiology or their contribution to nitrification(8). Here we report oligotrophic ammonia oxidation kinetics and cellular characteristics of the mesophilic crenarchaeon 'Candidatus Nitrosopumilus maritimus' strain SCM1. Unlike characterized ammonia-oxidizing bacteria, SCM1 is adapted to life under extreme nutrient limitation, sustaining high specific oxidation rates at ammonium concentrations found in open oceans. Its half-saturation constant (K-m = 133 nM total ammonium) and substrate threshold (<= 10 nM) closely resemble kinetics of in situ nitrification in marine systems(9,10) and directly link ammonia-oxidizing Archaea to oligotrophic nitrification. The remarkably high specific affinity for reduced nitrogen (68,700 l per g cells per h) of SCM1 suggests that Nitrosopumilus-like ammonia-oxidizing Archaea could successfully compete with heterotrophic bacterio-plankton and phytoplankton. Together these findings support the hypothesis that nitrification is more prevalent in the marine nitrogen cycle than accounted for in current biogeochemical models(11).	[Martens-Habbena, Willm; Berube, Paul M.; Urakawa, Hidetoshi; de la Torre, Jose R.; Stahl, David A.] Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle	Martens-Habbena, W (corresponding author), Univ Washington, Dept Civil & Environm Engn, Seattle, WA 98105 USA.	willmmh@u.washington.edu; dastahl@u.washington.edu	Martens-Habbena, Willm/AAK-1372-2021; Martens-Habbena, Willm/I-7656-2013; Urakawa, Hidetoshi/B-1337-2013; de la Torre, Jose R/H-2081-2012	Martens-Habbena, Willm/0000-0002-8495-9125; Martens-Habbena, Willm/0000-0002-8495-9125; Urakawa, Hidetoshi/0000-0003-3748-6027; de la Torre, Jose R/0000-0002-9553-6048; Berube, Paul/0000-0001-5598-6602	NSF [MCB-0604448, OCE-0623174]	NSF(National Science Foundation (NSF))	We thank A. M. Gee for technical assistance and C. B. Walker, K. C. Costa, S. Flagan, D. K. Button, M. G. Klotz, L. Bakken, S. Sandfest, M. Konneke, K. L. Hillesland and L. H. Larsen for discussions. This work was supported by NSF award MCB-0604448 to D. A. S. and J. R. T. and by NSF award OCE-0623174 to A. E. Ingalls, D. A. S. and A. H. Devol.	Agogue H, 2008, NATURE, V456, P788, DOI 10.1038/nature07535; Berube PM, 2007, J BACTERIOL, V189, P3935, DOI 10.1128/JB.01861-06; Bollmann A, 2005, APPL ENVIRON MICROB, V71, P1276, DOI 10.1128/AEM.71.3.1276-1282.2005; Bollmann A, 2002, APPL ENVIRON MICROB, V68, P4751, DOI 10.1128/AEM.68.10.4751-4757.2002; BUTTON DK, 1985, MICROBIOL REV, V49, P270, DOI 10.1128/MMBR.49.3.270-297.1985; Button DK, 1998, MICROBIOL MOL BIOL R, V62, P636, DOI 10.1128/MMBR.62.3.636-645.1998; Button DK, 1998, APPL ENVIRON MICROB, V64, P4467; CLEGG SL, 1995, GEOCHIM COSMOCHIM AC, V59, P2403, DOI 10.1016/0016-7037(95)00135-2; de la Torre JR, 2008, ENVIRON MICROBIOL, V10, P810, DOI 10.1111/j.1462-2920.2007.01506.x; EPPLEY RW, 1974, J PHYCOL, V10, P15, DOI 10.1111/j.0022-3646.1974.00015.x; EPPLEY RW, 1969, LIMNOL OCEANOGR, V14, P912, DOI 10.4319/lo.1969.14.6.0912; Francis CA, 2005, P NATL ACAD SCI USA, V102, P14683, DOI 10.1073/pnas.0506625102; Freitag TE, 2006, ENVIRON MICROBIOL, V8, P684, DOI 10.1111/j.1462-2920.2005.00947.x; GLOVER HE, 1985, ARCH MICROBIOL, V142, P45, DOI 10.1007/BF00409235; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Gundersen JK, 1998, LIMNOL OCEANOGR, V43, P1932; HASHIMOTO LK, 1983, DEEP-SEA RES, V30, P575, DOI 10.1016/0198-0149(83)90037-7; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Jiang QQ, 1999, FEMS MICROBIOL ECOL, V30, P171, DOI 10.1111/j.1574-6941.1999.tb00646.x; KARL DM, 1984, NATURE, V309, P54, DOI 10.1038/309054a0; Karner MB, 2001, NATURE, V409, P507, DOI 10.1038/35054051; KEEN GA, 1987, ARCH MICROBIOL, V147, P73, DOI 10.1007/BF00492908; Kirchman DL, 2007, LIMNOL OCEANOGR, V52, P495, DOI 10.4319/lo.2007.52.2.0495; KIRCHMAN DL, 1994, MICROBIAL ECOL, V28, P255, DOI 10.1007/BF00166816; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Laanbroek HJ, 1995, ADV MICROB ECOL, V14, P275; LEE S, 1987, APPL ENVIRON MICROB, V53, P1298, DOI 10.1128/AEM.53.6.1298-1303.1987; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Loureiro S, 2009, J PLANKTON RES, V31, P399, DOI 10.1093/plankt/fbn122; Lunau M, 2005, ENVIRON MICROBIOL, V7, P961, DOI 10.1111/j.1462-2920.2005.00767.x; Mincer TJ, 2007, ENVIRON MICROBIOL, V9, P1162, DOI 10.1111/j.1462-2920.2007.01239.x; OLSON RJ, 1981, J MAR RES, V39, P203; Ouverney CC, 2000, APPL ENVIRON MICROB, V66, P4829, DOI 10.1128/AEM.66.11.4829-4833.2000; Phillips CJ, 1999, APPL ENVIRON MICROB, V65, P779; PROSSER J. I., 1989, ADV MICROBIAL PHYSL, P125; Prosser JI, 2008, ENVIRON MICROBIOL, V10, P2931, DOI 10.1111/j.1462-2920.2008.01775.x; Reay DS, 1999, APPL ENVIRON MICROB, V65, P2577; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Stark JM, 1996, SOIL BIOL BIOCHEM, V28, P1307, DOI 10.1016/S0038-0717(96)00133-2; STEHR G, 1995, FEMS MICROBIOL ECOL, V17, P177, DOI 10.1016/0168-6496(95)00022-3; Stickland JDH, 1972, PRACTICAL HDB SEAWAT; SUWA Y, 1994, WATER RES, V28, P1523, DOI 10.1016/0043-1354(94)90218-6; SUZUKI I, 1974, J BACTERIOL, V120, P556, DOI 10.1128/JB.120.1.556-558.1974; Ward B. B., 1986, Special Publications of the Society for General Microbiology, V20, P157; WARD BB, 1984, CONT SHELF RES, V3, P383, DOI 10.1016/0278-4343(84)90018-9; WARD BB, 1990, MICROBIAL ECOL, V19, P211, DOI 10.1007/BF02017166; WARD BB, 1987, ARCH MICROBIOL, V147, P126, DOI 10.1007/BF00415273; Watson S. W., 1965, LIMNOL OCEANOGR, V10, pR274, DOI DOI 10.4319/LO.1965.10.SUPPL2.R274; Wuchter C, 2006, P NATL ACAD SCI USA, V103, P12317, DOI 10.1073/pnas.0600756103; Yool A, 2007, NATURE, V447, P999, DOI 10.1038/nature05885	53	1096	1172	28	725	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					976	U234		10.1038/nature08465	http://dx.doi.org/10.1038/nature08465			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19794413				2022-12-28	WOS:000270817700046
J	Neylon, C				Neylon, Cameron			Stitching science together	NATURE			English	Editorial Material									Rutherford Appleton Lab, Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Neylon, C (corresponding author), Rutherford Appleton Lab, Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England.	cameron.neylon@stfc.ac.uk		Neylon, Cameron/0000-0002-0068-716X					0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 15	2009	461	7266					881	881		10.1038/461881a	http://dx.doi.org/10.1038/461881a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	506ZF	19829355	Bronze			2022-12-28	WOS:000270817700022
J	Marsden, J; Eastwood, B; Bradbury, C; Dale-Perera, A; Farrell, M; Hammond, P; Knight, J; Randhawa, K; Wright, C				Marsden, John; Eastwood, Brian; Bradbury, Colin; Dale-Perera, Annette; Farrell, Michael; Hammond, Paul; Knight, Jonathan; Randhawa, Kulvir; Wright, Craig		Natl Drug Treatment Monitoring Sys	Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, in-treatment cohort study	LANCET			English	Article							CLINICAL-SIGNIFICANCE; FOLLOW-UP; OUTCOMES; DEPENDENCE; DRUGS; ABUSE; WALES; RISK	Background Addiction to heroin and crack cocaine is debilitating and persistent, but such disorders are treatable. We present the first effectiveness study of the main community interventions for addiction to heroin and crack cocaine in England, using data from the National Drug Treatment Monitoring System (NDTMS). Methods The study cohort consisted of all adults with a heroin or crack cocaine addiction, or both, who started pharmacological treatment (n=18428 patients) or psychosocial treatment (n=2647) between Jan 1 and Nov 30, 2008, received at least 6 months' treatment or were discharged by the study endpoint (May 31, 2009), and had outcome data submitted to the NDTMS. Effectiveness was assessed from change in days of heroin or crack cocaine use, or both in the 28 days before the start of treatment and in the 28 days before review. Findings 14656 clients-74% of the cohort eligible for analysis at review with available data-were analysed at the study endpoint. During the 28 days before review, 37% (5016/13 542) of heroin users abstained from heroin and 52% (3941/7636) of crack cocaine users abstained from crack cocaine. A higher proportion of users of heroin only abstained than did users of both heroin and crack cocaine (42% [2465/5863] vs 33% [2551/7679]; OR 1.46, 95% CI 1.36-1.56), and more users of crack cocaine only abstained than did users of both drugs (57% [295/522] vs 51% [3646/7114]; 1.24, 1.03-1.48). Overall heroin use reduced by 14.5 days (95% CI 14.3-14.7) and crack cocaine use by 7.7 days (7.5-7.9). For clients given pharmacological treatment, reduction in days of heroin use was smaller for users of both heroin and crack cocaine than for users of heroin alone (p<0.0001), but this differential effectiveness was not recorded for psychosocial treatment in heroin or crack cocaine users compared with users of both drugs. Interpretation The first 6 months of pharmacological or psychosocial treatment is associated with reduced heroin and crack cocaine use, but the effectiveness of pharmacological treatment is less pronounced for users of both drugs. New strategies are needed to treat individuals with combined heroin and crack cocaine addiction. Funding National Treatment Agency for Substance Misuse.	[Marsden, John] Kings Coll London, Inst Psychiat, Natl Addict Ctr, Div Psychol Med & Psychiat, London SE5 8AF, England; [Eastwood, Brian; Bradbury, Colin; Dale-Perera, Annette; Hammond, Paul; Randhawa, Kulvir] Natl Treatment Agcy Subst Misuse, London, England	University of London; King's College London	Marsden, J (corresponding author), Kings Coll London, Inst Psychiat, Natl Addict Ctr, Div Psychol Med & Psychiat, Box 48,Addict Sci Bldg,4 Windsor Walk, London SE5 8AF, England.	john.marsden@kcl.ac.uk	Farrell, Michael P/A-4769-2012; Marsden, John/B-4745-2012	Farrell, Michael P/0000-0001-7008-8130; Marsden, John/0000-0002-1307-2498; Eastwood, Brian/0000-0003-1485-5571	National Treatment Agency for Substance Misuse	National Treatment Agency for Substance Misuse	Funding National Treatment Agency for Substance Misuse.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; BELL J, 1992, AM J FOREN MED PATH, V13, P346; Caplehorn JRM, 1999, MED J AUSTRALIA, V170, P104, DOI 10.5694/j.1326-5377.1999.tb127675.x; Cisler RA, 2005, ALCOHOL CLIN EXP RES, V29, P1991, DOI 10.1097/01.alc.0000187159.75424.77; Cone EJ, 2002, J ANAL TOXICOL, V26, P541, DOI 10.1093/jat/26.8.541; Del Boca FK, 2000, ADDICTION, V95, pS347; Department of Health (England) and the devolved administrations, 2007, DRUG MIS DEP UK GUID; Fals-Stewart W, 2000, J CONSULT CLIN PSYCH, V68, P134, DOI 10.1037/0022-006X.68.1.134; Farrell M, 2008, ADDICTION, V103, P251, DOI 10.1111/j.1360-0443.2007.02081.x; Gossop M, 2003, ADDICTION, V98, P291, DOI 10.1046/j.1360-0443.2003.00296.x; GRELLA CE, 1995, DRUG ALCOHOL DEPEN, V37, P15, DOI 10.1016/0376-8716(94)01059-T; HAY G, MEASURING DIFFERENT; HAY G, 9 HOM OFF; *HM GOV, DRUGS PROT FAM COMM; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kraemer HC, 1987, MANY SUBJECTS STAT P; Marsden J, 2008, ADDICTION, V103, P1450, DOI 10.1111/j.1360-0443.2008.02284.x; MCCANCEKATZ EF, AM J ADDICT IN PRESS; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; McLellan AT, 2002, ADDICTION, V97, P249, DOI 10.1046/j.1360-0443.2002.00127.x; Moos RH, 1998, J STUD ALCOHOL, V59, P43, DOI 10.15288/jsa.1998.59.43; *NAT I DRUG AB, NIH PUBL; *NAT I HLTH CLIN E, NICE CLIN GUID, V51; *NAT I HLTH CLIN E, NICE CLIN GUID, V52; *NAT TREATM AG SUB, MOD CAR AD DRUG MIS; *NAT TREATM AG SUB, BLACK MIN ETHN COMM; *NAT TREATM AG SUB, CAR PLANN PRACT GUID; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4; Roberts LJ, 2000, J CONSULT CLIN PSYCH, V68, P500, DOI 10.1037/0022-006X.68.3.500; Teesson M, 2006, DRUG ALCOHOL DEPEN, V83, P174, DOI 10.1016/j.drugalcdep.2005.11.009; Umbricht A, 2004, J CLIN PSYCHOPHARM, V24, P479, DOI 10.1097/01.jcp.0000138766.15858.c6; Williamson A, 2006, DRUG ALCOHOL DEPEN, V81, P293, DOI 10.1016/j.drugalcdep.2005.08.010; World Health Organisation, 1993, INT STAT CLASS DIS H; 2007, STAT NATL DRUG TREAT	35	93	97	0	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 10	2009	374	9697					1262	1270		10.1016/S0140-6736(09)61420-3	http://dx.doi.org/10.1016/S0140-6736(09)61420-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	507KQ	19800681				2022-12-28	WOS:000270852500032
J	Ji, Q; Luo, ZX; Zhang, XL; Yuan, CX; Xu, L				Ji, Qiang; Luo, Zhe-Xi; Zhang, Xingliao; Yuan, Chong-Xi; Xu, Li			Evolutionary Development of the Middle Ear in Mesozoic Therian Mammals	SCIENCE			English	Article							DIVERSIFICATION; MAMMALIAFORM; CARTILAGE; BEARING; CHINA	The definitive mammalian middle ear (DMME) is defined by the loss of embryonic Meckel's cartilage and disconnection of the middle ear from the mandible in adults. It is a major feature distinguishing living mammals from nonmammalian vertebrates. We report a Cretaceous trechnotherian mammal with an ossified Meckel's cartilage in the adult, showing that homoplastic evolution of the DMME occurred in derived therian mammals, besides the known cases of eutriconodonts. The mandible with ossified Meckel's cartilage appears to be paedomorphic. Reabsorption of embryonic Meckel's cartilage to disconnect the ear ossicles from the mandible is patterned by a network of genes and signaling pathways. This fossil suggests that developmental heterochrony and gene patterning are major mechanisms in homplastic evolution of the DMME.	[Luo, Zhe-Xi] Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA; [Ji, Qiang; Yuan, Chong-Xi] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Zhang, Xingliao; Xu, Li] Henan Geol Museum, Zhengzhou 450003, Peoples R China	Chinese Academy of Geological Sciences	Luo, ZX (corresponding author), Carnegie Museum Nat Hist, Pittsburgh, PA 15213 USA.	LuoZ@CarnegieMNH.Org	Luo, Zhe-XI/AAU-2263-2021		Ministry of Science and Technology of China (Beijing); NSF (USA); National Natural Science Foundation (China); National Geographic Society; Henan Provincial Government	Ministry of Science and Technology of China (Beijing)(Ministry of Science and Technology, China); NSF (USA)(National Science Foundation (NSF)); National Natural Science Foundation (China)(National Natural Science Foundation of China (NSFC)); National Geographic Society(National Geographic Society); Henan Provincial Government	We thank G. Cui for fossil preparation; M. R. Dawson for improving the manuscript; and R. Asher, Y. Chai, and A. Tucker for discussion. Support from the 973 Project of Ministry of Science and Technology of China (Q. J.); from Institute of Geology of Chinese Academy of Geological Sciences (Beijing) (C.-X. Y.), from NSF (USA), National Natural Science Foundation (China), and National Geographic Society (Z.-X. L.); and from Henan Provincial Government (to Z.-L. Z. and L. X.).	ALLIN EF, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P587; CIFELLI CL, 1999, GEODIVERSITAS, V21, P167; Ji Q, 2006, SCIENCE, V311, P1123, DOI 10.1126/science.1123026; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Kirk EC, 2008, J HUM EVOL, V55, P278, DOI 10.1016/j.jhevol.2008.02.008; Li CK, 2003, CHINESE SCI BULL, V48, P1129, DOI 10.1360/02wd0134; Li G, 2006, NATURE, V439, P195, DOI 10.1038/nature04168; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2007, NATURE, V446, P288, DOI 10.1038/nature05627; Luo ZX, 2005, SCIENCE, V308, P103, DOI 10.1126/science.1108875; Luo ZX, 2003, SCIENCE, V302, P1934, DOI 10.1126/science.1090718; Luo ZX, 2002, ACTA PALAEONTOL POL, V47, P1; Luo ZX, 2001, SCIENCE, V292, P1535, DOI 10.1126/science.1058476; MAIER W, 1993, MAMMAL PHYLOGENY, V1, P165; Martin T, 2005, J VERTEBR PALEONTOL, V25, P414, DOI 10.1671/0272-4634(2005)025[0414:MADOAP]2.0.CO;2; MENG J, 1995, NATURE, V377, P141, DOI 10.1038/377141a0; Meng J, 2003, ZOOL J LINN SOC-LOND, V138, P431, DOI 10.1046/j.1096-3642.2003.00064.x; Meng J, 2006, NATURE, V444, P889, DOI 10.1038/nature05234; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; Rich TH, 2005, SCIENCE, V307, P910, DOI 10.1126/science.1105717; Rougier GW, 2007, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2007)507[1:NJMFPA]2.0.CO;2; Rougier GW, 2003, ACTA GEOL SIN-ENGL, V77, P7; Rowe T, 1996, SCIENCE, V273, P651, DOI 10.1126/science.273.5275.651; Rowe T, 2008, P NATL ACAD SCI USA, V105, P1238, DOI 10.1073/pnas.0706385105; Sanchez-Villagra MR, 2002, J MORPHOL, V251, P219, DOI 10.1002/jmor.1085; SHUM L, 1993, DEVELOPMENT, V118, P903; Sweetman SC, 2008, PALAEONTOLOGY, V51, P1367, DOI 10.1111/j.1475-4983.2008.00816.x; Tsubamoto T, 2004, ACTA PALAEONTOL POL, V49, P329; Tucker AS, 2004, DEVELOPMENT, V131, P1235, DOI 10.1242/dev.01017	29	86	95	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					278	281		10.1126/science.1178501	http://dx.doi.org/10.1126/science.1178501			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815774				2022-12-28	WOS:000270599500040
J	Hoeijmakers, JHJ				Hoeijmakers, Jan H. J.			MOLECULAR ORIGINS OF CANCER DNA Damage, Aging, and Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TRANSCRIPTION-COUPLED REPAIR; NUCLEOTIDE EXCISION-REPAIR; STRAND BREAK REPAIR; GENOME MAINTENANCE; LIFE-SPAN; CALORIC RESTRICTION; COCKAYNE-SYNDROME; MAMMALIAN-CELLS; FANCONI-ANEMIA; MICE		Erasmus Univ, Med Ctr, Canc Genom Ctr, Dept Genet, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Hoeijmakers, JHJ (corresponding author), Erasmus Univ, Med Ctr, Canc Genom Ctr, Dept Genet, POB 2040, NL-3000 CA Rotterdam, Netherlands.	j.hoeijmakers@erasmusmc.nl	Hoeijmakers, Jan/AAX-6972-2021		Dutch Science Organization, Medical Sciences; Netherlands Genomics Initiative; European Commission [EU-LSHG-CT-2007-036894]; National Institutes of Health [1PO1AG17242-02]; Dutch Cancer Society; International Agency for Research on Cancer;  [WO2007133076];  [EP1815245]	Dutch Science Organization, Medical Sciences; Netherlands Genomics Initiative; European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Cancer Society(KWF Kankerbestrijding); International Agency for Research on Cancer; ; 	Dr. Hoeijmakers reports owning equity in Pharming; receiving grant support from the Dutch Science Organization, Medical Sciences, the Netherlands Genomics Initiative, the European Commission ( Integrated Project on DNA Repair and LifeSpan, EU-LSHG-CT-2007-036894), the National Institutes of Health (1PO1AG17242-02), the Dutch Cancer Society, and the International Agency for Research on Cancer; developing inventions for which Erasmus University holds two pending patents ( numbers WO2007133076 and EP1815245); and serving as chief scientific officer of DNage BV. No other potential conflict of interest relevant to this article was reported.	Akbari M, 2008, MECH AGEING DEV, V129, P353, DOI 10.1016/j.mad.2008.01.007; Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Andressoo JO, 2005, MUTAT RES-FUND MOL M, V577, P179, DOI 10.1016/j.mrfmmm.2005.04.004; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartke A, 2008, AGING CELL, V7, P285, DOI 10.1111/j.1474-9726.2008.00387.x; Beneke S, 2007, NUCLEIC ACIDS RES, V35, P7456, DOI 10.1093/nar/gkm735; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P19605, DOI 10.1073/pnas.0610370103; Biton S, 2008, DNA REPAIR, V7, P1028, DOI 10.1016/j.dnarep.2008.03.006; BOHR VA, 2008, MOL BIOL AGING, P309; Brooks PJ, 2008, DNA REPAIR, V7, P1168, DOI 10.1016/j.dnarep.2008.03.016; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Campisi J, 2005, MECH AGEING DEV, V126, P51, DOI 10.1016/j.mad.2004.09.024; Cohn MA, 2008, MOL CELL, V32, P306, DOI 10.1016/j.molcel.2008.10.009; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Garinis GA, 2009, NAT CELL BIOL, V11, P604, DOI 10.1038/ncb1866; Giannakou ME, 2007, TRENDS BIOCHEM SCI, V32, P180, DOI 10.1016/j.tibs.2007.02.007; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Hughes KA, 2005, ANNU REV ENTOMOL, V50, P421, DOI 10.1146/annurev.ento.50.071803.130409; Jacinto FV, 2007, MUTAGENESIS, V22, P247, DOI 10.1093/mutage/gem009; Kanaar R, 2008, EMBO J, V27, P581, DOI 10.1038/emboj.2008.11; Kenyon C, 2001, CELL, V105, P165, DOI 10.1016/S0092-8674(01)00306-3; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Li H, 2007, MOL CELL BIOL, V27, P8205, DOI 10.1128/MCB.00785-07; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu BH, 2008, HISTOL HISTOPATHOL, V23, P747, DOI 10.14670/HH-23.747; Loizou JI, 2006, CELL CYCLE, V5, P696, DOI 10.4161/cc.5.7.2616; Marino G, 2008, HUM MOL GENET, V17, P2196, DOI 10.1093/hmg/ddn120; Martin GM, 2007, ANN NY ACAD SCI, V1100, P14, DOI 10.1196/annals.1395.002; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Muftuoglu M, 2008, HUM GENET, V124, P369, DOI 10.1007/s00439-008-0562-0; Neveling K, 2007, Z GERONTOL GERIATR, V40, P339, DOI 10.1007/s00391-007-0483-x; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pfeifer GP, 2009, HUM GENET, V125, P493, DOI 10.1007/s00439-009-0657-2; Piper MDW, 2008, J INTERN MED, V263, P179, DOI 10.1111/j.1365-2796.2007.01906.x; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rapic-Otrin V, 2002, NUCLEIC ACIDS RES, V30, P2588, DOI 10.1093/nar/30.11.2588; Sander M, 2005, TOXICOL APPL PHARM, V208, P1, DOI 10.1016/j.taap.2004.12.012; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Schumacher B, 2008, TRENDS GENET, V24, P77, DOI 10.1016/j.tig.2007.11.004; Sedivy JM, 2008, EXP CELL RES, V314, P1909, DOI 10.1016/j.yexcr.2008.02.023; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Shay JW, 2008, BRIT J CANCER, V98, P677, DOI 10.1038/sj.bjc.6604209; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Slupphaug G, 2003, MUTAT RES-FUND MOL M, V531, P231, DOI 10.1016/j.mrfmmm.2003.06.002; Sugasawa K, 2006, J MOL HISTOL, V37, P189, DOI 10.1007/s10735-006-9044-7; Tsutakawa SE, 2000, COLD SPRING HARB SYM, V65, P201, DOI 10.1101/sqb.2000.65.201; van de Ven Marieke, 2006, PLoS Genet, V2, pe192, DOI 10.1371/journal.pgen.0020192; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; Verbeek B, 2008, BRIT MED BULL, V85, P17, DOI 10.1093/bmb/ldm036; Vermeulen W, 2001, NAT GENET, V27, P299, DOI 10.1038/85864; Vijg J, 2005, ANN NY ACAD SCI, V1055, P35, DOI 10.1196/annals.1323.007; Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002; Wilson DM, 2008, MECH AGEING DEV, V129, P349, DOI 10.1016/j.mad.2008.02.013	76	1367	1411	3	160	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2009	361	15					1475	1485		10.1056/NEJMra0804615	http://dx.doi.org/10.1056/NEJMra0804615			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503MU	19812404				2022-12-28	WOS:000270540000009
J	Millar, M				Millar, Michael			Should we screen low risk patients for meticillin resistant Staphylococcus aureus?	BRITISH MEDICAL JOURNAL			English	Editorial Material							ACTIVE SURVEILLANCE CULTURES; MRSA; INFECTION; PREVENTION; ORGANISMS		Barts & London NHS Trust, Dept Infect, London E1 2ES, England	Barts Health NHS Trust	Millar, M (corresponding author), Barts & London NHS Trust, Dept Infect, London E1 2ES, England.	michael.millar@bartsandthelondon.nhs.uk						Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; *BRIGHT SUSS U HOS, MRSA SCREEN FREQ ASK; Coia JE, 2006, J HOSP INFECT, V63, pS1, DOI 10.1016/j.jhin.2006.01.001; *DEP HLTH, 2001, REF GUID CONT EX TRE; *DEP HLTH, TEMPL PAT LEAFL MRSA; Department of Health, 2008, IMP ASS SCREEN EL PA; Department of Health, NHS ENGL OP FRAM 200; Diekema DJ, 2007, CLIN INFECT DIS, V44, P1101, DOI 10.1086/512820; Edmond M, 2008, PUBLIC HEALTH ETH-UK, V1, P235, DOI 10.1093/phe/phn014; Harbarth S, 2008, JAMA-J AM MED ASSOC, V299, P1149, DOI 10.1001/jama.299.10.1149; Humphreys H, 2009, CLIN MICROBIOL INFEC, V15, P120, DOI 10.1111/j.1469-0691.2009.02699.x; Kluytmans J, 2009, BMJ-BRIT MED J, V338, P532; McGinigle KL, 2008, CLIN INFECT DIS, V46, P1717, DOI 10.1086/587901; Mill J. S., 1989, LIBERTY OTHER ESSAYS; Millar M, 2008, J HOSP INFECT, V69, P1, DOI 10.1016/j.jhin.2008.01.035; National Audit Office, 2009, RED HEALTHC ASS INF; *NETH HLTH COUNC, 2006, MRSA POL NETH; *NUFF COUNC BIOETH, 2007, PUBL HLTH ETH ISS; Santos RP, 2008, CLIN INFECT DIS, V47, P110, DOI 10.1086/588789; United Nations Environment Programme, 1992, RIO DECL ENV DEV; Weber SG, 2007, AM J INFECT CONTROL, V35, P73, DOI 10.1016/j.ajic.2007.01.001; Wenzel RP, 2008, INFECT CONT HOSP EP, V29, P1012, DOI 10.1086/593120; Wolk DM, 2009, J CLIN MICROBIOL, V47, P758, DOI 10.1128/JCM.01714-08; 1999, SAVING LIVES OUR HLT	24	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 8	2009	339								b4035	10.1136/bmj.b4035	http://dx.doi.org/10.1136/bmj.b4035			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TH	19815584				2022-12-28	WOS:000270719300004
J	Paroo, Z; Ye, XC; Chen, S; Liu, QH				Paroo, Zain; Ye, Xuecheng; Chen, She; Liu, Qinghua			Phosphorylation of the Human MicroRNA-Generating Complex Mediates MAPK/Erk Signaling	CELL			English	Article							SELF-RENEWAL; POSTTRANSCRIPTIONAL REGULATION; CELL-PROLIFERATION; TUMOR INVASION; NUCLEAR EXPORT; DICER; LET-7; GENE; PATHWAY; MATURATION	MicroRNAs (miRNAs) govern an expanding number of biological and disease processes. Understanding the mechanisms by which the miRNA pathway is regulated, therefore, represents an important area of investigation. We determined that the human miRNA-generating complex is comprised of Dicer and phospho-TRBP isoforms. Phosphorylation of TRBP is mediated by the mitogen-activated protein kinase (MAPK) Erk. Expression of phospho-mimic TRBP and TRBP phosphorylation enhanced miRNA production by increasing stability of the miRNA-generating complex. Mitogenic signaling in response to serum and the tumor promoter PMA was dependent on TRBP phosphorylation. These effects were accompanied by a coordinated increase in levels of growth-promoting miRNA and reduced expression of let-7 tumor suppressor miRNA. Conversely, pharmacological inhibition of MAPK/Erk resulted in an anti-growth miRNA profile. Taken together, these studies indicate that the MAPK/Erk pathway regulates the miRNA machinery and suggest a general principle, wherein signaling systems target the miRNA pathway to achieve biological responses.	[Paroo, Zain; Ye, Xuecheng; Liu, Qinghua] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, She] Natl Inst Biol Sci, Beijing 102206, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institute of Biological Sciences, Beijing	Liu, QH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	qinghua.liu@utsouthwestern.edu			National Center for Research Resources; National Institutes of Health [C06-RR15437-01, GM078163, GM084010]; Welch Foundation [I-1608]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084010, R01GM078163] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Dangsheng Li, Yi Liu, Eric Olson, Michael White, and Hongtao Yu for critical reading of the manuscript. We thank Fenghe Du and Drs. Yue Chen, Melanie Cobb, Bryan Cullen, Witold Filipowicz, Eric Olson, Patrick Provost, Ramin Shiekhattar, Bing Su, and Yingming Zhao for providing reagents and assistance in the development of this work. We thank Phi Luong, Andrew Williams, and Drs. Gaya Amarasinghe, Alex Pertsemlidis, Joan Reisch, and Michael White for insightful discussion. This work was conducted in a facility renovated with support from the National Center for Research Resources, National Institutes of Health (C06-RR15437-01) and was supported by the Welch Foundation (I-1608) and National Institutes of Health grants (GM078163 and GM084010) awarded to Q. L.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bilen J, 2006, MOL CELL, V24, P157, DOI 10.1016/j.molcel.2006.07.030; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Chan SP, 2008, RNA, V14, P2104, DOI 10.1261/rna.551208; Chen J, 2008, CANCER RES, V68, P3844, DOI 10.1158/0008-5472.CAN-07-5156; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Khokhlatchev A, 1997, J BIOL CHEM, V272, P11057; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Park JK, 2007, CURR BIOL, V17, P533, DOI 10.1016/j.cub.2007.01.060; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017	63	267	270	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					112	122		10.1016/j.cell.2009.06.044	http://dx.doi.org/10.1016/j.cell.2009.06.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804757	Green Accepted, Bronze			2022-12-28	WOS:000270388600020
J	Bouwman, RA; van Schijndel, RJMS				Bouwman, R. Arthur; van Schijndel, Rob J. M. Strack			Pericardial Calcification Noted Long after Sydenham's Chorea.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bouwman, R. Arthur; van Schijndel, Rob J. M. Strack] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Bouwman, RA (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands.	a.bouwman@vunc.nl	Bouwman, R. Arthur/ABH-9873-2020; Bouwman, R. Arthur/A-2937-2013	Bouwman, R. Arthur/0000-0002-2051-5947; 					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2009	361	14					1386	1386		10.1056/NEJMicm0801746	http://dx.doi.org/10.1056/NEJMicm0801746			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500KZ	19797285				2022-12-28	WOS:000270300000013
J	Hu, DY; Hou, LH; Zhang, LJ; Xu, X				Hu, Dongyu; Hou, Lianhai; Zhang, Lijun; Xu, Xing			A pre-Archaeopteryx troodontid theropod from China with long feathers on the metatarsus	NATURE			English	Article							4-WINGED DINOSAURS; ORIGIN; MANIRAPTORAN	The early evolution of the major groups of derived non-avialan theropods is still not well understood, mainly because of their poor fossil record in the Jurassic. A well-known result of this problemis the 'temporal paradox' argument that is sometimes made against the theropod hypothesis of avian origins(1). Here we report on an exceptionally well-preserved small theropod specimen collected from the earliest Late Jurassic Tiaojishan Formation of western Liaoning, China(2). The specimen is referable to the Troodontidae, which are among the theropods most closely related to birds. This new find refutes the 'temporal paradox'(1) and provides significant information on the temporal framework of theropod divergence. Furthermore, the extensive feathering of this specimen, particularly the attachment of long pennaceous feathers to the pes, sheds new light on the early evolution of feathers and demonstrates the complex distribution of skeletal and integumentary features close to the dinosaur-bird transition.	[Hu, Dongyu; Hou, Lianhai; Zhang, Lijun; Xu, Xing] Shenyang Normal Univ, Inst Paleontol, Shenyang 110034, Peoples R China; [Hou, Lianhai; Xu, Xing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Zhang, Lijun] Shenyang Inst Geol & Mineral Resources, Shenyang 110032, Peoples R China	Shenyang Normal University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Xu, X (corresponding author), Shenyang Normal Univ, Inst Paleontol, 253 N Huanghe St, Shenyang 110034, Peoples R China.	hudongyu@synu.edu.cn; xingxu@vip.sina.com			Education Bureau of Liaoning Province [20060805, 2008S214]; Special Fund of Shenyang Normal University; X. X. from the Chinese Academy of Sciences; National Natural Science Foundation of China; Major Basic Research Projects of the Ministry of Science and Technology, China	Education Bureau of Liaoning Province; Special Fund of Shenyang Normal University; X. X. from the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Basic Research Projects of the Ministry of Science and Technology, China	We thank S. Zheng for help with the fieldwork, T. Yu for preparing the specimen, C. Sullivan for editing and commenting on the manuscript, G. Sun, P. Cheng and F. Jin for discussions and comments, and J. Huang for Supplementary Fig. 4i. The fieldwork was supported by grants from the Education Bureau of Liaoning Province ( numbers 20060805 and 2008S214) and the Special Fund of Shenyang Normal University. This study was also supported by grants to X. X. from the Chinese Academy of Sciences, the National Natural Science Foundation of China, and Major Basic Research Projects of the Ministry of Science and Technology, China.	Chure Daniel J., 1994, Brigham Young University Geology Studies, V40, P11; Currie P.J., 1987, Journal of Vertebrate Paleontology, V7, P72; EVANS SE, 1985, SHADOW DINOSAURS, P303; Feduccia A, 2002, AUK, V119, P1187, DOI 10.1642/0004-8038(2002)119[1187:BADSAT]2.0.CO;2; JENSEN JA, 1989, J PALEONTOL, V63, P364, DOI 10.1017/S0022336000019533; Longrich N, 2006, PALEOBIOLOGY, V32, P417, DOI 10.1666/04014.1; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P184; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; Makovicky PJ, 2003, AM MUS NOVIT, P1; Norell MA, 2004, DINOSAURIA, 2ND EDITION, P196; Padian K, 2003, BIOSCIENCE, V53, P450; Sawyer RH, 2003, J EXP ZOOL PART B, V298B, P57, DOI 10.1002/jez.b.26; WEIDENSAUL S, 1995, RAPTORS BIRDS PREY; Wellnhofer P, 2008, ARCHAEOPTERYX URVOGE; Xu K., 2003, JURASSIC SYSTEM N CH, VVII; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Xu X, 2005, NATURE, V438, pE3, DOI 10.1038/nature04355; Xu X, 2004, NATURE, V431, P838, DOI 10.1038/nature02898; Xu X, 2001, J VERTEBR PALEONTOL, V21, P477, DOI 10.1671/0272-4634(2001)021[0477:ANTFTL]2.0.CO;2; Xu X, 2001, NATURE, V410, P200, DOI 10.1038/35065589; Xu Xing, 2004, Vertebrata Palasiatica, V42, P111; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; Zhang FC, 2004, NATURE, V431, P925, DOI 10.1038/431925a; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447	25	251	277	3	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					640	643		10.1038/nature08322	http://dx.doi.org/10.1038/nature08322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794491				2022-12-28	WOS:000270302600038
J	Taira, T; Silver, PG; Niu, FL; Nadeau, RM				Taira, Taka'aki; Silver, Paul G.; Niu, Fenglin; Nadeau, Robert M.			Remote triggering of fault-strength changes on the San Andreas fault at Parkfield	NATURE			English	Article							EARTHQUAKE; CALIFORNIA; DEFORMATION; SEISMICITY; MICROEARTHQUAKES; STRAINMETERS; TRANSIENT; INCREASE; LANDERS; RATES	Fault strength is a fundamental property of seismogenic zones, and its temporal changes can increase or decrease the likelihood of failure and the ultimate triggering of seismic events. Although changes in fault strength have been suggested to explain various phenomena, such as the remote triggering of seismicity(1), there has been no means of actually monitoring this important property in situ. Here we argue that similar to 20 years of observation (1987-2008) of the Parkfield area at the San Andreas fault have revealed a means of monitoring fault strength. We have identified two occasions where long-term changes in fault strength have been most probably induced remotely by large seismic events, namely the 2004 magnitude (M) 9.1 Sumatra-Andaman earthquake and the earlier 1992 M = 7.3 Landers earthquake. In both cases, the change possessed two manifestations: temporal variations in the properties of seismic scatterers-probably reflecting the stress-induced migration of fluids-and systematic temporal variations in the characteristics of repeating-earthquake sequences that are most consistent with changes in fault strength. In the case of the 1992 Landers earthquake, a period of reduced strength probably triggered the 1993 Parkfield aseismic transient(2-5) as well as the accompanying cluster of four M>4 earthquakes at Parkfield. The fault-strength changes produced by the distant 2004 Sumatra-Andaman earthquake are especially important, as they suggest that the very largest earthquakes may have a global influence on the strength of the Earth's fault systems. As such a perturbation would bring many fault zones closer to failure, it should lead to temporal clustering of global seismicity. This hypothesis seems to be supported by the unusually high number of M >= 8 earthquakes occurring in the few years following the 2004 Sumatra-Andaman earthquake.	[Taira, Taka'aki; Silver, Paul G.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [Niu, Fenglin] Rice Univ, Dept Earth Sci, Houston, TX 77005 USA; [Nadeau, Robert M.] Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94720 USA	Carnegie Institution for Science; Rice University; University of California System; University of California Berkeley	Taira, T (corresponding author), Carnegie Inst Washington, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA.	taira@dtm.ciw.edu	Nadeau, Robert/G-1884-2017; Niu, Fenglin/A-2548-2011; Taira, Taka'aki/L-5839-2013; Taira, Taka'aki/AHD-8524-2022	Nadeau, Robert/0000-0003-1255-0643; Taira, Taka'aki/0000-0002-6170-797X; Taira, Taka'aki/0000-0002-6170-797X	National Science Foundation [EAR-0337308, EAR-0408947, EAR-0409024, EAR-0453638, EAR-0537641, EAR-0544730, DTM-2025-01]; Department of Terrestrial Magnetism; Carnegie Institution of Washington; US Geological Survey (USGS) through National Earthquake Hazards Reduction Program [07HQAG0014]; Division Of Earth Sciences [0748455] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Department of Terrestrial Magnetism; Carnegie Institution of Washington; US Geological Survey (USGS) through National Earthquake Hazards Reduction Program(United States Geological Survey); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the National Science Foundation EAR-0337308, EAR-0408947, EAR-0409024, EAR-0453638, EAR-0537641, EAR-0544730 and DTM-2025-01, and by the Department of Terrestrial Magnetism, Carnegie Institution of Washington. The Parkfield High- Resolution Seismic Network is operated by University of California, Berkeley Seismological Laboratory with financial support from the US Geological Survey (USGS) through National Earthquake Hazards Reduction Program award 07HQAG0014. Seismic and geodetic data are archived at the Northern California Earthquake Data Center and USGS, respectively. We thank J. Murray-Moraleda for providing the slip rate data, and E. A. Roeloffs and A. T. Linde for discussions. This is Berkeley Seismological Laboratory contribution 09-14.	Baisch S, 2001, J GEOPHYS RES-SOL EA, V106, P16323, DOI 10.1029/2001JB000151; Brodsky EE, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003211; Burgmann R, 2000, SCIENCE, V289, P1178, DOI 10.1126/science.289.5482.1178; Elkhoury JE, 2006, NATURE, V441, P1135, DOI 10.1038/nature04798; Gao SS, 2000, NATURE, V406, P500, DOI 10.1038/35020045; Gao SS, 2000, J GEOPHYS RES-SOL EA, V105, P2955, DOI 10.1029/1999JB900383; Hill D. P., 2007, TREATISE GEOPHYS EAR, V4, P257, DOI [10.1016/B978-044452748-6.00070-5, DOI 10.1016/B978-044452748-6.00070-5]; HILL DP, 1993, SCIENCE, V260, P1617, DOI 10.1126/science.260.5114.1617; Langbein J, 2006, B SEISMOL SOC AM, V96, pS304, DOI 10.1785/0120050823; Langbein J, 1999, GEOPHYS RES LETT, V26, P2529, DOI 10.1029/1999GL900557; Li YG, 2006, B SEISMOL SOC AM, V96, pS349, DOI 10.1785/0120050803; Murray JR, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003651; Nadeau RM, 1999, SCIENCE, V285, P718, DOI 10.1126/science.285.5428.718; Nadeau RM, 1998, B SEISMOL SOC AM, V88, P790; Nadeau RM, 2004, SCIENCE, V303, P220, DOI 10.1126/science.1090353; Niu FL, 2003, NATURE, V426, P544, DOI 10.1038/nature02151; OKADA Y, 1992, B SEISMOL SOC AM, V82, P1018; Peng ZG, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022626; Schaff DP, 1998, GEOPHYS RES LETT, V25, P4549, DOI 10.1029/1998GL900192; SHIMAZAKI K, 1980, GEOPHYS RES LETT, V7, P279, DOI 10.1029/GL007i004p00279; Snieder R, 2002, SCIENCE, V295, P2253, DOI 10.1126/science.1070015; Taira T, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005151; West M, 2005, SCIENCE, V308, P1144, DOI 10.1126/science.1112462	23	55	56	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 1	2009	461	7264					636	U77		10.1038/nature08395	http://dx.doi.org/10.1038/nature08395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794490	Green Published			2022-12-28	WOS:000270302600037
J	Kaufman, DS; McDougal, WS; Harisinghani, MG; Wu, CL				Kaufman, Donald S.; McDougal, W. Scott; Harisinghani, Mukesh G.; Wu, Chin-Lee			A Man with Recurrent Transitional-Cell Carcinoma of the Ureter Transitional-cell carcinoma of the right renal pelvis and ureter (AJCC TNM pathological stage pT3NxMx). Transitional-cell carcinoma of the left ureter (AJCC TNM pathological stage pT1N0Mx).	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Conference on Genitourinary Oncology	NOV 06, 2008	Massachusetts Gen Hosp, Boston, MA		Massachusetts Gen Hosp		UPPER URINARY-TRACT; PROGNOSTIC-FACTORS; UROTHELIAL TUMORS; SURVIVAL; EXPERIENCE; MANAGEMENT; THERAPY; KIDNEY		[Kaufman, Donald S.] Massachusetts Gen Hosp, Div Hematol Oncol, Dept Med, Boston, MA 02114 USA; [McDougal, W. Scott] Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; [Harisinghani, Mukesh G.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Wu, Chin-Lee] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kaufman, Donald S.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [McDougal, W. Scott] Harvard Univ, Sch Med, Dept Urol, Cambridge, MA 02138 USA; [Harisinghani, Mukesh G.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Wu, Chin-Lee] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Kaufman, DS (corresponding author), Massachusetts Gen Hosp, Div Hematol Oncol, Dept Med, Boston, MA 02114 USA.		Harisinghani, Mukesh/D-7590-2011; Harisinghani, Mukesh/G-1347-2010					[Anonymous], 1997, AJCC CANC STAGING MA; BOOTH CM, 1980, BRIT J UROL, V52, P430, DOI 10.1111/j.1464-410X.1980.tb03083.x; BROOKLAND RK, 1985, J UROLOGY, V133, P952, DOI 10.1016/S0022-5347(17)49328-1; COZAD SC, 1995, UROLOGY, V46, P796, DOI 10.1016/S0090-4295(99)80346-X; Czito B, 2004, J UROLOGY, V172, P1271, DOI 10.1097/01.ju.0000137910.38441.8a; DAS AK, 1990, CANCER, V66, P1919, DOI 10.1002/1097-0142(19901101)66:9<1919::AID-CNCR2820660911>3.0.CO;2-Z; DONAT SM, 1997, UROLOGIC ONCOLOGY, P215; Goel MC, 2003, J UROLOGY, V169, P925, DOI 10.1097/01.ju.0000050242.68745.4d; GRABSTALD H, 1971, J AMER MED ASSOC, V218, P845, DOI 10.1001/jama.218.6.845; Hall MC, 1998, UROLOGY, V52, P594, DOI 10.1016/S0090-4295(98)00295-7; HENEY NM, 1981, J UROLOGY, V125, P632, DOI 10.1016/S0022-5347(17)55143-5; KIRKALI Z, 1989, BRIT J UROL, V64, P18, DOI 10.1111/j.1464-410X.1989.tb05516.x; MILLS C, 1983, J UROLOGY, V129, P275, DOI 10.1016/S0022-5347(17)52046-7; Mostofi FK, 1973, HISTOLOGICAL TYPING; MUFTI GR, 1989, BRIT J UROL, V63, P135, DOI 10.1111/j.1464-410X.1989.tb05149.x; Ozsahin M, 1999, EUR J CANCER, V35, P738, DOI 10.1016/S0959-8049(99)00012-X; REITELMAN C, 1987, J UROLOGY, V138, P1144, DOI 10.1016/S0022-5347(17)43528-2; RUBENSTEIN MA, 1978, J UROLOGY, V119, P594, DOI 10.1016/S0022-5347(17)57560-6; VAHLENSIECK W, 1989, EUR UROL, V16, P286	19	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2009	361	13					1292	1299		10.1056/NEJMcpc0900642	http://dx.doi.org/10.1056/NEJMcpc0900642			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	497RN	19776411				2022-12-28	WOS:000270078700012
J	Granseth, B; Odermatt, B; Royle, SJ; Lagnado, L				Granseth, Bjorn; Odermatt, Benjamin; Royle, Stephen J.; Lagnado, Leon			Comment on "The Dynamic Control of Kiss-and-Run and Vesicular Reuse Probed with Single Nanoparticles"	SCIENCE			English	Editorial Material							HIPPOCAMPAL SYNAPSES; VESICLE RETRIEVAL; ENDOCYTOSIS		[Odermatt, Benjamin; Lagnado, Leon] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Granseth, Bjorn] Linkoping Univ, Div Cell Biol, Dept Clin & Expt Med, SE-58183 Linkoping, Sweden; [Royle, Stephen J.] Univ Liverpool, Sch Biomed Sci, Physiol Lab, Liverpool L69 3BX, Merseyside, England	MRC Laboratory Molecular Biology; Linkoping University; University of Liverpool	Lagnado, L (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	LL1@mrc-lmb.cam.ac.uk	Granseth, Björn/AAG-2142-2020	Granseth, Bjorn/0000-0001-7526-923X; Royle, Stephen/0000-0001-8927-6967	Medical Research Council [MC_U105178794] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [MC_U105178794] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Granseth B, 2008, J PHYSIOL-LONDON, V586, P5969, DOI 10.1113/jphysiol.2008.159715; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Katz B., 1969, RELEASE NEURAL TRANS; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Royle Stephen J., 2008, V457, P293, DOI 10.1007/978-1-59745-261-8_22; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373; Zhu YL, 2009, NEURON, V61, P397, DOI 10.1016/j.neuron.2008.12.024	10	15	16	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947								10.1126/science.1175790	http://dx.doi.org/10.1126/science.1175790			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762627				2022-12-28	WOS:000269887900018
J	Mead, N; Roland, M				Mead, Nicola; Roland, Martin			Understanding why some ethnic minority patients evaluate medical care more negatively than white patients: a cross sectional analysis of a routine patient survey in English general practices	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-CARE; HEALTH-CARE; PATIENTS ASSESSMENTS; UNITED-KINGDOM; MANAGED CARE; RACE/ETHNICITY; SATISFACTION; QUESTIONNAIRE; EXPERIENCES; PROVIDERS	Objective To examine why patients from ethnic minorities give poorer evaluations of primary health care than white patients. Design Cross sectional analysis of patient surveys collected in general practice. Setting 1098 English general practices that undertook a routine survey of patients using the General Practice Assessment Questionnaire between April 2005 and March 2006. Participants 188 572 survey respondents, 95.8% of whom identified themselves as "white," "black/black British," "Asian/Asian British," or "Chinese." Analyses were restricted to between 133 441 (71%) and 147 686 (78%) respondents with complete data on relevant variables. Main outcome measures Patient evaluations of waiting times for general practitioner appointments, time spent waiting in surgeries for consultations to start, and continuity of care. Results All aspects of care were rated substantially lower by respondents from the three ethnic minority groups than by white patients. Poorer evaluations of time spent waiting for consultations to begin (rated lowest by Asian patients) and continuity of care (rated lowest by Chinese patients) appeared to reflect worse reported experiences by ethnic minority groups. Substantial differences between white and ethnic minority patients' ratings of appointment waiting times persisted, however, even after adjusting for the actual time patients reported waiting. This effect disappeared for Chinese and black respondents after adjusting for evaluations of reception staff and doctors' communication skills, but Asian patients' ratings remained considerably lower than those of white respondents. Conclusions Important differences in assessments of care exist in different ethnic minority groups. Some negative evaluations may reflect communication issues. Among Asian patients, lower ratings of waiting times for appointments may also reflect different expectations of care. Adjusting survey results for ethnicity may be justified when comparing healthcare providers; however, health services also have a responsibility to meet legitimate patient expectations.	[Roland, Martin] Univ Cambridge, Gen Practice & Primary Care Res Unit, Cambridge CB2 0SR, England	University of Cambridge	Roland, M (corresponding author), Univ Cambridge, Gen Practice & Primary Care Res Unit, Cambridge CB2 0SR, England.	martin.roland@medschl.cam.ac.uk	Schiaffino, Melody K/E-9629-2011	Roland, Martin/0000-0002-8533-3060	National Primary Care Research and Development Centre; Department of Health; National Institute for Health Research	National Primary Care Research and Development Centre; Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research conducted by the National Primary Care Research and Development Centre and supported by core funding from the Department of Health. NM is funded by the National Institute for Health Research. The views expressed in this publication are those of the authors and not those of the NHS, the National Institute for Health Research, or the Department of Health.	Bhopal R, 2009, J PUBLIC HEALTH-UK, V31, P315, DOI 10.1093/pubmed/fdp069; Bhopal RS, 2002, BRIT MED J, V325, P903; Bower P, 2003, BRIT MED J, V326, P258, DOI 10.1136/bmj.326.7383.258; Campbell JL, 2001, QUAL HEALTH CARE, V10, P90, DOI 10.1136/qhc.10.2.90; Campbell J, 2009, BRIT J GEN PRACT, V59, P18, DOI 10.3399/bjgp09X394815; Chapple A, 2002, SOC SCI MED, V54, P1215, DOI 10.1016/S0277-9536(01)00091-0; Cheraghi-Sohi S, 2008, ANN FAM MED, V6, P107, DOI 10.1370/afm.816; COHEN S, 2007, MCH 20 07 PRIMARY HL; Coyle J, 1999, SOCIOL HEALTH ILL, V21, P95, DOI 10.1111/1467-9566.00144; *DEP HLTH, GP PAT SURV; *DEP HLTH, 2007, GP PAT SURV 2007 NAT; DeVoe JE, 2009, HEALTH EXPECT, V12, P70, DOI 10.1111/j.1369-7625.2008.00516.x; Freeman GK, 2002, BRIT J GEN PRACT, V52, P36; Fung CH, 2005, HEALTH SERV RES, V40, P957, DOI 10.1111/j.1475-6773.2005.00395.x; *GEN PRACT ASS QUE, NAT GPAQ BENCHM BAS; Haviland MG, 2005, AM J MED QUAL, V20, P195, DOI 10.1177/1062860605275754; *HEALTHC COMM, 2004, PAT SURV REP 2004 PR; LAKHANI M, 2008, NO PATIENT LEFT CAN; LINDERPELZ S, 1982, SOC SCI MED, V16, P583, DOI 10.1016/0277-9536(82)90312-4; Mallinson S, 2002, SOC SCI MED, V54, P11, DOI 10.1016/S0277-9536(01)00003-X; McKenzie K, 1996, BRIT MED J, V312, P1054; Mead N, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-13; Mead N, 2008, BRIT J GEN PRACT, V58, P346, DOI 10.3399/bjgp08X280218; Nazroo JY, 2009, J EPIDEMIOL COMMUN H, V63, P1022, DOI 10.1136/jech.2009.089409; *OFF NAT STAT, CENS 2001 MOST COMPR; *OFF NAT STAT, RES GEN HOUS SURV GH; Office for National Statistics, 2003, ETHN GROUP STAT GUID; Rao M, 2006, BMJ-BRIT MED J, V333, P19, DOI 10.1136/bmj.38874.499167.7C; Richards SH, 2003, HEALTH SOC CARE COMM, V11, P510, DOI 10.1046/j.1365-2524.2003.00457.x; Ritter PL, 2001, J CLIN EPIDEMIOL, V54, P136, DOI 10.1016/S0895-4356(00)00261-4; Rodriguez HP, 2008, J GEN INTERN MED, V23, P1666, DOI 10.1007/s11606-008-0732-8; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Schnittker J, 2008, INT J HEALTH SERV, V38, P671, DOI 10.2190/HS.38.4.f; SENIOR PA, 1994, BRIT MED J, V309, P327, DOI 10.1136/bmj.309.6950.327; Taira DA, 2001, HEALTH SERV RES, V36, P1059; Weech-Maldonado R, 2001, HEALTH SERV RES, V36, P575; Weech-Maldonado R, 2003, HEALTH SERV RES, V38, P789, DOI 10.1111/1475-6773.00147; Williams B, 1998, SOC SCI MED, V47, P1351, DOI 10.1016/S0277-9536(98)00213-5	38	103	104	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2009	339								b3450	10.1136/bmj.b3450	http://dx.doi.org/10.1136/bmj.b3450			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	496RU	19762416	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000269994900001
J	Jarvik, JG; Comstock, BA; Kliot, M; Turner, JA; Chan, L; Heagerty, PJ; Hollingworth, W; Kerrigan, CL; Deyo, RA				Jarvik, Jeffrey G.; Comstock, Bryan A.; Kliot, Michel; Turner, Judith A.; Chan, Leighton; Heagerty, Patrick J.; Hollingworth, William; Kerrigan, Carolyn L.; Deyo, Richard A.			Surgery versus non-surgical therapy for carpal tunnel syndrome: a randomised parallel-group trial	LANCET			English	Article							WORKERS COMPENSATION; STEROID INJECTION; CLINICAL-TRIAL; HEALTH; RESPONSIVENESS; QUESTIONNAIRE; POPULATION; ULTRASOUND; SYMPTOMS	Background A previous randomised controlled trial reported greater efficacy of surgery than of splinting for patients with carpal tunnel syndrome. Our aim was to compare surgical versus multi-modality, non-surgical treatment for patients with carpal tunnel syndrome without denervation. We hypothesised that surgery would result in improved functional and symptom outcomes. Methods In this parallel-group randomised controlled trial, we randomly assigned 116 patients from eight academic and private practice centres, using computer-generated random allocation stratified by site, to carpal tunnel surgery (n=57) or to a well-defined, non-surgical treatment (including hand therapy and ultrasound; n=59). The primary outcome was hand function measured by the Carpal Tunnel Syndrome Assessment Questionnaire (CTSAQ) at 12 months assessed by research personnel unaware of group assignment. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00032227. Findings 44 (77%) patients assigned to surgery underwent surgery. At 12 months, 101 (87%) completed follow-up and were analysed (49 of 57 assigned to surgery and 52 of 59 assigned to non-surgical treatment). Analyses showed a significant 12-month adjusted advantage for surgery in function (CTSAQ function score: Delta -0.40, 95% CI 0.11-0.70, p=0.0081) and symptoms (CTSAQ symptom score: 0.34, 0.02-0.65, p=0.0357). There were no clinically important adverse events and no surgical complications. Interpretation Symptoms in both groups improved, but surgical treatment led to better outcome than did non-surgical treatment. However, the clinical relevance of this difference was modest. Overall, our study confirms that surgery is useful for patients with carpal tunnel syndrome without denervation. Funding NIH/NIAMS 5P60AR048093 and the Intramural Research Program of the NIH Clinical Center.	[Jarvik, Jeffrey G.] Univ Washington, Dept Radiol, Harborview Med Ctr, Sch Med, Seattle, WA 98104 USA; [Jarvik, Jeffrey G.; Kliot, Michel] Univ Washington, Dept Neurol Surg, Sch Med, Seattle, WA 98104 USA; [Turner, Judith A.] Univ Washington, Dept Psychiat & Behav Sci, Sch Med, Seattle, WA 98104 USA; [Jarvik, Jeffrey G.] Univ Washington, Dept Hlth Serv, Sch Publ Hlth, Seattle, WA 98104 USA; [Comstock, Bryan A.; Heagerty, Patrick J.] Univ Washington, Dept Biostat, Sch Publ Hlth, Seattle, WA 98104 USA; [Jarvik, Jeffrey G.; Comstock, Bryan A.; Turner, Judith A.; Heagerty, Patrick J.] Univ Washington, Comparat Effectiveness Cost & Outcomes Res Ctr, Seattle, WA 98104 USA; [Kliot, Michel] VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Chan, Leighton] NIH, Intramural Res Program, Ctr Clin, Bethesda, MD 20892 USA; [Kerrigan, Carolyn L.] Dartmouth Hitchcock Med Ctr, Sect Plast Surg, Lebanon, NH 03766 USA; [Hollingworth, William] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Family Med, Portland, OR 97201 USA; [Deyo, Richard A.] Oregon Hlth & Sci Univ, Dept Internal Med, Portland, OR 97201 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Dartmouth College; University of Bristol; Oregon Health & Science University; Oregon Health & Science University	Jarvik, JG (corresponding author), Univ Washington, Dept Radiol, Harborview Med Ctr, Sch Med, Box 359728,325 Ninth Ave, Seattle, WA 98104 USA.	jarviks@comcast.net	Jarvik, Jeffrey/AAL-4292-2021	Hollingworth, William/0000-0002-0840-6254	NIH/NIAMS [SP60AR048093]; Intramural Research Program of the NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR048093] Funding Source: NIH RePORTER; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [G0800800] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G0800800] Funding Source: researchfish	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	NIH/NIAMS SP60AR048093 and the Intramural Research Program of the NIH Clinical Center.	Amadio PC, 1996, J HAND SURG-AM, V21A, P338, DOI 10.1016/S0363-5023(96)80340-6; Amirfeyz R, 2009, INT ORTHOP, V33, P181, DOI 10.1007/s00264-007-0471-1; Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; Bakhtiary AH, 2004, AUST J PHYSIOTHER, V50, P147, DOI 10.1016/S0004-9514(14)60152-5; Bessette L, 1998, MED CARE, V36, P491, DOI 10.1097/00005650-199804000-00005; CHEADLE A, 1994, AM J PUBLIC HEALTH, V84, P190, DOI 10.2105/AJPH.84.2.190; Dennerlein JT, 2002, J OCCUP ENVIRON MED, V44, P176, DOI 10.1097/00043764-200202000-00013; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Ebenbichler GR, 1998, BRIT MED J, V316, P731, DOI 10.1136/bmj.316.7133.731; GARLAND H, 1964, LANCET, V13, P1129; Gerritsen AAM, 2002, JAMA-J AM MED ASSOC, V288, P1245, DOI 10.1001/jama.288.10.1245; Hui ACF, 2005, NEUROLOGY, V64, P2074, DOI 10.1212/01.WNL.0000169017.79374.93; Jarvik JG, 2008, J NEUROSURG, V108, P541, DOI 10.3171/JNS/2008/108/3/0541; Katz JN, 1996, AM J PUBLIC HEALTH, V86, P52, DOI 10.2105/AJPH.86.1.52; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; KATZMAN PL, 1990, J CARDIOVASC PHARM, V15, P360, DOI 10.1097/00005344-199003000-00003; LEVINE DW, 1993, J BONE JOINT SURG AM, V75A, P1585, DOI 10.2106/00004623-199311000-00002; Ly-Pen D, 2005, ARTHRITIS RHEUM-US, V52, P612, DOI 10.1002/art.20767; MacKinnon S., 1988, SURG PERIPHERAL NERV; Martin BI, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-2; MASSEY JT, 1989, VITAL HLTH STATISTIC, V2, P1; MULLER C, 1986, WOMEN HEALTH, V11, P27, DOI 10.1300/J013v11n01_03; *NIH, NIH POL DAT SAF MON; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; OSULLIVAN S, 2007, CLIN NEUROPHYSIOL, V118, pE153; PRYSEPHILLIPS WEM, 1984, J NEUROL NEUROSUR PS, V47, P870, DOI 10.1136/jnnp.47.8.870; SCHOLTEN RJ, 2002, COCHRANE DB SYST REV, V4; Verdugo RJ, 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001552; Verhagen A P, 2007, Eura Medicophys, V43, P391; Ware Jr JE, 2001, SCORE VERSION 2 SF 3; Weinstein JN, 2007, NEW ENGL J MED, V356, P2257, DOI 10.1056/NEJMoa070302	31	108	114	4	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP-OCT	2009	374	9695					1074	1081		10.1016/S0140-6736(09)61517-8	http://dx.doi.org/10.1016/S0140-6736(09)61517-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501HA	19782873				2022-12-28	WOS:000270370900029
J	Koivisto, T; Jaaskelainen, JE				Koivisto, Timo; Jaaskelainen, Juha E.			Chronic subdural haematoma-to drain or not to drain?	LANCET			English	Editorial Material							BURR-HOLE CRANIOSTOMY; MANAGEMENT; SYSTEM		[Koivisto, Timo; Jaaskelainen, Juha E.] Kuopio Univ Hosp, Dept Neurosurg, FIN-70211 Kuopio, Finland	Kuopio University Hospital	Koivisto, T (corresponding author), Kuopio Univ Hosp, Dept Neurosurg, FIN-70211 Kuopio, Finland.	Timo.Koivisto@kuh.fi						Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Cenic A, 2005, CAN J NEUROL SCI, V32, P501, DOI 10.1017/S0317167100004510; Gokmen M, 2008, ZBL NEUROCHIR, V69, P129, DOI 10.1055/s-2007-1004587; Rohde V, 2002, NEUROSURG REV, V25, P89, DOI 10.1007/s101430100182; Santarius T, 2008, BRIT J NEUROSURG, V22, P529, DOI 10.1080/02688690802195381; Santarius T, 2009, LANCET, V374, P1067, DOI 10.1016/S0140-6736(09)61115-6; Torihashi K, 2008, NEUROSURGERY, V63, P1125, DOI 10.1227/01.NEU.0000335782.60059.17; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937; Zumofen D, 2009, NEUROSURGERY, V64, P1116, DOI 10.1227/01.NEU.0000345633.45961.BB	9	8	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP-OCT	2009	374	9695					1040	1041		10.1016/S0140-6736(09)61682-2	http://dx.doi.org/10.1016/S0140-6736(09)61682-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501HA	19782854				2022-12-28	WOS:000270370900005
J	Salahudeen, AA; Thompson, JW; Ruiz, JC; Ma, HW; Kinch, LN; Li, QM; Grishin, NV; Bruick, RK				Salahudeen, Ameen A.; Thompson, Joel W.; Ruiz, Julio C.; Ma, He-Wen; Kinch, Lisa N.; Li, Qiming; Grishin, Nick V.; Bruick, Richard K.			An E3 Ligase Possessing an Iron-Responsive Hemerythrin Domain Is a Regulator of Iron Homeostasis	SCIENCE			English	Article							DEPENDENT DEGRADATION; MOLECULAR CONTROL; BINDING PROTEIN; IRP2; UBIQUITINATION; RNA	Cellular iron homeostasis is maintained by the coordinate posttranscriptional regulation of genes responsible for iron uptake, release, use, and storage through the actions of the iron regulatory proteins IRP1 and IRP2. However, the manner in which iron levels are sensed to affect IRP2 activity is poorly understood. We found that an E3 ubiquitin ligase complex containing the FBXL5 protein targets IRP2 for proteasomal degradation. The stability of FBXL5 itself was regulated, accumulating under iron-and oxygen-replete conditions and degraded upon iron depletion. FBXL5 contains an iron-and oxygen-binding hemerythrin domain that acted as a ligand-dependent regulatory switch mediating FBXL5's differential stability. These observations suggest a mechanistic link between iron sensing via the FBXL5 hemerythrin domain, IRP2 regulation, and cellular responses to maintain mammalian iron homeostasis.	[Salahudeen, Ameen A.; Thompson, Joel W.; Ruiz, Julio C.; Ma, He-Wen; Kinch, Lisa N.; Li, Qiming; Grishin, Nick V.; Bruick, Richard K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Bruick, RK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	richard.bruick@utsouthwestern.edu		Kinch, Lisa/0000-0003-3041-2615; Thompson, Joel/0000-0002-5131-3248; A Salahudeen, Ameen/0000-0001-9037-3481	Burroughs Wellcome Fund; Robert A. Welch Foundation; Texas Advanced Research Program; NIH [CA115962, C06 RR 15437-01]; NATIONAL CANCER INSTITUTE [R01CA115962] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015437] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Robert A. Welch Foundation(The Welch Foundation); Texas Advanced Research Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank R. Eisenstein for IRP1 reagents and helpful discussions; Z. Chen for SCF expression plasmids; W. Gao for K0-GST-Ubiquitin and helpful discussions; M. Brown and J. Goldstein for E2 expression constructs; K. Gardner and F. Correa for assistance with circular dichroism; the UTSW HTS facility for assistance with siRNA screening; and L. Wang, G. Pineda, S. Laxman, X. Du, and J. Wang for helpful discussions. R. K. B. is the Michael L. Rosenberg Scholar in Medical Research and was supported by the Burroughs Wellcome Fund, the Robert A. Welch Foundation, the Texas Advanced Research Program, and NIH grant CA115962. This investigation was conducted in a facility constructed with support from the Research Facilities Improvement Program (grant C06 RR 15437-01) from the NIH National Center for Research Resources.	Beutler E, 2006, ANNU REV MED, V57, P331, DOI 10.1146/annurev.med.57.121304.131310; Bourdon E, 2003, BLOOD CELL MOL DIS, V31, P247, DOI 10.1016/S1079-9796(03)00161-X; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; Fillebeen C, 2003, MOL CELL BIOL, V23, P6973, DOI 10.1128/MCB.23.19.6973-6981.2003; French CE, 2008, FEMS MICROBIOL LETT, V279, P131, DOI 10.1111/j.1574-6968.2007.01011.x; Galan JM, 1999, P NATL ACAD SCI USA, V96, P9124, DOI 10.1073/pnas.96.16.9124; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; KOELLER DM, 1989, P NATL ACAD SCI USA, V86, P3574, DOI 10.1073/pnas.86.10.3574; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Somers DE, 2009, TRENDS PLANT SCI, V14, P206, DOI 10.1016/j.tplants.2009.01.003; STENKAMP RE, 1994, CHEM REV, V94, P715, DOI 10.1021/cr00027a008; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wrighting DM, 2008, CURR TOP DEV BIOL, V82, P141, DOI 10.1016/S0070-2153(07)00006-3; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; ZHANG JH, 1991, BIOCHEMISTRY-US, V30, P583, DOI 10.1021/bi00216a037; Zhang N, 2007, BIOCHEM BIOPH RES CO, V359, P34, DOI 10.1016/j.bbrc.2007.05.068; Zumbrennen KB, 2008, BBA-MOL CELL RES, V1783, P246, DOI 10.1016/j.bbamcr.2007.07.010	26	274	289	3	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					722	726		10.1126/science.1176326	http://dx.doi.org/10.1126/science.1176326			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19762597	Green Accepted, Green Submitted			2022-12-28	WOS:000271233200036
J	Horton, R				Horton, Richard			Canada 2010: what should global health expect?	LANCET			English	Editorial Material							G8 SUMMIT; PEACE		The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Amorim C, 2007, LANCET, V369, P1373, DOI 10.1016/S0140-6736(07)60498-X; Commission on Social Determinants of Health, 2008, CLOS GAP GEN; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Hodgetts OA, 1919, LANCET, V1, P767; Horton R, 2009, LANCET, V374, P1400, DOI 10.1016/S0140-6736(09)61669-X; Jay M, 2009, LANCET, V374, P961, DOI [10.1016/S0140-6736(09)61603-2, 10.1136/bmj.b3669]; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; King M, 2009, LANCET, V374, P76, DOI 10.1016/S0140-6736(09)60827-8; Koumura M, 2007, LANCET, V370, P1983, DOI 10.1016/S0140-6736(07)61726-7; Kurokawa K, 2009, LANCET, V373, P526, DOI 10.1016/S0140-6736(09)60180-X; Lim V, 2009, LANCET, V374, P973, DOI 10.1016/S0140-6736(09)61641-X; MacQueen G, 2001, LANCET, V357, P1460, DOI 10.1016/S0140-6736(00)04668-7; Missoni E, 2009, LANCET, V374, P9, DOI 10.1016/S0140-6736(09)61216-2; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Neufeld V, 2004, LANCET, V364, P311, DOI 10.1016/S0140-6736(04)16738-X; Neufeld V, 2001, CAN MED ASSOC J, V164, P1158; Nixon SA, 2006, CAN J PUBLIC HEALTH, V97, P32, DOI 10.1007/BF03405209; Panter-Brick C, 2009, LANCET, V374, P807, DOI 10.1016/S0140-6736(09)61080-1; Reich MR, 2008, LANCET, V371, P865, DOI 10.1016/S0140-6736(08)60384-0; Reich MR, 2009, LANCET, V373, P508, DOI 10.1016/S0140-6736(08)61899-1; RUGGIERO ED, 2006, CAN J PUBLIC HLTH, V97, P29; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Santa Barbara J, 2004, LANCET, V364, P384; Saul John Ralston, 2008, FAIR COUNTRY; Schrecker T, 2008, LANCET, V372, P1670, DOI 10.1016/S0140-6736(08)61691-8; Takemi K, 2008, LANCET, V372, P13, DOI 10.1016/S0140-6736(08)60971-X	28	2	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2009	374	9697					1215	1216		10.1016/S0140-6736(09)61677-9	http://dx.doi.org/10.1016/S0140-6736(09)61677-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	507KQ	19781759	Bronze, Green Published			2022-12-28	WOS:000270852500004
J	Cutler, DM				Cutler, David M.			Will the Cost Curve Bend, Even without Reform?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Cutler, DM (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.			Cutler, David/0000-0002-4949-8917				Casalino LP, 2009, HEALTH AFFAIR, V28, pW533, DOI 10.1377/hlthaff.28.4.w533; Hendrich Ann, 2008, Perm J, V12, P25; *IMS HLTH, 2009, IMS HLTH LOW 2009 GL	3	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2009	361	15					1424	1425		10.1056/NEJMp0907417	http://dx.doi.org/10.1056/NEJMp0907417			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	503MU	19812398				2022-12-28	WOS:000270540000002
J	Claycomb, JM; Batista, PJ; Pang, KM; Gu, WF; Vasale, JJ; van Wolfswinkel, JC; Chaves, DA; Shirayama, M; Mitani, S; Ketting, RF; Conte, D; Mello, CC				Claycomb, Julie M.; Batista, Pedro J.; Pang, Ka Ming; Gu, Weifeng; Vasale, Jessica J.; van Wolfswinkel, Josien C.; Chaves, Daniel A.; Shirayama, Masaki; Mitani, Shohei; Ketting, Rene F.; Conte, Darryl, Jr.; Mello, Craig C.			The Argonaute CSR-1 and Its 22G-RNA Cofactors Are Required for Holocentric Chromosome Segregation	CELL			English	Article							DIRECTED RNA-POLYMERASE; GERM-LINE DEVELOPMENT; C-ELEGANS; CAENORHABDITIS-ELEGANS; P-GRANULES; CHROMATIN DIMINUTION; KINETOCHORE FUNCTION; GENE-EXPRESSION; INTERFERENCE; CENTROMERE	RNAi-related pathways regulate diverse processes, from developmental timing to transposon silencing. Here, we show that in C. elegans the Argonaute CSR-1, the RNA-dependent RNA polymerase EGO-1, the Dicer-related helicase DRH-3, and the Tudordomain protein EKL-1 localize to chromosomes and are required for proper chromosome segregation. In the absence of these factors chromosomes fail to align at the metaphase plate and kinetochores do not orient to opposing spindle poles. Surprisingly, the CSR-1-interacting small RNAs (22G-RNAs) are antisense to thousands of germline-expressed protein-coding genes. Nematodes assemble holocentric chromosomes in which continuous kinetochores must span the expressed domains of the genome. We show that CSR-1 interacts with chromatin at target loci but does not downregulate target mRNA or protein levels. Instead, our findings support a model in which CSR-1 complexes target protein-coding domains to promote their proper organization within the holocentric chromosomes of C. elegans.	[Claycomb, Julie M.; Batista, Pedro J.; Pang, Ka Ming; Gu, Weifeng; Vasale, Jessica J.; Chaves, Daniel A.; Shirayama, Masaki; Conte, Darryl, Jr.; Mello, Craig C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01606 USA; [Mello, Craig C.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Batista, Pedro J.] Gulbenkian PhD Programme Biomed, P-2780156 Oeiras, Portugal; [Chaves, Daniel A.] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Mitani, Shohei] Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; [Mitani, Shohei] Japan Sci & Technol Agcy, CREST, Tokyo 1628666, Japan; [van Wolfswinkel, Josien C.; Ketting, Rene F.] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [van Wolfswinkel, Josien C.; Ketting, Rene F.] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [van Wolfswinkel, Josien C.] Univ Utrecht, Dept Biomol Mass Spectrometry, NL-3584 CA Utrecht, Netherlands	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Universidade de Lisboa; Tokyo Women's Medical University; Japan Science & Technology Agency (JST); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University	Conte, D (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01606 USA.	darryl.conte@umassmed.edu; craig.mello@umassmed.edu	pang, ka ming/H-4082-2011; Batista, Pedro J/K-5303-2012; pang, Ka Ming Ming/AAW-4059-2021	pang, ka ming/0000-0001-7262-3918; Claycomb, Julie/0000-0003-3132-5206; Ketting, Rene/0000-0001-6161-5621	Fundacao para Ciencia e a Tecnologia, Portugal [SFRH/BD/11803/2003, SFRH/BD/17629/2004/H6BM]; NIGMS [GMO58800]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058800, R37GM058800] Funding Source: NIH RePORTER	Fundacao para Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	M. C. was an HHMI fellow of the LSRF. P.J.B. and D. A. C. were supported by predoctoral fellowships from Fundacao para Ciencia e a Tecnologia, Portugal (SFRH/BD/11803/2003 for P.J.B.; and SFRH/BD/17629/2004/H6BM for D.A.C.). C.C.M. is an HHMI investigator. Thanks to K. Hagstrom, J. Carey, and T. Tabuchi for discussion and reagents. Thanks to M. Hammell for bioinformatics assistance and to M. Stoltz and P. Furcinitti for assistance with confocal microscopy. We thank D. Moazed, M. Papamichos-Chronakis, R. Gassman, and A. Desai for discussion. Thanks to A. Ensminger, H.Y. Tsai, and E. Youngman for critical reading of the manuscript. Thanks to the UMMS C. elegans community, the CGC, E. Kittler, and the UMMS CFAR. This work was made possible by grant GMO58800 from the NIGMS.	ALBERTSON DG, 1982, CHROMOSOMA, V86, P409, DOI 10.1007/BF00292267; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Ambros Victor, 2004, Methods Mol Biol, V265, P131; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Carroll CW, 2006, TRENDS CELL BIOL, V16, P70, DOI 10.1016/j.tcb.2005.12.008; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chu DS, 2006, NATURE, V443, P101, DOI 10.1038/nature05050; Csankovszki G, 2009, CURR BIOL, V19, P9, DOI 10.1016/j.cub.2008.12.006; Dernburg AF, 2001, J CELL BIOL, V153, pF33, DOI 10.1083/jcb.153.6.F33; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; GODAY C, 1992, J CELL BIOL, V118, P23, DOI 10.1083/jcb.118.1.23; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; Maddox PS, 2004, CHROMOSOME RES, V12, P641, DOI 10.1023/B:CHRO.0000036588.42225.2f; Maine EM, 2005, CURR BIOL, V15, P1972, DOI 10.1016/j.cub.2005.09.049; Meneely PM, 2002, GENETICS, V162, P1169; Mito Y, 2003, MOL BIOL CELL, V14, P2399, DOI 10.1091/mbc.E02-09-0603; Moore LL, 2001, J CELL BIOL, V153, P1199, DOI 10.1083/jcb.153.6.1199; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nagaki K, 2005, PLANT CELL, V17, P1886, DOI 10.1105/tpc.105.032961; Nakamura M, 2007, GENES CELLS, V12, P997, DOI 10.1111/j.1365-2443.2007.01111.x; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; PIMPINELLI S, 1989, TRENDS GENET, V5, P310, DOI 10.1016/0168-9525(89)90114-5; Pitt JN, 2000, DEV BIOL, V219, P315, DOI 10.1006/dbio.2000.9607; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Rocheleau CE, 2008, GENETICS, V178, P1431, DOI 10.1534/genetics.107.084608; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Satzinger H, 2008, NAT REV GENET, V9, P231, DOI 10.1038/nrg2311; Schisa JA, 2001, DEVELOPMENT, V128, P1287; She XY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000624; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; van Wolfswinkel JC, 2009, CELL, V139, P135, DOI 10.1016/j.cell.2009.09.012; Vos LJ, 2006, BIOCHEM CELL BIOL, V84, P619, DOI 10.1139/O06-078; Vought VE, 2005, GENETICS, V170, P1121, DOI 10.1534/genetics.105.042135; Welburn JPI, 2008, DEV CELL, V15, P645, DOI 10.1016/j.devcel.2008.10.011; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Yao MC, 2005, ANNU REV GENET, V39, P537, DOI 10.1146/annurev.genet.39.073003.095906; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033	55	290	294	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					123	134		10.1016/j.cell.2009.09.014	http://dx.doi.org/10.1016/j.cell.2009.09.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804758	Green Accepted, Bronze			2022-12-28	WOS:000270388600021
J	Gagnidze, K; Pfaff, DW				Gagnidze, Khatuna; Pfaff, Donald W.			Sex on the Brain	CELL			English	Editorial Material							AROMATASE; HYPOTHALAMUS; ROLES	Release of testosterone during early development is necessary for masculinization of brain structures in rodents. Wu et al. (2009) now elucidate the neuronal changes caused by aromatase-mediated conversion of testosterone into estrogen in perinatal mice and the ensuing effects on adult behavior.	[Pfaff, Donald W.] Rockefeller Univ, Neurobiol & Behav Lab, New York, NY 10021 USA; [Gagnidze, Khatuna] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Rockefeller University; Icahn School of Medicine at Mount Sinai	Pfaff, DW (corresponding author), Rockefeller Univ, Neurobiol & Behav Lab, 1230 York Ave, New York, NY 10021 USA.	pfaff@mail.rockefeller.edu						Byne W, 2001, HORM BEHAV, V40, P86, DOI 10.1006/hbeh.2001.1680; Matsumoto T, 2003, J STEROID BIOCHEM, V86, P357, DOI 10.1016/S0960-0760(03)00345-5; Ogawa S, 1996, NEUROENDOCRINOLOGY, V64, P467, DOI 10.1159/000127154; Ogawa S, 2004, ANN NY ACAD SCI, V1036, P257, DOI 10.1196/annals.1330.016; Roselli CE, 1998, ENDOCRINOLOGY, V139, P3193, DOI 10.1210/en.139.7.3193; Roselli CF, 2007, J STEROID BIOCHEM, V106, P143, DOI 10.1016/j.jsbmb.2007.05.014; Simon NG, 1996, ANN NY ACAD SCI, V794, P8, DOI 10.1111/j.1749-6632.1996.tb32505.x; Swaab DF, 2001, HORM BEHAV, V40, P93, DOI 10.1006/hbeh.2001.1682; [No title captured]	9	7	8	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					19	21		10.1016/j.cell.2009.09.011	http://dx.doi.org/10.1016/j.cell.2009.09.011			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804747	Bronze			2022-12-28	WOS:000270388600009
J	Gray, R; Bonellie, SR; Chalmers, J; Greer, I; Jarvis, S; Kurinczuk, JJ; Williams, C				Gray, Ron; Bonellie, Sandra R.; Chalmers, James; Greer, Ian; Jarvis, Stephen; Kurinczuk, Jennifer J.; Williams, Claire			Contribution of smoking during pregnancy to inequalities in stillbirth and infant death in Scotland 1994-2003: retrospective population based study using hospital maternity records	BRITISH MEDICAL JOURNAL			English	Article							SOCIAL-CLASS; SOCIOECONOMIC-STATUS; PERINATAL-MORTALITY; NEONATAL-MORTALITY; UNITED-STATES; RISK; FETAL; DISPARITIES; COUNTRIES; OUTCOMES	Objective To quantify the contribution of smoking during pregnancy to social inequalities in stillbirth and infant death. Design Population based retrospective cohort study. Setting Scottish hospitals between 1994 and 2003. Participants Records of 529 317 singleton live births and 2699 stillbirths delivered at 24-44 weeks' gestation in Scotland from 1994 to 2003. Main outcome measures Rates of stillbirth and infant, neonatal, and post-neonatal death for each deprivation category (fifths of postcode sector Carstairs-Morris scores); contribution of smoking during pregnancy ("no," "yes," or "not known") in explaining social inequalities in these outcomes. Results The stillbirth rate increased from 3.8 per 1000 in the least deprived group to 5.9 per 1000 in the most deprived group. For infant deaths, the rate increased from 3.2 per 1000 in the least deprived group to 5.4 per 1000 in the most deprived group. Stillbirths were 56% more likely (odds ratio 1.56, 95% confidence interval 1.38 to 1.77) and infant deaths were 72% more likely (1.72, 1.50 to 1.97) in the most deprived compared with the least deprived category. Smoking during pregnancy accounted for 38% of the inequality in stillbirths and 31% of the inequality in infant deaths. Conclusions Both tackling smoking during pregnancy and reducing infants' exposure to tobacco smoke in the postnatal environment may help to reduce stillbirths and infant deaths overall and to reduce the socioeconomic inequalities in stillbirths and infant deaths perhaps by as much as 30-40%. However, action on smoking on its own is unlikely to be sufficient and other measures to improve the social circumstances, social support, and health of mothers and infants are needed.	[Gray, Ron; Kurinczuk, Jennifer J.] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; [Bonellie, Sandra R.; Williams, Claire] Napier Univ, Sch Accountancy Econ & Stat, Edinburgh EH10 5DT, Midlothian, Scotland; [Chalmers, James] NHS Natl Serv Scotland, ISD, Edinburgh EH12 9EB, Midlothian, Scotland; [Greer, Ian] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Jarvis, Stephen] Royal Victoria Infirm, Sir James Spence Inst Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	University of Oxford; Edinburgh Napier University; NHS National Services Scotland; University of Hull; University of York - UK; Newcastle University - UK	Gray, R (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England.	ron.gray@npeu.ox.ac.uk			Chief Scientist Office [CZH/4/293]	Chief Scientist Office	Partly funded by Chief Scientist Office project grant CZH/4/293. The funder had no part in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Bauld L, 2007, TOB CONTROL, V16, P400, DOI 10.1136/tc.2007.021626; Carstairs V., 1991, DEPRIVATION HLTH SCO; CHALMERS I, 1985, BRIT MED J, V291, P231, DOI 10.1136/bmj.291.6490.231; COLE SK, 1980, PERINATAL AUDIT SURV, P39; *DEP HLTH, 2007, REV HLTH IN INF MORT; Department of Health, 2007, IMPL PLAN RED HLTH I; Fairley L, 2006, J EPIDEMIOL COMMUN H, V60, P31, DOI 10.1136/jech.2005.038380; Finch BK, 2003, DEMOGRAPHY, V40, P675, DOI 10.2307/1515203; Fleming P, 2007, EARLY HUM DEV, V83, P721, DOI 10.1016/j.earlhumdev.2007.07.011; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Goy J, 2008, PAEDIATR PERINAT EP, V22, P314, DOI 10.1111/j.1365-3016.2008.00947.x; Gray R, 2008, BJOG-INT J OBSTET GY, V115, P82, DOI 10.1111/j.1471-0528.2007.01582.x; Hogberg L, 2007, BJOG-INT J OBSTET GY, V114, P699, DOI 10.1111/j.1471-0528.2007.01340.x; Jorgensen T, 2008, SCAND J PUBLIC HEALT, V36, P635, DOI 10.1177/1403494808089653; KLEINMAN JC, 1988, AM J EPIDEMIOL, V127, P274, DOI 10.1093/oxfordjournals.aje.a114803; Lu Michael C, 2003, Matern Child Health J, V7, P13, DOI 10.1023/A:1022537516969; Moon RY, 2007, LANCET, V370, P1578, DOI 10.1016/S0140-6736(07)61662-6; Olsen O, 1999, SCAND J PUBLIC HEALT, V27, P128, DOI 10.1177/14034948990270021301; PARSONS L, 1990, BRIT J OBSTET GYNAEC, V97, P237, DOI 10.1111/j.1471-0528.1990.tb01788.x; Pickett KE, 2005, PAEDIATR PERINAT EP, V19, P368, DOI 10.1111/j.1365-3016.2005.00660.x; RUSH D, 1983, J EPIDEMIOL COMMUN H, V37, P249, DOI 10.1136/jech.37.4.249; Salihu HM, 2007, EARLY HUM DEV, V83, P713, DOI 10.1016/j.earlhumdev.2007.08.002; Schneider S, 2008, EUR J CONTRACEP REPR, V13, P138, DOI 10.1080/13625180802027993; Singh GK, 2007, PEDIATRICS, V119, pE928, DOI 10.1542/peds.2005-2181; Singh-Manoux A, 2008, EPIDEMIOLOGY, V19, P599, DOI 10.1097/EDE.0b013e3181761cdc; Steinberg MB, 2008, ANN INTERN MED, V148, P554, DOI 10.7326/0003-4819-148-7-200804010-00012; Stephansson O, 2001, INT J EPIDEMIOL, V30, P1296, DOI 10.1093/ije/30.6.1296	27	51	51	1	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 1	2009	339								b3754	10.1136/bmj.b3754	http://dx.doi.org/10.1136/bmj.b3754			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502LB	19797343	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000270460000003
J	Jara, P; Hierro, L; Martinez-Fernandez, P; Alvarez-Doforno, R; Yanez, F; Diaz, MC; Camarena, C; De la Vega, A; Frauca, E; Munoz-Bartolo, G; Lopez-Santamaria, M; Larrauri, J; Alvarez, L				Jara, Paloma; Hierro, Loreto; Martinez-Fernandez, Pilar; Alvarez-Doforno, Rita; Yanez, Francisca; Diaz, Maria C.; Camarena, Carmen; De la Vega, Angela; Frauca, Esteban; Munoz-Bartolo, Gema; Lopez-Santamaria, Manuel; Larrauri, Javier; Alvarez, Luis			Brief Report: Recurrence of Bile Salt Export Pump Deficiency after Liver Transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; RECEPTOR; HEPATOCYTES; EXPRESSION; TRANSPORT; CHILDREN; SISTER; MICE; IGG	Severe bile salt export pump (BSEP) deficiency is a hereditary cholestatic condition that starts in infancy and leads to end-stage liver disease. Three children who underwent orthotopic liver transplantation for severe BSEP deficiency had post-transplantation episodes of cholestatic dysfunction that mimicked the original disease. Remission of all episodes was achieved by intensifying the immunosuppressive regimen. The phenotypic recurrence of the disease correlated with the presence of circulating high-titer antibodies against BSEP that inhibit transport by BSEP in vitro. When administered to rats, these antibodies targeted the bile canaliculi and impaired bile acid secretion.	[Alvarez, Luis] La Paz Univ Hosp, FIBHULP, Res Unit, Madrid 28046, Spain; [Jara, Paloma; Hierro, Loreto; Diaz, Maria C.; Camarena, Carmen; De la Vega, Angela; Frauca, Esteban; Munoz-Bartolo, Gema] La Paz Univ Hosp, Pediat Liver Serv, Madrid 28046, Spain; [Alvarez-Doforno, Rita; Yanez, Francisca] La Paz Univ Hosp, Serv Immunol, Madrid 28046, Spain; [Larrauri, Javier] La Paz Univ Hosp, Dept Pathol, Madrid 28046, Spain; [Lopez-Santamaria, Manuel] La Paz Univ Hosp, Dept Pediat Surg, Madrid 28046, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz	Alvarez, L (corresponding author), La Paz Univ Hosp, FIBHULP, Res Unit, Paseo La Castellana 261, Madrid 28046, Spain.	luisalvarez.hulp@salud.madrid.org		Hierro, Loreto/0000-0002-6173-4716; Jara Vega, Paloma/0000-0002-4669-7929	Fondo de Investigaciones Sanitarias [05/2373]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	Supported by a grant from the Fondo de Investigaciones Sanitarias (05/2373).	Alissa FT, 2008, J PEDIATR GASTR NUTR, V46, P241, DOI 10.1097/MPG.0b013e3181596060; Alvarez L, 2004, HUM MOL GENET, V13, P2451, DOI 10.1093/hmg/ddh261; Balistreri WF, 1999, SCHIFFS DIS LIVER, P1357; BITTNER RE, 1995, NEW ENGL J MED, V333, P732, DOI 10.1056/NEJM199509143331114; BLUMBERG RS, 1995, J CLIN INVEST, V95, P2397, DOI 10.1172/JCI117934; Bull LN, 1997, HEPATOLOGY, V26, P155; Byrne JA, 2002, GASTROENTEROLOGY, V123, P1649, DOI 10.1053/gast.2002.36591; Kashtan CE, 2006, PEDIATR TRANSPLANT, V10, P651, DOI 10.1111/j.1399-3046.2006.00528.x; Knisely AS, 2006, HEPATOLOGY, V44, P478, DOI 10.1002/hep.21287; Lam P, 2005, BIOCHEMISTRY-US, V44, P12598, DOI 10.1021/bi050943e; Migliazza L, 2000, J PEDIATR SURG, V35, P5, DOI 10.1016/S0022-3468(00)80066-4; Noe J, 2002, GASTROENTEROLOGY, V123, P1659, DOI 10.1053/gast.2002.36587; Stieger B, 2007, PFLUG ARCH EUR J PHY, V453, P611, DOI 10.1007/s00424-006-0152-8; Strautnieks SS, 2008, GASTROENTEROLOGY, V134, P1203, DOI 10.1053/j.gastro.2008.01.038; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; TALALAY PAUL, 1960, METHODS BIOCHEM ANAL, V8, P119; Telleman P, 2000, IMMUNOLOGY, V100, P245, DOI 10.1046/j.1365-2567.2000.00034.x; Thompson R, 2001, SEMIN LIVER DIS, V21, P545, DOI 10.1055/s-2001-19038; Tiao G, 2007, LIVER DISEASE IN CHILDREN, 3RD EDITION, P975, DOI 10.1017/CBO9780511547409.043; Wang RX, 2001, P NATL ACAD SCI USA, V98, P2011, DOI 10.1073/pnas.031465498; WHITINGTON PF, 1994, J PEDIATR GASTR NUTR, V18, P134, DOI 10.1097/00005176-199402000-00003	21	74	75	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2009	361	14					1359	1367		10.1056/NEJMoa0901075	http://dx.doi.org/10.1056/NEJMoa0901075			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500KZ	19797282				2022-12-28	WOS:000270300000010
J	Schep, LJ; Slaughter, RJ; Vale, JA; Beasley, DMG				Schep, Leo J.; Slaughter, Robin J.; Vale, J. Allister; Beasley, D. Michael G.			Case report A seaman with blindness and confusion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ETHYLENE-GLYCOL; METHANOL; FOMEPIZOLE; DIAGNOSIS; ANION; GAPS		[Schep, Leo J.; Slaughter, Robin J.; Beasley, D. Michael G.] Univ Otago, Dept Prevent & Social Med, Natl Poisons Ctr, Dunedin, New Zealand; [Vale, J. Allister] City Hosp, Natl Poisons Informat Serv, Birmingham Unit, Birmingham, W Midlands, England; [Vale, J. Allister] City Hosp, W Midlands Poisons Unit, Birmingham, W Midlands, England	University of Otago; University of Birmingham; University of Birmingham	Schep, LJ (corresponding author), Univ Otago, Dept Prevent & Social Med, Natl Poisons Ctr, Dunedin, New Zealand.	leo.schep@otago.ac.nz	Vale, Allister/AAA-9216-2019	Slaughter, Robin/0000-0003-3705-3491				Barceloux DG, 2002, J TOXICOL-CLIN TOXIC, V40, P415; Brent J, 1999, NEW ENGL J MED, V340, P832, DOI 10.1056/NEJM199903183401102; Brent J, 2001, NEW ENGL J MED, V344, P424, DOI 10.1056/NEJM200102083440605; Brent J, 2009, NEW ENGL J MED, V360, P2216, DOI 10.1056/NEJMct0806112; HOFFMAN RS, 1993, J TOXICOL-CLIN TOXIC, V31, P81, DOI 10.3109/15563659309000375; Hovda KE, 2004, INTENS CARE MED, V30, P1842, DOI 10.1007/s00134-004-2373-7; JACOBSEN D, 1982, ACTA MED SCAND, V212, P5; JACOBSEN D, 1986, MED TOXICOL ADV DRUG, V1, P309, DOI 10.1007/BF03259846; Krautt JA, 2008, CLIN J AM SOC NEPHRO, V3, P208, DOI 10.2215/CJN.03220807; Lepik KJ, 2009, ANN EMERG MED, V53, P439, DOI 10.1016/j.annemergmed.2008.05.008; MCMARTIN KE, 1980, AM J MED, V68, P414, DOI 10.1016/0002-9343(80)90113-8; Paasma R, 2007, CLIN TOXICOL, V45, P152, DOI 10.1080/15563650600956329; Schep LJ, 2009, CLIN TOXICOL, V47, P525, DOI 10.1080/15563650903086444; WINTER S D, 1990, Archives of Internal Medicine, V150, P311, DOI 10.1001/archinte.150.2.311	14	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 30	2009	339								b3929	10.1136/bmj.b3929	http://dx.doi.org/10.1136/bmj.b3929			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502KZ	19793790				2022-12-28	WOS:000270459800001
J	Paik, JC; Howard, G; Lorenz, RG				Paik, Jason C.; Howard, George; Lorenz, Robin G.			Postgraduate Choices of Graduates From Medical Scientist Training Programs, 2004-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Paik, Jason C.] Univ Alabama, Dept Cell Biol, Birmingham, AL USA; [Howard, George] Univ Alabama, Dept Biostat, Birmingham, AL USA; [Lorenz, Robin G.] Univ Alabama, Sch Med, Dept Pathol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Paik, JC (corresponding author), Univ Alabama, Dept Cell Biol, Birmingham, AL USA.	paik@uab.edu	Lorenz, Robin G/AAJ-1499-2021	Lorenz, Robin G/0000-0002-2514-9819; Paik, Jason/0000-0002-9075-4679; Howard, George/0000-0002-3068-5720	NIGMS NIH HHS [T32 GM008361, T32 GM008361-18, T32 GM008361-17, T32 GM008361-16, T32 GM008361-15] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008361] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn J, 2007, ACAD MED, V82, P633, DOI 10.1097/ACM.0b013e318065b907; Andriole DA, 2008, JAMA-J AM MED ASSOC, V300, P1165, DOI 10.1001/jama.300.10.1165; *NAT RES MATCH PRO, RES DAT 2008 MAIN RE; Rosenberg LE, 2008, JAMA-J AM MED ASSOC, V300, P1208, DOI 10.1001/jama.300.10.1208; *U AL BIRM MED SCI, SUPPL DAT POSTGR CHO; Whitcomb ME, 2007, ACAD MED, V82, P623, DOI 10.1097/ACM.0b013e318065b4ba	6	20	20	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1271	1273						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497AR	19773561	Green Accepted			2022-12-28	WOS:000270026000008
J	Aparicio, S; Eaves, CJ				Aparicio, Samuel; Eaves, Connie J.			p53: A New Kingpin in the Stem Cell Arena	CELL			English	Editorial Material							MAMMARY; GENERATION; PATHWAY	Identifying new regulators of the stem cell state offers potential for future gains in biomedicine. Evidence that the tumor suppressor p53 is a key regulator of the stem cell state (Cicalese et al., 2009) suggests a broad role for this protein and its pathways in the control of normal tissue homeostasis and tumor formation.	[Eaves, Connie J.] Univ British Columbia, British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Aparicio, Samuel] Univ British Columbia, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Eaves, Connie J.] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1L3, Canada; [Eaves, Connie J.] Univ British Columbia, Dept Lab Med, Vancouver, BC V5Z 1L3, Canada; [Eaves, Connie J.] Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Eaves, CJ (corresponding author), Univ British Columbia, British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada.	ceaves@bccrc.ca		Eaves, Connie/0000-0002-3452-1926; Aparicio, Samuel/0000-0002-0487-9599				Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285	9	15	15	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 18	2009	138	6					1060	1062		10.1016/j.cell.2009.09.004	http://dx.doi.org/10.1016/j.cell.2009.09.004			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766559	Bronze			2022-12-28	WOS:000269923200006
J	Malik, HS; Henikoff, S				Malik, Harmit S.; Henikoff, Steven			Major Evolutionary Transitions in Centromere Complexity	CELL			English	Review							HISTONE H3 VARIANT; POSITION EFFECT VARIEGATION; FISSION YEAST SCM3; CENP-A CHROMATIN; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; MEIOTIC DRIVE; ROBERTSONIAN TRANSLOCATIONS; TETRAHYMENA-THERMOPHILA; STRUCTURAL DETERMINANTS	Centromeres are chromosomal elements that are both necessary and sufficient for chromosome segregation. However, the puzzlingly broad range in centromere complexity, from simple "point" centromeres to multi-megabase arrays of DNA satellites, has defied explanation. We posit that ancestral centromeres were epigenetically defined and that point centromeres, such as those of budding yeast, have derived from the partitioning elements of selfish plasmids. We further propose that the larger centromere sizes in plants and animals and the rapid evolution of their centromeric proteins is the result of an intense battle for evolutionary dominance due to the asymmetric retention of only one product of female meiosis.	[Malik, Harmit S.; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Malik, Harmit S.; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Malik, HS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.	hsmalik@fhcrc.org	Malik, Harmit S/I-5591-2019; Malik, Harmit S/E-8519-2012	Malik, Harmit S/0000-0001-6005-0016; Henikoff, Steven/0000-0002-7621-8685	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074108] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM074108-05, R01-GM074108, R01 GM074108] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agudo M, 2000, CHROMOSOMA, V109, P190, DOI 10.1007/s004120050427; Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Alonso A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r148; Amor DJ, 2004, TRENDS CELL BIOL, V14, P359, DOI 10.1016/j.tcb.2004.05.009; Amor DJ, 2004, P NATL ACAD SCI USA, V101, P6542, DOI 10.1073/pnas.0308637101; Anderson JA, 2009, GENETICS, V181, P177, DOI 10.1534/genetics.108.093807; Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Baum M, 2006, P NATL ACAD SCI USA, V103, P14877, DOI 10.1073/pnas.0606958103; Bensasson D, 2008, GENETICS, V178, P2161, DOI 10.1534/genetics.107.083980; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Blaisonneau J, 1997, PLASMID, V38, P202, DOI 10.1006/plas.1997.1315; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Bowman GR, 2008, CELL, V134, P945, DOI 10.1016/j.cell.2008.07.015; Brar GA, 2008, NAT REV GENET, V9, P899, DOI 10.1038/nrg2454; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Burt A, 2006, GENES CONFLICT BIOL; Cardone MF, 2007, GENOMICS, V90, P35, DOI 10.1016/j.ygeno.2007.01.007; Carone DM, 2009, CHROMOSOMA, V118, P113, DOI 10.1007/s00412-008-0181-5; Cervantes MD, 2006, MOL BIOL CELL, V17, P485, DOI 10.1091/mbc.E05-07-0698; Chow JC, 2007, P NATL ACAD SCI USA, V104, P10104, DOI 10.1073/pnas.0610946104; Chueh AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000354; CLARKE L, 1980, NATURE, V287, P504, DOI 10.1038/287504a0; Collins KA, 2004, CURR BIOL, V14, P1968, DOI 10.1016/j.cub.2004.10.024; Collins KA, 2007, GENETICS, V175, P513, DOI 10.1534/genetics.106.064410; Colombie N, 2008, DEVELOPMENT, V135, P3239, DOI 10.1242/dev.022624; Cui BW, 2006, MOL CELL BIOL, V26, P4499, DOI 10.1128/MCB.00079-06; Dalai Y, 2007, P NATL ACAD SCI USA, V104, P15974, DOI 10.1073/pnas.0707648104; Dalal Y, 2007, PLOS BIOL, V5, P1798, DOI 10.1371/journal.pbio.0050218; Daniel A, 2002, AM J MED GENET, V111, P450, DOI 10.1002/ajmg.10618; Dawe RK, 2006, TRENDS BIOCHEM SCI, V31, P662, DOI 10.1016/j.tibs.2006.10.004; de Villena FPM, 2001, GENETICS, V159, P1179; de Villena FPM, 2001, HUM GENET, V108, P31, DOI 10.1007/s004390000437; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Eaker S, 2001, J CELL SCI, V114, P2953; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Ebersbach G, 2008, CELL, V134, P956, DOI 10.1016/j.cell.2008.07.016; Espelin CW, 2003, MOL BIOL CELL, V14, P4557, DOI 10.1091/mbc.E02-08-0533; Fishman L, 2008, SCIENCE, V322, P1559, DOI 10.1126/science.1161406; Flemming W., 1882, ZELLSUBSTANZ; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Foltz DR, 2006, NAT CELL BIOL, V8, P458, DOI 10.1038/ncb1397; Furuyama S, 2007, P NATL ACAD SCI USA, V104, P14706, DOI 10.1073/pnas.0706985104; Furuyama T, 2006, P NATL ACAD SCI USA, V103, P6172, DOI 10.1073/pnas.0601686103; Furuyama T, 2009, CELL, V138, P104, DOI 10.1016/j.cell.2009.04.049; FUTCHER AB, 1988, YEAST, V4, P27, DOI 10.1002/yea.320040104; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Ghosh SK, 2007, P NATL ACAD SCI USA, V104, P13034, DOI 10.1073/pnas.0702996104; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hajra S, 2006, J CELL BIOL, V174, P779, DOI 10.1083/jcb.200603042; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hemmerich P, 2008, J CELL BIOL, V180, P1101, DOI 10.1083/jcb.200710052; Henikoff S, 2001, SCIENCE, V293, P1098, DOI 10.1126/science.1062939; Heun P, 2006, DEV CELL, V10, P303, DOI 10.1016/j.devcel.2006.01.014; HEWITT GM, 1976, CHROMOSOMA, V56, P381, DOI 10.1007/BF00292957; Higgins AW, 2005, CHROMOSOME RES, V13, P745, DOI 10.1007/s10577-005-1009-2; Ishii K, 2008, SCIENCE, V321, P1088, DOI 10.1126/science.1158699; Jang JK, 2007, GENETICS, V177, P267, DOI 10.1534/genetics.107.076091; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Joglekar AP, 2008, J CELL BIOL, V181, P587, DOI 10.1083/jcb.200803027; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keith KC, 1999, MOL CELL BIOL, V19, P6130; Ketel C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000400; Lam AL, 2006, P NATL ACAD SCI USA, V103, P4186, DOI 10.1073/pnas.0507947103; Le HD, 2004, CHROMOSOMA, V112, P269, DOI 10.1007/s00412-003-0272-2; Lee HR, 2005, P NATL ACAD SCI USA, V102, P11793, DOI 10.1073/pnas.0503863102; Lermontova I, 2006, PLANT CELL, V18, P2443, DOI 10.1105/tpc.106.043174; Lomiento M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r173; Lundgren M, 2005, CURR OPIN MICROBIOL, V8, P662, DOI 10.1016/j.mib.2005.10.008; Malik HS, 2009, PROG MOL SUBCELL BIO, V48, P33, DOI 10.1007/978-3-642-00182-6_2; Malik HS, 2002, CURR OPIN GENET DEV, V12, P711, DOI 10.1016/S0959-437X(02)00351-9; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Marshall OJ, 2008, AM J HUM GENET, V82, P261, DOI 10.1016/j.ajhg.2007.11.009; Maruyama S, 2007, PLANT J, V49, P1122, DOI 10.1111/j.1365-313X.2006.03024.x; McKee BD, 1998, GENETICS, V149, P143; MEAD DJ, 1986, MOL GEN GENET, V205, P417, DOI 10.1007/BF00338076; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Metcalfe CJ, 2007, GENETICS, V177, P2507, DOI 10.1534/genetics.107.082313; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Moreno-Moreno O, 2006, NUCLEIC ACIDS RES, V34, P6247, DOI 10.1093/nar/gkl902; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Padmanabhan S, 2008, P NATL ACAD SCI USA, V105, P19797, DOI 10.1073/pnas.0809770105; PALMER DK, 1991, P NATL ACAD SCI USA, V88, P3734, DOI 10.1073/pnas.88.9.3734; Pearson CG, 2004, CURR BIOL, V14, P1962, DOI 10.1016/j.cub.2004.09.086; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; PIMPINELLI S, 1989, TRENDS GENET, V5, P310, DOI 10.1016/0168-9525(89)90114-5; Platero JS, 1999, MOL CELL, V4, P995, DOI 10.1016/S1097-2765(00)80228-2; Rudd MK, 2006, GENOME RES, V16, P88, DOI 10.1101/gr.3810906; Sanchez-Pulido L, 2009, CELL, V137, P1173, DOI 10.1016/j.cell.2009.06.010; Sandman K, 2006, CURR OPIN MICROBIOL, V9, P520, DOI 10.1016/j.mib.2006.08.003; Sanyal K, 2004, P NATL ACAD SCI USA, V101, P11374, DOI 10.1073/pnas.0404318101; SAWAMURA K, 1993, MOL GEN GENET, V239, P441, DOI 10.1007/BF00276943; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Scott-Drew S, 2002, CELL BIOL INT, V26, P393, DOI 10.1006/cbir.2002.0867; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Silva NCE, 2007, J MOL BIOL, V370, P555, DOI 10.1016/j.jmb.2007.04.064; STEINER NC, 1994, CELL, V79, P865, DOI 10.1016/0092-8674(94)90075-2; Stoler S, 2007, P NATL ACAD SCI USA, V104, P10571, DOI 10.1073/pnas.0703178104; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Sun XP, 2003, GENOME RES, V13, P182, DOI 10.1101/gr.681703; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Takayama Y, 2008, MOL BIOL CELL, V19, P682, DOI 10.1091/mbc.E07-05-0504; Talbert PB, 2008, KINETOCHORE; Topp CN, 2004, P NATL ACAD SCI USA, V101, P15986, DOI 10.1073/pnas.0407154101; Tyler-Smith C, 1999, AM J HUM GENET, V64, P1440, DOI 10.1086/302380; Van Hooser AA, 2001, J CELL SCI, V114, P3529; Vermaak D, 2002, MOL CELL BIOL, V22, P7553, DOI 10.1128/MCB.22.21.7553-7561.2002; Villasante A, 2007, P NATL ACAD SCI USA, V104, P10542, DOI 10.1073/pnas.0703808104; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; Weber SA, 2004, PLOS BIOL, V2, P1340, DOI 10.1371/journal.pbio.0020260; Wieland G, 2004, MOL CELL BIOL, V24, P6620, DOI 10.1128/mcb.24.15.6620-6630.2004; Wignall SM, 2009, NAT CELL BIOL, V11, P839, DOI 10.1038/ncb1891; WILLARD HF, 1990, TRENDS GENET, V6, P410, DOI 10.1016/0168-9525(90)90302-M; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Yan HH, 2008, PLOS BIOL, V6, P2563, DOI 10.1371/journal.pbio.0060286; Zou JW, 2008, J CELL BIOL, V180, P459, DOI 10.1083/jcb.200711031	124	241	247	4	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 18	2009	138	6					1067	1082		10.1016/j.cell.2009.08.036	http://dx.doi.org/10.1016/j.cell.2009.08.036			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766562	Bronze			2022-12-28	WOS:000269923200009
J	Arenkiel, BR; Ehlers, MD				Arenkiel, Benjamin R.; Ehlers, Michael D.			Molecular genetics and imaging technologies for circuit-based neuroanatomy	NATURE			English	Review							SUPERRESOLUTION FLUORESCENCE MICROSCOPY; OPTICAL RECONSTRUCTION MICROSCOPY; GROUND-STATE-DEPLETION; DENDRITIC SPINES; IN-VIVO; SYNAPTIC-TRANSMISSION; ELECTRON-MICROSCOPY; NEURAL CIRCUITRY; TRANSGENIC MICE; AMPA RECEPTORS	Brain function emerges from the morphologies, spatial organization and patterns of connectivity established between diverse sets of neurons. Historically, the notion that neuronal structure predicts function stemmed from classic histological staining and neuronal tracing methods. Recent advances in molecular genetics and imaging technologies have begun to reveal previously unattainable details about patterns of functional circuit connectivity and the subcellular organization of synapses in the living brain. This sophisticated molecular and genetic 'toolbox', coupled with new methods in optical and electron microscopy, provides an expanding array of techniques for probing neural anatomy and function.	[Arenkiel, Benjamin R.; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Ehlers, Michael D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	ehlers@neuro.duke.edu		Arenkiel, Benjamin/0000-0001-9047-2420	US National Institutes of Health (NIH) [K99]; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS064171] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I. Davison, D. Fitzpatrick, M. Fernandez Suarez, K. Harris, J. Hernandez, M. Kennedy, A. Mabb, R. Mooney, T. Newpher, T. Roberts, C. Robinson, J. Schwartz, R. Weinberg, X. Zhuang and J. Yi for helpful input and comments on the manuscript. We apologize to those whose work we could not cite owing to space limitations. B. R. A. is supported by a K99 award from the US National Institutes of Health (NIH). Work in the lab of M. D. E. is supported by grants from the National Institute of Neurological Disorders and Stroke, the National Institute of Mental Health and the National Institute on Aging of the NIH. M. D. E. is an Investigator of the Howard Hughes Medical Institute.	Ahmed B, 1997, J COMP NEUROL, V380, P230; ANDERSON JC, 1994, J COMP NEUROL, V341, P25, DOI 10.1002/cne.903410104; Arenkiel BR, 2008, NAT METHODS, V5, P299, DOI [10.1038/NMETH.1190, 10.1038/nmeth.1190]; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; BAILEY B, 1993, NATURE, V366, P44, DOI 10.1038/366044a0; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105; Boldogkoi Z, 2009, NAT METHODS, V6, P127, DOI [10.1038/NMETH.1292, 10.1038/nmeth.1292]; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Conklin BR, 2008, NAT METHODS, V5, P673, DOI 10.1038/nmeth.1232; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Drenan RM, 2008, NEURON, V60, P123, DOI 10.1016/j.neuron.2008.09.009; Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Gray NW, 2006, PLOS BIOL, V4, P2065, DOI 10.1371/journal.pbio.0040370; Groc L, 2007, J NEUROSCI, V27, P12433, DOI 10.1523/JNEUROSCI.3349-07.2007; Gustafsson MGL, 1999, J MICROSC-OXFORD, V195, P10, DOI 10.1046/j.1365-2818.1999.00576.x; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; Harris KM, 2006, J NEUROSCI, V26, P12101, DOI 10.1523/JNEUROSCI.3994-06.2006; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; HELL S, 1992, OPT COMMUN, V93, P277, DOI 10.1016/0030-4018(92)90185-T; Hell SW, 2009, NAT METHODS, V6, P24, DOI [10.1038/NMETH.1291, 10.1038/nmeth.1291]; HELL SW, 1995, APPL PHYS B-LASERS O, V60, P495, DOI 10.1007/BF01081333; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Howarth M, 2008, NAT METHODS, V5, P397, DOI 10.1038/NMETH.1206; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Huang B, 2008, NAT METHODS, V5, P1047, DOI 10.1038/nmeth.1274; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Lichtman JW, 2008, CURR OPIN NEUROBIOL, V18, P346, DOI 10.1016/j.conb.2008.08.010; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Lippincott-Schwartz J, 2009, NAT METHODS, V6, P21, DOI [10.1038/NMETH.F.233, 10.1038/nmeth.f.233]; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; MACAGNO ER, 1979, ANNU REV BIOPHYS BIO, V8, P323, DOI 10.1146/annurev.bb.08.060179.001543; Macke JH, 2008, J NEUROSCI METH, V167, P349, DOI 10.1016/j.jneumeth.2007.07.021; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mizrahi A, 2007, NAT NEUROSCI, V10, P444, DOI 10.1038/nn1875; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Nagerl UV, 2008, P NATL ACAD SCI USA, V105, P18982, DOI 10.1073/pnas.0810028105; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; PALAY SL, 1955, J BIOPHYS BIOCHEM CY, V1, P69, DOI 10.1083/jcb.1.1.69; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Petreanu L, 2007, NAT NEUROSCI, V10, P663, DOI 10.1038/nn1891; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; SAKMANN B, 1984, ANNU REV PHYSIOL, V46, P455, DOI 10.1146/annurev.ph.46.030184.002323; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; Soto G E, 1994, Neuroimage, V1, P230, DOI 10.1006/nimg.1994.1008; STEVENS JK, 1980, SCIENCE, V207, P317, DOI 10.1126/science.7350663; Svoboda K, 2006, NEURON, V50, P823, DOI 10.1016/j.neuron.2006.05.019; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Triller A, 2008, NEURON, V59, P359, DOI 10.1016/j.neuron.2008.06.022; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Wulff P, 2007, NAT NEUROSCI, V10, P923, DOI 10.1038/nn1927; Young P, 2008, NAT NEUROSCI, V11, P721, DOI 10.1038/nn.2118; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang Q, 2007, P NATL ACAD SCI USA, V104, P17843, DOI 10.1073/pnas.0706906104; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zhu YL, 2009, NEURON, V61, P397, DOI 10.1016/j.neuron.2008.12.024; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	94	64	72	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					900	907		10.1038/nature08536	http://dx.doi.org/10.1038/nature08536			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829369	Green Accepted			2022-12-28	WOS:000270817700034
J	Wright, SW				Wright, Scott W.			Oh, to Live in an Age When Men Had Breasts ...	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												swright@faegre.com						American Cancer Society, BREAST CANC FACTS FI; Contractor KB, 2008, WORLD J SURG ONCOL, V6, DOI 10.1186/1477-7819-6-58; Giordano SH, 2004, CANCER, V101, P51, DOI 10.1002/cncr.20312	3	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	2009	302	14					1511	1512		10.1001/jama.2009.1402	http://dx.doi.org/10.1001/jama.2009.1402			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505UA	19826013				2022-12-28	WOS:000270721800001
J	Chan, CM; Zhou, C; Huang, RH				Chan, Chio Mui; Zhou, Chun; Huang, Raven H.			Reconstituting Bacterial RNA Repair and Modification in Vitro	SCIENCE			English	Article							PLANT MICRORNA BIOGENESIS; CYTOTOXIC RIBONUCLEASE; METHYLTRANSFERASE; GERMLINE; ENZYME; HEN1		[Chan, Chio Mui; Zhou, Chun; Huang, Raven H.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Huang, Raven H.] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Huang, RH (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	huang@uiuc.edu		zhou, chun/0000-0002-9257-468X	NSF [MCB-0920966]	NSF(National Science Foundation (NSF))	We thank C. Wraight, D. Shapiro, and C. Vanderpool for critical reading of the manuscript; T. Thiel (University of Missouri St. Louis) and C. Hayes (University of California Santa Barbara) for materials; and X. Chen (University of California Riverside) for inspiration. Supported by NSF grant MCB-0920966.	Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Keppetipola N, 2007, NUCLEIC ACIDS RES, V35, P3624, DOI 10.1093/nar/gkm110; Martins A, 2005, RNA, V11, P1271, DOI 10.1261/rna.2690505; Ogawa T, 1999, SCIENCE, V283, P2097, DOI 10.1126/science.283.5410.2097; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Tkaczuk KL, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-6; Tomita K, 2000, P NATL ACAD SCI USA, V97, P8278, DOI 10.1073/pnas.140213797; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130	9	51	52	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					247	247		10.1126/science.1179480	http://dx.doi.org/10.1126/science.1179480			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815768				2022-12-28	WOS:000270599500032
J	Rechel, B; McKee, M				Rechel, Bernd; McKee, Martin			Health reform in central and eastern Europe and the former Soviet Union	LANCET			English	Review							CARE REFORM; INFORMAL PAYMENTS; GENERAL-PRACTICE; SERVICE; PERSPECTIVES; ASSISTANCE; PROFILES; PRIVATE; RUSSIA; ACCESS	In the two decades since the fall of the Berlin Wall, former communist countries in Europe have pursued wide-ranging changes to their health systems. We describe three key aspects of these changes-an almost universal switch to health insurance systems, a growing reliance on out-of-pocket payments (both formal and informal), and efforts to strengthen primary health care, often with a model of family medicine delivered by general practitioners. Many decisions about health policy, such as the introduction of health insurance systems or general practice, took into account political issues more than they did evidence. Evidence for whether health reforms have achieved their intended results is sparse. Of crucial importance is that lessons are learnt from experiences of countries to enable development of health systems that meet present and future health needs of populations.	[Rechel, Bernd; McKee, Martin] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Rechel, Bernd; McKee, Martin] European Observ Hlth Syst & Policies, London, England	University of London; London School of Hygiene & Tropical Medicine; European Observatory on Health Systems & Policies	Rechel, B (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	bernd.rechel@lshtm.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Rechel, Bernd/0000-0001-8020-3956	European Observatory on Health Systems and Policies	European Observatory on Health Systems and Policies	We thank Josep Figueras and Reinhard Busse for their helpful comments on an early draft. Both authors' work on health systems in central and eastern Europe is supported by the European Observatory on Health Systems and Policies.	AHMEDOV M, 2007, UZBEKISTAN HLTH SYST, P1; Ahmedov M, 2007, INT J HEALTH PLAN M, V22, P301, DOI 10.1002/hpm.897; ALBREHT T, 2002, HLTH CARE SYSTEMS TR; Andreev EM, 2003, INT J EPIDEMIOL, V32, P437, DOI 10.1093/ije/dyg085; ATUN R, 2008, MOLDOVA HLTH SYSTEM, P1; ATUN R, 2005, REV EXPERIENCE FAMIL; Atun RA, 2007, HEALTH POLICY PLANN, V22, P28, DOI 10.1093/heapol/czl031; Balabanova D, 2004, HEALTH SERV RES, V39, P1927, DOI 10.1111/j.1475-6773.2004.00326.x; BANOOB SN, 1994, WORLD HEALTH FORUM, V15, P329; Belli Paolo, 2001, 10 YEARS HLTH REFORM; BOERMA W, 2008, PRIMARY CARE QUALITY; Boerma WG, 2006, PRIMARY CARE DRIVERS, P22; Boerma WGW. C, 2006, PRIMARY CARE DRIVERS, P3; Bryndova L, 2009, HLTH SYSTEMS TRANSIT, V11, P1; Cain J., 2002, HLTH CARE SYSTEMS TR; Chawla M., 2007, RED GRAY 3 TRANSITIO; Chen MS, 1998, AM J PUBLIC HEALTH, V88, P1156, DOI 10.2105/AJPH.88.8.1156; Danichevski K, 2008, HEALTH POLICY, V85, P242, DOI 10.1016/j.healthpol.2007.08.001; Delcheva E, 1997, HEALTH POLICY, V42, P89, DOI 10.1016/S0168-8510(97)00061-4; DeLeon P., 1999, POLICY STUDIES REV, V16, P311, DOI DOI 10.1111/J.1541-1338.1999.TB00887.X; Delnoij DM, 2003, EUR J PUBLIC HEALTH, V13, P240, DOI 10.1093/eurpub/13.3.240; Deppe HU, 1996, INT J HEALTH SERV, V26, P777, DOI 10.2190/G36U-BC5G-J71G-PY00; DUBOIS GA, 2004, HLTH POLICY EUROPEAN, P43; Eldar R, 2001, CROAT MED J, V42, P692; Ensor T, 2004, SOC SCI MED, V58, P237, DOI 10.1016/S0277-9536(03)00007-8; Ensor T, 1998, HEALTH POLICY PLANN, V13, P41, DOI 10.1093/heapol/13.1.41; *EUR ROM RIGHTS CT, 2006, AMB NOT WAY DIGR HLT; Falkingham J, 2004, SOC SCI MED, V58, P247, DOI 10.1016/S0277-9536(03)00008-X; Figueras J, 2005, BMJ-BRIT MED J, V331, P170, DOI 10.1136/bmj.331.7510.170; Gaal P, 2005, SOC SCI MED, V60, P1445, DOI 10.1016/j.socscimed.2004.08.009; Gaal Peter, 2004, HLTH CARE SYSTEMS TR; GAMKRELIDZE A, 2002, HLTH CARE SYSTEMS TR; GEORGIEVA L, 2007, BULGARIA HLTH SYSTEM, P1; GJORGJEV D, 2006, FORMER YUGOSLAV REPU, P1; Gotsadze G, 2005, SOC SCI MED, V60, P809, DOI 10.1016/j.socscimed.2004.06.017; Grielen SJ, 2000, HEALTH POLICY, V53, P73, DOI 10.1016/S0168-8510(00)00088-9; Grielen SJ, 2000, EUR J PUBLIC HEALTH, V10, P249, DOI 10.1093/eurpub/10.4.249; HAKOBYAN T, 2006, ARMENIA HLTH SYSTEM, P1; Healy J, 1997, HEALTH POLICY PLANN, V12, P286, DOI 10.1093/heapol/12.4.286; Healy J, 2002, HEALTH POLICY, V61, P1, DOI 10.1016/S0168-8510(01)00213-5; Holley J., 2004, HLTH CARE SYSTEMS TR; JACOBY W, 2004, ENLARGEMENT EUROPEAN; JENNINGS R, 2003, EVIDENCE BASED HLTH, P181; Koppel A, 2003, SOC SCI MED, V56, P2461, DOI 10.1016/S0277-9536(02)00280-0; KOPPEL A, 2008, ESTONIA HLTH SYSTEM, P1; KRINGOS D, 2009, EVALUATION ORG MODEL; KULISH N, 2008, INT HERALD TRIB 0526; KULZHANOV M, 2007, HLTH SYSTEM REV HLTH, P1; Kuszewski K, 2005, HLTH CARE SYSTEMS TR; Lekhan V., 2004, HLTH CARE SYSTEMS TR, V6; Lember M, 2002, INT J HEALTH PLAN M, V17, P41, DOI 10.1002/hpm.651; Lewis M., 2000, WHO IS PAYING HLTH C; Lewis M, 2002, FUNDING HLTH CARE OP, P184; Lin V, 2003, EVIDENCE BASED HLTH, P3; Liseckiene I, 2007, HEALTH POLICY, V83, P105, DOI 10.1016/j.healthpol.2006.11.011; McKee M, 2000, HEALTH POLICY PLANN, V15, P263, DOI 10.1093/heapol/15.3.263; MCKEE M, 2004, DEMOGR RES      0416; McKee M., 2006, HLTH EC DEV S E EURO, P43; Mckee M, 2007, INT J EPIDEMIOL, V36, P269, DOI 10.1093/ije/dym002; McKee Martin, 2002, BMJ, V325, P488; Meimanaliev A-S, 2005, HLTH CARE SYSTEMS TR; MOSSIALOS E, 2002, FUNDING HLTH CARE OP, P1; Nolte E., 2008, CARING PEOPLE CHRONI, P1; Nordyke RJ, 2002, SOC SCI MED, V54, P939, DOI 10.1016/S0277-9536(01)00067-3; Nuri B., 2002, HLTH CARE SYSTEMS TR; Oreskovic S, 1998, Croat Med J, V39, P225; PAVLOKOVA K, 2009, HLTH SYSTEM FINANCIN; Preker A., 2002, FUNDING HLTH CARE OP, P80; Rechel B, 2004, B WORLD HEALTH ORGAN, V82, P539; Rechel B, 2008, BMJ-BRIT MED J, V337, P236; Rechel B., 2009, INVESTING HOSP FUTUR; Rechel B, 2009, HLTH TURKMENISTAN NI; Rechel B., 2010, CAN HLTH SYSTEMS RES; Rechel B, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-24; Rechel B, 2009, EUR J PUBLIC HEALTH, V19, P326, DOI 10.1093/eurpub/ckp027; Rese A, 2005, BMJ-BRIT MED J, V331, P204, DOI 10.1136/bmj.331.7510.204; Rokosova M., 2005, HLTH CARE SYSTEMS TR; Sabbat J, 1997, HEALTH POLICY, V41, P207, DOI 10.1016/S0168-8510(97)00034-1; Saric M, 1993, J Public Health Policy, V14, P220, DOI 10.2307/3342966; Seifert B, 2008, FAM PRACT, V25, P113, DOI 10.1093/fampra/cmn009; SHABAROVA Z, 2001, PRIMARY HLTH CARE NI; Somanathan A., 2019, STRENGTHENING INTEGR; Staines VS, 1999, HLTH SECTOR STRATEGY; Suhrcke M, 2005, B WORLD HEALTH ORGAN, V83, P920; Svab I, 2004, CROAT MED J, V45, P537; Szende A, 2006, HEALTH POLICY, V75, P262, DOI 10.1016/j.healthpol.2005.04.001; Tragakes E, 2003, HLTH CARE SYSTEMS TR; TRAGAKES E, 2008, LATVIA HLTH SYSTEM R, P1; Vladescu C, 2008, ROMANIA HLTH SYSTEM, P1; Vlassov V, 2000, J EPIDEMIOL COMMUN H, V54, P740, DOI 10.1136/jech.54.10.740; VONCINA L, 2006, CROATIA HLTH SYSTEM, P1; Wagstaff A, 2009, J HEALTH ECON, V28, P322, DOI 10.1016/j.jhealeco.2008.10.011; Waters HR, 2008, HEALTH AFFAIR, V27, P478, DOI 10.1377/hlthaff.27.2.478; Watson N, 2004, LANCET, V364, P1745, DOI 10.1016/S0140-6736(04)17419-9; WHO (World Health Organization), 2009, NAT HLTH ACC COUNTR; *WORLD BANK, 2008, WORLD DEV IND ONL DA; World Health Organization, 2009, EUR HLTH ALL DAT	97	147	147	1	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2009	374	9696					1186	1195		10.1016/S0140-6736(09)61334-9	http://dx.doi.org/10.1016/S0140-6736(09)61334-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505IZ	19801097				2022-12-28	WOS:000270688200035
J	Bray, PS; Anderson, KB				Bray, P. Sargent; Anderson, Ken B.			Identification of Carboniferous (320 Million Years Old) Class Ic Amber	SCIENCE			English	Article							NATURAL RESINS; GEOSPHERE; PYROLYSIS; CONIFERS; FATE; COAL	The presence of amber, the fossil form of the resins produced by many types of higher plants, has been reported from many localities in Mesozoic and Cenozoic rocks. We have found Class I (polylabdanoid) amber in Carboniferous sediments dating to similar to 320 million years ago. This result demonstrates that preconifer gymnosperms evolved the biosynthetic mechanisms to produce complex polyterpenoid resins earlier than previously believed and that the biosynthetic pathways leading to the types of polylabdanoid resins that are now typically found in conifers and those now typically found in angiosperms had already diverged by the Carboniferous.	[Bray, P. Sargent; Anderson, Ken B.] So Illinois Univ, Dept Geol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Anderson, KB (corresponding author), So Illinois Univ, Dept Geol, Carbondale, IL 62901 USA.	kanderson@geo.siu.edu						Anderson KB, 1995, ACS SYM SER, V617, P105; Anderson KB, 2006, GEOCHEM T, V7, P1, DOI 10.1186/1467-4866-7-2; ANDERSON KB, 1991, ANAL CHEM, V63, P2901, DOI 10.1021/ac00024a019; Bray PS, 2008, GEOCHEM T, V9, DOI 10.1186/1467-4866-9-3; Crelling JC, 1998, INT J COAL GEOL, V37, P55, DOI 10.1016/S0166-5162(98)00021-4; Jehlicka J, 2004, J RAMAN SPECTROSC, V35, P761, DOI 10.1002/jrs.1191; Langenheim J.H., 2003, PLANT RESINS; MURCHISON DG, 1966, ADV CHEM SER, V55, P307; NIP M, 1992, ENERG FUEL, V6, P125, DOI 10.1021/ef00032a003; Otto A, 2001, BOT REV, V67, P141, DOI 10.1007/BF02858076; POINAR GO, 1993, SCIENCE, V259, P222, DOI 10.1126/science.259.5092.222; Trapp S, 2001, ANNU REV PLANT PHYS, V52, P689, DOI 10.1146/annurev.arplant.52.1.689; vanBergen PF, 1995, ACS SYM SER, V617, P149	13	70	77	4	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					132	134		10.1126/science.1177539	http://dx.doi.org/10.1126/science.1177539			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797659				2022-12-28	WOS:000270355600052
J	Hanson, B				Hanson, Brooks			Light on the Origin of Man INTRODUCTION	SCIENCE			English	Editorial Material																			0	1	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 2	2009	326	5949					60	61						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501CA	19797652				2022-12-28	WOS:000270355600032
J	Comi, G; Martinelli, V; Rodegher, M; Moiola, L; Bajenaru, O; Carra, A; Elovaara, I; Fazekas, F; Hartung, HP; Hillert, J; King, J; Komoly, S; Lubetzki, C; Montalban, X; Myhr, KM; Ravnborg, M; Rieckmann, P; Wynn, D; Young, C; Filippi, M				Comi, G.; Martinelli, V.; Rodegher, M.; Moiola, L.; Bajenaru, O.; Carra, A.; Elovaara, I.; Fazekas, F.; Hartung, H. P.; Hillert, J.; King, J.; Komoly, S.; Lubetzki, C.; Montalban, X.; Myhr, K. M.; Ravnborg, M.; Rieckmann, P.; Wynn, D.; Young, C.; Filippi, M.		PreCISe Study Grp	Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							DIAGNOSTIC-CRITERIA; INTERFERON BETA-1A; AXONAL DAMAGE; MRI; INFLAMMATION; MULTICENTER; DISABILITY; GUIDELINES; RATIONALE; THERAPY	Background Glatiramer acetate, approved for the treatment of relapsing-remitting multiple sclerosis, reduces relapses and disease activity and burden monitored by MRI. We assessed the efficacy of early treatment with glatiramer acetate in delaying onset of clinically definite multiple sclerosis. Methods In this randomised, double-blind trial, undertaken in 80 sites in 16 countries, 481 patients presenting with a clinically isolated syndrome with unifocal manifestation, and two or more T2-weighted brain lesions measuring 6 mm or more, were randomly assigned to receive either subcutaneous glatiramer acetate 20 mg per day (n=243) or placebo (n=238) for up to 36 months, unless they converted to clinically definite multiple sclerosis. The randomisation scheme used SAS-based blocks stratified by Centre, and patients and all personnel were masked to treatment assignment. The primary endpoint was time to clinically definite multiple sclerosis, based on a second clinical attack. Analysis was by intention to treat. A preplanned interim analysis was done for data accumulated from 81% of the 3-year study exposure. This study was registered with ClinicalTrials.gov, number NCT00666224. Findings All randomly assigned participants were analysed for the primary outcome. Glatiramer acetate reduced the risk of developing clinically definite multiple sclerosis by 45% compared with placebo (hazard ratio 0.55, 95% Cl 0.40-0.77; p=0.0005). The time for 25% of patients to convert to clinically definite disease was prolonged by 115%, from 336 days for placebo to 722 days for glatiramer acetate. The most common adverse events in the glatiramer acetate group were injection-site reactions (135 [56%] glatiramer acetate vs 56 [24%] placebo) and immediate post-injection reactions (47 [19%] vs 12 [5%]). Interpretation Early treatment with glatiramer acetate is efficacious in delaying conversion to clinically definite multiple sclerosis in patients presenting with clinically isolated syndrome and brain lesions detected by MRI.	[Comi, G.; Martinelli, V.; Rodegher, M.; Moiola, L.] Univ Vita Salute, San Raffaele Sci Inst, Inst Expt Neurol, Dept Neurol, I-20132 Milan, Italy; [Filippi, M.] Inst Sci, Inst Expt Neurol, Neuroimaging Res Unit, Div Neurosci, Milan, Italy; [Filippi, M.] Univ Hosp San Raffaele, Milan, Italy; [Bajenaru, O.] Univ Med & Pharm Carol Davila Bucharest, Dept Neurol, Univ Hosp Emergency, Bucharest, Romania; [Carra, A.] Hosp Britan Buenos Aires, Buenos Aires, DF, Argentina; [Elovaara, I.] Univ Tampere, Sch Med, Dept Neurol, FIN-33101 Tampere, Finland; [Fazekas, F.] Med Univ Graz, Dept Neurol, Graz, Austria; [Hartung, H. P.] Univ Dusseldorf, Dept Neurol, D-4000 Dusseldorf, Germany; [Hillert, J.] Huddinge Univ Hosp, Dept Neurol, Stockholm, Sweden; [King, J.] Royal Melbourne Hosp, Dept Neurol, Parkville, Vic 3050, Australia; [Komoly, S.] Univ Pecs, Dept Neurol, Pecs, Hungary; [Lubetzki, C.] Hop La Pitie Salpetriere Federat Neurol, Clin Res Ctr, Paris, France; [Myhr, K. M.] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [Montalban, X.] Hosp Gen Univ Vail dHebron, Barcelona, Spain; [Ravnborg, M.] Copenhagen Univ Hosp, Dept Neurol, Copenhagen, Denmark; [Rieckmann, P.] Univ British Columbia, Div Neurol, Vancouver, BC V5Z 1M9, Canada; [Wynn, D.] Dept Neurol, Northbrook, IL USA; [Young, C.] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Carol Davila University of Medicine & Pharmacy; Hospital Britanico de Buenos Aires; Tampere University; Medical University of Graz; Heinrich Heine University Dusseldorf; Karolinska Institutet; Royal Melbourne Hospital; University of Pecs; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Bergen; Haukeland University Hospital; University of Copenhagen; University of British Columbia; Walton Centre	Comi, G (corresponding author), Univ Vita Salute, San Raffaele Sci Inst, Inst Expt Neurol, Dept Neurol, Via Olgettina 48, I-20132 Milan, Italy.	g.comi@hsr.it	Calabrese, Massimiliano/I-6195-2012; Martinelli, Vittorio/AAN-7240-2020; Filippi, Massimo/K-1755-2018; Rocca, Maria Assunta/K-1619-2018; Macedo, Ana/L-9912-2018; Montalban, Xavier/J-5938-2016; Moiola, Lucia/AAN-5568-2020; Bertolotto, Antonio/K-8346-2015; Myhr, Kjell-Morten/H-1528-2018; Agosta, Federica/J-9908-2016	Filippi, Massimo/0000-0002-5485-0479; Rocca, Maria Assunta/0000-0003-2358-4320; Macedo, Ana/0000-0002-6978-8989; Montalban, Xavier/0000-0002-0098-9918; Bertolotto, Antonio/0000-0002-7052-1907; Myhr, Kjell-Morten/0000-0002-0980-510X; , Carolyn/0000-0001-6971-8203; frederiksen, jette/0000-0003-1661-7438; Young, Carolyn/0000-0003-1745-7720; lebrun-frenay, christine/0000-0002-3713-2416; Agosta, Federica/0000-0003-3121-4979; Wiendl, Heinz/0000-0003-4310-3432; moiola, lucia/0000-0001-6313-4952; Gampel, Alexandra/0000-0001-6923-5818	Teva Pharmaceutical industries, Israel	Teva Pharmaceutical industries, Israel	Funding Teva Pharmaceutical industries, Israel.	Barkhof F, 1997, NEUROLOGY, V49, P1682, DOI 10.1212/WNL.49.6.1682; Beck RW, 2002, ANN NEUROL, V51, P481, DOI 10.1002/ana.10148; BORNSTEIN MB, 1987, NEW ENGL J MED, V317, P408, DOI 10.1056/NEJM198708133170703; Comi G, 2006, NEUROL SCI, V27, pS8, DOI 10.1007/s10072-006-0538-6; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64.abs; Comi G, 2008, NAT CLIN PRACT NEURO, V4, P234, DOI 10.1038/ncpneuro0772; De Stefano N, 2001, ARCH NEUROL-CHICAGO, V58, P65, DOI 10.1001/archneur.58.1.65; Filippi M, 1998, NEUROLOGY, V50, P238, DOI 10.1212/WNL.50.1.238; Filippi M, 2004, HUM BRAIN MAPP, V21, P108, DOI 10.1002/hbm.10160; Hohlfeld R, 2000, J NEUROIMMUNOL, V107, P161, DOI 10.1016/S0165-5728(00)00233-2; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Johnson KP, 1998, NEUROLOGY, V50, P701, DOI 10.1212/WNL.50.3.701; Kappos L, 2006, NEUROLOGY, V67, P1242, DOI 10.1212/01.wnl.0000237641.33768.8d; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Mikol DD, 2008, LANCET NEUROL, V7, P903, DOI 10.1016/S1474-4422(08)70200-X; Miller D, 2005, LANCET NEUROL, V4, P341, DOI 10.1016/S1474-4422(05)70095-8; Miller D, 2005, LANCET NEUROL, V4, P281, DOI 10.1016/S1474-4422(05)70071-5; MILLER DH, 1991, J NEUROL NEUROSUR PS, V54, P683, DOI 10.1136/jnnp.54.8.683; *NAT MS SOC US, 2009, DIS MOD DRUGS BROCH; Paolillo A, 2004, J NEUROL, V251, P432, DOI 10.1007/s00415-004-0349-8; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Sormani MP, 2004, NEUROLOGY, V62, P1432, DOI 10.1212/01.WNL.0000120663.85143.B3; Thrower BW, 2007, NEUROLOGY, V68, pS12, DOI 10.1212/01.wnl.0000277704.56189.85; Tintore M, 2008, J NEUROL, V255, P37, DOI 10.1007/s00415-008-1006-4; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502	27	416	428	0	29	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT-NOV	2009	374	9700					1503	1511		10.1016/S0140-6736(09)61259-9	http://dx.doi.org/10.1016/S0140-6736(09)61259-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517CS	19815268				2022-12-28	WOS:000271591300029
J	Stark, JR; Mucci, L; Rothman, KJ; Adami, HO				Stark, Jennifer R.; Mucci, Lorelei; Rothman, Kenneth J.; Adami, Hans-Olov			Screening for prostate cancer remains controversial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SOJOURN TIME; MORTALITY; ANTIGEN; TRENDS; OVERDIAGNOSIS; MEN		[Mucci, Lorelei; Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Mucci, Lorelei] Harvard Univ, Sch Med, Brigham & Womens Hosp, Channing Lab,Dept Med, Boston, MA 02115 USA; [Rothman, Kenneth J.] Res Triangle Inst, RTI Hlth Solut, Res Triangle Pk, NC 27709 USA; [Rothman, Kenneth J.] Boston Univ, Med Ctr, Dept Epidemiol, Boston, MA USA; [Rothman, Kenneth J.] Boston Univ, Med Ctr, Dept Med, Boston, MA USA; [Mucci, Lorelei; Adami, Hans-Olov] Dana Farber Harvard Canc Ctr, Boston, MA USA; [Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Research Triangle Institute; Boston University; Boston University; Harvard University; Dana-Farber Cancer Institute; Karolinska Institutet		stark@hsph.harvard.edu	Rider, Jennifer/T-1272-2019; Rider, Jennifer/A-5371-2011	Rider, Jennifer/0000-0002-2637-6036; Rothman, Kenneth/0000-0003-2398-1705				Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; *AM UR ASS, 2009, EARL DET PROST CANC; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; Collin SM, 2008, LANCET ONCOL, V9, P445, DOI 10.1016/S1470-2045(08)70104-9; DeFrances CJ, 2008, 2006 NATL HOSP DISCH; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Farwell WR, 2007, ARCH INTERN MED, V167, P2497, DOI 10.1001/archinte.167.22.2497; Federman D G, 1999, Eff Clin Pract, V2, P152; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Hussain S, 2008, BJU INT, V101, P547, DOI 10.1111/j.1464-410X.2007.07338.x; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Kvale R, 2007, JNCI-J NATL CANCER I, V99, P1881, DOI 10.1093/jnci/djm249; Lamplugh M, 2006, ANN ROY COLL SURG, V88, P284, DOI 10.1308/003588406X98685; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pashayan N, 2009, BRIT J CANCER, V100, P1198, DOI 10.1038/sj.bjc.6604973; SAKR WA, 1994, IN VIVO, V8, P439; Scales CD, 2008, CANCER-AM CANCER SOC, V113, P1315, DOI 10.1002/cncr.23667; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Shen Y, 2001, J CLIN ONCOL, V19, P3490, DOI 10.1200/JCO.2001.19.15.3490; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209	22	33	34	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2009	339								b3601	10.1136/bmj.b3601	http://dx.doi.org/10.1136/bmj.b3601			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OG	19778971				2022-12-28	WOS:000270231800004
J	Yeh, SW; Kug, JS; Dewitte, B; Kwon, MH; Kirtman, BP; Jin, FF				Yeh, Sang-Wook; Kug, Jong-Seong; Dewitte, Boris; Kwon, Min-Ho; Kirtman, Ben P.; Jin, Fei-Fei			El Nino in a changing climate	NATURE			English	Article							PACIFIC RIM; SENSITIVITY; ANOMALIES; MODOKI	El Nino events, characterized by anomalous warming in the eastern equatorial Pacific Ocean, have global climatic teleconnections and are the most dominant feature of cyclic climate variability on subdecadal timescales. Understanding changes in the frequency or characteristics of El Nino events in a changing climate is therefore of broad scientific and socioeconomic interest. Recent studies(1-5) show that the canonical El Nino has become less frequent and that a different kind of El Nino has become more common during the late twentieth century, in which warm sea surface temperatures (SSTs) in the central Pacific are flanked on the east and west by cooler SSTs. This type of El Nino, termed the central Pacific El Nino (CP-El Nino; also termed the dateline El Nino(2), El Nino Modoki(3) or warm pool El Nino(5)), differs from the canonical eastern Pacific El Nino (EP-El Nino) in both the location of maximum SST anomalies and tropical-midlatitude teleconnections. Here we show changes in the ratio of CP-El Nino to EP-El Nino under projected global warming scenarios from the Coupled Model Intercomparison Project phase 3 multi-model data set(6). Using calculations based on historical El Nino indices, we find that projections of anthropogenic climate change are associated with an increased frequency of the CP-El Nino compared to the EP-El Nino. When restricted to the six climate models with the best representation of the twentieth-century ratio of CP-El Nino to EP-El Nino, the occurrence ratio of CP-El Nino/EP-El Nino is projected to increase as much as five times under global warming. The change is related to a flattening of the thermocline in the equatorial Pacific.	[Yeh, Sang-Wook; Kug, Jong-Seong] Korea Ocean Res & Dev Inst, Climate Change & Coastal Disaster Res Dept, Ansan 426744, South Korea; [Dewitte, Boris] Lab Etud Geophys & Oceanog Spatiale, F-31400 Toulouse, France; [Kwon, Min-Ho; Jin, Fei-Fei] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Meteorol, Honolulu, HI 96822 USA; [Kirtman, Ben P.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	Korea Institute of Ocean Science & Technology (KIOST); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Laboratoire d'Etudes en Geophysique et oceanographie spatiales; University of Hawaii System; University of Miami	Yeh, SW (corresponding author), Korea Ocean Res & Dev Inst, Climate Change & Coastal Disaster Res Dept, Ansan 426744, South Korea.	swyeh@kordi.re.kr	Dewitte, Boris/S-4909-2019; KUG, JONG-SEONG/A-8053-2013; Yeh, Sang-Wook/G-3007-2014; Dewitte, Boris/F-5132-2015	Yeh, Sang-Wook/0000-0003-4549-1686; Dewitte, Boris/0000-0003-3817-8691; KUG, JONG-SEONG/0000-0003-2251-2579	KORDI [PE98401, PP00720]; PCCC project; ANR (Agence Nationale de la Recherche); NSF [ATM 060552, AMT 065145]; NOAA [GC01-229]	KORDI; PCCC project; ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); NSF(National Science Foundation (NSF)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	We acknowledge the international modelling groups for providing their data and PCMDI and the IPCC Data Archive at LLNL/DOE for collecting, archiving and making the data readily available. S.-W. Y. and J.-S. K. are supported by KORDI ( grants PE98401, PP00720). B. D. benefited from funding from the PCCC project ( Peru Chile Climate Change) of the ANR (Agence Nationale de la Recherche). J.- S. K. and F.- F. J. are also supported by NSF grants ATM 060552 and AMT 065145 and NOAA grant GC01-229.	Alexander MA, 2002, J CLIMATE, V15, P2205, DOI 10.1175/1520-0442(2002)015<2205:TABTIO>2.0.CO;2; An SI, 2000, J CLIMATE, V13, P2044, DOI 10.1175/1520-0442(2000)013<2044:ICOTSO>2.0.CO;2; An SI, 2004, J CLIMATE, V17, P2399, DOI 10.1175/1520-0442(2004)017<2399:NAAOE>2.0.CO;2; Ashok K, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003798; Barsugli JJ, 2002, J CLIMATE, V15, P3427, DOI 10.1175/1520-0442(2002)015<3427:GASTTS>2.0.CO;2; Bejarano L, 2008, J CLIMATE, V21, P3051, DOI 10.1175/2007JCLI1679.1; CAYAN DR, 1992, J PHYS OCEANOGR, V22, P859, DOI 10.1175/1520-0485(1992)022<0859:LASHFA>2.0.CO;2; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; EFRON B, 1982, JACKKNIFE BOOTSTRAP, P1; Fedorov AV, 2000, SCIENCE, V288, P1997, DOI 10.1126/science.288.5473.1997; Hoerling MP, 2002, J CLIMATE, V15, P2184, DOI 10.1175/1520-0442(2002)015<2184:ARPAWT>2.0.CO;2; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kao HY, 2009, J CLIMATE, V22, P615, DOI 10.1175/2008JCLI2309.1; Kug JS, 2009, J CLIMATE, V22, P1499, DOI 10.1175/2008JCLI2624.1; Kumar KK, 2006, SCIENCE, V314, P115, DOI 10.1126/science.1131152; Larkin NK, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022860; Latif M, 1997, J CLIMATE, V10, P2221, DOI 10.1175/1520-0442(1997)010<2221:GWDVOE>2.0.CO;2; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; RASMUSSON EM, 1982, MON WEATHER REV, V110, P354, DOI 10.1175/1520-0493(1982)110<0354:VITSST>2.0.CO;2; Smith TM, 2004, J CLIMATE, V17, P2466, DOI 10.1175/1520-0442(2004)017<2466:IEROS>2.0.CO;2; Solomon S., 2007, PHYS SCI BASIS WORKI; TRENBERTH KE, 1987, MON WEATHER REV, V115, P3078, DOI 10.1175/1520-0493(1987)115<3078:OTEOTS>2.0.CO;2; Trenberth KE, 2001, J CLIMATE, V14, P1697, DOI 10.1175/1520-0442(2001)014<1697:LIOENO>2.0.CO;2; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; Wang G, 2007, J CLIMATE, V20, P4211, DOI 10.1175/JCLI4228.1; Weng HY, 2007, CLIM DYNAM, V29, P113, DOI 10.1007/s00382-007-0234-0; Weng HY, 2009, CLIM DYNAM, V32, P663, DOI 10.1007/s00382-008-0394-6; Xie PP, 1997, B AM METEOROL SOC, V78, P2539, DOI 10.1175/1520-0477(1997)078<2539:GPAYMA>2.0.CO;2	28	1118	1196	31	523	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					511	U70		10.1038/nature08316	http://dx.doi.org/10.1038/nature08316			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19779449				2022-12-28	WOS:000270082900037
J	Bing-You, RG; Trowbridge, RL				Bing-You, Robert G.; Trowbridge, Robert L.			Why Medical Educators May Be Failing at Feedback	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERCEPTIONS; ACCURACY; SCHOOL		[Bing-You, Robert G.; Trowbridge, Robert L.] Maine Med Ctr, Dept Med Educ, Portland, ME 04102 USA	Maine Medical Center	Bing-You, RG (corresponding author), Maine Med Ctr, Dept Med Educ, 22 Bramhall St, Portland, ME 04102 USA.	bingyb@mmc.org	Trowbridge, Robert/U-8278-2019	Trowbridge, Robert/0000-0002-0460-2733; Bing-You, Robert/0000-0002-8125-3530				Bahar-Ozvaris S, 2004, TEACH LEARN MED, V16, P368, DOI 10.1207/s15328015tlm1604_11; Baumeister R. F., 1998, HDB SOCIAL PSYCHOL, V1-2, P680; Borges NJ, 2006, ACAD MED, V81, P571, DOI 10.1097/01.ACM.0000225222.38078.47; Branch WT, 2002, ACAD MED, V77, P1185, DOI 10.1097/00001888-200212000-00005; Brett JF, 2001, J APPL PSYCHOL, V86, P930, DOI 10.1037//0021-9010.86.5.930; Davis DA, 2006, JAMA-J AM MED ASSOC, V296, P1094, DOI 10.1001/jama.296.9.1094; De SK, 2004, J AM COLL SURGEONS, V199, P932, DOI 10.1016/j.jamcollsurg.2004.08.025; ENDE J, 1983, JAMA-J AM MED ASSOC, V250, P777, DOI 10.1001/jama.250.6.777; Quirk M., 2006, INTUITION METACOGNIT; Smither JW, 2005, PERS PSYCHOL, V58, P33, DOI 10.1111/j.1744-6570.2005.514_1.x	10	129	130	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1330	1331		10.1001/jama.2009.1393	http://dx.doi.org/10.1001/jama.2009.1393			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	497AR	19773569				2022-12-28	WOS:000270026000016
J	Patterson, DJ				Patterson, David J.			Seeing the Big Picture on Microbe Distribution	SCIENCE			English	Editorial Material							DIVERSITY		Marine Biol Lab, Encyclopedia Life, Woods Hole, MA 02543 USA	Marine Biological Laboratory - Woods Hole	Patterson, DJ (corresponding author), Marine Biol Lab, Encyclopedia Life, Woods Hole, MA 02543 USA.	dpatterson@eol.org		Patterson, David J./0000-0003-2645-7335				Ausubel JH, 2009, P NATL ACAD SCI USA, V106, P12569, DOI 10.1073/pnas.0906757106; Cermeno P, 2009, SCIENCE, V325, P1539, DOI 10.1126/science.1174159; De Rosnay J., 1975, MACROSCOPE VERS VISI; Doolittle F, 2002, ENVIRON MICROBIOL, V4, P10, DOI 10.1046/j.1462-2920.2002.gtfb00257.x; Finlay BJ, 2001, PROTIST, V152, P355, DOI 10.1078/1434-4610-00073; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Hubert C, 2009, SCIENCE, V325, P1541, DOI 10.1126/science.1174012; Lee WJ, 1998, PROTIST, V149, P229, DOI 10.1016/S1434-4610(98)70031-8; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Mayr E, 2004, WHAT MAKES BIOL UNIQ; O'Malley MA, 2007, NAT REV MICROBIOL, V5, P647, DOI 10.1038/nrmicro1711; O'Malley MA, 2008, STUD HIST PHI PART C, V39, P314, DOI 10.1016/j.shpsc.2008.06.005; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103	13	13	15	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1506	1507		10.1126/science.1179690	http://dx.doi.org/10.1126/science.1179690			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762632				2022-12-28	WOS:000269887900025
J	Atroshi, I; Gummesson, C				Atroshi, Isam; Gummesson, Christina			Non-surgical treatment in carpal tunnel syndrome	LANCET			English	Editorial Material							SURGERY; EFFICACY; RELEASE; SPLINT		[Atroshi, Isam] Lund Univ, Dept Clin Sci, Lund, Sweden; [Atroshi, Isam] Hassleholm Hosp, Dept Orthopaed, SE-28125 Hassleholm, Sweden; [Atroshi, Isam] Kristianstad Hosp, Dept Orthopaed, SE-28125 Hassleholm, Sweden; [Gummesson, Christina] Lund Univ, Dept Hlth Sci, Div Physiotherapy, Ctr Teaching & Learning, Lund, Sweden	Lund University; Lund University	Atroshi, I (corresponding author), Lund Univ, Dept Clin Sci, Lund, Sweden.	Isam.Atroshi@skane.se						Atroshi I, 2006, BRIT MED J, V332, P1473, DOI 10.1136/bmj.38863.632789.1F; Atroshi I, 1999, JAMA-J AM MED ASSOC, V282, P153, DOI 10.1001/jama.282.2.153; Atroshi I, 2009, J HAND SURG-AM, V34A, P266, DOI 10.1016/j.jhsa.2008.10.026; Brininger MAJTL, 2007, ARCH PHYS MED REHAB, V88, P1429, DOI 10.1016/j.apnir.2007.07.019; De Angelis MV, 2009, ACTA NEUROL SCAND, V119, P68, DOI 10.1111/j.1600-0404.2008.01072.x; Gelfman R, 2009, NEUROLOGY, V72, P33, DOI 10.1212/01.wnl.0000338533.88960.b9; Gerritsen AAM, 2002, JAMA-J AM MED ASSOC, V288, P1245, DOI 10.1001/jama.288.10.1245; Jarvik JG, 2009, LANCET, V374, P1074, DOI 10.1016/S0140-6736(09)61517-8; Katz JN, 2005, AM J IND MED, V47, P120, DOI 10.1002/ajim.20127; Latinovic R, 2006, J NEUROL NEUROSUR PS, V77, P263, DOI 10.1136/jnnp.2005.066696; Marshall S, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001554.pub2; Piazzini D, 2007, CLIN REHABIL, V21, P299, DOI 10.1177/0269215507077294; Scholten RJ, 2007, COCHRANE DB SYST REV, V4; Stutz N, 2006, J HAND SURG-BRIT EUR, V31B, P68, DOI 10.1016/j.jhsb.2005.09.022; VERDUGO RJ, 2002, COCHRANE DB SYST REV, V3	15	9	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2009	374	9695					1042	1044		10.1016/S0140-6736(09)61683-4	http://dx.doi.org/10.1016/S0140-6736(09)61683-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501HA	19782855				2022-12-28	WOS:000270370900006
J	Chilingarian, I; Cayatte, V; Revaz, Y; Dodonov, S; Durand, D; Durret, F; Micol, A; Slezak, E				Chilingarian, Igor; Cayatte, Veronique; Revaz, Yves; Dodonov, Serguei; Durand, Daniel; Durret, Florence; Micol, Alberto; Slezak, Eric			A Population of Compact Elliptical Galaxies Detected with the Virtual Observatory	SCIENCE			English	Article							DWARF GALAXIES; DARK-MATTER; CLUSTERS; DISCOVERY; OBJECTS; ORIGIN	Compact elliptical galaxies are characterized by small sizes and high stellar densities. They are thought to form through tidal stripping of massive progenitors. However, only a handful of them were known, preventing us from understanding the role played by this mechanism in galaxy evolution. We present a population of 21 compact elliptical galaxies gathered with the Virtual Observatory. Follow-up spectroscopy and data mining, using high-resolution images and large databases, show that all the galaxies exhibit old metal-rich stellar populations different from those of dwarf elliptical galaxies of similar masses but similar to those of more massive early-type galaxies, supporting the tidal stripping scenario. Their internal properties are reproduced by numerical simulations, which result in compact, dynamically hot remnants resembling the galaxies in our sample.	[Chilingarian, Igor] Observ Paris, Lab Etud Rayonnement & Mat Astrophys, UMR 8112, F-75014 Paris, France; [Chilingarian, Igor] Moscow MV Lomonosov State Univ, Sternberg Astron Inst, Moscow 119296, Russia; [Chilingarian, Igor] Observ Paris, VO Paris Data Ctr, F-75014 Paris, France; [Revaz, Yves] Ecole Polytech Fed Lausanne, Astrophys Lab, CH-1290 Sauverny, Switzerland; [Cayatte, Veronique] Observ Paris, Lab Univers & Theories, UMR 8102, F-92195 Meudon, France; [Dodonov, Serguei] Special Astrophys Observ, Nizhnii Arkhyz 369167, Zelenchukskij R, Russia; [Durand, Daniel] Natl Res Council Canada, Herzberg Inst Astrophys, Victoria, BC V9E 2E7, Canada; [Durret, Florence] Inst Astrophys, CNRS, UMR 7095, F-75014 Paris, France; [Durret, Florence] Univ Paris 06, UMR 7095, Inst Astrophys, F-75014 Paris, France; [Micol, Alberto] European So Observ, D-85748 Garching, Germany; [Slezak, Eric] Univ Nice Sophia Antipolis, CNRS, Observ Cote Azur, F-06304 Nice 4, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Lomonosov Moscow State University; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; Russian Academy of Sciences; Special Astrophysics Observatory of the Russian Academy of Sciences; National Research Council Canada; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; European Southern Observatory; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur	Chilingarian, I (corresponding author), Observ Paris, Lab Etud Rayonnement & Mat Astrophys, UMR 8112, 61 Ave Observ, F-75014 Paris, France.	igor.chilingarian@obspm.fr	Dodonov, Serguei/AAO-3472-2021; Chilingarian, Igor/N-5117-2016	Chilingarian, Igor/0000-0002-7924-3253; Micol, Alberto/0000-0001-5594-3354	Science Department of Russia [01-43]; Alfred P. Sloan Foundation; Japanese Monbukagakusho; Max Planck Society; Higher Education Funding Council for England; Swiss National Science Foundation; Russian Foundation for Basic Research [07-02-00229-a]	Science Department of Russia; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Japanese Monbukagakusho(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This study is based on observations made with the NASA/European Space Agency (ESA) Hubble Space Telescope and obtained from the Hubble Legacy Archive, which is a collaboration between the Space Telescope Science Institute ( NASA), the Space Telescope European Coordinating Facility ( ESA), and the Canadian Astronomy Data Centre (National Research Council Canada/Canadian Space Agency); observations collected with the 6-m telescope of the Special Astrophysical Observatory of the Russian Academy of Sciences operated under the financial support of the Science Department of Russia ( registration number 01-43). The simulations were run on the Callisto cluster at the Ecole Polytechnique Federale de Lausanne and on the Regor cluster of the Geneva Observatory. This research made use of SAOImage DS9, developed by Smithsonian Astrophysical Observatory; Aladin, developed by the Centre de Donnees Astronomiques de Strasbourg (CDS), "exploresdss" script by G. Mamon; the VizieR Catalogue access tool ( CDS); and the NASA/IPAC Extragalactic Database (NED) operated by the Jet Propulsion Laboratory, California Institute of Technology, under contract with NASA. Funding for the SDSS and SDSS-II has been provided by the Alfred P. Sloan Foundation, the participating institutions, the National Science Foundation, the U. S. Department of Energy, NASA, the Japanese Monbukagakusho, the Max Planck Society, and the Higher Education Funding Council for England. The SDSS Web site is www.sdss.org. The simulation data analysis and galaxy maps were done using the parallelized Python pNbody package (http://obswww.unige.ch/similar to revaz/pNbody). This work was supported by the Swiss National Science Foundation. I. C. acknowledges additional support from the Russian Foundation for Basic Research, grant 07-02-00229-a. Special thanks to F. Combes and G. Mamon for useful discussions and suggestions and to R. Trilling, who kindly agreed to edit the manuscript. The content of the workflow and its explicit description are available on the Web pages of the VO Paris Data Centre (http://vo-web.obspm.fr) and the European Virtual Observatory EURO-VO.	Abazajian KN, 2009, ASTROPHYS J SUPPL S, V182, P543, DOI 10.1088/0067-0049/182/2/543; Afanasiev VL, 2005, ASTRON LETT+, V31, P194, DOI 10.1134/1.1883351; Bekki K, 2001, ASTROPHYS J, V557, pL39, DOI 10.1086/323075; BENDER R, 1992, ASTROPHYS J, V399, P462, DOI 10.1086/171940; Bertin E, 1996, ASTRON ASTROPHYS SUP, V117, P393, DOI 10.1051/aas:1996164; Chilingarian I, 2007, ASTRON ASTROPHYS, V466, pL21, DOI 10.1051/0004-6361:20077291; Chilingarian I., 2007, P IAU S, V241, P175, DOI DOI 10.1017/S1743921307007752; Chilingarian IV, 2008, ASTRON ASTROPHYS, V486, P85, DOI 10.1051/0004-6361:20078709; Chilingarian IV, 2008, MON NOT R ASTRON SOC, V390, P906, DOI 10.1111/j.1365-2966.2008.13845.x; Chilingarian IV, 2008, MON NOT R ASTRON SOC, V385, pL83, DOI 10.1111/j.1745-3933.2008.00438.x; Chilingarian IV, 2009, MON NOT R ASTRON SOC, V394, P1229, DOI [10.1111/J.1365-2966.2009.14450.X, 10.1111/j.1365-2966.2009.14450.x]; Drinkwater MJ, 2003, NATURE, V423, P519, DOI 10.1038/nature01666; Emsellem E, 2008, ASTROPHYS J, V674, P653, DOI 10.1086/524720; FABER SM, 1976, ASTROPHYS J, V204, P668, DOI 10.1086/154215; FERGUSON HC, 1994, ASTRON ASTROPHYS REV, V6, P67, DOI 10.1007/BF01208252; Gallazzi A, 2005, MON NOT R ASTRON SOC, V362, P41, DOI 10.1111/j.1365-2966.2005.09321.x; Goto T, 2003, PUBL ASTRON SOC JPN, V55, P771, DOI 10.1093/pasj/55.4.771; Graham AW, 2002, ASTROPHYS J, V568, pL13, DOI 10.1086/340274; Mieske S, 2005, ASTRON ASTROPHYS, V430, pL25, DOI 10.1051/0004-6361:200400119; Mieske S, 2002, ASTRON ASTROPHYS, V383, P823, DOI 10.1051/0004-6361:20011833; Moore B, 1996, NATURE, V379, P613, DOI 10.1038/379613a0; Price J, 2009, MON NOT R ASTRON SOC, V397, P1816, DOI 10.1111/j.1365-2966.2009.15122.x; Renzini A, 2006, ANNU REV ASTRON ASTR, V44, P141, DOI 10.1146/annurev.astro.44.051905.092450; Springel V, 2005, MON NOT R ASTRON SOC, V364, P1105, DOI 10.1111/j.1365-2966.2005.09655.x	27	78	78	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1379	1382		10.1126/science.1175930	http://dx.doi.org/10.1126/science.1175930			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19797624	Green Submitted			2022-12-28	WOS:000272351100035
J	Lister, R; Pelizzola, M; Dowen, RH; Hawkins, RD; Hon, G; Tonti-Filippini, J; Nery, JR; Lee, L; Ye, Z; Ngo, QM; Edsall, L; Antosiewicz-Bourget, J; Stewart, R; Ruotti, V; Millar, AH; Thomson, JA; Ren, B; Ecker, JR				Lister, Ryan; Pelizzola, Mattia; Dowen, Robert H.; Hawkins, R. David; Hon, Gary; Tonti-Filippini, Julian; Nery, Joseph R.; Lee, Leonard; Ye, Zhen; Ngo, Que-Minh; Edsall, Lee; Antosiewicz-Bourget, Jessica; Stewart, Ron; Ruotti, Victor; Millar, A. Harvey; Thomson, James A.; Ren, Bing; Ecker, Joseph R.			Human DNA methylomes at base resolution show widespread epigenomic differences	NATURE			English	Article							EMBRYONIC STEM-CELLS; MAMMALIAN DEVELOPMENT; ENZYMATIC-PROPERTIES; HISTONE METHYLATION; CPG METHYLATION; HUMAN GENOME; GENE; METHYLTRANSFERASES; BINDING; DNMT3A	DNA cytosine methylation is a central epigenetic modification that has essential roles in cellular processes including genome regulation, development and disease. Here we present the first genome-wide, single-base-resolution maps of methylated cytosines in a mammalian genome, from both human embryonic stem cells and fetal fibroblasts, along with comparative analysis of messenger RNA and small RNA components of the transcriptome, several histone modifications, and sites of DNA-protein interaction for several key regulatory factors. Widespread differences were identified in the composition and patterning of cytosine methylation between the two genomes. Nearly one-quarter of all methylation identified in embryonic stem cells was in a non-CG context, suggesting that embryonic stem cells may use different methylation mechanisms to affect gene regulation. Methylation in non-CG contexts showed enrichment in gene bodies and depletion in protein binding sites and enhancers. Non-CG methylation disappeared upon induced differentiation of the embryonic stem cells, and was restored in induced pluripotent stem cells. We identified hundreds of differentially methylated regions proximal to genes involved in pluripotency and differentiation, and widespread reduced methylation levels in fibroblasts associated with lower transcriptional activity. These reference epigenomes provide a foundation for future studies exploring this key epigenetic modification in human disease and development.	[Lister, Ryan; Pelizzola, Mattia; Dowen, Robert H.; Nery, Joseph R.; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Hawkins, R. David; Hon, Gary; Lee, Leonard; Ye, Zhen; Ngo, Que-Minh; Edsall, Lee; Ren, Bing] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Tonti-Filippini, Julian; Millar, A. Harvey] Univ Western Australia, ARC Ctr Excellence Plant Energy Biol, Crawley, WA 6009, Australia; [Antosiewicz-Bourget, Jessica; Stewart, Ron; Ruotti, Victor; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Antosiewicz-Bourget, Jessica; Stewart, Ron; Ruotti, Victor; Thomson, James A.] Genome Ctr Wisconsin, Madison, WI 53706 USA; [Thomson, James A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Thomson, James A.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	Salk Institute; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Western Australia; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ecker, JR (corresponding author), Salk Inst Biol Studies, Genom Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ecker@salk.edu	Millar, A. Harvey/A-5452-2008; Nery, Joseph/AAE-8422-2019; Ecker, Joseph R/B-9144-2008; Tonti-Filippini, Julian S/L-8020-2018; Hu, Ruogu/B-2203-2008; Lister, Ryan/B-5168-2012	Millar, A. Harvey/0000-0001-9679-1473; Nery, Joseph/0000-0003-0153-5659; Ecker, Joseph R/0000-0001-5799-5895; Tonti-Filippini, Julian S/0000-0003-3464-0770; Lister, Ryan/0000-0001-6637-7239; Pelizzola, Mattia/0000-0001-6672-9636; Edsall, Lee Elizabeth/0000-0002-0326-2829	Mary K. Chapman Foundation; National Institutes of Health [U01 ES017166, U01 1U01ES017166-01]; Australian Research Council [CE0561495, DP0771156]; Morgridge Institute for Research, Madison, Wisconsin; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	Mary K. Chapman Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); Morgridge Institute for Research, Madison, Wisconsin; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank A. Elwell and A. Hernandez for assistance with sequence library preparation and Illumina sequencing. R. L. is supported by a Human Frontier Science Program Long-term Fellowship. R. D. H. is supported by an American Cancer Society Postdoctoral Fellowship. This work was supported by grants from the following: Mary K. Chapman Foundation, The National Institutes of Health (U01 ES017166 and U01 1U01ES017166-01), the California Institute for Regenerative Medicine (RS1-00292-1), the Australian Research Council Centre of Excellence Program (CE0561495, DP0771156) and Morgridge Institute for Research, Madison, Wisconsin. We thank the NIH Roadmap Reference Epigenome Consortium (http://nihroadmap.nih.gov/epigenomics/referenceepigenomeconsortium.asp) and C. Gunter (Hudson-Alpha Institute) for assistance. This study was carried out as part of the NIH Roadmap Epigenomics Program.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Aoki A, 2001, NUCLEIC ACIDS RES, V29, P3506, DOI 10.1093/nar/29.17.3506; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chan SWL, 2008, TRENDS PLANT SCI, V13, P383, DOI 10.1016/j.tplants.2008.05.001; Clark SJ, 1997, GENE, V195, P67, DOI 10.1016/S0378-1119(97)00164-9; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Ferguson-Smith AC, 2007, NATURE, V449, P148, DOI 10.1038/449148a; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Gowher H, 2001, J MOL BIOL, V309, P1201, DOI 10.1006/jmbi.2001.4710; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kitazawa S, 1999, J BIOL CHEM, V274, P28787, DOI 10.1074/jbc.274.40.28787; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Mancini DN, 1999, ONCOGENE, V18, P4108, DOI 10.1038/sj.onc.1202764; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; NICHOLS WW, 1977, SCIENCE, V196, P60, DOI 10.1126/science.841339; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Steinert S, 2004, MOL CELL BIOL, V24, P4571, DOI 10.1128/MCB.24.10.4571-4580.2004; Straussman R, 2009, NAT STRUCT MOL BIOL, V16, P564, DOI 10.1038/nsmb.1594; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Villesen Palle, 2004, Retrovirology, V1, P32, DOI 10.1186/1742-4690-1-32; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; WOODCOCK DM, 1987, BIOCHEM BIOPH RES CO, V145, P888, DOI 10.1016/0006-291X(87)91048-5	46	3070	3192	11	526	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					315	322		10.1038/nature08514	http://dx.doi.org/10.1038/nature08514			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19829295	Green Submitted, Green Accepted			2022-12-28	WOS:000271899300037
J	Stinchcombe, TE; West, HL				Stinchcombe, Thomas E.; West, Howard L.			Maintenance therapy in non-small-cell lung cancer	LANCET			English	Editorial Material							PHASE-III TRIAL; DOCETAXEL; CHEMOTHERAPY		[Stinchcombe, Thomas E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [West, Howard L.] Swedish Canc Inst, Seattle, WA USA	University of North Carolina; University of North Carolina Chapel Hill; Swedish Cancer Institute; Swedish Medical Center	Stinchcombe, TE (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	Thomas_Stinchcombe@med.unc.edu						[Anonymous], 2008, CHMPEWP185042006 EMA; Cappuzzo F, 2009, 13 WORLD C LUNG CANC; Ciuleanu T, 2009, LANCET, V374, P1432, DOI 10.1016/S0140-6736(09)61497-5; D'Addario G, 2009, ANN ONCOL, V20, P68, DOI 10.1093/annonc/mdp132; European Medicines Agency, 2009, COMM MED PROD HUM US; Fidias PM, 2009, J CLIN ONCOL, V27, P591, DOI 10.1200/JCO.2008.17.1405; Fossella FV, 2000, J CLIN ONCOL, V18, P2354, DOI 10.1200/JCO.2000.18.12.2354; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095, DOI 10.1200/JCO.2000.18.10.2095; *US FDA, 2008, AL INJ; *US FDA, 2009, FDA APPR 1 MAINT DRU	14	12	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 24	2009	374	9699					1398	1400		10.1016/S0140-6736(09)61598-1	http://dx.doi.org/10.1016/S0140-6736(09)61598-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MZ	19767096				2022-12-28	WOS:000271255000006
J	Rothschild, JM; Keohane, CA; Rogers, S; Gardner, R; Lipsitz, SR; Salzberg, CA; Yu, T; Yoon, CS; Williams, DH; Wien, MF; Czeisler, CA; Bates, DW; Landrigan, CP				Rothschild, Jeffrey M.; Keohane, Carol A.; Rogers, Selwyn; Gardner, Roxane; Lipsitz, Stuart R.; Salzberg, Claudia A.; Yu, Tony; Yoon, Catherine S.; Williams, Deborah H.; Wien, Matt F.; Czeisler, Charles A.; Bates, David W.; Landrigan, Christopher P.			Risks of Complications by Attending Physicians After Performing Nighttime Procedures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PATIENT SAFETY; WORK HOURS; CARE; IMPACT; RESIDENTS; EDUCATION; SURGEONS; QUALITY; EVENTS; ERRORS	Context Few data exist on the relationships between experienced physicians' work hours and sleep, and patient safety. Objective To determine if sleep opportunities for attending surgeons and obstetricians/gynecologists are associated with the risk of complications. Design, Setting, and Patients Matched retrospective cohort study of procedures performed from January 1999 through June 2008 by attending physicians (86 surgeons and 134 obstetricians/gynecologists) who had been in the hospital performing another procedure involving adult patients for at least part of the preceding night (12 AM-6 AM, postnighttime procedures). Sleep opportunity was calculated as the time between end of the overnight procedure and start of the first procedure the following day. Matched control procedures included as many as 5 procedures of the same type performed by the same physician on days without preceding overnight procedures. Complications were identified and classified by a blinded 3-step process that included administrative screening, medical record reviews, and clinician ratings. Main Outcome Measures Rates of complications in postnighttime procedures as compared with controls; rates of complications in postnighttime procedures among physicians with more than 6-hour sleep opportunities vs those with sleep opportunities of 6 hours or less. Results A total of 919 surgical and 957 obstetrical postnighttime procedures were matched with 3552 and 3945 control procedures, respectively. Complications occurred in 101 postnighttime procedures (5.4%) and 365 control procedures (4.9%) (odds ratio, 1.09; 95% confidence interval [CI], 0.84-1.41). Complications occurred in 82 of 1317 postnighttime procedures with sleep opportunities of 6 hours or less (6.2%) vs 19 of 559 postnighttime procedures with sleep opportunities of more than 6 hours (3.4%) (odds ratio, 1.72; 95% CI, 1.02-2.89). Postnighttime procedures completed after working more than than 12 hours (n=958) compared with 12 hours or less (n=918) had nonsignificantly higher complication rates (6.5% vs 4.3%; odds ratio, 1.47; 95% CI, 0.96-2.27). Conclusion Overall, procedures performed the day after attending physicians worked overnight were not associated with significantly increased complication rates, although there was an increased rate of complications among postnighttime surgical procedures performed by physicians with sleep opportunities of less than 6 hours. JAMA. 2009; 302(14): 1565-1572	[Rothschild, Jeffrey M.; Keohane, Carol A.; Lipsitz, Stuart R.; Salzberg, Claudia A.; Yu, Tony; Yoon, Catherine S.; Williams, Deborah H.; Wien, Matt F.; Bates, David W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gen Med & Primary Care, Boston, MA 02115 USA; [Czeisler, Charles A.; Landrigan, Christopher P.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Sleep Med, Boston, MA 02115 USA; [Rogers, Selwyn] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA; [Gardner, Roxane] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Obstet & Gynecol, Boston, MA 02115 USA; [Lipsitz, Stuart R.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Landrigan, Christopher P.] Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital	Rothschild, JM (corresponding author), Brigham & Womens Hosp, Div Gen Med, 1620 Tremont St, Boston, MA 02120 USA.	jrothschild@partners.org	Bates, David/AAE-7283-2019	Landrigan, Christopher/0000-0001-8386-4100	Rx Foundation, Cambridge, Massachusetts	Rx Foundation, Cambridge, Massachusetts	This study was supported by a grant from the Rx Foundation, Cambridge, Massachusetts.	Agency for Healthcare Research and Quality, 2003, AHRQ QUAL IND GUID P; American College of Obstetricians and Gynecologists, 2006, Obstet Gynecol, V107, P429; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Buchler P, 2003, SURGERY, V134, P3, DOI 10.1067/msy.2003.161; Dijk DJ, 2000, CHRONOBIOL INT, V17, P285, DOI 10.1081/CBI-100101049; Ellman PI, 2004, ANN THORAC SURG, V78, P906, DOI 10.1016/j.athoracsur.2004.04.006; Fletcher KE, 2004, ANN INTERN MED, V141, P851, DOI 10.7326/0003-4819-141-11-200412070-00009; Forster AJ, 2006, OBSTET GYNECOL, V108, P1073, DOI 10.1097/01.AOG.0000242565.28432.7c; Gaba DM, 2002, NEW ENGL J MED, V347, P1249, DOI 10.1056/NEJMsa020846; Gawande AA, 2003, SURGERY, V133, P614, DOI 10.1067/msy.2003.169; Hutter MM, 2006, ANN SURG, V243, P864, DOI 10.1097/01.sla.0000220042.48310.66; Hyman NH, 2009, ARCH SURG-CHICAGO, V144, P7, DOI 10.1001/archsurg.2008.518; *I MED COMM OPT GA, 2008, RES DUT HOURS ENH SL; IEZZONI LI, 1994, MED CARE, V32, P700, DOI 10.1097/00005650-199407000-00004; Karson AS, 1999, J EVAL CLIN PRACT, V5, P23, DOI 10.1046/j.1365-2753.1999.00158.x; Landrigan CP, 2007, JT COMM J QUAL PATIE, V33, P19, DOI 10.1016/S1553-7250(07)33110-3; Landrigan CP, 2006, JAMA-J AM MED ASSOC, V296, P1063, DOI 10.1001/jama.296.9.1063; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lydon-Rochelle M, 2000, JAMA-J AM MED ASSOC, V283, P2411, DOI 10.1001/jama.283.18.2411; Maa J, 2007, J AM COLL SURGEONS, V205, P704, DOI 10.1016/j.jamcollsurg.2007.05.008; Makary MA, 2006, ANN SURG, V243, P628, DOI 10.1097/01.sla.0000216410.74062.0f; Mann S, 2006, JT COMM J QUAL PATIE, V32, P497, DOI 10.1016/S1553-7250(06)32065-X; Pape HC, 2009, PATIENT SAF SURG, V3, DOI 10.1186/1754-9493-3-3; Rogers AE, 2004, HEALTH AFFAIR, V23, P202, DOI 10.1377/hlthaff.23.4.202; Romano PS, 2005, OBSTET GYNECOL, V106, P717, DOI 10.1097/01.AOG.0000179552.36108.6d; Sachs BP, 2005, JAMA-J AM MED ASSOC, V294, P833, DOI 10.1001/jama.294.7.833; Vincent C, 2004, ANN SURG, V239, P475, DOI 10.1097/01.sla.0000118753.22830.41; Weinstein L, 2003, AM J OBSTET GYNECOL, V188, P310, DOI 10.1067/mob.2003.133; Weissman JS, 2007, MED CARE, V45, P448, DOI 10.1097/01.mlr.0000257231.86368.09; WOFLINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI DOI 10.1080/00949659308811554	33	169	172	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	2009	302	14					1565	1572		10.1001/jama.2009.1423	http://dx.doi.org/10.1001/jama.2009.1423			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505UA	19826026	Bronze			2022-12-28	WOS:000270721800025
J	McLellan, AT				McLellan, A. Thomas			Public accountability in addiction treatment	LANCET			English	Editorial Material							OUTCOMES		White House Off Natl Drug Control Policy, Washington, DC 20503 USA		McLellan, AT (corresponding author), White House Off Natl Drug Control Policy, Washington, DC 20503 USA.	Andrew_T._McLellan@ondcp.eop.gov						Marsden J, 2008, ADDICTION, V103, P1450, DOI 10.1111/j.1360-0443.2008.02284.x; Marsden J, 2009, LANCET, V374, P1262, DOI 10.1016/S0140-6736(09)61420-3; McLellan AT, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2038; McLellan AT, 2005, ADDICTION, V100, P447, DOI 10.1111/j.1360-0443.2005.01012.x; Uhl GR, 2002, TRENDS GENET, V18, P420, DOI 10.1016/S0168-9525(02)02719-1	5	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 10	2009	374	9697					1220	1221		10.1016/S0140-6736(09)61764-5	http://dx.doi.org/10.1016/S0140-6736(09)61764-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	507KQ	19819374				2022-12-28	WOS:000270852500007
J	Coulibaly, YI; Dembele, B; Diallo, AA; Lipner, EM; Doumbia, SS; Coulibaly, SY; Konate, S; Diallo, DA; Yalcouye, D; Kubofcik, J; Doumbo, OK; Traore, AK; Keita, AD; Fay, MP; Traore, SF; Nutman, TB; Klion, AD				Coulibaly, Yaya I.; Dembele, Benoit; Diallo, Abdallah A.; Lipner, Ettie M.; Doumbia, Salif S.; Coulibaly, Siaka Y.; Konate, Siaka; Diallo, Dapa A.; Yalcouye, Daniel; Kubofcik, Joseph; Doumbo, Ogobara K.; Traore, Abdel K.; Keita, Adama D.; Fay, Michael P.; Traore, Sekou F.; Nutman, Thomas B.; Klion, Amy D.			A Randomized Trial of Doxycycline for Mansonella perstans Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WUCHERERIA-BANCROFTI; LOA-LOA; MACROFILARICIDAL ACTIVITY; MOLECULAR-IDENTIFICATION; WOLBACHIA; IVERMECTIN; ONCHOCERCIASIS; MICROFILAREMIA; FILARIASIS; EFFICACY	Background Mansonella perstans infection is common in areas of Africa where Wuchereria bancrofti, a causative agent of lymphatic filariasis, is endemic. M. perstans is refractory to standard antifilarial therapies. The recent discovery of bacterial endosymbionts ( e. g., wolbachia) in most filarial species, including M. perstans, provides new therapeutic options for reducing microfilaremia. Methods In an open-label, randomized trial, we recruited subjects with M. perstans microfilaremia, with or without concomitant W. bancrofti infection, from four villages in Mali and randomly assigned them to receive doxycycline, at a dose of 200 mg daily for 6 weeks ( 106 subjects), or no treatment ( 110). At 6 months, subjects who were co-infected with W. bancrofti underwent a second random assignment, to treatment with a single dose of albendazole ( 400 mg) and ivermectin ( 150 mu g per kilogram of body weight) or no treatment. Subjects were monitored daily during the first 6-week study period for adverse events. M. perstans and W. bancrofti microfilarial levels were assessed at 6, 12, and 36 months. Results At 12 months, 67 of 69 subjects who had received treatment with doxycycline only (97%) had no detectable M. perstans microfilariae per 60 mu l of blood, as compared with 10 of 63 subjects who had received no treatment (16%) ( relative risk, 6.18; 95% confidence interval, 3.63 to 11.89; P<0.001). At 36 months, M. perstans microfilaremia remained suppressed in 48 of 64 subjects who had received treatment with doxycycline only (75%), a finding that was consistent with a macrofilaricidal effect of doxycycline. Vomiting was more frequent in the doxycycline-treated group than in the untreated group (17% vs. 4%). Conclusions These results are consistent with previous findings that M. perstans harbors the intracellular endosymbiont, wolbachia, and suggest that doxycycline is an effective therapy for M. perstans infection. (ClinicalTrials.gov number, NCT00340691.)	[Kubofcik, Joseph; Nutman, Thomas B.; Klion, Amy D.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Coulibaly, Yaya I.; Dembele, Benoit; Diallo, Abdallah A.; Doumbia, Salif S.; Coulibaly, Siaka Y.; Konate, Siaka; Diallo, Dapa A.; Yalcouye, Daniel; Doumbo, Ogobara K.; Traore, Sekou F.] Univ Bamako, Fac Med Pharm & Odontostomatol, Bamako, Mali; [Traore, Abdel K.] Ctr Dis Control, Bamako, Mali; [Keita, Adama D.] Hosp Point G, Dept Radiol, Bamako, Mali; [Lipner, Ettie M.; Fay, Michael P.] NIAID, Biostat & Res Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Bamako; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Klion, AD (corresponding author), NIAID, Parasit Dis Lab, NIH, Bldg 50,Rm 6351, Bethesda, MD 20892 USA.	aklion@nih.gov	Fay, Michael P/A-2974-2008	Fay, Michael P/0000-0002-8643-9625; Coulibaly, Yaya Ibrahim/0000-0001-6786-1567; Klion, Amy/0000-0002-4986-5326	Division of Intramural Research of the National Institutes of Health; National Institute of Allergy and Infectious Diseases, Bethesda, MD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001063] Funding Source: NIH RePORTER	Division of Intramural Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Division of Intramural Research of the National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, MD.	Akue JP, 1996, T ROY SOC TROP MED H, V90, P115, DOI 10.1016/S0035-9203(96)90105-4; ASIO SM, 2008, ANN TROP MED PARASIT, V102, P1; Bregani ER, 2006, T ROY SOC TROP MED H, V100, P458, DOI 10.1016/j.trstmh.2005.07.009; Brouqui P, 2001, EMERG INFECT DIS, V7, P604; Buttner Dietrich W, 2003, Filaria J, V2, P10, DOI 10.1186/1475-2883-2-10; Casiraghi M, 2001, PARASITOL RES, V87, P417, DOI 10.1007/s004360000368; CHANTEAU S, 1994, J INFECT DIS, V170, P247, DOI 10.1093/infdis/170.1.247; Debrah AY, 2006, PLOS PATHOG, V2, P829, DOI 10.1371/journal.ppat.0020092; DEBRAH AY, 2006, FILARIA J, V5, P5; Duong TH, 1998, T ROY SOC TROP MED H, V92, P459, DOI 10.1016/S0035-9203(98)91093-8; Gardon J, 2002, T ROY SOC TROP MED H, V96, P325, DOI 10.1016/S0035-9203(02)90112-4; Grobusch MP, 2003, PARASITOL RES, V90, P405, DOI 10.1007/s00436-003-0872-z; Hoerauf A, 2008, MED MICROBIOL IMMUN, V197, P295, DOI 10.1007/s00430-007-0062-1; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Keiser PB, 2008, MOL BIOCHEM PARASIT, V160, P123, DOI 10.1016/j.molbiopara.2008.04.012; Keiser PB, 2003, AM J TROP MED HYG, V69, P331, DOI 10.4269/ajtmh.2003.69.331; KLION AD, 2006, TROPICAL INFECT DIS, P1163; Kyelem D, 2003, ANN TROP MED PARASIT, V97, P827, DOI 10.1179/000349803225002462; Mand Sabine, 2003, Filaria J, V2, P3, DOI 10.1186/1475-2883-2-3; McGarry Helen F., 2003, Filaria Journal, V2, pUnpaginated, DOI 10.1186/1475-2883-2-9; SCHULZKEY H, 1993, T ROY SOC TROP MED H, V87, P227, DOI 10.1016/0035-9203(93)90504-J; Taylor MJ, 2005, LANCET, V365, P2116, DOI 10.1016/S0140-6736(05)66591-9; Taylor MJ, 1999, EXP PARASITOL, V91, P356, DOI 10.1006/expr.1998.4383; Team RDCR, 2007, LANG ENV STAT COMP; Wanji S, 2003, MED MICROBIOL IMMUN, V192, P15, DOI 10.1007/s00430-002-0154-x	25	61	64	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2009	361	15					1448	1458		10.1056/NEJMoa0900863	http://dx.doi.org/10.1056/NEJMoa0900863			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503MU	19812401	Green Accepted			2022-12-28	WOS:000270540000006
J	Hopfner, KP				Hopfner, Karl-Peter			DNA Double-Strand Breaks Come into Focus	CELL			English	Editorial Material							HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; COMPLEX; REPAIR; COLLABORATE; PROTEIN; SAE2	The Mre11-Rad50-Nbs1 (MRN) complex senses DNA double-strand breaks and recruits different repair pathway and checkpoint proteins to break foci. Two new studies (Williams et al., 2009; Lloyd et al., 2009) identify Nbs1 as a key factor in this process and reveal how an N-terminal protein recruitment module in Nbs1 binds to different response factors through shared phosphopeptide motifs.	[Hopfner, Karl-Peter] Univ Munich, Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany; [Hopfner, Karl-Peter] Univ Munich, Munich Ctr Adv Photon, Gene Ctr, Dept Chem & Biochem, D-81377 Munich, Germany	University of Munich; University of Munich	Hopfner, KP (corresponding author), Univ Munich, Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany.	hopfner@lmb.uni-muenchen.de	Hopfner, Karl-Peter/B-6864-2014	Hopfner, Karl-Peter/0000-0002-4528-8357				Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Palmbos PL, 2008, GENETICS, V180, P1809, DOI 10.1534/genetics.108.095539; Takeda S, 2007, MOL CELL, V28, P351, DOI 10.1016/j.molcel.2007.10.016; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069	8	13	15	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 2	2009	139	1					25	27		10.1016/j.cell.2009.09.017	http://dx.doi.org/10.1016/j.cell.2009.09.017			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804750	Bronze			2022-12-28	WOS:000270388600012
J	Landon, MB; Spong, CY; Thom, E; Carpenter, MW; Ramin, SM; Casey, B; Wapner, RJ; Varner, MW; Rouse, DJ; Thorp, JM; Sciscione, A; Catalano, P; Harper, M; Saade, G; Lain, KY; Sorokin, Y; Peaceman, AM; Tolosa, JE; Anderson, GB				Landon, Mark B.; Spong, Catherine Y.; Thom, Elizabeth; Carpenter, Marshall W.; Ramin, Susan M.; Casey, Brian; Wapner, Ronald J.; Varner, Michael W.; Rouse, Dwight J.; Thorp, John M., Jr.; Sciscione, Anthony; Catalano, Patrick; Harper, Margaret; Saade, George; Lain, Kristine Y.; Sorokin, Yoram; Peaceman, Alan M.; Tolosa, Jorge E.; Anderson, Garland B.		Eunice Kennedy Shriver NICHHD Mate	A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLUCOSE-TOLERANCE; MANAGEMENT; MELLITUS	Background: It is uncertain whether treatment of mild gestational diabetes mellitus improves pregnancy outcomes. Methods: Women who were in the 24th to 31st week of gestation and who met the criteria for mild gestational diabetes mellitus (i.e., an abnormal result on an oral glucose-tolerance test but a fasting glucose level below 95 mg per deciliter [5.3 mmol per liter]) were randomly assigned to usual prenatal care (control group) or dietary intervention, self-monitoring of blood glucose, and insulin therapy, if necessary (treatment group). The primary outcome was a composite of stillbirth or perinatal death and neonatal complications, including hyperbilirubinemia, hypoglycemia, hyperinsulinemia, and birth trauma. Results: A total of 958 women were randomly assigned to a study group -- 485 to the treatment group and 473 to the control group. We observed no significant difference between groups in the frequency of the composite outcome (32.4% and 37.0% in the treatment and control groups, respectively; P=0.14). There were no perinatal deaths. However, there were significant reductions with treatment as compared with usual care in several prespecified secondary outcomes, including mean birth weight (3302 vs. 3408 g), neonatal fat mass (427 vs. 464 g), the frequency of large-for-gestational-age infants (7.1% vs. 14.5%), birth weight greater than 4000 g (5.9% vs. 14.3%), shoulder dystocia (1.5% vs. 4.0%), and cesarean delivery (26.9% vs. 33.8%). Treatment of gestational diabetes mellitus, as compared with usual care, was also associated with reduced rates of preeclampsia and gestational hypertension (combined rates for the two conditions, 8.6% vs. 13.6%; P=0.01). Conclusions: Although treatment of mild gestational diabetes mellitus did not significantly reduce the frequency of a composite outcome that included stillbirth or perinatal death and several neonatal complications, it did reduce the risks of fetal overgrowth, shoulder dystocia, cesarean delivery, and hypertensive disorders. (ClinicalTrials.gov number, NCT00069576.) N Engl J Med 2009;361:1339-48.	[Landon, Mark B.] Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Spong, Catherine Y.] Eunice Kennedy Shriver NICHHD, Bethesda, MD USA; [Thom, Elizabeth] George Washington Univ, Ctr Biostat, Washington, DC USA; [Carpenter, Marshall W.] Brown Univ, Dept Obstet, Providence, RI 02912 USA; [Carpenter, Marshall W.] Brown Univ, Dept Gynecol, Providence, RI 02912 USA; [Ramin, Susan M.] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA; [Casey, Brian] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Wapner, Ronald J.] Columbia Univ, New York, NY USA; [Varner, Michael W.] Univ Utah, Salt Lake City, UT USA; [Rouse, Dwight J.] Univ Alabama Birmingham, Birmingham, AL USA; [Thorp, John M., Jr.] Univ N Carolina, Chapel Hill, NC USA; [Sciscione, Anthony] Drexel Univ, Philadelphia, PA 19104 USA; [Catalano, Patrick] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Harper, Margaret] Wake Forest Univ Hlth Sci, Winston Salem, NC USA; [Saade, George; Anderson, Garland B.] Univ Texas Med Branch, Galveston, TX USA; [Lain, Kristine Y.] Univ Pittsburgh, Pittsburgh, PA USA; [Sorokin, Yoram] Wayne State Univ, Detroit, MI USA; [Peaceman, Alan M.] Northwestern Univ, Chicago, IL 60611 USA; [Tolosa, Jorge E.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); George Washington University; Brown University; Brown University; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University; Utah System of Higher Education; University of Utah; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; Drexel University; Case Western Reserve University; Wake Forest University; Wake Forest University School of Medicine; University of Texas System; University of Texas Medical Branch Galveston; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Wayne State University; Northwestern University; Oregon Health & Science University	Landon, MB (corresponding author), Ohio State Univ, Dept Obstet & Gynecol, Columbus, OH 43210 USA.	mark.landon@osumc.edu	Catalano, Patrick/GVR-9069-2022; Varner, Michael/K-9890-2013	Varner, Michael/0000-0001-9455-3973; Peaceman, Alan/0000-0002-4515-4850	Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD27915, HD34116, HD40485, HD34208, HD27869, HD40500, HD40560, HD34136, HD40544, HD27860, HD40545, HD53097, HD21410, HD27917, HD40512, HD53118, HD36801]; General Clinical Research Centers [M01-RR00034]; National Center for Research Resources [UL1-RR024989, M01-RR00080, UL1-RR025764, C06-RR11234]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [UG1HD027869, U10HD027915, U10HD040544, UG1HD053097, UG1HD034208, U10HD027869, UG1HD040512, U10HD021410, U10HD053097, U10HD034208, U10HD036801, UG1HD040500, U10HD040512, UG1HD027915, U10HD040485, UG1HD040485, U10HD040545, UG1HD040545, U10HD027917, R24HD050924, UG1HD034116, U10HD053118, U10HD040500, UG1HD040560, UG1HD040544, U10HD040560, U10HD034116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD027860, U10HD034136, U01HD036801, U01HD021410] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000080, UL1RR024989, M01RR000034, UL1RR025755, UL1RR025764, C06RR011234] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); General Clinical Research Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development ( HD27915, HD34116, HD40485, HD34208, HD27869, HD40500, HD40560, HD34136, HD40544, HD27860, HD40545, HD53097, HD21410, HD27917, HD40512, HD53118, HD36801), the General Clinical Research Centers (M01-RR00034), and the National Center for Research Resources (UL1-RR024989, M01-RR00080, UL1-RR025764, C06-RR11234).	Alexander G R, 1999, Matern Child Health J, V3, P225, DOI 10.1023/A:1022381506823; Am Diabetes Assoc, 2006, DIABETES CARE, V29, pS4; Amer Diabet Associat, 2008, DIABETES CARE, V31, pS61, DOI 10.2337/dc08-S061; American College of Obstetricians and Gynecologists Committee on Practice Bulletins--Obstetrics, 2001, Obstet Gynecol, V98, P525; Bancroft K, 2000, BRIT J OBSTET GYNAEC, V107, P959, DOI 10.1111/j.1471-0528.2000.tb10396.x; Bhutani VK, 1999, PEDIATRICS, V103, P6, DOI 10.1542/peds.103.1.6; Brody SC, 2003, OBSTET GYNECOL, V101, P380, DOI 10.1016/S0029-7844(02)03057-0; Buchanan TA, 1999, J CLIN ENDOCR METAB, V84, P1854, DOI 10.1210/jc.84.6.1854; Calonge N, 2008, ANN INTERN MED, V148, P759; CATALANO PM, 1995, AM J OBSTET GYNECOL, V173, P1176, DOI 10.1016/0002-9378(95)91348-3; COUSINS L, 2004, DIABETES WOMEN ADOLE, P351; COWETT RM, 1992, FETAL NEONATAL PHYSL, P406; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; GABBE SG, 1977, AM J OBSTET GYNECOL, V127, P465, DOI 10.1016/0002-9378(77)90436-7; Garner P, 1997, AM J OBSTET GYNECOL, V177, P190, DOI 10.1016/S0002-9378(97)70461-7; Hillier TA, 2007, DIABETES CARE, V30, P2287, DOI 10.2337/dc06-2361; HOD M, 1991, DIABETES, V40, P74, DOI 10.2337/diab.40.2.S74; Holt RIG, 2008, DIABETIC MED, V25, P1013, DOI 10.1111/j.1464-5491.2008.02559.x; Jovanovic L, 2001, JAMA-J AM MED ASSOC, V286, P2516, DOI 10.1001/jama.286.20.2516; LACHIN JM, 1988, CONTROL CLIN TRIALS, V9, P365, DOI 10.1016/0197-2456(88)90049-9; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Langer O, 2005, AM J OBSTET GYNECOL, V192, P989, DOI 10.1016/j.ajog.2004.11.039; LANGER O, 1994, AM J OBSTET GYNECOL, V170, P1036, DOI 10.1016/S0002-9378(94)70097-4; MCFARLAND LV, 1986, OBSTET GYNECOL, V68, P784; Metzger BE, 1998, DIABETES CARE, V21, pB161; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; MOORE TR, 1989, AM J OBSTET GYNECOL, V160, P1075, DOI 10.1016/0002-9378(89)90164-6; Naylor CD, 1996, JAMA-J AM MED ASSOC, V275, P1165, DOI 10.1001/jama.275.15.1165; OSULLIVAN JB, 1964, DIABETES, V13, P278; Persson B, 1998, DIABETES CARE, V21, pB79; SILVERMAN BL, 1995, DIABETES CARE, V18, P611, DOI 10.2337/diacare.18.5.611; Wolf M, 2002, J CLIN ENDOCR METAB, V87, P1563, DOI 10.1210/jc.87.4.1563	32	1349	1404	2	121	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2009	361	14					1339	1348		10.1056/NEJMoa0902430	http://dx.doi.org/10.1056/NEJMoa0902430			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500KZ	19797280	Green Accepted, Green Submitted			2022-12-28	WOS:000270300000008
J	Haszeldine, RS				Haszeldine, R. Stuart			Carbon Capture and Storage: How Green Can Black Be?	SCIENCE			English	Review							DIOXIDE	The capture of carbon dioxide at the point of emission from coal- or gas-burning power plants is an attractive route to reducing carbon dioxide emissions into the atmosphere. To commercialize carbon capture, as well as transport of liquified carbon dioxide and its storage in exploited oil fields or saline formations, many technological, commercial, and political hurdles remain to be overcome. Urgent action is required if carbon capture and storage is to play a large role in limiting climate change.	Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland	University of Edinburgh	Haszeldine, RS (corresponding author), Univ Edinburgh, Sch Geosci, W Mains Rd, Edinburgh EH9 3JW, Midlothian, Scotland.	s.haszeldine@ed.ac.uk		Haszeldine, Robert Stuart/0000-0002-7015-8394	Natural Environment Research Council; Engineering and Physical Sciences Research Council; Scottish Funding Council; U. K. Energy Research Centre; Scottish Centre for Carbon Storage (SCCS) Industry Consortium; Engineering and Physical Sciences Research Council [DT/F007744/1, EP/H022961/1] Funding Source: researchfish; EPSRC [EP/H022961/1, DT/F007744/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Scottish Funding Council; U. K. Energy Research Centre; Scottish Centre for Carbon Storage (SCCS) Industry Consortium; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	R. S. H. is funded by the Natural Environment Research Council, the Engineering and Physical Sciences Research Council, the Scottish Funding Council, the U. K. Energy Research Centre, and the Scottish Centre for Carbon Storage (SCCS) Industry Consortium. S. Brandani (Edinburgh Univ.) explained the Joule-Thomson effect, and J. Gibbins (Imperial College, London) discussed power plants. I thank all at SCCS for discussions, especially M. Wilkinson, M. Naylor, S. Gilfillan, and N. Markusson (Edinburgh Univ.); A. Todd and E. Mackay (Heriot-Watt Univ.); and M. Akhurst, M. Smith, and M. Quinn (British Geological Survey).	Anderson K, 2008, PHILOS T R SOC A, V366, P3863, DOI 10.1098/rsta.2008.0138; Burnett ES, 1923, PHYS REV, V22, P0590, DOI 10.1103/PhysRev.22.590; CHARNLEY A, 1955, PROC R SOC LON SER-A, V230, P354, DOI 10.1098/rspa.1955.0138; *DEP BUSS ENT REG, 2008, CCS DEM COMP; *DOOS BABC RENFR S, 2009, OXYCOAL FIR; *FUTUREGEN IND ALL, 2004, FUTUREGEN 2009; Gibbins J, 2008, ENERG POLICY, V36, P501, DOI 10.1016/j.enpol.2007.10.021; Hart A, 2009, ENRGY PROCED, V1, P697, DOI 10.1016/j.egypro.2009.01.092; Holloway S, 2009, P I MECH ENG A-J POW, V223, P239, DOI 10.1243/09576509JPE650; House KZ, 2009, ENERG ENVIRON SCI, V2, P193, DOI 10.1039/b811608c; *HUAN POW INT, 2009, GREENGEN 2009; HUGHES D, 2008, CARBON CAPTURE J, V2, P2; *INT EN AG, 2008, EN TECHN PERSP; International Energy Agency, 2007, WORLD EN OUTL; Lindeberg E, 2009, ENRGY PROCED, V1, P2777, DOI 10.1016/j.egypro.2009.02.049; Lu JM, 2009, GEOLOGY, V37, P35, DOI 10.1130/G25412A.1; *MCK CO, 2008, CARB CAPT STOR ASS E; McKinsey & Company, 2009, PATHW LOW CARB EC; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Metz B, 2005, SPECIAL REPORT CARBO; *NAT EN TECHN LAB, 2002, CLEAN COAL POW IN; Oldenburg CM, 2007, ENERG CONVERS MANAGE, V48, P1808, DOI 10.1016/j.enconman.2007.01.010; Orr FM, 2009, ENERG ENVIRON SCI, V2, P449, DOI 10.1039/b822107n; Poyry Energy Consult, 2009, IMP INT WIND VAR COU; ROCHON E, 2007, FALSE HOPE WHY CARBO; *SCOTT CTR CARB ST, 2009, CCS WORLD MAP; Scottish Centre for Carbon Storage, 2009, OPP CO2 STOR SCOTL I; UK Energy Research Centre, 2009, MAK TRANS SEC LOW CA; *US DOE, 2006, 10 BAS OR CO2 EOR AS; *US DOE, 2009, ENH OIL REC CO2 INJ; *YORKSH, 2009, CARB CAPT STOR NETW; ZERO EMISSIONS PLATF	32	1416	1454	47	935	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	2009	325	5948					1647	1652		10.1126/science.1172246	http://dx.doi.org/10.1126/science.1172246			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779187				2022-12-28	WOS:000270131800031
J	Kyriacou, CP				Kyriacou, Charalambos P.			Unraveling Traveling	SCIENCE			English	Editorial Material							MONARCH BUTTERFLIES; CENTRAL COMPLEX; CRYPTOCHROME; DROSOPHILA; CLOCK; NEURONS; INPUT		Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Leicester	Kyriacou, CP (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	cpk@leicester.ac.uk			Biotechnology and Biological Sciences Research Council [BB/F008988/1] Funding Source: Medline; BBSRC [BB/F008988/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Froy O, 2003, SCIENCE, V300, P1303, DOI 10.1126/science.1084874; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Heinze S, 2009, J NEUROSCI, V29, P4911, DOI 10.1523/JNEUROSCI.0332-09.2009; Martin JR, 1999, J COMP PHYSIOL A, V185, P277, DOI 10.1007/s003590050387; Merlin C, 2009, SCIENCE, V325, P1700, DOI 10.1126/science.1176221; Reppert SM, 2004, CURR BIOL, V14, P155, DOI 10.1016/j.cub.2003.12.034; Sauman I, 2005, NEURON, V46, P457, DOI 10.1016/j.neuron.2005.03.014; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Urquhart FA., 1987, MONARCH BUTTERFLY IN; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004; Zhu HS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-14	14	0	1	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1629	1630		10.1126/science.1178935	http://dx.doi.org/10.1126/science.1178935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779177				2022-12-28	WOS:000270131800021
J	Cicalese, A; Bonizzi, G; Pasi, CE; Faretta, M; Ronzoni, S; Giulini, B; Brisken, C; Minucci, S; Di Fiore, PP; Pelicci, PG				Cicalese, Angelo; Bonizzi, Giuseppina; Pasi, Cristina E.; Faretta, Mario; Ronzoni, Simona; Giulini, Barbara; Brisken, Cathrin; Minucci, Saverio; Di Fiore, Pier Paolo; Pelicci, Pier Giuseppe			The Tumor Suppressor p53 Regulates Polarity of Self-Renewing Divisions in Mammary Stem Cells	CELL			English	Article							IN-VIVO; MOUSE; RESTORATION; CANCER; MODEL; GLAND; MICE; ACTIVATION; PATHWAY	Stem-like cells may be integral to the development and maintenance of human cancers. Direct proof is still lacking, mainly because of our poor understanding of the biological differences between normal and cancer stem cells (SCs). Using the ErbB2 transgenic model of breast cancer, we found that self-renewing divisions of cancer SCs are more frequent than their normal counterparts, unlimited and symmetric, thus contributing to increasing numbers of SCs in tumoral tissues. SCs with targeted mutation of the tumor suppressor p53 possess the same self-renewal properties as cancer SCs, and their number increases progressively in the p53 null premalignant mammary gland. Pharmacological reactivation of p53 correlates with restoration of asymmetric divisions in cancer SCs and tumor growth reduction, without significant effects on additional cancer cells. These data demonstrate that p53 regulates polarity of cell division in mammary SCs and suggest that loss of p53 favors symmetric divisions of cancer SCs, contributing to tumor growth.	[Cicalese, Angelo; Bonizzi, Giuseppina; Pasi, Cristina E.; Faretta, Mario; Ronzoni, Simona; Giulini, Barbara; Minucci, Saverio; Di Fiore, Pier Paolo; Pelicci, Pier Giuseppe] IEO, Dept Expt Oncol, I-20139 Milan, Italy; [Di Fiore, Pier Paolo] Fdn Ist FIRC Oncol Mol IFOM, I-20139 Milan, Italy; [Brisken, Cathrin] Swiss Inst Expt Canc Res, Natl Ctr Competence Res Mol Oncol, Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Minucci, Saverio; Di Fiore, Pier Paolo; Pelicci, Pier Giuseppe] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20122 Milan, Italy	IRCCS European Institute of Oncology (IEO); IFOM - FIRC Institute of Molecular Oncology; IRCCS Istituti Fisioterapici Ospitalieri (IFO); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Milan	Di Fiore, PP (corresponding author), IEO, Dept Expt Oncol, IFOM IEO Campus,Via Adamello 16, I-20139 Milan, Italy.	pierpaolo.difiore@ifom-ieo-campus.it; piergiuseppe.pelicci@ifom-ieo-campus.it	Ronzoni, Simona/AAQ-1669-2020; Bonizzi, Giuseppina/AAD-9042-2022; Faretta, Mario/H-8946-2012; Di Fiore, Pier Paolo/K-2130-2012; Minucci, Saverio/J-9669-2012; Pelicci, Pier Giuseppe/AAL-6572-2020	Faretta, Mario/0000-0003-1678-5781; Di Fiore, Pier Paolo/0000-0002-2252-0950; Brisken, Cathrin/0000-0002-6857-3230	Associazione Italiana per la Ricerca Contro il Cancro; Cariplo Foundation; European Commission (EPITRON and GENICA); Swiss Bridge and Vollaro Foundations; Monzino Foundation; American Italian Cancer Foundation	Associazione Italiana per la Ricerca Contro il Cancro(Fondazione AIRC per la ricerca sul cancro); Cariplo Foundation(Fondazione Cariplo); European Commission (EPITRON and GENICA)(European CommissionEuropean Commission Joint Research Centre); Swiss Bridge and Vollaro Foundations; Monzino Foundation; American Italian Cancer Foundation	We thank R. Orecchia, B. Amati, S. Pece, and D. Tosoni for helpful discussions; A. Brozzi for statistical analysis; I. Muradore for FACS analysis; C. Saccomani for cell sorting; M. Capillo, D. Sardella, and A. Gobbi for help with mice; F. Della Valle, S. Pesce, M. Minora, and M. Scanarini for technical assistance; G. Viale and G. Mazzarol for histopathological analysis; and P. Dalton for editing the manuscript. This study was supported by grants from the Associazione Italiana per la Ricerca Contro il Cancro and the Cariplo Foundation to P. G. P and P. P. D. F., the European Commission (EPITRON and GENICA), the Swiss Bridge and Vollaro Foundations to P. G. P., and the Monzino Foundation to P. P. D. F. G. B. is a fellow of the American Italian Cancer Foundation.	Bonnefoix T, 1996, J IMMUNOL METHODS, V194, P113, DOI 10.1016/0022-1759(96)00077-4; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; DANIEL CW, 1968, P NATL ACAD SCI USA, V61, P53, DOI 10.1073/pnas.61.1.53; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gatza CE, 2008, DEV BIOL, V313, P130, DOI 10.1016/j.ydbio.2007.10.004; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Jerry DJ, 2000, ONCOGENE, V19, P1052, DOI 10.1038/sj.onc.1203270; Jerry DJ, 1998, ONCOGENE, V17, P2305, DOI 10.1038/sj.onc.1202157; Kise N, 2001, TETRAHEDRON LETT, V42, P2365, DOI 10.1016/S0040-4039(01)00178-2; Kuperwasser C, 2000, AM J PATHOL, V157, P2151, DOI 10.1016/S0002-9440(10)64853-5; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Rambhatla L., 2001, J BIOMED BIOTECHNOL, V1, P28, DOI DOI 10.1155/S1110724301000079; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Trichopoulos D, 2008, INT J CANCER, V122, P481, DOI 10.1002/ijc.23303; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhang M, 2006, CURR OPIN GENET DEV, V16, P60, DOI 10.1016/j.gde.2005.12.008; Zheng L, 2004, CELL RES, V14, P497, DOI 10.1038/sj.cr.7290253	29	532	553	0	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1083	1095		10.1016/j.cell.2009.06.048	http://dx.doi.org/10.1016/j.cell.2009.06.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766563	Bronze, Green Submitted			2022-12-28	WOS:000269923200010
J	Jo, GB; Lee, YR; Choi, JH; Christensen, CA; Kim, TH; Thywissen, JH; Pritchard, DE; Ketterle, W				Jo, Gyu-Boong; Lee, Ye-Ryoung; Choi, Jae-Hoon; Christensen, Caleb A.; Kim, Tony H.; Thywissen, Joseph H.; Pritchard, David E.; Ketterle, Wolfgang			Itinerant Ferromagnetism in a Fermi Gas of Ultracold Atoms	SCIENCE			English	Article							CONDENSATION; STATE	Can a gas of spin-up and spin-down fermions become ferromagnetic because of repulsive interactions? We addressed this question, for which there is not yet a definitive theoretical answer, in an experiment with an ultracold two-component Fermi gas. The observation of nonmonotonic behavior of lifetime, kinetic energy, and size for increasing repulsive interactions provides strong evidence for a phase transition to a ferromagnetic state. Our observations imply that itinerant ferromagnetism of delocalized fermions is possible without lattice and band structure, and our data validate the most basic model for ferromagnetism introduced by Stoner.	[Jo, Gyu-Boong; Lee, Ye-Ryoung; Choi, Jae-Hoon; Christensen, Caleb A.; Kim, Tony H.; Pritchard, David E.; Ketterle, Wolfgang] MIT, Harvard Ctr Ultracold Atoms, Elect Res Lab, Dept Phys, Cambridge, MA 02139 USA; [Thywissen, Joseph H.] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada	Harvard University; Massachusetts Institute of Technology (MIT); University of Toronto	Jo, GB (corresponding author), MIT, Harvard Ctr Ultracold Atoms, Elect Res Lab, Dept Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	gyuboong@mit.edu	Jo, Gyu-boong/E-5792-2010; Thywissen, Joseph H/E-8235-2010; LEE, YE-RYOUNG/GSN-7603-2022; Jo, Gyu Boong/ABD-5686-2021	Thywissen, Joseph H/0000-0002-7007-8204; Lee, Ye-Ryoung/0000-0003-4292-8424; Jo, Gyu Boong/0000-0002-0500-3572	NSF; Office of Naval Research; Multidisciplinary University Research Initiative program; Army Research Office [W911NF-07-10493]; Defense Advanced Research Projects Agency Optical Lattice Emulator program; Samsung Foundation	NSF(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Multidisciplinary University Research Initiative program(MURI); Army Research Office; Defense Advanced Research Projects Agency Optical Lattice Emulator program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Samsung Foundation(Samsung)	Supported by NSF and the Office of Naval Research, through the Multidisciplinary University Research Initiative program, and under Army Research Office grant no. W911NF-07-10493 with funds from the Defense Advanced Research Projects Agency Optical Lattice Emulator program. G.-B. J and Y.-R. L acknowledge additional support from the Samsung Foundation. We thank E. Demler, W. Hofstetter, A. Paramekanti, L. J. LeBlanc, and G. J. Conduit for useful discussions; T. Wang for experimental assistance; and A. Keshet for development of the computer control system.	Amoruso M, 2000, EUR PHYS J D, V8, P361; Berdnikov I, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.224403; Bloch F, 1929, Z PHYS, V57, P545, DOI 10.1007/BF01340281; Bourdel T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.020402; Brouwer PW, 1999, PHYS REV B, V60, P13977, DOI 10.1103/PhysRevB.60.R13977; Carlson J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.060401; D'Incao JP, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.213201; Grimm R., 2008, ULTRA COLD FERMI GAS; Gupta S, 2003, SCIENCE, V300, P1723, DOI 10.1126/science.1085335; Houbiers M, 1997, PHYS REV A, V56, P4864, DOI 10.1103/PhysRevA.56.4864; Kinast J, 2005, SCIENCE, V307, P1296, DOI 10.1126/science.1109220; Lahaye T, 2007, NATURE, V448, P672, DOI 10.1038/nature06036; LeBlanc LJ, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.013607; LIEB E, 1962, PHYS REV, V125, P164, DOI 10.1103/PhysRev.125.164; NOZIERES P, 1985, J LOW TEMP PHYS, V59, P195, DOI 10.1007/BF00683774; PFARR J, 1972, Z PHYS, V251, P152, DOI 10.1007/BF01380457; Sadler LE, 2006, NATURE, V443, P312, DOI 10.1038/nature05094; Salasnich L, 2000, J PHYS B-AT MOL OPT, V33, P3943, DOI 10.1088/0953-4075/33/19/309; Shin Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.030401; Sogo T, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.043611; Stenger J, 1998, NATURE, V396, P345, DOI 10.1038/24567; Stoner EC, 1933, PHILOS MAG, V15, P1018; Tanaka A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.116402; TASAKI H, 1995, PHYS REV LETT, V75, P4678, DOI 10.1103/PhysRevLett.75.4678; VOLLHARDT D, 1984, REV MOD PHYS, V56, P99, DOI 10.1103/RevModPhys.56.99; Vollhardt D., 2001, LECT NOTES PHYS, V580; Weber T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.123201; Zwierlein MW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.250401; [No title captured]	30	249	252	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 18	2009	325	5947					1521	1524		10.1126/science.1177112	http://dx.doi.org/10.1126/science.1177112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762638	Green Submitted			2022-12-28	WOS:000269887900033
J	Hennessy, BT; Coleman, RL; Markman, M				Hennessy, Bryan T.; Coleman, Robert L.; Markman, Maurie			Ovarian cancer	LANCET			English	Review							GYNECOLOGIC-ONCOLOGY-GROUP; PHASE-III TRIAL; PEGYLATED LIPOSOMAL DOXORUBICIN; INTRAVENOUS CISPLATIN PLUS; RANDOMIZED CLINICAL-TRIAL; SINGLE-AGENT CARBOPLATIN; STAGE-III; 1ST-LINE TREATMENT; INTRAPERITONEAL CHEMOTHERAPY; INTERGROUP TRIAL	The standard initial management of epithelial ovarian cancer consists of surgical staging, operative tumour debulking including total abdominal hysterectomy and bilateral salpingo-oophorectomy, and administration of six cycles of intravenous chemotherapy with carboplatin and paclitaxel. Extensive and largely retrospective experience has shown that optimum surgical debulking to leave residual tumour deposits that are less than 1 cm in size is associated with improved patient outcomes. However, 75% of patients present with advanced (stage III or IV) disease and, although more than 80% of these women benefit from first-line therapy, tumour recurrence occurs in almost all these patients at a median of 15 months from diagnosis. Second-line treatments can improve survival and quality of life but are not curative. Advances in screening and understanding of molecular pathogenesis of ovarian cancer and development of novel targeted therapies (eg, bevacizumab) and practical intraperitoneal techniques for drug delivery are most likely to improve patient outcomes.	[Hennessy, Bryan T.; Markman, Maurie] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Med Oncol, Houston, TX 77030 USA; [Coleman, Robert L.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Markman, M (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gynecol Med Oncol, Houston, TX 77030 USA.	mmarkman@mdanderson.org	Coleman, Robert/E-4346-2019; FALANDRY, Claire/H-6055-2012; yang, xiao-jun/B-1927-2009	FALANDRY, Claire/0000-0001-7267-4723; Hennessy, Bryan/0000-0002-7871-6477				Aabo K, 1998, BRIT J CANCER, V78, P1479, DOI 10.1038/bjc.1998.710; Alberts DS, 1996, NEW ENGL J MED, V335, P1950, DOI 10.1056/NEJM199612263352603; Aletti GD, 2006, GYNECOL ONCOL, V100, P283, DOI 10.1016/j.ygyno.2005.08.027; American College of Obstetricians and Gynecologists, 2009, OBSTET GYNECOL, V113, P957, DOI DOI 10.1097/AOG.0B013E3181A106D4; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Badgwell D, 2007, DIS MARKERS, V23, P397, DOI 10.1155/2007/309382; Bast RC, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.3500; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; Berek J, 2009, J CLIN ONCOL, V27, P418, DOI 10.1200/JCO.2008.17.8400; Berek JS, 2004, J CLIN ONCOL, V22, P3507, DOI 10.1200/JCO.2004.09.016; Berry DA, 2002, J CLIN ONCOL, V20, P2701, DOI 10.1200/JCO.2002.05.121; BERTELSEN K, 1993, GYNECOL ONCOL, V49, P30, DOI 10.1006/gyno.1993.1081; BESSETTE AR, 2008, IGCS BIENN M P BANGK; Bookman MA, 2006, J CLIN ONCOL, V24, p256S; Bookman MA, 2003, J CLIN ONCOL, V21, P283, DOI 10.1200/JCO.2003.10.104; Breidenbach M, 2005, GENE THER, V12, P187, DOI 10.1038/sj.gt.3302404; Brewster WR, 2005, NAT CLIN PRACT ONCOL, V2, P286, DOI 10.1038/ncponc0198; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Burger RA, 2007, J CLIN ONCOL, V25, P5165, DOI 10.1200/JCO.2007.11.5345; Burke W, 1997, JAMA-J AM MED ASSOC, V277, P997, DOI 10.1001/jama.277.12.997; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; *CAN RES UK, CANCSTAT INC UK; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen SN, 2006, J CLIN ONCOL, V24, P863, DOI 10.1200/JCO.2005.03.6772; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Cheng WJ, 2005, NAT MED, V11, P531, DOI 10.1038/nm1230; Cliby W, 2004, GYNECOL ONCOL, V94, P655, DOI 10.1016/j.ygyno.2004.04.032; Collinson FJ, 2008, EXPERT REV ANTICANC, V8, P21, DOI 10.1586/14737140.8.1.21; CRAMER DW, 1983, JNCI-J NATL CANCER I, V71, P717; Crum CP, 2007, CLIN MED RES, V5, P35, DOI 10.3121/cmr.2007.702; De Placido S, 2004, J CLIN ONCOL, V22, P2635, DOI 10.1200/JCO.2004.09.088; DELCAMPO JM, 1994, GYNECOL ONCOL, V53, P27, DOI 10.1006/gyno.1994.1082; du Bois A, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi961; du Bois A, 2003, JNCI-J NATL CANCER I, V95, P1320, DOI 10.1093/jnci/djg036; Eisenkop SM, 2006, GYNECOL ONCOL, V103, P329, DOI 10.1016/j.ygyno.2006.07.004; Eisenkop SM, 2001, GYNECOL ONCOL, V82, P489, DOI 10.1006/gyno.2001.6312; Elit L, 2004, CANCER, V101, P1926, DOI 10.1002/cncr.20595; Elit L, 2007, CANCER-AM CANCER SOC, V109, P692, DOI 10.1002/cncr.22466; Fader AN, 2007, J CLIN ONCOL, V25, P2873, DOI 10.1200/JCO.2007.11.0932; FATHALLA MF, 1971, LANCET, V2, P163; Ferrandina G, 2008, J CLIN ONCOL, V26, P890, DOI 10.1200/JCO.2007.13.6606; Fong PC, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.5510; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Friedman GD, 2005, FAM PRACT, V22, P548, DOI 10.1093/fampra/cmi044; Garcia M, 2007, GLOBAL CANC FACTS FI; Gordon AN, 2001, J CLIN ONCOL, V19, P3312, DOI 10.1200/JCO.2001.19.14.3312; Gore M, 1998, J CLIN ONCOL, V16, P2426, DOI 10.1200/JCO.1998.16.7.2426; Gore M, 2006, J CLIN ONCOL, V24, P4528, DOI 10.1200/JCO.2006.06.0376; HAKES TB, 1992, GYNECOL ONCOL, V45, P284, DOI 10.1016/0090-8258(92)90305-3; Hall GD, 2004, BRIT J CANCER, V91, P621, DOI 10.1038/sj.bjc.6602037; HANKINSON SE, 1993, JAMA-J AM MED ASSOC, V270, P2813, DOI 10.1001/jama.270.23.2813; Harter P, 2006, ANN SURG ONCOL, V13, P1702, DOI 10.1245/s10434-006-9058-0; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Hellstrom I, 2003, CANCER RES, V63, P3695; Hennessy BT, 2006, INT J BIOCHEM CELL B, V38, P1450, DOI 10.1016/j.biocel.2006.01.009; Hennessy BT, 2008, ADV EXP MED BIOL, V617, P23, DOI 10.1007/978-0-387-69080-3_3; Herzog TJ, 2006, GYNECOL ONCOL, V102, P218, DOI 10.1016/j.ygyno.2005.12.001; Hess LM, 2007, INT J GYNECOL CANCER, V17, P561, DOI 10.1111/j.1525-1438.2006.00846.x; Hirte H, 2006, GYNECOL ONCOL, V102, P300, DOI 10.1016/j.ygyno.2005.12.020; HOLGUIN T, 1986, GYNECOL ONCOL, V25, P128, DOI 10.1016/0090-8258(86)90074-0; Kamikihara T, 2005, INT J CANCER, V115, P690, DOI 10.1002/ijc.20971; Kodama Shoji, 1999, International Journal of Clinical Oncology, V4, P90, DOI 10.1007/s101470050033; Lambert HE, 1997, ANN ONCOL, V8, P327, DOI 10.1023/A:1008256431090; Markman M, 2006, J CLIN ONCOL, V24, P988, DOI 10.1200/JCO.2005.05.2456; Markman M, 2001, J CLIN ONCOL, V19, P1001, DOI 10.1200/JCO.2001.19.4.1001; Markman M, 2003, J CLIN ONCOL, V21, P2460, DOI 10.1200/JCO.2003.07.013; Markman M, 2008, DRUGS, V68, P771, DOI 10.2165/00003495-200868060-00004; Markman M, 2009, GYNECOL ONCOL, V113, P4, DOI 10.1016/j.ygyno.2008.12.022; MCGUIRE WP, 1995, J CLIN ONCOL, V13, P1589, DOI 10.1200/JCO.1995.13.7.1589; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Merritt WM, 2008, J NATL CANCER I, V100, P359, DOI 10.1093/jnci/djn024; Mobus V, 2007, J CLIN ONCOL, V25, P4187, DOI 10.1200/JCO.2006.09.7527; Monk BJ, 2008, ANN ONCOL, V19, P2; Morris CR, 2008, GYNECOL ONCOL, V108, P207, DOI 10.1016/j.ygyno.2007.09.026; Muggia FM, 2000, J CLIN ONCOL, V18, P106, DOI 10.1200/JCO.2000.18.1.106; Mutch DG, 2007, J CLIN ONCOL, V25, P2811, DOI 10.1200/JCO.2006.09.6735; National Cancer Institute, NCI ISS CLIN ANN PRE; NCCN, 2008, NCCN CLIN PRACT GUID; Neijt JP, 2000, J CLIN ONCOL, V18, P3084, DOI 10.1200/JCO.2000.18.17.3084; Nicholson S, 1998, ONCOL REP, V5, P223; Nossov V, 2008, AM J OBSTET GYNECOL, V199, P215, DOI 10.1016/j.ajog.2008.04.009; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Panici PB, 2005, JNCI-J NATL CANCER I, V97, P560, DOI 10.1093/jnci/dji102; Parmar MKB, 2003, LANCET, V361, P2099; Parmar MKB, 2002, LANCET, V360, P505; Paulsen T, 2006, INT J GYNECOL CANCER, V16, P11, DOI 10.1111/j.1525-1438.2006.00319.x; Pecorelli S, 2009, J CLIN ONCOL, V27, P4642, DOI 10.1200/JCO.2009.21.9691; Pfisterer J, 2006, J CLIN ONCOL, V24, P4699, DOI 10.1200/JCO.2006.06.0913; Pfisterer J, 2006, JNCI-J NATL CANCER I, V98, P1036, DOI 10.1093/jnci/djj296; Piccart MJ, 2000, JNCI-J NATL CANCER I, V92, P699, DOI 10.1093/jnci/92.9.699; Polverino G, 2005, GYNECOL ONCOL, V99, P343, DOI 10.1016/j.ygyno.2005.06.008; PUJADALAURAINE E, 2009, J CLIN ONCOL S, V27; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Rodriguez-Burford C, 2002, CLIN CANCER RES, V8, P202; Rose PG, 2004, NEW ENGL J MED, V351, P2489, DOI 10.1056/NEJMoa041125; Rustin GJ, 2009, J CLIN ONCOL, V27, DOI 10.1200/jco.2009.27.18_suppl.1; Sandercock J, 2002, BRIT J CANCER, V87, P815, DOI 10.1038/sj.bjc.6600567; Saygili U, 2002, J SURG ONCOL, V81, P132, DOI 10.1002/jso.10124; Schilder RJ, 2007, J CLIN ONCOL, V25; Schumer ST, 2003, J CLIN ONCOL, V21, P1180, DOI 10.1200/JCO.2003.10.019; Sehouli J, 2008, J CLIN ONCOL, V26, P3176, DOI 10.1200/JCO.2007.15.1258; Shaaban A, 2009, CLIN OBSTET GYNECOL, V52, P73, DOI 10.1097/GRF.0b013e3181961625; Shaw P. A., 1999, Modern Pathology, V12, p124A; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Silverberg S G, 1989, Curr Top Pathol, V78, P85; Skirnisdottir I, 2007, INT J GYNECOL CANCER, V17, P1231, DOI 10.1111/j.1525-1438.2007.00928.x; Smith DI, 2002, CYTOMETRY, V47, P60, DOI 10.1002/cyto.10042; Sorbe B, 2003, INT J GYNECOL CANCER, V13, P278, DOI 10.1046/j.1525-1438.2003.13193.x; Spriggs DR, 2007, J CLIN ONCOL, V25, P4466, DOI 10.1200/JCO.2006.10.3846; Suzuki S, 2000, CANCER RES, V60, P5382; Timmerman D, 2005, J CLIN ONCOL, V23, P8794, DOI 10.1200/JCO.2005.01.7632; Timmerman D, 2000, ULTRASOUND OBST GYN, V16, P500, DOI 10.1046/j.1469-0705.2000.00287.x; Trimbos JB, 2003, JNCI-J NATL CANCER I, V95, P105; Trimbos JB, 2003, JNCI-J NATL CANCER I, V95, P113, DOI 10.1093/jnci/95.2.113; Valentin L, 2006, GYNECOL ONCOL, V102, P41, DOI 10.1016/j.ygyno.2005.11.015; van Nagell JR, 1999, CURR OPIN OBSTET GYN, V11, P45, DOI 10.1097/00001703-199901000-00009; VANDERBURG MEL, 1995, NEW ENGL J MED, V332, P629, DOI 10.1056/NEJM199503093321002; Varia MA, 2003, J CLIN ONCOL, V21, P2849, DOI 10.1200/JCO.2003.11.018; Vasey PA, 2004, JNCI-J NATL CANCER I, V96, P1682, DOI 10.1093/jnci/djh323; Vergote I, 2001, LANCET, V357, P176, DOI 10.1016/S0140-6736(00)03590-X; Vernooij F, 2007, GYNECOL ONCOL, V105, P801, DOI 10.1016/j.ygyno.2007.02.030; Walker JL, 2009, GYNECOL ONCOL, V112, P439, DOI 10.1016/j.ygyno.2009.01.007; YOUNG RC, 1983, JAMA-J AM MED ASSOC, V250, P3072, DOI 10.1001/jama.250.22.3072; YOUNG RC, 1990, NEW ENGL J MED, V322, P1021, DOI 10.1056/NEJM199004123221501; Zeimet AG, 2003, LANCET ONCOL, V4, P415, DOI 10.1016/S1470-2045(03)01139-2	130	509	526	2	77	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2009	374	9698					1371	1382		10.1016/S0140-6736(09)61338-6	http://dx.doi.org/10.1016/S0140-6736(09)61338-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MW	19793610				2022-12-28	WOS:000271254600033
J	Schmidt, BE; Thomas, PC; Bauer, JM; Li, JY; McFadden, LA; Mutchler, MJ; Radcliffe, SC; Rivkin, AS; Russell, CT; Parker, JW; Stern, SA				Schmidt, B. E.; Thomas, P. C.; Bauer, J. M.; Li, J. -Y.; McFadden, L. A.; Mutchler, M. J.; Radcliffe, S. C.; Rivkin, A. S.; Russell, C. T.; Parker, J. Wm.; Stern, S. A.			The Shape and Surface Variation of 2 Pallas from the Hubble Space Telescope	SCIENCE			English	Article							TRIAXIAL ELLIPSOID DIMENSIONS; ADAPTIVE OPTICS; VESTA; ASTEROIDS; CERES	We obtained Hubble Space Telescope images of 2 Pallas in September 2007 that reveal distinct color and albedo variations across the surface of this large asteroid. Pallas's shape is an ellipsoid with radii of 291 (+/- 9), 278 (+/- 9), and 250 (+/- 9) kilometers, implying a density of 2400 (+/- 250) kilograms per cubic meter-a value consistent with a body that formed from water-rich material. Our observations are consistent with the presence of an impact feature, 240 (+/- 25) kilometers in diameter, within Pallas's ultraviolet-dark terrain. Our observations imply that Pallas is an intact protoplanet that has undergone impact excavation and probable internal alteration.	[Schmidt, B. E.; Russell, C. T.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; [Thomas, P. C.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Bauer, J. M.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Li, J. -Y.; McFadden, L. A.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Mutchler, M. J.] STScI, Baltimore, MD USA; [Radcliffe, S. C.] Hydraulx, Santa Monica, CA 90401 USA; [Rivkin, A. S.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Parker, J. Wm.; Stern, S. A.] SW Res Inst, Boulder, CO 80302 USA	University of California System; University of California Los Angeles; Cornell University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University System of Maryland; University of Maryland College Park; Space Telescope Science Institute; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Schmidt, BE (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA.	britneys@ucla.edu	McFadden, Lucy-Ann/I-4902-2013; Russell, Christopher T/E-7745-2012; Rivkin, Andrew S/B-7744-2016	McFadden, Lucy-Ann/0000-0002-0537-9975; Russell, Christopher T/0000-0003-1639-8298; Rivkin, Andrew S/0000-0002-9939-9976; Schmidt, Britney Elyce/0000-0001-7376-8510; Parker, Joel/0000-0002-3672-0603; Li, Jian-Yang/0000-0003-3841-9977; Mutchler, Maximilian/0000-0002-0088-3021	NASA [NAS 5-26555]; STScI [HST-GO-11115.01]	NASA(National Aeronautics & Space Administration (NASA)); STScI(Space Telescope Science Institute)	Based on observations made with the NASA/ESA Hubble Space Telescope, obtained at the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy Inc. under NASA contract NAS 5-26555. The observations are associated with program 11115. Supported by STScI grant HST-GO-11115.01 (C. T. R.).	Binzel RP, 1997, ICARUS, V128, P95, DOI 10.1006/icar.1997.5734; Britt D. T., 2002, ASTEROIDS 3, VIII, P485; Bussey DBJ, 2002, ICARUS, V155, P38, DOI 10.1006/icar.2001.6771; Carry B, 2008, ASTRON ASTROPHYS, V478, P235, DOI 10.1051/0004-6361:20078166; CARRY B, 2008, LUNAR PLANET I CONTR, V1805, P8303; Drummond J, 2008, ICARUS, V197, P480, DOI 10.1016/j.icarus.2008.05.009; DRUMMOND JD, 1989, ICARUS, V78, P323, DOI 10.1016/0019-1035(89)90180-2; DUNHAM DW, 1990, ASTRON J, V99, P1636, DOI 10.1086/115446; FEIERBERG MA, 1981, GEOCHIM COSMOCHIM AC, V14, P719; Foglia S, 2004, MINOR PLANET B, V31, P100; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; HALE WS, 1982, J GEOPHYS RES, V87, pA65, DOI 10.1029/JB087iS01p00A65; HENDRIX AR, 2008, LPI CONTRIB, V1805, P8361; Hiroi T, 1996, METORIT PLANET SCI, V31, P321, DOI 10.1111/j.1945-5100.1996.tb02068.x; Konopliv AS, 2006, ICARUS, V182, P23, DOI 10.1016/j.icarus.2005.12.025; LARSON HP, 1983, ICARUS, V56, P398, DOI 10.1016/0019-1035(83)90161-6; Li JY, 2006, ICARUS, V182, P143, DOI 10.1016/j.icarus.2005.12.012; McCord TB, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002244; McCord Thomas B., 2006, EOS T AM GEOPHYS UN, V87, P105, DOI DOI 10.1029/2006E0100002; Meech KJ, 1997, ASTRON ASTROPHYS, V326, P1268; Rivkin A.S., 2002, ASTEROIDS, VIII, P235, DOI DOI 10.1038/NATURE09028; Russell CT, 2007, EARTH MOON PLANETS, V101, P65, DOI 10.1007/s11038-007-9151-9; SAINTPE O, 1993, ICARUS, V105, P263, DOI 10.1006/icar.1993.1124; Thomas PC, 1997, SCIENCE, V277, P1492, DOI 10.1126/science.277.5331.1492; Thomas PC, 2005, NATURE, V437, P224, DOI 10.1038/nature03938; Thomas PC, 1998, ICARUS, V135, P175, DOI 10.1006/icar.1998.5987; [No title captured]	27	29	29	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					275	278		10.1126/science.1177734	http://dx.doi.org/10.1126/science.1177734			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815773				2022-12-28	WOS:000270599500039
J	Betley, JN; Wright, CVE; Kawaguchi, Y; Erdelyi, F; Szabo, G; Jessell, TM; Kaltschmidt, JA				Betley, J. Nicholas; Wright, Christopher V. E.; Kawaguchi, Yoshiya; Erdelyi, Ferenc; Szabo, Gabor; Jessell, Thomas M.; Kaltschmidt, Julia A.			Stringent Specificity in the Construction of a GABAergic Presynaptic Inhibitory Circuit	CELL			English	Article							GAMMA-AMINOBUTYRIC-ACID; MOTOR-NEURONS; INTERNEURON DIVERSITY; MOLECULAR-MECHANISMS; CRITICAL PERIOD; DORSAL-HORN; SYNAPSES; CONNECTIVITY; RECEPTOR; FEATURES	GABAergic interneurons are key elements in neural coding, but the mechanisms that assemble inhibitory circuits remain unclear. In the spinal cord, the transfer of sensory signals to motor neurons is filtered by GABAergic interneurons that act presynaptically to inhibit sensory transmitter release and postsynaptically to inhibit motor neuron excitability. We show here that the connectivity and synaptic differentiation of GABAergic interneurons that mediate presynaptic inhibition is directed by their sensory targets. In the absence of sensory terminals these GABAergic neurons shun other available targets, fail to undergo presynaptic differentiation, and withdraw axons from the ventral spinal cord. A sensory-specific source of brain derived neurotrophic factor induces synaptic expression of the GABA synthetic enzyme GAD65 a defining biochemical feature of this set of interneurons. The organization of a GABAergic circuit that mediates presynaptic inhibition in the mammalian CNS is therefore controlled by a stringent program of sensory recognition and signaling.	[Betley, J. Nicholas; Jessell, Thomas M.; Kaltschmidt, Julia A.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA; [Betley, J. Nicholas; Jessell, Thomas M.; Kaltschmidt, Julia A.] Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Wright, Christopher V. E.] Vanderbilt Univ, Program Dev Biol, Dept Cell & Dev Biol, Nashville, TN 37240 USA; [Kawaguchi, Yoshiya] Kyoto Univ, Sch Med, Dept Surg & Surg Basic Sci, Kyoto 606, Japan; [Erdelyi, Ferenc; Szabo, Gabor] Hungarian Acad Sci, Inst Expt Med, Dept Gene Technol & Dev Neurobiol, Budapest, Hungary; [Kaltschmidt, Julia A.] Sloan Kettering Inst, Dev Biol Program, New York, NY 10003 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute; Vanderbilt University; Kyoto University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Memorial Sloan Kettering Cancer Center	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Kavli Inst Brain Sci, Dept Neurosci, New York, NY 10032 USA.	tmj1@columbia.edu	Szabo, Gabor/A-5087-2008	Szabo, Gabor/0000-0001-5438-5151	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033245] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NINDS NIH HHS [R01 NS 33245, R01 NS033245-16, R01 NS033245] Funding Source: Medline; PHS HHS [NIH 527975] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome TrustEuropean Commission)		Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; BURRY RW, 1982, BRAIN RES, V247, P1, DOI 10.1016/0006-8993(82)91022-8; CASH S, 1992, J NEUROSCI, V12, P2051; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chen HH, 2002, J NEUROSCI, V22, P3512; Conradi S, 1969, Acta Physiol Scand Suppl, V332, P5; ECCLES JC, 1961, J PHYSIOL-LONDON, V159, P147, DOI 10.1113/jphysiol.1961.sp006798; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Glasgow SM, 2005, DEVELOPMENT, V132, P5461, DOI 10.1242/dev.02167; Glickfeld LL, 2006, NAT NEUROSCI, V9, P807, DOI 10.1038/nn1688; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Holstein GR, 1999, NEUROSCIENCE, V93, P183, DOI 10.1016/S0306-4522(99)00140-2; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Huang ZJ, 2008, CURR OPIN NEUROBIOL, V18, P77, DOI 10.1016/j.conb.2008.05.008; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Hughes DI, 2005, P NATL ACAD SCI USA, V102, P9038, DOI 10.1073/pnas.0503646102; Jankowska E, 2008, J NEUROSCI, V28, P3615, DOI 10.1523/JNEUROSCI.0466-08.2008; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Kanaani J, 2002, J CELL BIOL, V158, P1229, DOI 10.1083/jcb.200205053; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; KIDD M, 1962, J ANAT, V96, P179; Kubota Y, 2000, J NEUROSCI, V20, P375, DOI 10.1523/JNEUROSCI.20-01-00375.2000; Li WC, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-17; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Monyer H, 2004, TRENDS NEUROSCI, V27, P90, DOI 10.1016/j.tins.2003.12.008; Ohba S, 2005, CEREB CORTEX, V15, P291, DOI 10.1093/cercor/bhh130; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; PENG HB, 1981, NATURE, V292, P831, DOI 10.1038/292831a0; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808; Rudomin P, 2009, EXP BRAIN RES, V196, P139, DOI 10.1007/s00221-009-1758-9; SANES DH, 1989, NEURON, V2, P1237, DOI 10.1016/0896-6273(89)90308-5; Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2; Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X; Shen K, 2004, CURR OPIN NEUROBIOL, V14, P83, DOI 10.1016/j.conb.2004.01.007; Smith TC, 2002, NAT NEUROSCI, V5, P760, DOI 10.1038/nn882; SOTELO C, 1990, J EXP BIOL, V153, P225; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013; Stepien AE, 2008, NEURON, V60, P1, DOI 10.1016/j.neuron.2008.09.030; Stevens CF, 2007, J NEUROPHYSIOL, V98, P3221, DOI 10.1152/jn.00857.2007; Thomson AM, 2002, J NEUROCYTOL, V31, P239, DOI 10.1023/A:1024117908539; Tian N, 1999, P NATL ACAD SCI USA, V96, P12911, DOI 10.1073/pnas.96.22.12911; Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042; WALBERG F, 1965, EXP NEUROL, V13, P218, DOI 10.1016/0014-4886(65)90111-1; Windhorst U, 1996, PROG NEUROBIOL, V49, P517, DOI 10.1016/0301-0082(96)00023-8	52	149	151	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					161	174		10.1016/j.cell.2009.08.027	http://dx.doi.org/10.1016/j.cell.2009.08.027			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804761	Bronze, Green Accepted			2022-12-28	WOS:000270388600024
J	Kambris, Z; Cook, PE; Phuc, HK; Sinkins, SP				Kambris, Zakaria; Cook, Peter E.; Phuc, Hoang K.; Sinkins, Steven P.			Immune Activation by Life-Shortening Wolbachia and Reduced Filarial Competence in Mosquitoes	SCIENCE			English	Article							ANOPHELES-GAMBIAE; AEDES-AEGYPTI; DROSOPHILA-MELANOGASTER; ANTIMICROBIAL PEPTIDES; BRUGIA-PAHANGI; PLASMODIUM; COMPLEMENT; INFECTION; SUSCEPTIBILITY; TRANSMISSION	Wolbachia strain wMelPop reduces the longevity of its Drosophila melanogaster host and, when introduced into the mosquito Aedes aegypti, halves its life span. We show that wMelPop induces up-regulation of the mosquito's innate immune system and that its presence inhibits the development of filarial nematodes in the mosquito. These data suggest that wMelPop could be used in the global effort to eliminate lymphatic filariasis and possibly for the control of other mosquito-borne parasites where immune preactivation inhibits their development. The cost of constitutive immune up-regulation may contribute to the life-shortening phenotype.	[Sinkins, Steven P.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Sinkins, SP (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	steven.sinkins@zoo.ox.ac.uk			Wellcome Trust; European Union's Framework Programme F7 [223241]; European Molecular Biology Organization; University of Oxford John Fell Fund	Wellcome Trust(Wellcome TrustEuropean Commission); European Union's Framework Programme F7; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); University of Oxford John Fell Fund	This study was supported by the Wellcome Trust, European Union's Framework Programme F7 award 223241, European Molecular Biology Organization, and University of Oxford John Fell Fund. We thank S. O'Neill for providing us with the wMelPop-infected and cured Ae. aegypti lines PGYP1 and PGYP1. tet; to E. Devaney, for providing Brugia pahangi and Refm Ae. aegypti; to M. Povelones, for assistance identifying Ae. aegypti LRIM genes; and to A. Brown for comments on the manuscript. Microarray data have been submitted to the National Center for Biotechnology Information Gene Expression Omnibus database, accession GSE17469.	Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Bourtzis K, 2000, INSECT MOL BIOL, V9, P635, DOI 10.1046/j.1365-2583.2000.00224.x; Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X; Burkot TR, 2002, ANN TROP MED PARASIT, V96, pS61, DOI 10.1179/000349802125002419; Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8; CHALK R, 1995, EXP PARASITOL, V80, P401, DOI 10.1006/expr.1995.1052; Cook PE, 2008, ADV EXP MED BIOL, V627, P126, DOI 10.1007/978-0-387-78225-6_11; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; GWADZ RW, 1989, INFECT IMMUN, V57, P2628, DOI 10.1128/IAI.57.9.2628-2633.1989; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Kim W, 2004, J MED ENTOMOL, V41, P447, DOI 10.1603/0022-2585-41.3.447; Libert S, 2006, AGING CELL, V5, P533, DOI 10.1111/j.1474-9726.2006.00251.x; Lowenberger CA, 1996, EXP PARASITOL, V83, P191, DOI 10.1006/expr.1996.0066; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; MEEK SR, 1982, ANN TROP MED PARASIT, V76, P347, DOI 10.1080/00034983.1982.11687551; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Rasgon JL, 2003, J MED ENTOMOL, V40, P125, DOI 10.1603/0022-2585-40.2.125; Sinkins SP, 2000, INSECT TRANSGENESIS, P271; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Wachinger M, 1998, J GEN VIROL, V79, P731, DOI 10.1099/0022-1317-79-4-731; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102	27	367	386	1	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					134	136		10.1126/science.1177531	http://dx.doi.org/10.1126/science.1177531			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797660	Green Accepted			2022-12-28	WOS:000270355600053
J	Manucharyan, VE; Koch, J; Glazman, LI; Devoret, MH				Manucharyan, Vladimir E.; Koch, Jens; Glazman, Leonid I.; Devoret, Michel H.			Fluxonium: Single Cooper-Pair Circuit Free of Charge Offsets	SCIENCE			English	Article							JOSEPHSON-JUNCTIONS; BLOCH OSCILLATIONS; QUANTUM; QUBIT; STATES; BOX	The promise of single Cooper-pair quantum circuits based on tunnel junctions for metrology and quantum information applications is severely limited by the influence of offset charges: random, slowly drifting microscopic charges inherent in many solid-state systems. By shunting a small junction with the Josephson kinetic inductance of a series array of large-capacitance tunnel junctions, thereby ensuring that all superconducting islands are connected to the circuit by at least one large junction, we have realized a new superconducting artificial atom that is totally insensitive to offset charges. Yet its energy levels manifest the anharmonic structure associated with single Cooper-pair effects, a useful component for solid-state quantum computation.	[Devoret, Michel H.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA	Yale University; Yale University	Devoret, MH (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06520 USA.	michel.devoret@yale.edu	Koch, Jens/GVT-0089-2022; Koch, Jens/G-6789-2011	Koch, Jens/0000-0002-5047-631X; Koch, Jens/0000-0002-5047-631X	NSF [DMR-0754613, DMR-032-5580]; National Security Agency through ARO [W911NF-05-01-0365]; Keck Foundation; Agence Nationale pour la Recherche [ANR07-CEXC-003]; College de France	NSF(National Science Foundation (NSF)); National Security Agency through ARO(National Security Agency); Keck Foundation(W.M. Keck Foundation); Agence Nationale pour la Recherche(French National Research Agency (ANR)); College de France	We acknowledge discussions with M. Brink, E. Boaknin, M. Metcalfe, R. Vijay, D. Schuster, L. DiCarlo, L. Frunzio, R. Schoelkopf, and S. Girvin. This research was supported by NSF under grants DMR-0754613 and DMR-032-5580, the National Security Agency through ARO grant no. W911NF-05-01-0365, the Keck Foundation, and the Agence Nationale pour la Recherche under grant ANR07-CEXC-003. M. H. D. acknowledges partial support from the College de France.	Abragam A., 1961, PRINCIPLES NUCL MAGN; AVERIN DV, 1985, ZH EKSP TEOR FIZ+, V88, P692; Bladh K, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/180; Bouchiat V, 1998, PHYS SCRIPTA, VT76, P165, DOI 10.1238/Physica.Topical.076a00165; Chiorescu I, 2003, SCIENCE, V299, P1869, DOI 10.1126/science.1081045; Friedman JR, 2000, NATURE, V406, P43, DOI 10.1038/35017505; GRABERT H, 1992, SINGLE CHARGE TUNNEL; JOSEPHSON BD, 1964, REV MOD PHYS, V36, P216, DOI 10.1103/RevModPhys.36.216; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; KUZMIN LS, 1991, PHYS REV LETT, V67, P2890, DOI 10.1103/PhysRevLett.67.2890; Leggett AJ, 2002, J PHYS-CONDENS MAT, V14, pR415, DOI 10.1088/0953-8984/14/15/201; LIKHAREV KK, 1985, J LOW TEMP PHYS, V59, P347, DOI 10.1007/BF00683782; Matveev KA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.096802; Metcalfe M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.174516; NAGOURNEY W, 1986, PHYS REV LETT, V56, P2797, DOI 10.1103/PhysRevLett.56.2797; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Schuster DI, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.123602; Vion D, 2002, SCIENCE, V296, P886, DOI 10.1126/science.1069372; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Watanabe M, 2001, PHYS REV LETT, V86, P5120, DOI 10.1103/PhysRevLett.86.5120; [No title captured]	24	383	386	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					113	116		10.1126/science.1175552	http://dx.doi.org/10.1126/science.1175552			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797655	Green Submitted			2022-12-28	WOS:000270355600046
J	Pagani, MR; Oishi, K; Gelb, BD; Zhong, Y				Pagani, Mario R.; Oishi, Kimihiko; Gelb, Bruce D.; Zhong, Yi			The Phosphatase SHP2 Regulates the Spacing Effect for Long-Term Memory Induction	CELL			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SYNAPTIC PLASTICITY; NOONAN-SYNDROME; ENCODING VARIABILITY; DISTRIBUTED PRACTICE; CONSOLIDATED MEMORY; MUTANT DROSOPHILA; KINASE; PTPN11; MUTATIONS	A property of long-term memory (LTM) induction is the requirement for repeated training sessions spaced over time. This augmentation of memory formation with spaced resting intervals is called the spacing effect. We now show that in Drosophila, the duration of resting intervals required for inducing LTM is regulated by activity levels of the protein tyrosine phosphatase corkscrew (CSW). Overexpression of wild-type CSW in mushroom body neurons shortens the inter-trial interval required for LTM induction, whereas overexpression of constitutively active CSW proteins prolongs these resting intervals. These gain-of-function csw mutations are associated with a clinical condition of mental retardation. Biochemical analysis reveals that LTM-inducing training regimens generate repetitive waves of CSW-dependent MAPK activation, the length of which appears to define the duration of the resting interval. Constitutively active CSW proteins prolong the resting interval by altering the MAPK inactivation cycle. We thus provide insight into the molecular basis of the spacing effect.	[Pagani, Mario R.; Zhong, Yi] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Oishi, Kimihiko; Gelb, Bruce D.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Oishi, Kimihiko; Gelb, Bruce D.] Mt Sinai Sch Med, Dept Genet, New York, NY 10029 USA; [Oishi, Kimihiko; Gelb, Bruce D.] Mt Sinai Sch Med, Dept Genom Sci, New York, NY 10029 USA; [Oishi, Kimihiko; Gelb, Bruce D.] Mt Sinai Sch Med, Ctr Mol Cardiol, New York, NY 10029 USA	Cold Spring Harbor Laboratory; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Zhong, Y (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zhongyi@cshl.edu		Oishi, Kimihiko/0000-0001-9446-8912; Zhong, Yi/0000-0001-7810-9899; Zhong, Yi/0000-0002-7927-5976	National Institutes of Health (NIH) [5R01 DC05784-05A1, HL71207]; Dept. of Army [W81XWH-05-1-0142]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005784] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Army; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank L. Rela, Y. Wang, J. Dubnau, and the Zhong's lab for discussion on the experiments, S. Yichun for gal80ts; gal4 lines, L. Perkins for csw hypomorphic lines and antibody, and J. Beshel for comments on the manuscript. This work was supported by grants to Y.Z. from the National Institutes of Health (NIH) 5R01 DC05784-05A1 and Dept. of Army W81XWH-05-1-0142 and to B. D. G. from NIH (HL71207). B. D. G. is an inventor on U. S. Patent 7,335,469 entitled "Methods for diagnosing Noonan syndrome.'' He and his institution receive royalties for genetic testing of PTPN11 for Noonan syndrome.	Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Appleton-Knapp SL, 2005, J CONSUM RES, V32, P266, DOI 10.1086/432236; Beck CDO, 2000, J NEUROSCI, V20, P2944; BENNETT AM, 1994, P NATL ACAD SCI USA, V91, P7335, DOI 10.1073/pnas.91.15.7335; BJORK RA, 1970, J VERB LEARN VERB BE, V9, P567, DOI 10.1016/S0022-5371(70)80103-7; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cammarota M, 2008, BEHAV BRAIN RES, V195, P120, DOI 10.1016/j.bbr.2007.11.029; CAREW TJ, 1972, SCIENCE, V175, P451, DOI 10.1126/science.175.4020.451; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Ebbinghaus H., 1885, MEMORY CONTRIBUTION; ESTES WK, 1955, PSYCHOL REV, V62, P369, DOI 10.1037/h0046888; FISHMAN EJ, 1968, J EDUC PSYCHOL, V59, P290, DOI 10.1037/h0020055; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FREEMAN RM, 1992, P NATL ACAD SCI USA, V89, P11239, DOI 10.1073/pnas.89.23.11239; Ge XC, 2004, P NATL ACAD SCI USA, V101, P10172, DOI 10.1073/pnas.0403497101; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Gerber B, 1998, NEUROBIOL LEARN MEM, V69, P71, DOI 10.1006/nlme.1997.3801; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Hintzman D. L., 1974, THEORIES COGNITIVE P, P77; Ho IS, 2007, J NEUROSCI, V27, P6852, DOI 10.1523/JNEUROSCI.0933-07.2007; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; IZAWA C, 1967, J EXP PSYCHOL, V75, P194, DOI 10.1037/h0024971; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kontaridis MI, 2004, MOL CELL BIOL, V24, P5340, DOI 10.1128/MCB.24.12.5340-5352.2004; LANDAUER TK, 1969, PSYCHOL REV, V76, P82, DOI 10.1037/h0026746; Lee T, 1999, DEVELOPMENT, V126, P4065; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; MARTIN E, 1968, PSYCHOL REV, V75, P421, DOI 10.1037/h0026301; Mayford M, 2007, CURR OPIN NEUROBIOL, V17, P313, DOI 10.1016/j.conb.2007.05.001; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; NOONAN JA, 1968, AM J DIS CHILD, V116, P373, DOI 10.1001/archpedi.1968.02100020377005; Oishi K, 2006, HUM MOL GENET, V15, P543, DOI 10.1093/hmg/ddi471; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Perkins LA, 1996, DEV BIOL, V180, P63, DOI 10.1006/dbio.1996.0285; Philips GT, 2007, J NEUROSCI, V27, P13701, DOI 10.1523/JNEUROSCI.4262-07.2007; Purcell AL, 2003, TRENDS NEUROSCI, V26, P625, DOI 10.1016/j.tins.2003.09.005; QUINN WG, 1976, NATURE, V262, P576, DOI 10.1038/262576a0; Sutton MA, 2002, LEARN MEMORY, V9, P29, DOI 10.1101/lm.44802; TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; WICKELGREN WA, 1970, MODELS MEMORY; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030	54	114	114	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					186	198		10.1016/j.cell.2009.08.033	http://dx.doi.org/10.1016/j.cell.2009.08.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804763	Green Accepted, Bronze			2022-12-28	WOS:000270388600026
J	Kwak, JH; Hu, JZ; Mei, D; Yi, CW; Kim, DH; Peden, CHF; Allard, LF; Szanyi, J				Kwak, Ja Hun; Hu, Jianzhi; Mei, Donghai; Yi, Cheol-Woo; Kim, Do Heui; Peden, Charles H. F.; Allard, Lawrence F.; Szanyi, Janos			Coordinatively Unsaturated Al3+ Centers as Binding Sites for Active Catalyst Phases of Platinum on gamma-Al2O3	SCIENCE			English	Article							GAMMA-ALUMINA SURFACES; SYSTEM; IONS; NMR; DFT	In many heterogeneous catalysts, the interaction of metal particles with their oxide support can alter the electronic properties of the metal and can play a critical role in determining particle morphology and maintaining dispersion. We used a combination of ultrahigh magnetic field, solid-state magic-angle spinning nuclear magnetic resonance spectroscopy, and high-angle annular dark-field scanning transmission electron microscopy coupled with density functional theory calculations to reveal the nature of anchoring sites of a catalytically active phase of platinum on the surface of a gamma-Al2O3 catalyst support material. The results obtained show that coordinatively unsaturated pentacoordinate Al3+ (Al-penta(3+)) centers present on the (100) facets of the gamma-Al2O3 surface are anchoring Pt. At low loadings, the active catalytic phase is atomically dispersed on the support surface (Pt/Al-penta(3+) = 1), whereas two-dimensional Pt rafts form at higher coverages.	[Kwak, Ja Hun; Hu, Jianzhi; Mei, Donghai; Kim, Do Heui; Peden, Charles H. F.; Szanyi, Janos] Pacific NW Natl Lab, Inst Interfacial Catalysis, Richland, WA 99352 USA; [Yi, Cheol-Woo] Sungshin Womens Univ, Inst Basic Sci, Seoul 136742, South Korea; [Yi, Cheol-Woo] Sungshin Womens Univ, Dept Chem, Seoul 136742, South Korea; [Allard, Lawrence F.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Sungshin Women's University; Sungshin Women's University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Kwak, JH (corresponding author), Pacific NW Natl Lab, Inst Interfacial Catalysis, POB 999,MSIN K8-87, Richland, WA 99352 USA.	Kwak@pnl.gov; chuck.peden@pnl.gov; janos.szanyi@pnl.gov	Yi, Cheol-Woo/B-3082-2010; Mei, Donghai/D-3251-2011; Hu, Jian Zhi/F-7126-2012; Kim, Heui/I-3727-2015; Kwak, Ja Hun/J-4894-2014; Mei, Donghai/A-2115-2012	Yi, Cheol-Woo/0000-0003-4549-5433; Mei, Donghai/0000-0002-0286-4182; Hu, Jian Zhi/0000-0001-8879-747X; Mei, Donghai/0000-0002-0286-4182; Peden, Charles/0000-0001-6754-9928	U. S. Department of Energy (DOE), Office of Science, Basic Energy Sciences, Division of Chemical Sciences; Office of Energy Efficiency and Renewable Energy, Vehicle Technologies Program; DOE [DE-AC05-76RL01830]	U. S. Department of Energy (DOE), Office of Science, Basic Energy Sciences, Division of Chemical Sciences(United States Department of Energy (DOE)); Office of Energy Efficiency and Renewable Energy, Vehicle Technologies Program(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE))	We gratefully acknowledge the U. S. Department of Energy (DOE), Office of Science, Basic Energy Sciences, Division of Chemical Sciences, and Office of Energy Efficiency and Renewable Energy, Vehicle Technologies Program, for the support of this work. The research described in this paper was primarily carried out in the Environmental Molecular Sciences Laboratory (EMSL), a national scientific user facility sponsored by the DOE's Office of Biological and Environmental Research and located at Pacific Northwest National Laboratory (PNNL). PNNL is operated for the DOE by Battelle Memorial Institute under contract number DE-AC05-76RL01830. Computing time was granted by National Energy Research Scientific Center (NERSC). The HR-STEM images were recorded at Oak Ridge National Laboratory's High Temperature Materials Laboratory, sponsored by the DOE, Office of Energy Efficiency and Renewable Energy, Vehicle Technologies Program.	CHEN FR, 1992, J CATAL, V133, P263, DOI 10.1016/0021-9517(92)90239-E; Chen MS, 2004, SCIENCE, V306, P252, DOI 10.1126/science.1102420; Digne M, 2004, J CATAL, V226, P54, DOI 10.1016/j.jcat.2004.04.020; Digne M, 2002, J CATAL, V211, P1, DOI 10.1006/jcat.2002.3741; Fitzgerald JJ, 1997, J AM CHEM SOC, V119, P7832, DOI 10.1021/ja970788u; Kang JH, 2006, J AM CHEM SOC, V128, P12068, DOI 10.1021/ja064207p; KOBAYASHI M, 1980, J CATAL, V64, P74, DOI 10.1016/0021-9517(80)90480-7; Kwak JH, 2008, J PHYS CHEM C, V112, P9486, DOI 10.1021/jp802631u; Kwak JH, 2007, J CATAL, V251, P189, DOI 10.1016/j.jcat.2007.06.029; Kwak JH, 2009, J CATAL, V261, P17, DOI 10.1016/j.jcat.2008.10.016; Lopez N, 2004, J CATAL, V225, P86, DOI 10.1016/j.jcat.2004.03.036; Seriani N, 2006, J PHYS CHEM B, V110, P14860, DOI 10.1021/jp063281r; Sohlberg K, 2004, CHEMPHYSCHEM, V5, P1893, DOI 10.1002/cphc.200400212; SPENADEL L, 1960, J PHYS CHEM-US, V64, P204, DOI 10.1021/j100831a004; TAUSTER SJ, 1981, SCIENCE, V211, P1121, DOI 10.1126/science.211.4487.1121; Vaarkamp M, 1996, J CATAL, V163, P294, DOI 10.1006/jcat.1996.0330; YAO HC, 1979, J CATAL, V59, P365, DOI 10.1016/S0021-9517(79)80005-6	17	619	637	40	789	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1670	1673		10.1126/science.1176745	http://dx.doi.org/10.1126/science.1176745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779194				2022-12-28	WOS:000270131800040
J	Rose, J; Hawthorn, RL; Watts, B; Singer, ME				Rose, Johnie; Hawthorn, Rachael L.; Watts, Brook; Singer, Mendel E.			Public health impact and cost effectiveness of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in India: model based analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ORAL CHOLERA VACCINE; 1ST 2 YEARS; LATIN-AMERICAN; DOUBLE-BLIND; CHILDREN; EFFICACY; INFANTS; DISEASE; GASTROENTERITIS; DIARRHEA	Objectives To examine the public health impact of mass vaccination with live attenuated human rotavirus vaccine (RIX4414) in a birth cohort in India, and to estimate the cost effectiveness and affordability of such a programme. Design Decision analytical Markov model encompassing all direct medical costs. Infection risk and severity depended on age, number of previous infections, and vaccination history; probabilities of use of inpatient and outpatient health services depended on symptom severity. Data sources Published clinical, epidemiological, and economic data. When possible, parameter estimates were based on data specific for India. Population Simulated Indian birth cohort followed for five years. Main outcome measures Decrease in rotavirus gastroenteritis episodes (non-severe and severe), deaths, outpatient visits, and admission to hospital; incremental cost effectiveness ratio of vaccination expressed as net cost in 2007 rupees per life year saved. Results In the base case, vaccination prevented 28 943 (29.7%) symptomatic episodes, 6981 (38.2%) severe episodes, 164 deaths (41.0%), 7178 (33.3%) outpatient visits, and 812 (34.3%) admissions to hospital per 100 000 children. Vaccination cost 8023 rupees ( about 100 pound, (sic)113, $165) per life year saved, less than India's per capita gross domestic product, a common criterion for cost effectiveness. The net programme cost would be equivalent to 11.6% of the 2006-7 budget of the Indian Department of Health and Family Welfare. Model results were most sensitive to variations in access to outpatient care for those with severe symptoms. If this parameter was increased to its upper limit, the incremental cost effectiveness ratio for vaccination still fell between one and three times the per capita gross domestic product, meeting the World Health Organization's criterion for "cost effective" interventions. Uncertainty analysis indicated a 94.7% probability that vaccination would be cost effective according to a criterion of one times per capita gross domestic product per life year saved, and a 97.8% probability that it would be cost effective according to a criterion of three times per capita gross domestic product. Conclusions Across a wide range of assumptions, mass RIX4414 vaccination in India would probably prevent substantial morbidity and mortality at a cost per life year saved below typical thresholds of cost effectiveness. The opportunity costs of such a programme in this or similar settings, however, should be weighed up carefully.	[Rose, Johnie; Singer, Mendel E.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Div Hlth Serv Res & Policy, Cleveland, OH 44106 USA; [Watts, Brook] Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Rose, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Div Hlth Serv Res & Policy, 10900 Euclid Ave,WG-57, Cleveland, OH 44106 USA.	johnie.rose@case.edu	Singer, Mendel/S-8775-2019; /AAB-7864-2021; /AHA-3700-2022	/0000-0001-7458-9303; /0000-0001-7458-9303; Singer, Mendel/0000-0002-3331-3340	US Department of Health and Human Services Agency for Healthcare Research and Quality	US Department of Health and Human Services Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	JR and RLH received support from a US Department of Health and Human Services Agency for Healthcare Research and Quality institutional training grant. No other direct funding was received for this study.	Angel J, 2007, NAT REV MICROBIOL, V5, P529, DOI 10.1038/nrmicro1692; [Anonymous], 2005, GUID EST EC BURD DIA; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Bahl R, 2005, J INFECT DIS, V192, pS114, DOI 10.1086/431497; Banerjee I, 2006, J CLIN MICROBIOL, V44, P2468, DOI 10.1128/JCM.01882-05; BLACK RE, 1989, AM J EPIDEMIOL, V129, P785, DOI 10.1093/oxfordjournals.aje.a115193; Briggs AH, 2000, PHARMACOECONOMICS, V17, P479, DOI 10.2165/00019053-200017050-00006; *CIA, 2008, WORLF FACTB; Clark HF, 1996, J INFECT DIS, V174, pS73, DOI 10.1093/infdis/174.Supplement_1.S73; CLEMENS JD, 1987, J INFECT DIS, V155, P79, DOI 10.1093/infdis/155.1.79; Cortese Margaret M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Dayan GH, 2001, VACCINE, V19, P4204, DOI 10.1016/S0264-410X(01)00160-8; De Vos B, 2009, PEDIATR INFECT DIS J, V28, P261, DOI 10.1097/INF.0b013e3181907177; De Wals P, 2004, VACCINE, V22, P1233, DOI 10.1016/j.vaccine.2003.09.022; Del Rio RA, 2006, HEPATOLOGY, V44, P1598, DOI 10.1002/hep.21409; Dennehy PH, 2008, CLIN MICROBIOL REV, V21, P198, DOI 10.1128/CMR.00029-07; Dennehy PH, 2007, VACCINE, V25, P3137, DOI 10.1016/j.vaccine.2007.01.102; DEZOYSA I, 1985, B WORLD HEALTH ORGAN, V63, P569; Fischer TK, 2005, J INFECT DIS, V192, P1720, DOI 10.1086/497339; Fischer TK, 2002, J INFECT DIS, V186, P593, DOI 10.1086/342294; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; GEORGESCOURBOT MC, 1991, RES VIROLOGY, V142, P405, DOI 10.1016/0923-2516(91)90008-Q; Glass RI, 2005, J INFECT DIS, V192, pS160, DOI 10.1086/431504; Glass RI, 2006, LANCET, V368, P323, DOI 10.1016/S0140-6736(06)68815-6; Global Advisory Committee on Vaccine Safety, 2008, WKLY EPIDEMIOL REC, V84, P37; HANLON P, 1987, LANCET, V1, P1342; *IND NAT INF CTR, 2007, UN BUDG 2007 2008; *IND PRWIRE, 2006, IND MICR NAT INV PLA; Isakbaeva ET, 2007, VACCINE, V25, P373, DOI 10.1016/j.vaccine.2006.07.029; Jaffe S, 2005, SCIENTIST, V19, P37; Jain Vivek, 2001, Indian Journal of Pediatrics, V68, P855, DOI 10.1007/BF02762113; JOHN TJ, 1976, BRIT MED J, V1, P812, DOI 10.1136/bmj.1.6013.812; Kim SY, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-29; Kotecha Prakash V, 2008, Indian J Community Med, V33, P9, DOI 10.4103/0970-0218.39235; Lahiri S, 2005, AM J IND MED, V48, P503, DOI 10.1002/ajim.20222; LANATA CF, 1989, J INFECT DIS, V159, P452, DOI 10.1093/infdis/159.3.452; LINHARES AC, 1989, EPIDEMIOL INFECT, V102, P129, DOI 10.1017/S0950268800029769; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; LOPEZ P, 2006, 24 ANN M EUR SOC INF; Madhavi Y, 2006, CURR SCI INDIA, V90, P1465; Mendelsohn AS, 2008, TROP MED INT HEALTH, V13, P934, DOI 10.1111/j.1365-3156.2008.02094.x; Minor PD, 2004, NAT REV MICROBIOL, V2, P473, DOI 10.1038/nrmicro906; Mrukowicz J, 2008, J PEDIATR GASTR NUTR, V46, pS32, DOI 10.1097/MPG.0b013e31816f79b0; Naghipour M, 2008, VACCINE, V26, P3236, DOI 10.1016/j.vaccine.2008.04.004; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; Parashar UD, 2006, SCIENCE, V312, P851, DOI 10.1126/science.1128827; Patel Archana B, 2003, Cost Eff Resour Alloc, V1, P7, DOI 10.1186/1478-7547-1-7; *PATH, 2006, P 7 INT S ROT ROT VA; Podewils LJ, 2005, J INFECT DIS, V192, pS133, DOI 10.1086/431513; Qadri F, 2007, VACCINE, V25, P231, DOI 10.1016/j.vaccine.2006.08.031; Rheingans RD, 2007, REV PANAM SALUD PUBL, V21, P205, DOI 10.1590/S1020-49892007000300003; Richie E, 2000, VACCINE, V18, P2399, DOI 10.1016/S0264-410X(00)00006-2; RODRIGUEZ WJ, 1987, PEDIATR INFECT DIS J, V6, P170, DOI 10.1097/00006454-198702000-00006; Rose J, 2008, PHARMACOECONOMICS, V26, P185, DOI 10.2165/00019053-200826030-00003; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; RUUSKA T, 1990, SCAND J INFECT DIS, V22, P259, DOI 10.3109/00365549009027046; Samajdar S, 2008, J CLIN VIROL, V43, P334, DOI 10.1016/j.jcv.2008.07.007; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Sharma S, 2008, J CLIN MICROBIOL, V46, P1343, DOI 10.1128/JCM.02358-07; SIMHON A, 1985, J INFECT DIS, V152, P1134, DOI 10.1093/infdis/152.6.1134; Sisk JE, 2003, ANN INTERN MED, V138, P960, DOI 10.7326/0003-4819-138-12-200306170-00007; STEELE AD, 2008, VACCINE         0908; Thiry N, 2009, INT J TECHNOL ASSESS, V25, P161, DOI 10.1017/S0266462309090217; *USAID MICR PROGR, 2005, DIARRH TREATM GUID I; Valencia-Mendoza A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-103; Velazquez FR, 1996, NEW ENGL J MED, V335, P1022, DOI 10.1056/NEJM199610033351404; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; WHO, 2009, WKLY EPIDEMIOL REC, V84, P213; *WHO, 2008, IMM PROF IND; *WHO, 2006, LIF TABL WHO MEMB ST; World Bank, 2008, WORLD BANK COUNTRY, P1, DOI 10.1596/978-0-8213-7462-7; World Health Organisation, 2009, EST ROT DEATHS CHILD; World Health Organization, 2007, Wkly Epidemiol Rec, V82, P285; World Health Organization, 2001, NAT BURD DIS STUD PR; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zahn M, 2006, PEDIATR ANN, V35, P23, DOI 10.3928/0090-4481-20060101-10; ZAKI AM, 1986, AM J TROP MED HYG, V35, P1013, DOI 10.4269/ajtmh.1986.35.1013; Zaman K, 2009, VACCINE, V27, P1333, DOI 10.1016/j.vaccine.2008.12.059	79	38	38	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2009	339								b3653	10.1136/bmj.b3653	http://dx.doi.org/10.1136/bmj.b3653			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OH	19783581	Green Published, hybrid			2022-12-28	WOS:000270231900002
J	Sturgeon, CM; Lai, LC; Duffy, MJ				Sturgeon, C. M.; Lai, L. C.; Duffy, M. J.			Serum tumour markers: how to order and interpret them	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MEDICINE PRACTICE GUIDELINES; PROSTATE-CANCER; NATIONAL ACADEMY; DIAGNOSIS; MORTALITY; AUDIT		[Sturgeon, C. M.] Royal Infirm Edinburgh NHS Trust, Dept Clin Biochem, Edinburgh EH16 4SA, Midlothian, Scotland; [Lai, L. C.] Int Med Univ, Fac Med, Kuala Lumpur 57000, Malaysia; [Duffy, M. J.] St Vincents Univ Hosp, Dept Pathol & Lab Med, Dublin 4, Ireland; [Duffy, M. J.] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, UCD Sch Med & Med Sci, Dublin 4, Ireland	Royal Infirmary of Edinburgh; University of Edinburgh; International Medical University Malaysia; University College Dublin; Saint Vincent's University Hospital; University College Dublin	Sturgeon, CM (corresponding author), Royal Infirm Edinburgh NHS Trust, Dept Clin Biochem, Edinburgh EH16 4SA, Midlothian, Scotland.	C.Sturgeon@ed.ac.uk	Duffy, Michael/J-5610-2019	Duffy, Michael/0000-0002-9259-6619				*AM CANC SOC, 2009, CAN PROST CANC BE FO; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Barry MJ, 2009, NEW ENGL J MED, V360, P1351, DOI 10.1056/NEJMe0901166; *DEP HLTH, 2009, KEY MESS OV CANC HLT; Duffy MJ, 2010, ANN ONCOL, V21, P441, DOI 10.1093/annonc/mdp332; Duffy MJ, 2009, EUR J CANCER, V45, P335, DOI 10.1016/j.ejca.2008.12.008; Duffy MJ, 2008, CLIN CHEM, V54, P1770, DOI 10.1373/clinchem.2008.110056; Duffy MJ, 2007, EUR J INTERN MED, V18, P175, DOI 10.1016/j.ejim.2006.12.001; Duffy MJ, 2004, ANN CLIN BIOCHEM, V41, P370, DOI 10.1258/0004563041731529; Fleming LW, 2001, SCOT MED J, V46, P81, DOI 10.1177/003693300104600306; Graham J, 2008, BRIT MED J, V336, P610, DOI 10.1136/bmj.39498.525706.AD; Hellstrom I, 2003, CANCER RES, V63, P3695; Kilpatrick ES, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3111; Krege S, 2008, EUR UROL, V53, P478, DOI 10.1016/j.eururo.2007.12.024; Lai L C, 2003, Malays J Pathol, V25, P83; McDonnell M, 2004, ANN CLIN BIOCHEM, V41, P378, DOI 10.1258/0004563041731655; McGinley PJ, 2003, ANN CLIN BIOCHEM, V40, P643, DOI 10.1258/000456303770367234; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; *NAT COMPR CANC NE, 2009, NCCN CLIN PRACT GUID; Ntaios G, 2009, EUR J INTERN MED, V20, pE66, DOI 10.1016/j.ejim.2008.07.026; Rustin GJ, 2009, J CLIN ONCOL, V27, p18s; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Smith A, 2006, BRIT J HAEMATOL, V132, P410, DOI 10.1111/j.1365-2141.2005.05867.x; Sturgeon C, 2002, CLIN CHEM, V48, P1151; STURGEON C, 2005, CLIN VALUE PSA, P28; Sturgeon CM, 2008, CLIN CHEM, V54, pE11, DOI 10.1373/clinchem.2008.105601; Sturgeon CM, 2008, CLIN CHEM, V54, pE1, DOI 10.1373/clinchem.2007.094144; Sturgeon CM, 1996, EUR J CLIN CHEM CLIN, V34, P755; WANEBO HJ, 1978, NEW ENGL J MED, V299, P448, DOI 10.1056/NEJM197808312990904; Wang R, 2009, CANCER-AM CANCER SOC, V115, P3879, DOI 10.1002/cncr.24447	30	55	58	1	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2009	339								b3527	10.1136/bmj.b3527	http://dx.doi.org/10.1136/bmj.b3527			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OE	19773328				2022-12-28	WOS:000270231500005
J	Evans, KE; McAllister, R; Sanders, DS				Evans, Kate E.; McAllister, Ruth; Sanders, David S.			Should we screen for coeliac disease? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GLUTEN-FREE DIET; COST-EFFECTIVENESS ANALYSIS; POPULATION-BASED COHORT; ADULTS; IMPACT; RISK; MASS		[McAllister, Ruth; Sanders, David S.] Sheffield Teaching Hosp Trust, Dept Gastroenterol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Sanders, DS (corresponding author), Sheffield Teaching Hosp Trust, Dept Gastroenterol, Sheffield S10 2JF, S Yorkshire, England.	david.sanders@sth.nhs.uk						Corazza GR, 1996, BONE, V18, P525, DOI 10.1016/8756-3282(96)00071-3; Fabiani E, 2000, J PEDIATR-US, V136, P841, DOI 10.1016/S0022-3476(00)35904-2; Hallert C, 2002, SCAND J GASTROENTERO, V37, P39, DOI 10.1080/003655202753387338; Hopper AD, 2008, CLIN GASTROENTEROL H, V6, P314, DOI 10.1016/j.cgh.2007.12.008; Hopper AD, 2007, BMJ-BRIT MED J, V334, P729, DOI 10.1136/bmj.39133.668681.BE; Korponay-Szabo IR, 2007, BMJ-BRIT MED J, V335, P1244, DOI 10.1136/bmj.39405.472975.80; Leffler DA, 2008, DIGEST DIS SCI, V53, P1573, DOI 10.1007/s10620-007-0055-3; Lohi S, 2009, GUT, V58, P643, DOI 10.1136/gut.2007.140970; Marine M, 2009, WORLD J GASTROENTERO, V15, P1331, DOI 10.3748/wjg.15.1331; Mein SM, 2004, ALIMENT PHARM THER, V19, P1199, DOI 10.1111/j.1365-2036.2004.01958.x; Nachman F, 2009, DIGEST LIVER DIS, V41, P15, DOI 10.1016/j.dld.2008.05.011; *NAT I HLTH CLIN E, 2008, NICE CLIN GUID, V61; National Institute of Health and Clinical Excellence, 2009, NICE CLIN GUID; Shamir R, 2006, MED DECIS MAKING, V26, P282, DOI 10.1177/0272989X06289012; Simell S, 2007, AM J GASTROENTEROL, V102, P2026, DOI 10.1111/j.1572-0241.2007.01360.x; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; West J, 2004, ALIMENT PHARM THERAP, V20, P73, DOI 10.1111/j.1365-2036.2004.02008.x	17	19	19	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2009	339								b3674	10.1136/bmj.b3674	http://dx.doi.org/10.1136/bmj.b3674			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RU	19762414				2022-12-28	WOS:000269994900004
J	MacMahon, S; Yan, LJ				MacMahon, Stephen; Yan, Lijing			Responding to China's hypertensive crisis	LANCET			English	Editorial Material							HEALTH		[MacMahon, Stephen] Univ Sydney, George Inst, Sydney, NSW 2050, Australia; [Yan, Lijing] Peking Univ, Hlth Sci Ctr, George Inst China, Beijing 100871, Peoples R China	University of Sydney; Peking University	MacMahon, S (corresponding author), Univ Sydney, George Inst, Sydney, NSW 2050, Australia.	smacmahon@george.org.au		MacMahon, Stephen/0000-0003-2064-7699				[Anonymous], 2009, LANCET, V373, P2084, DOI 10.1016/S0140-6736(09)61129-6; Han QD, 2008, LANCET, V372, P1439, DOI 10.1016/S0140-6736(08)61350-1; HE G, 2009, LANCET, DOI DOI 10.1016/S0140-6736(09)61199-5; Joshi R, 2008, J AM COLL CARDIOL, V52, P1817, DOI 10.1016/j.jacc.2008.08.049; Li N, 2007, J HYPERTENS, V25, P2011, DOI 10.1097/HJH.0b013e3282b9714b; Rodgers A, 2004, J HYPERTENS, V22, P653, DOI 10.1097/00004872-200403000-00030; Sridhar D, 2008, LANCET, V372, P1185, DOI 10.1016/S0140-6736(08)61485-3; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; United Nations Development Programme (UNDP), 2008, HUM DEV REP 2007 200; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20	10	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2009	374	9703					1728	1729		10.1016/S0140-6736(09)61489-6	http://dx.doi.org/10.1016/S0140-6736(09)61489-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	525ID	19811815				2022-12-28	WOS:000272207700006
J	Pritchard, HD; Arthern, RJ; Vaughan, DG; Edwards, LA				Pritchard, Hamish D.; Arthern, Robert J.; Vaughan, David G.; Edwards, Laura A.			Extensive dynamic thinning on the margins of the Greenland and Antarctic ice sheets	NATURE			English	Article							SEA-LEVEL RISE; MASS-BALANCE; ACCELERATION; GLACIERS	Many glaciers along the margins of the Greenland and Antarctic ice sheets are accelerating and, for this reason, contribute increasingly to global sea-level rise(1-7). Globally, ice losses contribute similar to 1.8 mm yr(-1) (ref. 8), but this could increase if the retreat of ice shelves and tidewater glaciers further enhances the loss of grounded ice(9) or initiates the large-scale collapse of vulnerable parts of the ice sheets(10). Ice loss as a result of accelerated flow, known as dynamic thinning, is so poorly understood that its potential contribution to sea level over the twenty-first century remains unpredictable(11). Thinning on the ice-sheet scale has been monitored by using repeat satellite altimetry observations to track small changes in surface elevation, but previous sensors could not resolve most fast-flowing coastal glaciers(12). Here we report the use of high-resolution ICESat (Ice, Cloud and land Elevation Satellite) laser altimetry to map change along the entire grounded margins of the Greenland and Antarctic ice sheets. To isolate the dynamic signal, we compare rates of elevation change from both fast-flowing and slow-flowing ice with those expected from surface mass-balance fluctuations. We find that dynamic thinning of glaciers now reaches all latitudes in Greenland, has intensified on key Antarctic grounding lines, has endured for decades after ice-shelf collapse, penetrates far into the interior of each ice sheet and is spreading as ice shelves thin by ocean-driven melt. In Greenland, glaciers flowing faster than 100 m yr(-1) thinned at an average rate of 0.84 m yr(-1), and in the Amundsen Sea embayment of Antarctica, thinning exceeded 9.0 m yr(-1) for some glaciers. Our results show that the most profound changes in the ice sheets currently result from glacier dynamics at ocean margins.	[Pritchard, Hamish D.; Arthern, Robert J.; Vaughan, David G.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England; [Edwards, Laura A.] Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Bristol	Pritchard, HD (corresponding author), British Antarctic Survey, NERC, Madingley Rd, Cambridge CB3 0ET, England.	hprit@bas.ac.uk	Pritchard, Hamish Daniel/AAU-4696-2021; Vaughan, David/C-8348-2011	Vaughan, David/0000-0002-9065-0570	UK Natural Environment Research Council; NERC [earth010003, bas010018] Funding Source: UKRI; Natural Environment Research Council [bas010018, earth010003] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We are extremely grateful to the ICESat science team and all those at NASA involved in producing the ICESat data products distributed through the US National Snow and Ice Data Center. This work was funded by the UK Natural Environment Research Council.	Abshire JB, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024028; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Davis CH, 2005, SCIENCE, V308, P1898, DOI 10.1126/science.1110662; Helsen MM, 2008, SCIENCE, V320, P1626, DOI 10.1126/science.1153894; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Joughin I, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001029; Joughin I, 2002, SCIENCE, V295, P476, DOI 10.1126/science.1066875; Joughin I, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2008JF001023; Krabill W, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021533; Liu HX, 1999, J GEOPHYS RES-SOL EA, V104, P23199, DOI 10.1029/1999JB900224; Meier MF, 2007, SCIENCE, V317, P1064, DOI 10.1126/science.1143906; Mohr JJ, 2003, J GLACIOL, V49, P210, DOI 10.3189/172756503781830791; Pritchard HD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000597; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rignot E, 2002, SCIENCE, V297, P1502, DOI 10.1126/science.1073888; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Rignot E, 2006, PHILOS T R SOC A, V364, P1637, DOI 10.1098/rsta.2006.1793; Scambos TA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020670; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Scott JBT, 2009, CRYOSPHERE, V3, P125, DOI 10.5194/tc-3-125-2009; Shepherd A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021106; Shepherd A, 2003, SCIENCE, V302, P856, DOI 10.1126/science.1089768; Smith BE, 2005, GEOPHYS RES LETT, V32, DOI [10.1029/2005GL024365, 10.1029/2005GL022879]; Sole A, 2008, CRYOSPHERE, V2, P205, DOI 10.5194/tc-2-205-2008; Thomas R, 2004, SCIENCE, V306, P255, DOI 10.1126/science.1099650; Velicogna I, 2006, NATURE, V443, P329, DOI 10.1038/nature05168; Vieli A, 2001, J GLACIOL, V47, P595, DOI 10.3189/172756501781831747; Wingham DJ, 2006, PHILOS T R SOC A, V364, P1627, DOI 10.1098/rsta.2006.1792; Zwally HJ, 2005, J GLACIOL, V51, P509, DOI 10.3189/172756505781829007; ZWALLY HJ, 2007, GLAS ICESAT L2 ANTAR	31	671	700	7	356	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					971	975		10.1038/nature08471	http://dx.doi.org/10.1038/nature08471			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19776741				2022-12-28	WOS:000270817700045
J	Steinbrook, R				Steinbrook, Robert			Drug Shortages and Public Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Lauer MS, 2009, NEW ENGL J MED, V361, P841, DOI 10.1056/NEJMp0904735; National Research Council Committee on Medical Isotope Production Without Highly Enriched Uranium, 2009, MED IS PROD HIGHL EN	3	25	26	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2009	361	16					1525	1527		10.1056/NEJMp0906922	http://dx.doi.org/10.1056/NEJMp0906922			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	506LT	19828529				2022-12-28	WOS:000270777000003
J	Ji, JF; Shi, J; Budhu, A; Yu, ZP; Forgues, M; Roessler, S; Ambs, S; Chen, YD; Meltzer, PS; Croce, CM; Qin, LX; Man, K; Lo, CM; Lee, J; Ng, IOL; Fan, J; Tang, ZY; Sun, HC; Wang, XW				Ji, Junfang; Shi, Jiong; Budhu, Anuradha; Yu, Zhipeng; Forgues, Marshonna; Roessler, Stephanie; Ambs, Stefan; Chen, Yidong; Meltzer, Paul S.; Croce, Carlo M.; Qin, Lun-Xiu; Man, Kwan; Lo, Chung-Mau; Lee, Joyce; Ng, Irene O. L.; Fan, Jia; Tang, Zhao-You; Sun, Hui-Chuan; Wang, Xin Wei			MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATOCELLULAR-CARCINOMA; GENDER; PROFILES; INTERLEUKIN-6; RECURRENCE; PROGNOSIS; SIGNATURE; RESECTION; FEMALE	Background Hepatocellular carcinoma is a common and aggressive cancer that occurs mainly in men. We examined microRNA expression patterns, survival, and response to interferon alfa in both men and women with the disease. Methods We analyzed three independent cohorts that included a total of 455 patients with hepatocellular carcinoma who had undergone radical tumor resection between 1999 and 2003. MicroRNA-expression profiling was performed in a cohort of 241 patients with hepatocellular carcinoma to identify tumor-related microRNAs and determine their association with survival in men and women. In addition, to validate our findings, we used quantitative reverse-transcriptase-polymerase-chain-reaction assays to measure microRNAs and assess their association with survival and response to therapy with interferon alfa in 214 patients from two independent, prospective, randomized, controlled trials of adjuvant interferon therapy. Results In patients with hepatocellular carcinoma, the expression of miR-26a and miR-26b in nontumor liver tissue was higher in women than in men. Tumors had reduced levels of miR-26 expression, as compared with paired noncancerous tissues, which indicated that the level of miR-26 expression was also associated with hepatocellular carcinoma. Moreover, tumors with reduced miR-26 expression had a distinct transcriptomic pattern, and analyses of gene networks revealed that activation of signaling pathways between nuclear factor kappa B and interleukin-6 might play a role in tumor development. Patients whose tumors had low miR-26 expression had shorter overall survival but a better response to interferon therapy than did patients whose tumors had high expression of the microRNA. Conclusions The expression patterns of microRNAs in liver tissue differ between men and women with hepatocellular carcinoma. The miR-26 expression status of such patients is associated with survival and response to adjuvant therapy with interferon alfa.	[Ji, Junfang; Shi, Jiong; Budhu, Anuradha; Yu, Zhipeng; Forgues, Marshonna; Roessler, Stephanie; Wang, Xin Wei] NCI, Liver Carcinogenesis Sect, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Ambs, Stefan] NCI, Breast & Prostate Unit, Human Carcinogenesis Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Chen, Yidong; Meltzer, Paul S.] NCI, Genet Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Shi, Jiong; Qin, Lun-Xiu; Fan, Jia; Tang, Zhao-You; Sun, Hui-Chuan] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Shi, Jiong; Qin, Lun-Xiu; Fan, Jia; Tang, Zhao-You; Sun, Hui-Chuan] Fudan Univ, Liver Canc Inst, Shanghai 200433, Peoples R China; [Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Man, Kwan; Lo, Chung-Mau] Univ Hong Kong, Dept Surg, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Lee, Joyce; Ng, Irene O. L.] Univ Hong Kong, Dept Pathol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fudan University; Fudan University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Hong Kong; University of Hong Kong	Wang, XW (corresponding author), NCI, Liver Carcinogenesis Sect, Ctr Canc Res, NIH, 37 Convent Dr,Bldg 37,Rm 3044A, Bethesda, MD 20892 USA.	sun.huichuan@zs-hospital.sh.cn; xw3u@nih.gov	Wang, Xin Wei/B-6162-2009; Roessler, Stephanie/J-8432-2019; Fan, Jia/C-6689-2017; Young, Richard A/F-6495-2012	Wang, Xin Wei/0000-0001-9735-606X; Roessler, Stephanie/0000-0002-5333-5942; Young, Richard A/0000-0001-8855-8647; Sun, Hui-Chuan/0000-0003-3761-7058; Ambs, Stefan/0000-0001-7651-9309; Ng, Irene Oi-lin/0000-0001-7532-2029	Intramural Research Program of the Center for Cancer Research of the National Cancer Institute [Z01-BC 010313, Z01-BC 010876]; NATIONAL CANCER INSTITUTE [Z01BC010876, Z01BC010313, ZIABC011091, ZIABC010886] Funding Source: NIH RePORTER	Intramural Research Program of the Center for Cancer Research of the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by grants (Z01-BC 010313 and Z01-BC 010876) from the Intramural Research Program of the Center for Cancer Research of the National Cancer Institute.	Ashizawa Tatsuto, 2005, Gastric Cancer, V8, P124, DOI 10.1007/s10120-005-0315-x; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Clavien PA, 2007, ANN SURG, V245, P843, DOI 10.1097/SLA.0b013e31805d0788; Dohmen K, 2003, J GASTROEN HEPATOL, V18, P267, DOI 10.1046/j.1440-1746.2003.02936.x; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Ghebranious N, 1998, HEPATOLOGY, V27, P383, DOI 10.1002/hep.510270211; Kim JW, 2004, HEPATOLOGY, V39, P518, DOI 10.1002/hep.20053; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lo CM, 2007, ANN SURG, V245, P831, DOI 10.1097/01.sla.0000245829.00977.45; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Nakatani T, 2001, JPN J CANCER RES, V92, P249, DOI 10.1111/j.1349-7006.2001.tb01089.x; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; NG IOL, 1995, CANCER, V75, P18, DOI 10.1002/1097-0142(19950101)75:1<18::AID-CNCR2820750105>3.0.CO;2-#; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Porta C, 2008, ANN ONCOL, V19, P353, DOI 10.1093/annonc/mdm448; Rogers AB, 2007, CANCER RES, V67, P11536, DOI 10.1158/0008-5472.CAN-07-1479; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Sun HC, 2006, J CANCER RES CLIN, V132, P458, DOI 10.1007/s00432-006-0091-y; Tangkijvanich P, 2004, WORLD J GASTROENTERO, V10, P1547, DOI 10.3748/wjg.v10.i11.1547; Thyrell L, 2007, EXP CELL RES, V313, P4015, DOI 10.1016/j.yexcr.2007.08.007; Wands J, 2007, NEW ENGL J MED, V357, P1974, DOI 10.1056/NEJMcibr075652; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025	25	656	739	1	93	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2009	361	15					1437	1447		10.1056/NEJMoa0901282	http://dx.doi.org/10.1056/NEJMoa0901282			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503MU	19812400	Green Accepted, Green Published			2022-12-28	WOS:000270540000005
J	Patel, K; Wells, K				Patel, Kavita; Wells, Kenneth			Applying Health Care Reform Principles to Mental Health and Substance Abuse Services	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wells, Kenneth] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA; [Patel, Kavita] White House, Off Publ Engagement & Intergovt Affairs, Washington, DC USA; [Wells, Kenneth] Univ Calif Los Angeles, David Geffen Sch Med, Jane & Terry Semel Inst Neurosci & Human Behav, Dept Psychiat, Los Angeles, CA 90095 USA; [Wells, Kenneth] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biobehav Sci, Los Angeles, CA 90095 USA; [Wells, Kenneth] RAND Hlth Program, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RAND Corporation	Wells, K (corresponding author), Univ Calif Los Angeles, Sch Publ Hlth, 10920 Wilshire Blvd,Ste 300, Los Angeles, CA 90024 USA.	kwells@mednet.ucla.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078853, P30MH082760] Funding Source: NIH RePORTER; NIMH NIH HHS [1P30MH082760-01, R01 MH078853-02, R01 MH078853, P30 MH082760] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Committee on Crossing the Quality Chasm Adaptation to Mental Health Addictive Disorders, 2006, IMPR QUAL HLTH CAR M; Frank R. G., 2006, BETTER NOT WELL MENT; Frank RG, 2007, ANNU REV PUBL HEALTH, V28, P303, DOI 10.1146/annurev.publhealth.28.021406.144029; Office of the Surgeon General, 2019, SURG GEN ADV MAR US; Patel KK, 2006, HEALTH AFFAIR, V25, P681, DOI 10.1377/hlthaff.25.3.681; *US DEP HHS, PREV MENT DIS; *US DEP HHS, PROGR CAMP	7	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	2009	302	13					1463	1464		10.1001/jama.2009.1446	http://dx.doi.org/10.1001/jama.2009.1446			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	503CL	19809029	Green Accepted			2022-12-28	WOS:000270509600023
J	Hung, DZ; Tsan, YT; Yu, YJ; Hsu, CL				Hung, Dong-Zong; Tsan, Yu-Tse; Yu, Yi-Jung; Hsu, Chia-Lung			Cyanide poisoning in Taiwan	LANCET			English	Editorial Material									[Hung, Dong-Zong] China Med Univ Hosp, Div Toxicol, Trauma & Emergency Ctr, Taichung 404, Taiwan; [Tsan, Yu-Tse; Yu, Yi-Jung; Hsu, Chia-Lung] Taichung Vet Gen Hosp, Div Toxicol, Emergency Dept, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; Taichung Veterans General Hospital	Hung, DZ (corresponding author), China Med Univ Hosp, Div Toxicol, Trauma & Emergency Ctr, 2 Yu Der Rd, Taichung 404, Taiwan.	hung02241956@yahoo.com.tw						BALLANTYNE B, 1987, CLIN EXPT TOXICOLOGY, P41; Baud FJ, 2002, CRIT CARE MED, V30, P2044, DOI 10.1097/00003246-200209000-00015; Laffey JG, 2002, NEW ENGL J MED, V347, P43, DOI 10.1056/NEJMra012457; Mycyk Mark B, 2006, Am J Ther, V13, P485, DOI 10.1097/01.mjt.0000208878.53856.a5; RTI International, 2006, Clin Toxicol (Phila), V44 Suppl 1, P47	5	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2009	374	9696					1212	1212		10.1016/S0140-6736(09)61033-3	http://dx.doi.org/10.1016/S0140-6736(09)61033-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505IZ	19801099				2022-12-28	WOS:000270688200038
J	Buluta, I; Nori, F				Buluta, Iulia; Nori, Franco			Quantum Simulators	SCIENCE			English	Review							MOTT INSULATOR; SPIN; GAS; COMPUTATION; ALGORITHM; VORTICES; PHYSICS; MODEL; ATOMS	Quantum simulators are controllable quantum systems that can be used to simulate other quantum systems. Being able to tackle problems that are intractable on classical computers, quantum simulators would provide a means of exploring new physical phenomena. We present an overview of how quantum simulators may become a reality in the near future as the required technologies are now within reach. Quantum simulators, relying on the coherent control of neutral atoms, ions, photons, or electrons, would allow studying problems in various fields including condensed-matter physics, high-energy physics, cosmology, atomic physics, and quantum chemistry.	[Nori, Franco] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Buluta, Iulia; Nori, Franco] RIKEN, Adv Sci Inst, Wako, Saitama 3510198, Japan; [Nori, Franco] Univ Michigan, Ctr Theoret Phys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; RIKEN; University of Michigan System; University of Michigan	Nori, F (corresponding author), RIKEN, Adv Sci Inst, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	fnori@riken.jp	Georgescu, Iulia/C-6453-2008; Nori, Franco/B-1222-2009	Nori, Franco/0000-0003-3682-7432	National Security Agency (NSA); Laboratory for Physical Sciences (LPS); Army Research Office (ARO); NSF [EIA-0130383]	National Security Agency (NSA)(National Security Agency); Laboratory for Physical Sciences (LPS); Army Research Office (ARO); NSF(National Science Foundation (NSF))	F. N. acknowledges partial support from the National Security Agency (NSA), Laboratory for Physical Sciences (LPS), Army Research Office (ARO), and NSF grant no. EIA-0130383. The authors declare no competing financial interests.	Abrams DS, 1997, PHYS REV LETT, V79, P2586, DOI 10.1103/PhysRevLett.79.2586; Abrams DS, 1999, PHYS REV LETT, V83, P5162, DOI 10.1103/PhysRevLett.83.5162; Aguado M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.260501; Ahufinger V, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.063616; Alsing PM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.220401; Aspuru-Guzik A, 2005, SCIENCE, V309, P1704, DOI 10.1126/science.1113479; Barjaktarevic JP, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.012335; Benenti G, 2008, AM J PHYS, V76, P657, DOI 10.1119/1.2894532; Bermudez A, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.041801; Billy J, 2008, NATURE, V453, P891, DOI 10.1038/nature07000; Boghosian BM, 1998, PHYS REV E, V57, P54, DOI 10.1103/PhysRevE.57.54; Bravyi S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.070503; Brown KR, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050504; Brown KR, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.022327; Buchler HP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.040402; Byrnes T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.016405; Byrnes T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075320; Chiaverini J, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.022324; Cho J, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.062338; Deng XL, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.033403; Deng XL, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.063407; Dur W, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.052325; Emerson J, 2007, SCIENCE, V317, P1893, DOI 10.1126/science.1145699; Fallani L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.130404; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Fischer UR, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.063615; Friedenauer A, 2008, NAT PHYS, V4, P757, DOI 10.1038/nphys1032; Garcia-Ripoll JJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.250405; Garcia-Ripoll JJ, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.024522; Grajcar M, 2008, NAT PHYS, V4, P612, DOI 10.1038/nphys1019; Greentree AD, 2006, NAT PHYS, V2, P856, DOI 10.1038/nphys466; Han YJ, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.150404; Hartmann MJ, 2006, NAT PHYS, V2, P849, DOI 10.1038/nphys462; HORSTMANN B, 2009, ARXIV09044801V1; Howell JC, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.012304; Jaksch D, 2005, ANN PHYS-NEW YORK, V315, P52, DOI 10.1016/j.aop.2004.09.010; Jane E, 2003, QUANTUM INF COMPUT, V3, P15; Kassal I, 2008, P NATL ACAD SCI USA, V105, P18681, DOI 10.1073/pnas.0808245105; Kay A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/20001; Kitaev AY, 2003, ANN PHYS-NEW YORK, V303, P2, DOI 10.1016/S0003-4916(02)00018-0; Lamata L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.253005; LANYON BP, 2009, ARXIV09050887V3; Leibfried D, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.247901; Lewenstein M, 2007, ADV PHYS, V56, P243, DOI 10.1080/00018730701223200; Lidar DA, 1999, PHYS REV E, V59, P2429, DOI 10.1103/PhysRevE.59.2429; Lidar DA, 1997, PHYS REV E, V56, P3661, DOI 10.1103/PhysRevE.56.3661; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Lu CY, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.030502; Manousakis E, 2002, J LOW TEMP PHYS, V126, P1501, DOI 10.1023/A:1014295416763; Mostame S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.220501; NATION PD, 2009, ARXIV09042589V1; Neeley M, 2009, SCIENCE, V325, P722, DOI 10.1126/science.1173440; Negrevergne C, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.032344; Nori F, 2008, NAT PHYS, V4, P589, DOI 10.1038/nphys1044; Nori F, 2009, SCIENCE, V325, P689, DOI 10.1126/science.1178828; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; Philbin TG, 2008, SCIENCE, V319, P1367, DOI 10.1126/science.1153625; Piilo J, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.032303; Platzman PM, 1999, SCIENCE, V284, P1967, DOI 10.1126/science.284.5422.1967; Porras D, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.250501; Porras D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207901; Quan HT, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.036122; Rakhmanov AL, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.144507; Retzker A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.260504; Roumpos G, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.094415; Sanpera A, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.040401; Schmied R, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/045017; Schulte T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.170411; Smirnov AY, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/67008; Somaroo S, 1999, PHYS REV LETT, V82, P5381, DOI 10.1103/PhysRevLett.82.5381; Somma R, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.042323; Southwell K, 2008, NATURE, V453, P1003, DOI 10.1038/4531003a; Tseng CH, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.032309; Tsomokos DI, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/11/113020; Valenzuela SO, 2006, SCIENCE, V314, P1589, DOI 10.1126/science.1134008; vanOudenaarden A, 1996, PHYS REV LETT, V76, P4947, DOI 10.1103/PhysRevLett.76.4947; Vollbrecht KGH, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.042305; Wang HF, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.042335; Weinstein YS, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.157902; Wineland DJ, 1998, PHYS SCRIPTA, VT76, P147, DOI 10.1238/Physica.Topical.076a00147; Wu LA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.057904; Wurtz P, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.080404; Yamaguchi F, 2002, SUPERLATTICE MICROST, V32, P343, DOI 10.1016/S0749-6036(03)00039-9; Yamamoto T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.064505; Yang XD, 2006, CHEM PHYS LETT, V422, P20, DOI 10.1016/j.cplett.2006.02.023; You JQ, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.104516; You JQ, 2005, PHYS TODAY, V58, P42, DOI 10.1063/1.2155757; YOU JQ, 2008, ARXIV08090051V1; Zhou L, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.063827; Zwierlein MW, 2005, NATURE, V435, P1047, DOI 10.1038/nature03858	93	608	613	7	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					108	111		10.1126/science.1177838	http://dx.doi.org/10.1126/science.1177838			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797653				2022-12-28	WOS:000270355600044
J	van Wolfswinkel, JC; Claycomb, JM; Batista, PJ; Mello, CC; Berezikov, E; Ketting, RF				van Wolfswinkel, Josien C.; Claycomb, Julie M.; Batista, Pedro J.; Mello, Craig C.; Berezikov, Eugene; Ketting, Rene F.			CDE-1 Affects Chromosome Segregation through Uridylation of CSR-1-Bound siRNAs	CELL			English	Article							CYTOPLASMIC POLY(A) POLYMERASE; C-ELEGANS; CAENORHABDITIS-ELEGANS; RNA INTERFERENCE; FISSION YEAST; GERM-LINE; SCHIZOSACCHAROMYCES-POMBE; GENE-EXPRESSION; HETEROCHROMATIN; PROTEIN	We have studied the function of a conserved germline-specific nucleotidyltransferase protein, CDE-1, in RNAi and chromosome segregation in C. elegans. CDE-1 localizes specifically to mitotic chromosomes in embryos. This localization requires the RdRP EGO-1, which physically interacts with CDE-1, and the Argonaute protein CSR-1. We found that CDE-1 is required for the uridylation of CSR-1 bound siRNAs, and that in the absence of CDE-1 these siRNAs accumulate to inappropriate levels, accompanied by defects in both meiotic and mitotic chromosome segregation. Elevated siRNA levels are associated with erroneous gene silencing, most likely through the inappropriate loading of CSR-1 siRNAs into other Argonaute proteins. We propose a model in which CDE-1 restricts specific EGO-1-generated siRNAs to the CSR-1 mediated, chromosome associated RNAi pathway, thus separating it from other endogenous RNAi pathways. The conserved nature of CDE-1 suggests that similar sorting mechanisms may operate in other animals, including mammals.	[van Wolfswinkel, Josien C.; Berezikov, Eugene; Ketting, Rene F.] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [van Wolfswinkel, Josien C.; Berezikov, Eugene; Ketting, Rene F.] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [van Wolfswinkel, Josien C.] Univ Utrecht, Dept Biomol Mass Spectrometry, NL-3584 CT Utrecht, Netherlands; [Claycomb, Julie M.; Batista, Pedro J.; Mello, Craig C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Batista, Pedro J.] Gulbenkian PhD Programme Biomed, P-2780156 Oeiras, Portugal; [Mello, Craig C.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Utrecht University; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Ketting, RF (corresponding author), Hubrecht Inst KNAW, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	r.ketting@hubrecht.eu	Berezikov, Eugene/D-3363-2013; Batista, Pedro J/K-5303-2012	Berezikov, Eugene/0000-0002-1145-2884; Claycomb, Julie/0000-0003-3132-5206; Ketting, Rene/0000-0001-6161-5621	Developmental Studies Hybridoma Bank (DSHB) [OIC104]; National Proteomics Centre, the European Union Sixth Framework Program Integrated Project SIROCCO [LSHG-CT-2006-037900]; Netherlands Organisation for Scientific Research; European Union Seventh Framework Program [202819]	Developmental Studies Hybridoma Bank (DSHB); National Proteomics Centre, the European Union Sixth Framework Program Integrated Project SIROCCO; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Union Seventh Framework Program(European Commission)	We thank Abby Dernburg and members of her lab for protocols, reagents and support concerning the immunostainings and microscopy. We thank Alex Dammermann, Karen Oegema, Reto Gassmann, and Arshad Desai for antibodies and transgenic strains. Several strains were generously provided by the Caenorhabditis Genetics Center (CGC), by Shohei Mitani of the Japanese National Bioresources Project for C. elegans and Hendrik Korswagen. PGL-1 antibody (OIC104) was provided by the Developmental Studies Hybridoma Bank (DSHB). This work was supported by the National Proteomics Centre, the European Union Sixth Framework Program Integrated Project SIROCCO (Grant LSHG-CT-2006-037900), VIDI fellowships from the Netherlands Organisation for Scientific Research (NWO; R.F.K. and E.B.) and an ERC Starting Grant from the Ideas Program of the European Union Seventh Framework Program (R.F.K.; Grant 202819).	ALBERTSON DG, 1982, CHROMOSOMA, V86, P409, DOI 10.1007/BF00292267; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; BEANAN MJ, 1992, DEVELOPMENT, V116, P755; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Crittenden SL, 2003, PHILOS T ROY SOC B, V358, P1359, DOI 10.1098/rstb.2003.1333; DEMBURG AF, 2001, J CELL BIOL, V153, pF33; Ekwall K, 2004, CHROMOSOME RES, V12, P535, DOI 10.1023/B:CHRO.0000036584.40567.e5; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Gassmann R, 2008, GENE DEV, V22, P2385, DOI 10.1101/gad.1687508; Gu WF, 2009, MOL CELL, V36, P231, DOI 10.1016/j.molcel.2009.09.020; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Maddox PS, 2004, CHROMOSOME RES, V12, P641, DOI 10.1023/B:CHRO.0000036588.42225.2f; MAIDA Y, 2009, NATURE; Martienssen RA, 2005, TRENDS GENET, V21, P450, DOI 10.1016/j.tig.2005.06.005; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Moore LL, 1999, J CELL BIOL, V147, P471, DOI 10.1083/jcb.147.3.471; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Olsen A, 2006, SCIENCE, V312, P1381, DOI 10.1126/science.1124981; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; RISSLAND OS, 2009, NAT STRUCT MOL BIOL; Robert VJP, 2005, GENE DEV, V19, P782, DOI 10.1101/gad.332305; Schmid M, 2009, GENE DEV, V23, P824, DOI 10.1101/gad.494009; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Stear JH, 2002, GENE DEV, V16, P1498, DOI 10.1101/gad.989102; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039; Win TZ, 2006, MOL CELL BIOL, V26, P4435, DOI 10.1128/MCB.02205-05; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	51	136	139	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					135	148		10.1016/j.cell.2009.09.012	http://dx.doi.org/10.1016/j.cell.2009.09.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804759	Bronze			2022-12-28	WOS:000270388600022
J	Malmgren, RD; Stouffer, DB; Campanharo, ASLO; Amaral, LAN				Malmgren, R. Dean; Stouffer, Daniel B.; Campanharo, Andriana S. L. O.; Amaral, Luis A. Nunes			On Universality in Human Correspondence Activity	SCIENCE			English	Article							HUMAN DYNAMICS; HEAVY TAILS; FLUCTUATIONS	The identification and modeling of patterns of human activity have important ramifications for applications ranging from predicting disease spread to optimizing resource allocation. Because of its relevance and availability, written correspondence provides a powerful proxy for studying human activity. One school of thought is that human correspondence is driven by responses to received correspondence, a view that requires a distinct response mechanism to explain e-mail and letter correspondence observations. We demonstrate that, like e-mail correspondence, the letter correspondence patterns of 16 writers, performers, politicians, and scientists are well described by the circadian cycle, task repetition, and changing communication needs. We confirm the universality of these mechanisms by rescaling letter and e-mail correspondence statistics to reveal their underlying similarity.	[Malmgren, R. Dean; Stouffer, Daniel B.; Campanharo, Andriana S. L. O.; Amaral, Luis A. Nunes] Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA; [Malmgren, R. Dean] Datascope Analyt, Evanston, IL 60201 USA; [Stouffer, Daniel B.] Estac Biol Donana, Integrat Ecol Grp, Seville 41092, Spain; [Campanharo, Andriana S. L. O.] Inst Nacl Pesquisas Espaciais, BR-12227010 Sao Paulo, Brazil; [Amaral, Luis A. Nunes] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; [Amaral, Luis A. Nunes] Northwestern Univ, NW Inst Complex Syst, Evanston, IL 60208 USA	Northwestern University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Instituto Nacional de Pesquisas Espaciais (INPE); Howard Hughes Medical Institute; Northwestern University; Northwestern University	Malmgren, RD (corresponding author), Northwestern Univ, Dept Biol & Chem Engn, Evanston, IL 60208 USA.	dean.malmgren@u.northwestern.edu; amaral@northwestern.edu	Amaral, LAN/A-4980-2008; Campanharo, Andriana S L O/J-4600-2013; Amaral, Luis N./C-5485-2009; Stouffer, Daniel/C-2223-2008	Amaral, LAN/0000-0002-3762-789X; Campanharo, Andriana S L O/0000-0002-0501-5303; Stouffer, Daniel/0000-0001-9436-9674	Consejo Superior de Investigaciones Cientificas-Junta para la Ampliacion de Estudios (JAE) postdoctoral fellowship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Brazil) Percentage of occurrence Relative mRNA levels doctoral fellowship; NSF [SBE 0624318]	Consejo Superior de Investigaciones Cientificas-Junta para la Ampliacion de Estudios (JAE) postdoctoral fellowship; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Brazil) Percentage of occurrence Relative mRNA levels doctoral fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NSF(National Science Foundation (NSF))	We thank T. Sauer, R. Guimera, M. Sales-Pardo, M. J. Stringer, E. N. Sawardecker, J. Duch, and P. McMullen for insightful comments and suggestions. D. B. S. acknowledges the support of a Consejo Superior de Investigaciones Cientificas-Junta para la Ampliacion de Estudios (JAE) postdoctoral fellowship. A. S. L. O. C. acknowledges the support of a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (Brazil) Percentage of occurrence Relative mRNA levels doctoral fellowship. L. A. N. A. gratefully acknowledges the support of NSF award SBE 0624318. All figures were generated with PyGrace (http://pygrace.sourceforge.net) with color schemes from http://colorbrewer.org.Percentage of occurrence Relative mRNA levels	Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Amaral LAN, 1998, PHYS REV LETT, V80, P1385, DOI 10.1103/PhysRevLett.80.1385; Auerbach F, 1913, PETERMANNS MITT, V59, P74; Avnir D, 1998, SCIENCE, V279, P39, DOI 10.1126/science.279.5347.39; Bachelier L., 1900, ANN SCIENTIFIQUES LE, V3, P21; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; D'Agostino RB, 1986, GOODNESS OF FIT TECH; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Gibrat R., 1931, INEGALITES EC; Goldenfeld N., 2019, LECT PHASE TRANSITIO, DOI [https://doi.org/10.1201/9780429493492, DOI 10.1201/9780429493492]; Grinstein G, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.130201; Hausdorff JM, 1996, PHYS REV E, V54, P2154, DOI 10.1103/PhysRevE.54.2154; IJIRI Y, 1977, STUDIES MATH MANAGER, V24; Ma S. K., 2000, MODERN THEORY CRITIC; Malmgren RD, 2008, P NATL ACAD SCI USA, V105, P18153, DOI 10.1073/pnas.0800332105; Miller RGJ, 1991, SIMULTANEOUS STAT IN; Oliveira JG, 2005, NATURE, V437, P1251, DOI 10.1038/4371251a; PARETO V, 1906, MANUALE EC POLITICA; Plerou V, 1999, NATURE, V400, P433, DOI 10.1038/22719; SAUER T, COMMUNICATION; Stanley HE, 1996, PHYSICA A, V224, P302, DOI 10.1016/0378-4371(95)00409-2; Stanley HE, 2000, PHYSICA A, V283, P31, DOI 10.1016/S0378-4371(00)00256-9; Stanley HE., 1971, PHASE TRANSITIONS CR; TAYLOR HM, 1994, INTRO STOCHASTIC MOD; Towe BC., 2009, MS T09 P, DOI DOI 10.1145/1557019.1557088; Vazquez A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036127; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	27	146	155	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	2009	325	5948					1696	1700		10.1126/science.1174562	http://dx.doi.org/10.1126/science.1174562			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779200	Green Submitted			2022-12-28	WOS:000270131800048
J	Webb, SAR; Pettila, V; Seppelt, I; Bellomo, R; Bailey, M; Cooper, DJ; Cretikos, M; Davies, AR; Finfer, S; Harrigan, PWJ; Hart, GK; Howe, B; Iredell, JR; McArthur, C; Mitchell, I; Morrison, S; Nichol, AD; Paterson, DL; Peake, S; Richards, B; Stephens, D; Turner, A; Yung, M				Webb, Steven A. R.; Pettila, Ville; Seppelt, Ian; Bellomo, Rinaldo; Bailey, Michael; Cooper, David J.; Cretikos, Michelle; Davies, Andrew R.; Finfer, Simon; Harrigan, Peter W. J.; Hart, Graeme K.; Howe, Belinda; Iredell, Jonathan R.; McArthur, Colin; Mitchell, Imogen; Morrison, Siouxzy; Nichol, Alistair D.; Paterson, David L.; Peake, Sandra; Richards, Brent; Stephens, Dianne; Turner, Andrew; Yung, Michael		ANZIC Influenza Investigators	Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MORTALITY	Background: Planning for the treatment of infection with the 2009 pandemic influenza A (H1N1) virus through health care systems in developed countries during winter in the Northern Hemisphere is hampered by a lack of information from similar health care systems. Methods: We conducted an inception-cohort study in all Australian and New Zealand intensive care units (ICUs) during the winter of 2009 in the Southern Hemisphere. We calculated, per million inhabitants, the numbers of ICU admissions, bed-days, and days of mechanical ventilation due to infection with the 2009 H1N1 virus. We collected data on demographic and clinical characteristics of the patients and on treatments and outcomes. Results: From June 1 through August 31, 2009, a total of 722 patients with confirmed infection with the 2009 H1N1 virus (28.7 cases per million inhabitants; 95% confidence interval [CI], 26.5 to 30.8) were admitted to an ICU in Australia or New Zealand. Of the 722 patients, 669 (92.7%) were under 65 years of age and 66 (9.1%) were pregnant women; of the 601 adults for whom data were available, 172 (28.6%) had a body-mass index (the weight in kilograms divided by the square of the height in meters) greater than 35. Patients infected with the 2009 H1N1 virus were in the ICU for a total of 8815 bed-days (350 per million inhabitants). The median duration of treatment in the ICU was 7.0 days (interquartile range, 2.7 to 13.4); 456 of 706 patients (64.6%) with available data underwent mechanical ventilation for a median of 8 days (interquartile range, 4 to 16). The maximum daily occupancy of the ICU was 7.4 beds (95% CI, 6.3 to 8.5) per million inhabitants. As of September 7, 2009, a total of 103 of the 722 patients (14.3%; 95% CI, 11.7 to 16.9) had died, and 114 (15.8%) remained in the hospital. Conclusions: The 2009 H1N1 virus had a substantial effect on ICUs during the winter in Australia and New Zealand. Our data can assist planning for the treatment of patients during the winter in the Northern Hemisphere. N Engl J Med 2009;361:1925-34.	[Webb, Steven A. R.] Royal Perth Hosp, Intens Care Unit, Perth, WA 6000, Australia; [Webb, Steven A. R.] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia; [Webb, Steven A. R.] Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Pettila, Ville; Bellomo, Rinaldo; Bailey, Michael; Cooper, David J.; Davies, Andrew R.; Howe, Belinda; Morrison, Siouxzy; Nichol, Alistair D.] Monash Univ, Sch Publ Hlth & Prevent Med, ANZIC Res Ctr, Melbourne, Vic 3004, Australia; [Seppelt, Ian] Univ Sydney, Nepean Hosp, Sydney, NSW 2006, Australia; [Cooper, David J.; Davies, Andrew R.; Nichol, Alistair D.] Alfred Hosp, Melbourne, Vic, Australia; [Cretikos, Michelle] Univ Sydney, New S Wales Dept Hlth, Sydney, NSW 2006, Australia; [Cretikos, Michelle] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Finfer, Simon] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; [Harrigan, Peter W. J.] John Hunter Hosp, Newcastle, NSW, Australia; [Hart, Graeme K.] ANZIC Soc Ctr Outcome & Resources Evaluat, Melbourne, Vic, Australia; [Iredell, Jonathan R.] Univ Sydney, Ctr Infect Dis & Microbiol, Sydney, NSW 2006, Australia; [Iredell, Jonathan R.] Westmead Hosp, Sydney, NSW, Australia; [McArthur, Colin] Auckland City Hosp, Auckland, New Zealand; [Mitchell, Imogen] Canberra Hosp, Canberra, ACT, Australia; [Mitchell, Imogen] Australian Natl Univ, Canberra, ACT, Australia; [Paterson, David L.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Peake, Sandra] Queen Elizabeth Hosp, Adelaide, SA, Australia; [Richards, Brent] Gold Coast Hosp, Southport, Qld, Australia; [Stephens, Dianne] Royal Darwin Hosp, Darwin, NT, Australia; [Turner, Andrew] Royal Hobart Hosp, Intens Care Unit, Hobart, Tas, Australia; [Yung, Michael] Womens & Childrens Hosp Adelaide, Adelaide, SA, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia; Monash University; Nepean Hospital; University of Sydney; Florey Institute of Neuroscience & Mental Health; University of Sydney; University of Sydney; University of Sydney; John Hunter Hospital; University of Sydney; University of Sydney; Auckland City Hospital; Australian National University; Canberra Hospital; Australian National University; University of Queensland; Gold Coast University Hospital; Royal Hobart Hospital	Webb, SAR (corresponding author), Royal Perth Hosp, Intens Care Unit, Wellington St, Perth, WA 6000, Australia.	sarwebb@cyllene.uwa.edu.au	Cooper, D. James/G-7961-2013; Paterson, David L/A-9258-2010; blackwell, nikki/H-4222-2013; Presneill, Jeffrey J/B-4894-2012; Bailey, Michael J/A-4499-2012; Long, Debbie/L-2036-2016	Cooper, D. James/0000-0002-5872-9051; Presneill, Jeffrey J/0000-0001-7177-7667; Bailey, Michael J/0000-0002-5551-1401; Long, Debbie/0000-0002-0984-9559; Nichol, Alistair Dualta/0000-0002-4771-5615; Nichol, Alistair/0000-0002-4689-1238; Whitehead, Christina/0000-0003-4561-7082; Rajbhandari, Dorrilyn/0000-0001-8883-0428; Richards, Brent/0000-0003-2613-0308; Micallef, Sharon/0000-0002-8496-2324; Bersten, Andrew/0000-0001-9908-394X; Mitchell, Imogen/0000-0001-6013-4922; Bellomo, Rinaldo/0000-0002-1650-8939; Finfer, Simon/0000-0002-2785-5864; SHEHABI, Yahya/0000-0003-4707-7462; Morrison, Siouxzy/0000-0002-2561-5859; Paterson, David/0000-0003-2079-4437; Stephens, Dianne/0000-0002-3785-6828; /0000-0002-4157-5148	Department of Health and Ageing, Commonwealth Government of Australia; New South Wales Health, Government of New South Wales; Department of Health, Government of Victoria; Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Society; CSL Limited, Melbourne, Victoria	Department of Health and Ageing, Commonwealth Government of Australia(Australian Government); New South Wales Health, Government of New South Wales; Department of Health, Government of Victoria; Australian and New Zealand Intensive Care Research Centre; Australian and New Zealand Intensive Care Society; CSL Limited, Melbourne, Victoria	Supported by the Department of Health and Ageing, Commonwealth Government of Australia; New South Wales Health, Government of New South Wales; Department of Health, Government of Victoria; the Australian and New Zealand Intensive Care Research Centre; the Australian and New Zealand Intensive Care Society; and an unrestricted grant from CSL Limited, Melbourne, Victoria.	Australian Bureau of Statistics, 2008, 3201 0 POP AG SEX AU; Australian Institute of Health and Welfare, 2008, AUSTR HLTH 2008; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; *CDCP, INT GUID INF CONTR C; *CDCP, 2009 H1N1 FLU INT SI; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Cutler J, 2009, CAN MED ASSOC J, V181, P159, DOI 10.1503/cmaj.090859; Dal Grande E, 2005, AUST NZ J PUBL HEAL, V29, P343, DOI 10.1111/j.1467-842X.2005.tb00205.x; DRENNAN K, 2008, INTENSIVE CARE RESOU; *FLUC ORG, WORLDW H1N1 SWIN FLU; Gatherer D, 2009, J CLIN VIROL, V45, P174, DOI 10.1016/j.jcv.2009.06.004; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LI G, 2009, J CLIN VIROL    0819; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; *NOV SWIN OR INFL, 2009, NEW ENGL J MED, V361, P102; *STAT NZ, NAT POP EST; Stow PJ, 2006, J CRIT CARE, V21, P133, DOI 10.1016/j.jcrc.2005.11.010; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Webb SAR, 2009, CRIT CARE RESUSC, V11, P170; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8	25	745	770	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1925	1934		10.1056/NEJMoa0908481	http://dx.doi.org/10.1056/NEJMoa0908481			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518AI	19815860				2022-12-28	WOS:000271660500006
J	Katsumata, N; Yasuda, M; Takahashi, F; Isonishi, S; Jobo, T; Aoki, D; Tsuda, H; Sugiyama, T; Kodama, S; Kimura, E; Ochiai, K; Noda, K				Katsumata, Noriyuki; Yasuda, Makoto; Takahashi, Fumiaki; Isonishi, Seiji; Jobo, Toshiko; Aoki, Doisuke; Tsuda, Hiroshi; Sugiyama, Toru; Kodama, Shoji; Kimura, Eizo; Ochiai, Kazunori; Noda, Kiichiro		Japanese Gynecologic Oncology Grp	Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial	LANCET			English	Article							BREAST-CANCER; III TRIAL; 1ST-LINE TREATMENT; INTERGROUP TRIAL; TAXOL; ANGIOGENESIS; CARCINOMA	Background Paclitaxel and carboplatin given every 3 weeks is standard treatment for advanced ovarian carcinoma. Attempts to improve patient survival by including other drugs have yielded disappointing results. We compared a conventional regimen of paclitaxel and carboplatin with a dose-dense weekly regimen in women with advanced ovarian cancer. Methods Patients with stage II to IV epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer were eligible for enrolment in this phase 3, open-label, randomised controlled trial at 85 centres in Japan. Patients were randomly assigned by computer-generated randomisation sequence to receive six cycles of either paclitaxel (180 mg/m(2); 3-h intravenous infusion) plus carboplatin (area under the curve [AUC] 6 mg/mL per min), given on day 1 of a 21-day cycle (conventional regimen; n=320), or dose-dense paclitaxel (80 mg/m(2); 1-h intravenous infusion) given on days 1, 8, and 15 plus carboplatin given on day 1 of a 21-day cycle (dose-dense regimen; n=317). The primary endpoint was progression-free survival. Analysis was by intention to treat (ITT). This trial is registered with ClinicalTrials.gov, number NCT00226915. Findings 631 of the 637 enrolled patients were eligible for treatment and were included in the ITT population ((dose-dense regimen, n=312; conventional regimen, n=319). Median progression-free survival was longer in the dose-dense treatment group (28.0 months, 95% CI 22.3-35.4) than in the conventional treatment group (17.2 months, 15.7-21.1; hazard ratio [HR] 0.71; 95% CI 0.58-0.88; p=0.0015). Overall survival at 3 years was higher in the dose-dense regimen group (72.1%) than in the conventional treatment group (65.1%; HR 0.75, 0.57-0.98; p=0.03). 165 patients assigned to the dose-dense regimen and 117 assigned to the conventional regimen discontinued treatment early. Reasons for participant dropout were balanced between the groups, apart from withdrawal because of toxicity, which was higher in the dose-dense regimen group than in the conventional regimen group (n=113 vs n=69). The most common adverse event was neutropenia (dose-dense regimen, 286 [92%] of 312; conventional regimen, 276 [88%] of 314). The frequency of grade 3 and 4 anaemia was higher in the dose-dense treatment group (214 [69%]) than in the conventional treatment group (137 [44%]; p<0.0001). The frequencies of other toxic effects were similar between groups. Interpretation Dose-dense weekly paclitaxel plus carboplatin improved survival compared with the conventional regimen and represents a new treatment option in women with advanced epithelial ovarian cancer.	[Katsumata, Noriyuki] Natl Canc Ctr, Dept Med Oncol, Chuo Ku, Tokyo 1040045, Japan; [Yasuda, Makoto; Isonishi, Seiji; Ochiai, Kazunori] Jikei Univ, Dept Gynecol Oncol, Sch Med, Tokyo, Japan; [Takahashi, Fumiaki] Kitasato Univ, Dept Biostat, Tokyo, Japan; [Jobo, Toshiko] Kitasato Univ, Sch Med, Dept Gynecol, Sagamihara, Kanagawa 228, Japan; [Tsuda, Hiroshi] Keio Univ, Sch Med, Dept Obstet & Gynecol, Tokyo 160, Japan; [Sugiyama, Toru] Iwate Med Univ, Dept Gynecol Oncol, Morioka, Iwate 020, Japan; [Kodama, Shoji] Niigata Canc Ctr Hosp, Dept Gynecol Oncol, Niigata, Japan; [Kimura, Eizo] Kousei Gen Hosp, Dept Gynecol Oncol, Tokyo, Japan; [Noda, Kiichiro] Kinki Univ, Dept Gynecol, Osakasayama, Japan	National Cancer Center - Japan; Jikei University; Kitasato University; Kitasato University; Keio University; Iwate Medical University; Kindai University (Kinki University)	Katsumata, N (corresponding author), Natl Canc Ctr, Dept Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	nkatsuma@ncc.go.jp	Aoki, Daisuke/E-6650-2014		Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	This study was funded by an unrestricted grant from Bristol-Myers Squibb. We thank the women who participated in this trial and Akihiro Yanagisawa, Kei Matsubara for assisting protocol design and review, Keiichi Fujiwara for internal auditing, and Robert F Ozols for protocol design and manuscript review.	Bolis G, 2004, J CLIN ONCOL, V22, P686, DOI 10.1200/JCO.2004.03.017; Bookman MA, 2009, J CLIN ONCOL, V27, P1419, DOI 10.1200/JCO.2008.19.1684; CALVERT AH, 1989, J CLIN ONCOL, V7, P1748, DOI 10.1200/JCO.1989.7.11.1748; du Bois A, 2006, J CLIN ONCOL, V24, P1127, DOI 10.1200/JCO.2005.03.2938; du Bois A, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi961; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Hess V, 2004, J CLIN ONCOL, V22, P1040, DOI 10.1200/JCO.2004.08.078; HOSKINS PJ, 2008, 2008 ASCO ANN M CHIC; JELLIFFE RW, 1973, ANN INTERN MED, V79, P604, DOI 10.7326/0003-4819-79-4-604; Jordan MA, 1996, CANCER RES, V56, P816; KATSUMATA N, 2001, 2001 ASCO ANN M SAN; Klauber N, 1997, CANCER RES, V57, P81; LOPES NM, 1993, CANCER CHEMOTH PHARM, V32, P235, DOI 10.1007/BF00685842; National Cancer Institute, 1998, CANC THER EV PROGR C; Norton L, 2001, ONCOLOGIST, V6, P30; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Omura GA, 2003, J CLIN ONCOL, V21, P2843, DOI 10.1200/JCO.2003.10.082; Pignata S, 2008, CRIT REV ONCOL HEMAT, V66, P229, DOI 10.1016/j.critrevonc.2007.12.005; Rose PG, 2005, GYNECOL ONCOL, V96, P296, DOI 10.1016/j.ygyno.2004.03.046; Rustin GJS, 2006, J CLIN ONCOL, V24, P45, DOI 10.1200/JCO.2005.01.2757; Sehouli J, 2008, CANCER CHEMOTH PHARM, V61, P243, DOI 10.1007/s00280-007-0466-z; Seidman AD, 2008, J CLIN ONCOL, V26, P1642, DOI 10.1200/JCO.2007.11.6699; SHEPHERD JH, 1989, BRIT J OBSTET GYNAEC, V96, P889, DOI 10.1111/j.1471-0528.1989.tb03341.x; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; YEDEMA CA, 1992, TUMOR BIOL, V13, P18, DOI 10.1159/000217748	26	543	569	0	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2009	374	9698					1331	1338		10.1016/S0140-6736(09)61157-0	http://dx.doi.org/10.1016/S0140-6736(09)61157-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MW	19767092				2022-12-28	WOS:000271254600029
J	Abrams, D; Levy, Y; Losso, MH; Babilker, A; Collins, G; Cooper, DA; Darbyshire, J; Emery, S; Fox, L; Gordin, F; Lane, HC; Lundgren, JD; Mitsuyasu, R; Neaton, JD; Phillips, A; Routy, JP; Tambussi, G; Wentworth, D				Abrams, D.; Levy, Y.; Losso, M. H.; Babilker, A.; Collins, G.; Cooper, D. A.; Darbyshire, J.; Emery, S.; Fox, L.; Gordin, F.; Lane, H. C.; Lundgren, J. D.; Mitsuyasu, R.; Neaton, J. D.; Phillips, A.; Routy, J. P.; Tambussi, G.; Wentworth, D.		INSIGHT-ESPRIT Study Grp; SILCAAT Sci Comm	Interleukin-2 Therapy in Patients with HIV Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; CD4(+) CELL COUNTS; SUBCUTANEOUS INTERLEUKIN-2; ANTIRETROVIRAL THERAPY; CLINICAL-TRIALS; INTRAVENOUS INTERLEUKIN-2; T-LYMPHOCYTES; METAANALYSIS; SURVIVAL	BACKGROUND Used in combination with antiretroviral therapy, subcutaneous recombinant interleukin-2 raises CD4+ cell counts more than does antiretroviral therapy alone. The clinical implication of these increases is not known. METHODS We conducted two trials: the Subcutaneous Recombinant, Human Interleukin-2 in HIV-Infected Patients with Low CD4+ Counts under Active Antiretrovial Therapy (SILCAAT) study and the Evaluation of Subcutaneous Proleukin in a Randomized International Trial (ESPRIT). In each, patients infected with the human immunodeficiency virus (HIV) who had CD4+ cell counts of either 50 to 299 per cubic millimeter (SILCAAT) or 300 or more per cubic millimeter (ESPRIT) were randomly assigned to receive Interleukin-2 plus antiretrovial therapy or antiretrovial therapy alone. The Interleukin-2 regimen consisted of cycles of 5 consecutive days each, administered at 8-week intervals. The SILCAAT study involved six cycles and a dose or 4.5 million IU of interleukin-2 twice daily; ESPRIT involved three cycles and a dose of 7.5 million IU twice daily. Additional cycles were recommended to maintain the CD4+ cell count above predefined target levels. The primary end point of both studies was opportunistic disease or death from any cause. RESULTS In the SILCAAT study, 1695 patients (849 receiving interleukin-2 plus antiretroviral therapy and 846 receiving antiretroviral therapy alone) who had a median CD4+ cell count of 202 cells per cubic millimeter were enrolled; in ESPRIT, 4111 patients (2071 receiving interleukin 2 plus antiretroviral therapy and 2040 receiving antiretroviral therapy alone) who had a median CD4+ cell count of 457 cells per cubic millimeter were enrolled. Over a median follow-up period of 7 to 8 years, the CD4+ cell count was higher in the interleukin 2 group than in the group receiving antiretroviral therapy alone - by 53 and 159 cells per cubic millimeter, on average, in the SILCAAT study and ESPRIT, respectively. Hazard ratios for opportunistic disease or death from any cause with interleukin-2 plus antiretroviral therapy (vs. antiretroviral therapy alone) were 0.91 (95% confidence interval [CI], 0.70 to 1.18; P=0.47) in the SILCAAT study and 0.94 (95 h CI, 0.75 to 1.16; P=0.55) in ESPRIT. The hazard ratios for death from any cause and for grade 4 clinical events were 1.06 (P=0.73) and 1.10 (P=0.35), respectively; in the SILCAAT study and 0.90 (P=0.42) and 1.23 (P=0.003), respectively, in ESPRIT. CONCLUSIONS Despite a substantial and sustained increase in the CD4+ cell count, as compared with antiretroviral therapy alone, interleukin-2 plus antiretroviral therapy yielded no clinical benefit in either study. (ClinicalTrials.gov numbers, NCT00004978 [ESPRIT] and NCT00013611 [SILCAAT study].)	[Abrams, D.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Levy, Y.] Univ Paris 12, INSERM, U955, Paris, France; [Levy, Y.] Grp Henri Mondor Albert Chenevier, AP HP, Paris, France; [Losso, M. H.] Hosp Gen Agudos JM Ramos Mejia, Buenos Aires, DF, Argentina; [Babilker, A.; Darbyshire, J.] MRC, London, England; [Phillips, A.] UCL, Sch Med, London WC1E 6BT, England; [Neaton, J. D.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55414 USA; [Cooper, D. A.; Emery, S.] Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia; [Fox, L.; Lane, H. C.] NIAID, Bethesda, MD 20892 USA; [Gordin, F.] Washington Vet Med Ctr, Washington, DC USA; [Lundgren, J. D.] Rigshosp, DK-2100 Copenhagen, Denmark; [Lundgren, J. D.] Univ Copenhagen, Copenhagen, Denmark; [Mitsuyasu, R.] Univ Calif Los Angeles, Los Angeles, CA USA; [Routy, J. P.] McGill Univ, Royal Victoria Hosp, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; [Tambussi, G.] Fdn San Raffaele Monte Tabor, Milan, Italy	University of California System; University of California San Francisco; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Hospital Ramos Mejia; University of London; University College London; UCL Medical School; University of Minnesota System; University of Minnesota Twin Cities; University of New South Wales Sydney; Kirby Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rigshospitalet; University of Copenhagen; University of Copenhagen; University of California System; University of California Los Angeles; McGill University; Royal Victoria Hospital	Neaton, JD (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Biostat, 221 Univ Ave SE,Suite 200, Minneapolis, MN 55414 USA.	jim@ccbr.umn.edu	Lundgren, Jens/AAE-6876-2019; Yee, Thynn Thynn/H-5862-2012; Doerler, Martin/C-2015-2013; Bouza, Emilio/D-8661-2014; Emery, Sean/J-3825-2017; Soriano, Vicente/O-5730-2018; Victor, Moreno-Cuerda/G-3851-2016; Montes, Maria Luisa/H-8065-2017; Pulido, Federico/B-8417-2009	Magenta, Lorenzo/0000-0002-7644-3647; Lin, Enmoore/0000-0002-8584-7627; Okhuysen, Pablo/0000-0002-1596-3411; Bouza, Emilio/0000-0001-6967-9267; Emery, Sean/0000-0001-6072-8309; COSTANTINI, ANDREA/0000-0003-1588-7030; Medland, Nicholas Andrew/0000-0003-0403-8930; Tambussi, Giuseppe/0000-0002-0604-2960; Soriano, Vicente/0000-0002-4624-5199; Estrada, Vicente/0000-0002-7795-5986; Victor, Moreno-Cuerda/0000-0003-0262-8216; MARTIN CARBONERO, LUZ/0000-0001-8102-4079; Easterbrook, Philippa/0000-0002-2603-5418; Gonzalez-Garcia, Juan/0000-0002-3652-002X; OCAMPO HERMIDA, ANTONIO/0000-0002-3176-9758; Leen, Clifford/0000-0001-8439-7719; Montes, Maria Luisa/0000-0003-1748-813X; Pulido, Federico/0000-0002-7414-8812	MAID [U01 AI46957, U01 AI068641]; Chiron and Novartis; SILCAAT; MRC [MC_U122886352] Funding Source: UKRI; Medical Research Council [MC_U122886352] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI046957, U01AI068641, ZIAAI000585] Funding Source: NIH RePORTER	MAID; Chiron and Novartis; SILCAAT; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the MAID for ESPRIT (U01 AI46957 and U01 AI068641) and from Chiron and Novartis for ESPRIT and the SILCAAT study (to Dr. Neaton). For both studies, interleukin-2 was provided by Chiron-Novartis.	Aboulker JP, 1999, AIDS, V13, P565, DOI 10.1097/00002030-199904010-00005; Abrams DI, 2002, J ACQ IMMUN DEF SYND, V29, P221, DOI 10.1097/00126334-200203010-00002; Arduino RC, 2004, CLIN INFECT DIS, V39, P115, DOI 10.1086/421775; Carr A, 1998, J INFECT DIS, V178, P992, DOI 10.1086/515653; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Davey RT, 2000, JAMA-J AM MED ASSOC, V284, P183, DOI 10.1001/jama.284.2.183; de Boer AW, 2003, CLIN IMMUNOL, V106, P188, DOI 10.1016/S1521-6616(02)00038-4; Emery S, 2002, CONTROL CLIN TRIALS, V23, P198, DOI 10.1016/S0197-2456(01)00179-9; Emery S, 2000, J INFECT DIS, V182, P428, DOI 10.1086/315736; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Guiguet Marguerite, 2008, Open AIDS J, V2, P3, DOI 10.2174/1874613600802010003; Hughes MD, 1998, AIDS, V12, P1823, DOI 10.1097/00002030-199814000-00014; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Kovacs JA, 2005, J CLIN INVEST, V115, P2139, DOI 10.1172/JCI23196; Kovacs JA, 1996, NEW ENGL J MED, V335, P1350, DOI 10.1056/NEJM199610313351803; KOVACS JA, 1995, NEW ENGL J MED, V332, P567, DOI 10.1056/NEJM199503023320904; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Levy Y, 1999, LANCET, V353, P1923, DOI 10.1016/S0140-6736(98)07345-0; Levy Y, 2003, AIDS, V17, P343, DOI 10.1097/00002030-200302140-00008; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Losso MH, 2000, J INFECT DIS, V181, P1614, DOI 10.1086/315430; Mitsuyasu R, 2007, ARCH INTERN MED, V167, P597, DOI 10.1001/archinte.167.6.597; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Read SW, 2008, J INFECT DIS, V198, P843, DOI 10.1086/591250; Ruxrungtham K, 2000, AIDS, V14, P2509, DOI 10.1097/00002030-200011100-00013; Sereti I, 2004, BLOOD, V104, P775, DOI 10.1182/blood-2003-12-4355; Sereti I, 2007, J INFECT DIS, V196, P677, DOI 10.1086/520087	27	278	291	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2009	361	16					1548	1559						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506LT	19828532	Green Published, Green Accepted			2022-12-28	WOS:000270777000008
J	Meyhoff, CS; Wetterslev, J; Jorgensen, LN; Henneberg, SW; Hogdall, C; Lundvall, L; Svendsen, PE; Mollerup, H; Lunn, TH; Simonsen, I; Martinsen, KR; Pulawska, T; Bundgaard, L; Bugge, L; Hansen, EG; Riber, C; Gocht-Jensen, P; Walker, LR; Bendtsen, A; Johansson, G; Skovgaard, N; Helto, K; Poukinski, A; Korshin, A; Walli, A; Bulut, M; Carlsson, PS; Rodt, SA; Lundbech, LB; Rask, H; Buch, N; Perdawid, SK; Reza, J; Jensen, KV; Carlsen, CG; Jensen, FS; Rasmussen, LS				Meyhoff, Christian S.; Wetterslev, Jorn; Jorgensen, Lars N.; Henneberg, Steen W.; Hogdall, Claus; Lundvall, Lene; Svendsen, Poul-Erik; Mollerup, Hannah; Lunn, Troels H.; Simonsen, Inger; Martinsen, Kristian R.; Pulawska, Therese; Bundgaard, Lars; Bugge, Lasse; Hansen, Egon G.; Riber, Claus; Gocht-Jensen, Peter; Walker, Line R.; Bendtsen, Asger; Johansson, Gun; Skovgaard, Nina; Helto, Kim; Poukinski, Andrei; Korshin, Andre; Walli, Aqil; Bulut, Mustafa; Carlsson, Palle S.; Rodt, Svein A.; Lundbech, Liselotte B.; Rask, Henrik; Buch, Niels; Perdawid, Sharafaden K.; Reza, Joan; Jensen, Kirsten V.; Carlsen, Charlotte G.; Jensen, Frank S.; Rasmussen, Lars S.		PROXI Trial Grp	Effect of High Perioperative Oxygen Fraction on Surgical Site Infection and Pulmonary Complications After Abdominal Surgery The PROXI Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WOUND-INFECTION; SUPPLEMENTAL OXYGEN; POSTOPERATIVE NAUSEA; NITROUS-OXIDE; RISK; HYPEROXIA; INDEX; PREVENTION; REDUCE	Context Use of 80% oxygen during surgery has been suggested to reduce the risk of surgical wound infections, but this effect has not been consistently identified. The effect of 80% oxygen on pulmonary complications has not been well defined. Objective To assess whether use of 80% oxygen reduces the frequency of surgical site infection without increasing the frequency of pulmonary complications in patients undergoing abdominal surgery. Design, Setting, and Patients The PROXI trial, a patient-and observer-blinded randomized clinical trial conducted in 14 Danish hospitals between October 2006 and October 2008 among 1400 patients undergoing acute or elective laparotomy. Interventions Patients were randomly assigned to receive either 80% or 30% oxygen during and for 2 hours after surgery. Main Outcome Measures Surgical site infection within 14 days, defined according to the Centers for Disease Control and Prevention. Secondary outcomes included atelectasis, pneumonia, respiratory failure, and mortality. Results Surgical site infection occurred in 131 of 685 patients (19.1%) assigned to receive 80% oxygen vs 141 of 701 (20.1%) assigned to receive 30% oxygen (odds ratio [OR], 0.94; 95% confidence interval [CI], 0.72-1.22; P=.64). Atelectasis occurred in 54 of 685 patients (7.9%) assigned to receive 80% oxygen vs 50 of 701 (7.1%) assigned to receive 30% oxygen (OR, 1.11; 95% CI, 0.75-1.66; P=.60), pneumonia in 41 (6.0%) vs 44 (6.3%) (OR, 0.95; 95% CI, 0.61-1.48; P=.82), respiratory failure in 38 (5.5%) vs 31 (4.4%) (OR, 1.27; 95% CI, 0.78-2.07; P=.34), and mortality within 30 days in 30 (4.4%) vs 20 (2.9%) (OR, 1.56; 95% CI, 0.88-2.77; P=.13). Conclusion Administration of 80% oxygen compared with 30% oxygen did not result in a difference in risk of surgical site infection after abdominal surgery. Trial Registration clinicaltrials.gov Identifier: NCT00364741 JAMA. 2009; 302(14): 1543-1550	[Rasmussen, Lars S.] Rigshosp, Copenhagen Univ Hosp, Ctr Head & Orthopaed, Juliane Marie Ctr,Dept Anaesthesia,Sect 4231, DK-2100 Copenhagen, Denmark; [Wetterslev, Jorn] Rigshosp, Copenhagen Univ Hosp, Juliane Marie Ctr, Copenhagen Trial Unit,Ctr Clin Intervent Res, DK-2100 Copenhagen, Denmark; [Hogdall, Claus; Lundvall, Lene] Rigshosp, Copenhagen Univ Hosp, Juliane Marie Ctr, Dept Gynaecol, DK-2100 Copenhagen, Denmark; [Jorgensen, Lars N.; Simonsen, Inger] Univ Copenhagen, Bispebjerg Hosp, Dept Surg, Copenhagen, Denmark; [Svendsen, Poul-Erik; Mollerup, Hannah; Lunn, Troels H.] Univ Copenhagen, Bispebjerg Hosp, Dept Anaesthesia, Copenhagen, Denmark; [Martinsen, Kristian R.] Vejle Hosp, Dept Anaesthesia, Veijle, Denmark; [Pulawska, Therese; Bundgaard, Lars; Bugge, Lasse] Vejle Hosp, Dept Surg, Veijle, Denmark; [Hansen, Egon G.] Copenhagen Univ Hosp, Dept Anaesthesia, Herlev, Denmark; [Riber, Claus; Gocht-Jensen, Peter; Walker, Line R.] Copenhagen Univ Hosp, Dept Surg, Herlev, Denmark; [Skovgaard, Nina] Rigshosp, Copenhagen Univ Hosp, Dept Surg, DK-2100 Copenhagen, Denmark; [Helto, Kim; Poukinski, Andrei] Nykobing Falster Hosp, Dept Anaesthesia, Nykobing, Denmark; [Korshin, Andre; Walli, Aqil] Slagelse Hosp, Dept Anaesthesia, Slagelse, Denmark; [Bulut, Mustafa] Slagelse Hosp, Dept Surg, Slagelse, Denmark; [Carlsson, Palle S.; Rodt, Svein A.; Lundbech, Liselotte B.] Aarhus Univ Hosp, Dept Anaesthesiol, DK-8000 Aarhus, Denmark; [Rask, Henrik] Odense Univ Hosp, Dept Anaesthesiol, Svendborg, Denmark; [Buch, Niels] Odense Univ Hosp, Dept Surg, Svendborg, Denmark; [Perdawid, Sharafaden K.; Reza, Joan] Naestved Hosp, Dept Surg, Naestved, Denmark; [Jensen, Kirsten V.] Viborg Hosp, Dept Anaesthesia, Viborg, Denmark; [Carlsen, Charlotte G.] Viborg Hosp, Dept Surg, Viborg, Denmark; [Jensen, Frank S.] Copenhagen Univ Hosp, Dept Anaesthesia, Gentofte, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; Lillebaelt Hospital; University of Southern Denmark; Lillebaelt Hospital; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; Naestved Hospital; Aarhus University; Aarhus University; University of Copenhagen	Rasmussen, LS (corresponding author), Rigshosp, Copenhagen Univ Hosp, Ctr Head & Orthopaed, Juliane Marie Ctr,Dept Anaesthesia,Sect 4231, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	lsr@rh.dk	Meyhoff, Christian S./B-4777-2009; Wetterslev, Jørn/ABF-1251-2020	Meyhoff, Christian S./0000-0002-4885-4609; Wetterslev, Jørn/0000-0001-7778-1771; Henneberg, Steen/0000-0002-6576-623X; Hogdall, Claus/0000-0002-5959-8874; Bulut, Mustafa/0000-0003-1553-8180; Rasmussen, Lars/0000-0002-7480-3004; Jorgensen, Lars N/0000-0001-7465-5374	Danish Medical Research Council [271-05-0206]; Lundbeck Foundation [402/06]; Rigshospitalet's Research Council; Novo Nordisk Foundation; Aase and Ejnar Danielsens Foundation [105728]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Rigshospitalet's Research Council; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Aase and Ejnar Danielsens Foundation	Funding/Support: This study was supported by the Danish Medical Research Council (271-05-0206), the Lundbeck Foundation (402/06), Rigshospitalet's Research Council, the Novo Nordisk Foundation, the Aase and Ejnar Danielsens Foundation (105728), the A. P. Moller Foundation for the Advancement of Medical Science, the Danish Society of Anaesthesiology and Intensive Care Medicine's Research Initiative, the Beckett-Foundation, the Brodrene Hartmanns Foundation, and the Etly and Jorgen Stjerngrens Foundation.	Akca O, 1999, ANESTHESIOLOGY, V91, P991, DOI 10.1097/00000542-199910000-00019; Allen DB, 1997, ARCH SURG-CHICAGO, V132, P991; BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205; Bandali KS, 2003, J THORAC CARDIOV SUR, V126, P1730, DOI 10.1016/S0022-5223(03)01044-4; Belda FJ, 2005, JAMA-J AM MED ASSOC, V294, P2035, DOI 10.1001/jama.294.16.2035; Carpagnano GE, 2004, THORAX, V59, P1016, DOI 10.1136/thx.2003.020768; Centers for Disease Control and Prevention, CRIT DEF NOS PNEUM; Coello R, 2005, J HOSP INFECT, V60, P93, DOI 10.1016/j.jhin.2004.10.019; CULVER DH, 1991, AM J MED, V91, pS152, DOI 10.1016/0002-9343(91)90361-Z; Edmark L, 2003, ANESTHESIOLOGY, V98, P28, DOI 10.1097/00000542-200301000-00008; Fleischmann E, 2005, LANCET, V366, P1101, DOI 10.1016/S0140-6736(05)67422-3; Garcia-Botello SA, 2006, BRIT J SURG, V93, P698, DOI 10.1002/bjs.5370; Gardella C, 2008, OBSTET GYNECOL, V112, P545, DOI 10.1097/AOG.0b013e318182340c; Gotzsche PC, 1996, CONTROL CLIN TRIALS, V17, P285, DOI 10.1016/0197-2456(95)00263-4; Greif R, 1999, ANESTHESIOLOGY, V91, P1246, DOI 10.1097/00000542-199911000-00014; Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303; HALEY RW, 1985, AM J EPIDEMIOL, V121, P206, DOI 10.1093/oxfordjournals.aje.a113991; Harten JM, 2003, ANAESTHESIA, V58, P885, DOI 10.1046/j.1365-2044.2003.03333.x; Hopf HW, 2008, BEST PRACT RES-CLIN, V22, P553, DOI 10.1016/j.bpa.2008.06.001; Hopf HW, 1997, ARCH SURG-CHICAGO, V132, P997; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Mayzler O, 2005, Minerva Anestesiol, V71, P21; Meyhoff CS, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-58; MILES AA, 1957, BRIT J EXP PATHOL, V38, P79; Myles PS, 2007, ANESTHESIOLOGY, V107, P221, DOI 10.1097/01.anes.0000270723.30772.da; NIINIKOSKI J, 1973, AM J SURG, V126, P53, DOI 10.1016/S0002-9610(73)80094-7; Pryor KO, 2004, JAMA-J AM MED ASSOC, V291, P79, DOI 10.1001/jama.291.1.79; Qadan M, 2009, ARCH SURG-CHICAGO, V144, P359, DOI 10.1001/archsurg.2009.1; Squadrone V, 2005, JAMA-J AM MED ASSOC, V293, P589, DOI 10.1001/jama.293.5.589; Turan A, 2006, ANAESTHESIA, V61, P628, DOI 10.1111/j.1365-2044.2006.04703.x; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; WILSON APR, 1986, LANCET, V1, P311	34	271	283	2	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	2009	302	14					1543	1550		10.1001/jama.2009.1452	http://dx.doi.org/10.1001/jama.2009.1452			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505UA	19826023	Bronze			2022-12-28	WOS:000270721800022
J	Blair, PS; Sidebotham, P; Evason-Coombe, C; Edmonds, M; Heckstall-Smith, EMA; Fleming, P				Blair, Peter S.; Sidebotham, Peter; Evason-Coombe, Carol; Edmonds, Margaret; Heckstall-Smith, Ellen M. A.; Fleming, Peter			Hazardous cosleeping environments and risk factors amenable to change: case-control study of SIDS in south west England	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFANT-DEATH-SYNDROME; SLEEP ENVIRONMENT; CONFIDENTIAL INQUIRY; EPIDEMIOLOGY; POPULATION; STILLBIRTHS; ALCOHOL; SMOKING	Objectives To investigate the factors associated with sudden infant death syndrome (SIDS) from birth to age 2 years, whether recent advice has been followed, whether any new risk factors have emerged, and the specific circumstances in which SIDS occurs while cosleeping (infant sharing the same bed or sofa with an adult or child). Design Four year population based case-control study. Parents were interviewed shortly after the death or after the reference sleep (within 24 hours) of the two control groups. Setting South west region of England (population 4.9 million, 184 800 births). Participants 80 SIDS infants and two control groups weighted for age and time of reference sleep: 87 randomly selected controls and 82 controls at high risk of SIDS (young, socially deprived, multiparous mothers who smoked). Results The median age at death (66 days) was more than three weeks less than in a study in the same region a decade earlier. Of the SIDS infants, 54% died while cosleeping compared with 20% among both control groups. Much of this excess may be explained by a significant multivariable interaction between cosleeping and recent parental use of alcohol or drugs (31% v 3% random controls) and the increased proportion of SIDS infants who had coslept on a sofa (17% v 1%). One fifth of SIDS infants used a pillow for the last sleep (21% v 3%) and one quarter were swaddled (24% v 6%). More mothers of SIDS infants than random control infants smoked during pregnancy (60% v 14%), whereas one quarter of the SIDS infants were preterm (26% v 5%) or were in fair or poor health for the last sleep (28% v 6%). All of these differences were significant in the multivariable analysis regardless of which control group was used for comparison. The significance of covering the infant's head, postnatal exposure to tobacco smoke, dummy use, and sleeping in the side position has diminished although a significant proportion of SIDS infants were still found prone (29% v 10%). Conclusions Many of the SIDS infants had coslept in a hazardous environment. The major influences on risk, regardless of markers for socioeconomic deprivation, are amenable to change and specific advice needs to be given, particularly on use of alcohol or drugs before cosleeping and cosleeping on a sofa.	[Evason-Coombe, Carol; Edmonds, Margaret; Heckstall-Smith, Ellen M. A.; Fleming, Peter] Univ Bristol, Dept Community Based Med, Bristol BS8 1TH, Avon, England; [Sidebotham, Peter] Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England	University of Bristol; University of Warwick	Fleming, P (corresponding author), St Michaels Hosp, FSID Res Unit, Bristol BS2 8EG, Avon, England.	peter.fleming@bris.ac.uk	Fleming, Peter/O-3231-2019; Fleming, Peter J/A-9081-2010; Blair, Peter S/C-1213-2009; Sidebotham, Peter D/E-3011-2010	Fleming, Peter/0000-0003-2521-5764; Fleming, Peter J/0000-0003-2521-5764; Sidebotham, Peter D/0000-0003-4891-6926; Blair, Peter/0000-0002-7832-8087	Foundation for the Study of Infant Deaths (FSID); Babes in Arms; charitable trusts of University Hospitals Bristol	Foundation for the Study of Infant Deaths (FSID); Babes in Arms; charitable trusts of University Hospitals Bristol	This study was supported by research grants from the Foundation for the Study of Infant Deaths (FSID), Babes in Arms, and the charitable trusts of University Hospitals Bristol.	Alm B, 1999, ARCH DIS CHILD, V81, P107, DOI 10.1136/adc.81.2.107; Aoki Y, 1994, J Clin Forensic Med, V1, P87, DOI 10.1016/1353-1131(94)90006-X; Blair PS, 2008, ARCH DIS CHILD, V93, P778, DOI 10.1136/adc.2007.136366; Blair PS, 2006, LANCET, V367, P314, DOI 10.1016/S0140-6736(06)67968-3; Blair PS, 1996, BRIT MED J, V313, P195, DOI 10.1136/bmj.313.7051.195; Blair PS, 1999, BRIT MED J, V319, P1457, DOI 10.1136/bmj.319.7223.1457; BLAIR PS, 2007, RECENT ADV PAEDIAT, V24; BOURNE AJ, 1994, BRIT MED J, V308, P537, DOI 10.1136/bmj.308.6927.537c; Carpenter RG, 2004, LANCET, V363, P185, DOI 10.1016/S0140-6736(03)15323-8; DATTANI N, 2001, HLTH STAT Q, V10, P20; Fleming P., 2000, SUDDEN UNEXPECTED DE; Fleming PJ, 2004, BMJ-BRIT MED J, V328, P331, DOI 10.1136/bmj.328.7435.331; Fleming PJ, 1999, ARCH DIS CHILD, V81, P112, DOI 10.1136/adc.81.2.112; FLEMING PJ, 1990, BRIT MED J, V301, P85, DOI 10.1136/bmj.301.6743.85; Fleming PJ, 1996, BMJ-BRIT MED J, V313, P191, DOI 10.1136/bmj.313.7051.191; Glasgow J F T, 2006, Ulster Med J, V75, P65; Hauck FR, 2003, PEDIATRICS, V111, P1207; James C, 2003, ARCH DIS CHILD, V88, P112, DOI 10.1136/adc.88.2.112; KANDALL SR, 1993, J PEDIATR-US, V123, P120, DOI 10.1016/S0022-3476(05)81554-9; Kattwinkel J, 2005, PEDIATRICS, V116, P1245, DOI 10.1542/peds.2005-1499; Kennedy H, 2004, SUDDEN UNEXPECTED DE; King-Hele SA, 2007, ARCH GEN PSYCHIAT, V64, P1323, DOI 10.1001/archpsyc.64.11.1323; Klonoff-Cohen H, 2001, ARCH PEDIAT ADOL MED, V155, P765, DOI 10.1001/archpedi.155.7.765; KLONOFFCOHEN H, 1995, BMJ-BRIT MED J, V311, P1269, DOI 10.1136/bmj.311.7015.1269; L'Hoir MP, 1998, ARCH DIS CHILD, V79, P386, DOI 10.1136/adc.79.5.386; Leach CEA, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.4.e43; Limerick SR, 2004, J CLIN PATHOL, V57, P309, DOI 10.1136/jcp.2003.013052; McGarvey C, 2003, ARCH DIS CHILD, V88, P1058, DOI 10.1136/adc.88.12.1058; MCGLASHAN ND, 1989, SOC SCI MED, V29, P1015, DOI 10.1016/0277-9536(89)90059-2; Mitchell EA, 2006, PEDIATRICS, V117, P1755, DOI 10.1542/peds.2005-1625; *OFF NAT STAT, 2002, SOC TRENDS ONS, V32; RINTAHAKA RJ, 1986, FORENSIC SCI INT, V30, P219, DOI 10.1016/0379-0738(86)90017-4; SCRAGG R, 1993, BMJ-BRIT MED J, V307, P1312, DOI 10.1136/bmj.307.6915.1312; Scragg RKR, 2001, ACTA PAEDIATR, V90, P57; Tappin D, 2002, BMJ-BRIT MED J, V325, P1007, DOI 10.1136/bmj.325.7371.1007; van Sleuwen BE, 2007, PEDIATRICS, V120, pe1097, DOI 10.1542/peds.2006-2083; Vennemann MM, 2009, PEDIATRICS, V123, P1162, DOI 10.1542/peds.2008-0505; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	38	151	154	0	40	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2009	339								b3666	10.1136/bmj.b3666	http://dx.doi.org/10.1136/bmj.b3666			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508DO	19826174	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000270908100002
J	Haber, PS; Demirkol, A; Lange, K; Murnion, B				Haber, Paul S.; Demirkol, Abdullah; Lange, Kezia; Murnion, Bridin			Management of injecting drug users admitted to hospital	LANCET			English	Review							ADDICTION MOLECULAR-GENETICS; ACUTE PAIN MANAGEMENT; METHADONE-MAINTENANCE; SUBSTANCE-ABUSE; HEROIN-ADDICTS; BENZODIAZEPINE USE; COST-EFFECTIVENESS; OPIOID DEPENDENCE; BUPRENORPHINE; ALCOHOL	General hospital clinicians frequently deal with injecting drug users because substance use has diverse medical and psychiatric complications. Non-specialist clinicians often initiate management when specialist consultation is not available or accepted by the patient. Here, we summarise evidence for the management of hospitalised injecting drug users. The first challenge is to engage a drug user into medical care. A non-judgmental approach towards patients and acceptance of their lifestyle choices facilitates engagement. Pragmatic clinical goals can be negotiated and achieved. We also describe common conditions of injecting drug users. Accurate diagnosis and appropriate management focus on common issues such as intoxication, withdrawal, pain management, drug seeking, psychological comorbidity, behavioural difficulties, and pregnancy. Effective management can reduce the medical and social effect of these conditions and is not difficult.	[Haber, Paul S.; Demirkol, Abdullah; Murnion, Bridin] Royal Prince Alfred Hosp, Drug Hlth Serv, Camperdown, NSW 2050, Australia; [Haber, Paul S.; Demirkol, Abdullah; Murnion, Bridin] Univ Sydney, Discipline Addict Med, Sydney, NSW 2006, Australia; [Lange, Kezia] Oxleas NHS Fdn Trust, London, England	University of Sydney; University of Sydney	Haber, PS (corresponding author), Royal Prince Alfred Hosp, Drug Hlth Serv, Missenden Rd, Camperdown, NSW 2050, Australia.	phaber@mail.usyd.edu.au	Demirkol, Apo/AAC-4329-2020; murnion, Bridin/AAK-3057-2020; Demirkol, Apo/AAI-9933-2020	Demirkol, Apo/0000-0002-7937-7948; murnion, Bridin/0000-0001-7791-3025; 	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	We thank the National Health and Medical Research Council (practitioner fellowship to PSH) for its support.	Abdala N, 2001, J ACQ IMMUN DEF SYND, V28, P487; Alford DP, 2006, ANN INTERN MED, V144, P127, DOI 10.7326/0003-4819-144-2-200601170-00010; [Anonymous], 2007, WORLD DRUG REP; Apfelbaum JL, 2003, ANESTH ANALG, V97, P534, DOI 10.1213/01.ANE.0000068822.10113.9E; *AUSTR NZ COLL AN, AC PAIN MAN SCI EV; Baewert A, 2007, EUR ADDICT RES, V13, P127, DOI 10.1159/000101548; BAKER A, 2005, NATL DRUG STRATEGY M, V51; Baumann BM, 2000, J TOXICOL-CLIN TOXIC, V38, P283, DOI 10.1081/CLT-100100933; Bell J, 2007, ADDICTION, V102, P1899, DOI 10.1111/j.1360-0443.2007.01979.x; BERNARDI E, 1989, BRIT J PSYCHIAT, V154, P677, DOI 10.1192/bjp.154.5.677; Binswanger IA, 2000, CLIN INFECT DIS, V30, P579, DOI 10.1086/313703; Brady Kathleen T, 2007, Curr Psychiatry Rep, V9, P374, DOI 10.1007/s11920-007-0048-0; Broekmans S, 2004, INT J NURS STUD, V41, P183, DOI 10.1016/S0020-7489(03)00129-9; Brown HL, 1998, AM J OBSTET GYNECOL, V179, P459, DOI 10.1016/S0002-9378(98)70379-5; Buckley PF, 2006, J CLIN PSYCHIAT, V67, P5, DOI 10.4088/JCP.0706e01; Caplehorn JRM, 1999, MED J AUSTRALIA, V170, P104, DOI 10.5694/j.1326-5377.1999.tb127675.x; Cayol V, 2000, ANN MED INTERNE, V151, pB20; Collins ED, 2005, JAMA-J AM MED ASSOC, V294, P903, DOI 10.1001/jama.294.8.903; Comer SD, 2006, ARCH GEN PSYCHIAT, V63, P210, DOI 10.1001/archpsyc.63.2.210; Connock M, 2007, HEALTH TECHNOL ASSES, V11, P1; Crome IB, 2007, SEMIN FETAL NEONAT M, V12, P98, DOI 10.1016/j.siny.2006.12.002; Crowe AV, 2000, QJM-INT J MED, V93, P147, DOI 10.1093/qjmed/93.3.147; Darke S, 1997, DRUG ALCOHOL DEPEN, V48, P135, DOI 10.1016/S0376-8716(97)00117-8; Darke S, 1994, Drug Alcohol Rev, V13, P63, DOI 10.1080/09595239400185741; Davis L, 2008, CURR OPIN PSYCHIATR, V21, P14, DOI 10.1097/YCO.0b013e3282f32408; Devlin RJ, 2008, CRIT CARE, V12, DOI 10.1186/cc6166; Dinwiddie SH, 1996, DRUG ALCOHOL DEPEN, V43, P1, DOI 10.1016/S0376-8716(96)01290-2; Dix P, 2004, BRIT J ANAESTH, V92, P235, DOI 10.1093/bja/aeh052; Dodge R, 2005, J SUBST ABUSE TREAT, V28, P189, DOI 10.1016/j.jsat.2004.12.005; Dolan K, 1999, DRUG ALCOHOL REV, V18, P139; Douaihy Antoine B, 2003, AIDS Read, V13, P375; Fagin L., 2004, ADV PSYCHIAT TREATME, V10, P93, DOI [DOI 10.1192/APT.10.2.93, 10.1192/apt.10.2.93]; Farber NJ, 2000, J GEN INTERN MED, V15, P770, DOI 10.1046/j.1525-1497.2000.90734.x; FARRELL M, 1994, BMJ-BRIT MED J, V309, P997, DOI 10.1136/bmj.309.6960.997; French MT, 2000, SOC SCI MED, V50, P1703, DOI 10.1016/S0277-9536(99)00411-6; French MT, 1996, MED CARE, V34, P890, DOI 10.1097/00005650-199609000-00003; FUNKHOUSER AW, 1993, DRUG ALCOHOL DEPEN, V33, P1, DOI 10.1016/0376-8716(93)90027-N; Galea S, 2002, PUBLIC HEALTH REP, V117, pS135; Garcia-Altes A, 2002, ADDICTION, V97, P1145, DOI 10.1046/j.1360-0443.2002.00170.x; GARFENEFSKI N, 1996, J ADOLESCENCE, V19, P503; Gibson AE, 2007, MED J AUSTRALIA, V186, P152, DOI 10.5694/j.1326-5377.2007.tb00840.x; Godfrey C, 2004, ADDICTION, V99, P697, DOI 10.1111/j.1360-0443.2004.00752.x; Gossop M, 2002, ADDICTION, V97, P1259, DOI 10.1046/j.1360-0443.2002.00227.x; GOWING L, 2004, COCHRANE DB SYST REV, V4; GOWING L, 2004, COCHRANE DB SYST REV, V4; Green AI, 2005, J CLIN PSYCHIAT, V66, P21; Haas LJ, 2005, AM FAM PHYSICIAN, V72, P2063; Havens JR, 2006, SUBST USE MISUSE, V41, P245, DOI 10.1080/10826080500391811; Healey A, 1998, BRIT J PSYCHIAT, V173, P160, DOI 10.1192/bjp.173.2.160; Healey Andrew, 2003, J Health Serv Res Policy, V8, P134, DOI 10.1258/135581903322029476; Hickie IB, 2001, MED J AUSTRALIA, V175, pS31; Jansson LM, 2004, J HUM LACT, V20, P62, DOI 10.1177/0890334403261027; Jarvis MAE, 1999, J ADDICT DIS, V18, P51, DOI 10.1300/J069v18n04_05; JENNER L, 2006, MANAGEMENT PATIENTS; Johnson SD, 2004, ARCH SEX BEHAV, V33, P55, DOI 10.1023/B:ASEB.0000007462.97961.5a; Jones HE, 2008, J SUBST ABUSE TREAT, V35, P245, DOI 10.1016/j.jsat.2007.10.007; JUDSON BA, 1980, DRUG ALCOHOL DEPEN, V6, P295, DOI 10.1016/0376-8716(80)90197-0; Kao LW, 2003, ANN EMERG MED, V41, P546, DOI 10.1067/mem.2003.110; Kapadia F, 2002, EPIDEMIOLOGY, V13, P738, DOI 10.1097/00001648-200211000-00023; Kashiwagi M, 2005, ACTA OBSTET GYN SCAN, V84, P140, DOI 10.1111/j.0001-6349.2005.00497.x; Kerr T, 2005, J PUBLIC HEALTH-UK, V27, P62, DOI 10.1093/pubmed/fdh189; Latta Kenneth S, 2002, Am J Ther, V9, P53, DOI 10.1097/00045391-200201000-00010; Leonardi C, 2008, DRUG ALCOHOL DEPEN, V94, P125, DOI 10.1016/j.drugalcdep.2007.10.017; Lingford-Hughes AR, 2004, J PSYCHOPHARMACOL, V18, P293, DOI 10.1177/026988110401800321; Lintzeris N, 2008, MED J AUSTRALIA, V188, P441, DOI 10.5694/j.1326-5377.2008.tb01712.x; Liu QR, 2006, AM J MED GENET B, V141B, P918, DOI 10.1002/ajmg.b.30436; Luty J, 2003, J SUBST ABUSE TREAT, V24, P363, DOI 10.1016/S0740-5472(03)00035-7; Lynskey MT, 2007, PSYCHOL MED, V37, P1345, DOI 10.1017/S0033291707000396; Macleod J, 2004, LANCET, V363, P1579, DOI 10.1016/S0140-6736(04)16200-4; MADDUX JF, 1984, AM J DRUG ALCOHOL AB, V10, P237, DOI 10.3109/00952998409002783; March JC, 2006, EUR ADDICT RES, V12, P33, DOI 10.1159/000088581; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; McCaffery M, 2007, AM J NURS, V107, P35, DOI 10.1097/01.NAJ.0000301016.18877.19; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; Mehta V, 2006, ANAESTHESIA, V61, P269, DOI 10.1111/j.1365-2044.2005.04503.x; Miller NS, 2001, ACAD MED, V76, P410, DOI 10.1097/00001888-200105000-00007; Minozzi S, 2008, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD006318.PUB2; Mo W, 1999, PHARMACOL RES, V40, P139, DOI 10.1006/phrs.1999.0503; *NICE, 2007, NICE CLIN GUID, V52; NOYES R, 1988, J CLIN PSYCHIAT, V49, P382; *NSW DEP HLTH, NAT CLIN GUID MAN DR; *NSW DEP HLTH, CLIN GUID METH BUPR; Nunes EV, 2004, JAMA-J AM MED ASSOC, V291, P1887, DOI 10.1001/jama.291.15.1887; Palepu A, 2001, CAN MED ASSOC J, V165, P415; Parthasarathy S, 2005, DRUG ALCOHOL DEPEN, V80, P231, DOI 10.1016/j.drugalcdep.2005.04.004; Reece AS, 2007, AUST DENT J, V52, P144, DOI 10.1111/j.1834-7819.2007.tb00480.x; RENO RR, 1993, INT J ADDICT, V28, P211, DOI 10.3109/10826089309039624; Rhodes T, 1996, ADDICTION, V91, P753, DOI 10.1111/j.1360-0443.1996.tb03565.x; RIPPETH J, 2008, J CLIN EXP NEUROPSYC, V30, P494; Ross J, 1996, DRUG ALCOHOL REV, V15, P237, DOI 10.1080/09595239600185971; Roxburgh Amanda, 2005, Harm Reduct J, V2, P7, DOI 10.1186/1477-7517-2-7; SAMET JH, 1990, AM J MED, V89, P53, DOI 10.1016/0002-9343(90)90098-X; Schindler SD, 2003, ADDICTION, V98, P103, DOI 10.1046/j.1360-0443.2003.00245.x; SCHUTZ CG, 1994, DRUG ALCOHOL DEPEN, V36, P129, DOI 10.1016/0376-8716(94)90095-7; Shearer J, 2003, ADDICTION, V98, P1137, DOI 10.1046/j.1360-0443.2003.00447.x; Simpson DD, 1997, DRUG ALCOHOL DEPEN, V47, P227; Sporer KA, 2003, BMJ-BRIT MED J, V326, P442, DOI 10.1136/bmj.326.7386.442; SRISURAPANONT M, 2001, COCHRANE DB SYST REV, V4; Stein M D, 1993, J Subst Abuse, V5, P187, DOI 10.1016/0899-3289(93)90062-G; Stein MD, 2001, DRUG ALCOHOL DEPEN, V64, P117, DOI 10.1016/S0376-8716(00)00235-0; *SUBST AB MENT HLT, 2006, NSDUH SER H, V30; Substance Abuse and Mental Health Services Administration, 2006, DHHS PUBL, VSMA 06-4194; Swift R M, 1989, J Subst Abuse, V1, P453; Thomas G., 2005, HARM REDUCTION POLIC; Uhl GR, 2008, BIOCHEM PHARMACOL, V75, P98, DOI 10.1016/j.bcp.2007.06.042; Voshaar RCO, 2006, BRIT J PSYCHIAT, V189, P213, DOI 10.1192/bjp.189.3.213; WARNER LA, 1995, ARCH GEN PSYCHIAT, V52, P219; WASHTON AM, 1983, J CLIN PSYCHIAT, V44, P335; WHEELER SF, 1993, PRIMARY CARE, V20, P191; White MK, 1998, J CLIN OUTCOMES MANA, V5, P32; WHO, 2012, ICD 10 CLASS MENT BE; WHO, ESS MED; Wisniewski Amy B, 2005, J Neurovirol, V11, P138, DOI 10.1080/13550280590922748; Wodak A, 2008, AIDS, V22, pS81, DOI 10.1097/01.aids.0000327439.20914.33; Wolff K, 2005, EUR J CLIN PHARMACOL, V61, P763, DOI 10.1007/s00228-005-0035-5; Zimmerman JL, 2003, CRIT CARE MED, V31, P2794, DOI 10.1097/01.CCM.0000100123.50896.F0	117	82	82	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2009	374	9697					1284	1293		10.1016/S0140-6736(09)61036-9	http://dx.doi.org/10.1016/S0140-6736(09)61036-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	507KQ	19819393				2022-12-28	WOS:000270852500034
J	Benedito, R; Adams, RH				Benedito, Rui; Adams, Ralf H.			Aorta's Cardinal Secret	SCIENCE			English	Editorial Material							MOLECULAR-MECHANISMS; ANGIOGENESIS; ARTERY; NOTCH		[Benedito, Rui] Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany; Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; University of Munster	Benedito, R (corresponding author), Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, D-48149 Munster, Germany.	ralf.adams@mpi-muenster.mpg.de	Benedito, Rui/AAQ-8096-2020; Adams, Ralf H/AAE-9274-2019; Benedito, Rui/G-8295-2012	Benedito, Rui/0000-0003-2458-3055; Benedito, Rui/0000-0003-2458-3055				Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Benedito R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-117; Carlson TR, 2005, P NATL ACAD SCI USA, V102, P9884, DOI 10.1073/pnas.0504391102; Flamme I, 1997, J CELL PHYSIOL, V173, P206, DOI 10.1002/(SICI)1097-4652(199711)173:2<206::AID-JCP22>3.0.CO;2-C; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Kim YH, 2008, DEVELOPMENT, V135, P3755, DOI 10.1242/dev.022475; Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888; Lin FJ, 2007, EMBO REP, V8, P920, DOI 10.1038/sj.embor.7401076; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	12	3	3	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 9	2009	326	5950					242	243		10.1126/science.1181033	http://dx.doi.org/10.1126/science.1181033			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815764				2022-12-28	WOS:000270599500028
J	Friedberg, MW; Coltin, KL; Safran, DG; Dresser, M; Zaslavsky, AM; Schneider, EC				Friedberg, Mark W.; Coltin, Kathryn L.; Safran, Dana Gelb; Dresser, Marguerite; Zaslavsky, Alan M.; Schneider, Eric C.			Associations Between Structural Capabilities of Primary Care Practices and Performance on Selected Quality Measures	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; HEALTH-CARE; AMBULATORY-CARE; MEDICAL HOME; PHYSICIANS; TECHNOLOGY; DELIVERY; IMPROVE; RECORDS; ACCESS	Background: Recent proposals to reform primary care have encouraged physician practices to adopt such structural capabilities as performance feedback and electronic health records. Whether practices with these capabilities have higher performance on measures of primary care quality is unknown. Objective: To measure associations between structural capabilities of primary care practices and performance on commonly used quality measures. Design: Cross-sectional analysis. Setting: Massachusetts. Participants: 412 primary care practices. Measurements: During 2007, 1 physician from each participating primary care practice (median size, 4 physicians) was surveyed about structural capabilities of the practice (responses representing 308 practices were obtained). Data on practice structural capabilities were linked to multipayer performance data on 13 Healthcare Effectiveness Data and Information Set (HEDIS) process measures in 4 clinical areas: screening, diabetes, depression, and overuse. Results: Frequently used multifunctional electronic health records were associated with higher performance on 5 HEDIS measures (3 in screening and 2 in diabetes), with statistically significant differences in performance ranging from 3.1 to 7.6 percentage points. Frequent meetings to discuss quality were associated with higher performance on 3 measures of diabetes care (differences ranging from 2.3 to 3.1 percentage points). Physician awareness of patient experience ratings was associated with higher performance on screening for breast cancer and cervical cancer (1.9 and 2.2 percentage points, respectively). No other structural capabilities were associated with performance on more than 1 measure. No capabilities were associated with performance on depression care or overuse. Limitation: Structural capabilities of primary care practices were assessed by physician survey. Conclusion: Among the investigated structural capabilities of primary care practices, electronic health records were associated with higher performance across multiple HEDIS measures. Overall, the modest magnitude and limited number of associations between structural capabilities and clinical performance suggest the importance of continuing to measure the processes and outcomes of care for patients.	[Schneider, Eric C.] RAND Boston, Boston, MA 02116 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; Blue Cross & Blue Shield Massachusetts, Boston, MA USA; Harvard Pilgrim Hlth Care, Wellesley, MA USA; Massachusetts Hlth Qual Partners, Watertown, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard Pilgrim Health Care	Schneider, EC (corresponding author), RAND Boston, 20 Pk Plaza,7th Floor,Suite 720, Boston, MA 02116 USA.	eschneid@rand.org	Friedberg, Mark William/Y-2607-2019	Friedberg, Mark William/0000-0002-7907-8358; Schneider, Eric/0000-0002-1132-5084	Health Resources and Services Administration [5 T32 HP11001 20]	Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA))	By The Commonwealth Fund. Dr. Friedberg was supported by a National Research Service Award from the Health Resources and Services Administration (5 T32 HP11001 20).	*AM AC FAM PHYS, 2009, STAT MED HOM LEG; *AM AC FAM PHYS AM, 2007, JOINT PRINC PAT CTR; *AM COLL PHYS, 2009, PAT CTR MED HOM STAT; *AM MED ASS SPEC R, 2008, MED MED HOM DEM PROJ; American College of Physicians, 2006, ADV MED HOM PAT CTR; Audet AMJ, 2005, HEALTH AFFAIR, V24, P843, DOI 10.1377/hlthaff.24.3.843; Bates DW, 2003, J AM MED INFORM ASSN, V10, P1, DOI 10.1197/jamia.M1097; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bodenheimer T, 2003, JAMA-J AM MED ASSOC, V290, P259, DOI 10.1001/jama.290.2.259; Casalino L, 2003, JAMA-J AM MED ASSOC, V289, P434, DOI 10.1001/jama.289.4.434; Casalino LP, 2003, ARCH INTERN MED, V163, P1958, DOI 10.1001/archinte.163.16.1958; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Epstein AM, 2006, NEW ENGL J MED, V355, P406, DOI 10.1056/NEJMe068131; Fisher ES, 2008, NEW ENGL J MED, V359, P1202, DOI 10.1056/NEJMp0806233; Friedberg MW, 2007, J GEN INTERN MED, V22, P1385, DOI 10.1007/s11606-007-0234-0; Friedberg MW, 2009, J GEN INTERN MED, V24, P162, DOI 10.1007/s11606-008-0856-x; *I MED, 2002, UN TREATM CONFR RAC; Iglehart JK, 2008, NEW ENGL J MED, V359, P1200, DOI 10.1056/NEJMp0805225; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2006, PERF MEAS ACC IMPR; Institute of Medicine, 2003, KEY CAP EL HLTH REC; Kerr EA, 2004, HEALTH AFFAIR, V23, P247, DOI 10.1377/hlthaff.23.3.247; Linder JA, 2007, ARCH INTERN MED, V167, P1400, DOI 10.1001/archinte.167.13.1400; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Mehrotra A, 2006, ANN INTERN MED, V145, P826, DOI 10.7326/0003-4819-145-11-200612050-00007; Murray M, 2003, JAMA-J AM MED ASSOC, V289, P1035, DOI 10.1001/jama.289.8.1035; National Committee for Quality Assurance, 2008, STAND GUID PHYS PRAC; Pham HH, 2005, JAMA-J AM MED ASSOC, V294, P473, DOI 10.1001/jama.294.4.473; Rosenthal MB, 2008, NEW ENGL J MED, V359, P1197, DOI 10.1056/NEJMp0804658; Rosenthal MB, 2006, NEW ENGL J MED, V355, P1895, DOI 10.1056/NEJMsa063682; Sentell T, 2007, J GEN INTERN MED, V22, P289, DOI 10.1007/s11606-007-0345-7; Shortell SM, 2004, MED CARE, V42, P1040, DOI 10.1097/00005650-200411000-00002; Shortell SM, 2007, JAMA-J AM MED ASSOC, V298, P673, DOI 10.1001/jama.298.6.673; Simon SR, 2007, J AM MED INFORM ASSN, V14, P110, DOI 10.1197/jamia.M2187; Solberg LI, 2008, AM J MANAG CARE, V14, P85; Steinbrook R, 2009, NEW ENGL J MED, V360, P1057, DOI 10.1056/NEJMp0900665	36	107	108	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2009	151	7					456	W153		10.7326/0003-4819-151-7-200910060-00006	http://dx.doi.org/10.7326/0003-4819-151-7-200910060-00006			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	502OT	19805769				2022-12-28	WOS:000270470500003
J	Issigonis, M; Tulina, N; de Cuevas, M; Brawley, C; Sandler, L; Matunis, E				Issigonis, Melanie; Tulina, Natalia; de Cuevas, Margaret; Brawley, Crista; Sandler, Laurel; Matunis, Erika			JAK-STAT Signal Inhibition Regulates Competition in the Drosophila Testis Stem Cell Niche	SCIENCE			English	Article							SELF-RENEWAL; JAK/STAT PATHWAY; SOMATIC CONTROL; PROTEIN; CANCER; RECEPTOR	Adult stem cells often reside in local microenvironments, or niches. Although niches can contain multiple types of stem cells, the coordinate regulation of stem cell behavior is poorly understood. In the Drosophila testis, Janus kinase-signal transducer and activator of transcription (JAK-STAT) signaling is directly required for maintenance of the resident germline and somatic stem cells. We found that the JAK-STAT signaling target and inhibitor Suppressor of cytokine signaling 36E (SOCS36E) is required for germline stem cell maintenance. SOCS36E suppresses JAK-STAT signaling specifically in the somatic stem cells, preventing them from displacing neighboring germline stem cells in a manner that depends on the adhesion protein integrin. Thus, in niches housing multiple stem cell types, negative feedback loops can modulate signaling, preventing one stem cell population from outcompeting the other.	[Issigonis, Melanie; Tulina, Natalia; de Cuevas, Margaret; Brawley, Crista; Sandler, Laurel; Matunis, Erika] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Matunis, E (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.	matunis@jhmi.edu	de Cuevas, Margaret/GXV-8365-2022		NIH [RO1HD40307]; Basil O'Connor/March of Dimes [5-FY02-285]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052937, R01HD040307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basil O'Connor/March of Dimes(March of Dimes); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the Bloomington Stock Center, Developmental Studies Hybridoma Bank, and members of the fly community for reagents; M. Sepanski for electron microscopy; M. Gold for inverse polymerase chain reaction; B. Ohlstein, M. Wawersik, and M. Matunis for helpful comments; and J. Leatherman and S. DiNardo for sharing unpublished data. This work was supported by NIH grant RO1HD40307 ( to E. M.) and Basil O'Connor/March of Dimes grant 5-FY02-285 ( to M. C.). The authors have no conflicts of interest.	Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brown NH, 2002, DEV CELL, V3, P569, DOI 10.1016/S1534-5807(02)00290-3; Callus BA, 2002, ONCOGENE, V21, P4812, DOI 10.1038/sj.onc.1205618; Chen HW, 2002, GENE DEV, V16, P388, DOI 10.1101/gad.955202; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Ghiglione C, 2002, DEVELOPMENT, V129, P5437, DOI 10.1242/dev.00116; Gonzalez-Reyes A, 2003, J CELL SCI, V116, P949, DOI 10.1242/jcs.00310; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Karsten P, 2002, MECH DEVELOP, V117, P343, DOI 10.1016/S0925-4773(02)00216-2; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Leeman RJ, 2006, EXPERT OPIN BIOL TH, V6, P231, DOI 10.1517/14712598.6.3.231; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nystul TG, 2006, CURR OPIN GENET DEV, V16, P463, DOI 10.1016/j.gde.2006.08.003; Pontier SM, 2009, J CELL SCI, V122, P207, DOI 10.1242/jcs.040394; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sarkar A, 2007, CURR BIOL, V17, P1253, DOI 10.1016/j.cub.2007.06.048; Terry NA, 2006, DEV BIOL, V294, P246, DOI 10.1016/j.ydbio.2006.02.048; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; Wawersik M, 2005, NATURE, V436, P563, DOI 10.1038/nature03849	27	119	123	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					153	156		10.1126/science.1176817	http://dx.doi.org/10.1126/science.1176817			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797664	Green Accepted			2022-12-28	WOS:000270355600059
J	Wachter, RM; Pronovost, PJ				Wachter, Robert M.; Pronovost, Peter J.			Balancing "No Blame" with Accountability in Patient Safety.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SITE		[Wachter, Robert M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Pronovost, Peter J.] Johns Hopkins Sch Med, Dept Anesthesiol & Crit Care, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Sch Med, Dept Surg, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Sch Med, Dept Hlth Policy & Management, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA	University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Wachter, RM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.							Balch CM, 2009, ARCH SURG-CHICAGO, V144, P371, DOI 10.1001/archsurg.2008.575; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; Clarke JR, 2007, ANN SURG, V246, P395, DOI 10.1097/SLA.0b013e3181469987; DERGURAHIAN J, 2008, FORMER LEAPFROG CEO; Garnerin P, 2008, QUAL SAF HEALTH CARE, V17, P454, DOI 10.1136/qshc.2007.022301; Goldmann D, 2006, NEW ENGL J MED, V355, P121, DOI 10.1056/NEJMp068118; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Hickson GB, 2007, ACAD MED, V82, P1040, DOI 10.1097/ACM.0b013e31815761ee; Holmboe ES, 2008, J CONTIN EDUC HEALTH, V28, pS4, DOI 10.1002/chp.200; *I MED COMM QUAL H, 2000, ERR IS HUM BUILD SAF; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; Leape LL, 2006, ANN INTERN MED, V144, P107, DOI 10.7326/0003-4819-144-2-200601170-00008; Lee TH, 2004, NEW ENGL J MED, V350, P2409, DOI 10.1056/NEJMsb041193; Marx D, 2009, WHACK MOLE PRICE WE; Marx D, 2001, PATIENT SAFETY JUST; Mathews SC, 2008, JAMA-J AM MED ASSOC, V300, P2913, DOI 10.1001/jama.2008.846; Pittet D, 2006, LANCET INFECT DIS, V6, P641, DOI 10.1016/S1473-3099(06)70600-4; Pronovost PJ, 2008, JAMA-J AM MED ASSOC, V299, P2197, DOI 10.1001/jama.299.18.2197; Pronovost PJ, 2007, NEW ENGL J MED, V356, P1268; Pronovost PJ, 2008, JT COMM J QUAL PATIE, V34, P342, DOI 10.1016/S1553-7250(08)34043-4; Reason J., 1997, MANAGING RISKS ORG A, P205; Rhodes P, 2008, QUAL SAF HEALTH CARE, V17, P409, DOI 10.1136/qshc.2007.023010; Sax H, 2007, J HOSP INFECT, V67, P9, DOI 10.1016/j.jhin.2007.06.004; Senders JW, 2008, QUAL SAF HEALTH CARE, V17, P396, DOI 10.1136/qshc.2007.023564; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Spear SJ, 2005, ANN INTERN MED, V142, P627, DOI 10.7326/0003-4819-142-8-200504190-00011; Wachter R., 2008, UNDERSTANDING PATIEN; WACHTER RM, 2004, INTERNAL BLEEDING TR, P315; Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007; Wachter RM, 2006, JAMA-J AM MED ASSOC, V295, P2780, DOI 10.1001/jama.295.23.2780; 2008, SENTINEL EVENT  0709	32	177	178	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2009	361	14					1401	1406		10.1056/NEJMsb0903885	http://dx.doi.org/10.1056/NEJMsb0903885			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	500KZ	19797289				2022-12-28	WOS:000270300000019
J	Collins, MO				Collins, Mark O.			Evolving Cell Signals	SCIENCE			English	Editorial Material							PROTEIN-PHOSPHORYLATION; INTRINSIC DISORDER; REGIONS		Wellcome Trust Sanger Inst, Prote Mass Spectrometry Grp, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Collins, MO (corresponding author), Wellcome Trust Sanger Inst, Prote Mass Spectrometry Grp, Cambridge CB10 1SA, England.	moc@sanger.ac.uk	Collins, Mark/AAB-7484-2021	Collins, Mark/0000-0002-7656-4975				Brown CJ, 2002, J MOL EVOL, V55, P104, DOI 10.1007/s00239-001-2309-6; Collins MO, 2008, MOL CELL PROTEOMICS, V7, P1331, DOI 10.1074/mcp.M700564-MCP200; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Moses AM, 2007, P NATL ACAD SCI USA, V104, P17713, DOI 10.1073/pnas.0700997104; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Tan CSH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000316; Tan CSH, 2009, SCIENCE, V325, P1686, DOI 10.1126/science.1174301	14	10	10	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1635	1636		10.1126/science.1180331	http://dx.doi.org/10.1126/science.1180331			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779182				2022-12-28	WOS:000270131800026
J	Holmstrom, B; Johansson, M; Bergh, A; Stenman, UH; Hallmans, G; Stattin, P				Holmstrom, Benny; Johansson, Mattias; Bergh, Anders; Stenman, Ulf-Hakan; Hallmans, Goran; Stattin, Par			Prostate specific antigen for early detection of prostate cancer: longitudinal study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SCREENING TRIAL; LIMITATIONS; DIAGNOSIS; TESTS; RISK; STATISTICS; STRATEGIES; MORTALITY; INTERVAL; LEVEL	Objective To evaluate if prostate specific antigen test attains validity standards required for screening in view of recent prostate cancer screening trial results. Design Case-control study nested in longitudinal cohort. Setting Vasterbotten Intervention Project cohort, Umea, Sweden. Participants 540 cases and 1034 controls matched for age and date of blood draw. Main outcome measure Validity of prostate specific antigen for prediction of subsequent prostate cancer diagnosis by record linkage to cancer registry. Results Blood samples were drawn on average 7.1 (SD 3.7) years before diagnosis. The area under the curve for prostate specific antigen was 0.84 (95% confidence interval 0.82 to 0.86). At prostate specific antigen cut-off values of 3, 4, and 5 ng/ml, sensitivity estimates were 59%, 44%, and 33%, and specificity estimates were 87%, 92%, and 95%. The positive likelihood ratio commonly considered to "rule in disease" is 10; in this study the positive likelihood ratios were 4.5, 5.5, and 6.4 for prostate specific antigen cut-off values of 3, 4, and 5 ng/ml. The negative likelihood ratio commonly considered to "rule out disease" is 0.1; in this study the negative likelihood ratios were 0.47, 0.61, and 0.70 for prostate specific antigen cut-off values of 3, 4, and 5 ng/ml. For a cut-off of 1.0 ng/ml, the negative likelihood ratio was 0.08. Conclusions No single cut-off value for prostate specific antigen concentration attained likelihood ratios formally required for a screening test. Prostate specific antigen concentrations below 1.0 ng/ml virtually ruled out a prostate cancer diagnosis during the follow-up. Additional biomarkers for early detection of prostate cancer are needed before population based screening for prostate cancer should be introduced.	[Holmstrom, Benny] Gavle Cent Hosp, Dept Surg, S-80187 Gavle, Sweden; [Holmstrom, Benny; Stattin, Par] Umea Univ, Dept Surg & Perioperat Sci, S-90185 Umea, Sweden; [Bergh, Anders] Umea Univ, Dept Med Biosci, S-90187 Umea, Sweden; [Stenman, Ulf-Hakan] Univ Helsinki, Cent Hosp, Dept Clin Chem, FIN-00029 Helsinki, Finland; [Hallmans, Goran] Umea Univ, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden	Umea University; Umea University; University of Helsinki; Helsinki University Central Hospital; Umea University		JohanssonM@fellows.iarc.fr	Johansson, Mattias/ABF-3365-2020	Holmstrom, Benny/0000-0003-1160-3790; Johansson, Mattias/0000-0002-3116-5081	Swedish Cancer Foundation; Lion's Cancer Research Foundation	Swedish Cancer Foundation; Lion's Cancer Research Foundation	This study was supported by grants from the Swedish Cancer Foundation and the Lion's Cancer Research Foundation at Umea University. The funding source had no role in the study design; collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. The researchers were all independent from the funding source. Conflicts of interest: None declared.	Adolfsson J, 2007, SCAND J UROL NEPHROL, V41, P456, DOI 10.1080/00365590701673625; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Aus G, 2005, ARCH INTERN MED, V165, P1857, DOI 10.1001/archinte.165.16.1857; Baker SG, 2003, J NATL CANCER I, V95, P511, DOI 10.1093/jnci/95.7.511; Barry MJ, 2001, NEW ENGL J MED, V344, P1373, DOI 10.1056/NEJM200105033441806; de Koning HJ, 2002, INT J CANCER, V97, P237, DOI 10.1002/ijc.1588; Deeks JJ, 2004, BRIT MED J, V329, P168, DOI 10.1136/bmj.329.7458.168; FAGAN TJ, 1975, NEW ENGL J MED, V293, P257; Gann PH, 2002, J UROLOGY, V167, P2427, DOI 10.1016/S0022-5347(05)64998-1; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Hakama M, 2001, J UROLOGY, V166, P2189, DOI 10.1016/S0022-5347(05)65532-2; Hugosson J, 2004, CANCER-AM CANCER SOC, V100, P1397, DOI 10.1002/cncr.20126; Jaeschke R, 2002, USERS GUIDES MED LIT, P121; Kwiatkowski Maciej, 2008, Ther Umsch, V65, P493, DOI 10.1024/0040-5930.65.9.493; Lieberman Ronald, 2004, Am J Ther, V11, P501; LILIENFELD AM, 1974, CANCER-AM CANCER SOC, V33, P1720, DOI 10.1002/1097-0142(197406)33:6+<1720::AID-CNCR2820330705>3.0.CO;2-1; Lilja H, 2007, J CLIN ONCOL, V25, P431, DOI 10.1200/JCO.2006.06.9351; Maattanen L, 2007, BRIT J CANCER, V96, P56, DOI 10.1038/sj.bjc.6603522; Makinen T, 2001, J UROLOGY, V166, P1339, DOI 10.1016/S0022-5347(05)65764-3; PARKES C, 1995, BMJ-BRIT MED J, V311, P1340, DOI 10.1136/bmj.311.7016.1340; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Ross KS, 2000, JAMA-J AM MED ASSOC, V284, P1399, DOI 10.1001/jama.284.11.1399; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Smith R, 2008, CA-CANCER J CLIN, V58, P161, DOI 10.3322/CA.2007.0017; Stattin P, 2004, J CLIN ONCOL, V22, P3104, DOI 10.1200/JCO.2004.10.105; Stenman UH, 2005, SCAND J UROL NEPHROL, V39, P64, DOI 10.1080/03008880510030941; STENMAN UH, 1994, LANCET, V344, P1594, DOI 10.1016/S0140-6736(94)90405-7; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; VESSELLA RL, 1992, CLIN CHEM, V38, P2044; Ware JH, 2006, NEW ENGL J MED, V355, P2615, DOI 10.1056/NEJMp068249; Weinehall L, 1998, SCAND J PRIM HEALTH, V16, P171; Yao SL, 2001, J UROLOGY, V166, P861, DOI 10.1016/S0022-5347(05)65852-1	32	77	78	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 24	2009	339								b3537	10.1136/bmj.b3537	http://dx.doi.org/10.1136/bmj.b3537			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OG	19778969	Green Published, hybrid			2022-12-28	WOS:000270231800002
J	Sessler, DI				Sessler, Daniel I.			New surgical thermal management guidelines	LANCET			English	Editorial Material							WOUND-INFECTION; NORMOTHERMIA; HYPOTHERMIA		Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Sessler, DI (corresponding author), Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44195 USA.	DS@OR.org	Sessler, Daniel/D-3504-2011	Sessler, Daniel/0000-0001-9932-3077				Centers for Medicare and Medicaid Services, 2009, PHYS QUAL REP IN; Frank SM, 1997, JAMA-J AM MED ASSOC, V277, P1127, DOI 10.1001/jama.277.14.1127; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Lenhardt R, 1997, ANESTHESIOLOGY, V87, P1318, DOI 10.1097/00000542-199712000-00009; Melling AC, 2001, LANCET, V358, P876, DOI 10.1016/S0140-6736(01)06071-8; *QUAL NET, 2009, SURG CAR IMPR PROJ D; Rajagopalan S, 2008, ANESTHESIOLOGY, V108, P71, DOI 10.1097/01.anes.0000296719.73450.52; Sessler DI, 2008, ANESTHESIOLOGY, V109, P318, DOI 10.1097/ALN.0b013e31817f6d76; Sessler DI, 2000, ANESTHESIOLOGY, V92, P578, DOI 10.1097/00000542-200002000-00042	9	21	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2009	374	9695					1049	1050		10.1016/S0140-6736(09)61686-X	http://dx.doi.org/10.1016/S0140-6736(09)61686-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	501HA	19782858				2022-12-28	WOS:000270370900010
J	Jain, S; Kamimoto, L; Bramley, AM; Schmitz, AM; Benoit, SR; Louie, J; Sugerman, DE; Druckenmiller, JK; Ritger, KA; Chugh, R; Jasuja, S; Deutscher, M; Chen, S; Walker, JD; Duchin, JS; Lett, S; Soliva, S; Wells, EV; Swerdlow, D; Uyeki, TM; Fiore, AE; Olsen, SJ; Fry, AM; Bridges, CB; Finelli, L				Jain, Seema; Kamimoto, Laurie; Bramley, Anna M.; Schmitz, Ann M.; Benoit, Stephen R.; Louie, Janice; Sugerman, David E.; Druckenmiller, Jean K.; Ritger, Kathleen A.; Chugh, Rashmi; Jasuja, Supriya; Deutscher, Meredith; Chen, Sanny; Walker, John D.; Duchin, Jeffrey S.; Lett, Susan; Soliva, Susan; Wells, Eden V.; Swerdlow, David; Uyeki, Timothy M.; Fiore, Anthony E.; Olsen, Sonja J.; Fry, Alicia M.; Bridges, Carolyn B.; Finelli, Lyn		2009 Pandemic Influenza H1N1 Virus	Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREGNANT-WOMEN; VIRUS-INFECTION; CHILDREN; COMPLICATIONS; SURVEILLANCE; ADMISSIONS; CALIFORNIA; MORTALITY; VACCINES; HUMANS	Background: During the spring of 2009, a pandemic influenza A (H1N1) virus emerged and spread globally. We describe the clinical characteristics of patients who were hospitalized with 2009 H1N1 influenza in the United States from April 2009 to mid-June 2009. Methods: Using medical charts, we collected data on 272 patients who were hospitalized for at least 24 hours for influenza-like illness and who tested positive for the 2009 H1N1 virus with the use of a real-time reverse-transcriptase-polymerase-chain-reaction assay. Results: Of the 272 patients we studied, 25% were admitted to an intensive care unit and 7% died. Forty-five percent of the patients were children under the age of 18 years, and 5% were 65 years of age or older. Seventy-three percent of the patients had at least one underlying medical condition; these conditions included asthma; diabetes; heart, lung, and neurologic diseases; and pregnancy. Of the 249 patients who underwent chest radiography on admission, 100 (40%) had findings consistent with pneumonia. Of the 268 patients for whom data were available regarding the use of antiviral drugs, such therapy was initiated in 200 patients (75%) at a median of 3 days after the onset of illness. Data suggest that the use of antiviral drugs was beneficial in hospitalized patients, especially when such therapy was initiated early. Conclusions: During the evaluation period, 2009 H1N1 influenza caused severe illness requiring hospitalization, including pneumonia and death. Nearly three quarters of the patients had one or more underlying medical conditions. Few severe illnesses were reported among persons 65 years of age or older. Patients seemed to benefit from antiviral therapy. N Engl J Med 2009;361:1935-44.	[Jain, Seema; Kamimoto, Laurie; Bramley, Anna M.; Sugerman, David E.; Uyeki, Timothy M.; Fiore, Anthony E.; Olsen, Sonja J.; Fry, Alicia M.; Bridges, Carolyn B.; Finelli, Lyn] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Schmitz, Ann M.] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Natl Ctr Zoonot Vector Borne & Enter Dis, Atlanta, GA 30333 USA; [Benoit, Stephen R.] Ctr Dis Control & Prevent, Div Emergency Preparedness & Response, Natl Ctr Publ Hlth Informat, Atlanta, GA 30333 USA; [Deutscher, Meredith; Chen, Sanny; Swerdlow, David] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Off Workforce & Career Dev, Atlanta, GA 30333 USA; [Deutscher, Meredith] Ctr Dis Control & Prevent, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Louie, Janice] Calif Dept Publ Hlth, Richmond, CA USA; [Swerdlow, David] San Diego Cty Hlth & Human Serv, San Diego, CA USA; [Druckenmiller, Jean K.] Wisconsin Div Publ Hlth, Madison, WI USA; [Ritger, Kathleen A.] Chicago Dept Publ Hlth, Chicago, IL USA; [Chugh, Rashmi] DuPage Cty Hlth Dept, Wheaton, IL USA; [Jasuja, Supriya] Cook Cty Dept Publ Hlth, Oak Pk, IL USA; [Chen, Sanny] Arizona Dept Publ Hlth, Phoenix, AZ USA; [Walker, John D.] Texas Dept State Hlth Serv, Austin, TX USA; [Duchin, Jeffrey S.] Publ Health Seattle & King Cty, Seattle, WA USA; [Lett, Susan; Soliva, Susan] Massachusetts Dept Hlth, Jamaica Plain, MA USA; [Wells, Eden V.] Michigan Dept Community Hlth, Lansing, MI USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; California Department of Public Health; Chicago Department of Public Health; Texas Department of State Health Services; MDHHS - Michigan Department of Health & Human Services	Jain, S (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,MS A-32, Atlanta, GA 30333 USA.	bwc8@cdc.gov	Finelli, Lyn/AAK-2360-2020; Fiore, Anthony/AAO-8956-2020	Cocoros, Noelle/0000-0001-7090-2761; Meites, Elissa/0000-0002-0077-2591; Kainer, Marion/0000-0001-7678-8744; Read, Robert/0000-0002-4297-6728; Biggerstaff, Matthew/0000-0001-5108-8311	Influenza Division; Office of Workforce and Career Development	Influenza Division; Office of Workforce and Career Development(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported by the Influenza Division and Office of Workforce and Career Development at the CDC.	Ampofo K, 2006, PEDIATRICS, V118, P2409, DOI 10.1542/peds.2006-1475; [Anonymous], UPD INT REC US ANT M; [Anonymous], MMWR MORB MORTAL WKL; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P536; [Anonymous], 2009, HARRIET LANE HDB; CATE TR, 1977, J INFECT DIS, V136, pS518, DOI 10.1093/infdis/136.Supplement_3.S518; Centers for Disease Control and Prevention, FLUVIEW WEEKL INFL S; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; DOLIN R, 1977, J INFECT DIS, V136, pS435, DOI 10.1093/infdis/136.Supplement_3.S435; Finelli L, 2008, PEDIATRICS, V122, P805, DOI 10.1542/peds.2008-1336; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Keren R, 2005, JAMA-J AM MED ASSOC, V294, P2188, DOI 10.1001/jama.294.17.2188; LOURIA DB, 1959, J CLIN INVEST, V38, P213, DOI 10.1172/JCI103789; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Moore DL, 2006, PEDIATRICS, V118, pE610, DOI 10.1542/peds.2005-2744; Neuzil KM, 2003, CLIN INFECT DIS, V37, P201, DOI 10.1086/375604; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Nicholson K G, 1992, Semin Respir Infect, V7, P26; *NOV SWIN OR INFL, 2009, NEW ENGL J MED, V361, P102; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Schrag SJ, 2006, PEDIATR INFECT DIS J, V25, P395, DOI 10.1097/01.inf.0000214988.81379.71; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Walsh EE, 2002, J AM GERIATR SOC, V50, P1498, DOI 10.1046/j.1532-5415.2002.50404.x; World Health Organization, PAND H1N1 2009 UPD 6 PAND H1N1 2009 UPD 6; 2008, MMWR RECOMM REP, V57, P1	34	1278	1375	3	157	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1935	1944		10.1056/NEJMoa0906695	http://dx.doi.org/10.1056/NEJMoa0906695			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518AI	19815859				2022-12-28	WOS:000271660500007
J	Lederle, FA; Freischlag, JA; Kyriakides, TC; Padberg, FT; Matsumura, JS; Kohler, TR; Lin, PH; Jean-Claude, JM; Cikrit, DF; Swanson, KM; Peduzzi, PN				Lederle, Frank A.; Freischlag, Julie A.; Kyriakides, Tassos C.; Padberg, Frank T., Jr.; Matsumura, Jon S.; Kohler, Ted R.; Lin, Peter H.; Jean-Claude, Jessie M.; Cikrit, Dolores F.; Swanson, Kathleen M.; Peduzzi, Peter N.		OVER Vet Affairs Cooperative Study	Outcomes Following Endovascular vs Open Repair of Abdominal Aortic Aneurysm A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; SEXUAL DYSFUNCTION; ERECTILE FUNCTION; IMMEDIATE REPAIR; AAA REPAIR; MORTALITY; SURVEILLANCE; DISEASE; SURGERY; STATES	Context Limited data are available to assess whether endovascular repair of abdominal aortic aneurysm (AAA) improves short-term outcomes compared with traditional open repair. Objective To compare postoperative outcomes up to 2 years after endovascular or open repair of AAA in a planned interim report of a 9-year trial. Design, Setting, and Patients A randomized, multicenter clinical trial of 881 veterans (aged >= 49 years) from 42 Veterans Affairs Medical Centers with eligible AAA who were candidates for both elective endovascular repair and open repair of AAA. The trial is ongoing and this report describes the period between October 15, 2002, and October 15, 2008. Intervention Elective endovascular (n=444) or open (n=437) repair of AAA. Main Outcome Measures Procedure failure, secondary therapeutic procedures, length of stay, quality of life, erectile dysfunction, major morbidity, and mortality. Results Mean follow-up was 1.8 years. Perioperative mortality (30 days or inpatient) was lower for endovascular repair (0.5% vs 3.0%; P=.004), but there was no significant difference in mortality at 2 years (7.0% vs 9.8%, P=.13). Patients in the endovascular repair group had reduced median procedure time (2.9 vs 3.7 hours), blood loss (200 vs 1000 mL), transfusion requirement (0 vs 1.0 units), duration of mechanical ventilation (3.6 vs 5.0 hours), hospital stay (3 vs 7 days), and intensive care unit stay (1 vs 4 days), but required substantial exposure to fluoroscopy and contrast. There were no differences between the 2 groups in major morbidity, procedure failure, secondary therapeutic procedures, aneurysm-related hospitalizations, health-related quality of life, or erectile function. Conclusions In this report of short-term outcomes after elective AAA repair, perioperative mortality was low for both procedures and lower for endovascular than open repair. The early advantage of endovascular repair was not offset by increased morbidity or mortality in the first 2 years after repair. Longer-term outcome data are needed to fully assess the relative merits of the 2 procedures. Trial Registration clinicaltrials. gov Identifier: NCT00094575 JAMA. 2009; 302(14): 1535-1542	[Lederle, Frank A.] Vet Adm Med Ctr, Dept Med III 0, Med Serv, Minneapolis, MN 55417 USA; [Freischlag, Julie A.] Vet Affairs Med Ctr, Surg Serv, Baltimore, MD USA; [Kyriakides, Tassos C.; Peduzzi, Peter N.] Vet Affairs Med Ctr, Cooperat Studies Program Coordinating Ctr, West Haven, CT USA; [Padberg, Frank T., Jr.] Vet Affairs Med Ctr, Surg Serv, E Orange, NJ USA; [Matsumura, Jon S.] Vet Affairs Med Ctr, Surg Serv, Madison, WI USA; [Kohler, Ted R.] Vet Affairs Med Ctr, Surg Serv, Seattle, WA USA; [Lin, Peter H.] Vet Affairs Med Ctr, Surg Serv, Houston, TX 77030 USA; [Jean-Claude, Jessie M.] Vet Affairs Med Ctr, Surg Serv, Cleveland, OH USA; [Cikrit, Dolores F.] Vet Affairs Med Ctr, Surg Serv, Indianapolis, IN USA; [Swanson, Kathleen M.] Clin Res Pharm Coordinating Ctr, Cooperat Studies Program, Albuquerque, NM USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lederle, FA (corresponding author), Vet Adm Med Ctr, Dept Med III 0, Med Serv, 1 Vet Dr, Minneapolis, MN 55417 USA.	frank.lederle@va.gov	Kyriakides, Tassos/E-4980-2013	Kyriakides, Tassos/0000-0001-8913-108X; Padberg, Frank/0000-0001-5067-4247; Pipinos, Iraklis/0000-0001-6873-6346; Jacobowitz, Glenn/0000-0002-8136-2518	Cooperative Studies Program of the Department of Veterans Affairs (VA) Office of Research and Development, Washington, DC	Cooperative Studies Program of the Department of Veterans Affairs (VA) Office of Research and Development, Washington, DC(US Department of Veterans Affairs)	Funding/Support: This work was supported by the Cooperative Studies Program of the Department of Veterans Affairs (VA) Office of Research and Development, Washington, DC. Study nurses were compensated directly by the VA study grant. Physician time was donated by the respective VA Medical Centers. Statistical and other central VA personnel were employed by the VA to work on various studies, including this trial.	[Anonymous], SF 36 HLTH SURVEY UP; Aylin P, 2007, BMJ-BRIT MED J, V334, P1044, DOI 10.1136/bmj.39168.496366.55; Ballard DJ, 1992, ABDOMINAL AORTIC ANE; Blankensteijn JD, 2005, NEW ENGL J MED, V352, P2398, DOI 10.1056/NEJMoa051255; Diehr P, 2003, MED CARE, V41, P1065, DOI 10.1097/01.MLR.0000083748.86769.A9; *FDA PUBL HLTH NOT, UPD DAT MORT ASS MED; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Holt PJE, 2007, BRIT J SURG, V94, P441, DOI 10.1002/bjs.5725; Hutter MM, 2007, J AM COLL SURGEONS, V204, P1115, DOI 10.1016/j.jamcollsurg.2007.02.066; JOHNSTON KW, 1994, J VASC SURG, V20, P163, DOI 10.1016/0741-5214(94)90002-7; Kalbfleish J., 1980, STAT ANAL FAILURE TI; Koo V, 2007, J SEX MED, V4, P1147, DOI 10.1111/j.1743-6109.2006.00343.x; Koskas F, 1997, ANN VASC SURG, V11, P473, DOI 10.1007/s100169900078; Lederle FA, 2003, J VASC SURG, V38, P745, DOI 10.1016/S0741-5214(03)00423-3; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Lederle FA, 2007, ANN INTERN MED, V146, P735, DOI 10.7326/0003-4819-146-10-200705150-00007; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; McPhee JT, 2007, J VASC SURG, V45, P891, DOI 10.1016/j.jvs.2007.01.043; Powell JT, 1998, LANCET, V352, P1649; Prinssen M, 2004, J ENDOVASC THER, V11, P613, DOI 10.1583/04-1280R.1; Prinssen M, 2004, EUR J VASC ENDOVASC, V27, P121, DOI 10.1016/j.ejvs.2003.11.006; Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Schermerhorn ML, 2008, NEW ENGL J MED, V358, P464, DOI 10.1056/NEJMoa0707348; Shaw JW, 2005, MED CARE, V43, P203, DOI 10.1097/00005650-200503000-00003; Takagi H, 2007, EUR J VASC ENDOVASC, V33, P177, DOI 10.1016/j.ejvs.2006.07.009; Xenos ES, 2003, ANN VASC SURG, V17, P530, DOI 10.1007/s10016-003-0058-2	28	789	841	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	2009	302	14					1535	1542		10.1001/jama.2009.1426	http://dx.doi.org/10.1001/jama.2009.1426			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505UA	19826022	Bronze			2022-12-28	WOS:000270721800021
J	Bijl, PK; Schouten, S; Sluijs, A; Reichart, GJ; Zachos, JC; Brinkhuis, H				Bijl, Peter K.; Schouten, Stefan; Sluijs, Appy; Reichart, Gert-Jan; Zachos, James C.; Brinkhuis, Henk			Early Palaeogene temperature evolution of the southwest Pacific Ocean	NATURE			English	Article							SEA-SURFACE TEMPERATURES; EOCENE; CLIMATE; MIDDLE	Relative to the present day, meridional temperature gradients in the Early Eocene age (similar to 56-53 Myr ago) were unusually low, with slightly warmer equatorial regions(1) but with much warmer subtropical Arctic(2) and mid-latitude(3) climates. By the end of the Eocene epoch (similar to 34 Myr ago), the first major Antarctic ice sheets had appeared(4,5), suggesting that major cooling had taken place. Yet the global transition into this icehouse climate remains poorly constrained, as only a few temperature records are available portraying the Cenozoic climatic evolution of the high southern latitudes. Here we present a uniquely continuous and chronostratigraphically well-calibrated TEX86 record of sea surface temperature (SST) from an ocean sediment core in the East Tasman Plateau (palaeolatitude similar to 65 degrees S). We show that southwest Pacific SSTs rose above presentday tropical values (to similar to 34 degrees C) during the Early Eocene age (similar to 53 Myr ago) and had gradually decreased to about 21 degrees C by the early Late Eocene age (similar to 36 Myr ago). Our results imply that there was almost no latitudinal SST gradient between subequatorial and subpolar regions during the Early Eocene age (55-50 Myr ago). Thereafter, the latitudinal gradient markedly increased. In theory, if Eocene cooling was largely driven by a decrease in atmospheric greenhouse gas concentration(6), additional processes are required to explain the relative stability of tropical SSTs given that there was more significant cooling at higher latitudes.	[Bijl, Peter K.; Sluijs, Appy; Brinkhuis, Henk] Univ Utrecht, Palaeobot & Palynol Lab, Fac Sci, Inst Environm Biol, NL-3584 CD Utrecht, Netherlands; [Reichart, Gert-Jan] Univ Utrecht, Fac Geosci, Dept Geochem, NL-3584 CD Utrecht, Netherlands; [Schouten, Stefan] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Organ Biogeochem, NL-1790 AB Den Burg, Netherlands; [Zachos, James C.] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Zachos, James C.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	Utrecht University; Utrecht University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Bijl, PK (corresponding author), Univ Utrecht, Palaeobot & Palynol Lab, Fac Sci, Inst Environm Biol, Budapestlaan 4, NL-3584 CD Utrecht, Netherlands.	p.k.bijl@uu.nl	Reichart, Gert-Jan/N-6308-2018; Zachos, James C/A-7674-2008; Brinkhuis, Henk/B-4223-2009; Sluijs, Appy/B-3726-2009	Reichart, Gert-Jan/0000-0002-7256-2243; Zachos, James C/0000-0001-8439-1886; Sluijs, Appy/0000-0003-2382-0215; Bijl, Peter/0000-0002-1710-4012; Brinkhuis, Henk/0000-0003-0253-6610	Utrecht University; Netherlands Organisation for Scientific Research; LPP Foundation; US National Science Foundation	Utrecht University; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); LPP Foundation; US National Science Foundation(National Science Foundation (NSF))	Funding for this research was provided by Utrecht University, the Netherlands Organisation for Scientific Research (VICI grant to S. S.; VENI grant to A. S.) and the LPP Foundation. This research used samples and data provided by the Ocean Drilling Program (ODP). The ODP was sponsored by the US National Science Foundation and participating countries under the management of Joint Oceanographic Institutions, Inc. G. Nobbe, E. van Bentum, E. Speelman, J. Ossebaar, A. Mets and E. Hopmans are thanked for technical support. We acknowledge C. J. Hollis, P. N. Pearson and P. F. Sexton for providing published data. A. J. P. ( Sander) Houben, P. N. Pearson and M. Huber are thanked for critical comments.	Abbot DS, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032286; Barker PF, 2007, DEEP-SEA RES PT II, V54, P2293, DOI 10.1016/j.dsr2.2007.07.027; Barron EJ, 1987, PALEOCEANOGRAPHY, V2, P729, DOI 10.1029/PA002i006p00729; Bohaty SM, 2003, GEOLOGY, V31, P1017, DOI 10.1130/G19800.1; Burgess CE, 2008, GEOLOGY, V36, P651, DOI 10.1130/G24762A.1; EXON N, 2004, GEOPHYS MONOGR SER A, V151; GREENWOOD DR, 1995, GEOLOGY, V23, P1044, DOI 10.1130/0091-7613(1995)023<1044:ECCALT>2.3.CO;2; Hay WW, 1999, GEOL S AM S, P1; Hollis CJ, 2009, GEOLOGY, V37, P99, DOI 10.1130/G25200A.1; Huber M, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001014; Huber M, 2001, GEOPHYS RES LETT, V28, P3481, DOI 10.1029/2001GL012943; Huber M, 2008, SCIENCE, V321, P353, DOI 10.1126/science.1161170; Ivany LC, 2008, GEOL SOC AM BULL, V120, P659, DOI 10.1130/B26269.1; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Pearson PN, 2007, GEOLOGY, V35, P211, DOI 10.1130/G23175A.1; Pearson PN, 2001, NATURE, V413, P481, DOI 10.1038/35097000; Rohl U, 2004, GEOPH MONOG SERIES, V151, P127; Sangiorgi F, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001487; Schouten S, 2002, EARTH PLANET SC LETT, V204, P265, DOI 10.1016/S0012-821X(02)00979-2; SCHRAG DP, 1995, GEOCHIM COSMOCHIM AC, V59, P2265, DOI 10.1016/0016-7037(95)00105-9; SHEA DJ, 1992, J CLIMATE, V5, P987, DOI 10.1175/1520-0442(1992)005<0987:AGMSST>2.0.CO;2; Sluijs A, 2007, NATURE, V450, P1218, DOI 10.1038/nature06400; Sluijs A, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001615; STICKLEY C, 2004, P OCEAN DRILLING PRO, V0189; Stickley CE, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001022; Thomas DJ, 2003, EARTH PLANET SC LETT, V209, P309, DOI 10.1016/S0012-821X(03)00096-7; Weller P, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001472; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; ZACHOS JC, 1992, GEOLOGY, V20, P569, DOI 10.1130/0091-7613(1992)020<0569:EOISEO>2.3.CO;2	30	257	264	0	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					776	779		10.1038/nature08399	http://dx.doi.org/10.1038/nature08399			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19812670	Green Published			2022-12-28	WOS:000270547500032
J	Thomas, RH; Burke, C; Howlett, D				Thomas, Robert H.; Burke, Christopher; Howlett, David			Picture Quiz A breathless woman with asthma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Thomas, Robert H.; Burke, Christopher; Howlett, David] Eastbourne Dist Gen Hosp, Eastbourne BN21 2UD, England		Thomas, RH (corresponding author), Eastbourne Dist Gen Hosp, Eastbourne BN21 2UD, England.	roberththomas@gmail.com	Burke, Christopher/AAI-6000-2020	Burke, Christopher/0000-0001-7609-1146				British Thoracic Society and Scottish Intercollegiate Guidelines Network, 2008, BRIT GUID MAN ASTHM; DOWNIE A, 2001, LOBAR COLLAPSE TUTOR; Felson B., 1973, CHEST ROENTGENOLOGY; HARDY KA, 1996, RESP CARE CLIN N AM, V2, P233; MAXWELL GM, 1985, J ASTHMA, V22, P131, DOI 10.3109/02770908509073131; Office for National Statistics, 2009, CANC STAT REG REG CA; SANTIAGO M, 2007, FUNDAMENTALS DIAGNOS, P344; Tagaya Etsuko, 2007, Allergol Int, V56, P331	8	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2009	339								b4008	10.1136/bmj.b4008	http://dx.doi.org/10.1136/bmj.b4008			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TG	19812143				2022-12-28	WOS:000270719200003
J	Christensen, K; Doblhammer, G; Rau, R; Vaupel, JW				Christensen, Kaare; Doblhammer, Gabriele; Rau, Roland; Vaupel, James W.			Ageing populations: the challenges ahead	LANCET			English	Review							LATE-LIFE DISABILITY; ELDERLY US POPULATION; BIRTH COHORTS BORN; UNITED-STATES; FUNCTIONAL LIMITATIONS; AGE 65; ASSISTIVE TECHNOLOGY; DANISH CENTENARIANS; COGNITIVE FUNCTION; HEALTH EXPECTANCY	If the pace of increase in life expectancy in developed countries over the past two centuries continues through the 21st century, most babies born since 2000 in France, Germany, Italy, the UK, the USA, Canada, Japan, and other countries with long life expectancies will celebrate their 100th birthdays. Although trends differ between countries, populations of nearly all such countries are ageing as a result of low fertility, low immigration, and long lives. A key question is: are increases in life expectancy accompanied by a concurrent postponement of functional limitations and disability? The answer is still open, but research suggests that ageing processes are modifiable and that people are living longer without severe disability. This finding, together with technological and medical development and redistribution of work, will be important for our chances to meet the challenges of ageing populations.	[Christensen, Kaare] Univ So Denmark, Danish Ageing Res Ctr, DK-5000 Odense C, Denmark; [Doblhammer, Gabriele; Rau, Roland] Univ Rostock, Rostock, Germany; [Vaupel, James W.] Max Planck Inst Demog Res, Rostock, Germany	University of Southern Denmark; University of Rostock; Max Planck Society	Christensen, K (corresponding author), Univ So Denmark, Danish Ageing Res Ctr, DK-5000 Odense C, Denmark.	kchristensen@health.sdu.dk	Christensen, Kaare/C-2360-2009	Christensen, Kaare/0000-0002-5429-5292; Vaupel, James/0000-0003-0783-3905	NIH/NIA [P01 AG08761]; VELUX foundation; NATIONAL INSTITUTE ON AGING [P01AG008761] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); VELUX foundation(Velux Fonden); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Bernard Jeune for his helpful comments and suggestions. KC and JWV are supported by a grant from NIH/NIA, Grant No P01 AG08761. The Danish Ageing Research Centre is supported by a grant from the VELUX foundation.	Agree EM, 2005, J GERONTOL B-PSYCHOL, V60, pS272, DOI 10.1093/geronb/60.5.S272; Ahacic K, 2003, SOC SCI MED, V57, P2411, DOI 10.1016/S0277-9536(03)00136-9; Aijanseppa S, 2005, J EPIDEMIOL COMMUN H, V59, P413, DOI 10.1136/jech.2004.026302; Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; Alley Dawn E, 2008, LDI Issue Brief, V13, P1; [Anonymous], 2000, DEMOGR RES, DOI DOI 10.4054/DEMRES.2000.3.9; Baltes PB, 2003, GERONTOLOGY, V49, P123, DOI 10.1159/000067946; Bhattacharya J, 2008, MED CARE, V46, P92, DOI 10.1097/MLR.0b013e3181484335; Cambois E, 2007, POPULATION, V62, P363, DOI 10.2307/20451015; Cambois E, 2008, EUR J AGEING, V5, P287, DOI 10.1007/s10433-008-0097-1; Christensen K, 2008, P NATL ACAD SCI USA, V105, P13274, DOI 10.1073/pnas.0804931105; Crimmins EM, 2005, J GERONTOL A-BIOL, V60, P1409, DOI 10.1093/gerona/60.11.1409; Crimmins EM, 2004, ANNU REV PUBL HEALTH, V25, P79, DOI 10.1146/annurev.publhealth.25.102802.124401; Cutler DM, 2006, 12184 NBER; Desai M, 2001, Aging Trends, P1; Doblhammer G, 2001, SOC SCI MED, V52, P385, DOI 10.1016/S0277-9536(00)00141-6; Doblhammer G., 2006, GENDER HLTH AGEING E; Doblhammer G, 2010, J GERONTOL B-PSYCHOL, V65, P482, DOI 10.1093/geronb/gbp051; Doblhammer G, 2009, DEMOGR RES, V20, P37, DOI 10.4054/DemRes.2009.20.5; Engberg H, 2008, DEMENT GERIATR COGN, V26, P153, DOI 10.1159/000149819; Engberg H, 2008, J GERONTOL A-BIOL, V63, P1186, DOI 10.1093/gerona/63.11.1186; Engberg H, 2009, AGING CELL, V8, P270, DOI 10.1111/j.1474-9726.2009.00474.x; Fors S, 2008, EUR J PUBLIC HEALTH, V18, P138, DOI 10.1093/eurpub/ckm097; Freedman VA, 2000, AM J PUBLIC HEALTH, V90, P1755, DOI 10.2105/AJPH.90.11.1755; Freedman VA, 2006, GERONTOLOGIST, V46, P124, DOI 10.1093/geront/46.1.124; Freedman VA, 2004, DEMOGRAPHY, V41, P417, DOI 10.1353/dem.2004.0022; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Freedman VA, 1998, AM J PUBLIC HEALTH, V88, P1457, DOI 10.2105/AJPH.88.10.1457; Freedman VA, 2008, SOC SCI MED, V66, P1588, DOI 10.1016/j.socscimed.2007.11.037; Freedman VA, 2007, DEMOGRAPHY, V44, P459, DOI 10.1353/dem.2007.0026; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Hayflick L, 2003, EXP GERONTOL, V38, P1231, DOI 10.1016/j.exger.2003.09.003; Hayflick L, 2007, PLOS GENET, V3, P2351, DOI 10.1371/journal.pgen.0030220; JACOBZONE S, 2000, OECD EC STUDIES, V0030; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; Jagger C, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-156; Jeune B, 2008, EUR J AGEING, V5, P279, DOI 10.1007/s10433-008-0100-x; Juel K, 2008, SCAND J PUBLIC HEALT, V36, P11, DOI 10.1177/1403494808097590; Juel Knud, 2008, Ugeskr Laeger, V170, P2423; KANNISTO V, 1994, POPUL DEV REV, V20, P793, DOI 10.2307/2137662; Kannisto V, 1994, MONOGRAPHS POPULATIO; KANNISTO V, 1996, MONOGRAPHS POPULATIO, V3; Karim-Kos HE, 2008, EUR J CANCER, V44, P1345, DOI 10.1016/j.ejca.2007.12.015; Lafortune G, 2007, 26 OECD; Lakdawalla DN, 2004, HEALTH AFFAIR, V23, P168, DOI 10.1377/hlthaff.23.1.168; Langa KM, 2008, ALZHEIMERS DEMENT, V4, P134, DOI 10.1016/j.jalz.2008.01.001; Lubitz J, 2003, NEW ENGL J MED, V349, P1048, DOI 10.1056/NEJMsa020614; Manton KG, 2008, ANNU REV PUBL HEALTH, V29, P91, DOI 10.1146/annurev.publhealth.29.020907.090812; Manton KG, 2006, P NATL ACAD SCI USA, V103, P18374, DOI 10.1073/pnas.0608483103; Manton KG, 2001, P NATL ACAD SCI USA, V98, P6354, DOI 10.1073/pnas.111152298; MANTON KG, 1995, NEW ENGL J MED, V333, P1232, DOI 10.1056/NEJM199511023331824; Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593; Martin LG, 2007, J GERONTOL B-PSYCHOL, V62, pS11, DOI 10.1093/geronb/62.1.S11; Martin LG, 2009, J GERONTOL B-PSYCHOL, V64, P369, DOI 10.1093/geronb/gbn040; Mathers CD, 2001, LANCET, V357, P1685, DOI 10.1016/S0140-6736(00)04824-8; Meinow Bettina, 2006, Eur J Ageing, V3, P98, DOI 10.1007/s10433-006-0027-z; Murabito JM, 2008, AM J PUBLIC HEALTH, V98, P1256, DOI 10.2105/AJPH.2007.128132; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Oksuzyan A, 2008, AGING CLIN EXP RES, V20, P91; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Olshansky SJ, 2001, SCIENCE, V291, P1491, DOI 10.1126/science.291.5508.1491; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; Parker MG, 2007, GERONTOLOGIST, V47, P150, DOI 10.1093/geront/47.2.150; Parker M, 2008, EUR J AGEING, V5, P299, DOI 10.1007/s10433-008-0096-2; Parker MG, 2005, J GERONTOL A-BIOL, V60, P1351, DOI 10.1093/gerona/60.10.1351; Paul SL, 2007, CURR DRUG TARGETS, V8, P786; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Perenboom RJM, 2004, DISABIL REHABIL, V26, P377, DOI 10.1080/0963828032000174098; PRESTON SH, 1989, DEMOGRAPHY, V26, P691, DOI 10.2307/2061266; Puts MTE, 2008, AGE AGEING, V37, P187, DOI 10.1093/ageing/afm185; Qureshi AI, 2005, MED SCI MONITOR, V11, pCR403; Rau R, 2008, POPUL DEV REV, V34, P747, DOI 10.1111/j.1728-4457.2008.00249.x; Reynolds SL, 2005, GERONTOLOGIST, V45, P438, DOI 10.1093/geront/45.4.438; Riley J, 2001, RISING LIFE EXPECTAN; Robine J-M., 2003, DETERMINING HLTH EXP, P75, DOI 10.1002/0470858885.ch4; Robine JM, 2006, AGING CLIN EXP RES, V18, P349; Robine JM, 2002, SUMMARY MEASURES OF POPULATION HEALTH: CONCEPTS, ETHICS, MEASUREMENT AND APPLICATIONS, P205; Robine JM, 2004, J GERONTOL A-BIOL, V59, P590, DOI 10.1093/gerona/59.6.M590; Rodgers WL, 2003, J GERONTOL B-PSYCHOL, V58, pS338, DOI 10.1093/geronb/58.6.S338; Sagardui-Villamor J, 2005, J GERONTOL A-BIOL, V60, P1028, DOI 10.1093/gerona/60.8.1028; Schoenhofen EA, 2006, J AM GERIATR SOC, V54, P1237, DOI 10.1111/j.1532-5415.2006.00826.x; Schoeni RF, 2006, POP STUD-J DEMOG, V60, P39, DOI 10.1080/00324720500462280; Schoeni RF, 2008, MILBANK Q, V86, P47, DOI 10.1111/j.1468-0009.2007.00513.x; Smith J., 2001, EUR REV, V9, P461, DOI [10.1017/S1062798701000424, DOI 10.1017/S1062798701000424]; Spalton D, 2000, BRIT MED J, V321, P1304, DOI 10.1136/bmj.321.7272.1304; Spillman BC, 2004, MILBANK Q, V82, P157, DOI 10.1111/j.0887-378X.2004.00305.x; Statistisches Bundesamt, 2006, BEV DEUTSCHL BIS 205; Sturm R, 2004, HEALTH AFFAIR, V23, P199, DOI 10.1377/hlthaff.23.2.199; Sulander T, 2006, INT J EPIDEMIOL, V35, P1255, DOI 10.1093/ije/dyl183; Sulander TT, 2003, SCAND J PUBLIC HEALT, V31, P100, DOI 10.1080/14034940210133933; SUZMAN R, 1985, MILBANK FUND Q, V63, P177; SUZMAN RM, 1992, OLDEST OLD; Suzuki M, 1995, Nihon Ronen Igakkai Zasshi, V32, P416; Unger R, 2006, J PUBLIC HEALTH-HEID, V14, P155, DOI 10.1007/s10389-006-0037-5; Vallin Jacques, 2005, Genus, V61, P83; Van Oyen H, 2008, EUR J AGEING, V5, P137, DOI 10.1007/s10433-008-0082-8; Vaupel JW, 2006, SCIENCE, V312, P1911, DOI 10.1126/science.1127487; Vaupel JW, 1997, PHILOS T ROY SOC B, V352, P1799, DOI 10.1098/rstb.1997.0164; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; WAIDMANN T, 1995, MILBANK Q, V73, P253, DOI 10.2307/3350259; Wang HD, 2009, P NATL ACAD SCI USA, V106, P393, DOI 10.1073/pnas.0811809106; Wang Z., 1997, LONGEVITY LIMITS, P91; Wen XY, 2004, AUSTRALAS J AGEING, V23, P3, DOI 10.1111/j.1741-6612.2004.00007.x; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wolf DA, 2005, MILBANK Q, V83, P365, DOI 10.1111/j.1468-0009.2005.00406.x; Zamboni M, 2005, INT J OBESITY, V29, P1011, DOI 10.1038/sj.ijo.0803005; Zunzunegui MV, 2006, AGING CLIN EXP RES, V18, P352, DOI 10.1007/BF03324830	115	2136	2171	23	498	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2009	374	9696					1196	1208		10.1016/S0140-6736(09)61460-4	http://dx.doi.org/10.1016/S0140-6736(09)61460-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505IZ	19801098	Green Accepted, Green Submitted			2022-12-28	WOS:000270688200036
J	Robinson, M				Robinson, Mary			Realising the human right to health	LANCET			English	Editorial Material									Eth Globalizat Initiat, New York, NY 10016 USA		Robinson, M (corresponding author), Eth Globalizat Initiat, New York, NY 10016 USA.	info@eginitiative.org						*WHO, 2008, REP GAVI PROGR 2000; 2009, M TASKF INN INT FIN	2	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2009	374	9696					1121	1122		10.1016/S0140-6736(09)61723-2	http://dx.doi.org/10.1016/S0140-6736(09)61723-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505IZ	19801080				2022-12-28	WOS:000270688200004
J	Rappuoli, R; Del Giudice, G; Nabel, GJ; Osterhaus, ADME; Robinson, R; Salisbury, D; Stohr, K; Treanor, JJ				Rappuoli, Rino; Del Giudice, Giuseppe; Nabel, Gary J.; Osterhaus, Albert D. M. E.; Robinson, Robin; Salisbury, David; Stoehr, Klaus; Treanor, John J.			Rethinking Influenza	SCIENCE			English	Editorial Material							H5N1 VACCINE; TRIAL		[Rappuoli, Rino; Del Giudice, Giuseppe] Novartis Vaccines & Diagnost Srl, I-53100 Siena, Italy; [Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Osterhaus, Albert D. M. E.] Erasmus Univ, NL-3015E Rotterdam, Netherlands; [Robinson, Robin] US Dept Hlth & Human Serv HHS, Washington, DC 20201 USA; [Salisbury, David] WHO, SAGE, CH-1211 Geneva 27, Switzerland; [Stoehr, Klaus] Novartis Vaccines & Diagnost Inc, Cambridge, MA 02139 USA; [Treanor, John J.] Univ Rochester, Rochester, NY 14642 USA	Novartis; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Erasmus University Rotterdam; Sage Group; World Health Organization; Novartis; University of Rochester	Rappuoli, R (corresponding author), Novartis Vaccines & Diagnost Srl, I-53100 Siena, Italy.	rino.rappuoli@novartis.com		Osterhaus, Albert/0000-0002-6074-1172				Brooks WA, 2007, EMERG INFECT DIS, V13, P1507, DOI 10.3201/eid1310.070368; CLARK TW, 2009, N ENGL J MED, P144; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; GREENBERG HR, 2009, N ENGL J MED, P144; International Atomic Energy Agency, 2009, INT REACT PRESS VESS, P144; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; *WHO, 2009, UPD H1N1 PAND SEAS V, P144; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	10	14	14	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 2	2009	326	5949					50	50		10.1126/science.1179475	http://dx.doi.org/10.1126/science.1179475			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797644				2022-12-28	WOS:000270355600025
J	Sepulveda, J; Wendler, JE; Summons, RE; Hinrichs, KU				Sepulveda, Julio; Wendler, Jens E.; Summons, Roger E.; Hinrichs, Kai-Uwe			Rapid Resurgence of Marine Productivity After the Cretaceous-Paleogene Mass Extinction	SCIENCE			English	Article							TERTIARY BOUNDARY; STEVNS-KLINT; IMPACT EVENT; DENMARK; CONSEQUENCES; RECOVERY; DECREASE; ISOTOPE; OCEAN	The course of the biotic recovery after the impact-related disruption of photosynthesis and mass extinction event at the Cretaceous-Paleogene boundary has been intensely debated. The resurgence of marine primary production in the aftermath remains poorly constrained because of the paucity of fossil records tracing primary producers that lack skeletons. Here we present a high-resolution record of geochemical variation in the remarkably thick Fiskeler (also known as the Fish Clay) boundary layer at Kulstirenden, Denmark. Converging evidence from the stable isotopes of carbon and nitrogen and abundances of algal steranes and bacterial hopanes indicates that algal primary productivity was strongly reduced for only a brief period of possibly less than a century after the impact, followed by a rapid resurgence of carbon fixation and ecological reorganization.	[Sepulveda, Julio; Hinrichs, Kai-Uwe] Univ Bremen, Organ Geochem Grp, D-28334 Bremen, Germany; [Sepulveda, Julio; Hinrichs, Kai-Uwe] Univ Bremen, Int Grad Coll Proxies Earth Hist EUROPROX, D-28334 Bremen, Germany; [Wendler, Jens E.] Univ Bremen, Dept Geosci, Res Grp Geochronol Basin Anal, D-28334 Bremen, Germany; [Summons, Roger E.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	University of Bremen; University of Bremen; University of Bremen; Massachusetts Institute of Technology (MIT)	Sepulveda, J (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 45 Carleton St E25-623, Cambridge, MA 02139 USA.	juliosep@mit.edu	Sepulveda, Julio/K-8908-2013; Hinrichs, Kai-Uwe/C-7675-2009; Sepúlveda, Julio/AAC-9956-2020; Summons, Roger Everett/AAL-3789-2020; Sepúlveda, Julio/K-6268-2017	Hinrichs, Kai-Uwe/0000-0002-0739-9291; Sepúlveda, Julio/0000-0002-8251-6937; Sepúlveda, Julio/0000-0002-8251-6937	Deutsche Forschungsgemeinschaft through the European Graduate College EUROPROX; MARUM; NASA (Astrobiology Institute, Exobiology Program); Hanse-Wissenschaftskolleg; Alexander von Humboldt-Stiftung	Deutsche Forschungsgemeinschaft through the European Graduate College EUROPROX(German Research Foundation (DFG)); MARUM; NASA (Astrobiology Institute, Exobiology Program)(National Aeronautics & Space Administration (NASA)); Hanse-Wissenschaftskolleg; Alexander von Humboldt-Stiftung(Alexander von Humboldt Foundation)	This research was funded by the Deutsche Forschungsgemeinschaft through the European Graduate College EUROPROX and MARUM, and NASA (Astrobiology Institute, Exobiology Program). We thank X. Prieto, C. Colonero, L. Sherman, J. Salacup, H. Buschhoff, M. Segl, U. Beckert, P. Simundic, C. Gonzalez, A. Kelly, B. Schmincke, M. Milling-Goldbach, and A. Skorokhod for their laboratory and/or logistic assistance. R. E. S. acknowledges the Hanse-Wissenschaftskolleg and the Alexander von Humboldt-Stiftung. J. S. acknowledges EUROPROX for supporting his doctoral studies and a research visit to MIT.	ALTABET MA, 1994, GLOBAL BIOGEOCHEM CY, V8, P103, DOI 10.1029/93GB03396; ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; Arinobu T, 1999, GEOLOGY, V27, P723, DOI 10.1130/0091-7613(1999)027<0723:SOPPAH>2.3.CO;2; Brinkhuis H, 1998, PALAEOGEOGR PALAEOCL, V141, P67, DOI 10.1016/S0031-0182(98)00004-2; Cao CQ, 2009, EARTH PLANET SC LETT, V281, P188, DOI 10.1016/j.epsl.2009.02.012; D'Hondt S, 2005, ANNU REV ECOL EVOL S, V36, P295, DOI 10.1146/annurev.ecolsys.35.021103.105715; D'Hondt S, 1998, SCIENCE, V282, P276, DOI 10.1126/science.282.5387.276; Hart MB, 2004, J GEOL SOC LONDON, V161, P885, DOI 10.1144/0016-764903-071; HOLLANDER DJ, 1993, PALAEOGEOGR PALAEOCL, V104, P229, DOI 10.1016/0031-0182(93)90134-5; HOLLIS CJ, 1995, GEOLOGY, V23, P835, DOI 10.1130/0091-7613(1995)023<0835:SPBITE>2.3.CO;2; HSU KJ, 1982, SCIENCE, V216, P249, DOI 10.1126/science.216.4543.249; Kaiho K, 1999, PALEOCEANOGRAPHY, V14, P511, DOI 10.1029/1999PA900022; Keller G, 1996, PALAEOGEOGR PALAEOCL, V119, P221, DOI 10.1016/0031-0182(95)00009-7; KELLER G, 1993, GEOL SOC AM BULL, V105, P979, DOI 10.1130/0016-7606(1993)105<0979:GMESSA>2.3.CO;2; Knoll Andrew H., 2007, P133; Kring DA, 2007, PALAEOGEOGR PALAEOCL, V255, P4, DOI 10.1016/j.palaeo.2007.02.037; Kuypers MMM, 2004, GEOLOGY, V32, P853, DOI 10.1130/G20458.1; LAWS EA, 1995, GEOCHIM COSMOCHIM AC, V59, P1131, DOI 10.1016/0016-7037(95)00030-4; Medlin LK, 2008, MAR MICROPALEONTOL, V67, P69, DOI 10.1016/j.marmicro.2007.08.007; Mita H, 1999, GEOCHEM J, V33, P285, DOI 10.2343/geochemj.33.285; Mukhopadhyay S, 2001, SCIENCE, V291, P1952, DOI 10.1126/science.291.5510.1952; Pope KO, 1997, J GEOPHYS RES-PLANET, V102, P21645, DOI 10.1029/97JE01743; Rashid H, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001240; SCHMITZ B, 1988, GEOCHIM COSMOCHIM AC, V52, P229, DOI 10.1016/0016-7037(88)90072-5; SCHMITZ B, 1992, PALAEOGEOGR PALAEOCL, V96, P233, DOI 10.1016/0031-0182(92)90104-D; Sheehan Peter M., 1996, Geological Society of America Special Paper, V307, P477; Summons RE, 1999, NATURE, V400, P554, DOI 10.1038/23005; Surlyk F, 2006, B GEOL SOC DENMARK, V54, P1; Wendler J, 2002, GEOL SOC AM SPEC PAP, V356, P265	29	82	84	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					129	132		10.1126/science.1176233	http://dx.doi.org/10.1126/science.1176233			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797658				2022-12-28	WOS:000270355600051
J	White, TD; Ambrose, SH; Suwa, G; Su, DF; DeGusta, D; Bernor, RL; Boisserie, JR; Brunet, M; Delson, E; Frost, S; Garcia, N; Giaourtsakis, IX; Haile-Selassie, Y; Howell, FC; Lehmann, T; Likius, A; Pehlevan, C; Saegusa, H; Semprebon, G; Teaford, M; Vrba, E				White, Tim D.; Ambrose, Stanley H.; Suwa, Gen; Su, Denise F.; DeGusta, David; Bernor, Raymond L.; Boisserie, Jean-Renaud; Brunet, Michel; Delson, Eric; Frost, Stephen; Garcia, Nuria; Giaourtsakis, Ioannis X.; Haile-Selassie, Yohannes; Howell, F. Clark; Lehmann, Thomas; Likius, Andossa; Pehlevan, Cesur; Saegusa, Haruo; Semprebon, Gina; Teaford, Mark; Vrba, Elisabeth			Macrovertebrate Paleontology and the Pliocene Habitat of Ardipithecus ramidus	SCIENCE			English	Article							INFERRING PALEOHABITATS; FUNCTIONAL-MORPHOLOGY; PATTERNS; MAMMALS; GONA; AFAR	A diverse assemblage of large mammals is spatially and stratigraphically associated with Ardipithecus ramidus at Aramis. The most common species are tragelaphine antelope and colobine monkeys. Analyses of their postcranial remains situate them in a closed habitat. Assessment of dental mesowear, microwear, and stable isotopes from these and a wider range of abundant associated larger mammals indicates that the local habitat at Aramis was predominantly woodland. The Ar. ramidus enamel isotope values indicate a minimal C-4 vegetation component in its diet (plants using the C-4 photosynthetic pathway), which is consistent with predominantly forest/woodland feeding. Although the Early Pliocene Afar included a range of environments, and the local environment at Aramis and its vicinity ranged from forests to wooded grasslands, the integration of available physical and biological evidence establishes Ar. ramidus as a denizen of the closed habitats along this continuum.	[White, Tim D.; Howell, F. Clark] Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA; [White, Tim D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Ambrose, Stanley H.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Suwa, Gen] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Su, Denise F.] Bryn Mawr Coll, Dept Anthropol, Bryn Mawr, PA 19010 USA; [DeGusta, David] Stanford Univ, Dept Anthropol, Stanford, CA 94305 USA; [Bernor, Raymond L.] Natl Sci Fdn, Sedimentary Geol & Paleobiol Program, Arlington, VA 22230 USA; [Bernor, Raymond L.] Howard Univ, Coll Med, Dept Anat, Lab Evolutionary Biol, Washington, DC 20059 USA; [Boisserie, Jean-Renaud] Museum Natl Hist Nat, CNRS, UMR 5143, USM 0203, F-75231 Paris 05, France; [Boisserie, Jean-Renaud] Univ Poitiers, CNRS, UMR 6046, Inst Paleoprimatol & Paleontol Humaine Evolut & P, F-86022 Poitiers, France; [Brunet, Michel] Coll France, Chaire Paleontol Humaine, F-75231 Paris 05, France; [Delson, Eric] CUNY Herbert H Lehman Coll, Dept Anthropol, Bronx, NY 10468 USA; [Delson, Eric] Amer Museum Nat Hist, Dept Vertebrate Paleontol, New York, NY 10024 USA; [Frost, Stephen] Univ Oregon, Dept Anthropol, Eugene, OR 97403 USA; [Garcia, Nuria] Univ Complutense Madrid, Dept Paleontol, Madrid 28029, Spain; [Garcia, Nuria] ISCIII, Ctr Evoluc & Comportamiento Humanos, Madrid 28029, Spain; [Giaourtsakis, Ioannis X.] Univ Munich, Dept Geo & Environm Sci, Sect Paleontol, D-80333 Munich, Germany; [Haile-Selassie, Yohannes] Cleveland Museum Nat Hist, Dept Phys Anthropol, Cleveland, OH 44106 USA; [Howell, F. Clark] Univ Calif Berkeley, Dept Anthropol, Berkeley, CA 94720 USA; [Lehmann, Thomas] Senckenberg Forschungsinst, D-60325 Frankfurt, Germany; [Likius, Andossa] Univ NDjamena, Dept Paleontol, Ndjamena, Chad; [Pehlevan, Cesur] Yuzuncu Yil Univ, Dept Anthropol, Fac Sci & Letters, TR-65080 Zeve Yerlesimi, Van, Turkey; [Saegusa, Haruo] Hyogo Med Univ, Inst Nat & Environm Sci, Yayoigaoka, Sanda 6691546, Japan; [Semprebon, Gina] Bay Path Coll, Longmeadow, MA 01106 USA; [Teaford, Mark] Johns Hopkins Univ, Sch Med, Ctr Funct Anat & Evolut, Baltimore, MD 21205 USA; [Vrba, Elisabeth] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Illinois System; University of Illinois Urbana-Champaign; University of Tokyo; Bryn Mawr College; Stanford University; National Science Foundation (NSF); Howard University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; UDICE-French Research Universities; PSL Research University Paris; College de France; City University of New York (CUNY) System; Lehman College (CUNY); American Museum of Natural History (AMNH); University of Oregon; Complutense University of Madrid; Instituto de Salud Carlos III; University of Munich; Cleveland Museum of Natural History; University of California System; University of California Berkeley; Senckenberg Gesellschaft fur Naturforschung (SGN); Yuzuncu Yil University; University of Hyogo; Johns Hopkins University; Yale University	White, TD (corresponding author), Univ Calif Berkeley, Human Evolut Res Ctr, 3101 Valley Life Sci Bldg, Berkeley, CA 94720 USA.	timwhite@berkeley.edu	Lund, Laura/H-7335-2012	Giaourtsakis, Ioannis/0000-0003-0519-7642; Delson, Eric/0000-0002-4062-7567	NSF [SBR-82-10897, 93-18698, 9512534, 96-32389, 99-10344, 03-21893]; Japan Society for the Promotion of Science;  [SBR 98-71480]	NSF(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	Supported by NSF (grants SBR-82-10897, 93-18698, 9512534, 96-32389, 99-10344, and 03-21893 HOMINID-RHOI; and grant SBR 98-71480 for mass spectrometry instrumentation at the Environmental Isotope Paleobiogeochemistry Laboratory) and the Japan Society for the Promotion of Science (G. S. and H. S.). We thank L. Bach, H. Gilbert, and K. Brudvik for illustrations; the Ministry of Tourism and Culture, the Authority for Research and Conservation of the Cultural Heritage, and the National Museum of Ethiopia for permissions and facilitation; and the Afar Regional Government, the Afar people of the Middle Awash, and many other field workers for contributing directly to the data.	AMBROSE SH, 1986, OECOLOGIA, V69, P395, DOI 10.1007/BF00377062; ANDREWS P, 1979, BIOL J LINN SOC, V11, P177, DOI 10.1111/j.1095-8312.1979.tb00034.x; Andrews P, 1999, HUMAN EVOLUT SER, P282; Benefit BR, 1999, HUMAN EVOLUT SER, P172; Bobe R, 2006, J ARID ENVIRON, V66, P564, DOI 10.1016/j.jaridenv.2006.01.010; Bobe R, 2001, PALEOBIOLOGY, V27, P1, DOI 10.1666/0094-8373(2001)027<0001:ROABTP>2.0.CO;2; Carter ML, 2001, THESIS U CHICAGO; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; DeGusta D, 2005, J ARCHAEOL SCI, V32, P1099, DOI 10.1016/j.jas.2005.02.010; DeGusta D, 2003, J ARCHAEOL SCI, V30, P1009, DOI 10.1016/S0305-4403(02)00286-8; Elton S, 2002, FOLIA PRIMATOL, V73, P252, DOI 10.1159/000067457; Fleagle J.G., 1976, YB PHYS ANTHR, V20, P440, DOI [10.1002/ajpa.1330460211, DOI 10.1002/AJPA.1330460211]; Fortelius Mikael, 2000, American Museum Novitates, V3301, P1, DOI 10.1206/0003-0082(2000)301<0001:FCOUMU>2.0.CO;2; Frost Stephen R., 2001, American Museum Novitates, V3350, P1, DOI 10.1206/0003-0082(2001)350<0001:NEPCMP>2.0.CO;2; Haile-Selassie Y, 2004, GEOBIOS-LYON, V37, P536, DOI 10.1016/j.geobios.2003.03.012; Hespenheide H.A., 1973, Annual Rev Ecol Syst, V4, P213, DOI 10.1146/annurev.es.04.110173.001241; Hlusko Leslea J., 2007, Kirtlandia, V56, P163; Kovarovic K, 2002, J HUM EVOL, V43, P395, DOI 10.1006/jhev.2002.0580; KRENTZ HB, 1993, THEROPITHECUS, P383, DOI 10.1017/CBO9780511565540.015; Leakey M, 1999, HUMAN EVOLUT SER, P271; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; Levin NE, 2008, GEOL SOC AM SPEC PAP, V446, P215, DOI 10.1130/2008.2446(10); Louchart A, 2009, SCIENCE, V326, DOI 10.1126/science.1175823; Oates John F., 1994, P45; Quade J, 2008, GEOL SOC AM SPEC PAP, V446, P1, DOI 10.1130/2008.2446(01); Reed KE, 2008, J HUM EVOL, V54, P743, DOI 10.1016/j.jhevol.2007.08.013; Shipman P., 1988, P343; Sikes Nancy E., 1995, Evolutionary Anthropology, V4, P155, DOI 10.1002/evan.1360040504; Sorkin B, 2006, HIST BIOL, V18, P375, DOI 10.1080/08912960600618073; Sponheimer M, 2006, J HUM EVOL, V51, P128, DOI 10.1016/j.jhevol.2006.02.002; Sponheimer Matt, 2007, P555, DOI 10.1007/978-3-540-33761-4_18; SU DF, 2005, THESIS NEW YORK U; Suwa G, 2003, J VERTEBR PALEONTOL, V23, P901, DOI 10.1671/2469-15; van der Merwe NJ, 2008, S AFR J SCI, V104, P153; Vrba E.S., 1980, P247; WHITE F, 1983, VEGETATION AFRICA NA, V20; White T.D., 1988, P449; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; WoldeGabriel G, 2009, SCIENCE, V326, DOI 10.1126/science.1175817	41	192	197	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					87	93		10.1126/science.1175822	http://dx.doi.org/10.1126/science.1175822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501CA	19810193	Green Published			2022-12-28	WOS:000270355600041
J	Kirschner, KL; Curry, RH				Kirschner, Kristi L.; Curry, Raymond H.			Educating Health Care Professionals to Care for Patients With Disabilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kirschner, Kristi L.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Kirschner, Kristi L.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil & Med Humanities & Bioeth, Chicago, IL 60611 USA; [Curry, Raymond H.] Northwestern Univ, Feinberg Sch Med, Dept Med & Med Educ, Chicago, IL 60611 USA	Shirley Ryan AbilityLab; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Kirschner, KL (corresponding author), Rehabil Inst Chicago, 345 E Super St,Room 1136, Chicago, IL 60611 USA.	kkirschner@ric.org	Curry, Raymond H./ABD-2043-2020	Curry, Raymond H./0000-0003-3381-0125				*AM MED STUD ASS, DIS WEB RES; [Anonymous], SURGEON GENERALS CAL; *ASS AM MED COLL, 2008, DIR AM MED ED 2008 2; *ASS AM MED COLL, 2008, GER COMP MED STUD RE; *ASS U CTR DIS, EL TOOL KIT TRAIN RE; Sonu IS, 2006, AM J MED, V119, P995, DOI 10.1016/j.amjmed.2006.07.038	6	54	55	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1334	1335		10.1001/jama.2009.1398	http://dx.doi.org/10.1001/jama.2009.1398			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497AR	19773571				2022-12-28	WOS:000270026000018
J	Clarke, R; Emberson, J; Fletcher, A; Breeze, E; Marmot, M; Shipley, MJ				Clarke, Robert; Emberson, Jonathan; Fletcher, Astrid; Breeze, Elizabeth; Marmot, Michael; Shipley, Martin J.			Life expectancy in relation to cardiovascular risk factors: 38 year follow-up of 19 000 men in the Whitehall study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE MORTALITY; CIVIL-SERVANTS; RE-SURVEY; DECLINE; AGE; CHOLESTEROL; POPULATION; SMOKING; TRENDS	Objective To assess life expectancy in relation to cardiovascular risk factors recorded in middle age. Design Prospective cohort study. Setting Men employed in the civil service in London, England. Participants 18 863 men examined at entry in 1967-70 and followed for 38 years, of whom 13 501 died and 4811 were re-examined in 1997. Main outcome measures Life expectancy estimated in relation to fifths and dichotomous categories of risk factors (smoking, "low" or "high" blood pressure (>= 140 mm Hg), and "low" or "high" cholesterol (>= 5 mmol/l)), and a risk score from these risk factors. Results At entry, 42% of the men were current smokers, 39% had high blood pressure, and 51% had high cholesterol. At the re-examination, about two thirds of the previously "current" smokers had quit smoking shortly after entry and the mean differences in levels of those with high and low levels of blood pressure and cholesterol were attenuated by two thirds. Compared with men without any baseline risk factors, the presence of all three risk factors at entry was associated with a 10 year shorter life expectancy from age 50 (23.7 v 33.3 years). Compared with men in the lowest 5% of a risk score based on smoking, diabetes, employment grade, and continuous levels of blood pressure, cholesterol concentration, and body mass index (BMI), men in the highest 5% had a 15 year shorter life expectancy from age 50 (20.2 v 35. 4 years). Conclusion Despite substantial changes in these risk factors over time, baseline differences in risk factors were associated with 10 to 15 year shorter life expectancy from age 50.	[Clarke, Robert; Emberson, Jonathan] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Clarke, Robert; Emberson, Jonathan] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford OX3 7LF, England; [Fletcher, Astrid] London Sch Hyg & Trop Med, London WC1E 6HT, England; [Breeze, Elizabeth; Marmot, Michael; Shipley, Martin J.] UCL, Sch Med, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; UCL Medical School	Clarke, R (corresponding author), Univ Oxford, Clin Trial Serv Unit, Richard Doll Bldg, Oxford OX3 7LF, England.	robert.clarke@ctsu.ox.ac.uk	Breeze, Elizabeth/AAK-4927-2021; Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419; Emberson, Jonathan/0000-0001-7792-9422	British Heart Foundation; Medical Research Council; MM; MRC [MC_U137686857] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [G0100222, G19/35, G8802774, MC_U137686857] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MM; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Whitehall study was supported by the British Heart Foundation and Medical Research Council. JE and MJS are supported by the British Heart Foundation and MM by a MRC research professorship. All of the analyses were carried out independently of the sources of support.	ALLENDER S, 2006, CORONARY HEART DIS S; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; *CHOL TREATM TRIAL, 2006, LANCET, V366, P1267; Clarke R, 1998, J EPIDEMIOL COMMUN H, V52, P364, DOI 10.1136/jech.52.6.364; Clarke R, 2000, J CARDIOVASC RISK, V7, P251; Clarke R, 2007, ARCH INTERN MED, V167, P1373, DOI 10.1001/archinte.167.13.1373; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Driver JA, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2467; Emberson J, 2004, EUR HEART J, V25, P484, DOI 10.1016/j.ehj.2003.11.012; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Kivimaki M, 2008, OBESITY, V16, P1926, DOI 10.1038/oby.2008.322; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; *NAT STAT, 2007, IN LIF EXP 65 UK; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; OFLAHERTY M, 2003, HLTH STAT Q, V18, P5; REID DD, 1974, LANCET, V1, P469; ROSE G, 1977, LANCET, V1, P105; Rose G., 1992, STRATEGY PREVENTIVE; SMITH GD, 1991, ANN NUTR METAB, V35, P53, DOI 10.1159/000177678; Turnbull F, 2003, LANCET, V362, P1527; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; Yates LB, 2008, ARCH INTERN MED, V168, P284, DOI 10.1001/archinternmed.2007.77	26	66	70	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2009	339								b3513	10.1136/bmj.b3513	http://dx.doi.org/10.1136/bmj.b3513			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RU	19762417	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000269994900002
J	Zhang, Q; Davis, JC; Lamborn, IT; Freeman, AF; Jing, H; Favreau, AJ; Matthews, HF; Davis, J; Turner, ML; Uzel, G; Holland, SM; Su, HC				Zhang, Qian; Davis, Jeremiah C.; Lamborn, Ian T.; Freeman, Alexandra F.; Jing, Huie; Favreau, Amanda J.; Matthews, Helen F.; Davis, Joie; Turner, Maria L.; Uzel, Gulbu; Holland, Steven M.; Su, Helen C.			Combined Immunodeficiency Associated with DOCK8 Mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPER-IGE SYNDROME; T-CELL IMMUNODEFICIENCY; STAT3 MUTATIONS; DIFFERENTIATION; DEFICIENCIES; ACTIVATOR; DELETION; DISEASES; EGRESS; FAMILY	BACKGROUND Recurrent sinopulmonary and cutaneous viral infections with elevated serum levels of IgE are features of some variants of combined immunodeficiency. The genetic causes of these variants are unknown. METHODS We collected longitudinal clinical data on 11 patients from eight families who had recurrent sinopulmonary and cutaneous viral infections. We performed comparative genomic hybridization arrays and targeted gene sequencing. Variants with predicted loss-of-expression mutations were confirmed by means of a quantitative reverse-transcriptase-polymerase-chain-reaction assay and immunoblotting. We evaluated the number and function of lymphocytes with the use of in vitro assays and flow cytometry. RESULTS Patients had recurrent otitis media, sinusitis, and pneumonias; recurrent Staphylococcus aureus skin infections with otitis externa; recurrent, severe herpes simplex virus or herpes zoster infections; extensive and persistent infections with molluscum contagiosum; and human papillomavirus infections. Most patients had severe atopy with anaphylaxis; several had squamous-cell carcinomas, and one had T-cell lymphoma-leukemia. Elevated serum IgE levels, hypereosinophilia, low numbers of T cells and B cells, low serum IgM levels, and variable IgG antibody responses were common. Expansion in vitro of activated CD8 T cells was impaired. Novel homozygous or compound heterozygous deletions and point mutations in the gene encoding the dedicator of cytokinesis 8 protein (DOCK8) led to the absence of DOCK8 protein in lymphocytes. CONCLUSIONS Autosomal recessive DOCK8 deficiency is associated with a novel variant of combined immunodeficiency.	[Su, Helen C.] NIAID, NIH, Host Def Lab, Bethesda, MD 20892 USA; [Freeman, Alexandra F.; Davis, Joie; Uzel, Gulbu; Holland, Steven M.] NIAID, Lab Clin Infect Dis, Bethesda, MD 20892 USA; [Favreau, Amanda J.] NIAID, Res Technol Branch, Bethesda, MD 20892 USA; [Matthews, Helen F.] NIAID, Immunol Lab, Bethesda, MD 20892 USA; [Davis, Jeremiah C.] Howard Hughes Med Inst, Bethesda, MD 20817 USA; [Turner, Maria L.] NCI, Dermatol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Su, HC (corresponding author), NIAID, NIH, Host Def Lab, CRC 5W3940,MSC 1456, Bethesda, MD 20892 USA.	hsu@niaid.nih.gov	Su, Helen C/H-9541-2015	Su, Helen C/0000-0002-5582-9110; Zhang, Qian/0000-0002-9040-3289	National Institutes of Health; National Institute of Allergy and Infectious Diseases; National Cancer Institute; Howard Hughes Medical Institute-National Institutes of Health Research Scholar Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000646, ZIAAI001059] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute-National Institutes of Health Research Scholar Program(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Intramural Research Program of the National Institutes of Health, the National Institute of Allergy and Infectious Diseases, and the National Cancer Institute, and by a grant from the Howard Hughes Medical Institute-National Institutes of Health Research Scholar Program ( to Mr. Davis). Sequencing was performed by the Genomics Unit of the Rocky Mountain Laboratories Research Technologies Section of the National Institute of Allergy and Infectious Diseases.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Brito-Babapulle F, 2003, BRIT J HAEMATOL, V121, P203, DOI 10.1046/j.1365-2141.2003.04195.x; Bustamante J, 2008, IMMUNOL ALLERGY CLIN, V28, P235, DOI 10.1016/j.iac.2008.01.009; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; CUSTER JW, 2009, HARRIET LANE HDB MAN; de Beaucoudrey L, 2008, J EXP MED, V205, P1543, DOI 10.1084/jem.20080321; Fischer A, 2007, IMMUNITY, V27, P835, DOI 10.1016/j.immuni.2007.11.012; Freeman AF, 2008, IMMUNOL ALLERGY CLIN, V28, P277, DOI 10.1016/j.iac.2008.01.005; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Griggs BL, 2008, GENOMICS, V91, P195, DOI 10.1016/j.ygeno.2007.10.011; Grimbacher B, 1999, AM J HUM GENET, V65, P735, DOI 10.1086/302547; Holland SM, 2007, NEW ENGL J MED, V357, P1608, DOI 10.1056/NEJMoa073687; Idbaih A, 2008, J NEURO-ONCOL, V90, P133, DOI 10.1007/s11060-008-9644-z; Kalman L, 2004, GENET MED, V6, P16, DOI 10.1097/01.GIM.0000105752.80592.A3; Kawai T, 2009, CURR OPIN HEMATOL, V16, P20, DOI 10.1097/MOH.0b013e32831ac557; Lei JY, 2000, AM J DERMATOPATH, V22, P524, DOI 10.1097/00000372-200012000-00008; Liston A, 2008, NAT REV IMMUNOL, V8, P545, DOI 10.1038/nri2336; MARKERT ML, 1987, J CLIN IMMUNOL, V7, P389, DOI 10.1007/BF00917017; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Minegishi Y, 2007, NATURE, V448, P1058, DOI 10.1038/nature06096; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; Ozcan E, 2008, J ALLERGY CLIN IMMUN, V122, P1054, DOI 10.1016/j.jaci.2008.10.023; Pignata C, 1996, AM J MED GENET, V65, P167, DOI 10.1002/(SICI)1096-8628(19961016)65:2<167::AID-AJMG17>3.0.CO;2-O; PRAWER SE, 1977, ARCH DERMATOL, V113, P495, DOI 10.1001/archderm.113.4.495; Renner ED, 2004, J PEDIATR-US, V144, P93, DOI 10.1016/S0022-3476(03)00449-9; Renner ED, 2008, J ALLERGY CLIN IMMUN, V122, P181, DOI 10.1016/j.jaci.2008.04.037; Ruusala A, 2004, FEBS LETT, V572, P159, DOI 10.1016/j.febslet.2004.06.095; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Takahashi K, 2006, INT J ONCOL, V28, P321; Tanaka Y, 2007, NAT IMMUNOL, V8, P1067, DOI 10.1038/ni1506; van der Burg M, 2006, J CLIN INVEST, V116, P137, DOI 10.1172/JCI26121; van der Burg M, 2009, J CLIN INVEST, V119, P91, DOI 10.1172/JCI37141; Vinci G, 2007, MOL HUM REPROD, V13, P685, DOI 10.1093/molehr/gam045; Woellner C, 2007, IMMUNITY, V26, P535, DOI 10.1016/j.immuni.2007.05.007	39	486	500	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21					2046	2055		10.1056/NEJMoa0905506	http://dx.doi.org/10.1056/NEJMoa0905506			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	521DA	19776401	Green Accepted			2022-12-28	WOS:000271898600009
J	Engelberg, AB; Kesselheim, AS; Avorn, J				Engelberg, Alfred B.; Kesselheim, Aaron S.; Avorn, Jerry			Balancing Innovation, Access, and Profits -- Market Exclusivity for Biologics.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Engelberg, Alfred B.] Engelberg Fdn, Palm Beach, FL 33480 USA; [Kesselheim, Aaron S.; Avorn, Jerry] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Kesselheim, Aaron S.; Avorn, Jerry] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Engelberg, AB (corresponding author), Engelberg Fdn, Palm Beach, FL 33480 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Dudzinski DM, 2008, NEW ENGL J MED, V358, P843, DOI 10.1056/NEJMhle0706973; Engelberg A., 1999, IDEA, V39, P389; *FED TRAD COMM, 2009, FOLL ON BIOL DRUG CO; SYRE S, 2009, BOSTON GLOBE    0821	4	48	49	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1917	1919		10.1056/NEJMp0908496	http://dx.doi.org/10.1056/NEJMp0908496			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	518AI	19828525				2022-12-28	WOS:000271660500001
J	Gowers, T; Nielsen, M				Gowers, Timothy; Nielsen, Michael			Massively collaborative mathematics	NATURE			English	Editorial Material									[Gowers, Timothy] Univ Cambridge, Dept Pure Math & Math Stat, Cambridge CB3 0WB, England	University of Cambridge	Gowers, T (corresponding author), Univ Cambridge, Dept Pure Math & Math Stat, Wilberforce Rd, Cambridge CB3 0WB, England.	W.T.Gowers@dpmms.cam.ac.uk; mn@michaelnielsen.org		Nielsen, Michael/0000-0002-6188-5389					0	78	79	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					879	881		10.1038/461879a	http://dx.doi.org/10.1038/461879a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	506ZF	19829354				2022-12-28	WOS:000270817700021
J	Wiebe, C; Reslerova, M; Komenda, P; Bueti, J; Rigatto, C; Sood, MM				Wiebe, Chris; Reslerova, Martina; Komenda, Paul; Bueti, Joe; Rigatto, Claudio; Sood, Manish M.			Atypical clinical presentation of H1N1 influenza in a dialysis patient	LANCET			English	Editorial Material									[Sood, Manish M.] St Boniface Gen Hosp, Manitoba Renal Program, Dept Med, Winnipeg, MB, Canada; [Wiebe, Chris] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Bueti, Joe] Hlth Sci Ctr, Deparment Med, Winnipeg, MB, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba	Sood, MM (corresponding author), St Boniface Gen Hosp, Manitoba Renal Program, Dept Med, Bg007,409 Tache Ave, Winnipeg, MB, Canada.	msood99@gmail.com	Sood, Manish M/H-3134-2019	Sood, Manish M/0000-0002-9146-2344; Wiebe, Chris/0000-0002-1006-3545; Komenda, Paul/0000-0001-7016-7146				Hauser AB, 2008, PERITON DIALYSIS INT, V28, pS183; Robson R, 2006, NEPHROL DIAL TRANSPL, V21, P2556, DOI 10.1093/ndt/gfl267; *US CDC, UPD INT REC US ANT M; *US CDC, INT GUID CLIN ID CAR; World Health Organization, PAND H1N1 2009 UPD 6 PAND H1N1 2009 UPD 6	5	9	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2009	374	9697					1300	1300		10.1016/S0140-6736(09)61596-8	http://dx.doi.org/10.1016/S0140-6736(09)61596-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	507KQ	19819394				2022-12-28	WOS:000270852500036
J	Severinghaus, JP				Severinghaus, Jeffrey P.			Monsoons and Meltdowns	SCIENCE			English	Editorial Material							ABRUPT CLIMATE-CHANGE; CYCLES		Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Severinghaus, JP (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	jseveringhaus@ucsd.edu						Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; Byrd BF, 2005, J ARCHAEOL RES, V13, P231, DOI 10.1007/s10814-005-3107-2; Cheng CH, 2008, GEOCHIM COSMOCHIM AC, V72, P1598, DOI 10.1016/j.gca.2008.01.010; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Denton G.H., 2006, PAGES NEWS, V14, P14, DOI DOI 10.22498/PAGES.14.2.14; Denton GH, 2005, QUATERNARY SCI REV, V24, P1159, DOI 10.1016/j.quascirev.2004.12.002; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Paillard D, 2001, REV GEOPHYS, V39, P325, DOI 10.1029/2000RG000091; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; Severinghaus JP, 2009, SCIENCE, V324, P1431, DOI 10.1126/science.1169473	11	7	8	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 9	2009	326	5950					240	241		10.1126/science.1179941	http://dx.doi.org/10.1126/science.1179941			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815763				2022-12-28	WOS:000270599500027
J	Alam, HB; Fricchione, GL; Guimaraes, ASR; Zukerberg, LR				Alam, Hasan B.; Fricchione, Gregory L.; Guimaraes, Alexander S. R.; Zukerberg, Lawrence R.			A Man with Abdominal Distention and Shock Acute megacolon (Ogilvie's syndrome), with extensive mucosal ischemic necrosis, due to clozapine-induced gastrointestinal hypomotility.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEPTIC SHOCK; INTRAABDOMINAL HYPERTENSION; EARLY COAGULOPATHY; TOXIC MEGACOLON; CRITICALLY-ILL; DAMAGE-CONTROL; SEVERE SEPSIS; CHLORPROMAZINE; MANAGEMENT; THERAPY		[Alam, Hasan B.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Fricchione, Gregory L.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Guimaraes, Alexander S. R.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Zukerberg, Lawrence R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Alam, Hasan B.] Harvard Univ, Sch Med, Dept Surg, Cambridge, MA 02138 USA; [Fricchione, Gregory L.] Harvard Univ, Sch Med, Dept Psychiat, Cambridge, MA 02138 USA; [Guimaraes, Alexander S. R.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Zukerberg, Lawrence R.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Alam, HB (corresponding author), Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA.							Berman L, 2008, J CLIN GASTROENTEROL, V42, P476, DOI 10.1097/MCG.0b013e31804bbe12; Bharucha, 1999, Curr Treat Options Gastroenterol, V2, P517, DOI 10.1007/s11938-999-0055-9; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140; CENTORRINO F, 1994, AM J PSYCHIAT, V151, P123; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dirkmann D, 2008, ANESTH ANALG, V106, P1627, DOI 10.1213/ane.0b013e31817340ad; Gan SI, 2003, AM J GASTROENTEROL, V98, P2363, DOI 10.1016/S0002-9270(03)00702-0; GOFF DC, 2008, COMPREHENSIVE CLIN P, P577; Goyal RK, 1996, NEW ENGL J MED, V334, P1106, DOI 10.1056/NEJM199604253341707; Hanauer Stephen B, 2007, Curr Treat Options Gastroenterol, V10, P237, DOI 10.1007/s11938-007-0017-z; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; Lee JC, 2006, CURR OPIN CRIT CARE, V12, P346, DOI 10.1097/01.ccx.0000235213.63988.9a; Leong Quor M, 2007, World J Emerg Surg, V2, P21, DOI 10.1186/1749-7922-2-21; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Maerz L, 2008, CRIT CARE MED, V36, pS212, DOI 10.1097/CCM.0b013e318168e333; Malbrain MLNG, 2005, CRIT CARE MED, V33, P315, DOI 10.1097/01.CCM.0000153408.09806.1B; Malbrain MLNG, 2005, CURR OPIN CRIT CARE, V11, P156, DOI 10.1097/01.ccx.0000155355.86241.1b; Niles SE, 2008, J TRAUMA, V64, P1459, DOI 10.1097/TA.0b013e318174e8bc; Palmer SE, 2008, J CLIN PSYCHIAT, V69, P759, DOI 10.4088/JCP.v69n0509; Regueira T, 2008, J CRIT CARE, V23, P461, DOI 10.1016/j.jcrc.2007.12.013; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; ROTONDO MF, 1993, J TRAUMA, V35, P375, DOI 10.1097/00005373-199309000-00008; Sebat F, 2005, CHEST, V127, P1729, DOI 10.1378/chest.127.5.1729; Shapiro NI, 2006, CRIT CARE MED, V34, P1025, DOI 10.1097/01.CCM.0000206104.18647.A8; Singh Manpreet K, 2006, J Psychiatr Pract, V12, P90, DOI 10.1097/00131746-200603000-00004; Tieu BH, 2007, WORLD J SURG, V31, P1055, DOI 10.1007/s00268-006-0653-9; Townsend G, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-43; *WORLD SOC ABD COM, WSACS CONS GUID SUMM	30	9	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2009	361	15					1487	1496		10.1056/NEJMcpc0900643	http://dx.doi.org/10.1056/NEJMcpc0900643			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503MU	19812406				2022-12-28	WOS:000270540000013
J	Costa, LDM; Maher, CG; McAuley, JH; Hancock, MJ; Herbert, RD; Refshauge, KM; Henschke, N				Costa, Luciola da C. Menezes; Maher, Christopher G.; McAuley, James H.; Hancock, Mark J.; Herbert, Robert D.; Refshauge, Kathryn M.; Henschke, Nicholas			Prognosis for patients with chronic low back pain: inception cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; GENERAL-PRACTICE; CLINICAL-COURSE; FOLLOW-UP; MANAGEMENT; DESIGN; GUIDELINES	Objectives To describe the course of chronic low back pain in an inception cohort and to identify prognostic markers at the onset of chronicity. Design Inception cohort study with one year follow-up. Setting Primary care clinics in Sydney, Australia. Participants The study sample was a subcohort of an inception cohort of 973 consecutive patients presenting to primary care with acute low back pain (< 2 weeks' duration). 406 participants whose pain persisted for three months formed the inception cohort of patients with chronic low back pain. Main outcome measures Outcomes and putative predictors measured at initial presentation, onset of chronicity ( study entry), and follow-up at nine and 12 months. Recovery was determined from measures of pain intensity, disability, and work status. The association between potential prognostic factors and time to recovery was modelled with Cox regression. Results Completeness of follow-up was 97% of total person time for all outcomes. The cumulative probability of being pain-free was 35% at nine months and 42% at 12 months and for complete recovery was 35% at nine months and 41% at 12 months. Of the 259 participants who had not recovered from pain related disability at entry to the chronic study, 47% had recovered by 12 months. Previous sick leave due to low back pain, high disability levels or high pain intensity at onset of chronicity, low levels of education, greater perceived risk of persistent pain, and being born outside Australia were associated with delayed recovery. Conclusion More than one third of patients with recent onset, non-radicular chronic low back pain recover within 12 months. The prognosis is less favourable for those who have taken previous sick leave for low back pain, have high disability levels or high pain intensity at onset of chronic low back pain, have lower education, perceive themselves as having a high risk of persistent pain, and were born outside Australia.	[Costa, Luciola da C. Menezes; Maher, Christopher G.; McAuley, James H.; Herbert, Robert D.] Univ Sydney, George Inst Int Hlth, Sydney, NSW 2006, Australia; [McAuley, James H.; Hancock, Mark J.; Refshauge, Kathryn M.] Univ Sydney, Fac Hlth Sci, Back Pain Res Grp, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Costa, LDM (corresponding author), POB M201,Missenden Rd, Sydney, NSW 2050, Australia.	lmenezes@george.org.au	Herbert, Rob/E-9442-2012; Maher, Christopher/AAC-6267-2019; Hancock, Mark J/B-6999-2013; McAuley, James Henry/HHC-3949-2022; Henschke, Nicholas/C-2975-2014; Costa, Luciola Menezes/B-4844-2013	Herbert, Rob/0000-0003-4188-9195; Maher, Christopher/0000-0002-1628-7857; Hancock, Mark J/0000-0002-9277-5377; McAuley, James Henry/0000-0002-0550-828X; Henschke, Nicholas/0000-0002-9624-2519; Costa, Luciola Menezes/0000-0003-1859-2799; refshauge, kathryn/0000-0002-8127-6847	National Health and Medical Research Council of Australia; The National Health and Medical Research Council; CGM; RDH; NH	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); The National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); CGM; RDH; NH	This study was supported by a grant from the National Health and Medical Research Council of Australia. The funder had no role in the study design; collection, analysis, and interpretation of data; writing of the report; or decision to submit the article for publication. The National Health and Medical Research Council of Australia funds the research fellowships of CGM, RDH, and NH.	Airaksinen O, 2006, EUR SPINE J, V15, pS192, DOI 10.1007/s00586-006-1072-1; Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Bland JM, 2004, BRIT MED J, V328, P1073, DOI 10.1136/bmj.328.7447.1073; Carey TS, 2000, SPINE, V25, P115, DOI 10.1097/00007632-200001010-00019; CAREY TS, 1995, SPINE, V20, P312, DOI 10.1097/00007632-199502000-00009; CAREY TS, 1995, NEW ENGL J MED, V333, P913, DOI 10.1056/NEJM199510053331406; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; COSTE J, 1994, BRIT MED J, V308, P577, DOI 10.1136/bmj.308.6928.577; Croft PR, 1998, BRIT MED J, V316, P1356, DOI 10.1136/bmj.316.7141.1356; de Vet HCW, 2002, SPINE, V27, P2409, DOI 10.1097/00007632-200211010-00016; Fletcher RH, 1988, CLIN EPIDEMIOLOGY ES; Grotle M, 2006, SPINE, V31, P1038, DOI 10.1097/01.brs.0000214878.01709.0e; Henschke N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a171; Henschke N, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-54; Herbert R., 2005, PRACTICAL EVIDENCE B, V(Chap. 4); Koes BW, 2001, SPINE, V26, P2504, DOI 10.1097/00007632-200111150-00022; Mak K, 2005, WORLD J SURG, V29, P567, DOI 10.1007/s00268-005-7914-x; Costa LDM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-11; Mounce K, 2002, RHEUMATOLOGY, V41, P1, DOI 10.1093/rheumatology/41.1.1; National Health & Medical Research Council, 2003, EV BAS MAN AC MUSC P; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Schiottz-Christensen B, 1999, FAM PRACT, V16, P223, DOI 10.1093/fampra/16.3.223; van Tulder MW, 1998, FAM PRACT, V15, P126, DOI 10.1093/fampra/15.2.126; vandenHoogen H, 1997, SPINE, V22, P1515, DOI 10.1097/00007632-199707010-00019; vanTulder MW, 1997, SPINE, V22, P76, DOI 10.1097/00007632-199701010-00013; VonKorff M, 1996, SPINE, V21, P2833, DOI 10.1097/00007632-199612150-00004; Walker BF, 2000, J SPINAL DISORD, V13, P205, DOI 10.1097/00002517-200006000-00003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watson KD, 2003, ARCH DIS CHILD, V88, P12, DOI 10.1136/adc.88.1.12	30	243	249	2	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2009	339								b3829	10.1136/bmj.b3829	http://dx.doi.org/10.1136/bmj.b3829			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TF	19808766	Green Published, hybrid			2022-12-28	WOS:000270719100003
J	Doyle, Y; McKee, M; Rechel, B; Grundy, E				Doyle, Yvonne; McKee, Martin; Rechel, Bernd; Grundy, Emily			Meeting the challenge of population ageing	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICAL-ACTIVITY; OLDER-ADULTS; DEMENTIA; PATTERNS; DISEASE; TIME; RISK		[Doyle, Yvonne] NHS SE Coast, Horley RH6 7DE, Surrey, England; [McKee, Martin; Rechel, Bernd; Grundy, Emily] London Sch Hyg & Trop Med, London, England	University of London; London School of Hygiene & Tropical Medicine	Doyle, Y (corresponding author), NHS SE Coast, Horley RH6 7DE, Surrey, England.	yvonne.doyle@southeastcoast.nhs.uk	Mckee, Martin/E-6673-2018; Grundy, Emily/AAC-3260-2019; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; Grundy, Emily/0000-0002-9633-1116; McKee, Marc D/0000-0001-8349-965X; Rechel, Bernd/0000-0001-8020-3956				Albertini M, 2007, J EUR SOC POLICY, V17, P319, DOI 10.1177/0958928707081068; Angevaren M, 2008, COCHRANE DATABASE SY; Anstey KJ, 2007, AM J EPIDEMIOL, V166, P367, DOI 10.1093/aje/kwm116; *ASS PUBL HLTH OBS, IND PUBL HLTH REG 9; Attias-Donfut Claudine, 2005, Eur J Ageing, V2, P161, DOI 10.1007/s10433-005-0008-7; Clarke P, 2009, MATURITAS, V64, P14, DOI 10.1016/j.maturitas.2009.07.011; Coley N, 2008, EPIDEMIOL REV, V30, P35, DOI 10.1093/epirev/mxn010; Daatland SO, 2003, AGEING SOC, V23, P537, DOI 10.1017/S0144686X03001272; *EUR COMM EUR COUN, 2009, JOINT REP SOC PROT S; *FLASH EUR, 2009, INT SOL; Flicker L, 2009, MATURITAS, V63, P319, DOI 10.1016/j.maturitas.2009.06.008; GRUBER J, 1999, EBRI ISSUE BRIEF, V209, P1; Grundy E, 2001, ENVIRON PLANN A, V33, P685, DOI 10.1068/a33165; Grundy E, 2005, BRIT J SOCIOL, V56, P233, DOI 10.1111/j.1468-4446.2005.00057.x; Harbers M., 2008, OLD AGE DEPENDENCY R; *HM GOV, 2009, BUILD SOC ALL AG; Humphrey A., 2003, FACTORS AFFECTING LA; *IUS LAB, 2006, RES AG DISCR SURV; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; Kapteyn A, 2004, LABOUR ECON, V11, P293, DOI 10.1016/j.labeco.2003.08.001; Kenny GP, 2008, AM J IND MED, V51, P610, DOI 10.1002/ajim.20600; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Libby P, 2006, AM J CLIN NUTR, V83, p456S; LUND T, 2004, EUR J AGEING, V2, P275; LUPTON MK, 2009, INT J GERIATR P 0520; Mayhew L., 2009, INCREASING LONGEVITY; Naegele G., 2006, EUROPEAN FDN IMPROVE; Nolte E, 2008, CARING PEOPLE CHRONI; *OECD, ANN LAB FORC STAT; Oliveira Martins J., 2005, IMPACT AGEING DEMAND; Oxley H., 2009, POLICIES HLTH AGEING; Rechel B., 2010, CAN HLTH SYSTEMS RES; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; United Nations, 2002, SOC POL DEV AG 2 WOR; Varraso R, 2007, AM J CLIN NUTR, V86, P488, DOI 10.1093/ajcn/86.2.488; 2009, DAILY TELEGRAPH 0818; 2007, TIMES           0625	37	49	49	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 5	2009	339								b3926	10.1136/bmj.b3926	http://dx.doi.org/10.1136/bmj.b3926			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TE	19805472	Green Accepted			2022-12-28	WOS:000270718700002
J	Reilly, LAO; Tai, L; Lee, L; Kruse, EA; Grabow, S; Fairlie, WD; Haynes, NM; Tarlinton, DM; Zhang, JG; Belz, GT; Smyth, MJ; Bouillet, P; Robb, L; Strasser, A				Reilly, Lorraine A. O'; Tai, Lin; Lee, Lily; Kruse, Elizabeth A.; Grabow, Stephanie; Fairlie, W. Douglas; Haynes, Nicole M.; Tarlinton, David M.; Zhang, Jian-Guo; Belz, Gabrielle T.; Smyth, Mark J.; Bouillet, Philippe; Robb, Lorraine; Strasser, Andreas			Membrane-bound Fas ligand only is essential for Fas-induced apoptosis	NATURE			English	Article							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; DENDRITIC CELLS; DOWN-REGULATION; REGULATORS BIM; IMMUNE-SYSTEM; MICE; GENE; EXPRESSION; DEATH; ACTIVATION	Fas ligand (FasL), an apoptosis-inducing member of the TNF cytokine family, and its receptor Fas are critical for the shutdown of chronic immune responses(1-3) and prevention of autoimmunity(4,5). Accordingly, mutations in their genes cause severe lymphadenopathy and autoimmune disease in mice(6,7) and humans(8,9). FasL function is regulated by deposition in the plasma membrane and metalloprotease-mediated shedding(10,11). Here we generated gene-targeted mice that selectively lack either secreted FasL (sFasL) or membrane-bound FasL (mFasL) to resolve which of these forms is required for cell killing and to explore their hypothesized non-apoptotic activities. Mice lacking sFasL (FasL(Delta s/Delta s)) appeared normal and their T cells readily killed target cells, whereas T cells lacking mFasL (FasL(Delta m/Delta m)) could not kill cells through Fas activation. FasL(Delta m/Delta m) mice developed lymphadenopathy and hypergammaglobulinaemia, similar to FasL(gld/gld) mice, which express a mutant form of FasL that cannot bind Fas, but surprisingly, FasL(Delta m/Delta m) mice (on a C57BL/6 background) succumbed to systemic lupus erythematosus (SLE)-like autoimmune kidney destruction and histiocytic sarcoma, diseases that occur only rarely and much later in FasL(gld/gld) mice. These results demonstrate that mFasL is essential for cytotoxic activity and constitutes the guardian against lymphadenopathy, autoimmunity and cancer, whereas excess sFasL appears to promote autoimmunity and tumorigenesis through nonapoptotic activities.	[Reilly, Lorraine A. O'; Tai, Lin; Lee, Lily; Kruse, Elizabeth A.; Grabow, Stephanie; Fairlie, W. Douglas; Tarlinton, David M.; Zhang, Jian-Guo; Belz, Gabrielle T.; Bouillet, Philippe; Robb, Lorraine; Strasser, Andreas] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Kruse, Elizabeth A.; Grabow, Stephanie] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Haynes, Nicole M.; Smyth, Mark J.] Peter MacCallum Canc Ctr, Melbourne, Vic 3002, Australia	Walter & Eliza Hall Institute; University of Melbourne; Peter Maccallum Cancer Center	Strasser, A (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	strasser@wehi.edu.au	Strasser, Andreas/C-7581-2013; Lee, Lily/GWZ-7968-2022; Smyth, Mark J/H-8709-2014; Fairlie, Walter/M-8401-2015; Belz, Gabrielle T/C-9350-2013; Bouillet, Philippe/E-1241-2013	Strasser, Andreas/0000-0002-5020-4891; Smyth, Mark J/0000-0001-7098-7240; Fairlie, Walter/0000-0002-2498-1160; Belz, Gabrielle T/0000-0002-9660-9587; Bouillet, Philippe/0000-0002-9012-6058; Tarlinton, David/0000-0001-9928-686X	NHMRC [461221, 454569]; IRIISS [361646, 257502]; Victorian State Government; Leukemia and Lymphoma Society [7015]; NIH [CA043540-18, CA80188-6]; JDRF/NHMRC; Association for International Cancer Research; Charles and Sylvia Viertel Charitable Foundation; Leukemia Research Foundation; NATIONAL CANCER INSTITUTE [R01CA043540, R01CA080188] Funding Source: NIH RePORTER	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); IRIISS; Victorian State Government; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JDRF/NHMRC(Juvenile Diabetes Research FoundationNational Health and Medical Research Council (NHMRC) of Australia); Association for International Cancer Research; Charles and Sylvia Viertel Charitable Foundation; Leukemia Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Genentech, in particular A. Ashkenazi and S. Masters, for Fas-Fc fusion proteins. We also thank our colleagues at the Walter and Eliza Hall Institute of Medical Research ( Melbourne), G. Siciliano, N. Iannarella, J. Coughlin for animal care; J. Corbin for automated blood analysis; B. Helbert and C. Young for genotyping; S. Mihajlovic, E. Tsui, A. Hasanein, V. Babo and K. Weston for histological sections; A. Light and K. O'Donnell for help with antibody measurements; and S. Drake for help with cytokine quantification. We also thank J. Melny ( Royal Melbourne Hospital) for measuring anti-DNA antibody levels; A. Banerjee, S. Gerondakis and R. Gugasyan ( Burnet Medical Research Institute, Prahran) for antibodies and advice; J. Silke and L. Wong ( La Trobe University, Bundoora) for TNFa; P. Morgan for assistance with protein purification; and A. Silva and J. Sharkey for help with animal procedures ( Peter MacCallum Cancer Centre). This work was supported in part by the NHMRC ( programme numbers 461221 and 454569, a CJ Martin fellowship to N. M. H. and an RD Wright fellowship to L. A. O'R.). We also acknowledge support from the IRIISS ( grant numbers 361646 and 257502 to P. B.), the Victorian State Government ( an OIS grant), the Leukemia and Lymphoma Society ( SCOR grant number 7015), the NIH ( grant numbers CA043540-18 and CA80188-6), the JDRF/NHMRC, the Association for International Cancer Research, the Charles and Sylvia Viertel Charitable Foundation ( to P. B.) and the Leukemia Research Foundation.	Ahn JH, 2001, J BIOL CHEM, V276, P47100, DOI 10.1074/jbc.M107385200; Belz GT, 2000, J VIROL, V74, P3486, DOI 10.1128/JVI.74.8.3486-3493.2000; Belz GT, 2001, J IMMUNOL, V166, P4627, DOI 10.4049/jimmunol.166.7.4627; Blott EJ, 2001, J CELL SCI, V114, P2405; Chen JJ, 1998, SCIENCE, V282, P1714, DOI 10.1126/science.282.5394.1714; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Fredrickson TN, 2000, ATLAS MOUSE HEMATOPA; FRITH CH, 1981, J GERONTOL, V36, P534, DOI 10.1093/geronj/36.5.534; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Hohlbaum AM, 2000, J EXP MED, V191, P1209, DOI 10.1084/jem.191.7.1209; Huang DCS, 1999, P NATL ACAD SCI USA, V96, P14871, DOI 10.1073/pnas.96.26.14871; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; Karray S, 2004, J IMMUNOL, V172, P2118, DOI 10.4049/jimmunol.172.4.2118; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; Kono D H, 1999, Curr Dir Autoimmun, V1, P72; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Naik S, 2003, BLOOD, V102, P601, DOI 10.1182/blood-2002-10-3186; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Oliveira JB, 2007, P NATL ACAD SCI USA, V104, P8953, DOI 10.1073/pnas.0702975104; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Phillips JM, 2007, DIABETES, V56, P634, DOI 10.2337/db06-0832; Pileri SA, 2002, HISTOPATHOLOGY, V41, P1, DOI 10.1046/j.1365-2559.2002.01418.x; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Schneider P, 1998, J EXP MED, V187, P1205, DOI 10.1084/jem.187.8.1205; Schulte M, 2007, CELL DEATH DIFFER, V14, P1040, DOI 10.1038/sj.cdd.4402101; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Sun M, 2007, J IMMUNOL, V179, P4307, DOI 10.4049/jimmunol.179.7.4307; Suzuki I, 1998, J EXP MED, V187, P123, DOI 10.1084/jem.187.1.123; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Trambas CM, 2003, NAT IMMUNOL, V4, P399, DOI 10.1038/ni0503-399; WATANABE D, 1995, EMBO J, V14, P12, DOI 10.1002/j.1460-2075.1995.tb06970.x; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; Weant AE, 2008, IMMUNITY, V28, P218, DOI 10.1016/j.immuni.2007.12.014; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Xiao S, 2002, J BIOL CHEM, V277, P50907, DOI 10.1074/jbc.M206093200	41	287	302	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					659	U106		10.1038/nature08402	http://dx.doi.org/10.1038/nature08402			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794494	Green Accepted			2022-12-28	WOS:000270302600042
J	Ansmann, M; Wang, H; Bialczak, RC; Hofheinz, M; Lucero, E; Neeley, M; O'Connell, AD; Sank, D; Weides, M; Wenner, J; Cleland, AN; Martinis, JM				Ansmann, Markus; Wang, H.; Bialczak, Radoslaw C.; Hofheinz, Max; Lucero, Erik; Neeley, M.; O'Connell, A. D.; Sank, D.; Weides, M.; Wenner, J.; Cleland, A. N.; Martinis, John M.			Violation of Bell's inequality in Josephson phase qubits	NATURE			English	Article							SUPERCONDUCTING QUBITS; ENTANGLEMENT	The measurement process plays an awkward role in quantum mechanics, because measurement forces a system to 'choose' between possible outcomes in a fundamentally unpredictable manner. Therefore, hidden classical processes have been considered as possibly predetermining measurement outcomes while preserving their statistical distributions(1). However, a quantitative measure that can distinguish classically determined correlations from stronger quantum correlations exists in the form of the Bell inequalities, measurements of which provide strong experimental evidence that quantum mechanics provides a complete description(2-4). Here we demonstrate the violation of a Bell inequality in a solid-state system. We use a pair of Josephson phase qubits(5-7) acting as spin-1/2 particles, and show that the qubits can be entangled(8,9) and measured so as to violate the Clauser-Horne-Shimony-Holt (CHSH) version of the Bell inequality(10). We measure a Bell signal of 2.0732 +/- 0.0003, exceeding the maximum amplitude of 2 for a classical system by 244 standard deviations. In the experiment, we deterministically generate the entangled state, and measure both qubits in a single-shot manner, closing the detection loophole(11). Because the Bell inequality was designed to test for non-classical behaviour without assuming the applicability of quantum mechanics to the system in question, this experiment provides further strong evidence that a macroscopic electrical circuit is really a quantum system(7).	[Ansmann, Markus; Wang, H.; Bialczak, Radoslaw C.; Hofheinz, Max; Lucero, Erik; Neeley, M.; O'Connell, A. D.; Sank, D.; Weides, M.; Wenner, J.; Cleland, A. N.; Martinis, John M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Martinis, JM (corresponding author), Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA.	martinis@physics.ucsb.edu	Wenner, James/G-3777-2014; Hofheinz, Max/F-3288-2010; Cleland, Andrew/AAG-7581-2019; Wang, Haohua/G-8875-2011; Weides, Martin/C-1470-2009	Wenner, James/0000-0001-7107-4734; Wang, Haohua/0000-0001-5380-4297; Weides, Martin/0000-0002-2718-6795	IARPA [W911NF-04-1-0204]; NSF [CCF-0507227]	IARPA; NSF(National Science Foundation (NSF))	We thank A. Korotkov and A. Kofman for discussions of our measurement process. Devices were made at the UCSB Nanofabrication Facility, a part of the NSF-funded National Nanotechnology Infrastructure Network. This work was supported by IARPA under grant W911NF-04-1-0204 and by the NSF under grant CCF-0507227.	ASPECT A, 1981, PHYS REV LETT, V47, P460, DOI 10.1103/PhysRevLett.47.460; Bell JS., 1964, PHYS, V1, P195, DOI [10.1103/PhysicsPhysiqueFizika.1.195, 10.1103/Physics-PhysiqueFizika.1.195, DOI 10.1103/PHYSICSPHYSIQUEFIZIKA.1.195]; Bialczak RC, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.187006; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; Cooper KB, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.180401; Devoret MH, 2004, QUANTUM INF PROCESS, V3, P163, DOI 10.1007/s11128-004-3101-5; DiCarlo L, 2009, NATURE, V460, P240, DOI 10.1038/nature08121; DiVincenzo D. P., 2000, PHYS IMPLEMENTATION; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Hill S, 1997, PHYS REV LETT, V78, P5022, DOI 10.1103/PhysRevLett.78.5022; Hofheinz M, 2008, NATURE, V454, P310, DOI 10.1038/nature07136; Hofheinz M, 2009, NATURE, V459, P546, DOI 10.1038/nature08005; KOCHER CA, 1967, PHYS REV LETT, V18, P575, DOI 10.1103/PhysRevLett.18.575; Kofman AG, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.104502; Lucero E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.247001; Majer J, 2007, NATURE, V449, P443, DOI 10.1038/nature06184; Martinis JM, 2009, QUANTUM INF PROCESS, V8, P81, DOI 10.1007/s11128-009-0105-1; Matsukevich DN, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.150404; McDermott R, 2005, SCIENCE, V307, P1299, DOI 10.1126/science.1107572; PEARLE PM, 1970, PHYS REV D, V2, P1418, DOI 10.1103/PhysRevD.2.1418; Roos CF, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.220402; Rowe MA, 2001, NATURE, V409, P791, DOI 10.1038/35057215; Sillanpaa MA, 2007, NATURE, V449, P438, DOI 10.1038/nature06124; Steffen M, 2006, SCIENCE, V313, P1423, DOI 10.1126/science.1130886; Wei LF, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.052307; Weihs G, 1998, PHYS REV LETT, V81, P5039, DOI 10.1103/PhysRevLett.81.5039	27	278	285	4	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					504	506		10.1038/nature08363	http://dx.doi.org/10.1038/nature08363			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19779447				2022-12-28	WOS:000270082900035
J	Charpinet, S; Fontaine, G; Brassard, P				Charpinet, S.; Fontaine, G.; Brassard, P.			Seismic evidence for the loss of stellar angular momentum before the white-dwarf stage	NATURE			English	Article							EVOLUTION MODELS; MAGNETIC-FIELDS; ROTATION; STARS; SEARCH; PG-1159-035	White-dwarf stars represent the final products of the evolution of some 95% of all stars(1). If stars were to keep their angular momentum throughout their evolution, their white-dwarf descendants, owing to their compact nature, should all rotate relatively rapidly, with typical periods of the order of a few seconds. Observations of their photospheres show, in contrast, that they rotate much more slowly, with periods ranging from hours to tens of years(2-5). It is not known, however, whether a white dwarf could 'hide' some of its original angular momentum below the superficial layers, perhaps spinning much more rapidly inside than at its surface. Here we report a determination of the internal rotation profile of a white dwarf using a method based on asteroseismology. We show that the pulsating white dwarf PG 1159-035 rotates as a solid body (encompassing more than 97.5% of its mass) with the relatively long period of 33.61 +/- 0.59 h. This implies that it has lost essentially all of its angular momentum, thus favouring theories which suggest important angular momentum transfer and loss in evolutionary phases before the white-dwarf stage(6,7).	[Fontaine, G.; Brassard, P.] Univ Montreal, Dept Phys, Montreal, PQ H3C 3J7, Canada; [Charpinet, S.] Univ Toulouse, CNRS, Lab Astrophys Toulouse Tarbes, F-31400 Toulouse, France	Universite de Montreal; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse	Fontaine, G (corresponding author), Univ Montreal, Dept Phys, CP 6128,Succ Ctr Ville, Montreal, PQ H3C 3J7, Canada.	fontaine@astro.umontreal.ca		Charpinet, Stephane/0000-0002-6018-6180	NSERC (Canada); FQRNT (Quebec); Canada Research Chair Program	NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); FQRNT (Quebec)(FQRNT); Canada Research Chair Program(Canada Research Chairs)	This work was supported in part by the NSERC (Canada) and in part by the FQRNT (Quebec). G.F. also acknowledges the contribution of the Canada Research Chair Program.	Berger L, 2005, ASTRON ASTROPHYS, V444, P565, DOI 10.1051/0004-6361:20053340; Charbonneau P, 1999, ASTROPHYS J, V527, P445, DOI 10.1086/308050; Charpinet S, 2008, ASTRON ASTROPHYS, V489, P377, DOI 10.1051/0004-6361:200809907; Corsico AH, 2008, ASTRON ASTROPHYS, V478, P869, DOI 10.1051/0004-6361:20078646; Costa JES, 2008, ASTRON ASTROPHYS, V477, P627, DOI 10.1051/0004-6361:20053470; Di Mauro M. P., 1998, Memorie della Societa Astronomica Italiana, V69, P559; Ferrario L, 2005, MON NOT R ASTRON SOC, V356, P615, DOI 10.1111/j.1365-2966.2004.08474.x; Fontaine G, 2008, PUBL ASTRON SOC PAC, V120, P1043, DOI 10.1086/592788; FONTAINE G, 2000, ENCY ASTRONOMY ASTRO, P1894; Koester D, 1998, ASTRON ASTROPHYS, V338, P612; Langer N, 1999, ASTRON ASTROPHYS, V346, pL37; Langer N, 2007, ASTR SOC P, V372, P3; Rabello-Soares MC, 1999, MON NOT R ASTRON SOC, V309, P35, DOI 10.1046/j.1365-8711.1999.02785.x; SAIO H, 1983, ASTROPHYS J, V265, P982, DOI 10.1086/160740; SCHMIDT GD, 1995, ASTROPHYS J, V448, P305, DOI 10.1086/175962; Silvotti R, 2007, ASTR SOC P, V372, P593; Spruit HC, 2002, ASTRON ASTROPHYS, V381, P923, DOI 10.1051/0004-6361:20011465; Suijs MPL, 2008, ASTRON ASTROPHYS, V481, pL87, DOI 10.1051/0004-6361:200809411; TASSOUL M, 1983, ASTROPHYS J, V267, P334, DOI 10.1086/160872; Unno W., 1989, NONRADIAL OSCILLATIO, V2nd ed.	20	59	59	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					501	503		10.1038/nature08307	http://dx.doi.org/10.1038/nature08307			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19779446				2022-12-28	WOS:000270082900034
J	Tseng, CA; Chou, AL				Tseng, Chang-An; Chou, An-Liang			Pelvic Spleen	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tseng, Chang-An; Chou, An-Liang] Buddhist Dalin Tzu Chi Gen Hosp, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Tseng, CA (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Chiayi, Taiwan.								0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2009	361	13					1291	1291		10.1056/NEJMicm0802024	http://dx.doi.org/10.1056/NEJMicm0802024			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497RN	19776410				2022-12-28	WOS:000270078700010
J	Kneebone, RL				Kneebone, Roger L.			Practice, Rehearsal, and Performance An Approach for Simulation-Based Surgical and Procedure Training	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SKILLS		Univ London Imperial Coll Sci Technol & Med, Dept Biosurg & Surg Technol, London W2 1NY, England	Imperial College London	Kneebone, RL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biosurg & Surg Technol, Praed St,2nd Floor,QEQM Wing, London W2 1NY, England.	r.kneebone@imperial.ac.uk						Aggarwal R, 2006, NEW ENGL J MED, V355, P2695, DOI 10.1056/NEJMe068179; Chaffin R., 2002, PRACTICING PERFECTIO; Davidson J. W., 2004, MUSICAL EXCELLENCE S, P105, DOI DOI 10.1093/ACPROF:OSO/9780198525356.003.0006; Ericsson KA, 2004, ACAD MED, V79, pS70, DOI 10.1097/00001888-200410001-00022; Gaba DM, 2007, QUAL SAF HLTH CAR S1, V2, P126, DOI DOI 10.1136/QSHC.2004.009878; Kneebone R, 2006, ACAD MED, V81, P919, DOI 10.1097/01.ACM.0000238323.73623.c2; LEHMANN AC, 2007, PSYCHOL MUSICIANS UN; Nestel DF, 2008, MED TEACH, V30, P407, DOI 10.1080/01421590701784331; Paige JT, 2009, SURGERY, V145, P138, DOI 10.1016/j.surg.2008.09.010; Yule S, 2006, SURGERY, V139, P140, DOI 10.1016/j.surg.2005.06.017	10	64	64	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1336	1338		10.1001/jama.2009.1392	http://dx.doi.org/10.1001/jama.2009.1392			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497AR	19773572				2022-12-28	WOS:000270026000019
J	Ho, CH; Lin, SH; Hu, HC; Tsay, YF				Ho, Cheng-Hsun; Lin, Shan-Hua; Hu, Heng-Cheng; Tsay, Yi-Fang			CHL1 Functions as a Nitrate Sensor in Plants	CELL			English	Article							PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; CALCIUM SENSORS; ROOT ARCHITECTURE; TRANSPORTER GENE; ARABIDOPSIS; REVEALS; EXPRESSION; GLUCOSE; NRT1.1	Ions serve as essential nutrients in higher plants and can also act as signaling molecules. Little is known about how plants sense changes in soil nutrient concentrations. Previous studies showed that T101-phosphorylated CHL1 is a high-affinity nitrate transporter, whereas T101-dephosphorylated CHL1 is a low-affinity transporter. In this study, analysis of an uptake- and sensing-decoupled mutant showed that the nitrate transporter CHL1 functions as a nitrate sensor. Primary nitrate responses in CHL1T101D and CHLT101A transgenic plants showed that phosphorylated and dephosphorylated CHL1 lead to a low- and high-level response, respectively. In vitro and in vivo studies showed that, in response to low nitrate concentrations, protein kinase CIPK23 can phosphorylate T101 of CHL1 to maintain a low- level primary response. Thus, CHL1 uses dual-affinity binding and a phosphorylation switch to sense a wide range of nitrate concentrations in the soil, thereby functioning as an ion sensor in higher plants. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.	[Ho, Cheng-Hsun; Tsay, Yi-Fang] Natl Def Med Ctr, Acad Sinica, Inst Mol Biol, Taiwan Int Grad Program, Taipei, Taiwan; [Ho, Cheng-Hsun; Tsay, Yi-Fang] Natl Def Med Ctr, Acad Sinica, Grad Inst Life Sci, Taiwan Int Grad Program, Taipei, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; Academia Sinica - Taiwan; National Defense Medical Center	Tsay, YF (corresponding author), Natl Def Med Ctr, Acad Sinica, Inst Mol Biol, Taiwan Int Grad Program, Taipei, Taiwan.	yftsay@gate.sinica.edu.tw	Tsay, Yi-Fang/ABB-3662-2021	Tsay, Yi-Fang/0000-0003-4271-0687; Ho, Cheng-Hsun/0000-0002-0895-1914	Taiwan International Graduate Program; Institute of Molecular Biology, Academia Sinica, Taiwan; National Science Council [96-2628-B-001-017-MY3]	Taiwan International Graduate Program; Institute of Molecular Biology, Academia Sinica, Taiwan(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	We thank the Salk Institute Genomic Analysis Laboratory for the Arabidopsis T-DNA insertion mutants, Dr. Hsou-Min Li for the anti-T110 antibody, Dr. Nigel Crawford for critical reading, Lin-Yun Kuang from Transgenic Plant Core Laboratory for technique help, and Dr. Tom Barkas and Dr. Harry Wilson for English editing. This work was supported by the Taiwan International Graduate Program and grants from the Institute of Molecular Biology, Academia Sinica, Taiwan, and the National Science Council ( NSC 96-2628-B-001-017-MY3).	Alboresi A, 2005, PLANT CELL ENVIRON, V28, P500, DOI 10.1111/j.1365-3040.2005.01292.x; Almagro A, 2008, PLANT CELL, V20, P3289, DOI 10.1105/tpc.107.056788; Batistic O, 2004, PLANTA, V219, P915, DOI 10.1007/s00425-004-1333-3; Castaings L, 2009, PLANT J, V57, P426, DOI 10.1111/j.1365-313X.2008.03695.x; Cheng NH, 2004, J BIOL CHEM, V279, P2922, DOI 10.1074/jbc.M309084200; Cheong YH, 2007, PLANT J, V52, P223, DOI 10.1111/j.1365-313X.2007.03236.x; CRAWFORD NM, 1995, PLANT CELL, V7, P859, DOI 10.1105/tpc.7.7.859; De Angeli A, 2009, PHILOS T R SOC B, V364, P195, DOI 10.1098/rstb.2008.0128; DENG MD, 1989, PLANT PHYSIOL, V91, P304, DOI 10.1104/pp.91.1.304; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Forde BG, 2000, BBA-BIOMEMBRANES, V1465, P219, DOI 10.1016/S0005-2736(00)00140-1; Gong DM, 2004, PLANT PHYSIOL, V134, P919, DOI 10.1104/pp.103.037440; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Huang NC, 1999, PLANT CELL, V11, P1381, DOI 10.1105/tpc.11.8.1381; Kolukisaoglu U, 2004, PLANT PHYSIOL, V134, P43, DOI 10.1104/pp.103.033068; Li LG, 2006, P NATL ACAD SCI USA, V103, P12625, DOI 10.1073/pnas.0605129103; Li WB, 2007, PLANT PHYSIOL, V143, P425, DOI 10.1104/pp.106.091223; Little DY, 2005, P NATL ACAD SCI USA, V102, P13693, DOI 10.1073/pnas.0504219102; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236; Munos S, 2004, PLANT CELL, V16, P2433, DOI 10.1105/tpc.104.024380; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; REDINBAUGH MG, 1993, PLANT PHYSIOL, V101, P1249, DOI 10.1104/pp.101.4.1249; REDINBAUGH MG, 1991, PHYSIOL PLANTARUM, V82, P640, DOI 10.1111/j.1399-3054.1991.tb02958.x; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; Waadt R, 2008, PLANT J, V56, P505, DOI 10.1111/j.1365-313X.2008.03612.x; Walch-Liu P, 2005, PHOTOSYNTH RES, V83, P239, DOI 10.1007/s11120-004-2080-9; Walch-Liu P, 2008, PLANT J, V54, P820, DOI 10.1111/j.1365-313X.2008.03443.x; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang RC, 1998, P NATL ACAD SCI USA, V95, P15134, DOI 10.1073/pnas.95.25.15134; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407	38	819	889	18	271	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1184	1194		10.1016/j.cell.2009.07.004	http://dx.doi.org/10.1016/j.cell.2009.07.004			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766570	Bronze			2022-12-28	WOS:000269923200018
J	Koo, HC; Kwon, JH; Eom, J; Chang, J; Han, SH; Johnson, M				Koo, Hyun Cheol; Kwon, Jae Hyun; Eom, Jonghwa; Chang, Joonyeon; Han, Suk Hee; Johnson, Mark			Control of Spin Precession in a Spin-Injected Field Effect Transistor	SCIENCE			English	Article							ELECTRICAL DETECTION; ORBIT INTERACTION; GATE CONTROL; TRANSPORT; HETEROSTRUCTURE; ELECTRONS; METALS; VALVE	Spintronics increases the functionality of information processing while seeking to overcome some of the limitations of conventional electronics. The spin-injected field effect transistor, a lateral semiconducting channel with two ferromagnetic electrodes, lies at the foundation of spintronics research. We demonstrated a spin-injected field effect transistor in a high-mobility InAs heterostructure with empirically calibrated electrical injection and detection of ballistic spin-polarized electrons. We observed and fit to theory an oscillatory channel conductance as a function of monotonically increasing gate voltage.	[Koo, Hyun Cheol; Kwon, Jae Hyun; Eom, Jonghwa; Chang, Joonyeon; Han, Suk Hee] Korea Inst Sci & Technol, Ctr Spintron Res, Seoul 136791, South Korea; [Eom, Jonghwa] Sejong Univ, Dept Phys, Seoul 143747, South Korea; [Johnson, Mark] USN, Res Lab, Washington, DC 20375 USA	Korea Institute of Science & Technology (KIST); Sejong University; United States Department of Defense; United States Navy; Naval Research Laboratory	Chang, J (corresponding author), Korea Inst Sci & Technol, Ctr Spintron Res, 39-1 Hawolgok Dong, Seoul 136791, South Korea.	presto@kist.re.kr		Koo, Hyun Cheol/0000-0001-5044-1355	Korea Institute of Science and Technology Institutional Program	Korea Institute of Science and Technology Institutional Program	This work was supported by the Korea Institute of Science and Technology Institutional Program.	Aleshkin VY, 2008, SEMICONDUCTORS+, V42, P828, DOI 10.1134/S1063782608070129; Appelbaum I, 2007, NATURE, V447, P295, DOI 10.1038/nature05803; Crooker SA, 2005, SCIENCE, V309, P2191, DOI 10.1126/science.1116865; DATTA S, 1990, APPL PHYS LETT, V56, P665, DOI 10.1063/1.102730; DYAKONOV MI, 1986, SOV PHYS SEMICOND+, V20, P110; Hu CM, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.125333; JANOSSY A, 1976, PHYS REV LETT, V37, P612, DOI 10.1103/PhysRevLett.37.612; Jedema FJ, 2002, NATURE, V416, P713, DOI 10.1038/416713a; Ji Y, 2004, APPL PHYS LETT, V85, P6218, DOI 10.1063/1.1841455; JOHNSON M, 1993, SCIENCE, V260, P320, DOI 10.1126/science.260.5106.320; JOHNSON M, 1985, PHYS REV LETT, V55, P1790, DOI 10.1103/PhysRevLett.55.1790; Johnson M, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.153107; Kimura T, 2004, APPL PHYS LETT, V85, P3501, DOI 10.1063/1.1805698; Koo HC, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2430688; Lo I, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.161306; Lou XH, 2007, NAT PHYS, V3, P197, DOI 10.1038/nphys543; Nitta J, 1998, PHYSICA E, V2, P527, DOI 10.1016/S1386-9477(98)00109-X; Nitta J, 1997, PHYS REV LETT, V78, P1335, DOI 10.1103/PhysRevLett.78.1335; Perel V, 1972, SOV PHYS-SOLID STATE, V13, P3023; Rowe ACH, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.201307; Sander TH, 1998, PHYS REV B, V58, P13856, DOI 10.1103/PhysRevB.58.13856; Zutic I, 2004, REV MOD PHYS, V76, P323, DOI 10.1103/RevModPhys.76.323	23	431	436	18	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1515	1518		10.1126/science.1173667	http://dx.doi.org/10.1126/science.1173667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762637				2022-12-28	WOS:000269887900031
J	Vert, G; Chory, J				Vert, Gregory; Chory, Joanne			A Toggle Switch in Plant Nitrate Uptake	CELL			English	Editorial Material							PROTEIN-KINASE; ARABIDOPSIS; TRANSPORTER; NRT1.1; CHL1; GENE; AKT1	In plants, the uptake of nitrate from the soil is a critical process controlled by complex regulatory networks that target nitrate transporters in the roots. In this issue, Ho et al. (2009) show that phosphorylation of the CHL1 nitrate transporter allows the plant root to sense and respond to different nitrate concentrations in the soil.	[Vert, Gregory] CNRS, BPMP, UMR 5004, F-34060 Montpellier 1, France; [Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; Montpellier SupAgro; Universite de Montpellier; Salk Institute; Howard Hughes Medical Institute; Salk Institute	Vert, G (corresponding author), CNRS, BPMP, UMR 5004, F-34060 Montpellier 1, France.	gregory.vert@supagro.inra.fr		Vert, Greg/0000-0002-0844-9991	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Batistic O, 2009, BBA-MOL CELL RES, V1793, P985, DOI 10.1016/j.bbamcr.2008.10.006; Guo FQ, 2001, PLANT CELL, V13, P1761, DOI 10.1105/tpc.13.8.1761; Hu HC, 2009, PLANT J, V57, P264, DOI 10.1111/j.1365-313X.2008.03685.x; Lagarde D, 1996, PLANT J, V9, P195, DOI 10.1046/j.1365-313X.1996.09020195.x; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Munos S, 2004, PLANT CELL, V16, P2433, DOI 10.1105/tpc.104.024380; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Xu J, 2006, CELL, V125, P1347, DOI 10.1016/j.cell.2006.06.011	9	15	22	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 18	2009	138	6					1064	1066		10.1016/j.cell.2009.09.005	http://dx.doi.org/10.1016/j.cell.2009.09.005			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766561	Bronze			2022-12-28	WOS:000269923200008
J	Young, J; Walker, SM; Bomphrey, RJ; Taylor, GK; Thomas, ALR				Young, John; Walker, Simon M.; Bomphrey, Richard J.; Taylor, Graham K.; Thomas, Adrian L. R.			Details of Insect Wing Design and Deformation Enhance Aerodynamic Function and Flight Efficiency	SCIENCE			English	Article							LOCUST SCHISTOCERCA-GREGARIA; LEADING-EDGE VORTICES; FLAPPING FLIGHT; DESERT LOCUST; HOVERING FLIGHT; FORCES; PERFORMANCE; MORPHOLOGY; SIMULATION; KINEMATICS	Insect wings are complex structures that deform dramatically in flight. We analyzed the aerodynamic consequences of wing deformation in locusts using a three-dimensional computational fluid dynamics simulation based on detailed wing kinematics. We validated the simulation against smoke visualizations and digital particle image velocimetry on real locusts. We then used the validated model to explore the effects of wing topography and deformation, first by removing camber while keeping the same time-varying twist distribution, and second by removing camber and spanwise twist. The full-fidelity model achieved greater power economy than the uncambered model, which performed better than the untwisted model, showing that the details of insect wing topography and deformation are important aerodynamically. Such details are likely to be important in engineering applications of flapping flight.	[Walker, Simon M.; Bomphrey, Richard J.; Taylor, Graham K.; Thomas, Adrian L. R.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Young, John] Univ New S Wales, Australian Def Force Acad, Sch Informat Technol & Engn, Canberra, ACT 2600, Australia	University of Oxford; Australian Defense Force Academy; University of New South Wales Sydney	Thomas, ALR (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	adrian.thomas@zoo.ox.ac.uk	Taylor, Graham/A-5041-2010; Young, John/G-5473-2011; Bomphrey, Richard/I-6272-2013	Young, John/0000-0002-8671-990X; Bomphrey, Richard/0000-0002-4748-0510	Engineering and Physical Sciences Research Council (EPSRC) [GR/S23049/01]; European Research Council ( ERC) [FP7/2007-2013]; ERC [204513]; Merit Allocation Scheme on the National Facility of the Australian National Computing Infrastructure (NCI-NF); Rector of the University of New South Wales at the Australian Defense Force Academy; EPSRC; Research Councils UK Academic Fellow; Royal Society University Research Fellow; EPSRC [EP/H004025/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H004025/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council ( ERC)(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission); Merit Allocation Scheme on the National Facility of the Australian National Computing Infrastructure (NCI-NF); Rector of the University of New South Wales at the Australian Defense Force Academy; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Research Councils UK Academic Fellow(UK Research & Innovation (UKRI)); Royal Society University Research Fellow(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The research leading to these results has received funding from the Engineering and Physical Sciences Research Council (EPSRC) under grant GR/S23049/01 to A. L. R. T. and from the European Research Council ( ERC) under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 204513 to G. K. T. J. Y. was supported by the Merit Allocation Scheme on the National Facility of the Australian National Computing Infrastructure (NCI-NF) and gratefully acknowledges the Rector of the University of New South Wales at the Australian Defense Force Academy for the award of a sabbatical scholarship to perform this work. R. J. B. holds an EPSRC Career Acceleration Fellowship. G. K. T. is a Research Councils UK Academic Fellow and Royal Society University Research Fellow. We gratefully acknowledge the EPSRC Instrument Loan Pool and thank N. J. Lawson for advice and the loan of equipment for the DPIV measurements.	Aono H, 2008, J EXP BIOL, V211, P239, DOI 10.1242/jeb.008649; Bomphrey RJ, 2006, J R SOC INTERFACE, V3, P311, DOI 10.1098/rsif.2005.0090; Bos FM, 2008, J FLUID MECH, V594, P341, DOI 10.1017/S0022112007009172; Du G, 2008, APPL MATH MECH-ENGL, V29, P731, DOI 10.1007/s10483-008-0605-9; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; Ishihara D, 2009, J EXP BIOL, V212, P1, DOI 10.1242/jeb.020404; Isogai K, 2004, AIAA J, V42, P2053, DOI 10.2514/1.6274; Liu H, 1998, J EXP BIOL, V201, P461; Ramamurti R, 2007, J EXP BIOL, V210, P881, DOI 10.1242/jeb.02704; Shyy W, 2007, AIAA J, V45, P2817, DOI 10.2514/1.33205; Sun M, 2004, J EXP BIOL, V207, P1887, DOI 10.1242/jeb.00969; Thomas ALR, 2004, J EXP BIOL, V207, P4299, DOI 10.1242/jeb.01262; Vandenberghe N, 2004, J FLUID MECH, V506, P147, DOI 10.1017/S0022112004008468; Vanella M, 2009, J EXP BIOL, V212, P95, DOI 10.1242/jeb.016428; Walker SM, 2009, J R SOC INTERFACE, V6, P735, DOI 10.1098/rsif.2008.0435; Walker SM, 2009, J R SOC INTERFACE, V6, P351, DOI 10.1098/rsif.2008.0245; Wang ZJ, 2008, J EXP BIOL, V211, P234, DOI 10.1242/jeb.013797; Wang ZJ, 2004, J EXP BIOL, V207, P449, DOI 10.1242/jeb.00739; Wootton RJ, 2000, J EXP BIOL, V203, P2921; WOOTTON RJ, 1992, ANNU REV ENTOMOL, V37, P113, DOI 10.1146/annurev.en.37.010192.000553; Young J, 2008, AIAA J, V46, P918, DOI 10.2514/1.31610	21	293	300	10	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 18	2009	325	5947					1549	1552		10.1126/science.1175928	http://dx.doi.org/10.1126/science.1175928			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762645	Green Published			2022-12-28	WOS:000269887900042
J	Zwerger, W				Zwerger, Wilhelm			Itinerant Ferromagnetism with Ultracold Atoms	SCIENCE			English	Editorial Material									Tech Univ Munich, Dept Phys, D-85747 Garching, Germany	Technical University of Munich	Zwerger, W (corresponding author), Tech Univ Munich, Dept Phys, D-85747 Garching, Germany.	zwerger@ph.tum.de						Bloch F, 1929, Z PHYS, V57, P545, DOI 10.1007/BF01340281; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; DUCK I., 1997, PAULI SPIN STAT THEO; HERRING C, 1966, MAGNETISM          B, V2, P1; Herring C., 1966, MAGNETISM, VIV; Jo GB, 2009, SCIENCE, V325, P1521, DOI 10.1126/science.1177112; KETTERLE W, 2008, COURS 164 VAR 20 30; Petrov DS, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.010703; Stoner EC, 1933, PHILOS MAG, V15, P1018; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; von Lohneysen H, 2007, REV MOD PHYS, V79, P1015, DOI 10.1103/RevModPhys.79.1015; Zong FH, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.036703	12	9	9	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 18	2009	325	5947					1507	1509		10.1126/science.1179767	http://dx.doi.org/10.1126/science.1179767			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762633				2022-12-28	WOS:000269887900026
J	Davies, A; Jones, D; Bailey, M; Beca, J; Bellomo, R; Blackwell, N; Forrest, P; Gattas, D; Granger, E; Herkes, R; Jackson, A; McGuinness, S; Nair, P; Pellegrino, V; Pettila, V; Plunkett, B; Pye, R; Torzillo, P; Webb, S; Wilson, M; Ziegenfuss, M				Davies, Andrew; Jones, Daryl; Bailey, Michael; Beca, John; Bellomo, Rinaldo; Blackwell, Nikki; Forrest, Paul; Gattas, David; Granger, Emily; Herkes, Robert; Jackson, Andrew; McGuinness, Shay; Nair, Priya; Pellegrino, Vincent; Pettilae, Ville; Plunkett, Brian; Pye, Roger; Torzillo, Paul; Webb, Steve; Wilson, Michael; Ziegenfuss, Marc		ANZ ECMO Influenza Investigators	Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LIFE-SUPPORT; A H1N1; PREGNANCY; FAILURE	Context The novel influenza A(H1N1) pandemic affected Australia and New Zealand during the 2009 southern hemisphere winter. It caused an epidemic of critical illness and some patients developed severe acute respiratory distress syndrome (ARDS) and were treated with extracorporeal membrane oxygenation (ECMO). Objectives To describe the characteristics of all patients with 2009 influenza A(H1N1) associated ARDS treated with ECMO and to report incidence, resource utilization, and patient outcomes. Design, Setting, and Patients An observational study of all patients (n=68) with 2009 influenza A(H1N1)-associated ARDS treated with ECMO in 15 intensive care units (ICUs) in Australia and New Zealand between June 1 and August 31, 2009. Main Outcome Measures Incidence, clinical features, degree of pulmonary dysfunction, technical characteristics, duration of ECMO, complications, and survival. Results Sixty-eight patients with severe influenza-associated ARDS were treated with ECMO, of whom 61 had either confirmed 2009 influenza A(H1N1) (n=53) or influenza A not subtyped (n=8), representing an incidence rate of 2.6 ECMO cases per million population. An additional 133 patients with influenza A received mechanical ventilation but no ECMO in the same ICUs. The 68 patients who received ECMO had a median (interquartile range [IQR]) age of 34.4 (26.6-43.1) years and 34 patients (50%) were men. Before ECMO, patients had severe respiratory failure despite advanced mechanical ventilatory support with a median (IQR) PaO(2)/fraction of inspired oxygen (FIO(2)) ratio of 56 (48-63), positive end-expiratory pressure of 18 (15-20) cm H(2)O, and an acute lung injury score of 3.8 (3.5-4.0). The median (IQR) duration of ECMO support was 10 (7-15) days. At the time of reporting, 48 of the 68 patients (71%; 95% confidence interval [CI], 60%-82%) had survived to ICU discharge, of whom 32 had survived to hospital discharge and 16 remained as hospital inpatients. Fourteen patients (21%; 95% CI, 11%-30%) had died and 6 remained in the ICU, 2 of whom were still receiving ECMO. Conclusions During June to August 2009 in Australia and New Zealand, the ICUs at regional referral centers provided mechanical ventilation for many patients with 2009 influenza A(H1N1) -associated respiratory failure, one-third of whom received ECMO. These ECMO-treated patients were often young adults with severe hypoxemia and had a 21% mortality rate at the end of the study period. JAMA. 2009;302(17):1888-1895	[Davies, Andrew] Alfred Hosp, Intens Care Unit, Melbourne, Vic 3004, Australia; [Davies, Andrew; Jones, Daryl; Bailey, Michael; Bellomo, Rinaldo; Pettilae, Ville] Monash Univ, Australian & New Zealand Intens Care Res Ctr, Melbourne, Vic 3004, Australia; [Jones, Daryl; Bellomo, Rinaldo] Austin Hosp, Melbourne, Vic 3084, Australia; [Beca, John; McGuinness, Shay] Auckland City Hosp, Auckland, New Zealand; [Blackwell, Nikki; Ziegenfuss, Marc] Prince Charles Hosp, Brisbane, Qld 4032, Australia; [Forrest, Paul; Gattas, David; Herkes, Robert; Plunkett, Brian; Torzillo, Paul; Wilson, Michael] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Granger, Emily; Jackson, Andrew; Nair, Priya; Pye, Roger] St Vincents Hosp, Sydney, NSW 2010, Australia; [Webb, Steve] Univ Western Australia, Royal Perth Hosp, Perth, WA 6009, Australia; [Webb, Steve] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Webb, Steve] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia	Florey Institute of Neuroscience & Mental Health; Monash University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Auckland City Hospital; Prince Charles Hospital; University of Sydney; St Vincents Hospital Sydney; Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Western Australia	Davies, A (corresponding author), Alfred Hosp, Intens Care Unit, Commercial Rd, Melbourne, Vic 3004, Australia.	a.davies@alfred.org.au	Bailey, Michael J/A-4499-2012; Joyce, Christopher/B-7437-2013; Gattas, David/AAN-9668-2020; blackwell, nikki/H-4222-2013	Bailey, Michael J/0000-0002-5551-1401; Gattas, David/0000-0002-9282-7093; Micallef, Sharon/0000-0002-8496-2324; McGuinness, Shay/0000-0003-0620-4787; Ziegenfuss, Marc/0000-0002-1488-2994; Rajbhandari, Dorrilyn/0000-0001-8883-0428; Bellomo, Rinaldo/0000-0002-1650-8939; Whitehead, Christina/0000-0003-4561-7082				[Anonymous], WORLDWIDE H1N1 SWINE; *AUSRT DEP HLTH AG, PAND H1N1 2009 UPD B; *AUSTR DEP HLTH AG, PAND H1N1 2009 UPD B; *AUSTR DEP HLTH AG, AUSTR NAT INFL SURV; Australian Bureau of Statistics, AUSTR DEM STAT; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; CHOW AW, 1992, CLIN INFECT DIS, V15, pS62, DOI 10.1093/clind/15.Supplement_1.S62; Conrad SA, 2005, ASAIO J, V51, P4, DOI 10.1097/01.mat.0000151922.67540.E9; Cunningham JA, 2006, OBSTET GYNECOL, V108, P792, DOI 10.1097/01.AOG.0000209184.33709.ec; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Hemmila MR, 2004, ANN SURG, V240, P595, DOI 10.1097/01.sla.0000141159.90676.2d; King PT, 2000, LANCET, V356, P45, DOI 10.1016/S0140-6736(00)02438-7; Linden VB, 2009, ACTA ANAESTH SCAND, V53, P489, DOI 10.1111/j.1399-6576.2008.01808.x; LUM ME, 2009, MED J AUSTRALIA, V191, P1; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; *NZ MIN HLTH, PAND INFL H1N1 09 SW; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Peek GJ, 1997, CHEST, V112, P759, DOI 10.1378/chest.112.3.759; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; *STAT NZ, POP IND; Webb SAR, 2009, CRIT CARE RESUSC, V11, P170; WHO, INFL LIK ILLN US MEX	22	1113	1169	4	154	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 4	2009	302	17					1888	1895		10.1001/jama.2009.1535	http://dx.doi.org/10.1001/jama.2009.1535			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514DU	19822628	Bronze			2022-12-28	WOS:000271375300020
J	Peek, GJ; Mugford, M; Tiruvoipati, R; Wilson, A; Allen, E; Thalanany, MM; Hibbert, CL; Truesdale, A; Clemens, F; Cooper, N; Firmin, RK; Elbourne, D				Peek, Giles J.; Mugford, Miranda; Tiruvoipati, Ravindranath; Wilson, Andrew; Allen, Elizabeth; Thalanany, Mariamma M.; Hibbert, Clare L.; Truesdale, Ann; Clemens, Felicity; Cooper, Nicola; Firmin, Richard K.; Elbourne, Diana		CESAR Trial Collaboration	Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; COST-EFFECTIVENESS ANALYSIS; INTENSIVE-CARE UNITS; DISTRESS-SYNDROME; CLINICAL-TRIALS; SURVIVAL; OUTCOMES; EPIDEMIOLOGY	Background Severe acute respiratory failure in adults causes high mortality despite improvements in ventilation techniques and other treatments (eg, steroids, prone positioning, bronchoscopy, and inhaled nitric oxide). We aimed to delineate the safety clinical efficacy, and cost-effectiveness of extracorporeal membrane oxygenation (ECMO) compared with conventional ventilation support. Methods in this UK-based multicentre trial, we used an independent central randomisation service to randomly assign 180 adults in a 1:1 ratio to receive continued conventional management or referral to consideration for treatment by ECMO. Eligible patients were aged 18-65 years and had severe (Murray score >3.0 or pH <7.20) but potentially reversible respiratory failure. Exclusion criteria were: high pressure (>30 cm H2O of peak inspiratory pressure) or high FiO(2) (>0.8) ventilation for more than 7 days; intracranial bleeding; any other contraindication to limited heparinisation; or any contraindication to continuation of active treatment. The primary outcome was death or severe disability at 6 months after randomisation or before discharge from hospital. Primary analysis was by intention to treat. Only researchers who did the 6-month follow-up were masked to treatment assignment. Data about resource use and economic outcomes (quality-adjusted life-years) were collected. Studies of the key cost generating events were undertaken, and we did analyses of cost-utility at 6 months after randomisation and modelled lifetime cost-utility. This study is registered, number ISRCTN47279827. Findings 766 patients were screened; 180 were enrolled and randomly allocated to consideration for treatment by ECMO (n=90 patients) or to receive conventional management (n=90). 68 (75%) patients actually received ECMO; 63% (57/90) of patients allocated to consideration for treatment by ECMO survived to 6 months without disability compared with 47% (41/87) of those allocated to conventional management (relative risk 0.69; 95% CI 0.05-0.97, p=0.03). Referral to consideration for treatment by ECMO treatment led to a gain of 0.03 quality-adjusted life-years (QALYs) at 6-month follow-up. A lifetime model predicted the cost per QALY of ECMO to be 19252 pound (95% CI 7622-59 200) at a discount rate of 3.5%. Interpretation We recommend transferring of adult patients with severe but potentially reversible respiratory failure, whose Murray score exceeds 3.0 or who have a pH of less than 7.20 on optimum conventional management, to a centre with an ECMO-based management protocol to significantly improve survival without severe disability. This strategy is also likely to be cost effective in settings with similar services to those in the UK.	[Peek, Giles J.; Firmin, Richard K.] Glenfield Gen Hosp, Dept Cardiothorac Surg, Leicester LE3 9QP, Leics, England; [Peek, Giles J.; Tiruvoipati, Ravindranath; Firmin, Richard K.] Glenfield Gen Hosp, Dept Extracorporeal Membrane Oxygenat, Leicester LE3 9QP, Leics, England; [Mugford, Miranda; Thalanany, Mariamma M.] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [Wilson, Andrew; Cooper, Nicola] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Allen, Elizabeth; Truesdale, Ann; Clemens, Felicity; Elbourne, Diana] London Sch Hyg & Trop Med, Med Stat Unit, London WC1, England; [Hibbert, Clare L.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of East Anglia; University of Leicester; University of London; London School of Hygiene & Tropical Medicine; University of Sheffield	Peek, GJ (corresponding author), Glenfield Gen Hosp, Dept Cardiothorac Surg & Extracorporeal Membrane, Leicester LE3 9QP, Leics, England.	giles.peek@uhl-tr.nhs.uk	Peek, Giles/I-1530-2019; Tiruvoipati, Ravindranath/Q-9365-2019	Humphreys, Sally/0000-0002-4397-6404; peek, giles/0000-0002-1313-6498; Macrae, Duncan/0000-0002-7158-6585; Tiruvoipati, Ravindranath/0000-0003-3800-902X	UK NHS Health Technology Assessment; English National Specialist Commissioning Advisory Group; Scottish Department of Health; Welsh Department of Health; MRC [G106/1170] Funding Source: UKRI; Medical Research Council [G106/1170] Funding Source: researchfish; National Institute for Health Research [99/01/01] Funding Source: researchfish	UK NHS Health Technology Assessment; English National Specialist Commissioning Advisory Group; Scottish Department of Health; Welsh Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding UK NHS Health Technology Assessment, English National Specialist Commissioning Advisory Group, Scottish Department of Health, and Welsh Department of Health.	Angus DC, 2001, AM J RESP CRIT CARE, V163, P1389, DOI 10.1164/ajrccm.163.6.2005123; BARTLETT RH, 1985, PEDIATRICS, V76, P479; Bersten AD, 2002, AM J RESP CRIT CARE, V165, P443, DOI 10.1164/ajrccm.165.4.2101124; BIFANO E M, 1992, Pediatric Research, V31, p196A; Briggs AH, 1997, HEALTH ECON, V6, P327, DOI 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brun-Buisson C, 2004, INTENS CARE MED, V30, P51, DOI 10.1007/s00134-003-2022-6; CURTIS L, 2005, UNIT COSTS HLTH SOCI; Davidson TA, 1999, JAMA-J AM MED ASSOC, V281, P354, DOI 10.1001/jama.281.4.354; DEAN JE, 2002, CARE CRIT 3, V18, P3; *DEP HLTH, NHS REF COSTS 2005; *DEP HLTH, HLTH SURV ENGL 1996; Derdak S, 2002, AM J RESP CRIT CARE, V166, P801, DOI 10.1164/rccm.2108052; Edbrooke D, 1999, ANAESTHESIA, V54, P110, DOI 10.1046/j.1365-2044.1999.00650.x; Field D, 1996, LANCET, V348, P75; Foley DS, 2002, ASAIO J, V48, P612, DOI 10.1097/00002480-200211000-00007; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; *GOV ACT DEP, 2007, LIF TABL UK; Graf J, 2005, CRIT CARE MED, V33, P547, DOI 10.1097/01.ccm.0000155990.35290.03; HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793; Hemmila MR, 2004, ANN SURG, V240, P595, DOI 10.1097/01.sla.0000141159.90676.2d; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; HIBBERT C, 2007, DEV APPL METHOD ESTI; *HM GOV, 2004, COMM HANS PARL P; *HM TREAS, 2007, GREEN BOOK APPR EV C; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Johnson A, 1998, PEDIATRICS, V101; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kolla S, 1997, ANN SURG, V226, P544, DOI 10.1097/00000658-199710000-00015; Mancebo J, 2006, AM J RESP CRIT CARE, V173, P1233, DOI 10.1164/rccm.200503-353OC; MORRIS AH, 1994, AM J RESP CRIT CARE, V149, P295, DOI 10.1164/ajrccm.149.2.8306022; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; *ORG EC COOP DEV, OECD STAT PURCH POW; Orme J, 2003, AM J RESP CRIT CARE, V167, P690, DOI 10.1164/rccm.200206-542OC; OROURKE PP, 1989, PEDIATRICS, V84, P957; Peek GJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-163; Peek GJ, 1997, CHEST, V112, P759, DOI 10.1378/chest.112.3.759; PEEK GJ, 2005, EXTRACORPOREAL LIFE; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Rimachi R, 2007, ANAESTH INTENS CARE, V35, P62, DOI 10.1177/0310057X0703500108; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Stevens VC, 1998, ANAESTHESIA, V53, P944, DOI 10.1046/j.1365-2044.1998.00576.x; Sznajder M, 2001, INTENS CARE MED, V27, P146, DOI 10.1007/s001340000760; Thalanany MM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-94; Van Meurs K, 2005, ECMO EXTRACORPOREAL; VASILYEV S, 1995, CHEST, V107, P1083, DOI 10.1378/chest.107.4.1083; WARE JE, 1993, SF 36 HLTH SUVREY MA; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; WILLIAMS SJ, 2006, HEALTH CARE ANAL, V4, P273; ZAPOL WM, 1979, JAMA-J AM MED ASSOC, V242, P2193, DOI 10.1001/jama.242.20.2193; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	54	2031	2175	6	158	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2009	374	9698					1351	1363		10.1016/S0140-6736(09)61069-2	http://dx.doi.org/10.1016/S0140-6736(09)61069-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MW	19762075				2022-12-28	WOS:000271254600031
J	Renton, BJ				Renton, Bryan Joseph			Picture quiz A 79 year old woman with a swollen right leg	BRITISH MEDICAL JOURNAL			English	Editorial Material							FINE-NEEDLE-ASPIRATION; MALIGNANT-LYMPHOMA; CLASSIFICATION; CYTOPATHOLOGY; DIAGNOSIS		Warrington Hosp, Warrington WA5 1QG, Cheshire, England		Renton, BJ (corresponding author), Warrington Hosp, Warrington WA5 1QG, Cheshire, England.	bjrenton@doctors.net.uk						BATTISTA AF, 1991, SURG GYNECOL OBSTET, V173, P142; Bazemore AW, 2002, AM FAM PHYSICIAN, V66, P2103; Das DK, 1999, DIAGN CYTOPATHOL, V21, P240, DOI 10.1002/(SICI)1097-0339(199910)21:4<240::AID-DC3>3.0.CO;2-Z; Dunphy CH, 1997, DIAGN CYTOPATHOL, V16, P200, DOI 10.1002/(SICI)1097-0339(199703)16:3<200::AID-DC2>3.0.CO;2-J; Ely JW, 2006, J AM BOARD FAM MED, V19, P148, DOI 10.3122/jabfm.19.2.148; *EMEDICINE, LYMPH DIFF LARG CELL; *EMEDICINE, CHRON VEN INS; Harper PL, 2007, INTERN MED J, V37, P607, DOI 10.1111/j.1445-5994.2007.01388.x; Layfield L J, 1996, Pathology (Phila), V4, P409; *LYMPH, CLASS; *MEDICINENET, REFL SYMP DYSTR SYND; *PATHOLOGYOUTLINES, LYMPH B CELL PLASM C; *UPTODATE, DIS ASS INCR PLASM L; Wakely PE, 1998, CLIN LAB MED, V18, P541; Wakely PE, 2000, DIAGN CYTOPATHOL, V22, P120, DOI 10.1002/(SICI)1097-0339(200002)22:2<120::AID-DC14>3.0.CO;2-8; *WRONGDIAGNOSIS, CAUS UN OED LOW EXTR	16	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 14	2009	339								b3996	10.1136/bmj.b3996	http://dx.doi.org/10.1136/bmj.b3996			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508DP	19828649				2022-12-28	WOS:000270908200001
J	Adamsen, L; Quist, M; Andersen, C; Moller, T; Herrstedt, J; Kronborg, D; Baadsgaard, MT; Vistisen, K; Midtgaard, J; Christiansen, B; Stage, M; Kronborg, MT; Rorth, M				Adamsen, Lis; Quist, Morten; Andersen, Christina; Moller, Tom; Herrstedt, Jorn; Kronborg, Dorte; Baadsgaard, Marie T.; Vistisen, Kirsten; Midtgaard, Julie; Christiansen, Birgitte; Stage, Maria; Kronborg, Morten T.; Rorth, Mikael			Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; BREAST-CANCER; RESISTANCE EXERCISE; PHYSICAL CAPACITY; FATIGUE; SURVIVORS; HEALTH; INSTRUMENT; SYMPTOMS; PROGRAM	Objective To assess the effect of a multimodal group exercise intervention, as an adjunct to conventional care, on fatigue, physical capacity, general wellbeing, physical activity, and quality of life in patients with cancer who were undergoing adjuvant chemotherapy or treatment for advanced disease. Design Randomised controlled trial. Setting Two university hospitals in Copenhagen, Denmark. Participants 269 patients with cancer; 73 men, 196 women, mean age 47 years (range 20-65) representing 21 diagnoses. Main exclusion criteria were brain or bone metastases. 235 patients completed follow-up. Intervention Supervised exercise comprising high intensity cardiovascular and resistance training, relaxation and body awareness training, massage, nine hours weekly for six weeks in addition to conventional care, compared with conventional care. Main outcome measures European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30), Medical Outcomes Study Short Form (MOS SF-36), Leisure Time Physical Activity Questionnaire, muscular strength (one repetition maximum), maximum oxygen consumption (Vo(2)max). Statistical methods The general linear model was used for continuous outcome while analysis of associates between categorical outcomes was performed as analysis of marginal homogeneity in contingency tables. Results Adjusted for baseline score, disease, and demographic covariates, the intervention group showed an estimated improvement at six weeks for the primary outcome, fatigue, of -6.6 points (95% confidence interval -12.3 to -0.9, P=0.02; effect size=0.33, 0.04 to 0.61). Significant effects were seen on vitality (effect size 0.55, 95% CI 0.27 to 0.82), physical functioning (0.37, 0.09 to 0.65), role physical (0.37, 0.10 to 0.64), role emotional (0.32, 0.05 to 0.59), and mental health (0.28, 0.02 to 0.56) scores. Improvement was noted in physical capacity: estimated mean difference between groups for maximum oxygen consumption was 0.16 l/min (95% CI 0.1 to 0.2, P<0.0001) and for muscular strength (leg press) was 29.7 kg (23.4 to 34.9, P<0.0001). No significant effect was seen on global health status/quality of life. Conclusion A supervised multimodal exercise intervention including high and low intensity components was feasible and could safely be used in patients with various cancers who were receiving adjuvant chemotherapy or treatment for advanced disease. The intervention reduced fatigue and improved vitality, aerobic capacity, muscular strength, and physical and functional activity, and emotional wellbeing, but not quality of life.	[Adamsen, Lis; Quist, Morten; Andersen, Christina; Moller, Tom; Baadsgaard, Marie T.; Midtgaard, Julie; Stage, Maria] Copenhagen Univ Hosp, Univ Hosp, Ctr Nursing & Care Res, DK-2100 Copenhagen, Denmark; [Adamsen, Lis] Univ Copenhagen, Inst Publ Hlth, Copenhagen, Denmark; [Herrstedt, Jorn] Odense Univ Hosp, Dept Oncol, DK-5000 Odense, Denmark; [Kronborg, Dorte] Copenhagen Business Sch, Ctr Stat, Frederiksberg, Denmark; [Vistisen, Kirsten; Christiansen, Birgitte] Herlev Univ Hosp, Dept Oncol, DK-2730 Herlev, Denmark; [Kronborg, Morten T.] Univ Copenhagen, Dept Math Sci, Copenhagen, Denmark; [Rorth, Mikael] Copenhagen Univ Hosp, Dept Oncol, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; Copenhagen Business School; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; University of Copenhagen	Adamsen, L (corresponding author), Copenhagen Univ Hosp, Univ Hosp, Ctr Nursing & Care Res, DK-2100 Copenhagen, Denmark.	la@ucsf.dk	Herrstedt, Jørn/AAB-7400-2022; Midtgaard, Julie/P-9211-2019	Kronborg, Dorte/0000-0001-6511-4138; Quist, Morten/0000-0002-0983-957X; Moller, Tom/0000-0003-1908-258X; Midtgaard, Julie/0000-0003-2381-2127	Lundbeck Foundation; Novo Nordic Foundation; Egmont Foundation; Danish Cancer Society; Svend Andersen Foundation; Aase and Ejnar Danielsen Foundation; Beckett Foundation; WedellWedellsborg Foundation; Hede Nielsen Family Foundation; Gangsted Foundation; Copenhagen University Hospital	Lundbeck Foundation(Lundbeckfonden); Novo Nordic Foundation(Novo Nordisk Foundation); Egmont Foundation; Danish Cancer Society(Danish Cancer Society); Svend Andersen Foundation; Aase and Ejnar Danielsen Foundation; Beckett Foundation; WedellWedellsborg Foundation; Hede Nielsen Family Foundation; Gangsted Foundation; Copenhagen University Hospital	This research was supported by grants from The Lundbeck Foundation, The Novo Nordic Foundation, The Egmont Foundation, The Danish Cancer Society, The Svend Andersen Foundation, The Aase and Ejnar Danielsen Foundation, The Beckett Foundation, The WedellWedellsborg Foundation, The Hede Nielsen Family Foundation, The Gangsted Foundation, Copenhagen University Hospital. The authors' work was independent from the funders.	Aadahl M, 2003, MED SCI SPORT EXER, V35, P1196, DOI 10.1249/01.MSS.0000074446.02192.14; AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Adamsen L, 2006, SUPPORT CARE CANCER, V14, P116, DOI 10.1007/s00520-005-0864-x; Adamsen L, 2004, EUR J CANCER CARE, V13, P362, DOI 10.1111/j.1365-2354.2004.00502.x; Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Anderson BD, 2000, ORTHOP PHYS THER CLI, V9, P395; Andersen L. B., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P318; Baum A, 2001, PSYCHOSOC INTERV, P3; Bjorner JB., 1997, DANSK MANUAL SF 36 S; Bower Julienne E, 2005, Cancer Control, V12, P165; Brzycki M., 1993, J PHYS ED REC DANCE, V64, P88, DOI [10.1080/07303084.1993.10606684, DOI 10.1080/07303084.1993.10606684]; Canadian Cancer Society/National Cancer Institute of Canada, 2008, CAN CANC STAT 2008; *CANC RES UK, 2005, UK CANC INC STAT COU; CLEMMENSEN IH, 2006, KRAEFT DANMARK OPSLA; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Courneya KS, 2007, J CLIN ONCOL, V25, P4396, DOI 10.1200/JCO.2006.08.2024; da Costa BR, 2008, J REHABIL MED, V40, P321, DOI 10.2340/16501977-0204; De Bruin A., 1996, HLTH INTERVIEW SURVE; Dimeo F, 2003, SUPPORT CARE CANCER, V11, P623, DOI 10.1007/s00520-003-0512-2; Espey DK, 2007, CANCER-AM CANCER SOC, V110, P2119, DOI 10.1002/cncr.23044; FENTEM P, 1994, BRIT MED J, V308, P1291, DOI 10.1136/bmj.308.6939.1291; FERRELLTORRY AT, 1993, CANCER NURS, V16, P93; Galvao DA, 2005, J CLIN ONCOL, V23, P899, DOI 10.1200/JCO.2005.06.085; Gayda M, 2009, J ELECTROMYOGR KINES, V19, pE32, DOI 10.1016/j.jelekin.2007.08.009; Henry DH, 2008, SUPPORT CARE CANCER, V16, P791, DOI 10.1007/s00520-007-0380-2; Jarden M, 2007, BONE MARROW TRANSPL, V40, P793, DOI 10.1038/sj.bmt.1705807; Kangas M, 2008, PSYCHOL BULL, V134, P700, DOI 10.1037/a0012825; King MT, 1996, QUAL LIFE RES, V5, P555, DOI 10.1007/BF00439229; Klee M, 1997, QUAL LIFE RES, V6, P27; Kraemer WJ, 2002, MED SCI SPORT EXER, V34, P364, DOI 10.1097/00005768-200202000-00027; Kwekkeboom Kristine L, 2008, Complement Ther Clin Pract, V14, P185, DOI 10.1016/j.ctcp.2008.04.002; Lucia A, 2003, LANCET ONCOL, V4, P616, DOI 10.1016/S1470-2045(03)01221-X; Luebbert K, 2001, PSYCHO-ONCOLOGY, V10, P490, DOI 10.1002/pon.537; Markes M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005001; McCaffery M., 2008, PAIN CLIN MANUAL NUR; McNeely ML, 2006, CAN MED ASSOC J, V175, P34, DOI 10.1503/cmaj.051073; Milne HM, 2008, BREAST CANCER RES TR, V108, P279, DOI 10.1007/s10549-007-9602-z; Moinuddin I, 2008, ADV CHRONIC KIDNEY D, V15, P83, DOI 10.1053/j.ackd.2007.10.004; Mutrie N, 2007, BMJ-BRIT MED J, V334, P517, DOI 10.1136/bmj.39094.648553.AE; Nader GA, 2006, MED SCI SPORT EXER, V38, P1965, DOI 10.1249/01.mss.0000233795.39282.33; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; O'Connor PJ, 2005, MED SCI SPORT EXER, V37, P299, DOI 10.1249/01.MSS.0000152802.89770.CF; Pinto BM, 2000, ANN BEHAV MED, V22, P38, DOI 10.1007/BF02895166; Quist M, 2006, SCAND J MED SCI SPOR, V16, P349, DOI 10.1111/j.1600-0838.2005.00503.x; Roila F, 2006, ANN ONCOL, V17, P20, DOI 10.1093/annonc/mdj078; SALTIN B, 1968, CIRCULATION, V38, P1104, DOI 10.1161/01.CIR.38.6.1104; SALTIN B, 1983, HDB PHYSL, V10, P555; Schmitz KH, 2005, CANCER EPIDEM BIOMAR, V14, P1588, DOI 10.1158/1055-9965.EPI-04-0703; Segal R, 2001, J CLIN ONCOL, V19, P657, DOI 10.1200/JCO.2001.19.3.657; SMETS EMA, 1993, BRIT J CANCER, V68, P220, DOI 10.1038/bjc.1993.319; Thomas DR, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002968.pub2; Uitterhoeve RJ, 2004, BRIT J CANCER, V91, P1050, DOI 10.1038/sj.bjc.6602103; van Emmerik AAP, 2002, LANCET, V360, P766, DOI 10.1016/S0140-6736(02)09897-5; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	54	299	303	1	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2009	339								b3410	10.1136/bmj.b3410	http://dx.doi.org/10.1136/bmj.b3410			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508DO	19826172	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000270908100001
J	Chlebowski, RT; Schwartz, AG; Wakelee, H; Anderson, GL; Stefanick, ML; Manson, JE; Rodabough, RJ; Chien, JW; Wactawski-Wende, J; Gass, M; Kotchen, JM; Johnson, KC; O'Sullivan, MJ; Ockene, JK; Chen, C; Hubbell, FA				Chlebowski, Rowan T.; Schwartz, Ann G.; Wakelee, Heather; Anderson, Garnet L.; Stefanick, Marcia L.; Manson, JoAnn E.; Rodabough, Rebecca J.; Chien, Jason W.; Wactawski-Wende, Jean; Gass, Margery; Kotchen, Jane Morley; Johnson, Karen C.; O'Sullivan, Mary Jo; Ockene, Judith K.; Chen, Chu; Hubbell, F. Allan		Women's Hlth Initiative Investigat	Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial	LANCET			English	Article							HORMONE REPLACEMENT THERAPY; BREAST-CANCER; REPRODUCTIVE FACTORS; RISK; ANGIOGENESIS; SURVIVAL; BEVACIZUMAB; MAMMOGRAPHY; PACLITAXEL; BENEFITS	Background In the post-intervention period of the Women's Health Initiative (WHI) trial, women assigned to treatment with oestrogen plus progestin had a higher risk of cancer than did those assigned to placebo. Results also suggested that the combined hormone therapy might increase mortality from lung cancer. To assess whether such an association exists, we undertook a post-hoc analysis of lung cancers diagnosed in the trial over the entire follow-up period. Methods The WHI study was a randomised, double-blind, placebo-controlled trial undertaken in 40 centres in the USA. 16608 postmenopausal women aged 50-79 years with an intact uterus were randomly assigned by a computerised, stratified, permuted block algorithm to receive a once-daily tablet of 0.625 mg conjugated equine oestrogen plus 2.5 mg medroxyprogesterone acetate (n=8506) or matching placebo (n=8102). We assessed incidence and mortality rates for all lung cancer, small-cell lung cancer, and non-small-cell lung cancer by use of data from treatment and post-intervention follow-up periods. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00000611. Findings After a mean of 5.6 years (SD 1.3) of treatment and 2.4 years (0.4) of additional follow-up, 109 women in the combined hormone therapy group had been diagnosed with lung cancer compared with 85 in the placebo group (incidence per year 0.16% vs 0.13%; hazard ratio [HR] 1.23, 95% CI 0.92-1.63, p=0.16). 96 women assigned to combined therapy had non-small-cell lung cancer compared with 72 assigned to placebo (0.14% vs 0.11%; HR 1.28, 0.94-1.73, p=0.12). More women died from lung cancer in the combined hormone therapy group than in the placebo group (73 vs 40 deaths; 0.11% vs 0.06%; HR 1.71, 1.16-2.52, p=0.01), mainly as a result of a higher number of deaths from non-small-cell lung cancer in the combined therapy group (62 vs 31 deaths; 0.09% vs 0.05%; HR 1.87, 1.22-2.88, p=0.004). incidence and mortality rates of small-cell lung cancer were similar between groups. Interpretation Although treatment with oestrogen plus progestin in postmenopausal women did not increase incidence of lung cancer, it increased the number of deaths from lung cancer, in particular deaths from non-small-cell lung cancer. These findings should be incorporated into risk-benefit discussions with women considering combined hormone therapy, especially those with a high risk of lung cancer. Funding National Heart, Lung and Blood Institute, National Institutes of Health.	[Chlebowski, Rowan T.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90502 USA; [Schwartz, Ann G.] Karmanos Canc Inst, Dept Internal Med, Detroit, MI USA; [Wakelee, Heather; Stefanick, Marcia L.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Anderson, Garnet L.; Rodabough, Rebecca J.; Chien, Jason W.; Chen, Chu] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Manson, JoAnn E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA; [Gass, Margery] Univ Cincinnati, Cincinnati, OH USA; [Kotchen, Jane Morley] Med Coll Wisconsin, Dept Populat Hlth, Milwaukee, WI 53226 USA; [Johnson, Karen C.] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; [O'Sullivan, Mary Jo] Univ Miami, Dept Obstet & Gynecol, Miami, FL USA; [Ockene, Judith K.] Univ Massachusetts, Fallon Clin, Dept Med, Worcester, MA 01605 USA; [Hubbell, F. Allan] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Barbara Ann Karmanos Cancer Institute; Stanford University; Fred Hutchinson Cancer Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University System of Ohio; University of Cincinnati; Medical College of Wisconsin; University of Tennessee System; University of Tennessee Health Science Center; University of Miami; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Irvine	Chlebowski, RT (corresponding author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, 1124 W Carson St, Torrance, CA 90502 USA.	rchlebowski@gmail.com	Wakelee, Heather/P-2623-2019; Wactawski-Wende, Jean/AGH-5457-2022; Cauley, Jane A/N-4836-2015; Stafford, Randall/F-3974-2017	Wactawski-Wende, Jean/0000-0003-3096-9595; Cauley, Jane A/0000-0003-0752-4408; Anderson, Garnet/0000-0001-5087-7837; Caan, Bette/0000-0002-5803-310X; Stafford, Randall/0000-0003-1805-1271	National Heart, Lung and Blood Institute; National Institutes of Health; Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH [N01WH042130, N01WH042129, N01WH042115, N01WH042110, N01WH022110, N01WH042132, N01WH042126, N01WH042114, N01WH032119, N01WH032102, N01WH032109, N01WH032115, N01WH042113, N01WH042116, N01WH032118, N01WH032105, N01WH032112, N01WH042111, N01WH042131, N01WH042117, N01WH032100, N01WH032111, N01WH042124, N01WH032101, N01WH032106, N01WH042107, N01WH042123, N01WH042118, N01WH042112, N01WH032122, N01WH042121, N01WH032113, N01WH042122, N01WH042109, N01WH042108, N01WH032108, N01WH042120, N01WH042119, N01WH042125] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); WOMEN&apos;S HEALTH INITIATIVE - OFFICE OF THE DIRECTOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge the dedicated efforts of investigators and staffat the Women's Health Initiative (WHI) clinical centres, the WHI Clinical Coordinating Center, and the National Heart, Lung and Blood program office (listing available at http://www.whi.org). We also recognise the WH I participants for their extraordinary commitment to the WH I programme. The WHI programme is funded by the National Heart, Lung and Blood Institute, National Institutes of Health, Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221.	ALBAIN KS, 2007, 2007 ASCO ANN M CHIC; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Anderson GL, 2003, ANN EPIDEMIOL, V13, pS5, DOI 10.1016/S1047-2797(03)00043-7; Baik CS, 2009, J CLIN ONCOL, V27; Bremnes RM, 2003, LUNG CANCER, V39, P303, DOI 10.1016/S0169-5002(02)00508-1; CAGLE PT, 1990, CANCER RES, V50, P6632; Calvo A, 2008, ONCOGENE, V27, P5373, DOI 10.1038/onc.2008.155; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; Chlebowski RT, 2008, ARCH INTERN MED, V168, P370, DOI 10.1001/archinternmed.2007.123; Chlebowski RT, 2009, NEW ENGL J MED, V360, P573, DOI 10.1056/NEJMoa0807684; Chlebowski RT, 1996, NUTRITION, V12, pS43; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; COX DR, 1972, J R STAT SOC B, V187, P220; Cushman M, 2004, JAMA-J AM MED ASSOC, V292, P1573, DOI 10.1001/jama.292.13.1573; Dobrzycka B, 2009, ENDOKRYNOL POL, V60, P210; Elkin M, 2004, JNCI-J NATL CANCER I, V96, P875, DOI 10.1093/jnci/djh140; Ganti AK, 2006, J CLIN ONCOL, V24, P59, DOI 10.1200/JCO.2005.02.9827; Hammoud Z, 2008, ENDOCR-RELAT CANCER, V15, P475, DOI 10.1677/ERC-08-0002; Heiss G, 2008, JAMA-J AM MED ASSOC, V299, P1036, DOI 10.1001/jama.299.9.1036; Henschke CI, 2006, JAMA-J AM MED ASSOC, V296, P180; Huang B, 2009, CANCER, V115, P4167, DOI 10.1002/cncr.24475; Hulley S, 2002, JAMA-J AM MED ASSOC, V288, P58, DOI 10.1001/jama.288.1.58; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kreuzer M, 2003, INT J EPIDEMIOL, V32, P263, DOI 10.1093/ije/dyg064; Liu Y, 2005, INT J CANCER, V117, P662, DOI 10.1002/ijc.21229; Losordo DW, 2001, ARTERIOSCL THROM VAS, V21, P6, DOI 10.1161/01.ATV.21.1.6; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Marquez-Garban DC, 2009, ANN NY ACAD SCI, V1155, P194, DOI 10.1111/j.1749-6632.2009.04116.x; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Rodriguez C, 2008, CANCER EPIDEM BIOMAR, V17, P655, DOI 10.1158/1055-9965.EPI-07-2683; ROSS H, 2007, 2007 ASCO ANN M CHIC; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Schabath MB, 2004, CLIN CANCER RES, V10, P113, DOI 10.1158/1078-0432.CCR-0911-3; Schwartz AG, 2007, J CLIN ONCOL, V25, P5785, DOI 10.1200/JCO.2007.13.3975; Stabile LP, 2002, CANCER RES, V62, P2141; Stabile LP, 2005, CANCER RES, V65, P1459, DOI 10.1158/0008-5472.CAN-04-1872; Stefanick ML, 2006, JAMA-J AM MED ASSOC, V295, P1647, DOI 10.1001/jama.295.14.1647; TAIOLI E, 1994, J NATL CANCER I, V86, P869, DOI 10.1093/jnci/86.11.869; The Coronary Drug Project, 1973, JAMA-J AM MED ASSOC, V226, P652, DOI DOI 10.1001/JAMA.1973.03230060030009; Wakelee HA, 2006, J THORAC ONCOL, V1, P441, DOI 10.1097/01243894-200606000-00011; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101	45	217	223	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2009	374	9697					1243	1251		10.1016/S0140-6736(09)61526-9	http://dx.doi.org/10.1016/S0140-6736(09)61526-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	507KQ	19767090	Green Accepted			2022-12-28	WOS:000270852500030
J	Lieberman-Aiden, E; van Berkum, NL; Williams, L; Imakaev, M; Ragoczy, T; Telling, A; Amit, I; Lajoie, BR; Sabo, PJ; Dorschner, MO; Sandstrom, R; Bernstein, B; Bender, MA; Groudine, M; Gnirke, A; Stamatoyannopoulos, J; Mirny, LA; Lander, ES; Dekker, J				Lieberman-Aiden, Erez; van Berkum, Nynke L.; Williams, Louise; Imakaev, Maxim; Ragoczy, Tobias; Telling, Agnes; Amit, Ido; Lajoie, Bryan R.; Sabo, Peter J.; Dorschner, Michael O.; Sandstrom, Richard; Bernstein, Bradley; Bender, M. A.; Groudine, Mark; Gnirke, Andreas; Stamatoyannopoulos, John; Mirny, Leonid A.; Lander, Eric S.; Dekker, Job			Comprehensive Mapping of Long-Range Interactions Reveals Folding Principles of the Human Genome	SCIENCE			English	Article							GENE-REGULATION; IN-VIVO; CHROMOSOME CONFORMATION; NUCLEAR-ORGANIZATION; CHROMATIN ENVIRONMENT; INTERPHASE NUCLEUS; DNA; PROTEIN; CELLS; ARCHITECTURE	We describe Hi-C, a method that probes the three-dimensional architecture of whole genomes by coupling proximity-based ligation with massively parallel sequencing. We constructed spatial proximity maps of the human genome with Hi-C at a resolution of 1 megabase. These maps confirm the presence of chromosome territories and the spatial proximity of small, gene-rich chromosomes. We identified an additional level of genome organization that is characterized by the spatial segregation of open and closed chromatin to form two genome-wide compartments. At the megabase scale, the chromatin conformation is consistent with a fractal globule, a knot-free, polymer conformation that enables maximally dense packing while preserving the ability to easily fold and unfold any genomic locus. The fractal globule is distinct from the more commonly used globular equilibrium model. Our results demonstrate the power of Hi-C to map the dynamic conformations of whole genomes.	[Lieberman-Aiden, Erez; Williams, Louise; Amit, Ido; Bernstein, Bradley; Gnirke, Andreas; Lander, Eric S.] Broad Inst Harvard, Cambridge, MA 02139 USA; [Lieberman-Aiden, Erez; Imakaev, Maxim; Mirny, Leonid A.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Lieberman-Aiden, Erez] Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Lieberman-Aiden, Erez] Harvard Univ, Dept Appl Math, Cambridge, MA 02138 USA; [van Berkum, Nynke L.; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [van Berkum, Nynke L.; Lajoie, Bryan R.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Ragoczy, Tobias; Telling, Agnes; Groudine, Mark] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Ragoczy, Tobias; Telling, Agnes; Groudine, Mark] Univ Washington, Sch Med, Dept Radiat Oncol, Seattle, WA 98195 USA; [Sabo, Peter J.; Dorschner, Michael O.; Sandstrom, Richard; Stamatoyannopoulos, John] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bernstein, Bradley] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Bender, M. A.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Mirny, Leonid A.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Lieberman-Aiden, E (corresponding author), Broad Inst Harvard, Cambridge, MA 02139 USA.	lander@broadinstitute.org; job.dekker@umassmed.edu	Mirny, Leonid/ABE-8083-2020; Aiden, Erez Lieberman/A-2908-2010	Mirny, Leonid/0000-0002-0785-5410; Sandstrom, Richard/0000-0002-3356-1547	Fannie and John Hertz Foundation; National Defense Science and Engineering; NSF; National Space Biomedical Research Institute; National Human Genome Research Institute (NHGRI) [T32 HG002295]; American Society of Hematology; National Heart, Lung, and Blood Institute [R01HL06544]; National Institute of Diabetes and Digestive and Kidney Diseases [R37DK44746]; NIH [U54HG004592]; NHGRI [HG003143]; Keck Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004592, T32HG002295, R01HG003143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK044746] Funding Source: NIH RePORTER	Fannie and John Hertz Foundation; National Defense Science and Engineering; NSF(National Science Foundation (NSF)); National Space Biomedical Research Institute; National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); American Society of Hematology; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Keck Foundation(W.M. Keck Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a Fannie and John Hertz Foundation graduate fellowship, a National Defense Science and Engineering graduate fellowship, an NSF graduate fellowship, the National Space Biomedical Research Institute, and grant no. T32 HG002295 from the National Human Genome Research Institute (NHGRI) (E. L.); a fellowship from the American Society of Hematology (T. R.); award no. R01HL06544 from the National Heart, Lung, and Blood Institute and R37DK44746 from the National Institute of Diabetes and Digestive and Kidney Diseases (M. G.); NIH grant U54HG004592 (J. S.); i2b2 (Informatics for Integrating Biology and the Bedside), the NIH-supported Center for Biomedical Computing at Brigham and Women's Hospital (L. A. M.), grant no. HG003143 from the NHGRI, and a Keck Foundation distinguished young scholar award (J. D.). We thank J. Goldy, K. Lee, S. Vong, and M. Weaver for assistance with DNaseI experiments; A. Kosmrlj for discussions and code; A. P. Aiden, X. R. Bao, M. Brenner, D. Galas, W. Gosper, A. Jaffer, A. Melnikov, A. Miele, G. Giannoukos, C. Nusbaum, A. J. M. Walhout, L. Wood, and K. Zeldovich for discussions; and L. Gaffney and B. Wong for help with visualization. We also acknowledge the ENCODE chromatin group at Broad Institute and Massachusetts General Hospital. Hi-C sequence data has been deposited at the GEO database (www. ncbi. nlm. nih. gov/geo/), accession no. GSE18199. Expression data are also available at GEO, accession no. GSE18350. Chromatin immunoprecipitation sequence (ChIP-Seq) data and DNAseI sensitivity data are available at the University of California Santa Cruz (UCSC) browser (http://genome. ucsc. edu/). Additional visualizations are available at http://hic. umassmed. edu. A provisional patent on the Hi-C method (no. 61/100,151) is under review.	Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; De Gennes PG., 1979, SCALING CONCEPTS POL; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2008, SCIENCE, V319, P1793, DOI 10.1126/science.1152850; Dekker J, 2008, J BIOL CHEM, V283, P34532, DOI 10.1074/jbc.M806479200; Dernburg AF, 1996, CELL, V85, P745, DOI 10.1016/S0092-8674(00)81240-4; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; GROSBERG A, 1993, EUROPHYS LETT, V23, P373, DOI 10.1209/0295-5075/23/5/012; GROSBERG AY, 1988, J PHYS-PARIS, V49, P2095, DOI 10.1051/jphys:0198800490120209500; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Kolesov G, 2007, NUCLEIC ACIDS RES, V35, pW425, DOI 10.1093/nar/gkm312; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; Munkel C, 1998, PHYS REV E, V57, P5888, DOI 10.1103/PhysRevE.57.5888; Naumann S, 2001, LEUKEMIA RES, V25, P313, DOI 10.1016/S0145-2126(00)00125-9; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sexton T, 2007, NAT STRUCT MOL BIOL, V14, P1049, DOI 10.1038/nsmb1324; Shopland LS, 2006, J CELL BIOL, V174, P27, DOI 10.1083/jcb.200603083; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Tanabe H, 2002, MUTAT RES-FUND MOL M, V504, P37, DOI 10.1016/S0027-5107(02)00077-5; Vasilyev OA, 2003, THEOR MATH PHYS+, V134, P142, DOI 10.1023/A:1022267802220; YOKOTA H, 1995, J CELL BIOL, V130, P1239, DOI 10.1083/jcb.130.6.1239; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	36	4565	4716	31	779	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					289	293		10.1126/science.1181369	http://dx.doi.org/10.1126/science.1181369			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815776	Green Accepted, Green Submitted			2022-12-28	WOS:000270599500043
J	Martin, T; Ruf, I				Martin, Thomas; Ruf, Irina			On the Mammalian Ear	SCIENCE			English	Editorial Material							MIDDLE-EAR; MECKELS CARTILAGE; EVOLUTION		[Martin, Thomas; Ruf, Irina] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-53115 Bonn, Germany	University of Bonn	Martin, T (corresponding author), Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, Nussallee 8, D-53115 Bonn, Germany.	tmartin@uni-bonn.de						[Anonymous], 1991, HETEROCHRONY EVOLUTI; Fleischer G, 1978, Adv Anat Embryol Cell Biol, V55, P3; Gaupp E., 1913, Archiv fuer Anatomie und Physiologie Leipzig Anat Abt, V1912; Gould S. J., 1977, ONTOGENY PHYLOGENY; Haeckel E. H., 1866, GENERELLE MORPHOLOGI; Hall BK, 2002, PALAEONTOLOGY, V45, P647, DOI 10.1111/1475-4983.00253; Ito Y, 2002, DEV DYNAM, V224, P69, DOI 10.1002/dvdy.10088; Ji Q, 2009, SCIENCE, V326, P278, DOI 10.1126/science.1178501; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Luo ZX, 2007, NATURE, V446, P288, DOI 10.1038/nature05627; Meng J, 2003, ZOOL J LINN SOC-LOND, V138, P431, DOI 10.1046/j.1096-3642.2003.00064.x; Oka K, 2007, DEV BIOL, V303, P391, DOI 10.1016/j.ydbio.2006.11.025; REICHERT C, 1837, MULLERS ARCH ANAT PH, P120; Rich TH, 2005, SCIENCE, V307, P910, DOI 10.1126/science.1105717; Rowe T, 2008, P NATL ACAD SCI USA, V105, P1238, DOI 10.1073/pnas.0706385105; Ruf I, 2009, J ANAT, V214, P679, DOI 10.1111/j.1469-7580.2009.01059.x; Tucker AS, 2004, DEVELOPMENT, V131, P1235, DOI 10.1242/dev.01017	17	10	10	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 9	2009	326	5950					243	244		10.1126/science.1181131	http://dx.doi.org/10.1126/science.1181131			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815765				2022-12-28	WOS:000270599500029
J	O'Connor, SJ; Verma, H; Grubnic, S; Rayner, CFJ				O'Connor, S. J.; Verma, H.; Grubnic, S.; Rayner, C. F. J.			Lesson of the Week Chest radiographs in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[O'Connor, S. J.] Mayday Univ Hosp, Croydon CR7 7YE, Surrey, England; [Verma, H.; Grubnic, S.; Rayner, C. F. J.] Univ London St Georges Hosp, London, England	Croydon University Hospital; St Georges University London	O'Connor, SJ (corresponding author), Mayday Univ Hosp, Croydon CR7 7YE, Surrey, England.	sallyjeanoconnor@yahoo.co.uk						Antonelli N M, 1996, Obstet Gynecol Surv, V51, P125, DOI 10.1097/00006254-199602000-00022; *COLL RAD NAT RAD, 2001, XRAYS SAF AR THEY; Damilakis J, 2003, EUR RADIOL, V13, P406, DOI 10.1007/s00330-002-1352-z; Morice AH, 2006, THORAX, V61, pI1, DOI 10.1136/thx.2006.065144; *ROYAL COLL RAD BO, 1999, GOOD PRACT GUID CLIN; Sharp C, 1998, DIAGNOSTIC MED EXPOS; The Royal College of Radiologists, 2007, MAK BEST US DEP CLIN, V6th; Toppenberg KS, 1999, AM FAM PHYSICIAN, V59, P1813	8	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2009	339								b4057	10.1136/bmj.b4057	http://dx.doi.org/10.1136/bmj.b4057			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TI	19819929				2022-12-28	WOS:000270719400002
J	Vakulin, A; Baulk, SD; Catcheside, PG; Antic, NA; van den Heuvel, CJ; Dorrian, J; McEvoy, RD				Vakulin, Andrew; Baulk, Stuart D.; Catcheside, Peter G.; Antic, Nick A.; van den Heuvel, Cameron J.; Dorrian, Jillian; McEvoy, R. Doug			Effects of Alcohol and Sleep Restriction on Simulated Driving Performance in Untreated Patients With Obstructive Sleep Apnea	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-DOSE ALCOHOL; DAYTIME SLEEPINESS; RISK-FACTORS; DEPRIVATION; IMPAIRMENT; FATIGUE; ADULTS; MEN; ASSOCIATION; WAKEFULNESS	Background: Because of previous sleep disturbance and sleep hypoxia, patients with obstructive sleep apnea (OSA) might be more vulnerable to the effects of alcohol and sleep restriction than healthy persons. Objective: To compare the effects of sleep restriction and alcohol on driving simulator performance in patients with OSA and age-matched control participants. Design: Driving simulator assessments in 2 groups under 3 different conditions presented in random order. Setting: Adelaide Institute for Sleep Health, Sleep Laboratory, Adelaide, Australia. Participants: 38 untreated patients with OSA and 20 control participants. Measurements: Steering deviation, crashes, and braking reaction time. Intervention: Unrestricted sleep, sleep restricted to a maximum of 4 hours, and ingestion of an amount of 40% vodka calculated to achieve a blood alcohol level of 0.05 g/dL. Results: Patients with OSA demonstrated increased steering deviation compared with control participants (mean, 50.5 cm [95% CI, 46.1 to 54.9 cm] in the OSA group and 38.4 cm [CI, 32.4 to 44.4 cm] in the control group; P < 0.01) and significantly greater steering deterioration over time (group by time interaction, P = 0.02). The increase in steering deviation after sleep restriction and alcohol was approximately 40% greater in patients with OSA than in control participants (group by condition interaction, P = 0.04). Patients with OSA crashed more frequently than control participants (1 vs. 24 participants; odds ratio [OR], 25.4; P = 0.03) and crashed more frequently after sleep restriction (OR, 4.0; P < 0.01) and alcohol consumption (OR, 2.3; P = 0.02) than after normal sleep. In patients with OSA, prolonged eye closure (>2 seconds) and microsleeps (>2 seconds of theta activity on electroencephalography) were significant crash predictors (OR, 19.2 and 7.2, respectively; P < 0.01). Braking reaction time was slower after sleep restriction than after normal sleep (mean, 1.39 [SD, 0.06] seconds vs. 1.22 [SD, 0.04] seconds; P < 0.01) but not after alcohol consumption. No group differences were found. Limitation: Simulated driving was assessed rather than on-road driving. Conclusion: Patients with OSA are more vulnerable than healthy persons to the effects of alcohol consumption and sleep restriction on various driving performance variables.	[Vakulin, Andrew] Univ Adelaide, Adelaide Inst Sleep Hlth, Repatriat Gen Hosp, Adelaide, SA 5041, Australia; Univ S Australia, Ctr Sleep Res, Adelaide, SA 5001, Australia; Flinders Univ S Australia, Park, Australia	Flinders University South Australia; University of Adelaide; University of South Australia; Flinders University South Australia	Vakulin, A (corresponding author), Univ Adelaide, Adelaide Inst Sleep Hlth, Repatriat Gen Hosp, Daws Rd,Daw Pk, Adelaide, SA 5041, Australia.	andrew.vakulin@health.sa.gov.au	McEvoy, Doug/ABB-8052-2020; Dorrian, Jillian/C-1339-2010; van den Heuvel, Cameron J./E-1993-2012; Dorrian, Jillian/K-6496-2019; Vakulin, Andrew/Q-3360-2019	Dorrian, Jillian/0000-0002-6485-1643; van den Heuvel, Cameron J./0000-0001-7264-4655; Vakulin, Andrew/0000-0002-3919-1313; Catcheside, Peter/0000-0002-9372-6788	Australian National Health and Medical Research Council [390400]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	By the Australian National Health and Medical Research Council (project grant 390400).	Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Ayalon L, 2006, NEUROIMAGE, V31, P1817, DOI 10.1016/j.neuroimage.2006.02.042; Banks S, 2004, SLEEP, V27, P1063, DOI 10.1093/sleep/27.6.1063; Barrett PR, 2004, HUM PSYCHOPHARM CLIN, V19, P421, DOI 10.1002/hup.601; BEARPARK H, 1995, AM J RESP CRIT CARE, V151, P1459, DOI 10.1164/ajrccm.151.5.7735600; BEDARD MA, 1993, J CLIN EXP NEUROPSYC, V15, P330, DOI 10.1080/01688639308402567; Beebe DW, 2003, SLEEP, V26, P298, DOI 10.1093/sleep/26.3.298; Beebe DW, 2002, J SLEEP RES, V11, P1, DOI 10.1046/j.1365-2869.2002.00289.x; Berry JG, 2007, ADDICTION, V102, P1399, DOI 10.1111/j.1360-0443.2007.01893.x; CROW KA, 1989, HUMAN METABOLISM ALC, V1; Desai AV, 2006, J CLIN SLEEP MED, V2, P63; Drummond SPA, 2005, PSYCHIAT RES-NEUROIM, V140, P211, DOI 10.1016/j.pscychresns.2005.06.007; Drummond SPA, 1999, NEUROREPORT, V10, P3745, DOI 10.1097/00001756-199912160-00004; Drummond SPA, 2001, J SLEEP RES, V10, P85, DOI 10.1046/j.1365-2869.2001.00245.x; Eckert Danny J, 2008, Proc Am Thorac Soc, V5, P144, DOI 10.1513/pats.200707-114MG; Engleman H, 1999, SLEEP MED REV, V3, P59, DOI 10.1016/S1087-0792(99)90014-X; Flemons WW, 2004, AM J RESP CRIT CARE, V169, P668, DOI 10.1164/rccm.200308-1124PP; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; George CFP, 1996, AM J RESP CRIT CARE, V154, P175, DOI 10.1164/ajrccm.154.1.8680676; George CFP, 2002, AM J RESP CRIT CARE, V165, P746, DOI 10.1164/ajrccm.165.6.2107112; Gozal D, 2001, J NEUROSCI, V21, P2442, DOI 10.1523/JNEUROSCI.21-07-02442.2001; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Howard ME, 2007, SLEEP, V30, P1334, DOI 10.1093/sleep/30.10.1334; Howard ME, 2004, AM J RESP CRIT CARE, V170, P1014, DOI 10.1164/rccm.200312-1782oc; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Juniper M, 2000, EUR RESPIR J, V15, P590, DOI 10.1034/j.1399-3003.2000.15.27.x; Kamba M, 2001, J NEUROL NEUROSUR PS, V71, P334, DOI 10.1136/jnnp.71.3.334; Kapur Vishesh, 2002, Sleep Breath, V6, P49, DOI 10.1055/s-2002-32318; Kotterba S, 1998, J NEUROL SCI, V159, P45, DOI 10.1016/S0022-510X(98)00131-2; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; Moselhy HF, 2001, ALCOHOL ALCOHOLISM, V36, P357, DOI 10.1093/alcalc/36.5.357; *NAT SLEEP FDN, 2008, SLEEP AM POLL; O'Donoghue FJ, 2005, AM J RESP CRIT CARE, V171, P1185, DOI 10.1164/rccm.200406-738OC; Philip P, 2005, SLEEP, V28, P1511, DOI 10.1093/sleep/28.12.1511; Philip P, 2003, SLEEP, V26, P277, DOI 10.1093/sleep/26.3.277; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Risser MR, 2000, SLEEP, V23, P393; Sassani A, 2004, SLEEP, V27, P453, DOI 10.1093/sleep/27.3.453; Stockwell TR, 2002, MED J AUSTRALIA, V176, P91, DOI 10.5694/j.1326-5377.2002.tb04308.x; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Thiffault P, 2003, ACCIDENT ANAL PREV, V35, P381, DOI 10.1016/S0001-4575(02)00014-3; Thomas RJ, 2005, J APPL PHYSIOL, V98, P2226, DOI 10.1152/japplphysiol.01225.2004; Turkington PM, 2001, THORAX, V56, P800, DOI 10.1136/thorax.56.10.800; Vakulin A, 2007, SLEEP, V30, P1327, DOI 10.1093/sleep/30.10.1327; Veasey SC, 2004, SLEEP, V27, P194, DOI 10.1093/sleep/27.2.194; Vgontzas AN, 1998, ARCH INTERN MED, V158, P1333, DOI 10.1001/archinte.158.12.1333; Weaver Terri E, 2008, Proc Am Thorac Soc, V5, P173, DOI 10.1513/pats.200708-119MG; Wong KKH, 2008, J SLEEP RES, V17, P322, DOI 10.1111/j.1365-2869.2008.00665.x; Young T, 1997, SLEEP, V20, P608, DOI 10.1093/sleep/20.8.608; Young T, 2004, JAMA-J AM MED ASSOC, V291, P2013, DOI 10.1001/jama.291.16.2013; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	54	61	62	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2009	151	7					447	W145		10.7326/0003-4819-151-7-200910060-00005	http://dx.doi.org/10.7326/0003-4819-151-7-200910060-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502OT	19805768				2022-12-28	WOS:000270470500002
J	Mets, DG; Meyer, BJ				Mets, David G.; Meyer, Barbara J.			Condensins Regulate Meiotic DNA Break Distribution, thus Crossover Frequency, by Controlling Chromosome Structure	CELL			English	Article							DOUBLE-STRAND BREAKS; YEAST SACCHAROMYCES-CEREVISIAE; RECOMBINATION HOT-SPOT; CROSSING-OVER; C-ELEGANS; CAENORHABDITIS-ELEGANS; SYNAPTONEMAL COMPLEX; INITIATION SITE; MEIOSIS; PROTEIN	Meiotic crossover (CO) recombination facilitates evolution and accurate chromosome segregation. CO distribution is tightly regulated: homolog pairs receive at least one CO, CO spacing is nonrandom, and COs occur preferentially in short genomic intervals called hotspots. We show that CO number and distribution are controlled on a chromosome-wide basis at the level of DNA double-strand break (DSB) formation by a condensin complex composed of subunits from two known condensins: the C. elegans dosage compensation complex and mitotic condensin II. Disruption of any subunit of the CO-controlling condensin dominantly changes DSB distribution, and thereby COs, and extends meiotic chromosome axes. These phenotypes are cosuppressed by disruption of a chromosome axis element. Our data implicate higher-order chromosome structure in the regulation of CO recombination, provide a model for the rapid evolution of CO hotspots, and show that reshuffling of interchangeable molecular parts can create independent machines with similar architectures but distinct biological functions.	[Mets, David G.; Meyer, Barbara J.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Mets, David G.; Meyer, Barbara J.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Meyer, BJ (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	bjmeyer@berkeley.edu		Meyer, Barbara/0000-0002-6530-4588	Howard HughesMedical Institute [T32GM07127, T32GM07232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007127, T32GM007232, R01GM030702] Funding Source: NIH RePORTER	Howard HughesMedical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	thank S. Uzawa for microscopy advice, A. Gartner for RAD-51 antibody, A. Dernburg for HTP-3 antibody, S. Ruzen for computing facilities, J. Gunther for figure design, and T. Cline, A. Severson, C. Tsai, S. Uzawa, and A. Wood for discussions. D. G. M. was funded by training grants T32GM07127 and T32GM07232. B.J.M. is an investigator of the Howard HughesMedical Institute.	Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Buhler C, 2007, PLOS BIOL, V5, P2797, DOI 10.1371/journal.pbio.0050324; Chan RC, 2004, J CELL BIOL, V167, P613, DOI 10.1083/jcb.200408061; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Coop G, 2007, PLOS GENET, V3, P377, DOI 10.1371/journal.pgen.0030035; Couteau F, 2004, CURR BIOL, V14, P585, DOI 10.1016/j.cub.2004.03.033; Csankovszki G, 2009, CURR BIOL, V19, P9, DOI 10.1016/j.cub.2008.12.006; DEMASSY B, 1995, EMBO J, V14, P4589, DOI 10.1002/j.1460-2075.1995.tb00138.x; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Goodyer W, 2008, DEV CELL, V14, P263, DOI 10.1016/j.devcel.2007.11.016; Greenawalt DM, 2006, GENOME RES, V16, P208, DOI 10.1101/gr.4641706; Grey C, 2009, PLOS BIOL, V7, P327, DOI 10.1371/journal.pbio.1000035; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kauppi L, 2007, P NATL ACAD SCI USA, V104, P13396, DOI 10.1073/pnas.0701965104; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Maloisel L, 1998, GENE DEV, V12, P1381, DOI 10.1101/gad.12.9.1381; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Martin JS, 2005, MOL CELL BIOL, V25, P3127, DOI 10.1128/MCB.25.8.3127-3139.2005; Meyer BJ., 2005, WORMBOOK, P1, DOI [10.1895/wormbook.1.8.1, DOI 10.1895/WORMBOOK.1.8.1]; Moens PB, 2002, J CELL SCI, V115, P1611; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; Novak I, 2008, J CELL BIOL, V180, P83, DOI 10.1083/jcb.200706136; OGAWA T, 1993, SCIENCE, V58, P567; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Page SL, 2004, ANNU REV CELL DEV BI, V20, P525, DOI 10.1146/annurev.cellbio.19.111301.155141; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Sturtevant AH, 1913, J EXP ZOOL, V14, P43, DOI 10.1002/jez.1400140104; Tsai CJ, 2008, GENE DEV, V22, P194, DOI 10.1101/gad.1618508; VILLENEUVE AM, 1994, GENETICS, V136, P887; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; XU LH, 1995, EMBO J, V14, P5115, DOI 10.1002/j.1460-2075.1995.tb00194.x; Yauk CL, 2003, EMBO J, V22, P1389, DOI 10.1093/emboj/cdg136; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	46	170	177	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					73	86		10.1016/j.cell.2009.07.035	http://dx.doi.org/10.1016/j.cell.2009.07.035			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19781752	Green Accepted, Bronze			2022-12-28	WOS:000270388600017
J	Cortese, DA; Korsmo, JO				Cortese, Denis A.; Korsmo, Jeffrey O.			Putting US Health Care on the Right Track.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cortese, Denis A.; Korsmo, Jeffrey O.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Cortese, DA (corresponding author), Mayo Clin, Rochester, MN 55905 USA.							IGLEHART J, 2009, HLTH AFFAIRS BL 0728; Smoldt RK, 2007, MAYO CLIN PROC, V82, P210; WENNBERG JE, 2008, AGENDA CHANGE IMPROV	3	11	11	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2009	361	14					1326	1327		10.1056/NEJMp0907561	http://dx.doi.org/10.1056/NEJMp0907561			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	500KZ	19776399				2022-12-28	WOS:000270300000003
J	Balazs, AC; Epstein, IR				Balazs, Anna C.; Epstein, Irving R.			Emergent or Just Complex?	SCIENCE			English	Editorial Material							LIFE; ORIGIN; GUIDE; CELLS		[Balazs, Anna C.] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA; [Epstein, Irving R.] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA; [Epstein, Irving R.] Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brandeis University; Brandeis University	Balazs, AC (corresponding author), Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA.	balazs@pitt.edu; epstein@brandeis.edu		Balazs, Anna/0000-0002-5555-2692				Barish RD, 2009, P NATL ACAD SCI USA, V106, P6054, DOI 10.1073/pnas.0808736106; Dayal P, 2009, LANGMUIR, V25, P4298, DOI 10.1021/la900051b; Deamer DW, 2008, NATURE, V454, P37, DOI 10.1038/454037a; Gandhi N, 2007, J THEOR BIOL, V249, P58, DOI 10.1016/j.jtbi.2007.07.004; GARDNER M, 1970, SCI AM, V223, P120, DOI 10.1038/scientificamerican1070-120; Hud NV, 2007, CHEM BIODIVERS, V4, P768, DOI 10.1002/cbdv.200790063; Kiss IZ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.046204; Leunissen ME, 2009, SOFT MATTER, V5, P2422, DOI 10.1039/b817679e; Norris V, 2007, ORIGINS LIFE EVOL B, V37, P429, DOI 10.1007/s11084-007-9088-z; Pizzarello S, 2007, CHEM BIODIVERS, V4, P680, DOI 10.1002/cbdv.200790058; Pooley CM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228103; Rasmussen S, 2004, SCIENCE, V303, P963, DOI 10.1126/science.1093669; Snezhko A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118103; Stojanovic MN, 2003, NAT BIOTECHNOL, V21, P1069, DOI 10.1038/nbt862; Taylor AF, 2009, SCIENCE, V323, P614, DOI 10.1126/science.1166253; *U AL, 2009, EM CHEM SYST 2 0; Vanag VK, 2003, P NATL ACAD SCI USA, V100, P14635, DOI 10.1073/pnas.2534816100; Wolfram S., 2002, NEW KIND SCI	18	24	24	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	2009	325	5948					1632	1634		10.1126/science.1178323	http://dx.doi.org/10.1126/science.1178323			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779180				2022-12-28	WOS:000270131800024
J	Wood, WB				Wood, William B.			Revising the AP Biology Curriculum	SCIENCE			English	Editorial Material									[Wood, William B.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Wood, William B.] Univ Colorado, Sci Educ Initiat, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Wood, WB (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	wood@colorado.edu						Bransford J. D, 1999, PEOPLE LEARN BRAIN M; *COLL BOARD, 2009, AP COURS DESCR AP BI; College Board, 2001, ACC EXC REP COMM FUT; Gollub J. P., 2002, LEARNING UNDERSTANDI; Mervis J, 2009, SCIENCE, V325, P1488, DOI 10.1126/science.325_1488; Wood HB, 2009, NAT CLIN PRACT NEURO, V5, P1, DOI 10.1038/ncpneuro0989; WOOD WB, 2002, LEARNING UNDERSTANDI	7	32	32	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	2009	325	5948					1627	1628		10.1126/science.1180821	http://dx.doi.org/10.1126/science.1180821			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	498II	19779176				2022-12-28	WOS:000270131800020
J	Lowenberg, B; Ossenkoppele, GJ; van Putten, W; Schouten, HC; Graux, C; Ferrant, A; Sonneveld, P; Maertens, J; Jongen-Lavrencic, M; von Lilienfeld-Toal, M; Biemond, BJ; Vellenga, E; Kooy, MV; Verdonck, LF; Beck, J; Dohner, H; Gratwohl, A; Pabst, T; Verhoef, G				Lowenberg, Bob; Ossenkoppele, Gert J.; van Putten, Wim; Schouten, Harry C.; Graux, Carlos; Ferrant, Augustin; Sonneveld, Pieter; Maertens, Johan; Jongen-Lavrencic, Mojca; von Lilienfeld-Toal, Marie; Biemond, Bart J.; Vellenga, Edo; Kooy, Marinus van Marwijk; Verdonck, Leo F.; Beck, Joachim; Doehner, Hartmut; Gratwohl, Alois; Pabst, Thomas; Verhoef, Gregor		Dutch-Belgian Cooperative Trial Gr; German AML Study Grp AMLSG; Swiss Grp Clinical Canc Res SAKK C	High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REMISSION-INDUCTION CHEMOTHERAPY; RISK MYELODYSPLASTIC SYNDROME; COLONY-STIMULATING FACTOR; RANDOMIZED PHASE-III; ELDERLY-PATIENTS; EUROPEAN ORGANIZATION; CYTARABINE; TRIAL; AML; AGE	Background A complete remission is essential for prolonging survival in patients with acute myeloid leukemia (AML). Daunorubicin is a cornerstone of the induction regimen, but the optimal dose is unknown. In older patients, it is usual to give daunorubicin at a dose of 45 to 50 mg per square meter of body-surface area. Methods Patients in whom AML or high-risk refractory anemia had been newly diagnosed and who were 60 to 83 years of age ( median, 67) were randomly assigned to receive cytarabine, at a dose of 200 mg per square meter by continuous infusion for 7 days, plus daunorubicin for 3 days, either at the conventional dose of 45 mg per square meter ( 411 patients) or at an escalated dose of 90 mg per square meter ( 402 patients); this treatment was followed by a second cycle of cytarabine at a dose of 1000 mg per square meter for 6 days. The primary end point was event-free survival. Results The complete remission rates were 64% in the group that received the escalated dose of daunorubicin and 54% in the group that received the conventional dose (P = 0.002); the rates of remission after the first cycle of induction treatment were 52% and 35%, respectively (P<0.001). There was no significant difference between the two groups in the incidence of hematologic toxic effects, 30-day mortality (11% and 12% in the two groups, respectively), or the incidence of moderate, severe, or life-threatening adverse events (P=0.08). Survival end points in the two groups did not differ significantly overall, but patients in the escalated-treatment group who were 60 to 65 years of age, as compared with the patients in the same age group who received the conventional dose, had higher rates of complete remission (73% vs. 51%), event-free survival (29% vs. 14%), and overall survival (38% vs. 23%). Conclusions In patients with AML who are older than 60 years of age, escalation of the dose of daunorubicin to twice the conventional dose, with the entire dose administered in the first induction cycle, effects a more rapid response and a higher response rate than does the conventional dose, without additional toxic effects. ( Current Controlled Trials number, ISRCTN77039377; and Netherlands National Trial Register number, NTR212.)	[Lowenberg, Bob] Erasmus Univ, Med Ctr, Dept Hematol L413, NL-3000 CA Rotterdam, Netherlands; [Ossenkoppele, Gert J.] Free Univ Med Ctr, Dept Hematol, Amsterdam, Netherlands; [van Putten, Wim] Erasmus Univ, Med Ctr, HOVON Data Ctr, NL-3000 CA Rotterdam, Netherlands; [van Putten, Wim] Erasmus Univ, Med Ctr, Dept Trials & Stat, NL-3000 CA Rotterdam, Netherlands; [Schouten, Harry C.] Univ Med Ctr, Maastricht, Netherlands; [Biemond, Bart J.] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Vellenga, Edo] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Kooy, Marinus van Marwijk] Isala Hosp, Zwolle, Netherlands; [Verdonck, Leo F.] Univ Med Ctr, Utrecht, Netherlands; [Graux, Carlos] Hop Mont Godinne, Yvoir, Belgium; [Ferrant, Augustin] Hop St Luc, Brussels, Belgium; [Maertens, Johan; Verhoef, Gregor] Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium; [von Lilienfeld-Toal, Marie] Univ Hosp, Bonn, Germany; [Beck, Joachim] Univ Hosp, Dept Internal Med 3, Mainz, Germany; [Doehner, Hartmut] Univ Ulm, Dept Internal Med 3, D-7900 Ulm, Germany; [Gratwohl, Alois] Univ Basel Hosp, CH-4031 Basel, Switzerland; [Pabst, Thomas] Univ Bern, Inselspital, CH-3010 Bern, Switzerland	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Maastricht University; Maastricht University Medical Centre (MUMC); University of Amsterdam; University of Groningen; Utrecht University; Utrecht University Medical Center; Universite Catholique Louvain; Universite Catholique Louvain Hospital; KU Leuven; University Hospital Leuven; University of Bonn; University Hospital Mainz; Ulm University; University of Basel; University of Bern	Lowenberg, B (corresponding author), Erasmus Univ, Med Ctr, Dept Hematol L413, POB 2040, NL-3000 CA Rotterdam, Netherlands.	b.lowenberg@erasmusmc.nl	Biesma, Douwe H./AAV-6343-2020; Zachee, Pierre/B-5391-2018; Döhner, Hartmut/C-8933-2016	Biesma, Douwe H./0000-0001-8334-3057; Zachee, Pierre/0000-0002-2275-5143; Döhner, Hartmut/0000-0003-2116-5536	Dutch Cancer Society Queen Wilhelmina Foundation	Dutch Cancer Society Queen Wilhelmina Foundation	Supported by the Dutch Cancer Society Queen Wilhelmina Foundation.	Anderson JE, 2002, BLOOD, V100, P3869, DOI 10.1182/blood-2001-12-0354; Appelbaum FR, 2006, BLOOD, V107, P3481, DOI 10.1182/blood-2005-09-3724; Baer MR, 2002, BLOOD, V100, P1224, DOI 10.1182/blood.V100.4.1224.h81602001224_1224_1232; Baz R, 2007, CANCER, V110, P1752, DOI 10.1002/cncr.22976; Breems DA, 2008, J CLIN ONCOL, V26, P4791, DOI 10.1200/JCO.2008.16.0259; Buchner T, 2003, J CLIN ONCOL, V21, P4496, DOI 10.1200/JCO.2003.02.133; Buchner T, 2009, J CLIN ONCOL, V27, P61, DOI 10.1200/JCO.2007.15.4245; Burnett AK, 2009, BRIT J HAEMATOL, V145, P318, DOI 10.1111/j.1365-2141.2009.07604.x; DOMBRET H, 1995, NEW ENGL J MED, V332, P1678, DOI 10.1056/NEJM199506223322504; Erba Harry P, 2007, Hematology Am Soc Hematol Educ Program, P420; Estey E, 2007, J CLIN ONCOL, V25, P1908, DOI 10.1200/JCO.2006.10.2731; Frohling S, 2006, BLOOD, V108, P3280, DOI 10.1182/blood-2006-04-014324; Godwin JE, 1998, BLOOD, V91, P3607, DOI 10.1182/blood.V91.10.3607.3607_3607_3615; Goldstone AH, 2001, BLOOD, V98, P1302, DOI 10.1182/blood.V98.5.1302; Greenberg, 1998, BLOOD, V91, P1100; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; KAHN SB, 1984, J CLIN ONCOL, V2, P865, DOI 10.1200/JCO.1984.2.8.865; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1090, DOI 10.1002/cncr.21723; Lopez A, 2001, LEUKEMIA RES, V25, P685, DOI 10.1016/S0145-2126(01)00006-6; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; LOWENBERG B, 1989, J CLIN ONCOL, V7, P1268; Lowenberg B, 1998, J CLIN ONCOL, V16, P872; MAYER RJ, 1994, NEW ENGL J MED, V331, P896, DOI 10.1056/NEJM199410063311402; Rowe JM, 2004, BLOOD, V103, P479, DOI 10.1182/blood-2003-05-1686; Stone RM, 2001, BLOOD, V98, P548, DOI 10.1182/blood.V98.3.548; van der Holt B, 2005, BLOOD, V106, P2646, DOI 10.1182/blood-2005-04-1395; van der Holt B, 2007, BRIT J HAEMATOL, V136, P96, DOI 10.1111/j.1365-2141.2006.06403.x; Wheatley K, 2009, BRIT J HAEMATOL, V145, P598, DOI 10.1111/j.1365-2141.2009.07663.x	28	615	648	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2009	361	13					1235	1248		10.1056/NEJMoa0901409	http://dx.doi.org/10.1056/NEJMoa0901409			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497RN	19776405				2022-12-28	WOS:000270078700005
J	Yeo, H; Viola, K; Berg, D; Lin, ZQ; Nunez-Smith, M; Cammann, C; Bell, RH; Sosa, JA; Krumholz, HM; Curry, LA				Yeo, Heather; Viola, Kate; Berg, David; Lin, Zhenqiu; Nunez-Smith, Marcella; Cammann, Cortland; Bell, Richard H., Jr.; Sosa, Julie Ann; Krumholz, Harlan M.; Curry, Leslie A.			Attitudes, Training Experiences, and Professional Expectations of US General Surgery Residents A National Survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GRADUATE SURGICAL EDUCATION; QUALITATIVE RESEARCH; UNITED-STATES; ATTRITION; WORKFORCE; PERCEPTIONS; GENDER; CAREER; SATISFACTION; SERVICES	Context General surgery residency programs are facing multiple pressures, including attracting and retaining residents. Despite the importance of resident perspectives in designing effective responses to these pressures, understanding of residents' views is limited. Objective To profile US general surgery residents; characterize resident attitudes, experiences, and expectations regarding training; and examine differences by sex and training year. Design, Setting, and Participants Cross-sectional study of all general surgery residents completing a survey in January 2008 following administration of the American Board of Surgery In-Training Examination. Main Outcome Measures Resident satisfaction; perceived supports, strains and concern; career motivations; and professional expectations. Results Of 5345 categorical general surgery residents, 4402 (82.4%) responded, representing 248 of 249 surgical residency programs. Most respondents expressed satisfaction with training (3686 [85.2%]; 95% confidence interval [CI], 84.1%-86.3%) and supportive peer relationships (3433 [84.2%]; 95% CI, 83.1%-85.3%). However, residents also reported unmet needs and apprehensions about training and careers. Worry that they will not feel confident performing procedures independently was reported by 1185 (27.5%; 95% CI, 26.2%-28.8%), while 2681 (63.8%; 95% CI, 62.4%-65.3%) reported that they must complete specialty training to be competitive. Perceptions of program support differ, with men more likely than women to report that their program provides support (2188 [74.5%] vs 895 [65.6%]; P < .001), and that they can turn to faculty when having difficulties (2193 [74.5%] vs 901 [66.4%]; P < .001). Reports of having considered leaving training in the prior year differed significantly across years (P < .001), highest in postgraduate year 2 (19.2%) and lowest in postgraduate year 5 (7.2%). Conclusions General surgery residents' attitudes, experiences, and expectations regarding training reflect both high levels of satisfaction and sources of strain. These factors vary by sex and training year. JAMA. 2009;302(12):1301-1308	[Yeo, Heather] Yale Univ, Sch Med, Div Surg, New Haven, CT 06520 USA; [Viola, Kate; Nunez-Smith, Marcella; Krumholz, Harlan M.; Curry, Leslie A.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA; [Nunez-Smith, Marcella] Yale Univ, Sch Med, Gen Internal Med Sect, New Haven, CT 06520 USA; [Sosa, Julie Ann] Yale Univ, Sch Med, Div Endocrine Surg, New Haven, CT 06520 USA; [Sosa, Julie Ann] Yale Univ, Sch Med, Div Surg Oncol, New Haven, CT 06520 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA; [Curry, Leslie A.] Yale Univ, Sch Publ Hlth, Div Hlth Policy & Adm, Sch Med, New Haven, CT 06520 USA; [Berg, David] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Lin, Zhenqiu; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Cammann, Cortland] Capella Univ, Minneapolis, MN USA; [Bell, Richard H., Jr.] Amer Board Surg Inc, Philadelphia, PA USA	Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University; Yale University	Curry, LA (corresponding author), Yale Univ, Sch Publ Hlth, Div Hlth Policy & Adm, Sch Med, 60 Coll St, New Haven, CT 06520 USA.	leslie.curry@yale.edu	curry, leslie/AAA-6100-2022; , Harlan/AAI-2875-2020; Curry, Leslie A/ABA-1890-2021	curry, leslie/0000-0002-3419-4654; Nunez-Smith, Marcella/0000-0003-2797-4756	Robert Wood Johnson Clinical Scholars Program at the Yale School of Medicine	Robert Wood Johnson Clinical Scholars Program at the Yale School of Medicine	This study was supported by The Robert Wood Johnson Clinical Scholars Program at the Yale School of Medicine.	Andriole DA, 2007, J AM COLL SURGEONS, V204, P469, DOI 10.1016/j.jamcollsurg.2006.12.035; *ASS AM MED COLL, 2006, PHYS SPEC DAT CHART; Association of American Medical Colleges, 2008, DIV MED ED FACTS FIG; Aufses AH, 1998, AM J SURG, V175, P236, DOI 10.1016/S0002-9610(97)00292-4; Baxter N, 1996, AM J SURG, V172, P373, DOI 10.1016/S0002-9610(96)00185-7; Bell RH, 2007, SURG CLIN N AM, V87, P811, DOI 10.1016/j.suc.2007.06.005; Bergen PC, 1998, J SURG RES, V77, P59, DOI 10.1006/jsre.1998.5335; Borman KR, 2008, J AM COLL SURGEONS, V206, P782, DOI 10.1016/j.jamcollsurg.2007.12.012; Borman KR, 2007, AM SURGEON, V73, P161; Borman KR, 2009, J SURG RES, V154, P274, DOI 10.1016/j.jss.2008.05.027; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Breen Elizabeth, 2005, Curr Surg, V62, P543, DOI 10.1016/j.cursur.2005.05.002; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Davenport DL, 2008, SURGERY, V144, P332, DOI 10.1016/j.surg.2008.03.038; Debas HT, 2002, ANN SURG, V236, P263, DOI 10.1097/00000658-200209000-00002; Dodson Thomas F, 2005, Curr Surg, V62, P128, DOI 10.1016/j.cursur.2004.07.009; Everett CB, 2007, AM J SURG, V194, P751, DOI 10.1016/j.amjsurg.2007.08.033; Fischer JE, 2007, JAMA-J AM MED ASSOC, V298, P2191, DOI 10.1001/jama.298.18.2191; Gargiulo DA, 2006, ARCH SURG-CHICAGO, V141, P405, DOI 10.1001/archsurg.141.4.405; Glaser B.G., 1965, AWARENESS DYING; Incorvaia Angelo N, 2005, Curr Surg, V62, P429, DOI 10.1016/j.cursur.2005.02.002; Irani JL, 2005, SURGERY, V138, P246, DOI 10.1016/j.surg.2005.06.010; Ko CY, 2005, ANN SURG, V241, P373, DOI 10.1097/01.sla.0000150257.04889.70; Kohanzadeh S, 2007, AM SURGEON, V73, P963; Krause N, 2002, J GERONTOL B-PSYCHOL, V57, pS263, DOI 10.1093/geronb/57.5.S263; Kwakwa F, 1999, J AM COLL SURGEONS, V189, P602, DOI 10.1016/S1072-7515(99)00198-2; Leibrandt TJ, 2006, J AM COLL SURGEONS, V202, P340, DOI 10.1016/j.jamcollsurg.2005.09.018; Longo WE, 2007, AM J SURG, V194, P567, DOI 10.1016/j.amjsurg.2007.08.010; Lynge DC, 2008, ARCH SURG-CHICAGO, V143, P345, DOI 10.1001/archsurg.143.4.345; Miles M., 2013, QUALITATIVE DATA ANA; Morris JB, 2003, J AM COLL SURGEONS, V196, P611, DOI 10.1016/S1072-7515(02)01832-X; Myers JS, 2006, ACAD MED, V81, P1052, DOI 10.1097/01.ACM.0000246687.03462.59; Naylor RA, 2008, ARCH SURG-CHICAGO, V143, P647, DOI 10.1001/archsurg.143.7.647; Neumayer L, 2002, AM J SURG, V183, P146, DOI 10.1016/S0002-9610(01)00863-7; OLeary JP, 1997, CURR SURG, V54, P275; Patton MQ., 2015, QUALITATIVE RES EVAL, V3; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Powell AC, 2004, AM J SURG, V188, P1, DOI 10.1016/j.amjsurg.2003.12.054; Schenarts Paul J, 2006, Curr Surg, V63, P269, DOI 10.1016/j.cursur.2006.04.004; Sheldon GF, 2007, AM SURGEON, V73, P100; Stabile BE, 2008, ARCH SURG-CHICAGO, V143, P827, DOI 10.1001/archsurg.143.9.827; SUDMAN S., 1996, THINKING ANSWERS APP; Sudman Seymour, 1982, ASKING QUESTIONS PRA; Whang EE, 2003, J AM COLL SURGEONS, V197, P624, DOI 10.1016/S1072-7515(03)00602-1	44	219	220	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1301	1308		10.1001/jama.2009.1386	http://dx.doi.org/10.1001/jama.2009.1386			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497AR	19773565	Bronze			2022-12-28	WOS:000270026000012
J	Osterhues, A; Holzgreve, W; Michels, KB				Osterhues, Anja; Holzgreve, Wolfgang; Michels, Karin B.			Shall we put the world on folate?	LANCET			English	Editorial Material							FOLIC-ACID; COLORECTAL-CANCER; FORTIFICATION; PREVENTION; RISK		[Osterhues, Anja; Holzgreve, Wolfgang; Michels, Karin B.] Univ Med Ctr Freiburg, Ctr Comprehens Canc, Div Canc Epidemiol, Freiburg, Germany; [Michels, Karin B.] Harvard Univ, Brigham & Womans Hosp, Dept Obstet Gynecol & Reprod Biol, Obstet & Gynecol Epidemiol Ctr,Med Sch, Boston, MA 02115 USA	University of Freiburg; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michels, KB (corresponding author), Univ Med Ctr Freiburg, Ctr Comprehens Canc, Div Canc Epidemiol, Freiburg, Germany.	kmichels@rics.bwh.harvard.edu						Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Eichholzer M, 2006, LANCET, V367, P1352, DOI 10.1016/S0140-6736(06)68582-6; *FOOD STAND AG, NUTR FOL AC FORT; Hirsch S, 2009, EUR J GASTROEN HEPAT, V21, P346, DOI 10.1097/MEG.0b013e328306ccdb; Kim YI, 2006, GUT, V55, P1387, DOI 10.1136/gut.2006.095463; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Mason JB, 2007, CANCER EPIDEM BIOMAR, V16, P1325, DOI 10.1158/1055-9965.EPI-07-0329; Mason JB, 2009, NUTR REV, V67, P206, DOI 10.1111/j.1753-4887.2009.00190.x; McNulty H, 2008, P NUTR SOC, V67, P232, DOI 10.1017/S0029665108007076; Shane B, 2003, AM J CLIN NUTR, V77, P8, DOI 10.1093/ajcn/77.1.8; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Tjonneland A, 2006, EUR J CLIN NUTR, V60, P280, DOI 10.1038/sj.ejcn.1602313	12	23	30	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2009	374	9694					959	961		10.1016/S0140-6736(09)61646-9	http://dx.doi.org/10.1016/S0140-6736(09)61646-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498PK	19766871				2022-12-28	WOS:000270154100009
J	Novitch, BG; Butler, SJ				Novitch, Bennett G.; Butler, Samantha J.			Reducing the Mystery of Neuronal Differentiation	CELL			English	Editorial Material							OXIDATIVE STRESS; PEROXIREDOXINS; PROLIFERATION; MECHANISMS	In the developing nervous system, neural progenitors exit the cell cycle and differentiate on a precise schedule, yet the mechanisms driving this process remain poorly defined. Yan et al. ( 2009) now identify a thiol-redox reaction mediated by the membrane protein GDE2 and the peroxiredoxin protein Prdx1 that promotes neurogenesis.	[Butler, Samantha J.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Novitch, Bennett G.] Univ Calif Los Angeles, David Geffen Sch Med, Broad Ctr Regenerat Med & Stem Cell Res, Dept Neurobiol, Los Angeles, CA 90095 USA	University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Novitch, BG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Broad Ctr Regenerat Med & Stem Cell Res, Dept Neurobiol, Los Angeles, CA 90095 USA.	bnovitch@ucla.edu; butlersj@usc.edu		Novitch, Bennett/0000-0002-2696-3708				Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Briscoe J, 2008, PHILOS T R SOC B, V363, P57, DOI 10.1098/rstb.2006.2012; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Holmberg J, 2008, DEVELOPMENT, V135, P1843, DOI 10.1242/dev.020180; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Rao M, 2005, SCIENCE, V309, P2212, DOI 10.1126/science.1117156; Skwarek LC, 2007, DEV CELL, V13, P783, DOI 10.1016/j.devcel.2007.10.020; Ulloa F, 2007, CELL CYCLE, V6, P2640, DOI 10.4161/cc.6.21.4822	9	5	5	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 18	2009	138	6					1062	1064		10.1016/j.cell.2009.09.001	http://dx.doi.org/10.1016/j.cell.2009.09.001			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766560	Bronze			2022-12-28	WOS:000269923200007
J	Rossant, J				Rossant, Janet			Reprogramming to Pluripotency: From Frogs to Stem Cells	CELL			English	Editorial Material							GENERATION; MOUSE; FIBROBLASTS; NUCLEI; NANOG	This year's Albert Lasker Basic Medical Research Award goes to John Gurdon and Shinya Yamanaka for their contributions to our understanding of how to reprogram adult cells back to early embryonic states.	[Rossant, Janet] Univ Toronto, Hosp Sick Children Res Inst, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Rossant, Janet] Univ Toronto, Dept Mol Genet, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Rossant, J (corresponding author), Univ Toronto, Hosp Sick Children Res Inst, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada.	janet.rossant@sickkids.ca						Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Gurdon JB, 2006, ANNU REV CELL DEV BI, V22, P1, DOI 10.1146/annurev.cellbio.22.090805.140144; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	15	7	7	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1047	1050		10.1016/j.cell.2009.09.003	http://dx.doi.org/10.1016/j.cell.2009.09.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766555	Bronze			2022-12-28	WOS:000269923200002
J	Acero, F; Aharonian, F; Akhperjanian, AG; Anton, G; de Almeida, UB; Bazer-Bachi, AR; Becherini, Y; Behera, B; Bernlohr, K; Bochow, A; Boisson, C; Bolmont, J; Borrel, V; Brucker, J; Brun, F; Brun, P; Buhler, R; Bulik, T; Busching, I; Boutelier, T; Chadwick, PM; Charbonnier, A; Chaves, RCG; Cheesebrough, A; Chounet, LM; Clapson, AC; Coignet, G; Dalton, M; Daniel, MK; Davids, ID; Degrange, B; Deil, C; Dickinson, HJ; Djannati-Atai, A; Domainko, W; Drury, LO; Dubois, F; Dubus, G; Dyks, J; Dyrda, M; Egberts, K; Emmanoulopoulos, D; Espigat, P; Farnier, C; Fegan, S; Feinstein, F; Fiasson, A; Forster, A; Fontaine, G; Fussling, M; Gabici, S; Gallant, YA; Gerard, L; Gerbig, D; Giebels, B; Glicenstein, JF; Gluck, B; Goret, P; Goring, D; Hauser, D; Hauser, M; Heinz, S; Heinzelmann, G; Henri, G; Hermann, G; Hinton, JA; Hoffmann, A; Hofmann, W; Hofverberg, P; Hoppe, S; Horns, D; Jacholkowska, A; de Jager, OC; Jahn, C; Jung, I; Katarzynski, K; Katz, U; Kaufmann, S; Kerschhaggl, M; Khangulyan, D; Khelifi, B; Keogh, D; Klochkov, D; Kluzniak, W; Kneiske, T; Komin, N; Kosack, K; Kossakowski, R; Lamanna, G; Lenain, JP; Lohse, T; Marandon, V; Martineau-Huynh, O; Marcowith, A; Masbou, J; Maurin, D; McComb, TJL; Medina, MC; Mehault, J; Moderski, R; Moulin, E; Naumann-Godo, M; de Naurois, M; Nedbal, D; Nekrassov, D; Nicholas, B; Niemiec, J; Nolan, SJ; Ohm, S; Olive, JF; Wilhelmi, ED; Orford, KJ; Ostrowski, M; Panter, M; Arribas, MP; Pedaletti, G; Pelletier, G; Petrucci, PO; Pita, S; Puhlhofer, G; Punch, M; Quirrenbach, A; Raubenheimer, BC; Raue, M; Rayner, SM; Reimer, O; Renaud, M; Rieger, F; Ripken, J; Rob, L; Rosier-Lees, S; Rowell, G; Rudak, B; Rulten, CB; Ruppel, J; Sahakian, V; Santangelo, A; Schlickeiser, R; Schock, FM; Schwanke, U; Schwarzburg, S; Schwemmer, S; Shalchi, A; Sikora, M; Skilton, JL; Sol, H; Stawarz, L; Steenkamp, R; Stegmann, C; Stinzing, F; Superina, G; Szostek, A; Tam, PH; Tavernet, JP; Terrier, R; Tibolla, O; Tluczykont, M; van Eldik, C; Vasileiadis, G; Venter, C; Venter, L; Vialle, JP; Vincent, P; Vivier, M; Volk, HJ; Volpe, F; Wagner, SJ; Ward, M; Zdziarski, AA; Zech, A				Acero, F.; Aharonian, F.; Akhperjanian, A. G.; Anton, G.; de Almeida, U. Barres; Bazer-Bachi, A. R.; Becherini, Y.; Behera, B.; Bernloehr, K.; Bochow, A.; Boisson, C.; Bolmont, J.; Borrel, V.; Brucker, J.; Brun, F.; Brun, P.; Buehler, R.; Bulik, T.; Buesching, I.; Boutelier, T.; Chadwick, P. M.; Charbonnier, A.; Chaves, R. C. G.; Cheesebrough, A.; Chounet, L. -M.; Clapson, A. C.; Coignet, G.; Dalton, M.; Daniel, M. K.; Davids, I. D.; Degrange, B.; Deil, C.; Dickinson, H. J.; Djannati-Atai, A.; Domainko, W.; Drury, L. O'C.; Dubois, F.; Dubus, G.; Dyks, J.; Dyrda, M.; Egberts, K.; Emmanoulopoulos, D.; Espigat, P.; Farnier, C.; Fegan, S.; Feinstein, F.; Fiasson, A.; Foerster, A.; Fontaine, G.; Fuessling, M.; Gabici, S.; Gallant, Y. A.; Gerard, L.; Gerbig, D.; Giebels, B.; Glicenstein, J. F.; Glueck, B.; Goret, P.; Goering, D.; Hauser, D.; Hauser, M.; Heinz, S.; Heinzelmann, G.; Henri, G.; Hermann, G.; Hinton, J. A.; Hoffmann, A.; Hofmann, W.; Hofverberg, P.; Hoppe, S.; Horns, D.; Jacholkowska, A.; de Jager, O. C.; Jahn, C.; Jung, I.; Katarzynski, K.; Katz, U.; Kaufmann, S.; Kerschhaggl, M.; Khangulyan, D.; Khelifi, B.; Keogh, D.; Klochkov, D.; Kluzniak, W.; Kneiske, T.; Komin, Nu.; Kosack, K.; Kossakowski, R.; Lamanna, G.; Lenain, J. -P.; Lohse, T.; Marandon, V.; Martineau-Huynh, O.; Marcowith, A.; Masbou, J.; Maurin, D.; McComb, T. J. L.; Medina, M. C.; Mehault, J.; Moderski, R.; Moulin, E.; Naumann-Godo, M.; de Naurois, M.; Nedbal, D.; Nekrassov, D.; Nicholas, B.; Niemiec, J.; Nolan, S. J.; Ohm, S.; Olive, J-F.; Wilhelmi, E. de Ona; Orford, K. J.; Ostrowski, M.; Panter, M.; Arribas, M. Paz; Pedaletti, G.; Pelletier, G.; Petrucci, P. -O.; Pita, S.; Puehlhofer, G.; Punch, M.; Quirrenbach, A.; Raubenheimer, B. C.; Raue, M.; Rayner, S. M.; Reimer, O.; Renaud, M.; Rieger, F.; Ripken, J.; Rob, L.; Rosier-Lees, S.; Rowell, G.; Rudak, B.; Rulten, C. B.; Ruppel, J.; Sahakian, V.; Santangelo, A.; Schlickeiser, R.; Schoeck, F. M.; Schwanke, U.; Schwarzburg, S.; Schwemmer, S.; Shalchi, A.; Sikora, M.; Skilton, J. L.; Sol, H.; Stawarz, L.; Steenkamp, R.; Stegmann, C.; Stinzing, F.; Superina, G.; Szostek, A.; Tam, P. H.; Tavernet, J. -P.; Terrier, R.; Tibolla, O.; Tluczykont, M.; van Eldik, C.; Vasileiadis, G.; Venter, C.; Venter, L.; Vialle, J. P.; Vincent, P.; Vivier, M.; Voelk, H. J.; Volpe, F.; Wagner, S. J.; Ward, M.; Zdziarski, A. A.; Zech, A.			Detection of Gamma Rays from a Starburst Galaxy	SCIENCE			English	Article							NGC 253; NGC-253; EMISSION; DISCOVERY; OUTFLOW; NUCLEUS; NEBULA; HESS	Starburst galaxies exhibit in their central regions a highly increased rate of supernovae, the remnants of which are thought to accelerate energetic cosmic rays up to energies of similar to 10(15) electron volts. We report the detection of gamma rays-tracers of such cosmic rays-from the starburst galaxy NGC 253 using the High Energy Stereoscopic System (H. E. S. S.) array of imaging atmospheric Cherenkov telescopes. The gamma-ray flux above 220 billion electron volts is F = (5.5 +/- 1.0(stat) +/- 2.8(sys)) x 10(-13) cm(-2) s(-1), implying a cosmic-ray density about three orders of magnitude larger than that in the center of the Milky Way. The fraction of cosmic-ray energy channeled into gamma rays in this starburst environment is five times as large as that in our Galaxy.	[Nedbal, D.; Rob, L.] Charles Univ Prague, Fac Math & Phys, Inst Particle & Nucl Phys, CR-18000 Prague, Czech Republic; [Acero, F.; Farnier, C.; Feinstein, F.; Gallant, Y. A.; Marcowith, A.; Mehault, J.; Vasileiadis, G.] Univ Montpellier 2, CNRS, IN2P3, Lab Phys Theor & Astroparticules, F-34095 Montpellier 5, France; [Aharonian, F.; Bernloehr, K.; Bochow, A.; Buehler, R.; Chaves, R. C. G.; Clapson, A. C.; Deil, C.; Domainko, W.; Egberts, K.; Foerster, A.; Hermann, G.; Hofmann, W.; Hofverberg, P.; Hoppe, S.; Khangulyan, D.; Kosack, K.; Nekrassov, D.; Ohm, S.; Wilhelmi, E. de Ona; Panter, M.; Raue, M.; Renaud, M.; Rieger, F.; Tibolla, O.; van Eldik, C.; Voelk, H. J.; Volpe, F.] Max Planck Inst Kernphys, D-69029 Heidelberg, Germany; [Akhperjanian, A. G.; Sahakian, V.] Yerevan Phys Inst, Yerevan 375036, Armenia; [Bazer-Bachi, A. R.; Borrel, V.; Olive, J-F.] UPS, CNRS, Ctr Etud Spatiale Rayonnements, F-31029 Toulouse 4, France; [Heinzelmann, G.; Horns, D.; Kneiske, T.; Ripken, J.; Tluczykont, M.] Univ Hamburg, Inst Expt Phys, D-22761 Hamburg, Germany; [Bernloehr, K.; Dalton, M.; Fuessling, M.; Kerschhaggl, M.; Lohse, T.; Arribas, M. Paz; Schwanke, U.] Humboldt Univ, Inst Phys, D-12489 Berlin, Germany; [Boisson, C.; Lenain, J. -P.; Medina, M. C.; Moulin, E.; Sol, H.; Venter, L.; Zech, A.] Univ Paris Diderot, CNRS, Observ Paris, Lab Univers & Theories, F-92190 Meudon, France; [Brun, P.; Glicenstein, J. F.; Goret, P.; Komin, Nu.; Vivier, M.] CEA, CE Saclay, Inst Rech Lois Fondament Univers, La Direct Sci Mat, F-91191 Gif Sur Yvette, France; [de Almeida, U. Barres; Chadwick, P. M.; Cheesebrough, A.; Daniel, M. K.; Dickinson, H. J.; Keogh, D.; McComb, T. J. L.; Nolan, S. J.; Orford, K. J.; Rayner, S. M.; Rulten, C. B.; Ward, M.] Univ Durham, Dept Phys, Durham DH1 3LE, England; [Buesching, I.; Davids, I. D.; de Jager, O. C.; Raubenheimer, B. C.; Venter, C.] North West Univ, Unit Space Phys, ZA-2520 Potchefstroom, South Africa; [Chounet, L. -M.; Degrange, B.; Fegan, S.; Fontaine, G.; Giebels, B.; Khelifi, B.; Naumann-Godo, M.; Superina, G.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Coignet, G.; Dubois, F.; Fiasson, A.; Kossakowski, R.; Lamanna, G.; Masbou, J.; Rosier-Lees, S.; Vialle, J. P.] Univ Savoie, CNRS, IN2P3, Lab Annecy Le Vieux Phys Particules, F-74941 Annecy Le Vieux, France; [Becherini, Y.; Djannati-Atai, A.; Espigat, P.; Gerard, L.; Marandon, V.; Pita, S.; Punch, M.; Renaud, M.; Terrier, R.] Univ Paris 07, CNRS, UMR 7164, CEA,Observ Paris, F-75205 Paris 13, France; [Aharonian, F.; Drury, L. O'C.; Gabici, S.] Dublin Inst Adv Studies, Dublin 2, Ireland; [Behera, B.; Emmanoulopoulos, D.; Hauser, D.; Hauser, M.; Kaufmann, S.; Pedaletti, G.; Puehlhofer, G.; Quirrenbach, A.; Schwemmer, S.; Tam, P. H.; Wagner, S. J.] Univ Heidelberg, D-69117 Heidelberg, Germany; [Anton, G.; Brucker, J.; Glueck, B.; Goering, D.; Heinz, S.; Jahn, C.; Jung, I.; Katz, U.; Schoeck, F. M.; Stegmann, C.; Stinzing, F.] Univ Erlangen Nurnberg, Inst Phys, D-91058 Erlangen, Germany; [Boutelier, T.; Dubus, G.; Henri, G.; Pelletier, G.; Petrucci, P. -O.; Szostek, A.] Univ Grenoble 1, CNRS, Astrophys Lab, Inst Natl Sci Univers, F-38041 Grenoble 9, France; [Hoffmann, A.; Klochkov, D.; Puehlhofer, G.; Santangelo, A.; Schwarzburg, S.] Univ Tubingen, Inst Astron & Astrophys, D-72076 Tubingen, Germany; [Bolmont, J.; Brun, F.; Charbonnier, A.; Jacholkowska, A.; Martineau-Huynh, O.; Maurin, D.; de Naurois, M.; Tavernet, J. -P.; Vincent, P.] Univ Paris 07, CNRS, Univ Paris 06, Lab Phys Nucl & Hautes Energies,IN2P3, F-75252 Paris 5, France; [Gerbig, D.; Ruppel, J.; Schlickeiser, R.; Shalchi, A.] Ruhr Univ Bochum, Inst Theoret Phys, Lehrstuhl Weltraum & Astrophys 4, D-44780 Bochum, Germany; [Davids, I. D.; Steenkamp, R.] Univ Namibia, Windhoek, Namibia; [Ostrowski, M.; Stawarz, L.; Szostek, A.] Uniwersytet Jagiellonski, Obserwatorium Astron, PL-30244 Krakow, Poland; [Dyks, J.; Kluzniak, W.; Moderski, R.; Rudak, B.; Sikora, M.; Zdziarski, A. A.] Nicolaus Copernicus Astron Ctr, PL-00716 Warsaw, Poland; [Hinton, J. A.; Skilton, J. L.] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; [Nicholas, B.; Rowell, G.] Univ Adelaide, Sch Chem & Phys, Adelaide, SA 5005, Australia; [Katarzynski, K.] Nicholas Copernicus Univ, Torun Ctr Astron, PL-87100 Torun, Poland; [Dyrda, M.; Niemiec, J.] Inst Fizyki Jadrowej PAN, PL-31342 Krakow, Poland; [Bulik, T.] Univ Warsaw, Astron Observ, PL-00478 Warsaw, Poland; [Raue, M.; Rieger, F.] European Associated Lab Gamma Ray Astron, F-75252 Paris 5, France; [Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Reimer, O.] Stanford Univ, KIPAC Kavli Inst Particle Phys & Cosmol, Stanford, CA 94305 USA	Charles University Prague; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; Max Planck Society; Yerevan Physics Institute; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Hamburg; Humboldt University of Berlin; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Durham University; North West University - South Africa; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Savoie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; PSL Research University Paris; Universite Paris Cite; Observatoire de Paris; CEA; Dublin Institute for Advanced Studies; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Eberhard Karls University of Tubingen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Ruhr University Bochum; University of Namibia; Jagiellonian University; Polish Academy of Sciences; Nicolaus Copernicus Astronomical Center of the Polish Academy of Sciences; University of Leeds; University of Adelaide; Nicolaus Copernicus University; Polish Academy of Sciences; Institute of Nuclear Physics - Polish Academy of Sciences; University of Warsaw; University of Innsbruck; Stanford University	Nedbal, D (corresponding author), Charles Univ Prague, Fac Math & Phys, Inst Particle & Nucl Phys, Holesovickach 2, CR-18000 Prague, Czech Republic.	nedbal@ipnp.troja.mff.cuni.cz	Djannati-Atai, Arache/ABA-9249-2021; Horns, Dieter/ABE-9516-2020; Khangulyan, Dmitry/AAH-1940-2019; Horns, Dieter/C-9727-2011; Venter, Christo/E-6884-2011; Reimer, Olaf/A-3117-2013; Anton, Gisela/C-4840-2013; White, Richard/AAF-4527-2019; Bulik, Tomasz/AAJ-6742-2020; de Ona Wilhelmi, Emma/U-5587-2017; Pühlhofer, Gerd/Q-2336-2018; van Eldik, Christopher/C-3901-2013; Niemiec, Jacek/R-5432-2017; Drury, Luke O'C/B-1916-2017; Marcowith, Alexandre/ABH-1254-2020; Katz, Uli F/E-1925-2013; Moderski, Rafal/ABG-8777-2020; Jung-Richardt, Ira/AAT-8884-2020; Fontaine, Gerard/D-6420-2014; Barres de Almeida, Ulisses/V-4025-2019; Katarzyński, Krzysztof/G-4528-2014; Daniel, Michael K/A-2903-2010; Moulin, Emmanuel/B-5959-2017; Komin, Nukri/J-6781-2015	Horns, Dieter/0000-0003-1945-0119; Khangulyan, Dmitry/0000-0002-7576-7869; Venter, Christo/0000-0002-2666-4812; Reimer, Olaf/0000-0001-6953-1385; Anton, Gisela/0000-0003-2039-4724; White, Richard/0000-0002-3356-0763; de Ona Wilhelmi, Emma/0000-0002-5401-0744; van Eldik, Christopher/0000-0001-9669-645X; Niemiec, Jacek/0000-0001-6036-8569; Drury, Luke O'C/0000-0002-9257-2270; Marcowith, Alexandre/0000-0002-3971-0910; Katz, Uli F/0000-0002-7063-4418; Moderski, Rafal/0000-0002-8663-3882; Fontaine, Gerard/0000-0002-6443-5025; Barres de Almeida, Ulisses/0000-0001-7909-588X; Katarzyński, Krzysztof/0000-0002-8806-4863; Daniel, Michael K/0000-0002-8053-7910; Maurin, David/0000-0002-5331-0606; Buehler, Rolf/0000-0003-4425-6641; Zdziarski, Andrzej/0000-0002-0333-2452; Bolmont, Julien/0000-0003-4739-8389; Marandon, Vincent/0000-0001-9077-4058; Bulik, Tomasz/0000-0003-2045-4803; Acero, Fabio/0000-0002-6606-2816; Sikora, Marek/0000-0003-1667-7334; Clapson, Andre-Claude/0000-0002-6327-1073; Quirrenbach, Andreas/0000-0002-3302-1962; Punch, Michael/0000-0002-4710-2165; Moulin, Emmanuel/0000-0003-4007-0145; Tibolla, Omar/0000-0002-9074-0584; Hermann, German/0000-0002-4595-1032; Rulten, Cameron/0000-0001-7483-4348; Hinton, James/0000-0002-1031-7760; Rowell, Gavin/0000-0002-9516-1581; Chadwick, Paula/0000-0002-1468-2685; Kneiske, Tanja M./0000-0002-3210-6200; Dubus, Guillaume/0000-0002-5130-2514; Lamanna, Giovanni/0000-0002-2307-0023; Komin, Nukri/0000-0003-3280-0582; Rudak, Bronislaw/0000-0003-0452-3805; Bernlohr, Konrad/0000-0001-8065-3252; Davids, Isak D./0000-0002-6476-964X; Dyks, Jaroslaw/0000-0002-8383-2472; Santangelo, Andrea/0000-0003-4187-9560; Khelifi, Bruno/0000-0001-6876-5577; Rieger, Frank/0000-0003-1334-2993; Terrier, Regis/0000-0002-8219-4667; Lenain, Jean-Philippe/0000-0001-7284-9220	German Ministry for Education and Research (BMBF); Max Planck Society; French Ministry for Research; CNRS-IN2P3; CNRS; UK Science and Technology Facilities Council (STFC); IPNP of Charles University; Polish Ministry of Science and Higher Education; South African Department of Science and Technology; National Research Foundation; University of Namibia; CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Foundation; Ministry of Education of Brazil; Max-Planck-Gesellschaft; STFC [PP/E001319/1, ST/F002963/1, ST/G003084/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/G003084/1, PP/E001319/1, ST/F002963/1] Funding Source: researchfish	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); French Ministry for Research(Ministry of Research, France); CNRS-IN2P3(Centre National de la Recherche Scientifique (CNRS)); CNRS(Centre National de la Recherche Scientifique (CNRS)); UK Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); IPNP of Charles University; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); South African Department of Science and Technology; National Research Foundation; University of Namibia; CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministry of Education of Brazil; Max-Planck-Gesellschaft(Max Planck Society); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The support of the Namibian authorities and of the University of Namibia in facilitating the construction and operation of H. E. S. S. is gratefully acknowledged, as is the support by the German Ministry for Education and Research (BMBF), the Max Planck Society, the French Ministry for Research, the CNRS-IN2P3 and the Astroparticle Interdisciplinary Programme of the CNRS, the UK Science and Technology Facilities Council (STFC), the IPNP of Charles University, the Polish Ministry of Science and Higher Education, the South African Department of Science and Technology and National Research Foundation, and the University of Namibia. U. Barres de Almeida is supported by the CAPES Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Foundation, Ministry of Education of Brazil. The European Associated Laboratory for Gamma-Ray Astronomy is jointly supported by CNRS and Max-Planck-Gesellschaft. We appreciate the excellent work of the technical support staff in Berlin, Durham, Hamburg, Heidelberg, Palaiseau, Paris, Saclay, and Namibia in the construction and operation of the equipment.	Aharonian F, 2006, ASTRON ASTROPHYS, V457, P899, DOI 10.1051/0004-6361:20065351; Aharonian F, 2006, NATURE, V439, P695, DOI 10.1038/nature04467; Aharonian F, 2005, ASTRON ASTROPHYS, V442, P177, DOI 10.1051/0004-6361:20053521; Aharonian FA, 2004, NATURE, V432, P75, DOI 10.1038/nature02960; ANTONUCCI RRJ, 1988, ASTROPHYS J, V330, pL97, DOI 10.1086/185213; Bauer M, 2008, ASTRON ASTROPHYS, V489, P1029, DOI 10.1051/0004-6361:20078935; Bauer M, 2007, ASTRON ASTROPHYS, V467, P979, DOI 10.1051/0004-6361:20066340; Blom JJ, 1999, ASTROPHYS J, V516, P744, DOI 10.1086/307155; Breiman L., 1984, CLASSIFICATION REGRE; Brunthaler A, 2009, ASTRON ASTROPHYS, V497, P103, DOI 10.1051/0004-6361/200911615; CARILLI CL, 1992, ASTROPHYS J, V399, pL59, DOI 10.1086/186606; Dahlem M, 1998, ASTROPHYS J SUPPL S, V118, P401, DOI 10.1086/313137; DENAUROIS M, ASTROPARTIC IN PRESS; Domingo-Santamaria E, 2005, ASTRON ASTROPHYS, V444, P403, DOI 10.1051/0004-6361:20053613; Engelbracht CW, 1998, ASTROPHYS J, V505, P639, DOI 10.1086/306176; Heesen V, 2009, ASTRON ASTROPHYS, V494, P563, DOI 10.1051/0004-6361:200810543; Itoh C., 2007, Astronomy & Astrophysics, V462, P67, DOI 10.1051/0004-6361:20066244; Ohm S, 2009, ASTROPART PHYS, V31, P383, DOI 10.1016/j.astropartphys.2009.04.001; Paglione TAD, 1996, ASTROPHYS J, V460, P295, DOI 10.1086/176969; PENCE WD, 1980, ASTROPHYS J, V239, P54, DOI 10.1086/158088; PUCHE D, 1988, ASTRON J, V95, P1025, DOI 10.1086/114698; Rekola R, 2005, MON NOT R ASTRON SOC, V361, P330, DOI 10.1111/j.1365-2966.2005.09166.x; REPHAELI Y, MON NOT R A IN PRESS; RICE W, 1988, ASTROPHYS J SUPPL S, V68, P91, DOI 10.1086/191283; Sorai K, 2000, PUBL ASTRON SOC JPN, V52, P785, DOI 10.1093/pasj/52.5.785; SREEKUMAR P, 1992, ASTROPHYS J, V400, pL67, DOI 10.1086/186651; SWORDY SP, 1990, ASTROPHYS J, V349, P625, DOI 10.1086/168349; Thompson TA, 2007, ASTROPHYS J, V654, P219, DOI 10.1086/509068; VANBUREN D, 1994, ASTROPHYS J, V431, P640, DOI 10.1086/174515; Volk HJ, 1996, SPACE SCI REV, V75, P279; VOLK HJ, 1989, ASTRON ASTROPHYS, V213, pL12; Zirakashvili VN, 2006, ASTROPHYS J, V636, P140, DOI 10.1086/497900	32	150	154	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1080	1082		10.1126/science.1178826	http://dx.doi.org/10.1126/science.1178826			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19779150	Green Submitted			2022-12-28	WOS:000271951000033
J	Sur, D; Lopez, AL; Kanungo, S; Paisley, A; Manna, B; Ali, M; Niyogi, SK; Park, JK; Sarkar, B; Puri, MK; Kim, DR; Deen, JL; Holmgren, J; Carbis, R; Rao, R; Van, NT; Donner, A; Ganguly, NK; Nair, GB; Battacharya, SK; Clemens, JD				Sur, Dipika; Lopez, Anna Lena; Kanungo, Suman; Paisley, Allison; Manna, Byomkesh; Ali, Mohammad; Niyogi, Swapan K.; Park, Jin Kyung; Sarkar, Banawarilal; Puri, Mahesh K.; Kim, Deok Ryun; Deen, Jacqueline L.; Holmgren, Jan; Carbis, Rodney; Rao, Raman; Van, Nguyen Thu; Donner, Allan; Ganguly, Nirmal K.; Nair, G. Balakrish; Battacharya, Sujit K.; Clemens, John D.			Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial	LANCET			English	Article							FIELD TRIAL; PROTECTIVE EFFICACY; BANGLADESH; CHILDREN; VIETNAM; ADULTS; MODEL	Background Oral cholera vaccines consisting of killed whole cells have been available for many years, but they have not been used extensively in populations with endemic disease. An inexpensive, locally produced oral killed-whole-cell vaccine has been used in high-risk areas in Vietnam. To expand the use of this vaccine, it was modified to comply with WHO standards. We assessed the efficacy and safety of this modified vaccine in a population with endemic cholera. Methods In this double-blind trial, 107 774 non-pregnant residents of Kolkata, India, aged 1 year or older, were cluster-randomised by dwelling to receive two doses of either modified killed-whole-cell cholera vaccine (n=52212; 1966 clusters) or heat-killed Escherichia coli K12 placebo (n=55 562; 1967 clusters), both delivered orally. Randomisation was done by computer-generated sequence in blocks of four. The primary endpoint was prevention of episodes of culture-confirmed Vibrio cholerae 01 diarrhoea severe enough for the patient to seek treatment in a health-care facility. We undertook an interim, per-protocol analysis at 2 years of follow-up that included individuals who received two completely ingested doses of vaccine or placebo. We assessed first episodes of cholera that occurred between 14 days and 730 days after receipt of the second dose. This study is registered with ClinicalTrials.gov, number NCT00289224. Findings 31932 participants assigned to vaccine (1721 clusters) and 34 968 assigned to placebo (1757 clusters) received two doses of study treatment. There were 20 episodes of cholera in the vaccine group and 68 episodes in the placebo group (protective efficacy 67%; one-tailed 99% CI, lower bound 35%, p<0.0001). The vaccine protected individuals in age-groups 1.0-4.9 years, 5.0-14.9 years, and 15 years and older, and protective efficacy did not differ significantly between age-groups (p=0.28). We recorded no vaccine-related serious adverse events. Interpretation This modified killed-whole-cell oral vaccine, compliant with WHO standards, is safe, provides protection against clinically significant cholera in an endemic setting, and can be used in children aged 1.0-4.9 years, who are at highest risk of developing cholera in endemic settings.	[Lopez, Anna Lena; Paisley, Allison; Ali, Mohammad; Park, Jin Kyung; Puri, Mahesh K.; Kim, Deok Ryun; Deen, Jacqueline L.; Carbis, Rodney; Clemens, John D.] Int Vaccine Inst, Seoul 151818, South Korea; [Sur, Dipika; Kanungo, Suman; Manna, Byomkesh; Niyogi, Swapan K.; Sarkar, Banawarilal; Nair, G. Balakrish; Battacharya, Sujit K.] Natl Inst Cholera & Enter Dis, Kolkata, India; [Holmgren, Jan] Univ Gothenburg, Dept Microbiol & Immunol, Gothenburg, Sweden; [Rao, Raman] Shantha Biotech, Hyderabad, Andhra Pradesh, India; [Van, Nguyen Thu] Co Vaccine & Biol Prod VaBiotech, Hanoi, Vietnam; [Donner, Allan] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [Ganguly, Nirmal K.; Battacharya, Sujit K.] Indian Council Med Res, New Delhi, India; [Ganguly, Nirmal K.] Natl Inst Immunol, New Delhi 110067, India	International Vaccine Institute; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); University of Gothenburg; Sanofi-Aventis; Western University (University of Western Ontario); Indian Council of Medical Research (ICMR); Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Lopez, AL (corresponding author), Int Vaccine Inst, SNU Res Pk,San 4-8,Bongcheon 7 Dong, Seoul 151818, South Korea.	anlopez@ivi.int	Ali, Mohammad/E-2365-2017; Kanungo, Sloka/HHM-7508-2022; Lopez, Anna Lena/AAF-6481-2019	Ali, Mohammad/0000-0003-1410-388X; Lopez, Anna Lena/0000-0003-0013-620X; Holmgren, Jan/0000-0003-1784-5918; Kanungo, Suman/0000-0003-4441-4443	Bill & Melinda Gates Foundation; Swedish International Development Cooperation Agency; Governments of South Korea; Governments of Sweden; Governments of Kuwait	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Swedish International Development Cooperation Agency; Governments of South Korea; Governments of Sweden; Governments of Kuwait	This study is supported by the Bill & Melinda Gates Foundation through the Diseases of the Most Impoverished Program and the Cholera Vaccine Initiative. Additional funding is provided by the Swedish International Development Cooperation Agency and the Governments of South Korea, Sweden, and Kuwait. Shantha Biotechnics donated vaccine and placebo for the study. We are grateful to the people of Kolkata where our study is being undertaken and to our field staff, to Roger Glass, Duncan Steele, and Taesung Park, who served as our data safety monitoring board; and to Alok Deb, Anup Palit, Young Ae You, and R Leon Ochiai, who provided valuable support in our study.	Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; Ali M, 2008, PEDIATR INFECT DIS J, V27, P33, DOI 10.1097/INF.0b013e318149dffd; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Anh DD, 2007, VACCINE, V25, P1149, DOI 10.1016/j.vaccine.2006.09.049; [Anonymous], 2001, Wkly Epidemiol Rec, V76, P117; Bopp CA, 1999, LAB METHODS DIAGNOSI; Chaignat CL, 2007, J HEALTH POPUL NUTR, V25, P244; CLEMENS JD, 1986, LANCET, V2, P124; CLEMENS JD, 1990, LANCET, V335, P270, DOI 10.1016/0140-6736(90)90080-O; Deen JL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000173; *EXP WORK GROUP EF, 1995, EXP WORK GROUP EFF I; HALLORAN ME, 1991, AM J EPIDEMIOL, V133, P323, DOI 10.1093/oxfordjournals.aje.a115884; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; Mahalanabis D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002323; Miller R. G., 1981, SURVIVAL ANAL; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; REID N, 1985, BIOMETRIKA, V72, P1; SANCHEZ JL, 1994, LANCET, V344, P1273, DOI 10.1016/S0140-6736(94)90755-2; Taylor DN, 2000, J INFECT DIS, V181, P1667, DOI 10.1086/315462; Thiem VD, 2003, J HEALTH POPUL NUTR, V21, P304; Thiem VD, 2006, VACCINE, V24, P4297, DOI 10.1016/j.vaccine.2006.03.008; Trach DD, 1997, LANCET, V349, P231, DOI 10.1016/S0140-6736(96)06107-7; *WHO, 2003, CHOL UNV; *WHO EXP COMM BIOL, 2004, 52 WHO EXP COMM BIOL; World Health Organization, 2005, TREATM DIARRH MAN PH	28	181	182	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2009	374	9702					1694	1702		10.1016/S0140-6736(09)61297-6	http://dx.doi.org/10.1016/S0140-6736(09)61297-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	522LP	19819004				2022-12-28	WOS:000271999700025
J	Fuchs, VR				Fuchs, Victor R.			Four Health Care Reforms for 2009	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TECHNOLOGY		Stanford Univ, Stanford, CA 94305 USA	Stanford University	Fuchs, VR (corresponding author), Stanford Univ, Stanford, CA 94305 USA.							Emanuel EJ, 2007, JAMA-J AM MED ASSOC, V298, P1323, DOI 10.1001/jama.298.11.1323; *EMPL BEN RES I ES, MARCH 2009 S; ENTHOVEN AC, 2009, HLTH AFFAIRS BL 0731; Pauly MV, 2005, HEALTH AFFAIR, V24, P1523, DOI 10.1377/hlthaff.24.6.1523	4	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2009	361	18					1720	1722		10.1056/NEJMp0907979	http://dx.doi.org/10.1056/NEJMp0907979			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	511RY	19812393				2022-12-28	WOS:000271185600002
J	Hacker, JS				Hacker, Jacob S.			Poor Substitutes - Why Cooperatives and Triggers Can't Achieve the Goals of a Public Option	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Yale Univ, New Haven, CT 06520 USA	Yale University	Hacker, JS (corresponding author), Yale Univ, New Haven, CT 06520 USA.							ELMENDORF DW, 2009, COMMUNICATION   0916; Hacker Jacob S., 2008, CASE PUBLIC PLAN CHO; JOST TS, 2009, JOST COOPERATIVES; Keyhani S, 2009, NEW ENGL J MED, V361, DOI 10.1056/NEJMp0908239	4	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2009	361	17					1617	1619		10.1056/NEJMp0907659	http://dx.doi.org/10.1056/NEJMp0907659			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	508YW	19776396				2022-12-28	WOS:000270977400001
J	Gendrel, M; Rapti, G; Richmond, JE; Bessereau, JL				Gendrel, Marie; Rapti, Georgia; Richmond, Janet E.; Bessereau, Jean-Louis			A secreted complement-control-related protein ensures acetylcholine receptor clustering	NATURE			English	Article							ELEGANS NEUROMUSCULAR-JUNCTION; HIKARU GENKI PROTEIN; CAENORHABDITIS-ELEGANS; C-ELEGANS; LEVAMISOLE RESISTANCE; GLUTAMATE RECEPTORS; DROSOPHILA; SYSTEM; GENES; TRAFFICKING	Efficient neurotransmission at chemical synapses relies on spatial congruence between the presynaptic active zone, where synaptic vesicles fuse, and the postsynaptic differentiation, where neurotransmitter receptors concentrate. Diverse molecular systems have evolved to localize receptors at synapses, but in most cases, they rely on scaffolding proteins localized below the plasma membrane(1-3). A few systems have been suggested to control the synaptic localization of neurotransmitter receptors through extracellular interactions, such as the pentraxins that bind AMPA receptors and trigger their aggregation(4). However, it is not yet clear whether these systems have a central role in the organization of postsynaptic domains in vivo or rather provide modulatory functions(5). Here we describe an extracellular scaffold that is necessary to cluster acetylcholine receptors at neuromuscular junctions in the nematode Caenorhabditis elegans. It involves the ectodomain of the previously identified transmembrane protein LEV-10 (ref. 6) and a novel extracellular protein, LEV-9. LEV-9 is secreted by the muscle cells and localizes at cholinergic neuromuscular junctions. Acetylcholine receptors, LEV-9 and LEV-10 are interdependent for proper synaptic localization and physically interact based on biochemical evidence. Notably, the function of LEV-9 relies on eight complement control protein (CCP) domains. These domains, also called 'sushi domains', are usually found in proteins regulating complement activity in the vertebrate immune system(7). Because the complement system does not exist in protostomes, our results suggest that some of the numerous uncharacterized CCP proteins expressed in the mammalian brain might be directly involved in the organization of the synapse, independently from immune functions.	[Gendrel, Marie; Rapti, Georgia; Bessereau, Jean-Louis] ENS, Dept Biol, F-75005 Paris, France; [Gendrel, Marie; Rapti, Georgia; Bessereau, Jean-Louis] INSERM, U789, F-75005 Paris, France; [Richmond, Janet E.] Univ Illinois, Dept Biol, Chicago, IL 60607 USA	UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bessereau, JL (corresponding author), ENS, Dept Biol, F-75005 Paris, France.	jlbesse@biologie.ens.fr	Rapti, Georgia/Q-9345-2019; Bessereau, Jean-Louis/M-2988-2017	Rapti, Georgia/0000-0003-4836-8640; Bessereau, Jean-Louis/0000-0002-3088-7621; Gendrel, Marie/0000-0002-0991-0479	Ministere de la Recherche; Association Francaise contre les Myopathies; Ministere de la Recherche fellow; INSERM Avenir; Agence Nationale de la Recherche [ANR-07-NEURO-032-01]; NIH [RO1 MH073156]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073156] Funding Source: NIH RePORTER	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Ministere de la Recherche fellow; INSERM Avenir(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E. M. Jorgensen and D. Williams for the lev-9(ox171::Mos1) strain, M. Labouesse for the anti-VHA-5 antibodies, J. Rand for the anti-UNC-17 antibodies, A. Fire for the GFP vectors, the Caenorhabditis Genetic Center and W. R. Schafer for strains, I. Katic, M. Zhen and S. Marty for critical reading of the manuscript, and H. Gendrot and B. Mathieu for technical help. M. G. was supported by a fellowship from the Ministere de la Recherche and by the Association Francaise contre les Myopathies. G. R. is a Ministere de la Recherche fellow. This work was funded by an INSERM Avenir grant, the Agence Nationale de la Recherche (ANR-07-NEURO-032-01) and the Association Francaise contre les Myopathies. J. E. R. was supported by NIH RO1 MH073156.	Arlaud GJ, 2007, MOL IMMUNOL, V44, P3809, DOI 10.1016/j.molimm.2007.06.147; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; Bingle CD, 2008, TRENDS IMMUNOL, V29, P444, DOI 10.1016/j.it.2008.07.001; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; Boulin Thomas, 2006, WormBook, P1, DOI 10.1895/wormbook.1.106.1; BRENNER S, 1974, GENETICS, V77, P71; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Duerr JS, 2001, AM J PHYSIOL-CELL PH, V280, pC1616, DOI 10.1152/ajpcell.2001.280.6.C1616; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Fares H, 2001, GENETICS, V159, P133; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fleming JT, 1997, J NEUROSCI, V17, P5843; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Gally C, 2004, NATURE, V431, P578, DOI 10.1038/nature02893; Gally C, 2003, J NEUROSCI, V23, P2591; Hoshino M, 1999, DEV GENES EVOL, V209, P1, DOI 10.1007/s004270050221; Hoshino M, 1996, DEVELOPMENT, V122, P589; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Kneussel M, 2007, BIOL CELL, V99, P297, DOI 10.1042/BC20060120; LEWIS JA, 1980, GENETICS, V95, P905; Liegeois S, 2006, J CELL BIOL, V173, P949, DOI 10.1083/jcb.200511072; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Nonaka M, 2004, IMMUNOL REV, V198, P203, DOI 10.1111/j.0105-2896.2004.00118.x; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Qian H, 2008, FASEB J, V22, P3247, DOI 10.1096/fj.08-110502; Richmond Janet E, 2006, WormBook, P1, DOI 10.1895/wormbook.1.112.1; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; ROBERT VJ, METHODS IN PRESS, DOI DOI 10.1016/J.YMETH.2009.02.013; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Ruaud AF, 2006, DEVELOPMENT, V133, P2211, DOI 10.1242/dev.02392; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Soares DC, 2005, PROTEIN ENG DES SEL, V18, P379, DOI 10.1093/protein/gzi039; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Williams DC, 2005, GENETICS, V169, P1779, DOI 10.1534/genetics.104.038265; Zhang W, 2009, NEURON, V61, P385, DOI 10.1016/j.neuron.2008.12.014; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244	41	80	91	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					992	U258		10.1038/nature08430	http://dx.doi.org/10.1038/nature08430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19794415				2022-12-28	WOS:000270817700050
J	Haralson, RH; Zuckerman, JD				Haralson, Robert H., III; Zuckerman, Joseph D.			Prevalence, Health Care Expenditures, and Orthopedic Surgery Workforce for Musculoskeletal Conditions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Zuckerman, Joseph D.] NYU, Dept Orthopaed Surg, Hosp Joint Dis, New York, NY 10003 USA; [Haralson, Robert H., III; Zuckerman, Joseph D.] Amer Acad Orthopaed Surg, Rosemont, IL USA	New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC	Zuckerman, JD (corresponding author), NYU, Dept Orthopaed Surg, Hosp Joint Dis, 301 E 17th St,Room 1402, New York, NY 10003 USA.	joseph.zuckerman@nyumc.org						*AM AC ORTH SURG, 2008, BURD MUS DIS US; *DEP RES SCI AFF A, 2006, ORTH SURG CENS; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; McNeil JM, 2001, JAMA-J AM MED ASSOC, V285, P1571; *NAT CTR HLTH STAT, NAT HLTH INT SURV AD; *NAT OST FDN, NAT OST FDN FAST FAC; *NAT OST FDN, 2000, AM BON HLTH STAT OST	7	31	31	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	2009	302	14					1586	1587		10.1001/jama.2009.1489	http://dx.doi.org/10.1001/jama.2009.1489			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505UA	19826031				2022-12-28	WOS:000270721800030
J	Hadley, C; Maes, K				Hadley, Craig; Maes, Kenneth			A new global monitoring system for food insecurity?	LANCET			English	Editorial Material							PSYCHOMETRIC PROPERTIES; EXPERIENCE; CAMPINAS; BRAZIL; MODULE; TOOL		[Hadley, Craig; Maes, Kenneth] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA	Emory University	Hadley, C (corresponding author), Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA.	chadley@emory.edu						Bickel G., 2000, GUIDE MEASURING FOOD; Coates J, 2006, J NUTR, V136, P1438, DOI 10.1093/jn/136.5.1438S; Council NR, 2005, MEAS FOOD INS HUNG P; *FAO, 2009, GET INV WORLD FOOD D; Frongillo EA, 2006, J NUTR, V136, P1409; Hackett M, 2008, INT J EPIDEMIOL, V37, P766, DOI 10.1093/ije/dyn084; Hadley C, 2008, AM J PHYS ANTHROPOL, V135, P225, DOI 10.1002/ajpa.20724; Masters WA, 2008, AGR ECON-BLACKWELL, V39, P373, DOI 10.1111/j.1574-0862.2008.00344.x; Melgar-Quinonez HR, 2008, EUR J CLIN NUTR, V62, P665, DOI 10.1038/sj.ejcn.1602760; NAIKEN L, 2003, FAO METHODOLOGY ESTI; Perez-Escamilla R, 2004, J NUTR, V134, P1923, DOI 10.1093/jn/134.8.1923; Swindale A, 2006, J NUTR, V136, P1449, DOI 10.1093/jn/136.5.1449S; *WORLD FOOD PROGR, 1 02 BILL PEOPL HUNG	13	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2009	374	9697					1223	1224		10.1016/S0140-6736(09)61766-9	http://dx.doi.org/10.1016/S0140-6736(09)61766-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	507KQ	19819376				2022-12-28	WOS:000270852500009
J	Field, D; Sansone, SA; Collis, A; Booth, T; Dukes, P; Gregurick, SK; Kennedy, K; Kolar, P; Kolker, E; Maxon, M; Millard, S; Mugabushaka, AM; Perrin, N; Remacle, JE; Remington, K; Rocca-Serra, P; Taylor, CF; Thorley, M; Tiwari, B; Wilbanks, J				Field, Dawn; Sansone, Susanna-Assunta; Collis, Amanda; Booth, Tim; Dukes, Peter; Gregurick, Susan K.; Kennedy, Karen; Kolar, Patrik; Kolker, Eugene; Maxon, Mary; Millard, Sian; Mugabushaka, Alexis-Michel; Perrin, Nicola; Remacle, Jacques E.; Remington, Karin; Rocca-Serra, Philippe; Taylor, Chris F.; Thorley, Mark; Tiwari, Bela; Wilbanks, John			'Omics Data Sharing	SCIENCE			English	Editorial Material							STANDARDS; DATABASES; GENOMICS; SUPPORT		[Kolker, Eugene] Seattle Childrens Hosp, Seattle, WA USA	Seattle Children's Hospital		dfield@ceh.ac.uk	Booth, Tim/C-6751-2011; Field, Dawn/C-1653-2010; Kolker, Eugene/C-6711-2008	Taylor, Christopher/0000-0002-9666-798X; wilbanks, john/0000-0002-4510-0385; Mugabushaka, Alexis-Michel/0000-0003-4624-568X; Sansone, Susanna-Assunta/0000-0001-5306-5690	Biotechnology and Biological Sciences Research Council [BB/E025080/1] Funding Source: researchfish; Natural Environment Research Council [CEH010021] Funding Source: researchfish; BBSRC [BB/E025080/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		[Anonymous], 2008, NAT CELL BIOL, V10, P1123; Barsnes H, 2009, NAT BIOTECHNOL, V27, P598, DOI 10.1038/nbt0709-598; Brooksbank C, 2006, OMICS, V10, P94, DOI 10.1089/omi.2006.10.94; *EC, SCI INF DIG AG ACC D; *EMEA, GUID PHARM BRIEF M; *EPA, POT IMPL GEN REG RIS; *ESF, 2008, REP ESF DTSCH FORSCH; *FDA, GEN DAT SUBM; Field D, 2005, PLOS BIOL, V3, P1352, DOI 10.1371/journal.pbio.0030297; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Field D, 2006, OMICS, V10, P84, DOI 10.1089/omi.2006.10.84; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; Human Genome Organization, 1996, 1 INT STRAT M HUM GE; *ISA, INFR MAN EXP MET; Jones AR, 2007, NAT BIOTECHNOL, V25, P1127, DOI 10.1038/nbt1347; Merali Z, 2005, NATURE, V435, P1010, DOI 10.1038/4351010a; Organization for Economic Cooperation and Development, 2007, OECD PRINC GUID ACC; Pennisi E, 2009, SCIENCE, V324, P1000, DOI 10.1126/science.324_1000b; Sansone SA, 2008, OMICS, V12, P143, DOI 10.1089/omi.2008.0019; Schofield PN, 2009, NATURE, V461, P171, DOI 10.1038/461171a; *SHAR DAT LARG SCA, 2003, SYST TRIP RESP; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Taylor CF, 2008, NAT BIOTECHNOL, V26, P889, DOI 10.1038/nbt.1411; Thomas C, 2009, SCIENCE, V324, P1632, DOI 10.1126/science.324_1632; Tiwari B, 2006, NATURE, V439, P912, DOI 10.1038/439912a; Toronto Int Data Release Workshop, 2009, NATURE, V461, P168, DOI 10.1038/461168a; Wiley S, 2009, SCIENTIST, V23, P33; PROTOCOL IMPLEMENTIN; PISTOIA VISION; 2008, NATURE, V455, P1	30	105	107	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					234	236		10.1126/science.1180598	http://dx.doi.org/10.1126/science.1180598			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	504EX	19815759	Green Accepted			2022-12-28	WOS:000270599500023
J	Subang, MC; Richardson, PM				Subang, M. C.; Richardson, P. M.			Nuclear Power for Axonal Growth	SCIENCE			English	Editorial Material							PLURIPOTENT STEM-CELLS; TUMOR-SUPPRESSOR; SENSORY NEURONS; P53; PATHWAY		[Subang, M. C.] Barts & London Queen Marys Sch Med & Dent, London EC1M 6BQ, England; [Richardson, P. M.] Barts Hosp, London E1 1BB, England; [Richardson, P. M.] London Hosp, London E1 1BB, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Subang, MC (corresponding author), Barts & London Queen Marys Sch Med & Dent, Charterhouse Sq, London EC1M 6BQ, England.	m.c.subang@qmul.ac.uk; p.richardson@qmul.ac.uk						Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Liu RY, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-17-j0003.2001; Miao T, 2006, J NEUROSCI, V26, P9512, DOI 10.1523/JNEUROSCI.2160-06.2006; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Nandan MO, 2009, HISTOL HISTOPATHOL, V24, P1343, DOI 10.14670/HH-24.1343; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; Zou HY, 2009, J NEUROSCI, V29, P7116, DOI 10.1523/JNEUROSCI.5397-08.2009	14	5	6	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 9	2009	326	5950					238	239		10.1126/science.1181038	http://dx.doi.org/10.1126/science.1181038			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	504EX	19815761				2022-12-28	WOS:000270599500025
J	Castro, JM; Dingwell, DB				Castro, Jonathan M.; Dingwell, Donald B.			Rapid ascent of rhyolitic magma at Chaiten volcano, Chile	NATURE			English	Article							ROCK FRACTURE; 1912 ERUPTION; CRYSTALLIZATION; DECOMPRESSION; NOVARUPTA; PRECURSOR; FLOW	Rhyolite magma has fuelled some of the Earth's largest explosive volcanic eruptions(1). Our understanding of these events is incomplete, however, owing to the previous lack of directly observed eruptions. Chaiten volcano, in Chile's northern Patagonia, erupted rhyolite magma unexpectedly and explosively on 1 May 2008 (ref. 2). Chaiten residents felt earthquakes about 24 hours before ash fell in their town and the eruption escalated into a Plinian column. Although such brief seismic forewarning of a major explosive basaltic eruption has been documented(3), it is unprecedented for silicic magmas. As precursory volcanic unrest relates to magma migration from the storage region to the surface, the very short pre-eruptive warning at Chaiten probably reflects very rapid magma ascent through the sub-volcanic system. Here we present petrological and experimental data that indicate that the hydrous rhyolite magma at Chaiten ascended very rapidly, with velocities of the order of one metre per second. Such rapid ascent implies a transit time from storage depths greater than five kilometres to the near surface in about four hours. This result has implications for hazard mitigation because the rapidity of ascending rhyolite means that future eruptions may provide little warning.	[Castro, Jonathan M.] Univ Orleans, Univ Tours, CNRS, INSU,Inst Sci Terre Orleans,UMR 6113, F-45071 Orleans 2, France; [Dingwell, Donald B.] Univ Munich, Dept Earth & Environm Sci, D-80333 Munich, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Orleans; Universite de Tours; University of Munich	Castro, JM (corresponding author), Univ Orleans, Univ Tours, CNRS, INSU,Inst Sci Terre Orleans,UMR 6113, Campus Geosci,1A Rue Ferolleire, F-45071 Orleans 2, France.	jonathan.castro@cnrs-orleans.fr	1.4, ALS Beamline/I-1886-2014; Dingwell, Donald B/A-4724-2011; Auerbach, Leslie E Wallace/A-4606-2011	Dingwell, Donald B/0000-0002-3332-789X; 	Alexander von Humboldt Stiftung; Smithsonian Institution; ERC [202844]	Alexander von Humboldt Stiftung(Alexander von Humboldt Foundation); Smithsonian Institution(Smithsonian Institution); ERC(European Research Council (ERC)European Commission)	We are grateful for funding from the Alexander von Humboldt Stiftung, the Smithsonian Institution, and ERC grant 202844. N. La Penna provided an eyewitness account of the eruption sequence and critical field assistance. We thank T. Fehr, S. Bernstein and A. Logan for their analytical support. M. Rutherford and H. Tuffen provided comments that greatly improved the manuscript.	BACON CR, 1988, AM MINERAL, V73, P57; Blundy J, 2006, NATURE, V443, P76, DOI 10.1038/nature05100; Carn S.A., 2009, EOS, V90, P205, DOI [10.1029/2009EO240001, DOI 10.1029/2009E0240001]; Castro JM, 2008, AM MINERAL, V93, P1816, DOI 10.2138/am.2008.2904; Castro JM, 2008, GEOLOGY, V36, P279, DOI 10.1130/G24453A.1; Chouet BA, 1996, NATURE, V380, P309, DOI 10.1038/380309a0; Coombs ML, 2001, GEOLOGY, V29, P775, DOI 10.1130/0091-7613(2001)029<0775:SSCFTR>2.0.CO;2; Dingwell DB, 1996, SCIENCE, V273, P1054, DOI 10.1126/science.273.5278.1054; Gardner JE, 1999, EARTH PLANET SC LETT, V168, P201, DOI 10.1016/S0012-821X(99)00051-5; Ghiorso MS, 2008, AM J SCI, V308, P957, DOI 10.2475/09.2008.01; Giordano D, 2008, EARTH PLANET SC LETT, V271, P123, DOI 10.1016/j.epsl.2008.03.038; Gonnermann HM, 2003, NATURE, V426, P432, DOI 10.1038/nature02138; Hammer JE, 2003, GEOLOGY, V31, P79, DOI 10.1130/0091-7613(2003)031<0079:PIOPMD>2.0.CO;2; Hammer JE, 2002, CONTRIB MINERAL PETR, V144, P144, DOI 10.1007/s00410-002-0393-2; HAMMER JE, 2002, J GEOPHYS RES, V107, DOI DOI 10.1029//2001JB000281; Kilburn CR, 1998, GEOPHYS RES LETT, V25, P3665, DOI 10.1029/98GL01609; Kilburn CRJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024184; Lavallee Y, 2008, NATURE, V453, P507, DOI 10.1038/nature06980; Llewellin EW, 2005, J VOLCANOL GEOTH RES, V143, P205, DOI 10.1016/j.jvolgeores.2004.09.018; NARANJO J, 2004, REV GEOL CHILE, V31, P291; Papale P, 1999, NATURE, V397, P425, DOI 10.1038/17109; Roman DC, 2006, GEOLOGY, V34, P457, DOI 10.1130/G22269.1; Rutherford MJ, 2008, REV MINERAL GEOCHEM, V69, P241, DOI 10.2138/rmg.2008.69.7; Scandone R, 2007, EARTH PLANET SC LETT, V253, P513, DOI 10.1016/j.epsl.2006.11.016; SILVER LA, 1990, CONTRIB MINERAL PETR, V104, P142, DOI 10.1007/BF00306439; Smith R, 2007, B VOLCANOL, V69, P681, DOI 10.1007/s00445-006-0102-5; Soosalu H, 2002, B VOLCANOL, V63, P536, DOI 10.1007/s00445-001-0177-y; Tuffen H, 2003, GEOLOGY, V31, P1089, DOI 10.1130/G19777.1; Tuffen H, 2008, NATURE, V453, P511, DOI 10.1038/nature06989; VOIGHT B, 1991, NATURE, V350, P695, DOI 10.1038/350695a0; Watt SFL, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006219; WILSON CJN, 1985, PHILOS T R SOC A, V314, P199, DOI 10.1098/rsta.1985.0019	32	178	180	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					780	U29		10.1038/nature08458	http://dx.doi.org/10.1038/nature08458			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19812671	Green Submitted			2022-12-28	WOS:000270547500033
J	Okike, K; Kocher, MS; Wei, EX; Mehlman, CT; Bhandari, M				Okike, Kanu; Kocher, Mininder S.; Wei, Erin X.; Mehlman, Charles T.; Bhandari, Mohit			Accuracy of Conflict-of-Interest Disclosures Reported by Physicians	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; PHARMACEUTICAL-INDUSTRY; FUNDING SOURCE; ASSOCIATION; SPONSORSHIP; CONCLUSIONS; OUTCOMES; IMPACT; BIAS	Background The recent public reporting of payments made to physicians by manufacturers of orthopedic devices provides an opportunity to assess the accuracy of physicians' conflict-of-interest disclosures. Methods We analyzed the reports of payments made to physicians by five manufacturers of total hip and knee prostheses in 2007. For each payment recipient who was an author of a presentation or served as a committee member or board member at the 2008 annual meeting of the American Academy of Orthopaedic Surgeons, the disclosure statement was reviewed to determine whether the payment had been disclosed. To ascertain the reasons for nondisclosure, a survey was administered to physicians who had received payments that were not disclosed. Results The overall rate of disclosure was 71.2% (245 of 344 payments). For payments that were directly related to the topic of the presentation at the meeting, the rate was 79.3% (165 of 208); for payments that were indirectly related, the rate was 50.0% (16 of 32); and for payments that were unrelated, the rate was 49.2% (29 of 59) (P = 0.008). In the multivariate analysis, payments were also more likely to have been disclosed if they exceeded $10,000 (P<0.001), were directed toward an individual physician rather than a company or organization (P=0.04), or included an in-kind component (P=0.002). Among the 36 physicians who responded to the survey regarding reasons for nondisclosure (response rate, 39.6%), the reasons most commonly given for nondisclosure were that the payment was unrelated to the topic of presentation at the annual meeting (38.9% of respondents) and that the physician had misunderstood the disclosure requirements (13.9%); 11.1% reported that the payment had been disclosed but was mistakenly omitted from the program. Conclusions In this study of self-reported conflict-of-interest disclosure by physicians at a large annual meeting, the rate of disclosure was 79.3% for directly related payments and 50.0% for indirectly related payments.	[Okike, Kanu] Massachusetts Gen Hosp, Dept Orthoped Surg, Boston, MA 02114 USA; [Okike, Kanu] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Kocher, Mininder S.] Childrens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Kocher, Mininder S.; Wei, Erin X.] Harvard Univ, Sch Med, Boston, MA USA; [Mehlman, Charles T.] Univ Cincinnati, Med Ctr, Coll Med,Cincinnati Childrens Hosp, Div Pediat Orthoped Surg, Cincinnati, OH 45267 USA; [Bhandari, Mohit] McMaster Univ, Hamilton Gen Hosp, Dept Orthopaed Surg, Hamilton, ON, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; McMaster University	Okike, K (corresponding author), Massachusetts Gen Hosp, Dept Orthoped Surg, 55 Fruit St, Boston, MA 02114 USA.	okike@post.harvard.edu	Bhandari, Mohit/AAQ-1675-2021; Kocher, Mininder S./K-1604-2019	Okike, Kanu/0000-0001-9310-9969	ConMed Linvatec; DePuy; Smith and Nephew; Stryker; Zimmer	ConMed Linvatec; DePuy; Smith and Nephew; Stryker; Zimmer	Dr. Kocher reports receiving grant support from ConMed Linvatec and serving as a consultant for ConMed Linvatec, Covidien, EBI ( a subsidiary of Biomet), and Smith and Nephew; Dr. Mehlman, receiving grant support from Abbott Spine ( now part of Zimmer), DePuy Spine, Globus Medical, Medtronic, and Synthes; and Dr. Bhandari, receiving grant support from DePuy, Smith and Nephew, Stryker, and Zimmer and serving as a consultant for Amgen, Osteogenix, Pfizer, and Zelos Therapeutics. No other potential conflict of interest relevant to this article was reported.	Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; *AM AC ORTH SURG, 2008, 2008 ANN M FIN PROGR; Baker CB, 2003, BRIT J PSYCHIAT, V183, P498, DOI 10.1192/bjp.183.6.498; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bell CM, 2006, BMJ-BRIT MED J, V332, P699, DOI 10.1136/bmj.38737.607558.80; Berenson Alex, 2005, N Y Times Web, pC13; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; *BIOM, DEF PROS AGR CO CONS; Cunningham MRA, 2007, CLIN ORTHOP RELAT R, P235, DOI 10.1097/BILO.0b013e3180312057; *DEP ORTH, CO CONS ID PAYM; Etter JF, 2007, ADDICTION, V102, P815, DOI 10.1111/j.1360-0443.2007.01822.x; Fenton JJ, 2007, SPINE, V32, P471, DOI 10.1097/01.brs.0000255809.95593.3b; Finucane TE, 2004, AM J MED, V117, P842, DOI 10.1016/j.amjmed.2004.05.029; Friedman LS, 2004, J GEN INTERN MED, V19, P51, DOI 10.1111/j.1525-1497.2004.30617.x; Jorgensen AW, 2006, BMJ-BRIT MED J, V333, P782, DOI 10.1136/bmj.38973.444699.0B; Kelly RE, 2006, PSYCHOL MED, V36, P1647, DOI 10.1017/S0033291706008567; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Leopold SS, 2003, CLIN ORTHOP RELAT R, P293, DOI 10.1097/01.blo.0000093888.12372.d9; Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Montgomery JH, 2004, CONTROL CLIN TRIALS, V25, P598, DOI 10.1016/j.cct.2004.09.002; Okike K, 2008, INJURY, V39, P666, DOI 10.1016/j.injury.2008.02.013; Okike K, 2007, J BONE JOINT SURG AM, V89A, P608, DOI 10.2106/JBJS.F.00994; Peppercorn J, 2007, CANCER-AM CANCER SOC, V109, P1239, DOI 10.1002/cncr.22528; Perlis RH, 2005, AM J PSYCHIAT, V162, P1957, DOI 10.1176/appi.ajp.162.10.1957; Rennie D, 1997, JAMA-J AM MED ASSOC, V277, P1238, DOI 10.1001/jama.277.15.1238; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Schafer A, 2004, J MED ETHICS, V30, P8, DOI 10.1136/jme.2003.005702; Shah RV, 2005, SPINE, V30, P1099, DOI 10.1097/01.brs.0000161004.15308.b4; *SMITH NEPH, SMITH NEPH DPA AGR; *STRYK, SURG CONS; Tong EK, 2005, PEDIATRICS, V115, pE356, DOI 10.1542/peds.2004-1922; Tungaraza T, 2007, BRIT J PSYCHIAT, V191, P82, DOI 10.1192/bjp.bp.106.024547; *US DEP JUST, 5 COMP HIP KNEE REPL; Yaphe J, 2001, FAM PRACT, V18, P565, DOI 10.1093/fampra/18.6.565; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; *ZIMM, DEF PROS AGR; *ZIMM, CO CONS	40	137	139	3	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2009	361	15					1466	1474		10.1056/NEJMsa0807160	http://dx.doi.org/10.1056/NEJMsa0807160			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503MU	19812403				2022-12-28	WOS:000270540000008
J	Weiss, LA; Arking, DE				Weiss, Lauren A.; Arking, Dan E.		Johns Hopkins & Autism Consortium	A genome-wide linkage and association scan reveals novel loci for autism	NATURE			English	Article							SPECTRUM DISORDERS; WILLIAMS-SYNDROME; GENETIC VARIANT; COMMON DISEASES; EXPRESSION; GTF2IRD1; DEFICITS; MARKERS; CNTNAP2; CORTEX	Although autism is a highly heritable neurodevelopmental disorder, attempts to identify specific susceptibility genes have thus far met with limited success(1). Genome-wide association studies using half a million or more markers, particularly those with very large sample sizes achieved through meta-analysis, have shown great success in mapping genes for other complex genetic traits. Consequently, we initiated a linkage and association mapping study using half a million genome-wide single nucleotide polymorphisms (SNPs) in a common set of 1,031 multiplex autism families ( 1,553 affected offspring). We identified regions of suggestive and significant linkage on chromosomes 6q27 and 20p13, respectively. Initial analysis did not yield genome-wide significant associations; however, genotyping of top hits in additional families revealed an SNP on chromosome 5p15 ( between SEMA5A and TAS2R1) that was significantly associated with autism (P = 2 x 10(-7)). We also demonstrated that expression of SEMA5A is reduced in brains from autistic patients, further implicating SEMA5A as an autism susceptibility gene. The linkage regions reported here provide targets for rare variation screening whereas the discovery of a single novel association demonstrates the action of common variants.	[Weiss, Lauren A.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Weiss, Lauren A.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Weiss, Lauren A.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Arking, Dan E.] Johns Hopkins Univ, Ctr Complex Dis Genom, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johns Hopkins University	Weiss, LA (corresponding author), Univ Calif San Francisco, Dept Psychiat, Inst Human Genet, Ctr Neurobiol & Psychiat, San Francisco, CA 94143 USA.		Leboyer, Marion/AAW-3648-2021; Pickles, Andrew/A-9625-2011; Bailey, Anthony/J-2860-2014; Pinto, Dalila/C-4218-2016; Oliveira, Guiomar/AAF-3911-2021; Altshuler, David M/A-4476-2009; Monaco, Anthony P/A-4495-2010; Battaglia, Agatino/AAG-1406-2020; Betancur, Catalina/K-3791-2017; Sutcliffe, James S/C-1348-2012; Paterson, Andrew/AAQ-7511-2020; Haines, Jonathan/C-3374-2012; Tansey, Katherine E/B-1033-2013; Munir, Kerim/D-6910-2015; Fombonne, Eric/M-4893-2018; Morrow, Eric/J-2767-2013; Vicente, Astrid/F-8692-2014; Paterson, Andrew D/A-4088-2011; Scherer, Stephen W./B-3785-2013	Leboyer, Marion/0000-0001-5473-3697; Pickles, Andrew/0000-0003-1283-0346; Bailey, Anthony/0000-0003-4257-972X; Pinto, Dalila/0000-0002-8769-0846; Oliveira, Guiomar/0000-0002-7049-1277; Altshuler, David M/0000-0002-7250-4107; Monaco, Anthony P/0000-0001-7480-3197; Battaglia, Agatino/0000-0002-7128-7606; Betancur, Catalina/0000-0002-3327-4804; Sutcliffe, James S/0000-0001-5200-6007; Paterson, Andrew/0000-0002-9169-118X; Haines, Jonathan/0000-0002-4351-4728; Tansey, Katherine E/0000-0002-9663-3376; Munir, Kerim/0000-0002-2404-1806; Fombonne, Eric/0000-0002-8605-3538; Morrow, Eric/0000-0003-3430-3520; Vicente, Astrid/0000-0001-7134-8037; Paterson, Andrew D/0000-0002-9169-118X; Scherer, Stephen W./0000-0002-8326-1999; Ennis, Sean/0000-0002-4330-1386; Dawson, Geraldine/0000-0003-1410-2764; Mottron, Laurent/0000-0001-5668-5422; Yaspan, Brian/0000-0002-3787-2510; McNeil, Kirsty/0000-0003-0437-3608; Guter, Stephen/0000-0002-4476-2045; Gill, Michael/0000-0003-0206-5337; Freitag, Christine Margarete/0000-0001-9676-4782; Wassink, Thomas/0000-0002-0952-8333; Bolte, Sven/0000-0002-4579-4970; Sheffield, Val/0000-0002-6282-0835; MAESTRINI, ELENA/0000-0001-5924-3179; Holm, Ingrid/0000-0003-4712-8821; Gallagher, Louise/0000-0001-9462-2836; Liu, Xiao-Qing/0000-0002-4034-5156; R Magalhaes, Tiago/0000-0002-5528-2119; Stevens, Christine/0000-0002-2621-2234; Correia, Catarina/0000-0001-5481-2010; Green, Jonathan/0000-0002-0143-181X; Lamb, Janine/0000-0002-7248-0539; Joseph, Robert/0000-0001-6879-0254; Green, Andrew/0000-0002-1077-7417; Anney, Richard/0000-0002-6083-407X; Buxbaum, Joseph/0000-0001-8898-8313; Wijsman, Ellen/0000-0002-2725-6669; Nurnberger, John/0000-0002-7674-1767; Oliveira, Guiomar Goncalves/0000-0003-4031-3880; Estes, Annette/0000-0003-2687-4155; West, Andrew/0000-0002-3034-4061	National Center for Research Resources [U54 RR020278]; National Institutes of Mental Health [MH60007, MH081754]; Simons Foundation; Autism Consortium of Boston; NIMH [1R01 MH083565, 1K23MH080954]; Nancy Lurie Marks ( NLM) Family Foundation; National Institute of Health [MH52708, MH39437, MH00219, MH00980, MH6454, MH61009, MH55135, MH55284, HD055782, NS042165]; National Health Medical Research Council [0034328]; Scottish Rite; Spunk Fund, Inc.; Rebecca and Solomon Baker Fund; APEX Foundation; National Alliance for Research in Schizophrenia and Affective Disorders ( NARSAD),; Nancy Pritzker Laboratory; Cure Autism Now Foundation; Fundacao Calouste Gulbenkian; INSERM, Fondation de France, Fondation Orange; Fondation pour la Recherche Medicale; Swedish Science Council; The Seaver Foundation; The Children's Medical & Research Foundation; Our Lady's Children's Hospital, Crumlin, Ireland; The Medical Research Council ( MRC); MRC [G0601030] Funding Source: UKRI; Medical Research Council [G0601030] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055748, P50HD055782] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060007, R01MH052708, K23MH080954, R01MH083565, R01MH081754, R10MH055135, R01MH055284, R10MH055284, R01MH064547, P01MH039437, K05MH000219, R01MH055135, R01MH061009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042165] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; Autism Consortium of Boston; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Nancy Lurie Marks ( NLM) Family Foundation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Scottish Rite; Spunk Fund, Inc.; Rebecca and Solomon Baker Fund; APEX Foundation; National Alliance for Research in Schizophrenia and Affective Disorders ( NARSAD),(NARSAD); Nancy Pritzker Laboratory; Cure Autism Now Foundation; Fundacao Calouste Gulbenkian(European Commission); INSERM, Fondation de France, Fondation Orange(Institut National de la Sante et de la Recherche Medicale (Inserm)Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Swedish Science Council; The Seaver Foundation; The Children's Medical & Research Foundation; Our Lady's Children's Hospital, Crumlin, Ireland; The Medical Research Council ( MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The Autism Genome Project ( AGP) work was supported by the following grants: ( 1) The Hilibrand Foundation ( Principal Investigaor Joachim F. Hallmayer); ( 2) Autism Speaks ( for the AGP); ( 3) grants from the National Institutes of Health (NIH) MH61009 ( James S. Sutcliffe), MH55135 ( Susan E. Folstein), MH55284 ( Joseph Piven), HD055782 ( Ellen M. Wijsman), NS042165 (Joachim F. Hallmayer); ( 4) Fundacao para a Ciencia e Tecnologia (POCTI/39636/ESP/2001) Fundacao Calouste Gulbenkian ( Astrid Vincente); ( 5) INSERM, Fondation de France, Fondation Orange, Fondation pour la Recherche Medicale ( Catalina Betancur, Marion Leboyer), and the Swedish Science Council ( Christopher Gillberg); ( 6) The Seaver Foundation ( Joseph D. Buxbaum); ( 7) The Children's Medical & Research Foundation ( CMRF), Our Lady's Children's Hospital, Crumlin, Ireland (Sean Ennis); ( 8) The Medical Research Council ( MRC) ( Anthony P. Monaco, Anthony J. Bailey). Fresh-frozen brain tissue samples were obtained through the Autism Tissue Program and the Harvard Brain Bank.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Auranen M, 2002, AM J HUM GENET, V71, P777, DOI 10.1086/342720; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; Bhangale TR, 2008, NAT GENET, V40, P841, DOI 10.1038/ng.180; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell DB, 2007, ANN NEUROL, V62, P243, DOI 10.1002/ana.21180; Campbell DB, 2006, P NATL ACAD SCI USA, V103, P16834, DOI 10.1073/pnas.0605296103; Di Rienzo A, 2006, CURR OPIN GENET DEV, V16, P630, DOI 10.1016/j.gde.2006.10.002; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; Gaffrey MS, 2007, NEUROPSYCHOLOGIA, V45, P1672, DOI 10.1016/j.neuropsychologia.2007.01.008; Gauthier J, 2006, MOL PSYCHIATR, V11, P206, DOI 10.1038/sj.mp.4001756; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Hirota H, 2003, GENET MED, V5, P311, DOI 10.1097/01.GIM.0000076975.10224.67; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; LANDA R, 1992, PSYCHOL MED, V22, P245, DOI 10.1017/S0033291700032918; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mattila ML, 2007, J AM ACAD CHILD PSY, V46, P636, DOI 10.1097/chi.0b013e318033ff42; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Melin M, 2006, NEUROPSYCHOBIOLOGY, V54, P64, DOI 10.1159/000096040; Mitchell AA, 2003, AM J HUM GENET, V72, P598, DOI 10.1086/368203; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tyrer P., 1988, PERSONALITY DISORDER; van Hagen JM, 2007, NEUROBIOL DIS, V26, P112, DOI 10.1016/j.nbd.2006.12.009; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wechsler D., 1991, WISC 3 WECHSLER INTE; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; World Health Organization, 1993, ICD 10 CLASS MENT BE, V10th ed.; Zafeiriou DI, 2007, BRAIN DEV-JPN, V29, P257, DOI 10.1016/j.braindev.2006.09.003	42	458	478	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 8	2009	461	7265					802	U62		10.1038/nature08490	http://dx.doi.org/10.1038/nature08490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19812673	Green Submitted, Green Accepted			2022-12-28	WOS:000270547500038
J	Helfand, M; Buckley, DI; Freeman, M; Fu, RW; Rogers, K; Fleming, C; Humphrey, LL				Helfand, Mark; Buckley, David I.; Freeman, Michele; Fu, Rongwei; Rogers, Kevin; Fleming, Craig; Humphrey, Linda L.			Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							C-REACTIVE PROTEIN; INTIMA-MEDIA THICKNESS; PERIPHERAL ARTERIAL-DISEASE; PLASMA TOTAL HOMOCYSTEINE; ALL-CAUSE MORTALITY; DENSITY-LIPOPROTEIN CHOLESTEROL; NESTED CASE-CONTROL; BLOOD-CELL COUNT; MIDDLE-AGED MEN; INCIDENT MYOCARDIAL-INFARCTION	Background: Traditional risk factors do not explain all of the risk for incident coronary heart disease (CHD) events. Various new or emerging risk factors have the potential to improve global risk assessment for CHD. Purpose: To summarize the results of 9 systematic reviews of novel risk factors to help the U. S. Preventive Services Task Force (USPSTF) evaluate the factors' clinical usefulness. Data Sources: Results from a MEDLINE search for English-language articles published from 1966 to September 2008, using the Medical Subject Heading terms cohort studies and cardiovascular diseases in combination with terms for each risk factor. Study Selection: Studies were included if the participants had no baseline cardiovascular disease and the investigators adjusted for at least 6 Framingham risk factors. Data Extraction: Study quality was evaluated by using USPSTF criteria and overall quality of evidence for each risk factor by using a modified version of the Grading of Recommendations, Assessment, Development, and Evaluation framework. Each factor's potential clinical value was evaluated by using a set of criteria that emphasized the importance of the effect of that factor on the reclassification of intermediate-risk persons. Data Synthesis: 9 systematic reviews were conducted. C-reactive protein (CRP) was the best candidate for use in screening and the most rigorously studied, but evidence that changes in CRP level lead to primary prevention of CHD events is inconclusive. The other evaluated risk factors were coronary artery calcium score as measured by electron-beam computed tomography, lipoprotein(a) level, homocysteine level, leukocyte count, fasting blood glucose, periodontal disease, ankle-brachial index, and carotid intima-media thickness. The availability and validity of the evidence varied considerably across the risk factors in terms of aggregate quality, consistency of findings, and applicability to intermediate-risk persons in the general population. For most risk factors, no studies assessed their usefulness for reclassifying intermediate-risk persons. Limitations: Because of lack of access to original data, no firm conclusions could be drawn about differences in risk prediction among racial and ethnic groups. The review did not emphasize within-cohort comparisons of multiple risk factors. Conclusion: The current evidence does not support the routine use of any of the 9 risk factors for further risk stratification of intermediate-risk persons.	[Helfand, Mark] Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Vet Affairs Med Ctr, Portland, OR 97239 USA; Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA; Grp Hlth Olympia Med Ctr, Olympia, WA USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah	Helfand, M (corresponding author), Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Vet Affairs Med Ctr, Mailcode BICC,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.				Agency for Healthcare Research and Quality [290-02-0024]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality (contract no. 290-02-0024, Task Order Number 2).	Abbott RD, 2000, AM J CARDIOL, V86, P280, DOI 10.1016/S0002-9149(00)00914-0; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Ajwani Shilpi, 2003, Spec Care Dentist, V23, P125, DOI 10.1111/j.1754-4505.2003.tb00297.x; Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; ALFTHAN G, 1994, ATHEROSCLEROSIS, V106, P9, DOI 10.1016/0021-9150(94)90078-7; Antonicelli R, 2001, CLIN CARDIOL, V24, P341, DOI 10.1002/clc.4960240416; Arad Y, 2005, J AM COLL CARDIOL, V46, P166, DOI 10.1016/j.jacc.2005.02.089; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; ARNESEN E, 1995, INT J EPIDEMIOL, V24, P704, DOI 10.1093/ije/24.4.704; Ballantyne CM, 2004, CIRCULATION, V109, P837, DOI 10.1161/01.CIR.0000116763.91992.F1; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; Becker A, 2008, AM HEART J, V155, P154, DOI 10.1016/j.ahj.2007.08.024; Belcaro G, 1996, ARTERIOSCL THROM VAS, V16, P851, DOI 10.1161/01.ATV.16.7.851; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Blake GJ, 2003, CIRCULATION, V108, P2993, DOI 10.1161/01.CIR.0000104566.10178.AF; Boekholdt SM, 2006, ATHEROSCLEROSIS, V187, P415, DOI 10.1016/j.atherosclerosis.2005.09.023; Bostom AG, 1996, JAMA-J AM MED ASSOC, V276, P544, DOI 10.1001/jama.276.7.544; BOSTOM AG, 1994, CIRCULATION, V90, P1688, DOI 10.1161/01.CIR.90.4.1688; Bostom AG, 1999, ARCH INTERN MED, V159, P1077, DOI 10.1001/archinte.159.10.1077; Bots ML, 2007, EUR HEART J, V28, P398, DOI 10.1093/eurheartj/ehl482; Bots ML, 1999, ARCH INTERN MED, V159, P38, DOI 10.1001/archinte.159.1.38; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; Brotman DJ, 2005, ARCH INTERN MED, V165, P138, DOI 10.1001/archinte.165.2.138; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Callaghan JV, 2006, CLIN CHEM, V52, P1256, DOI 10.1373/clinchem.2006.072009; Cantin B, 1998, J AM COLL CARDIOL, V31, P519, DOI 10.1016/S0735-1097(97)00528-7; Cao JJ, 2007, CIRCULATION, V116, P32, DOI 10.1161/CIRCULATIONAHA.106.645606; Cao JJ, 2003, CIRCULATION, V108, P166, DOI 10.1161/01.CIR.0000079160.07364.6A; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Chambless LE, 2000, AM J EPIDEMIOL, V151, P478; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Chambless LE, 2003, J CLIN EPIDEMIOL, V56, P880, DOI 10.1016/S0895-4356(03)00055-6; Choi EK, 2008, J AM COLL CARDIOL, V52, P357, DOI 10.1016/j.jacc.2008.02.086; Chung H, 2008, AM J ROENTGENOL, V190, pW87, DOI 10.2214/AJR.07.2726; Cohen HW, 2004, HYPERTENSION, V43, P983, DOI 10.1161/01.HYP.0000124918.30897.55; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Cremer P, 1997, ATHEROSCLEROSIS, V129, P221, DOI 10.1016/S0021-9150(96)06030-3; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Dahlen GH, 1998, J INTERN MED, V244, P425; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Danik JS, 2006, JAMA-J AM MED ASSOC, V296, P1363, DOI 10.1001/jama.296.11.1363; de Bree A, 2003, ATHEROSCLEROSIS, V166, P369, DOI 10.1016/S0021-9150(02)00373-8; DESTEFANO F, 1993, BRIT MED J, V306, P688, DOI 10.1136/bmj.306.6879.688; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Evans RW, 1997, ARTERIOSCL THROM VAS, V17, P1947, DOI 10.1161/01.ATV.17.10.1947; Evans RW, 2001, J CLIN EPIDEMIOL, V54, P51, DOI 10.1016/S0895-4356(00)00260-2; Everett BM, 2006, J AM COLL CARDIOL, V48, P2235, DOI 10.1016/j.jacc.2006.09.030; Fallon UB, 2001, HEART, V85, P153, DOI 10.1136/heart.85.2.153; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; Folsom AR, 1997, DIABETES CARE, V20, P935, DOI 10.2337/diacare.20.6.935; Folsom AR, 1998, CIRCULATION, V98, P204, DOI 10.1161/01.CIR.98.3.204; Folsom AR, 2002, AM HEART J, V144, P233, DOI 10.1067/mhj.2002.124054; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Fowler B, 2002, AUST NZ J PUBL HEAL, V26, P219, DOI 10.1111/j.1467-842X.2002.tb00677.x; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; Ganji V, 2006, AM J CLIN NUTR, V84, P989, DOI 10.1093/ajcn/84.5.989; GILLUM RF, 1993, AM HEART J, V125, P855, DOI 10.1016/0002-8703(93)90181-8; Gram J, 2000, J INTERN MED, V247, P205, DOI 10.1046/j.1365-2796.2000.00604.x; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; HELFAND M, 2009, EVIDENCE SYNTHESIS, V73; Henneman MM, 2008, EUR HEART J, V29, P2006, DOI 10.1093/eurheartj/ehn284; HIATT WR, 1995, CIRCULATION, V91, P1472, DOI 10.1161/01.CIR.91.5.1472; Hodis HN, 1998, ANN INTERN MED, V128, P262, DOI 10.7326/0003-4819-128-4-199802150-00002; Hoogeveen EK, 2000, CIRCULATION, V101, P1506, DOI 10.1161/01.CIR.101.13.1506; Hooi JD, 2004, J CLIN EPIDEMIOL, V57, P294, DOI 10.1016/j.jclinepi.2003.09.003; HOWARD G, 1993, STROKE, V24, P1297, DOI 10.1161/01.STR.24.9.1297; Howell TH, 2001, J AM COLL CARDIOL, V37, P445, DOI 10.1016/S0735-1097(00)01130-X; Hujoel PP, 2000, JAMA-J AM MED ASSOC, V284, P1406, DOI 10.1001/jama.284.11.1406; Hujoel PP, 2001, J AM DENT ASSOC, V132, P883, DOI 10.14219/jada.archive.2001.0300; Humphrey LL, 2008, MAYO CLIN PROC, V83, P1203, DOI 10.4065/83.11.1203; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Hung HC, 2004, J PUBLIC HEALTH DENT, V64, P209, DOI 10.1111/j.1752-7325.2004.tb02755.x; Jager A, 1999, ARTERIOSCL THROM VAS, V19, P617, DOI 10.1161/01.ATV.19.3.617; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; JAUHIAINEN M, 1991, ATHEROSCLEROSIS, V89, P59, DOI 10.1016/0021-9150(91)90007-P; Johnsen SH, 2007, STROKE, V38, P2873, DOI 10.1161/STROKEAHA.107.487264; KANNEL WB, 1992, JAMA-J AM MED ASSOC, V267, P1253, DOI 10.1001/jama.267.9.1253; Kitamura A, 2004, STROKE, V35, P2788, DOI 10.1161/01.STR.0000147723.52033.9e; Knekt P, 2001, ARCH INTERN MED, V161, P1589, DOI 10.1001/archinte.161.13.1589; Knekt P, 2001, J INTERN MED, V249, P461, DOI 10.1046/j.1365-2796.2001.00830.x; Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3; Koenig W, 2004, CIRCULATION, V110, P1903, DOI 10.1161/01.CIR.0000143377.53389.C8; Koenig W, 2006, ARTERIOSCL THROM VAS, V26, P2745, DOI 10.1161/01.ATV.0000248096.62495.73; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; KORNITZER M, 1995, ANGIOLOGY, V46, P211, DOI 10.1177/000331979504600304; Kronenberg F, 1999, CIRCULATION, V100, P1154, DOI 10.1161/01.CIR.100.11.1154; Kronmal RA, 2007, CIRCULATION, V115, P2722, DOI 10.1161/CIRCULATIONAHA.106.674143; LaMonte MJ, 2005, AM J EPIDEMIOL, V162, P421, DOI 10.1093/aje/kwi228; Lawlor DA, 2005, THROMB HAEMOSTASIS, V93, P955, DOI 10.1160/TH04-12-0805; Leng GC, 1996, BMJ-BRIT MED J, V313, P1440, DOI 10.1136/bmj.313.7070.1440; Lind P, 2003, ANGIOLOGY, V54, P401, DOI 10.1177/000331970305400403; Lloyd-Jones DM, 2006, ANN INTERN MED, V145, P35, DOI 10.7326/0003-4819-145-1-200607040-00129; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Lowe GDO, 2001, ARTERIOSCL THROM VAS, V21, P603, DOI 10.1161/01.ATV.21.4.603; Lowe GDO, 2004, ARTERIOSCL THROM VAS, V24, P1957, DOI 10.1161/01.ATV.0000141842.27810.a9; Luc G, 2002, ATHEROSCLEROSIS, V163, P377, DOI 10.1016/S0021-9150(02)00026-6; Luc G, 2003, ARTERIOSCL THROM VAS, V23, P1255, DOI 10.1161/01.ATV.0000079512.66448.1D; MANTTARI M, 1992, AM HEART J, V123, P873, DOI 10.1016/0002-8703(92)90690-W; Marcovina SM, 2000, CLIN CHEM, V46, P1956; Margolis KL, 2005, ARCH INTERN MED, V165, P500, DOI 10.1001/archinte.165.5.500; McCollough CH, 2007, RADIOLOGY, V243, P527, DOI 10.1148/radiol.2432050808; McDermott MM, 2000, CIRCULATION, V101, P1007, DOI 10.1161/01.CIR.101.9.1007; McDermott MM, 2004, J AM GERIATR SOC, V52, P405, DOI 10.1111/j.1532-5415.2004.52113.x; McGill HC, 1997, ARTERIOSCL THROM VAS, V17, P95, DOI 10.1161/01.ATV.17.1.95; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Miller M, 2005, ARCH INTERN MED, V165, P2063, DOI 10.1001/archinte.165.18.2063; Moons KGM, 2003, ACAD RADIOL, V10, P670, DOI 10.1016/S1076-6332(03)80087-9; Mora S, 2006, CIRCULATION, V114, P381, DOI 10.1161/CIRCULATIONAHA.106.634089; Morrison HI, 1999, J CARDIOVASC RISK, V6, P7; Morrow DA, 2007, CIRCULATION, V115, P949, DOI 10.1161/CIRCULATIONAHA.106.683110; Mosca L, 2000, CIRCULATION, V101, pE223, DOI 10.1161/01.CIR.101.1.e3; Murabito JM, 2002, AM HEART J, V143, P961, DOI 10.1067/mhj.2002.122871; Murakami S, 2005, BIOMED PHARMACOTHER, V59, pS49, DOI 10.1016/S0753-3322(05)80010-1; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Nguyen TT, 1997, CIRCULATION, V96, P1390, DOI 10.1161/01.CIR.96.5.1390; Nicklas BJ, 2005, CAN MED ASSOC J, V172, P1199, DOI 10.1503/cmaj.1040769; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Nurk E, 2002, ARCH INTERN MED, V162, P1374, DOI 10.1001/archinte.162.12.1374; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; OGREN M, 1993, LANCET, V342, P1138, DOI 10.1016/0140-6736(93)92123-B; OHLSON LO, 1986, DIABETIC MED, V3, P33, DOI 10.1111/j.1464-5491.1986.tb00702.x; OLIVARES R, 1993, AM J EPIDEMIOL, V137, P49, DOI 10.1093/oxfordjournals.aje.a116601; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Park R, 2002, CIRCULATION, V106, P2073, DOI 10.1161/01.CIR.0000033819.29662.09; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2008, AM J EPIDEMIOL, V167, P362, DOI 10.1093/aje/kwm305; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; PHILLIPS AN, 1992, AM J EPIDEMIOL, V136, P59, DOI 10.1093/oxfordjournals.aje.a116421; PIGNONE M, 2003, SYSTEMATIC EVIDENCE, V22; Pirro M, 2001, ARCH INTERN MED, V161, P2474, DOI 10.1001/archinte.161.20.2474; Pischon T, 2005, CIRCULATION, V112, P3375, DOI 10.1161/CIRCULATIONAHA.104.532499; Pischon T, 2007, EUR J EPIDEMIOL, V22, P429, DOI 10.1007/s10654-007-9141-2; Pletcher MJ, 2004, ARCH INTERN MED, V164, P1285, DOI 10.1001/archinte.164.12.1285; Prabhakaran S, 2006, STROKE, V37, P2696, DOI 10.1161/01.STR.0000244780.82190.a4; Prabhakaran Shyam, 2007, Atherosclerosis, V195, pe197, DOI 10.1016/j.atherosclerosis.2007.03.044; Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980; PRENTICE RL, 1982, AM J EPIDEMIOL, V116, P496, DOI 10.1093/oxfordjournals.aje.a113434; Price JF, 2001, ATHEROSCLEROSIS, V157, P241, DOI 10.1016/S0021-9150(00)00719-X; PYORALA K, 1985, ACTA MED SCAND, P38; Qiao Q, 2002, EUR HEART J, V23, P1267, DOI 10.1053/euhj.2001.3113; Raggi P, 2001, AM HEART J, V141, P375, DOI 10.1067/mhj.2001.113220; Rana JS, 2007, J INTERN MED, V262, P678, DOI 10.1111/j.1365-2796.2007.01864.x; Resnick HE, 2004, CIRCULATION, V109, P733, DOI 10.1161/01.CIR.0000112642.63927.54; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; RIDKER PM, 1993, JAMA-J AM MED ASSOC, V270, P2195, DOI 10.1001/jama.270.18.2195; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ridker PM, 2004, CIRCULATION, V109, P1955, DOI 10.1161/01.CIR.0000125690.80303.A8; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rifai N, 2002, ANN INTERN MED, V136, P529, DOI 10.7326/0003-4819-136-7-200204020-00010; ROSENGREN A, 1990, BRIT MED J, V301, P1248, DOI 10.1136/bmj.301.6763.1248; Rosvall M, 2005, J INTERN MED, V257, P430, DOI 10.1111/j.1365-2796.2005.01485.x; Sacco RL, 2004, STROKE, V35, P2263, DOI 10.1161/01.STR.0000142374.33919.92; Salomaa V, 2002, ARTERIOSCL THROM VAS, V22, P353, DOI 10.1161/hq0202.104078; SALONEN JT, 1991, ARTERIOSCLER THROMB, V11, P1245, DOI 10.1161/01.ATV.11.5.1245; SCHAEFER EJ, 1994, JAMA-J AM MED ASSOC, V271, P999, DOI 10.1001/jama.271.13.999; SCHREINER P, 1994, CHEM PHYS LIPIDS, V67-8, P405, DOI 10.1016/0009-3084(94)90163-5; Seed M, 2001, AM J MED, V110, P22, DOI 10.1016/S0002-9343(00)00652-5; Sevrukov AB, 2005, AM J ROENTGENOL, V185, P1546, DOI 10.2214/AJR.04.1589; Shai I, 2004, ATHEROSCLEROSIS, V177, P375, DOI 10.1016/j.atherosclerosis.2004.07.020; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; St-Pierre AC, 2005, ATHEROSCLEROSIS, V182, P315, DOI 10.1016/j.atherosclerosis.2005.02.009; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; Stehouwer CDA, 1998, ARTERIOSCL THROM VAS, V18, P1895, DOI 10.1161/01.ATV.18.12.1895; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Sweetnam PM, 1997, AM J EPIDEMIOL, V145, P416; Taylor AJ, 2005, J AM COLL CARDIOL, V46, P807, DOI 10.1016/j.jacc.2005.05.049; Thogersen AM, 2004, EUR J CARDIOV PREV R, V11, P33, DOI 10.1097/01.hjr.0000116824.84388.a2; Tuominen R, 2003, J DENT RES, V82, P713, DOI 10.1177/154405910308200911; Tuomisto K, 2006, THROMB HAEMOSTASIS, V95, P511, DOI 10.1160/TH05-08-0571; Tzou Wendy S, 2007, Prev Cardiol, V10, P181, DOI 10.1111/j.1520-037X.2007.06450.x; Tzoulaki I, 2007, CIRCULATION, V115, P2119, DOI 10.1161/CIRCULATIONAHA.106.635029; van der Meer IM, 2004, CIRCULATION, V109, P1089, DOI 10.1161/01.CIR.0000120708.59903.1B; van der Meer IM, 2003, ARCH INTERN MED, V163, P1323, DOI 10.1001/archinte.163.11.1323; Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIONAHA.104.488916; Vollset SE, 2001, AM J CLIN NUTR, V74, P130; von Eckardstein A, 2001, J AM COLL CARDIOL, V37, P434, DOI 10.1016/S0735-1097(00)01126-8; Voutilainen S, 2004, AM J CLIN NUTR, V80, P317, DOI 10.1093/ajcn/80.2.317; Wald NJ, 1998, ARCH INTERN MED, V158, P862, DOI 10.1001/archinte.158.8.862; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373; Weatherley Beth D, 2007, BMC Cardiovasc Disord, V7, P3, DOI 10.1186/1471-2261-7-3; Weijenberg MP, 1996, ARTERIOSCL THROM VAS, V16, P499, DOI 10.1161/01.ATV.16.4.499; Wheeler JG, 2004, EUR HEART J, V25, P1287, DOI 10.1016/j.ehj.2004.05.002; Wild SH, 1997, ARTERIOSCL THROM VAS, V17, P239, DOI 10.1161/01.ATV.17.2.239; Wilson PWF, 2005, ARCH INTERN MED, V165, P2473, DOI 10.1001/archinte.165.21.2473; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Witherell HL, 2003, ANN EPIDEMIOL, V13, P170, DOI 10.1016/S1047-2797(02)00276-4; Wong ND, 2000, AM J CARDIOL, V86, P495, DOI 10.1016/S0002-9149(00)01000-6; Woodward M, 2007, J THROMB HAEMOST, V5, P1795, DOI 10.1111/j.1538-7836.2007.02677.x; Yarnell JWG, 2004, EUR HEART J, V25, P1049, DOI 10.1016/j.ehj.2004.04.011; YARNELL JWG, 1994, J CLIN EPIDEMIOL, V47, P383, DOI 10.1016/0895-4356(94)90159-7; Yu CM, 2007, HEART, V93, P933, DOI 10.1136/hrt.2006.102848; Zakai NA, 2007, J THROMB HAEMOST, V5, P1128, DOI 10.1111/j.1538-7836.2007.02528.x; ZALOKAR JB, 1981, NEW ENGL J MED, V304, P465, DOI 10.1056/NEJM198102193040806; Zylberstein DE, 2004, CIRCULATION, V109, P601, DOI 10.1161/01.CIR.0000112581.96154.EA	212	279	289	1	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2009	151	7					496	W164		10.7326/0003-4819-151-7-200910060-00010	http://dx.doi.org/10.7326/0003-4819-151-7-200910060-00010			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502OT	19805772				2022-12-28	WOS:000270470500007
J	Philips, GT; Carew, TJ				Philips, Gary T.; Carew, Thomas J.			It's All about Timing	CELL			English	Editorial Material							LONG-TERM-MEMORY; ACTIVATION; INDUCTION; APLYSIA; CREB	In the formation of long-term memories, a "spaced" distribution of study sessions is more beneficial than closely spaced "massed" study sessions. Pagani et al. (2009) examine the molecular basis of this spacing effect in Drosophila and find a role for the SHP2 homolog, corkscrew, an activator of Ras/MAPK signaling, in establishing optimal spacing intervals.	[Philips, Gary T.; Carew, Thomas J.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92607 USA; [Philips, Gary T.; Carew, Thomas J.] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92607 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Carew, TJ (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92607 USA.	tcarew@uci.edu		Philips, Gary/0000-0001-9815-4291				Ajay SM, 2004, EUR J NEUROSCI, V20, P2671, DOI 10.1111/j.1460-9568.2004.03725.x; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Muzzio IA, 1999, BEHAV NEUROSCI, V113, P103, DOI 10.1037/0735-7044.113.1.103; Philips GT, 2007, J NEUROSCI, V27, P13701, DOI 10.1523/JNEUROSCI.4262-07.2007; Ye XJ, 2008, P NATL ACAD SCI USA, V105, P20511, DOI 10.1073/pnas.0808110105; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	9	5	5	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					23	25		10.1016/j.cell.2009.09.020	http://dx.doi.org/10.1016/j.cell.2009.09.020			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804749	Bronze			2022-12-28	WOS:000270388600011
J	Selman, JR				Selman, J. R.			Poison-Tolerant Fuel Cells	SCIENCE			English	Editorial Material							SULFUR		IIT, Dept Chem & Biol Engn, Chicago, IL 60616 USA	Illinois Institute of Technology	Selman, JR (corresponding author), IIT, Dept Chem & Biol Engn, Chicago, IL 60616 USA.	selman@iit.edu						Gong MY, 2007, J POWER SOURCES, V168, P289, DOI 10.1016/j.jpowsour.2007.03.026; IVERSTIFFEE E, 2010, HDB FUEL CELLS, DOI DOI 10.1002/9780470974001.F500063; SELMAN JR, 1993, FUEL CELL SYSTEMS, pCH9; Virkar A.V., 2003, HIGH TEMPERATURE SOL; Yang L, 2009, SCIENCE, V326, P126, DOI 10.1126/science.1174811	5	17	18	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					52	53		10.1126/science.1180820	http://dx.doi.org/10.1126/science.1180820			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797646				2022-12-28	WOS:000270355600027
J	Williams, RS; Dodson, GE; Limbo, O; Yamada, Y; Williams, JS; Guenther, G; Classen, S; Glover, JNM; Iwasaki, H; Russell, P; Tainer, JA				Williams, R. Scott; Dodson, Gerald E.; Limbo, Oliver; Yamada, Yoshiki; Williams, Jessica S.; Guenther, Grant; Classen, Scott; Glover, J. N. Mark; Iwasaki, Hiroshi; Russell, Paul; Tainer, John A.			Nbs1 Flexibly Tethers Ctp1 and Mre11-Rad50 to Coordinate DNA Double-Strand Break Processing and Repair	CELL			English	Article							PHOSPHOPEPTIDE RECOGNITION; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; SCATTERING SAXS; DAMAGE-RESPONSE; ATM ACTIVATION; BRCT REPEATS; FHA DOMAIN; COMPLEX; MDC1	The Nijmegen breakage syndrome 1 (Nbs1) subunit of the Mre11-Rad50-Nbs1 (MRN) complex protects genome integrity by coordinating double-strand break (DSB) repair and checkpoint signaling through undefined interactions with ATM, MDC1, and Sae2/Ctp1/CtIP. Here, fission yeast and human Nbs1 structures defined by X-ray crystallography and small angle X-ray scattering (SAXS) reveal Nbs1 cardinal features: fused, extended, FHA-BRCT1-BRCT2 domains flexibly linked to C-terminal Mre11- and ATM-binding motifs. Genetic, biochemical, and structural analyses of an Nbs1-Ctp1 complex show Nbs1 recruits phosphorylated Ctp1 to DSBs via binding of the Nbs1 FHA domain to a Ctp1 pThr- Asp motif. Nbs1 structures further identify an extensive FHA-BRCT interface, a bipartite MDC1-binding scaffold, an extended conformational switch, and the molecular consequences associated with cancer predisposing Nijmegen breakage syndrome mutations. Tethering of Ctp1 to a flexible Nbs1 arm suggests a mechanism for restricting DNA end processing and homologous recombination activities of Sae2/Ctp1/CtIP to the immediate vicinity of DSBs.	[Williams, R. Scott; Dodson, Gerald E.; Limbo, Oliver; Yamada, Yoshiki; Williams, Jessica S.; Guenther, Grant; Russell, Paul; Tainer, John A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Dodson, Gerald E.; Limbo, Oliver; Yamada, Yoshiki; Williams, Jessica S.; Russell, Paul] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Williams, R. Scott; Guenther, Grant; Tainer, John A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Classen, Scott; Tainer, John A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Mol Biol, Div Life Sci, Berkeley, CA 94720 USA; [Glover, J. N. Mark] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Iwasaki, Hiroshi] Yokohama City Univ, Int Grad Sch Arts & Sci, Div Mol & Cellular Biol, Kanagawa 2300045, Japan	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Alberta; Yokohama City University	Russell, P (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,MB4, La Jolla, CA 92037 USA.	prussell@scripps.edu; jat@scripps.edu	Classen, Scott/AAY-8176-2020; Tainer, John/GWQ-4878-2022; Iwasaki, Hiroshi/Y-7946-2018; Williams, R Scott/A-6059-2015	Tainer, John/0000-0003-1659-2429; Iwasaki, Hiroshi/0000-0002-0153-6873; Limbo, Oliver/0000-0003-1686-1414; Williams, R Scott/0000-0002-4610-8397	Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research; National Cancer Institute [CA117638, CA92584, CA77325]; SIBYLS beamline [BL12.3.1]; United States Department of Energy program Integrated Diffraction Analysis Technologies [DE-AC02-05CH11231]; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R01CA117638, R01CA077325, P01CA092584] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); SIBYLS beamline; United States Department of Energy program Integrated Diffraction Analysis Technologies(United States Department of Energy (DOE)); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Fellowship support was provided to R. S. W. (Canadian Institutes of Health Research, the Alberta Heritage Foundation for Medical Research, and the Skaggs Institute for Chemical Biology), G.E.D. (National Institutes of Health National Research Service Award), and Y.Y. (The Uehara Memorial Foundation). Work on Mre11 complex and Ctp1 in the authors' laboratories is supported by National Cancer Institute grants CA117638, CA92584, and CA77325. SIBYLS beamline (BL12.3.1) efforts at the Advanced Light Source of Lawrence Berkeley National Laboratory are supported by United States Department of Energy program Integrated Diffraction Analysis Technologies (for integrating crystallography and X-ray scattering) under contract number DE-AC02-05CH11231. We thank SIBYLS staff G. Hura and M. Hammel for expert SAXS data collection assistance, B. Chapados, C. Chahwan for discussions, and E. Getzoff and G. Williams for comments.	Akamatsu Y, 2008, MOL CELL BIOL, V28, P3639, DOI 10.1128/MCB.01828-07; Bernstein NK, 2005, MOL CELL, V17, P657, DOI 10.1016/j.molcel.2005.02.012; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chapados BR, 2004, CELL, V116, P39, DOI 10.1016/S0092-8674(03)01036-5; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chen PL, 2005, MOL CELL BIOL, V25, P3535, DOI 10.1128/MCB.25.9.3535-3542.2005; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; DiDonato M, 2003, J MOL BIOL, V332, P601, DOI 10.1016/S0022-2836(03)00889-1; Difilippantonio S, 2005, NAT CELL BIOL, V7, P675, DOI 10.1038/ncb1270; Digweed M, 2004, DNA REPAIR, V3, P1207, DOI 10.1016/j.dnarep.2004.03.004; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Heikkinen K, 2006, CARCINOGENESIS, V27, P1593, DOI 10.1093/carcin/bgi360; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2002, NATURE, V418, P562, DOI 10.1038/nature00922; Hopfner KP, 2001, CELL, V105, P473, DOI 10.1016/S0092-8674(01)00335-X; Hopkins BB, 2008, CELL, V135, P250, DOI 10.1016/j.cell.2008.09.054; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Kruger L, 2007, CARCINOGENESIS, V28, P107, DOI 10.1093/carcin/bgl126; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lloyd J, 2009, CELL, V139, P100, DOI 10.1016/j.cell.2009.07.043; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moreno-Herrero F, 2005, NATURE, V437, P440, DOI 10.1038/nature03927; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Palmbos PL, 2008, GENETICS, V180, P1809, DOI 10.1534/genetics.108.095539; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Seemanova E, 2006, J MED GENET, V43, P218, DOI 10.1136/jmg.2005.035287; Shima H, 2005, GENETICS, V170, P71, DOI 10.1534/genetics.104.037580; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Williams RS, 2008, CELL, V135, P97, DOI 10.1016/j.cell.2008.08.017; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	54	240	244	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					87	99		10.1016/j.cell.2009.07.033	http://dx.doi.org/10.1016/j.cell.2009.07.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804755	Green Accepted, Bronze			2022-12-28	WOS:000270388600018
J	Gunnell, D; Irvine, D; Wise, L; Davies, C; Martin, RM				Gunnell, D.; Irvine, D.; Wise, L.; Davies, C.; Martin, R. M.			Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database	BRITISH MEDICAL JOURNAL			English	Article							SUSTAINED-RELEASE BUPROPION; RANDOMIZED CONTROLLED-TRIAL; RECEPTOR PARTIAL AGONIST; SMOKING-CESSATION; DEPENDENCE; PLACEBO; RISK	Objective To determine whether varenicline, a recently licensed smoking cessation product, is associated with an increased risk of suicide and suicidal behaviour compared with alternative treatments bupropion and nicotine replacement therapy. Design Cohort study nested within the General Practice Research Database. Setting Primary care in the United Kingdom. Participants 80 660 men and women aged 18-95 years were prescribed a new course of a smoking cessation product between 1 September 2006 and 31 May 2008; the initial drugs prescribed during follow-up were nicotine replacement products (n=63 265), varenicline (n=10 973), and bupropion (n=6422). Main outcome measures Primary outcomes were fatal and non-fatal self harm, secondary outcomes were suicidal thoughts and depression, all investigated with Cox's proportional hazards models. Results There was no clear evidence that varenicline was associated with an increased risk of fatal (n=2) or non-fatal (n=166) self harm, although a twofold increased risk cannot be ruled out on the basis of the upper limit of the 95% confidence interval. Compared with nicotine replacement products, the hazard ratio for self harm among people prescribed varenicline was 1.12 (95% CI 0.67 to 1.88), and it was 1.17 (0.59 to 2.32) for people prescribed bupropion. There was no evidence that varenicline was associated with an increased risk of depression (n=2244) (hazard ratio 0.88 (0.77 to 1.00)) or suicidal thoughts (n=37) (1.43 (0.53 to 3.85)). Conclusion Although a twofold increased risk of self harm with varenicline cannot be ruled out, these findings provide some reassurance concerning its association with suicidal behaviour.	[Gunnell, D.; Martin, R. M.] Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England; [Irvine, D.; Wise, L.; Davies, C.] Med & Healthcare Prod Regulatory Agcy, London SW8 5NQ, England	University of Bristol; The Medicines & Healthcare Products Regulatory Agency	Gunnell, D (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England.	d.j.gunnell@bristol.ac.uk	Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470; Martin, Richard/0000-0002-7992-7719	Medicines and Healthcare Products Regulatory Agency (MHRA); ESRC [ES/G007543/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish	Medicines and Healthcare Products Regulatory Agency (MHRA); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Small grant from the Medicines and Healthcare Products Regulatory Agency (MHRA).	Boden JM, 2008, PSYCHOL MED, V38, P433, DOI 10.1017/S0033291707001547; Cahill K, 2009, DRUG SAFETY, V32, P119, DOI 10.2165/00002018-200932020-00005; Farrell M, 2001, BRIT J PSYCHIAT, V179, P432, DOI 10.1192/bjp.179.5.432; Gonzales D, 2006, JAMA-J AM MED ASSOC, V296, P47, DOI 10.1001/jama.296.1.47; Gunnell D, 2004, BRIT J PSYCHIAT, V185, P385, DOI 10.1192/bjp.185.5.385; Hays JT, 2008, NEW ENGL J MED, V359, P2018, DOI 10.1056/NEJMct0800146; Hemmingsson T, 2003, INT J EPIDEMIOL, V32, P1000, DOI 10.1093/ije/dyg203; Hughes JR, 2008, DRUG ALCOHOL DEPEN, V98, P169, DOI 10.1016/j.drugalcdep.2008.06.003; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jorenby DE, 2006, JAMA-J AM MED ASSOC, V296, P56, DOI 10.1001/jama.296.1.56; Leistikow BN, 1999, PREV MED, V28, P255, DOI 10.1006/pmed.1998.0412; Lewis G, 1998, BMJ-BRIT MED J, V317, P1283, DOI 10.1136/bmj.317.7168.1283; Martinez C, 2005, BRIT MED J, V330, P389, DOI 10.1136/bmj.330.7488.389; Medicines and Healthcare Products Regulatory Agency (MHRA), 2007, DRUG SAFETY UPDATE, V1, P12; Miller M, 2000, AM J PUBLIC HEALTH, V90, P768, DOI 10.2105/AJPH.90.5.768; *OFF NAT STAT, IND DEPR UK SIM DIFF; Patterson F, 2009, BIOL PSYCHIAT, V65, P144, DOI 10.1016/j.biopsych.2008.08.028; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419	18	144	151	0	8	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 1	2009	339								b3805	10.1136/bmj.b3805	http://dx.doi.org/10.1136/bmj.b3805			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502LB	19797344	Green Published, hybrid			2022-12-28	WOS:000270460000004
J	Martin, RE; Marchetti, RV; Cowan, AI; Howitt, SM; Broer, S; Kirk, K				Martin, Rowena E.; Marchetti, Rosa V.; Cowan, Anna I.; Howitt, Susan M.; Broeer, Stefan; Kirk, Kiaran			Chloroquine Transport via the Malaria Parasite's Chloroquine Resistance Transporter	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM; DIGESTIVE VACUOLE; PFCRT MUTATIONS; PH; EFFLUX; MECHANISM; AGENTS	The emergence and spread of chloroquine-resistant Plasmodium falciparum malaria parasites has been a disaster for world health. Resistance is conferred by mutations in the Chloroquine Resistance Transporter (PfCRT), an integral membrane protein localized to the parasite's internal digestive vacuole. These mutations result in a marked reduction in the accumulation of chloroquine (CQ) by the parasite. However, the mechanism by which this occurs is unclear. We expressed both wild-type and resistant forms of PfCRT at the surface of Xenopus laevis oocytes. The resistant form of PfCRT transported CQ, whereas the wild-type protein did not. CQ transport via the mutant PfCRT was inhibited by CQ analogs and by the resistance-reverser verapamil. Thus, CQ resistance is due to direct transport of the drug via mutant PfCRT.	[Martin, Rowena E.; Marchetti, Rosa V.; Howitt, Susan M.; Broeer, Stefan; Kirk, Kiaran] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Cowan, Anna I.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia	Australian National University; Australian National University; John Curtin School of Medical Research	Martin, RE (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 0200, Australia.	rowena.martin@anu.edu.au	Howitt, Susan M/C-9308-2009; Kirk, Kiaran/C-8299-2009; Martin, Rowena E/C-9992-2009; Broer, Stefan/A-1286-2008	Howitt, Susan M/0000-0002-2192-2317; Kirk, Kiaran/0000-0002-5613-2622; Martin, Rowena E/0000-0001-7408-5295; Broer, Stefan/0000-0002-8040-1634; Cowan, Anna/0000-0002-5681-6610	Australian National Health and Medical Research Council (NHMRC) [471472, 520320]; Australian Research Council [DP0559433]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	We thank J. Abbey, R. Summers, E. Baker, and R. Slatyer for technical assistance. This work was supported by the Australian National Health and Medical Research Council (NHMRC) (grant 471472) and the Australian Research Council (grant DP0559433). R. E. M. was supported by an NHMRC Australian Biomedical Fellowship (fellowship 520320).	Bennett TN, 2004, MOL BIOCHEM PARASIT, V133, P99, DOI 10.1016/j.molbiopara.2003.09.008; Bray PG, 2006, MOL MICROBIOL, V62, P238, DOI 10.1111/j.1365-2958.2006.05368.x; Bray PG, 2005, MOL MICROBIOL, V56, P323, DOI 10.1111/j.1365-2958.2005.04556.x; Cortazzo P, 2002, BIOCHEM BIOPH RES CO, V293, P537, DOI 10.1016/S0006-291X(02)00226-7; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FITCH CD, 1969, P NATL ACAD SCI USA, V64, P1181, DOI 10.1073/pnas.64.4.1181; Hayward R, 2006, J CELL SCI, V119, P1016, DOI 10.1242/jcs.02795; Johnson DJ, 2004, MOL CELL, V15, P867, DOI 10.1016/j.molcel.2004.09.012; Klonis N, 2007, BIOCHEM J, V407, P343, DOI 10.1042/BJ20070934; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Lakshmanan V, 2005, EMBO J, V24, P2294, DOI 10.1038/sj.emboj.7600681; Lehane AM, 2008, ANTIMICROB AGENTS CH, V52, P4374, DOI 10.1128/AAC.00666-08; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; Naude B, 2005, J BIOL CHEM, V280, P25596, DOI 10.1074/jbc.M503227200; Sanchez CP, 2007, MOL MICROBIOL, V64, P407, DOI 10.1111/j.1365-2958.2007.05664.x; Sanchez CP, 2005, BIOCHEMISTRY-US, V44, P9862, DOI 10.1021/bi050061f; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; van Schalkwyk DA, 2006, DRUG RESIST UPDATE, V9, P211, DOI 10.1016/j.drup.2006.09.002; Wagner CA, 2000, CELL PHYSIOL BIOCHEM, V10, P1, DOI 10.1159/000016341	21	214	221	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	2009	325	5948					1680	1682		10.1126/science.1175667	http://dx.doi.org/10.1126/science.1175667			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779197				2022-12-28	WOS:000270131800043
J	Schrag, DP				Schrag, Daniel P.			Storage of Carbon Dioxide in Offshore Sediments	SCIENCE			English	Editorial Material								The battle to reduce greenhouse gas emissions and prevent the most dangerous consequences of climate change will be waged across multiple fronts, including efforts to increase energy efficiency; efforts to deploy nonfossil fuel sources, including renewable and nuclear energy; and investment in adaptation to reduce the impacts of the climate change that will occur regardless of the actions we take. But with more than 80% of the world's energy coming from fossil fuel, winning the battle also requires capturing CO(2) from large stationary sources and storing that CO(2) in geologic repositories. Offshore geological repositories have received relatively little attention as potential CO(2) storage sites, despite their having a number of important advantages over onshore sites, and should be considered more closely.	[Schrag, Daniel P.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02136 USA; [Schrag, Daniel P.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02136 USA	Harvard University; Harvard University	Schrag, DP (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02136 USA.	schrag@eps.harvard.edu						Archer D, 2008, CLIMATIC CHANGE, V90, P283, DOI 10.1007/s10584-008-9413-1; *CARB MON ACT, POW PLANT DAT; Chadwick R.A., 2009, ENERGY PROCEDIA, V1, P2103, DOI DOI 10.1016/J.EGYPRO.2009.01.274; House KZ, 2006, P NATL ACAD SCI USA, V103, P12291, DOI 10.1073/pnas.0605318103; LIBBYFRENCH J, 1984, AAPG BULL, V68, P50	5	85	87	8	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	2009	325	5948					1658	1659		10.1126/science.1175750	http://dx.doi.org/10.1126/science.1175750			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779191				2022-12-28	WOS:000270131800035
J	Brotherton, SE; Etzel, SI				Brotherton, Sarah E.; Etzel, Sylvia I.			Graduate Medical Education, 2008-2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									[Brotherton, Sarah E.; Etzel, Sylvia I.] Amer Med Assoc, Div Grad Med Educ, Chicago, IL 60654 USA	American Medical Association	Brotherton, SE (corresponding author), Amer Med Assoc, Div Grad Med Educ, 515 N State St, Chicago, IL 60654 USA.	sarah.brotherton@ama-assn.org							0	60	60	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1357	1372		10.1001/jama.2009.1221	http://dx.doi.org/10.1001/jama.2009.1221			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497AR	19773575				2022-12-28	WOS:000270026000022
J	Yan, Y; Sabharwal, P; Rao, M; Sockanathan, S				Yan, Ye; Sabharwal, Priyanka; Rao, Meenakshi; Sockanathan, Shanthini			The Antioxidant Enzyme Prdx1 Controls Neuronal Differentiation by Thiol-Redox-Dependent Activation of GDE2	CELL			English	Article							GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE; TRYPAREDOXIN PEROXIDASE; MEMBRANE-PROTEIN; SPINAL-CORD; IN-VIVO; PEROXIREDOXIN; CELLS; SPECIFICATION; OLIG2; NEUROGENESIS	The six-transmembrane protein GDE2 controls the onset and progression of spinal motor neuron differentiation through extracellular glycerophosphodiester phosphodiesterase metabolism. Although this process is likely to be tightly regulated, the relevant mechanisms that modulate its activity are unknown. Here we show that the antioxidant scavenger peroxiredoxin1 (Prdx1) interacts with GDE2, and that loss of Prdx1 causes motor neuron deficits analogous to GDE2 ablation. Prdx1 cooperates with GDE2 to drive motor neuron differentiation, and this synergy requires Prdx1 thiol-dependent catalysis. Prdx1 activates GDE2 through reduction of an intramolecular disulfide bond that bridges its intracellular N- and C-terminal domains. GDE2 variants incapable of disulfide bond formation acquire independence from Prdx1 and are potent inducers of motor neuron differentiation. These findings define Prdx1 as a pivotal regulator of GDE2 activity and suggest roles for coupled thiol-redox-dependent cascades in controlling neuronal differentiation in the spinal cord.	[Yan, Ye; Sabharwal, Priyanka; Rao, Meenakshi; Sockanathan, Shanthini] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Sockanathan, S (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	ssockan1@jhmi.edu	Sabharwal, Priyanka/AAA-3303-2019	Sabharwal, Priyanka/0000-0002-2099-1994	National Institute of Neurological Disorders and Stroke; Muscular Dystrophy Association; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046336, R56NS046336] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Lawson for technical help; B. Selvakumar for advice; J. Rotty for help in initial candidate screens; M. Goulding, T. M. Jessell, L. Pevny, and B. Novitch for antibodies; E. Prochownik and Y. F. Shi for Prdx1 null animals; C. H. Lee, G. Periz, L. M. Wang, and B. Q. Zhuang for discussions; and A. L. Kolodkin, G. Periz, W. Watson, and P. F. Worley for critical reading and comments on the manuscript. This work was funded by the National Institute of Neurological Disorders and Stroke and the Muscular Dystrophy Association.	Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Bertram John S., 2000, Molecular Aspects of Medicine, V21, P167, DOI 10.1016/S0098-2997(00)00007-8; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Flohe L, 2002, ARCH BIOCHEM BIOPHYS, V397, P324, DOI 10.1006/abbi.2001.2688; Funato Y, 2006, NAT CELL BIOL, V8, P501, DOI 10.1038/ncb1405; Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2; Hollyday M, 2001, INT J DEV NEUROSCI, V19, P161, DOI 10.1016/S0736-5748(00)00093-9; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kintner C, 2002, J NEUROSCI, V22, P639, DOI 10.1523/JNEUROSCI.22-03-00639.2002; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Megason SG, 2002, DEVELOPMENT, V129, P2087; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Montemartini M, 1999, EUR J BIOCHEM, V264, P516, DOI 10.1046/j.1432-1327.1999.00656.x; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Nogusa Y, 2004, GENE, V337, P173, DOI 10.1016/j.gene.2004.04.026; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Paget MSB, 2003, ANNU REV GENET, V37, P91, DOI 10.1146/annurev.genet.37.110801.142538; Rao M, 2004, DEV DYNAM, V231, P592, DOI 10.1002/dvdy.20161; Rao M, 2005, SCIENCE, V309, P2212, DOI 10.1126/science.1117156; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Ritz D, 2001, SCIENCE, V294, P158, DOI 10.1126/science.1063143; Santelli E, 2004, PROTEINS, V56, P167, DOI 10.1002/prot.20120; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yanaka N, 2003, J BIOL CHEM, V278, P43595, DOI 10.1074/jbc.M302867200; Yanaka N, 2007, BIOSCI BIOTECH BIOCH, V71, P1811, DOI 10.1271/bbb.70062; Yanaka N, 2007, FEBS LETT, V581, P712, DOI 10.1016/j.febslet.2007.01.035; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100	37	84	91	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1209	1221		10.1016/j.cell.2009.06.042	http://dx.doi.org/10.1016/j.cell.2009.06.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766572	Bronze, Green Accepted			2022-12-28	WOS:000269923200020
J	Coelho, AS; Barbosa, FAS; Cassemiro, KN; Villar, AS; Martinelli, M; Nussenzveig, P				Coelho, A. S.; Barbosa, F. A. S.; Cassemiro, K. N.; Villar, A. S.; Martinelli, M.; Nussenzveig, P.			Three-Color Entanglement	SCIENCE			English	Article							SUDDEN-DEATH; QUANTUM; STATES; SYSTEMS	Entanglement is an essential quantum resource for the acceleration of information processing as well as for sophisticated quantum communication protocols. Quantum information networks are expected to convey information from one place to another by using entangled light beams. We demonstrated the generation of entanglement among three bright beams of light, all of different wavelengths (532.251, 1062.102, and 1066.915 nanometers). We also observed disentanglement for finite channel losses, the continuous variable counterpart to entanglement sudden death.	[Coelho, A. S.; Barbosa, F. A. S.; Martinelli, M.; Nussenzveig, P.] Univ Sao Paulo, Inst Fis, BR-05314970 Sao Paulo, Brazil; [Cassemiro, K. N.; Villar, A. S.] Max Planck Inst Sci Light, D-91058 Erlangen, Germany; [Villar, A. S.] Univ Erlangen Nurnberg, D-91058 Erlangen, Germany	Universidade de Sao Paulo; Max Planck Society; University of Erlangen Nuremberg	Nussenzveig, P (corresponding author), Univ Sao Paulo, Inst Fis, POB 66318, BR-05314970 Sao Paulo, Brazil.	nussen@if.usp.br	Nussenzveig, Paulo/P-3270-2016; Barbosa, Felippe/ABF-7989-2020; quantica, Inct Informacao/H-9493-2013; Barbosa, Felippe/AGZ-3796-2022; Martinelli, Marcelo/C-1915-2012	Nussenzveig, Paulo/0000-0002-8789-7505; Barbosa, Felippe/0000-0002-7856-5779; Barbosa, Felippe/0000-0002-7856-5779; Martinelli, Marcelo/0000-0002-6504-7040; Villar, Alessandro/0000-0001-9949-2567	Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Novel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Brazilian National Institute of Science and Technology for Quantum Information; Alexander von Humboldt Foundation	Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Novel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Institute of Science and Technology for Quantum Information; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank P. van Loock, M. Wolf, and S. Walborn for discussions and H. M. Nussenzveig, W. P. Schleich, and R. W. Boyd for comments on the manuscript. This work was funded by the Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Novel Superior ( CAPES), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). It was performed as part of the Brazilian National Institute of Science and Technology for Quantum Information. K. N. C. and A. S. V. acknowledge support from the Alexander von Humboldt Foundation.	Almeida MP, 2007, SCIENCE, V316, P579, DOI 10.1126/science.1139892; Aoki T, 2009, NAT PHYS, V5, P541, DOI 10.1038/NPHYS1309; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Blatt R, 2008, NATURE, V453, P1008, DOI 10.1038/nature07125; Bloch I, 2008, NATURE, V453, P1016, DOI 10.1038/nature07126; Cassemiro KN, 2007, OPT EXPRESS, V15, P18236, DOI 10.1364/OE.15.018236; Cesar JES, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.063816; Chou CH, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011112; Clarke J, 2008, NATURE, V453, P1031, DOI 10.1038/nature07128; Deleglise S, 2008, NATURE, V455, P510, DOI 10.1038/nature07288; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Giedke G, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052303; Grosse NB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.243601; Hanson R, 2008, NATURE, V453, P1043, DOI 10.1038/nature07129; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Paz JP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.220401; Scarani V, 2009, REV MOD PHYS, V81, P1301, DOI 10.1103/RevModPhys.81.1301; Schori C, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.033802; Schrodinger E, 1935, P CAMB PHILOS SOC, V31, P555, DOI 10.1017/S0305004100013554; Shor PW, 1997, SIAM J COMPUT, V26, P1484, DOI [10.1137/S0097539795293172, 10.1137/S0036144598347011]; Simon R, 2000, PHYS REV LETT, V84, P2726, DOI 10.1103/PhysRevLett.84.2726; van Loock P, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.052315; Villar AS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.140504; Villar AS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.243603; Werner RF, 2001, PHYS REV LETT, V86, P3658, DOI 10.1103/PhysRevLett.86.3658; Yu T, 2009, SCIENCE, V323, P598, DOI 10.1126/science.1167343; Zurek WH, 2009, NAT PHYS, V5, P181, DOI 10.1038/NPHYS1202	28	194	200	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 6	2009	326	5954					823	826		10.1126/science.1178683	http://dx.doi.org/10.1126/science.1178683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19762598	Green Submitted			2022-12-28	WOS:000271468000035
J	Iglehart, JK				Iglehart, John K.			The Baucus Bill and the Hope for Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		ADAMY J, 2009, WALL STREET J   0916, pA6; ELMENDORF DW, 2009, COMMUNICATION   1009; PEAR R, 2009, NY TIMES        1105, pA22; PricewaterhouseCoopers Staff, 2009, POT IMP HLTH REF COS; 2009, WALL STREET J   1006, pA22	5	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 29	2009	361	18								10.1056/NEJMp0909696	http://dx.doi.org/10.1056/NEJMp0909696			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	511RY	19828524				2022-12-28	WOS:000271185600004
J	Ciuleanu, T; Brodowicz, T; Zielinski, C; Kim, JH; Krzakowski, M; Laack, E; Wu, YL; Bover, I; Begbie, S; Tzekova, V; Cucevic, B; Pereira, JR; Yang, SH; Madhavan, J; Sugarman, KP; Peterson, P; John, WJ; Krejcy, K; Belani, CP				Ciuleanu, Tudor; Brodowicz, Thomas; Zielinski, Christoph; Kim, Joo Hang; Krzakowski, Maciej; Laack, Eckart; Wu, Yi-Long; Bover, Isabel; Begbie, Stephen; Tzekova, Valentina; Cucevic, Branka; Pereira, Jose Rodrigues; Yang, Sung Hyun; Madhavan, Jayaprakash; Sugarman, Katherine P.; Peterson, Patrick; John, William J.; Krejcy, Kurt; Belani, Chandra P.			Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study	LANCET			English	Article							III TRIAL; LINE THERAPY; CHEMOTHERAPY; CISPLATIN; GEMCITABINE; COMBINATION; NSCLC; CARBOPLATIN; DURATION; DOCETAXEL	Background Several studies have shown the efficacy, tolerability, and ease of administration of pemetrexed-an antifolate antineoplastic agent-in patients with advanced non-small-cell lung cancer. We assessed pemetrexed as maintenance therapy in patients with this disease. Methods This randomised double-blind study was undertaken in 83 centres in 20 countries. 663 patients with stage IIIB or IV disease who had not progressed on four cycles of platinum-based chemotherapy were randomly assigned (21 ratio) to receive pemetrexed (500 mg/m(2), day 1) plus best supportive care (n=441) or placebo plus best supportive care (n=222) in 21-day cycles until disease progression. Treatment was randomised with the Simon and Pocock minimisation method. Patients and investigators were masked to treatment. All patients received vitamin B-12, folic acid, and dexamethasone. The primary endpoint of progression-free survival and the secondary endpoint of overall survival were analysed by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00102804. Findings All randomly assigned participants were analysed. Pemetrexed significantly improved progression-free survival (4.3 months [95% CI 4.1-4.7] vs 2.6 months [1.7-2.8]; hazard ratio [HR] 0.50, 95% CI 0.42-0.61, p<0.0001) and overall survival (13.4 months [11.9-15.91 vs 10.6 months [8.7-12.0]; HR 0.79, 0.65-0.95, p=0.012) compared with placebo. Treatment discontinuations due to drug-related toxic effects were higher in the pemetrexed group than in the placebo group (21 [5%] vs three [1%]). Drug-related grade three or higher toxic effects were higher with pemetrexed than with placebo (70 [16%] vs nine [4%]; p<0.0001), specifically fatigue (22 [5%] vs one [1%], p=0.001) and neutropenia (13 [3%] vs 0, p=0.006). No pemetrexed-related deaths occurred. Relatively fewer patients in the pemetrexed group than in the placebo group received systemic post-discontinuation therapy (227 [51%] vs 149 [67%]; p=0.0001). Interpretation Maintenance therapy with pemetrexed is well tolerated and offers improved progression-free and overall survival compared with placebo in patients with advanced non-small-cell lung cancer. Funding Eli Lilly.	[Belani, Chandra P.] Penn State Hershey Canc Inst, Hershey, PA 17033 USA; [Krejcy, Kurt] Lilly Reg Operat, Vienna, Austria; [Ciuleanu, Tudor] Oncol Inst Ion Chiricuta, Cluj Napoca, Romania; [Ciuleanu, Tudor; Brodowicz, Thomas; Zielinski, Christoph; Krzakowski, Maciej; Tzekova, Valentina; Cucevic, Branka] CECOG, Vienna, Austria; [Brodowicz, Thomas; Zielinski, Christoph] Med Univ Vienna Gen Hosp, Dept Med 1, Div Clin Oncol, Vienna, Austria; [Kim, Joo Hang] Yonsei Canc Ctr, Seoul, South Korea; [Krzakowski, Maciej] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Krzakowski, Maciej] Inst Oncol, Warsaw, Poland; [Laack, Eckart] Univ Hosp Hamburg Eppendorf, Univ Canc Ctr Hamburg, Hamburg, Germany; [Wu, Yi-Long] Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China; [Bover, Isabel] Fdn Hosp Son Llatzer Ctra Manacor, Manacor, Spain; [Begbie, Stephen] N Coast Canc Inst, Port Macquarie, NSW, Australia; [Tzekova, Valentina] Univ Hosp Queen Joanna, Sofia, Bulgaria; [Cucevic, Branka] Hosp Lung Dis, Jordanovac, Croatia; [Pereira, Jose Rodrigues] Inst Canc Arnaldo Vieira de Carvalho, Sao Paulo, Brazil; [Yang, Sung Hyun] Korea Canc Ctr Hosp, Seoul, South Korea; [Madhavan, Jayaprakash] Reg Canc Ctr, Trivandrum 695011, Kerala, India; [Sugarman, Katherine P.; Peterson, Patrick; John, William J.] Eli Lilly & Co, Indianapolis, IN 46285 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Oncology Institute Prof. Dr. Ion Chiricuta; Medical University of Vienna; University Hospital Vienna; Yonsei University; Yonsei University Health System; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of Hamburg; University Medical Center Hamburg-Eppendorf; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Medical University Sofia; National Cancer Center - Korea (NCC); Eli Lilly	Belani, CP (corresponding author), Penn State Hershey Canc Inst, 500 Univ Dr,CH72, Hershey, PA 17033 USA.	cbelani@psu.edu	Wu, Yi-Long/AAW-9832-2020; Ciuleanu, Tudor-Eliade/ABH-8452-2020; Ciuleanu, Tudor Eliade/C-3996-2011; Wu, Yi-Long/GRJ-9238-2022; Wu, Yi-Long/C-3396-2008; Wu, Yi-Long/AAB-9137-2022	Wu, Yi-Long/0000-0002-3611-0258; Wu, Yi-Long/0000-0002-3611-0258; Ciuleanu, Tudor Eliade/0000-0003-0958-5597; Belani, Chandra/0000-0001-5049-5329; Krzakowski, Maciej/0000-0003-3324-0900	Eli Lilly	Eli Lilly(Eli Lilly)	The study was sponsored and funded by Eli Lilly We thank all patients, their families, and the staff at participating centres; and Asavari Wagle and Noelle Gasco of Eli Lilly, Indianapolis, USA, for editorial support. This Article is an original report that was presented in part at the 44th American Society of Clinical Oncology Annual Meeting in Chicago, I L, USA on May 30-June 3, 2008, and at the 45th American Society of Clinical Oncology Annual Meeting in Orlando, FL, USA on May 28-June 1, 2009.	Belani C.P., 2009, J CLIN ONCOL, V27, p806s; Boulikas T, 2004, ONCOL REP, V11, P559; Brodowicz T, 2006, LUNG CANCER, V52, P155, DOI 10.1016/j.lungcan.2006.01.006; Cappuzzo F, 2009, J CLIN ONCOL S, V27, p407s; Cox DR., 1989, ANAL BINARY DATA; Felip E, 2005, ANN ONCOL, V16, P28, DOI 10.1093/annonc/mdi821; Fidias PM, 2009, J CLIN ONCOL, V27, P591, DOI 10.1200/JCO.2008.17.1405; Fleming ID, 1997, AJCC CANC STAGING MA, P127; Gatzemeier U, 2007, J CLIN ONCOL, V25, P1545, DOI 10.1200/JCO.2005.05.1474; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Giovannetti E, 2005, MOL PHARMACOL, V68, P110, DOI 10.1124/mol.104.009373; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Hensing TA, 2005, LUNG CANCER-J IASLC, V47, P253, DOI 10.1016/j.lungcan.2004.07.040; HOLLEN PJ, 1994, CANCER-AM CANCER SOC, V73, P2087, DOI 10.1002/1097-0142(19940415)73:8<2087::AID-CNCR2820730813>3.0.CO;2-X; Johnson EA, 2008, LUNG CANCER, V60, P200, DOI 10.1016/j.lungcan.2007.10.003; MILLER VA, 2009, J CLIN ONCOL, V27, pS799; National Comprehensive Cancer Network, 2007, NCCN CLIN PRACT GUID; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pfister DG, 2004, J CLIN ONCOL, V22, P330, DOI 10.1200/JCO.2004.09.053; Pirker R, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.3; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shih C, 1997, CANCER RES, V57, P1116; Smith IE, 2001, J CLIN ONCOL, V19, P1336, DOI 10.1200/JCO.2001.19.5.1336; Socinski MA, 2002, J CLIN ONCOL, V20, P1335, DOI 10.1200/JCO.20.5.1335; Socinski MA, 2003, CHEST, V123, p226S, DOI 10.1378/chest.123.1_suppl.226S; Soon YY, 2009, J CLIN ONCOL, V27, P3277, DOI 10.1200/JCO.2008.19.4522; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Travis W, 1999, HISTOLOGICAL TYPING, P7; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wakelee H, 2005, ONCOLOGIST, V10, P1, DOI 10.1634/theoncologist.10-90003-1; Westeel F, 2005, JNCI-J NATL CANCER I, V97, P499, DOI 10.1093/jnci/dji096; ZIELINSKI CC, 2008, J CLIN ONCOL, V26, pS438	36	885	945	0	56	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2009	374	9699					1432	1440		10.1016/S0140-6736(09)61497-5	http://dx.doi.org/10.1016/S0140-6736(09)61497-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MZ	19767093				2022-12-28	WOS:000271255000032
J	Pagel, C; Lewycka, S; Colbourn, T; Mwansambo, C; Meguid, T; Chiudzu, G; Utley, M; Costello, AML				Pagel, Christina; Lewycka, Sonia; Colbourn, Tim; Mwansambo, Charles; Meguid, Tarek; Chiudzu, Grace; Utley, Martin; Costello, Anthony M. L.			Estimation of potential effects of improved community-based drug provision, to augment health-facility strengthening, on maternal mortality due to post-partum haemorrhage and sepsis in sub-Saharan Africa: an equity-effectiveness model	LANCET			English	Article							CHILD UNDERNUTRITION; MANAGEMENT; SURVIVAL; STRATEGIES; MALARIA; INTERVENTIONS; MISOPROSTOL; PREVENTION; PNEUMONIA; COUNTRIES	Background Maternal mortality in Africa has changed little since 1990. We developed a mathematical model with the aim to assess whether improved community-based access to life-saving drugs, to augment a core programme of health-facility strengthening, could reduce maternal mortality due to post-partum haemorrhage or sepsis. Methods We developed a mathematical model by considering the key events leading to maternal death from post-partum haemorrhage or sepsis after delivery. With parameter estimates from published work of occurrence of post-partum haemorrhage and sepsis, case fatality and the effectiveness of drugs, we used this model to estimate the effect of three potential packages of interventions: 1) health-facility strengthening; 2) health-facility strengthening combined with improved drug provision via antenatal-care appointments and community health workers; and 3) all interventions in package two combined with improved community-based drug provision via female volunteers in villages. The model was applied to Malawi and sub-Saharan Africa. Findings In the implementation of the model, the lowest risk deliveries were those in health facilities. With the model we estimated that of 2860 maternal deaths from post-partum haemorrhage or sepsis per year in Malawi, intervention package one could prevent 210 (7%) deaths, package two 720 (25%) deaths, and package three 1020 (36%) deaths. In sub-Saharan Africa, we estimated that of 182 000 of such maternal deaths per year, these three packages could prevent 21300 (12%), 43 800 (24%), and 59 000 (32%) deaths, respectively. The estimated effect of community-based drug provision was greatest for the poorest women. Interpretation Community provision of misoprostol and antibiotics to reduce maternal deaths from post-partum haemorrhage and sepsis could be a highly effective addition to health-facility strengthening in Africa. Investigation of such interventions is urgently needed to establish the risks, benefits, and challenges of widespread implementation. Funding Institute of Child Health and Faculty of Mathematical and Physical Sciences, University College London, and a donation from John and Ann-Margaret Walton.	[Pagel, Christina; Utley, Martin] UCL, Clin Operat Res Unit, Dept Math, London WC1H 0BT, England; [Lewycka, Sonia; Colbourn, Tim; Costello, Anthony M. L.] UCL, Ctr Int Hlth & Dev, Inst Child Hlth, London WC1H 0BT, England; [Meguid, Tarek; Chiudzu, Grace] Kamuzu Cent Hosp, Dept Obstet & Gynaecol, Lilongwe, Malawi; [Meguid, Tarek; Chiudzu, Grace] Bwaila Hosp, Lilongwe, Malawi; [Lewycka, Sonia; Colbourn, Tim; Mwansambo, Charles] Univ Malawi, Kamuzu Cent Hosp, Dept Paediat, Parent & Child Hlth Initiat, Lilongwe, Malawi	University of London; University College London; University of London; University College London; University of Malawi	Pagel, C (corresponding author), UCL, Clin Operat Res Unit, Dept Math, 4 Taviton St, London WC1H 0BT, England.	c.pagel@ucl.ac.uk	Colbourn, Tim/AAE-6645-2019; Lewycka, Sonia/J-1234-2019; Lewycka, Sonia/G-4698-2012	Colbourn, Tim/0000-0002-6917-6552; Lewycka, Sonia/0000-0002-5923-9468; Pagel, Christina/0000-0002-2857-1628; Utley, Martin/0000-0001-9928-1516	Institute of Child Health; Dean of the Faculty of Mathematical and Physical Sciences; The Health Foundation; UK Department for International Development; UK Department of Health Policy Research Programme	Institute of Child Health; Dean of the Faculty of Mathematical and Physical Sciences; The Health Foundation; UK Department for International Development; UK Department of Health Policy Research Programme	This study was funded jointly by the Institute of Child Health and the Dean of the Faculty of Mathematical and Physical Sciences (Richard Catlow) at University College London; and John and Ann-Margaret Walton contributed a generous donation. The Health Foundation and the UK Department for International Development provided funding support via salary provision for TC and SL. The Clinical Operational Research Unit (MU) receives funding from the UK Department of Health Policy Research Programme. We thank Wronique Fihppi for her valuable input.	AbouZahr C, 2003, BRIT MED BULL, V67, P13, DOI 10.1093/bmb/ldg014; Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Alfirevic Z, 2007, INT J GYNECOL OBSTET, V99, pS198, DOI 10.1016/j.ijgo.2007.09.012; BANG AT, 1994, B WORLD HEALTH ORGAN, V72, P897; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Collin Simon M, 2007, BMC Pregnancy Childbirth, V7, P6, DOI 10.1186/1471-2393-7-6; Costello A, 2004, BMJ-BRIT MED J, V329, P1166, DOI 10.1136/bmj.329.7475.1166; Das LK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-75; Derman RJ, 2006, LANCET, V368, P1248, DOI 10.1016/S0140-6736(06)69522-6; Elmardi KA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-39; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Geller SE, 2006, INT J GYNECOL OBSTET, V92, P202, DOI 10.1016/j.ijgo.2005.12.009; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Hadi A, 2003, B WORLD HEALTH ORGAN, V81, P183; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hofmeyr GJ, 2008, BEST PRACT RES CL OB, V22, P1025, DOI 10.1016/j.bpobgyn.2008.08.005; Holloway KA, 2009, TROP MED INT HEALTH, V14, P101, DOI 10.1111/j.1365-3156.2008.02191.x; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kidney E, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-2; Koblinsky MA, 1999, B WORLD HEALTH ORGAN, V77, P399; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Lilford RJ, 1998, BMJ-BRIT MED J, V317, P405; Maine D, 1997, INT J GYNECOL OBSTET, V59, pS23, DOI 10.1016/S0020-7292(97)00144-6; Maine D, 1997, INT J GYNECOL OBSTET, V59, pS259, DOI 10.1016/S0020-7292(97)00174-4; *MED SANS FRONT, 2008, FULL PRESCR BETT MAL; Okech BA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004050; Prata N, 2009, HEALTH POLICY, V89, P131, DOI 10.1016/j.healthpol.2008.05.007; RAIBHANDARI S, 2006, INT J GYNECOL OBS S2, V94, pS143; Rasmussen Z, 2000, INT J TUBERC LUNG D, V4, P807; Ross JS, 2004, AM J PUBLIC HEALTH, V94, P1174, DOI 10.2105/AJPH.94.7.1174; SANGHVI H, PREVENTING PPH HOMEB; Sebitloane HM, 2008, BEST PRACT RES CL OB, V22, P489, DOI 10.1016/j.bpobgyn.2007.11.003; Wagstaff A, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P181; WHO, 1996, WHOFHEMSM9411	37	51	52	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2009	374	9699					1441	1448		10.1016/S0140-6736(09)61566-X	http://dx.doi.org/10.1016/S0140-6736(09)61566-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MZ	19783291				2022-12-28	WOS:000271255000033
J	Birge, NO				Birge, Norman O.			Sensing a Small But Persistent Current	SCIENCE			English	Editorial Material							MESOSCOPIC RINGS; CYLINDERS; SINGLE; LOOP		Michigan State Univ, Dept Phys, E Lansing, MI 48824 USA	Michigan State University	Birge, NO (corresponding author), Michigan State Univ, Dept Phys, E Lansing, MI 48824 USA.	birge@pa.msu.edu						AMBEGAOKAR V, 1990, PHYS REV LETT, V65, P381, DOI 10.1103/PhysRevLett.65.381; AMBEGAOKAR V, 1991, PHYS REV LETT, V67, P3192, DOI 10.1103/PhysRevLett.67.3192; Bary-Soroker H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057001; Bleszynski-Jayich AC, 2009, SCIENCE, V326, P272, DOI 10.1126/science.1178139; Bluhm H, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.136802; BUTTIKER M, 1983, PHYS LETT A, V96, P365, DOI 10.1016/0375-9601(83)90011-7; BYERS N, 1961, PHYS REV LETT, V7, P46, DOI 10.1103/PhysRevLett.7.46; CHANDRASEKHAR V, 1991, PHYS REV LETT, V67, P3578, DOI 10.1103/PhysRevLett.67.3578; CHEUNG HF, 1989, PHYS REV LETT, V62, P587, DOI 10.1103/PhysRevLett.62.587; Jariwala EMQ, 2001, PHYS REV LETT, V86, P1594, DOI 10.1103/PhysRevLett.86.1594; LEVY LP, 1990, PHYS REV LETT, V64, P2074, DOI 10.1103/PhysRevLett.64.2074; MAILLY D, 1993, PHYS REV LETT, V70, P2020, DOI 10.1103/PhysRevLett.70.2020; RIEDEL EK, 1993, PHYS REV B, V47, P15449, DOI 10.1103/PhysRevB.47.15449	13	26	27	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 9	2009	326	5950					244	245		10.1126/science.1180577	http://dx.doi.org/10.1126/science.1180577			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815766	Green Submitted			2022-12-28	WOS:000270599500030
J	Wald, HS				Wald, Hedy S.			Separation Anxiety	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												hedy_wald@brown.edu							0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	2009	302	13					1403	1404		10.1001/jama.2009.1339	http://dx.doi.org/10.1001/jama.2009.1339			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503CL	19809014				2022-12-28	WOS:000270509600001
J	Gillespie, PG; Muller, U				Gillespie, Peter G.; Mueller, Ulrich			Mechanotransduction by Hair Cells: Models, Molecules, and Mechanisms	CELL			English	Review							TIP LINKS; MECHANOELECTRICAL TRANSDUCTION; COCHLEAR AMPLIFICATION; MYOSIN-XVA; SENSORY TRANSDUCTION; CALCIUM CHELATION; ADAPTATION-MOTOR; STEREOCILIA TIPS; BLOCK ADAPTATION; BUNDLE MOVEMENTS	Mechanotransduction, the transformation of mechanical force into an electrical signal, allows living organisms to hear, register movement and gravity, detect touch, and sense changes in cell volume and shape. Hair cells in the inner ear are specialized mechanoreceptor cells that detect sound and head movement. The mechanotransduction machinery of hair cells is extraordinarily sensitive and responds to minute physical displacements on a submillisecond timescale. The recent discovery of several molecular constituents of the mechanotransduction machinery of hair cells provides a new framework for the interpretation of biophysical data and necessitates revision of prevailing models of mechanotransduction.	[Gillespie, Peter G.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; [Gillespie, Peter G.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Mueller, Ulrich] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Oregon Health & Science University; Oregon Health & Science University; Scripps Research Institute	Gillespie, PG (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA.	gillespp@ohsu.edu; umueller@scripps.edu		Barr-Gillespie, Peter/0000-0002-9787-5860	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007704, R01DC005965] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC007704-04, R01 DC005965-04, R01 DC007704, R01 DC005965] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; ASSAD JA, 1991, NEURON, V7, P985, DOI 10.1016/0896-6273(91)90343-X; ASSAD JA, 1992, J NEUROSCI, V12, P3291; Bashtanov ME, 2004, J PHYSIOL-LONDON, V559, P287, DOI 10.1113/jphysiol.2004.065565; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Beurg M, 2008, BIOPHYS J, V94, P2639, DOI 10.1529/biophysj.107.123257; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Bozovic D, 2003, P NATL ACAD SCI USA, V100, P958, DOI 10.1073/pnas.0337433100; Cheung ELM, 2006, BIOPHYS J, V90, P124, DOI 10.1529/biophysj.105.061226; COREY DP, 1983, J NEUROSCI, V3, P962; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; CRAWFORD AC, 1991, J PHYSIOL-LONDON, V434, P369, DOI 10.1113/jphysiol.1991.sp018475; Cueva JG, 2007, J NEUROSCI, V27, P14089, DOI 10.1523/JNEUROSCI.4179-07.2007; Cyr JL, 2002, J NEUROSCI, V22, P2487, DOI 10.1523/JNEUROSCI.22-07-02487.2002; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Dallos P, 2008, CURR OPIN NEUROBIOL, V18, P370, DOI 10.1016/j.conb.2008.08.016; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; Drexl M, 2008, J NEUROPHYSIOL, V99, P1607, DOI 10.1152/jn.01216.2007; Farris HE, 2004, J PHYSIOL-LONDON, V558, P769, DOI 10.1113/jphysiol.2004.061267; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Fettiplace R, 2006, J PHYSIOL-LONDON, V576, P29, DOI 10.1113/jphysiol.2006.115949; FURNESS DN, 1985, HEARING RES, V18, P177, DOI 10.1016/0378-5955(85)90010-3; Garcia JA, 1998, J NEUROSCI, V18, P8637; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; GILLESPIE PG, 1993, P NATL ACAD SCI USA, V90, P2710, DOI 10.1073/pnas.90.7.2710; Gillespie PG, 2002, NAT NEUROSCI, V5, P3, DOI 10.1038/nn0102-3; GOLD T, 1948, PROC R SOC SER B-BIO, V135, P492, DOI 10.1098/rspb.1948.0025; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; HACKNEY CM, 1993, HEARING RES, V69, P163, DOI 10.1016/0378-5955(93)90104-9; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Holt JR, 1997, J NEUROSCI, V17, P8739; Holt JR, 2002, CELL, V108, P371, DOI 10.1016/S0092-8674(02)00629-3; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; Hudspeth AJ, 2008, NEURON, V59, P530, DOI 10.1016/j.neuron.2008.07.012; HUDSPETH AJ, 1992, SOC GEN PHY, V47, P357; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; HUDSPETH AJ, 1982, J NEUROSCI, V2, P1; JACOBS RA, 1990, COLD SPRING HARB SYM, V55, P547; JARAMILLO F, 1993, P NATL ACAD SCI USA, V90, P1330, DOI 10.1073/pnas.90.4.1330; JARAMILLO F, 1991, NEURON, V7, P409, DOI 10.1016/0896-6273(91)90293-9; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kennedy HJ, 2005, NATURE, V433, P880, DOI 10.1038/nature03367; Kozlov AS, 2007, NAT NEUROSCI, V10, P87, DOI 10.1038/nn1818; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Lelli A, 2009, J NEUROPHYSIOL, V101, P2961, DOI 10.1152/jn.00136.2009; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; LUMPKIN EA, 1995, P NATL ACAD SCI USA, V92, P10297, DOI 10.1073/pnas.92.22.10297; Martin P, 2003, J NEUROSCI, V23, P4533; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Muller U, 2008, CURR OPIN CELL BIOL, V20, P557, DOI 10.1016/j.ceb.2008.06.004; NARINS PM, 1984, J ACOUST SOC AM, V76, P1384, DOI 10.1121/1.391455; Phillips KR, 2006, J NEUROSCI, V26, P10777, DOI 10.1523/JNEUROSCI.1847-06.2006; PICKLES JO, 1991, SCANNING MICROSCOPY, V5, P1115; PICKLES JO, 1984, HEARING RES, V15, P103, DOI 10.1016/0378-5955(84)90041-8; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Prost J, 2007, BIOPHYS J, V93, P1124, DOI 10.1529/biophysj.106.098038; RHODE WS, 1967, J ACOUST SOC AM, V42, P185, DOI 10.1121/1.1910547; Ricci AJ, 2000, J NEUROSCI, V20, P7131; Ricci AJ, 1998, J NEUROSCI, V18, P8261; Ricci AJ, 2003, NEURON, V40, P983, DOI 10.1016/S0896-6273(03)00721-9; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Schneider ME, 2006, J NEUROSCI, V26, P10243, DOI 10.1523/JNEUROSCI.2812-06.2006; Schwander M, 2009, P NATL ACAD SCI USA, V106, P5252, DOI 10.1073/pnas.0900691106; SHEPHERD GMG, 1994, J NEUROSCI, V14, P6217; SHEPHERD GMG, 1992, J GEN PHYSIOL, V98, pA25; SHOTWELL SL, 1981, ANN NY ACAD SCI, V374, P1, DOI 10.1111/j.1749-6632.1981.tb30854.x; Siemens J, 2004, NATURE, V428, P950, DOI 10.1038/nature02483; Sotomayor M, 2008, BIOPHYS J, V94, P4621, DOI 10.1529/biophysj.107.125591; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; Stauffer EA, 2007, J NEUROPHYSIOL, V98, P3360, DOI 10.1152/jn.00914.2007; Stepanyan R, 2009, J NEUROSCI, V29, P4023, DOI 10.1523/JNEUROSCI.4566-08.2009; Steyger PS, 1998, J NEUROSCI, V18, P4603; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Tsuprun V, 2004, BIOPHYS J, V87, P4106, DOI 10.1529/biophysj.104.049031; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Vollrath MA, 2007, ANNU REV NEUROSCI, V30, P339, DOI 10.1146/annurev.neuro.29.051605.112917; Waguespack J, 2007, J NEUROSCI, V27, P13890, DOI 10.1523/JNEUROSCI.2159-07.2007; Walsh T, 2002, P NATL ACAD SCI USA, V99, P7518, DOI 10.1073/pnas.102091699; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Yamoah EN, 1996, NEURON, V17, P523, DOI 10.1016/S0896-6273(00)80184-1; Zhao YD, 1996, P NATL ACAD SCI USA, V93, P15469, DOI 10.1073/pnas.93.26.15469	92	281	291	2	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 2	2009	139	1					33	44		10.1016/j.cell.2009.09.010	http://dx.doi.org/10.1016/j.cell.2009.09.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804752	Green Accepted, Bronze			2022-12-28	WOS:000270388600014
J	Corey, L; Wald, A				Corey, Lawrence; Wald, Anna			Current Concepts: Maternal and Neonatal Herpes Simplex Virus Infections.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CONGENITAL-RUBELLA SYNDROME; GENITAL HERPES; UNITED-STATES; PREGNANT-WOMEN; PSYCHOSOCIAL IMPACT; COST-EFFECTIVENESS; TRANSMISSION; ACYCLOVIR; RISK; DELIVERY		[Corey, Lawrence; Wald, Anna] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, Seattle, WA 98109 USA; [Corey, Lawrence; Wald, Anna] Univ Washington, Dept Med, Seattle, WA USA; [Corey, Lawrence; Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Wald, Anna] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Corey, L (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Inst, 1100 Fairview Ave N,LE-500, Seattle, WA 98109 USA.	lcorey@u.washington.edu	Wald, Anna/B-6272-2012; Corey, Lawrence/AAE-1796-2020	Wald, Anna/0000-0003-3486-6438; Corey, Lawrence/0000-0002-2179-2436	National Institutes of Health [PO1 AI-30731, R37 AI-42528, CA-15704]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042528, P01AI030731] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the National Institutes of Health ( PO1 AI-30731, R37 AI-42528, and CA-15704).	*ACOG COMM PRACT B, 2007, OBSTET GYNECOL, V109, P1489; Andrews WW, 2006, AM J OBSTET GYNECOL, V194, P774, DOI 10.1016/j.ajog.2005.11.051; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P279; Apostol M., 2009, Morbidity and Mortality Weekly Report, V58, P109; ARMSTRONG D, 2006, WALL STREET J   1215; Averhoff F, 2006, CLIN INFECT DIS, V43, pS151, DOI 10.1086/505948; Bergeron MG, 2000, NEW ENGL J MED, V343, P175, DOI 10.1056/NEJM200007203430303; Bravo FJ, 1996, J INFECT DIS, V173, P1, DOI 10.1093/infdis/173.1.1; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; Caviness AC, 2008, ARCH PEDIAT ADOL MED, V162, P665, DOI 10.1001/archpedi.162.7.665; *CDCP, 2007, GEN HERP CDC FACT SH; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P592; Cleary KL, 2005, BJOG-INT J OBSTET GY, V112, P731, DOI 10.1111/j.1471-0528.2005.00540.x; COCHI SL, 1989, AM J EPIDEMIOL, V129, P349, DOI 10.1093/oxfordjournals.aje.a115138; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Diamond C, 1999, PEDIATR INFECT DIS J, V18, P487, DOI 10.1097/00006454-199906000-00002; DiCenso A, 2002, BMJ-BRIT MED J, V324, P1426, DOI 10.1136/bmj.324.7351.1426; Edozien A. O., 2004, Morbidity and Mortality Weekly Report, V53, P716; Gardella C, 2005, AM J OBSTET GYNECOL, V193, P1891, DOI 10.1016/j.ajog.2005.07.041; Gesundheit B, 2004, PEDIATRICS, V114, P259, DOI 10.1542/peds.114.2.e259; Gutierrez KM, 1999, J INFECT DIS, V180, P199, DOI 10.1086/314848; Hensleigh PA, 1997, OBSTET GYNECOL, V89, P891, DOI 10.1016/S0029-7844(97)00121-X; HERPES S, 2009, RED BOOK 2009 REPORT, P363; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; Kimberlin David W, 2005, Semin Pediatr Infect Dis, V16, P271, DOI 10.1053/j.spid.2005.06.007; Kimberlin DW, 2001, PEDIATRICS, V108, P230, DOI 10.1542/peds.108.2.230; Kimberlin DW, 2001, PEDIATRICS, V108, P223, DOI 10.1542/peds.108.2.223; Kropp RY, 2006, PEDIATRICS, V117, P1955, DOI 10.1542/peds.2005-1778; KULHANJIAN JA, 1992, NEW ENGL J MED, V326, P916, DOI 10.1056/NEJM199204023261403; Mark KE, 2006, AM J OBSTET GYNECOL, V194, P408, DOI 10.1016/j.ajog.2005.08.018; Marum E, 2006, JAMA-J AM MED ASSOC, V296, P859, DOI 10.1001/jama.296.7.859; Meissner HC, 2006, PEDIATRICS, V117, P933, DOI 10.1542/peds.2005-1760; Miyai T, 2004, SEX TRANSM DIS, V31, P517, DOI 10.1097/01.olq.0000137901.71284.6b; Money D, 2008, J OBSTET GYNAECOL CA, V30, P770, DOI 10.1016/S1701-2163(16)32805-5; Morris SR, 2008, SEX TRANSM DIS, V35, P14, DOI 10.1097/OLQ.0b013e3180f62bc7; Morrow RA, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-84; Morrow RA, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-11; *OH DEP HLTH, REP CAS SEL NOT DIS; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Qutub M, 2001, INT J STD AIDS, V12, P14, DOI 10.1258/0956462011916677; Reef SE, 2006, CLIN INFECT DIS, V43, pS126, DOI 10.1086/505944; Reef SE, 2006, CLIN INFECT DIS, V43, pS123, DOI 10.1086/505943; Rosenthal SL, 2006, SEX TRANSM INFECT, V82, P154, DOI 10.1136/sti.2005.016311; Schillinger JA, 2006, 2006 NAT STD PREV C; Sheffield JS, 2003, OBSTET GYNECOL, V102, P1396, DOI 10.1016/j.obstetgynecol.2003.08.015; SULLENDER WM, 1988, J INFECT DIS, V157, P164, DOI 10.1093/infdis/157.1.164; Thung SF, 2005, AM J OBSTET GYNECOL, V192, P483, DOI 10.1016/j.ajog.2004.09.134; Underhill K, 2007, BMJ-BRIT MED J, V335, P248, DOI 10.1136/bmj.39245.446586.BE; Urato AC, 2006, LANCET, V368, P898, DOI 10.1016/S0140-6736(06)69348-3; *WA STAT DEP HLTH, WASH STAT HIV AIDS F; Wald A, 2003, J INFECT DIS, V188, P1345, DOI 10.1086/379043; Watts DH, 2003, AM J OBSTET GYNECOL, V188, P836, DOI 10.1067/mob.2003.185; Whitley R, 2007, SEX TRANSM DIS, V34, P704, DOI 10.1097/01.olq.0000258432.33412.e2; WHITLEY RJ, 1988, J INFECT DIS, V158, P109, DOI 10.1093/infdis/158.1.109; WHITLEY RJ, 1980, PEDIATRICS, V66, P495; 2005, ANN INTERN MED, V143, P707; 2002, MMWR MORB MORTAL WKL, V51, P93	58	213	219	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2009	361	14					1376	1385		10.1056/NEJMra0807633	http://dx.doi.org/10.1056/NEJMra0807633			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500KZ	19797284	Green Accepted			2022-12-28	WOS:000270300000012
J	Crosson, FJ				Crosson, Francis J.			21st-Century Health Care -- The Case for Integrated Delivery Systems.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICARE		Kaiser Permanente Inst Hlth Policy, Oakland, CA 94612 USA	Kaiser Permanente	Crosson, FJ (corresponding author), Kaiser Permanente Inst Hlth Policy, Oakland, CA 94612 USA.							[Anonymous], NEW YORKER; Crosson FJ, 2009, HEALTH AFFAIR, V28, pW232, DOI 10.1377/hlthaff.28.2.w232; FALK IS, 1933, COSTS MED CARE SUMMA, P515; Guterman S, 2009, HEALTH AFFAIR, V28, pW238, DOI 10.1377/hlthaff.28.2.w238; Shih A., 2008, ORG US HLTH CARE DEL	5	44	44	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2009	361	14					1324	1325		10.1056/NEJMp0906917	http://dx.doi.org/10.1056/NEJMp0906917			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	500KZ	19776400				2022-12-28	WOS:000270300000002
J	Moriniere, J; Rousseaux, S; Steuerwald, U; Soler-Lopez, M; Curtet, S; Vitte, AL; Govin, J; Gaucher, J; Sadoul, K; Hart, DJ; Krijgsveld, J; Khochbin, S; Muller, CW; Petosa, C				Moriniere, Jeanne; Rousseaux, Sophie; Steuerwald, Ulrich; Soler-Lopez, Montserrat; Curtet, Sandrine; Vitte, Anne-Laure; Govin, Jerome; Gaucher, Jonathan; Sadoul, Karin; Hart, Darren J.; Krijgsveld, Jeroen; Khochbin, Saadi; Mueller, Christoph W.; Petosa, Carlo			Cooperative binding of two acetylation marks on a histone tail by a single bromodomain	NATURE			English	Article							CHROMATIN MODIFICATIONS; MITOTIC CHROMOSOMES; RECOGNITION; PROTEINS; BRDT; CBP; H4	A key step in many chromatin-related processes is the recognition of histone post-translational modifications by effector modules such as bromodomains and chromo-like domains of the Royal family(1,2). Whereas effector-mediated recognition of single post-translational modifications is well characterized(3), how the cell achieves combinatorial readout of histones bearing multiple modifications is poorly understood. One mechanism involves multivalent binding by linked effector modules(4). For example, the tandem bromodomains of human TATA-binding protein-associated factor-1 (TAF1) bind better to a diacetylated histone H4 tail than to monoacetylated tails, a cooperative effect attributed to each bromodomain engaging one acetyl-lysine mark(5). Here we report a distinct mechanism of combinatorial readout for the mouse TAF1 homologue Brdt, a testis-specific member of the BET protein family(6). Brdt associates with hyperacetylated histone H4 (ref. 7) and is implicated in the marked chromatin remodelling that follows histone hyperacetylation during spermiogenesis, the stage of spermatogenesis in which post-meiotic germ cells mature into fully differentiated sperm(7-10). Notably, we find that a single bromodomain (BD1) of Brdt is responsible for selectively recognizing histone H4 tails bearing two or more acetylation marks. The crystal structure of BD1 bound to a diacetylated H4 tail shows how two acetyl-lysine residues cooperate to interact with one binding pocket. Structure-based mutagenesis that reduces the selectivity of BD1 towards diacetylated tails destabilizes the association of Brdt with acetylated chromatin in vivo. Structural analysis suggests that other chromatin-associated proteins may be capable of a similar mode of ligand recognition, including yeast Bdf1, human TAF1 and human CBP/p300 (also known as CREBBP and EP300, respectively). Our findings describe a new mechanism for the combinatorial readout of histone modifications in which a single effector module engages two marks on a histone tail as a composite binding epitope.	[Steuerwald, Ulrich; Krijgsveld, Jeroen; Mueller, Christoph W.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Moriniere, Jeanne; Soler-Lopez, Montserrat; Hart, Darren J.] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; [Moriniere, Jeanne; Soler-Lopez, Montserrat; Hart, Darren J.] Univ Grenoble 1, CNRS, EMBL, Unit Virus Host Cell Interact,UMI 3265, F-38042 Grenoble 9, France; [Rousseaux, Sophie; Curtet, Sandrine; Vitte, Anne-Laure; Govin, Jerome; Gaucher, Jonathan; Sadoul, Karin; Khochbin, Saadi] Univ Grenoble 1, INSERM, U823, Inst Albert Bonniot, F-38700 Grenoble, France; [Petosa, Carlo] Univ Grenoble 1, CNRS, CEA, Inst Biol Struct Jean Pierre Ebel,UMR 5075, F-38027 Grenoble 1, France	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Muller, CW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	christoph.mueller@embl.de	Sadoul, Karin/N-2649-2013; Khochbin, Saadi/M-8090-2013; CURTET, Sandrine/N-3517-2013; Govin, Jerome/B-2326-2014; CURTET, Sandrine/E-8217-2019; GAUCHER, Jonathan/AGD-9327-2022; Müller, Christoph W/I-7420-2012; Rousseaux, Sophie/G-1697-2013; Krijgsveld, Jeroen/F-5974-2011; Hart, Darren/C-4858-2015	Sadoul, Karin/0000-0001-7174-5016; Khochbin, Saadi/0000-0002-0455-0857; Govin, Jerome/0000-0001-5511-6965; CURTET, Sandrine/0000-0002-9419-8868; GAUCHER, Jonathan/0000-0002-1654-8009; Müller, Christoph W/0000-0003-2176-8337; Rousseaux, Sophie/0000-0001-5246-5350; Petosa, Carlo/0000-0002-9975-1167; Hart, Darren/0000-0002-3502-2002; Krijgsveld, Jeroen/0000-0001-7549-9326	Rhone-Alpes region; EU; ANRS/Fondation de France AIJC; CNRS ATIP programmes	Rhone-Alpes region(Region Auvergne-Rhone-Alpes); EU(European Commission); ANRS/Fondation de France AIJC(ANRS); CNRS ATIP programmes	We thank the ESRF and EMBL staff for beamline assistance, the Partnership for Structural Biology (PSB) for access to technical platforms, M. Jamin for MALLS experiments, G. Natrajan and V. Rybin for help with ITC, C. Soucier for help with FRAP, D. Panne and C. Clapier for comments on the manuscript, and S. Cusack for critical support. Work in the S. K. laboratory was supported by ANR blanche 'EpiSperm' and 'Empreinte', INCa and 'ARECA' ( ARC) research programmes. J. Ga. was supported by a Ph. D. fellowship from the Rhone-Alpes region. J. M. was supported by an 'E-STAR' fellowship funded by EU FP6. C. P. acknowledges support from the ANRS/Fondation de France AIJC and CNRS ATIP programmes.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Crowley TE, 2002, MOL ENDOCRINOL, V16, P1727, DOI 10.1210/me.2001-0353; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Florence B, 2001, FRONT BIOSCI-LANDMRK, V6, pD1008, DOI 10.2741/Florence; Govin J, 2004, EUR J BIOCHEM, V271, P3459, DOI 10.1111/j.1432-1033.2004.04266.x; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Matangkasombut O, 2003, MOL CELL, V11, P353, DOI 10.1016/S1097-2765(03)00033-9; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Pivot-Pajot C, 2003, MOL CELL BIOL, V23, P5354, DOI 10.1128/MCB.23.15.5354-5365.2003; Polesskaya A, 2001, MOL CELL BIOL, V21, P5312, DOI 10.1128/MCB.21.16.5312-5320.2001; Rousseaux S, 2005, GENE, V345, P139, DOI 10.1016/j.gene.2004.12.004; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Toyama R, 2008, DEV DYNAM, V237, P1636, DOI 10.1002/dvdy.21576; Wei LL, 2008, BIOCHEM BIOPH RES CO, V368, P279, DOI 10.1016/j.bbrc.2008.01.071	28	322	347	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					664	U112		10.1038/nature08397	http://dx.doi.org/10.1038/nature08397			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794495				2022-12-28	WOS:000270302600043
J	Smith, HJ; Fahrenkamp-Uppenbrink, J; Coontz, R				Smith, H. Jesse; Fahrenkamp-Uppenbrink, Julia; Coontz, Robert			Clearing the Air INTRODUCTION	SCIENCE			English	Editorial Material																			0	14	14	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	2009	325	5948					1641	1641		10.1126/science.325_1641	http://dx.doi.org/10.1126/science.325_1641			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	498II	19779183				2022-12-28	WOS:000270131800027
J	D'Agostino, RB				D'Agostino, Ralph B., Sr.			The Delayed-Start Study Design	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		Boston Univ, Dept Math & Stat, Boston, MA 02215 USA	Boston University	D'Agostino, RB (corresponding author), Boston Univ, Dept Math & Stat, 111 Cummington St, Boston, MA 02215 USA.	ralph@bu.edu						D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Leber P, 1997, ALZ DIS ASSOC DIS, V11, pS10; Mallinckrodt C H, 2001, J Biopharm Stat, V11, P9, DOI 10.1081/BIP-100104194; Mani RB, 2004, STAT MED, V23, P305, DOI 10.1002/sim.1718; Olanow CW, 2009, NEW ENGL J MED, V361, P1268, DOI 10.1056/NEJMoa0809335; Siderowf A, 2004, ARCH NEUROL-CHICAGO, V61, P561	6	82	82	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2009	361	13					1304	1306		10.1056/NEJMsm0904209	http://dx.doi.org/10.1056/NEJMsm0904209			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497RN	19776413				2022-12-28	WOS:000270078700014
J	Gines, P; Schrier, RW				Gines, Pere; Schrier, Robert W.			MEDICAL PROGRESS Renal Failure in Cirrhosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SPONTANEOUS BACTERIAL PERITONITIS; LIVER-KIDNEY TRANSPLANTATION; TYPE-1 HEPATORENAL-SYNDROME; INTERNATIONAL-ASCITES-CLUB; SERUM CREATININE; NITRIC-OXIDE; RISK-FACTORS; ADRENAL INSUFFICIENCY; TERLIPRESSIN THERAPY; CONSENSUS CONFERENCE		[Schrier, Robert W.] Univ Colorado Denver, Dept Med, Div Renal Dis & Hypertens, Aurora, CO USA; [Gines, Pere] Univ Barcelona, Hosp Clin Barcelona, Liver Unit, Barcelona, Catalonia, Spain; [Gines, Pere] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Invest Biomed August Pi & Sunyer, Barcelona, Catalonia, Spain	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Schrier, RW (corresponding author), Univ Colorado, Hlth Sci Ctr, 12700 E 19th Ave,C281, Denver, CO 80045 USA.		Gines, Pere/B-6646-2009	Gines, Pere/0000-0003-4657-4504	Ministerio de Educacion y Ciencia [SAF 2005/01917]; Fondo de Investigacion Sanitaria [FIS05/0246, EC07/90077]; National Institute of Diabetes and Digestive and Kidney Diseases [P01 DK 19928]; General Clinical Research Center, University of Colorado Denver; Instituto de Salud Carlos III; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK019928] Funding Source: NIH RePORTER	Ministerio de Educacion y Ciencia(Spanish Government); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); General Clinical Research Center, University of Colorado Denver(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported in part by grants from the Ministerio de Educacion y Ciencia (SAF 2005/01917) and Fondo de Investigacion Sanitaria (FIS05/0246 and EC07/90077), the National Institute of Diabetes and Digestive and Kidney Diseases (P01 DK 19928), and the General Clinical Research Center, University of Colorado Denver. Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD) is funded by the Instituto de Salud Carlos III.	Albillos A, 2003, HEPATOLOGY, V37, P208, DOI 10.1053/jhep.2003.50038; Alessandria C, 2005, HEPATOLOGY, V41, P1282, DOI 10.1002/hep.20687; Angeli P, 1999, HEPATOLOGY, V29, P1690, DOI 10.1002/hep.510290629; Angeli P, 2008, J HEPATOL, V48, pS93, DOI 10.1016/j.jhep.2008.01.010; Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; Bataller R, 1997, SEMIN LIVER DIS, V17, P233, DOI 10.1055/s-2007-1007201; Becker T, 2003, LIVER TRANSPLANT, V9, P1067, DOI 10.1053/jlts.2003.50210; Bernard B, 1999, HEPATOLOGY, V29, P1655, DOI 10.1002/hep.510290608; Bories PN, 1997, HEPATOLOGY, V25, P1328, DOI 10.1002/hep.510250604; Bosch J, 2008, SEMIN LIVER DIS, V28, P3, DOI 10.1055/s-2008-1040318; Boyer TD, 2003, GASTROENTEROLOGY, V124, P1700, DOI 10.1016/S0016-5085(03)00377-9; CAMPBELL MS, 2005, LIVER TRANSPLANT; Capling RK, 2004, RENAL FAILURE, V26, P563, DOI 10.1081/JDI-200035988; Cardenas A, 2001, HEPATOLOGY, V34, P671, DOI 10.1053/jhep.2001.27830; CAREGARO L, 1994, ARCH INTERN MED, V154, P201, DOI 10.1001/archinte.154.2.201; ChinDusting JPF, 1997, ANN INTERN MED, V127, P985, DOI 10.7326/0003-4819-127-11-199712010-00007; Davis CL, 2007, AM J TRANSPLANT, V7, P1702, DOI 10.1111/j.1600-6143.2007.01856.x; Davis CL, 2002, LIVER TRANSPLANT, V8, P193, DOI 10.1053/jlts.2002.32504; Demirci GI, 2004, LIVER TRANSPLANT, V10, P329; *DEP HLTH HUM SERV, 2000, 2000 ANN REP US SCI; Duvoux C, 2002, HEPATOLOGY, V36, P374, DOI 10.1053/jhep.2002.34343; Eason JD, 2008, AM J TRANSPLANT, V8, P2243, DOI 10.1111/j.1600-6143.2008.02416.x; Esrailian E, 2007, DIGEST DIS SCI, V52, P742, DOI 10.1007/s10620-006-9312-0; Fabrizi F, 2006, ALIMENT PHARM THER, V24, P935, DOI 10.1111/j.1365-2036.2006.03086.x; Fasolato S, 2007, HEPATOLOGY, V45, P223, DOI 10.1002/hep.21443; Fernandez J, 2004, J HEPATOL, V41, P384, DOI 10.1016/j.jhep.2004.05.009; Fernandez J, 2007, GASTROENTEROLOGY, V133, P818, DOI 10.1053/j.gastro.2007.06.065; Fernandez J, 2006, HEPATOLOGY, V44, P1288, DOI 10.1002/hep.21352; Fernandez J, 2006, GASTROENTEROLOGY, V131, P1049, DOI 10.1053/j.gastro.2006.07.010; Frances R, 2008, HEPATOLOGY, V47, P978, DOI 10.1002/hep.22083; Garcia-Tsao G, 2001, GASTROENTEROLOGY, V120, P726, DOI 10.1053/gast.2001.22580; Garcia-Tsao G, 2008, HEPATOLOGY, V48, P2064, DOI 10.1002/hep.22605; GINES A, 1993, GASTROENTEROLOGY, V105, P229, DOI 10.1016/0016-5085(93)90031-7; GINES P, 2007, DIS KIDNEY URINARY T, P2179; Gines P, 2007, HEPATOLOGY, V46, P1685, DOI 10.1002/hep.22097; GLUUD LL, 2006, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD005162.PUB2; Gonwa TA, 2006, AM J TRANSPLANT, V6, P2651, DOI 10.1111/j.1600-6143.2006.01526.x; GONWA TA, 1995, TRANSPLANTATION, V59, P361, DOI 10.1097/00007890-199502150-00010; Gonwa TA, 2005, LIVER TRANSPLANT, V11, P1022, DOI 10.1002/lt.20454; Grange JD, 2004, EUR J GASTROEN HEPAT, V16, P567, DOI 10.1097/01.meg.0000108308.52416.7c; Grewal Priya, 2007, Clin Liver Dis, V11, P431, DOI 10.1016/j.cld.2007.04.009; Guevara M, 1998, HEPATOLOGY, V27, P35, DOI 10.1002/hep.510270107; Gulberg V, 1999, HEPATOLOGY, V30, P870, DOI 10.1002/hep.510300430; Hampel H, 2001, AM J GASTROENTEROL, V96, P2206, DOI 10.1016/S0002-9270(01)02521-7; Han WK, 2008, KIDNEY INT, V73, P863, DOI 10.1038/sj.ki.5002715; Jeyarajah DR, 1997, TRANSPLANTATION, V64, P1760, DOI 10.1097/00007890-199712270-00024; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; KELLER F, 1995, RENAL FAILURE, V17, P135, DOI 10.3109/08860229509026250; Kiser TH, 2005, NEPHROL DIAL TRANSPL, V20, P1813, DOI 10.1093/ndt/gfh930; Levey AS, 2003, ANN INTERN MED, V139, P605, DOI 10.7326/0003-4819-139-7-200310070-00029; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Locke JE, 2008, TRANSPLANTATION, V85, P935, DOI 10.1097/TP.0b013e318168476d; MacAulay J, 2006, CAN J GASTROENTEROL, V20, P521, DOI 10.1155/2006/858053; Machicao VI, 2006, LIVER TRANSPLANT, V12, P754, DOI 10.1002/lt.20686; Marik PE, 2006, NEPHROL DIAL TRANSPL, V21, P478, DOI 10.1093/ndt/gfi212; Martin P, 2008, J HEPATOL, V49, P613, DOI 10.1016/j.jhep.2008.06.003; Martin PY, 1998, NEW ENGL J MED, V339, P533, DOI 10.1056/NEJM199808203390807; Martin-Llahi M, 2008, GASTROENTEROLOGY, V134, P1352, DOI 10.1053/j.gastro.2008.02.024; McCormick PA, 2008, PHARMACOL THERAPEUT, V119, P1, DOI 10.1016/j.pharmthera.2008.02.012; McCullough PA, 2008, J AM COLL CARDIOL, V51, P2197, DOI 10.1016/j.jacc.2008.04.007; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Meyers CM, 2003, AM J KIDNEY DIS, V42, P631, DOI 10.1016/S0272-6386(03)00828-X; Mitzner SR, 2000, LIVER TRANSPLANT, V6, P277, DOI 10.1053/lv.2000.6355; Moore KP, 2003, HEPATOLOGY, V38, P258, DOI 10.1053/jhep.2003.50315; Moreau R, 2002, GASTROENTEROLOGY, V122, P923, DOI 10.1053/gast.2002.32364; Moreau R, 2006, HEPATOLOGY, V43, P385, DOI 10.1002/hep.21094; Moreau R, 2003, HEPATOLOGY, V37, P233, DOI 10.1053/jhep.2003.50084; Nair S, 2002, HEPATOLOGY, V35, P1179, DOI 10.1053/jhep.2002.33160; Olausson M, 2007, AM J TRANSPLANT, V7, P130, DOI 10.1111/j.1600-6143.2006.01592.x; Ortega R, 2002, HEPATOLOGY, V36, P941, DOI 10.1053/jhep.2002.35819; Pawarode A, 2003, LIVER TRANSPLANT, V9, P741, DOI 10.1053/jlts.2003.50113; Pham PTT, 2007, NAT CLIN PRACT NEPHR, V3, P507, DOI 10.1038/ncpneph0574; Poole BD, 2005, ASCITES AND RENAL DYSFUNCTION IN LIVER DISEASE: PATHOGENESIS, DIAGNOSIS, AND TREATMENT, 2ND EDITION, P360, DOI 10.1002/9780470987476.ch29; Proulx NL, 2005, NEPHROL DIAL TRANSPL, V20, P1617, DOI 10.1093/ndt/gfh839; Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720; Rasaratnam B, 2003, ANN INTERN MED, V139, P186, DOI 10.7326/0003-4819-139-3-200308050-00008; Restuccia T, 2004, J HEPATOL, V40, P140, DOI 10.1016/j.jhep.2003.09.019; Ros J, 2002, GASTROENTEROLOGY, V122, P85, DOI 10.1053/gast.2002.30305; Ruiz R, 2006, ARCH SURG-CHICAGO, V141, P735, DOI 10.1001/archsurg.141.8.735; Ruiz-del-Arbol L, 2005, HEPATOLOGY, V42, P439, DOI 10.1002/hep.20766; Salerno F, 2005, ASCITES AND RENAL DYSFUNCTION IN LIVER DISEASE: PATHOGENESIS, DIAGNOSIS, AND TREATMENT, 2ND EDITION, P372, DOI 10.1002/9780470987476.ch30; Salerno F, 2007, GUT, V56, P1310, DOI 10.1136/gut.2006.107789; Sanyal AJ, 2008, GASTROENTEROLOGY, V134, P1360, DOI 10.1053/j.gastro.2008.02.014; Schepke M, 2006, LIVER INT, V26, P834, DOI 10.1111/j.1478-3231.2006.01302.x; Schmidt LE, 2006, CURR PHARM DESIGN, V12, P4637, DOI 10.2174/138161206779010413; SCHRIER RW, 1988, HEPATOLOGY, V8, P1151, DOI 10.1002/hep.1840080532; Sherman DS, 2003, AM J KIDNEY DIS, V41, P269, DOI 10.1053/ajkd.2003.50035; Simpson N, 2006, TRANSPLANTATION, V82, P1298, DOI 10.1097/01.tp.0000241104.58576.e6; Skluzacek PA, 2003, AM J KIDNEY DIS, V42, P1169, DOI 10.1053/j.ajkd.2003.08.017; Sort P, 1999, NEW ENGL J MED, V341, P403, DOI 10.1056/NEJM199908053410603; Tandon P, 2008, SEMIN LIVER DIS, V28, P26, DOI 10.1055/s-2008-1040319; Terg R, 2009, LIVER INT, V29, P415, DOI 10.1111/j.1478-3231.2008.01877.x; Terra C, 2005, GASTROENTEROLOGY, V129, P1944, DOI 10.1053/j.gastro.2005.09.024; Thabut D, 2007, HEPATOLOGY, V46, P1872, DOI 10.1002/hep.21920; Tsai MH, 2006, HEPATOLOGY, V43, P673, DOI 10.1002/hep.21101; Wiesner R, 2003, GASTROENTEROLOGY, V124, P91, DOI 10.1053/gast.2003.50016; Wiest R, 1999, J CLIN INVEST, V104, P1223, DOI 10.1172/JCI7458; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Wong F, 2005, GUT, V54, P718, DOI 10.1136/gut.2004.038679; Wong F, 2004, HEPATOLOGY, V40, P55, DOI 10.1002/hep.20262	100	529	554	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2009	361	13					1279	1290		10.1056/NEJMra0809139	http://dx.doi.org/10.1056/NEJMra0809139			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497RN	19776409				2022-12-28	WOS:000270078700009
J	Schmidt, H; Gerber, A; Stock, S				Schmidt, Harald; Gerber, Andreas; Stock, Stephanie			What can we learn from German health incentive schemes?	BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVENTION; DISEASE		[Schmidt, Harald] Univ London London Sch Econ & Polit Sci, LSE Hlth, London WC2A 2AE, England; [Gerber, Andreas; Stock, Stephanie] Univ Cologne, Inst Hlth Econ & Clin Epidemiol, D-50935 Cologne, Germany	University of London; London School Economics & Political Science; University of Cologne	Schmidt, H (corresponding author), Univ London London Sch Econ & Polit Sci, LSE Hlth, Houghton St, London WC2A 2AE, England.	h.t.schmidt@lse.ac.uk						Bodeker W, 2008, BKK, V4, P214; Boesen E, 2007, PSYCHOSOMATICS, V48, P510, DOI 10.1176/appi.psy.48.6.510; Born G, 2006, GESUNDHEITSWESEN, V68, P257, DOI 10.1055/s-2006-926723; Braun B, 2006, ANREIZE VERHALTENSST; Cohen JT, 2008, NEW ENGL J MED, V358, P661, DOI 10.1056/NEJMp0708558; Dreier M, 2006, GESUNDHEITSWESEN, V7, P68; Jochelson K., 2007, PAYING PATIENT IMPRO; KNAACK N, 2008, THESIS U DORTMUND; Lauterbach KW, 2001, MODELL FAIREN WETTBE; LEGRAND J, 2008, EC INCENTIVES LONG T; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Russell LB, 2009, HEALTH AFFAIR, V28, P42, DOI 10.1377/hlthaff.28.1.42; SCHMIDT H, 2008, GERMANY I INCENTIVES; Stock S, 2008, INT J PUBLIC HEALTH, V53, P78, DOI 10.1007/s00038-008-7026-0; Weide U., 2005, GERMAN LAW J, V6, P1143; WIKLER DI, 1978, MILBANK FUND Q, V56, P303, DOI 10.2307/3349651; *WISS I ORTSKR, 2003, GKV MON 2003; Woolf SH, 2009, JAMA-J AM MED ASSOC, V301, P536, DOI 10.1001/jama.2009.51	18	13	13	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 24	2009	339								b3504	10.1136/bmj.b3504	http://dx.doi.org/10.1136/bmj.b3504			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OG	19778973				2022-12-28	WOS:000270231800001
J	Pedersen, LH; Henriksen, TB; Vestergaard, M; Olsen, J; Bech, BH				Pedersen, Lars Henning; Henriksen, Tine Brink; Vestergaard, Mogens; Olsen, Jorn; Bech, Bodil Hammer			Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIRTH-DEFECTS; RISK; PAROXETINE; EXPOSURE; ANTIDEPRESSANTS; METAANALYSIS; FLUOXETINE; OUTCOMES	Objective To investigate any association between selective serotonin reuptake inhibitors (SSRIs) taken during pregnancy and congenital major malformations. Design Population based cohort study. Participants 493 113 children born in Denmark, 1996-2003. Main outcome measure Major malformations categorised according to Eurocat (European Surveillance of Congenital Anomalies) with additional diagnostic grouping of heart defects. Nationwide registers on medical redemptions (filled prescriptions), delivery, and hospital diagnosis provided information on mothers and newborns. Follow-up data available to December 2005. Results Redemptions for SSRIs were not associated with major malformations overall but were associated with septal heart defects (odds ratio 1.99, 95% confidence interval 1.13 to 3.53). For individual SSRIs, the odds ratio for septal heart defects was 3.25 (1.21 to 8.75) for sertraline, 2.52 (1.04 to 6.10) for citalopram, and 1.34 (0.33 to 5.41) for fluoxetine. Redemptions for more than one type of SSRI were associated with septal heart defects (4.70, 1.74 to 12.7)). The absolute increase in the prevalence of malformations was low-for example, the prevalence of septal heart defects was 0.5% (2315/493 113) among unexposed children, 0.9% (12/1370) among children whose mothers were prescribed any SSRI, and 2.1% (4/193) among children whose mothers were prescribed more than one type of SSRI. Conclusion There is an increased prevalence of septal heart defects among children whose mothers were prescribed an SSRI in early pregnancy, particularly sertraline and citalopram. The largest association was found for children of women who redeemed prescriptions for more than one type of SSRI.	[Pedersen, Lars Henning; Bech, Bodil Hammer] Aarhus Univ, Dept Epidemiol, Inst Publ Hlth, DK-8000 Aarhus C, Denmark; [Olsen, Jorn] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA; [Henriksen, Tine Brink] Aarhus Univ Hosp, Dept Paediat, DK-8200 Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Inst Publ Hlth, Dept Gen Practice, DK-8000 Aarhus, Denmark	Aarhus University; University of California System; University of California Los Angeles; Aarhus University; Aarhus University	Pedersen, LH (corresponding author), Aarhus Univ, Dept Epidemiol, Inst Publ Hlth, Bartolins Alle 2, DK-8000 Aarhus C, Denmark.	LHP@dadlnet.dk	Vestergaard, Mogens/M-9333-2014; Bech, Bodil Hammer/B-9646-2016	Vestergaard, Mogens/0000-0001-8830-2174; Bech, Bodil Hammer/0000-0002-0287-3687	Lundbeck Foundation [95092485, sted 2214]; pharmaceutical company Lundbeck; National Danish Research Foundation; University of Aarhus; Danish Society of Obstetrics and Gynaecology; Ville Heise Foundation; Rosalie Petersen Foundation	Lundbeck Foundation(Lundbeckfonden); pharmaceutical company Lundbeck; National Danish Research Foundation; University of Aarhus; Danish Society of Obstetrics and Gynaecology; Ville Heise Foundation; Rosalie Petersen Foundation	This work was funded by a grant from the Lundbeck Foundation (grant No 95092485, sted 2214), an independent foundation supported by the pharmaceutical company Lundbeck, and has received support from the National Danish Research Foundation, the University of Aarhus, the Danish Society of Obstetrics and Gynaecology, the Ville Heise Foundation, and the Rosalie Petersen Foundation. Part of the work was done during LHP's mployment at the Centre for Clinical Pharmacology, University Hospital of Aarhus, Aarhus, Denmark. JO has received grants from the Lundbeck Foundation.	Alwan S, 2007, NEW ENGL J MED, V356, P2684, DOI 10.1056/NEJMoa066584; Andersen TF, 1999, DAN MED BULL, V46, P263; Bar-Oz B, 2007, CLIN THER, V29, P918, DOI 10.1016/j.clinthera.2007.05.003; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Berard A, 2007, BIRTH DEFECTS RES B, V80, P18, DOI 10.1002/bdrb.20099; Chambers CD, 1996, NEW ENGL J MED, V335, P1010, DOI 10.1056/NEJM199610033351402; Diav-Citrin O, 2008, BRIT J CLIN PHARMACO, V66, P695, DOI 10.1111/j.1365-2125.2008.03261.x; Dolk H, 2005, ARCH DIS CHILD-FETAL, V90, pF355, DOI 10.1136/adc.2004.062810; Einarson TR, 2005, PHARMACOEPIDEM DR S, V14, P823, DOI 10.1002/pds.1084; Ericson A, 1999, EUR J CLIN PHARMACOL, V55, P503, DOI 10.1007/s002280050664; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; *GLAXOSMITHKLINE, 2007, UPD PREL REP BUPR OU; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; International Epidemiological Association (IEA), 2007, GOOD EP PRACT IEA GU; Kallen B, 2006, REPROD TOXICOL, V21, P221, DOI 10.1016/j.reprotox.2005.11.006; Knudsen LB, 1998, DAN MED BULL, V45, P221; Knudsen LB, 1998, DAN MED BULL, V45, P320; Larsen H, 2003, SCAND J PUBLIC HEALT, V31, P12, DOI 10.1080/14034940210134194; Louik C, 2007, NEW ENGL J MED, V356, P2675, DOI 10.1056/NEJMoa067407; Malm H, 2005, OBSTET GYNECOL, V106, P1289, DOI 10.1097/01.AOG.0000187302.61812.53; Oberlander TF, 2008, BIRTH DEFECTS RES B, V83, P68, DOI 10.1002/bdrb.20144; Simon GE, 2002, AM J PSYCHIAT, V159, P2055, DOI 10.1176/appi.ajp.159.12.2055; *US FDA, 2005, FDA PUBL HLTH ADV PA; WHO Collaborating Centre for Drug Statistics Methodology, 2008, ATC CLASS STRUCT PRI; Wogelius P, 2006, EPIDEMIOLOGY, V17, P701, DOI 10.1097/01.ede.0000239581.76793.ae	25	204	207	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2009	339								b3569	10.1136/bmj.b3569	http://dx.doi.org/10.1136/bmj.b3569			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OF	19776103	Green Published, hybrid			2022-12-28	WOS:000270231700002
J	Barraclough, K; Bronstein, A				Barraclough, Kevin; Bronstein, Adolfo			Diagnosis in General Practice Vertigo	BRITISH MEDICAL JOURNAL			English	Article							BENIGN POSITIONAL VERTIGO; DIZZINESS; POPULATION; STROKE; PEOPLE; EPIDEMIOLOGY; DYSFUNCTION; INFARCTION; HEADACHE; REGISTRY		[Bronstein, Adolfo] Univ London Imperial Coll Sci Technol & Med, Div Neurosci & Mental Hlth, Neurootol Unit, London SW7 2AZ, England	Imperial College London		k.barraclough@btinternet.com			Medical Research Council [G0600183, MC_U950770497] Funding Source: Medline; MRC [MC_U950770497, G0600183] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baloh RW, 2003, ARCH NEUROL-CHICAGO, V60, P835, DOI 10.1001/archneur.60.6.835; BALOH RW, 1987, NEUROLOGY, V37, P371, DOI 10.1212/WNL.37.3.371; Bath AP, 2000, AM J OTOL, V21, P92, DOI 10.1016/S0196-0709(00)80081-2; BELAL A, 1986, J LARYNGOL OTOL, V100, P1037, DOI 10.1017/S0022215100100520; Bronstein AM, 2007, DIZZINESS PRACTICAL; Caplan LR, 2004, ANN NEUROL, V56, P389, DOI 10.1002/ana.20204; Clemis J, 1973, OTOLARYNGOL CLIN N A, V6, P1; Colledge N, 2002, J NEUROL NEUROSUR PS, V72, P587, DOI 10.1136/jnnp.72.5.587; DIX MR, 1952, ANN OTO RHINOL LARYN, V61, P987, DOI 10.1177/000348945206100403; Drachman DA, 1998, JAMA-J AM MED ASSOC, V280, P2111, DOI 10.1001/jama.280.24.2111; Drachman DA, 1972, NEUROLOGY, V22, P223; EVANS JG, 1990, AGE AGEING, V19, P43, DOI 10.1093/ageing/19.1.43; FROEHLING DA, 1991, MAYO CLIN PROC, V66, P596, DOI 10.1016/S0025-6196(12)60518-7; Guilemany JM, 2004, ACTA OTO-LARYNGOL, V124, P49, DOI 10.1080/00016480310002122; Hanley K, 2002, BRIT J GEN PRACT, V52, P809; KENTALA A, 1996, AM J OTOL, V17, P892; Kerber KA, 2006, STROKE, V37, P2484, DOI 10.1161/01.STR.0000240329.48263.0d; KUMRAL E, 1995, J NEUROL NEUROSUR PS, V58, P490, DOI 10.1136/jnnp.58.4.490; Lee H, 2006, NEUROLOGY, V67, P1178, DOI 10.1212/01.wnl.0000238500.02302.b4; Lee H, 2002, STROKE, V33, P2807, DOI 10.1161/01.STR.0000038692.17290.24; LEMPERT T, 1995, BRIT MED J, V311, P489, DOI 10.1136/bmj.311.7003.489; Lempert T, 2009, J NEUROL, V256, P333, DOI 10.1007/s00415-009-0149-2; MADLONKAY DJ, 1985, J FAM PRACTICE, V21, P109; Matthews W. B, 1963, PRACTICAL NEUROLOGY; MCCORMICK A, 1995, MORBIDITY STAT GEN P; Mitsias PD, 2006, CEPHALALGIA, V26, P150, DOI 10.1111/j.1468-2982.2005.01012.x; NEDZELSKI JM, 1986, J OTOLARYNGOL, V15, P101; Neuhauser HK, 2007, CURR OPIN NEUROL, V20, P40, DOI 10.1097/WCO.0b013e328013f432; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Norman G, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3490; Seemungal Barry M, 2008, Pract Neurol, V8, P211, DOI 10.1136/jnnp.2008.154799; Thakar A, 2001, J LARYNGOL OTOL, V115, P782; von Brevern M, 2005, BRAIN, V128, P365, DOI 10.1093/brain/awh351; WLADISLAVOSKYWASERMAN P, 1984, LARYNGOSCOPE, V94, P1098; Yardley L, 1998, BRIT J GEN PRACT, V48, P1131	35	12	12	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 22	2009	339								b3493	10.1136/bmj.b3493	http://dx.doi.org/10.1136/bmj.b3493			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OE	19773327				2022-12-28	WOS:000270231500004
J	Richardson, JM; Colloms, SD; Finnegan, DJ; Walkinshaw, MD				Richardson, Julia M.; Colloms, Sean D.; Finnegan, David J.; Walkinshaw, Malcolm D.			Molecular Architecture of the Mos1 Paired-End Complex: The Structural Basis of DNA Transposition in a Eukaryote	CELL			English	Article							V(D)J RECOMBINATION; SYNAPTIC COMPLEX; TRANSPOSABLE ELEMENTS; MARINER TRANSPOSASE; TN5 TRANSPOSITION; CRYSTAL-STRUCTURE; TC3 TRANSPOSASE; BINDING DOMAIN; ACTIVE-SITE; C-ELEGANS	A key step in cut-and-paste DNA transposition is the pairing of transposon ends before the element is excised and inserted at a new site in its host genome. Crystallographic analyses of the paired-end complex (PEC) formed from precleaved transposon ends and the transposase of the eukaryotic element Mos1 reveals two parallel ends bound to a dimeric enzyme. The complex has a trans arrangement, with each transposon end recognized by the DNA binding region of one transposase monomer and by the active site of the other monomer. Two additional DNA duplexes in the crystal indicate likely binding sites for flanking DNA. Biochemical data provide support for a model of the target capture complex and identify Arg186 to be critical for target binding. Mixing experiments indicate that a transposase dimer initiates first-strand cleavage and suggest a pathway for PEC formation.	[Richardson, Julia M.; Finnegan, David J.; Walkinshaw, Malcolm D.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland; [Colloms, Sean D.] Xermit, Glasgow G12 0NF, Lanark, Scotland	University of Edinburgh	Richardson, JM (corresponding author), Univ Edinburgh, Sch Biol Sci, Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	jrichard@staffmail.ed.ac.uk	walkinshaw, malcolm/AAB-7497-2019; Richardson, Julia/D-1808-2013	Richardson, Julia/0000-0002-1547-3009; walkinshaw, malcolm/0000-0001-5955-9325; Colloms, Sean/0000-0003-2369-8168	Wellcome Trust; Medical Research Council; MRC [G0301082] Funding Source: UKRI; Medical Research Council [G0301082] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Wellcome Trust and the Medical Research Council. X-ray data were collected at the ESRF (beam-lines BM14 and ID231), and we thank Martin Walsh for his expert assistance. We are grateful to Marshall Stark, Jean Beggs, and Adrian Bird for their insightful comments on the manuscript.	Ason B, 2002, J BIOL CHEM, V277, P11284, DOI 10.1074/jbc.M111119200; Auge-Gouillou C, 2005, MOL CELL BIOL, V25, P2861, DOI 10.1128/MCB.25.7.2861-2870.2005; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Dawson A, 2003, MOL CELL, V11, P225, DOI 10.1016/S1097-2765(02)00798-0; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Grundy GJ, 2007, P NATL ACAD SCI USA, V104, P3078, DOI 10.1073/pnas.0611293104; Guimond N, 2003, MOL GENET GENOMICS, V268, P779, DOI 10.1007/s00438-002-0800-4; Ivics Z, 2006, CURR GENE THER, V6, P593, DOI 10.2174/156652306778520647; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Lipkow K, 2004, MOL CELL BIOL, V24, P8301, DOI 10.1128/MCB.24.18.8301-8311.2004; Lohe AR, 1996, MOL BIOL EVOL, V13, P549, DOI 10.1093/oxfordjournals.molbev.a025615; Lovell S, 2002, NAT STRUCT BIOL, V9, P278, DOI 10.1038/nsb778; Luo GB, 1998, P NATL ACAD SCI USA, V95, P10769, DOI 10.1073/pnas.95.18.10769; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Mouw KW, 2008, MOL CELL, V30, P145, DOI 10.1016/j.molcel.2008.02.023; Naumann TA, 2000, P NATL ACAD SCI USA, V97, P8944, DOI 10.1073/pnas.160107997; Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1; Rice PA, 2001, NAT STRUCT BIOL, V8, P302, DOI 10.1038/86166; Richardson JM, 2006, EMBO J, V25, P1324, DOI 10.1038/sj.emboj.7601018; Richardson JM, 2004, ACTA CRYSTALLOGR D, V60, P962, DOI 10.1107/S0907444904003798; Richardson JM, 2007, ACTA CRYSTALLOGR F, V63, P434, DOI 10.1107/S1744309107019045; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Robinson AS, 2004, INSECT BIOCHEM MOLEC, V34, P113, DOI 10.1016/j.ibmb.2003.10.004; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; Savilahti H, 1996, CELL, V85, P271, DOI 10.1016/S0092-8674(00)81103-4; Shevchenko Y, 2002, NUCLEIC ACIDS RES, V30, P2469, DOI 10.1093/nar/30.11.2469; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Swanson PC, 2001, MOL CELL BIOL, V21, P449, DOI 10.1128/MCB.21.2.449-458.2001; VANLUENEN HGAM, 1994, CELL, V79, P293, DOI 10.1016/0092-8674(94)90198-8; vanPouderoyen G, 1997, EMBO J, V16, P6044, DOI 10.1093/emboj/16.19.6044; Watkins S, 2004, NUCLEIC ACIDS RES, V32, P4306, DOI 10.1093/nar/gkh770; Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263; Yang W, 2006, MOL CELL, V22, P5, DOI 10.1016/j.molcel.2006.03.013; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157	38	101	103	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1096	1108		10.1016/j.cell.2009.07.012	http://dx.doi.org/10.1016/j.cell.2009.07.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766564	Green Accepted, Bronze			2022-12-28	WOS:000269923200011
J	Trimbuch, T; Beed, P; Vogt, J; Schuchmann, S; Maier, N; Kintscher, M; Breustedt, J; Schuelke, M; Streu, N; Kieselmann, O; Brunk, I; Laube, G; Strauss, U; Battefeld, A; Wende, H; Birchmeier, C; Wiese, S; Sendtner, M; Kawabe, H; Kishimoto-Suga, M; Brose, N; Baumgart, J; Geist, B; Aoki, J; Savaskan, NE; Brauer, AU; Chun, J; Ninnemann, O; Schmitz, D; Nitsch, R				Trimbuch, Thorsten; Beed, Prateep; Vogt, Johannes; Schuchmann, Sebastian; Maier, Nikolaus; Kintscher, Michael; Breustedt, Joerg; Schuelke, Markus; Streu, Nora; Kieselmann, Olga; Brunk, Irene; Laube, Gregor; Strauss, Ulf; Battefeld, Arne; Wende, Hagen; Birchmeier, Carmen; Wiese, Stefan; Sendtner, Michael; Kawabe, Hiroshi; Kishimoto-Suga, Mika; Brose, Nils; Baumgart, Jan; Geist, Beate; Aoki, Junken; Savaskan, Nic E.; Braeuer, Anja U.; Chun, Jerold; Ninnemann, Olaf; Schmitz, Dietmar; Nitsch, Robert			Synaptic PRG-1 Modulates Excitatory Transmission via Lipid Phosphate-Mediated Signaling	CELL			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; POSTSYNAPTIC DENSITY PROTEINS; LYSOPHOSPHATIDIC ACID; SPHINGOSINE 1-PHOSPHATE; RAT-BRAIN; IDENTIFICATION; EXPRESSION; PLASTICITY; COMPLEXES; NEURONS	Plasticity related gene-1 (PRG-1) is a brain-specific membrane protein related to lipid phosphate phosphatases, which acts in the hippocampus specifically at the excitatory synapse terminating on glutamatergic neurons. Deletion of prg-1 in mice leads to epileptic seizures and augmentation of EPSCs, but not IPSCs. In utero electroporation of PRG-1 into deficient animals revealed that PRG-1 modulates excitation at the synaptic junction. Mutation of the extracellular domain of PRG-1 crucial for its interaction with lysophosphatidic acid (LPA) abolished the ability to prevent hyperexcitability. As LPA application in vitro induced hyperexcitability in wild-type but not in LPA(2) receptor-deficient animals, and uptake of phospholipids is reduced in PRG-1-deficient neurons, we assessed PRG-1/LPA(2) receptor deficient animals, and found that the pathophysiology observed in the PRG-1-deficient mice was fully reverted. Thus, we propose PRG-1 as an important player in the modulatory control of hippocampal excitability dependent on presynaptic LPA(2) receptor signaling.	[Trimbuch, Thorsten; Vogt, Johannes; Kintscher, Michael; Streu, Nora; Kieselmann, Olga; Strauss, Ulf; Battefeld, Arne; Baumgart, Jan; Geist, Beate; Savaskan, Nic E.; Braeuer, Anja U.; Ninnemann, Olaf; Nitsch, Robert] Charite, Inst Cell Biol & Neurobiol & NeuroCure, D-10117 Berlin, Germany; [Beed, Prateep; Schuchmann, Sebastian; Maier, Nikolaus; Kintscher, Michael; Breustedt, Joerg; Schmitz, Dietmar] Charite, Neurosci Res Ctr & NeuroCure, D-10117 Berlin, Germany; [Schuelke, Markus] Charite, Dept Neuropediat, D-10117 Berlin, Germany; [Schuelke, Markus] Charite, NeuroCure Clin Res Ctr, D-10117 Berlin, Germany; [Brunk, Irene; Laube, Gregor] Charite, Inst Integrat Neuroanat, D-10117 Berlin, Germany; [Wende, Hagen; Birchmeier, Carmen] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Wiese, Stefan; Sendtner, Michael] Univ Wurzburg, Inst Clin Neurobiol, D-97078 Wurzburg, Germany; [Kawabe, Hiroshi; Kishimoto-Suga, Mika; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Chun, Jerold] Scripps Res Inst, La Jolla, CA 92037 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg; Max Planck Society; Tohoku University; Scripps Research Institute	Nitsch, R (corresponding author), Charite, Inst Cell Biol & Neurobiol & NeuroCure, Charitepl 1, D-10117 Berlin, Germany.	robert.nitsch@charite.de	Sendtner, Michael/J-1542-2012; Chun, Jerold/Y-4670-2019; Bräuer, Anja/N-3692-2019; Vogt, Johannes/O-4289-2019; Kawabe, Hiroshi/U-7325-2018; Braeuer, Anja/K-8339-2013; Sendtner, Michael/M-8137-2014; Maier, Nikolaus/CAF-2990-2022; Maier, Nikolaus/CAH-9008-2022; Nitsch, Robert/AAI-9129-2021; Vogt, Johannes/K-2278-2015; Strauss, Ulf/I-4146-2012; Savaskan, Nicolai/D-2923-2018	Sendtner, Michael/0000-0002-4737-2974; Sendtner, Michael/0000-0002-4737-2974; Maier, Nikolaus/0000-0001-5203-0736; Schuelke, Markus/0000-0003-2824-3891; Vogt, Johannes/0000-0003-2439-8247; Brunk, Irene/0000-0002-2668-7002; Battefeld, Arne/0000-0003-1777-4523; Schmitz, Dietmar/0000-0003-2741-5241; Kawabe, Hiroshi/0000-0001-5650-8696; Aoki, Junken/0000-0001-9435-1896; Strauss, Ulf/0000-0002-1534-6624; Baumgart, Jan/0000-0003-1996-4267; Trimbuch, Thorsten/0000-0001-7512-8955; Savaskan, Nicolai/0000-0003-1348-094X; Wende, Hagen/0000-0002-9168-8095; Kintscher, Michael/0000-0003-2355-1369	NIMH NIH HHS [MH51699, R01 MH051699] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051699, R29MH051699] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anliker B, 2004, SEMIN CELL DEV BIOL, V15, P457, DOI 10.1016/j.semcdb.2004.05.005; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Ben-Ari Y, 2006, EPILEPTIC DISORD, V8, P91; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brandt N, 2007, EMBO J, V26, P2371, DOI 10.1038/sj.emboj.7601680; Brauer AU, 2003, NAT NEUROSCI, V6, P572, DOI 10.1038/nn1052; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Contos JJA, 2000, MOL PHARMACOL, V58, P1188, DOI 10.1124/mol.58.6.1188; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Contos JJA, 2000, GENOMICS, V64, P155, DOI 10.1006/geno.2000.6122; COTMAN CW, 1972, J CELL BIOL, V55, P696, DOI 10.1083/jcb.55.3.696; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; FUKUSHIMA N, 2001, LPA RECEPTORS PROSTA, V64, P21; Hermansson M, 2005, J NEUROCHEM, V95, P609, DOI 10.1111/j.1471-4159.2005.03376.x; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; Krauss A, 2007, J NEUROCHEM, V103, P679, DOI 10.1111/j.1471-4159.2007.04770.x; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; MacLennan AJ, 2001, EUR J NEUROSCI, V14, P203, DOI 10.1046/j.0953-816x.2001.01634.x; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; McDermott MI, 2004, NAT NEUROSCI, V7, P789, DOI 10.1038/nn0804-789a; Milstien S, 2007, ACTA PAEDIATR, V96, P40, DOI 10.1111/j.1651-2227.2007.00206.x; Mokin M, 2006, J NEUROSCI METH, V157, P218, DOI 10.1016/j.jneumeth.2006.04.016; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Neuwald AF, 1997, PROTEIN SCI, V6, P1764, DOI 10.1002/pro.5560060817; Pan CY, 2007, J NEUROCHEM, V102, P944, DOI 10.1111/j.1471-4159.2007.04584.x; Peeva GP, 2006, EUR J NEUROSCI, V24, P2152, DOI 10.1111/j.1460-9568.2006.05091.x; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Pyne S, 2005, BIOCHEM SOC T, V33, P1370, DOI 10.1042/BST0331370; Renault AD, 2004, SCIENCE, V305, P1963, DOI 10.1126/science.1102421; Roberts RZ, 2000, BBA-MOL CELL BIOL L, V1487, P33, DOI 10.1016/S1388-1981(00)00081-0; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Sassoe-Pognetto M, 2000, EUR J NEUROSCI, V12, P2205, DOI 10.1046/j.1460-9568.2000.00106.x; Savaskan NE, 2004, EUR J NEUROSCI, V19, P212, DOI 10.1046/j.1460-9568.2003.03078.x; Shida D, 2004, LAB INVEST, V84, P1352, DOI 10.1038/labinvest.3700146; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Sigal YJ, 2007, J CELL SCI, V120, P340, DOI 10.1242/jcs.03335; Spiegel S, 2002, TRENDS CELL BIOL, V12, P236, DOI 10.1016/S0962-8924(02)02277-8; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Todd AE, 2002, STRUCTURE, V10, P1435, DOI 10.1016/S0969-2126(02)00861-4; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Wouterlood FG, 2003, J NEUROSCI METH, V128, P129, DOI 10.1016/S0165-0270(03)00171-7; Ye XQ, 2002, NEUROREPORT, V13, P2169, DOI 10.1097/00001756-200212030-00002; Zhang QX, 2000, BIOCHEM J, V345, P181, DOI 10.1042/0264-6021:3450181	47	99	109	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1222	1235		10.1016/j.cell.2009.06.050	http://dx.doi.org/10.1016/j.cell.2009.06.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766573	Green Accepted, Bronze			2022-12-28	WOS:000269923200021
J	Kim, K; Sato, K; Shibuya, M; Zeiger, DM; Butcher, RA; Ragains, JR; Clardy, J; Touhara, K; Sengupta, P				Kim, Kyuhyung; Sato, Koji; Shibuya, Mayumi; Zeiger, Danna M.; Butcher, Rebecca A.; Ragains, Justin R.; Clardy, Jon; Touhara, Kazushige; Sengupta, Piali			Two Chemoreceptors Mediate Developmental Effects of Dauer Pheromone in C-elegans	SCIENCE			English	Article							RECEPTOR GENE-EXPRESSION; GUANYLYL CYCLASE DAF-11; CAENORHABDITIS-ELEGANS; LARVAL DEVELOPMENT; SIGNALING PATHWAY; BRAIN; ACTS	Intraspecific chemical communication is mediated by signals called pheromones. Caenorhabditis elegans secretes a mixture of small molecules (collectively termed dauer pheromone) that regulates entry into the alternate dauer larval stage and also modulates adult behavior via as yet unknown receptors. Here, we identify two heterotrimeric GTP-binding protein (G protein)-coupled receptors (GPCRs) that mediate dauer formation in response to a subset of dauer pheromone components. The SRBC-64 and SRBC-66 GPCRs are members of the large Caenorhabditis-specific SRBC subfamily and are expressed in the ASK chemosensory neurons, which are required for pheromone-induced dauer formation. Expression of both, but not each receptor alone, confers pheromone-mediated effects on heterologous cells. Identification of dauer pheromone receptors will allow a better understanding of the signaling cascades that transduce the context-dependent effects of ecologically important chemic al signals.	[Kim, Kyuhyung; Shibuya, Mayumi; Zeiger, Danna M.; Sengupta, Piali] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; [Kim, Kyuhyung; Shibuya, Mayumi; Zeiger, Danna M.; Sengupta, Piali] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Sato, Koji; Touhara, Kazushige] Univ Tokyo, Dept Integrated Biosci, Chiba 2778562, Japan; [Butcher, Rebecca A.; Ragains, Justin R.; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Brandeis University; Brandeis University; University of Tokyo; Harvard University; Harvard Medical School	Sengupta, P (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	sengupta@brandeis.edu		xing zhi, zuo teng/0000-0001-6198-6406	NSF [IOS 0542372]; NIH [R01 GM56223, P30 NS45713, R01 CA24487, F32 GM077943]; Ministry of Education, Science, Sports, and Culture, Japan; NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056223, F32GM077943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045713] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to E. Macosko, C. Bargmann, J. Thomas, and R. Shingai for advice, assistance, and reagents. We thank the Caenorhabditis Genetics Center and S. Mitani for strains, members of the Sengupta lab and P. Garrity for discussion, and C. Li for critical comments. This work was supported by NSF ( IOS 0542372 to P. S.), NIH (R01 GM56223 to P. S., P30 NS45713, R01 CA24487 to J. C., and F32 GM077943 to R. A. B.), and the Ministry of Education, Science, Sports, and Culture, Japan ( K. T.).	Alaux C, 2009, GENES BRAIN BEHAV, V8, P309, DOI 10.1111/j.1601-183X.2009.00480.x; Alewijnse AE, 1997, FEBS LETT, V419, P171, DOI 10.1016/S0014-5793(97)01440-3; [Anonymous], 2014, PHEROMONES ANIMAL BE; Birnby DA, 2000, GENETICS, V155, P85; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Butcher RA, 2008, P NATL ACAD SCI USA, V105, P14288, DOI 10.1073/pnas.0806676105; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Dowell P, 2005, ANNU REV BIOCHEM, V74, P515, DOI 10.1146/annurev.biochem.73.011303.074027; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Grus WE, 2008, MOL BIOL EVOL, V25, P1593, DOI 10.1093/molbev/msn107; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Murakami M, 2001, MECH DEVELOP, V109, P27, DOI 10.1016/S0925-4773(01)00507-X; Nolan KM, 2002, GENE DEV, V16, P3061, DOI 10.1101/gad.1027702; Peckol EL, 2001, P NATL ACAD SCI USA, V98, P11032, DOI 10.1073/pnas.191352498; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Thomas JH, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-42; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Zwaal RR, 1997, GENETICS, V145, P715	26	144	157	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					994	998		10.1126/science.1176331	http://dx.doi.org/10.1126/science.1176331			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19797623	Green Accepted			2022-12-28	WOS:000271712300040
J	Loeb, M; Dafoe, N; Mahony, J; John, M; Sarabia, A; Glavin, V; Webby, R; Smieja, M; Earn, DJD; Chong, S; Webb, A; Walter, SD				Loeb, Mark; Dafoe, Nancy; Mahony, James; John, Michael; Sarabia, Alicia; Glavin, Verne; Webby, Richard; Smieja, Marek; Earn, David J. D.; Chong, Sylvia; Webb, Ashley; Walter, Stephen D.			Surgical Mask vs N95 Respirator for Preventing Influenza Among Health Care Workers A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VIRUS; INFECTION; TRANSMISSION; NONINFERIORITY; PATHOGENESIS; EMERGENCE; LEAKAGE	Context Data about the effectiveness of the surgical mask compared with the N95 respirator for protecting health care workers against influenza are sparse. Given the likelihood that N95 respirators will be in short supply during a pandemic and not available in many countries, knowing the effectiveness of the surgical mask is of public health importance. Objective To compare the surgical mask with the N95 respirator in protecting health care workers against influenza. Design, Setting, and Participants Noninferiority randomized controlled trial of 446 nurses in emergency departments, medical units, and pediatric units in 8 tertiary care Ontario hospitals. Intervention Assignment to either a fit-tested N95 respirator or a surgical mask when providing care to patients with febrile respiratory illness during the 2008-2009 influenza season. Main Outcome Measures The primary outcome was laboratory-confirmed influenza measured by polymerase chain reaction or a 4-fold rise in hemagglutinin titers. Effectiveness of the surgical mask was assessed as noninferiority of the surgical mask compared with the N95 respirator. The criterion for noninferiority was met if the lower limit of the 95% confidence interval (CI) for the reduction in incidence (N95 respirator minus surgical group) was greater than -9%. Results Between September 23, 2008, and December 8, 2008, 478 nurses were assessed for eligibility and 446 nurses were enrolled and randomly assigned the intervention; 225 were allocated to receive surgical masks and 221 to N95 respirators. Influenza infection occurred in 50 nurses (23.6%) in the surgical mask group and in 48 (22.9%) in the N95 respirator group (absolute risk difference, -0.73%; 95% CI, -8.8% to 7.3%; P=.86), the lower confidence limit being inside the noninferiority limit of -9%. Conclusion Among nurses in Ontario tertiary care hospitals, use of a surgical mask compared with an N95 respirator resulted in noninferior rates of laboratory-confirmed influenza. Trial Registration clinicaltrials.gov Identifier: NCT00756574 JAMA. 2009;302(17):1865-1871	[Loeb, Mark; Dafoe, Nancy; Mahony, James; Smieja, Marek] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; [Loeb, Mark] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Loeb, Mark; Smieja, Marek; Earn, David J. D.; Walter, Stephen D.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Earn, David J. D.] McMaster Univ, Dept Math & Stat, Hamilton, ON L8N 3Z5, Canada; [Loeb, Mark; Mahony, James; Smieja, Marek; Earn, David J. D.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON L8N 3Z5, Canada; [Mahony, James; Chong, Sylvia] St Josephs Hosp, Reg Virol Lab, Hamilton, ON, Canada; [John, Michael] Univ Western Ontario, Dept Pathol, London, ON N6A 3K7, Canada; [John, Michael] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 3K7, Canada; [Sarabia, Alicia] Credit Valley Hosp, Dept Microbiol, Mississauga, ON, Canada; [Glavin, Verne] Joseph Brant Mem Hosp, Burlington, ON, Canada; [Webby, Richard; Webb, Ashley] St Jude Childrens Res Hosp, WHO, Collaborating Ctr Studies Ecol Influenza Anim & B, Memphis, TN USA	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; McGill University; McMaster University; Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; Trillium Health Partners; Credit Valley Hospital; St Jude Children's Research Hospital; World Health Organization	Loeb, M (corresponding author), McMaster Univ, Dept Pathol & Mol Med, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	loebm@mcmaster.ca	Webby, Richard J/N-5657-2018; Walter, Stephen/AAB-5548-2022	Walter, Stephen/0000-0003-4157-8928; Earn, David/0000-0002-7562-1341	Public Health Agency of Canada	Public Health Agency of Canada	This study was supported by the Public Health Agency of Canada.	AGAH R, 1987, AM J DIS CHILD, V141, P695, DOI 10.1001/archpedi.1987.04460060111049; ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Brosseau LM, 1997, APPL OCCUP ENV HYG, V12; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Cohen J, 2009, SCIENCE, V324, P1496, DOI 10.1126/science.324_1496; COOPER DW, 1983, AM IND HYG ASSOC J, V44, P720, DOI 10.1202/0002-8894(1983)044<0720:CMFERP>2.3.CO;2; *COUNC CAN AC EXP, INFL TRANSM ROL PERS; COWLING BJ, ANN INTERN MED; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Gotzsche PC, 2006, JAMA-J AM MED ASSOC, V295, P1172, DOI 10.1001/jama.295.10.1172; Langley JM, 2004, CAN MED ASSOC J, V171, P1213, DOI 10.1503/cmaj.1031737; Loosli CG, 1943, P SOC EXP BIOL MED, V53, P205, DOI 10.3181/00379727-53-14251P; Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167; Mahony J, 2007, J CLIN MICROBIOL, V45, P2965, DOI 10.1128/JCM.02436-06; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; McCullough NV, 1997, ANN OCCUP HYG, V41, P677, DOI 10.1093/annhyg/41.6.677; *MIN HLTH LONG TER, 2005, PREV RESP ILLN PROT; Mitakakis TZ, 2002, CLIN EXP ALLERGY, V32, P1166, DOI 10.1046/j.1365-2745.2002.01432.x; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; SNYDER MH, 1986, J INFECT DIS, V154, P709, DOI 10.1093/infdis/154.4.709; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; TUOMI T, 1985, AM IND HYG ASSOC J, V46, P308, DOI 10.1080/15298668591394879; *US DEP LAB, OSHA TECHN MAN SECT, pCH2; Willeke K, 1996, AM IND HYG ASSOC J, V57, P348, DOI 10.1080/15428119691014882	29	319	328	1	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 4	2009	302	17					1865	1871		10.1001/jama.2009.1466	http://dx.doi.org/10.1001/jama.2009.1466			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514DU	19797474	Bronze			2022-12-28	WOS:000271375300017
J	Demaurex, N; Poburko, D				Demaurex, Nicolas; Poburko, Damon			A Revolving Door for Calcium	SCIENCE			English	Editorial Material							WOLF-HIRSCHHORN-SYNDROME; LETM1; CA2+		[Demaurex, Nicolas; Poburko, Damon] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Poburko, Damon] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	University of Geneva; Stanford University	Demaurex, N (corresponding author), Univ Geneva, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	nicolas.demaurex@unige.ch		Demaurex, Nicolas/0000-0002-9933-6772				Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Brookes PS, 2008, NAT CELL BIOL, V10, P1235, DOI 10.1038/ncb1108-1235; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Hasegawa A, 2007, HUM MOL GENET, V16, P2061, DOI 10.1093/hmg/ddm154; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Rauch A, 2001, AM J MED GENET, V99, P338, DOI 10.1002/ajmg.1203; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556	10	8	8	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 2	2009	326	5949					57	58		10.1126/science.1180482	http://dx.doi.org/10.1126/science.1180482			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797650				2022-12-28	WOS:000270355600031
J	Grimaldi, D				Grimaldi, David			Pushing Back Amber Production	SCIENCE			English	Editorial Material							NATURAL RESINS; GEOSPHERE; FATE		Amer Museum Nat Hist, Dept Invertebrate Zool, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Grimaldi, D (corresponding author), Amer Museum Nat Hist, Dept Invertebrate Zool, New York, NY 10024 USA.	grimaldi@amnh.org						Anderson KB, 1995, ACS SYM SER, V617, P105; ANDERSON KB, 1993, ORG GEOCHEM, V20, P1027, DOI 10.1016/0146-6380(93)90111-N; ANDERSON KB, 1994, ORG GEOCHEM, V21, P209, DOI 10.1016/0146-6380(94)90155-4; Bray PS, 2009, SCIENCE, V326, P132, DOI 10.1126/science.1177539; Labandeira CC, 1998, ANNU REV EARTH PL SC, V26, P329, DOI 10.1146/annurev.earth.26.1.329; Lambert J.B., 1995, ARCHAEOMETRY, V38, P325, DOI DOI 10.1111/j.1475-4754.1996.tb00780.x; LANGENHEIM J, 2003, PLANT RESINS, P144; LYONS PC, 1984, INT J COAL GEOL, V3, P257, DOI 10.1016/0166-5162(84)90020-X; VANBERGEN PF, 1996, ACS SYM SER, V617, P149	9	16	17	2	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 2	2009	326	5949					51	52		10.1126/science.1179328	http://dx.doi.org/10.1126/science.1179328			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797645				2022-12-28	WOS:000270355600026
J	Richards, T				Richards, Tessa			Health Policy Europe's knowledge broker	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Richards, T (corresponding author), BMJ, London WC1H 9JR, England.	trichards@bmj.com						DANZON M, 2009, 59 SESS 14 17 SEPT; Economist, 2009, ECONOMIST       0822; Richards T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a621; 1996, BMJ, V312, P1664	4	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 23	2009	339								b3871	10.1136/bmj.b3871	http://dx.doi.org/10.1136/bmj.b3871			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OF	19776110				2022-12-28	WOS:000270231700006
J	Kadokura, H; Beckwith, J				Kadokura, Hiroshi; Beckwith, Jon			Detecting Folding Intermediates of a Protein as It Passes through the Bacterial Translocation Channel	CELL			English	Article							DISULFIDE BOND FORMATION; SIGNAL RECOGNITION PARTICLE; ESCHERICHIA-COLI; IN-VIVO; ALKALINE-PHOSPHATASE; NONCONSECUTIVE DISULFIDE; MEMBRANE; DSBA; ISOMERASE; OXIDOREDUCTASES	Most bacterial exported proteins cross the cytoplasmic membrane as unfolded polypeptides. However, little is known about how they fold during or after this process due to the difficulty in detecting folding intermediates. Here we identify cotranslational and posttranslational folding intermediates of a periplasmic protein in which the protein and DsbA, a periplasmic disulfide bond-forming enzyme, are covalently linked by a disulfide bond. The cotranslational mixed-disulfide intermediate is, upon further chain elongation, resolved, releasing the oxidized polypeptide, thus allowing us to follow the folding process. This analysis reveals that two cysteines that are joined to form a structural disulfide can play different roles during the folding reaction and that the mode of translocation ( cotranslational verse posttranslational) can affect the folding process of a protein in the periplasm. The latter finding leads us to propose that the activity of the ribosome ( translation) can modulate protein folding even in an extracytosolic compartment.	[Kadokura, Hiroshi; Beckwith, Jon] Harvard Univ, Dept Microbiol & Mol Genet, Sch Med, Boston, MA 02115 USA; [Kadokura, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan	Harvard University; Harvard Medical School; Nara Institute of Science & Technology	Kadokura, H (corresponding author), Harvard Univ, Dept Microbiol & Mol Genet, Sch Med, 200 Longwood Ave, Boston, MA 02115 USA.	hkadokura@bs.naist.jp; jbeckwith@hms.harvard.edu	Kadokura, Hiroshi/AAE-1645-2019	Kadokura, Hiroshi/0000-0001-7308-7141	NIH [GM41883]; MEXT of Japan [21580092]; JSPS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of J. B.'s laboratory, especially Markus Eser, and SeungHyun Cho for discussions. H. K. thanks Kenji Kohno, in whose laboratory part of this work was done. J. B. is an American Cancer Society Professor. This work was supported by NIH grant GM41883 ( to J. B.) and in part by an international research fellowship from the Global COE program in NAIST from MEXT of Japan and Grant-in-Aid for Scientific Research ( C) ( 21580092) from JSPS ( to H. K.).	AKIYAMA Y, 1993, J BIOL CHEM, V268, P8146; Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; Berkmen M, 2005, J BIOL CHEM, V280, P11387, DOI 10.1074/jbc.M411774200; BRADSHAW RA, 1981, P NATL ACAD SCI-BIOL, V78, P3473, DOI 10.1073/pnas.78.6.3473; Cho SH, 2007, EMBO J, V26, P3509, DOI 10.1038/sj.emboj.7601799; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P3576, DOI 10.1021/bi00011a012; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; Duguay AR, 2004, BBA-MOL CELL RES, V1694, P121, DOI 10.1016/j.bbamcr.2004.04.012; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; ENNIS HL, 1972, ANTIMICROB AGENTS CH, V1, P197, DOI 10.1128/AAC.1.3.197; Evans MS, 2008, J MOL BIOL, V383, P683, DOI 10.1016/j.jmb.2008.07.035; Fedorov AN, 1997, J BIOL CHEM, V272, P32715, DOI 10.1074/jbc.272.52.32715; Frech C, 1996, EMBO J, V15, P392, DOI 10.1002/j.1460-2075.1996.tb00369.x; Harms N, 2001, J BIOL CHEM, V276, P18804, DOI 10.1074/jbc.M011194200; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; ITO K, 1981, CELL, V24, P707, DOI 10.1016/0092-8674(81)90097-0; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; JOSEFSSON LG, 1981, CELL, V25, P151, DOI 10.1016/0092-8674(81)90239-7; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; KAMITANI S, 1992, EMBO J, V11, P57, DOI 10.1002/j.1460-2075.1992.tb05027.x; LIU G, 1988, J BIOL CHEM, V263, P14790; MATSUYAMA S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P77, DOI 10.1016/0167-4838(92)90130-6; Messens J, 2007, J BIOL CHEM, V282, P31302, DOI 10.1074/jbc.M705236200; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Powers T, 1997, EMBO J, V16, P4880, DOI 10.1093/emboj/16.16.4880; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Sone M, 1997, J BIOL CHEM, V272, P10349; Sone M, 1997, J BIOL CHEM, V272, P6174, DOI 10.1074/jbc.272.10.6174; Tian P, 2009, J BIOL CHEM, V284, P11396, DOI 10.1074/jbc.M900375200; Ureta AR, 2007, J BACTERIOL, V189, P446, DOI 10.1128/JB.01103-06; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752	39	81	86	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 18	2009	138	6					1164	1173		10.1016/j.cell.2009.07.030	http://dx.doi.org/10.1016/j.cell.2009.07.030			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766568	Green Accepted, Bronze			2022-12-28	WOS:000269923200016
J	Varga, V; Leduc, C; Bormuth, V; Diez, S; Howard, J				Varga, Vladimir; Leduc, Cecile; Bormuth, Volker; Diez, Stefan; Howard, Jonathon			Kinesin-8 Motors Act Cooperatively to Mediate Length-Dependent Microtubule Depolymerization	CELL			English	Article							FISSION YEAST; CHROMOSOME CONGRESSION; CARGO MOVEMENT; DEPOLYMERASE; PROTEIN; CELLS; MOLECULES; DYNAMICS; SPINDLE; KIF18A	Motor proteins in the kinesin-8 family depolymerize microtubules in a length-dependent manner that may be crucial for controlling the length of organelles such as the mitotic spindle. We used single-molecule microscopy to understand the mechanism of length-dependent depolymerization by the budding yeast kinesin-8, Kip3p. We found that after binding at a random position on a microtubule and walking to the plus end, an individual Kip3p molecule pauses there until an incoming Kip3p molecule bumps it off. Kip3p dissociation is accompanied by removal of just one or two tubulin dimers (on average). Such a cooperative mechanism leads to a depolymerization rate that is proportional to the flux of motors to the microtubule end and accounts for the length dependence of depolymerization. This type of feedback between length and disassembly may serve as a model for understanding how an ensemble of molecules can measure and control polymer length.	[Varga, Vladimir; Leduc, Cecile; Bormuth, Volker; Diez, Stefan; Howard, Jonathon] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Howard, J (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	howard@mpi-cbg.de	Howard, Jonathon/J-7492-2016; Howard, Jonathon/D-4229-2011; Leduc, Cécile/AGB-1431-2022; Leduc, Cecile/AAC-1998-2019; Diez, Stefan/E-8172-2010	Howard, Jonathon/0000-0003-0086-1196; Howard, Jonathon/0000-0003-0086-1196; Leduc, Cécile/0000-0002-1806-4120; Diez, Stefan/0000-0002-0750-8515; Varga, Vladimir/0000-0002-0384-1281	German Ministry of Science and Education [03 N 8712]; Max Planck Society; Gottlieb Daimler and Karl Benz Foundation; Boehringer Ingelheim Fonds	German Ministry of Science and Education; Max Planck Society(Max Planck Society); Gottlieb Daimler and Karl Benz Foundation; Boehringer Ingelheim Fonds(Boehringer Ingelheim)	We thank Frauke Hussmann and Burkhard Rammner for structural insights into the Kip3p motor domain, Felix Ruhnow for tracking software, and Regine Hartmann, Corina Brauer, and Jan Ribbe for help with proteinexpression. We thank members of the Howard and Diez labs and Erik Schaeffer and Jonne Helenius for comments on an earlier draft of this manuscript. We acknowledge financial support by the German Ministry of Science and Education ( grant 03 N 8712) and the Max Planck Society. C. L. was supported by the Gottlieb Daimler and Karl Benz Foundation and V. B. by a fellowship from the Boehringer Ingelheim Fonds.	Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005; Crevenna AH, 2008, BIOPHYS J, V95, P5216, DOI 10.1529/biophysj.108.132449; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goshima G, 2005, CURR BIOL, V15, P1979, DOI 10.1016/j.cub.2005.09.054; Grissom PM, 2009, MOL BIOL CELL, V20, P963, DOI 10.1091/mbc.E08-09-0979; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J., 2001, MECH MOTOR PROTEINS; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; HYMAN AA, 1995, J CELL BIOL, V128, P117, DOI 10.1083/jcb.128.1.117; Leduc C, 2007, P NATL ACAD SCI USA, V104, P10847, DOI 10.1073/pnas.0701B64104; Marshall WF, 2005, MOL BIOL CELL, V16, P270, DOI 10.1091/mbc.E04-07-0586; Marshall WF, 2004, ANNU REV CELL DEV BI, V20, P677, DOI 10.1146/annurev.cellbio.20.012103.094437; Mayr MI, 2007, CURR BIOL, V17, P488, DOI 10.1016/j.cub.2007.02.036; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Rogers KR, 2001, EMBO J, V20, P5101, DOI 10.1093/emboj/20.18.5101; Seitz A, 2006, EMBO J, V25, P267, DOI 10.1038/sj.emboj.7600937; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Stumpff J, 2008, DEV CELL, V14, P252, DOI 10.1016/j.devcel.2007.11.014; TAYLOR DL, 1980, NATURE, V284, P405, DOI 10.1038/284405a0; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; TYSON CB, 1979, J BACTERIOL, V138, P92, DOI 10.1128/JB.138.1.92-98.1979; Unsworth A, 2008, MOL BIOL CELL, V19, P5104, DOI 10.1091/mbc.E08-02-0224; Varga V, 2006, NAT CELL BIOL, V8, P957, DOI 10.1038/ncb1462; WADSWORTH P, 1983, J CELL BIOL, V97, P1249, DOI 10.1083/jcb.97.4.1249	29	205	206	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1174	1183		10.1016/j.cell.2009.07.032	http://dx.doi.org/10.1016/j.cell.2009.07.032			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766569	Bronze			2022-12-28	WOS:000269923200017
J	Ashrafian, H; Rao, C; Darzi, A; Athanasiou, T				Ashrafian, Hutan; Rao, Christopher; Darzi, Ara; Athanasiou, Thanos			Benchmarking in surgical research	LANCET			English	Editorial Material							SURGERY		[Ashrafian, Hutan; Rao, Christopher; Darzi, Ara; Athanasiou, Thanos] Univ London Imperial Coll Sci Technol & Med, Dept Biosurg & Surg Technol, London W2 1NY, England	Imperial College London	Athanasiou, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biosurg & Surg Technol, London W2 1NY, England.	t.athanasiou@imperial.ac.uk	Rao, Christopher/G-5330-2010	Rao, Christopher/0000-0003-3244-3888				Ashrafian H, 2008, CIRCULATION, V118, P2091, DOI 10.1161/CIRCULATIONAHA.107.721027; Eckhouse S, 2008, MOL ONCOL, V2, P206, DOI 10.1016/j.molonc.2008.06.001; Hanney Stephen R, 2004, Health Res Policy Syst, V2, P4, DOI 10.1186/1478-4505-2-4; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Horton R, 1996, LANCET, V347, P984, DOI 10.1016/S0140-6736(96)90137-3; McCulloch P, 2002, BRIT MED J, V324, P1448, DOI 10.1136/bmj.324.7351.1448; Souba WW, 2000, ANN SURG, V232, P32, DOI 10.1097/00000658-200007000-00005; Tannock IF, 1998, LANCET, V351, P9; Vecht JA, 2009, EUR J CARDIO-THORAC, V35, P480, DOI 10.1016/j.ejcts.2008.11.025; Watts G, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b553	10	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2009	374	9695					1045	1047		10.1016/S0140-6736(09)61684-6	http://dx.doi.org/10.1016/S0140-6736(09)61684-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	501HA	19782856				2022-12-28	WOS:000270370900008
J	McCulloch, P; Altman, DG; Campbell, WB; Flum, DR; Glasziou, P; Marshall, JC; Nicholl, J				McCulloch, Peter; Altman, Douglas G.; Campbell, W. Bruce; Flum, David R.; Glasziou, Paul; Marshall, John C.; Nicholl, Jon		Balliol Collaboration	Surgical Innovation and Evaluation 3 No surgical innovation without evaluation: the IDEAL recommendations	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIALS; MORTALITY; SURGEONS	Surgery and other invasive therapies are complex interventions, the assessment of which is challenged by factors that depend on operator, team, and setting, such as learning curves, quality variations, and perception of equipoise. We propose recommendations for the assessment of surgery based on a five-stage description of the surgical development process. We also encourage the widespread use of prospective databases and registries. Reports of new techniques should be registered as a professional duty, anonymously if necessary when outcomes are adverse. Case series studies should be replaced by prospective development studies for early technical modifications and by prospective research databases for later pre-trial evaluation. Protocols for these studies should be registered publicly. Statistical process control techniques can be useful in both early and late assessment. Randomised trials should be used whenever possible to investigate efficacy, but adequate pre-trial data are essential to allow power calculations, clarify the definition and indications of the intervention, and develop quality measures. Difficulties in doing randomised clinical trials should be addressed by measures to evaluate learning curves and alleviate equipoise problems. Alternative prospective designs, such as interrupted time series studies, should be used when randomised trials are not feasible. Established procedures should be monitored with prospective databases to analyse outcome variations and to identify late and rare events. Achievement of improved design, conduct, and reporting of surgical research will need concerted action by editors, funders of health care and research, regulatory bodies, and professional societies.	[McCulloch, Peter] Univ Oxford, Nuffield Dept Surg, Oxford, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England; [Campbell, W. Bruce] Natl Inst Hlth & Clin Excellence, London, England; [Flum, David R.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Flum, David R.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Flum, David R.] Univ Washington, Surg Outcomes Res Ctr, Seattle, WA 98195 USA; [Glasziou, Paul] Univ Oxford, Dept Primary Hlth Care, Oxford, England; [Marshall, John C.] Univ Toronto, St Michaels Hosp, Dept Surg, Toronto, ON M5B 1W8, Canada; [Nicholl, Jon] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England	University of Oxford; University of Oxford; National Institute for Health & Care Excellence; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Oxford; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Sheffield	McCulloch, P (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg, Headley Way, Oxford OX3 9DU, England.	peter.mcculloch@nds.ox.ac.uk	Flum, David/GPX-7976-2022; Glasziou, Paul/A-7832-2008; Burton, Martin/F-8579-2012; Blazeby, Jane/H-6703-2019; Cook, Jonathan/D-3648-2015; Altman, Douglas G/A-9714-2012	Glasziou, Paul/0000-0001-7564-073X; Blazeby, Jane/0000-0002-3354-3330; Cook, Jonathan/0000-0002-4156-6989; Campbell, Marion/0000-0001-5386-4097; McCulloch, Peter/0000-0002-3210-8273; Burton, Martin/0000-0002-1261-5876; Boutron, Isabelle/0000-0002-5263-6241	Ethicon UK; National Institute of Health Research Health Technology Assessment Programme; Nuffield Department of Surgery at the University of Oxford; Department of Surgery at McGill University; Medical Research Council [G0800808] Funding Source: researchfish; Chief Scientist Office [HSRU1] Funding Source: researchfish; MRC [G0800808] Funding Source: UKRI	Ethicon UK; National Institute of Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Nuffield Department of Surgery at the University of Oxford; Department of Surgery at McGill University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Balliol Colloquium has been supported by Ethicon UK with unrestricted educational grants and by the National Institute of Health Research Health Technology Assessment Programme. The Balliol Colloquium was administratively and financially supported by the Nuffield Department of Surgery at the University of Oxford and the Department of Surgery at McGill University.	Adler DG, 2003, AM J GASTROENTEROL, V98, P98; Altman DG, 1996, BRIT MED J, V313, P570; *AM SOC COL RECT S, 1994, DIS COLON RECTUM, V37, P8; Ashley SW, 2001, ANN SURG, V234, P572, DOI 10.1097/00000658-200110000-00016; Aultman DF, 1997, AM SURGEON, V63, P1114; Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Bednarska E, 2008, CLIN ORTHOP RELAT R, V466, P1734, DOI 10.1007/s11999-008-0273-9; Beiles CB, 2004, ANZ J SURG, V74, P146, DOI 10.1046/j.1445-2197.2004.02913.x; BURCH JM, 1992, ANN SURG, V215, P476, DOI 10.1097/00000658-199205000-00010; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; De Allegri Manuela, 2008, Health Res Policy Syst, V6, P10, DOI 10.1186/1478-4505-6-10; Degiuli M, 2004, BRIT J CANCER, V90, P1727, DOI 10.1038/sj.bjc.6601761; Della Flora E, 2008, ANN SURG, V247, P583, DOI 10.1097/SLA.0b013e3181656ce9; DETRE KM, 1985, CIRCULATION, V72, P84; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Horton R, 1996, LANCET, V347, P984, DOI 10.1016/S0140-6736(96)90137-3; KEOGH BE, 2004, 5 NAT AD CARD SURG D; Kirkley A, 2008, NEW ENGL J MED, V359, P1097, DOI 10.1056/NEJMoa0708333; Lilford RJ, 2000, BRIT MED J, V320, P43, DOI 10.1136/bmj.320.7226.43; McAllister TN, 2009, LANCET, V373, P1440, DOI 10.1016/S0140-6736(09)60248-8; McCulloch P, 2005, BRIT J SURG, V92, P1293, DOI 10.1002/bjs.4930; McCulloch P, 2009, J ROY SOC MED, V102, P51, DOI 10.1258/jrsm.2008.080308; *MED RES COUNC, 2000, FRAM DEV EV RCTS COM; Mier J, 1997, AM J SURG, V173, P71, DOI 10.1016/S0002-9610(96)00425-4; Mills N, 2003, CONTROL CLIN TRIALS, V24, P272, DOI 10.1016/S0197-2456(03)00020-5; MOHAMMED MA, 2009, BMJ-BRIT MED J, V338, P817; Novick RJ, 2002, ANN THORAC SURG, V73, P358; RANSON JHC, 1976, SURG GYNECOL OBSTET, V143, P209; Shadish WR, 2002, EXPT QUASIEXPERIMENT, P171; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Strain PM, 2005, HANDB ENVIRON CHEM, V5, P29; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; WIEBERS DO, 1992, MAYO CLIN PROC, V67, P513	35	1112	1129	1	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2009	374	9695					1105	1112		10.1016/S0140-6736(09)61116-8	http://dx.doi.org/10.1016/S0140-6736(09)61116-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501HA	19782876				2022-12-28	WOS:000270370900033
J	Palfrey, JS				Palfrey, Judith S.			How Health Care Reform Can Benefit Children and Adolescents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Palfrey, JS (corresponding author), Childrens Hosp, Div Gen Pediat, 300 Longwood Ave, Boston, MA 02115 USA.							DeVol R, 2007, UNHEALTHY AM EC BURD; Homer CJ, 2008, PEDIATRICS, V122, pE922, DOI 10.1542/peds.2007-3762; Szilagyi PG, 2009, ACAD PEDIATR, V9, P4, DOI 10.1016/j.acap.2008.12.002; Unicef, 2007, 7 UNICEF; *US BUR CENS, 2008, CURR POP SURV TABL H	5	7	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 22	2009	361	17								10.1056/NEJMp0908051	http://dx.doi.org/10.1056/NEJMp0908051			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	508YW	19812392	Bronze			2022-12-28	WOS:000270977400004
J	Casino, P; Rubio, V; Marina, A				Casino, Patricia; Rubio, Vicente; Marina, Alberto			Structural Insight into Partner Specificity and Phosphoryl Transfer in Two-Component Signal Transduction	CELL			English	Article							HISTIDINE KINASE ENVZ; RESPONSE REGULATOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; SELENOMETHIONYL PROTEINS; MOLECULAR RECOGNITION; PHOSPHATASE-ACTIVITY; DOMAIN; SENSOR; COMPLEX	The chief mechanism used by bacteria for sensing their environment is based on two conserved proteins: a sensor histidine kinase (HK) and an effector response regulator (RR). The signal transduction process involves highly conserved domains of both proteins that mediate autokinase, phospho-transfer, and phosphatase activities whose output is a finely tuned RR phosphorylation level. Here, we report the structure of the complex between the entire cytoplasmic portion of Thermotoga maritima class I HK853 and its cognate, RR468, as well as the structure of the isolated RR468, both free and BeF3- bound. Our results provide insight into partner specificity in two-component systems, recognition of the phosphorylation state of each partner, and the catalytic mechanism of the phosphatase reaction. Biochemical analysis shows that the HK853-catalyzed autokinase reaction proceeds by a cis autophosphorylation mechanism within the HK subunit. The results suggest a model for the signal transduction mechanism in two-component systems.	[Marina, Alberto] CSIC, IBV, Valencia 46010, Spain; CIBERER, Valencia 46010, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Marina, A (corresponding author), CSIC, IBV, Jaume Roig 11, Valencia 46010, Spain.	amarina@ibv.csic.es	Rubio, Vicente/K-7919-2014; Marina, Alberto/H-6264-2011; Casino, Patricia/ABE-5756-2020; CASINO, PATRICIA/L-1579-2014	Rubio, Vicente/0000-0001-8124-1196; Marina, Alberto/0000-0002-1334-5273; Casino, Patricia/0000-0002-2144-188X; CASINO, PATRICIA/0000-0002-2144-188X	European Union; Spanish Ministry of Science [BIO2005-0153, BIO2008-04592, BFU2008-05021]	European Union(European Commission); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We thank W. A. Hendrickson (Columbia University, New York) for sparking this work, A.J. Fernandez and M. Lopez-Redondo (IBV-CSIC) for experimental help, I. Fita (Instituto de Biologia Molecular de Barcelona-Consejo Superior de Investigaciones Cientificas [IBMB-CSIC]), S. Ramon, A. Alt, and L. Sevilla (IBV-CSIC) for critical reading the manuscript, the European Synchrotron Radiation Facility (ESRF) personnel at BM16, BM30A, and ID14-3 beamlines for help with data collection, the European Union and ESRF for support for synchrotron use, and the Spanish Ministry of Science for grants BIO2005-0153, BIO2008-04592, and BFU2008-05021.	ATKINSON MR, 1992, J BACTERIOL, V174, P4538, DOI 10.1128/JB.174.14.4538-4548.1992; Bick MJ, 2009, J MOL BIOL, V386, P163, DOI 10.1016/j.jmb.2008.12.006; Brandon L, 2000, MOL MICROBIOL, V38, P1086, DOI 10.1046/j.1365-2958.2000.02219.x; Cai SJ, 2003, J MOL BIOL, V328, P409, DOI 10.1016/S0022-2836(03)00275-4; Casino P, 2007, BBA-PROTEINS PROTEOM, V1774, P603, DOI 10.1016/j.bbapap.2007.02.005; Depardieu F, 2003, MOL MICROBIOL, V50, P1069, DOI 10.1046/j.1365-2958.2003.03771.x; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Dutta R, 1999, MOL MICROBIOL, V34, P633, DOI 10.1046/j.1365-2958.1999.01646.x; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Lee SY, 2001, J BIOL CHEM, V276, P16425, DOI 10.1074/jbc.M101002200; Lewis RJ, 1999, J MOL BIOL, V294, P9, DOI 10.1006/jmbi.1999.3261; LUKAT GS, 1991, J BIOL CHEM, V266, P8348; Marina A, 2005, EMBO J, V24, P4247, DOI 10.1038/sj.emboj.7600886; Mildvan AS, 1997, PROTEINS, V29, P401, DOI 10.1002/(SICI)1097-0134(199712)29:4<401::AID-PROT1>3.3.CO;2-#; NINFA EG, 1993, J BACTERIOL, V175, P7024, DOI 10.1128/jb.175.21.7024-7032.1993; Qin L, 2003, J BACTERIOL, V185, P3429, DOI 10.1128/JB.185.11.3429-3435.2003; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Ruiz D, 2008, MICROBIOL-SGM, V154, P3002, DOI 10.1099/mic.0.2008/020677-0; Russo F D, 1993, Trends Microbiol, V1, P306, DOI 10.1016/0966-842X(93)90007-E; Saito K, 2003, MOL MICROBIOL, V48, P373, DOI 10.1046/j.1365-2958.2003.03446.x; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tao W, 2002, MOL MICROBIOL, V43, P459, DOI 10.1046/j.1365-2958.2002.02757.x; Tomomori C, 1999, NAT STRUCT BIOL, V6, P729; Tzeng YL, 1997, J MOL BIOL, V272, P200, DOI 10.1006/jmbi.1997.1226; Varughese KI, 2006, J BACTERIOL, V188, P4970, DOI 10.1128/JB.00160-06; Yamada S, 2006, J MOL BIOL, V362, P123, DOI 10.1016/j.jmb.2006.07.012; YANG Y, 1991, P NATL ACAD SCI USA, V88, P11057, DOI 10.1073/pnas.88.24.11057; Yoshida T, 2002, MOL MICROBIOL, V46, P1283, DOI 10.1046/j.1365-2958.2002.03240.x; Zapf J, 2000, STRUCTURE, V8, P851, DOI 10.1016/S0969-2126(00)00174-X; Zapf J, 1998, BIOCHEMISTRY-US, V37, P7725, DOI 10.1021/bi9729615; Zhu Y, 2000, P NATL ACAD SCI USA, V97, P7808, DOI 10.1073/pnas.97.14.7808	36	286	292	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					325	336		10.1016/j.cell.2009.08.032	http://dx.doi.org/10.1016/j.cell.2009.08.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19800110	Bronze			2022-12-28	WOS:000270857500016
J	Brook, RH				Brook, Robert H.			Disruption and Innovation in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brook, Robert H.] RAND Corp, Santa Monica, CA 90407 USA; [Brook, Robert H.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Brook, Robert H.] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA	RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Brook, RH (corresponding author), RAND Corp, 1776 Main St,POB 2138, Santa Monica, CA 90407 USA.	robert_brook@rand.org						Bentley TGK, 2008, MILBANK Q, V86, P629, DOI 10.1111/j.1468-0009.2008.00537.x; BOWER JL, 1995, HARVARD BUS REV, V73, P43; HUNDLEY RO, 1999, REVOLUTIONS FUTURE T; HUNDLEY VA, 1994, BRIT MED J, V309, P1400, DOI 10.1136/bmj.309.6966.1400; Milstein A, 2007, HEALTH AFFAIR, V26, P137, DOI 10.1377/hlthaff.26.1.137; Mundinger MO, 2009, J PROF NURS, V25, P69, DOI 10.1016/j.profnurs.2008.01.009; Mundinger MO, 2000, JAMA-J AM MED ASSOC, V283, P59, DOI 10.1001/jama.283.1.59; *NEW ENGL HLTH CAR, 2008, MAN MOR STUD WILL IT	8	13	13	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	2009	302	13					1465	1466		10.1001/jama.2009.1427	http://dx.doi.org/10.1001/jama.2009.1427			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	503CL	19809030				2022-12-28	WOS:000270509600024
J	Filippone, M; Bonetto, G; Cherubin, E; Carraro, S; Baraldi, E				Filippone, Marco; Bonetto, Gea; Cherubin, Emanuele; Carraro, Silvia; Baraldi, Eugenio			Childhood Course of Lung Function in Survivors of Bronchopulmonary Dysplasia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							INFANCY; AGE		[Filippone, Marco; Bonetto, Gea; Cherubin, Emanuele; Carraro, Silvia; Baraldi, Eugenio] Univ Padua, Sch Med, Dept Pediat, Padua, Italy	University of Padua	Filippone, M (corresponding author), Univ Padua, Sch Med, Dept Pediat, Padua, Italy.	baraldi@pediatria.unipd.it	baraldi, eugenio/AAC-5233-2022	BARALDI, EUGENIO/0000-0002-1829-3652				Baraldi E, 1997, AM J RESP CRIT CARE, V155, P149, DOI 10.1164/ajrccm.155.1.9001304; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Filippone M, 2003, LANCET, V361, P753, DOI 10.1016/S0140-6736(03)12633-5; Hoo AF, 2002, AM J RESP CRIT CARE, V165, P1084, DOI 10.1164/ajrccm.165.8.2103035; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8	6	57	57	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	2009	302	13					1418	1420		10.1001/jama.2009.1419	http://dx.doi.org/10.1001/jama.2009.1419			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503CL	19809022				2022-12-28	WOS:000270509600013
J	McLean, SAM				McLean, Sheila A. M.			Legal Tender Live and let die	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Glasgow, Inst Law & Eth Med, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	McLean, SAM (corresponding author), Univ Glasgow, Inst Law & Eth Med, Glasgow G12 8QQ, Lanark, Scotland.	s.mclean@lbss.gla.ac.uk							0	12	12	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 7	2009	339								b4112	10.1136/bmj.b4112	http://dx.doi.org/10.1136/bmj.b4112			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505TG	19812136				2022-12-28	WOS:000270719200013
J	Buckley, DI; Fu, RW; Freeman, M; Rogers, K; Helfand, M				Buckley, David I.; Fu, Rongwei; Freeman, Michele; Rogers, Kevin; Helfand, Mark			C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							MIDDLE-AGED MEN; FIBRIN D-DIMER; CARDIOVASCULAR-DISEASE; INCIDENT CORONARY; PHOSPHOLIPASE A(2); MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; FOLLOW-UP; INFLAMMATORY MARKERS; ATTRIBUTABLE RISK	Background: C-reactive protein (CRP) may help to refine global risk assessment for coronary heart disease (CHD), particularly among persons who are at intermediate risk on the basis of traditional risk factors alone. Purpose: To assist the U. S. Preventive Services Task Force (USPSTF) in determining whether CRP should be incorporated into guidelines for CHD risk assessment. Data Sources: MEDLINE search of English-language articles (1966 to November 2007), supplemented by reference lists of reviews, pertinent studies, editorials, and Web sites and by expert suggestions. Study Selection: Prospective cohort, case-cohort, and nested case-control studies relevant to the independent predictive ability of CRP when used in intermediate-risk persons. Data Extraction: Included studies were reviewed according to pre-defined criteria, and the quality of each study was rated. Data Synthesis: The validity of the body of evidence and the net benefit or harm of using CRP for CHD risk assessment were evaluated. The combined magnitude of effect was determined by meta-analysis. The body of evidence is of good quality, consistency, and applicability. For good studies that adjusted for all Framingham risk variables, the summary estimate of relative risk for incident CHD was 1.58 (95% CI, 1.37 to 1.83) for CRP levels greater than 3.0 mg/L compared with levels less than 1.0 mg/L. Analyses from 4 large cohorts were consistent in finding evidence that including CRP improves risk stratification among initially intermediate-risk persons. C-reactive protein has desirable test characteristics, and good data exist on the prevalence of elevated CRP levels in intermediate-risk persons. Limited evidence links changes in CRP level to primary prevention of CHD events. Limitations: Study methods for measuring Framingham risk variables and other covariates varied. Ethnic and racial minority populations were poorly represented in most studies, limiting generalizability. Few studies directly assessed the effect of CRP on risk reclassification in intermediate-risk persons. Conclusion: Strong evidence indicates that CRP is associated with CHD events. Moderate, consistent evidence suggests that adding CRP to risk prediction models among initially intermediate-risk persons improves risk stratification. However, sufficient evidence that reducing CRP levels prevents CHD events is lacking.	[Buckley, David I.] Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA; Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA	Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Utah System of Higher Education; University of Utah	Buckley, DI (corresponding author), Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Mailcode FM,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.				Agency for Healthcare Research and Quality [290-02-0024]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality (contract no. 290-02-0024, Task Order Number 2).	Agewall S, 1998, J HYPERTENS, V16, P537, DOI 10.1097/00004872-199816040-00016; Ajani UA, 2004, CLIN CHEM, V50, P1618, DOI 10.1373/clinchem.2004.036004; Albert MA, 2003, CIRCULATION, V108, P161, DOI 10.1161/01.CIR.0000080289.72166.CF; Ballantyne CM, 2004, CIRCULATION, V109, P837, DOI 10.1161/01.CIR.0000116763.91992.F1; Bermudez EA, 2002, ARTERIOSCL THROM VAS, V22, P1668, DOI 10.1161/01.ATV.0000029781.31325.66; Blake GJ, 2003, CIRCULATION, V108, P2993, DOI 10.1161/01.CIR.0000104566.10178.AF; Boekholdt SM, 2006, ATHEROSCLEROSIS, V187, P415, DOI 10.1016/j.atherosclerosis.2005.09.023; Brotman DJ, 2005, ARCH INTERN MED, V165, P138, DOI 10.1001/archinte.165.2.138; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Cushman M, 2005, CIRCULATION, V112, P25, DOI 10.1161/CIRCULATIONAHA.104.504159; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engstrom G, 2006, ARCH INTERN MED, V166, P1040, DOI 10.1001/archinte.166.9.1040-a; Everett BM, 2006, J AM COLL CARDIOL, V48, P2235, DOI 10.1016/j.jacc.2006.09.030; Ferdinand KC, 2006, AM J CARDIOL, V97, p12A, DOI 10.1016/j.amjcard.2005.11.011; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Folsom AR, 2002, AM HEART J, V144, P233, DOI 10.1067/mhj.2002.124054; Gram J, 2000, J INTERN MED, V247, P205, DOI 10.1046/j.1365-2796.2000.00604.x; Greenland P, 2005, ARCH INTERN MED, V165, P2454, DOI 10.1001/archinte.165.21.2454; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; HELFAND M, 2009, EVIDENCE SYNTHESIS, V73; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hingorani AD, 2006, EUR HEART J, V27, P1261, DOI 10.1093/eurheartj/ehi852; Hlatky MA, 2008, NEW ENGL J MED, V359, P2280, DOI 10.1056/NEJMe0808320; Howard Barbara V., 1994, Annals of Epidemiology, V4, P341; Hutchinson WL, 2000, CLIN CHEM, V46, P934; Jager A, 1999, ARTERIOSCL THROM VAS, V19, P3071, DOI 10.1161/01.ATV.19.12.3071; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3; Koenig W, 2003, AM J EPIDEMIOL, V158, P357, DOI 10.1093/aje/kwg135; Koenig W, 2004, CIRCULATION, V110, P1903, DOI 10.1161/01.CIR.0000143377.53389.C8; Koenig W, 2007, CIRCULATION, V116, P3, DOI 10.1161/CIRCULATIONAHA.107.707984; Koenig W, 2006, ARTERIOSCL THROM VAS, V26, P2745, DOI 10.1161/01.ATV.0000248096.62495.73; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Lawlor DA, 2005, THROMB HAEMOSTASIS, V93, P955, DOI 10.1160/TH04-12-0805; Lemieux I, 2001, ARTERIOSCL THROM VAS, V21, P961, DOI 10.1161/01.ATV.21.6.961; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Lloyd-Jones DM, 2006, ANN INTERN MED, V145, P35, DOI 10.7326/0003-4819-145-1-200607040-00129; Lowe GDO, 2001, ARTERIOSCL THROM VAS, V21, P603, DOI 10.1161/01.ATV.21.4.603; Lowe GDO, 2004, ARTERIOSCL THROM VAS, V24, P1957, DOI 10.1161/01.ATV.0000141842.27810.a9; Luc G, 2003, ARTERIOSCL THROM VAS, V23, P1255, DOI 10.1161/01.ATV.0000079512.66448.1D; McGill HC, 1997, ARTERIOSCL THROM VAS, V17, P95, DOI 10.1161/01.ATV.17.1.95; Miller M, 2005, ARCH INTERN MED, V165, P2063, DOI 10.1001/archinte.165.18.2063; Moons KGM, 2003, ACAD RADIOL, V10, P670, DOI 10.1016/S1076-6332(03)80087-9; Mora S, 2006, CIRCULATION, V114, P381, DOI 10.1161/CIRCULATIONAHA.106.634089; Mosca L, 2000, CIRCULATION, V101, pE223, DOI 10.1161/01.CIR.101.1.e3; Nicklas BJ, 2005, CAN MED ASSOC J, V172, P1199, DOI 10.1503/cmaj.1040769; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Ockene IS, 2001, CLIN CHEM, V47, P444; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Park R, 2002, CIRCULATION, V106, P2073, DOI 10.1161/01.CIR.0000033819.29662.09; Pasternak Richard C., 2003, Journal of the American College of Cardiology, V41, P1863, DOI 10.1016/S0735-1097(03)00358-9; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pepe MS, 2008, AM J EPIDEMIOL, V167, P362, DOI 10.1093/aje/kwm305; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pirro M, 2001, ARCH INTERN MED, V161, P2474, DOI 10.1001/archinte.161.20.2474; Pischon T, 2007, EUR J EPIDEMIOL, V22, P429, DOI 10.1007/s10654-007-9141-2; Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2005, JAMA-J AM MED ASSOC, V294, P326, DOI 10.1001/jama.294.3.326; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ridker PM, 2004, CIRCULATION, V109, P1955, DOI 10.1161/01.CIR.0000125690.80303.A8; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rifai N, 2002, ANN INTERN MED, V136, P529, DOI 10.7326/0003-4819-136-7-200204020-00010; Roivainen M, 2000, CIRCULATION, V101, P252, DOI 10.1161/01.CIR.101.3.252; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Scirica BM, 2006, CIRCULATION, V113, P2128, DOI 10.1161/CIRCULATIONAHA.105.611350; Scirica BM, 2006, CIRCULATION, V113, P2150; Smith SC, 2006, AM J CARDIOL, V97, p28A, DOI 10.1016/j.amjcard.2005.11.013; St-Pierre AC, 2005, ATHEROSCLEROSIS, V182, P315, DOI 10.1016/j.atherosclerosis.2005.02.009; Strandberg TE, 2000, ARTERIOSCL THROM VAS, V20, P1057, DOI 10.1161/01.ATV.20.4.1057; Tuomisto K, 2006, THROMB HAEMOSTASIS, V95, P511, DOI 10.1160/TH05-08-0571; Tzoulaki I, 2007, CIRCULATION, V115, P2119, DOI 10.1161/CIRCULATIONAHA.106.635029; van der Meer IM, 2003, ARCH INTERN MED, V163, P1323, DOI 10.1001/archinte.163.11.1323; Wang WY, 2002, ANN EPIDEMIOL, V12, P107, DOI 10.1016/S1047-2797(01)00273-3; Wilkins J, 1998, CLIN CHEM, V44, P1358; Wilson PWF, 2008, CIRC-CARDIOVASC QUAL, V1, P92, DOI 10.1161/CIRCOUTCOMES.108.831198; Wilson PWF, 2005, ARCH INTERN MED, V165, P2473, DOI 10.1001/archinte.165.21.2473; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Witherell HL, 2003, ANN EPIDEMIOL, V13, P170, DOI 10.1016/S1047-2797(02)00276-4	99	395	414	1	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2009	151	7					483	W161		10.7326/0003-4819-151-7-200910060-00009	http://dx.doi.org/10.7326/0003-4819-151-7-200910060-00009			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502OT	19805771				2022-12-28	WOS:000270470500006
J	Selman, C; Tullet, JMA; Wieser, D; Irvine, E; Lingard, SJ; Choudhury, AI; Claret, M; Al-Qassab, H; Carmignac, D; Ramadani, F; Woods, A; Robinson, ICA; Schuster, E; Batterham, RL; Kozma, SC; Thomas, G; Carling, D; Okkenhaug, K; Thornton, JM; Partridge, L; Gems, D; Withers, DJ				Selman, Colin; Tullet, Jennifer M. A.; Wieser, Daniela; Irvine, Elaine; Lingard, Steven J.; Choudhury, Agharul I.; Claret, Marc; Al-Qassab, Hind; Carmignac, Danielle; Ramadani, Faruk; Woods, Angela; Robinson, Iain C. A.; Schuster, Eugene; Batterham, Rachel L.; Kozma, Sara C.; Thomas, George; Carling, David; Okkenhaug, Klaus; Thornton, Janet M.; Partridge, Linda; Gems, David; Withers, Dominic J.			Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span	SCIENCE			English	Article							DIET-INDUCED OBESITY; CAENORHABDITIS-ELEGANS; INSULIN SENSITIVITY; C-ELEGANS; MICE; GROWTH; AMPK; AGE; RESTRICTION; LONGEVITY	Caloric restriction (CR) protects against aging and disease, but the mechanisms by which this affects mammalian life span are unclear. We show in mice that deletion of ribosomal S6 protein kinase 1 (S6K1), a component of the nutrient-responsive mTOR (mammalian target of rapamycin) signaling pathway, led to increased life span and resistance to age-related pathologies, such as bone, immune, and motor dysfunction and loss of insulin sensitivity. Deletion of S6K1 induced gene expression patterns similar to those seen in CR or with pharmacological activation of adenosine monophosphate (AMP)-activated protein kinase (AMPK), a conserved regulator of the metabolic response to CR. Our results demonstrate that S6K1 influences healthy mammalian life span and suggest that therapeutic manipulation of S6K1 and AMPK might mimic CR and could provide broad protection against diseases of aging.	[Selman, Colin; Irvine, Elaine; Lingard, Steven J.; Choudhury, Agharul I.; Claret, Marc; Al-Qassab, Hind; Batterham, Rachel L.; Withers, Dominic J.] UCL, Dept Med, Ctr Diabet & Endocrinol, Inst Healthy Ageing, London WC1E 6JJ, England; [Tullet, Jennifer M. A.; Partridge, Linda; Gems, David] UCL, Dept Genet Evolut & Environm, Inst Healthy Ageing, London WC1E 6BT, England; [Wieser, Daniela; Schuster, Eugene; Thornton, Janet M.] European Bioinformat Inst, Cambridge CB10 1SD, England; [Carmignac, Danielle; Robinson, Iain C. A.] Natl Inst Med Res, MRC, Div Mol Neuroendocrinol, London NW7 1AA, England; [Ramadani, Faruk; Okkenhaug, Klaus] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge CB22 3AT, England; [Woods, Angela; Carling, David] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Cellular Stress Grp, London W12 0NN, England; [Kozma, Sara C.; Thomas, George] Univ Cincinnati, Genome Res Inst, Dept Canc & Cell Biol, Cincinnati, OH 45237 USA; [Withers, Dominic J.] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, Metab Signaling Grp, London W12 0NN, England	University of London; University College London; University of London; University College London; European Molecular Biology Laboratory (EMBL); MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Imperial College London; University System of Ohio; University of Cincinnati; Imperial College London	Withers, DJ (corresponding author), UCL, Dept Med, Ctr Diabet & Endocrinol, Inst Healthy Ageing, London WC1E 6JJ, England.	d.withers@ucl.ac.uk	Ramadani, Faruk/HHM-9664-2022; Okkenhaug, Klaus/D-5149-2012; Okkenhaug, Klaus/H-3154-2019; Partridge, Linda/A-5501-2010; Partridge, Linda/E-7342-2015; Carling, David/F-1943-2014; Withers, Dominic J/D-7671-2014; Thomas, George/K-9235-2014	Ramadani, Faruk/0000-0001-8228-4868; Okkenhaug, Klaus/0000-0002-9432-4051; Okkenhaug, Klaus/0000-0002-9432-4051; Carling, David/0000-0002-2316-1830; Withers, Dominic J/0000-0002-8009-7521; Thomas, George/0000-0003-3518-8149; Batterham, Rachel/0000-0002-5477-8585; Partridge, Linda/0000-0001-9615-0094; Selman, Colin/0000-0002-8727-0593; Irvine, Elaine/0000-0001-5508-8140; Claret, Marc/0000-0001-7766-9296; Tullet, Jennifer/0000-0002-2037-526X; Thornton, Janet/0000-0003-0824-4096; Schuster, Eugene/0000-0001-5076-2810; Gems, David/0000-0002-6653-4676	Wellcome Trust Functional Genomics; Wellcome Trust Strategic Award; Medical Research Council, Research into Aging; Biological and Biotechnology Research Council; BBSRC [BBS/E/B/0000C236] Funding Source: UKRI; MRC [MC_U120097114, G108/551, G0800339, MC_U117531708] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C236, BBS/E/B/0000M979] Funding Source: researchfish; Medical Research Council [MC_U120097114, G108/551, MC_U117531708, G0800339, MC_U120027537, G0700729B] Funding Source: researchfish	Wellcome Trust Functional Genomics(Wellcome Trust); Wellcome Trust Strategic Award(Wellcome Trust); Medical Research Council, Research into Aging(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biological and Biotechnology Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a Wellcome Trust Functional Genomics award to J. M. T., L. P., D. G., and D. J. W.; a Wellcome Trust Strategic Award to J. M. T., L. P., D. G., and D. J. W.; and grants from the Medical Research Council, Research into Aging, and the Biological and Biotechnology Research Council to D. J. W.	Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Bartke A, 2008, AGING CELL, V7, P285, DOI 10.1111/j.1474-9726.2008.00387.x; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chang GR, 2009, J PHARMACOL SCI, V109, P496, DOI 10.1254/jphs.08215FP; Curtis R, 2006, AGING CELL, V5, P119, DOI 10.1111/j.1474-9726.2006.00205.x; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gulati P, 2007, BIOCHEM SOC T, V35, P236, DOI 10.1042/BST0350236; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Masternak MM, 2009, J GERONTOL A-BIOL, V64, P516, DOI 10.1093/gerona/glp024; Mieulet V, 2007, AM J PHYSIOL-CELL PH, V293, pC712, DOI 10.1152/ajpcell.00499.2006; Miller RA, 2001, J GERONTOL A-BIOL, V56, pB180, DOI 10.1093/gerona/56.4.B180; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Picard F, 2005, INT J OBESITY, V29, pS36, DOI 10.1038/sj.ijo.0802912; Piper MDW, 2008, J INTERN MED, V263, P179, DOI 10.1111/j.1365-2796.2007.01906.x; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	28	800	848	2	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					140	144		10.1126/science.1177221	http://dx.doi.org/10.1126/science.1177221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797661	Green Accepted			2022-12-28	WOS:000270355600055
J	Zid, BM; Rogers, AN; Katewa, SD; Vargas, MA; Kolipinski, MC; Lu, TA; Benzer, S; Kapahi, P				Zid, Brian M.; Rogers, Aric N.; Katewa, Subhash D.; Vargas, Misha A.; Kolipinski, Marysia C.; Lu, Tony Au; Benzer, Seymour; Kapahi, Pankaj			4E-BP Extends Lifespan upon Dietary Restriction by Enhancing Mitochondrial Activity in Drosophila	CELL			English	Article							CAENORHABDITIS-ELEGANS; MESSENGER-RNAS; SIGNALING PATHWAY; GENE-EXPRESSION; FACTOR EIF-4E; CELL-GROWTH; TRANSLATION; EXTENSION; CANCER; TOR	Dietary restriction (DR) extends lifespan in multiple species. To examine the mechanisms of lifespan extension upon DR, we assayed genome-wide translational changes in Drosophila. A number of nuclear encoded mitochondrial genes, including those in Complex I and IV of the electron transport chain, showed increased ribosomal loading and enhanced overall activity upon DR. We found that various mitochondrial genes possessed shorter and less structured 5'UTRs, which were important for their enhanced mRNA translation. The translational repressor 4E-BP, the eukaryotic translation initiation factor 4E binding protein, was upregulated upon DR and mediated DR dependent changes in mitochondrial activity and lifespan extension. Inhibition of individual mitochondrial subunits from Complex I and IV diminished the lifespan extension obtained upon DR, reflecting the importance of enhanced mitochondrial function during DR. Our results imply that translational regulation of nuclear-encoded mitochondrial gene expression by 4E-BP plays an important role in lifespan extension upon DR. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.	[Rogers, Aric N.; Katewa, Subhash D.; Vargas, Misha A.; Kolipinski, Marysia C.; Kapahi, Pankaj] Buck Inst Age Res, Novato, CA 94945 USA; [Zid, Brian M.; Lu, Tony Au; Benzer, Seymour] CALTECH, Pasadena, CA 91125 USA	Buck Institute for Research on Aging; California Institute of Technology	Zid, BM (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	zid@fas.harvard.edu; pkapahi@buckinstitute.org	Rogers, Aric/AAH-2748-2019	Rogers, Aric/0000-0002-6149-6842; Zid, Brian/0000-0003-1876-2479	National Institutes of Health [RL1AAG032113, 1R21AG028241-01]; Ellison Medical Foundation; American Foundation; Hillblom foundation; Nathan Shock Startup; Reta Haynes Family Foundation; Millard and Muriel Jacobs Genetics and Genomics Laboratory at California Institute of Technology; NATIONAL INSTITUTE ON AGING [RL1AG032113, R21AG028241, P30AG025708, T32AG000266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); American Foundation; Hillblom foundation; Nathan Shock Startup; Reta Haynes Family Foundation; Millard and Muriel Jacobs Genetics and Genomics Laboratory at California Institute of Technology; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This manuscript is dedicated to the memory of Seymour Benzer, who passed away in the interim between research and publication of the manuscript. We thank David Nicholls, Martin Brand, Judith Campisi, Gordon Lithgow, Nagendra Yadav, Paul Sternberg, Eric Schwarz, Eimear Kenny, and members of the Kapahi and Benzer Labs, for helpful discussions. We would also like to thank the Kimbrell, Lasko, Sonenberg, Tijan, Tower, and Hafen labs for donation of strains and antibodies. This work was funded by grants from the National Institutes of Health (S. B.), a T32 NIH training grant fellowship (A. R.), grants from the Ellison Medical Foundation, American Foundation for aging research, Hillblom foundation, a Nathan Shock Startup award, a gift from the Harold J. and Reta Haynes Family Foundation, and the NIH (RL1AAG032113, 1R21AG028241-01) ( P. K.). The microarray work was supported by the Millard and Muriel Jacobs Genetics and Genomics Laboratory at California Institute of Technology.	Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Bernal A, 2000, P NATL ACAD SCI USA, V97, P6019, DOI 10.1073/pnas.100391597; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen D, 2007, AGING CELL, V6, P525, DOI 10.1111/j.1474-9726.2007.00305.x; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Ford D, 2007, EXP GERONTOL, V42, P483, DOI 10.1016/j.exger.2007.01.004; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Giannakou ME, 2008, AGING CELL, V7, P187, DOI 10.1111/j.1474-9726.2007.00362.x; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Henderson ST, 2006, J GERONTOL A-BIOL, V61, P444, DOI 10.1093/gerona/61.5.444; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; JOSHIBARVE S, 1992, J BIOL CHEM, V267, P21038; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; KAPAHI P, 2004, SCI AGING KNOWLEDGE, pPE34; Katewa SD, 2007, INSECT BIOCHEM MOLEC, V37, P213, DOI 10.1016/j.ibmb.2006.11.002; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Lachance PED, 2002, MOL CELL BIOL, V22, P1656, DOI 10.1128/MCB.22.6.1656-1663.2002; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Lewis E.B., 1960, DROS INFORM SERV, V34, P117, DOI DOI 10.1101/PDB.REC081414; Lopez-Lluch G, 2006, P NATL ACAD SCI USA, V103, P1768, DOI 10.1073/pnas.0510452103; Magwere T, 2006, J GERONTOL A-BIOL, V61, P36, DOI 10.1093/gerona/61.1.36; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Mair W, 2004, EXP GERONTOL, V39, P1011, DOI 10.1016/j.exger.2004.03.018; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Nusbaum TJ, 1999, J GERONTOL A-BIOL, V54, pB192, DOI 10.1093/gerona/54.5.B192; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Petroulakis E, 2006, BRIT J CANCER, V94, P195, DOI 10.1038/sj.bjc.6602902; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Shamji AF, 2003, MOL CELL, V12, P271, DOI 10.1016/j.molcel.2003.08.016; Shantz LM, 1996, CANCER RES, V56, P3265; Sonenberg N, 2000, TRANSLATIONAL CONTRO; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037; Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603; Teleman AA, 2005, GENE DEV, V19, P1844, DOI 10.1101/gad.341505; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; WARBURG O, 1956, SCIENCE, V124, P269; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Zahn JM, 2006, PLOS GENET, V2, P1058, DOI 10.1371/journal.pgen.0020115; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zong Q, 1999, P NATL ACAD SCI USA, V96, P10632, DOI 10.1073/pnas.96.19.10632	59	386	403	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					149	160		10.1016/j.cell.2009.07.034	http://dx.doi.org/10.1016/j.cell.2009.07.034			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804760	Green Accepted, Bronze			2022-12-28	WOS:000270388600023
J	Hattori, D; Chen, Y; Matthews, BJ; Salwinski, L; Sabatti, C; Grueber, WB; Zipursky, SL				Hattori, Daisuke; Chen, Yi; Matthews, Benjamin J.; Salwinski, Lukasz; Sabatti, Chiara; Grueber, Wesley B.; Zipursky, S. Lawrence			Robust discrimination between self and non-self neurites requires thousands of Dscam1 isoforms	NATURE			English	Article							DROSOPHILA MUSHROOM BODIES; SENSORY NEURONS; AXON GUIDANCE; MOLECULAR DIVERSITY; STRUCTURAL BASIS; SPECIFICITY; BINDING; MORPHOGENESIS; ORGANIZATION; RECOGNITION	Down Syndrome cell adhesion molecule (Dscam) genes encode neuronal cell recognition proteins of the immunoglobulin superfamily(1,2). In Drosophila, Dscam1 generates 19,008 different ectodomains by alternative splicing of three exon clusters, each encoding half or a complete variable immunoglobulin domain(3). Identical isoforms bind to each other, but rarely to isoforms differing at any one of the variable immunoglobulin domains(4,5). Binding between isoforms on opposing membranes promotes repulsion(6). Isoform diversity provides the molecular basis for neurite self-avoidance(6-11). Self-avoidance refers to the tendency of branches from the same neuron (self-branches) to selectively avoid one another(12). To ensure that repulsion is restricted to self-branches, different neurons express different sets of isoforms in a biased stochastic fashion(7,13). Genetic studies demonstrated that Dscam1 diversity has a profound role in wiring the fly brain(11). Here we show how many isoforms are required to provide an identification system that prevents non-self branches from inappropriately recognizing each other. Using homologous recombination, we generated mutant animals encoding 12, 24, 576 and 1,152 potential isoforms. Mutant animals with deletions encoding 4,752 and 14,256 isoforms(14) were also analysed. Branching phenotypes were assessed in three classes of neurons. Branching patterns improved as the potential number of isoforms increased, and this was independent of the identity of the isoforms. Although branching defects in animals with 1,152 potential isoforms remained substantial, animals with 4,752 isoforms were indistinguishable from wild-type controls. Mathematical modelling studies were consistent with the experimental results that thousands of isoforms are necessary to ensure acquisition of unique Dscam1 identities in many neurons. We conclude that thousands of isoforms are essential to provide neurons with a robust discrimination mechanism to distinguish between self and non-self during self-avoidance.	[Hattori, Daisuke; Chen, Yi; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Matthews, Benjamin J.] Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, New York, NY 10032 USA; [Salwinski, Lukasz] Univ Calif Los Angeles, Inst Mol Biol, Howard Hughes Med Inst, DOE Inst Genom & Prote, Los Angeles, CA 90095 USA; [Sabatti, Chiara] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Grueber, Wesley B.] Columbia Univ, Med Ctr, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Grueber, Wesley B.] Columbia Univ, Med Ctr, Dept Neurosci, New York, NY 10032 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University; Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University; Columbia University	Zipursky, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA.	lzipursky@mednet.ucla.edu		Grueber, Wesley/0000-0001-6751-256X; Zipursky, Stephen/0000-0001-5630-7181; Salwinski, Lukasz/0000-0003-4522-1969; Matthews, Benjamin/0000-0002-8697-699X	NIH; NRSA; NIH/NINDS; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS060341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006485] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank T. Lee and B. Dickson for fly stocks, B. Dickson and E. Demir for advice on homologous recombination procedures, S. Miura for staining of embryos, and N. Nocera and other members of the Zipursky laboratory for help in screening homologous recombinants. We thank D. Eisenberg for helpful discussion on mathematical modelling. We thank R. Axel, A. Nern, W. Wojtowicz and other members of the Zipursky and Grueber laboratories for discussion and comments on the manuscript. This work was supported by a grant from the NIH ( S.L.Z.), and NRSA from NIH/NINDS (B.J.M.). W. B. G. is a Searle Scholar, McKnight Scholar and Klingenstein Fellow. S. L. Z. is an investigator of the Howard Hughes Medical Institute.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Brites D, 2008, MOL BIOL EVOL, V25, P1429, DOI 10.1093/molbev/msn087; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; Graveley BR, 2004, RNA, V10, P1499, DOI 10.1261/rna.7105504; Grillenzoni N, 1998, DEVELOPMENT, V125, P3563; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; KRAMER AP, 1985, J NEUROSCI, V5, P768; Lee T, 1999, DEVELOPMENT, V126, P4065; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Sawaya MR, 2008, CELL, V134, P1007, DOI 10.1016/j.cell.2008.07.042; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schmucker D, 2009, GENE DEV, V23, P147, DOI 10.1101/gad.1752909; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652	26	114	114	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					644	U87		10.1038/nature08431	http://dx.doi.org/10.1038/nature08431			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794492	Green Accepted			2022-12-28	WOS:000270302600039
J	Wolpin, BM; Weller, PF; Katz, JT; Levy, BD; Loscalzo, J				Wolpin, Brian M.; Weller, Peter F.; Katz, Joel T.; Levy, Bruce D.; Loscalzo, Joseph			The Writing on the Wall.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EOSINOPHILIC GASTROENTERITIS; HYPEREOSINOPHILIC-SYNDROMES		[Wolpin, Brian M.; Katz, Joel T.; Levy, Bruce D.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Weller, Peter F.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Wolpin, Brian M.; Weller, Peter F.; Katz, Joel T.; Levy, Bruce D.; Loscalzo, Joseph] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	blevy@partners.org	Loscalzo, Joseph/ABD-8980-2021		NIAID NIH HHS [R01 AI020241] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020241] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bolukbas FF, 2004, DIGEST DIS SCI, V49, P1782, DOI 10.1007/s10620-004-9570-7; Caldwell James H., 2002, Curr Treat Options Gastroenterol, V5, P9, DOI 10.1007/s11938-002-0002-5; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; JAFFE JS, 1994, J CLIN IMMUNOL, V14, P299, DOI 10.1007/BF01540983; Justinich C, 1996, J PEDIATR GASTR NUTR, V23, P81, DOI 10.1097/00005176-199607000-00014; Klion AD, 2006, J ALLERGY CLIN IMMUN, V117, P1292, DOI 10.1016/j.jaci.2006.02.042; Martinelli G, 2007, SEMIN HEMATOL, V44, pS4, DOI 10.1053/j.seminhematol.2007.02.002; Mendez-Sanchez N, 2007, DIGEST DIS SCI, V52, P2904, DOI 10.1007/s10620-005-9011-2; Pitini Vincenzo, 2006, Br J Haematol, V132, P123, DOI 10.1111/j.1365-2141.2005.05698.x; Rothenberg ME, 2004, J ALLERGY CLIN IMMUN, V113, P11, DOI 10.1016/j.jaci.2003.10.047; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Sutton SA, 2005, CLIN IMMUNOL, V115, P51, DOI 10.1016/j.clim.2005.02.006; Urek MC, 2006, GUT, V55, P1363, DOI 10.1136/gut.2006.099465; Yun MY, 2007, WORLD J GASTROENTERO, V13, P1758, DOI 10.3748/wjg.v13.i11.1758	14	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2009	361	14					1387	1392		10.1056/NEJMcps0707685	http://dx.doi.org/10.1056/NEJMcps0707685			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500KZ	19797286	Green Accepted			2022-12-28	WOS:000270300000015
J	Sun, Q; Townsend, MK; Okereke, OI; Franco, OH; Hu, FB; Grodstein, F				Sun, Qi; Townsend, Mary K.; Okereke, Olivia I.; Franco, Oscar H.; Hu, Frank B.; Grodstein, Francine			Adiposity and weight change in mid-life in relation to healthy survival after age 70 in women: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; UNITED-STATES; WAIST CIRCUMFERENCE; FAT DISTRIBUTION; RISK-FACTORS; OBESITY; MEN; PREVALENCE; PREDICTORS; OVERWEIGHT	Objective To examine the hypothesis that mid-life adiposity is associated with a reduced probability of maintaining an optimal health status among those who survive to older ages. Design Prospective cohort study. Setting The Nurses' Health Study, United States. Participants 17 065 women who survived until at least the age of 70, provided information on occurrence of chronic disease, cognitive function, physical function, and mental health at older ages, and were free from major chronic diseases at mid-life (mean age was 50 at baseline in 1976). Main outcome measures Healthy survival to age 70 and over was defined as having no history of 11 major chronic diseases and having no substantial cognitive, physical, or mental limitations. Results Of the women who survived until at least age 70, 1686 (9.9%) met our criteria for healthy survival. Increased body mass index (BMI) at baseline was significantly associated with linearly reduced odds of healthy survival compared with usual survival, after adjustment for various lifestyle and dietary variables (P<0.001 for trend). Compared with lean women (BMI 18.5-22.9), obese women (BMI >= 30) had 79% lower odds of healthy survival (odds ratio 0.21, 95% confidence interval 0.15 to 0.29). In addition, the more weight gained from age 18 until mid-life, the less likely was healthy survival after the age of 70. The lowest odds of healthy survival were among women who were overweight (BMI >= 25) at age 18 and gained >= 10 kg weight (0.18, 0.09 to 0.36), relative to women who were lean (BMI 18.5-22.9) and maintained a stable weight. Conclusions These data provide evidence that adiposity in mid-life is strongly related to a reduced probability of healthy survival among women who live to older ages, and emphasise the importance of maintaining a healthy weight from early adulthood.	[Sun, Qi; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.; Grodstein, Francine] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Okereke, Olivia I.; Hu, Frank B.; Grodstein, Francine] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Okereke, Olivia I.; Hu, Frank B.; Grodstein, Francine] Harvard Univ, Sch Med, Boston, MA USA; [Franco, Oscar H.] Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Warwick	Sun, Q (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 655 Huntington Ave, Boston, MA 02115 USA.	qisun@hsph.harvard.edu	Okereke, Olivia I/R-9934-2016; Franco, Óscar H/ABE-2305-2020; Hu, Frank/C-1919-2013; Okereke, Olivia/AAF-7031-2021	Franco, Óscar H/0000-0002-4606-4929; 	National Institutes of Health [AG13482, AG15424, CA40356]; Boston Obesity Nutrition Research Center [DK46200]; Unilever Corporate Research; Yerby postdoctoral fellowship programme; NATIONAL CANCER INSTITUTE [R01CA040356, R37CA040356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015424, R29AG013482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Obesity Nutrition Research Center; Unilever Corporate Research(Unilever); Yerby postdoctoral fellowship programme; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by the National Institutes of Health (grants AG13482, AG15424, and CA40356) and the Pilot and Feasibility program sponsored by the Boston Obesity Nutrition Research Center (DK46200). QS is supported by a postdoctoral fellowship from the Unilever Corporate Research. MKT is supported by the Yerby postdoctoral fellowship programme.	Alonso A, 2008, ACTA NEUROL SCAND, V117, P15, DOI 10.1111/j.1600-0404.2007.00898.x; Barr RG, 2002, AM J EPIDEMIOL, V155, P965, DOI 10.1093/aje/155.10.965; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Depp Colin A, 2007, Curr Psychiatry Rep, V9, P7, DOI 10.1007/s11920-007-0003-0; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Hetzel L., 2001, 65 YEARS POPULATION; Houston DK, 2005, INT J OBESITY, V29, P1457, DOI 10.1038/sj.ijo.0803043; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Koster A, 2008, AM J EPIDEMIOL, V167, P1465, DOI 10.1093/aje/kwn079; Li TY, 2006, CIRCULATION, V113, P499, DOI 10.1161/CIRCULATIONAHA.105.574087; Lopez Oscar L, 2010, Neuroepidemiology, V34, P63, DOI 10.1159/000264678; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Michael YL, 2001, AM J EPIDEMIOL, V153, P123, DOI 10.1093/aje/153.2.123; Newman AB, 2003, ARCH INTERN MED, V163, P2315, DOI 10.1001/archinte.163.19.2315; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Reed DM, 1998, AM J PUBLIC HEALTH, V88, P1463, DOI 10.2105/AJPH.88.10.1463; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Stampfer MJ, 2005, NEW ENGL J MED, V352, P245, DOI 10.1056/NEJMoa041152; Strawbridge WJ, 1996, AM J EPIDEMIOL, V144, P135, DOI 10.1093/oxfordjournals.aje.a008900; Sun Q, 2007, CIRCULATION, V115, P1858, DOI 10.1161/CIRCULATIONAHA.106.679985; TROY LM, 1995, INT J OBESITY, V19, P570; Ware JE, 1993, SF36 HLTH SURVEY MAN; Whitmer RA, 2008, NEUROLOGY; Willcox BJ, 2006, JAMA-J AM MED ASSOC, V296, P2343, DOI 10.1001/jama.296.19.2343; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607; WORLD H, 2000, WHO TECH REP SER, V894, P1; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]	33	71	72	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 29	2009	339								b3796	10.1136/bmj.b3796	http://dx.doi.org/10.1136/bmj.b3796			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502KX	19789407	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000270459600002
J	Aarestrup, K; Okland, F; Hansen, MM; Righton, D; Gargan, P; Castonguay, M; Bernatchez, L; Howey, P; Sparholt, H; Pedersen, MI; McKinley, RS				Aarestrup, Kim; Okland, Finn; Hansen, Michael M.; Righton, David; Gargan, Patrik; Castonguay, Martin; Bernatchez, Louis; Howey, Paul; Sparholt, Henrik; Pedersen, Michael I.; McKinley, Robert S.			Oceanic Spawning Migration of the European Eel (Anguilla anguilla)	SCIENCE			English	Article									[Aarestrup, Kim; Hansen, Michael M.; McKinley, Robert S.] Tech Univ Denmark, Natl Inst Aquat Resources, DK-8600 Silkeborg, Denmark; [Okland, Finn] Norwegian Inst Nat Res NINA, NO-7485 Trondheim, Norway; [Righton, David] CEFAS, Lowestoft NR33 0HT, Suffolk, England; [Gargan, Patrik] CFB, Dublin, Ireland; [Castonguay, Martin] Fisheries & Oceans Canada DFO, Inst Maurice Lamontagne, Mont Joli, PQ G5H 3Z4, Canada; [Bernatchez, Louis] Univ Laval, IBIS, Quebec City, PQ G1V 0A6, Canada; [Howey, Paul] Microwave Telemetry Inc, Columbia, MD 21045 USA; [Sparholt, Henrik] ICES, DK-1553 Copenhagen V, Denmark; [McKinley, Robert S.] Univ British Columbia, W Vancouver, BC V7V 1N6, Canada	Technical University of Denmark; Norwegian Institute Nature Research; Centre for Environment Fisheries & Aquaculture Science; Fisheries & Oceans Canada; Laval University; University of British Columbia	Aarestrup, K (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Vejlsovej 39, DK-8600 Silkeborg, Denmark.	kaa@aqua.dtu.dk	Hansen, Michael/I-5979-2013; Pedersen, Michael Ingemann/AAJ-8755-2021; Righton, David/D-6140-2013; Hansen, Michael M./Z-5047-2019; Aarestrup, Kim/AAK-9155-2021	Hansen, Michael/0000-0001-5372-4828; Pedersen, Michael Ingemann/0000-0002-3030-0704; Hansen, Michael M./0000-0001-5372-4828; Aarestrup, Kim/0000-0001-8521-6270; Righton, David/0000-0001-8643-3672; Bernatchez, Louis/0000-0002-8085-9709				Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; BOETIUS INGE, 1967, MEDD DANMARKS FISKERI HAVUNDERSOGELSER, V4, P339; FRICKE H, 1995, NATURWISSENSCHAFTEN, V82, P32, DOI 10.1007/s001140050136; IWASA Y, 1982, AM NAT, V120, P171, DOI 10.1086/283980; Jellyman D, 2005, MAR ECOL PROG SER, V286, P261, DOI 10.3354/meps286261; Tesch F.-W., 2003, EEL, P1	6	223	226	5	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1660	1660		10.1126/science.1178120	http://dx.doi.org/10.1126/science.1178120			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779192				2022-12-28	WOS:000270131800036
J	Reich, D; Thangaraj, K; Patterson, N; Price, AL; Singh, L				Reich, David; Thangaraj, Kumarasamy; Patterson, Nick; Price, Alkes L.; Singh, Lalji			Reconstructing Indian population history	NATURE			English	Article							Y-CHROMOSOME; GENETIC AFFINITIES; MITOCHONDRIAL; INFERENCE; GENOTYPE; CASTE; HAPLOTYPE; PATTERNS; ORIGINS	India has been underrepresented in genome-wide surveys of human variation. We analyse 25 diverse groups in India to provide strong evidence for two ancient populations, genetically divergent, that are ancestral to most Indians today. One, the 'Ancestral North Indians' ( ANI), is genetically close to Middle Easterners, Central Asians, and Europeans, whereas the other, the 'Ancestral South Indians' (ASI), is as distinct from ANI and East Asians as they are from each other. By introducing methods that can estimate ancestry without accurate ancestral populations, we show that ANI ancestry ranges from 39-71% in most Indian groups, and is higher in traditionally upper caste and Indo-European speakers. Groups with only ASI ancestry may no longer exist in mainland India. However, the indigenous Andaman Islanders are unique in being ASI-related groups without ANI ancestry. Allele frequency differences between groups in India are larger than in Europe, reflecting strong founder effects whose signatures have been maintained for thousands of years owing to endogamy. We therefore predict that there will be an excess of recessive diseases in India, which should be possible to screen and map genetically.	[Reich, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Reich, David; Patterson, Nick; Price, Alkes L.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Thangaraj, Kumarasamy; Singh, Lalji] Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Price, Alkes L.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	reich@genetics.med.harvard.edu; lalji@ccmb.res.in	Thangaraj, Kumarasamy/G-5596-2010	Thangaraj, Kumarasamy/0000-0002-0075-0106	NIH [HG004168]; Burroughs Wellcome Career Development Award; Council of Scientific and Industrial Research of the Government of India; UKIERI Major Award [RG-4772]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004168, R01HG006399] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Development Award(Burroughs Wellcome Fund); Council of Scientific and Industrial Research of the Government of India(Council of Scientific & Industrial Research (CSIR) - India); UKIERI Major Award; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the volunteers from throughout India who donated DNA; A. G. Reddy, A. Shah and R. Tamang for generating the Y chromosome and mtDNA data; J. Neubauer for sample preparation; and A. Tandon for data curation. We thank B. N. Sarkar and A. G. Roy for helping with group census size estimates, and D. Falush, J. Novembre, A. Ruiz-Linares and S. Watkins for comments on the manuscript. D. R., N. P. and A. L. P. were supported by NIH grant HG004168, and D. R. was supported by a Burroughs Wellcome Career Development Award in the Biomedical Sciences. K. T. and L. S. were supported by grants from the Council of Scientific and Industrial Research of the Government of India, and K. T. was supported by a UKIERI Major Award (RG-4772).	Abbi A, 2009, LANG SCI, V31, P791, DOI 10.1016/j.langsci.2008.02.002; Baird SJE, 2006, HEREDITY, V97, P81, DOI 10.1038/sj.hdy.6800850; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Barik SS, 2008, AM J PHYS ANTHROPOL, V136, P19, DOI 10.1002/ajpa.20773; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Bhasin MK., 2001, GENETICS CASTES TRIB; Boivin N, 2007, VERTEBR PALEOBIOL PA, P341, DOI 10.1007/1-4020-5562-5_15; Brahmachari SK, 2008, J GENET, V87, P3; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chikhi L, 2001, GENETICS, V158, P1347; Cordaux R, 2003, EUR J HUM GENET, V11, P253, DOI 10.1038/sj.ejhg.5200949; Das B M, 1986, Anthropol Anz, V44, P239; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; Dirks Nicholas B., 2001, CASTES MIND COLONIAL; DRONAMRA.KR, 1964, COLD SPRING HARB SYM, V29, P81, DOI 10.1101/SQB.1964.029.01.013; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; HALDANE JBS, 1964, PERSPECT BIOL MED, V7, P343; Hellenthal G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000078; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Karve IK, 1968, HINDU SOC INTERPRETA; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lohmueller KE, 2009, GENETICS, V182, P217, DOI 10.1534/genetics.108.099275; Majumdar D.N., 1960, RACE ELEMENTS BENGAL; MALLORY J.P., 2006, OXFORD INTRO PROTO I; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; NEI M, 1983, ANN HUM GENET, V47, P253, DOI 10.1111/j.1469-1809.1983.tb00993.x; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Palanichamy MG, 2006, SCIENCE, V311, DOI 10.1126/science.1120176; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pemberton TJ, 2008, ANN HUM GENET, V72, P535, DOI 10.1111/j.1469-1809.2008.00457.x; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2006, PLOS GENET, V2, P2052, DOI 10.1371/journal.pgen.0020215; ROYCHOUDHURY AK, 1985, HUM HERED, V35, P201, DOI 10.1159/000153545; SINGH KS, 1993, PEOPLE INDIA NATL SE, V3; SINGH KS, 1994, PEOPLE INDIA NATL SE, V3; Southworth F.C, 2005, LINGUISTIC ARCHAEOLO; Thangaraj K, 1999, ELECTROPHORESIS, V20, P1743, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1743::AID-ELPS1743>3.0.CO;2-V; Thangaraj K, 2003, CURR BIOL, V13, P86, DOI 10.1016/S0960-9822(02)01336-2; Thangaraj K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-151; Thanseem I, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-42; THORBURN D, 1977, SCAND J STAT, V4, P113; Watkins WS, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-86; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Zerjal T, 2007, HUM GENET, V121, P137, DOI 10.1007/s00439-006-0282-2	52	1010	1020	7	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					489	U50		10.1038/nature08365	http://dx.doi.org/10.1038/nature08365			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	497SP	19779445	Green Accepted			2022-12-28	WOS:000270082900032
J	Chretien, KC; Greysen, SR; Chretien, JP; Kind, T				Chretien, Katherine C.; Greysen, S. Ryan; Chretien, Jean-Paul; Kind, Terry			Online Posting of Unprofessional Content by Medical Students	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROFESSIONAL COMPETENCE; SOCIAL NETWORKING; PEER ASSESSMENT; EDUCATION; PHYSICIANS; BEHAVIOR; SCHOOLS; HEALTH	Context Web 2.0 applications, such as social networking sites, are creating new challenges for medical professionalism. The scope of this problem in undergraduate medical education is not well-defined. Objective To assess the experience of US medical schools with online posting of unprofessional content by students and existing medical school policies to address online posting. Design, Setting, and Participants An anonymous electronic survey was sent to deans of student affairs, their representatives, or counterparts from each institution in the Association of American Medical Colleges. Data were collected in March and April 2009. Main Outcome Measures Percentage of schools reporting incidents of students posting unprofessional content online, type of professionalism infraction, disciplinary actions taken, existence of institution policies, and plans for policy development. Results Sixty percent of US medical schools responded (78/130). Of these schools, 60% (47/78) reported incidents of students posting unprofessional online content. Violations of patient confidentiality were reported by 13% (6/46). Student use of profanity (52%; 22/42), frankly discriminatory language (48%; 19/40), depiction of intoxication (39%; 17/44), and sexually suggestive material (38%; 16/42) were commonly reported. Of 45 schools that reported an incident and responded to the question about disciplinary actions, 30 gave informal warning (67%) and 3 reported student dismissal (7%). Policies that cover student-posted online content were reported by 38% (28/73) of deans. Of schools without such policies, 11% (5/46) were actively developing new policies to cover online content. Deans reporting incidents were significantly more likely to report having such a policy (51% vs 18%; P = .006), believing these issues could be effectively addressed (91% vs 63%; P = .003), and having higher levels of concern (P = .02). Conclusion Many responding schools had incidents of unprofessional student online postings, but they may not have adequate policy in place. JAMA. 2009;302(12):1309-1315	[Chretien, Katherine C.; Greysen, S. Ryan] George Washington Univ, Sch Med & Hlth Sci, Med Serv, Washington DC VA Med Ctr, Washington, DC 20052 USA; [Chretien, Katherine C.; Greysen, S. Ryan] George Washington Univ, Sch Med & Hlth Sci, Dept Med, Washington, DC 20052 USA; [Greysen, S. Ryan] George Washington Univ, Sch Publ Policy & Publ Adm, Dept Hlth Policy, Washington, DC 20052 USA; [Kind, Terry] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA; [Kind, Terry] Childrens Natl Med Ctr, Dept Med Educ, Washington, DC 20010 USA; [Chretien, Jean-Paul] Johns Hopkins Sch Med, Div Hlth Sci Informat, Baltimore, MD USA	George Washington University; George Washington University; George Washington University; George Washington University; Children's National Health System; Johns Hopkins University; Johns Hopkins Medicine	Chretien, KC (corresponding author), Med Serv 111, 50 Irving St NW, Washington, DC 20422 USA.	katherine.chretien@va.gov		Kind, Terry/0000-0002-3017-5683				Barzansky B, 2003, JAMA-J AM MED ASSOC, V290, P1190, DOI 10.1001/jama.290.9.1190; Boulos MNK, 2007, HEALTH INFO LIBR J, V24, P2, DOI 10.1111/j.1471-1842.2007.00701.x; Boulos Maged N Kamel, 2006, BMC Med Educ, V6, P41, DOI 10.1186/1472-6920-6-41; Charon R, 2007, CAN FAM PHYSICIAN, V53, P1265; Chretien K, 2008, J GEN INTERN MED, V23, P2066, DOI 10.1007/s11606-008-0796-5; Coutts J., 2007, P SOC INF TECHN TEAC; Cresswell J., 1997, QUALITATIVE INQUIRY; Cruess RL, 2008, PERSPECT BIOL MED, V51, P579, DOI 10.1353/pbm.0.0045; Dannefer EF, 2005, MED EDUC, V39, P713, DOI 10.1111/j.1365-2929.2005.02193.x; DasGupta S, 2004, ACAD MED, V79, P351, DOI 10.1097/00001888-200404000-00013; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Farnan JM, 2008, PERSPECT BIOL MED, V51, P517, DOI 10.1353/pbm.0.0048; Gorrindo T, 2008, JAMA-J AM MED ASSOC, V300, P213, DOI 10.1001/jama.2008.44; Hayter CRR, 2006, J MED HUMANIT, V27, P215, DOI 10.1007/s10912-006-9019-4; Kao A, 2003, JAMA-J AM MED ASSOC, V290, P1151, DOI 10.1001/jama.290.9.1151; Lagu T, 2008, J GEN INTERN MED, V23, P1642, DOI 10.1007/s11606-008-0726-6; Lemley T, 2009, J MED LIBR ASSOC, V97, P50, DOI 10.3163/1536-5050.97.1.010; Lenhart Amanda, 2009, ADULTS SOCIAL NETWOR; Ludmerer K., 1999, TIME HEAL AM MED ED; Ludmerer KM, 1999, JAMA-J AM MED ASSOC, V282, P881, DOI 10.1001/jama.282.9.881; Papadakis MA, 2005, NEW ENGL J MED, V353, P2673, DOI 10.1056/NEJMsa052596; Peluchette J, 2008, CYBERPSYCHOL BEHAV, V11, P95, DOI 10.1089/cpb.2007.9927; R Core Team, 2020, R LANG ENV STAT COMP; Reed DA, 2008, JAMA-J AM MED ASSOC, V300, P1326, DOI 10.1001/jama.300.11.1326; Schoenrock-Adema J, 2007, MED EDUC, V41, P836, DOI 10.1111/j.1365-2923.2007.02817.x; SHAPIRA I, 2008, WASHINGTON POST 0428, pA1; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; Stern DT, 2006, NEW ENGL J MED, V355, P1794, DOI 10.1056/NEJMra054783; STROSS R, 2007, NY TIMES        1230; Swick HM, 1999, JAMA-J AM MED ASSOC, V282, P830, DOI 10.1001/jama.282.9.830; Thompson LA, 2008, J GEN INTERN MED, V23, P954, DOI 10.1007/s11606-008-0538-8	32	281	291	0	45	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1309	1315		10.1001/jama.2009.1387	http://dx.doi.org/10.1001/jama.2009.1387			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497AR	19773566	Bronze			2022-12-28	WOS:000270026000013
J	Cermeno, P; Falkowski, PG				Cermeno, Pedro; Falkowski, Paul G.			Controls on Diatom Biogeography in the Ocean	SCIENCE			English	Article							MOLECULAR EVIDENCE; DIVERSITY; POPULATIONS; DISPERSAL	The extent to which the spatial distribution of marine planktonic microbes is controlled by local environmental selection or dispersal is poorly understood. Our ability to separate the effects of these two biogeographic controls is limited by the enormous environmental variability both in space and through time. To circumvent this limitation, we analyzed fossil diatom assemblages over the past similar to 1.5 million years from the world oceans and show that these eukaryotic microbes are not limited by dispersal. The lack of dispersal limitation in marine diatoms suggests that the biodiversity at the microbial level fundamentally differs from that of macroscopic animals and plants for which geographic isolation is a common component of speciation.	[Cermeno, Pedro; Falkowski, Paul G.] Rutgers State Univ, Environm Biophys & Mol Ecol Program, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Falkowski, Paul G.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Cermeno, P (corresponding author), Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Spain.	pedro@uvigo.es; falko@marine.rutgers.edu		Cermeno, Pedro/0000-0002-3902-3475	Marie Curie International Fellowship	Marie Curie International Fellowship(European Commission)	We thank all the people who contributed to the collection and management of data and C. de Vargas, J. Grassle, M. Katz, and P. Morin for comments on the manuscript. The Neptune database is hosted by Chronos (www.chronos.org). This work was supported by a Marie Curie International Fellowship within the 6th European Community framework Program (P.C.).	Baas Becking LGM, 1934, GEOBIOLOGIE INLEIDIN; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; De Vargas C, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P271; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; DiMichele WA, 2004, ANNU REV ECOL EVOL S, V35, P285, DOI 10.1146/annurev.ecolsys.35.120202.110110; Fenchel T, 2006, PHILOS T R SOC B, V361, P1965, DOI 10.1098/rstb.2006.1924; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Hedlund B.P., 2004, MICROBIAL DIVERSITY, P225, DOI DOI 10.1128/9781555817770.CH22; Hubbell Stephen P., 2001, V32, pi; Kooistra WHCF, 2008, PROTIST, V159, P177, DOI 10.1016/j.protis.2007.09.004; Lee WJ, 1998, PROTIST, V149, P229, DOI 10.1016/S1434-4610(98)70031-8; Lomolino M. V., 2006, BIOGEOGRAPHY; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; Norris RD, 1999, RECONSTRUCTING OCEAN HISTORY, P173; Sexton PF, 2008, GEOLOGY, V36, P899, DOI 10.1130/G25232A.1; Slapeta J, 2006, MOL BIOL EVOL, V23, P23, DOI 10.1093/molbev/msj001; Soininen J, 2004, ECOGRAPHY, V27, P330, DOI 10.1111/j.0906-7590.2004.03749.x; Spencer-Cervato Cinzia, 1999, Palaeontologia Electronica, V2, pUnpaginated; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Telford RJ, 2006, SCIENCE, V312, P1015, DOI 10.1126/science.1125669; Vanormelingen P, 2008, BIODIVERS CONSERV, V17, P393, DOI 10.1007/s10531-007-9257-4; Vyverman W, 2007, ECOLOGY, V88, P1924, DOI 10.1890/06-1564.1; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909	26	110	111	4	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1539	1541		10.1126/science.1174159	http://dx.doi.org/10.1126/science.1174159			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762642				2022-12-28	WOS:000269887900039
J	Garg, AX; Iansavichus, AV; Wilczynski, NL; Kastner, M; Baier, LA; Shariff, SZ; Rehman, F; Weir, M; McKibbon, KA; Haynes, RB				Garg, Amit X.; Iansavichus, Arthur V.; Wilczynski, Nancy L.; Kastner, Monika; Baier, Leslie A.; Shariff, Salimah Z.; Rehman, Faisal; Weir, Matthew; McKibbon, K. Ann; Haynes, R. Brian			Filtering Medline for a clinical discipline: diagnostic test assessment framework	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEARCH; METAANALYSIS; CONSISTENCY; DYSFUNCTION; DATABASES; FAILURE; RISK	Objective To develop and test a Medline filter that allows clinicians to search for articles within a clinical discipline, rather than searching the entire Medline database. Design Diagnostic test assessment framework with development and validation phases. Setting Sample of 4657 articles published in 2006 from 40 journals. Reviews Each article was manually reviewed, and 19.8% contained information relevant to the discipline of nephrology. The performance of 1 155 087 unique renal filters was compared with the manual review. Main outcome measures Sensitivity, specificity, precision, and accuracy of each filter. Results The best renal filters combined two to 14 terms or phrases and included the terms "kidney" with multiple endings (that is, truncation), "renal replacement therapy", "renal dialysis", "kidney function tests", "renal", "nephr" truncated, "glomerul" truncated, and "proteinuria". These filters achieved peak sensitivities of 97.8% and specificities of 98.5%. Performance of filters remained excellent in the validation phase. Conclusions Medline can be filtered for the discipline of nephrology in a reliable manner. Storing these high performance renal filters in PubMed could help clinicians with their everyday searching. Filters can also be developed for other clinical disciplines by using similar methods.	[Garg, Amit X.; Iansavichus, Arthur V.; Shariff, Salimah Z.; Rehman, Faisal] Univ Western Ontario, Div Nephrol, London, ON N6A 5C1, Canada; [Garg, Amit X.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON N6A 5C1, Canada; [Garg, Amit X.; Wilczynski, Nancy L.; Baier, Leslie A.; McKibbon, K. Ann; Haynes, R. Brian] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Kastner, Monika] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON M5T 3M6, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); McMaster University; University of Toronto	Garg, AX (corresponding author), London Hlth Sci Ctr, London Kidney Clin Res Unit, Room ELL-101,800 Commissioners Rd E, London, ON N6A 4G5, Canada.	amit.garg@lhsc.on.ca	Weir, Matthew/G-3354-2011; Garg, Amit X/G-3295-2011; Rehman, Faisal/GYA-3738-2022	Shariff, Salimah/0000-0002-1219-6763; Haynes, Robert Brian/0000-0002-1453-3196	Kidney Foundation of Canada; Canadian Institutes of Health Research	Kidney Foundation of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Kidney Foundation of Canada. AXG was supported by a clinician scientist award from the Canadian Institutes of Health Research. The researchers were independent of the funders. The funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	*AM KIDN FUND, 2007, KIDN DIS DICT; Boersma C, 2006, PHARMACOECONOMICS, V24, P523, DOI 10.2165/00019053-200624060-00001; Boynton J, 1998, J INFORM SCI, V24, P137, DOI 10.1177/016555159802400301; Brenner BM, 1996, BRENNER RECTORS KIDN; Campbell SB, 2003, TRANSPLANTATION, V76, P1452, DOI 10.1097/01.TP.0000083895.64198.10; Coumou HCH, 2006, J MED LIBR ASSOC, V94, P55; Cullen RJ, 2002, J MED LIBR ASSOC, V90, P370; Danovitch GM, 2001, HDB KIDNEY TRANSPLAN; DAUGIRDAS J, 1994, HDB DIALYSIS; *DEP HLTH, 2007, NAT SERV FRAM REN SE; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Excerpta Medica, 2001, EMTREE THES; Fabrizi F, 2006, ALIMENT PHARM THER, V24, P497, DOI 10.1111/j.1365-2036.2006.03002.x; *FAM PRACT NOT, 2007, NEPHR; FEISTLE K, 2006, CLIN NEPHROLOGY; Friedrich JO, 2005, ANN INTERN MED, V142, P510, DOI 10.7326/0003-4819-142-7-200504050-00010; FUNK ME, 1983, B MED LIBR ASSOC, V71, P176; Garcia MR, 2005, J NEPHROL, V18, P458; Garg AX, 2006, KIDNEY INT, V70, P1995, DOI 10.1038/sj.ki.5001896; Haafkens J, 2006, OCCUP MED-OXFORD, V56, P39, DOI 10.1093/occmed/kqi193; Haynes RB, 2005, BMJ-BRIT MED J, V330, P1179, DOI 10.1136/bmj.38446.498542.8F; Hersh WR, 2002, J AM MED INFORM ASSN, V9, P283, DOI 10.1197/jamia.M0996; HOLMAN CDJ, 1984, AM J EPIDEMIOL, V120, P154, DOI 10.1093/oxfordjournals.aje.a113864; Hsu C, 2000, AM J KIDNEY DIS, V36, P415, DOI 10.1053/ajkd.2000.8996; *INT SOC NEPHR, 2006, NEPHR; *KIDN FDN CAN, 2007, KFOC SK BRANCH GLOSS; *KIDN FDN CAN ONT, 2007, GLOSS TERMS; Landoni G, 2007, AM J KIDNEY DIS, V49, P56, DOI 10.1053/j.ajkd.2006.10.013; *LOM LIND U MED CT, 2007, KIDN TRANSPL GLOSS L; Mazzaferro S, 2006, Clin Ter, V157, P327; *NAT KIDN FDN, 2008, NKF KDOQI GUID; *NAT KIDN FED, 2007, GLOSS; *NAT LIB MED, 2009, NUMB TITL CURR IND I; *NAT LIB MED, 2008, KEY MEDL IND; *NAT LIB MED, 2008, MESH BROWS 2008 MESH; National Library of Medicine, 2003, PERM MED SUBJ HEAD; *NKUDIC, 2007, KIDN FAIL GLOSS; *NLM, 2009, NLM SYST DAT NEWS UP; Portaluppi F, 2007, CHRONOBIOL INT, V24, P1213, DOI 10.1080/07420520701791570; *PUBMED, 2008, CLIN QUER; RAMOSREMUS C, 1994, J RHEUMATOL, V21, P1912; Salmela Kaija, 2004, Ann Transplant, V9, P51; Sandhu S, 2006, J AM SOC NEPHROL, V17, P2006, DOI 10.1681/ASN.2006010012; Sladek RM, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-18; *U SO CA DEP SURG, 2007, KIDN TRANSPL INF GLO; Webster A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003961.pub2; Wilczynski Nancy L, 2006, Ann Gen Psychiatry, V5, P4, DOI 10.1186/1744-859X-5-4; Wilczynski Nancy L, 2005, BMC Med Inform Decis Mak, V5, P20, DOI 10.1186/1472-6947-5-20	48	27	27	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2009	339								b3435	10.1136/bmj.b3435	http://dx.doi.org/10.1136/bmj.b3435			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RV	19767336	hybrid, Green Published			2022-12-28	WOS:000269995000002
J	Kumar, A; Zarychanski, R; Pinto, R; Cook, DJ; Marshall, J; Lacroix, J; Stelfox, T; Bagshaw, S; Choong, K; Lamontagne, F; Turgeon, AF; Lapinsky, S; Ahern, SP; Smith, O; Siddiqui, F; Jouvet, P; Khwaja, K; McIntyre, L; Menon, K; Hutchison, J; Hornstein, D; Joffe, A; Lauzier, F; Singh, J; Karachi, T; Wiebe, K; Olafson, K; Ramsey, C; Sharma, S; Dodek, P; Meade, M; Hall, R; Fowler, RA				Kumar, Anand; Zarychanski, Ryan; Pinto, Ruxandra; Cook, Deborah J.; Marshall, John; Lacroix, Jacques; Stelfox, Tom; Bagshaw, Sean; Choong, Karen; Lamontagne, Francois; Turgeon, Alexis F.; Lapinsky, Stephen; Ahern, Stephane P.; Smith, Orla; Siddiqui, Faisal; Jouvet, Philippe; Khwaja, Kosar; McIntyre, Lauralyn; Menon, Kusum; Hutchison, Jamie; Hornstein, David; Joffe, Ari; Lauzier, Francois; Singh, Jeffrey; Karachi, Tim; Wiebe, Kim; Olafson, Kendiss; Ramsey, Clare; Sharma, Sat; Dodek, Peter; Meade, Maureen; Hall, Richard; Fowler, Robert A.		Canadian Critical Care Trials Grp	Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MORTALITY; EPIDEMIOLOGY	Context Between March and July 2009, the largest number of confirmed cases of 2009 influenza A(H1N1) infection occurred in North America. Objective To describe characteristics, treatment, and outcomes of critically ill patients in Canada with 2009 influenza A(H1N1) infection. Design, Setting, and Patients A prospective observational study of 168 critically ill patients with 2009 influenza A(H1N1) infection in 38 adult and pediatric intensive care units (ICUs) in Canada between April 16 and August 12, 2009. Main Outcome Measures The primary outcome measures were 28-day and 90-day mortality. Secondary outcomes included frequency and duration of mechanical ventilation and duration of ICU stay. Results Critical illness occurred in 215 patients with confirmed (n=162), probable (n=6), or suspected (n=47) community-acquired 2009 influenza A(H1N1) infection. Among the 168 patients with confirmed or probable 2009 influenza A(H1N1), the mean(SD) age was 32.3 (21.4) years; 113 were female (67.3%) and 50 were children (29.8%). Overall mortality among critically ill patients at 28 days was 14.3% (95% confidence interval, 9.5%-20.7%). There were 43 patients who were aboriginal Canadians (25.6%). The median time from symptom onset to hospital admission was 4 days (interquartile range [IQR], 2-7 days) and from hospitalization to ICU admission was 1 day (IQR, 0-2 days). Shock and nonpulmonary acute organ dysfunction was common (Sequential Organ Failure Assessment mean [SD] score of 6.8 [3.6] on day 1). Neuraminidase inhibitors were administered to 152 patients (90.5%). All patients were severely hypoxemic (mean [SD] ratio of PaO2 to fraction of inspired oxygen [FIO2] of 147 [128] mm Hg) at ICU admission. Mechanical ventilation was received by 136 patients (81.0%). The median duration of ventilation was 12 days (IQR, 6-20 days) and ICU stay was 12 days (IQR, 5-20 days). Lung rescue therapies included neuromuscular blockade (28% of patients), inhaled nitric oxide (13.7%), high-frequency oscillatory ventilation (11.9%), extracorporeal membrane oxygenation (4.2%), and prone positioning ventilation (3.0%). Overall mortality among critically ill patients at 90 days was 17.3%(95% confidence interval, 12.0%-24.0%; n=29). Conclusion Critical illness due to 2009 influenza A(H1N1) in Canada occurred rapidly after hospital admission, often in young adults, and was associated with severe hypoxemia, multisystem organ failure, a requirement for prolonged mechanical ventilation, and the frequent use of rescue therapies. JAMA. 2009;302(17):1872-1879	[Kumar, Anand; Siddiqui, Faisal; Wiebe, Kim; Olafson, Kendiss; Ramsey, Clare; Sharma, Sat] Hlth Sci Ctr, Sect Crit Care Med, Winnipeg, MB R3E 0Z3, Canada; [Kumar, Anand; Siddiqui, Faisal; Wiebe, Kim; Olafson, Kendiss; Ramsey, Clare; Sharma, Sat] St Boniface Gen Hosp, Winnipeg, MB R2H 2A6, Canada; [Zarychanski, Ryan] Cancercare Manitoba, Dept Med Oncol & Hematol, Winnipeg, MB, Canada; [Pinto, Ruxandra; Fowler, Robert A.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Cook, Deborah J.; Meade, Maureen] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Karachi, Tim] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Choong, Karen] McMaster Univ, McMaster Childrens Hosp, Hamilton, ON, Canada; [Marshall, John; Smith, Orla] St Michaels Hosp, Dept Crit Care Med, Toronto, ON M5B 1W8, Canada; [Lacroix, Jacques; Jouvet, Philippe] Univ Montreal, Dept Pediat, CHU St Justine, Montreal, PQ H3C 3J7, Canada; [Stelfox, Tom] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Stelfox, Tom] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Bagshaw, Sean; Joffe, Ari] Univ Alberta, Div Crit Care Med, Edmonton, AB, Canada; [Lamontagne, Francois] Univ Sherbrooke, Dept Med, Med Ctr, Sherbrooke, PQ J1K 2R1, Canada; [Turgeon, Alexis F.; Lauzier, Francois] Univ Laval, Hop Enfants Jesus, Ctr Rech CHA, Quebec City, PQ, Canada; [Lapinsky, Stephen] Univ Toronto, Mt Sinai Hosp, Intens Care Unit, Toronto, ON M5G 1X5, Canada; [Singh, Jeffrey] Univ Toronto, Univ Hlth Network, Toronto, ON M5G 1X5, Canada; [Ahern, Stephane P.] Univ Montreal, Dept Med, Hop Maison Neuve Rosemont, Montreal, PQ H3C 3J7, Canada; [Khwaja, Kosar] McGill Univ, Ctr Hlth, Trauma Serv, Montreal, PQ, Canada; [McIntyre, Lauralyn] Ottawa Hlth Res Inst, Clin Epidemiol Unit, Ottawa, ON, Canada; [Menon, Kusum] Childrens Hosp Eastern Ontario, Clin Res Unit, Ottawa, ON K1H 8L1, Canada; [Hutchison, Jamie] Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada; [Hornstein, David] SMBD Jewish Gen Hosp, Montreal, PQ, Canada; [Dodek, Peter] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Hall, Richard] Queen Elizabeth 2 Hlth Sci Ctr, Dept Anesthesia, Halifax, NS, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; CancerCare Manitoba Foundation; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Calgary; University of Calgary; University of Alberta; University of Sherbrooke; Laval University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Universite de Montreal; McGill University; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of British Columbia; Queen Elizabeth II Health Sciences Centre	Kumar, A (corresponding author), Hlth Sci Ctr, Sect Crit Care Med, JJ 399,700 William Ave, Winnipeg, MB R3E 0Z3, Canada.	akumar61@yahoo.com	Tuluc, Petronel/C-2527-2011; Lapinsky, Stephen/C-4624-2015; Jouvet, Philippe A/H-3293-2018; Zarychanski, Ryan/AAB-6369-2022; Lauzier, Francois/B-9237-2015; Choong, Karen/ABB-7867-2021; Ferguson, Niall/D-7619-2019; Griesdale, Donald/AAT-7762-2021; McIntyre, Lauralyn/AAR-7710-2021	Lapinsky, Stephen/0000-0002-6930-0306; Jouvet, Philippe A/0000-0001-5684-3398; Lauzier, Francois/0000-0002-6530-5513; Choong, Karen/0000-0002-4608-4508; Ferguson, Niall/0000-0002-6213-5264; Griesdale, Donald/0000-0001-5985-8624; McIntyre, Lauralyn/0000-0001-7421-1407; Stelfox, Henry/0000-0003-1231-1490; Friedrich, Jan/0000-0001-7248-2350; Zarychanski, Ryan/0000-0001-9455-6138; Singh, Jeffrey/0000-0003-3499-574X	Public Health Agency of Canada; Ontario Ministry of Health and Longterm Care; Heart and Stroke Foundation Canada; Canadian Institutes of Health Research	Public Health Agency of Canada; Ontario Ministry of Health and Longterm Care(Ministry of Health and Long-Term Care, Ontario); Heart and Stroke Foundation Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	The Public Health Agency of Canada, the Ontario Ministry of Health and Longterm Care, the Heart and Stroke Foundation Canada, and the Canadian Institutes of Health Research provided support for this article.	ABRAMOWITZ U, 1959, S AFR MED J, V32, P1155; Adhikari NKJ, 2007, BMJ-BRIT MED J, V334, P779, DOI 10.1136/bmj.39139.716794.55; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P171; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P173; [Anonymous], 1919, PUBLIC HLTH REP, V34, P2298; Beigi RH, 2007, OBSTET GYNECOL, V109, P1193, DOI 10.1097/01.AOG.0000262051.71925.ac; *CAN CRIT CAR TRIA, CAS REP FORM; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chan M., WORLD NOW START 2009; CHU C M, 1958, J Hyg Epidemiol Microbiol Immunol, V2, P1; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Crosby Alfred W., 1976, EPIDEMIC PEACE 1918; Cunha BA, 2004, INFECT DIS CLIN N AM, V18, P141, DOI 10.1016/S0891-5520(03)00095-3; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; *ED TEAM, 2009, EUROSURVEILLANCE, V14, P1; Fowler RA, 2003, JAMA-J AM MED ASSOC, V290, P367, DOI 10.1001/jama.290.3.367; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Goulenok C, 2004, CHEST, V125, P1441, DOI 10.1378/chest.125.4.1441; Graham-Cumming G, 1967, Med Serv J Can, V23, P115; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; MacMillan HL, 1996, CAN MED ASSOC J, V155, P1569; Markham N., 1986, THEM DAYS, V11, P4; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mcfee RB, 2007, DM-DIS MON, V53, P348, DOI 10.1016/j.disamonth.2007.05.006; Meade MO, 2009, AM J RESP CRIT CARE, V179; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; NAPOLITANO LM, 2009, MMWR-MORBID MORTAL W, V58, P1; *OSCAR TRIAL WEBS, HIGH FREQ OSC ARDS; Oxford JS, 2000, REV MED VIROL, V10, P119, DOI 10.1002/(SICI)1099-1654(200003/04)10:2&lt;119::AID-RMV272&gt;3.0.CO;2-O; Patterson KD., 1986, PANDEMIC INFLUENZA 1; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; *PUBL HLTH AG CAN, FLU WATCH AUG 16 23; *PUBL HLTH AG CAN, FLU WATCH JUL 5 2009; *PUBL HLTHA G CAN, CAS DEF NAT SURV H1N; Sakr Y, 2008, INTENS CARE MED, V34, P1999, DOI 10.1007/s00134-008-1243-0; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Valdez R, 1999, AM J PUBLIC HEALTH, V89, P1715, DOI 10.2105/AJPH.89.11.1715; WHO, INF; [No title captured]	46	1001	1071	1	65	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 4	2009	302	17					1872	1879		10.1001/jama.2009.1496	http://dx.doi.org/10.1001/jama.2009.1496			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514DU	19822627	Bronze			2022-12-28	WOS:000271375300018
J	Hu, JC; Gu, XM; Lipsitz, SR; Barry, MJ; D'Amico, AV; Weinberg, AC; Keating, NL				Hu, Jim C.; Gu, Xiangmei; Lipsitz, Stuart R.; Barry, Michael J.; D'Amico, Anthony V.; Weinberg, Aaron C.; Keating, Nancy L.			Comparative Effectiveness of Minimally Invasive vs Open Radical Prostatectomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSISTED LAPAROSCOPIC PROSTATECTOMY; RETROPUBIC PROSTATECTOMY; CANCER; COMPLICATIONS; REGRESSION; EVOLUTION; OUTCOMES; UROLOGY; SURGERY; TRENDS	Context Minimally invasive radical prostatectomy (MIRP) has diffused rapidly despite limited data on outcomes and greater costs compared with open retropubic radical prostatectomy (RRP). Objective To determine the comparative effectiveness of MIRP vs RRP. Design, Setting, and Patients Population-based observational cohort study using US Surveillance, Epidemiology, and End Results Medicare linked data from 2003 through 2007. We identified men with prostate cancer who underwent MIRP (n=1938) vs RRP (n=6899). Main Outcome Measures We compared postoperative 30-day complications, anastomotic stricture 31 to 365 days postoperatively, long-term incontinence and erectile dysfunction more than 18 months postoperatively, and postoperative use of additional cancer therapies, a surrogate for cancer control. Results Among men undergoing prostatectomy, use of MIRP increased from 9.2% (95% confidence interval [CI], 8.1%-10.5%) in 2003 to 43.2% (95% CI, 39.6%-46.9%) in 2006-2007. Men undergoing MIRP vs RRP were more likely to be recorded as Asian (6.1% vs 3.2%), less likely to be recorded as black (6.2% vs 7.8%) or Hispanic (5.6% vs 7.9%), and more likely to live in areas with at least 90% high school graduation rates (50.2% vs 41.0%) and with median incomes of at least $60 000 (35.8% vs 21.5%) (all P<.001). In propensity score-adjusted analyses, MIRP vs RRP was associated with shorter length of stay (median, 2.0 vs 3.0 days; P<.001) and lower rates of blood transfusions (2.7% vs 20.8%; P<.001), postoperative respiratory complications (4.3% vs 6.6%; P=.004), miscellaneous surgical complications (4.3% vs 5.6%; P=.03), and anastomotic stricture (5.8% vs 14.0%; P<.001). However, MIRP vs RRP was associated with an increased risk of genitourinary complications (4.7% vs 2.1%; P=.001) and diagnoses of incontinence (15.9 vs 12.2 per 100 person-years; P=.02) and erectile dysfunction (26.8 vs 19.2 per 100 person-years; P=.009). Rates of use of additional cancer therapies did not differ by surgical procedure (8.2 vs 6.9 per 100 person-years; P=.35). Conclusion Men undergoing MIRP vs RRP experienced shorter length of stay, fewer respiratory and miscellaneous surgical complications and strictures, and similar postoperative use of additional cancer therapies but experienced more genitourinary complications, incontinence, and erectile dysfunction. JAMA. 2009; 302(14): 1557-1564	[Hu, Jim C.] Brigham & Womens Hosp, Div Neurol, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA; [Hu, Jim C.; Weinberg, Aaron C.] Div Urol Surg, Boston, MA USA; [Hu, Jim C.; Gu, Xiangmei; Lipsitz, Stuart R.; Weinberg, Aaron C.] Ctr Surg & Publ Hlth, Boston, MA USA; [D'Amico, Anthony V.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Keating, Nancy L.] Div Gen Internal Med, Boston, MA USA; [Barry, Michael J.] Massachusetts Gen Hosp, Med Practices Evaluat Ctr, Boston, MA 02114 USA; [Keating, Nancy L.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Hu, JC (corresponding author), Brigham & Womens Hosp, Div Neurol, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, 45 Francis St,ASBII 3, Boston, MA 02115 USA.	jhu2@partners.org	Keating, Nancy L/I-9968-2019	Keating, Nancy L/0000-0002-8274-4681; weinberg, aaron/0000-0002-0957-5703	Department of Defense Prostate Cancer Physician Training Award	Department of Defense Prostate Cancer Physician Training Award(United States Department of Defense)	This research was funded by a Department of Defense Prostate Cancer Physician Training Award to Dr Hu.	Abbou CC, 2001, J UROLOGY, V165, P1964, DOI 10.1016/S0022-5347(05)66251-9; Badani KK, 2007, CANCER-AM CANCER SOC, V110, P1951, DOI 10.1002/cncr.23027; BARRETT J, 2005, NEWSWEEK, V24, P50; Basra R, 2007, EUR UROL, V52, P230, DOI 10.1016/j.eururo.2006.11.015; Begg CB, 2002, NEW ENGL J MED, V346, P1138, DOI 10.1056/NEJMsa011788; Bhayani SB, 2003, UROLOGY, V61, P612, DOI 10.1016/S0090-4295(02)02416-0; Blute ML, 2008, J CLIN ONCOL, V26, P2248, DOI 10.1200/JCO.2008.16.0796; Chen AB, 2006, J CLIN ONCOL, V24, P5298, DOI 10.1200/JCO.2006.07.9954; Cropper CM, 2005, BUS WEEK, P110; Guillonneau B, 2000, J UROLOGY, V163, P418, DOI 10.1016/S0022-5347(05)67890-1; Guillonneau B, 2001, UROL CLIN N AM, V28, P189, DOI 10.1016/S0094-0143(01)80021-5; Guru KA, 2009, CAN J UROL, V16, P4736; Guru KA, 2009, CAN J UROL, V16, P4736; Herrell SD, 2005, UROLOGY, V66, P105, DOI 10.1016/j.urology.2005.06.084; HOLFORD TR, 1980, BIOMETRICS, V36, P299, DOI 10.2307/2529982; Hu JC, 2003, J UROLOGY, V169, P1443, DOI 10.1097/01.ju.0000056046.16588.e4; Hu JC, 2003, J CLIN ONCOL, V21, P401, DOI 10.1200/JCO.2003.05.169; Hu JC, 2006, J UROLOGY, V175, P541, DOI 10.1016/S0022-5347(05)00156-4; Hu JC, 2008, J UROLOGY, V180, P1969, DOI 10.1016/j.juro.2008.07.054; Hu JC, 2008, J CLIN ONCOL, V26, P2278, DOI 10.1200/JCO.2007.13.4528; Janoff DM, 2005, J UROLOGY, V173, P1863, DOI 10.1097/01.ju.0000161483.65619.b3; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Klotz L, 2007, CUAJ-CAN UROL ASSOC, V1, P87; LAIRD N, 1981, J AM STAT ASSOC, V76, P231, DOI 10.2307/2287816; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; Lepor Herbert, 2009, Rev Urol, V11, P61; Link BA, 2008, J UROLOGY, V180, P928, DOI 10.1016/j.juro.2008.05.029; Link RE, 2004, J UROLOGY, V172, P269, DOI 10.1097/01.ju.0000128773.99707.5b; Litwin MS, 2001, J UROLOGY, V166, P587, DOI 10.1016/S0022-5347(05)65989-7; LUYAO GL, 1993, JAMA-J AM MED ASSOC, V269, P2633, DOI 10.1001/jama.269.20.2633; LuYao GL, 1996, J NATL CANCER I, V88, P166, DOI 10.1093/jnci/88.3-4.166; Menon M, 2002, UROLOGY, V60, P864, DOI 10.1016/S0090-4295(02)01881-2; Moore CG, 2009, EPIDEMIOLOGY, V20, P382, DOI 10.1097/EDE.0b013e318196cd65; Moul JW, 2009, EUR UROL, V55, P1266, DOI 10.1016/j.eururo.2009.03.062; Mouraviev V, 2007, UROLOGY, V69, P311, DOI 10.1016/j.urology.2006.10.025; National Comprehensive Cancer Network, NCCN PRACT GUID ONC; Nelson B, 2007, J UROLOGY, V177, P929, DOI 10.1016/j.juro.2006.10.070; Paiva CS, 2009, BJU INT, V104, P1219, DOI 10.1111/j.1464-410X.2009.08551.x; Pappas TN, 2004, NEW ENGL J MED, V350, P2091, DOI 10.1056/NEJMe048076; Park R, 2001, UROLOGY, V57, P742, DOI 10.1016/S0090-4295(00)01048-7; POTOSKY AL, 1993, MED CARE, V31, P732; Rassweiler J, 2003, J UROLOGY, V169, P1689, DOI 10.1097/01.ju.0000062614.56629.41; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; ROBINS JM, 1994, J AM STAT ASSOC, V89, P846, DOI 10.2307/2290910; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Schroeck FR, 2008, EUR UROL, V54, P785, DOI 10.1016/j.eururo.2008.06.063; Smith JA, 2005, J CLIN ONCOL, V23, P8170, DOI 10.1200/JCO.2005.03.1963; Smith JA, 2008, J UROLOGY, V180, P1216, DOI 10.1016/j.juro.2008.07.088; Tewari AK, 2008, J CLIN ONCOL, V26, P4999, DOI 10.1200/JCO.2008.18.8078; Vickers AJ, 2007, JNCI-J NATL CANCER I, V99, P1171, DOI 10.1093/jnci/djm060; Walsh PC, 1998, J UROLOGY, V160, P2418, DOI 10.1016/S0022-5347(01)62202-X; WALSH PC, 1982, J UROLOGY, V128, P492, DOI 10.1016/S0022-5347(17)53012-8; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	54	618	629	2	57	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	2009	302	14					1557	1564		10.1001/jama.2009.1451	http://dx.doi.org/10.1001/jama.2009.1451			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505UA	19826025	Bronze			2022-12-28	WOS:000270721800024
J	Juni, P; Egger, M				Juni, Peter; Egger, Matthias			PRISMAtic reporting of systematic reviews and meta-analyses	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; EXPLANATION; STATEMENT; QUALITY		[Juni, Peter; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland	University of Bern	Juni, P (corresponding author), Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland.	juni@ispm.unibe.ch	Juni, Peter/Q-8700-2016	Juni, Peter/0000-0002-5985-0670; Egger, Matthias/0000-0001-7462-5132				Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; ANDREW E, 1994, JAMA-J AM MED ASSOC, V272, P1926, DOI 10.1001/jama.1994.03520240054041; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Egger M, 2002, INT J EPIDEMIOL, V31, P1, DOI 10.1093/ije/31.1.1; FACKLER ML, 1994, ANN INTERN MED, V121, P894, DOI 10.7326/0003-4819-121-11-199412010-00015; Gerber S, 2007, J CLIN EPIDEMIOL, V60, P773, DOI 10.1016/j.jclinepi.2006.10.022; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; World Health Organization, 2021, LANCET	14	31	34	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2009	374	9697					1221	1223						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	507KQ	19819375				2022-12-28	WOS:000270852500008
J	Coombes, R				Coombes, Rebecca			Medicine and the Media Cervarix: definitely not the new MMR	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 7	2009	339								b4124	10.1136/bmj.b4124	http://dx.doi.org/10.1136/bmj.b4124			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505TG	19812140				2022-12-28	WOS:000270719200017
J	Lloyd, J; Chapman, JR; Clapperton, JA; Haire, LF; Hartsuiker, E; Li, JJ; Carr, AM; Jackson, SP; Smerdon, SJ				Lloyd, Janette; Chapman, J. Ross; Clapperton, Julie A.; Haire, Lesley F.; Hartsuiker, Edgar; Li, Jiejin; Carr, Antony M.; Jackson, Stephen P.; Smerdon, Stephen J.			A Supramodular FHA/BRCT-Repeat Architecture Mediates Nbs1 Adaptor Function in Response to DNA Damage	CELL			English	Article							NIJMEGEN-BREAKAGE-SYNDROME; DOUBLE-STRAND BREAKS; FORKHEAD-ASSOCIATED DOMAIN; SCHIZOSACCHAROMYCES-POMBE; FHA DOMAIN; CHROMATIN RETENTION; TUMOR-SUPPRESSOR; FOCUS FORMATION; MRE11 COMPLEX; BRCT DOMAIN	The Mre11/Rad50/Nbs1 protein complex plays central enzymatic and signaling roles in the DNA-damage response. Nuclease (Mre11) and scaffolding (Rad50) components of MRN have been extensively characterized, but the molecular basis of Nbs1 function has remained elusive. Here, we present a 2.3A crystal structure of the N-terminal region of fission yeast Nbs1, revealing an unusual but conserved architecture in which the FHA- and BRCT-repeat domains structurally coalesce. We demonstrate that diphosphorylated pSer-Asp-pThr-Asp motifs, recently identified as multicopy docking sites within Mdc1, are evolutionarily conserved Nbs1 binding targets. Furthermore, we show that similar phosphomotifs within Ctp1, the fission yeast ortholog of human CtIP, promote interactions with the Nbs1 FHA domain that are necessary for Ctp1-dependent resistance to DNA damage. Finally, we establish that human Nbs1 interactions with Mdc1 occur through both its FHA- and BRCT-repeat domains, suggesting how their structural and functional interdependence underpins Nbs1 adaptor functions in the DNA-damage response.	[Chapman, J. Ross; Jackson, Stephen P.] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Chapman, J. Ross; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England; [Lloyd, Janette; Clapperton, Julie A.; Haire, Lesley F.; Li, Jiejin; Smerdon, Stephen J.] Natl Inst Med Res, MRC, Div Mol Struct, London NW7 1AA, England; [Hartsuiker, Edgar; Carr, Antony M.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Cambridge; University of Cambridge; MRC National Institute for Medical Research; University of Sussex	Jackson, SP (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk; stephen.smerdon@nimr.mrc.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014; Chapman, J Ross/C-7973-2012; Li, Jiejin/G-4980-2010	Jackson, Stephen Philip/0000-0001-9317-7937; Li, Jiejin/0000-0003-1525-7768; Hartsuiker, Edgar/0000-0002-7257-6389; Carr, Antony Michael/0000-0002-2028-2389; Chapman, Ross/0000-0002-6477-4254; Smerdon, Stephen/0000-0001-5688-8465	Cancer Research UK [C20600/A6620]; Medical Research Council program [G0600233]; Cancer Research UK; European Union [LSHG-CT-2005-512113]; Genomic Instability in Cancer and Precancer, GENICA [HEALTH-F2-2007-201630]; Medical Research Council, UK; Diamond Light Source, UK; MRC [G0600233, MC_U117584228, G0001129] Funding Source: UKRI; Medical Research Council [G0001129, MC_U117584228, G0600233] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council program(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); European Union(European Commission); Genomic Instability in Cancer and Precancer, GENICA; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diamond Light Source, UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank H. Iwasaki for the kind gift of reagents, P. Walker for invaluable assistance with X-ray data collection, and K. Rittinger for advice on ITC measurements and are grateful for support from the NIMR large-scale laboratory. E. H. is supported by Cancer Research UK grant C20600/A6620, and T. C. acknowledges funding by Medical Research Council program grant G0600233. Research in the S.P.J. laboratory is supported by grants from Cancer Research UK, the European Union (Integrated Project DNA repair, LSHG-CT-2005-512113, and Genomic Instability in Cancer and Precancer, GENICA, HEALTH-F2-2007-201630), and core infrastructure funding from Cancer Research UK and the Wellcome Trust. S.J.S. is grateful to the Medical Research Council, UK, for continuing support and to Diamond Light Source, UK, for synchrotron access and beamline support.	Akamatsu Y, 2008, MOL CELL BIOL, V28, P3639, DOI 10.1128/MCB.01828-07; Becker E, 2006, BIOINFORMATICS, V22, P1289, DOI 10.1093/bioinformatics/btl075; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cerosaletti KM, 2003, J BIOL CHEM, V278, P21944, DOI 10.1074/jbc.M211689200; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; D'Amours D, 2002, NAT REV MOL CELL BIO, V3, P317, DOI 10.1038/nrm805; Derbyshire DJ, 2002, EMBO J, V21, P3863, DOI 10.1093/emboj/cdf383; Desai-Mehta A, 2001, MOL CELL BIOL, V21, P2184, DOI 10.1128/MCB.21.6.2184-2191.2001; Difilippantonio S, 2007, CELL CYCLE, V6, P2366, DOI 10.4161/cc.6.19.4758; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Gardino AK, 2006, SEMIN CANCER BIOL, V16, P173, DOI 10.1016/j.semcancer.2006.03.007; Giglione C, 2004, CELL MOL LIFE SCI, V61, P1455, DOI 10.1007/s00018-004-3466-8; Joo WS, 2002, GENE DEV, V16, P583, DOI 10.1101/gad.959202; Kobayashi J, 2002, CURR BIOL, V12, P1846, DOI 10.1016/S0960-9822(02)01259-9; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Li JJ, 2002, MOL CELL, V9, P1045, DOI 10.1016/S1097-2765(02)00527-0; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Martinez A, 2008, PROTEOMICS, V8, P2809, DOI 10.1002/pmic.200701191; Maser RS, 2001, NAT GENET, V27, P417, DOI 10.1038/86920; Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549; Matsuzaki K, 2008, GENETICS, V179, P213, DOI 10.1534/genetics.107.079236; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Nott TJ, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000212; Palmbos PL, 2008, GENETICS, V180, P1809, DOI 10.1534/genetics.108.095539; Riches LC, 2008, MUTAGENESIS, V23, P331, DOI 10.1093/mutage/gen039; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Suga M, 2005, YEAST, V22, P799, DOI 10.1002/yea.1247; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Watson AT, 2008, GENE, V407, P63, DOI 10.1016/j.gene.2007.09.024; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Williams RS, 2009, CELL, V139, P87, DOI 10.1016/j.cell.2009.07.033; Wu LM, 2008, P NATL ACAD SCI USA, V105, P11200, DOI 10.1073/pnas.0802885105; Xu C, 2008, J MOL BIOL, V381, P361, DOI 10.1016/j.jmb.2008.05.087; You ZS, 2005, MOL CELL BIOL, V25, P5363, DOI 10.1128/MCB.25.13.5363-5379.2005; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhao S, 2000, NATURE, V405, P473, DOI 10.1038/35013083; Zhu J, 2001, CURR BIOL, V11, P105, DOI 10.1016/S0960-9822(01)00019-7	44	130	132	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					100	111		10.1016/j.cell.2009.07.043	http://dx.doi.org/10.1016/j.cell.2009.07.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804756	Green Accepted, Bronze			2022-12-28	WOS:000270388600019
J	Nishida, K; Montagner, JP; Kawakatsu, H				Nishida, Kiwamu; Montagner, Jean-Paul; Kawakatsu, Hitoshi			Global Surface Wave Tomography Using Seismic Hum	SCIENCE			English	Article							FREE OSCILLATIONS; EXCITATION		[Nishida, Kiwamu; Montagner, Jean-Paul; Kawakatsu, Hitoshi] Univ Tokyo, ERI, Bunkyo Ku, Tokyo, Japan; [Montagner, Jean-Paul] Inst Phys Globe, F-75005 Paris, France	University of Tokyo; UDICE-French Research Universities; Universite Paris Cite	Nishida, K (corresponding author), Univ Tokyo, ERI, Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan.	knishida@eri.u-tokyo.ac.jp	Montagner, Jean-Paul/A-8733-2011; Nishida, Kiwamu/B-5416-2012	Montagner, Jean-Paul/0000-0001-9958-3012; Nishida, Kiwamu/0000-0001-6778-8080				DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Kobayashi N, 1998, NATURE, V395, P357, DOI 10.1038/26427; Lognonne P., 2007, TREATISE GEOPHYS, V10, P69, DOI DOI 10.1016/B978-044452748-6.00154-1; Montagner J.P., 2007, TREATISE GEOPHYS, V1, P559, DOI DOI 10.1016/B978-044452748-6.00018-3; Nishida K, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004720; Rhie J, 2004, NATURE, V431, P552, DOI 10.1038/nature02942; Shapiro NM, 2005, SCIENCE, V307, P1615, DOI 10.1126/science.1108339; Snieder R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.046610; Suda N, 1998, SCIENCE, V279, P2089, DOI 10.1126/science.279.5359.2089; SUDA N, 2002, EOS, V83, P47	10	106	115	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 2	2009	326	5949					112	112		10.1126/science.1176389	http://dx.doi.org/10.1126/science.1176389			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797654				2022-12-28	WOS:000270355600045
J	Ledesma, FC; El Khamisy, SF; Zuma, MC; Osborn, K; Caldecott, KW				Ledesma, Felipe Cortes; El Khamisy, Sherif F.; Zuma, Maria C.; Osborn, Kay; Caldecott, Keith W.			A human 5 '-tyrosyl DNA phosphodiesterase that repairs topoisomerase-mediated DNA damage	NATURE			English	Article							RECEPTOR-ASSOCIATED FACTORS; STRAND BREAK REPAIR; SPINOCEREBELLAR ATAXIA; COVALENT COMPLEXES; TTRAP; TDP1; PROTEIN; ENZYME; CD40	Topoisomerases regulate DNA topology and are fundamental to many aspects of chromosome metabolism(1,2). Their activity involves the transient cleavage of DNA, which, if it occurs near sites of endogenous DNA damage or in the presence of topoisomerase poisons, can result in abortive topoisomerase-induced DNA strand breaks(3-5). These breaks feature covalent linkage of the enzyme to the DNA termini by a 3'- or 5'-phosphotyrosyl bond and are implicated in hereditary human disease(6-8), chromosomal instability and cancer(4,9), and underlie the clinical efficacy of an important class of anti-tumour poisons(3,9,10). The importance of liberating DNA termini from trapped topoisomerase is illustrated by the progressive neurodegenerative disease observed in individuals containing a mutation in tyrosyl-DNA phosphodiesterase 1 (TDP1), an enzyme that cleaves 3'-phosphotyrosyl bonds(6-8). However, a complementary human enzyme that cleaves 5'-phosphotyrosyl bonds has not been reported, despite the effect of DNA double-strand breaks containing such termini on chromosome instability and cancer(6-8). Here we identify such an enzyme in human cells and show that this activity efficiently restores 5'-phosphate termini at DNA double-strand breaks in preparation for DNA ligation. This enzyme, TTRAP, is a member of the Mg2+/Mn2+-dependent family of phosphodiesterases. Cellular depletion of TTRAP results in increased susceptibility and sensitivity to topoisomerase-II-induced DNA double-strand breaks. TTRAP is, to our knowledge, the first human 5'-tyrosyl DNA phosphodiesterase to be identified, and we suggest that this enzyme is denoted tyrosyl DNA phosphodiesterase-2 (TDP2).	[Ledesma, Felipe Cortes; El Khamisy, Sherif F.; Zuma, Maria C.; Osborn, Kay; Caldecott, Keith W.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [El Khamisy, Sherif F.] Ain Shams Univ, Fac Pharm, Dept Biochem, Cairo 11566, Egypt	University of Sussex; Egyptian Knowledge Bank (EKB); Ain Shams University	Caldecott, KW (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Sci Pk Rd, Brighton BN1 9RQ, E Sussex, England.	fc55@sussex.ac.uk; k.w.caldecott@sussex.ac.uk	Ledesma, Felipe Cortés/F-4803-2014; Caldecott, Keith/S-4245-2019	Ledesma, Felipe Cortés/0000-0002-0440-6783; , Sherif/0000-0003-2721-7763; Caldecott, Keith/0000-0003-4255-9016; Osborn, Kay/0000-0003-0825-0322	MRC [G0600776]; BBSRC [BB/C516595/1]; CR-UK [C6563/A10192]; Wellcome Trust [085284]; Marie Curie [2007-2-1-IEF-221222]; EMBO [ALTF 956-2006]; Biotechnology and Biological Sciences Research Council [BB/C516595/1] Funding Source: researchfish; Medical Research Council [G0600776] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); CR-UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie(European Commission); EMBO(European Molecular Biology Organization (EMBO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the MRC (G0600776), the BBSRC (BB/C516595/1), and CR-UK (C6563/A10192). S. F. E. K. and F. C. L. were also funded by Fellowships from the Wellcome Trust ( S. F. E. K.; 085284), Marie Curie (FCL; 2007-2-1-IEF-221222) and EMBO ( FCL; ALTF 956-2006). We thank T. Wilson, H. Nash, M. Neale, J. Nitiss and E. Hoffmann for materials.	Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Connelly JC, 2004, MOL CELL, V13, P307, DOI 10.1016/S1097-2765(04)00056-5; Deweese JE, 2009, NUCLEIC ACIDS RES, V37, P738, DOI 10.1093/nar/gkn937; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Esguerra CV, 2007, DEVELOPMENT, V134, P4381, DOI 10.1242/dev.000026; Hartsuiker E, 2009, MOL CELL, V33, P117, DOI 10.1016/j.molcel.2008.11.021; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; Kingma PS, 1998, BBA-GENE STRUCT EXPR, V1400, P223, DOI 10.1016/S0167-4781(98)00138-9; Li TK, 2001, ANNU REV PHARMACOL, V41, P53, DOI 10.1146/annurev.pharmtox.41.1.53; Liu CY, 2002, P NATL ACAD SCI USA, V99, P14970, DOI 10.1073/pnas.182557199; Mielke C, 2004, J BIOL CHEM, V279, P20559, DOI 10.1074/jbc.C400032200; Mielke C, 2007, DNA REPAIR, V6, P1757, DOI 10.1016/j.dnarep.2007.06.014; NITISS JL, 1992, CANCER RES, V52, P4467; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; Parsons JL, 2004, NUCLEIC ACIDS RES, V32, P3531, DOI 10.1093/nar/gkh676; Pei HP, 2003, ONCOGENE, V22, P2699, DOI 10.1038/sj.onc.1206374; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pourquier P, 2001, ADV CANCER RES, V80, P189, DOI 10.1016/S0065-230X(01)80016-6; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Reynolds JJ, 2009, MOL CELL BIOL, V29, P1354, DOI 10.1128/MCB.01471-08; Rodrigues-Lima F, 2001, BIOCHEM BIOPH RES CO, V285, P1274, DOI 10.1006/bbrc.2001.5328; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Vance JR, 2001, MOL CELL BIOL, V21, P7191, DOI 10.1128/MCB.21.21.7191-7198.2001; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Xu GL, 2008, BIOCHEM BIOPH RES CO, V375, P395, DOI 10.1016/j.bbrc.2008.08.023; Yang SW, 1996, P NATL ACAD SCI USA, V93, P11534, DOI 10.1073/pnas.93.21.11534; Zucchelli S, 2009, CELL DEATH DIFFER, V16, P428, DOI 10.1038/cdd.2008.169	30	289	298	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					674	U125		10.1038/nature08444	http://dx.doi.org/10.1038/nature08444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794497				2022-12-28	WOS:000270302600045
J	Wertheim, HFL; Farrar, J; Horby, P				Wertheim, Heiman F. L.; Farrar, Jeremy; Horby, Peter			Medicine and the Media Online video sharing and patients' privacy	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Wertheim, Heiman F. L.] Univ Oxford, Clin Res Unit, Microbiol Res Lab, Oxford OX1 2JD, England; [Horby, Peter] Univ Oxford, Clin Res Unit, Hanoi Unit, Oxford OX1 2JD, England	University of Oxford; University of Oxford	Wertheim, HFL (corresponding author), Univ Oxford, Clin Res Unit, Microbiol Res Lab, Oxford OX1 2JD, England.	hwertheim@oucru.org	Wertheim, Heiman FL/F-3338-2016; Farrar, Jeremy J./HGA-7610-2022; Horby, Peter/D-1585-2013	Wertheim, Heiman FL/0000-0002-5003-5565; Horby, Peter/0000-0002-9822-1586; Farrar, Jeremy/0000-0002-2700-623X					0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 30	2009	339								b3991	10.1136/bmj.b3991	http://dx.doi.org/10.1136/bmj.b3991			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502KZ	19793782				2022-12-28	WOS:000270459800006
J	Bridgham, JT; Ortlund, EA; Thornton, JW				Bridgham, Jamie T.; Ortlund, Eric A.; Thornton, Joseph W.			An epistatic ratchet constrains the direction of glucocorticoid receptor evolution	NATURE			English	Article							DOLLOS LAW; IRREVERSIBLE EVOLUTION; REVERSIBILITY; SOFTWARE; PROTEINS	The extent to which evolution is reversible has long fascinated biologists(1-8). Most previous work on the reversibility of morphological and life-history evolution(9-13) has been indecisive, because of uncertainty and bias in the methods used to infer ancestral states for such characters(14,15). Further, despite theoretical work on the factors that could contribute to irreversibility(1,8,16), there is little empirical evidence on its causes, because sufficient understanding of the mechanistic basis for the evolution of new or ancestral phenotypes is seldom available(3,8,17). By studying the reversibility of evolutionary changes in protein structure and function, these limitations can be overcome. Here we show, using the evolution of hormone specificity in the vertebrate glucocorticoid receptor as a case-study, that the evolutionary path by which this protein acquired its new function soon became inaccessible to reverse exploration. Using ancestral gene reconstruction, protein engineering and X-ray crystallography, we demonstrate that five subsequent 'restrictive' mutations, which optimized the new specificity of the glucocorticoid receptor, also destabilized elements of the protein structure that were required to support the ancestral conformation. Unless these ratchet-like epistatic substitutions are restored to their ancestral states, reversing the key function-switching mutations yields a non-functional protein. Reversing the restrictive substitutions first, however, does nothing to enhance the ancestral function. Our findings indicate that even if selection for the ancestral function were imposed, direct reversal would be extremely unlikely, suggesting an important role for historical contingency in protein evolution.	[Bridgham, Jamie T.; Thornton, Joseph W.] Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA; [Thornton, Joseph W.] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA; [Ortlund, Eric A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30332 USA	University of Oregon; Howard Hughes Medical Institute; University of Oregon; Emory University	Thornton, JW (corresponding author), Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA.	joet@uoregon.edu	Thornton, Joseph/GSN-4190-2022; Ortlund, Eric Anthony/P-3121-2019; Ortlund, Eric Anthony/F-4672-2014	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029	National Science Foundation [IOB-0546906]; National Institutes of Health [R01-GM081592, F32-GM074398]; Sloan Foundation Fellowship	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Foundation Fellowship(Alfred P. Sloan Foundation)	Supported by National Science Foundation IOB-0546906, National Institutes of Health R01-GM081592 and F32-GM074398, and a Sloan Foundation Fellowship to J. W. T. We thank M. Harms and members of the Thornton, Cresko and Phillips laboratories for comments.	Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BULL JJ, 1985, EVOLUTION, V39, P1149, DOI 10.2307/2408742; Chippindale PT, 2004, EVOLUTION, V58, P2809; Collin R, 2003, P ROY SOC B-BIOL SCI, V270, P2551, DOI 10.1098/rspb.2003.2517; Collin R, 2008, TRENDS ECOL EVOL, V23, P602, DOI 10.1016/j.tree.2008.06.013; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; Dawkins R, 1994, BLIND WATCHMAKER; Dean AM, 2007, NAT REV GENET, V8, P675, DOI 10.1038/nrg2160; Dennett Daniel C., 1995, DARWINS DANGEROUS ID; DOBZHANSKY TG, 1971, GENETICS EVOLUTIONAR, P428; Domes K, 2007, P NATL ACAD SCI USA, V104, P7139, DOI 10.1073/pnas.0700034104; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goldberg EE, 2008, EVOLUTION, V62, P2727, DOI 10.1111/j.1558-5646.2008.00505.x; GOULD S J, 1970, Journal of the History of Biology, V3, P189, DOI 10.1007/BF00137351; Kohlsdorf T, 2006, EVOLUTION, V60, P1896; LEWONTIN RC, 1966, BIOSCIENCE, V16, P25, DOI 10.2307/1293548; MACBETH N, 1980, SYST ZOOL, V29, P402, DOI 10.2307/2992345; MAJERUS MEN, 1998, MELANISM EVOLUTION A, P151; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller HJ, 1939, BIOL REV CAMB PHILOS, V14, P261, DOI 10.1111/j.1469-185X.1939.tb00934.x; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagel M, 2004, TRENDS ECOL EVOL, V19, P278, DOI 10.1016/j.tree.2004.03.020; Simpson GG., 1953, MAJOR FEATURES EVOLU, P310; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Teotonio H, 2001, EVOLUTION, V55, P653, DOI 10.1554/0014-3820(2001)055[0653:PRE]2.0.CO;2; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; WAGNER GP, 1982, J THEOR BIOL, V96, P337, DOI 10.1016/0022-5193(82)90114-X; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Whiting MF, 2003, NATURE, V421, P264, DOI 10.1038/nature01313; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; YANG ZH, 1995, GENETICS, V141, P1641; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Zufall RA, 2004, NATURE, V428, P847, DOI 10.1038/nature02489	35	284	288	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					515	U78		10.1038/nature08249	http://dx.doi.org/10.1038/nature08249			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19779450	Green Accepted			2022-12-28	WOS:000270082900038
J	Humphrey, JH				Humphrey, Jean H.			Child undernutrition, tropical enteropathy, toilets, and handwashing	LANCET			English	Editorial Material							DIARRHEA; HEALTH; WATER; SANITATION		[Humphrey, Jean H.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, Baltimore, MD 21205 USA; [Humphrey, Jean H.] ZVITAMBO project, Harare, Zimbabwe	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Humphrey, JH (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, 615 N Wolfe St, Baltimore, MD 21205 USA.	jhumphrey@zvitambo.co.zw			NICHD NIH HHS [1R01HD060338-01] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060338] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; BLUM D, 1983, INT J EPIDEMIOL, V12, P357, DOI 10.1093/ije/12.3.357; BRIEND A, 1990, EUR J CLIN NUTR, V44, P611; Campbell DI, 2003, J NUTR, V133, P1332; Checkley W, 2004, LANCET, V363, P112, DOI 10.1016/S0140-6736(03)15261-0; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Clasen T, 2007, BMJ-BRIT MED J, V334, P782, DOI 10.1136/bmj.39118.489931.BE; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Esrey SA, 1996, AM J EPIDEMIOL, V143, P608, DOI 10.1093/oxfordjournals.aje.a008791; Haghighi P, 1997, CRIT REV CL LAB SCI, V34, P313, DOI 10.3109/10408369708998096; HALSTENSEN TS, 1993, EUR J IMMUNOL, V23, P505, DOI 10.1002/eji.1830230231; LUNN PG, 1991, LANCET, V338, P907, DOI 10.1016/0140-6736(91)91772-M; NETO UF, 1994, J AM COLL NUTR, V13, P51; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; ROURA E, 1992, J NUTR, V122, P2383, DOI 10.1093/jn/122.12.2383; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; SOLOMONS NW, 1993, NUTR REV, V51, P327, DOI 10.1111/j.1753-4887.1993.tb03758.x; Veitch AM, 2001, EUR J GASTROEN HEPAT, V13, P1175, DOI 10.1097/00042737-200110000-00009; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4	21	469	470	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2009	374	9694					1032	1035		10.1016/S0140-6736(09)60950-8	http://dx.doi.org/10.1016/S0140-6736(09)60950-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	498PK	19766883				2022-12-28	WOS:000270154100034
J	Katzourakis, A; Gifford, RJ; Tristem, M; Gilbert, MTP; Pybus, OG				Katzourakis, Aris; Gifford, Robert J.; Tristem, Michael; Gilbert, M. Thomas P.; Pybus, Oliver G.			Macroevolution of Complex Retroviruses	SCIENCE			English	Article							MAMMALS		[Katzourakis, Aris; Gifford, Robert J.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Katzourakis, Aris] Univ Oxford, Inst Emergent Infect, Oxford OX1 3PS, England; [Tristem, Michael] Univ London Imperial Coll Sci Technol & Med, Div Biol, London SL5 7PY, England; [Gilbert, M. Thomas P.] Univ Copenhagen, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark	University of Oxford; University of Oxford; Imperial College London; University of Copenhagen	Katzourakis, A (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	aris.katzourakis@zoo.ox.ac.uk; robert.gifford@zoo.ox.ac.uk	Gilbert, Marcus TP/A-8936-2013; Pybus, Oliver G/B-2640-2012	Gilbert, Marcus TP/0000-0002-5805-7195; Pybus, Oliver G/0000-0002-8797-2667; Gifford, Robert/0000-0003-4028-9884; Katzourakis, Aris/0000-0003-3328-6204	James Martin 21st Century School; Danish Natural Science Research Council; Royal Society	James Martin 21st Century School; Danish Natural Science Research Council(Danish Natural Science Research Council); Royal Society(Royal Society of London)	We thank the Washington University St. Louis Genome Sequencing Center for the C. hoffmanni genome assembly; B. Voirin, A. Hedayat, and the University of Copenhagen Zoological Museum for xenarthran tissue samples; and R. Blakey for tectonic maps. A. K. was funded by the James Martin 21st Century School, M. T. P. G. by the Danish Natural Science Research Council, and O. G. P. by the Royal Society. GenBank accession numbers are GQ169506 to GQ169527.	Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Delsuc F, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-11; Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003; Huchon D, 2000, P ROY SOC B-BIOL SCI, V267, P393, DOI 10.1098/rspb.2000.1014; Switzer WM, 2005, NATURE, V434, P376, DOI 10.1038/nature03341; Weiss RA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-67; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704	7	122	123	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 18	2009	325	5947					1512	1512		10.1126/science.1174149	http://dx.doi.org/10.1126/science.1174149			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762636				2022-12-28	WOS:000269887900029
J	Walpole, M; Almond, REA; Besancon, C; Butchart, SHM; Campbell-Lendrum, D; Carr, GM; Collen, B; Collette, L; Davidson, NC; Dulloo, E; Fazel, AM; Galloway, JN; Gill, M; Goverse, T; Hockings, M; Leaman, DJ; Morgan, DHW; Revenga, C; Rickwood, CJ; Schutyser, F; Simons, S; Stattersfield, AJ; Tyrrell, TD; Vie, JC; Zimsky, M				Walpole, Matt; Almond, Rosamunde E. A.; Besancon, Charles; Butchart, Stuart H. M.; Campbell-Lendrum, Diarmid; Carr, Genevieve M.; Collen, Ben; Collette, Linda; Davidson, Nick C.; Dulloo, Ehsan; Fazel, Asghar M.; Galloway, James N.; Gill, Michael; Goverse, Tessa; Hockings, Marc; Leaman, Danna J.; Morgan, David H. W.; Revenga, Carmen; Rickwood, Carrie J.; Schutyser, Frederik; Simons, Sarah; Stattersfield, Alison J.; Tyrrell, Tristan D.; Vie, Jean-Christophe; Zimsky, Mark			Tracking Progress Toward the 2010 Biodiversity Target and Beyond	SCIENCE			English	Editorial Material							LIVING PLANET INDEX		[Campbell-Lendrum, Diarmid] WHO, Global Environm Change Publ Hlth & Environm, Geneva, Switzerland; [Collen, Ben] Zool Soc London, Inst Zool, London, England; [Galloway, James N.] Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA; [Hockings, Marc] Univ Queensland, Sch Integrat Syst, Brisbane, Qld 4072, Australia; [Leaman, Danna J.] IUCN SSC, Med Plant Specialist Grp, Gland, Switzerland; [Revenga, Carmen] Nature Conservancy, Arlington, VA USA; [Vie, Jean-Christophe] IUCN, Species Programme, Gland, Switzerland	World Health Organization; Zoological Society of London; University of Virginia; University of Queensland; Nature Conservancy		matt.walpole@unep-wcmc.org	Collen, Ben/D-5055-2011; Butchart, Stuart/AAJ-1852-2021; Leaman, Danna/AAN-7510-2020; Hockings, Marc/A-1283-2007; Butchart, Stuart HM/Y-2711-2018; Davidson, Nicholas/AAA-9921-2019; Galloway, James N/C-2769-2013; Collen, Ben/F-2543-2016	Butchart, Stuart/0000-0002-1140-4049; Hockings, Marc/0000-0003-4419-8963; Davidson, Nicholas/0000-0002-2466-0658; Galloway, James N/0000-0001-7676-8698; Collen, Ben/0000-0003-2564-4243; Collette, Laurence/0000-0003-2518-7281				Baillie JEM, 2008, CONSERV LETT, V1, P18, DOI 10.1111/j.1755-263X.2008.00009.x; Balmford A, 2005, SCIENCE, V307, P212, DOI 10.1126/science.1106281; Butchart SHM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000140; CARR GM, 2007, WATER QUALITY INDEX; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Convention on Biological Diversity (CBD), 2006, GLOB BIOD OUTL; *FAO, 2006, GLOB FOR RES ASS 200; GOLDFINGER EBS, 2008, ECOLOGICAL FOOTPRINT; Hansen MC, 2008, P NATL ACAD SCI USA, V105, P9439, DOI 10.1073/pnas.0804042105; Loh J, 2005, PHILOS T R SOC B, V360, P289, DOI 10.1098/rstb.2004.1584; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; Pereira HM, 2006, TRENDS ECOL EVOL, V21, P123, DOI 10.1016/j.tree.2005.10.015; Scholes RJ, 2008, SCIENCE, V321, P1044, DOI 10.1126/science.1162055; UNEP-WCMC, 2008, STAT WORLDS PROT AR	14	152	162	1	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 18	2009	325	5947					1503	1504		10.1126/science.1175466	http://dx.doi.org/10.1126/science.1175466			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	495JS	19762630				2022-12-28	WOS:000269887900023
J	Tripati, AK; Roberts, CD; Eagle, RA				Tripati, Aradhna K.; Roberts, Christopher D.; Eagle, Robert A.			Coupling of CO2 and Ice Sheet Stability Over Major Climate Transitions of the Last 20 Million Years	SCIENCE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; MIOCENE; MIDDLE; PACIFIC; STRATIFICATION; DECLINE; RATIOS; RECORD; MA; PH	The carbon dioxide (CO2) content of the atmosphere has varied cyclically between similar to 180 and similar to 280 parts per million by volume over the past 800,000 years, closely coupled with temperature and sea level. For earlier periods in Earth's history, the partial pressure of CO2 (pCO(2)) is much less certain, and the relation between pCO(2) and climate remains poorly constrained. We use boron/calcium ratios in foraminifera to estimate pCO(2) during major climate transitions of the past 20 million years. During the Middle Miocene, when temperatures were similar to 3 degrees to 6 degrees C warmer and sea level was 25 to 40 meters higher than at present, pCO(2) appears to have been similar to modern levels. Decreases in pCO(2) were apparently synchronous with major episodes of glacial expansion during the Middle Miocene (similar to 14 to 10 million years ago) and Late Pliocene (similar to 3.3 to 2.4 million years ago).	[Tripati, Aradhna K.] Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Tripati, Aradhna K.] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Tripati, Aradhna K.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; [Tripati, Aradhna K.; Roberts, Christopher D.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Eagle, Robert A.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Cambridge; California Institute of Technology	Tripati, AK (corresponding author), Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA.	ripple@zephyr.ess.ucla.edu	Roberts, Christopher/F-6197-2011; Tripati, Aradhna/C-9419-2011; Roberts, Christopher D/GRR-4034-2022; Roberts, Chris/M-9058-2018; Roberts, Christopher David/AAA-6692-2020; Eagle, Robert/A-2679-2011	Tripati, Aradhna/0000-0002-1695-1754; Roberts, Christopher D/0000-0002-2958-6637; Roberts, Chris/0000-0002-2958-6637; Roberts, Christopher David/0000-0002-2958-6637; Eagle, Robert/0000-0003-0304-6111	UCLA; National Environmental Research Council (NERC) [NE/D009049/1, NER/S/A/2006/14070]; Magdalene College; Caltech Chancellors Postdoctoral Scholarship;  [NE/F004966/]; NERC [NE/G001456/1, NE/D009049/1] Funding Source: UKRI; Natural Environment Research Council [NE/D009049/1, NE/G001456/1] Funding Source: researchfish	UCLA; National Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Magdalene College; Caltech Chancellors Postdoctoral Scholarship; ; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank K. Caldeira, H. Elderfield, J. Eiler, T. Naish, D. Sigman, anonymous reviewers, and the editor for their comments on this work, which substantially improved the manuscript. We also thank J. Booth, E. Khadun, O. Shorttle, L. Thanalasundaram, and A. Bufe for invaluable assistance with sample preparation; L. Booth, J. Day, and M. Greaves (supported by grant NE/F004966/1) for technical assistance; L. Lisiecki for assistance with the age model; and S. Crowhurst, A. Gagnon, S. John, N. Meckler, B. Passey, N. Thiagarajan, and J. Yu for discussing this work. Support was provided to A. K. T. by UCLA, National Environmental Research Council (NERC) ( fellowship NE/D009049/1), and Magdalene College; to C. D. R. by NERC ( studentship NER/S/A/2006/14070); and to R. A. E. by a Caltech Chancellors Postdoctoral Scholarship. Samples for this study were obtained from the Godwin Laboratory sample archives and the Ocean Drilling Program.	Billups K, 2003, EARTH PLANET SC LETT, V209, P181, DOI 10.1016/S0012-821X(03)00067-0; COWAN EA, 2001, P OCEAN DRILLING PRO, V0178; DeConto RM, 2008, NATURE, V455, P652, DOI 10.1038/nature07337; Fedorov AV, 2006, SCIENCE, V312, P1485, DOI 10.1126/science.1122666; FLOWER BP, 1993, PALEOCEANOGRAPHY, V8, P811, DOI 10.1029/93PA02196; FLOWER BP, 1995, PALEOCEANOGRAPHY, V10, P1095, DOI 10.1029/95PA02022; Haug GH, 1999, NATURE, V401, P779, DOI 10.1038/44550; HODELL DA, 1994, PALEOCEANOGRAPHY, V9, P405, DOI 10.1029/94PA00292; Honisch B, 2009, SCIENCE, V324, P1551, DOI 10.1126/science.1171477; Holbourn A, 2005, NATURE, V438, P483, DOI 10.1038/nature04123; Krissek L. A., 1995, PROC OCEAN DRILL SCI, V145, P179, DOI DOI 10.2973/ODP.PROC.SR.145.118; Krylov AA, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001497; Lemarchand D, 2002, CHEM GEOL, V190, P123, DOI 10.1016/S0009-2541(02)00114-6; Lewis AR, 2008, P NATL ACAD SCI USA, V105, P10676, DOI 10.1073/pnas.0802501105; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Lunt DJ, 2008, NATURE, V454, P1102, DOI 10.1038/nature07223; Medina-Elizalde M, 2005, SCIENCE, V310, P1009, DOI 10.1126/science.1115933; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; NAISH T, 2007, INT S ANT EARTH SCI; Nathan SA, 2009, PALAEOGEOGR PALAEOCL, V274, P140, DOI 10.1016/j.palaeo.2009.01.007; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Shevenell AE, 2004, SCIENCE, V305, P1766, DOI 10.1126/science.1100061; Sigman DM, 2004, NATURE, V428, P59, DOI 10.1038/nature02357; Solomon S., 2007, PHYS SCI BASIS WORKI; SPIVACK AJ, 1993, NATURE, V363, P149, DOI 10.1038/363149a0; Vincent E., 1985, CARBON CYCLE ATMOSPH, V32, P455, DOI [10.1029/GM032p0455, DOI 10.1029/GM032P0455]; Wara MW, 2005, SCIENCE, V309, P758, DOI 10.1126/science.1112596; Wolf-Welling Thomas C.W., 1996, Proceedings of the Ocean Drilling Program Scientific Results, V151, P515; Yu JM, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001347; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	33	260	277	4	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1394	1397		10.1126/science.1178296	http://dx.doi.org/10.1126/science.1178296			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19815724				2022-12-28	WOS:000272351100040
J	Khare, A; Santorelli, LA; Strassmann, JE; Queller, DC; Kuspa, A; Shaulsky, G				Khare, Anupama; Santorelli, Lorenzo A.; Strassmann, Joan E.; Queller, David C.; Kuspa, Adam; Shaulsky, Gad			Cheater-resistance is not futile	NATURE			English	Article							DICTYOSTELIUM-DISCOIDEUM; SOCIAL AMEBA; COOPERATION; DNA; EVOLUTION; SOCIETIES; RESPONSES; MUTANTS	Cooperative social systems are susceptible to cheating by individuals that reap the benefits of cooperation without incurring the costs(1). There are various theoretical mechanisms for the repression of cheating(2) and many have been tested experimentally. One possibility that has not been tested rigorously is the evolution of mutations that confer resistance to cheating. Here we show that the presence of a cheater in a population of randomly mutated social amoebae can select for cheater-resistance. Furthermore, we show that this cheater-resistance can be a noble strategy because the resister strain does not necessarily exploit other strains. Thus, the evolution of resisters may be instrumental in preserving cooperative behaviour in the face of cheating.	[Khare, Anupama; Santorelli, Lorenzo A.; Kuspa, Adam; Shaulsky, Gad] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Santorelli, Lorenzo A.; Strassmann, Joan E.; Queller, David C.; Kuspa, Adam; Shaulsky, Gad] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA; [Kuspa, Adam] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Rice University; Baylor College of Medicine	Shaulsky, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	gadi@bcm.edu	Khare, Anupama/N-9220-2018	Khare, Anupama/0000-0003-1231-670X; Shaulsky, Gad/0000-0002-0532-0551; Santorelli, Lorenzo/0000-0002-8392-801X; Kuspa, Adam/0000-0002-9156-149X; Strassmann, Joan/0000-0003-0638-8440	National Science Foundation; Cullen Foundation	National Science Foundation(National Science Foundation (NSF)); Cullen Foundation	This work was supported by a grant from the National Science Foundation. A. Khare was supported by a pre-doctoral fellowship from the Cullen Foundation.	CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Ennis HL, 2000, P NATL ACAD SCI USA, V97, P3292, DOI 10.1073/pnas.050005097; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Fiegna F, 2006, NATURE, V441, P310, DOI 10.1038/nature04677; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; Gilbert OM, 2007, P NATL ACAD SCI USA, V104, P8913, DOI 10.1073/pnas.0702723104; Greig D, 2004, P ROYAL SOC B S, V271, P25, DOI [DOI 10.1098/RSBL.2003.0083), 10.1098/rsbl.2003.0083]; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Huang EY, 2006, DEVELOPMENT, V133, P449, DOI 10.1242/dev.02240; Katoh M, 2006, EUKARYOT CELL, V5, P18, DOI 10.1128/EC.5.1.18-25.2006; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; KNECHT DA, 1986, MOL CELL BIOL, V6, P3973, DOI 10.1128/MCB.6.11.3973; KUSPA A, 1992, P NATL ACAD SCI USA, V89, P8803, DOI 10.1073/pnas.89.18.8803; Marques JT, 2007, TRENDS GENET, V23, P359, DOI 10.1016/j.tig.2007.04.004; Mehdiabadi NJ, 2006, NATURE, V442, P881, DOI 10.1038/442881a; Ostrowski EA, 2008, PLOS BIOL, V6, P2376, DOI 10.1371/journal.pbio.0060287; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Sachs JL, 2004, Q REV BIOL, V79, P135, DOI 10.1086/383541; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; Smith J. M., 1997, MAJOR TRANSITIONS EV; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; VOLLRATH D, 1988, P NATL ACAD SCI USA, V85, P6027, DOI 10.1073/pnas.85.16.6027; Vulic M, 2001, GENETICS, V158, P519	26	50	51	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					980	U240		10.1038/nature08472	http://dx.doi.org/10.1038/nature08472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19794414				2022-12-28	WOS:000270817700047
J	Campbell, DA; Dellinger, EP				Campbell, Darrell A., Jr.; Dellinger, E. Patchen			Multihospital Collaborations for Surgical Quality Improvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Campbell, Darrell A., Jr.] Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA; [Dellinger, E. Patchen] Univ Washington, Med Ctr, Dept Surg, Seattle, WA 98195 USA	University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle	Campbell, DA (corresponding author), Univ Michigan Hlth Syst, C201 Med Inn Bldg, Ann Arbor, MI 48109 USA.	darrellc@umich.edu						Balas E A, 2000, Yearb Med Inform, P65; Fung-Kee-Fung M, 2009, ANN SURG, V249, P565, DOI 10.1097/SLA.0b013e31819ec608; Lenfant C, 2003, NEW ENGL J MED, V349, P868, DOI 10.1056/NEJMsa035507; Nembhard IM, 2009, ACAD MANAGE PERSPECT, V23, P24, DOI 10.5465/AMP.2009.37008001; Nugent WC, 2005, SEMIN CARDIOTHORAC V, V9, P115, DOI 10.1177/108925320500900202; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; *SURG CAR OUTC ASS, PUBL REL SCOAP DAT; Westfall JM, 2007, JAMA-J AM MED ASSOC, V297, P403, DOI 10.1001/jama.297.4.403; World Health Organization, WORLD HLTH REP 2000	9	19	19	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	2009	302	14					1584	1585		10.1001/jama.2009.1474	http://dx.doi.org/10.1001/jama.2009.1474			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505UA	19826030				2022-12-28	WOS:000270721800029
J	Cheng, H; Edwards, RL; Broecker, WS; Denton, GH; Kong, XG; Wang, YJ; Zhang, R; Wang, XF				Cheng, Hai; Edwards, R. Lawrence; Broecker, Wallace S.; Denton, George H.; Kong, Xinggong; Wang, Yongjin; Zhang, Rong; Wang, Xianfeng			Ice Age Terminations	SCIENCE			English	Article							ABRUPT CLIMATE-CHANGE; MILLENNIAL-SCALE; ASIAN MONSOON; HIGH-RESOLUTION; DONGGE CAVE; HULU CAVE; ATLANTIC; RECORD; VARIABILITY; HOLOCENE	Th-230-dated oxygen isotope records of stalagmites from Sanbao Cave, China, characterize Asian Monsoon (AM) precipitation through the ends of the third-and fourthmost recent ice ages. As a result, AM records for the past four glacial terminations can now be precisely correlated with those from ice cores and marine sediments, establishing the timing and sequence of major events. In all four cases, observations are consistent with a classic Northern Hemisphere summer insolation intensity trigger for an initial retreat of northern ice sheets. Meltwater and icebergs entering the North Atlantic alter oceanic and atmospheric circulation and associated fluxes of heat and carbon, causing increases in atmospheric CO2 and Antarctic temperatures that drive the termination in the Southern Hemisphere. Increasing CO2 and summer insolation drive recession of northern ice sheets, with probable positive feedbacks between sea level and CO2.	[Cheng, Hai; Edwards, R. Lawrence; Wang, Xianfeng] Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA; [Broecker, Wallace S.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Denton, George H.] Univ Maine, Climate Change Inst, Bryand Global Sci Ctr, Dept Earth Sci, Orono, ME 04469 USA; [Kong, Xinggong; Wang, Yongjin] Nanjing Normal Univ, Coll Geog Sci, Nanjing 210097, Peoples R China; [Zhang, Rong] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA	University of Minnesota System; University of Minnesota Twin Cities; Columbia University; University of Maine System; University of Maine Orono; Nanjing Normal University; National Oceanic Atmospheric Admin (NOAA) - USA	Edwards, RL (corresponding author), Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA.	edwar001@umn.edu	Zhang, Rong/D-9767-2014; NSONWU-ANYANWU, AUGUSTA CHINYERE/P-3820-2019; Wang, Xianfeng/F-1233-2014; Edwards, R. Lawrence/I-3124-2014; Usoro, Chinyere A.O./N-6860-2018; CHENG, HAI/H-3413-2017	Zhang, Rong/0000-0002-8493-6556; NSONWU-ANYANWU, AUGUSTA CHINYERE/0000-0003-1141-5992; Wang, Xianfeng/0000-0002-8614-5627; Edwards, R. Lawrence/0000-0002-7027-5881; Usoro, Chinyere A.O./0000-0001-5864-4798; CHENG, HAI/0000-0002-5305-9458	U.S. NSF [0502535]; Gary Comer Science and Education Foundation [CC8]; NOAA; National Natural Science Foundation of China [40631003, 40771009]	U.S. NSF(National Science Foundation (NSF)); Gary Comer Science and Education Foundation; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the late Gary Comer for his generous support and J. Severinghaus, V. Masson-Delmotte, and P. Clark for valuable suggestions. This work was supported by U.S. NSF grant 0502535, Gary Comer Science and Education Foundation grant CC8, NOAA grants to G. H. D., and National Natural Science Foundation of China grants 40631003 and 40771009.	Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; ALLEY RB, 1993, NATURE, V362, P527, DOI 10.1038/362527a0; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Archer D, 2000, REV GEOPHYS, V38, P159, DOI 10.1029/1999RG000066; BARNETT TP, 1988, SCIENCE, V239, P504, DOI 10.1126/science.239.4839.504; BENDER M, 1994, GLOBAL BIOGEOCHEM CY, V8, P363, DOI 10.1029/94GB00724; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI 10.1016/0033-5894(78)90064-9; Birchfield GE, 1990, PALEOCEANOGRAPHY, V5, P835, DOI 10.1029/PA005i006p00835; Blanford HF., 1884, P R SOC LOND, V37, P3, DOI DOI 10.1098/RSPL.1884.0003; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Broecker WS, 2006, GLOBAL PLANET CHANGE, V54, P211, DOI 10.1016/j.gloplacha.2006.06.019; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; BROECKER WS, 1970, REV GEOPHYS SPACE GE, V8, P169, DOI 10.1029/RG008i001p00169; BROECKER WS, 1985, NATURE, V315, P21, DOI 10.1038/315021a0; Cheng H, 2006, GEOLOGY, V34, P217, DOI 10.1130/G22289.1; Chiang JCH, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000916; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Clark PU, 2004, SCIENCE, V304, P1141, DOI 10.1126/science.1094449; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; DANSGAARD W, 1964, TELLUS, V16, P436; Denton G.H., 2006, PAGES NEWS, V14, P14, DOI DOI 10.22498/PAGES.14.2.14; Denton GH, 2005, QUATERNARY SCI REV, V24, P1159, DOI 10.1016/j.quascirev.2004.12.002; Dykoski CA, 2005, EARTH PLANET SC LETT, V233, P71, DOI 10.1016/j.epsl.2005.01.036; EMILIANI C, 1955, J GEOL, V63, P538, DOI 10.1086/626295; Fleitmann D, 2007, QUATERNARY SCI REV, V26, P170, DOI 10.1016/j.quascirev.2006.04.012; HAYS JD, 1976, SCIENCE, V194, P1121, DOI 10.1126/science.194.4270.1121; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; HENDY CH, 1971, GEOCHIM COSMOCHIM AC, V35, P801, DOI 10.1016/0016-7037(71)90127-X; Hu CY, 2008, EARTH PLANET SC LETT, V266, P221, DOI 10.1016/j.epsl.2007.10.015; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; Johnson KR, 2004, EARTH PLANET SC LETT, V220, P365, DOI 10.1016/S0012-821X(04)00036-6; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Keeling RF, 2001, PALEOCEANOGRAPHY, V16, P112, DOI 10.1029/2000PA000529; Kelly MJ, 2006, PALAEOGEOGR PALAEOCL, V236, P20, DOI 10.1016/j.palaeo.2005.11.042; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; MARTIN JH, 1988, NATURE, V331, P341, DOI 10.1038/331341a0; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; OPDYKE BN, 1992, GEOLOGY, V20, P733, DOI 10.1130/0091-7613(1992)020<0733:ROTCRH>2.3.CO;2; Paillard D, 2001, REV GEOPHYS, V39, P325, DOI 10.1029/2000RG000091; PELTIER WR, 1994, SCIENCE, V265, P195, DOI 10.1126/science.265.5169.195; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; Severinghaus JP, 2009, NATURE, V457, P1093, DOI 10.1038/4571093a; Severinghaus JP, 2009, SCIENCE, V324, P1431, DOI 10.1126/science.1169473; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Sinha A, 2005, GEOLOGY, V33, P813, DOI 10.1130/G21498.1; STOCKER TF, 1992, J CLIMATE, V5, P773, DOI 10.1175/1520-0442(1992)005<0773:AZACOA>2.0.CO;2; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Suwa M, 2008, QUATERNARY SCI REV, V27, P1093, DOI 10.1016/j.quascirev.2008.02.017; Thompson LG, 2002, SCIENCE, V298, P589, DOI 10.1126/science.1073198; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Wang X, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2007GL030766, 10.1029/2007GL031149]; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692	60	643	743	10	361	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					248	252		10.1126/science.1177840	http://dx.doi.org/10.1126/science.1177840			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815769				2022-12-28	WOS:000270599500033
J	Herbert, SP; Huisken, J; Kim, TN; Feldman, ME; Houseman, BT; Wang, RA; Shokat, KM; Stainier, DYR				Herbert, Shane P.; Huisken, Jan; Kim, Tyson N.; Feldman, Morri E.; Houseman, Benjamin T.; Wang, Rong A.; Shokat, Kevan M.; Stainier, Didier Y. R.			Arterial-Venous Segregation by Selective Cell Sprouting: An Alternative Mode of Blood Vessel Formation	SCIENCE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; VASCULAR MORPHOGENESIS; NOTCH; P110-ALPHA; ANGIOGENESIS; EPHRINB2; HEDGEHOG; SUBUNIT; PATHWAY; ROLES	Blood vessels form de novo (vasculogenesis) or upon sprouting of capillaries from preexisting vessels (angiogenesis). With high-resolution imaging of zebrafish vascular development, we uncovered a third mode of blood vessel formation whereby the first embryonic artery and vein, two unconnected blood vessels, arise from a common precursor vessel. The first embryonic vein formed by selective sprouting of progenitor cells from the precursor vessel, followed by vessel segregation. These processes were regulated by the ligand EphrinB2 and its receptor EphB4, which are expressed in arterial-fated and venous-fated progenitors, respectively, and interact to orient the direction of progenitor migration. Thus, directional control of progenitor migration drives arterial-venous segregation and generation of separate parallel vessels from a single precursor vessel, a process essential for vascular development.	[Herbert, Shane P.; Huisken, Jan; Stainier, Didier Y. R.] Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94158 USA; [Herbert, Shane P.; Huisken, Jan; Stainier, Didier Y. R.] Univ Calif San Francisco, Dept Genet, San Francisco, CA 94158 USA; [Herbert, Shane P.; Huisken, Jan; Stainier, Didier Y. R.] Univ Calif San Francisco, Cardiovasc Res Inst, Program Human Genet, San Francisco, CA 94158 USA; [Herbert, Shane P.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds LS2 9JT, W Yorkshire, England; [Herbert, Shane P.] Univ Leeds, Inst Mol & Cellular Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Kim, Tyson N.; Wang, Rong A.] Univ Calif San Francisco, Dept Surg, Div Vasc Surg, Lab Accelerated Vasc Res, San Francisco, CA 94143 USA; [Feldman, Morri E.] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA; [Houseman, Benjamin T.; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Houseman, Benjamin T.; Shokat, Kevan M.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Leeds; University of Leeds; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Program Dev Biol, San Francisco, CA 94158 USA.	Didier.Stainier@ucsf.edu	Huisken, Jan/B-2472-2009	Huisken, Jan/0000-0001-7250-3756; Stainier, Didier/0000-0002-0382-0026; Kim, Tyson/0000-0002-5275-6614; Herbert, Shane/0000-0003-2517-1845	Wellcome Trust; Human Frontier Science Program Organization; Cardiovascular Research Institute fellowship; NIH [HL54737]; Packard Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075033, R01HL054737] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontier Science Program Organization(Human Frontier Science Program); Cardiovascular Research Institute fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Foundation(The David & Lucile Packard Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank J. E. Cooke, S. Schulte-Merker, and H. Okamoto for reagents and D. Shin, P. Gut, and S. Woo for critical reading of the manuscript. S. P. H. is a Wellcome Trust Sir Henry Wellcome postdoctoral fellow. J. H. was supported by the Human Frontier Science Program Organization and is supported by a Cardiovascular Research Institute fellowship. This study was supported in part by grants from the NIH (HL54737) and Packard Foundation to D. Y. R. S.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Adams RH, 2001, CELL, V104, P57, DOI 10.1016/S0092-8674(01)00191-X; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bi L, 1999, J BIOL CHEM, V274, P10963, DOI 10.1074/jbc.274.16.10963; Cermenati S, 2008, BLOOD, V111, P2657, DOI 10.1182/blood-2007-07-100412; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Kim YH, 2008, DEVELOPMENT, V135, P3755, DOI 10.1242/dev.022475; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Lawson ND, 2003, GENE DEV, V17, P1346, DOI 10.1101/gad.1072203; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Lin FJ, 2007, EMBO REP, V8, P920, DOI 10.1038/sj.embor.7401076; Parker LH, 2004, NATURE, V428, P754, DOI 10.1038/nature02416; Pendeville H, 2008, DEV BIOL, V317, P405, DOI 10.1016/j.ydbio.2008.01.028; Sato T, 2007, J NEUROSCI, V27, P5271, DOI 10.1523/JNEUROSCI.0883-07.2007; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Sly LM, 2009, BLOOD, V113, P2945, DOI 10.1182/blood-2008-06-166082; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Ueki K, 2002, P NATL ACAD SCI USA, V99, P419, DOI 10.1073/pnas.012581799; Zhong TP, 2001, NATURE, V414, P216, DOI 10.1038/35102599	26	227	235	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					294	298		10.1126/science.1178577	http://dx.doi.org/10.1126/science.1178577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815777	Green Accepted			2022-12-28	WOS:000270599500044
J	Clement, FM; Harris, A; Li, JJ; Yong, K; Lee, KM; Manns, BJ				Clement, Fiona M.; Harris, Anthony; Li, Jing Jing; Yong, Karen; Lee, Karen M.; Manns, Braden J.			Using Effectiveness and Cost-effectiveness to Make Drug Coverage Decisions A Comparison of Britain, Australia, and Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURROGATE END-POINTS; NATIONAL-INSTITUTE; HEALTH; NICE; MANAGEMENT; THRESHOLD; APPROVAL; MARKERS; MONEY	Context National public insurance for drugs is often based on evidence of comparative effectiveness and cost-effectiveness. This study describes how that evidence has been used across 3 jurisdictions (Australia, Canada, and Britain) that have been at the forefront of evidence-based coverage internationally. Objectives To describe how clinical and cost-effectiveness evidence is used in coverage decisions both within and across jurisdictions and to identify common issues in the process of evidence-based coverage. Design, Setting, and Participants Descriptive analysis of retrospective data from the Common Drug Review (CDR) of Canada, National Institute for Health and Clinical Excellence (NICE) in Britain, and Pharmaceutical Benefits Advisory Committee (PBAC) of Australia. All publicly available information as of December 31, 2008, was gathered from each committee's Web site (data set begins in January 2004 [CDR], February 2001 [NICE], and July 2005 [PBAC]). Main Outcome Measure Listing recommendations for each drug by disease indication. Results NICE recommended 87.4% (174/199) of submissions for listing compared with a listing rate of 49.6% (60/121) and 54.3% (153/282) for the CDR and PBAC, respectively. Significant uncertainty around clinical effectiveness, typically resulting from inadequate study design or the use of inappropriate comparators and unvalidated surrogate end points, was identified as a key issue in coverage decisions. Recommendations varied considerably across countries, possibly because of differences in the medications reviewed; different agency processes, including the willingness to negotiate on price; and the approach to "me too" drugs. The data suggest that the 3 agencies make recommendations that are consistent with evidence on effectiveness and cost-effectiveness but that other factors are often important. Conclusions NICE, PBAC, and CDR face common issues with respect to the quality and strength of the experimental evidence in support of a clinically meaningful effect. However, comparative effectiveness and cost-effectiveness, along with other relevant factors, can be used by national agencies to support drug decision making. The results of the evaluation process in different countries are influenced by the context, agency processes, ability to engage in price negotiation, and perhaps differences in social values. JAMA. 2009; 302(13): 1437-1443	[Clement, Fiona M.; Manns, Braden J.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Manns, Braden J.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Manns, Braden J.] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada; [Harris, Anthony; Li, Jing Jing; Yong, Karen] Monash Univ, Ctr Hlth Econ, Melbourne, Vic 3004, Australia; [Lee, Karen M.] Canadian Agcy Drugs & Technol Hlth, Ottawa, ON, Canada	University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; Monash University	Manns, BJ (corresponding author), Foothills Med Ctr, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.	braden.manns@albertahealthservices.ca	Manns, Braden J/I-8942-2012; Lee, Karen/GVT-9602-2022	Harris, Anthony/0000-0003-1641-3320	Canadian Health Services Research Foundation; Alberta Heritage Foundation for Medical Research; Canadian Institutes for Health Research New Investigator Award; Canadian Agency for Drugs and Technologies in Health	Canadian Health Services Research Foundation; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Institutes for Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Canadian Agency for Drugs and Technologies in Health	Dr Clement is supported by a postdoctoral fellowship from the Canadian Health Services Research Foundation and the Alberta Heritage Foundation for Medical Research. Dr Manns is supported by a Canadian Institutes for Health Research New Investigator Award. This project was supported by an unrestricted grant from the Canadian Agency for Drugs and Technologies in Health.	Aaron HJ, 2008, NEW ENGL J MED, V359, P1865, DOI 10.1056/NEJMp0807204; Alexander GC, 2009, JAMA-J AM MED ASSOC, V301, P2488, DOI 10.1001/jama.2009.851; [Anonymous], GUIDELINES PREPARING; Aspinall SL, 2005, MED CARE, V43, P20; *AUSTR GOV, 2001, INT PHARM PRIC DIFF; *AUSTR I HLTH WELF, HLTH WELF EXP SER, V35; *CAN AG DRUGS TECH, 2007, CADTH PRES COMM DRUG; *CAN I HLTH INF, 2007, DRUG EXP CAN 1985 20; Chalkidou K, 2009, MILBANK Q, V87, P339, DOI 10.1111/j.1468-0009.2009.00560.x; Collier J, 2008, BRIT MED J, V336, P56, DOI 10.1136/bmj.39454.496748.80; *CONGR BUDG OFF, BUDG EC OUTL FISC YE; *CTR MED MED SERV, POT NCD NAT COV DET; Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; Duerden Martin, 2004, J Ambul Care Manage, V27, P132; Felson D, 2007, ARTHRIT RHEUM-ARTHR, V57, P193, DOI 10.1002/art.22552; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Fuchs VR, 2008, NEW ENGL J MED, V359, P1749, DOI 10.1056/NEJMp0807432; Harris AH, 2008, MED DECIS MAKING, V28, P713, DOI 10.1177/0272989X08315247; Henry DA, 2005, JAMA-J AM MED ASSOC, V294, P2630, DOI 10.1001/jama.294.20.2630; HILL S, 1924, JAMA-J AM MED ASSOC, V284, P1922; Hill SR, 2000, JAMA-J AM MED ASSOC, V283, P2116, DOI 10.1001/jama.283.16.2116; *HLTH CAN, HLTH CAR SYST; Kirschner N, 2008, ANN INTERN MED, V148, P956, DOI 10.7326/0003-4819-148-12-200806170-00222; Manns B, 2006, AM J KIDNEY DIS, V48, P159, DOI 10.1053/j.ajkd.2006.03.044; Manns Braden J, 2007, Int J Health Care Finance Econ, V7, P149, DOI 10.1007/s10754-007-9022-y; McMahon M, 2006, HEALTH POLICY, V77, P339, DOI 10.1016/j.healthpol.2005.08.006; Miners AH, 2005, BMJ-BRIT MED J, V330, P65, DOI 10.1136/bmj.38285.482350.82; Morgan SG, 2006, HEALTH AFFAIR, V25, P337, DOI 10.1377/hlthaff.25.2.337; *NIH CLIN EXC, 2008, 1 REP HLTH COMM 2007; Poisal JA, 2004, HEALTH CARE FINANC R, V25, P1; Psaty BM, 1999, JAMA-J AM MED ASSOC, V282, P786, DOI 10.1001/jama.282.8.786; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1474, DOI 10.1001/jama.299.12.1474; Sales MM, 2005, AM J MANAG CARE, V11, P104; Steinbrook R, 2008, NEW ENGL J MED, V359, P1977, DOI 10.1056/NEJMp0806862; Temple R, 1999, JAMA-J AM MED ASSOC, V282, P790, DOI 10.1001/jama.282.8.790; Tierney M, 2008, CAN MED ASSOC J, V178, P432, DOI 10.1503/cmaj.070713; Wilensky GR, 2008, ANN INTERN MED, V148, P967, DOI 10.7326/0003-4819-148-12-200806170-00224; Williams Iestyn, 2007, J Health Serv Res Policy, V12, P73, DOI 10.1258/135581907780279521	38	238	241	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	2009	302	13					1437	1443		10.1001/jama.2009.1409	http://dx.doi.org/10.1001/jama.2009.1409			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	503CL	19809025	Bronze			2022-12-28	WOS:000270509600018
J	Margolis, P; Halfon, N				Margolis, Peter; Halfon, Neal			Innovation Networks A Strategy to Transform Primary Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Margolis, Peter] Cincinnati Childrens Hosp, Med Ctr, Ctr Hlth Care Qual, Div Hlth Policy & Clin Effectiveness, Cincinnati, OH 45229 USA; [Halfon, Neal] Univ Calif Los Angeles, Ctr Healthier Children Families & Communities, Los Angeles, CA USA; [Halfon, Neal] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Halfon, Neal] Univ Calif Los Angeles, Sch Publ Hlth, Dept Hlth Serv, Los Angeles, CA 90024 USA; [Halfon, Neal] Univ Calif Los Angeles, Sch Publ Affairs, Dept Publ Policy, Los Angeles, CA 90024 USA	Cincinnati Children's Hospital Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Margolis, P (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Ctr Hlth Care Qual, Div Hlth Policy & Clin Effectiveness, MLC 7014,3333 Burnet Ave, Cincinnati, OH 45229 USA.	Peter.Margolis@cchmc.org			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016957] Funding Source: NIH RePORTER; AHRQ HHS [U18 HS016957-03] Funding Source: Medline; PHS HHS [U45MCO8263] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BENKLER Y, 2006, WEALTH NETWORKS; *COMM FUND COMM HI, FRAM HIGH PERF HLTH; Gloor P.A., 2006, SWARM CREATIVITY COM; *IMPR PERF PRACT, COACH PRACT IMPR HEA; Kilo C M, 1998, Qual Manag Health Care, V6, P1; Mandel KE, 2007, ARCH PEDIAT ADOL MED, V161, P650, DOI 10.1001/archpedi.161.7.650; NAMBESAN S, 2009, STANFORD SOCIAL  SUM, P1; von Hippel E., 2005, DEMOCRATIZING INNOVA	8	14	14	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	2009	302	13					1461	1462		10.1001/jama.2009.1428	http://dx.doi.org/10.1001/jama.2009.1428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503CL	19809028				2022-12-28	WOS:000270509600022
J	Lovejoy, CO; Suwa, G; Simpson, SW; Matternes, JH; White, TD				Lovejoy, C. Owen; Suwa, Gen; Simpson, Scott W.; Matternes, Jay H.; White, Tim D.			The Great Divides: Ardipithecus ramidus Reveals the Postcrania of Our Last Common Ancestors with African Apes	SCIENCE			English	Article							NATURAL-HISTORY; BODY-WEIGHT; HUMAN GAIT; MIOCENE; HOMINID; HUMANS; ORIGINS; FEMUR; NACHOLAPITHECUS; ADAPTATIONS	Genomic comparisons have established the chimpanzee and bonobo as our closest living relatives. However, the intricacies of gene regulation and expression caution against the use of these extant apes in deducing the anatomical structure of the last common ancestor that we shared with them. Evidence for this structure must therefore be sought from the fossil record. Until now, that record has provided few relevant data because available fossils were too recent or too incomplete. Evidence from Ardipithecus ramidus now suggests that the last common ancestor lacked the hand, foot, pelvic, vertebral, and limb structures and proportions specialized for suspension, vertical climbing, and knuckle-walking among extant African apes. If this hypothesis is correct, each extant African ape genus must have independently acquired these specializations from more generalized ancestors who still practiced careful arboreal climbing and bridging. African apes and hominids acquired advanced orthogrady in parallel. Hominoid spinal invagination is an embryogenetic mechanism that reoriented the shoulder girdle more laterally. It was unaccompanied by substantial lumbar spine abbreviation, an adaptation restricted to vertical climbing and/ or suspension. The specialized locomotor anatomies and behaviors of chimpanzees and gorillas therefore constitute poor models for the origin and evolution of human bipedality.	[Lovejoy, C. Owen] Kent State Univ, Sch Biomed Sci, Dept Anthropol, Kent, OH 44242 USA; [Suwa, Gen] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Simpson, Scott W.] Case Western Reserve Univ, Sch Med, Dept Anat, Cleveland, OH 44106 USA; [White, Tim D.] Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA; [White, Tim D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of Tokyo; Case Western Reserve University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lovejoy, CO (corresponding author), Kent State Univ, Sch Biomed Sci, Dept Anthropol, Kent, OH 44242 USA.	olovejoy@aol.com; suwa@um.u-tokyo.ac.jp	Simpson, Scott/GRS-0081-2022; , owen/N-7301-2019	, owen/0000-0003-0053-4523	U. S. National Science Foundation; Japan Society for the Promotion of Science	U. S. National Science Foundation(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	For funding, we thank the U. S. National Science Foundation and the Japan Society for the Promotion of Science. We thank the Ministry of Tourism and Culture, the Authority for Research and Conservation of the Cultural Heritage, and the National Museum of Ethiopia for permissions and facilitation. We thank the Afar Regional Government, the Afar people of the Middle Awash, and many other field workers for contributing directly to the data. We thank the following institutions and staff for access to comparative materials: National Museum of Ethiopia; National Museums of Kenya; Transvaal Museum South Africa; Cleveland Museum of Natural History; Royal Museum of Central Africa Tervuren; and the University of California at Berkeley Human Evolution Research Center. We thank K. Brudvik for illustration and editorial assistance. We thank the following individuals for cooperation with comparative data: M. Brunet and C. V. Ward. We thank R. Meindl for statistical advice and assistance and P. L. Reno, M. A. Serrat, M. A. McCollum, M. Selby, and B. A. Rosenman for aid in data collection and exceptionally helpful discussions.	Almecija S, 2007, P ROY SOC B-BIOL SCI, V274, P2375, DOI 10.1098/rspb.2007.0750; ANDREWS P, 1986, COLD SPRING HARB SYM, V51, P419, DOI 10.1101/SQB.1986.051.01.050; Asfaw B, 1999, SCIENCE, V284, P629, DOI 10.1126/science.284.5414.629; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; CACCONE A, 1989, EVOLUTION, V43, P925, DOI 10.1111/j.1558-5646.1989.tb02540.x; Carroll S. B., 2001, DNA DIVERSITY MOL GE; CARTMILL M, 1977, AM J PHYS ANTHROPOL, V47, P249, DOI 10.1002/ajpa.1330470206; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Clarke RJ, 2002, S AFR J SCI, V98, P523; COOLIDGE H J, 1982, Primates, V23, P245, DOI 10.1007/BF02381164; DeSilva JM, 2009, P NATL ACAD SCI USA, V106, P6567, DOI 10.1073/pnas.0900270106; DeSilva JM., 2008, THESIS U MICHIGAN; Gregory William King, 1934, MANS PLACE ANTHROPOI; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Harrison T., 1991, P235; HORAI S, 1992, J MOL EVOL, V35, P32, DOI 10.1007/BF00160258; Huxley T., 1863, EVIDENCE MANS PLACE; JOHANSON DC, 1979, SCIENCE, V203, P321, DOI 10.1126/science.104384; JUNGERS WL, 1982, NATURE, V297, P676, DOI 10.1038/297676a0; Keith A, 1923, BRIT MED J, V1923, P545; Keith A, 1923, BRIT MED J, V1923, P499; Keith A, 1923, BMJ-BRIT MED J, V1923, P451, DOI 10.1136/bmj.1.3246.451; KEITH A, 1923, BRIT MED J, V1, P502; KEITH A, 1923, BRIT MED J, V1, P454; Kunimatsu Y, 2007, P NATL ACAD SCI USA, V104, P19220, DOI 10.1073/pnas.0706190104; LEAKEY MD, 1979, NATURE, V278, P317, DOI 10.1038/278317a0; LEMINOR JM, 1994, ACTA ANAT, V150, P227; LEWIS OJ, 1971, NATURE, V230, P577, DOI 10.1038/230577a0; Lovejoy CO, 2007, P ROY SOC B-BIOL SCI, V274, P2373, DOI 10.1098/rspb.2007.0855; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175827; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175831; Lovejoy CO, 1999, P NATL ACAD SCI USA, V96, P13247, DOI 10.1073/pnas.96.23.13247; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Lovejoy CO, 2005, GAIT POSTURE, V21, P113, DOI 10.1016/j.gaitpost.2004.06.010; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; MCCOLLUM MA, J EXP ZOOL PART B, V312, DOI DOI 10.1002/JEZ.B.21316; McGrew William, 2004, CULTURED CHIMPANZEE; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; Nakatsukasa M, 2003, J HUM EVOL, V45, P179, DOI 10.1016/S0047-2484(03)00092-7; Nakatsukasa M, 2007, PRIMATES, V48, P171, DOI 10.1007/s10329-007-0040-7; Nakatsukasa M, 2009, EVOL ANTHROPOL, V18, P103, DOI 10.1002/evan.20208; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pilbeam D, 2004, J EXP ZOOL PART B, V302B, P241, DOI 10.1002/jez.b.22; PORTER AMW, 1995, INT J OSTEOARCHAEOL, V5, P203, DOI 10.1002/oa.1390050302; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; RAFFERTY KL, 1995, AM J PHYS ANTHROPOL, V97, P391, DOI 10.1002/ajpa.1330970406; Reno PL, 2008, J EXP ZOOL PART B, V310B, P240, DOI 10.1002/jez.b.21207; Reno PL, 2005, CURR ANTHROPOL, V46, P575, DOI 10.1086/431528; Reno PL, 2005, J HUM EVOL, V49, P279, DOI 10.1016/j.jhevol.2005.04.008; Richmond BG, 2001, YEARB PHYS ANTHROPOL, V44, P70, DOI 10.1002/ajpa.10019; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; SCHULTZ A. H., 1930, HUMAN BIOL, V2, P303; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Sonntag CF, 1923, P ZOOL SOC LOND, V1923, P323; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; STRAUS WL, 1949, Q REV BIOL, V24, P200, DOI 10.1086/397067; Suwa G, 2007, NATURE, V448, P921, DOI 10.1038/nature06113; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; Suwa G, 2009, SCIENCE, V326, DOI 10.1126/science.1175825; Thorpe SKS, 2009, P NATL ACAD SCI USA, V106, P12646, DOI 10.1073/pnas.0811537106; TUTTLE R, 1972, NATURE, V236, P33, DOI 10.1038/236033a0; TUTTLE RH, 1969, SCIENCE, V166, P953, DOI 10.1126/science.166.3908.953; Wagner GP, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-213; WARD C V, 1991, American Journal of Physical Anthropology, P180; WARD CV, 1993, AM J PHYS ANTHROPOL, V90, P77, DOI 10.1002/ajpa.1330900106; WASHBURN SL, 1968, STUDY HUMAN EVOLUTIO; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; WILSON AC, 1969, P NATL ACAD SCI USA, V63, P1088, DOI 10.1073/pnas.63.4.1088; Wood B, 2008, J ANAT, V212, P354, DOI 10.1111/j.1469-7580.2008.00871.x; Wrangham R, 2001, DEV PRIMATOL-PROG PR, P5; ZIHLMAN AL, 1978, NATURE, V275, P744, DOI 10.1038/275744a0; ZIHLMAN AL, 1978, FOLIA PRIMATOL, V29, P86, DOI 10.1159/000155830	78	193	200	2	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					100	106		10.1126/science.1175833	http://dx.doi.org/10.1126/science.1175833			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501CA	19810199				2022-12-28	WOS:000270355600043
J	Ghaferi, AA; Birkmeyer, JD; Dimick, JB				Ghaferi, Amir A.; Birkmeyer, John D.; Dimick, Justin B.			Variation in Hospital Mortality Associated with Inpatient Surgery.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARE; OUTCOMES; QUALITY	Background: Hospital mortality that is associated with inpatient surgery varies widely. Reducing rates of postoperative complications, the current focus of payers and regulators, may be one approach to reducing mortality. However, effective management of complications once they have occurred may be equally important. Methods: We studied 84,730 patients who had undergone inpatient general and vascular surgery from 2005 through 2007, using data from the American College of Surgeons National Surgical Quality Improvement Program. We first ranked hospitals according to their risk-adjusted overall rate of death and divided them into five groups. For hospitals in each overall mortality quintile, we then assessed the incidence of overall and major complications and the rate of death among patients with major complications. Results: Rates of death varied widely across hospital quintiles, from 3.5% in very-low-mortality hospitals to 6.9% in very-high-mortality hospitals. Hospitals with either very high mortality or very low mortality had similar rates of overall complications (24.6% and 26.9%, respectively) and of major complications (18.2% and 16.2%, respectively). Rates of individual complications did not vary significantly across hospital mortality quintiles. In contrast, mortality in patients with major complications was almost twice as high in hospitals with very high overall mortality as in those with very low overall mortality (21.4% vs. 12.5%, P<0.001). Differences in rates of death among patients with major complications were also the primary determinant of variation in overall mortality with individual operations. Conclusions: In addition to efforts aimed at avoiding complications in the first place, reducing mortality associated with inpatient surgery will require greater attention to the timely recognition and management of complications once they occur. N Engl J Med 2009;361:1368-75.	[Ghaferi, Amir A.; Birkmeyer, John D.; Dimick, Justin B.] Univ Michigan, Dept Surg, Michigan Surg Collaborat Outcomes Res & Evaluat, Ann Arbor, MI 48104 USA	University of Michigan System; University of Michigan	Ghaferi, AA (corresponding author), Univ Michigan, Dept Surg, Michigan Surg Collaborat Outcomes Res & Evaluat, 211 N 4th Ave,Suite 201, Ann Arbor, MI 48104 USA.	aghaferi@umich.edu			National Cancer Institute [T32 CA009672, R01-CA098481, K05-CA115571-01]; Agency for Healthcare Research and Quality [K08-HS017765]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS017765] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K05CA115571, T32CA009672, R01CA098481] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a training grant from the National Cancer Institute ( T32 CA009672, to Dr. Ghaferi), grants from the National Cancer Institute (R01-CA098481 and K05-CA115571-01, to Dr. Birkmeyer), and a career development award from the Agency for Healthcare Research and Quality (K08-HS017765, to Dr. Dimick).	AIKEN LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI [DOI 10.1001/JAMA.288.16.1987, 10.1001/jama.288.16.1987]; *AM COLL SURG NAT, ACS NSQIP DAT COLL O; *AM MED ASS, 2005, CPT 2006 CURR PROC T; Birkmeyer JD, 2004, SURGERY, V135, P569, DOI 10.1016/j.surg.2004.03.004; Carayon Pascale, 2005, Intensive Crit Care Nurs, V21, P284, DOI 10.1016/j.iccn.2004.12.003; Dellinger RP, 2008, CRIT CARE MED, V36, P1394; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Haynes Alex B, 2009, N Engl J Med, V360, P491, DOI 10.1056/NEJMsa0810119; HOUGHTON A, 1994, BRIT J SURG, V81, P653, DOI 10.1002/bjs.1800810508; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Pronovost PJ, 1999, JAMA-J AM MED ASSOC, V281, P1310, DOI 10.1001/jama.281.14.1310; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Pronovost PJ, 2004, CRIT CARE MED, V32, P1247, DOI 10.1097/01.CCM.0000128609.98470.8B; Sasichay-Akkadechanunt T, 2003, J NURS ADMIN, V33, P478, DOI 10.1097/00005110-200309000-00008; SILBER JH, 1992, MED CARE, V30, P615, DOI 10.1097/00005650-199207000-00004; Silber JH, 1997, MED CARE, V35, pOS77, DOI 10.1097/00005650-199710001-00011; SILBER JH, 1995, JAMA-J AM MED ASSOC, V274, P317, DOI 10.1001/jama.274.4.317; Zambon M, 2008, J CRIT CARE, V23, P455, DOI 10.1016/j.jcrc.2007.08.003	20	976	987	0	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2009	361	14					1368	1375		10.1056/NEJMsa0903048	http://dx.doi.org/10.1056/NEJMsa0903048			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500KZ	19797283	Bronze			2022-12-28	WOS:000270300000011
J	Bonetta, L				Bonetta, Laura			New Citizens for the Life Sciences	CELL			English	Editorial Material								For years, the general public have been helping scientists to track weather, count birds, and observe the universe. Now such citizen scientists are starting to tackle research projects in the life sciences. Laura Bonetta reports.											0	9	10	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 18	2009	138	6					1043	1045		10.1016/j.cell.2009.09.007	http://dx.doi.org/10.1016/j.cell.2009.09.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766554	Bronze			2022-12-28	WOS:000269923200001
J	Panesar, SS; Cleary, K; Bhandari, M; Sheikh, A				Panesar, Sukhmeet S.; Cleary, Kevin; Bhandari, Mohit; Sheikh, Aziz			To cement or not in hip fracture surgery?	LANCET			English	Editorial Material									[Panesar, Sukhmeet S.; Cleary, Kevin] Natl Patient Safety Agcy, London W1T 5HD, England; [Bhandari, Mohit] McMaster Univ, Hamilton, ON, Canada; [Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	McMaster University; University of Edinburgh	Panesar, SS (corresponding author), Natl Patient Safety Agcy, London W1T 5HD, England.	sukhmeet.panesar@npsa.nhs.uk	Sheikh, Aziz/D-2818-2009; Bhandari, Mohit/AAQ-1675-2021	Sheikh, Aziz/0000-0001-7022-3056; 				Ahn J, 2008, CLIN ORTHOP RELAT R, V466, P2513, DOI 10.1007/s11999-008-0368-3; Donaldson AJ, 2009, BRIT J ANAESTH, V102, P12, DOI 10.1093/bja/aen328; DONALDSON L, 2008, STATE PUBLIC HLTH AN; Gullberg B, 1997, OSTEOPOROSIS INT, V7, P407, DOI 10.1007/PL00004148; Haleem S, 2008, INJURY, V39, P1157, DOI 10.1016/j.injury.2008.03.022; *NAT JOINT REG, 2007, NAT JOINT REG 4 ANN; *NAT PAT SAF AG, 2009, RAP RESP REP MIT SUR; *NIH CLIN EXC, 2000, HIP DIS REPL PROTH S; ORSINI EC, 1987, J BONE JOINT SURG AM, V69A, P822, DOI 10.2106/00004623-198769060-00005; PARKER MJ, 2006, COCHRANE DB SYST REV, V2; PARVIZI J, 1999, CLIN ORTHOP RELAT R, V369, P39; Sierra RJ, 2009, J ARTHROPLASTY, V24, P325, DOI 10.1016/j.arth.2008.01.301	12	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2009	374	9695					1047	1049		10.1016/S0140-6736(09)61685-8	http://dx.doi.org/10.1016/S0140-6736(09)61685-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501HA	19782857				2022-12-28	WOS:000270370900009
J	Bartholomaus, I; Kawakami, N; Odoardi, F; Schlager, C; Miljkovic, D; Ellwart, JW; Klinkert, WEF; Flugel-Koch, C; Issekutz, TB; Wekerle, H; Flugel, A				Bartholomaeus, Ingo; Kawakami, Naoto; Odoardi, Francesca; Schlaeger, Christian; Miljkovic, Djordje; Ellwart, Joachim W.; Klinkert, Wolfgang E. F.; Fluegel-Koch, Cassandra; Issekutz, Thomas B.; Wekerle, Hartmut; Fluegel, Alexander			Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions	NATURE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; GERMLINE TRANSMISSION; DENDRITIC CELLS; CHOROID-PLEXUS; ANTIGEN; PROTEIN; LYMPHOCYTES; BRAIN; EXTRAVASATION	The tissues of the central nervous system are effectively shielded from the blood circulation by specialized vessels that are impermeable not only to cells, but also to most macromolecules circulating in the blood. Despite this seemingly absolute seclusion, central nervous system tissues are subject to immune surveillance and are vulnerable to autoimmune attacks(1). Using intravital two-photon imaging in a Lewis rat model of experimental autoimmune encephalomyelitis, here we present in real-time the interactive processes between effector T cells and cerebral structures from their first arrival to manifest autoimmune disease. We observed that incoming effector T cells successively scanned three planes. The T cells got arrested to leptomeningeal vessels and immediately monitored the luminal surface, crawling preferentially against the blood flow. After diapedesis, the cells continued their scan on the abluminal vascular surface and the underlying leptomeningeal (pial) membrane. There, the T cells encountered phagocytes that effectively present antigens, foreign as well as myelin proteins. These contacts stimulated the effector T cells to produce pro-inflammatory mediators, and provided a trigger to tissue invasion and the formation of inflammatory infiltrations.	[Bartholomaeus, Ingo; Kawakami, Naoto; Odoardi, Francesca; Schlaeger, Christian; Miljkovic, Djordje; Klinkert, Wolfgang E. F.; Wekerle, Hartmut; Fluegel, Alexander] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany; [Odoardi, Francesca; Schlaeger, Christian; Fluegel, Alexander] Inst Multiple Sclerosis Res, Dept Neuroimmunol, Gemeinnutzige Hertie Stiftung, D-37073 Gottingen, Germany; [Odoardi, Francesca; Schlaeger, Christian; Fluegel, Alexander] Univ Med Ctr Gottingen, D-37073 Gottingen, Germany; [Odoardi, Francesca; Fluegel, Alexander] Univ Munich, Inst Immunol, D-80336 Munich, Germany; [Ellwart, Joachim W.] Helmholtz Ctr, Inst Expt Hematol, D-81377 Munich, Germany; [Fluegel-Koch, Cassandra] Univ Erlangen Nurnberg, Inst Anat 2, D-91054 Erlangen, Germany; [Issekutz, Thomas B.] Dalhousie Univ, Dept Pediat, Div Immunol, Halifax, NS B3K 6R8, Canada	Max Planck Society; University of Gottingen; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Erlangen Nuremberg; Dalhousie University	Flugel, A (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	hwekerle@neuro.mpg.de; Fluegel@med.uni-goettingen.de	Miljković, Đorđe/F-1378-2015	Miljković, Đorđe/0000-0002-5613-9306; Issekutz, Thomas/0000-0001-5486-9463; Kawakami, Naoto/0000-0001-7693-3489	Deutsche Forschungsgemeinschaft [SFB455 A8, SFB571 C6]; Hertie foundation [1.01.1/04/010]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hertie foundation	We thank S. Kosin, I. Haarmann, C. Federle, T. H. Ngugen and K. Nispel for technical assistance. We thank M. Krumbholz for help in statistical analysis, M. Hubener for support in 3D analysis software, and K. Dornmair, E. Meinl and E. Lutjen-Drecoll for critical comments on the paper. We are grateful to V. Staiger for providing software and R. Schorner for help with the artwork. This work was supported by the Deutsche Forschungsgemeinschaft (SFB455 project A8 and SFB571 project C6) and the Hertie foundation (Hertie no. 1.01.1/04/010).	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Becher B, 2006, J MOL MED, V84, P532, DOI 10.1007/s00109-006-0065-1; Bechmann I, 2007, TRENDS IMMUNOL, V28, P5, DOI 10.1016/j.it.2006.11.007; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Eylar E H, 1974, Methods Enzymol, V32, P323; Flugel A, 1999, NAT MED, V5, P843, DOI 10.1038/10567; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; Geissmann F, 2005, PLOS BIOL, V3, P650, DOI 10.1371/journal.pbio.0030113; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; HICKEY WF, 1992, J NEUROPATH EXP NEUR, V51, P246, DOI 10.1097/00005072-199205000-00002; HINRICHS DJ, 1987, J EXP MED, V166, P1906, DOI 10.1084/jem.166.6.1906; ISSEKUTZ TB, 1993, AM J PATHOL, V143, P1286; Kawakami N, 2005, J IMMUNOL, V175, P69, DOI 10.4049/jimmunol.175.1.69; Kawakami N, 2005, J EXP MED, V201, P1805, DOI 10.1084/jem.20050011; Kawakami N, 2004, J EXP MED, V199, P185, DOI 10.1084/jem.20031064; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; KUCHROO VK, 1992, J IMMUNOL, V148, P3776; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Matyszak MK, 1996, NEUROSCIENCE, V74, P599, DOI 10.1016/0306-4522(96)00160-1; McMenamin PG, 2003, CELL TISSUE RES, V313, P259, DOI 10.1007/s00441-003-0779-0; Odoardi F, 2007, P NATL ACAD SCI USA, V104, P18625, DOI 10.1073/pnas.0705033104; Odoardi F, 2007, P NATL ACAD SCI USA, V104, P920, DOI 10.1073/pnas.0608383104; Phillipson M, 2006, J EXP MED, V203, P2569, DOI 10.1084/jem.20060925; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Schenkel AR, 2004, NAT IMMUNOL, V5, P393, DOI 10.1038/ni1051; TAMATANI T, 1991, EUR J IMMUNOL, V21, P627, DOI 10.1002/eji.1830210314; TRAUGOTT U, 1979, Journal of the Neurological Sciences, V42, P331, DOI 10.1016/0022-510X(79)90166-7; TSUCHIDA M, 1994, IMMUNOLOGY, V81, P420; Vajkoczy P, 2001, J CLIN INVEST, V108, P557; Walther M, 2001, J NEUROIMMUNOL, V117, P30, DOI 10.1016/S0165-5728(01)00302-2; WEKERLE H, 1986, TRENDS NEUROSCI, V9, P271, DOI 10.1016/0166-2236(86)90077-9; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	36	468	476	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 5	2009	462	7269					94	U104		10.1038/nature08478	http://dx.doi.org/10.1038/nature08478			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514TT	19829296				2022-12-28	WOS:000271419200039
J	Coffin, JM; Stoye, JP				Coffin, John M.; Stoye, Jonathan P.			A New Virus for Old Diseases?	SCIENCE			English	Editorial Material							MURINE LEUKEMIA-VIRUS; PROSTATE-CANCER; XMRV; TUMORS		[Coffin, John M.] Tufts Univ, Dept Mol Microbiol, Boston, MA 02111 USA; [Stoye, Jonathan P.] Natl Inst Med Res, London NW4 1AA, England	Tufts University; MRC National Institute for Medical Research	Coffin, JM (corresponding author), Tufts Univ, Dept Mol Microbiol, Boston, MA 02111 USA.	john.coffin@tufts.edu		Stoye, Jonathan/0000-0003-3377-323X	MRC [MC_U117512710] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R37CA089441] Funding Source: NIH RePORTER; Medical Research Council [MC_U117512710] Funding Source: Medline; NCI NIH HHS [R37 CA089441, R37 CA089441-09] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Devanur LD, 2006, J CLIN VIROL, V37, P139, DOI 10.1016/j.jcv.2006.08.013; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Dong BH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003144; Hong SH, 2009, J VIROL, V83, P6995, DOI 10.1128/JVI.00268-09; Kim S, 2008, J VIROL, V82, P9964, DOI 10.1128/JVI.01299-08; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Van Dooren S, 2004, MOL BIOL EVOL, V21, P603, DOI 10.1093/molbev/msh053; Weiss R, 1982, RNA TUMOR VIRUSES	11	28	28	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 23	2009	326	5952					530	531		10.1126/science.1181349	http://dx.doi.org/10.1126/science.1181349			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19815721	Green Accepted			2022-12-28	WOS:000271019400026
J	Lucey, PG				Lucey, Paul G.			A Lunar Waterworld	SCIENCE			English	Editorial Material							MOON; MERCURY; STABILITY; ICE		Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA	University of Hawaii System	Lucey, PG (corresponding author), Univ Hawaii, Hawaii Inst Geophys & Planetol, 1680 East West Rd,POST 504, Honolulu, HI 96822 USA.	lucey@higp.hawaii.edu						Clark RN, 2009, SCIENCE, V326, P562, DOI 10.1126/science.1178105; COLAPRETE A, 2008, LPI CONTRIB, V1415; ELGORESY A, 1973, EARTH PLANET SC LETT, V18, P411, DOI 10.1016/0012-821X(73)90097-6; INGERSOLL AP, 1992, ICARUS, V100, P40, DOI 10.1016/0019-1035(92)90016-Z; Lucey PG, 2009, ELEMENTS, V5, P41, DOI 10.2113/gselements.5.1.41; MCCUBBIN FM, 2008, LUNAR PLANET SCI, V39; Papike J., 1991, LUNAR SOURCEBOOK USE, P121; Pieters CM, 2009, SCIENCE, V326, P568, DOI 10.1126/science.1178658; Saal AE, 2008, NATURE, V454, P192, DOI 10.1038/nature07047; SALVAIL JR, 1994, ICARUS, V111, P441, DOI 10.1006/icar.1994.1155; Sunshine JM, 2009, SCIENCE, V326, P565, DOI 10.1126/science.1179788; Taylor L.A., 1974, GEOLOGY, V2, P429; Vasavada AR, 1999, ICARUS, V141, P179, DOI 10.1006/icar.1999.6175	13	19	21	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 23	2009	326	5952					531	532		10.1126/science.1181471	http://dx.doi.org/10.1126/science.1181471			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19779147				2022-12-28	WOS:000271019400027
J	Morrow, M; Jagsi, R; Alderman, AK; Griggs, JJ; Hawley, ST; Hamilton, AS; Graff, JJ; Katz, SJ				Morrow, Monica; Jagsi, Reshma; Alderman, Amy K.; Griggs, Jennifer J.; Hawley, Sarah T.; Hamilton, Ann S.; Graff, John J.; Katz, Steven J.			Surgeon Recommendations and Receipt of Mastectomy for Treatment of Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREOPERATIVE CHEMOTHERAPY; CONSERVING SURGERY; INFORMED DECISION; LOCAL THERAPY; WOMEN; OUTCOMES; TRENDS; TRIAL; RATES; MRI	Context There is concern that mastectomy is overused in the United States. Objectives To evaluate the association of patient-reported initial recommendations by surgeons and those given when a second opinion was sought with receipt of initial mastectomy; and to assess the use of mastectomy after attempted breast-conserving surgery (BCS). Design, Setting, and Patients A survey of women aged 20 to 79 years with intraductal or stage I and II breast cancer diagnosed between June 2005 and February 2007 and reported to the National Cancer Institute's Surveillance, Epidemiology, and End Results registries for the metropolitan areas of Los Angeles, California, and Detroit, Michigan. Patients were identified using rapid case ascertainment, and Latinas and blacks were oversampled. Of 3133 patients sent surveys, 2290 responded (73.1%). A mailed survey was completed by 96.5% of respondents and 3.5% completed a telephone survey. The final sample included 1984 female patients (502 Latinas, 529 blacks, and 953 non-Hispanic white or other). Main Outcome Measures The rate of initial mastectomy and the perceived reason for its use (surgeon recommendation, patient driven, medical contraindication) and the rate of mastectomy after attempted BCS. Results Of the 1984 patients, 1468 had BCS as an initial surgical therapy (75.4%) and 460 had initial mastectomy, including 13.4% following surgeon recommendation and 8.8% based on patient preference. Approximately 20% of patients (n=378) sought a second opinion; this was more common for those patients advised by their initial surgeon to undergo mastectomy (33.4%) than for those advised to have BCS (15.6%) or for those not receiving a recommendation for one procedure over another (21.2%) (P<.001). Discordance in treatment recommendations between surgeons occurred in 12.1% (n=43) of second opinions and did not differ on the basis of patient race/ethnicity, education, or geographic site. Among the 1459 women for whom BCS was attempted, additional surgery was required in 37.9% of patients, including 358 with reexcision (26.0%) and 167 with mastectomy (11.9%). Mastectomy was most common in patients with stage II cancer (P<.001). Conclusion Breast-conserving surgery was recommended by surgeons and attempted in the majority of patients evaluated, with surgeon recommendation, patient decision, and failure of BCS all contributing to the mastectomy rate. JAMA. 2009; 302(14): 1551-1556	[Morrow, Monica] Mem Sloan Kettering Canc Ctr, Breast Surg Serv, New York, NY 10065 USA; [Jagsi, Reshma; Alderman, Amy K.; Griggs, Jennifer J.; Hawley, Sarah T.; Katz, Steven J.] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Hamilton, Ann S.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Graff, John J.] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI USA	Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan; University of Southern California; Barbara Ann Karmanos Cancer Institute; Wayne State University	Morrow, M (corresponding author), Mem Sloan Kettering Canc Ctr, Breast Surg Serv, 1275 York Ave, New York, NY 10065 USA.	morrowm@mskcc.org	KATZ, STEVEN/ABH-8886-2020	Jagsi, Reshma/0000-0001-6562-1228	National Cancer Institute [R01 CA109696, R01 CA088370, K05CA111340, N01-PC-35139, N01-PC-35145]; American Cancer Society [MRSG-09-145-01];  [N01-PC-54404]; NATIONAL CANCER INSTITUTE [K05CA111340, R01CA109696, R55CA054404, R01CA088370, R01CA054404] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP000807] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by grants R01 CA109696 and R01 CA088370 from the National Cancer Institute to the University of Michigan. Dr Katz was supported by an Established Investigator Award in Cancer Prevention, Control, Behavioral, and Population Sciences Research from the National Cancer Institute (K05CA111340). Dr Jagsi is supported by Mentored Research Scholar grant MRSG-09-145-01 from the American Cancer Society. The collection of Los Angeles County cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code 103885. The National Cancer Institute's Surveillance, Epidemiology, and End Results Program under contract N01-PC-35139 was awarded to the University of Southern California. Contract N01-PC-54404 and agreement 1U58DP00807-01 were awarded to the Public Health Institute. The collection of metropolitan Detroit cancer incidence data was supported by the National Cancer Institute's Surveillance, Epidemiology, and End Results Program under contract N01-PC-35145.	[Anonymous], 2007, J AM COLL SURGEONS, V205, P362, DOI 10.1016/j.jamcollurg.2007.02.057; [Anonymous], 1978, MAIL TELEPHONE SURVE; *AV FDN BREAST CTR, QUAL CORN; Bleicher RJ, 2009, J AM COLL SURGEONS, V209, P180, DOI 10.1016/j.jamcollsurg.2009.04.010; *CED SIN MED CTR, MEAS QUAL CAR SAUL J; Collins ED, 2009, J CLIN ONCOL, V27, P519, DOI 10.1200/JCO.2008.16.6215; Drew PJ, 2009, CANCER RES, V69, p75S; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Fagerlin A, 2006, PATIENT EDUC COUNS, V64, P303, DOI 10.1016/j.pec.2006.03.010; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Grobmyer SR, 2008, J AM COLL SURGEONS, V206, P1045, DOI 10.1016/j.jamcollsurg.2007.12.039; Hamilton AS, 2009, CANCER EPIDEM BIOMAR, V18, P2022, DOI 10.1158/1055-9965.EPI-09-0238; Hawley ST, 2009, JNCI-J NATL CANCER I, V101, P1337, DOI 10.1093/jnci/djp271; Katipamula R, 2009, J CLIN ONCOL, V27, P4082, DOI 10.1200/JCO.2008.19.4225; Katz IR, 2007, INFORM TECHNOL LIBR, V26, P3, DOI 10.6017/ital.v26i3.3271; Katz SJ, 2005, CANCER, V104, P1854, DOI 10.1002/cncr.21396; Katz SJ, 2005, J CLIN ONCOL, V23, P5526, DOI 10.1200/JCO.2005.06.217; Katz SJ, 2005, J CLIN ONCOL, V23, P3001, DOI 10.1200/JCO.2005.04.028; Lee MC, 2009, BREAST J, V15, P34, DOI 10.1111/j.1524-4741.2008.00668.x; Locker GY, 2004, CANCER-AM CANCER SOC, V101, P735, DOI 10.1002/cncr.20435; Mandelblatt J, 2006, J CLIN ONCOL, V24, P4908, DOI 10.1200/JCO.2006.07.1159; MORROW M, 2008, J CLIN ONCOL, V26, P629; Nattinger AB, 1996, MED CARE, V34, P479, DOI 10.1097/00005650-199605000-00009; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; *STATACORP, 2007, STATA REF MAN REL 10; Taghian A, 2005, ANN SURG, V241, P629, DOI 10.1097/01.sla.0000157272.04803.1b; Tuttle TM, 2007, J CLIN ONCOL, V25, P5203, DOI 10.1200/JCO.2007.12.3141; *U VIRG HLTH SYST, BREAST CANC PAG; van der Hage JA, 2001, J CLIN ONCOL, V19, P4224, DOI 10.1200/JCO.2001.19.22.4224; Wright MJ, 2007, J AM COLL SURGEONS, V204, P541, DOI 10.1016/j.jamcollsurg.2007.01.031	30	254	259	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	2009	302	14					1551	1556		10.1001/jama.2009.1450	http://dx.doi.org/10.1001/jama.2009.1450			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505UA	19826024	Bronze, Green Accepted			2022-12-28	WOS:000270721800023
J	Jensen, TS; Finnerup, NB				Jensen, Troels Staehelin; Finnerup, Nanna Brix			Neuropathic pain treatment: a further step forward	LANCET			English	Editorial Material							GABAPENTIN		[Jensen, Troels Staehelin] Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark; [Jensen, Troels Staehelin; Finnerup, Nanna Brix] Aarhus Univ Hosp, Danish Pain Res Ctr, DK-8000 Aarhus C, Denmark	Aarhus University; Aarhus University	Jensen, TS (corresponding author), Aarhus Univ Hosp, Dept Neurol, DK-8000 Aarhus C, Denmark.	tsjensen@ki.au.dk	Jensen, Troels Staehelin/A-3418-2009; Finnerup, Nanna Brix/ABA-8219-2020	Jensen, Troels Staehelin/0000-0002-3487-6380; Finnerup, Nanna Brix/0000-0001-5541-0240				Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Dooley DJ, 2007, TRENDS PHARMACOL SCI, V28, P75, DOI 10.1016/j.tips.2006.12.006; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Finnerup NB, 2006, NAT CLIN PRACT NEURO, V2, P107, DOI 10.1038/ncpneuro0118; Finnerup NB, 2005, PAIN, V118, P289, DOI 10.1016/j.pain.2005.08.013; Gilron I, 2005, NEW ENGL J MED, V352, P1324, DOI 10.1056/NEJMoa042580; Gilron I, 2009, LANCET, V374, P1252, DOI 10.1016/S0140-6736(09)61081-3; Hanna M, 2008, EUR J PAIN, V12, P804, DOI 10.1016/j.ejpain.2007.12.010; Simpson D A, 2001, J Clin Neuromuscul Dis, V3, P53; Sindrup SH, 2005, BASIC CLIN PHARMACOL, V96, P399, DOI 10.1111/j.1742-7843.2005.pto_96696601.x	10	19	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2009	374	9697					1218	1219		10.1016/S0140-6736(09)61205-8	http://dx.doi.org/10.1016/S0140-6736(09)61205-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	507KQ	19796803				2022-12-28	WOS:000270852500006
J	Talisuna, A; Grewal, P; Rwakimari, JB; Mukasa, S; Jagoe, G; Banerji, J				Talisuna, Ambrose; Grewal, Penny; Rwakimari, John Bosco; Mukasa, Susan; Jagoe, George; Banerji, Jaya			Cost is killing patients: subsidising effective antimalarials	LANCET			English	Editorial Material							MALARIA		[Talisuna, Ambrose; Grewal, Penny; Jagoe, George; Banerji, Jaya] Med Malaria Venture, CH-1215 Geneva 15, Switzerland; [Rwakimari, John Bosco] Minist Hlth, Kampala, Uganda; [Mukasa, Susan] Program Accessible Hlth Commun & Educ, Kampala, Uganda		Banerji, J (corresponding author), Med Malaria Venture, CH-1215 Geneva 15, Switzerland.	banerjij@mmv.org						[Anonymous], 2008, WORLD MAL REP 2008; [Anonymous], UND ANT MARK UG 2007; Bate R, 2009, LANCET INFECT DIS, V9, P396, DOI 10.1016/S1473-3099(09)70158-6; *GLOB FUND FIGHT A, 2009, AFF MED FAC MAL FREQ; *GLOB FUND FIGHT A, 2008, REP AFF MED FAC MAL; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; Moon S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000106; *ROLL BACK MAL, 2008, INTR GLOB MAL ACT PL; Sabot O, 2009, DISTRIBUTION ARTEMIS; Samarasekera U, 2008, LANCET, V371, P1403, DOI 10.1016/S0140-6736(08)60611-X; *WHO, 2000, US ANT DRUGS REP WHO	11	25	25	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2009	374	9697					1224	1226		10.1016/S0140-6736(09)61767-0	http://dx.doi.org/10.1016/S0140-6736(09)61767-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	507KQ	19819377				2022-12-28	WOS:000270852500010
J	Gawande, AA; Fisher, ES; Gruber, J; Rosenthal, MB				Gawande, Atul A.; Fisher, Elliott S.; Gruber, Jonathan; Rosenthal, Meredith B.			PERSPECTIVE ROUNDTABLE The Cost of Health Care - Highlights from a Discussion about Economics and Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gawande, Atul A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Gawande, Atul A.] Harvard Univ, Sch Med, Boston, MA USA; [Gawande, Atul A.; Rosenthal, Meredith B.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Fisher, Elliott S.] Dartmouth Med Sch, Lebanon, NH USA; [Fisher, Elliott S.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Gruber, Jonathan] MIT, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Dartmouth College; Dartmouth College; Massachusetts Institute of Technology (MIT)	Gawande, AA (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.			Gawande, Atul/0000-0002-1824-9176; Rosenthal, Meredith/0000-0003-3410-0184					0	21	21	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2009	361	15					1421	1423		10.1056/NEJMp0907810	http://dx.doi.org/10.1056/NEJMp0907810			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	503MU	19776398				2022-12-28	WOS:000270540000001
J	Kuijper, B; Tans, JTJ; Beelen, A; Nollet, F; de Visser, M				Kuijper, Barbara; Tans, Jos Th J.; Beelen, Anita; Nollet, Frans; de Visser, Marianne			Cervical collar or physiotherapy versus wait and see policy for recent onset cervical radiculopathy: randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICALLY SIGNIFICANT DIFFERENCE; NECK DISABILITY INDEX; ANALOG SCALE PAIN; RELIABILITY; SEVERITY; VALIDITY; DISCS	Objective To evaluate the effectiveness of treatment with collar or physiotherapy compared with a wait and see policy in recent onset cervical radiculopathy. Design Randomised controlled trial. Setting Neurology outpatient clinics in three Dutch hospitals. Participants 205 patients with symptoms and signs of cervical radiculopathy of less than one month's duration Interventions Treatment with a semi-hard collar and taking rest for three to six weeks; 12 twice weekly sessions of physiotherapy and home exercises for six weeks; or continuation of daily activities as much as possible without specific treatment (control group). Main outcome measures Time course of changes in pain scores for arm and neck pain on a 100 mm visual analogue scale and in the neck disability index during the first six weeks. Results In the wait and see group, arm pain diminished by 3 mm/week on the visual analogue scale (beta=-3.1 mm, 95% confidence interval -4.0 to -2.2 mm) and by 19 mm in total over six weeks. Patients who were treated with cervical collar or physiotherapy achieved additional pain reduction (collar: beta=-1.9 mm, -3.3 to -0.5 mm; physiotherapy: beta=-1.9, -3.3 to -0.8), resulting in an extra pain reduction compared with the control group of 12 mm after six weeks. In the wait and see group, neck pain did not decrease significantly in the first six weeks (beta= -0.9 mm, -2.0 to 0.3). Treatment with the collar resulted in a weekly reduction on the visual analogue scale of 2.8 mm (-4.2 to -1.3), amounting to 17 mm in six weeks, whereas physiotherapy gave a weekly reduction of 2.4 mm (-3.9 to -0.8) resulting in a decrease of 14 mm after six weeks. Compared with a wait and see policy, the neck disability index showed a significant change with the use of the collar and rest (beta=-0.9 mm, -1.6 to -0.1) and a non-significant effect with physiotherapy and home exercises. Conclusion A semi-hard cervical collar and rest for three to six weeks or physiotherapy accompanied by home exercises for six weeks reduced neck and arm pain substantially compared with a wait and see policy in the early phase of cervical radiculopathy.	[Kuijper, Barbara] Maasstad Hosp, Dept Neurol, NL-3078 AC Rotterdam, Netherlands; [Kuijper, Barbara; Tans, Jos Th J.] Med Ctr Haaglanden, Dept Neurol, The Hague, Netherlands; [Beelen, Anita] Univ Amsterdam, Acad Med Ctr, Dept Rehabil, Res Grp, NL-1105 AZ Amsterdam, Netherlands; [de Visser, Marianne] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands	Maasstad Hospital; Haaglanden Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Kuijper, B (corresponding author), Maasstad Hosp, Dept Neurol, POB 9119, NL-3078 AC Rotterdam, Netherlands.	kuijperb@maasstadziekenhuis.nl			Non-profit Foundation, dr Eduard Hoelen Stichting, Wassenaar, Netherlands	Non-profit Foundation, dr Eduard Hoelen Stichting, Wassenaar, Netherlands(Netherlands Government)	The salary for the research nurse was paid by the Non-profit Foundation, dr Eduard Hoelen Stichting, Wassenaar, Netherlands.	Adams C, 1976, HDB CLIN NEUROLOGY 2, V26, P97; Binder AI, 2007, BMJ-BRIT MED J, V334, P527, DOI 10.1136/bmj.39127.608299.80; Bird SB, 2001, ANN EMERG MED, V38, P639, DOI 10.1067/mem.2001.118012; Bush K, 1997, SPINE, V22, P183, DOI 10.1097/00007632-199701150-00009; ELLENBERG MR, 1994, ARCH PHYS MED REHAB, V75, P342, DOI 10.1016/0003-9993(94)90040-X; Heckmann JG, 1999, J SPINAL DISORD, V12, P396; Kelly AM, 1998, ACAD EMERG MED, V5, P1086, DOI 10.1111/j.1553-2712.1998.tb02667.x; Kelly AM, 2001, EMERG MED J, V18, P205, DOI 10.1136/emj.18.3.205; Kuijper B, 2009, EUR J NEUROL, V16, P15, DOI 10.1111/j.1468-1331.2008.02365.x; Mazanec D, 2007, NEUROSURGERY, V60, P43, DOI 10.1227/01.NEU.0000215386.05760.6D; McCarthy MJH, 2007, EUR SPINE J, V16, P2111, DOI 10.1007/s00586-007-0503-y; Nardin RA, 1999, MUSCLE NERVE, V22, P151, DOI 10.1002/(SICI)1097-4598(199902)22:2<151::AID-MUS2>3.0.CO;2-B; NAYLOR JR, 1991, BRIT J RHEUMATOL, V30, P282; Persson L C, 1997, Eur Spine J, V6, P256, DOI 10.1007/BF01322448; Persson LCG, 1997, SPINE, V22, P751, DOI 10.1097/00007632-199704010-00007; Polston DW, 2007, NEUROL CLIN, V25, P373, DOI 10.1016/j.ncl.2007.01.012; RADHAKRISHNAN K, 1994, BRAIN, V117, P325, DOI 10.1093/brain/117.2.325; ROSOMOFF HL, 1992, SPINE, V17, pS362, DOI 10.1097/00007632-199210001-00004; Sengupta DK, 1999, EUR SPINE J, V8, P199, DOI 10.1007/s005860050157; SPURLING RG, 1953, JAMA-J AM MED ASSOC, V151, P354; Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X; Todd KH, 1996, ANN EMERG MED, V27, P439, DOI 10.1016/S0196-0644(96)70226-3; Twisk JWR, 2003, APPL LONGITUDINAL DA; *UK MRC, 1978, 45 MED RES COUNC UK; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vinas FC, 2001, J CLIN NEUROSCI, V8, P542, DOI 10.1054/jocn.2000.0894; 1966, BMJ, V1, P253	27	68	73	0	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 7	2009	339								b3883	10.1136/bmj.b3883	http://dx.doi.org/10.1136/bmj.b3883			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TG	19812130	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000270719200001
J	Garcia-Garcia, L; Valdespino-Gomez, JL; Lazcano-Ponce, E; Jimenez-Corona, A; Higuera-Iglesias, A; Cruz-Hervert, P; Cano-Arellano, B; Garcia-Anaya, A; Ferreira-Guerrero, E; Baez-Saldana, R; Ferreyra-Reyes, L; Ponce-de-Leon-Rosales, S; Alpuche-Aranda, C; Rodriguez-Lopez, MH; Perez-Padilla, R; Hernandez-Avila, M				Garcia-Garcia, Lourdes; Luis Valdespino-Gomez, Jose; Lazcano-Ponce, Eduardo; Jimenez-Corona, Aida; Higuera-Iglesias, Anjarath; Cruz-Hervert, Pablo; Cano-Arellano, Bulmaro; Garcia-Anaya, Antonio; Ferreira-Guerrero, Elizabeth; Baez-Saldana, Renata; Ferreyra-Reyes, Leticia; Ponce-de-Leon-Rosales, Samuel; Alpuche-Aranda, Celia; Henry Rodriguez-Lopez, Mario; Perez-Padilla, Rogelio; Hernandez-Avila, Mauricio			Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; A H1N1 VIRUS; ANTIGENIC MATCH; WORKING ADULTS; CHILDREN; IMMUNOGENICITY; INFECTION; EVOLUTION; HEALTHY; CARE	Objective To evaluate the association of 2008-9 seasonal trivalent inactivated vaccine with cases of influenza A/H1N1 during the epidemic in Mexico. Design Frequency matched case-control study. Setting Specialty hospital in Mexico City, March to May 2009. Participants 60 patients with laboratory confirmed influenza A/H1N1 and 180 controls with other diseases ( not influenza-like illness or pneumonia) living in Mexico City or the State of Mexico and matched for age and socioeconomic status. Main outcome measures Odds ratio and effectiveness of trivalent inactivated vaccine against influenza A/H1N1. Results Cases were more likely than controls to be admitted to hospital, undergo invasive mechanical ventilation, and die. Controls were more likely than cases to have chronic conditions that conferred a higher risk of influenza related complications. In the multivariate model, influenza A/H1N1 was independently associated with trivalent inactivated vaccine ( odds ratio 0.27, 95% confidence interval 0.11 to 0.66) and underlying conditions (0.15, 0.08 to 0.30). Vaccine effectiveness was 73% ( 95% confidence interval 34% to 89%). None of the eight vaccinated cases died. Conclusions Preliminary evidence suggests some protection from the 2008-9 trivalent inactivated vaccine against pandemic influenza A/H1N1 2009, particularly severe forms of the disease, diagnosed in a specialty hospital during the influenza epidemic in Mexico City.	[Luis Valdespino-Gomez, Jose; Ponce-de-Leon-Rosales, Samuel] Labs Biol React Mexico BIRMEX, Mexico City 03100, DF, Mexico; [Garcia-Garcia, Lourdes; Lazcano-Ponce, Eduardo; Jimenez-Corona, Aida; Cruz-Hervert, Pablo; Cano-Arellano, Bulmaro; Garcia-Anaya, Antonio; Ferreira-Guerrero, Elizabeth; Baez-Saldana, Renata; Ferreyra-Reyes, Leticia; Henry Rodriguez-Lopez, Mario] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Higuera-Iglesias, Anjarath; Perez-Padilla, Rogelio] INER, Mexico City, DF, Mexico; [Alpuche-Aranda, Celia] InDRE, Mexico City, DF, Mexico; [Hernandez-Avila, Mauricio] Subsecretariat Hlth Prevent & Promot, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica	Valdespino-Gomez, JL (corresponding author), Labs Biol React Mexico BIRMEX, Amores 1240, Mexico City 03100, DF, Mexico.	jvaldespinog@birmex.gob.mx	Mamelund, Svenn-Erik/Q-3158-2019; Cruz-Hervert, Luis Pablo/AEI-4595-2022; García, Maria de Lourdes/I-2724-2019; Mamelund, Svenn-Erik/G-4495-2016	Mamelund, Svenn-Erik/0000-0002-3980-3818; Cruz-Hervert, Luis Pablo/0000-0002-6094-958X; García, Maria de Lourdes/0000-0001-5262-1157; Mamelund, Svenn-Erik/0000-0002-3980-3818	Mexican Ministry of Health	Mexican Ministry of Health	This study was supported by the Mexican Ministry of Health. The funding source did not influence or participate in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; in writing the manuscript; or in the decision to submit the article for publication. The researchers were independent of the funder. Competing interests: JLV-G and SPdeLR are employed by Laboratorios de Biologicos y Reactivos de Mexico (BIRMEX).	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P185; [Anonymous], MMWR MORB MORTAL WKL; Barraza-Llorens M, 2002, HEALTH AFFAIR, V21, P47, DOI 10.1377/hlthaff.21.3.47; Belongia EA, 2009, J INFECT DIS, V199, P159, DOI 10.1086/595861; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Carrillo-Rodriguez JG, 2000, SALUD PUBLICA MEXICO, V42, P201; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gobierno Federal, MAN VAC 2008 2009; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Herrera GA, 2007, VACCINE, V25, P154, DOI 10.1016/j.vaccine.2006.05.129; Leyva-Flores R, 2001, HEALTH POLICY, V57, P15, DOI 10.1016/S0168-8510(00)00136-6; MOGABGAB WJ, 1970, J AMER MED ASSOC, V211, P1672, DOI 10.1001/jama.211.10.1672; *NAT CTR BIOT INF, 2009, GENBANK SEQ 2009 H1N; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; ORENSTEIN WA, 1988, EPIDEMIOL REV, V10, P212, DOI 10.1093/oxfordjournals.epirev.a036023; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Ritzwoller DP, 2005, PEDIATRICS, V116, P153, DOI 10.1542/peds.2005-0049; Shuler CM, 2007, PEDIATRICS, V119, pE587, DOI 10.1542/peds.2006-1878; Tumpey TM, 2004, P NATL ACAD SCI USA, V101, P3166, DOI 10.1073/pnas.0308391100; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2009, SWIN FLU ILLN US MEX; *WHO, 2009, INFL A H1N1 UPD 58; World Health Organization, WHO REC PAND H1N1 20; World Health Organization, 2009, VACC NEW INFL A H1N1; World Health Organization, 2009, CDC PROT REALT RTPCR; 2009, MMWR MORB MORTAL WKL, V58, P521; 2009, MMWR MORB MORTAL WKL, V58, P585	28	127	132	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2009	339								b3928	10.1136/bmj.b3928	http://dx.doi.org/10.1136/bmj.b3928			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TF	19808768	Green Published, hybrid			2022-12-28	WOS:000270719100006
J	Jiang, DW; Zhao, LL; Clapham, DE				Jiang, Dawei; Zhao, Linlin; Clapham, David E.			Genome-Wide RNAi Screen Identifies Letm1 as a Mitochondrial Ca2+/H+ Antiporter	SCIENCE			English	Article							WOLF-HIRSCHHORN-SYNDROME; PERMEABILITY TRANSITION; CRYSTAL-STRUCTURE; CELL-DEATH; CALCIUM; TRANSPORTER; CHANNEL; CORA	Mitochondria are integral components of cellular calcium (Ca2+) signaling. Calcium stimulates mitochondrial adenosine 5'-triphosphate production, but can also initiate apoptosis. In turn, cytoplasmic Ca2+ concentrations are regulated by mitochondria. Although several transporter and ion-channel mechanisms have been measured in mitochondria, the molecules that govern Ca2+ movement across the inner mitochondrial membrane are unknown. We searched for genes that regulate mitochondrial Ca2+ and H+ concentrations using a genome-wide Drosophila RNA interference (RNAi) screen. The mammalian homolog of one Drosophila gene identified in the screen, Letm1, was found to specifically mediate coupled Ca2+/H+ exchange. RNAi knockdown, overexpression, and liposome reconstitution of the purified Letm1 protein demonstrate that Letm1 is a mitochondrial Ca2+/H+ antiporter.	[Clapham, David E.] Childrens Hosp Boston, Manton Ctr Orphan Dis, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Clapham, DE (corresponding author), Childrens Hosp Boston, Manton Ctr Orphan Dis, Howard Hughes Med Inst, Dept Cardiol, Enders Bldg 1309,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/R-5974-2019; Clapham, David/S-1123-2019	Clapham, David/0000-0002-4459-9428	Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	We thank B. Mathey-Prevot, N. Ramadan, M. Booker, and staff at the Drosophila RNAi Screening Center for assistance with the screen; A. Miyawaki for pericam; R. Tsien for CherryFP; T. Schwarz for the PMK33 vector; R. Kaplan for advice on the proteoliposome study; D. Baker for assistance with Robetta; and G. Krapivinsky, Y. Kirichok, and J. Jin for discussions. D. J. is a recipient of fellowship awards from the Canadian Institutes of Health Research and the Alberta Heritage Foundation for Medical Research.	Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Brookes PS, 2008, NAT CELL BIOL, V10, P1235, DOI 10.1038/ncb1108-1235; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; Dimmer KS, 2008, HUM MOL GENET, V17, P201, DOI 10.1093/hmg/ddm297; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; Giacomello M, 2007, CELL DEATH DIFFER, V14, P1267, DOI 10.1038/sj.cdd.4402147; GUNTER KK, 1994, J BIOENERG BIOMEMBR, V26, P471, DOI 10.1007/BF00762732; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hasegawa A, 2007, HUM MOL GENET, V16, P2061, DOI 10.1093/hmg/ddm154; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Nicholls DG, 2008, BBA-BIOENERGETICS, V1777, P550, DOI 10.1016/j.bbabio.2008.03.014; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Piao L, 2009, CANCER RES, V69, P3397, DOI 10.1158/0008-5472.CAN-08-3235; Ramadan N, 2007, NAT PROTOC, V2, P2245, DOI 10.1038/nprot.2007.250; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rizzuto R, 2000, J PHYSIOL-LONDON, V529, P37, DOI 10.1111/j.1469-7793.2000.00037.x; Schindl R, 2007, BIOPHYS J, V93, P3872, DOI 10.1529/biophysj.107.112318; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Tamai S, 2008, J CELL SCI, V121, P2588, DOI 10.1242/jcs.026625; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556	23	380	384	3	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 2	2009	326	5949					144	147		10.1126/science.1175145	http://dx.doi.org/10.1126/science.1175145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797662	Green Accepted			2022-12-28	WOS:000270355600056
J	Yang, L; Wang, SZ; Blinn, K; Liu, MF; Liu, Z; Cheng, Z; Liu, ML				Yang, Lei; Wang, Shizhong; Blinn, Kevin; Liu, Mingfei; Liu, Ze; Cheng, Zhe; Liu, Meilin			Enhanced Sulfur and Coking Tolerance of a Mixed Ion Conductor for SOFCs: BaZr0.1Ce0.7Y0.2-xYbxO3-delta	SCIENCE			English	Article							OXIDE FUEL-CELL; LOW-TEMPERATURE SOFCS; ANODE; WATER; HYDROCARBONS; OPERATION; OXIDATION; BACEO3	The anode materials that have been developed for solid oxide fuel cells (SOFCs) are vulnerable to deactivation by carbon buildup (coking) from hydrocarbon fuels or by sulfur contamination (poisoning). We report on a mixed ion conductor, BaZr0.1Ce0.7Y0.2-xYbxO3-delta, that allows rapid transport of both protons and oxide ion vacancies. It exhibits high ionic conductivity at relatively low temperatures (500 degrees to 700 degrees C). Its ability to resist deactivation by sulfur and coking appears linked to the mixed conductor's enhanced catalytic activity for sulfur oxidation and hydrocarbon cracking and reforming, as well as enhanced water adsorption capability.	[Yang, Lei; Wang, Shizhong; Blinn, Kevin; Liu, Mingfei; Liu, Ze; Cheng, Zhe; Liu, Meilin] Georgia Inst Technol, Sch Mat Sci & Engn, Ctr Innovat Fuel Cell & Battery Technol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Liu, ML (corresponding author), Georgia Inst Technol, Sch Mat Sci & Engn, Ctr Innovat Fuel Cell & Battery Technol, Atlanta, GA 30332 USA.	meilin.liu@mse.gatech.edu	Shao, Zongping/AAY-8177-2020; Liu, Mingfei/A-4081-2009; Yang, Lei/D-4967-2011; Cheng, Zhe/AAT-5120-2021; Liu, Meilin/E-5782-2010	Liu, Mingfei/0000-0003-4534-5101; Liu, Meilin/0000-0002-6188-2372; Cheng, Zhe/0000-0002-7332-604X	U. S. Department of Energy Basic Energy Science Catalysis Science Program [DE-FG02-06ER15837]	U. S. Department of Energy Basic Energy Science Catalysis Science Program	Supported by U. S. Department of Energy Basic Energy Science Catalysis Science Program grant DE-FG02-06ER15837.	Anedda A, 2003, J PHYS CHEM B, V107, P13661, DOI 10.1021/jp036691d; Atkinson A, 2004, NAT MATER, V3, P17, DOI 10.1038/nmat1040; Chen FZ, 2004, SOLID STATE IONICS, V166, P269, DOI 10.1016/j.ssi.2003.12.004; Crupi V, 2000, J PHYS CHEM A, V104, P11000, DOI [10.1021/jp001736l, 10.1021/jp0017361]; Flytzani-Stephanopoulos M, 2006, SCIENCE, V312, P1508, DOI 10.1126/science.1125684; Hansen JB, 2009, HDB FUEL CELLS FUNDA; Huang YH, 2006, SCIENCE, V312, P254, DOI 10.1126/science.1125877; Katahira K, 2000, SOLID STATE IONICS, V138, P91, DOI 10.1016/S0167-2738(00)00777-3; Kreuer KD, 2003, ANNU REV MATER RES, V33, P333, DOI 10.1146/annurev.matsci.33.022802.091825; Marina OA, 2002, SOLID STATE IONICS, V149, P21, DOI 10.1016/S0167-2738(02)00140-6; Mogensen M, 2003, ANNU REV MATER RES, V33, P321, DOI 10.1146/annurev.matsci.33.022802.092713; Murray EP, 1999, NATURE, V400, P649, DOI 10.1038/23220; Park SD, 2000, NATURE, V404, P265, DOI 10.1038/35005040; Pillai MR, 2008, J POWER SOURCES, V185, P1086, DOI 10.1016/j.jpowsour.2008.07.063; Ratajska-Gadomska B, 2004, J CHEM PHYS, V121, P12583, DOI 10.1063/1.1826051; Ruiz-Morales JC, 2006, NATURE, V439, P568, DOI 10.1038/nature04438; Ryu KH, 1999, SOLID STATE IONICS, V125, P355, DOI 10.1016/S0167-2738(99)00196-4; Singhal SC, 2000, SOLID STATE IONICS, V135, P305, DOI 10.1016/S0167-2738(00)00452-5; Tanner CW, 1996, J ELECTROCHEM SOC, V143, P1386, DOI 10.1149/1.1836647; Tao SW, 2003, NAT MATER, V2, P320, DOI 10.1038/nmat871; Wang JH, 2008, J POWER SOURCES, V176, P23, DOI 10.1016/j.jpowsour.2007.10.025; Wang JH, 2007, ELECTROCHEM COMMUN, V9, P2212, DOI 10.1016/j.elecom.2007.06.022; Yang L, 2008, ADV MATER, V20, P3280, DOI 10.1002/adma.200702762; Zhan ZL, 2005, SCIENCE, V308, P844, DOI 10.1126/science.1109213; Zuo CD, 2006, ADV MATER, V18, P3318, DOI 10.1002/adma.200601366	26	782	799	22	562	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 2	2009	326	5949					126	129		10.1126/science.1174811	http://dx.doi.org/10.1126/science.1174811			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797657				2022-12-28	WOS:000270355600050
J	Gosling, RD; Gesase, S; Mosha, JF; Carneiro, I; Hashim, R; Lemnge, M; Mosha, FW; Greenwood, B; Chandramohan, D				Gosling, Roly D.; Gesase, Samwel; Mosha, Jacklin F.; Carneiro, Ilona; Hashim, Ramadhan; Lemnge, Martha; Mosha, Frank W.; Greenwood, Brian; Chandramohan, Daniel			Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							SULFADOXINE-PYRIMETHAMINE; PLASMODIUM-FALCIPARUM; ROUTINE VACCINATIONS; TANZANIAN INFANTS; CLINICAL MALARIA; RESISTANCE; TRANSMISSION; MEFLOQUINE; CHILDREN; ANEMIA	Background Administration of sulfadoxine-pyrimethamine at times of vaccination-intermittent preventive treatment in infants (IPTi)-is a promising strategy to prevent malaria. However, rising resistance to this combination is a concern. We investigated a shortacting and longacting antimalarial drug as alternative regimens for IPTi. Methods We undertook a double-blind, placebo-controlled trial of IPTi in an area of high resistance to sulfadoxine-pyrimethamine at sites of moderate (n=1280 infants enrolled) and low (n=1139) intensity of malaria transmission in Tanzania. Infants aged 8-16 weeks were randomly assigned in blocks of 16 to sulfadoxine (250 mg) plus pyrimethamine (12.5 mg; n=319 in moderate-transmission and 283 in low-transmission sites), chlorproguanil (15 mg) plus dapsone (18.75 mg; n=317 and 285), mefloquine (125 mg; n=320 and 284), or placebo (n=320 and 284), given at the second and third immunisations for diphtheria, pertussis, and tetanus, and for measles. Research team and child were masked to treatment. Recruitment was stopped early at the low-transmission site because of low malaria incidence. The primary endpoint was protective efficacy against all episodes of clinical malaria at 2-11 months of age. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00158574. Findings All randomly assigned infants were analysed. At the moderate-transmission site, mefloquine had a protective efficacy of 38.1% (95% Cl 11.8-56.5, p=0.008) against clinical malaria in infants aged 2-11 months, but neither sulfadoxine-pyrimethamine (-6.7%, -45.9 to 22.0) nor chlorproguanil-dapsone (10.8%, -24.6 to 36.1) had a protective effect. No regimen had any protective efficacy against anaemia. or hospital admission. Mefloquine caused vomiting in 141 of 1731 (8%) doses given on day 1 (odds ratio vs placebo 5.50, 95% Cl 3.56-8.46). More infants died in the chlorproguanil-dapsone and mefloquine groups (18 and 15, respectively) than in the sulfadoxine-pyrimethamine or placebo groups (eight deaths per group; p=0.05 for difference between chlorproguanil-dapsone and placebo). Interpretation IPTi with a longacting, efficacious drug such as mefloquine can reduce episodes of malaria in infants in a moderate-transmission setting. IPTi with sulfadoxine-pyrimethamine has no benefit in areas of very high resistance to this combination. The appropriateness of IPTi should be measured by the expected incidence of malaria and the efficacy, tolerability, and safety of the drug.	[Gosling, Roly D.] Univ London London Sch Hyg & Trop Med, Dis Control & Vector Biol Unit, Dept Infect & Trop Dis, London WC1E 7HT, England; [Gesase, Samwel; Hashim, Ramadhan; Lemnge, Martha] Tanga Ctr, Natl Inst Med Res, Tanga, Tanzania; [Mosha, Jacklin F.; Mosha, Frank W.] Kilimanjaro Christian Med Coll, Moshi, Tanzania	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research	Gosling, RD (corresponding author), Univ London London Sch Hyg & Trop Med, Dis Control & Vector Biol Unit, Dept Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	Roly.Gosling@gmail.com		Mosha, Jacklin/0000-0001-7940-8903	IPTi Consortium; Gates Malaria Partnership	IPTi Consortium; Gates Malaria Partnership	Funding IPTi Consortium and the Gates Malaria Partnership.	Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Ashley EA, 2006, ANTIMICROB AGENTS CH, V50, P2281, DOI 10.1128/AAC.00040-06; Cairns M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002227; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Gesase S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004569; Grobusch MP, 2007, CURR OPIN INFECT DIS, V20, P613, DOI 10.1097/QCO.0b013e3282f1ae3b; Grobusch MP, 2007, J INFECT DIS, V196, P1595, DOI 10.1086/522160; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Luxemburger C, 1996, ANN TROP PAEDIATR, V16, P281, DOI 10.1080/02724936.1996.11747839; Macete E, 2006, J INFECT DIS, V194, P276, DOI 10.1086/505431; Massaga JJ, 2003, LANCET, V361, P1853, DOI 10.1016/S0140-6736(03)13504-0; Maxwell CA, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-28; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; Mwangi TW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002196; *NBS, 2005, TANZ DEM HLTH SURV 2, P126; Ronn AM, 1996, T ROY SOC TROP MED H, V90, P179, DOI 10.1016/S0035-9203(96)90129-7; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Simpson JA, 1999, CLIN PHARMACOL THER, V66, P472, DOI 10.1016/S0009-9236(99)70010-X; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; Trigg JK, 1997, ACTA TROP, V63, P185, DOI 10.1016/S0001-706X(96)00617-1; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; *WHO, 2009, REP TECHN CONS INT P; *WHO, 2004, US ANT DRUGS 2; *WHO, 2005, MOD IMCI HDB INT MAN; World Health Organization, 2004, REV SAF CHLORPR DAPS; 2008, MED NEWS TODAY   MAR	30	69	70	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2009	374	9700					1521	1532		10.1016/S0140-6736(09)60997-1	http://dx.doi.org/10.1016/S0140-6736(09)60997-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517CS	19765815				2022-12-28	WOS:000271591300031
J	Kawamichi, T; Haneda, T; Kawano, M; Fujita, M				Kawamichi, Takehide; Haneda, Tsuyoshi; Kawano, Masaki; Fujita, Makoto			X-ray observation of a transient hemiaminal trapped in a porous network	NATURE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; COORDINATION NETWORKS; FRAMEWORKS; MECHANISM; ALDOLASE; PORES	X-ray crystallography is the method of choice for the direct structural analysis of crystalline compounds(1). Extending its use to the in situ mapping of chemical transformations could provide valuable insights, as illustrated by time-resolved X-ray crystallography studies(2,3); however, the transient nature of unstable reaction intermediates often poses a significant challenge. It has recently been demonstrated that standard chemical reactions can occur within the pores of porous coordination networks(4-6) and that the robust crystallinity of these networks facilitates in situ X-ray analysis of the adducts and products(7-11). Here we show that such systems even enable X-ray observations of reaction intermediates that are usually transient and non-isolable. Our proof-of-concept demonstration examines the simple and ubiquitous reaction between an amine and an aldehyde, which normally form a very short-lived hemiaminal that then yields the Schiff-base product. The mechanism of this reaction has been exhaustively examined, but the hemiaminal intermediate has only rarely been observed(12-16). We first determine the structure of a porous network with an aromatic amine embedded in it, then diffuse an aldehyde substrate into the material to transform the amine into a hemiaminal intermediate that is kinetically trapped and thus amenable to X-ray analysis, and finally raise the temperature of the system to obtain the imine product and determine its structure. These results establish that porous network materials provide a means of obtaining sequential X-ray-based snapshots of the structural transformations that occur during chemical reactions.	[Kawamichi, Takehide; Haneda, Tsuyoshi; Kawano, Masaki; Fujita, Makoto] Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; [Fujita, Makoto] Japan Sci & Technol Agcy, Bunkyo Ku, Tokyo 1138656, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Kawano, M (corresponding author), Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan.	mkawano@postech.ac.kr; mfujita@appchem.t.u-tokyo.ac.jp	Fujita, Makoto/E-6350-2012	Fujita, Makoto/0000-0001-6105-7340	Japan Science and Technology Agency; KAKENHI; Japan Society for the Promotion of Science, the Global COE Program (Chemistry Innovation through Cooperation of Science and Engineering), MEXT, Japan; Koei Chemical Co. Ltd	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science, the Global COE Program (Chemistry Innovation through Cooperation of Science and Engineering), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Koei Chemical Co. Ltd	This research was supported by the CREST project of the Japan Science and Technology Agency, of which M. F. is the principal investigator, and also in part by KAKENHI, the Japan Society for the Promotion of Science, the Global COE Program ( Chemistry Innovation through Cooperation of Science and Engineering), MEXT, Japan, and Koei Chemical Co. Ltd. This work has been approved by the Photon Factory Program Advisory Committee.	Batten SR, 1998, ANGEW CHEM INT EDIT, V37, P1460, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1460::AID-ANIE1460>3.0.CO;2-Z; Burrows AD, 2008, ANGEW CHEM INT EDIT, V47, P8482, DOI 10.1002/anie.200802908; CHUDEK JA, 1985, J CHEM SOC PERK T 2, P1285, DOI 10.1039/p29850001285; Coppens P, 2005, ACTA CRYSTALLOGR A, V61, P162, DOI 10.1107/S0108767304029551; Costa JS, 2008, EUR J INORG CHEM, P1551, DOI 10.1002/ejic.200800002; Eddaoudi M, 2001, ACCOUNTS CHEM RES, V34, P319, DOI 10.1021/ar000034b; Evans DA, 2002, ANGEW CHEM INT EDIT, V41, P3188, DOI 10.1002/1521-3773(20020902)41:17<3188::AID-ANIE3188>3.0.CO;2-H; FORLANI L, 1984, J CHEM RES-S, P126; Haneda T, 2008, J AM CHEM SOC, V130, P1578, DOI 10.1021/ja7111564; Heine A, 2001, SCIENCE, V294, P369, DOI 10.1126/science.1063601; Hooley RJ, 2007, J AM CHEM SOC, V129, P15330, DOI 10.1021/ja0759343; Iwasawa T, 2007, SCIENCE, V317, P493, DOI 10.1126/science.1143272; Kawamichi T, 2008, ANGEW CHEM INT EDIT, V47, P8030, DOI 10.1002/anie.200802545; Kawano M, 2007, J AM CHEM SOC, V129, P15418, DOI 10.1021/ja0752540; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Lorentzen E, 2005, BIOCHEMISTRY-US, V44, P4222, DOI 10.1021/bi048192o; Moffat K, 2001, CHEM REV, V101, P1569, DOI 10.1021/cr990039q; Ohashi Y, 2008, MODELS, MYSTERIES AND MAGIC OF MOLECULES, P109, DOI 10.1007/978-1-4020-5941-4_5; Thorell S, 2002, J MOL BIOL, V319, P161, DOI 10.1016/S0022-2836(02)00258-9; Wang ZQ, 2009, CHEM SOC REV, V38, P1315, DOI 10.1039/b802258p	20	221	221	2	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					633	635		10.1038/nature08326	http://dx.doi.org/10.1038/nature08326			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	500LH	19794489				2022-12-28	WOS:000270302600036
J	Rochelle, GT				Rochelle, Gary T.			Amine Scrubbing for CO2 Capture	SCIENCE			English	Editorial Material							FLUE-GAS	Amine scrubbing has been used to separate carbon dioxide (CO2) from natural gas and hydrogen since 1930. It is a robust technology and is ready to be tested and used on a larger scale for CO2 capture from coal-fired power plants. The minimum work requirement to separate CO2 from coal-fired flue gas and compress CO2 to 150 bar is 0.11 megawatt-hours per metric ton of CO2. Process and solvent improvements should reduce the energy consumption to 0.2 megawatt-hour per ton of CO2. Other advanced technologies will not provide energy-efficient or timely solutions to CO2 emission from conventional coal-fired power plants.	Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Rochelle, GT (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	gtr@che.utexas.edu						ARNOLD DS, 1982, OIL GAS J, V80, P130; Bottoms R.R., 1930, United States Patent, Patent No. 1783901; DANIEL F, 1991, IE7365 EL POW RES I; Davis J. D., 2009, THESIS U TEXAS AUSTI; Fisher KS, 2007, DEFG0206ER84625; Lichtfers U, 2007, PCT Int. Appl., Patent No. [WO 2007068695 A1 20070621, 2007068695]; National Air Pollution Control Administration, 1970, LIM LIM WET SCRUBB S; Nonhebel G, 1936, T FARADAY SOC, V32, P1291, DOI 10.1039/tf9363201291; Oyenekan B. A., 2007, THESIS U TEXAS AUSTI; Ramezan M., 2007, CHEM ENG PROG, V401; REDDY S, 2003, 2 NAT C CARB SEQ NET; ROCHELLE G, 2009, 5 TRONDH C CO2 CAPT; Sexton A. J., 2008, THESIS U TEXAS AUSTI; STCLAIR JH, 1983, OIL GAS J, V81, P109; *US EPA, 1973, P FLUE GAS DES S 197; 2009, CARBON CAPTURE  0526; [No title captured]	17	2918	3030	73	1285	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1652	1654		10.1126/science.1176731	http://dx.doi.org/10.1126/science.1176731			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779188				2022-12-28	WOS:000270131800032
J	Fernandez, HF; Sun, ZX; Yao, XP; Litzow, MR; Luger, SM; Paietta, EM; Racevskis, J; Dewald, GW; Ketterling, RP; Bennett, JM; Rowe, JM; Lazarus, HM; Tallman, MS				Fernandez, Hugo F.; Sun, Zhuoxin; Yao, Xiaopan; Litzow, Mark R.; Luger, Selina M.; Paietta, Elisabeth M.; Racevskis, Janis; Dewald, Gordon W.; Ketterling, Rhett P.; Bennett, John M.; Rowe, Jacob M.; Lazarus, Hillard M.; Tallman, Martin S.			Anthracycline Dose Intensification in Acute Myeloid Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE NONLYMPHOCYTIC LEUKEMIA; ACUTE MYELOCYTIC-LEUKEMIA; UNTREATED ADULT PATIENTS; CYTOSINE-ARABINOSIDE; INDUCTION CHEMOTHERAPY; REMISSION INDUCTION; DAUNORUBICIN; CYTARABINE; THERAPY; CONSOLIDATION	Background In young adults with acute myeloid leukemia (AML), intensification of the anthracycline dose during induction therapy has improved the rate of complete remission but not of overall survival. We evaluated the use of cytarabine plus either standard-dose or high-dose daunorubicin as induction therapy, followed by intensive consolidation therapy, in inducing complete remission to improve overall survival. Methods In this phase 3 randomized trial, we assigned 657 patients between the ages of 17 and 60 years who had untreated AML to receive three once-daily doses of daunorubicin at either the standard dose (45 mg per square meter of body-surface area) or a high dose (90 mg per square meter), combined with seven daily doses of cytarabine (100 mg per square meter) by continuous intravenous infusion. Patients who had a complete remission were offered either allogeneic hematopoietic stem-cell transplantation or high-dose cytarabine, with or without a single dose of the monoclonal antibody gemtuzumab ozogamicin, followed by autologous stem-cell transplantation. The primary end point was overall survival. Results In the intention-to-treat analysis, high-dose daunorubicin, as compared with a standard dose of the drug, resulted in a higher rate of complete remission (70.6% vs. 57.3%, P<0.001) and improved overall survival (median, 23.7 vs. 15.7 months; P = 0.003). The rates of serious adverse events were similar in the two groups. Median follow-up was 25.2 months. Conclusions In young adults with AML, intensifying induction therapy with a high daily dose of daunorubicin improved the rate of complete remission and the duration of overall survival, as compared with the standard dose. (ClinicalTrials.gov number, NCT00049517.)	[Fernandez, Hugo F.] Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat, Tampa, FL 33612 USA; [Sun, Zhuoxin; Yao, Xiaopan] Dana Farber Canc Inst, Boston, MA 02115 USA; [Litzow, Mark R.; Dewald, Gordon W.; Ketterling, Rhett P.] Mayo Clin, Rochester, MN USA; [Luger, Selina M.] Univ Penn, Philadelphia, PA 19104 USA; [Paietta, Elisabeth M.; Racevskis, Janis] Montefiore Med Ctr, North Div, Bronx, NY 10467 USA; [Bennett, John M.] Univ Rochester, Rochester, NY USA; [Rowe, Jacob M.] Rambam Med Ctr, Haifa, Israel; [Lazarus, Hillard M.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Tallman, Martin S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Harvard University; Dana-Farber Cancer Institute; Mayo Clinic; University of Pennsylvania; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Rochester; Rambam Health Care Campus; Technion Israel Institute of Technology; Case Western Reserve University; Case Western Reserve University Hospital; Northwestern University; Feinberg School of Medicine	Fernandez, HF (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat, 12902 Magnolia Dr,Rm 3116, Tampa, FL 33612 USA.	hugo.fernandez@moffitt.org		Ketterling, Rhett/0000-0001-6479-7897	Public Health Service [CA23318, CA66636, CA21115, CA13650, CA15488, CA17145, CA14548]; National Cancer Institute and the Department of Health and Human Services; Wyeth Pharmaceuticals and Immunex; NATIONAL CANCER INSTITUTE [U10CA015488, U10CA011083, U10CA023318, U10CA066636, U10CA013650, U10CA073590, U10CA021115, U10CA014548, U10CA017145, U24CA114737, U10CA014958] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute and the Department of Health and Human Services; Wyeth Pharmaceuticals and Immunex; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported in part by grants from the Public Health Service (CA23318, CA66636, CA21115, CA13650, CA15488, CA17145, and CA14548) and from the National Cancer Institute and the Department of Health and Human Services. Funding for laboratory correlative studies was provided by Wyeth Pharmaceuticals and Immunex through a grant to the ECOG.	APPELBAUM FR, 1984, ANN INTERN MED, V101, P581, DOI 10.7326/0003-4819-101-5-581; ARLIN Z, 1990, LEUKEMIA, V4, P177; Bennett JM, 1997, CANCER, V80, P2205; Bishop JF, 1998, LEUKEMIA LYMPHOMA, V28, P315, DOI 10.3109/10428199809092687; BUCHNER T, 1985, J CLIN ONCOL, V3, P1583; Cassileth PA, 2005, LEUKEMIA LYMPHOMA, V46, P55, DOI 10.1080/10428190412331283288; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Jaffe ES, 2001, WHO CLASSIFICATION T; Kolitz JE, 2004, J CLIN ONCOL, V22, P4290, DOI 10.1200/JCO.2004.11.106; MAYER RJ, 1994, NEW ENGL J MED, V331, P896, DOI 10.1056/NEJM199410063311402; Noguera N, 2002, LEUKEMIA, V16, P2185, DOI 10.1038/sj.leu.2402723; PREISLER H, 1987, BLOOD, V69, P1441; RAI KR, 1981, BLOOD, V58, P1203; Rowe JM, 1997, BLOOD, V90, P2121; ROWE JM, 1995, BLOOD, V86, P457, DOI 10.1182/blood.V86.2.457.bloodjournal862457; SCHILLER G, 1992, BRIT J HAEMATOL, V81, P170, DOI 10.1111/j.1365-2141.1992.tb08203.x; SCHILLER G, 1992, BLOOD, V80, P2977; Schnittger S, 2000, LEUKEMIA, V14, P796, DOI 10.1038/sj.leu.2401773; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; van Dongen JJM, 1999, LEUKEMIA, V13, P1901, DOI 10.1038/sj.leu.2401592; Vance GH, 2007, LEUKEMIA RES, V31, P605, DOI 10.1016/j.leukres.2006.07.026; Weick JK, 1996, BLOOD, V88, P2841, DOI 10.1182/blood.V88.8.2841.bloodjournal8882841; Wheatley D, 1998, BRIT J HAEMATOL, V103, P100; WIERNIK PH, 1992, BLOOD, V79, P313; Willman CL, 1996, LEUKEMIA, V10, pS33; YATES J, 1982, BLOOD, V60, P454	26	642	671	4	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2009	361	13					1249	1259		10.1056/NEJMoa0904544	http://dx.doi.org/10.1056/NEJMoa0904544			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497RN	19776406	Green Accepted			2022-12-28	WOS:000270078700006
J	Monto, AS; Ohmit, SE; Petrie, JG; Johnson, E; Truscon, R; Teich, E; Rotthoff, J; Boulton, M; Victor, JC				Monto, Arnold S.; Ohmit, Suzanne E.; Petrie, Joshua G.; Johnson, Emileigh; Truscon, Rachel; Teich, Esther; Rotthoff, Judy; Boulton, Matthew; Victor, John C.			Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SEASONAL INFLUENZA; WORKING ADULTS; VIRUS VACCINE; IMMUNOGENICITY; PREVENTION; CHILDREN; SAFETY; TRIVALENT; HEALTHY	Background The efficacy of influenza vaccines may vary from year to year, depending on a variety of factors, and may differ for inactivated and live attenuated vaccines. Methods We carried out a randomized, double-blind, placebo-controlled trial of licensed inactivated and live attenuated influenza vaccines in healthy adults during the 2007-2008 influenza season and estimated the absolute and relative efficacies of the two vaccines. Results A total of 1952 subjects were enrolled and received study vaccines in the fall of 2007. Influenza activity occurred from January through April 2008, with the circulation of influenza types A (H3N2) ( about 90%) and B (about 9%). Absolute efficacy against both types of influenza, as measured by isolating the virus in culture, identifying it on real-time polymerase-chain-reaction assay, or both, was 68% (95% confidence interval [CI], 46 to 81) for the inactivated vaccine and 36% (95% CI, 0 to 59) for the live attenuated vaccine. In terms of relative efficacy, there was a 50% (95% CI, 20 to 69) reduction in laboratory-confirmed influenza among subjects who received inactivated vaccine as compared with those given live attenuated vaccine. The absolute efficacy against the influenza A virus was 72% ( 95% CI, 49 to 84) for the inactivated vaccine and 29% (95% CI, -14 to 55) for the live attenuated vaccine, with a relative efficacy of 60% (95% CI, 33 to 77) for the inactivated vaccine. Conclusions In the 2007-2008 season, the inactivated vaccine was efficacious in preventing laboratory-confirmed symptomatic influenza A (predominately H3N2) in healthy adults. The live attenuated vaccine also prevented influenza illnesses but was less efficacious. (ClinicalTrials. gov number, NCT00538512.)	[Monto, Arnold S.; Ohmit, Suzanne E.; Petrie, Joshua G.; Johnson, Emileigh; Truscon, Rachel; Teich, Esther; Rotthoff, Judy; Boulton, Matthew] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Victor, John C.] PATH, Seattle, WA USA	University of Michigan System; University of Michigan	Monto, AS (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, 109 S Observ St,M5156 SPH 2, Ann Arbor, MI 48109 USA.	asmonto@umich.edu		Victor, John/0000-0002-7970-6588; Boulton, Matthew/0000-0002-0565-9010	Sanofi Pasteur	Sanofi Pasteur	Dr. Monto reports receiving consulting fees from GlaxoSmithKline, Novartis, and Baxter, lecture fees from Sanofi Pasteur and GlaxoSmithKline, and grant support from Sanofi Pasteur; and Dr. Ohmit, Mr. Petrie, Ms. Johnson, Ms. Truscon, Ms. Teich, and Ms. Rotthoff, grant support from Sanofi Pasteur. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P173; Bernstein DI, 2008, J INFECT DIS, V197, P667, DOI 10.1086/527489; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; *CDCP, 2009, CDC VACC PRIC LIST V; Centers for Disease Control and P, 2008, INFL ACT US WORLDW 2, P692; Couch RB, 2007, VACCINE, V25, P7656, DOI 10.1016/j.vaccine.2007.08.042; Davenport F M, 1973, Med J Aust, V1, P33; EDWARDS KM, 1994, J INFECT DIS, V169, P68, DOI 10.1093/infdis/169.1.68; Fiore AE., 2008, PREVENTION CONTROL I; Fleming DM, 2006, PEDIATR INFECT DIS J, V25, P860, DOI 10.1097/01.inf.0000237797.14283.cf; Gorse GJ, 2004, J INFECT DIS, V190, P11, DOI 10.1086/421121; Jackson LA, 2009, J INFECT DIS, V199, P917; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; Ohmit SE, 2008, J INFECT DIS, V198, P312, DOI 10.1086/589885; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Walter EB, 2006, PEDIATRICS, V118, pE570, DOI 10.1542/peds.2006-0198; 2007, WKLY EPIDEMIOL REC, V82, P351; 2005, WKLY EPIDEMIOL REC, V80, P71; 2009, MMWR MORB MORTAL WKL, V58, P521	24	204	223	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2009	361	13					1260	1267		10.1056/NEJMoa0808652	http://dx.doi.org/10.1056/NEJMoa0808652			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497RN	19776407				2022-12-28	WOS:000270078700007
J	Fisher, CE				Fisher, Carl Erik			Manipulation and the Match	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIRECTORS; PROGRAM					cf2141@columbia.edu						Anderson, 2000, Curr Surg, V57, P460, DOI 10.1016/S0149-7944(00)00309-3; Anderson KD, 1999, AM J SURG, V177, P237, DOI 10.1016/S0002-9610(99)00019-7; Carek PJ, 2000, FAM MED, V32, P258; Miller FH, 2003, JAMA-J AM MED ASSOC, V289, P913, DOI 10.1001/jama.289.7.913; Opel D, 2007, PEDIATRICS, V120, pE826, DOI 10.1542/peds.2006-3189; Roth AE, 2003, JAMA-J AM MED ASSOC, V289, P909, DOI 10.1001/jama.289.7.909; Shetty SK, 2006, ACAD RADIOL, V13, P121, DOI 10.1016/j.acra.2005.09.085	7	15	15	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1266	1267		10.1001/jama.2009.1388	http://dx.doi.org/10.1001/jama.2009.1388			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497AR	19773557				2022-12-28	WOS:000270026000001
J	Young, JQ; Wachter, RM				Young, John Q.; Wachter, Robert M.			Academic Year-End Transfers of Outpatients From Outgoing to Incoming Residents An Unaddressed Patient Safety Issue	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SIGN-OUT; CARE; COMMUNICATION; CONSEQUENCES; STRATEGIES		[Young, John Q.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Wachter, Robert M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Young, JQ (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	jqyoung@lppi.ucsf.edu	Young, John Q./L-5916-2019	Young, John Q./0000-0003-2219-5657	NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060482] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arora V, 2005, QUAL SAF HEALTH CARE, V14, P401, DOI 10.1136/qshc.2005.015107; Arora V, 2006, JT COMM J QUAL PATIE, V32, P646, DOI 10.1016/S1553-7250(06)32084-3; Arora VM, 2008, MED CLIN N AM, V92, P315, DOI 10.1016/j.mcna.2007.11.002; Boockvar K, 2004, ARCH INTERN MED, V164, P545, DOI 10.1001/archinte.164.5.545; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Horwitz LI, 2008, ARCH INTERN MED, V168, P1755, DOI 10.1001/archinte.168.16.1755; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Mischoulon D, 2000, ACAD PSYCHIATR, V24, P156, DOI 10.1176/appi.ap.24.3.156; Patterson ES, 2004, INT J QUAL HEALTH C, V16, P125, DOI 10.1093/intqhc/mzh026; Roy MJ, 2003, J GEN INTERN MED, V18, P364, DOI 10.1046/j.1525-1497.2003.20747.x; Salsberg E, 2008, JAMA-J AM MED ASSOC, V300, P1174, DOI 10.1001/jama.300.10.1174; Scalise D, 2006, HOSP HEALTH NETWORK, V80, P40; Sinha M, 2007, ACAD EMERG MED, V14, P192, DOI 10.1197/j.aem.2006.09.048; Vidyarthi AR, 2006, J HOSP MED, V1, P257, DOI 10.1002/jhm.103; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487	15	35	35	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1327	1329		10.1001/jama.2009.1399	http://dx.doi.org/10.1001/jama.2009.1399			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	497AR	19773568				2022-12-28	WOS:000270026000015
J	Norden, C; Young, S; Link, BA; Harris, WA				Norden, Caren; Young, Stephen; Link, Brian A.; Harris, William A.			Actomyosin Is the Main Driver of Interkinetic Nuclear Migration in the Retina	CELL			English	Article							NEUROEPITHELIAL CELLS; IN-VIVO; DIVISION; BINDING; PHOSPHORYLATION; NEUROGENESIS; ZEBRAFISH; MOVEMENT; DYNAMICS; MOTILITY	Progenitor cell nuclei in the rapidly expanding epithelium of the embryonic vertebrate central nervous system undergo a process called interkinetic nuclear migration (IKNM). Movements of IKNM are generally believed to involve smooth migration of nuclei from apical to basal and back during the G1 and G2 phases of the cell cycle, respectively. Yet, this has not been formally demonstrated, nor have the molecular mechanisms that drive IKNM been identified. Using time-lapse confocal microscopy to observe nuclear movements in zebrafish retinal neuroepithelial cells, we show that, except for brief apical nuclear translocations preceding mitosis, IKNM is stochastic rather than smooth and directed. We also show that IKNM is driven largely by actomyosin-dependent forces as it still occurs when the microtubule cytoskeleton is compromised but is blocked when MyosinII activity is inhibited.	[Norden, Caren; Young, Stephen; Harris, William A.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; [Link, Brian A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	University of Cambridge; Medical College of Wisconsin	Harris, WA (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.	harris@mole.bio.cam.ac.uk	Norden, Caren/I-3918-2014	Norden, Caren/0000-0001-8835-1451	European Molecular Biology Organization; Human Frontier Science Program; Wellcome Trust; NATIONAL EYE INSTITUTE [R01EY014167] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We would like to thank J. C. Bulinski, N. Galjart, V. Lecaudey, C. J. Wilkinson, W. M. Bements, and H. Hosoya for sharing constructs and morpholinos. J. Skepper and A. Sossick are thanked for help with electron and confocal microscopy, and A. McNabb and G. Stooke- Vaughan for help with fish maintenance and cloning. We are grateful to J. Sanes for discussing the manuscript. S. Y. would like to thank G. B. Blanchard and A. J. Kabla for advice on data analysis, and R. J. Adams for encouraging him to pursue the collaboration. C. N. was supported by the European Molecular Biology Organization and a Human Frontier Science Program long- term fellowship. S. Y. is a member of the Wellcome Trust PhD program in developmental biology. B. A. L. is supported by the National Institutes of Health. This work was supported by a Wellcome Trust Programme Grant to W. A. H. C. N. designed and performed the experiments, measured all trajectories, made all figures and wrote the manuscript. S. Y. designed and implemented the trajectory analysis, prepared graphs and contributed to the manuscript. B. L. made and supplied constructs, helped designing experiments, and contributed to figures and the manuscript. W. A. H conceived the study, helped in designing experiments, and wrote the manuscript together with C. N.	Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; BRESNICK AR, 1995, BIOCHEMISTRY-US, V34, P12576, DOI 10.1021/bi00039a012; Bulinski JC, 1999, CELL STRUCT FUNCT, V24, P313; Burkel BM, 2007, CELL MOTIL CYTOSKEL, V64, P822, DOI 10.1002/cm.20226; Carlier MF, 1998, CURR OPIN CELL BIOL, V10, P45, DOI 10.1016/S0955-0674(98)80085-9; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; CRAMER LP, 1995, J CELL BIOL, V131, P179, DOI 10.1083/jcb.131.1.179; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; GOLDMAN RD, 1971, J CELL BIOL, V51, P752, DOI 10.1083/jcb.51.3.752; Huet S, 2006, BIOPHYS J, V91, P3542, DOI 10.1529/biophysj.105.080622; Iwasaki T, 2001, CELL STRUCT FUNCT, V26, P677, DOI 10.1247/csf.26.677; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kusch J, 2003, TRENDS CELL BIOL, V13, P562, DOI 10.1016/j.tcb.2003.09.008; Miyata T, 2008, DEV GROWTH DIFFER, V50, pS105, DOI 10.1111/j.1440-169x.2007.00980.x; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; Nowakowski R.S., 2005, DEV NEUROBIOL, P21; Owens DF, 1998, J NEUROSCI, V18, P5374, DOI 10.1523/JNEUROSCI.18-14-05374.1998; Pearson RA, 2005, J NEUROSCI, V25, P10803, DOI 10.1523/JNEUROSCI.2312-05.2005; Poggi L, 2005, J CELL BIOL, V171, P991, DOI 10.1083/jcb.200509098; R Core Team, 2020, R LANG ENV STAT COMP; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Stepanova T, 2003, J NEUROSCI, V23, P2655; TAKEMURA R, 1992, J CELL SCI, V103, P953; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Vaughan PS, 2001, J BIOL CHEM, V276, P26171, DOI 10.1074/jbc.M102649200; WEBSTER W, 1978, AM J ANAT, V152, P209, DOI 10.1002/aja.1001520204; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026	31	182	182	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1195	1208		10.1016/j.cell.2009.06.032	http://dx.doi.org/10.1016/j.cell.2009.06.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766571	hybrid, Green Published			2022-12-28	WOS:000269923200019
J	Santarius, T; Kirkpatrick, PJ; Ganesan, D; Chia, HL; Jalloh, I; Smielewski, P; Richards, HK; Marcus, H; Parker, RA; Price, SJ; Kirollos, RW; Pickard, JD; Hutchinson, PJ				Santarius, Thomas; Kirkpatrick, Peter J.; Ganesan, Dharmendra; Chia, Hui Ling; Jalloh, Ibrahim; Smielewski, Peter; Richards, Hugh K.; Marcus, Hani; Parker, Richard A.; Price, Stephen J.; Kirollos, Ramez W.; Pickard, John D.; Hutchinson, Peter J.			Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial	LANCET			English	Article							CLOSED-SYSTEM DRAINAGE; MANAGEMENT; RECURRENCE; SURGERY	Background Chronic subdural haematoma causes serious morbidity and mortality. It recurs after surgical evacuation in 5-30% of patients. Drains might reduce recurrence but are not used routinely. Our aim was to investigate the effect of drains on recurrence rates and clinical outcomes. Methods We did a randomised controlled trial at one UK centre between November, 2004, and November, 2007. 269 patients aged 18 years and older with a chronic subdural haematoma for burr-hole drainage were assessed for eligibility 108 were randomly assigned by block randomisation to receive a drain inserted into the subdural space and 107 to no drain after evacuation. The primary endpoint was recurrence needing redrainage. The trial was stopped early because of a significant benefit in reduction of recurrence. Analyses were done on an intention-to-treat basis. This study is registered with the International Standard Randomised Controlled Trial Register (ISRCTN 97314294). Findings Recurrence occurred in ten of 108 (9.3%) people with a drain, and 26 of 107 (24%) without (p=0003; 95% CI 0.14-0.70). At 6 months mortality was nine of 105 (8.6%) and 19 of 105 (18.1%), respectively (p=0.042; 95% CI 0.1-0.99). Medical and surgical complications were much the same between the study groups. Interpretation Use of a drain after burr-hole drainage of chronic subdural haematoma is safe and associated with reduced recurrence and mortality at 6 months. Funding Academy of Medical Sciences, Health Foundation, and NIHR Biomedical Research Centre (Neurosciences Theme).	[Santarius, Thomas; Kirkpatrick, Peter J.; Ganesan, Dharmendra; Chia, Hui Ling; Jalloh, Ibrahim; Smielewski, Peter; Richards, Hugh K.; Marcus, Hani; Price, Stephen J.; Kirollos, Ramez W.; Pickard, John D.; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Neurosurg, Cambridge CB2 2QQ, England; [Parker, Richard A.] Univ Cambridge, Ctr Appl Med Stat, Dept Publ Hlth & Primary Care, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Hutchinson, PJ (corresponding author), Addenbrookes Hosp, Acad Dept Neurosurg, Hills Rd, Cambridge CB2 0QQ, England.	pjah2@cam.ac.uk	GANESAN, DHARMENDRA/B-8437-2010; Price, Stephen J/B-1068-2011; Ganesan, Dharmendra/D-6001-2011; Marcus, Hani/E-2885-2013	GANESAN, DHARMENDRA/0000-0003-1595-3659; Price, Stephen J/0000-0002-7535-3009; Smielewski, Peter/0000-0001-5096-3938; Santarius, Thomas/0000-0002-1416-9566	Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; Medical Research Council [G9439390, G0600986, G0001237] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10327] Funding Source: researchfish; MRC [G0001237, G0600986, G9439390] Funding Source: UKRI	Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the registrars of the Department of Neurosurgery at Addenbrooke's Hospital, Cambridge-Adel Helmy, Damian Holliman, Nicole Keong, Richard Mannion, Chris Schwindack, Ivan Timofeev, Rikin Trivedi, Martin Wilby, and Martin Wood-for their help with recruitment patients to the trial. PJH is supported by an Academy of Medical Sciences/Health Foundation Senior Surgical Scientist Fellowship.	Banks JL, 2007, STROKE, V38, P1091, DOI 10.1161/01.STR.0000258355.23810.c6; Cenic A, 2005, CAN J NEUROL SCI, V32, P501, DOI 10.1017/S0317167100004510; Dunn LT, 2003, J NEUROL NEUROSUR PS, V74, P842, DOI 10.1136/jnnp.74.7.842; Kinsella K, 2001, US CENSUS BUREAU SER, VP95/01-1; KUDO H, 1992, Neurologia Medico-Chirurgica, V32, P207, DOI 10.2176/nmc.32.207; Kuroki T, 2001, ACTA NEUROCHIR, V143, P1041, DOI 10.1007/s007010170010; LAUMER R, 1989, NEUROSURGERY, V25, P991, DOI 10.1227/00006123-198912000-00026; Lind CRP, 2003, J NEUROSURG, V99, P44, DOI 10.3171/jns.2003.99.1.0044; MARKWALDER TM, 1981, J NEUROSURG, V55, P390, DOI 10.3171/jns.1981.55.3.0390; MARKWALDER TM, 1985, NEUROSURGERY, V16, P185, DOI 10.1227/00006123-198502000-00010; MCKISSOCK W, 1960, LANCET, V1, P1365; Mori K, 2001, NEUROL MED-CHIR, V41, P371, DOI 10.2176/nmc.41.371; POCOCK SJ, 1992, BMJ-BRIT MED J, V305, P235, DOI 10.1136/bmj.305.6847.235; Ramachandran R, 2007, SURG NEUROL, V67, P367, DOI 10.1016/j.surneu.2006.07.022; Saghaei Mahmood, 2004, BMC Med Res Methodol, V4, P26, DOI 10.1186/1471-2288-4-26; Santarius T, 2008, BRIT J NEUROSURG, V22, P529, DOI 10.1080/02688690802195381; Santarius T, 2004, BRIT J NEUROSURG, V18, P328, DOI 10.1080/02688690400004845; SCOTTI G, 1977, J NEUROSURG, V47, P311, DOI 10.3171/jns.1977.47.3.0311; Tsutsumi K, 1997, J NEUROSURG, V87, P870, DOI 10.3171/jns.1997.87.6.0870; WAKAI S, 1990, NEUROSURGERY, V26, P771, DOI 10.1227/00006123-199005000-00006; Weigel R, 2003, J NEUROL NEUROSUR PS, V74, P937, DOI 10.1136/jnnp.74.7.937	21	370	384	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2009	374	9695					1067	1073		10.1016/S0140-6736(09)61115-6	http://dx.doi.org/10.1016/S0140-6736(09)61115-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501HA	19782872				2022-12-28	WOS:000270370900028
J	Horton, R				Horton, Richard			What will it take to stop maternal deaths?	LANCET			English	Editorial Material							CHILD SURVIVAL; MORTALITY; HEALTH; STRATEGIES; NEWBORN; CARE		The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chopra M, 2009, LANCET, V374, P835, DOI 10.1016/S0140-6736(09)61123-5; Chowdhury ME, 2007, LANCET, V370, P1320, DOI 10.1016/S0140-6736(07)61573-6; Costello A, 2005, LANCET, V366, P603, DOI 10.1016/S0140-6736(05)66703-7; Costello A, 2006, LANCET, V368, P1477, DOI 10.1016/S0140-6736(06)69388-4; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Greco G, 2008, LANCET, V371, P1268, DOI 10.1016/S0140-6736(08)60561-9; KEBER KJ, 2007, LANCET, V340, P1358; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Pagel C, 2009, LANCET, V374, P1441, DOI 10.1016/S0140-6736(09)61566-X; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; *UNICEF, 2008, COUNTD 2015 MAT NEWB; United Nations, 2009, MILL DEV GOALS REP 2	15	20	20	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 24	2009	374	9699					1400	1402		10.1016/S0140-6736(09)61669-X	http://dx.doi.org/10.1016/S0140-6736(09)61669-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	512MZ	19783292				2022-12-28	WOS:000271255000007
J	Sunshine, JM; Farnham, TL; Feaga, LM; Groussin, O; Merlin, F; Milliken, RE; A'Hearn, MF				Sunshine, Jessica M.; Farnham, Tony L.; Feaga, Lori M.; Groussin, Olivier; Merlin, Frederic; Milliken, Ralph E.; A'Hearn, Michael F.			Temporal and Spatial Variability of Lunar Hydration As Observed by the Deep Impact Spacecraft	SCIENCE			English	Article							SPECTRAL PROPERTIES; WATER; MONTMORILLONITE; MIXTURES; MINERALS	The Moon is generally anhydrous, yet the Deep Impact spacecraft found the entire surface to be hydrated during some portions of the day. Hydroxyl (OH) and water (H2O) absorptions in the near infrared were strongest near the North Pole and are consistent with <0.5 weight percent H2O. Hydration varied with temperature, rather than cumulative solar radiation, but no inherent absorptivity differences with composition were observed. However, comparisons between data collected 1 week (a quarter lunar day) apart show a dynamic process with diurnal changes in hydration that were greater for mare basalts (similar to 70%) than for highlands (similar to 50%). This hydration loss and return to a steady state occurred entirely between local morning and evening, requiring a ready daytime source of water-group ions, which is consistent with a solar wind origin.	[Sunshine, Jessica M.; Farnham, Tony L.; Feaga, Lori M.; Merlin, Frederic; A'Hearn, Michael F.] Univ Maryland, College Pk, MD 20742 USA; [Groussin, Olivier] Lab Astrophys Marseille, F-13388 Marseille, France; [Milliken, Ralph E.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University System of Maryland; University of Maryland College Park; UDICE-French Research Universities; Aix-Marseille Universite; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Sunshine, JM (corresponding author), Univ Maryland, College Pk, MD 20742 USA.	jess@astro.umd.edu	Callahan, Charles D/L-1641-2013	Feaga, Lori/0000-0002-4230-6759; Sunshine, Jessica/0000-0002-9413-8785	NASA Discovery Program [NNM07AA99C, NNG06GJ31G]	NASA Discovery Program(National Aeronautics & Space Administration (NASA))	EPOXI, the Deep Impact extended mission, is supported by the NASA Discovery Program under contract NNM07AA99C to the University of Maryland. The Deep Impact spacecraft and HRI-IR instrument were built by Ball Aerospace. We gratefully acknowledge the efforts and support of the EPOXI project team at the Jet Propulsion Laboratory in acquiring the data presented here and the continuing work of members of the EPOXI science team in improving the instrument calibration. Laboratory spectra of lunar soils were acquired with the NASA/Keck RELAB, a multi-user facility supported by NASA grant NNG06GJ31G. We also thank R. Clark for discussions on the spectral interpretations of the 3-mm feature and L. McFadden for comments that improved this manuscript.	BISHOP JL, 1994, CLAY CLAY MINER, V42, P702, DOI 10.1346/CCMN.1994.0420606; CLARK RN, 1983, J GEOPHYS RES, V88, P635, DOI 10.1029/JB088iB12p10635; CLARK RN, 1984, J GEOPHYS RES, V89, P6341, DOI 10.1029/JB089iB07p06341; Clark RN, 2009, SCIENCE, V326, P562, DOI 10.1126/science.1178105; Crider DH, 2002, ADV SPACE RES, V30, P1869, DOI 10.1016/S0273-1177(02)00493-3; Farmer V.C., 1974, INFRARED SPECTRA MIN, V4; GLOECKLER G, 2008, EOS T AGU, V89; Groussin O, 2007, ICARUS, V187, P16, DOI 10.1016/j.icarus.2006.08.030; Hampton DL, 2005, SPACE SCI REV, V117, P43, DOI 10.1007/s11214-005-3390-8; HAPKE B, 1983, THEORY REFLECTANCE E; Jouglet D, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002846; Milliken RE, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002853; Milliken RE, 2007, ICARUS, V189, P550, DOI 10.1016/j.icarus.2007.02.017; MILLIKEN RE, 2006, THESIS BROWN U; Pieters CM, 2009, SCIENCE, V326, P568, DOI 10.1126/science.1178658; Rivkin AS, 2003, METEORIT PLANET SCI, V38, P1383, DOI 10.1111/j.1945-5100.2003.tb00321.x; SINTON WM, 1967, ICARUS, V6, P222, DOI 10.1016/0019-1035(67)90018-8	17	289	300	4	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					565	568		10.1126/science.1179788	http://dx.doi.org/10.1126/science.1179788			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19779149				2022-12-28	WOS:000271019400039
J	Eroglu, C; Allen, NJ; Susman, MW; O'Rourke, NA; Park, CY; Ozkan, E; Chakraborty, C; Mulinyawe, SB; Annis, DS; Huberman, AD; Green, EM; Lawler, J; Dolmetsch, R; Garcia, KC; Smith, SJ; Luo, ZD; Rosenthal, A; Mosher, DF; Barres, BA				Eroglu, Cagla; Allen, Nicola J.; Susman, Michael W.; O'Rourke, Nancy A.; Park, Chan Young; Oezkan, Engin; Chakraborty, Chandrani; Mulinyawe, Sara B.; Annis, Douglas S.; Huberman, Andrew D.; Green, Eric M.; Lawler, Jack; Dolmetsch, Ricardo; Garcia, K. Christopher; Smith, Stephen J.; Luo, Z. David; Rosenthal, Arnon; Mosher, Deane F.; Barres, Ben A.			Gabapentin Receptor alpha 2 delta-1 Is a Neuronal Thrombospondin Receptor Responsible for Excitatory CNS Synaptogenesis	CELL			English	Article							CALCIUM-CHANNEL; ALPHA(2)DELTA SUBUNIT; NERVOUS-SYSTEM; RAT; GLUTAMATE; SYNAPSES; DOMAINS; BINDING; TARGET; BRAIN	Synapses are asymmetric cellular adhesions that are critical for nervous system development and function, but the mechanisms that induce their formation are not well understood. We have previously identified thrombospondin as an astrocyte-secreted protein that promotes central nervous system (CNS) synaptogenesis. Here, we identify the neuronal thrombospondin receptor involved in CNS synapse formation as alpha 2 delta-1, the receptor for the anti-epileptic and analgesic drug gabapentin. We show that the VWF-A domain of alpha 2 delta-1 interacts with the epidermal growth factor-like repeats common to all thrombospondins. alpha 2 delta-1 overexpression increases synaptogenesis in vitro and in vivo and is required postsynaptically for thrombospondin-and astrocyte-induced synapse formation in vitro. Gabapentin antagonizes thrombospondin binding to alpha 2 delta-1 and powerfully inhibits excitatory synapse formation in vitro and in vivo. These findings identify alpha 2 delta-1 as a receptor involved in excitatory synapse formation and suggest that gabapentin may function therapeutically by blocking new synapse formation.	[Eroglu, Cagla] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Eroglu, Cagla; Allen, Nicola J.; Susman, Michael W.; Park, Chan Young; Chakraborty, Chandrani; Mulinyawe, Sara B.; Huberman, Andrew D.; Green, Eric M.; Dolmetsch, Ricardo; Barres, Ben A.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [O'Rourke, Nancy A.; Oezkan, Engin; Garcia, K. Christopher; Smith, Stephen J.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Biol Struct, Stanford, CA 94305 USA; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Med Sci Ctr, Dept Med, Madison, WI 53706 USA; [Luo, Z. David] Univ Calif Irvine, Med Ctr, Dept Anesthesiol & Perioperat Care, Orange, CA 92868 USA; [Luo, Z. David] Univ Calif Irvine, Med Ctr, Dept Pharmacol, Orange, CA 92868 USA; [Lawler, Jack] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Rosenthal, Arnon] MazoRx Inc, Redwood City, CA 94061 USA	Duke University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Irvine; University of California System; University of California Irvine; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Eroglu, C (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	c.eroglu@cellbio.duke.edu	Eroglu, Cagla/P-5315-2014; Tuluc, Petronel/C-2527-2011; Park, Chan Young/F-5696-2010; Lawler, Jack/AAJ-1379-2020	Eroglu, Cagla/0000-0002-7204-0218; Park, Chan Young/0000-0002-5183-3665; Ozkan, Engin/0000-0002-0263-6729; Smith, Stephen/0000-0002-2290-8701; Green, Eric/0000-0001-7874-9482	National Institute of Drug Addiction [DA15043]; National Heart, Lung and Blood Institute [HL49081]; National Institute of Neurological Disorders and Stroke; National Institute of Dental and Craniofacial Research [NS40135, DE14545]; Human Frontiers Scientific Program long-term fellowships; Helen Hay Whitney postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE014545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015043, R01DA015043] Funding Source: NIH RePORTER	National Institute of Drug Addiction; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Human Frontiers Scientific Program long-term fellowships; Helen Hay Whitney postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Maria L. Fabian, Navid Nouri, and Mark Duquette for excellent technical assistance, and Beth Stevens, Junryo Watanabe, and Alissa Winzeler for critical reading of the manuscript. This work was supported by grants from the National Institute of Drug Addiction (DA15043 to B. A. B.), the National Heart, Lung and Blood Institute (HL49081 to J.L.), and the National Institute of Neurological Disorders and Stroke and National Institute of Dental and Craniofacial Research (NS40135 and DE14545 to Z.D.L.). C. E. and N.J.A. were supported by the Human Frontiers Scientific Program long-term fellowships and A. D. H by the Helen Hay Whitney postdoctoral fellowship. Arnon Rosenthal is founder and president of MazoRx Inc.	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Annis DS, 2007, J BIOL CHEM, V282, P27067, DOI 10.1074/jbc.M703804200; Annis DS, 2006, J THROMB HAEMOST, V4, P459, DOI 10.1111/j.1538-7836.2006.01723.x; ARBER S, 1995, J CELL BIOL, V131, P1083, DOI 10.1083/jcb.131.4.1083; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; BORK P, 1991, BIOCHEM J, V279, P908, DOI 10.1042/bj2790908; Bornstein P, 2004, INT J BIOCHEM CELL B, V36, P1115, DOI 10.1016/j.biocel.2004.01.012; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cole RL, 2005, J COMP NEUROL, V491, P246, DOI 10.1002/cne.20693; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Dickman DK, 2008, J NEUROSCI, V28, P31, DOI 10.1523/JNEUROSCI.4498-07.2008; Dooley DJ, 2007, TRENDS PHARMACOL SCI, V28, P75, DOI 10.1016/j.tips.2006.12.006; Eroglu Cagla, 2008, P683, DOI 10.1007/978-0-387-77232-5_23; Erzurumlu RS, 2006, ANAT REC PART A, V288A, P121, DOI 10.1002/ar.a.20285; Field MJ, 2006, P NATL ACAD SCI USA, V103, P17537, DOI 10.1073/pnas.0409066103; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Garcia K, 2007, J PHYSL, V586, P727; Gee NS, 1996, J BIOL CHEM, V271, P5768, DOI 10.1074/jbc.271.10.5768; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; Kaltenbach LS, 2007, PLOS GENET, V3, P689, DOI 10.1371/journal.pgen.0030082; Klugbauer N, 2003, J BIOENERG BIOMEMBR, V35, P639, DOI 10.1023/B:JOBB.0000008028.41056.58; Kurshan PT, 2009, NAT NEUROSCI, V12, P1415, DOI 10.1038/nn.2417; Li CY, 2006, PAIN, V125, P20, DOI 10.1016/j.pain.2006.04.022; Li CY, 2004, J NEUROSCI, V24, P8494, DOI 10.1523/JNEUROSCI.2982-04.2004; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lin TN, 2003, STROKE, V34, P177, DOI 10.1161/01.STR.0000047100.84604.BA; Liu L, 2000, EXP BRAIN RES, V131, P64, DOI 10.1007/s002219900273; Lohmann C, 2008, NEURON, V59, P253, DOI 10.1016/j.neuron.2008.05.025; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Nakamura K, 2005, J COMP NEUROL, V492, P263, DOI 10.1002/cne.20705; Pluskota E, 2005, BLOOD, V106, P3970, DOI 10.1182/blood-2005-03-1292; Prince D A, 1999, Adv Neurol, V79, P665; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; SUMANCHAUHAN N, 1993, EUR J PHARM-MOLEC PH, V244, P293, DOI 10.1016/0922-4106(93)90155-3; Traa BS, 2008, PEDIATR RES, V64, P81, DOI 10.1203/PDR.0b013e318174e70e; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; Valder CR, 2003, J NEUROCHEM, V87, P560, DOI 10.1046/j.1471-4159.2003.02016.x; Wang H, 2002, NEUROSCIENCE, V114, P529, DOI 10.1016/S0306-4522(02)00341-X; Wang MH, 1999, BIOCHEM J, V342, P313, DOI 10.1042/0264-6021:3420313; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wierenga CJ, 2008, NAT NEUROSCI, V11, P1044, DOI 10.1038/nn.2180; Wilkins JA, 1996, J BIOL CHEM, V271, P3046, DOI 10.1074/jbc.271.6.3046; Wycisk KA, 2006, INVEST OPHTH VIS SCI, V47, P3523, DOI 10.1167/iovs.06-0271	48	575	590	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 16	2009	139	2					380	392		10.1016/j.cell.2009.09.025	http://dx.doi.org/10.1016/j.cell.2009.09.025			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	507MI	19818485	Green Accepted, Bronze			2022-12-28	WOS:000270857500020
J	Freeman, R; Block, F; Greenberg, D; Levi, M; Segal, AM; Crow, M; Teitelbaum, MS				Freeman, Richard; Block, Fred; Greenberg, Daniel; Levi, Michael; Segal, Adam M.; Crow, Michael; Teitelbaum, Michael S.			Is the stimulus working for you?	NATURE			English	Editorial Material									[Block, Fred] Univ Calif Davis, Dept Sociol, Davis, CA 95616 USA; [Crow, Michael] Arizona State Univ, Tempe, AZ 85287 USA; [Teitelbaum, Michael S.] Alfred P Sloan Fdn, New York, NY USA	University of California System; University of California Davis; Arizona State University; Arizona State University-Tempe					Economic and Social Research Council [RES-107-28-1001] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 15	2009	461	7266					876	878		10.1038/461876a	http://dx.doi.org/10.1038/461876a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	506ZF	19829353				2022-12-28	WOS:000270817700020
J	Gray, N; Chouard, T				Gray, Noah; Chouard, Tanguy			NEUROTECHNIQUES	NATURE			English	Editorial Material														Gray, Noah/0000-0002-4672-7403					0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 15	2009	461	7266					899	899		10.1038/461899a	http://dx.doi.org/10.1038/461899a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829368	Bronze			2022-12-28	WOS:000270817700033
J	Kendall, M; Murray, SA; Carduff, E; Worth, A; Harris, F; Lloyd, A; Cavers, D; Grant, L; Boyd, K; Sheikh, A				Kendall, Marilyn; Murray, Scott A.; Carduff, Emma; Worth, Allison; Harris, Fiona; Lloyd, Anna; Cavers, Debbie; Grant, Liz; Boyd, Kirsty; Sheikh, Aziz			Use of multiperspective qualitative interviews to understand patients' and carers' beliefs, experiences, and needs	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PALLIATIVE CARE; ILL PATIENTS; CANCER; FAMILY; FAILURE		[Murray, Scott A.; Grant, Liz; Boyd, Kirsty; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Gen Practice Sect, Edinburgh EH8 9DX, Midlothian, Scotland	University of Edinburgh		Marilyn.Kendall@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Boyd, Kirsty/0000-0002-5526-1078; Grant, Liz/0000-0001-7248-7792; Harris, Fiona/0000-0003-3258-5624	Department of Health Funding Source: Medline; Chief Scientist Office Funding Source: Medline	Department of Health; Chief Scientist Office		Akeson N, 2007, CLIN EXP ALLERGY, V37, P1213, DOI 10.1111/j.1365-2222.2007.02758.x; Back AL, 2002, ARCH INTERN MED, V162, P1257, DOI 10.1001/archinte.162.11.1257; Clayton JA, 2005, J PAIN SYMPTOM MANAG, V30, P132, DOI 10.1016/j.jpainsymman.2005.02.014; Dixon-Woods M, 2008, MED LAW INT, V9, P131, DOI [DOI 10.1177/096853320800900203, 10.1177/096853320800900203]; Forrest G, 2006, BMJ-BRIT MED J, V332, P998, DOI 10.1136/bmj.38793.567801.AE; Grant Elizabeth, 2004, Palliat Support Care, V2, P371; Gysels Marjolein, 2008, BMC Med Ethics, V9, P7, DOI 10.1186/1472-6939-9-7; Harden JK, 2006, CANCER NURS, V29, P367, DOI 10.1097/00002820-200609000-00004; Jaarsma T, 2009, EUR J HEART FAIL, V11, P433, DOI 10.1093/eurjhf/hfp041; Johnson M, 2006, HEART FAILURE PALLIA; Kirk P, 2004, BMJ-BRIT MED J, V328, P1343, DOI 10.1136/bmj.38103.423576.55; Lewis F M, 1995, Oncol Nurs Forum, V22, P943; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; MURRAY SA, 2003, PROGR PALLIATIVE CAR, V11, P321; Murray Sa, 2007, PATIENTS CARERS PROF; Murray SA, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3702; PRATT R, 2002, PERSPECTIVES PEOPLE; Schumacher KL, 2006, ADV NURS SCI, V29, P271, DOI 10.1097/00012272-200607000-00009; Steinhauser KE, 2006, PALLIATIVE MED, V20, P745, DOI 10.1177/0269216306073112; Woodgate RL, 2004, J ADV NURS, V46, P358, DOI 10.1111/j.1365-2648.2004.03002.x; Worth A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b183; Yin R.K., 2017, APPL CASE STUDY RES	22	90	89	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 14	2009	339								b4122	10.1136/bmj.b4122	http://dx.doi.org/10.1136/bmj.b4122			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	508DP	19828645	Green Submitted			2022-12-28	WOS:000270908200005
J	Shah, SP; Morin, RD; Khattra, J; Prentice, L; Pugh, T; Burleigh, A; Delaney, A; Gelmon, K; Guliany, R; Senz, J; Steidl, C; Holt, RA; Jones, S; Sun, M; Leung, G; Moore, R; Severson, T; Taylor, GA; Teschendorff, AE; Tse, K; Turashvili, G; Varhol, R; Warren, RL; Watson, P; Zhao, YJ; Caldas, C; Huntsman, D; Hirst, M; Marra, MA; Aparicio, S				Shah, Sohrab P.; Morin, Ryan D.; Khattra, Jaswinder; Prentice, Leah; Pugh, Trevor; Burleigh, Angela; Delaney, Allen; Gelmon, Karen; Guliany, Ryan; Senz, Janine; Steidl, Christian; Holt, Robert A.; Jones, Steven; Sun, Mark; Leung, Gillian; Moore, Richard; Severson, Tesa; Taylor, Greg A.; Teschendorff, Andrew E.; Tse, Kane; Turashvili, Gulisa; Varhol, Richard; Warren, Rene L.; Watson, Peter; Zhao, Yongjun; Caldas, Carlos; Huntsman, David; Hirst, Martin; Marra, Marco A.; Aparicio, Samuel			Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution	NATURE			English	Article							GENOME; IDENTIFICATION	Recent advances in next generation sequencing(1-4) have made it possible to precisely characterize all somatic coding mutations that occur during the development and progression of individual cancers. Here we used these approaches to sequence the genomes (>43-fold coverage) and transcriptomes of an oestrogen-receptor-apositive metastatic lobular breast cancer at depth. We found 32 somatic non-synonymous coding mutations present in the metastasis, and measured the frequency of these somatic mutations in DNA from the primary tumour of the same patient, which arose 9 years earlier. Five of the 32 mutations (in ABCB11, HAUS3, SLC24A4, SNX4 and PALB2) were prevalent in the DNA of the primary tumour removed at diagnosis 9 years earlier, six ( in KIF1C, USP28, MYH8, MORC1, KIAA1468 and RNASEH2A) were present at lower frequencies (1-13%), 19 were not detected in the primary tumour, and two were undetermined. The combined analysis of genome and transcriptome data revealed two new RNA-editing events that recode the amino acid sequence of SRP9 and COG3. Taken together, our data show that single nucleotide mutational heterogeneity can be a property of low or intermediate grade primary breast cancers and that significant evolution can occur with disease progression.	[Morin, Ryan D.; Pugh, Trevor; Delaney, Allen; Holt, Robert A.; Jones, Steven; Moore, Richard; Severson, Tesa; Taylor, Greg A.; Varhol, Richard; Warren, Rene L.; Zhao, Yongjun; Hirst, Martin; Marra, Marco A.] British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Shah, Sohrab P.; Senz, Janine; Steidl, Christian; Huntsman, David; Aparicio, Samuel] British Columbia Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC V5Z 1L3, Canada; [Steidl, Christian; Huntsman, David; Aparicio, Samuel] Univ British Columbia, Dept Pathol, Vancouver, BC V6T 2B5, Canada; [Teschendorff, Andrew E.; Caldas, Carlos] Li Ka Shing Ctr, Cambridge Res Inst, Canc Res UK, Cambridge CB2 0RE, England; [Watson, Peter] BC Canc Agcy, Deeley Res Ctr, Victoria, BC V8R 6V5, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; British Columbia Cancer Agency	Marra, MA (corresponding author), British Columbia Canc Agcy, Michael Smith Genome Sci Ctr, 675 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	mmarra@bcgsc.ca; saparicio@bccrc.ca	Holt, Robert A/C-3303-2009; Hirst, Martin/B-7684-2016; Morin, Ryan/AAE-7824-2019; Jones, Steven J/C-3621-2009; Caldas, Carlos/A-7543-2008; Pugh, Trevor/Y-2535-2019; Huntsman, David/ABE-6082-2020; Caldas, Carlos/U-7250-2019; Turashvili, Gulisa/A-6056-2008; Marra, Marco A/B-5987-2008; Warren, Rene/R-7681-2016	Holt, Robert A/0000-0002-7259-1247; Morin, Ryan/0000-0003-2932-7800; Jones, Steven J/0000-0003-3394-2208; Pugh, Trevor/0000-0002-8073-5888; Caldas, Carlos/0000-0003-3547-1489; Marra, Marco A/0000-0001-7146-7175; Watson, Peter/0000-0002-1642-0638; Turashvili, Gulisa/0000-0001-6125-5865; Aparicio, Samuel/0000-0002-0487-9599; Warren, Rene/0000-0002-9890-2293	Michael Smith Foundation for Health Research; Vanier scholar (CIHR); NSERC; Canada Foundation for Innovation; BC Cancer Foundation	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Vanier scholar (CIHR)(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); BC Cancer Foundation	We thank C. Eaves and M. Pollak for comments on earlier versions of the manuscript. We thank and acknowledge the patients of the BC Cancer Agency for donations of tumour tissues to the TTR-BREAST tumour banking program. S. A. is supported by a Canada Research Chair in Molecular Oncology, S. P. S., J. K., L. P., A. B. and T. P. are supported by Michael Smith Foundation for Health Research awards. R. D. M. is a Vanier scholar (CIHR). A. B. is also supported by an NSERC award, and L. P. by a CIHR award. We are grateful for platform support from CIHR, Genome Canada, Genome BC, Canada Foundation for Innovation and the Michael Smith Foundation for Health Research. The work was funded by the BC Cancer Foundation and the CBCF BC/Yukon chapter.	Athanasiadis A, 2004, PLOS BIOL, V2, P2144, DOI 10.1371/journal.pbio.0020391; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blow M, 2004, GENOME RES, V14, P2379, DOI 10.1101/gr.2951204; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Lawo S, 2009, CURR BIOL, V19, P816, DOI 10.1016/j.cub.2009.04.033; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li JB, 2009, SCIENCE, V324, P1210, DOI 10.1126/science.1170995; Maas Stefan, 2006, RNA Biol, V3, P1; Meireles M, 2009, J CELL BIOL, V184, P777, DOI 10.1083/jcb.200811102; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pauklin S, 2009, J EXP MED, V206, P99, DOI 10.1084/jem.20080521; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	19	852	895	1	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					809	U67		10.1038/nature08489	http://dx.doi.org/10.1038/nature08489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19812674	hybrid			2022-12-28	WOS:000270547500039
J	Manzoni, P; Rinaldi, M; Cattani, S; Pugni, L; Romeo, MG; Messner, H; Stolfi, I; Decembrino, L; Laforgia, N; Vagnarelli, F; Memo, L; Bordignon, L; Saia, OS; Maule, M; Gallo, E; Mostert, M; Magnani, C; Quercia, M; Bollani, L; Pedicino, R; Renzullo, L; Betta, P; Mosca, F; Ferrari, F; Magaldi, R; Stronati, M; Farina, D				Manzoni, Paolo; Rinaldi, Matteo; Cattani, Silvia; Pugni, Lorenza; Romeo, Mario Giovanni; Messner, Hubert; Stolfi, Ilaria; Decembrino, Lidia; Laforgia, Nicola; Vagnarelli, Federica; Memo, Luigi; Bordignon, Linda; Saia, Onofrio Sergio; Maule, Milena; Gallo, Elena; Mostert, Michael; Magnani, Cristiana; Quercia, Michele; Bollani, Lina; Pedicino, Roberto; Renzullo, Livia; Betta, Pasqua; Mosca, Fabio; Ferrari, Fabrizio; Magaldi, Rosario; Stronati, Mauro; Farina, Daniele		Italian Task Force Study & Prevent; Italian Soc Neonatology	Bovine Lactoferrin Supplementation for Prevention of Late-Onset Sepsis in Very Low-Birth-Weight Neonates A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-MILK PROTEINS; INFANTS; MODULATION; INFECTIONS; IMMUNITY; PEPTIDE; DEFENSE; MICE	Context Sepsis is a common and severe complication in premature neonates, particularly those with very low birth weight (VLBW) (<1500 g). Whether lactoferrin, a mammalian milk glycoprotein involved in innate immune host defenses, can reduce the incidence of sepsis is unknown. In animal models, the probiotic Lactobacillus rhamnosus GG (LGG) enhances the activity of lactoferrin but has not been studied in human infants. Objective To establish whether bovine lactoferrin (BLF), alone or in combination with LGG, reduces the incidence of late-onset sepsis in VLBW neonates. Design, Setting, and Patients Prospective, multicenter, double-blind, placebo-controlled, randomized trial conducted in 11 Italian tertiary neonatal intensive care units. Patients were 472 VLBW infants enrolled from October 1, 2007, through July 31, 2008, and assessed until discharge for development of sepsis. Intervention Infants were randomly assigned to receive orally administered BLF (100 mg/d) alone (n = 153), BLF plus LGG (6 x 10(9) colony-forming units/d) (n = 151), or placebo (n = 168) from birth until day 30 of life (day 45 for neonates <1000 g at birth). Main Outcome Measure First episode of late-onset sepsis, ie, sepsis occurring more than 72 hours after birth with isolation of any pathogen from blood or from peritoneal or cerebrospinal fluid. Results Demographic, clinical, and management characteristics of the 3 groups were similar, including type of feeding and intake of maternal milk. Incidence of late-onset sepsis was significantly lower in the BLF and BLF plus LGG groups (9/153 [5.9%] and 7/151 [4.6%], respectively) than in the control group receiving placebo (29/168 [17.3%]) (risk ratio, 0.34; 95% confidence interval, 0.17-0.70; P = .002 for BLF vs control and risk ratio, 0.27; 95% confidence interval, 0.12-0.60; P < .001 for BLF plus LGG vs control). The decrease occurred for both bacterial and fungal sepsis. No adverse effects or intolerances to treatment occurred. Conclusion Compared with placebo, BLF supplementation alone or in combination with LGG reduced the incidence of a first episode of late-onset sepsis in VLBW neonates. Trial Registration isrctn.org Identifier: ISRCTN53107700 JAMA. 2009; 302(13): 1421-1428	[Manzoni, Paolo; Gallo, Elena; Farina, Daniele] St Anna Hosp, Neonatal Intens Care Unit, Turin, Italy; [Rinaldi, Matteo; Magaldi, Rosario] Osped Riuniti Foggia, NICU, Foggia, Italy; [Cattani, Silvia; Ferrari, Fabrizio] Univ Modena, NICU, I-41100 Modena, Italy; [Pugni, Lorenza; Mosca, Fabio] IRCCS Mangiagalli Hosp, NICU, Milan, Italy; [Romeo, Mario Giovanni; Betta, Pasqua] Azienda Osped Univ Policlin, NICU, Catania, Italy; [Messner, Hubert; Renzullo, Livia] Osped Regionale, NICU, Bolzano, Italy; [Stolfi, Ilaria; Pedicino, Roberto] Policlin Umberto 1, NICU, Rome, Italy; [Decembrino, Lidia; Bollani, Lina; Stronati, Mauro] IRCCS San Matteo, NICU, Pavia, Italy; [Laforgia, Nicola; Quercia, Michele] Policlin Univ Hosp, NICU, Bari, Italy; [Vagnarelli, Federica; Magnani, Cristiana] Arcispedale SM Nuova, NICU, Reggio Emilia, Italy; [Memo, Luigi; Bordignon, Linda; Saia, Onofrio Sergio] Ca Foncello Hosp, NICU, Treviso, Italy; [Maule, Milena] Univ Turin, Dept Biomed Sci, Turin, Italy; [Maule, Milena] Univ Turin, Canc Epidemiol Unit, Dept Human Oncol, Turin, Italy; [Mostert, Michael] Univ Turin, Dept Pediat, I-10124 Turin, Italy	A.O.U. Citta della Salute e della Scienza di Torino; University of Ferrara; Arcispedale Sant'Anna; Universita di Modena e Reggio Emilia; University of Catania; Sapienza University Rome; University Hospital Sapienza Rome; IRCCS Fondazione San Matteo; Universita degli Studi di Bari Aldo Moro; IRCCS Arcispedale S. Maria Nuova; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; University of Turin; University of Turin; University of Turin	Manzoni, P (corresponding author), Azienda Osped Regina Margherita S Anna, S Anna Hosp, Neonatol & Neonatal Intens Care Unit, C Spezia 60, I-10126 Turin, Italy.	paolomanzoni@hotmail.com	Ferrari, Fabrizio/F-5980-2012; Maule, Milena M/K-3858-2018; Decembrino, Lidia/AAC-3477-2021; Mosca, Fabio/C-5826-2017; Laforgia, Nicola/T-4088-2019; Borghesi, Alessandro/K-8157-2016; Tzialla, Chryssoula/GYU-0266-2022	Ferrari, Fabrizio/0000-0001-6504-4715; Maule, Milena M/0000-0003-2142-1288; Mosca, Fabio/0000-0001-6477-0299; Laforgia, Nicola/0000-0002-4610-1216; Borghesi, Alessandro/0000-0002-8773-9144; Tzialla, Chryssoula/0000-0002-6040-2381; Stronati, Mauro/0000-0002-8367-3264; decembrino, lidia/0000-0002-6272-8668	Dicofarm SpA	Dicofarm SpA	Dicofarm SpA supported this study with a grant and supplied the drugs and placebo used in the study.	Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Berlutti F, 2006, BIOCHEM CELL BIOL, V84, P351, DOI 10.1139/O06-039; Bhimani RS, 1999, J APPL MICROBIOL, V86, P135, DOI 10.1046/j.1365-2672.1999.00644.x; BORTNER CA, 1989, CAN J MICROBIOL, V35, P1048, DOI 10.1139/m89-174; Buccigrossi V, 2007, PEDIATR RES, V61, P410, DOI 10.1203/pdr.0b013e3180332c8d; *CFSAN OFF FOOD AD, 000077 GRAS GRN CFSA; DAVIDSON LA, 1987, ACTA PAEDIATR SCAND, V76, P733, DOI 10.1111/j.1651-2227.1987.tb10557.x; de Ferrer PAR, 2000, J AM COLL NUTR, V19, P370; Farnaud S, 2003, MOL IMMUNOL, V40, P395, DOI 10.1016/S0161-5890(03)00152-4; Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Good WV, 2005, PEDIATRICS, V116, P15, DOI 10.1542/peds.2004-1413; HIRAI Y, 1990, J NUTR SCI VITAMINOL, V36, P531, DOI 10.3177/jnsv.36.531; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kaufman D, 2004, CLIN MICROBIOL REV, V17, P638, DOI 10.1128/CMR.17.3.638-680.2004; KAWAKAMI H, 1991, AM J PHYSIOL, V261, pG841, DOI 10.1152/ajpgi.1991.261.5.G841; Kuipers ME, 1999, ANTIMICROB AGENTS CH, V43, P2635, DOI 10.1128/AAC.43.11.2635; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; Lupetti A, 2003, ANTIMICROB AGENTS CH, V47, P262, DOI 10.1128/AAC.47.1.262-267.2003; Manzoni P, 2006, CLIN INFECT DIS, V42, P1735, DOI 10.1086/504324; Manzoni P, 2004, Pediatr Med Chir, V26, P89; Murray P. R., 2003, Manual of clinical microbiology: Volumes 1 and 2; [NCCLS]National Committee for Clinical Laboratory Standards, 1997, M27A NCCLS; Orsi N, 2004, BIOMETALS, V17, P189, DOI 10.1023/B:BIOM.0000027691.86757.e2; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Schanler RJ, 2005, PEDIATRICS, V116, P400, DOI 10.1542/peds.2004-1974; Sherman MP, 2004, BIOMETALS, V17, P285, DOI 10.1023/B:BIOM.0000027706.51112.62; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Tsubota A, 2008, J HEPATOL, V48, P486, DOI 10.1016/j.jhep.2007.11.013; Venkatesh MP, 2007, ADV THER, V24, P941, DOI 10.1007/BF02877698; Wakabayashi H, 2006, CLIN VACCINE IMMUNOL, V13, P239, DOI 10.1128/CVI.13.2.239-245.2006; Ward PP, 2002, BIOCHEM CELL BIOL, V80, P95, DOI 10.1139/o01-214; Zuccotti GV, 2007, INT J ANTIMICROB AG, V29, P353, DOI 10.1016/j.ijantimicag.2006.11.017	35	361	382	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	2009	302	13					1421	1428		10.1001/jama.2009.1403	http://dx.doi.org/10.1001/jama.2009.1403			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503CL	19809023	Bronze			2022-12-28	WOS:000270509600016
J	Piot, P; Garnett, G				Piot, Peter; Garnett, Geoff			Health is global	LANCET			English	Editorial Material							DISEASES		[Piot, Peter; Garnett, Geoff] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth, London SW1 1NA, England	Imperial College London	Piot, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth, London SW1 1NA, England.	p.piot@imperial.ac.uk	Garnett, Geoffrey P/A-9312-2008		Medical Research Council [G0600719B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Adli M, 2009, LANCET, V373, P519, DOI 10.1016/S0140-6736(09)60177-X; COPLAND JP, 2009, LANCET, V373, P1993; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Daar AS, 2009, SCIENCE, V324, P1642, DOI 10.1126/science.324_1642; HM Government, 2008, HLTH IS GLOB UK GOV; *I MED, 2009, US COMM GLOB HLTH RE; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Merson M.H., 2009, DRAMATIC EXPANSION U; Weber K., 2009, GENERATION WE MILLEN	9	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2009	374	9696					1122	1123		10.1016/S0140-6736(09)61724-4	http://dx.doi.org/10.1016/S0140-6736(09)61724-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505IZ	19801081				2022-12-28	WOS:000270688200005
J	Wuebbles, DJ				Wuebbles, Donald J.			Nitrous Oxide: No Laughing Matter	SCIENCE			English	Editorial Material									Univ Illinois, Dept Atmospher Sci, Sch Earth Soc & Environm, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Wuebbles, DJ (corresponding author), Univ Illinois, Dept Atmospher Sci, Sch Earth Soc & Environm, 105 S Gregory Ave, Urbana, IL 61801 USA.	wuebbles@illinois.edu						Garcia RR, 2008, J ATMOS SCI, V65, P2731, DOI 10.1175/2008JAS2712.1; LI Y, 2005, THESIS U ILLINOIS UR; Newman PA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025232; Ravishankara A. R., 2009, Science (Washington), V326, P123, DOI 10.1126/science.1176985; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; *WORLD MET ORG, 2007, 50 WORLD MET ORG; Wuebbles DJ, 2002, EARTH-SCI REV, V57, P177, DOI 10.1016/S0012-8252(01)00062-9; WUEBBLES DJ, 2004, OZONE, P177	8	168	184	4	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					56	57		10.1126/science.1179571	http://dx.doi.org/10.1126/science.1179571			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797649				2022-12-28	WOS:000270355600030
J	Macrakis, K				Macrakis, Kristie			Science and the Stasi	NATURE			English	Editorial Material									Georgia Inst Technol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology	Macrakis, K (corresponding author), Georgia Inst Technol, Atlanta, GA 30332 USA.	macrakis@gatech.edu							0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 1	2009	461	7264					594	595		10.1038/461594a	http://dx.doi.org/10.1038/461594a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	500LH	19794475				2022-12-28	WOS:000270302600018
J	Stevens, B; Feingold, G				Stevens, Bjorn; Feingold, Graham			Untangling aerosol effects on clouds and precipitation in a buffered system	NATURE			English	Review							LARGE-EDDY SIMULATIONS; SHALLOW CUMULUS; EFFECTIVE-RADIUS; WATER CLOUDS; STRATOCUMULUS; CLIMATE; ALBEDO; DRIZZLE; RAIN; PARAMETERIZATION	It is thought that changes in the concentration of cloud-active aerosol can alter the precipitation efficiency of clouds, thereby changing cloud amount and, hence, the radiative forcing of the climate system. Despite decades of research, it has proved frustratingly difficult to establish climatically meaningful relationships among the aerosol, clouds and precipitation. As a result, the climatic effect of the aerosol remains controversial. We propose that the difficulty in untangling relationships among the aerosol, clouds and precipitation reflects the inadequacy of existing tools and methodologies and a failure to account for processes that buffer cloud and precipitation responses to aerosol perturbations.	[Stevens, Bjorn] Max Planck Inst Meteorol, D-20251 Hamburg, Germany; [Stevens, Bjorn] Univ Calif Los Angeles, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA; [Feingold, Graham] NOAA, Earth Syst Res Lab, Div Chem Sci, Boulder, CO 80305 USA	Max Planck Society; University of California System; University of California Los Angeles; National Oceanic Atmospheric Admin (NOAA) - USA	Stevens, B (corresponding author), Max Planck Inst Meteorol, KlimaCampus, D-20251 Hamburg, Germany.	bjorn.stevens@zmaw.de	feingold, graham/B-6152-2009; feingold, graham/AAQ-2010-2020; Stevens, Bjorn/A-1757-2013	feingold, graham/0000-0002-0774-2926; feingold, graham/0000-0002-0774-2926; Stevens, Bjorn/0000-0003-3795-0475				Ackerman AS, 2004, NATURE, V432, P1014, DOI 10.1038/nature03174; Ackerman AS, 2000, SCIENCE, V288, P1042, DOI 10.1126/science.288.5468.1042; ALBRECHT BA, 1989, SCIENCE, V245, P1227, DOI 10.1126/science.245.4923.1227; Anderson J. B., 1931, MON WEA REV, V59, P264, DOI DOI 10.1175/1520-0493(1931)59<264:OFAOCA>2.0.CO;2; Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; Avey L, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007581; Ayala O, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/075015; BAKER MB, 1990, NATURE, V345, P142, DOI 10.1038/345142a0; Bony S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023851; BOUCHER O, 1995, TELLUS B, V47, P281, DOI 10.1034/j.1600-0889.47.issue3.1.x; Brenguier JL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002682; Bretherton CS, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027648; Charlson RJ, 2007, TELLUS B, V59, P715, DOI [10.1111/j.1600-0889.2007.00297.x, 10.1111/J.1600-0889.2007.00297.x]; COAKLEY JA, 1987, SCIENCE, V237, P1020, DOI 10.1126/science.237.4818.1020; Comstock KK, 2005, J ATMOS SCI, V62, P3792, DOI 10.1175/JAS3567.1; Comstock KK, 2004, Q J ROY METEOR SOC, V130, P2891, DOI 10.1256/qj.03.187; Feingold G, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021369; Feingold G, 1996, J ATMOS SCI, V53, P1108, DOI 10.1175/1520-0469(1996)053<1108:TRBDIC>2.0.CO;2; FEINGOLD G, 2009, CLOUDS PERTURBED CLI, pCH14; Han QY, 2002, J ATMOS SCI, V59, P726, DOI 10.1175/1520-0469(2002)059<0726:TDBOLW>2.0.CO;2; HAN QY, 1994, J CLIMATE, V7, P465, DOI 10.1175/1520-0442(1994)007<0465:NGSOED>2.0.CO;2; HARTMANN DL, 1980, J GEOPHYS RES, V96, P869; Hegg DA, 1996, GEOPHYS RES LETT, V23, P2613, DOI 10.1029/96GL02419; HELIERE A, 2007, P GEOSC REM SENS S 2, P4975; HENSON R, 2008, SATELLITE OBSERVATIO, P10; Hoose C, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038568; HOPPEL WA, 1990, J GEOPHYS RES-ATMOS, V95, P3659, DOI 10.1029/JD095iD04p03659; Houze RA, 2004, REV GEOPHYS, V42, DOI 10.1029/2004RG000150; JAMISON L, 2005, TR234 RAND CORP; Jiang HL, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026024; JOHNSON DB, 1982, J ATMOS SCI, V39, P448, DOI 10.1175/1520-0469(1982)039<0448:TROGAU>2.0.CO;2; Kaufman YJ, 2005, P NATL ACAD SCI USA, V102, P11207, DOI 10.1073/pnas.0505191102; Kay JE, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032628; Khain AP, 2008, J ATMOS SCI, V65, P1721, DOI 10.1175/2007JAS2515.1; Knutti R, 2002, NATURE, V416, P719, DOI 10.1038/416719a; Koren I, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023187; Koren I, 2004, SCIENCE, V303, P1342, DOI 10.1126/science.1089424; Koren I, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029253; Latham J, 2008, PHILOS T R SOC A, V366, P3969, DOI 10.1098/rsta.2008.0137; Lau KM, 2006, CLIM DYNAM, V26, P855, DOI 10.1007/s00382-006-0114-2; Lee SS, 2008, Q J ROY METEOR SOC, V134, P1201, DOI 10.1002/qj.287; LEVIN Z, 2008, AEROSOL POLLUTION IM; LIOU KN, 1989, J GEOPHYS RES-ATMOS, V94, P8599, DOI 10.1029/JD094iD06p08599; Loeb NG, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009763; Lohmann U, 2005, ATMOS CHEM PHYS, V5, P715, DOI 10.5194/acp-5-715-2005; Lohmann U, 1997, J GEOPHYS RES-ATMOS, V102, P13685, DOI 10.1029/97JD00631; Lu ML, 2005, J ATMOS SCI, V62, P3909, DOI 10.1175/JAS3584.1; MARTIN GM, 1994, J ATMOS SCI, V51, P1823, DOI 10.1175/1520-0469(1994)051<1823:TMAPOE>2.0.CO;2; Matheson MA, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006165; Matsui T, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006097; Mauger GS, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029952; McComiskey A, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011006; MURPHY DM, J GEOPHYS R IN PRESS; Nakajima T, 2001, GEOPHYS RES LETT, V28, P1171, DOI 10.1029/2000GL012186; Nuijens L, 2009, J ATMOS SCI, V66, P1962, DOI 10.1175/2008JAS2841.1; O'Dowd CD, 1999, Q J ROY METEOR SOC, V125, P1295, DOI 10.1256/smsqj.55609; Pawlowska H, 2003, J GEOPHYS RES, V33; Petters MD, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2004JD005694; PINCUS R, 1994, NATURE, V372, P250, DOI 10.1038/372250a0; QUAAS J, 2009, ATMOS CHEM PHYS DISC, V9, P12731; RADKE LF, 1989, SCIENCE, V246, P1146, DOI 10.1126/science.246.4934.1146; Ramanathan V, 2001, SCIENCE, V294, P2119, DOI 10.1126/science.1064034; Rauber RM, 2007, B AM METEOROL SOC, V88, P1912, DOI 10.1175/BAMS-88-12-1912; Rosenfeld D, 1999, GEOPHYS RES LETT, V26, P3105, DOI 10.1029/1999GL006066; Rosenfeld D, 2008, SCIENCE, V321, P1309, DOI 10.1126/science.1160606; Rotstayn LD, 1999, J GEOPHYS RES-ATMOS, V104, P9369, DOI 10.1029/1998JD900009; Sandu I, 2008, J ATMOS SCI, V65, P2705, DOI 10.1175/2008JAS2451.1; Seifert A, 2001, ATMOS RES, V59, P265, DOI 10.1016/S0169-8095(01)00126-0; Sekiguchi M, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003359; Sharon TM, 2006, J ATMOS SCI, V63, P983, DOI 10.1175/JAS3667.1; SMALL JD, GEOPHYS RES IN PRESS; Sorooshian A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038993; SQUIRES P, 1958, TELLUS, V10, P256, DOI 10.1111/j.2153-3490.1958.tb02011.x; Stephens GL, 2002, B AM METEOROL SOC, V83, P1771, DOI 10.1175/BAMS-83-12-1771; Stevens B, 1998, J ATMOS SCI, V55, P3616, DOI 10.1175/1520-0469(1998)055<3616:LESOSP>2.0.CO;2; Stevens B, 2005, B AM METEOROL SOC, V86, P51, DOI 10.1175/BAMS-86-1-51; Stevens B, 2008, J METEOROL SOC JPN, V86A, P143, DOI 10.2151/jmsj.86a.143; Stevens B, 2007, J ATMOS SCI, V64, P2916, DOI 10.1175/JAS3983.1; Stevens B, 2009, CLOUDS IN THE PERTURBED CLIMATE SYSTEM: THEIR RELATIONSHIP TO ENERGY BALANCE, ATMOSPHERIC DYNAMICS, AND PRECIPITATION, P173; Storelvmo T, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/045001; Tao WK, 2007, J METEOROL SOC JPN, V85B, P305, DOI 10.2151/jmsj.85B.305; TIEDTKE M, 1989, MON WEATHER REV, V117, P1779, DOI 10.1175/1520-0493(1989)117<1779:ACMFSF>2.0.CO;2; TWOMEY S, 1977, J ATMOS SCI, V34, P1149, DOI 10.1175/1520-0469(1977)034<1149:TIOPOT>2.0.CO;2; Twomey S., 1959, GEOFIS PURA APPL, V43, P243, DOI [10.1007/BF01993560, DOI 10.1007/BF01993560]; vanZanten MC, 2005, J ATMOS SCI, V62, P88, DOI 10.1175/JAS-3355.1; Varnai T, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037089; Wang SP, 2003, J ATMOS SCI, V60, P262, DOI 10.1175/1520-0469(2003)060<0262:TCALWT>2.0.CO;2; Wood JM, 2007, INFLUENZA OTHER RESP, V1, P5, DOI 10.1111/j.1750-2659.2006.00003.x; Wood R, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007553; Wood R, 2007, J ATMOS SCI, V64, P2657, DOI 10.1175/JAS3942.1; Xue HW, 2008, J ATMOS SCI, V65, P392, DOI 10.1175/2007JAS2428.1; Xue HW, 2006, J ATMOS SCI, V63, P1605, DOI 10.1175/JAS3706.1; [No title captured]	93	716	728	18	280	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					607	613		10.1038/nature08281	http://dx.doi.org/10.1038/nature08281			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794487				2022-12-28	WOS:000270302600031
J	Reis, BY; Kohane, IS; Mandl, KD				Reis, Ben Y.; Kohane, Isaac S.; Mandl, Kenneth D.			Longitudinal histories as predictors of future diagnoses of domestic abuse: modelling study	BRITISH MEDICAL JOURNAL			English	Article							INTIMATE PARTNER VIOLENCE; EMERGENCY-DEPARTMENT; HEALTH-CARE; BATTERED WOMEN; PREVALENCE; PATIENT; OPPORTUNITIES; PERSPECTIVE; SETTINGS; BARRIERS	Objective To determine whether longitudinal data in patients' historical records, commonly available in electronic health record systems, can be used to predict a patient's future risk of receiving a diagnosis of domestic abuse. Design Bayesian models, known as intelligent histories, used to predict a patient's risk of receiving a future diagnosis of abuse, based on the patient's diagnostic history. Retrospective evaluation of the model's predictions using an independent testing set. Setting A state-wide claims database covering six years of inpatient admissions to hospital, admissions for observation, and encounters in emergency departments. Population All patients aged over 18 who had at least four years between their earliest and latest visits recorded in the database (561 216 patients). Main outcome measures Timeliness of detection, sensitivity, specificity, positive predictive values, and area under the ROC curve. Results 1.04% (5829) of the patients met the narrow case definition for abuse, while 3.44% (19 303) met the broader case definition for abuse. The model achieved sensitive, specific (area under the ROC curve of 0.88), and early (10-30 months in advance, on average) prediction of patients' future risk of receiving a diagnosis of abuse. Analysis of model parameters showed important differences between sexes in the risks associated with certain diagnoses. Conclusions Commonly available longitudinal diagnostic data can be useful for predicting a patient's future risk of receiving a diagnosis of abuse. This modelling approach could serve as the basis for an early warning system to help doctors identify high risk patients for further screening.	[Reis, Ben Y.; Kohane, Isaac S.; Mandl, Kenneth D.] Childrens Hosp Boston, Harvard Mit Div Hlth Sci & Technol, Childrens Hosp Informat Program, Boston, MA USA; [Reis, Ben Y.; Kohane, Isaac S.; Mandl, Kenneth D.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Reis, BY (corresponding author), 1 Autumn St,Room 540-1, Boston, MA 02115 USA.	Ben_Reis@harvard.edu	Kohane, Isaac Kohane/K-3716-2012	Kohane, Isaac Kohane/0000-0003-2192-5160	US Centers for Disease Control and Prevention [R01 PH000040]; National Library of Medicine [R01 LM009879, R01 LM007677, G08LM009778]; NATIONAL LIBRARY OF MEDICINE [R01LM009879, R01LM007677, G08LM009778] Funding Source: NIH RePORTER; PUBLIC HEALTH PRACTICE PROGRAM OFFICE [R01PH000040] Funding Source: NIH RePORTER	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); PUBLIC HEALTH PRACTICE PROGRAM OFFICE(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the US Centers for Disease Control and Prevention (grant R01 PH000040) and the National Library of Medicine (grants R01 LM009879, R01 LM007677, and G08LM009778). The funders have no involvement with the research.	ABBOTT J, 1995, JAMA-J AM MED ASSOC, V273, P1763, DOI 10.1001/jama.273.22.1763; BARNETT GO, 2004, MEDINFO, V11, P273; Bederson BB, 2002, ACM T GRAPHIC, V21, P833, DOI 10.1145/571647.571649; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Coleman EA, 2003, J AM GERIATR SOC, V51, P549, DOI 10.1046/j.1532-5415.2003.51185.x; Dearwater SR, 1998, JAMA-J AM MED ASSOC, V280, P433, DOI 10.1001/jama.280.5.433; Ernst AA, 2002, WOMEN HEALTH, V35, P71, DOI 10.1300/J013v35n02_05; Fanslow JL, 1998, ANN EMERG MED, V32, P341, DOI 10.1016/S0196-0644(98)70011-3; Gielen AC, 2000, AM J PREV MED, V19, P279, DOI 10.1016/S0749-3797(00)00234-8; Glass N, 2001, J Emerg Nurs, V27, P141, DOI 10.1067/men.2001.114387; Goodyear-Smith Felicity, 2002, Appl Health Econ Health Policy, V1, P197; Groth B, 2001, WMJ, V100, P24; GROTH B, 2001, WISC MED J, V100, P36; Hall Amanda, 2004, Health Info Libr J, V21, P102, DOI 10.1111/j.1471-1842.2004.00506.x; HCUP CCS, 2009, HEALTHC COST UT PROJ; Heron SL, 2003, ANN EMERG MED, V42, P483, DOI 10.1067/S0196-0644(03)00718-2; Houry D, 2004, J INTERPERS VIOLENCE, V19, P955, DOI 10.1177/0886260504267999; Houry D, 2008, ANN EMERG MED, V51, P433, DOI 10.1016/j.annemergmed.2007.11.019; Hripcsak G, 2007, J AM MED INFORM ASSN, V14, P235, DOI 10.1197/jamia.M2206; Kmietowicz Z, 2007, BRIT MED J, V334, P1289, DOI 10.1136/bmj.39252.343958.4E; KOSS MP, 1991, ARCH INTERN MED, V151, P342, DOI 10.1001/archinte.151.2.342; Kothari CL, 2006, ANN EMERG MED, V47, P190, DOI 10.1016/j.annemergmed.2005.10.016; Krasnoff M, 2002, ANN EMERG MED, V40, P485, DOI 10.1067/mem.2002.128872; Kyriacou DN, 1999, NEW ENGL J MED, V341, P1892, DOI 10.1056/NEJM199912163412505; Larkin GL, 1999, ANN EMERG MED, V33, P669, DOI 10.1016/S0196-0644(99)70196-4; Liebschutz J, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-229; McCloskey LA, 2005, ACAD EMERG MED, V12, P712, DOI 10.1197/j.aem.2005.03.529; McCloskey LA, 2007, J GEN INTERN MED, V22, P1067, DOI 10.1007/s11606-007-0199-z; MCLEER SV, 1987, ANN EMERG MED, V16, P1155, DOI 10.1016/S0196-0644(87)80476-6; MCLEER SV, 1989, AM J PUBLIC HEALTH, V79, P65, DOI 10.2105/AJPH.79.1.65; MCLEER SV, 1989, ANN EMERG MED, V18, P651, DOI 10.1016/S0196-0644(89)80521-9; McNulty Anna, 2006, Sex Health, V3, P179, DOI 10.1071/SH05056; NOONE J, 1998, MEDINFO 2, V9, P1287; Ortiz JJ, 2005, JOGNN-J OBST GYN NEO, V34, P63, DOI 10.1177/0884217504272812; Overhage JM, 2002, ANN EMERG MED, V39, P14, DOI 10.1067/mem.2002.120794; Ramsay J, 2002, BRIT MED J, V325, P314, DOI 10.1136/bmj.325.7359.314; Ross J, 2004, SOC WORK HEALTH CARE, V38, P1, DOI 10.1300/J010v38n04_01; Saltzman LE, 2000, AM J PREV MED, V19, P325, DOI 10.1016/S0749-3797(00)00241-5; Stiell A, 2003, CAN MED ASSOC J, V169, P1023; Stone D A, 1999, Inj Prev, V5, P136; Thompson RS, 2000, AM J PREV MED, V19, P253, DOI 10.1016/S0749-3797(00)00231-2; Trautman DE, 2007, ANN EMERG MED, V49, P526, DOI 10.1016/j.annemergmed.2006.11.022; Waalen J, 2000, AM J PREV MED, V19, P230, DOI 10.1016/S0749-3797(00)00229-4	44	38	38	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 29	2009	339								b3677	10.1136/bmj.b3677	http://dx.doi.org/10.1136/bmj.b3677			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	502KX	19789406	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000270459600001
J	Gouverneur, V				Gouverneur, Veronique			A New Departure in Fluorination Chemistry	SCIENCE			English	Editorial Material							REDUCTIVE ELIMINATION; PALLADIUM FLUORIDE		Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England	University of Oxford	Gouverneur, V (corresponding author), Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England.	veronique.gouverneur@chem.ox.ac.uk						Furuya T, 2008, J AM CHEM SOC, V130, P10060, DOI 10.1021/ja803187x; Grushin VV, 2002, CHEM-EUR J, V8, P1006, DOI 10.1002/1521-3765(20020301)8:5<1006::AID-CHEM1006>3.0.CO;2-M; Hull KL, 2006, J AM CHEM SOC, V128, P7134, DOI 10.1021/ja061943k; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Yandulov DV, 2007, J AM CHEM SOC, V129, P1342, DOI 10.1021/ja066930l	6	28	28	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	2009	325	5948					1630	1631		10.1126/science.1179671	http://dx.doi.org/10.1126/science.1179671			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779178				2022-12-28	WOS:000270131800022
J	Krasner, MS; Epstein, RM; Beckman, H; Suchman, AL; Chapman, B; Mooney, CJ; Quill, TE				Krasner, Michael S.; Epstein, Ronald M.; Beckman, Howard; Suchman, Anthony L.; Chapman, Benjamin; Mooney, Christopher J.; Quill, Timothy E.			Association of an Educational Program in Mindful Communication With Burnout, Empathy, and Attitudes Among Primary Care Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STRESS REDUCTION; JEFFERSON SCALE; LIFE-STYLE; SATISFACTION; MEDICINE; SPECIALTY; VALIDITY; BELIEFS; GENDER; HEALTH	Context Primary care physicians report high levels of distress, which is linked to burnout, attrition, and poorer quality of care. Programs to reduce burnout before it results in impairment are rare; data on these programs are scarce. Objective To determine whether an intensive educational program in mindfulness, communication, and self-awareness is associated with improvement in primary care physicians' well-being, psychological distress, burnout, and capacity for relating to patients. Design, Setting, and Participants Before-and-after study of 70 primary care physicians in Rochester, New York, in a continuing medical education (CME) course in 2007-2008. The course included mindfulness meditation, self-awareness exercises, narratives about meaningful clinical experiences, appreciative interviews, didactic material, and discussion. An 8-week intensive phase (2.5 h/wk, 7-hour retreat) was followed by a 10-month maintenance phase (2.5 h/mo). Main Outcome Measures Mindfulness (2 subscales), burnout (3 subscales), empathy (3 subscales), psychosocial orientation, personality (5 factors), and mood (6 subscales) measured at baseline and at 2, 12, and 15 months. Results Over the course of the program and follow-up, participants demonstrated improvements in mindfulness (raw score, 45.2 to 54.1; raw score change [Delta], 8.9; 95% confidence interval [CI], 7.0 to 10.8); burnout (emotional exhaustion, 26.8 to 20.0; Delta = -6.8; 95% CI, -4.8 to -8.8; depersonalization, 8.4 to 5.9; Delta = -2.5; 95% CI, -1.4 to -3.6; and personal accomplishment, 40.2 to 42.6; Delta = 2.4; 95% CI, 1.2 to 3.6); empathy (116.6 to 121.2; Delta = 4.6; 95% CI, 2.2 to 7.0); physician belief scale (76.7 to 72.6; Delta = -4.1; 95% CI, -1.8 to -6.4); total mood disturbance (33.2 to 16.1; Delta = -17.1; 95% CI, -11 to -23.2), and personality (conscientiousness, 6.5 to 6.8; Delta = 0.3; 95% CI, 0.1 to 5 and emotional stability, 6.1 to 6.6; Delta = 0.5; 95% CI, 0.3 to 0.7). Improvements in mindfulness were correlated with improvements in total mood disturbance (r = -0.39, P < .001), perspective taking subscale of physician empathy (r = 0.31, P < .001), burnout (emotional exhaustion and personal accomplishment subscales, r = -0.32 and 0.33, respectively; P < .001), and personality factors (conscientiousness and emotional stability, r = 0.29 and 0.25, respectively; P < .001). Conclusions Participation in a mindful communication program was associated with short-term and sustained improvements in well-being and attitudes associated with patient-center care. Because before-and-after designs limit inferences about intervention effects, these findings warrant randomized trials involving a variety of practicing physicians. JAMA. 2009;302(12):1284-1293	[Krasner, Michael S.; Beckman, Howard; Suchman, Anthony L.; Quill, Timothy E.] Univ Rochester, Med Ctr, Dept Internal Med, Rochester, NY 14618 USA; [Epstein, Ronald M.; Beckman, Howard] Univ Rochester, Med Ctr, Dept Family Med, Rochester, NY 14618 USA; [Epstein, Ronald M.; Chapman, Benjamin; Quill, Timothy E.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14618 USA; [Epstein, Ronald M.; Quill, Timothy E.] Univ Rochester, Med Ctr, Dept Oncol, Rochester, NY 14618 USA; [Mooney, Christopher J.] Univ Rochester, Med Ctr, Off Med Educ, Rochester, NY 14618 USA; [Epstein, Ronald M.; Quill, Timothy E.] Univ Rochester, Med Ctr, Ctr Improve Commun Hlth Care, Rochester, NY 14618 USA; [Epstein, Ronald M.; Quill, Timothy E.] Univ Rochester, Med Ctr, Ctr Eth Humanities & Palliat Care, Rochester, NY 14618 USA; [Beckman, Howard] Rochester Individual Practice Assoc, Rochester, NY USA; [Suchman, Anthony L.] Relationship Ctr Hlth Care, Rochester, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Krasner, MS (corresponding author), Univ Rochester, Sch Med & Dent, Dept Med, Olsan Med Grp, 2400 5 Clinton Ave,Bldg H,230, Rochester, NY 14618 USA.	michael_krasner@urmc.rochester.edu	Girault, Johann/B-2430-2012	Chapman, Benjamin/0000-0002-5170-3131	Physicians' Foundation for Health Systems Excellence; New York Chapter of the American College of Physicians; National Institutes of Health [K08AG31328]; NATIONAL INSTITUTE ON AGING [K08AG031328] Funding Source: NIH RePORTER	Physicians' Foundation for Health Systems Excellence; New York Chapter of the American College of Physicians; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was funded by the Physicians' Foundation for Health Systems Excellence and sponsored by the New York Chapter of the American College of Physicians. Work done on this project by Dr Chapman was facilitated by grant K08AG31328 from the National Institutes of Health.	ASHWORTH CD, 1984, SOC SCI MED, V19, P1235, DOI 10.1016/0277-9536(84)90376-9; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003; Beddoe AE, 2004, J NURS EDUC, V43, P305; Bellini LM, 2002, JAMA-J AM MED ASSOC, V287, P3143, DOI 10.1001/jama.287.23.3143; Benjamini Y, 2001, ANN STAT, V29, P1165; Berwick DM, 2008, JAMA-J AM MED ASSOC, V299, P1182, DOI 10.1001/jama.299.10.1182; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Buchbinder SB, 1999, AM J MANAG CARE, V5, P1431; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; CHARON R, 1994, SOC SCI MED, V39, P955, DOI 10.1016/0277-9536(94)90207-0; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Connelly JE, 2005, PERSPECT BIOL MED, V48, P84, DOI 10.1353/pbm.2005.0006; Cooperrider DL, 2005, APPRECIATIVE INQUIRY; Crane M, 1998, Med Econ, V75, P210; CRANE M, 1998, MED ECON, V75, P215; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; DOHERTY WJ, 1989, JAMA-J AM MED ASSOC, V261, P2374, DOI 10.1001/jama.261.16.2374; Dorsey ER, 2003, JAMA-J AM MED ASSOC, V290, P1173, DOI 10.1001/jama.290.9.1173; Dunn PM, 2007, J GEN INTERN MED, V22, P1544, DOI 10.1007/s11606-007-0363-5; Dyrbye LN, 2008, ANN INTERN MED, V149, P334, DOI 10.7326/0003-4819-149-5-200809020-00008; Dyrbye LN, 2006, MAYO CLIN PROC, V81, P1435, DOI 10.4065/81.11.1435; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Epstein RM, 2005, ANN FAM MED, V3, P415, DOI 10.1370/afm.348; Epstein RM, 2008, J CONTIN EDUC HEALTH, V28, P5, DOI 10.1002/chp.149; Epstein RM, 2007, ANN FAM MED, V5, P21, DOI 10.1370/afm.621; Everitt B. S., 2004, STAT ASPECTS DESIGN; Field CA, 2007, J R STAT SOC B, V69, P369, DOI 10.1111/j.1467-9868.2007.00593.x; Fiscella K, 2004, MED CARE, V42, P1049, DOI 10.1097/00005650-200411000-00003; Grepmair L, 2007, PSYCHOTHER PSYCHOSOM, V76, P332, DOI 10.1159/000107560; Haas JS, 2000, J GEN INTERN MED, V15, P122, DOI 10.1046/j.1525-1497.2000.02219.x; Hassed C, 2009, ADV HEALTH SCI EDUC, V14, P387, DOI 10.1007/s10459-008-9125-3; Hojat M, 2002, AM J PSYCHIAT, V159, P1563, DOI 10.1176/appi.ajp.159.9.1563; Hojat M, 2002, ACAD MED, V77, pS58, DOI 10.1097/00001888-200210001-00019; Hojat M, 2001, EDUC PSYCHOL MEAS, V61, P349, DOI 10.1177/00131640121971158; HOROWITZ CR, 1995, ANN INTERN MED, V138, P772; Kabat-Zinn J., 1994, WHEREVER YOU GO THER; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kalauokalani D, 2007, PAIN MED, V8, P17, DOI 10.1111/j.1526-4637.2007.00170.x; KRASNER M, 2007, BEST BUDDHIST WRITIN, P200; Krupat E, 2001, J FAM PRACTICE, V50, P1057; Landon BE, 2006, MED CARE, V44, P234, DOI 10.1097/01.mlr.0000199848.17133.9b; Lovas JG, 2008, J DENT EDUC, V72, P998; Ludwig DS, 2008, JAMA-J AM MED ASSOC, V300, P1350, DOI 10.1001/jama.300.11.1350; MASLACH C, 1998, EVALUATING STRESS BO, P191; McNair D., 1971, MANUAL PROFILE MOOD; Mercer SL, 2007, AM J PREV MED, V33, P139, DOI 10.1016/j.amepre.2007.04.005; Michels PJ, 2003, ACAD MED, V78, P69, DOI 10.1097/00001888-200301000-00013; Musick DW, 2006, ACAD MED, V81, P759, DOI 10.1097/00001888-200608000-00015; Nyenhuis DL, 1999, J CLIN PSYCHOL, V55, P79, DOI 10.1002/(SICI)1097-4679(199901)55:1<79::AID-JCLP8>3.0.CO;2-7; OConnor PG, 1997, MED CLIN N AM, V81, P1037, DOI 10.1016/S0025-7125(05)70562-9; Ospina-Kammerer Veronika, 2003, Int J Emerg Ment Health, V5, P29; RAFFERTY JP, 1986, J CLIN PSYCHOL, V42, P488, DOI 10.1002/1097-4679(198605)42:3<488::AID-JCLP2270420315>3.0.CO;2-S; Reuben DB, 2007, AM J MED, V120, P99, DOI 10.1016/j.amjmed.2006.10.019; Rosenzweig S, 2003, TEACH LEARN MED, V15, P88, DOI 10.1207/S15328015TLM1502_03; Santorelli S., 1999, HEAL THY SELF LESSON; SAUCIER G, 1994, J PERS ASSESS, V63, P506, DOI 10.1207/s15327752jpa6303_8; Segal Z. V., 2002, MINDFULNESS BASED CO; Shadish W. R., 2001, EXPT QUASIEXPERIMENT, V2nd; Shanafelt TD, 2005, J GEN INTERN MED, V20, P559, DOI 10.1007/s11606-005-0102-8; Shanafelt TD, 2005, ONCOLOGY-BASEL, V68, P23, DOI 10.1159/000084519; Shanafelt TD, 2003, AM J MED, V114, P513, DOI 10.1016/S0002-9343(03)00117-7; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Shapiro S L, 2000, Adv Mind Body Med, V16, P128; Shapiro S. L., 2005, INT J STRESS MANAGE, V12, P164, DOI [10.1037/1072-5245.12.2.164, DOI 10.1037/1072-5245.12.2.164]; Shapiro SL, 1998, J BEHAV MED, V21, P581, DOI 10.1023/A:1018700829825; SHAPIRO SL, 1998, INTEGRATIVE MED, V1, P93, DOI DOI 10.1016/S1096-2190(98)00034-1; Singh NN, 2006, BEHAV MODIF, V30, P423, DOI 10.1177/0145445504272971; Spickard A, 2002, JAMA-J AM MED ASSOC, V288, P1447, DOI 10.1001/jama.288.12.1447; Street RL, 2007, MED DECIS MAKING, V27, P550, DOI 10.1177/0272989x07307581; Suchman AL, 2001, WESTERN J MED, V174, P43, DOI 10.1136/ewjm.174.1.43; Thomas NK, 2004, JAMA-J AM MED ASSOC, V292, P2880, DOI 10.1001/jama.292.23.2880; Treadway K, 2008, NEW ENGL J MED, V359, P2086, DOI 10.1056/NEJMp0805762; *U MA MED SCH, STRESS RED PROGR TUI; Williams ES, 2001, HEALTH CARE MANAGE R, V26, P7, DOI 10.1097/00004010-200101000-00002; 2003, APPRECIATIVE INQUIRY	77	914	933	8	238	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1284	1293		10.1001/jama.2009.1384	http://dx.doi.org/10.1001/jama.2009.1384			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	497AR	19773563	Bronze			2022-12-28	WOS:000270026000010
J	Jack, A				Jack, Andrew			Pandemic Flu Flu's unexpected bonus	BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	Andrew.Jack@ft.com		Jack, Andrew/0000-0001-9679-2898				JACK A, 2009, FINANCIAL TIMES 0906; JACK A, 2009, FINANCIAL TIMES 0720; JACK A, 2009, FINANCIAL TIMES 0729; Roche, 2009, TAM MED BRIEF; Schwartz Nelson D., 2005, CNN MONEY 1031	5	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 18	2009	339								b3811	10.1136/bmj.b3811	http://dx.doi.org/10.1136/bmj.b3811			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RV	19767343				2022-12-28	WOS:000269995000008
J	Zippo, A; Serafini, R; Rocchigiani, M; Pennacchini, S; Krepelova, A; Oliviero, S				Zippo, Alessio; Serafini, Riccardo; Rocchigiani, Marina; Pennacchini, Susanna; Krepelova, Anna; Oliviero, Salvatore			Histone Crosstalk between H3S10ph and H4K16ac Generates a Histone Code that Mediates Transcription Elongation	CELL			English	Article							RNA-POLYMERASE-II; BROMODOMAIN PROTEIN BRD4; P-TEFB; DEPENDENT TRANSCRIPTION; H3; PHOSPHORYLATION; ACETYLATION; ACTIVATION; DROSOPHILA; PROMOTER	The phosphorylation of the serine 10 at histone H3 has been shown to be important for transcriptional activation. Here, we report the molecular mechanism through which H3S10ph triggers transcript elongation of the FOSL1 gene. Serum stimulation induces the PIM1 kinase to phosphorylate the preacetylated histone H3 at the FOSL1 enhancer. The adaptor protein 14-3-3 binds the phosphorylated nucleosome and recruits the histone acetyltransferase MOF, which triggers the acetylation of histone H4 at lysine 16 (H4K16ac). This histone crosstalk generates the nucleosomal recognition code composed of H3K9acS10ph/H4K16ac determining a nucleosome platform for the bromodomain protein BRD4 binding. The recruitment of the positive transcription elongation factor b (P-TEFb) via BRD4 induces the release of the promoter-proximal paused RNA polymerase II and the increase of its processivity. Thus, the single phosphorylation H3S10ph at the FOSL1 enhancer triggers a cascade of events which activate transcriptional elongation.	[Zippo, Alessio; Serafini, Riccardo; Rocchigiani, Marina; Pennacchini, Susanna; Krepelova, Anna; Oliviero, Salvatore] Univ Siena, Dipartimento Biol Mol, I-53100 Siena, Italy	University of Siena	Oliviero, S (corresponding author), Univ Siena, Dipartimento Biol Mol, Via Fiorentina 1, I-53100 Siena, Italy.	oliviero@unisi.it	oliviero, salvatore/R-6657-2019	oliviero, salvatore/0000-0002-3405-765X; zippo, Alessio/0000-0002-3686-6151; Krepelova, Anna/0000-0002-2775-1336	Associazione Italiana Ricerca sul cancro (AIRC); Fondazione Monte dei Paschi di Siena, and Istituto Toscano Tumori	Associazione Italiana Ricerca sul cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Monte dei Paschi di Siena, and Istituto Toscano Tumori	This work was supported by Associazione Italiana Ricerca sul cancro (AIRC), Fondazione Monte dei Paschi di Siena, and Istituto Toscano Tumori ( ITT). We are in indebted to Isabel Delany, Marco Bianchi, Alessandra Agresti, and Enzo Scarlato for helpful suggestions and critical reading of the manuscript.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Agresti A, 2005, MOL CELL, V18, P109, DOI 10.1016/j.molcel.2005.03.005; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Cai WL, 2008, DEVELOPMENT, V135, P2917, DOI 10.1242/dev.024927; Calestagne-Morelli A, 2006, BIOCHEM CELL BIOL, V84, P518, DOI 10.1139/O06-067; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cirillo LA, 2004, METHOD ENZYMOL, V375, P131; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Ferrai C, 2007, J BIOL CHEM, V282, P12537, DOI 10.1074/jbc.M700867200; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Ivaldi MS, 2007, GENE DEV, V21, P2818, DOI 10.1101/gad.1604007; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kind J, 2008, CELL, V133, P813, DOI 10.1016/j.cell.2008.04.036; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Lee DK, 2001, J BIOL CHEM, V276, P9978, DOI 10.1074/jbc.M002285200; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Rea S, 2007, ONCOGENE, V26, P5385, DOI 10.1038/sj.onc.1210607; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Simone C, 2002, ONCOGENE, V21, P4137, DOI 10.1038/sj.onc.1205493; Smith ER, 2005, MOL CELL BIOL, V25, P9175, DOI 10.1128/MCB.25.21.9175-9188.2005; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Taipale M, 2005, MOL CELL BIOL, V25, P6798, DOI 10.1128/MCB.25.15.6798-6810.2005; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Wade JT, 2008, CURR OPIN GENET DEV, V18, P130, DOI 10.1016/j.gde.2007.12.008; Walter W, 2008, MOL CELL BIOL, V28, P2840, DOI 10.1128/MCB.01457-07; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	50	297	304	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1122	1136		10.1016/j.cell.2009.07.031	http://dx.doi.org/10.1016/j.cell.2009.07.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766566	Bronze			2022-12-28	WOS:000269923200013
J	Batista, VS				Batista, Victor S.			Energy Flow Under Control	SCIENCE			English	Editorial Material							LASER-PULSES; LIGHT; DENDRIMERS		Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Batista, VS (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	victor.batista@yale.edu						Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Atas E, 2005, J PHYS CHEM B, V109, P13553, DOI 10.1021/jp051488z; Batista VS, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.143201; BRUMER P, 1986, CHEM PHYS LETT, V126, P541, DOI 10.1016/S0009-2614(86)80171-3; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; Flores SC, 2004, J PHYS CHEM B, V108, P6745, DOI 10.1021/jp0370526; Herek JL, 2002, NATURE, V417, P533, DOI 10.1038/417533a; Kuroda DG, 2009, SCIENCE, V326, P263, DOI 10.1126/science.1176524; Levis RJ, 2001, SCIENCE, V292, P709, DOI 10.1126/science.1059133; Savolainen J, 2008, P NATL ACAD SCI USA, V105, P7641, DOI 10.1073/pnas.0711927105; TANNOR DJ, 1985, J CHEM PHYS, V83, P5013, DOI 10.1063/1.449767; Tretiak S, 1998, J PHYS CHEM B, V102, P3310, DOI 10.1021/jp980745f	12	5	5	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 9	2009	326	5950					245	246		10.1126/science.1179694	http://dx.doi.org/10.1126/science.1179694			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815767				2022-12-28	WOS:000270599500031
J	Bleszynski-Jayich, AC; Shanks, WE; Peaudecerf, B; Ginossar, E; von Oppen, F; Glazman, L; Harris, JGE				Bleszynski-Jayich, A. C.; Shanks, W. E.; Peaudecerf, B.; Ginossar, E.; von Oppen, F.; Glazman, L.; Harris, J. G. E.			Persistent Currents in Normal Metal Rings	SCIENCE			English	Article							UNIVERSAL CONDUCTANCE FLUCTUATIONS; MESOSCOPIC RINGS; SINGLE; FIELD; LOOP	Quantum mechanics predicts that the equilibrium state of a resistive metal ring will contain a dissipationless current. This persistent current has been the focus of considerable theoretical and experimental work, but its basic properties remain a topic of controversy. The main experimental challenges in studying persistent currents have been the small signals they produce and their exceptional sensitivity to their environment. We have developed a technique for detecting persistent currents that allows us to measure the persistent current in metal rings over a wide range of temperatures, ring sizes, and magnetic fields. Measurements of both a single ring and arrays of rings agree well with calculations based on a model of non-interacting electrons.	[Bleszynski-Jayich, A. C.; Shanks, W. E.; Peaudecerf, B.; Ginossar, E.; Glazman, L.; Harris, J. G. E.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [von Oppen, F.] Free Univ Berlin, Inst Theoret Phys, D-14195 Berlin, Germany; [Glazman, L.; Harris, J. G. E.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA	Yale University; Free University of Berlin; Yale University	Bleszynski-Jayich, AC (corresponding author), Yale Univ, Dept Phys, New Haven, CT 06520 USA.		Harris, Jack/AAA-3829-2020; von Oppen, Felix/O-6730-2016	Jayich, Ania/0000-0003-3480-7032; Peaudecerf, Bruno/0000-0002-2221-2034; Shanks, William/0000-0002-5045-8808	NSF [0706380, 0653377]; Deutsche-Israelische Projektkooperation; Sloan Foundation; UNESCO-L'Oreal; U. S. Department of Energy [DE-FG02-08ER46482]	NSF(National Science Foundation (NSF)); Deutsche-Israelische Projektkooperation; Sloan Foundation(Alfred P. Sloan Foundation); UNESCO-L'Oreal; U. S. Department of Energy(United States Department of Energy (DOE))	We thank M. Devoret, R. Ilic, T. Ojanen, and J. C. Sankey for their assistance. A. C. B.-J., W. E. S., and J. G. E. H. are supported by NSF grants 0706380 and 0653377. F. v. O. is supported in part by the Deutsche-Israelische Projektkooperation. J. G. E. H. acknowledges support from the Sloan Foundation. A. C. B.-J. acknowledges support from UNESCO-L'Oreal. L. G. is supported in part by U. S. Department of Energy grant DE-FG02-08ER46482. F. v. O and L. G. acknowledge the hospitality of the Kavli Institute for Theoretical Physics in the final stages of this work.	ALTSHULER BL, 1991, PHYS REV LETT, V66, P88, DOI 10.1103/PhysRevLett.66.88; AMBEGAOKAR V, 1990, PHYS REV LETT, V65, P381, DOI 10.1103/PhysRevLett.65.381; AMBEGAOKAR V, 1990, EUROPHYS LETT, V13, P733, DOI 10.1209/0295-5075/13/8/011; Bary-Soroker H, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057001; Bleszynski-Jayich AC, 2008, J VAC SCI TECHNOL B, V26, P1412, DOI 10.1116/1.2958247; Bleszynski-Jayich AC, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2821828; Bluhm H, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.136802; BUTTIKER M, 1983, PHYS LETT A, V96, P365, DOI 10.1016/0375-9601(83)90011-7; Cedraschi P, 2000, PHYS REV LETT, V84, P346, DOI 10.1103/PhysRevLett.84.346; CHANDRASEKHAR V, 1991, PHYS REV LETT, V67, P3578, DOI 10.1103/PhysRevLett.67.3578; Eckern U, 1995, ADV PHYS, V44, P387, DOI 10.1080/00018739500101556; Jariwala EMQ, 2001, PHYS REV LETT, V86, P1594, DOI 10.1103/PhysRevLett.86.1594; Kopp A, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.220401; KRAVTSOV VE, 1993, PHYS REV LETT, V70, P210, DOI 10.1103/PhysRevLett.70.210; LAFARGE P, 1993, NATURE, V365, P422, DOI 10.1038/365422a0; LEE PA, 1987, PHYS REV B, V35, P1039, DOI 10.1103/PhysRevB.35.1039; LEVY LP, 1990, PHYS REV LETT, V64, P2074, DOI 10.1103/PhysRevLett.64.2074; MAILLY D, 1993, PHYS REV LETT, V70, P2020, DOI 10.1103/PhysRevLett.70.2020; RIEDEL EK, 1993, PHYS REV B, V47, P15449, DOI 10.1103/PhysRevB.47.15449; Saminadayar L., 2004, ENCY NANOSCI NANOTEC, V3, P267; Schwab P, 1997, Z PHYS B CON MAT, V103, P97, DOI 10.1007/s002570050341; SKOCPOL WJ, 1986, PHYS REV LETT, V56, P2865, DOI 10.1103/PhysRevLett.56.2865; Song C, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.174512	24	237	241	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 9	2009	326	5950					272	275		10.1126/science.1178139	http://dx.doi.org/10.1126/science.1178139			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815772				2022-12-28	WOS:000270599500038
J	Eldridge, S; Kerry, S; Torgerson, DJ				Eldridge, Sandra; Kerry, Sally; Torgerson, David J.			Bias in identifying and recruiting participants in cluster randomised trials: what can be done?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRIMARY-CARE; GENERAL-PRACTITIONERS; SELECTION BIAS; PREVENTION; INTERVENTION; BEHAVIOR; RISK		[Torgerson, David J.] Univ York, Dept Hlth Sci, York Trials Unit, York YO10 5DD, N Yorkshire, England; [Eldridge, Sandra] Univ London, Ctr Hlth Sci, Barts & London Sch Med & Dent, London E1 2AT, England; [Kerry, Sally] Univ London, Dept Community Hlth Sci, London SW17 0RE, England	University of York - UK; University of London; Queen Mary University London; University of London	Torgerson, DJ (corresponding author), Univ York, Dept Hlth Sci, York Trials Unit, York YO10 5DD, N Yorkshire, England.	djt6@york.ac.uk	Torgerson, David/L-4566-2019	Torgerson, David/0000-0002-1667-4275				Berger VW, 2005, STAT PRACT, P1, DOI 10.1002/0470863641; Borm GF, 2005, STAT MED, V24, P3535, DOI 10.1002/sim.2200; Eldridge S, 2008, BMJ-BRIT MED J, V336, P876, DOI 10.1136/bmj.39517.495764.25; Eldridge SM, 2005, CLIN TRIALS, V2, P91, DOI 10.1191/1740774505cn070oa; Farrin A, 2005, CLIN TRIALS, V2, P119, DOI 10.1191/1740774505cn073oa; Feder G, 1999, BRIT MED J, V318, P1522, DOI 10.1136/bmj.318.7197.1522; Giraudeau B, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000065; Griffiths C, 2004, BMJ-BRIT MED J, V328, P144, DOI 10.1136/bmj.37950.784444.EE; Hahn Seokyung, 2005, BMC Med Res Methodol, V5, P10, DOI 10.1186/1471-2288-5-10; Hewitt CE, 2006, CAN MED ASSOC J, V175, P347, DOI 10.1503/cmaj.051625; Hutton JL, 2001, STAT MED, V20, P473, DOI 10.1002/1097-0258(20010215)20:3<473::AID-SIM805>3.0.CO;2-D; Kannus P, 2000, NEW ENGL J MED, V343, P1506, DOI 10.1056/NEJM200011233432101; Kendrick D, 2005, BRIT J GEN PRACT, V55, P582; Kerry SM, 2005, CLIN TRIALS, V2, P125, DOI 10.1191/1740774505cn074oa; King M, 2002, BRIT MED J, V324, P947, DOI 10.1136/bmj.324.7343.947; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Kontiokari T, 2001, BMJ-BRIT MED J, V322, P1571, DOI 10.1136/bmj.322.7302.1571; Lindquist E. F., 1940, STAT ANAL ED RES; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Little P, 1997, BRIT MED J, V314, P1478; Mohan P, 2004, BRIT MED J, V329, P266, DOI 10.1136/bmj.38149.703380.47; Murray DM, 1998, DESIGN ANAL GROUP RA; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; Sondergaard J, 2006, FAM PRACT, V23, P198, DOI 10.1093/fampra/cmi090; Torgerson DJ, 2008, DESIGNING RANDOMISED TRIALS IN HEALTH, EDUCATION AND THE SOCIAL SCIENCES: AN INTRODUCTION, P1, DOI 10.1057/9780230583993; TURK V, CLUSTER RAN IN PRESS; PRIMARY CARE IDENTIF	27	85	86	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2009	339								b4006	10.1136/bmj.b4006	http://dx.doi.org/10.1136/bmj.b4006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TI	19819928	Green Accepted			2022-12-28	WOS:000270719400001
J	Moore, DL; Blackmore, MG; Hu, Y; Kaestner, KH; Bixby, JL; Lemmon, VP; Goldberg, JL				Moore, Darcie L.; Blackmore, Murray G.; Hu, Ying; Kaestner, Klaus H.; Bixby, John L.; Lemmon, Vance P.; Goldberg, Jeffrey L.			KLF Family Members Regulate Intrinsic Axon Regeneration Ability	SCIENCE			English	Article							KRUPPEL-LIKE FACTOR; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; TRANSCRIPTION FACTORS; DEVELOPMENTAL LOSS; SPINAL-CORD; CELLS; PATHWAY; GROWTH; GENE	Neurons in the central nervous system (CNS) lose their ability to regenerate early in development, but the underlying mechanisms are unknown. By screening genes developmentally regulated in retinal ganglion cells (RGCs), we identified Kruppel-like factor-4 (KLF4) as a transcriptional repressor of axon growth in RGCs and other CNS neurons. RGCs lacking KLF4 showed increased axon growth both in vitro and after optic nerve injury in vivo. Related KLF family members suppressed or enhanced axon growth to differing extents, and several growth-suppressive KLFs were up-regulated postnatally, whereas growth-enhancing KLFs were down-regulated. Thus, coordinated activities of different KLFs regulate the regenerative capacity of CNS neurons.	[Moore, Darcie L.; Hu, Ying; Goldberg, Jeffrey L.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Moore, Darcie L.; Bixby, John L.; Lemmon, Vance P.; Goldberg, Jeffrey L.] Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA; [Blackmore, Murray G.; Bixby, John L.; Lemmon, Vance P.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Kaestner, Klaus H.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA	Bascom Palmer Eye Institute; University of Miami; University of Miami; University of Miami; University of Pennsylvania	Goldberg, JL (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	jgoldberg@med.miami.edu	Lemmon, Vance/A-2565-2008; Ying, Hu/F-3581-2010; Lemmon, Vance/A-7410-2010	Lemmon, Vance/0000-0003-3550-7576; Bixby, John/0000-0003-1633-5318; Goldberg, Jeffrey/0000-0002-1390-7360; Moore, Darcie/0000-0002-0854-7655	National Eye Institute (NEI) [EY016790, EY014801]; National Institute of Neurological Disorders and Stroke (NINDS) [NS061348, T32 NS07492, T32 NS007459]; Glaucoma Foundation; Seigal Foundation; C. H. Neilsen Foundation; Ralph Wilson Medical Research Foundation; W. G. Ross Foundation; Buoniconti Fund to Cure Paralysis; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R03EY016790, P30EY014801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061348, T32NS007459, T32NS007492, R01NS059866] Funding Source: NIH RePORTER	National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Glaucoma Foundation; Seigal Foundation; C. H. Neilsen Foundation; Ralph Wilson Medical Research Foundation; W. G. Ross Foundation; Buoniconti Fund to Cure Paralysis; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by a National Eye Institute (NEI) R03 grant (EY016790, J. L. G.) and subsequently by a National Institute of Neurological Disorders and Stroke (NINDS) R01 grant (NS061348, J. L. G.) and critical funding from The Glaucoma Foundation and the Seigal Foundation (J. L. G.), the C. H. Neilsen Foundation (V. P. L. and J. L. G.), the Ralph Wilson Medical Research Foundation and the W. G. Ross Foundation (V. P. L.), The Buoniconti Fund to Cure Paralysis (V. P. L. and J. L. B.), an NEI P30 grant (EY014801), and an unrestricted grant from Research to Prevent Blindness to the University of Miami. D. L. M. is a Lois Pope LIFE Fellow, with support from NINDS training grants T32 NS07492 and T32 NS007459. We are indebted for generous gifts of FLAG-tagged KLF4 (C. Liu, University of Texas), mCherry (R. Tsien, University of California, San Diego), and KLF2 constructs (J. Lingrel, University of Cincinnati). We are grateful to W. Feuer (University of Miami) for statistical contributions and to R. Corredor (University of Miami) for optimizing RGC electroporation. We thank the following lab members and collaborators for their meaningful contributions: Ne. Patel, Ni. Patel, J. Gallardo, N. Sharifai, E. Walford, M. Velarde, A. Sloan, M. Benny, A. Oliva, Y. Shi, E. Hernandez, G. Lambert, and G. Gaidosh. The authors declare they have no conflicts of interest.	Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Blackmore M, 2006, J NEUROBIOL, V66, P348, DOI 10.1002/neu.20224; Bouslama-Oueghlani L, 2003, J NEUROSCI, V23, P8318; BREGMAN BS, 1989, J COMP NEUROL, V282, P355, DOI 10.1002/cne.902820304; Buchser WJ, 2006, BIOTECHNIQUES, V41, P619, DOI 10.2144/000112279; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Cayrou C, 2002, ENDOCRINOLOGY, V143, P2242, DOI 10.1210/en.143.6.2242; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; CHEN DF, 1995, P NATL ACAD SCI USA, V92, P7287, DOI 10.1073/pnas.92.16.7287; Cho KS, 2005, J CELL SCI, V118, P863, DOI 10.1242/jcs.01658; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; Dang DT, 2002, NUCLEIC ACIDS RES, V30, P2736, DOI 10.1093/nar/gkf400; Dusart I, 1997, J NEUROSCI, V17, P3710; Eaton SA, 2008, J BIOL CHEM, V283, P26937, DOI 10.1074/jbc.M804831200; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Ghaleb AM, 2007, ONCOGENE, V26, P2365, DOI 10.1038/sj.onc.1210022; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Hagos EG, 2009, ONCOGENE, V28, P1197, DOI 10.1038/onc.2008.465; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Katz JP, 2002, DEVELOPMENT, V129, P2619; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Lasorella A, 2006, NATURE, V442, P471, DOI 10.1038/nature04895; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; LI D, 1995, EUR J NEUROSCI, V7, P1164, DOI 10.1111/j.1460-9568.1995.tb01106.x; Nicholls J, 1996, TRENDS NEUROSCI, V19, P229, DOI 10.1016/0166-2236(96)10021-7; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Veldman MB, 2007, DEV BIOL, V312, P596, DOI 10.1016/j.ydbio.2007.09.019; Wang JT, 2007, J NEUROSCI, V27, P8593, DOI 10.1523/JNEUROSCI.4488-06.2007; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006; Zhao R, 2008, J CELL BIOCHEM, V105, P949, DOI 10.1002/jcb.21871; Zhu SS, 2009, BRAIN RES, V1250, P49, DOI 10.1016/j.brainres.2008.11.013	39	496	508	3	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					298	301		10.1126/science.1175737	http://dx.doi.org/10.1126/science.1175737			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815778	Green Accepted			2022-12-28	WOS:000270599500045
J	Manolio, TA; Collins, FS; Cox, NJ; Goldstein, DB; Hindorff, LA; Hunter, DJ; McCarthy, MI; Ramos, EM; Cardon, LR; Chakravarti, A; Cho, JH; Guttmacher, AE; Kong, A; Kruglyak, L; Mardis, E; Rotimi, CN; Slatkin, M; Valle, D; Whittemore, AS; Boehnke, M; Clark, AG; Eichler, EE; Gibson, G; Haines, JL; Mackay, TFC; McCarroll, SA; Visscher, PM				Manolio, Teri A.; Collins, Francis S.; Cox, Nancy J.; Goldstein, David B.; Hindorff, Lucia A.; Hunter, David J.; McCarthy, Mark I.; Ramos, Erin M.; Cardon, Lon R.; Chakravarti, Aravinda; Cho, Judy H.; Guttmacher, Alan E.; Kong, Augustine; Kruglyak, Leonid; Mardis, Elaine; Rotimi, Charles N.; Slatkin, Montgomery; Valle, David; Whittemore, Alice S.; Boehnke, Michael; Clark, Andrew G.; Eichler, Evan E.; Gibson, Greg; Haines, Jonathan L.; Mackay, Trudy F. C.; McCarroll, Steven A.; Visscher, Peter M.			Finding the missing heritability of complex diseases	NATURE			English	Review							GENOME-WIDE ASSOCIATION; DENSITY-LIPOPROTEIN CHOLESTEROL; COPY-NUMBER VARIATION; RARE VARIANTS; SUSCEPTIBILITY LOCI; BREAST-CANCER; STRUCTURAL VARIATION; MENTAL-RETARDATION; CROHNS-DISEASE; INCREASE RISK	Genome-wide association studies have identified hundreds of genetic variants associated with complex human diseases and traits, and have provided valuable insights into their genetic architecture. Most variants identified so far confer relatively small increments in risk, and explain only a small proportion of familial clustering, leading many to question how the remaining, 'missing' heritability can be explained. Here we examine potential sources of missing heritability and propose research strategies, including and extending beyond current genome-wide association approaches, to illuminate the genetics of complex diseases and enhance its potential to enable effective disease prevention or treatment.	[Collins, Francis S.] NIH, Bethesda, MD 20892 USA; [Cox, Nancy J.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Cox, Nancy J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Goldstein, David B.] Duke Univ, IGSP, Durham, NC 27708 USA; [Hindorff, Lucia A.; Ramos, Erin M.] NHGRI, Off Populat Genom, Rockville, MD 20892 USA; [Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Cardon, Lon R.] GlaxoSmithKline, King Of Prussia, PA 19406 USA; [Chakravarti, Aravinda; Valle, David] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Cho, Judy H.] Yale Univ, Dept Med, Div Digest Dis, New Haven, CT 06520 USA; [Kong, Augustine] DeCODE Genet, IS-101 Reykjavik, Iceland; [Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Kruglyak, Leonid] Princeton Univ, Howard Hughes Med Inst, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Mardis, Elaine] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA; [Manolio, Teri A.; Rotimi, Charles N.] NHGRI, Ctr Res Genom & Global Hlth, Bethesda, MD 20892 USA; [Slatkin, Montgomery] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Whittemore, Alice S.] Stanford Univ, Stanford, CA 94305 USA; [Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Gibson, Greg] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37232 USA; [Mackay, Trudy F. C.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Visscher, Peter M.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	National Institutes of Health (NIH) - USA; University of Chicago; University of Chicago; Duke University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; GlaxoSmithKline; Johns Hopkins University; Yale University; Princeton University; Howard Hughes Medical Institute; Princeton University; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Berkeley; Stanford University; University of Michigan System; University of Michigan; Cornell University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Queensland; Vanderbilt University; University of North Carolina; North Carolina State University; Harvard University; Harvard Medical School; QIMR Berghofer Medical Research Institute	Manolio, TA (corresponding author), NHGRI, Ctr Res Genom & Global Hlth, Bldg 31,Room 4B09,31 Ctr Dr,MSC 2152, Bethesda, MD 20892 USA.	manoliot@mail.nih.gov	Visscher, Peter/ABB-6151-2020; Goldstein, David/AAY-8125-2020; Haines, Jonathan/C-3374-2012; Califano, Andrea/F-7239-2012; Mardis, Elaine/W-2202-2019; McCarthy, Mark/M-3763-2015	Visscher, Peter/0000-0002-2143-8760; Haines, Jonathan/0000-0002-4351-4728; Kong, Augustine/0000-0001-8193-5438; McCarthy, Mark/0000-0002-4393-0510; McCarroll, Steven/0000-0002-6954-8184; Clark, Andrew/0000-0001-7159-8511	NCRR NIH HHS [UL1 RR024992] Funding Source: Medline; NHGRI NIH HHS [R01 HG003229] Funding Source: Medline; NHLBI NIH HHS [U01 HL084706, R01 HL072904, R01 HL072904-07] Funding Source: Medline; NIGMS NIH HHS [P50 GM065509, P50 GM065509-080006] Funding Source: Medline; NIMH NIH HHS [R01 MH084695] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072904, U01HL084706] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362, R01HG003229, ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM065509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084695] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABECASIS GR, 2009, BIOL GENOMES, P246; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bassett AS, 2008, HUM MOL GENET, V17, P4045, DOI 10.1093/hmg/ddn307; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Collins FS, 2006, AM J HUM GENET, V79, P421, DOI 10.1086/507611; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CRAWFORD MH, 2006, ANTHR GENETICS THEOR, P341; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; FALCONER DS, 1996, INTRO QUANTITATIVE G, P123; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Gibson G, 2009, NAT REV GENET, V10, P134, DOI 10.1038/nrg2502; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Hindorff LA, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Keller MC, 2006, BEHAV BRAIN SCI, V29, P385, DOI 10.1017/S0140525X06009095; Khoury MJ, 2009, GENET MED, V11, P559, DOI 10.1097/GIM.0b013e3181b13a6c; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Lee SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000231; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lifton Richard P, 2004, Harvey Lect, V100, P71; Lord C, 2000, NEURON, V28, P355, DOI 10.1016/S0896-6273(00)00115-X; Lusis AJ, 2008, NAT GENET, V40, P129, DOI 10.1038/ng0208-129; MACLEAN CJ, 1993, AM J HUM GENET, V53, P353; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarroll SA, 2008, HUM MOL GENET, V17, pR135, DOI 10.1093/hmg/ddn282; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McCarthy MI, 2008, HUM MOL GENET, V17, pR156, DOI 10.1093/hmg/ddn289; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Meuwissen THE, 2001, GENETICS, V157, P1819; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pearson TA, 2008, JAMA-J AM MED ASSOC, V299, P1335, DOI 10.1001/jama.299.11.1335; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Thomas A, 2008, ANN HUM GENET, V72, P279, DOI 10.1111/j.1469-1809.2007.00406.x; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; Visscher PM, 2008, NAT GENET, V40, P489, DOI 10.1038/ng0508-489; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Waters KM, 2009, CANCER EPIDEM BIOMAR, V18, P1285, DOI 10.1158/1055-9965.EPI-08-1142; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhao JY, 2006, AM J HUM GENET, V79, P831, DOI 10.1086/508571; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	83	5478	5651	14	791	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					747	753		10.1038/nature08494	http://dx.doi.org/10.1038/nature08494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19812666	Green Accepted			2022-12-28	WOS:000270547500027
J	Riches, PL; McRorie, E; Fraser, WD; Determann, C; van't Hof, R; Ralston, SH				Riches, Philip L.; McRorie, Euan; Fraser, William D.; Determann, Catherine; van't Hof, Rob; Ralston, Stuart H.			BRIEF REPORT Osteoporosis Associated with Neutralizing Autoantibodies against Osteoprotegerin	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; CELIAC-DISEASE; PAGETS-DISEASE; MUTATIONS; CALCIUM; RANKL	Autoantibodies against osteoprotegerin, which block the inhibitory effect of osteoprotegerin on signaling by the receptor activator of nuclear factor (NF)-kappa B (RANK), were identified in a man with celiac disease who presented with severe osteoporosis and high bone turnover. The osteoporosis did not respond to the treatment of his celiac disease but was completely reversed by bisphosphonate therapy. Autoantibodies against osteoprotegerin were detected in three additional patients with celiac disease. Such autoantibodies may be associated with the development of high-turnover osteoporosis, but whether autoantibodies against osteoprotegerin commonly contribute to the pathogenesis of osteoporosis in patients with celiac disease remains to be determined.	[Riches, Philip L.; McRorie, Euan; Determann, Catherine; van't Hof, Rob; Ralston, Stuart H.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Rheumat Dis Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Fraser, William D.] Univ Liverpool, Sch Clin Sci, Unit Clin Chem, Liverpool L69 3BX, Merseyside, England	University of Edinburgh; University of Liverpool	Ralston, SH (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Rheumat Dis Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	stuart.ralston@ed.ac.uk	Riches, Philip/C-7308-2013	Riches, Philip/0000-0003-3029-7098; van 't Hof, Rob/0000-0002-8193-6788	Institute of Genetics and Molecular Medicine [15389, 17687]	Institute of Genetics and Molecular Medicine	Supported in part by an academic support grant ( 15389) and an integrated clinical arthritis center grant ( 17687) from the Arthritis Research Campaign and a clinical research fellowship from the Institute of Genetics and Molecular Medicine ( to Dr. Riches).	Bekker PJ, 2004, J BONE MINER RES, V19, P1059, DOI 10.1359/JBMR.040305; Bianchi ML, 2002, CALCIFIED TISSUE INT, V71, P465, DOI 10.1007/s00223-001-2131-6; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; CARR AJ, 1995, J BONE JOINT SURG BR, V77, P820, DOI 10.1302/0301-620X.77B5.7559718; Chong B, 2003, J BONE MINER RES, V18, P2095, DOI 10.1359/jbmr.2003.18.12.2095; Daroszewska A, 2004, J BONE MINER RES, V19, P1506, DOI 10.1359/JBMR.040602; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Meyer D, 2001, AM J GASTROENTEROL, V96, P112; Minich WB, 2004, J CLIN ENDOCR METAB, V89, P352, DOI 10.1210/jc.2003-030823; O'Neill SG, 2007, ANN RHEUM DIS, V66, P989, DOI 10.1136/ard.2007.073312; Pazianas M, 2005, OSTEOPOROSIS INT, V16, P56, DOI 10.1007/s00198-004-1641-2; PEACOCK M, 1969, LANCET, V1, P384; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Sobacchi C, 2007, NAT GENET, V39, P960, DOI 10.1038/ng2076; Whyte MP, 2002, NEW ENGL J MED, V347, P175, DOI 10.1056/NEJMoa013096	16	68	71	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2009	361	15					1459	1465		10.1056/NEJMoa0810925	http://dx.doi.org/10.1056/NEJMoa0810925			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503MU	19812402	Bronze			2022-12-28	WOS:000270540000007
J	Smith, TG; Talbot, NP; Privat, C; Rivera-Ch, M; Nickol, AH; Ratcliffe, PJ; Dorrington, KL; Leon-Velarde, F; Robbins, PA				Smith, Thomas G.; Talbot, Nick P.; Privat, Catherine; Rivera-Ch, Maria; Nickol, Annabel H.; Ratcliffe, Peter J.; Dorrington, Keith L.; Leon-Velarde, Fabiola; Robbins, Peter A.			Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension Two Randomized Controlled Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INDUCIBLE FACTOR; HIF-ALPHA; ALTITUDE; RESPONSES; PRESSURE; ERYTHROCYTOSIS; DEFICIENCY; BINDING; HUMANS; HEART	Context Hypoxia is a major cause of pulmonary hypertension in respiratory disease and at high altitude. Recent work has established that the effect of hypoxia on pulmonary arterial pressure may depend on iron status, possibly acting through the transcription factor hypoxia-inducible factor, but the pathophysiological and clinical importance of this interaction is unknown. Objective To determine whether increasing or decreasing iron availability modifies altitude-induced hypoxic pulmonary hypertension. Design, Setting, and Participants Two randomized, double-blind, placebo-controlled protocols conducted in October-November 2008. In the first protocol, 22 healthy sea-level resident men (aged 19-60 years) were studied over 1 week of hypoxia at Cerro de Pasco, Peru (altitude 4340 m). In the second protocol, 11 high-altitude resident men (aged 30-59 years) diagnosed with chronic mountain sickness were studied over 1 month of hypoxia at Cerro de Pasco, Peru. Intervention In the first protocol, participants received intravenous infusions of Fe(III)-hydroxide sucrose (200 mg) or placebo on the third day of hypoxia. In the second protocol, patients underwent staged isovolemic venesection of 2 L of blood. Two weeks later, patients received intravenous infusions of Fe(III)-hydroxide sucrose (400 mg) or placebo, which were subsequently crossed over. Main Outcome Measure Effect of varying iron availability on pulmonary artery systolic pressure (PASP) assessed by Doppler echocardiography. Results In the sea-level resident protocol, approximately 40% of the pulmonary hypertensive response to hypoxia was reversed by infusion of iron, which reduced PASP by 6 mm Hg (95% confidence interval [CI], 4-8 mm Hg), from 37 mm Hg (95% CI, 34-40 mm Hg) to 31 mm Hg (95% CI, 29-33 mm Hg; P=.01). In the chronic mountain sickness protocol, progressive iron deficiency induced by venesection was associated with an approximately 25% increase in PASP of 9 mm Hg (95% CI, 4-14 mm Hg), from 37 mm Hg (95% CI, 30-44 mm Hg) to 46 mm Hg (95% CI, 40-52 mm Hg; P=.003). During the subsequent crossover period, no acute effect of iron replacement on PASP was detected. Conclusion Hypoxic pulmonary hypertension may be attenuated by iron supplementation and exacerbated by iron depletion. Trial Registration clinicaltrials.gov Identifier: NCT00952302 JAMA. 2009; 302(13): 1444-1450	[Smith, Thomas G.; Talbot, Nick P.; Nickol, Annabel H.; Dorrington, Keith L.; Robbins, Peter A.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Ratcliffe, Peter J.] Univ Oxford, Nuffield Dept Clin Med, Oxford OX1 3PT, England; [Smith, Thomas G.; Dorrington, Keith L.] John Radcliffe Hosp, Nuffield Dept Anaesthet, Oxford OX3 9DU, England; [Talbot, Nick P.; Nickol, Annabel H.] Churchill Hosp, Oxford Ctr Resp Med, Oxford OX3 7LJ, England; [Privat, Catherine; Rivera-Ch, Maria; Leon-Velarde, Fabiola] Univ Peruana Cayetano Heredia, High Altitude Adaptat Lab, Lima, Peru	University of Oxford; University of Oxford; University of Oxford; University of Oxford; Universidad Peruana Cayetano Heredia	Robbins, PA (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England.	peter.robbins@dpag.ox.ac.uk	; Robbins, Peter/C-7846-2016	Leon-Velarde Servetto, Fabiola/0000-0001-8398-2406; Robbins, Peter/0000-0002-4975-0609; Talbot, Nick/0000-0002-9186-8950; Ratcliffe, Peter/0000-0002-2853-806X; Rivera-Chira, Maria/0000-0001-9470-6642; Smith, Thomas/0000-0002-5197-5030	Dunhill Medical Trust (UK expenses); Wellcome Trust	Dunhill Medical Trust (UK expenses)(Dunhill Medical Trust); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the Dunhill Medical Trust (UK expenses) and the Wellcome Trust.	Allemann Y, 2000, AM J PHYSIOL-HEART C, V279, pH2013, DOI 10.1152/ajpheart.2000.279.4.H2013; Balanos GM, 2002, J APPL PHYSIOL, V92, P2501, DOI 10.1152/japplphysiol.00965.2001; Barbera JA, 2003, EUR RESPIR J, V21, P892, DOI 10.1183/09031936.03.00115402; Bartsch P, 2005, J APPL PHYSIOL, V98, P1101, DOI 10.1152/japplphysiol.01167.2004; Brusselmans K, 2003, J CLIN INVEST, V111, P1519, DOI 10.1172/JCI200315496; Bushuev VI, 2006, HAEMATOLOGICA, V91, P744; Diller GP, 2007, CIRCULATION, V115, P1039, DOI 10.1161/CIRCULATIONAHA.105.592386; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Gale DP, 2008, BLOOD, V112, P919, DOI 10.1182/blood-2008-04-153718; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Knowles HJ, 2003, CANCER RES, V63, P1764; Leon-Velarde F, 2005, HIGH ALT MED BIOL, V6, P147, DOI 10.1089/ham.2005.6.147; McLaughlin VV, 2006, CIRCULATION, V114, P1417, DOI 10.1161/CIRCULATIONAHA.104.503540; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; Penaloza D, 2007, CIRCULATION, V115, P1132, DOI 10.1161/CIRCULATIONAHA.106.624544; Percy MJ, 2009, AM J HEMATOL, V84, P46, DOI 10.1002/ajh.21313; RAKITA L, 1965, AM HEART J, V70, P466, DOI 10.1016/0002-8703(65)90358-3; RICHALET JP, 1994, AM J PHYSIOL, V266, pR756, DOI 10.1152/ajpregu.1994.266.3.R756; Semenza GL, 2007, ANTIOXID REDOX SIGN, V9, P1391, DOI 10.1089/ars.2007.1691; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Shimoda LA, 2001, AM J PHYSIOL-LUNG C, V281, pL202, DOI 10.1152/ajplung.2001.281.1.L202; Smith TG, 2008, BRIT J HAEMATOL, V141, P325, DOI 10.1111/j.1365-2141.2008.07029.x; Smith TG, 2006, PLOS MED, V3, P1178, DOI 10.1371/journal.pmed.0030290; Smith TG, 2008, J PHYSIOL-LONDON, V586, P5999, DOI 10.1113/jphysiol.2008.160960; Talbot NP, 2005, J APPL PHYSIOL, V98, P1125, DOI 10.1152/japplphysiol.00903.2004; WANG GL, 1993, BLOOD, V82, P3610; WEISSE AB, 1975, AM J MED, V58, P92, DOI 10.1016/0002-9343(75)90538-0; YOCK PG, 1984, CIRCULATION, V70, P657, DOI 10.1161/01.CIR.70.4.657; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498	33	123	126	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	2009	302	13					1444	1450		10.1001/jama.2009.1404	http://dx.doi.org/10.1001/jama.2009.1404			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503CL	19809026	Bronze			2022-12-28	WOS:000270509600019
J	Triplett, JW; Owens, MT; Yamada, J; Lemke, G; Cang, JH; Stryker, MP; Feldheim, DA				Triplett, Jason W.; Owens, Melinda T.; Yamada, Jena; Lemke, Greg; Cang, Jianhua; Stryker, Michael P.; Feldheim, David A.			Retinal Input Instructs Alignment of Visual Topographic Maps	CELL			English	Article							EPHRIN-AS; SUPERIOR COLLICULUS; MICE LACKING; FUNCTIONAL MAPS; GANGLION-CELL; WAVES; PROJECTIONS; REFINEMENT; MECHANISMS; SEGREGATION	Sensory information is represented in the brain in the form of topographic maps, in which neighboring neurons respond to adjacent external stimuli. In the visual system, the superior colliculus receives topographic projections from the retina and primary visual cortex (V1) that are aligned. Alignment may be achieved through the use of a gradient of shared axon guidance molecules, or through a retinal-matching mechanism in which axons that monitor identical regions of visual space align. To distinguish between these possibilities, we take advantage of genetically engineered mice that we show have a duplicated functional retinocollicular map but only a single map in V1. Anatomical tracing revealed that the corticocollicular projection bifurcates to align with the duplicated retinocollicular map in a manner dependent on the normal pattern of spontaneous activity during development. These data suggest a general model in which convergent maps use coincident activity patterns to achieve alignment.	[Triplett, Jason W.; Yamada, Jena; Feldheim, David A.] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Owens, Melinda T.; Stryker, Michael P.] Univ Calif San Francisco, Dept Physiol, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; [Lemke, Greg] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Cang, Jianhua] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	University of California System; University of California Santa Cruz; University of California System; University of California San Francisco; Salk Institute; Northwestern University	Feldheim, DA (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	feldheim@biology.ucsc.edu		Owens, Melinda/0000-0001-8286-5419; Stryker, Michael/0000-0003-1546-5831	NIH [R01-EY014689, R01-EY02874, R01-EY018621, R01-NS031249]; NIH National Research Service Award Postdoctoral Fellowship [F32-EY18531]; NIH Training Program for the Visual Sciences [T32-EY007120]; NATIONAL EYE INSTITUTE [R01EY014689, R01EY018621, R01EY002874, F32EY018531, T32EY007120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS031249] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Research Service Award Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Training Program for the Visual Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH (R01-EY014689 to D. A. F., R01-EY02874 to M. P. S., R01-EY018621 to J.C., R01-NS031249 to G. L.). J.W.T. was supported by an NIH National Research Service Award Postdoctoral Fellowship (F32-EY18531). M.T.O was supported by an NIH Training Program for the Visual Sciences (T32-EY007120). We thank Bin Chen, Yi Zuo, and members of the Feldheim and Stryker labs for discussion and critical reading of the manuscript.	Bansal A, 2000, J NEUROSCI, V20, P7672; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Brown NL, 2001, DEVELOPMENT, V128, P2497; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; Cang JH, 2008, J NEUROSCI, V28, P11015, DOI 10.1523/JNEUROSCI.2478-08.2008; Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025; Chandrasekaran AR, 2007, J NEUROSCI, V27, P1746, DOI 10.1523/JNEUROSCI.4383-06.2007; Chandrasekaran AR, 2005, J NEUROSCI, V25, P6929, DOI 10.1523/JNEUROSCI.1470-05.2005; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Chklovskii DB, 2004, ANNU REV NEUROSCI, V27, P369, DOI 10.1146/annurev.neuro.27.070203.144226; Del Cano GG, 2002, J COMP NEUROL, V446, P166, DOI 10.1002/cne.10179; Demas J, 2006, NEURON, V50, P247, DOI 10.1016/j.neuron.2006.03.033; DRAGER UC, 1976, J NEUROPHYSIOL, V39, P91, DOI 10.1152/jn.1976.39.1.91; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Firth SI, 2005, CELL CALCIUM, V37, P425, DOI 10.1016/j.ceca.2005.01.010; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gallarda BW, 2008, SCIENCE, V320, P233, DOI 10.1126/science.1153758; Hebb D. O., 1949, ORG BEHAV NEUROPHYSI; Hindges R, 2002, NEURON, V35, P475, DOI 10.1016/S0896-6273(02)00799-7; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; Khachab MY, 1999, DEV BRAIN RES, V114, P179, DOI 10.1016/S0165-3806(99)00020-6; KING AJ, 1988, NATURE, V332, P73, DOI 10.1038/332073a0; KNUDSEN EI, 1991, SCIENCE, V253, P85, DOI 10.1126/science.2063209; Lemke G, 2005, ANNU REV CELL DEV BI, V21, P551, DOI 10.1146/annurev.cellbio.20.022403.093702; Lin B, 2004, NEURON, V43, P475, DOI 10.1016/j.neuron.2004.08.002; Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Pak W, 2004, CELL, V119, P567, DOI 10.1016/j.cell.2004.10.026; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; SCHILLER PH, 1974, J NEUROPHYSIOL, V37, P181, DOI 10.1152/jn.1974.37.1.181; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Sun C, 2008, P NATL ACAD SCI USA, V105, P13638, DOI 10.1073/pnas.0807178105; Syed MM, 2004, J PHYSIOL-LONDON, V560, P533, DOI 10.1113/jphysiol.2004.066597; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Xu W, 1999, J NEUROSCI, V19, P9298	49	81	82	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					175	185		10.1016/j.cell.2009.08.028	http://dx.doi.org/10.1016/j.cell.2009.08.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804762	Green Accepted, Bronze			2022-12-28	WOS:000270388600025
J	Phillpot, SR; Sinnott, SB				Phillpot, Simon R.; Sinnott, Susan B.			Simulating Multifunctional Structures	SCIENCE			English	Editorial Material							MOLECULAR-DYNAMICS SIMULATIONS; ATOM SIMULATIONS; HYDROCARBONS; POTENTIALS; INTERFACES; STRENGTH; FILMS		[Phillpot, Simon R.; Sinnott, Susan B.] Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Phillpot, SR (corresponding author), Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA.	sphil@mse.ufl.edu; ssinn@mse.ufl.edu	Sinnott, Susan B/P-8523-2014; Phillpot, Simon R/J-9117-2012	Sinnott, Susan B/0000-0002-3598-0403; Phillpot, Simon/0000-0002-7774-6535				BRENNER DW, 1990, PHYS REV B, V42, P9458, DOI 10.1103/PhysRevB.42.9458; BRENNER DW, 1989, PHYS REV LETT, V63, P1022, DOI 10.1103/PhysRevLett.63.1022; Carter EA, 2008, SCIENCE, V321, P800, DOI 10.1126/science.1158009; DAW MS, 1983, PHYS REV LETT, V50, P1285, DOI 10.1103/PhysRevLett.50.1285; Iwasaki T, 2001, J MATER RES, V16, P1789, DOI 10.1557/JMR.2001.0247; Klein ML, 2008, SCIENCE, V321, P798, DOI 10.1126/science.1157834; Nakano A, 2007, COMP MATER SCI, V38, P642, DOI 10.1016/j.commatsci.2006.04.012; RAPPE AK, 1991, J PHYS CHEM-US, V95, P3358, DOI 10.1021/j100161a070; STREITZ FH, 1994, PHYS REV B, V50, P11996, DOI 10.1103/PhysRevB.50.11996; van Duin ACT, 2001, J PHYS CHEM A, V105, P9396, DOI 10.1021/jp004368u; Vashishta P, 2006, J PHYS CHEM B, V110, P3727, DOI 10.1021/jp0556153; Yasukawa A, 1996, JSME INT J A-MECH M, V39, P313, DOI 10.1299/jsmea1993.39.3_313; Yu JG, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.085311	13	28	28	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1634	1635		10.1126/science.1177794	http://dx.doi.org/10.1126/science.1177794			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	498II	19779181				2022-12-28	WOS:000270131800025
J	Cross, M				Cross, Michael			Health Informatics Can the NHS get connected?	BRITISH MEDICAL JOURNAL			English	Editorial Material												michaelcross@fastmail.fm						DAVIS E, 2009, DEFENCE SPINE E HLTH; IT Policy Review Group, 2009, IND REV NHS SOC CAR; *NAT AUD OFF, 2008, NAT PROGR IT NHS PRO	3	1	1	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 24	2009	339								b3647	10.1136/bmj.b3647	http://dx.doi.org/10.1136/bmj.b3647			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OG	19778974				2022-12-28	WOS:000270231800005
J	Melbourne, BA; Hastings, A				Melbourne, Brett A.; Hastings, Alan			Highly Variable Spread Rates in Replicated Biological Invasions: Fundamental Limits to Predictability	SCIENCE			English	Article							CHAOTIC DYNAMICS; VARIABILITY; DISPERSAL; ECOLOGY; MODELS	Although mean rates of spread for invasive species have been intensively studied, variance in spread rates has been neglected. Variance in spread rates can be driven exogenously by environmental variability or endogenously by demographic or genetic stochasticity in reproduction, survival, and dispersal. Endogenous variability is likely to be important in spread but has not been studied empirically. We show that endogenously generated variance in spread rates is remarkably high between replicated invasions of the flour beetle Tribolium castaneum in laboratory microcosms. The observed variation between replicate invasions cannot be explained by demographic stochasticity alone, which indicates inherent limitations to predictability in even the simplest ecological settings.	[Melbourne, Brett A.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Hastings, Alan] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California Davis	Melbourne, BA (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	brett.melbourne@colorado.edu	Hastings, Alan/O-6864-2019	Hastings, Alan/0000-0002-0717-8026; MELBOURNE, BRETT/0000-0002-8843-4131	National Science Foundation [DEB 0516150]; NSF Biological Invasions Integrative Graduate Education and Research Traineeship (IGERT) [DGE 0114432]	National Science Foundation(National Science Foundation (NSF)); NSF Biological Invasions Integrative Graduate Education and Research Traineeship (IGERT)(National Science Foundation (NSF))	We thank M. Gibson, D. Hodgkiss, C. Koenig, T. McCabe, D. Paulus, D. Smith, N. Tcheou, R. Villalobos, and M. Wu for assistance. This study was funded by National Science Foundation grant DEB 0516150 to A. H. and B. A. M. and by NSF Biological Invasions Integrative Graduate Education and Research Traineeship (IGERT) DGE 0114432.	ANDOW DA, 1990, LANDSCAPE ECOL, V4, P177, DOI 10.1007/BF00132860; Carpenter SR, 2002, ECOLOGY, V83, P2069, DOI 10.2307/3072038; Clark JS, 2001, SCIENCE, V293, P657, DOI 10.1126/science.293.5530.657; CLARK JS, 1979, ECOLOGY, V84, P2003; Costantino R. F., 1991, POPULATION DYNAMICS; Costantino RF, 1997, SCIENCE, V275, P389, DOI 10.1126/science.275.5298.389; Dennis B, 2001, ECOL MONOGR, V71, P277, DOI 10.1890/0012-9615(2001)071[0277:ECACDI]2.0.CO;2; Gibson GJ, 2006, STAT COMPUT, V16, P391, DOI 10.1007/s11222-006-0019-z; Gibson GJ, 1999, P ROY SOC B-BIOL SCI, V266, P1743, DOI 10.1098/rspb.1999.0841; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hengeveld R., 1989, Dynamics of biological invasions., P116; Henson SM, 2001, SCIENCE, V294, P602, DOI 10.1126/science.1063358; Kleczkowski A, 1996, P ROY SOC B-BIOL SCI, V263, P777, DOI 10.1098/rspb.1996.0116; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Lewis MA, 2000, J MATH BIOL, V41, P430, DOI 10.1007/s002850000022; Lewis MA, 2000, J MATH BIOL, V41, P387, DOI 10.1007/s002850000050; LEWIS MA, 1993, THEOR POPUL BIOL, V43, P141, DOI 10.1006/tpbi.1993.1007; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; MOLLISON D, 1991, MATH BIOSCI, V107, P255, DOI 10.1016/0025-5564(91)90009-8; National Invasive Species Council, 2008, 2008 2012 NAT INV SP; NAYLOR AF, 1961, ECOLOGY, V42, P231, DOI 10.2307/1932074; Otten W, 2003, ECOLOGY, V84, P3232, DOI 10.1890/02-0564; PARK T, 1948, ECOL MONOGR, V18, P265, DOI 10.2307/1948641; SHIGESADA N, 1995, AM NAT, V146, P229, DOI 10.1086/285796; SKELLAM JG, 1951, BIOMETRIKA, V38, P196, DOI 10.2307/2332328; VANDENBOSCH F, 1992, J BIOGEOGR, V19, P135, DOI 10.2307/2845500; Weinberger HF, 2002, J MATH BIOL, V45, P183, DOI 10.1007/s002850200145; Wikle CK, 2003, ECOLOGY, V84, P1382, DOI 10.1890/0012-9658(2003)084[1382:HBMFPT]2.0.CO;2	30	119	120	3	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1536	1539		10.1126/science.1176138	http://dx.doi.org/10.1126/science.1176138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762641				2022-12-28	WOS:000269887900038
J	Scully, MO; Svidzinsky, AA				Scully, Marlan O.; Svidzinsky, Anatoly A.			The Super of Superradiance	SCIENCE			English	Editorial Material							EMISSION; PHOTON		[Scully, Marlan O.; Svidzinsky, Anatoly A.] Texas A&M Univ, College Stn, TX 77843 USA; [Scully, Marlan O.] Princeton Univ, Princeton, NJ 08544 USA	Texas A&M University System; Texas A&M University College Station; Princeton University	Scully, MO (corresponding author), Texas A&M Univ, College Stn, TX 77843 USA.	scully@tamu.edu						Das S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.153601; DICKE RH, 1954, PHYS REV, V93, P99, DOI 10.1103/PhysRev.93.99; Eberly JH, 2006, J PHYS B-AT MOL OPT, V39, pS599, DOI 10.1088/0953-4075/39/15/S07; Friedberg R, 2008, PHYS LETT A, V372, P2514, DOI 10.1016/j.physleta.2007.11.064; Haroche S., 2006, EXPLORING QUANTUM; Mazets IE, 2007, J PHYS B-AT MOL OPT, V40, pF105, DOI 10.1088/0953-4075/40/6/F01; Prasad S, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.063814; SCULLY M, 2006, PHYS REV LETT, V72, P241; Scully MO, 2007, LASER PHYS, V17, P635, DOI 10.1134/S1054660X07050064; Scully MO, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.143601; SKRIBANO.N, 1973, PHYS REV LETT, V30, P309, DOI 10.1103/PhysRevLett.30.309; Svidzinsky A, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.043833; Svidzinsky AA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.160504; Svidzinsky AA, 2009, OPT COMMUN, V282, P2894, DOI 10.1016/j.optcom.2009.04.011	14	192	193	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1510	1511		10.1126/science.1176695	http://dx.doi.org/10.1126/science.1176695			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762635				2022-12-28	WOS:000269887900028
J	Weiser, TG; Makary, MA; Haynes, AB; Dziekan, G; Berry, WR; Gawande, AA				Weiser, Thomas G.; Makary, Martin A.; Haynes, Alex B.; Dziekan, Gerald; Berry, William R.; Gawande, Atul A.		Safe Surg Saves Lives Measurement; Safe Surg Saves Lives Study Grp	Standardised metrics for global surgical surveillance	LANCET			English	Article							CARE	Public health surveillance relies on standardised metrics to evaluate disease burden and health system performance. Such metrics have not been developed for surgical services despite increasing volume, substantial cost, and high rates of death and disability associated with surgery. The Safe Surgery Saves Lives initiative of WHO's Patient Safety Programme has developed standardised public health metrics for surgical care that are applicable worldwide. We assembled an international panel of experts to develop and define metrics for measuring the magnitude and effect of surgical care in a population, while taking into account economic feasibility and practicability. This panel recommended six measures for assessing surgical services at a national level: number of operating rooms, number of operations, number of accredited surgeons, number of accredited anaesthesia professionals, day-of-surgery death ratio, and postoperative in-hospital death ratio. We assessed the feasibility of gathering such statistics at eight diverse hospitals in eight countries and incorporated them into the WHO Guidelines for Safe Surgery, in which methods for data collection, analysis, and reporting are outlined.	[Weiser, Thomas G.; Haynes, Alex B.; Berry, William R.; Gawande, Atul A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Weiser, Thomas G.; Gawande, Atul A.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; [Makary, Martin A.] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA; [Haynes, Alex B.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Dziekan, Gerald] WHO Patient Safety Programme, Geneva, Switzerland	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Johns Hopkins University; Harvard University; Massachusetts General Hospital; World Health Organization	Gawande, AA (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Kresge 400,677 Huntington Ave, Boston, MA 02115 USA.	safesurgery@hsph.harvard.edu	Weiser, Thomas G/AAC-4609-2022; Haynes, Alex/K-1446-2013	Weiser, Thomas G/0000-0002-3118-3888; Haynes, Alex/0000-0002-5731-329X; Gawande, Atul/0000-0002-1824-9176; STORR, JULIE/0000-0002-3052-2905; Merry, Alan/0000-0001-7100-009X	WHO	WHO(World Health Organization)	This work was supported by WHO, which also provided funding for AAG as lead of the Safe Surgery Saves Lives Initiative. WHO had no role in the decision to submit this work for publication. We would like to thank the following people for help in supplying data: Vanessa Beavis, Kylie Edwards, Ian Civil (Auckland, New Zealand); Amit Vats (London, UK); Chandra Meghrajani (Manila, Philippines); Vickie Kolios-Morris (Seattle, USA); Robert Bell, Joe Slack (Toronto, Canada).	AbouZahr C, 2007, LANCET, V370, P1791, DOI 10.1016/S0140-6736(07)61310-5; [Anonymous], 2008, WORLD HLTH STAT 2008; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; GAWANDE A, 1992, SURGERY, V126, P66; Gosselin RA, 2006, WORLD J SURG, V30, P505, DOI 10.1007/s00268-005-0609-5; Gosselin RA, 2008, WORLD J SURG, V32, P2450, DOI 10.1007/s00268-008-9708-4; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Kable AK, 2002, INT J QUAL HEALTH C, V14, P269, DOI 10.1093/intqhc/14.4.269; Mahapatra P, 2007, LANCET, V370, P1653, DOI 10.1016/S0140-6736(07)61308-7; McCord C, 2003, INT J GYNECOL OBSTET, V81, P83, DOI 10.1016/S0020-7292(03)00072-9; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; *WHO, 2006, WORLD ALL PAT SAF PR; *WHO WORLD ALL PAT, 2008, WHO GUID SAF SURG; World Health Organization, 2007, MAT MORT 2005 EST DE	15	99	100	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2009	374	9695					1113	1117		10.1016/S0140-6736(09)61161-2	http://dx.doi.org/10.1016/S0140-6736(09)61161-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501HA	19782877	Green Submitted			2022-12-28	WOS:000270370900034
J	Levy, SE; Mandell, DS; Schultz, RT				Levy, Susan E.; Mandell, David S.; Schultz, Robert T.			Autism	LANCET			English	Review							PERVASIVE DEVELOPMENTAL DISORDERS; SPECTRUM DISORDERS; YOUNG-CHILDREN; DIAGNOSTIC INTERVIEW; ASPERGER-SYNDROME; PSYCHOSOCIAL INTERVENTIONS; COMMUNICATION DISORDERS; SOCIAL COMMUNICATION; QUANTITATIVE MEASURE; BEHAVIOR CHECKLIST	Autism spectrum disorders are characterised by severe deficits in socialisation, communication, and repetitive or unusual behaviours. Increases over time in the frequency of these disorders (to present rates of about 60 cases per 10000 children) might be attributable to factors such as new administrative classifications, policy and practice changes, and increased awareness. Surveillance and screening strategies for early identification could enable early treatment and improved outcomes. Autism spectrum disorders are highly genetic and multifactorial, with many risk factors acting together. Genes that affect synaptic maturation are implicated, resulting in neurobiological theories focusing on connectivity and neural effects of gene expression. Several treatments might address core and comorbid symptoms. However, not all treatments have been adequately studied. Improved strategies for early identification with phenotypic characteristics and biological markers (eg, electrophysiological changes) might hopefully improve effectiveness of treatment. Further knowledge about early identification, neurobiology of autism, effective treatments, and the effect of this disorder on families is needed.	[Levy, Susan E.; Schultz, Robert T.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Ctr Autism Res, Philadelphia, PA 19104 USA; [Levy, Susan E.; Mandell, David S.; Schultz, Robert T.] Univ Penn, Sch Med, Dept Psychiat, Ctr Autism Res, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Levy, SE (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Sch Med, Ctr Autism Res, 3535 Market St, Philadelphia, PA 19104 USA.	levys@email.chop.edu			Center for Disease Control and Prevention [1-U10-DD-000182-03]; National Institutes of Health [1-RO1-MH-073807, 1-RO1-DC008871-01, RO1 ES016443-01, 1 P50 HD055726-01, 1 RO1 HD055741-01, 5R01mh076189-03]; National Science Foundation [sbe-0542013]; NIH/NIMS [SRO1MH073084]; Pennsylvania Department of Health [410042728]; National Institute of Mental Health [1K01MH067628-1, 1 R01 MH077000-01]; Department of Defense [W81XWH-07-ASDRP-CA]; NIMH [1 RO1 MH083717-01A1]; Department of Education [IES-NCSER-2008-1]; CENTERS FOR DISEASE CONTROL AND PREVENTION [U10DD000182] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH067628, R01MH083717, R01MH073084, R01MH077000, R01MH076189, R01MH073807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008871] Funding Source: NIH RePORTER	Center for Disease Control and Prevention; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NIH/NIMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Defense(United States Department of Defense); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Department of Education(US Department of Education); CENTERS FOR DISEASE CONTROL AND PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported in part by grants from: the Center for Disease Control and Prevention (grant number 1-U10-DD-000182-03), the National Institutes of Health (NIH; 1-RO1-MH-073807, 1-RO1-DC008871-01, and RO1 ES016443-01) for SEL; from the National Science Foundation (sbe-0542013), NIH/NIMS (SRO1MH073084), NIH (1 P50 HD055726-01, 1 RO1 HD055741-01, and 5R01mh076189-03), and Pennsylvania Department of Health (SAP#410042728) for RTS; the National Institute of Mental Health (1K01MH067628-1 and 1 R01 MH077000-01) and Department of Defense (W81XWH-07-ASDRP-CA) for DSM; and NIMH (1 RO1 MH083717-01A1) and Department of Education (IES-NCSER-2008-1) for DSM and SEL.	ALBIN RW, 1996, POSITIVE BEHAV SUPPO; Allison C, 2008, J AUTISM DEV DISORD, V38, P1414, DOI 10.1007/s10803-007-0509-7; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Auyeung B, 2008, J AUTISM DEV DISORD, V38, P1230, DOI 10.1007/s10803-007-0504-z; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Baron-Cohen S, 2000, J ROY SOC MED, V93, P521, DOI 10.1177/014107680009301007; Bryson SE, 2008, J AUTISM DEV DISORD, V38, P731, DOI 10.1007/s10803-007-0440-y; Chandler S, 2007, J AM ACAD CHILD PSY, V46, P1324, DOI 10.1097/chi.0b013e31812f7d8d; Charman T, 2002, J CHILD PSYCHOL PSYC, V43, P289, DOI 10.1111/1469-7610.00022; Cohen IL, 2003, J AUTISM DEV DISORD, V33, P47, DOI 10.1023/A:1022278420716; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Dawson G, 2008, DEV PSYCHOPATHOL, V20, P775, DOI 10.1017/S0954579408000370; DeVincent C, 2008, J DEV BEHAV PEDIATR, V29, P1, DOI 10.1097/DBP.0b013e3181468c32; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Eaves RC, 2000, PSYCHOL SCHOOLS, V37, P311, DOI 10.1002/1520-6807(200007)37:4<323::AID-PITS2>3.0.CO;2-S; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Gadow KD, 2008, J AUTISM DEV DISORD, V38, P419, DOI 10.1007/s10803-007-0408-y; Geurts HM, 2004, J CHILD PSYCHOL PSYC, V45, P1437, DOI 10.1111/j.1469-7610.2004.00326.x; Gillberg C, 2000, ACTA PSYCHIAT SCAND, V102, P321, DOI 10.1034/j.1600-0447.2000.102005321.x; Gray KM, 2008, J AUTISM DEV DISORD, V38, P1003, DOI 10.1007/s10803-007-0473-2; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hartley SL, 2008, J INTELL DISABIL RES, V52, P819, DOI 10.1111/j.1365-2788.2008.01065.x; Herring S, 2006, J INTELL DISABIL RES, V50, P874, DOI 10.1111/j.1365-2788.2006.00904.x; Hess KL, 2008, J AUTISM DEV DISORD, V38, P961, DOI 10.1007/s10803-007-0470-5; Hollander E, 2003, LANCET, V362, P732, DOI 10.1016/S0140-6736(03)14236-5; Honda H, 2009, J CHILD PSYCHOL PSYC, V50, P972, DOI 10.1111/j.1469-7610.2009.02055.x; Howard JS, 2005, RES DEV DISABIL, V26, P359, DOI 10.1016/j.ridd.2004.09.005; Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x; Howlin P, 1999, DEV MED CHILD NEUROL, V41, P834, DOI 10.1017/S0012162299001656; Howlin P, 2009, AJIDD-AM J INTELLECT, V114, P23, DOI [10.1352/2009.114:23-41, 10.1352/2009.114:23;nd41]; Ingersoll B, 2007, RES DEV DISABIL, V28, P163, DOI 10.1016/j.ridd.2006.02.004; Jahromi LB, 2009, J AUTISM DEV DISORD, V39, P395, DOI 10.1007/s10803-008-0636-9; Johnson CP, 2007, PEDIATRICS, V120, P1183, DOI 10.1542/peds.2007-2361; Kadesjo B, 1999, J AUTISM DEV DISORD, V29, P327, DOI 10.1023/A:1022115520317; Karabekiroglu K, 2009, CHILD PSYCHIAT HUM D, V40, P99, DOI 10.1007/s10578-008-0108-7; King BH, 2006, CHILD ADOL PSYCH CL, V15, P161, DOI 10.1016/j.chc.2005.08.005; King BH, 2009, ARCH GEN PSYCHIAT, V66, P583, DOI 10.1001/archgenpsychiatry.2009.30; Koegel RL, 2001, J CLIN CHILD PSYCHOL, V30, P19, DOI 10.1207/S15374424JCCP3001_4; KOEGEL RL, 1987, J AUTISM DEV DISORD, V17, P187, DOI 10.1007/BF01495055; Kolevzon A, 2006, J CLIN PSYCHIAT, V67, P407, DOI 10.4088/JCP.v67n0311; Kraijer D, 2005, J AUTISM DEV DISORD, V35, P499, DOI 10.1007/s10803-005-5040-0; Krug DA., 2003, KRUG ASPERGERS DISOR; Kumar RA, 2009, CURR NEUROL NEUROSCI, V9, P188, DOI 10.1007/s11910-009-0029-2; Lam KSL, 2007, J AUTISM DEV DISORD, V37, P855, DOI 10.1007/s10803-006-0213-z; Lam KSL, 2006, RES DEV DISABIL, V27, P254, DOI 10.1016/j.ridd.2005.03.003; Lecavalier L, 2006, AM J MENT RETARD, V111, P199, DOI 10.1352/0895-8017(2006)111[199:VOTADI]2.0.CO;2; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; Levy SE, 2008, CHILD ADOL PSYCH CL, V17, P803, DOI 10.1016/j.chc.2008.06.004; Limoges E, 2005, BRAIN, V128, P1049, DOI 10.1093/brain/awh425; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Lord C, 2005, J AUTISM DEV DISORD, V35, P695, DOI 10.1007/s10803-005-0017-6; Losh M, 2008, AM J MED GENET B, V147B, P424, DOI 10.1002/ajmg.b.30612; Magyar CI, 2007, J AUTISM DEV DISORD, V37, P1787, DOI 10.1007/s10803-006-0313-9; Mandell DS, 2008, PEDIATRICS, V121, pE441, DOI 10.1542/peds.2007-0984; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Matson JL, 2007, RES DEV DISABIL, V28, P341, DOI 10.1016/j.ridd.2005.12.004; McBride SMJ, 2005, NEURON, V45, P753, DOI 10.1016/j.neuron.2005.01.038; McDougle CJ, 2000, CHILD ADOL PSYCH CL, V9, P201; McGee GG, 1999, J ASSOC PERS SEVERE, V24, P133, DOI 10.2511/rpsd.24.3.133; Minshew NJ, 2007, ARCH NEUROL-CHICAGO, V64, P945, DOI 10.1001/archneur.64.7.945; Myers SM, 2009, PEDIATR ANN, V38, P42, DOI 10.3928/00904481-20090101-08; MYLES BS, 2000, ASDS ASPERGER SYNDRO; *NAT IN AUT, 2003, NAT AUT PLAN CHILDR; National Research Council, 2001, ED CHILDR AUT; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Nikolov RN, 2009, J AUTISM DEV DISORD, V39, P405, DOI 10.1007/s10803-008-0637-8; O'Roak BJ, 2008, AUTISM RES, V1, P4, DOI 10.1002/aur.3; Osborne LA, 2008, J AUTISM DEV DISORD, V38, P1092, DOI 10.1007/s10803-007-0497-7; Ospina MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003755; Ozonoff S, 2005, J CLIN CHILD ADOLESC, V34, P523, DOI 10.1207/s15374424jccp3403_8; *PA DEP PUBL WELF, 2007, PENNS AUT ASS DIAGN; Pardo CA, 2007, BRAIN PATHOL, V17, P434, DOI 10.1111/j.1750-3639.2007.00102.x; PARR J, 2007, BMJ CLIN EVID, V12, P322; Paul R, 2008, CHILD ADOL PSYCH CL, V17, P835, DOI 10.1016/j.chc.2008.06.011; Piven J, 1997, AM J PSYCHIAT, V154, P185; Posey DJ, 2008, CHILD ADOL PSYCH CL, V17, P787, DOI 10.1016/j.chc.2008.06.010; Prizant BM, 2003, INFANT YOUNG CHILD, V16, P296, DOI 10.1097/00001163-200310000-00004; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Rapin I, 2008, PEDIATR CLIN N AM, V55, P1129, DOI 10.1016/j.pcl.2008.07.005; Rellini E, 2004, J AUTISM DEV DISORD, V34, P703, DOI 10.1007/s10803-004-5290-2; Reznick JS, 2007, J AUTISM DEV DISORD, V37, P1691, DOI 10.1007/s10803-006-0303-y; Roberts TPL, 2008, INT J PSYCHOPHYSIOL, V68, P149, DOI 10.1016/j.ijpsycho.2008.01.012; Robins DL, 2001, J AUTISM DEV DISORD, V31, P131, DOI 10.1023/A:1010738829569; Rogers SJ, 2008, J CLIN CHILD ADOLESC, V37, P8, DOI 10.1080/15374410701817808; Rogers SJ, 2003, J AUTISM DEV DISORD, V33, P631, DOI 10.1023/B:JADD.0000006000.38991.a7; ROGERS SJ, 1991, TOP EARLY CHILD SPEC, V11, P29, DOI 10.1177/027112149101100205; Schaefer GB, 2008, GENET MED, V10, P4, DOI 10.1097/GIM.0b013e31815efdd7; Schlosser RW, 2008, AM J SPEECH-LANG PAT, V17, P212, DOI 10.1044/1058-0360(2008/021); Schreibman L., 2005, SCI FICTION AUTISM; Schultz RT, 2005, INT J DEV NEUROSCI, V23, P125, DOI 10.1016/j.ijdevneu.2004.12.012; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Seida JK, 2009, DEV MED CHILD NEUROL, V51, P95, DOI 10.1111/j.1469-8749.2008.03211.x; Shattuck PT, 2006, PEDIATRICS, V117, P1028, DOI 10.1542/peds.2005-1516; Sikora D., 2005, FOCUS AUTISM OTHER D, V20, P213, DOI [10.1177/10883576050200040301, DOI 10.1177/10883576050200040301]; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Skuse D, 2004, J AM ACAD CHILD PSY, V43, P548, DOI 10.1097/00004583-200405000-00008; Skuse DH, 2005, BRIT J PSYCHIAT, V187, P568, DOI 10.1192/bjp.187.6.568; Sponheim E, 1998, J AUTISM DEV DISORD, V28, P217, DOI 10.1023/A:1026017405150; Stone WL, 2004, J AUTISM DEV DISORD, V34, P691, DOI 10.1007/s10803-004-5289-8; Stone WL, 2003, AUTISM, V7, P9, DOI 10.1177/1362361303007001003; Tabuchi K, 2007, SCIENCE, V318, P71, DOI 10.1126/science.1146221; Taffe JR, 2007, AM J MENT RETARD, V112, P31, DOI 10.1352/0895-8017(2007)112[31:SFOTDB]2.0.CO;2; Tebruegge Marc, 2004, BMC Pediatr, V4, P4, DOI 10.1186/1471-2431-4-4; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Volkmar FR, 2003, LANCET, V362, P1133, DOI 10.1016/S0140-6736(03)14471-6; Volkmar FR, 2008, WORLD PSYCHIATRY, V7, P19; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; WHO, 2012, ICD 10 CLASS MENT BE; Wieder S, 2003, AUTISM, V7, P425, DOI 10.1177/1362361303007004008; Wing L, 1997, LANCET, V350, P1761, DOI 10.1016/S0140-6736(97)09218-0; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; Wong V, 2004, PEDIATRICS, V114, P166	118	493	521	2	203	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 7	2009	374	9701					1627	1638		10.1016/S0140-6736(09)61376-3	http://dx.doi.org/10.1016/S0140-6736(09)61376-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	518EZ	19819542	Green Accepted			2022-12-28	WOS:000271674600037
J	Beloqui, A; Guazzaroni, ME; Pazos, F; Vieites, JM; Godoy, M; Golyshina, OV; Chernikova, TN; Waliczek, A; Silva-Rocha, R; Al-ramahi, Y; La Cono, V; Mendez, C; Salas, JA; Solano, R; Yakimov, MM; Timmis, KN; Golyshin, PN; Ferrer, M				Beloqui, Ana; Guazzaroni, Maria-Eugenia; Pazos, Florencio; Vieites, Jose M.; Godoy, Marta; Golyshina, Olga V.; Chernikova, Tatyana N.; Waliczek, Agnes; Silva-Rocha, Rafael; Al-ramahi, Yamal; La Cono, Violetta; Mendez, Carmen; Salas, Jose A.; Solano, Roberto; Yakimov, Michail M.; Timmis, Kenneth N.; Golyshin, Peter N.; Ferrer, Manuel			RETRACTED: Reactome Array: Forging a Link Between Metabolome and Genome (Retracted article. See vol. 330, pg. 912, 2010)	SCIENCE			English	Article; Retracted Publication							METAGENOMICS; PATHWAYS; ARCHAEA; STRESS	We describe a sensitive metabolite array for genome sequence-independent functional analysis of metabolic phenotypes and networks, the reactomes, of cell populations and communities. The array includes 1676 dye-linked substrate compounds collectively representing central metabolic pathways of all forms of life. Application of cell extracts to the array leads to specific binding of enzymes to cognate substrates, transformation to products, and concomitant activation of the dye signals. Proof of principle was shown by reconstruction of the metabolic maps of model bacteria. Utility of the array for unsequenced organisms was demonstrated by reconstruction of the global metabolisms of three microbial communities derived from acidic volcanic pool, deep-sea brine lake, and hydrocarbon-polluted seawater. Enzymes of interest are captured on nanoparticles coated with cognate metabolites, sequenced, and their functions unequivocally established.	[Golyshina, Olga V.; Chernikova, Tatyana N.; Waliczek, Agnes; Timmis, Kenneth N.; Golyshin, Peter N.] HZI Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Pazos, Florencio; Godoy, Marta; Silva-Rocha, Rafael; Solano, Roberto] CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain; [Beloqui, Ana; Guazzaroni, Maria-Eugenia; Vieites, Jose M.; Al-ramahi, Yamal; Ferrer, Manuel] CSIC, Inst Catalysis, E-28049 Madrid, Spain; [La Cono, Violetta; Yakimov, Michail M.] CNR, Inst Coastal Marine Environm, I-98122 Messina, Italy; [Mendez, Carmen; Salas, Jose A.] Univ Oviedo, E-33006 Oviedo, Spain; [Timmis, Kenneth N.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Golyshin, Peter N.] Bangor Univ, Sch Biol Sci, Bangor LL57 2UW, Gwynedd, Wales; [Golyshin, Peter N.] Aberystwyth Univ Bangor Univ Partnership CIRRE, Ctr Integrated Res Rural Environm, Aberystwyth, Dyfed, Wales	Helmholtz Association; Helmholtz-Center for Infection Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Catalisis y Petroleoquimica (ICP); Consiglio Nazionale delle Ricerche (CNR); University of Oviedo; Braunschweig University of Technology; Bangor University; Aberystwyth University	Golyshin, PN (corresponding author), HZI Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany.	p.golyshin@bangor.ac.uk; mferrer@icp.csic.es	La Cono, Violetta/AAY-1416-2020; Mendez-Fernandez, Carmen/ABE-5745-2020; La Cono, Violetta/S-9890-2017; Guazzaroni, Maria-Eugenia/E-2599-2013; Ferrer, Manuel/K-4535-2014; Yakimov, Michail/H-1829-2016	Mendez-Fernandez, Carmen/0000-0003-2729-841X; Chernikova, Tatyana/0000-0001-6684-9099; Golyshin, Peter/0000-0002-5433-0350; La Cono, Violetta/0000-0002-3306-4938; Guazzaroni, Maria-Eugenia/0000-0002-4657-3731; Ferrer, Manuel/0000-0003-4962-4714; Yakimov, Michail/0000-0003-1418-363X	Spanish MEC [BIO2006-15318]; Federal Ministry for Science and Education (BMBF); Fonds der Chemischen Industrie;  [BIO2006-11738];  [CSD2007-00005];  [GEN2006-27750-C-4-E];  [BFU2008-04398-E/BMC];  [KBBE-226977]	Spanish MEC(Spanish Government); Federal Ministry for Science and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); ; ; ; ; 	This research was supported by the BIO2006-11738, CSD2007-00005, GEN2006-27750-C-4-E, BFU2008-04398-E/BMC, and KBBE-226977 projects. A. B and Y. A-R thank the Spanish MEC for the FPU and FPI fellowships. F. P. thanks the Spanish MEC for the BIO2006-15318 project. K. N. T, O. V. G., and P. N. G acknowledge the Federal Ministry for Science and Education (BMBF) for a grant in the framework of the BiotechGenoMik program, and K. N. T. thanks the Fonds der Chemischen Industrie for generous support. Authors are deeply indebted to A. Yanenko for sampling Kolguev Island coastal water and to the captain and crew of Research Vessel Urania for their assistance in deep-sea sampling in the Mediterranean Sea and to J. Manuel Franco for statistical analyses.	Biddle JF, 2008, P NATL ACAD SCI USA, V105, P10583, DOI 10.1073/pnas.0709942105; Daffonchio D, 2006, NATURE, V440, P203, DOI 10.1038/nature04418; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Golyshina OV, 2005, ENVIRON MICROBIOL, V7, P1277, DOI 10.1111/j.1462-2920.2005.00861.x; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; Huang EY, 1997, J BACTERIOL, V179, P5648, DOI 10.1128/jb.179.17.5648-5653.1997; Jiao YYQ, 2005, APPL ENVIRON MICROB, V71, P4487, DOI 10.1128/AEM.71.8.4487-4496.2005; Jimenez JI, 2002, ENVIRON MICROBIOL, V4, P824, DOI 10.1046/j.1462-2920.2002.00370.x; Kalyuzhnaya MG, 2008, NAT BIOTECHNOL, V26, P1029, DOI 10.1038/nbt.1488; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Lombardot T, 2006, NUCLEIC ACIDS RES, V34, pD390, DOI 10.1093/nar/gkj070; Northen TR, 2008, P NATL ACAD SCI USA, V105, P3678, DOI 10.1073/pnas.0712332105; Pearce DA, 1999, J BACTERIOL, V181, P4774, DOI 10.1128/JB.181.16.4774-4779.1999; PRONK AF, 1995, J BACTERIOL, V177, P75, DOI 10.1128/jb.177.1.75-81.1995; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Turnbaugh PJ, 2008, CELL, V134, P708, DOI 10.1016/j.cell.2008.08.025; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569; Vieites JM, 2009, FEMS MICROBIOL REV, V33, P236, DOI 10.1111/j.1574-6976.2008.00152.x; Whitham TG, 2008, SCIENCE, V320, P492, DOI 10.1126/science.1153918; Woodson JD, 2003, J BACTERIOL, V185, P7193, DOI 10.1128/JB.185.24.7193-7201.2003; Yakimov MM, 2007, CURR OPIN BIOTECH, V18, P257, DOI 10.1016/j.copbio.2007.04.006	26	32	36	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					252	257		10.1126/science.1174094	http://dx.doi.org/10.1126/science.1174094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815770				2022-12-28	WOS:000270599500034
J	Dermitzakis, ET; Clark, AG				Dermitzakis, Emmanouil T.; Clark, Andrew G.			Life After GWA Studies	SCIENCE			English	Editorial Material							LOCI; HEIGHT		[Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	University of Geneva; Cornell University	Dermitzakis, ET (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	emmanouil.dermitzakis@unige.ch; ac347@cornell.edu	Dermitzakis, Emmanouil/B-7687-2013	Clark, Andrew/0000-0001-7159-8511	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084706] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG003229-05, R01 HG003229] Funding Source: Medline; NHLBI NIH HHS [U01 HL084706, U01 HL084706-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Dermitzakis ET, 2008, NAT GENET, V40, P492, DOI 10.1038/ng0508-492; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Macdonald SJ, 2005, GENETICS, V171, P1741, DOI 10.1534/genetics.105.045344; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	9	27	30	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					239	240		10.1126/science.1182009	http://dx.doi.org/10.1126/science.1182009			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	504EX	19815762	Green Accepted			2022-12-28	WOS:000270599500026
J	Richards, H				Richards, Helen			Personal View We must defend personal continuity in primary care	BRITISH MEDICAL JOURNAL			English	Editorial Material												Helen.cowan3@btinternet.com						2007, BRIT MED J, V335, P941	1	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 6	2009	339								b3923	10.1136/bmj.b3923	http://dx.doi.org/10.1136/bmj.b3923			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505TF	19808748				2022-12-28	WOS:000270719100005
J	Zhang, EE; Liu, AC; Hirota, T; Miraglia, LJ; Welch, G; Pongsawakul, PY; Liu, XZ; Atwood, A; Huss, JW; Janes, J; Su, AI; Hogenesch, JB; Kay, SA				Zhang, Eric E.; Liu, Andrew C.; Hirota, Tsuyoshi; Miraglia, Loren J.; Welch, Genevieve; Pongsawakul, Pagkapol Y.; Liu, Xianzhong; Atwood, Ann; Huss, Jon W., III; Janes, Jeff; Su, Andrew I.; Hogenesch, John B.; Kay, Steve A.			A Genome-wide RNAi Screen for Modifiers of the Circadian Clock in Human Cells	CELL			English	Article							GENE-EXPRESSION; RESPONSE ELEMENT; REVEALS; TRANSCRIPTION; MOUSE; IDENTIFICATION; CRYPTOCHROME; COMPONENT; MUTATION; FBXL3	Two decades of research identified more than a dozen clock genes and defined a biochemical feedback mechanism of circadian oscillator function. To identify additional clock genes and modifiers, we conducted a genome-wide small interfering RNA screen in a human cellular clock model. Knockdown of nearly 1000 genes reduced rhythm amplitude. Potent effects on period length or increased amplitude were less frequent; we found hundreds of these and confirmed them in secondary screens. Characterization of a subset of these genes demonstrated a dosage-dependent effect on oscillator function. Protein interaction network analysis showed that dozens of gene products directly or indirectly associate with known clock components. Pathway analysis revealed these genes are overrepresented for components of insulin and hedgehog signaling, the cell cycle, and the folate metabolism. Coupled with data showing many of these pathways are clock regulated, we conclude the clock is interconnected with many aspects of cellular function.	[Hogenesch, John B.] Univ Penn, Sch Med, Penn Genome Frontiers Inst, Inst Translat Med & Therapeut,Dept Pharmacol, Philadelphia, PA 19104 USA; [Zhang, Eric E.; Liu, Andrew C.; Hirota, Tsuyoshi; Miraglia, Loren J.; Welch, Genevieve; Liu, Xianzhong; Huss, Jon W., III; Janes, Jeff; Su, Andrew I.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Zhang, Eric E.; Hirota, Tsuyoshi; Pongsawakul, Pagkapol Y.; Atwood, Ann; Kay, Steve A.] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Liu, Andrew C.] Univ Memphis, Dept Biol, Memphis, TN 38152 USA	University of Pennsylvania; Pennsylvania Medicine; Novartis; University of California System; University of California San Diego; University of Memphis	Hogenesch, JB (corresponding author), Univ Penn, Sch Med, Penn Genome Frontiers Inst, Inst Translat Med & Therapeut,Dept Pharmacol, Philadelphia, PA 19104 USA.	hogenesc@mail.med.upenn.edu; skay@ucsd.edu	Kay, Steve A/F-6025-2011; Pongsawakul, Pagkapol Y./GSD-2959-2022; Liu, Andrew C/B-3548-2009; Hirota, Tsuyoshi/D-8158-2015	Kay, Steve A/0000-0002-0402-2878; Liu, Andrew C/0000-0003-1927-0900; Hirota, Tsuyoshi/0000-0003-4876-3608; Zhang, Eric/0000-0002-4472-7493; Su, Andrew I./0000-0002-9859-4104	National Institutes of Health [MH51573, GM74868]; Pennsylvania Commonwealth Health Research Formula Funds; National Institute of Neurological Disease and Stroke [1R01NS054794]; National Institute of Mental Health [P50 MH074924-01]; University of Memphis startup fund; National Science Foundation [IOS-0920417]; NIGMS [1R01GM083924]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074868, R01GM083924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051573, P50MH074924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Commonwealth Health Research Formula Funds; National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); University of Memphis startup fund; National Science Foundation(National Science Foundation (NSF)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Buu Tu for technical support in the screens, Jia Zhang and Tony Orth for help with Qiagen siRNA libraries, Chunlei Wu and Ghislain Bonamy for help with BioGPS, and Richard Glynne and Peter Schultz for their institutional support and encouragement. We also thank Jose Pruneda-Paz, Elizabeth Hamilton, Dmitri A. Nusinow, Michael Hughes, Julie Baggs, and Jason DeBruyne for critically reading the manuscript. This work is supported by National Institutes of Health grants to S. A. K. (MH51573 and GM74868). J.B.H. is supported by the Pennsylvania Commonwealth Health Research Formula Funds, the National Institute of Neurological Disease and Stroke (1R01NS054794), and the National Institute of Mental Health (P50 MH074924-01, awarded to Joseph S. Takahashi, Northwestern University). A. C. L. is supported by The University of Memphis startup fund and the National Science Foundation (IOS-0920417). S. A. K. is a founder of ReSet Therapeutics and is a member of its Scientific Advisory Board. BioGPS development is supported by NIGMS (1R01GM083924 to A. I. S.). This is manuscript number 090513 of the Genomics Institute of the Novartis Research Foundation.	Andre E, 1998, EMBO J, V17, P3867, DOI 10.1093/emboj/17.14.3867; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Baggs JE, 2009, PLOS BIOL, V7, P563, DOI 10.1371/journal.pbio.1000052; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; FLORENES VA, 1994, J NATL CANCER I, V86, P1297, DOI 10.1093/jnci/86.17.1297; Gachon F, 2006, CELL METAB, V4, P25, DOI 10.1016/j.cmet.2006.04.015; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Liu AC, 2007, NAT CHEM BIOL, V3, P630, DOI 10.1038/nchembio.2007.37; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Maier B, 2009, GENE DEV, V23, P708, DOI 10.1101/gad.512209; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Mullenders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004798; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takahashi JS, 2004, J BIOL RHYTHM, V19, P339, DOI 10.1177/0748730404269151; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Ukai-Tadenuma M, 2008, NAT CELL BIOL, V10, P1154, DOI 10.1038/ncb1775; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453	43	303	312	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					199	210		10.1016/j.cell.2009.08.031	http://dx.doi.org/10.1016/j.cell.2009.08.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19765810	Green Accepted, Bronze			2022-12-28	WOS:000270388600027
J	Azzopardi, DV; Strohm, B; Edwards, AD; Dyet, L; Halliday, HL; Juszczak, E; Kapellou, O; Levene, M; Marlow, N; Porter, E; Thoresen, M; Whitelaw, A; Brocklehurst, P				Azzopardi, Denis V.; Strohm, Brenda; Edwards, A. David; Dyet, Leigh; Halliday, Henry L.; Juszczak, Edmund; Kapellou, Olga; Levene, Malcolm; Marlow, Neil; Porter, Emma; Thoresen, Marianne; Whitelaw, Andrew; Brocklehurst, Peter		TOBY Study Grp	Moderate Hypothermia to Treat Perinatal Asphyxial Encephalopathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; WHOLE-BODY HYPOTHERMIA; NEONATAL ENCEPHALOPATHY; MILD HYPOTHERMIA; NEWBORN PIGLET; OUTCOMES; INFANTS; SAFETY; MODEL; TRIAL	Background: Whether hypothermic therapy improves neurodevelopmental outcomes in newborn infants with asphyxial encephalopathy is uncertain. Methods: We performed a randomized trial of infants who were less than 6 hours of age and had a gestational age of at least 36 weeks and perinatal asphyxial encephalopathy. We compared intensive care plus cooling of the body to 33.5 degreesC for 72 hours and intensive care alone. The primary outcome was death or severe disability at 18 months of age. Prespecified secondary outcomes included 12 neurologic outcomes and 14 other adverse outcomes. Results: Of 325 infants enrolled, 163 underwent intensive care with cooling, and 162 underwent intensive care alone. In the cooled group, 42 infants died and 32 survived but had severe neurodevelopmental disability, whereas in the noncooled group, 44 infants died and 42 had severe disability (relative risk for either outcome, 0.86; 95% confidence interval [CI], 0.68 to 1.07; P=0.17). Infants in the cooled group had an increased rate of survival without neurologic abnormality (relative risk, 1.57; 95% CI, 1.16 to 2.12; P=0.003). Among survivors, cooling resulted in reduced risks of cerebral palsy (relative risk, 0.67; 95% CI, 0.47 to 0.96; P=0.03) and improved scores on the Mental Developmental Index and Psychomotor Developmental Index of the Bayley Scales of Infant Development II (P=0.03 for each) and the Gross Motor Function Classification System (P=0.01). Improvements in other neurologic outcomes in the cooled group were not significant. Adverse events were mostly minor and not associated with cooling. Conclusions: Induction of moderate hypothermia for 72 hours in infants who had perinatal asphyxia did not significantly reduce the combined rate of death or severe disability but resulted in improved neurologic outcomes in survivors. (Current Controlled Trials number, ISRCTN89547571.) N Engl J Med 2009;361:1349-58.	[Azzopardi, Denis V.; Edwards, A. David; Dyet, Leigh; Kapellou, Olga; Porter, Emma] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Clin Sci, London W12 0NN, England; [Azzopardi, Denis V.; Edwards, A. David; Dyet, Leigh; Kapellou, Olga; Porter, Emma] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC, Ctr Clin Sci, London W12 0NN, England; [Strohm, Brenda; Juszczak, Edmund; Brocklehurst, Peter] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England; [Halliday, Henry L.] Queens Univ Belfast, Dept Child Hlth, Belfast BT7 1NN, Antrim, North Ireland; [Halliday, Henry L.] Royal Matern Hosp, Dept Perinatal Med, Belfast, Antrim, North Ireland; [Levene, Malcolm] Univ Leeds, Leeds, W Yorkshire, England; [Levene, Malcolm] Leeds Gen Infirm, Leeds, W Yorkshire, England; [Marlow, Neil] Queens Med Ctr, Acad Div Child Hlth, Nottingham NG7 2UH, England; [Thoresen, Marianne] Univ Bristol, St Michaels Hosp, Dept Clin Sci, Bristol, Avon, England; [Whitelaw, Andrew] Southmead Hosp, Bristol, Avon, England	Imperial College London; Imperial College London; University of Oxford; Queens University Belfast; University of Leeds; Leeds General Infirmary; University of Leeds; University of Nottingham; University of Bristol; Southmead Hospital	Azzopardi, DV (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Clin Sci, Du Cane Rd, London W12 0NN, England.	d.azzopardi@imperial.ac.uk	Ramenghi, Luca/AAB-4067-2020; Marlow, Neil/D-2918-2009; Dore, Caroline J/J-4716-2012; Brocklehurst, Peter/B-5804-2011; Edwards, Anthony/HCI-9626-2022; Petrou, Stavros/ABD-8323-2021	Ramenghi, Luca/0000-0003-0065-762X; Marlow, Neil/0000-0001-5890-2953; Dore, Caroline J/0000-0001-9796-4970; Hubbard, Marie/0000-0003-0388-4983; Petrou, Stavros/0000-0003-3121-6050; Edwards, Anthony David/0000-0003-4801-7066; Blennow, Mats/0000-0001-9517-0261; Halliday, Henry/0000-0001-7978-4992	U. K. Medical Research Council; U. K. Department of Health; Medical Research Council [G0100126, MC_U120081323, G0200270, G0501681] Funding Source: researchfish; MRC [G0100126, G0200270, G0501681, MC_U120081323] Funding Source: UKRI	U. K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U. K. Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the U. K. Medical Research Council and the U. K. Department of Health.	al Naqeeb N, 1999, PEDIATRICS, V103, P1263, DOI 10.1542/peds.103.6.1263; Allmark P, 2006, J MED ETHICS, V32, P439, DOI 10.1136/jme.2005.013722; Amess PN, 1997, PEDIATR RES, V41, P803, DOI 10.1203/00006450-199706000-00002; Azzopardi D, 2000, PEDIATRICS, V106, P684, DOI 10.1542/peds.106.4.684; Barks JDE, 2008, SEMIN FETAL NEONAT M, V13, P30, DOI 10.1016/j.siny.2007.09.004; Barnett AL, 2004, ARCH DIS CHILD, V89, P637, DOI 10.1136/adc.2002.019349; Bayley N, 1993, BAYLEY SCALES INFANT; Bona E, 1998, PEDIATR RES, V43, P738, DOI 10.1203/00006450-199806000-00005; Colbourne F, 2000, J CEREBR BLOOD F MET, V20, P1702, DOI 10.1097/00004647-200012000-00009; Edwards AD, 1995, BIOCHEM BIOPH RES CO, V217, P1193, DOI 10.1006/bbrc.1995.2895; Eicher DJ, 2005, PEDIATR NEUROL, V32, P18, DOI 10.1016/j.pediatrneurol.2004.06.015; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Gunn AJ, 1998, PEDIATRICS, V102, P885, DOI 10.1542/peds.102.4.885; Haataja L, 1999, J PEDIATR-US, V135, P153, DOI 10.1016/S0022-3476(99)70016-8; Higgins RD, 2006, J PEDIATR-US, V148, P170, DOI 10.1016/j.jpeds.2005.12.009; JACOBS S, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003311.PUB2; Kirpalani H, 2007, PEDIATRICS, V120, P1126, DOI 10.1542/peds.2006-2776; Palisano RJ, 2000, PHYS THER, V80, P974, DOI 10.1093/ptj/80.10.974; Schulzke Sven M, 2007, BMC Pediatr, V7, P30; Shah PS, 2007, ARCH PEDIAT ADOL MED, V161, P951, DOI 10.1001/archpedi.161.10.951; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Shankaran S, 2008, PEDIATRICS, V122, pE791, DOI 10.1542/peds.2008-0456; Sirimanne ES, 1996, PEDIATR RES, V39, P591, DOI 10.1203/00006450-199604000-00005; THORESEN M, 1995, PEDIATR RES, V37, P667, DOI 10.1203/00006450-199505000-00019; Voss W, 2007, ACTA PAEDIATR, V96, P342, DOI 10.1111/j.1651-2227.2006.00130.x; Wyatt JS, 2007, PEDIATRICS, V119, P912, DOI 10.1542/peds.2006-2839	26	1151	1186	0	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2009	361	14					1349	1358		10.1056/NEJMoa0900854	http://dx.doi.org/10.1056/NEJMoa0900854			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500KZ	19797281	Green Published			2022-12-28	WOS:000270300000009
J	Leonard, P				Leonard, Phil			Personal View Improving the use of IT in the NHS	BRITISH MEDICAL JOURNAL			English	Editorial Material												pleonard@uk.ey.com							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 29	2009	339								b3922	10.1136/bmj.b3922	http://dx.doi.org/10.1136/bmj.b3922			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	502KX	19808830				2022-12-28	WOS:000270459600005
J	Olanow, CW; Rascol, O; Hauser, R; Feigin, PD; Jankovic, J; Lang, A; Langston, W; Melamed, E; Poewe, W; Stocchi, F; Tolosa, E				Olanow, C. Warren; Rascol, Olivier; Hauser, Robert; Feigin, Paul D.; Jankovic, Joseph; Lang, Anthony; Langston, William; Melamed, Eldad; Poewe, Werner; Stocchi, Fabrizio; Tolosa, Eduardo		ADAGIO Study Investigators	A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BCL-2 FAMILY-MEMBERS; MOTOR FLUCTUATIONS; DRUG RASAGILINE; NEUROPROTECTION; PROGRESSION; LEVODOPA; DERIVATIVES; MECHANISM; DEPRENYL; THERAPY	Background A therapy that slows disease progression is the major unmet need in Parkinson's disease. Methods In this double-blind trial, we examined the possibility that rasagiline has disease-modifying effects in Parkinson's disease. A total of 1176 subjects with untreated Parkinson's disease were randomly assigned to receive rasagiline (at a dose of either 1 mg or 2 mg per day) for 72 weeks (the early-start group) or placebo for 36 weeks followed by rasagiline (at a dose of either 1 mg or 2 mg per day) for 36 weeks (the delayed-start group). To determine a positive result with either dose, the early-start treatment group had to meet each of three hierarchical end points of the primary analysis based on the Unified Parkinson's Disease Rating Scale (UPDRS, a 176-point scale, with higher numbers indicating more severe disease): superiority to placebo in the rate of change in the UPDRS score between weeks 12 and 36, superiority to delayed-start treatment in the change in the score between baseline and week 72, and noninferiority to delayed-start treatment in the rate of change in the score between weeks 48 and 72. Results Early-start treatment with rasagiline at a dose of 1 mg per day met all end points in the primary analysis: a smaller mean (+/- SE) increase ( rate of worsening) in the UPDRS score between weeks 12 and 36 (0.09 +/- 0.02 points per week in the early-start group vs. 0.14 +/- 0.01 points per week in the placebo group, P=0.01), less worsening in the score between baseline and week 72 (2.82 +/- 0.53 points in the early-start group vs. 4.52 +/- 0.56 points in the delayed-start group, P=0.02), and noninferiority between the two groups with respect to the rate of change in the UPDRS score between weeks 48 and 72 (0.085 +/- 0.02 points per week in the early-start group vs. 0.085 +/- 0.02 points per week in the delayed-start group, P<0.001). All three end points were not met with rasagiline at a dose of 2 mg per day, since the change in the UPDRS score between baseline and week 72 was not significantly different in the two groups (3.47 +/- 0.50 points in the early-start group and 3.11 +/- 0.50 points in the delayed- start group, P=0.60). Conclusions Early treatment with rasagiline at a dose of 1 mg per day provided benefits that were consistent with a possible disease-modifying effect, but early treatment with rasagiline at a dose of 2 mg per day did not. Because the two doses were associated with different outcomes, the study results must be interpreted with caution. (ClinicalTrials. gov number, NCT00256204.)	[Olanow, C. Warren] Mt Sinai Sch Med, Dept Neurol & Neurosci, New York, NY 10029 USA; [Rascol, Olivier] Ctr Hosp Univ, INSERM, CIC 9302, Toulouse, France; [Rascol, Olivier] Ctr Hosp Univ, UMR 825, Dept Clin Pharmacol, Toulouse, France; [Rascol, Olivier] Ctr Hosp Univ, Dept Neurosci, Toulouse, France; [Rascol, Olivier] Univ Toulouse, Fac Med, Toulouse, France; [Hauser, Robert] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA; [Feigin, Paul D.] Technion Israel Inst Technol, Dept Ind Engn & Management, Haifa, Israel; [Jankovic, Joseph] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Lang, Anthony] Univ Toronto, Div Neurol, Toronto, ON, Canada; [Langston, William] Calif Parkinson Inst, Sunnyvale, CA USA; [Melamed, Eldad] Rabin Med Ctr, Dept Neurol, Petah Tiqwa, Israel; [Melamed, Eldad] Sackler Sch Med, Tel Aviv, Israel; [Poewe, Werner] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria; [Stocchi, Fabrizio] Ist Ricovero & Cura Carattere Sci San Raffaele Pi, Inst Neurol, Rome, Italy; [Tolosa, Eduardo] Univ Barcelona, Dept Neurol, Barcelona, Spain; [Tolosa, Eduardo] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain	Icahn School of Medicine at Mount Sinai; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; CHU de Toulouse; Universite de Toulouse; State University System of Florida; University of South Florida; Technion Israel Institute of Technology; Baylor College of Medicine; University of Toronto; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Medical University of Innsbruck; University of Barcelona; CIBERNED	Olanow, CW (corresponding author), Mt Sinai Sch Med, Dept Neurosci, 1 Gustave Levy Pl,Annenberg 14-94, New York, NY 10029 USA.	warren.olanow@mssm.edu	stocchi, fabrizio/K-5089-2016; Lang, Anthony/ABF-8114-2021; Schnitzler, Alfons/K-4625-2014; Deuschl, Gunther/A-7986-2010; Gasser, Thomas/GNH-5293-2022; LICEND, CEMND/F-1296-2015; Micheli, Federico E/A-8358-2012; Schnitzler, Alfons/Q-5520-2019	stocchi, fabrizio/0000-0002-5763-0033; Schnitzler, Alfons/0000-0002-6414-7939; Deuschl, Gunther/0000-0002-4176-9196; Gasser, Thomas/0000-0002-1069-1146; Schnitzler, Alfons/0000-0002-6414-7939; Calopa, Matilde/0000-0002-6943-3707; Cunha, Luis/0000-0002-0828-3485; Lang, Anthony/0000-0003-1229-3667; Feigin, Paul/0000-0002-5665-0331	Eutherapie; Novartis; Boehringer Ingelheim; Pierre Fabre; GlaxoSmithKline; Lund beck; Advanced Neuromodulation Systems; Ceregene; Medtronic Neurological; Kyowa; Schwarz Biosciences; SkyePharm; Chelsea Therapeutics; Solvay; Neurogen; Eisai; AstraZeneca	Eutherapie; Novartis(Novartis); Boehringer Ingelheim(Boehringer Ingelheim); Pierre Fabre; GlaxoSmithKline(GlaxoSmithKline); Lund beck(Lundbeck Corporation); Advanced Neuromodulation Systems; Ceregene; Medtronic Neurological; Kyowa; Schwarz Biosciences; SkyePharm; Chelsea Therapeutics; Solvay(Solvay SA); Neurogen; Eisai(Eisai Co Ltd); AstraZeneca(AstraZeneca)	Dr. Olanow reports receiving consulting and lecture fees from Teva and Lundbeck and consulting fees from Boehringer Ingelheim, Novartis/Orion, Solvay, Ceregene, and Merck Serono and owning equity in Ceregene; Dr. Rascol, receiving consulting fees from Eisai, Eutherapie, GlaxoSmithKline, Osmotica, Novartis, Schering- Plough, Boehringer Ingelheim, Solvay, and Teva, lecture fees from Eutherapie, Novartis, Boehringer Ingelheim, and Lundbeck, and grant support from Eutherapie, Novartis, Boehringer Ingelheim, Pierre Fabre, GlaxoSmithKline, and Lund beck; Dr. Hauser, receiving consulting and lecture fees from Allergan Neuroscience, Alphamedica, ApotheCom, Axis Healthcare, Bayer Schering, Boehringer Ingelheim, CNS Schering-Plough, Centopharm, Embryon, Eisai, Genzyme, GlaxoSmithKline, Impax, Ipsen, Kyowa, Merck, Novartis, Ortho- McNeil, Pfizer, Prestwick, Quintiles, Santhera, Schwarz Pharma, Schering- Plough, Solvay, Teva Neuroscience, Valeant Pharm, and Vernalis and serving as an investigator for Allergan, Solvay, Schering-Plough, Acadia, Eisai, Bayer, SkyePharma, GlaxoSmithKline, UCB Pharma, Novartis, Kyowa, Boehringer Ingelheim, INC Research, Mentor, Asubio, Valeant Pharm, Quintiles, Vernalis, i3 Research, Teva Neuroscience, and Chelsea Therapeutics; Dr. Feigin, receiving consulting fees from Teva and being an employee of Technion-Israel Institute of Technology, a subsidiary of which receives royalties from sales of Azilect; Dr. Jankovic, receiving consulting fees from Teva and grant support from Boehringer Ingelheim, Advanced Neuromodulation Systems, Ceregene, Medtronic Neurological, Kyowa, Novartis, Schwarz Biosciences (UCB Pharma), SkyePharm (GlaxoSmithKline), Chelsea Therapeutics, Solvay, Neurogen, and Eisai; Dr. Lang, receiving consulting and lecture fees from Teva; Dr. Langston, receiving consulting and lecture fees from Teva and consulting fees from Merck Serono and Newron; Dr. Melamed, receiving lecture fees from Lundbeck; Dr. Poewe, receiving consulting fees from Teva, Boehringer Ingelheim, Genzyme, Solvay, and Novartis, lecture fees from Teva, Boehringer Ingelheim, Novartis, UCB, and Orion, and grant support from Boehringer Ingelheim and AstraZeneca; Dr. Stocchi, receiving consulting and lecture fees from Lundbeck and Teva; and Dr. Tolosa, receiving consulting fees from Teva, UCB, Novartis, and Boehringer Ingelheim and lecture fees from Novartis, Lundbeck, and Boehringer Ingelheim. No other potential conflict of interest relevant to this article was reported.	Bar-Am O, 2007, J NEUROCHEM, V103, P500, DOI 10.1111/j.1471-4159.2007.04777.x; Blandini F, 2004, EXP NEUROL, V187, P455, DOI 10.1016/j.expneurol.2004.03.005; Carlile GW, 2000, MOL PHARMACOL, V57, P2; Clarke CE, 2008, MOVEMENT DISORD, V23, P784, DOI 10.1002/mds.21918; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Leber P, 1996, ALZ DIS ASSOC DIS, V10, P31, DOI 10.1097/00002093-199601031-00009; Leber P, 1997, ALZ DIS ASSOC DIS, V11, pS10; Mandel S, 2005, BRAIN RES REV, V48, P379, DOI 10.1016/j.brainresrev.2004.12.027; Olanow CW, 2006, LANCET NEUROL, V5, P1013, DOI 10.1016/S1474-4422(06)70602-0; Olanow CW, 2008, MOVEMENT DISORD, V23, P2194, DOI 10.1002/mds.22218; Olanow CW, 2004, ANNU REV MED, V55, P41, DOI 10.1146/annurev.med.55.091902.104422; OLANOW CW, 1995, ANN NEUROL, V38, P771, DOI 10.1002/ana.410380512; Rascol O, 2005, LANCET, V365, P947, DOI 10.1016/S0140-6736(05)71083-7; Sagi Y, 2007, NEUROBIOL DIS, V25, P35, DOI 10.1016/j.nbd.2006.07.020; Schapira AHV, 2006, ANN NEUROL, V59, P559, DOI 10.1002/ana.20789; Schapira AHV, 2004, JAMA-J AM MED ASSOC, V291, P358, DOI 10.1001/jama.291.3.358; Schwid SR, 2005, ARCH NEUROL-CHICAGO, V62, P241; SHOULSON I, 1993, NEW ENGL J MED, V328, P176, DOI 10.1056/NEJM199301213280305; Siderowf A, 2002, ARCH NEUROL-CHICAGO, V59, P1937; Siderowf A, 2004, ARCH NEUROL-CHICAGO, V61, P561; Stefanova N, 2008, EXP NEUROL, V210, P421, DOI 10.1016/j.expneurol.2007.11.022; Weinreb O, 2005, ANN NY ACAD SCI, V1053, P348, DOI 10.1196/annals.1344.030; Weinreb O, 2004, FASEB J, V18, P1471, DOI 10.1096/fj.04-1916fje; Youdim MBH, 2001, ANN NY ACAD SCI, V939, P450	27	609	627	1	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2009	361	13					1268	1278		10.1056/NEJMoa0809335	http://dx.doi.org/10.1056/NEJMoa0809335			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497RN	19776408				2022-12-28	WOS:000270078700008
J	Lloyd, FJ; Reyna, VF				Lloyd, Farrell J.; Reyna, Valerie F.			Clinical Gist and Medical Education Connecting the Dots	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DECISION-MAKING; HEALTH-CARE; MEMORY; TRUE		[Lloyd, Farrell J.] Mayo Clin, Coll Med, Div Gen Internal Med, Dept Med, Rochester, MN 55905 USA; [Lloyd, Farrell J.] Mayo Clin, Coll Med, Educ Technol Ctr, Rochester, MN 55905 USA; [Reyna, Valerie F.] Cornell Univ, Ctr Behav Econ & Decis Res, Ithaca, NY USA	Mayo Clinic; Mayo Clinic; Cornell University	Lloyd, FJ (corresponding author), Mayo Clin, Coll Med, Div Gen Internal Med, Dept Med, 200 1st St, Rochester, MN 55905 USA.	lloyd.farrell@mayo.edu						Choudhry NK, 2005, ANN INTERN MED, V142, P260, DOI 10.7326/0003-4819-142-4-200502150-00008; Dennis NA, 2008, J COGNITIVE NEUROSCI, V20, P1390, DOI 10.1162/jocn.2008.20096; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kaminski JA, 2008, SCIENCE, V320, P454, DOI 10.1126/science.1154659; Leach DC, 2008, CHEST, V134, P1299, DOI 10.1378/chest.08-1022; Lloyd FJ, 2001, J GEN INTERN MED, V16, P94, DOI 10.1111/j.1525-1497.2001.00214.x; Reyna VF, 2008, MED DECIS MAKING, V28, P850, DOI 10.1177/0272989X08327066; Reyna VF, 2006, J EXP PSYCHOL-APPL, V12, P179, DOI 10.1037/1076-898X.12.3.179; Slotnick SD, 2004, NAT NEUROSCI, V7, P664, DOI 10.1038/nn1252; Stahl C, 2008, J EXP PSYCHOL LEARN, V34, P570, DOI 10.1037/0278-7393.34.3.570	10	44	45	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1332	1333		10.1001/jama.2009.1383	http://dx.doi.org/10.1001/jama.2009.1383			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	497AR	19773570				2022-12-28	WOS:000270026000017
J	Sachs, JD; Baillie, JEM; Sutherland, WJ; Armsworth, PR; Ash, N; Beddington, J; Blackburn, TM; Collen, B; Gardiner, B; Gaston, KJ; Godfray, HCJ; Green, RE; Harvey, PH; House, B; Knapp, S; Kumpel, NF; Macdonald, DW; Mace, GM; Mallet, J; Matthews, A; May, RM; Petchey, O; Purvis, A; Roe, D; Safi, K; Turner, K; Walpole, M; Watson, R; Jones, KE				Sachs, Jeffrey D.; Baillie, Jonathan E. M.; Sutherland, William J.; Armsworth, Paul R.; Ash, Neville; Beddington, John; Blackburn, Tim M.; Collen, Ben; Gardiner, Barry; Gaston, Kevin J.; Godfray, H. Charles J.; Green, Rhys E.; Harvey, Paul H.; House, Brett; Knapp, Sandra; Kuempel, Noelle F.; Macdonald, David W.; Mace, Georgina M.; Mallet, James; Matthews, Adam; May, Robert M.; Petchey, Owen; Purvis, Andy; Roe, Dilys; Safi, Kamran; Turner, Kerry; Walpole, Matt; Watson, Robert; Jones, Kate E.			Biodiversity Conservation and the Millennium Development Goals	SCIENCE			English	Editorial Material									[Baillie, Jonathan E. M.; Blackburn, Tim M.; Collen, Ben; Harvey, Paul H.; Kuempel, Noelle F.; Safi, Kamran; Jones, Kate E.] Zool Soc London, London, England; [Sachs, Jeffrey D.; House, Brett] Columbia Univ, New York, NY 10027 USA; [Sutherland, William J.; Green, Rhys E.] Univ Cambridge, Cambridge CB2 1TN, England; [Armsworth, Paul R.; Gaston, Kevin J.; Petchey, Owen] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England; [Ash, Neville] IUCN, Gland, Switzerland; [Beddington, John; Mace, Georgina M.; Purvis, Andy] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Godfray, H. Charles J.; Harvey, Paul H.; Macdonald, David W.; May, Robert M.] Univ Oxford, Oxford OX1 2JD, England; [Knapp, Sandra] Nat Hist Museum London, London, England; [Mallet, James] UCL, London WC1E 6BT, England; [Matthews, Adam] GLOBE Int, London, England; [Roe, Dilys] Int Inst Environm & Dev, London, England; [Turner, Kerry; Watson, Robert] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Watson, Robert] Dept Environm Food & Rural Affairs, London, England; [Gardiner, Barry] House Commons, London, England	Zoological Society of London; Columbia University; University of Cambridge; University of Sheffield; Imperial College London; University of Oxford; Natural History Museum London; University of London; University College London; University of East Anglia	Jones, KE (corresponding author), Zool Soc London, London, England.	kate.jones@ioz.ac.uk	Knapp, Sandra/A-4856-2011; Sutherland, William/B-1291-2013; Mace, Georgina M/I-3072-2016; Collen, Ben/D-5055-2011; mallet, james L.B./B-5114-2008; Blackburn, Tim M/A-7685-2011; Jones, Kate E/G-4768-2010; Safi, Kamran/B-2079-2008; Petchey, Owen/D-8851-2011; Purvis, Andy/A-7529-2008; Blackburn, Tim/AAC-3144-2019; Jones, Kate/Y-3317-2019; Collen, Ben/F-2543-2016	Knapp, Sandra/0000-0001-7698-3945; Mace, Georgina M/0000-0001-8965-5211; Jones, Kate E/0000-0001-5231-3293; Safi, Kamran/0000-0002-8418-6759; Petchey, Owen/0000-0002-7724-1633; Purvis, Andy/0000-0002-8609-6204; Blackburn, Tim/0000-0003-0152-2663; Jones, Kate/0000-0001-5231-3293; Collen, Ben/0000-0003-2564-4243; Sutherland, William/0000-0002-6498-0437; Roe, Dilys/0000-0002-6547-6427; Mallet, James/0000-0002-3370-0367; Armsworth, Paul/0000-0003-0918-0573				Adams W., 2007, CONSERV SOC, V5, P147, DOI DOI 10.2307/26392879; Adams WM, 2004, SCIENCE, V306, P1146, DOI 10.1126/science.1097920; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; DAO MQ, 2008, J STUD EC ECONOMETR, V32, P47; DASGUPTA P, 2003, HDB ENV EC ENV DEGRA, P192; Dasgupta S, 2002, J ECON PERSPECT, V16, P147, DOI 10.1257/0895330027157; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; MACE GM, 2005, MILLENNIUM ECOSYSTEM, V1, pCH4; Sachs J. D., 2005, END POVERTY EC POSSI; Strassburg B, 2009, GLOBAL ENVIRON CHANG, V19, P265, DOI 10.1016/j.gloenvcha.2008.11.004; UN Millennium Project, 2005, INV DEV PRACT PLAN A; Walpole M, 2009, SCIENCE, V325, P1503, DOI 10.1126/science.1175466; POVERTY MAPS	15	182	185	9	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1502	1503		10.1126/science.1175035	http://dx.doi.org/10.1126/science.1175035			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	495JS	19762629				2022-12-28	WOS:000269887900022
J	Roberts, RB; Ser, JR; Kocher, TD				Roberts, Reade B.; Ser, Jennifer R.; Kocher, Thomas D.			Sexual Conflict Resolved by Invasion of a Novel Sex Determiner in Lake Malawi Cichlid Fishes	SCIENCE			English	Article							NEURAL CREST; CHROMOSOMES; EVOLUTION; COLORATION; SPECIATION; SELECTION	Sex determination mechanisms differ among animal species, but it is not clear how these differences evolve. New sex determiners may arise in response to sexual conflicts, which occur when traits benefit one sex but hinder the other. We identified the genetic basis for the orange-blotch ( OB) color pattern, a trait under sexually antagonistic selection in the cichlid fish of Lake Malawi, East Africa. The OB phenotype is due to a cis-regulatory mutation in the Pax7 gene. OB provides benefits of camouflage to females but disrupts the species-specific male color patterns used for mate recognition. We suggest that the resulting sexual conflict over the OB allele has been resolved by selection for a novel female sex determination locus that has invaded populations with an ancestral male sex determination system.	[Roberts, Reade B.; Ser, Jennifer R.; Kocher, Thomas D.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Kocher, TD (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	tdk@umd.edu	Kocher, Thomas D/B-3089-2013	Roberts, Reade/0000-0003-2551-3761; Kocher, Thomas/0000-0002-7547-0133	NIH [F32HD051383, R01HD058635]; NSF [DEB-0445212]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058635, F32HD051383] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank O. Seehausen for providing cichlid tissues from Lake Victoria, and S. Salzberg for assistance in aligning cichlid genome sequences to the Tetraodon genome. Supported by NIH fellowship F32HD051383 ( R. B. R.) and by NSF grant DEB-0445212 and NIH grant R01HD058635 ( T. D. K.). Sequences generated in this study are deposited in GenBank under accession numbers GQ403984 to GQ403986.	Allender CJ, 2003, P NATL ACAD SCI USA, V100, P14074, DOI 10.1073/pnas.2332665100; Arnqvist Goran, 2005, pUnpaginated; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Fisher RA, 1931, BIOL REV BIOL P CAMB, V6, P345, DOI 10.1111/j.1469-185X.1931.tb01030.x; HOLZBERG S, 1978, Z ZOOL SYST EVOL, V16, P171; Konings A., 2016, MALAWI CICHLIDS THEI; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lacosta AM, 2005, PIGM CELL RES, V18, P243, DOI 10.1111/j.1600-0749.2005.00238.x; Lande R, 2001, GENETICA, V112, P435, DOI 10.1023/A:1013379521338; Minchin JEN, 2008, DEV BIOL, V317, P508, DOI 10.1016/j.ydbio.2008.02.058; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; RICE WR, 1987, EVOLUTION, V41, P911, DOI 10.1111/j.1558-5646.1987.tb05864.x; Schaefer HM, 2006, P R SOC B, V273, P2427, DOI 10.1098/rspb.2006.3615; Streelman JT, 2003, MOL ECOL, V12, P2465, DOI 10.1046/j.1365-294X.2003.01920.x; van Doorn GS, 2007, NATURE, V449, P909, DOI 10.1038/nature06178; Van Oppen MJH, 1998, MOL ECOL, V7, P991, DOI 10.1046/j.1365-294x.1998.00417.x	16	238	244	4	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					998	1001		10.1126/science.1174705	http://dx.doi.org/10.1126/science.1174705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19797625	Green Accepted			2022-12-28	WOS:000271712300041
J	Vashisht, AA; Zumbrennen, KB; Huang, XH; Powers, DN; Durazo, A; Sun, DH; Bhaskaran, N; Persson, A; Uhlen, M; Sangfelt, O; Spruck, C; Leibold, EA; Wohlschlegel, JA				Vashisht, Ajay A.; Zumbrennen, Kimberly B.; Huang, Xinhua; Powers, David N.; Durazo, Armando; Sun, Dahui; Bhaskaran, Nimesh; Persson, Anja; Uhlen, Mathias; Sangfelt, Olle; Spruck, Charles; Leibold, Elizabeth A.; Wohlschlegel, James A.			Control of Iron Homeostasis by an Iron-Regulated Ubiquitin Ligase	SCIENCE			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; ELEMENT-BINDING PROTEIN; DEGRADATION; IRP2; PROTEASOME; PATHWAY; OXYGEN	Eukaryotic cells require iron for survival and have developed regulatory mechanisms for maintaining appropriate intracellular iron concentrations. The degradation of iron regulatory protein 2 (IRP2) in iron-replete cells is a key event in this pathway, but the E3 ubiquitin ligase responsible for its proteolysis has remained elusive. We found that a SKP1-CUL1-FBXL5 ubiquitin ligase protein complex associates with and promotes the iron-dependent ubiquitination and degradation of IRP2. The F-box substrate adaptor protein FBXL5 was degraded upon iron and oxygen depletion in a process that required an iron-binding hemerythrin-like domain in its N terminus. Thus, iron homeostasis is regulated by a proteolytic pathway that couples IRP2 degradation to intracellular iron levels through the stability and activity of FBXL5.	[Vashisht, Ajay A.; Huang, Xinhua; Powers, David N.; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Zumbrennen, Kimberly B.; Leibold, Elizabeth A.] Univ Utah, Dept Med, Salt Lake City, UT 84112 USA; [Zumbrennen, Kimberly B.; Leibold, Elizabeth A.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Durazo, Armando] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sun, Dahui; Spruck, Charles] Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; [Bhaskaran, Nimesh; Sangfelt, Olle] Karolinska Hosp, Dept Pathol & Oncol, Canc Ctr Karolinska, SE-17176 Stockholm, Sweden; [Persson, Anja; Uhlen, Mathias] Royal Inst Technol AlbaNova, Dept Prote, Sch Biotechnol, SE-10691 Stockholm, Sweden	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology	Wohlschlegel, JA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	jwohl@mednet.ucla.edu	Uhlen, Mathias/AAV-8746-2021; Uhlen, Mathias/B-3262-2016	Uhlen, Mathias/0000-0002-4858-8056	NIH [GM45201]; Swedish Cancer Society; Swedish Children Cancer Foundation; Swedish Research Council; Cancer Society in Stockholm; Knut and Alice Wallenberg Foundation; Stein-Oppenheimer Foundation; Jonsson Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045201, R01GM089778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Cancer Society(Swedish Cancer Society); Swedish Children Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Society in Stockholm; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Stein-Oppenheimer Foundation; Jonsson Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from NIH (GM45201 to E. A. L), the Swedish Cancer Society (N.B. and O.S.), the Swedish Children Cancer Foundation (O.S.), the Swedish Research Council (O.S.), the Cancer Society in Stockholm (O.S.), the Knut and Alice Wallenberg Foundation (A. P. and M. U.), the Stein-Oppenheimer Foundation (J.A.W.), and the Jonsson Comprehensive Cancer Center (J.A.W.). We thank D. Lim for graphic support.	Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; GUO B, 1994, J BIOL CHEM, V269, P24252; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; IWAI K, 1995, EMBO J, V14, P5350, DOI 10.1002/j.1460-2075.1995.tb00219.x; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; STENKAMP RE, 1994, CHEM REV, V94, P715, DOI 10.1021/cr00027a008; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Wang J, 2007, MOL CELL BIOL, V27, P2423, DOI 10.1128/MCB.01111-06; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Zumbrennen KB, 2008, BBA-MOL CELL RES, V1783, P246, DOI 10.1016/j.bbamcr.2007.07.010	21	290	307	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					718	721		10.1126/science.1176333	http://dx.doi.org/10.1126/science.1176333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19762596	Green Accepted			2022-12-28	WOS:000271233200035
J	Bao, SQ; Tang, FC; Li, XH; Hayashi, K; Gillich, A; Lao, KQ; Surani, MA				Bao, Siqin; Tang, Fuchou; Li, Xihe; Hayashi, Katsuhiko; Gillich, Astrid; Lao, Kaiqin; Surani, M. Azim			Epigenetic reversion of post-implantation epiblast to pluripotent embryonic stem cells	NATURE			English	Article							X-CHROMOSOME; GERM-CELLS; MOUSE; METHYLATION; HETEROGENEITY; ESTABLISHMENT; STATES; LINES	The pluripotent state, which is first established in the primitive ectoderm cells of blastocysts, is lost progressively and irreversibly during subsequent development(1). For example, development of post-implantation epiblast cells from primitive ectoderm involves significant transcriptional and epigenetic changes, including DNA methylation and X chromosome inactivation(2), which create a robust epigenetic barrier and prevent their reversion to a primitive-ectoderm-like state. Epiblast cells are refractory to leukaemia inhibitory factor (LIF)-STAT3 signalling, but they respond to activin/basic fibroblast growth factor to form self-renewing epiblast stem cells (EpiSCs), which exhibit essential properties of epiblast cells(3,4) and that differ from embryonic stem (ES) cells derived from primitive ectoderm(5). Here we show reprogramming of advanced epiblast cells fromembryonic day 5.5-7.5mouseembryos with uniform expression of N-cadherin and inactive X chromosome to ES-cell-like cells (rESCs) in response to LIF-STAT3 signalling. Cultured epiblast cells overcome the epigenetic barrier progressively as they proceed with the erasure of key properties of epiblast cells, resulting in DNA demethylation, X reactivation and expression of E-cadherin. The accompanying changes in the transcriptome result in a loss of phenotypic and epigenetic memory of epiblast cells. Using this approach, we report reversion of established EpiSCs to rESCs. Moreover, unlike epiblast and EpiSCs, rESCs contribute to somatic tissues and germ cells in chimaeras. Further studies may reveal how signalling-induced epigenetic reprogramming may promote reacquisition of pluripotency.	[Bao, Siqin; Tang, Fuchou; Hayashi, Katsuhiko; Gillich, Astrid; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Li, Xihe] Inner Mongolia Univ, Mengniu RB CO Ltd, Coll Life Sci, Hohhot 010021, Inner Mongolia, Peoples R China; [Lao, Kaiqin] Appl Biosyst Inc, Mol Cell Biol, Foster City, CA 94404 USA	University of Cambridge; Inner Mongolia University; Thermo Fisher Scientific; Applied Biosystems	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	a.surani@gurdon.cam.ac.uk		Bao, Siqin/0000-0002-9582-3194; Surani, Azim/0000-0002-8640-4318	Wellcome Trust; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Lee for assistance. This work was supported by grants from the Wellcome Trust to M. A. S.	Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Lopes SMCD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040030; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Hayashi K, 2009, CELL STEM CELL, V4, P493, DOI 10.1016/j.stem.2009.05.007; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Ohinata Y, 2009, CELL, V137, P571, DOI 10.1016/j.cell.2009.03.014; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rathjen J, 2003, BIOL REPROD, V69, P1863, DOI 10.1095/biolreprod.103.017384; Shovlin TC, 2008, DEV BIOL, V313, P674, DOI 10.1016/j.ydbio.2007.11.007; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Surani MA, 2008, COLD SH Q B, V73, P9, DOI 10.1101/sqb.2008.73.015; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; TAKAGI N, 1982, CHROMOSOMA, V85, P275, DOI 10.1007/BF00294971; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Yeom YI, 1996, DEVELOPMENT, V122, P881	31	295	307	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 29	2009	461	7268					1292	1295		10.1038/nature08534	http://dx.doi.org/10.1038/nature08534			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19816418	Green Accepted			2022-12-28	WOS:000271190800051
J	Clark, RN				Clark, Roger N.			Detection of Adsorbed Water and Hydroxyl on the Moon	SCIENCE			English	Article							LUNAR POLES; ICE; HYDROGEN; INTERIOR; SURFACE	Data from the Visual and Infrared Mapping Spectrometer (VIMS) on Cassini during its flyby of the Moon in 1999 show a broad absorption at 3 micrometers due to adsorbed water and near 2.8 micrometers attributed to hydroxyl in the sunlit surface on the Moon. The amounts of water indicated in the spectra depend on the type of mixing and the grain sizes in the rocks and soils but could be 10 to 1000 parts per million and locally higher. Water in the polar regions may be water that has migrated to the colder environments there. Trace hydroxyl is observed in the anorthositic highlands at lower latitudes.	US Geol Survey, Denver, CO 80227 USA	United States Department of the Interior; United States Geological Survey	Clark, RN (corresponding author), US Geol Survey, Mail Stop 964,Box 25046 Fed Ctr, Denver, CO 80227 USA.	rclark@usgs.gov			NASA Cassini VIMS	NASA Cassini VIMS	This research was funded by NASA Cassini VIMS under contract to the U. S. Geological Survey; R. C. is a VIMS team member.	ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; Brown RH, 2004, SPACE SCI REV, V115, P111, DOI 10.1007/s11214-004-1453-x; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; CLARK R, 2009, LUNAR PLANET SCI, V40; Clark R. N., 2007, US GEOLOGICAL SURVEY, V231; CLARK RN, 1979, ICARUS, V40, P94, DOI 10.1016/0019-1035(79)90056-3; Farmer V. C., 1974, INFRARED SPECTRA MIN; Feldman WC, 2000, J GEOPHYS RES-PLANET, V105, P4175, DOI 10.1029/1999JE001129; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Feldman WC, 2001, J GEOPHYS RES-PLANET, V106, P23231, DOI 10.1029/2000JE001444; Hapke B., 1993, THEORY REFLECTANCE E; HESS PC, 1995, EARTH PLANET SC LETT, V134, P501, DOI 10.1016/0012-821X(95)00138-3; HOOD LL, 2000, ORIGIN EARTH MOON, P397; Lucey P, 2006, REV MINERAL GEOCHEM, V60, P83, DOI 10.2138/rmg.2006.60.2; Noble SK, 2007, ICARUS, V192, P629, DOI 10.1016/j.icarus.2007.07.021; Pieters CM, 2009, SCIENCE, V326, P568, DOI 10.1126/science.1178658; Saal AE, 2008, NATURE, V454, P192, DOI 10.1038/nature07047; Starukhina LV, 2000, ICARUS, V147, P585, DOI 10.1006/icar.2000.6476; Sunshine JM, 2009, SCIENCE, V326, P565, DOI 10.1126/science.1179788; Urey H.C., 1952, PLANETS THEIR ORIGIN, DOI [10.1063/1.3067687, DOI 10.1063/1.3067687]; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033	21	257	269	5	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 23	2009	326	5952					562	564		10.1126/science.1178105	http://dx.doi.org/10.1126/science.1178105			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19779152	Green Published			2022-12-28	WOS:000271019400038
J	Belle, MDC; Diekman, CO; Forger, DB; Piggins, HD				Belle, Mino D. C.; Diekman, Casey O.; Forger, Daniel B.; Piggins, Hugh D.			Daily Electrical Silencing in the Mammalian Circadian Clock	SCIENCE			English	Article							SUPRACHIASMATIC NUCLEUS NEURONS; PACEMAKER; ELECTROPHYSIOLOGY; EXCITABILITY; RHYTHMICITY; DYNAMICS; PER1	Neurons in the brain's suprachiasmatic nuclei (SCNs), which control the timing of daily rhythms, are thought to encode time of day by changing their firing frequency, with high rates during the day and lower rates at night. Some SCN neurons express a key clock gene, period 1 (per1). We found that during the day, neurons containing per1 sustain an electrically excited state and do not fire, whereas non-per1 neurons show the previously reported daily variation in firing activity. Using a combined experimental and theoretical approach, we explain how ionic currents lead to the unusual electrophysiological behaviors of per1 cells, which unlike other mammalian brain cells can survive and function at depolarized states.	[Belle, Mino D. C.; Piggins, Hugh D.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Diekman, Casey O.] Univ Michigan, Dept Ind & Operat Engn, Ann Arbor, MI 48109 USA; [Forger, Daniel B.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [Diekman, Casey O.; Forger, Daniel B.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA	University of Manchester; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Piggins, HD (corresponding author), Univ Manchester, Fac Life Sci, AV Hill Bldg, Manchester M13 9PT, Lancs, England.	hugh.d.piggins@manchester.ac.uk	Forger, Daniel/C-5552-2015; Belle, Mino/AAV-6093-2020	Forger, Daniel/0000-0001-7581-4031; Belle, Mino/0000-0002-4917-957X; Piggins, Hugh/0000-0003-2555-9858	Biotechnology and Biological Sciences Research Council [BB/E00511X]; NSF; Air Force Office of Scientific Research Young Investigator [FA 9550-08-01-0076]; BBSRC [BB/E00511X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E00511X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research Young Investigator(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. McMahon, Vanderbilt University, for providing us with the per1::2dGFP mice and R. Lucas and R. Baines, University of Manchester, C. Diniz Behn, University of Michigan, and D. Paydarfar, University of Massachusetts Medical School, for their critical reading of the manuscript. This work was funded by a project grant from the Biotechnology and Biological Sciences Research Council awarded to H. D. P. (BB/E00511X). M. D. C. B. is a Research Associate. C. O. D. is a NSF Graduate Research Fellow. D. B. F. is an Air Force Office of Scientific Research Young Investigator (FA 9550-08-01-0076).	Brown TM, 2007, PROG NEUROBIOL, V82, P229, DOI 10.1016/j.pneurobio.2007.05.002; Cao G, 2008, J NEUROSCI, V28, P6493, DOI 10.1523/JNEUROSCI.1503-08.2008; Cutler DJ, 2003, EUR J NEUROSCI, V17, P197, DOI 10.1046/j.1460-9568.2003.02425.x; GILLETTE MU, 1995, CIBA F SYMP, V183, P134; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Herbison AE, 2008, ENDOCRINOLOGY, V149, P3598, DOI 10.1210/en.2007-1631; Hughes ATL, 2008, J NEUROCHEM, V106, P1646, DOI 10.1111/j.1471-4159.2008.05520.x; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Irwin RP, 2007, J NEUROSCI, V27, P11748, DOI 10.1523/JNEUROSCI.1840-07.2007; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; Jackson AC, 2004, J NEUROSCI, V24, P7985, DOI 10.1523/JNEUROSCI.2146-04.2004; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kuhlman SJ, 2003, J NEUROSCI, V23, P1441, DOI 10.1523/JNEUROSCI.23-04-01441.2003; MICHEL S, 1993, SCIENCE, V259, P239, DOI 10.1126/science.8421785; Mrugala M, 2000, AM J PHYSIOL-REG I, V278, pR987, DOI 10.1152/ajpregu.2000.278.4.R987; Paydarfar D, 2006, J NEUROPHYSIOL, V96, P3338, DOI 10.1152/jn.00486.2006; Pennartz CMA, 2002, NATURE, V416, P286, DOI 10.1038/nature728; Pitts GR, 2006, BRAIN RES, V1071, P54, DOI 10.1016/j.brainres.2005.11.078; RINZEL J, 1998, METHODS NEURONAL MOD, P251; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Sim CK, 2007, J BIOL RHYTHM, V22, P445, DOI 10.1177/0748730407306041; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Vansteensel MJ, 2003, CURR BIOL, V13, P1538, DOI 10.1016/S0960-9822(03)00560-8; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287	24	126	129	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					281	284		10.1126/science.1169657	http://dx.doi.org/10.1126/science.1169657			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815775				2022-12-28	WOS:000270599500041
J	Matsuno, M; Compagnon, V; Schoch, GA; Schmitt, M; Debayle, D; Bassard, JE; Pollet, B; Hehn, A; Heintz, D; Ullmann, P; Lapierre, C; Bernier, F; Ehlting, J; Werck-Reichhart, D				Matsuno, Michiyo; Compagnon, Vincent; Schoch, Guillaume A.; Schmitt, Martine; Debayle, Delphine; Bassard, Jean-Etienne; Pollet, Brigitte; Hehn, Alain; Heintz, Dimitri; Ullmann, Pascaline; Lapierre, Catherine; Bernier, Francois; Ehlting, Juergen; Werck-Reichhart, Daniele			Evolution of a Novel Phenolic Pathway for Pollen Development	SCIENCE			English	Article							DETECTING POSITIVE SELECTION; ARABIDOPSIS-THALIANA; REPRODUCTIVE PROTEINS; CYTOCHROME P4502C8; PLANT-GROWTH; LIKELIHOOD; ACID; ACYLTRANSFERASE; ACCUMULATION; SPERMIDINES	Metabolic plasticity, which largely relies on the creation of new genes, is an essential feature of plant adaptation and speciation and has led to the evolution of large gene families. A typical example is provided by the diversification of the cytochrome P450 enzymes in plants. We describe here a retroposition, neofunctionalization, and duplication sequence that, via selective and local amino acid replacement, led to the evolution of a novel phenolic pathway in Brassicaceae. This pathway involves a cascade of six successive hydroxylations by two partially redundant cytochromes P450, leading to the formation of N-1,N-5-di(hydroxyferuloyl)-N-10-sinapoylspermidine, a major pollen constituent and so-far-overlooked player in phenylpropanoid metabolism. This example shows how positive Darwinian selection can favor structured clusters of nonsynonymous substitutions that are needed for the transition of enzymes to new functions.	[Matsuno, Michiyo; Compagnon, Vincent; Debayle, Delphine; Bassard, Jean-Etienne; Heintz, Dimitri; Ullmann, Pascaline; Bernier, Francois; Werck-Reichhart, Daniele] Univ Strasbourg, CNRS, Inst Biol Mol Plantes, UPR2357, F-67083 Strasbourg, France; [Schoch, Guillaume A.] F Hoffmann La Roche & Co Ltd, Discovery Technol, Pharma Res, CH-4070 Basel, Switzerland; [Schmitt, Martine] Fac Pharm Strasbourg, CNRS, Inst Gilbert Laustriat LC1, UMR ULP 7175, F-67401 Illkirch Graffenstaden, France; [Pollet, Brigitte; Lapierre, Catherine] AgroParisTech, UMR Chim Biol AgroParisTech INRA 206, F-78850 Thiverval Grignon, France; [Hehn, Alain] Nancy Univ, UMR, INRA Agron & Environm, F-54505 Vandoeuvre Les Nancy, France; [Ehlting, Juergen] Univ Victoria, Ctr Forest Biol, Victoria, BC V8W 3N5, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Novartis; Roche Holding; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Lorraine; University of Victoria	Werck-Reichhart, D (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol Plantes, UPR2357, 28 Rue Goethe, F-67083 Strasbourg, France.	daniele.werck@ibmp-ulp.u-strasbg.fr	Schmitt, Martine/B-5878-2016; Lapierre, Catherine/AAD-9209-2020; Bernier, Francois/AAP-2174-2020; Bernier, Francois/V-7150-2018; Bassard, Jean-Etienne/AAH-1680-2019; WERCK-REICHHART, Danièle/U-3713-2019	Schmitt, Martine/0000-0002-8723-9502; Bassard, Jean-Etienne/0000-0002-7937-8027; WERCK-REICHHART, Danièle/0000-0003-2869-4262; Hehn, Alain/0000-0003-4507-8031; Lapierre, Catherine/0000-0002-6757-1524; Ehlting, Jurgen/0000-0003-2302-696X	Human Frontier Science program; Natural Sciences and Engineering Council of Canada	Human Frontier Science program(Human Frontier Science Program); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank J. J. Bourguignon, M. Legrand, E Grienenberger, D. Banner, and S. J. Perlman for helpful advice; D. Nelson for naming P450s; and N. Abdulrazzak for his contribution. M. M. and J. E. are grateful for funding of European Marie Curie actions; D. W.-R., M. M., V. C., and J.-E. B. acknowledge support from the Human Frontier Science program; and J. E. acknowledges support from the Natural Sciences and Engineering Council of Canada.	Abdulrazzak N, 2006, PLANT PHYSIOL, V140, P30, DOI 10.1104/pp.105.069690; Besseau S, 2007, PLANT CELL, V19, P148, DOI 10.1105/tpc.106.044495; Bienz S, 2005, NAT PROD REP, V22, P647, DOI 10.1039/b413742f; Clark NL, 2006, REPRODUCTION, V131, P11, DOI 10.1530/rep.1.00357; Cona A, 2006, TRENDS PLANT SCI, V11, P80, DOI 10.1016/j.tplants.2005.12.009; Ehlting J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-47; Fellenberg C, 2008, PLANT J, V56, P132, DOI 10.1111/j.1365-313X.2008.03576.x; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Franke R, 2002, PLANT J, V30, P33, DOI 10.1046/j.1365-313X.2002.01266.x; Grienenberger E, 2009, PLANT J, V58, P246, DOI 10.1111/j.1365-313X.2008.03773.x; Jain M, 2008, FUNCT INTEGR GENOMIC, V8, P69, DOI 10.1007/s10142-007-0052-9; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; KAKKAR RK, 1993, PHYTOCHEMISTRY, V33, P1281, DOI 10.1016/0031-9422(93)85076-4; Luo J, 2009, PLANT CELL, V21, P318, DOI 10.1105/tpc.108.063511; MARTINTANGUY J, 1982, PHYTOCHEMISTRY, V21, P1939, DOI 10.1016/0031-9422(82)83019-7; MEURERGRIMES B, 1995, BRITTONIA, V47, P130, DOI 10.2307/2806952; Meyer K, 1996, P NATL ACAD SCI USA, V93, P6869, DOI 10.1073/pnas.93.14.6869; Morant M, 2007, PLANT MOL BIOL, V63, P1, DOI 10.1007/s11103-006-9028-8; Pacini E, 2005, FLORA, V200, P399, DOI 10.1016/j.flora.2005.02.006; Paquette SM, 2000, DNA CELL BIOL, V19, P307, DOI 10.1089/10445490050021221; Schoch G, 2001, J BIOL CHEM, V276, P36566, DOI 10.1074/jbc.M104047200; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Schoch GA, 2008, J BIOL CHEM, V283, P17227, DOI 10.1074/jbc.M802180200; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Walters D, 2001, FEMS MICROBIOL LETT, V201, P255, DOI 10.1111/j.1574-6968.2001.tb10765.x; Wang W, 2006, PLANT CELL, V18, P1791, DOI 10.1105/tpc.106.041905; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zamble A, 2006, CHEM BIODIVERS, V3, P982, DOI 10.1002/cbdv.200690107; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	30	119	122	3	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1688	1692		10.1126/science.1174095	http://dx.doi.org/10.1126/science.1174095			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779199				2022-12-28	WOS:000270131800046
J	Barzansky, B; Etzel, SI				Barzansky, Barbara; Etzel, Sylvia I.			Medical Schools in the United States, 2008-2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Amer Med Assoc, Div Grad Med Educ, Chicago, IL 60654 USA; Amer Med Assoc, Div Undergrad, Chicago, IL 60654 USA	American Medical Association; American Medical Association	Barzansky, B (corresponding author), Amer Med Assoc, Div Undergrad Med Educ, 515 N State St, Chicago, IL 60654 USA.	barbara.barzansky@ama-assn.org							0	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1349	1355		10.1001/jama.2009.1324	http://dx.doi.org/10.1001/jama.2009.1324			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497AR	19773574				2022-12-28	WOS:000270026000021
J	Frey, P; Church, M				Frey, Philippe; Church, Michael			How River Beds Move	SCIENCE			English	Editorial Material							GRANULAR MEDIA; FLOWS; LAYER; SEGREGATION; TRANSPORT		[Frey, Philippe] Cemagref, Unite Rech Eros Torrentielle Neige & Avalanches, F-38402 St Martin Dheres, France; [Church, Michael] Univ British Columbia, Dept Geog, Vancouver, BC V6T 1Z2, Canada	INRAE; University of British Columbia	Frey, P (corresponding author), Cemagref, Unite Rech Eros Torrentielle Neige & Avalanches, BP 76, F-38402 St Martin Dheres, France.	philippe.frey@cemagref.fr						Armanini A, 2005, J FLUID MECH, V532, P269, DOI 10.1017/S0022112005004283; Bathurst JC, 2007, J HYDRAUL ENG-ASCE, V133, P1192, DOI 10.1061/(ASCE)0733-9429(2007)133:11(1192); Berzi D, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011304; Bohm T, 2006, EXP FLUIDS, V41, P1, DOI 10.1007/s00348-006-0134-9; Cates ME, 1998, PHYS REV LETT, V81, P1841, DOI 10.1103/PhysRevLett.81.1841; Church M, 1998, WATER RESOUR RES, V34, P3169, DOI 10.1029/98WR00484; Forterre Y, 2008, ANNU REV FLUID MECH, V40, P1, DOI 10.1146/annurev.fluid.40.111406.102142; Goldhirsch I, 2003, ANNU REV FLUID MECH, V35, P267, DOI 10.1146/annurev.fluid.35.101101.161114; Hill KM, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.061303; Jain N, 2004, J FLUID MECH, V508, P23, DOI 10.1017/S0022112004008869; PAOLA C, 1995, WATER RESOUR RES, V31, P1395, DOI 10.1029/94WR02975; SAVAGE SB, 1988, J FLUID MECH, V189, P311, DOI 10.1017/S002211208800103X; Sumer BM, 1996, J HYDRAUL ENG-ASCE, V122, P549, DOI 10.1061/(ASCE)0733-9429(1996)122:10(549); Thomas N, 2000, PHYS REV E, V62, P961, DOI 10.1103/PhysRevE.62.961; Wilcock PR, 1997, WATER RESOUR RES, V33, P235, DOI 10.1029/96WR02672; Wooster JK, 2008, WATER RESOUR RES, V44, DOI 10.1029/2006WR005815	16	76	77	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 18	2009	325	5947					1509	1510		10.1126/science.1178516	http://dx.doi.org/10.1126/science.1178516			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762634	Green Submitted			2022-12-28	WOS:000269887900027
J	Zhang, Y; Thiele, I; Weekes, D; Li, ZW; Jaroszewski, L; Ginalski, K; Deacon, AM; Wooley, J; Lesley, SA; Wilson, IA; Palsson, B; Osterman, A; Godzik, A				Zhang, Ying; Thiele, Ines; Weekes, Dana; Li, Zhanwen; Jaroszewski, Lukasz; Ginalski, Krzysztof; Deacon, Ashley M.; Wooley, John; Lesley, Scott A.; Wilson, Ian A.; Palsson, Bernhard; Osterman, Andrei; Godzik, Adam			Three-Dimensional Structural View of the Central Metabolic Network of Thermotoga maritima	SCIENCE			English	Article							EVOLUTION; RECONSTRUCTION; GENE; PATHWAYS; BIOSYNTHESIS; BIOCHEMISTRY; RESOLUTION; SEQUENCES; PROTEINS; DATABASE	Metabolic pathways have traditionally been described in terms of biochemical reactions and metabolites. With the use of structural genomics and systems biology, we generated a three-dimensional reconstruction of the central metabolic network of the bacterium Thermotoga maritima. The network encompassed 478 proteins, of which 120 were determined by experiment and 358 were modeled. Structural analysis revealed that proteins forming the network are dominated by a small number (only 182) of basic shapes (folds) performing diverse but mostly related functions. Most of these folds are already present in the essential core (similar to 30%) of the network, and its expansion by nonessential proteins is achieved with relatively few additional folds. Thus, integration of structural data with networks analysis generates insight into the function, mechanism, and evolution of biological networks.	[Zhang, Ying; Li, Zhanwen; Godzik, Adam] Burnham Inst Med Res, JCMM, La Jolla, CA 92037 USA; [Thiele, Ines; Palsson, Bernhard] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Weekes, Dana; Jaroszewski, Lukasz; Godzik, Adam] Burnham Inst Med Res, JCSG, La Jolla, CA 92037 USA; [Ginalski, Krzysztof] Warsaw Univ, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland; [Deacon, Ashley M.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, JCSG, Menlo Pk, CA 94025 USA; [Wooley, John; Godzik, Adam] Univ Calif San Diego, JCSG, La Jolla, CA 92093 USA; [Lesley, Scott A.] Novartis Res Fdn, Genom Inst, JCSG, San Diego, CA 92121 USA; [Wilson, Ian A.] Scripps Res Inst, JCSG, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute; University of Warsaw; Interdisciplinary Centre for Mathematical & Computational Modelling; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California San Diego; Novartis; Scripps Research Institute	Godzik, A (corresponding author), Burnham Inst Med Res, JCMM, La Jolla, CA 92037 USA.	adam@burnham.org	Zhang, Ying/L-7614-2013; Thiele, Ines/A-7629-2014; Godzik, Adam/A-7279-2009; Zhang, Ying/ABA-6518-2021; Godzik, Adam/AAW-1467-2020	Zhang, Ying/0000-0001-8759-0194; Thiele, Ines/0000-0002-8071-7110; Godzik, Adam/0000-0002-2425-852X; Zhang, Ying/0000-0001-8759-0194; Godzik, Adam/0000-0002-2425-852X; Palsson, Bernhard/0000-0003-2357-6785	National Institute of General Medical Sciences (NIGMS); NIGMS [P20 GM076221, U54 GM074898]; Office of Science [DE-FG02-08ER64686]; U. S. Department of Energy; Betty Moore Foundation CAMERA project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074898, P20GM076221] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science(United States Department of Energy (DOE)); U. S. Department of Energy(United States Department of Energy (DOE)); Betty Moore Foundation CAMERA project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We specifically acknowledge the invaluable work of individual crystallographers at the JCSG and other Protein Structure Initiative (PSI) centers, as well as individual research groups, who have solved structures analyzed here, either directly or that we used as modeling templates. The full list of these proteins is provided in the supporting online material. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences (NIGMS). This work was supported by the NIH PSI grants P20 GM076221 (JCCM) and U54 GM074898 (JCSG) from the NIGMS; grant DE-FG02-08ER64686 from the Office of Science ( Biological and Environmental Research), U. S. Department of Energy; and the Gordon and Betty Moore Foundation CAMERA project.	Conners SB, 2006, FEMS MICROBIOL REV, V30, P872, DOI 10.1111/j.1574-6976.2006.00039.x; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Durot M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-85; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Holliday GL, 2007, NAT PROD REP, V24, P972, DOI 10.1039/b703107f; HOROWITZ NH, 1945, P NATL ACAD SCI USA, V31, P153, DOI 10.1073/pnas.31.6.153; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; Ideker T, 2003, TRENDS BIOTECHNOL, V21, P255, DOI 10.1016/S0167-7799(03)00115-X; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Joyce Andrew R, 2007, Prog Drug Res, V64, P267; Karp PD, 2001, SCIENCE, V293, P2040, DOI 10.1126/science.1064621; Koehn EM, 2009, NATURE, V458, P919, DOI 10.1038/nature07973; Koonin EV, 1996, TRENDS GENET, V12, P334, DOI 10.1016/0168-9525(96)20010-1; Kuhn P, 2002, PROTEINS, V49, P142, DOI 10.1002/prot.10202; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Matthews BW, 2007, NAT STRUCT MOL BIOL, V14, P459, DOI 10.1038/nsmb0607-459; Murzin AG, 2002, SCIENCE, V297, P61, DOI 10.1126/science.1073910; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pal C, 2006, NATURE, V440, P667, DOI 10.1038/nature04568; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rison SCG, 2002, CURR OPIN STRUC BIOL, V12, P374, DOI 10.1016/S0959-440X(02)00331-7; Schilling CH, 2000, BIOTECHNOL BIOENG, V71, P286, DOI 10.1002/1097-0290(2000)71:4<286::AID-BIT1018>3.0.CO;2-R; Senger RS, 2008, BIOTECHNOL BIOENG, V101, P1036, DOI 10.1002/bit.22010; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Yang C, 2008, J BACTERIOL, V190, P1773, DOI 10.1128/JB.01469-07; Yang ZR, 2003, J BIOL CHEM, V278, P8804, DOI 10.1074/jbc.M211892200; 2007, WORKSH SAN DIEG CA 9	31	130	134	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1544	1549		10.1126/science.1174671	http://dx.doi.org/10.1126/science.1174671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762644	Green Accepted			2022-12-28	WOS:000269887900041
J	Choh, CTP; Rai, S; Abdelhamid, M; Lester, W; Vohra, RK				Choh, Clarisa T. P.; Rai, S.; Abdelhamid, M.; Lester, W.; Vohra, R. K.			Lesson of the Week Unrecognised scurvy	BMJ-BRITISH MEDICAL JOURNAL			English	Article							VITAMIN-C-DEFICIENCY; REFEEDING SYNDROME; HEALTH		[Choh, Clarisa T. P.; Vohra, R. K.] Univ Hosp Birmingham NHS Fdn Trust, Dept Vasc Surg, Birmingham B29 6JD, W Midlands, England; [Lester, W.] Univ Hosp Birmingham NHS Fdn Trust, Dept Haematol, Birmingham B15 2TH, W Midlands, England	University of Birmingham; University of Birmingham	Choh, CTP (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Dept Vasc Surg, Birmingham B29 6JD, W Midlands, England.	clarisa.choh@gmail.com	Lester, Will/ABC-1873-2021	Lester, Will/0000-0001-8790-7112				Boulinguez S, 2000, ANN DERMATOL VENER, V127, P510; Carpenter Kenneth, 1988, HIST SCURVY VITAMIN; Chaudhry SI, 2005, CLIN EXP DERMATOL, V30, P735, DOI 10.1111/j.1365-2230.2005.01901.x; ELLIS CN, 1984, ARCH DERMATOL, V120, P1212, DOI 10.1001/archderm.120.9.1212; Emadi-Konjin P, 2005, CLIN BIOCHEM, V38, P450, DOI 10.1016/j.clinbiochem.2005.01.018; Expert Group on Vitamins and Minerals, 2003, SAF UPP LEV VIT MIN; Hampl JS, 2004, AM J PUBLIC HEALTH, V94, P870, DOI 10.2105/AJPH.94.5.870; Hearing SD, 2004, BRIT MED J, V328, P908, DOI 10.1136/bmj.328.7445.908; Hirschmann JV, 1999, J AM ACAD DERMATOL, V41, P895, DOI 10.1016/S0190-9622(99)70244-6; Li R, 2008, AM J OTOLARYNG, V29, P426, DOI 10.1016/j.amjoto.2007.11.006; LLANO JRG, 1996, AN MED INTERN, V13, P462; Mehanna HM, 2008, BRIT MED J, V336, P1495, DOI 10.1136/bmj.a301; Mosdol A, 2008, J PUBLIC HEALTH-UK, V30, P456, DOI 10.1093/pubmed/fdn076; NADIGER HA, 1980, BRIT J NUTR, V44, P211, DOI 10.1079/BJN19800033; *NAT I HLTH CLIN E, 2006, CLIN GUID NAT I H CG, V32; *NHS CHOIC, 2009, YOUR HLTH YOUR CHOIC; NORMANDIN L, 1988, CAN J SURG, V31, P65; Olmedo JM, 2006, INT J DERMATOL, V45, P909, DOI 10.1111/j.1365-4632.2006.02844.x; Polenakovik H, 2005, CLIN INFECT DIS, V41, P764, DOI 10.1086/432626; Ruston D., 2004, NATL DIET NUTR SURVE, V4; Salvi Andrea, 1992, Recenti Progressi in Medicina, V83, P652; SCHECTMAN G, 1993, ANN NY ACAD SCI, V686, P345; Weber P, 1996, INT J VITAM NUTR RES, V66, P19	23	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 17	2009	339								b3580	10.1136/bmj.b3580	http://dx.doi.org/10.1136/bmj.b3580			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RU	19762412				2022-12-28	WOS:000269994900007
J	Ergina, PL; Cook, JA; Blazeby, JM; Boutron, I; Clavien, PA; Reeves, BC; Seiler, CM				Ergina, Patrick L.; Cook, Jonathan A.; Blazeby, Jane M.; Boutron, Isabelle; Clavien, Pierre-Alain; Reeves, Barnaby C.; Seiler, Christoph M.		Balliol Collaboration	Surgical Innovation and Evaluation 2 Challenges in evaluating surgical innovation	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIALS; COMPLEX INTERVENTIONS; KNOWLEDGE TRANSLATION; LEARNING-CURVE; SURGERY; IMPROVE; NEED; OUTCOMES; DISEASE; CANCER	Research on surgical interventions is associated with several methodological and practical challenges of which few, if any, apply only to surgery. However, surgical evaluation is especially demanding because many of these challenges coincide. In this report, the second of three on surgical innovation and evaluation, we discuss obstacles related to the study design of randomised controlled trials and non-randomised studies assessing surgical interventions. We also describe the issues related to the nature of surgical procedures-for example, their complexity, surgeon-related factors, and the range of outcomes. Although difficult, surgical evaluation is achievable and necessary. Solutions tailored to surgical research and a framework for generating evidence on which to base surgical practice are essential.	[Ergina, Patrick L.] McGill Univ, Dept Surg, Ctr Hlth, Montreal, PQ H3A 2T5, Canada; [Ergina, Patrick L.] Univ Oxford Balliol Coll, Oxford Int Programme Evidence Based Hlth Care, Oxford OX1 3BJ, England; [Cook, Jonathan A.] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Reeves, Barnaby C.] Univ Bristol, Dept Clin Sci, Bristol, Avon, England; [Blazeby, Jane M.] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Boutron, Isabelle] Univ Oxford, Ctr Stat Med, Oxford, England; [Clavien, Pierre-Alain] Univ Zurich Hosp, Dept Surg, Zurich, Switzerland; [Seiler, Christoph M.] Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany	McGill University; University of Oxford; University of Aberdeen; University of Bristol; University of Bristol; University of Oxford; University of Zurich; University Zurich Hospital; Ruprecht Karls University Heidelberg	Ergina, PL (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Cardiothorac Surg, 687 Pine Ave W,S8-76B, Montreal, PQ H3A 1A1, Canada.	patrick.ergina@muhc.mcgill.ca	Blazeby, Jane/H-6703-2019; Burton, Martin/F-8579-2012; Seiler, Christoph/AAG-7056-2021; Cook, Jonathan/D-3648-2015; Cook, Jonathan/A-3474-2012; Cook, Jonathan/Z-5970-2019	Blazeby, Jane/0000-0002-3354-3330; Cook, Jonathan/0000-0002-4156-6989; Boutron, Isabelle/0000-0002-5263-6241; Burton, Martin/0000-0002-1261-5876	Ethicon UK; National Institute of Health Research Health Technology Assessment Programme; Nuffield Department of Surgery at the University of oxford; Department of Surgery at McGill University; Medical Research Council UK; Chief Scientist Office of the Scottish Government Health Directorates; Societe Francaise de Rhumatologie and Lavoisier Program (Ministere des Affaires Etrangeres et Europeennes); MRC [G0601938, G0800808] Funding Source: UKRI; Medical Research Council [G0800808, G0601938] Funding Source: researchfish; Chief Scientist Office [HSRU1] Funding Source: researchfish	Ethicon UK; National Institute of Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Nuffield Department of Surgery at the University of oxford; Department of Surgery at McGill University; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Government Health Directorates; Societe Francaise de Rhumatologie and Lavoisier Program (Ministere des Affaires Etrangeres et Europeennes); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	The Balliol Colloquium has been supported by Ethicon UK with unrestricted educational grants and by the National Institute of Health Research Health Technology Assessment Programme. The Balliol Colloquium was administratively and financially supported by the Nuffield Department of Surgery at the University of oxford and the Department of Surgery at McGill University. JAC holds a Medical Research Council UK special training fellowship. The University of Aberdeen's Health Services Research Unit is core funded by the Chief Scientist Office of the Scottish Government Health Directorates. IB is supported by a grant from the Societe Francaise de Rhumatologie and Lavoisier Program (Ministere des Affaires Etrangeres et Europeennes). PLE is a DPhil Candidate in Evidence-Based Health Care at Oxford University.	Bakaeen FG, 2009, ANN THORAC SURG, V87, P1127, DOI 10.1016/j.athoracsur.2008.12.080; Barker CF, 2004, J AM COLL SURGEONS, V198, P1, DOI 10.1016/j.jamcollsurg.2003.08.021; BARNETT HJM, 1985, NEW ENGL J MED, V313, P1191, DOI 10.1056/nejm198511073131904; Baskett RJF, 2002, ANN THORAC SURG, V74, P1043, DOI 10.1016/S0003-4975(02)03679-2; Birkmeyer JD, 2004, J AM COLL SURGEONS, V198, P626, DOI 10.1016/j.jamcollsurg.2003.11.017; Black N, 1996, BRIT MED J, V312, P1215; Blazeby JM, 2006, J CLIN ONCOL, V24, P3178, DOI 10.1200/JCO.2005.05.2951; Boutron I, 2007, PLOS MED, V4, P370, DOI 10.1371/journal.pmed.0040061; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Britton A, 1998, HLTH TECHNOLOGY ASSE, V2, P1; Bruce J, 2001, Health Technol Assess, V5, P1; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; CAMPBELL MK, 2007, ENCY CLIN TRIALS; CLAVIEN PA, ANN SURG IN PRESS; Cook JA, 2007, INT J TECHNOL ASSESS, V23, P255, DOI 10.1017/S0266462307070341; Cook Jonathan A, 2004, Clin Trials, V1, P421, DOI 10.1191/1740774504cn042oa; Cook JA, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-9; Cook TD, 2002, EXPT QUASIEXPERIMENT, P1, DOI 10.1198/jasa.2005.s22; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Davis D, 2003, BMJ-BRIT MED J, V327, P33, DOI 10.1136/bmj.327.7405.33; DeOliveira ML, 2006, ANN SURG, V244, P931, DOI 10.1097/01.sla.0000246856.03918.9a; Devereaux PJ, 2005, BMJ-BRIT MED J, V330, P88, DOI 10.1136/bmj.330.7482.88; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; EDMUNDS LH, 2004, CARDIAC SURG ADULT, P261; EDWARDS FH, 1994, ANN THORAC SURG, V58, P1841, DOI 10.1016/0003-4975(94)91724-8; FIELDING LP, 1978, LANCET, V2, P778; Fischer L, 2009, J SURG EDUC, V66, P15, DOI 10.1016/j.jsurg.2008.08.003; Fishman A, 2001, NEW ENGL J MED, V345, P1075; Freeman TB, 1999, NEW ENGL J MED, V341, P988, DOI 10.1056/NEJM199909233411311; GLASZIOU P, 2001, BMJ-BRIT MED J, V334, P349; Gordon B, 1998, BRIT J OBSTET GYNAEC, V105, P435, DOI 10.1111/j.1471-0528.1998.tb10130.x; Grant AM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2664; Hardoon SL, 2006, J BONE JOINT SURG BR, V88B, P716, DOI 10.1302/0301-620X.88B6; Harrison JD, 2007, SURGERY, V142, P94, DOI 10.1016/j.surg.2007.01.013; Hawe P, 2004, BMJ-BRIT MED J, V328, P1561, DOI 10.1136/bmj.328.7455.1561; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hunt S, 2000, BRIT MED J, V321, P526, DOI 10.1136/bmj.321.7260.526; Ioannidis JPA, 2001, BRIT MED J, V322, P879, DOI 10.1136/bmj.322.7291.879; Lilford RJ, 2000, BRIT MED J, V320, P43, DOI 10.1136/bmj.320.7226.43; London AJ, 2002, STAT METHODS MED RES, V11, P413, DOI 10.1191/0962280202sm300ra; Maddern G, 2008, ANZ J SURG, V78, P853, DOI 10.1111/j.1445-2197.2008.04679.x; Majeed AW, 1996, LANCET, V347, P989, DOI 10.1016/S0140-6736(96)90143-9; Margo CE, 2001, J MED ETHICS, V27, P40, DOI 10.1136/jme.27.1.40; McCulloch P, 2005, BRIT J SURG, V92, P1293, DOI 10.1002/bjs.4930; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Meakins JL, 2001, CAN J SURG, V44, P84; MEYERS WC, 1991, NEW ENGL J MED, V324, P1073; Mills N, 2003, CONTROL CLIN TRIALS, V24, P272, DOI 10.1016/S0197-2456(03)00020-5; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Neumayer L, 2004, NEW ENGL J MED, V350, P1819, DOI 10.1056/NEJMoa040093; OXMAN AD, 1993, JAMA-J AM MED ASSOC, V270, P2093; Plumb J, 2009, INT J TECHNOL ASSESS, V25, P124, DOI 10.1017/S0266462309090175; Pocock SJ, 1983, CLIN TRIALS PRACTICA, P66; Poolman RW, 2007, J BONE JOINT SURG AM, V89A, P550, DOI 10.2106/JBJS.F.00683; Rahbari NN, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-3; Ramsay C R, 2001, Health Technol Assess, V5, P1; Rangel SJ, 2004, SURGERY, V136, P232, DOI 10.1016/j.surg.2004.04.025; Reeves S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002213.pub2; Rothenberger DA, 2004, BRIT J SURG, V91, P1387, DOI 10.1002/bjs.4749; SOLOMON MJ, 1993, DIS COLON RECTUM, V36, P43, DOI 10.1007/BF02050300; Taggart DP, 2006, ANN THORAC SURG, V82, P1966, DOI 10.1016/j.athoracsur.2006.06.035; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; TAYLOR KM, 1985, CANCER TREAT REP, V69, P1095; Thabut G, 2008, LANCET, V371, P744, DOI 10.1016/S0140-6736(08)60344-X; Tugwell P, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-38; Vandenbroucke JP, 2008, PLOS MED, V5, P339, DOI 10.1371/journal.pmed.0050067; Vickers AJ, 2007, JNCI-J NATL CANCER I, V99, P1171, DOI 10.1093/jnci/djm060; Weil RJ, 2004, PLOS MED, V1, P17, DOI 10.1371/journal.pmed.0010013; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; Wente MN, 2003, DIGEST SURG, V20, P263, DOI 10.1159/000071183; Wright FC, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-4; Yang SH, 2009, AM J SURG, V197, P246, DOI 10.1016/j.amjsurg.2008.05.001; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	73	425	432	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2009	374	9695					1097	1104		10.1016/S0140-6736(09)61086-2	http://dx.doi.org/10.1016/S0140-6736(09)61086-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501HA	19782875	Green Accepted			2022-12-28	WOS:000270370900032
J	Kang, JE; Lim, MM; Bateman, RJ; Lee, JJ; Smyth, LP; Cirrito, JR; Fujiki, N; Nishino, S; Holtzman, DM				Kang, Jae-Eun; Lim, Miranda M.; Bateman, Randall J.; Lee, James J.; Smyth, Liam P.; Cirrito, John R.; Fujiki, Nobuhiro; Nishino, Seiji; Holtzman, David M.			Amyloid-beta Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle	SCIENCE			English	Article							NEUROBIOLOGY; DROSOPHILA; PLAQUES; SYSTEMS; NEURONS; MICE	Amyloid-beta (A beta) accumulation in the brain extracellular space is a hallmark of Alzheimer's disease. The factors regulating this process are only partly understood. A beta aggregation is a concentration-dependent process that is likely responsive to changes in brain interstitial fluid (ISF) levels of A beta. Using in vivo microdialysis in mice, we found that the amount of ISF A beta correlated with wakefulness. The amount of ISF A beta also significantly increased during acute sleep deprivation and during orexin infusion, but decreased with infusion of a dual orexin receptor antagonist. Chronic sleep restriction significantly increased, and a dual orexin receptor antagonist decreased, A beta plaque formation in amyloid precursor protein transgenic mice. Thus, the sleep-wake cycle and orexin may play a role in the pathogenesis of Alzheimer's disease.	[Kang, Jae-Eun; Lim, Miranda M.; Bateman, Randall J.; Lee, James J.; Smyth, Liam P.; Cirrito, John R.; Holtzman, David M.] Washington Univ, Dept Neurol, St Louis, MO 63110 USA; [Bateman, Randall J.; Cirrito, John R.; Holtzman, David M.] Washington Univ, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Bateman, Randall J.; Holtzman, David M.] Washington Univ, Alzheimers Dis Res Ctr, St Louis, MO 63110 USA; [Fujiki, Nobuhiro; Nishino, Seiji] Stanford Univ, Sleep & Circadian Neurobiol Lab, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; [Holtzman, David M.] Washington Univ, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Stanford University; Washington University (WUSTL)	Holtzman, DM (corresponding author), Washington Univ, Dept Neurol, St Louis, MO 63110 USA.	holtzman@neuro.wustl.edu		Bateman, Randall/0000-0002-7729-1702	NIH [AG025824, AG030946, NS065667, AG029524, MH072525]; Neuroscience Blueprint Center Core [P30 NS057105]; Cure Alzheimer's Fund; Alzheimer's Association Zenith Award; Eli Lilly; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065667, P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG029524, P50AG005681, R01AG025824, K23AG030946] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neuroscience Blueprint Center Core; Cure Alzheimer's Fund; Alzheimer's Association Zenith Award(Alzheimer's Association); Eli Lilly(Eli Lilly); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank E. D. Herzog and G. M. Freeman Jr. for assistance and P. J. Shaw for discussion. This work was supported by NIH grants AG025824, AG030946, NS065667, AG029524, and MH072525; Neuroscience Blueprint Center Core Grant P30 NS057105; Cure Alzheimer's Fund; Alzheimer's Association Zenith Award; and Eli Lilly.	Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Gagnon JF, 2008, CURR PHARM DESIGN, V14, P3430, DOI 10.2174/138161208786549353; Gilestro GF, 2009, SCIENCE, V324, P109, DOI 10.1126/science.1166673; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang ZL, 2001, P NATL ACAD SCI USA, V98, P9965, DOI 10.1073/pnas.181330998; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kang JE, 2007, P NATL ACAD SCI USA, V104, P10673, DOI 10.1073/pnas.0700148104; Kilduff TS, 2008, J NEUROSCI, V28, P11814, DOI 10.1523/JNEUROSCI.3768-08.2008; Peyron C, 1998, J NEUROSCI, V18, P9996; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035; Yan P, 2009, J NEUROSCI, V29, P10706, DOI 10.1523/JNEUROSCI.2637-09.2009; Yoshida Y, 2001, EUR J NEUROSCI, V14, P1075, DOI 10.1046/j.0953-816x.2001.01725.x	14	913	979	10	172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					1005	1007		10.1126/science.1180962	http://dx.doi.org/10.1126/science.1180962			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19779148	Green Accepted			2022-12-28	WOS:000271712300043
J	Wang, Z; Chong, YD; Joannopoulos, JD; Soljacic, M				Wang, Zheng; Chong, Yidong; Joannopoulos, J. D.; Soljacic, Marin			Observation of unidirectional backscattering-immune topological electromagnetic states	NATURE			English	Article							MAGNETIC RESPONSE; QUANTUM; PHASE; LIGHT; SLOW	One of the most striking phenomena in condensed-matter physics is the quantum Hall effect, which arises in two-dimensional electron systems(1-4) subject to a large magnetic field applied perpendicular to the plane in which the electrons reside. In such circumstances, current is carried by electrons along the edges of the system, in so-called chiral edge states (CESs). These are states that, as a consequence of nontrivial topological properties of the bulk electronic band structure, have a unique directionality and are robust against scattering from disorder. Recently, it was theoretically predicted(5-7) that electromagnetic analogues of such electronic edge states could be observed in photonic crystals, which are materials having refractive-index variations with a periodicity comparable to the wavelength of the light passing through them. Here we report the experimental realization and observation of such electromagnetic CESs in a magneto-optical photonic crystal(7) fabricated in the microwave regime. We demonstrate that, like their electronic counterparts(8-13), electromagnetic CESs can travel in only one direction and are very robust against scattering from disorder; we find that even large metallic scatterers placed in the path of the propagating edge modes do not induce reflections. These modes may enable the production of new classes of electromagnetic device and experiments that would be impossible using conventional reciprocal photonic states alone. Furthermore, our experimental demonstration and study of photonic CESs provides strong support for the generalization and application of topological band theories to classical and bosonic systems, and may lead to the realization and observation of topological phenomena in a generally much more controlled and customizable fashion than is typically possible with electronic systems.	[Wang, Zheng; Chong, Yidong; Joannopoulos, J. D.; Soljacic, Marin] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Wang, Z (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	zhwang@mit.edu	Chong, Yidong/B-6995-2011; Joannopoulos, John D/E-6401-2013; Wang, Zheng/B-9804-2009; Chong, Yidong/AAG-5144-2020; Chong, Yidong/E-1375-2012; Soljacic, Marin/AAA-4868-2019	Chong, Yidong/0000-0002-8649-7884; Wang, Zheng/0000-0003-4255-0206; Chong, Yidong/0000-0002-8649-7884; Chong, Yidong/0000-0002-8649-7884; 	Materials Research Science and Engineering Program; US National Science Foundation [DMR-0819762]; US Army Research Office through the Institute for Soldier Nanotechnologies [W911NF-07-D-0004]	Materials Research Science and Engineering Program; US National Science Foundation(National Science Foundation (NSF)); US Army Research Office through the Institute for Soldier Nanotechnologies	We are very grateful to P. Fisher and U. J. Becker for generously providing access to the synchrotron magnet atMassachusetts Institute of Technology. We should like to thank I. Chuang, P. Bermel, J. Bravo-Abad, S. Johnson and P. Rakich for comments. This work was supported in part by the Materials Research Science and Engineering Program of the US National Science Foundation under award number DMR-0819762, and also in part by the US Army Research Office through the Institute for Soldier Nanotechnologies under contract no. W911NF-07-D-0004.	[Anonymous], 1987, QUANTUM HALL EFFECT; Baba T, 2008, NAT PHOTONICS, V2, P465, DOI 10.1038/nphoton.2008.146; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; Chong YD, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235125; Haldane FDM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013904; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; HATSUGAI Y, 1993, PHYS REV LETT, V71, P3697, DOI 10.1103/PhysRevLett.71.3697; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Joannopoulos JD, 2008, PHOTONIC CRYSTALS: MOLDING THE FLOW OF LIGHT, 2ND EDITION, P1; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; KOHMOTO M, 1985, ANN PHYS-NEW YORK, V160, P343, DOI 10.1016/0003-4916(85)90148-4; Linden S, 2004, SCIENCE, V306, P1351, DOI 10.1126/science.1105371; Moore JE, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.186805; Murakami S, 2003, SCIENCE, V301, P1348, DOI 10.1126/science.1087128; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Povinelli ML, 2004, APPL PHYS LETT, V84, P3639, DOI 10.1063/1.1723686; Pozar D. M., 1998, MICROWAVE ENG, V2nd; Raghu S, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.033834; SIMON B, 1983, PHYS REV LETT, V51, P2167, DOI 10.1103/PhysRevLett.51.2167; Thevenaz L, 2008, NAT PHOTONICS, V2, P474, DOI 10.1038/nphoton.2008.147; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Wang Z, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013905; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; Yen TJ, 2004, SCIENCE, V303, P1494, DOI 10.1126/science.1094025; Yu ZF, 2009, NAT PHOTONICS, V3, P91, DOI 10.1038/NPHOTON.2008.273; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	30	1764	1787	51	508	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					772	U20		10.1038/nature08293	http://dx.doi.org/10.1038/nature08293			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19812669	Green Submitted			2022-12-28	WOS:000270547500031
J	Kivimaki, M; Lawlor, DA; Singh-Manoux, A; Batty, GD; Ferrie, JE; Shipley, MJ; Nabi, H; Sabia, S; Marmot, MG; Jokela, M				Kivimaki, Mika; Lawlor, Debbie A.; Singh-Manoux, Archana; Batty, G. David; Ferrie, Jane E.; Shipley, Martin J.; Nabi, Hermann; Sabia, Severine; Marmot, Michael G.; Jokela, Markus			Common mental disorder and obesity-insight from four repeat measures over 19 years: prospective Whitehall II cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BRITISH CIVIL-SERVANTS; PSYCHOLOGICAL DISTRESS; DEPRESSIVE SYMPTOMS; BODY-WEIGHT; HEALTH; ASSOCIATION; STRESS; ADULTS; MOOD	Objectives To examine potential reciprocal associations between common mental disorders and obesity, and to assess whether dose-response relations exist. Design Prospective cohort study with four measures of common mental disorders and obesity over 19 years (Whitehall II study). Setting Civil service departments in London. Participants 4363 adults (28% female, mean age 44 years at baseline). Main outcome Common mental disorder defined as general health questionnaire "caseness;" overweight and obesity based on Word Health Organization definitions. Results In models adjusted for age, sex, and body mass index at baseline, odds ratios for obesity at the fourth screening were 1.33 (95% confidence interval 1.00 to 1.77), 1.64 (1.13 to 2.36), and 2.01 (1.21 to 3.34) for participants with common mental disorder at one, two, or three preceding screenings compared with people free from common mental disorder ( P for trend<0.001). The corresponding mean differences in body mass index at the most recent screening were 0.20, 0.31, and 0.50 (P for trend<0.001). These associations remained after adjustment for baseline characteristics related to mental health and exclusion of participants who were obese at baseline. In addition, obesity predicted future risk of common mental disorder, again with evidence of a dose-response relation ( P for trend=0.02, multivariable model). However, this association was lost when people with common mental disorder at baseline were excluded ( P for trend=0.33). Conclusions These findings suggest that in British adults the direction of association between common mental disorders and obesity is from common mental disorder to increased future risk of obesity. This association is cumulative such that people with chronic or repeat episodes of common mental disorder are particularly at risk of weight gain.	[Kivimaki, Mika; Shipley, Martin J.; Marmot, Michael G.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Kivimaki, Mika] Finnish Inst Occupat Hlth, Helsinki, Finland; [Lawlor, Debbie A.] Univ Bristol, MRC Ctr Causal Analyses Translat Epidemiol, Bristol BS8 1TH, Avon, England	University of London; University College London; Finnish Institute of Occupational Health; University of Bristol	Kivimaki, M (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Mortimer St, London WC1E 6BT, England.	m.kivimaki@ucl.ac.uk	Batty, GD/Y-4401-2018; Ferrie, Jane/AAZ-2009-2020; Sabia, Séverine/G-2966-2017; Singh-Manoux, Archana/F-6804-2013; Marmot, M G/Y-3920-2019; Kivimaki, Mika/B-3607-2012; Jokela, Markus/A-4669-2009	Batty, GD/0000-0003-1822-5753; Sabia, Séverine/0000-0003-3109-9720; Singh-Manoux, Archana/0000-0002-1244-5037; Marmot, M G/0000-0002-2431-6419; Kivimaki, Mika/0000-0002-4699-5627; Jokela, Markus/0000-0003-0117-0012; Nabi, Hermann/0000-0002-7832-0413; Lawlor, Debbie A/0000-0002-6793-2262	Medical Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute, NIH; National Institute on Aging, US, NIH [R01AG034454-01, R01AG013196, R01HL036310-20A2]; Agency for Health Care Policy Research; John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socioeconomic Status and Health; Academy of Finland; Wellcome Trust; European Science Foundation; MRC research professorship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454, R01AG013196] Funding Source: NIH RePORTER; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Medical Research Council [MC_U130059821, G0100222, G0700704B, G19/35, G0600705, G8802774] Funding Source: researchfish; MRC [MC_U130059821, G0600705] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging, US, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socioeconomic Status and Health; Academy of Finland(Academy of Finland); Wellcome Trust(Wellcome Trust); European Science Foundation(European Science Foundation (ESF)European Commission); MRC research professorship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Whitehall II study has been supported by grants from the Medical Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute, US, NIH (R01HL036310-20A2); National Institute on Aging, US, NIH (R01AG034454-01 and R01AG013196); Agency for Health Care Policy Research; and the John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socioeconomic Status and Health. MK is supported by the Academy of Finland; GDB is a Wellcome Trust research fellow; AS-M is supported by a "EURYI" award from the European Science Foundation; JEF is supported by the Medical Research Council; MJS is supported by the British Heart Foundation; and MGM is supported by an MRC research professorship. The funders did not contribute to the study design and had no role in data collection, data analysis, data interpretation, or writing of the report. The researchers were independent from the funders.	Andrew G, 2006, SIGHT SOUND, V16, P34; Atlantis E, 2008, INT J OBESITY, V32, P881, DOI 10.1038/ijo.2008.54; Bornstein SR, 2006, MOL PSYCHIATR, V11, P892, DOI 10.1038/sj.mp.4001873; Compton WM, 2006, AM J PSYCHIAT, V163, P2141, DOI 10.1176/appi.ajp.163.12.2141; CRISP AH, 1976, BRIT MED J, V1, P7, DOI 10.1136/bmj.1.6000.7; Dallman MF, 2003, P NATL ACAD SCI USA, V100, P11696, DOI 10.1073/pnas.1934666100; Demyttenaere K, 2008, J PSYCHOPHARMACOL, V22, P792, DOI 10.1177/0269881107083798; Farmer A, 2008, BRIT J PSYCHIAT, V192, P351, DOI 10.1192/bjp.bp.107.038380; Gluck ME, 2004, PSYCHOSOM MED, V66, P876, DOI 10.1097/01.psy.0000143637.63508.47; GOLDBERG DP, 1972, DETECTING PSYCHIAT I; Golden SH, 2008, JAMA-J AM MED ASSOC, V299, P2751, DOI 10.1001/jama.299.23.2751; Goodman E, 2002, PEDIATRICS, V110, P497, DOI 10.1542/peds.110.3.497; Heo M, 2006, INT J OBESITY, V30, P513, DOI 10.1038/sj.ijo.0803122; HUPPERT FA, 1995, PSYCHOL MED, V25, P1073, DOI 10.1017/S0033291700037569; ISTVAN J, 1992, INT J OBESITY, V16, P999; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Magnusson PKE, 2006, AM J EPIDEMIOL, V163, P1, DOI 10.1093/aje/kwj002; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634; Mead GE, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004366.pub3; Pallister E, 2008, CLIN PSYCHOL REV, V28, P366, DOI 10.1016/j.cpr.2007.07.001; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Roberts RE, 2003, INT J OBESITY, V27, P514, DOI 10.1038/sj.ijo.0802204; STANSFELD SA, 1992, PSYCHOL MED, V22, P739, DOI 10.1017/S0033291700038186; Stunkard AJ, 2003, BIOL PSYCHIAT, V54, P330, DOI 10.1016/S0006-3223(03)00608-5; Sussman N, 2001, J CLIN PSYCHIAT, V62, P256, DOI 10.4088/JCP.v62n0407; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Vogelzangs N, 2008, ARCH GEN PSYCHIAT, V65, P1386, DOI 10.1001/archpsyc.65.12.1386; Weil E, 2002, JAMA-J AM MED ASSOC, V288, P1265, DOI 10.1001/jama.288.10.1265; *WHO, 1997, INT STAT CLASS DIS R; World Health Organization, 1995, WHO TECH REP SER, V854, P1	31	79	93	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2009	339								b3765	10.1136/bmj.b3765	http://dx.doi.org/10.1136/bmj.b3765			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505TF	19808765	Green Submitted, Green Accepted, hybrid, Green Published			2022-12-28	WOS:000270719100002
J	Wu, MV; Manoli, DS; Fraser, EJ; Coats, JK; Tollkuhn, J; Honda, SI; Harada, N; Shah, NM				Wu, Melody V.; Manoli, Devanand S.; Fraser, Eleanor J.; Coats, Jennifer K.; Tollkuhn, Jessica; Honda, Shin-Ichiro; Harada, Nobuhiro; Shah, Nirao M.			Estrogen Masculinizes Neural Pathways and Sex-Specific Behaviors	CELL			English	Article							STRIA TERMINALIS; BED NUCLEUS; VENTROMEDIAL NUCLEUS; ANDROGEN RECEPTOR; MICE LACKING; REPRODUCTIVE BEHAVIORS; INTERMALE AGGRESSION; MATING-BEHAVIOR; MEDIAL NUCLEUS; MESSENGER-RNA	Sex hormones are essential for neural circuit development and sex-specific behaviors. Male behaviors require both testosterone and estrogen, but it is unclear how the two hormonal pathways intersect. Circulating testosterone activates the androgen receptor (AR) and is also converted into estrogen in the brain via aromatase. We demonstrate extensive sexual dimorphism in the number and projections of aromatase-expressing neurons. The masculinization of these cells is independent of AR but can be induced in females by either testosterone or estrogen, indicating a role for aromatase in sexual differentiation of these neurons. We provide evidence suggesting that aromatase is also important in activating male-specific aggression and urine marking because these behaviors can be elicited by testosterone in males mutant for AR and in females subjected to neonatal estrogen exposure. Our results suggest that aromatization of testosterone into estrogen is important for the development and activation of neural circuits that control male territorial behaviors.	[Wu, Melody V.; Coats, Jennifer K.; Shah, Nirao M.] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA; [Fraser, Eleanor J.; Shah, Nirao M.] Univ Calif San Francisco, Genet Program, San Francisco, CA 94158 USA; [Tollkuhn, Jessica; Shah, Nirao M.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA; [Manoli, Devanand S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Shah, Nirao M.] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94158 USA; [Honda, Shin-Ichiro; Harada, Nobuhiro] Fujita Hlth Univ, Sch Med, Aichi, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Fujita Health University	Shah, NM (corresponding author), Univ Calif San Francisco, Program Neurosci, MC 2722, San Francisco, CA 94158 USA.	nms@ucsf.edu		Manoli, Devanand/0000-0002-7238-2330; Tollkuhn, Jessica/0000-0001-5991-7620; Wu, Melody/0000-0002-5246-2659	Genentech Graduate Fellowships; National Science Foundation Graduate Research Fellowship; National Institutes of Health Institutional Training Grant; National Institutes of Health [R01]; Biomedical Sciences, UCSF Program for Breakthrough Biomedical Research; McKnight Foundation for Neuroscience; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049488] Funding Source: NIH RePORTER	Genentech Graduate Fellowships; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Institutes of Health Institutional Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Sciences, UCSF Program for Breakthrough Biomedical Research; McKnight Foundation for Neuroscience; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Barberini for software programming; C. Cheung for technical assistance with ISH; D. Lubahn for providing us with aromatase<SUP>-/+</SUP> animals; V. Mandiyan, L. Crothers, and C. Carey for technical assistance; P. Ohara for assistance with stereology; and R. Axel, T. Clandinin, H. Ingraham, D. Julius, S. Lomvardas, and Shah lab members for critical discussions and comments on the manuscript. This work was supported by Genentech Graduate Fellowships (M.V.W., J.K.C.); National Science Foundation Graduate Research Fellowship (E.J.F.); Achievement Rewards for College Scientists Scholarship (J.K.C.); National Institutes of Health Institutional Training Grant (J.T.); National Institutes of Health (R01), Career Awards in the Biomedical Sciences, UCSF Program for Breakthrough Biomedical Research, Edward Mallinckrodt, Jr. Foundation, and McKnight Foundation for Neuroscience (N.M.S.).	ALBERT DJ, 1984, NEUROSCI BIOBEHAV R, V8, P5, DOI 10.1016/0149-7634(84)90017-4; AlShamma HA, 1996, J NEUROBIOL, V29, P91, DOI 10.1002/(SICI)1097-4695(199601)29:1<91::AID-NEU7>3.0.CO;2-2; Amateau SK, 2004, ENDOCRINOLOGY, V145, P2906, DOI 10.1210/en.2003-1363; Arai Y, 1996, NEUROSCI RES, V25, P403; Arnold AP, 2003, ANN NY ACAD SCI, V1007, P176, DOI 10.1196/annals.1286.018; BAUM MJ, 1974, HORM BEHAV, V5, P175, DOI 10.1016/0018-506X(74)90042-7; BAYER SA, 1980, J COMP NEUROL, V194, P845, DOI 10.1002/cne.901940409; BEACH FA, 1976, HORM BEHAV, V7, P105, DOI 10.1016/0018-506X(76)90008-8; BEEMAN EA, 1947, PHYSIOL ZOOL, V20, P373, DOI 10.1086/physzool.20.4.30151969; Bodo C, 2006, ENDOCRINOLOGY, V147, P415, DOI 10.1210/en.2005-0834; Burns-Cusato M, 2004, PHYSIOL BEHAV, V83, P217, DOI 10.1016/j.physbeh.2004.08.015; Byne W, 2006, MT SINAI J MED, V73, P950; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; CHAREST NJ, 1991, MOL ENDOCRINOL, V5, P573, DOI 10.1210/mend-5-4-573; Choi GB, 2005, NEURON, V46, P647, DOI 10.1016/j.neuron.2005.04.011; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; Dong HW, 2004, J COMP NEUROL, V471, P396, DOI 10.1002/cne.20002; EDWARDS DA, 1971, HORM BEHAV, V2, P49, DOI 10.1016/0018-506X(71)90037-7; FINNEY HC, 1976, HORM BEHAV, V7, P391, DOI 10.1016/0018-506X(76)90010-6; Gotsiridze T, 2007, DEV NEUROBIOL, V67, P355, DOI 10.1002/dneu.20353; Goy R. W., 1980, SEXUAL DIFFERENTIATI; HARADA N, 1992, ENDOCRINOLOGY, V131, P2306, DOI 10.1210/en.131.5.2306; HINES M, 1992, BRAIN RES, V579, P321, DOI 10.1016/0006-8993(92)90068-K; Hines M, 2006, EUR J ENDOCRINOL, V155, pS115, DOI 10.1530/eje.1.02236; Honda S, 1998, BIOCHEM BIOPH RES CO, V252, P445, DOI 10.1006/bbrc.1998.9672; Juntti SA, 2008, HORM BEHAV, V53, P627, DOI 10.1016/j.yhbeh.2007.12.012; Jyotika J, 2007, DEV NEUROBIOL, V67, P1511, DOI 10.1002/dneu.20525; KIMURA T, 1985, HORM BEHAV, V19, P64, DOI 10.1016/0018-506X(85)90006-6; Kondo Y, 1998, BEHAV BRAIN RES, V91, P213; Liu YC, 1997, J NEUROSCI, V17, P5245; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; MATSUMOTO A, 1986, NEUROSCI LETT, V68, P165, DOI 10.1016/0304-3940(86)90135-7; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; Miczek KA, 2001, BEHAV BRAIN RES, V125, P167, DOI 10.1016/S0166-4328(01)00298-4; MILLHOUSE OE, 1973, BRAIN RES, V55, P89, DOI 10.1016/0006-8993(73)90490-3; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Morris JA, 2008, J COMP NEUROL, V506, P851, DOI 10.1002/cne.21536; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Musatov S, 2006, P NATL ACAD SCI USA, V103, P10456, DOI 10.1073/pnas.0603045103; NAFTOLIN F, 1975, J STEROID BIOCHEM, V6, P993, DOI 10.1016/0022-4731(75)90340-4; Ogawa S, 1999, P NATL ACAD SCI USA, V96, P12887, DOI 10.1073/pnas.96.22.12887; Ogawa S, 2004, ANN NY ACAD SCI, V1036, P257, DOI 10.1196/annals.1330.016; Ogawa S, 2000, P NATL ACAD SCI USA, V97, P14737, DOI 10.1073/pnas.250473597; OHNO S, 1974, CELL, V3, P235, DOI 10.1016/0092-8674(74)90137-8; Perez SE, 2003, DEV BRAIN RES, V145, P117, DOI 10.1016/S0165-3806(03)00223-2; PETERS PJ, 1972, PHYSIOL BEHAV, V8, P265, DOI 10.1016/0031-9384(72)90371-X; PHOENIX CH, 1959, ENDOCRINOLOGY, V65, P369, DOI 10.1210/endo-65-3-369; RALLS K, 1971, SCIENCE, V171, P443, DOI 10.1126/science.171.3970.443; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rissman EF, 1997, HORM BEHAV, V31, P232, DOI 10.1006/hbeh.1997.1390; Roselli CE, 1998, BIOL REPROD, V58, P79, DOI 10.1095/biolreprod58.1.79; ROSELLI CE, 1987, ENDOCRINOLOGY, V121, P2205, DOI 10.1210/endo-121-6-2205; Sato T, 2004, P NATL ACAD SCI USA, V101, P1673, DOI 10.1073/pnas.0305303101; Scordalakes EM, 2004, GENES BRAIN BEHAV, V3, P20, DOI 10.1111/j.1601-183X.2004.00036.x; Shah NM, 2004, NEURON, V43, P313, DOI 10.1016/j.neuron.2004.07.008; SIMERLY RB, 1988, J COMP NEUROL, V270, P209, DOI 10.1002/cne.902700205; SIMON NG, 1984, PHYSIOL BEHAV, V33, P379, DOI 10.1016/0031-9384(84)90157-4; Spors H, 2007, NEURON, V55, P689, DOI 10.1016/j.neuron.2007.08.016; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Toda K, 2001, J ENDOCRINOL, V168, P217, DOI 10.1677/joe.0.1680217; VALE JR, 1973, DEV PSYCHOBIOL, V6, P319, DOI 10.1002/dev.420060405; Varoqueaux F, 1999, ANAT EMBRYOL, V199, P249, DOI 10.1007/s004290050226; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wagner CK, 1996, J COMP NEUROL, V370, P71; WALLIS CJ, 1975, J ENDOCRINOL, V66, P257, DOI 10.1677/joe.0.0660257; WHALEN RE, 1963, SCIENCE, V141, P273, DOI 10.1126/science.141.3577.273	67	267	271	0	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					61	72		10.1016/j.cell.2009.07.036	http://dx.doi.org/10.1016/j.cell.2009.07.036			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804754	Green Accepted, Bronze			2022-12-28	WOS:000270388600016
J	Ferreri, AJM; Reni, M; Foppoli, M; Martelli, M; Pangalis, GA; Frezzato, M; Cabras, MG; Fabbri, A; Corazzelli, G; Ilariucci, F; Rossi, G; Soffietti, R; Stelitano, C; Vallisa, D; Zaja, F; Zoppegno, L; Aondio, GM; Avvisati, G; Balzarotti, M; Brandes, AA; Fajardo, J; Gomez, H; Guarini, A; Pinotti, G; Rigacci, L; Uhlmann, C; Picozzi, P; Vezzulli, P; Ponzoni, M; Zucca, E; Caligaris-Cappio, F; Cavalli, F				Ferreri, Andres J. M.; Reni, Michele; Foppoli, Marco; Martelli, Maurizio; Pangalis, Gerasimus A.; Frezzato, Maurizio; Cabras, Maria Giuseppina; Fabbri, Alberto; Corazzelli, Gaetano; Ilariucci, Fiorella; Rossi, Giuseppe; Soffietti, Riccardo; Stelitano, Caterina; Vallisa, Daniele; Zaja, Francesco; Zoppegno, Lucia; Aondio, Gian Marco; Avvisati, Giuseppe; Balzarotti, Monica; Brandes, Alba A.; Fajardo, Jose; Gomez, Henry; Guarini, Attilio; Pinotti, Graziella; Rigacci, Luigi; Uhlmann, Catrina; Picozzi, Piero; Vezzulli, Paolo; Ponzoni, Maurilio; Zucca, Emanuele; Caligaris-Cappio, Federico; Cavalli, Franco		IELSG	High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial	LANCET			English	Article							CENTRAL-NERVOUS-SYSTEM; NON-HODGKINS-LYMPHOMA; B-CELL LYMPHOMA; CONSOLIDATING RADIOTHERAPY; INTERNATIONAL WORKSHOP; DEFERRED RADIOTHERAPY; EUROPEAN ORGANIZATION; CEREBROSPINAL-FLUID; RESPONSE CRITERIA; INITIAL TREATMENT	Background Chemotherapy with high-dose methotrexate is the conventional approach to treat primary CNS lymphomas, but superiority of polychemotherapy compared with high-dose methotrexate alone is unproven. We assessed the effect of adding high-dose cytarabine to methotrexate in patients with newly diagnosed primary CNS lymphoma. Methods This open, randomised, phase 2 trial was undertaken in 24 centres in six countries. 79 patients with non-Hodgkin lymphoma exclusively localised into the CNS, cranial nerves, or eyes, aged 18-75 years, and with Eastern Cooperative Oncology Group performance status of 3 or lower and measurable disease were centrally randomly assigned by computer to receive four courses of either methotrexate 3.5 g/m(2) on day 1 (n=40) or methotrexate 3.5 g/m(2) on day 1 plus cytarabine 2 g/m(2) twice a day on days 2-3 (n=39). Both regimens were administered every 3 weeks and were followed by whole-brain irradiation. The primary endpoint was complete remission rate after chemotherapy. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00210314. Findings All randomly assigned participants were analysed. After chemotherapy, seven patients given methotrexate and 18 given methotrexate plus cytarabine achieved a complete remission, with a complete remission rate of 18% (95% CI 6-30) and 46% (31-61), respectively, (p=0.006). Nine patients receiving methotrexate and nine receiving methotrexate plus cytarabine achieved a partial response, with an overall response rate of 40% (25-55) and 69% (55-83), respectively, (p=0.009). Grade 3-4 haematological toxicity was more common in the methotrexate plus cytarabine group than in the methotrexate group (36 [92%] vs six [15%]). Four patients died of toxic effects (three vs one). Interpretation In patients aged 75 years and younger with primary CNS lymphoma, the addition of high-dose cytarabine to high-dose methotrexate provides improved outcome with acceptable toxicity compared with high-dose methotrexate alone.	[Ferreri, Andres J. M.] Ist Sci San Raffaele, Med Oncol Unit, Dept Oncol, I-20132 Milan, Italy; [Ferreri, Andres J. M.; Foppoli, Marco; Ponzoni, Maurilio; Caligaris-Cappio, Federico] Ist Sci San Raffaele, Unit Lymphoid Malignancies, I-20132 Milan, Italy; [Foppoli, Marco; Caligaris-Cappio, Federico] Ist Sci San Raffaele, Internal Med Unit, I-20132 Milan, Italy; [Picozzi, Piero] Ist Sci San Raffaele, Dept Oncol, Neurosurg Unit, I-20132 Milan, Italy; [Vezzulli, Paolo] Ist Sci San Raffaele, Neuroradiol Unit, I-20132 Milan, Italy; [Ponzoni, Maurilio] Ist Sci San Raffaele, Pathol Unit, I-20132 Milan, Italy; [Caligaris-Cappio, Federico] Univ Vita & Salute, San Raffaele Sci Inst, Milan, Italy; [Martelli, Maurizio] Univ Roma La Sapienza, Dept Haematol, Rome, Italy; [Pangalis, Gerasimus A.] Univ Athens, Dept Haematol, Athens, Greece; [Frezzato, Maurizio] San Bortolo Hosp, Div Haematol, Vicenza, Italy; [Cabras, Maria Giuseppina] Hosp Businco, Div Haematol, Cagliari, Italy; [Fabbri, Alberto] Policlin Le Scotte, Div Haematol, Siena, Italy; [Corazzelli, Gaetano] Ist Pascale, Div Haematol, Naples, Italy; [Ilariucci, Fiorella] Azienda Osped Reggio Emilia, Div Haematol, Reggio Emilia, Italy; [Rossi, Giuseppe] Spedali Civil Brescia, Dept Haematol, I-25125 Brescia, Italy; [Soffietti, Riccardo] Azienda Osped San Giovanni Battista, Div Neurol, Turin, Italy; [Stelitano, Caterina] Azienda Osped Reggio Calabria, Div Haematol, Reggio Di Calabria, Italy; [Vallisa, Daniele] Osped Civile, Div Haematol, Piacenza, Italy; [Zaja, Francesco] Univ Udine, Clin Haematol, I-33100 Udine, Italy; [Zoppegno, Lucia] HIGA San Martin, La Plata, Argentina; [Aondio, Gian Marco] Azienda Osped Gravedona, Div Haematol, Gravedona, Italy; [Avvisati, Giuseppe] Univ Campus Biomed Roma, Div Haematol, Rome, Italy; [Balzarotti, Monica] Ist Clin Humanitas, Dept Haematol & Oncol, Rozzano, Italy; [Brandes, Alba A.] AUSL Bologna, Bellaria Hosp, Div Oncol, Bologna, Italy; [Fajardo, Jose] Hosp Santa Maria, Div Haematol, Lisbon, Portugal; [Gomez, Henry] Inst Nacl Enfermedades Neoplas, Lima, Peru; [Guarini, Attilio] Azienda Osped Bari, Div Haematol, Bari, Italy; [Pinotti, Graziella] Fdn Macchi, Osped Circolo, Med Oncol Unit, Varese, Italy; [Rigacci, Luigi] Azienda Osped Univ Careggi, Div Haematol, Florence, Italy; [Uhlmann, Catrina] Kantonospital, Aarau, Switzerland; [Zucca, Emanuele; Cavalli, Franco] Oncol Inst So Switzerland, Lymphoma Unit, Bellinzona, Switzerland	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Sapienza University Rome; National & Kapodistrian University of Athens; ULSS 8 Berica; Ospedale San Bortolo di Vicenza; University of Siena; IRCCS Fondazione Pascale; IRCCS Arcispedale S. Maria Nuova; Hospital Spedali Civili Brescia; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Udine; University Campus Bio-Medico - Rome Italy; IRCCS Humanitas Research Hospital; AUSL di Bologna; Universidade de Lisboa; Hospital Santa Maria; Instituto Nacional de Enfermedades Neoplasicas; Ospedale Circolo & Fondazione Macchi; University of Florence; Azienda Ospedaliero Universitaria Careggi; Kantonsspital Aarau AG (KSA); Institute of Oncology Research (IOR)	Ferreri, AJM (corresponding author), Ist Sci San Raffaele, Med Oncol Unit, Dept Oncol, Via Olgettina 60, I-20132 Milan, Italy.	andres.ferreri@hsr.it	Balzarotti, Monica/ABG-4444-2021; Rossi, Giuseppe/K-3376-2016; rigacci, luigi/AAJ-3193-2020; Ferreri, Andrés J. M./A-6662-2013; ilariucci, fiorella/AAA-8256-2019; Rigacci, Luigi/K-4454-2018; Soffietti, Riccardo/AAA-7965-2022; Reni, Michele/J-8296-2016; Guarini, Attilio/AAK-3156-2020	Balzarotti, Monica/0000-0003-4666-5115; Rossi, Giuseppe/0000-0001-8377-2898; rigacci, luigi/0000-0002-9320-9334; Ferreri, Andrés J. M./0000-0001-9606-6124; ilariucci, fiorella/0000-0002-4279-3358; Rigacci, Luigi/0000-0002-9320-9334; Soffietti, Riccardo/0000-0002-9204-7038; Reni, Michele/0000-0002-6463-0293; Guarini, Attilio/0000-0002-9304-6651; Picozzi, Piero/0000-0002-1743-4732; Vallisa, Daniele/0000-0002-3130-1979; Fabbri, Alberto/0000-0003-2603-9715; Vezzulli, Paolo/0000-0002-3568-4946; Zucca, Emanuele/0000-0002-5522-6109; Zaja, Francesco/0000-0003-3995-8817; Brandes, Alba/0000-0002-2503-9089; Avvisati, Giuseppe/0000-0002-5027-5868; Gomez, Henry/0000-0003-2660-1843	Oncosuisse (Swiss Cancer League [ICP OCS-1356-03-2003]	Oncosuisse (Swiss Cancer League	We thank Valter Torri (Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy) for the relevant contribution to the trial design and statistical considerations; Cristina Morinini, Oxanna Lopez, Monica Bertini, and Elena Porro (The International Extranodal Lymphoma Study Group, Bellinzona, Switzerland) for assistance; and Stefania Dell'Oro (San Raffaele Scientific institute, Milan, Italy) and Annarita Conconi (The International Extranodal Lymphoma Study Group, Bellinzona, Switzerland) for their sustained scientific collaboration. The sponsor of this study was The International Extranodal Lymphoma Study Group, who has received an unrestricted grant from Oncosuisse (Swiss Cancer League; grant number ICP OCS-1356-03-2003).	Abrey LE, 2005, J CLIN ONCOL, V23, P5034, DOI 10.1200/JCO.2005.13.524; Abrey LE, 1998, J CLIN ONCOL, V16, P859, DOI 10.1200/JCO.1998.16.3.859; Abrey LE, 2000, J CLIN ONCOL, V18, P3144, DOI 10.1200/JCO.2000.18.17.3144; Batchelor T, 2003, J CLIN ONCOL, V21, P1044, DOI 10.1200/JCO.2003.03.036; Bessell EM, 1996, J CLIN ONCOL, V14, P945, DOI 10.1200/JCO.1996.14.3.945; BLAY JY, 1995, BLOOD, V86, P2922; Brada M, 1998, INT J RADIAT ONCOL, V40, P1157, DOI 10.1016/S0360-3016(98)00002-9; Cheson BD, 1999, J CLIN ONCOL, V17, P1244, DOI 10.1200/JCO.1999.17.4.1244; Coiffier B, 2005, J CLIN ONCOL, V23, P6387, DOI 10.1200/JCO.2005.05.015; DeAngelis LM, 2002, J CLIN ONCOL, V20, P4643, DOI 10.1200/JCO.2002.11.013; Ferreri AJM, 2000, ANN ONCOL, V11, P927, DOI 10.1023/A:1008376412784; Ferreri AJM, 2006, NEUROLOGY, V66, P1435, DOI 10.1212/01.wnl.0000210464.94122.e1; Ferreri AJM, 2003, J CLIN ONCOL, V21, P2407, DOI 10.1200/JCO.2003.01.135; Ferreri AJM, 2003, J CLIN ONCOL, V21, P266, DOI 10.1200/JCO.2003.09.139; Ferreri AJM, 2002, NEUROLOGY, V58, P1513, DOI 10.1212/WNL.58.10.1513; Ferreri AJM, 2008, LEUKEMIA LYMPHOMA, V49, P2042, DOI 10.1080/10428190802381238; Feugier P, 2004, ANN ONCOL, V15, P129, DOI 10.1093/annonc/mdh013; GLASS J, 1994, J NEUROSURG, V81, P188, DOI 10.3171/jns.1994.81.2.0188; Guha-Thakurta N, 1999, J NEURO-ONCOL, V43, P259, DOI 10.1023/A:1006210703827; Harjunpaa A, 2001, LEUKEMIA LYMPHOMA, V42, P731, DOI 10.3109/10428190109099335; Herrlinger U, 2005, ANN NEUROL, V57, P843, DOI 10.1002/ana.20495; Hiraga S, 1999, J NEUROSURG, V91, P221, DOI 10.3171/jns.1999.91.2.0221; Hoang-Xuan K, 2003, J CLIN ONCOL, V21, P2726, DOI 10.1200/JCO.2003.11.036; HRYNIUK WM, 1990, J CLIN ONCOL, V8, P1935, DOI 10.1200/JCO.1990.8.12.1935; Illerhaus G, 2007, HAEMATOLOGICA, V93, P147, DOI 10.3324/haematol.11771; Korfel A, 1998, LEUKEMIA LYMPHOMA, V30, P609, DOI 10.3109/10428199809057573; Mead GM, 2000, CANCER, V89, P1359, DOI 10.1002/1097-0142(20000915)89:6<1359::AID-CNCR21>3.0.CO;2-9; O'Brien PC, 2006, INT J RADIAT ONCOL, V64, P408, DOI 10.1016/j.ijrobp.2005.07.958; Pels H, 2003, J CLIN ONCOL, V21, P4489, DOI 10.1200/JCO.2003.04.056; Poortmans PMP, 2003, J CLIN ONCOL, V21, P4483, DOI 10.1200/JCO.2003.03.108; Reni M, 2001, INT J RADIAT ONCOL, V51, P419, DOI 10.1016/S0360-3016(01)01639-X; Rubinstein LV, 2005, J CLIN ONCOL, V23, P7199, DOI 10.1200/JCO.2005.01.149; Shah GD, 2007, J CLIN ONCOL, V25, P4730, DOI 10.1200/JCO.2007.12.5062; SHAPIRO WR, 1975, NEW ENGL J MED, V293, P161, DOI 10.1056/NEJM197507242930402; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6	35	440	469	1	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT-NOV	2009	374	9700					1512	1520		10.1016/S0140-6736(09)61416-1	http://dx.doi.org/10.1016/S0140-6736(09)61416-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517CS	19767089	Green Submitted			2022-12-28	WOS:000271591300030
J	Licciardi, JM; Schaefer, JM; Taggart, JR; Lund, DC				Licciardi, Joseph M.; Schaefer, Joerg M.; Taggart, Jean R.; Lund, David C.			Holocene Glacier Fluctuations in the Peruvian Andes Indicate Northern Climate Linkages	SCIENCE			English	Article							CORDILLERA BLANCA; ERDALEN EVENT; ICE-AGE; GLACIATION; JOSTEDALSBREEN; PRECIPITATION; HISTORY; NORWAY	The role of the tropics in triggering, transmitting, and amplifying interhemispheric climate signals remains a key debate in paleoclimatology. Tropical glacier fluctuations provide important insight on regional paleoclimatic trends and forcings, but robust chronologies are scarce. Here, we report precise moraine ages from the Cordillera Vilcabamba (13 degrees 20'S) of southern Peru that indicate prominent glacial events and associated climatic shifts in the outer tropics during the early Holocene and late in the "Little Ice Age" period. Our glacier chronologies differ from the New Zealand record but are broadly correlative with well-dated glacial records in Europe, suggesting climate linkages between the tropics and the North Atlantic region.	[Licciardi, Joseph M.; Taggart, Jean R.] Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA; [Schaefer, Joerg M.] Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Lund, David C.] Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA	University System Of New Hampshire; University of New Hampshire; Columbia University; University of Michigan System; University of Michigan	Licciardi, JM (corresponding author), Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA.	joe.licciardi@unh.edu			University of New Hampshire (UNH) Summer Faculty Fellowship; Geological Society of America; Sigma Xi; UNH Earth Sciences; Comer Science and Educational Foundation; U. S. NSF [EAR-0345835]	University of New Hampshire (UNH) Summer Faculty Fellowship; Geological Society of America; Sigma Xi; UNH Earth Sciences; Comer Science and Educational Foundation; U. S. NSF(National Science Foundation (NSF))	We thank R. Finkel and D. Rood for careful measurements of <SUP>10</SUP>Be at Lawrence Livermore National Laboratory; S. Rico, Y. Chemin, and R. P. Perez for logistical support in Peru; and M. Kelly, T. Lowell, G. Balco, and N. Lifton for discussions. Constructive comments by two anonymous reviewers improved the manuscript. This work was supported by a University of New Hampshire (UNH) Summer Faculty Fellowship to J. M. L. and Geological Society of America, Sigma Xi, and UNH Earth Sciences student research grants to J. R. T. J. M. S. acknowledges support from the Comer Science and Educational Foundation and the U. S. NSF (EAR-0345835). This is LDEO contribution 7284.	Abbott MB, 2003, PALAEOGEOGR PALAEOCL, V194, P123, DOI 10.1016/S0031-0182(03)00274-8; Baker PA, 2001, SCIENCE, V291, P640, DOI 10.1126/science.291.5504.640; BERGER AL, 1992, QUATERNARY SCI REV, V11, P571, DOI 10.1016/0277-3791(92)90014-Y; Cane M, 1999, GEOPH MONOG SERIES, V112, P373; Chiang JCH, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033292; Clapperton C. M., 1983, Quaternary Science Reviews, V2, P83, DOI 10.1016/0277-3791(83)90005-7; Dahl SO, 2002, HOLOCENE, V12, P17, DOI 10.1191/0959683602hl516rp; Dillehay TD, 2004, P NATL ACAD SCI USA, V101, P4325, DOI 10.1073/pnas.0400538101; Douglass DC, 2005, GEOLOGY, V33, P237, DOI 10.1130/G21144.1; Farber DL, 2005, J QUATERNARY SCI, V20, P759, DOI 10.1002/jqs.994; Grove J.M., 2004, LITTLE ICE AGES ANCI, V1; GROVE J.M., 2004, LITTLE ICE AGES ANCI; Gutierrez D, 2009, BIOGEOSCIENCES, V6, P835, DOI 10.5194/bg-6-835-2009; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Holzhauser H, 2005, HOLOCENE, V15, P789, DOI 10.1191/0959683605hl853ra; Jomelli V, 2008, GEOMORPHOLOGY, V93, P201, DOI 10.1016/j.geomorph.2007.02.021; Kaser G., 2002, TROPICAL GLACIERS; Kerschner H, 2008, GLOBAL PLANET CHANGE, V60, P58, DOI 10.1016/j.gloplacha.2006.07.034; Lund DC, 2006, NATURE, V444, P601, DOI 10.1038/nature05277; Lund DC, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001218; Matthews JA, 2008, HOLOCENE, V18, P1155, DOI 10.1177/0959683608096585; MERCER JH, 1977, GEOLOGY, V5, P600, DOI 10.1130/0091-7613(1977)5<600:RDOTLG>2.0.CO;2; Nesje A, 2003, HOLOCENE, V13, P139, DOI 10.1191/0959683603hl603fa; Nesje A, 2001, HOLOCENE, V11, P267, DOI 10.1191/095968301669980885; Rabatel A, 2008, QUATERNARY RES, V70, P198, DOI 10.1016/j.yqres.2008.02.012; Rodbell DT, 1992, HOLOCENE, V2, P19, DOI 10.1177/095968369200200103; Schaefer JM, 2009, SCIENCE, V324, P622, DOI 10.1126/science.1169312; Smith JA, 2008, J QUATERNARY SCI, V23, P609, DOI 10.1002/jqs.1224; THOMPSON LG, 1986, SCIENCE, V234, P361, DOI 10.1126/science.234.4774.361; Vuille M, 2008, EARTH-SCI REV, V89, P79, DOI 10.1016/j.earscirev.2008.04.002	30	73	76	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1677	1679		10.1126/science.1175010	http://dx.doi.org/10.1126/science.1175010			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779196	Green Published			2022-12-28	WOS:000270131800042
J	Striano, P; Zara, F; Minetti, C; Striano, S				Striano, Pasquale; Zara, Federico; Minetti, Carlo; Striano, Salvatore			Drug point Chitosan may decrease serum valproate and increase the risk of seizure reappearance	BRITISH MEDICAL JOURNAL			English	Article									[Striano, Pasquale; Zara, Federico; Minetti, Carlo] Univ Genoa, G Gaslini Inst, Unit Muscular & Neurodegenerat Dis, I-16147 Genoa, Italy; [Striano, Salvatore] Univ Naples Federico 2, Dept Neurol Sci, Epilepsy Ctr, Naples, Italy	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Naples Federico II	Striano, P (corresponding author), Univ Genoa, G Gaslini Inst, Unit Muscular & Neurodegenerat Dis, Largo Gaslini 5, I-16147 Genoa, Italy.	pstriano@email.it	Minetti, Carlo/K-4666-2018; Zara, Federico/U-3477-2017; Striano, Pasquale/F-9117-2014	Minetti, Carlo/0000-0002-0640-1804; Zara, Federico/0000-0001-9744-5222; Striano, Pasquale/0000-0002-6065-1476				Huang SS, 2007, ANN PHARMACOTHER, V41, P1912, DOI 10.1345/aph.1K173; JULL AB, 2008, COCHRANE DB SYST REV, V16; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Vinsova J, 2008, CURR PHARM DESIGN, V14, P1311, DOI 10.2174/138161208799316410; Zhang JL, 2008, NUTR RES, V28, P383, DOI 10.1016/j.nutres.2007.12.013	5	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 24	2009	339								b3751	10.1136/bmj.b3751	http://dx.doi.org/10.1136/bmj.b3751			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OG	19778975				2022-12-28	WOS:000270231800006
J	Kilpatrick, ES; Lind, MJ				Kilpatrick, Eric S.; Lind, Michael J.			Rational Testing Appropriate requesting of serum tumour markers	BRITISH MEDICAL JOURNAL			English	Editorial Material							OVARIAN-CANCER; MALIGNANCY; GUIDELINES; BENIGN		[Kilpatrick, Eric S.] Hull Royal Infirm, Dept Clin Biochem, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Lind, Michael J.] Castle Hill Hosp, Acad Dept Oncol, Cottingham, England	University of Hull; University of Hull	Kilpatrick, ES (corresponding author), Hull Royal Infirm, Dept Clin Biochem, Kingston Upon Hull HU3 2JZ, N Humberside, England.	Eric.Kilpatrick@hey.nhs.uk						Bailey J, 2006, INT J GYNECOL CANCER, V16, P30, DOI 10.1111/j.1525-1438.2006.00468.x; Duffy MJ, 2005, INT J GYNECOL CANCER, V15, P679, DOI 10.1111/j.1525-1438.2005.00130.x; Krishnan STM, 2002, BRIT MED J, V325, P946, DOI 10.1136/bmj.325.7370.946; Maestranzi S, 1998, ANN CLIN BIOCHEM, V35, P99, DOI 10.1177/000456329803500113; McGinley PJ, 2003, ANN CLIN BIOCHEM, V40, P643, DOI 10.1258/000456303770367234; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Sturgeon C, 2002, CLIN CHEM, V48, P1151; Sturgeon CM, 2008, CLIN CHEM, V54, pE11, DOI 10.1373/clinchem.2008.105601; Topalak O, 2002, GYNECOL ONCOL, V85, P108, DOI 10.1006/gyno.2001.6575	9	16	16	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 22	2009	339								b3111	10.1136/bmj.b3111	http://dx.doi.org/10.1136/bmj.b3111			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OE	19773324				2022-12-28	WOS:000270231500001
J	Gelber, AC				Gelber, Allan C.			Distinctly different purpura on different arms	LANCET			English	Editorial Material									Johns Hopkins Univ, Sch Med, Div Rheumatol, Dept Med, Baltimore, MD 21224 USA	Johns Hopkins University	Gelber, AC (corresponding author), Johns Hopkins Univ, Sch Med, Div Rheumatol, Dept Med, 5200 Eastern Ave, Baltimore, MD 21224 USA.	agelber@jhmi.edu							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 19	2009	374	9694					1010	1010		10.1016/S0140-6736(09)60290-7	http://dx.doi.org/10.1016/S0140-6736(09)60290-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498PK	19766882				2022-12-28	WOS:000270154100031
J	Bland, PA; Spurny, P; Towner, MC; Bevan, AWR; Singleton, AT; Bottke, WF; Greenwood, RC; Chesley, SR; Shrbeny, L; Borovicka, J; Ceplecha, Z; McClafferty, TP; Vaughan, D; Benedix, GK; Deacon, G; Howard, KT; Franchi, IA; Hough, RM				Bland, Philip A.; Spurny, Pavel; Towner, Martin C.; Bevan, Alex W. R.; Singleton, Andrew T.; Bottke, William F., Jr.; Greenwood, Richard C.; Chesley, Steven R.; Shrbeny, Lukas; Borovicka, Jiri; Ceplecha, Zdenek; McClafferty, Terence P.; Vaughan, David; Benedix, Gretchen K.; Deacon, Geoff; Howard, Kieren T.; Franchi, Ian A.; Hough, Robert M.			An Anomalous Basaltic Meteorite from the Innermost Main Belt	SCIENCE			English	Article							IRON-METEORITES; PARENT BODY; ASTEROIDS; VESTA; ACHONDRITE; CHONDRITES; REGION; ORIGIN; BODIES; SYSTEM	Triangulated observations of fireballs allow us to determine orbits and fall positions for meteorites. The great majority of basaltic meteorites are derived from the asteroid 4 Vesta. We report on a recent fall that has orbital properties and an oxygen isotope composition that suggest a distinct parent body. Although its orbit was almost entirely contained within Earth's orbit, modeling indicates that it originated from the innermost main belt. Because the meteorite parent body would likely be classified as a V-type asteroid, V-type precursors for basaltic meteorites unrelated to Vesta may reside in the inner main belt. This starting location is in agreement with predictions of a planetesimal evolution model that postulates the formation of differentiated asteroids in the terrestrial planet region, with surviving fragments concentrated in the innermost main belt.	[Bland, Philip A.; Towner, Martin C.; Shrbeny, Lukas] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, IARC, London SW7 2AZ, England; [Spurny, Pavel; Shrbeny, Lukas; Borovicka, Jiri; Ceplecha, Zdenek] Acad Sci Czech Republic, Astron Inst, CZ-25165 Ondrejov, Czech Republic; [Bevan, Alex W. R.; Deacon, Geoff] Western Australian Museum, Dept Earth & Planetary Sci, Welshpool Dc, WA 6986, Australia; [Singleton, Andrew T.] Univ London Imperial Coll Sci Technol & Med, Dept Phys, Space & Atmospher Phys Grp, London SW7 2AZ, England; [Bottke, William F., Jr.] SW Res Inst, Boulder, CO 80302 USA; [Greenwood, Richard C.; Franchi, Ian A.] Open Univ, PSSRI, Milton Keynes MK7 6AA, Bucks, England; [Chesley, Steven R.] CALTECH, Jet Prop Lab, Solar Syst Dynam Grp, Pasadena, CA 91109 USA; [McClafferty, Terence P.] Curtin Univ Technol, Off Res & Dev, Perth, WA 6845, Australia; [Benedix, Gretchen K.; Howard, Kieren T.] Nat Hist Museum, Dept Mineral, IARC, London SW7 5BD, England; [Hough, Robert M.] ARRC, CRCLEME, CSIRO Explorat & Min, Perth, WA 6151, Australia	Imperial College London; Natural History Museum London; Czech Academy of Sciences; Astronomical Institute of the Czech Academy of Sciences; Western Australian Museum; Imperial College London; Open University - UK; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Curtin University; Imperial College London; Natural History Museum London; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Bland, PA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, IARC, London SW7 2AZ, England.	p.a.bland@imperial.ac.uk	Benedix, Gretchen/L-1953-2018; Spurný, Pavel/X-9268-2019; Spurny, Pavel/G-9044-2014; Borovicka, Jiri/F-4257-2014; Shrbeny, Lukas/G-9040-2014; Bland, Phil/M-9392-2018	Benedix, Gretchen/0000-0003-0990-8878; Spurný, Pavel/0000-0001-5944-3090; Borovicka, Jiri/0000-0002-5569-8982; Shrbeny, Lukas/0000-0002-3930-770X; Greenwood, Richard/0000-0002-5544-8027; Bland, Phil/0000-0002-4681-7898	UK Science and Technology Facilities Council [PP/C502406/1, ST/F003072/1]; Czech Science Foundation [205/08/0411]; EU [MRTN-CT-2006-035519]; Czech Academy of Sciences [AV0Z10030501]; Western Australian Museum; STFC [ST/F003102/1, PP/E003257/1, ST/F003072/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F003072/1, PP/E003257/1, ST/F003102/1] Funding Source: researchfish	UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Czech Science Foundation(Grant Agency of the Czech Republic); EU(European Commission); Czech Academy of Sciences(Czech Academy of Sciences); Western Australian Museum; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Supported by UK Science and Technology Facilities Council grants PP/C502406/1 and ST/F003072/1; grant 205/08/0411 of the Czech Science Foundation; and EU grant MRTN-CT-2006-035519. P. S. thanks the Czech Academy of Sciences for support through institutional research project AV0Z10030501. We also thank the people of the Nullarbor, and M. Cupak, M. Halik, J. Ullrich, A. Forte, M. Creasy, L. Beazley, T. Smith, C. Daw, T. Kennedy, G. Kennedy, W. Moore, T. Davies, and the trustees of the Western Australian Museum for their help and support over the course of this project, and Australia Post for in-kind sponsorship.	BEVAN AWR, 1989, METEORITICS, V24, P127, DOI 10.1111/j.1945-5100.1989.tb00954.x; BINZEL RP, 1993, SCIENCE, V260, P186, DOI 10.1126/science.260.5105.186; Bottke WF, 2002, ICARUS, V156, P399, DOI 10.1006/icar.2001.6788; Bottke WF, 2006, NATURE, V439, P821, DOI 10.1038/nature04536; Burbine TH, 2001, METEORIT PLANET SCI, V36, P761, DOI 10.1111/j.1945-5100.2001.tb01915.x; Carruba V, 2005, ASTRON ASTROPHYS, V441, P819, DOI 10.1051/0004-6361:20053355; Carruba V, 2003, ICARUS, V162, P308, DOI 10.1016/S0019-1035(02)00062-3; GREENBERG R, 1989, ASTEROIDS, V2, P778; Greenwood RC, 2005, NATURE, V435, P916, DOI 10.1038/nature03612; Jenniskens P, 2009, NATURE, V458, P485, DOI 10.1038/nature07920; JUREWICZ AJG, 1993, GEOCHIM COSMOCHIM AC, V57, P2123, DOI 10.1016/0016-7037(93)90098-H; Kleine T, 2005, GEOCHIM COSMOCHIM AC, V69, P5805, DOI 10.1016/j.gca.2005.07.012; Lazzaro D, 2000, SCIENCE, V288, P2033, DOI 10.1126/science.288.5473.2033; LENTZ R, 2007, LUNAR PLANET SCI C, V98; Miller MF, 2002, GEOCHIM COSMOCHIM AC, V66, P1881, DOI 10.1016/S0016-7037(02)00832-3; Mittlefehldt DW, 2005, METEORIT PLANET SCI, V40, P665, DOI 10.1111/j.1945-5100.2005.tb00972.x; Moskovitz NA, 2008, ICARUS, V198, P77, DOI 10.1016/j.icarus.2008.07.006; Nesvorny D, 2008, ICARUS, V193, P85, DOI 10.1016/j.icarus.2007.08.034; Scott ERD, 2009, GEOCHIM COSMOCHIM AC, V73, P5835, DOI 10.1016/j.gca.2009.06.024; SCOTT ERD, 2008, LUNAR PLANET SCI C, V39; Spurny P, 2003, NATURE, V423, P151, DOI 10.1038/nature01592; Wiechert UH, 2004, EARTH PLANET SC LETT, V221, P373, DOI 10.1016/S0012-821X(04)00090-1; Yamaguchi A, 2002, SCIENCE, V296, P334, DOI 10.1126/science.1069408	23	85	85	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 18	2009	325	5947					1525	1527		10.1126/science.1174787	http://dx.doi.org/10.1126/science.1174787			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762639				2022-12-28	WOS:000269887900034
J	Krueger, AB; Maleckova, J				Krueger, Alan B.; Maleckova, Jitka			Attitudes and Action: Public Opinion and the Occurrence of International Terrorism	SCIENCE			English	Article							POVERTY	The predictors of terrorism are unclear. This paper examines the effect of public opinion in one country toward another country on the number of terrorist attacks perpetrated by people or groups from the former country against targets in the latter country. Public opinion was measured by the percentage of people in Middle Eastern and North African countries who disapprove of the leadership of nine world powers. Count models for 143 pairs of countries were used to estimate the effect of public opinion on terrorist incidents, controlling for other relevant variables and origin-country fixed effects. We found a greater incidence of international terrorism when people of one country disapprove of the leadership of another country.	[Krueger, Alan B.] Princeton Univ, Dept Econ, Princeton, NJ 08544 USA; [Maleckova, Jitka] Acad Sci Czech Republ, Inst Econ, Prague 11000, Czech Republic; [Maleckova, Jitka] Charles Univ Prague, Dept Near Eastern & African Studies, Prague 11000, Czech Republic	Princeton University; Czech Academy of Sciences; Economics Institute of the Czech Academy of Sciences; Charles University Prague	Krueger, AB (corresponding author), Princeton Univ, Dept Econ, Princeton, NJ 08544 USA.	akrueger@princeton.edu	Maleckova, Jitka/H-2897-2014		European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	Work on this project was partly supported by a grant from the European Commission to the European Security Economics project. We thank M. McIntosh, J. Yi, and J. Ezekowitz for excellent research assistance and J. Gardeazabal, B. Keohane, E. Klor, D. Laitin, and three reviewers for helpful comments.	Abadie A, 2006, AM ECON REV, V96, P50, DOI 10.1257/000282806777211847; BERREBI C, 2007, SCI PUBL POLICY, V13, P1; Chiozza G., 2006, ANTIAMERICANISMS WOR, P93; Crespi I., 1988, PREELECTION POLLING; DERIN P, 2008, DOES TERRORISM HAVE; Heinsohn Gunnar, 2003, SOHNE WELTMACHT TERR; Krueger A., 2007, WHAT MAKES TERRORIST; Krueger AB, 2003, J ECON PERSPECT, V17, P119, DOI 10.1257/089533003772034925; Krueger AB, 2008, TERRORISM, ECONOMIC DEVELOPMENT, AND POLITICAL OPENNESS, P148, DOI 10.1017/CBO9780511754388.006; Pape Robert., 2005, DYING WIN STRATEGIC; Piazza JA, 2006, TERROR POLIT VIOLENC, V18, P159, DOI 10.1080/095465590944578; Pillar P., 2001, TERRORISM US FOREIGN; Robinson WS, 1950, AM SOCIOL REV, V15, P351, DOI 10.2307/2087176; Urdal H, 2006, INT STUD QUART, V50, P607, DOI 10.1111/j.1468-2478.2006.00416.x	14	36	36	4	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1534	1536		10.1126/science.1170867	http://dx.doi.org/10.1126/science.1170867			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	495JS	19762640				2022-12-28	WOS:000269887900037
J	Kostrewa, D; Zeller, ME; Armache, KJ; Seizl, M; Leike, K; Thomm, M; Cramer, P				Kostrewa, Dirk; Zeller, Mirijam E.; Armache, Karim-Jean; Seizl, Martin; Leike, Kristin; Thomm, Michael; Cramer, Patrick			RNA polymerase II-TFIIB structure and mechanism of transcription initiation	NATURE			English	Article							START SITE SELECTION; N-TERMINAL REGION; PREINITIATION COMPLEX; ANGSTROM RESOLUTION; ELONGATION COMPLEX; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; ZINC RIBBON; YEAST; DNA	To initiate gene transcription, RNA polymerase II (Pol II) requires the transcription factor IIB (B). Here we present the crystal structure of the complete Pol II-B complex at 4.3 angstrom resolution, and complementary functional data. The results indicate the mechanism of transcription initiation, including the transition to RNA elongation. Promoter DNA is positioned over the Pol II active centre cleft with the 'B-core' domain that binds the wall at the end of the cleft. DNA is then opened with the help of the 'B-linker' that binds the Pol II rudder and clamp coiled-coil at the edge of the cleft. The DNA template strand slips into the cleft and is scanned for the transcription start site with the help of the 'B-reader' that approaches the active site. Synthesis of the RNA chain and rewinding of upstream DNA displace the B-reader and B-linker, respectively, to trigger B release and elongation complex formation.	[Kostrewa, Dirk; Armache, Karim-Jean; Seizl, Martin; Leike, Kristin; Cramer, Patrick] Univ Munich, Gene Ctr Munich, D-81377 Munich, Germany; [Kostrewa, Dirk; Armache, Karim-Jean; Seizl, Martin; Leike, Kristin; Cramer, Patrick] Univ Munich, Dept Chem & Biochem, CIPSM, D-81377 Munich, Germany; [Zeller, Mirijam E.; Thomm, Michael] Univ Regensburg, Inst Biochem Genet & Mikrobiol, D-93053 Regensburg, Germany	University of Munich; University of Munich; University of Regensburg	Cramer, P (corresponding author), Univ Munich, Gene Ctr Munich, Feodor Lynen Str 25, D-81377 Munich, Germany.	cramer@lmb.uni-muenchen.de			Deutsche Forschungsgemeinschaft; Sonderforschungsbereich [SFB646]; Transregio 5; Forschergruppe 'Regulation und Mechanismen der Ribosomen-Biogenese'; Nanosystems Initiative Munich (NIM); Ernst-Jung-Stiftung; Fonds der chemischen Industrie; Boehringer-Ingelheim-Fonds and Elitenetzwerk Bayern; DFG Forschergruppe 'Regulation und Mechanismen der Ribosomenbiogenese'	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG)); Transregio 5; Forschergruppe 'Regulation und Mechanismen der Ribosomen-Biogenese'; Nanosystems Initiative Munich (NIM); Ernst-Jung-Stiftung; Fonds der chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Boehringer-Ingelheim-Fonds and Elitenetzwerk Bayern; DFG Forschergruppe 'Regulation und Mechanismen der Ribosomenbiogenese'(German Research Foundation (DFG))	P. C. was supported by the Deutsche Forschungsgemeinschaft, the Sonderforschungsbereich SFB646, the Transregio 5, the Forschergruppe 'Regulation und Mechanismen der Ribosomen-Biogenese', the Nanosystems Initiative Munich (NIM), the Ernst-Jung-Stiftung, and the Fonds der chemischen Industrie. M. S. was supported by the Boehringer-Ingelheim-Fonds and Elitenetzwerk Bayern. Part of this work was performed at the ESRF at Grenoble, France, and at the Swiss Light Source (SLS) at the Paul Scherrer Institut, Villigen, Switzerland. M. T. and M.E.Z. were supported by the DFG Forschergruppe 'Regulation und Mechanismen der Ribosomenbiogenese'. We thank members of the Cramer laboratory, in particular E. Lehmann and K. Maier, and members of the Thomm laboratory, in particular P. Decartes, W. Forster and F. Hirchaud. We thank K. Romer and the Romer-Stiftung for support.	Andrecka J, 2009, NUCLEIC ACIDS RES, V37, P5803, DOI 10.1093/nar/gkp601; Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Bangur CS, 1997, MOL CELL BIOL, V17, P6784, DOI 10.1128/MCB.17.12.6784; Bartlett MS, 2004, J BIOL CHEM, V279, P5894, DOI 10.1074/jbc.M311429200; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chen BS, 2004, MOL CELL BIOL, V24, P3983, DOI 10.1128/MCB.24.9.3983-3991.2004; Chen HT, 2004, CELL, V119, P169, DOI 10.1016/j.cell.2004.09.028; Chen HT, 2003, MOL CELL, V12, P437, DOI 10.1016/S1097-2765(03)00306-X; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Cho EJ, 1999, J BIOL CHEM, V274, P25807, DOI 10.1074/jbc.274.36.25807; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Cramer P, 2002, BIOESSAYS, V24, P724, DOI 10.1002/bies.10127; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Faitar SL, 2001, MOL CELL BIOL, V21, P4427, DOI 10.1128/MCB.21.14.4427-4440.2001; Geszvain K, 2004, J MOL BIOL, V343, P569, DOI 10.1016/j.jmb.2004.08.063; GIARDINA C, 1993, SCIENCE, V261, P759, DOI 10.1126/science.8342041; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Hirata A, 2008, NATURE, V451, P851, DOI 10.1038/nature06530; Kassavetis GA, 2001, EMBO J, V20, P2823, DOI 10.1093/emboj/20.11.2823; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Kuehner JN, 2008, MOL CELL, V31, P201, DOI 10.1016/j.molcel.2008.05.018; Kuehner JN, 2006, J BIOL CHEM, V281, P14119, DOI 10.1074/jbc.M601937200; Kusser AG, 2008, J MOL BIOL, V376, P303, DOI 10.1016/j.jmb.2007.08.066; Kuznedelov K, 2002, EMBO J, V21, P1369, DOI 10.1093/emboj/21.6.1369; Kwapisz M, 2008, EMBO J, V27, P2411, DOI 10.1038/emboj.2008.165; LI Y, 1994, SCIENCE, V263, P805, DOI 10.1126/science.8303296; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Murakami KS, 2002, SCIENCE, V296, P1285, DOI 10.1126/science.1069595; Naji S, 2008, NUCLEIC ACIDS RES, V36, P676, DOI 10.1093/nar/gkm1086; Naji S, 2007, J BIOL CHEM, V282, P11047, DOI 10.1074/jbc.M611674200; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Pardee TS, 1998, J BIOL CHEM, V273, P17859, DOI 10.1074/jbc.273.28.17859; PINTO I, 1994, J BIOL CHEM, V269, P30569; Ranish JA, 1999, GENE DEV, V13, P49, DOI 10.1101/gad.13.1.49; Renfrow MB, 2004, J BIOL CHEM, V279, P2825, DOI 10.1074/jbc.M311433200; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; SEVERINOV K, 1994, J BIOL CHEM, V269, P20826; Thiebaut M, 2008, MOL CELL, V31, P671, DOI 10.1016/j.molcel.2008.08.010; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Werner F, 2005, MOL CELL BIOL, V25, P8344, DOI 10.1128/MCB.25.18.8344-8355.2005; Young BA, 2004, SCIENCE, V303, P1382, DOI 10.1126/science.1092462; Zhang DY, 2002, NUCLEIC ACIDS RES, V30, P3078, DOI 10.1093/nar/gkf422; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583; Zhu WL, 1996, NAT STRUCT BIOL, V3, P122, DOI 10.1038/nsb0296-122	50	224	228	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 19	2009	462	7271					323	330		10.1038/nature08548	http://dx.doi.org/10.1038/nature08548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521DF	19820686				2022-12-28	WOS:000271899300038
J	Rosenbaum, S				Rosenbaum, Sara			Medicaid and National Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenbaum, Sara] George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA; [Rosenbaum, Sara] George Washington Univ, Sch Med & Law, Washington, DC USA	George Washington University; George Washington University	Rosenbaum, S (corresponding author), George Washington Univ, Sch Publ Hlth & Hlth Serv, Washington, DC 20052 USA.							ELMENDORF D, 2009, COMMUNICATION   1007; *KAIS COMM MED UN, 2009, STAT HLTH FACTS ONL; Kaiser Commission on Medicaid and the Uninsured, 2009, STAT FISC COND MED; Ku L, 2008, HEALTH AFFAIR, V27, pW318, DOI 10.1377/hlthaff.27.4.w318	4	23	23	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 19	2009	361	21					2009	2012		10.1056/NEJMp0909449	http://dx.doi.org/10.1056/NEJMp0909449			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	521DA	19828526				2022-12-28	WOS:000271898600001
J	Schermerhorn, M				Schermerhorn, Marc			A 66-Year-Old Man With an Abdominal Aortic Aneurysm Review of Screening and Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MECHANICAL WALL STRESS; TERM RELATIVE SURVIVAL; RISK-FACTORS; ENDOVASCULAR REPAIR; OPERATIVE MORTALITY; COST-EFFECTIVENESS; RANDOMIZED-TRIAL; EXPANSION RATE; FOLLOW-UP; RUPTURE	Ruptured abdominal aortic aneurysm (AAA) is a common cause of death. Abdominal aortic aneurysms tend to be asymptomatic until the time of rupture, which has a mortality rate of greater than 80%. Therefore, elective repair prior to rupture is preferred if life expectancy is reasonable and the risk of rupture outweighs the risk of repair. Mr F, a 66-year-old man with a 5.2-cm AAA, illustrates the issues surrounding monitoring and treating AAA. Risk factors for AAA include older age, male sex, smoking history, and a family history of AAA. Screening for AAA with ultrasound has been shown to prevent rupture, prevent AAA-related death, and be cost-effective. Risk factors for rupture include larger diameter, female sex, and smoking history. Endovascular repair has lower operative mortality and complications and has replaced standard open surgery in more than half of patients. However, long-term survival is similar after endovascular and open surgical repair. Those at risk of AAA who would benefit from repair should undergo screening. JAMA. 2009; 302(18): 2015-2022	[Schermerhorn, Marc] Beth Israel Deaconess Med Ctr, Sect Endovasc Surg, Boston, MA 02215 USA; [Schermerhorn, Marc] Beth Israel Deaconess Med Ctr, Div Vasc Surg, Boston, MA 02215 USA; [Schermerhorn, Marc] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Schermerhorn, M (corresponding author), Beth Israel Deaconess Med Ctr, Sect Endovasc Surg, 110 Francis St,5B, Boston, MA 02215 USA.	mscherm@bidmc.harvard.edu						*AM HEART ASS, 2002, HEART DIS STROK STAT; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Ashton HA, 2002, BMJ-BRIT MED J, V325, P1135; AUNE S, 1995, EUR J VASC ENDOVASC, V9, P293, DOI 10.1016/S1078-5884(05)80133-9; Batt M, 1999, EUR J VASC ENDOVASC, V17, P338, DOI 10.1053/ejvs.1998.0779; BAXTER BT, 1990, AM J SURG, V160, P197, DOI 10.1016/S0002-9610(05)80306-X; BENGTSSON H, 1992, EUR J SURG, V158, P19; BENGTSSON H, 1993, J VASC SURG, V18, P74, DOI 10.1067/mva.1993.42107; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Blankensteijn JD, 2005, NEW ENGL J MED, V352, P2398, DOI 10.1056/NEJMoa051255; Bosch JL, 2002, RADIOLOGY, V225, P337, DOI 10.1148/radiol.2252011687; Bosch JL, 2001, RADIOLOGY, V220, P492, DOI 10.1148/radiology.220.2.r01au29492; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Brady AR, 2002, NEW ENGL J MED, V346, P1445; Brown LC, 1999, ANN SURG, V230, P289, DOI 10.1097/00000658-199909000-00002; Calonge N, 2005, ANN INTERN MED, V142, P198, DOI 10.7326/0003-4819-142-3-200502010-00011; Cheng C T, 1992, Leg Med, P31; CHERVU A, 1995, SURGERY, V117, P454, DOI 10.1016/S0039-6060(05)80067-4; Chuter TAM, 2007, SEMIN VASC SURG, V20, P90, DOI 10.1053/j.semvascsurg.2007.04.006; Cornuz J, 2004, EUR J PUBLIC HEALTH, V14, P343, DOI 10.1093/eurpub/14.4.343; Cosford PA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002945.pub2; CREECH O, 1966, ANN SURG, V164, P935, DOI 10.1097/00000658-196612000-00001; CRONENWETT JL, 1990, J VASC SURG, V11, P260, DOI 10.1067/mva.1990.16697; Cronenwett JL, 1996, ANN NY ACAD SCI, V800, P56, DOI 10.1111/j.1749-6632.1996.tb33298.x; CRONENWETT JL, 2010, RUTHERFORDS VASCULAR, P1409; DeRubertis BG, 2007, J VASC SURG, V46, P630, DOI 10.1016/j.jvs.2007.06.024; Diwan A, 2000, J VASC SURG, V31, P863, DOI 10.1067/mva.2000.105955; Fillinger M, 2006, ANN NY ACAD SCI, V1085, P22, DOI 10.1196/annals.1383.037; Fillinger MF, 2003, J VASC SURG, V37, P724, DOI 10.1067/mva.2003.213; Fillinger MF, 2002, J VASC SURG, V36, P589, DOI 10.1067/mva.2002.125478; Fleisher LA, 2007, CIRCULATION, V116, P1971, DOI 10.1161/CIRCULATIONAHA.107.185700; Forbes TL, 2004, J AM COLL SURGEONS, V198, P329, DOI 10.1016/j.jamcollsurg.2003.09.019; Forsdahl SH, 2009, CIRCULATION, V119, P2202, DOI 10.1161/CIRCULATIONAHA.108.817619; GILES KA, 2009, SOC VASC SURG ANN M; Giles KA, 2009, J VASC SURG, V50, P256, DOI 10.1016/j.jvs.2009.01.044; Giles KA, 2009, J VASC SURG, V49, P543, DOI 10.1016/j.jvs.2008.09.067; Greenhalgh RM, 2005, LANCET, V365, P2179, DOI 10.1016/S0140-6736(05)66627-5; Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1; Hallin A, 2001, EUR J VASC ENDOVASC, V22, P197, DOI 10.1053/ejvs.2001.1422; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hobo R, 2006, J VASC SURG, V43, P896, DOI 10.1016/j.jvs.2006.01.010; JOHNSTON KW, 1994, J VASC SURG, V20, P163, DOI 10.1016/0741-5214(94)90002-7; Kalman PG, 1999, J VASC SURG, V29, P442, DOI 10.1016/S0741-5214(99)70272-7; Kent KC, 2004, J VASC SURG, V39, P267, DOI 10.1016/j.jvs.2003.08.019; Kertai Miklos D, 2003, Vasc Endovascular Surg, V37, P13, DOI 10.1177/153857440303700102; Kim LG, 2007, ANN INTERN MED, V146, P699, DOI 10.7326/0003-4819-146-10-200705150-00003; Koelemay MJW, 2009, EUR J VASC ENDOVASC, V37, P739, DOI 10.1016/j.ejvs.2009.02.018; Kuivaniemi H, 2008, CIRCULATION, V117, P242, DOI 10.1161/CIRCULATIONAHA.107.690982; KVILEKVAL KHV, 1990, J VASC SURG, V12, P28, DOI 10.1067/mva.1990.19859; Laupacis A, 2002, J VASC SURG, V35, P72, DOI 10.1067/mva.2002.121308; Lawrence-Brown MMD, 2001, CARDIOVASC SURG, V9, P234, DOI 10.1016/S0967-2109(00)00143-5; Lederle FA, 1999, JAMA-J AM MED ASSOC, V281, P77, DOI 10.1001/jama.281.1.77; Lederle FA, 2000, ARCH INTERN MED, V160, P1117, DOI 10.1001/archinte.160.8.1117; Lederle FA, 2000, ARCH INTERN MED, V160, P1425, DOI 10.1001/archinte.160.10.1425; Lederle FA, 2002, NEW ENGL J MED, V346, P1437, DOI 10.1056/NEJMoa012573; Lederle FA, 1997, ANN INTERN MED, V126, P441, DOI 10.7326/0003-4819-126-6-199703150-00004; Lederle FA, 2009, JAMA-J AM MED ASSOC, V302, P1535, DOI 10.1001/jama.2009.1426; Lee TY, 2002, SURGERY, V132, P399, DOI 10.1067/msy.2002.126510; LIMET R, 1991, J VASC SURG, V14, P540, DOI 10.1016/0741-5214(91)90249-T; Lindholt JS, 2008, EUR J VASC ENDOVASC, V36, P167, DOI 10.1016/j.ejvs.2008.03.006; Lindholt JS, 2006, EUR J VASC ENDOVASC, V32, P608, DOI 10.1016/j.ejvs.2006.06.008; Lindholt JS, 1999, EUR J VASC ENDOVASC, V17, P472, DOI 10.1053/ejvs.1999.0835; Mani K, 2008, J ENDOVASC THER, V15, P1, DOI 10.1583/07-2258.1; MARTIN MC, ANN VASC SU IN PRESS; MCFARLANE MJ, 1991, JAMA-J AM MED ASSOC, V265, P2085, DOI 10.1001/jama.265.16.2085; MEENAN RT, 2004, COST EFFECTIVENESS A; Mosorin M, 2001, J VASC SURG, V34, P606, DOI 10.1067/mva.2001.117891; *NAT CTR HLTH STAT, 2001, DEATHS PERC TOT DEAT; Norman PE, 2007, CIRCULATION, V115, P2865, DOI 10.1161/CIRCULATIONAHA.106.671859; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Norman PE, 2001, CARDIOVASC SURG, V9, P219, DOI 10.1016/S0967-2109(00)00126-5; OSullivan JP, 1996, J CLIN PATHOL, V49, P737, DOI 10.1136/jcp.49.9.737; Parodi J C, 1991, Ann Vasc Surg, V5, P491, DOI 10.1007/BF02015271; Powell JT, 2007, BRIT J SURG, V94, P702, DOI 10.1002/bjs.5778; Powell JT, 1998, LANCET, V352, P1649; Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002; Santilli SM, 2002, J VASC SURG, V35, P666, DOI 10.1067/mva.2002.121572; Schermerhorn ML, 2008, NEW ENGL J MED, V358, P464, DOI 10.1056/NEJMoa0707348; Schroeder SA, 2009, JAMA-J AM MED ASSOC, V301, P522, DOI 10.1001/jama.2008.982; Scott RAP, 2002, BRIT J SURG, V89, P283, DOI 10.1046/j.0007-1323.2001.02014.x; STEYERBERG EW, 1995, ARCH INTERN MED, V155, P1998, DOI 10.1001/archinte.155.18.1998; SULLIVAN CA, 1990, J VASC SURG, V11, P799, DOI 10.1067/mva.1990.19420; Vardulaki KA, 2002, BRIT J SURG, V89, P861, DOI 10.1046/j.1365-2168.2002.02133.x; Vardulaki KA, 2000, BRIT J SURG, V87, P195, DOI 10.1046/j.1365-2168.2000.01353.x; Vardulaki KA, 1998, BRIT J SURG, V85, P1674; Vorp DA, 1998, J VASC SURG, V27, P632, DOI 10.1016/S0741-5214(98)70227-7; Wanhainen A, 2006, J VASC SURG, V43, P908, DOI 10.1016/j.jvs.2005.12.064; Wilmink ABM, 1998, BRIT J SURG, V85, P155; Wilmink TBM, 1999, J VASC SURG, V30, P1099, DOI 10.1016/S0741-5214(99)70049-2; Wyers MC, 2003, J VASC SURG, V38, P730, DOI 10.1016/S0741-5214(03)00552-4	91	32	35	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 11	2009	302	18					2015	2022		10.1001/jama.2009.1502	http://dx.doi.org/10.1001/jama.2009.1502			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517MY	19809012				2022-12-28	WOS:000271619700029
J	Lombardi, VC; Ruscetti, FW; Das Gupta, J; Pfost, MA; Hagen, KS; Peterson, DL; Ruscetti, SK; Bagni, RK; Petrow-Sadowski, C; Gold, B; Dean, M; Silverman, RH; Mikovits, JA				Lombardi, Vincent C.; Ruscetti, Francis W.; Das Gupta, Jaydip; Pfost, Max A.; Hagen, Kathryn S.; Peterson, Daniel L.; Ruscetti, Sandra K.; Bagni, Rachel K.; Petrow-Sadowski, Cari; Gold, Bert; Dean, Michael; Silverman, Robert H.; Mikovits, Judy A.			RETRACTED: Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome (Retracted article. See vol. 334, pg. 1636, 2011)	SCIENCE			English	Article; Retracted Publication							MURINE LEUKEMIA-VIRUS; FOCUS-FORMING VIRUS; CENTRIFUGAL ENHANCEMENT; GROWTH-FACTOR; RNASE-L; GENE; LYMPHOMA; REGION	Chronic fatigue syndrome (CFS) is a debilitating disease of unknown etiology that is estimated to affect 17 million people worldwide. Studying peripheral blood mononuclear cells (PBMCs) from CFS patients, we identified DNA from a human gammaretrovirus, xenotropic murine leukemia virus-related virus (XMRV), in 68 of 101 patients (67%) as compared to 8 of 218 (3.7%) healthy controls. Cell culture experiments revealed that patient-derived XMRV is infectious and that both cell-associated and cell-free transmission of the virus are possible. Secondary viral infections were established in uninfected primary lymphocytes and indicator cell lines after their exposure to activated PBMCs, B cells, T cells, or plasma derived from CFS patients. These findings raise the possibility that XMRV may be a contributing factor in the pathogenesis of CFS.	[Lombardi, Vincent C.; Pfost, Max A.; Hagen, Kathryn S.; Peterson, Daniel L.; Mikovits, Judy A.] Whittemore Peterson Inst, Reno, NV 89557 USA; [Ruscetti, Francis W.; Gold, Bert; Dean, Michael] NCI, Expt Immunol Lab, Frederick, MD 21701 USA; [Das Gupta, Jaydip; Silverman, Robert H.] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Ruscetti, Sandra K.] NCI, Lab Canc Prevent, Frederick, MD 21701 USA; [Bagni, Rachel K.] NCI, Adv Technol Program, Frederick, MD 21701 USA; [Petrow-Sadowski, Cari] NCI, Basic Res Program, Sci Applicat Int Corp, Frederick, MD 21701 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Mikovits, JA (corresponding author), Whittemore Peterson Inst, Reno, NV 89557 USA.	judym@wpinstitute.org	Dean, Michael/G-8172-2012	Dean, Michael/0000-0003-2234-0631	Whittemore Peterson Institute; Whittemore Family foundation; National Cancer Institute (NCI); NIH [HHSN26120080001E]; NCI/ NIH [CA104943]; U. S. DoD Prostate Cancer Research Program [W81XWH-07-1338]; V Foundation for Cancer Research; Charlotte Geyer Foundation; Mal and Lea Bank; NATIONAL CANCER INSTITUTE [ZIABC005657, ZIABC010252, ZIABC011301] Funding Source: NIH RePORTER	Whittemore Peterson Institute; Whittemore Family foundation; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI/ NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U. S. DoD Prostate Cancer Research Program; V Foundation for Cancer Research; Charlotte Geyer Foundation; Mal and Lea Bank; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Bertolette, Y. Huang, C. Hanson, and J. Troxler for technical assistance; K. Nagashima for EM; and C. Ware and K. Hunter for discussions. Funded by the Whittemore Peterson Institute and the Whittemore Family foundation; the National Cancer Institute (NCI); NIH (under contract HHSN26120080001E); and grants to R. H. S. from NCI/ NIH (CA104943), the U. S. DoD Prostate Cancer Research Program (W81XWH-07-1338), the V Foundation for Cancer Research, the Charlotte Geyer Foundation, and Mal and Lea Bank. The content of this publication does not reflect the views or policies of the U. S. DHHS, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. government. R. H. S. may receive royalty payments in the future from Abbott Laboratories. GenBank accession numbers are as follows: WPI-1130, GQ483508; WPI-1138, GQ483509; WPI-1169,GQ483510; WPI-1178, GQ497343; WPI-1106, GQ497344; and WPI-1104, GQ497345.; Note added in proof: V. C. L. is operations manager of Viral Immune Pathologies Laboratory, which is in negotiations with the Whittemore Peterson Institute to offer a diagnostic test for XMRV.	Casey G, 2002, NAT GENET, V32, P582, DOI 10.1038/ng1021; CHESEBRO B, 1983, VIROLOGY, V127, P134, DOI 10.1016/0042-6822(83)90378-1; Devanur LD, 2006, J CLIN VIROL, V37, P139, DOI 10.1016/j.jcv.2006.08.013; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Dunn GP, 2005, CANCER RES, V65, P3447, DOI 10.1158/0008-5472.CAN-04-4316; LEVINE PH, 1992, CANCER RES, V52, pS5516; Li XJ, 2009, J VIROL, V83, P4912, DOI 10.1128/JVI.02343-08; Lisco Andrea, 2009, Curr HIV/AIDS Rep, V6, P5, DOI 10.1007/s11904-009-0002-3; Peterson KE, 2006, CURR TOP MICROBIOL, V303, P67, DOI 10.1007/978-3-540-33397-5_4; PIETROBONI GR, 1989, J VIROL METHODS, V24, P85, DOI 10.1016/0166-0934(89)90010-4; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Power C, 2001, TRENDS NEUROSCI, V24, P162, DOI 10.1016/S0166-2236(00)01737-9; SMITH KA, 1981, ADV IMMUNOL, V31, P137, DOI 10.1016/S0065-2776(08)60920-7; Suhadolnik RJ, 1997, J INTERF CYTOK RES, V17, P377, DOI 10.1089/jir.1997.17.377; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Whiteside Theresa L., 1998, American Journal of Medicine, V105, p27S, DOI 10.1016/S0002-9343(98)00155-7; WOLFF L, 1983, P NATL ACAD SCI-BIOL, V80, P4718, DOI 10.1073/pnas.80.15.4718; WOLFF L, 1982, J VIROL, V43, P472, DOI 10.1128/JVI.43.2.472-481.1982; Xiang Y, 2003, CANCER RES, V63, P6795; Yoo SM, 2008, J VIROL METHODS, V154, P160, DOI 10.1016/j.jviromet.2008.07.026	20	407	422	4	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					585	589		10.1126/science.1179052	http://dx.doi.org/10.1126/science.1179052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19815723				2022-12-28	WOS:000271019400045
J	Bodenheimer, T; Berry-Millett, R				Bodenheimer, Thomas; Berry-Millett, Rachel			Follow the Money - Controlling Expenditures by Improving Care for Patients Needing Costly Services	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONTROLLED-TRIAL		[Bodenheimer, Thomas; Berry-Millett, Rachel] Univ Calif San Francisco, Sch Med, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Bodenheimer, T (corresponding author), Univ Calif San Francisco, Sch Med, Dept Family & Community Med, Ctr Excellence Primary Care, San Francisco, CA 94143 USA.							Anderson G, 2007, CHRONIC CONDITIONS M; BODENHEIMER T, 2009, CARE MANAGE IN PRESS; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Leff B, 2009, AM J MANAG CARE, V15, P555; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x	5	96	98	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2009	361	16					1521	1523		10.1056/NEJMp0907185	http://dx.doi.org/10.1056/NEJMp0907185			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	506LT	19797277				2022-12-28	WOS:000270777000001
J	Trabacca, A; DiCuonzo, F				Trabacca, Antonio; DiCuonzo, Franca			Living with One Hemisphere - A Large Porencephalic Cyst	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Trabacca, Antonio] Sci Inst IRCCS Eugenio Medea, Ostuni, Italy; [DiCuonzo, Franca] Univ Bari, Bari, Italy	IRCCS Eugenio Medea; Universita degli Studi di Bari Aldo Moro	Trabacca, A (corresponding author), Sci Inst IRCCS Eugenio Medea, Ostuni, Italy.		TRABACCA, ANTONIO/ABF-6907-2020; TRABACCA, ANTONIO/N-8047-2013	TRABACCA, ANTONIO/0000-0003-3165-0105; TRABACCA, ANTONIO/0000-0003-3165-0105; Dicuonzo, Franca/0000-0003-3999-6346					0	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2009	361	16					1584	1584		10.1056/NEJMicm0803613	http://dx.doi.org/10.1056/NEJMicm0803613			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506LT	19828535				2022-12-28	WOS:000270777000011
J	Collins, GA; Lipford, JR; Deshaies, RJ; Tansey, WP				Collins, Galen A.; Lipford, J. Russell; Deshaies, Raymond J.; Tansey, William P.			Gal4 turnover and transcription activation	NATURE			English	Letter							PROTEOLYSIS		[Collins, Galen A.] Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Collins, Galen A.; Tansey, William P.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Lipford, J. Russell; Deshaies, Raymond J.] CALTECH, Div Biol, Pasadena, CA 91125 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; California Institute of Technology	Collins, GA (corresponding author), Vanderbilt Univ, Med Ctr, 465 21st Ave S, Nashville, TN 37232 USA.	william.p.tansey@vanderbilt.edu	Deshaies, Raymond/B-8354-2014	Deshaies, Raymond/0000-0002-3671-9354; Collins, Galen/0000-0002-3926-9483	NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA013106-310027, P01 CA013106] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ezhkova Elena, 2006, Methods Mol Biol, V313, P225; GINIGER E, 1988, P NATL ACAD SCI USA, V85, P382, DOI 10.1073/pnas.85.2.382; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597	8	23	23	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					E7	E8		10.1038/nature08406	http://dx.doi.org/10.1038/nature08406			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19812621	Green Accepted, Bronze			2022-12-28	WOS:000270547500047
J	Iglehart, JK				Iglehart, John K.			Baucus's Bill and the Long Road to Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		ABELSON R, 2009, NY TIMES        0917, pA20; ADAMY J, 2009, WALL STREET J   0512, pA4; Connolly Ceci, 2009, WASHINGTON POST 0130, pA1; ENTHOVEN A, 2009, KAISER HLTH NEW 0910	4	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2009	361	15								10.1056/NEJMp0908719	http://dx.doi.org/10.1056/NEJMp0908719			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	503MU	19776397				2022-12-28	WOS:000270540000003
J	Rajaian, S; Kekre, NS				Rajaian, Shanmugasundaram; Kekre, Nitin Sudhakar			Staghorn Calculus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rajaian, Shanmugasundaram; Kekre, Nitin Sudhakar] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India	Christian Medical College & Hospital (CMCH) Vellore	Rajaian, S (corresponding author), Christian Med Coll & Hosp, Vellore, Tamil Nadu, India.								0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2009	361	15					1486	1486		10.1056/NEJMicm0805190	http://dx.doi.org/10.1056/NEJMicm0805190			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503MU	19812405				2022-12-28	WOS:000270540000011
J	Rudick, RA; Trapp, BD				Rudick, Richard A.; Trapp, Bruce D.			Gray-Matter Injury in Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rudick, Richard A.] Cleveland Clin, Neurol Inst, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA; [Trapp, Bruce D.] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Rudick, RA (corresponding author), Cleveland Clin, Neurol Inst, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA.							Derfuss T, 2009, P NATL ACAD SCI USA, V106, P8302, DOI 10.1073/pnas.0901496106; FISHER E, 2008, ANN NEUROL, V282, P106; Fisniku LK, 2008, ANN NEUROL, V64, P247, DOI 10.1002/ana.21423; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Tiberio M, 2005, NEUROLOGY, V64, P1001, DOI 10.1212/01.WNL.0000154526.22878.30	5	48	50	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2009	361	15					1505	1506		10.1056/NEJMcibr0905482	http://dx.doi.org/10.1056/NEJMcibr0905482			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503MU	19812410				2022-12-28	WOS:000270540000017
J	Yudkin, JS				Yudkin, John S.			Doctors and Human Rights The Israeli Medical Association and doctors' complicity in torture	BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, London WC1E 6BT, England	University of London; University College London	Yudkin, JS (corresponding author), UCL, London WC1E 6BT, England.	j.yudkin@blueyonder.co.uk	Yudkin, John S/C-1988-2008					*AMN INT, CONST MED SUP TORT I; BLACHAR Y, 2009, COMMUNICATION   0721; *BRIT MED ASS, 2009, MED INV TORT ILL TRE; DERFNER L, 2009, JERUSALEM POST  0916; EVEN D, 2009, HAARETZ         0811; *ISR MED ASS, 2007, PROH PHYS PART INT T; Kmietowicz Z, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2556; LIVNEH N, 2009, HAARETZ         0814; Public Committee Against Torture in Israel, 2007, TICK BOMBS TEST TORT; RAVID B, 2009, HAARETZ         0804; RECHES A, 2009, COMMUNICATION   0309; *UN FACT FIND MISS, HUM RIGHTS PAL OTH O; World Medical Association, 2006, GUID PHYS TORT OTH C; Yudkin JS, 2009, LANCET, V373, P1155, DOI 10.1016/S0140-6736(09)60373-1	14	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 7	2009	339								b4078	10.1136/bmj.b4078	http://dx.doi.org/10.1136/bmj.b4078			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505TG	19812132				2022-12-28	WOS:000270719200007
J	Victora, CG				Victora, Cesar G.			Nutrition in early life: a global priority	LANCET			English	Editorial Material							CHILD UNDERNUTRITION; ORIGINS; HEALTH		Univ Fed Pelotas, BR-96001970 Pelotas, Brazil	Universidade Federal de Pelotas	Victora, CG (corresponding author), Univ Fed Pelotas, BR-96001970 Pelotas, Brazil.	cvictora@gmail.com	Victora, Cesar G/D-4476-2013; Victora, Cesar Gomes/Y-2455-2019	Victora, Cesar G/0000-0002-2465-2180; Victora, Cesar Gomes/0000-0002-2465-2180				Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 2007, OBES REV, V8, P45, DOI 10.1111/j.1467-789X.2007.00317.x; Barros FC, 2005, LANCET, V365, P847, DOI 10.1016/S0140-6736(05)71042-4; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Hoddinott J, 2008, LANCET, V371, P411, DOI 10.1016/S0140-6736(08)60205-6; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; Morris SS, 2008, LANCET, V371, P608, DOI 10.1016/S0140-6736(07)61695-X; Prentice AM, 2005, ARCH DIS CHILD, V90, P429, DOI 10.1136/adc.2004.059030; SCRIMSHAW NS, 1959, AM J MED SCI, V237, P367; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; VICTORA CG, PEDIATRICS IN PRESS; World Bank, 2006, REP NUTR CENTR DEV S	15	23	24	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2009	374	9696					1123	1125		10.1016/S0140-6736(09)61725-6	http://dx.doi.org/10.1016/S0140-6736(09)61725-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505IZ	19801082				2022-12-28	WOS:000270688200006
J	Orr, FM				Orr, Franklin M., Jr.			Onshore Geologic Storage of CO2	SCIENCE			English	Editorial Material							INJECTION; WATER	The possibility that substantial quantities of CO2 can be injected into subsurface porous rock formations has been investigated sufficiently to show that pore space available to contain the CO2 is abundant. Multiple rock types and physical mechanisms can be used to trap the CO2 indefinitely. With careful site selection and operations, leakage to the near-surface region can be avoided. The next step is to test these injection processes at the scale of a large power plant.	Stanford Univ, Precourt Inst Energy, Stanford, CA 94305 USA	Stanford University	Orr, FM (corresponding author), Stanford Univ, Precourt Inst Energy, Stanford, CA 94305 USA.	fmorr@stanford.edu		Orr, Franklin/0000-0001-9708-7621				Aines RD, 2009, ENRGY PROCED, V1, P2421, DOI 10.1016/j.egypro.2009.02.003; Bradshaw J, 2007, INT J GREENH GAS CON, V1, P62, DOI 10.1016/S1750-5836(07)00027-8; Chiaramonte L, 2008, ENVIRON GEOL, V54, P1667, DOI 10.1007/s00254-007-0948-7; Dooley J.J., 2006, CARBON DIOXIDE CAPTU; Duncan IJ, 2009, ENRGY PROCED, V1, P2037, DOI 10.1016/j.egypro.2009.01.265; Gilfillan SMV, 2009, NATURE, V458, P614, DOI 10.1038/nature07852; Ide ST, 2007, INT J GREENH GAS CON, V1, P481, DOI 10.1016/S1750-5836(07)00091-6; *INT EN AG, CO2 CAPT STOR RD D D; Jessen K, 2008, TRANSPORT POROUS MED, V73, P141, DOI 10.1007/s11242-007-9165-9; Johnson J.W., 2004, GEOL SOC SPEC PUBL, V233, P107, DOI [10.1144/GSL.SP.2004.233.01.08, DOI 10.1144/GSL.SP.2004.233.01.08]; Kharaka YK, 2006, GEOLOGY, V34, P577, DOI 10.1130/G22357.1; McGrail BP, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004169; Metz B, 2005, INTERGOVERNMENTAL PA; *NAT EN TECHN LAB, 2008, CO2 SEQ ATL 2; Nuttall BC, 2005, DEFC2602NT41442 KENT; Riaz A, 2006, J FLUID MECH, V548, P87, DOI 10.1017/S0022112005007494; van der Meer LGH, 2009, ENRGY PROCED, V1, P2615, DOI 10.1016/j.egypro.2009.02.028; Vidas H, 2009, ENRGY PROCED, V1, P4281, DOI 10.1016/j.egypro.2009.02.240; ZOBACK MD, 2009, ROCK MOUNT EN EP COL	19	252	258	7	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	2009	325	5948					1656	1658		10.1126/science.1175677	http://dx.doi.org/10.1126/science.1175677			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779190				2022-12-28	WOS:000270131800034
J	Relman, AS				Relman, Arnold S.			Doctors as the Key to Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Relman, AS (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.							[Anonymous], 2009, RECOMMENDATIONS SPEC; Relman A, 2009, NEW YORK REV BOOKS, V56, P38; RELMAN AS, 2007, 2 OPINION RESCUING A; Steinbrook R, 2009, NEW ENGL J MED, V361, P1036, DOI 10.1056/NEJMp0906556	4	16	16	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2009	361	13					1225	1227		10.1056/NEJMp0907925	http://dx.doi.org/10.1056/NEJMp0907925			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	497RN	19776404				2022-12-28	WOS:000270078700001
J	He, J; Gu, D; Chen, J; Wu, X; Kelly, TN; Huang, JF; Chen, JC; Chen, CS; Bazzano, LA; Reynolds, K; Whelton, PK; Klag, MJ				He, Jiang; Gu, Dongfeng; Chen, Jing; Wu, Xigui; Kelly, Tanika N.; Huang, Jian-feng; Chen, Ji-chun; Chen, Chung-Shiuan; Bazzano, Lydia A.; Reynolds, Kristi; Whelton, Paul K.; Klag, Michael J.			Premature deaths attributable to blood pressure in China: a prospective cohort study	LANCET			English	Article							JOINT NATIONAL COMMITTEE; CARDIOVASCULAR-DISEASE; GLOBAL BURDEN; HYPERTENSION; HEALTH; PREVALENCE; RISK; ADULTS; PREHYPERTENSION; POPULATION	Background Hypertension is a major global-health challenge because of its high prevalence and concomitant risks of cardiovascular disease. We estimated premature deaths attributable to increased blood pressure in China. Methods We did a prospective cohort study in a nationally representative sample of 169871 Chinese adults aged 40 years and older. Blood pressure and other risk factors were measured at a baseline examination in 1991 and follow-up assessment was done in 1999-2000. Premature death was defined as mortality before age 72 years in men and 75 years in women, which were the average life expectancies in China in 2005. We calculated the numbers of total and premature deaths attributable to blood pressure using population-attributable risk, mortality; and the population size of China in 2005. Findings Hypertension and prehypertension were significantly associated with increased all-cause and cardiovascular mortality (p<0.0001). We estimated that in 2005, 2.33 million (95% CI 2.21-2.45) cardiovascular deaths were attributable to increased blood pressure in China: 2.11 million (2.03-2.20) in adults with hypertension and 0.22 million (0.19-0.25) in adults with prehypertension. Additionally, 1.27 million (1.18-1.36) premature cardiovascular deaths were attributable to raised blood pressure in China: 1.15 million (1.08-1.22) in adults with hypertension and 0.12 million (0.10-0.14) in adults with prehypertension. Most blood pressure-related deaths were caused by cerebrovascular diseases: 1.86 million (1.76-1.96) total deaths and 1.08 million (1.00-1.15) premature deaths. Interpretation Increased blood pressure is the leading preventable risk factor for premature mortality in the Chinese general population. Prevention and control of this condition should receive top public-health priority in China.	[He, Jiang; Kelly, Tanika N.; Chen, Chung-Shiuan; Bazzano, Lydia A.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; [He, Jiang; Chen, Jing; Bazzano, Lydia A.] Tulane Univ, Sch Med, Dept Med, New Orleans, LA 70112 USA; [He, Jiang; Chen, Jing; Bazzano, Lydia A.] Tulane Univ, Sch Med, Tulane Hypertens & Renal Ctr Excellence, New Orleans, LA 70112 USA; [Gu, Dongfeng; Wu, Xigui; Huang, Jian-feng; Chen, Ji-chun] Cardiovasc Inst, Dept Evidence Based Med, Beijing, Peoples R China; [Gu, Dongfeng; Wu, Xigui; Huang, Jian-feng; Chen, Ji-chun] Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100037, Peoples R China; [Gu, Dongfeng; Wu, Xigui; Huang, Jian-feng; Chen, Ji-chun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Gu, Dongfeng; Wu, Xigui; Huang, Jian-feng; Chen, Ji-chun] Natl Cardiovasc Ctr, Beijing, Peoples R China; [Reynolds, Kristi] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA USA; [Whelton, Paul K.] Loyola Univ Med Ctr, Maywood, IL 60153 USA; [Klag, Michael J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Tulane University; Tulane University; Tulane University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Kaiser Permanente; Loyola University Chicago; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	He, J (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA.	jhe@tulane.edu	Reynolds, Kristi/AAN-1434-2021; He, Jiang/AAF-5303-2020	Reynolds, Kristi/0000-0001-7619-1649; He, Jiang/0000-0002-8286-9652	American Heart Association (USA); National Heart, Lung, and Blood Institute, National institutes of Health (USA); Ministry of Health (China); Ministry of Science and Technology (China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL072507] Funding Source: NIH RePORTER	American Heart Association (USA)(American Heart Association); National Heart, Lung, and Blood Institute, National institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Ministry of Health (China); Ministry of Science and Technology (China)(Ministry of Science and Technology, China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	American Heart Association (USA); National Heart, Lung, and Blood Institute, National institutes of Health (USA); Ministry of Health (China); and Ministry of Science and Technology (China).	*ATH RISK COMM STU, 1997, MAN 3 SURV COMP PROC; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Choi KM, 2006, J HYPERTENS, V24, P1515, DOI 10.1097/01.hjh.0000239286.02389.0f; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; FROHLICH ED, 1988, CIRCULATION, V77, pA502; Gu DF, 2002, HYPERTENSION, V40, P920, DOI 10.1161/01.HYP.0000040263.94619.D5; Gu DF, 2008, AM J HYPERTENS, V21, P265, DOI 10.1038/ajh.2007.59; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hsia J, 2007, CIRCULATION, V115, P855, DOI 10.1161/CIRCULATIONAHA.106.656850; INGRAM DD, 1994, VITAL HLTH STAT 2, V121, P1; KAHN HA, 1989, STAT METHODS EPIDEMI, P73; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kelly TN, 2008, CIRCULATION, V118, P1558, DOI 10.1161/CIRCULATIONAHA.107.723593; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Liu M, 2007, LANCET NEUROL, V6, P456, DOI 10.1016/S1474-4422(07)70004-2; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Martiniuk ALC, 2007, J HYPERTENS, V25, P73, DOI 10.1097/HJH.0b013e328010775f; *MIN HLTH PEOPL RE, 2001, HLTH STAT INF CHIN 2; Perkovic V, 2007, HYPERTENSION, V50, P991, DOI 10.1161/HYPERTENSIONAHA.107.095497; Rao C, 2007, INT J EPIDEMIOL, V36, P642, DOI 10.1093/ije/dym003; Rodgers A, 2004, PLOS MED, V1, P44, DOI 10.1371/journal.pmed.0010027; United Nations, 2000, UN MILL DECL GEN ASS; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; WHELTON PK, 2004, CLIN TRIALS CARDIOVA, P282; *WHO, 2006, LIF TABL CHIN; Wu XG, 1995, INT J CARDIOL, V52, P39, DOI 10.1016/0167-5273(95)02443-Z; Wu YF, 2006, CIRCULATION, V114, P2217, DOI 10.1161/CIRCULATIONAHA.105.607499; Wu YF, 2008, CIRCULATION, V118, P2679, DOI 10.1161/CIRCULATIONAHA.108.788166	33	176	215	1	35	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2009	374	9703					1765	1772		10.1016/S0140-6736(09)61199-5	http://dx.doi.org/10.1016/S0140-6736(09)61199-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ID	19811816				2022-12-28	WOS:000272207700025
J	Sarfaty, M				Sarfaty, Mona			Senator Kennedy's Legacy to US Health and Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sarfaty, Mona] Thomas Jefferson Univ, Dept Family & Community Med, Philadelphia, PA 19107 USA; [Sarfaty, Mona] Thomas Jefferson Univ, Sch Populat Hlth, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University	Sarfaty, M (corresponding author), Thomas Jefferson Univ, Dept Family & Community Med, Philadelphia, PA 19107 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2009	361	16								10.1056/NEJMp0908059	http://dx.doi.org/10.1056/NEJMp0908059			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	506LT	19797276				2022-12-28	WOS:000270777000005
J	Ganti, AK				Ganti, Apar Kishor			Another nail in the coffin for hormone-replacement therapy?	LANCET			English	Editorial Material							CELL LUNG-CANCER; ESTROGEN PLUS PROGESTIN; WOMEN; SURVIVAL; RECEPTOR; RISK; EXPRESSION		[Ganti, Apar Kishor] Univ Nebraska Med Ctr, Dept Internal Med, Hematol Oncol Sect, Omaha, NE 68198 USA; [Ganti, Apar Kishor] VA Nebraska Western Iowa Hlth Care Syst, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System	Ganti, AK (corresponding author), Univ Nebraska Med Ctr, Dept Internal Med, Hematol Oncol Sect, Omaha, NE 68198 USA.	aganti@unmc.edu	Ganti, Apar Kishor/D-5498-2015	Ganti, Apar Kishor/0000-0003-3724-2671				Chlebowski RT, 2009, LANCET, V374, P1243, DOI 10.1016/S0140-6736(09)61526-9; Ettinger B, 1996, OBSTET GYNECOL, V87, P6, DOI 10.1016/0029-7844(95)00358-4; Ganti AK, 2006, J CLIN ONCOL, V24, P59, DOI 10.1200/JCO.2005.02.9827; Hays J, 2003, NEW ENGL J MED, V348, P1839, DOI 10.1056/NEJMoa030311; Huang B, 2009, CANCER, V115, P4167, DOI 10.1002/cncr.24475; Ishibashi H, 2005, CANCER RES, V65, P6450, DOI 10.1158/0008-5472.CAN-04-3087; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Marquez-Garban DC, 2009, ANN NY ACAD SCI, V1155, P194, DOI 10.1111/j.1749-6632.2009.04116.x; Moore KA, 2003, ANN THORAC SURG, V76, P1789, DOI 10.1016/S0003-4975(03)01024-5; Omoto Y, 2001, BIOCHEM BIOPH RES CO, V285, P340, DOI 10.1006/bbrc.2001.5158; Schabath MB, 2004, CLIN CANCER RES, V10, P113, DOI 10.1158/1078-0432.CCR-0911-3; Schwartz AG, 2007, J CLIN ONCOL, V25, P5785, DOI 10.1200/JCO.2007.13.3975	12	9	9	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 10	2009	374	9697					1217	1218		10.1016/S0140-6736(09)61571-3	http://dx.doi.org/10.1016/S0140-6736(09)61571-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	507KQ	19767095				2022-12-28	WOS:000270852500005
J	Gilron, I; Bailey, JM; Tu, D; Holden, RR; Jackson, AC; Houlden, RL				Gilron, Ian; Bailey, Joan M.; Tu, Dongsheng; Holden, Ronald R.; Jackson, Alan C.; Houlden, Robyn L.			Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial	LANCET			English	Article							AMITRIPTYLINE; EPIDEMIOLOGY; EFFICACY; MORPHINE; PLACEBO; DRUGS	Background Drugs for neuropathic pain have incomplete efficacy and dose-limiting side-effects when given as monotherapy. We assessed the efficacy and tolerability of combined nortriptyline and gabapentin compared with each drug given alone. Methods In this double-blind, double-dummy, crossover trial, patients with diabetic polyneuropathy or postherpetic neuralgia, and who had a daily pain score of at least 4 (scale 0-10), were enrolled and treated at one study site in Canada between Nov 5, 2004, and Dec 13, 2007. 56 patients were randomised in a 1:11 ratio with a balanced Latin square design to receive one of three sequences of daily oral gabapentin, nortriptyline, and their combination. In sequence, a different drug was given to each randomised group in three treatment periods. During each 6-week treatment period, drug doses were titrated towards maximum tolerated dose. The primary outcome was mean daily pain at maximum tolerated dose. Analysis was by intention to treat. This trial is registered, number ISRCTN73178636. Findings 45 patients completed all three treatment periods; 47 patients completed at least two treatment periods and were analysed for the primary outcome. Mean daily pain (0-10; numerical rating scale) was 5.4 (95% CI 5.0 to 5.8) at baseline, and at maximum tolerated dose, pain was 3.2 (2.5 to 3.8) for gabapentin, 2.9 (2.4 to 3.4) for nortriptyline, and 2.3 (1.8 to 2.8) for combination treatment. Pain with combination treatment was significantly lower than with gabapentin (-0.9, 95% CI -1.4 to -0.3, p=0.001) or nortriptyline alone (-0.6, 95% CI -1.1 to -0.1, p=0.02). At maximum tolerated dose, the most common adverse event was dry mouth, which was significantly less frequent in patients on gabapentin than on nortriptyline (p<0.0001) or combination treatment (p<0.0001). No serious adverse events were recorded for any patients during the trial. Interpretation Combined gabapentin and nortriptyline seems to be more efficacious than either drug given alone for neuropathic pain, therefore we recommend use of this combination in patients who show a partial response to either drug given alone and seek additional pain relief Future trials should compare other combinations to their respective monotherapies for treatment of such pain. Funding Canadian institutes of Health Research.	[Gilron, Ian; Bailey, Joan M.] Queens Univ, Dept Anesthesiol, Kingston, ON K7L 2V7, Canada; [Gilron, Ian] Queens Univ, Dept Pharmacol & Toxicol, Kingston, ON K7L 2V7, Canada; [Tu, Dongsheng] Queens Univ, Dept Math & Stat, Kingston, ON K7L 2V7, Canada; [Holden, Ronald R.] Queens Univ, Dept Psychol, Kingston, ON K7L 2V7, Canada; [Houlden, Robyn L.] Queens Univ, Dept Med, Div Endocrinol, Kingston, ON K7L 2V7, Canada; [Gilron, Ian; Bailey, Joan M.; Houlden, Robyn L.] Kingston Gen Hosp, Kingston, ON K7L 2V7, Canada; [Jackson, Alan C.] Univ Manitoba, Dept Internal Med, Neurol Sect, Winnipeg, MB, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada; Queens University - Canada; University of Manitoba	Gilron, I (corresponding author), Queens Univ, Dept Anesthesiol, 76 Stuart St, Kingston, ON K7L 2V7, Canada.	gilroni@queensu.ca	Jackson, Alan C/ABD-9312-2020	Jackson, Alan C/0000-0003-0413-4236; Holden, Ronald/0000-0002-9070-2510	Canadian Institutes of Health Research [MCT-69422, MSH-55041]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We dedicate this trial to the memory of Mitchell B Max. We thank Mark Wallace for thoughtful comments made on previous versions. This study was funded by the Canadian Institutes of Health Research (grant numbers MCT-69422 and MSH-55041). Study drugs were supplied free of charge by Novopharm (gabapentin) and Apotex (nortriptyline); neither of these companies had any control over the conduct or publication of this trial. We thank Chris Gray for his valuable technical support on this trial.	Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Amer Diabet Assoc, 2005, DIABETES CARE, V28, pS37; Beck A., 1993, BECK DEPRESSION INVE; Berger A, 2004, J PAIN, V5, P143, DOI 10.1016/j.jpain.2003.12.004; Bouhassira D, 2008, PAIN, V136, P380, DOI 10.1016/j.pain.2007.08.013; Chandra K, 2006, INT J CLIN PHARM TH, V44, P358; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Dworkin RH, 2007, PAIN, V132, P237, DOI 10.1016/j.pain.2007.08.033; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Field MJ, 2006, P NATL ACAD SCI USA, V103, P17537, DOI 10.1073/pnas.0409066103; Finnerup NB, 2005, PAIN, V118, P289, DOI 10.1016/j.pain.2005.08.013; Freynhagen R, 2005, PAIN, V115, P254, DOI 10.1016/j.pain.2005.02.032; Galer BS, 2000, DIABETES RES CLIN PR, V47, P123, DOI 10.1016/S0168-8227(99)00112-6; Gandek, 1997, SF 36 HLTH SURVEY MA; Gilron I, 2005, NEW ENGL J MED, V352, P1324, DOI 10.1056/NEJMoa042580; Gilron Ian, 2005, Expert Rev Neurother, V5, P823, DOI 10.1586/14737175.5.6.823; Graff-Radford SB, 2000, CLIN J PAIN, V16, P188, DOI 10.1097/00002508-200009000-00002; Hall GC, 2006, PAIN, V122, P156, DOI 10.1016/j.pain.2006.01.030; Harden CL, 1999, EPILEPSIA, V40, P1129, DOI 10.1111/j.1528-1157.1999.tb00830.x; Heughan CE, 2002, ANESTH ANALG, V94, P975, DOI 10.1097/00000539-200204000-00037; Hochberg Y., 1987, MULTIPLE COMP PROCED; Jones B., 2003, DESIGN ANAL CROSS OV, V2nd; Juniper Elizabeth F, 2002, Am J Respir Med, V1, P435; Khoromi S, 2007, PAIN, V130, P66, DOI 10.1016/j.pain.2006.10.029; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Lilenbaum RC, 1998, CANCER, V82, P116, DOI 10.1002/(SICI)1097-0142(19980101)82:1<116::AID-CNCR14>3.0.CO;2-5; MAX MB, 2001, BONICAS MANAGEMENT P; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Merskey HH, 1994, CLASSIFICATION CHRON, P212; Morello CM, 1999, ARCH INTERN MED, V159, P1931, DOI 10.1001/archinte.159.16.1931; Raja SN, 2005, NEW ENGL J MED, V352, P1373, DOI 10.1056/NEJMe058039; Rice ASC, 2006, ANNU REV MED, V57, P535, DOI 10.1146/annurev.med.57.121304.131324; Rintala DH, 2007, ARCH PHYS MED REHAB, V88, P1547, DOI 10.1016/j.apmr.2007.07.038; Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Turk DC, 2002, CLIN J PAIN, V18, P355, DOI 10.1097/00002508-200211000-00003	37	294	308	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2009	374	9697					1252	1261		10.1016/S0140-6736(09)61081-3	http://dx.doi.org/10.1016/S0140-6736(09)61081-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	507KQ	19796802				2022-12-28	WOS:000270852500031
J	Dawson, MA; Bannister, AJ; Gottgens, B; Foster, SD; Bartke, T; Green, AR; Kouzarides, T				Dawson, Mark A.; Bannister, Andrew J.; Goettgens, Berthold; Foster, Samuel D.; Bartke, Till; Green, Anthony R.; Kouzarides, Tony			JAK2 phosphorylates histone H3Y41 and excludes HP1 alpha from chromatin	NATURE			English	Article							DNA-REPLICATION; LYSINE 9; H3; MUTATIONS; PROTEIN; CELLS; HP1; METHYLATION; ACTIVATION; THERAPY	Activation of Janus kinase 2 (JAK2) by chromosomal translocations or point mutations is a frequent event in haematological malignancies(1-6). JAK2 is a non-receptor tyrosine kinase that regulates several cellular processes by inducing cytoplasmic signalling cascades. Here we show that human JAK2 is present in the nucleus of haematopoietic cells and directly phosphorylates Tyr 41 (Y41) on histone H3. Heterochromatin protein 1 alpha (HP1 alpha), but not HP1 beta, specifically binds to this region of H3 through its chromo-shadow domain. Phosphorylation of H3Y41 by JAK2 prevents this binding. Inhibition of JAK2 activity in human leukaemic cells decreases both the expression of the haematopoietic oncogene lmo2 and the phosphorylation of H3Y41 at its promoter, while simultaneously increasing the binding of HP1a at the same site. These results identify a previously unrecognized nuclear role for JAK2 in the phosphorylation of H3Y41 and reveal a direct mechanistic link between two genes, jak2 and lmo2, involved in normal haematopoiesis and leukaemia(1-9).	[Dawson, Mark A.; Goettgens, Berthold; Foster, Samuel D.; Green, Anthony R.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Dawson, Mark A.; Goettgens, Berthold; Foster, Samuel D.; Green, Anthony R.] Univ Cambridge, Dept Haematol, Cambridge CB2 0XY, England; [Dawson, Mark A.; Green, Anthony R.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England; [Bannister, Andrew J.; Bartke, Till; Kouzarides, Tony] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Bannister, Andrew J.; Bartke, Till; Kouzarides, Tony] Univ Cambridge, Dept Pathol, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge	Green, AR (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	arg1000@cam.ac.uk; t.kouzarides@gurdon.cam.ac.uk	Dawson, Mark A/B-9317-2017	Dawson, Mark A/0000-0002-5464-5029; Foster, Samuel/0000-0001-5375-7080; Green, Anthony/0000-0002-9795-0218; Bannister, Andrew/0000-0002-6312-4436; Kouzarides, Tony/0000-0002-8918-4162	General Sir John Monash Foundation; Cambridge Commonwealth Trust; Raymond and Beverly Sackler; UK Leukaemia Research Fund; Wellcome Trust; Leukemia & Lymphoma Society of America; National Institute for Health Research Cambridge Biomedical Research Centre; Leukaemia Research Fund; Cancer Research UK; Medical Research Council; 6th Research Framework Programme of the European Union ( Epitron, HEROIC and SMARTER).; Medical Research Council [G0800784, G0800784B, G0300723B] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	General Sir John Monash Foundation; Cambridge Commonwealth Trust; Raymond and Beverly Sackler; UK Leukaemia Research Fund; Wellcome Trust(Wellcome Trust); Leukemia & Lymphoma Society of America(Leukemia and Lymphoma Society); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Leukaemia Research Fund; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); 6th Research Framework Programme of the European Union ( Epitron, HEROIC and SMARTER).; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Flicek, S. Wilder, B. Huntly, S. J. Dawson and all the members of the A. R. G., B. G. and T. K. laboratories, in particular P. Hurd, B. Xhemalce, E. J. Baxter and P. Beer, for helpful discussions; A. Wood for sharing unpublished data; and J. LeQuesne for help with image analysis. This work was supported by PhD fellowship grants to M. A. D. from the General Sir John Monash Foundation, the Cambridge Commonwealth Trust and Raymond and Beverly Sackler. The Green ( A. R. G.) laboratory is funded by the UK Leukaemia Research Fund, the Wellcome Trust, the Leukemia & Lymphoma Society of America and the National Institute for Health Research Cambridge Biomedical Research Centre. The Gottgens ( B. G.) laboratory is funded by the Leukaemia Research Fund, Cancer Research UK, the Leukemia & Lymphoma Society of America and a Medical Research Council studentship to S. D. F. The Kouzarides ( T. K.) laboratory is funded by grants from Cancer Research UK and the 6th Research Framework Programme of the European Union ( Epitron, HEROIC and SMARTER).	Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bercovich D, 2008, LANCET, V372, P1484, DOI 10.1016/S0140-6736(08)61341-0; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Cummings WJ, 2007, PLOS BIOL, V5, P2145, DOI 10.1371/journal.pbio.0050246; Donaldson IJ, 2005, BIOINFORMATICS, V21, P3058, DOI 10.1093/bioinformatics/bti461; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Krude T, 2000, J BIOL CHEM, V275, P13699, DOI 10.1074/jbc.275.18.13699; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Ma ACH, 2007, BLOOD, V110, P1824, DOI 10.1182/blood-2007-03-078287; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207; Mullighan CG, 2009, P NATL ACAD SCI USA, V106, P9414, DOI 10.1073/pnas.0811761106; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; OSBORN L, 1989, P NATL ACAD SCI USA, V86, P2336, DOI 10.1073/pnas.86.7.2336; Panteleeva I, 2007, EMBO J, V26, P3616, DOI 10.1038/sj.emboj.7601789; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; Plo I, 2008, BLOOD, V112, P1402, DOI 10.1182/blood-2008-01-134114; Quentmeier H, 2006, LEUKEMIA, V20, P471, DOI 10.1038/sj.leu.2404081; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Shi S, 2006, NAT GENET, V38, P1071, DOI 10.1038/ng1860; SQUIRES MS, 2007, BLOOD, V110; Walz C, 2006, J BIOL CHEM, V281, P18177, DOI 10.1074/jbc.M600064200; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; Wood AD, 2009, BLOOD, V114, P1820, DOI 10.1182/blood-2009-02-206573; Xie SH, 2001, ONCOGENE, V20, P6188, DOI 10.1038/sj.onc.1204834; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217; Zhao R, 2008, NEW ENGL J MED, V359, P2778, DOI 10.1056/NEJMoa0804953	33	66	67	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					819	U79		10.1038/nature08448	http://dx.doi.org/10.1038/nature08448			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19783980	Green Accepted			2022-12-28	WOS:000270547500041
J	Huang, Y; Ji, LJ; Huang, QC; Vassylyev, DG; Chen, XM; Ma, JB				Huang, Ying; Ji, Lijuan; Huang, Qichen; Vassylyev, Dmitry G.; Chen, Xuemei; Ma, Jin-Biao			Structural insights into mechanisms of the small RNA methyltransferase HEN1	NATURE			English	Article							SMALL INTERFERING RNA; PIWI-INTERACTING RNAS; 3'-END RECOGNITION; MICRORNA; METHYLATION; PROTEIN; HOMOLOG; FAMILY; LA; 2'-O-METHYLATION	RNA silencing is a conserved regulatory mechanism in fungi, plants and animals that regulates gene expression and defence against viruses and transgenes(1). Small silencing RNAs of similar to 20-30 nucleotides and their associated effector proteins, the Argonaute family proteins, are the central components in RNA silencing(2). A subset of small RNAs, such as microRNAs and small interfering RNAs (siRNAs) in plants, Piwi-interacting RNAs in animals and siRNAs in Drosophila, requires an additional crucial step for their maturation; that is, 2'-O-methylation on the 39 terminal nucleotide(3-6). A conserved S-adenosyl-L-methionine-dependent RNA methyltransferase, HUA ENHANCER 1 (HEN1), and its homologues are responsible for this specific modification(3-5,7,8). Here we report the 3.1 angstrom crystal structure of full-length HEN1 from Arabidopsis in complex with a 22-nucleotide small RNA duplex and cofactor product S-adenosyl-L-homocysteine. Highly cooperative recognition of the small RNA substrate by multiple RNA binding domains and the methyltransferase domain in HEN1 measures the length of the RNA duplex and determines the substrate specificity. Metal ion coordination by both 2' and 3' hydroxyls on the 3'-terminal nucleotide and four invariant residues in the active site of the methyltransferase domain suggests a novel Mg2+-dependent 2'-O-methylation mechanism.	[Huang, Ying; Huang, Qichen; Vassylyev, Dmitry G.; Ma, Jin-Biao] Univ Alabama Birmingham, Dept Biochem, Birmingham, AL 35294 USA; [Huang, Ying; Huang, Qichen; Vassylyev, Dmitry G.; Ma, Jin-Biao] Univ Alabama Birmingham, Sch Med, Dept Mol Genet, Birmingham, AL 35294 USA; [Huang, Ying; Huang, Qichen; Vassylyev, Dmitry G.; Ma, Jin-Biao] Univ Alabama Birmingham, Sch Dent, Birmingham, AL 35294 USA; [Ji, Lijuan; Chen, Xuemei] Univ Calif Riverside, Dept Bot & Plant Sci, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Ma, Jin-Biao] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Riverside; University of Alabama System; University of Alabama Birmingham	Ma, JB (corresponding author), Univ Alabama Birmingham, Dept Biochem, Birmingham, AL 35294 USA.	jma@biochemistry.uab.edu	Huang, Ying/AFM-0838-2022; Vassylyev, Dmitry/A-9005-2008; Ji, Lijuan/C-4919-2012	Huang, Ying/0000-0002-2806-2874; Ji, Lijuan/0000-0003-0678-6131; Chen, Xuemei/0000-0002-5209-1157	V Foundation for Cancer Research; National Science Foundation [MCB-0718029]; National Institutes of Health [R01 GM074252, R01 GM074840]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074252, R01GM061146, R01GM074840] Funding Source: NIH RePORTER	V Foundation for Cancer Research; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Sergiy for assistance with the in- house X- ray generator operation, and the staff at Advanced Photon Source beamlines 19ID and 23ID, Argonne National Laboratory, for help with data collection. We thank T. Townes and H. Wang for critical reading of the manuscript. This work was supported by a start-up fund ( to J.- B. M.) and partly by a grant from the V Foundation for Cancer Research ( to J.- B. M.) and a grant from the National Science Foundation (MCB-0718029 to X. C.). D. G. V. is supported by grants from National Institutes of Health (R01 GM074252 and R01 GM074840).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen XM, 2002, DEVELOPMENT, V129, P1085; Curry S, 2006, TRENDS BIOCHEM SCI, V31, P303, DOI 10.1016/j.tibs.2006.04.008; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kang CB, 2008, NEUROSIGNALS, V16, P318, DOI 10.1159/000123041; Kirino Y, 2007, RNA, V13, P1397, DOI 10.1261/rna.659307; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Maraia RJ, 2006, MOL CELL, V21, P149, DOI 10.1016/j.molcel.2006.01.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Ryter JM, 1998, EMBO J, V17, P7505, DOI 10.1093/emboj/17.24.7505; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; STUMP WT, 1995, RNA, V1, P55; Teplova M, 2006, MOL CELL, V21, P75, DOI 10.1016/j.molcel.2005.10.027; Tian B, 2004, NAT REV MOL CELL BIO, V5, P1013, DOI 10.1038/nrm1528; Tkaczuk KL, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-6; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292; Yang ZY, 2007, METHOD ENZYMOL, V427, P139, DOI 10.1016/S0076-6879(07)27008-9; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Yu B, 2006, FEBS LETT, V580, P3117, DOI 10.1016/j.febslet.2006.04.063	38	96	102	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					823	U86		10.1038/nature08433	http://dx.doi.org/10.1038/nature08433			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19812675	Green Accepted			2022-12-28	WOS:000270547500042
J	Steinbeck, G; Andresen, D; Seidl, K; Brachmann, J; Hoffmann, E; Wojciechowski, D; Kornacewicz-Jach, Z; Sredniawa, B; Lupkovics, G; Hofgartner, F; Lubinski, A; Rosenqvist, M; Habets, A; Wegscheider, K; Senges, J				Steinbeck, Gerhard; Andresen, Dietrich; Seidl, Karlheinz; Brachmann, Johannes; Hoffmann, Ellen; Wojciechowski, Dariusz; Kornacewicz-Jach, Zdzislawa; Sredniawa, Beata; Lupkovics, Geza; Hofgaertner, Franz; Lubinski, Andrzej; Rosenqvist, Marten; Habets, Alphonsus; Wegscheider, Karl; Senges, Jochen		IRIS Investigators	Defibrillator Implantation Early after Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEFT-VENTRICULAR DYSFUNCTION; CARDIOVERTER-DEFIBRILLATOR; SUDDEN-DEATH; HEART-RATE; PROPHYLACTIC IMPLANTATION; MORTALITY; RISK; FAILURE; SHOCKS	Background The rate of death, including sudden cardiac death, is highest early after a myocardial infarction. Yet current guidelines do not recommend the use of an implantable cardioverter-defibrillator (ICD) within 40 days after a myocardial infarction for the prevention of sudden cardiac death. We tested the hypothesis that patients at increased risk who are treated early with an ICD will live longer than those who receive optimal medical therapy alone. Methods This randomized, prospective, open-label, investigator-initiated, multicenter trial registered 62,944 unselected patients with myocardial infarction. Of this total, 898 patients were enrolled 5 to 31 days after the event if they met certain clinical criteria: a reduced left ventricular ejection fraction (<= 40%)and a heart rate of 90 or more beats per minute on the first available electrocardiogram (ECG) (criterion 1: 602 patients), nonsustained ventricular tachycardia (>= 150 beats per minute) during Holter monitoring (criterion 2: 208 patients), or both criteria (88 patients). Of the 898 patients, 445 were randomly assigned to treatment with an ICD and 453 to medical therapy alone. Results During a mean follow- up of 37 months, 233 patients died: 116 patients in the ICD group and 117 patients in the control group. Overall mortality was not reduced in the ICD group (hazard ratio, 1.04; 95% confidence interval [CI], 0.81 to 1.35; P = 0.78). There were fewer sudden cardiac deaths in the ICD group than in the control group (27 vs. 60; hazard ratio, 0.55; 95% CI, 0.31 to 1.00; P = 0.049), but the number of non-sudden cardiac deaths was higher (68 vs. 39; hazard ratio, 1.92; 95% CI, 1.29 to 2.84; P = 0.001). Hazard ratios were similar among the three groups of patients categorized according to the enrollment criteria they met (criterion 1, criterion 2, or both). Conclusions Prophylactic ICD therapy did not reduce overall mortality among patients with acute myocardial infarction and clinical features that placed them at increased risk. (ClinicalTrials.gov number, NCT00157768.)	[Steinbeck, Gerhard] Univ Munich, Dept Internal Med 1, D-81377 Munich, Germany; [Andresen, Dietrich] Klinikum Urban, Berlin, Germany; [Seidl, Karlheinz; Senges, Jochen] Klinikum Stadt Ludwigshafen, Ludwigshafen Am Rhein, Germany; [Brachmann, Johannes] Klinikum Coburg, Coburg, Germany; [Hoffmann, Ellen] Stadt Krankenhaus Munchen Bogenhausen, Munich, Germany; [Hofgaertner, Franz] Klin Eichert, Goppingen, Germany; [Wegscheider, Karl] Univ Hamburg Hosp, D-2000 Hamburg, Germany; [Wojciechowski, Dariusz] Szpital Wolski, Warsaw, Poland; [Kornacewicz-Jach, Zdzislawa] Pomeranian Med Univ, Szczecin, Poland; [Sredniawa, Beata] Med Univ Silesia, Zabrze, Poland; [Lubinski, Andrzej] Uniwersytecki Szpital, Lodz, Poland; [Lupkovics, Geza] Zala Cty Hosp, Zalaegerszeg, Hungary; [Rosenqvist, Marten] Soder Sjukhuset, Karolinska Inst, Stockholm, Sweden; [Habets, Alphonsus] Medtron Bakken Res Ctr, Maastricht, Netherlands	University of Munich; Ludwigshafen Hospital; Klinikum Coburg; Munchen Klinik; University of Hamburg; University Medical Center Hamburg-Eppendorf; Pomeranian Medical University; Medical University Silesia; Karolinska Institutet; Sodersjukhuset Hospital; Medtronic Bakken Research Center B.V.	Steinbeck, G (corresponding author), Univ Munich, Dept Internal Med 1, Campus Grosshadern,Marchioninistr 15, D-81377 Munich, Germany.	gerhard.steinbeck@med.uni-muenchen.de	Lubinski, Andrzej/S-9756-2016; Bissinger, Andrzej Pawel/S-9688-2016; Sobiczewski, Wojciech T/E-9256-2012; Hoffmann, Ellen/AAP-4442-2020; Kubica, Jacek/D-6906-2014; Brachmann, Johannes/AAD-1499-2021; Ponikowski, Piotr/O-6454-2015; Stolarz, Przemysław/V-3897-2018	Sobiczewski, Wojciech T/0000-0001-6583-9147; Hoffmann, Ellen/0000-0003-1953-9383; Kubica, Jacek/0000-0001-8250-754X; Ponikowski, Piotr/0000-0002-3391-7064; Stolarz, Przemysław/0000-0002-5588-825X; Fabiszak, Tomasz/0000-0001-7317-5088; Sredniawa, Beata/0000-0003-1591-3972; Opolski, Grzegorz/0000-0003-4744-2554	Medtronic Bakken Research Center; AstraZeneca; R. Becker; Medtronic; St. Jude Medical; Biotronik	Medtronic Bakken Research Center(Medtronic); AstraZeneca(AstraZeneca); R. Becker; Medtronic(Medtronic); St. Jude Medical(St. Jude Medical); Biotronik	Supported by grants from Medtronic Bakken Research Center, AstraZeneca, and R. Becker (to Dr. Steinbeck).; Dr. Steinbeck reports receiving consulting fees from Medtronic, lecture fees from Medtronic, St. Jude Medical, and Boston Scientific, and grant support from Medtronic and St. Jude Medical; Dr. Andresen, receiving consulting fees from Medtronic and Biotronik, lecture fees from Medtronic, Biotronik, and St. Jude Medical, and grant support from Medtronic; Dr. Seidl, receiving consulting fees from St. Jude Medical and Medtronic, lecture fees from St. Jude Medical and Biotronik, and grant support from St. Jude Medical and Medtronic; Dr. Brachmann, receiving consulting fees from Medtronic and Biotronik, lecture fees from Medtronic, St. Jude Medical, and Biotronik, and grant support from Biotronik and Medtronic; Dr. Hoffmann, receiving consulting fees from Medtronic, lecture fees from Medtronic, St. Jude Medical, and Biotronik, and grant support from Medtronic, Biotronik, and Sorin; Dr. Wojciechowski, receiving lecture fees from Medtronic; Dr. Sredniawa, receiving consulting fees from Medtronic; Dr. Rosenqvist, receiving consulting fees and lecture fees from Medtronic; Dr. Habets, being an employee of and holding stock options in Medtronic; Dr. Wegscheider, receiving payment as a statistician from Medtronic; and Dr. Senges, receiving consulting fees from Medtronic, Cordis, and Astra, lecture fees from Medtronic, Cordis, and Astra, and grant support from Cordis, St. Jude Medical, and Medtronic. No other potential conflict of interest relevant to this article was reported.	Adabag AS, 2008, JAMA-J AM MED ASSOC, V300, P2022, DOI 10.1001/jama.2008.553; *ADDPLAN GMBH, 2007, ADDPLAN AD DES PLANS; Andresen D., 1999, European Heart Journal, V20, P232; Andresen D, 1999, J AM COLL CARDIOL, V33, P131, DOI 10.1016/S0735-1097(98)00516-6; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bauer A, 2006, LANCET, V367, P1674, DOI 10.1016/S0140-6736(06)68735-7; BIGGER JT, 1984, CIRCULATION, V69, P250, DOI 10.1161/01.CIR.69.2.250; Cheema AN, 1998, CIRCULATION, V98, P2030, DOI 10.1161/01.CIR.98.19.2030; Connolly SJ, 1997, LANCET, V350, P1417; Daubert JP, 2008, J AM COLL CARDIOL, V51, P1357, DOI 10.1016/j.jacc.2007.09.073; DISEGNI E, 1995, J CLIN EPIDEMIOL, V48, P1197, DOI 10.1016/0895-4356(95)00022-V; Ezekowitz JA, 2009, J AM COLL CARDIOL, V53, P13, DOI 10.1016/j.jacc.2008.08.067; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Goldenberg I, 2006, CIRCULATION, V113, P2810, DOI 10.1161/CIRCULATIONAHA.105.577262; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; HJALMARSON A, 1990, AM J CARDIOL, V65, P547, DOI 10.1016/0002-9149(90)91029-6; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Jordaens L, 2001, EUR HEART J, V22, P1214, DOI 10.1053/euhj.2000.2464; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KOBER L, 1995, AM J CARDIOL, V76, P1, DOI 10.1016/S0002-9149(99)80791-7; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; McAnulty J, 1997, NEW ENGL J MED, V337, P1576; Moss AJ, 2004, CIRCULATION, V110, P3760, DOI 10.1161/01.CIR.0000150390.04704.B7; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098; ROSENBAUM DS, 1994, NEW ENGL J MED, V330, P235, DOI 10.1056/NEJM199401273300402; Solomon SD, 2005, NEW ENGL J MED, V352, P2581, DOI 10.1056/NEJMoa043938; Steinbeck G, 2004, EUROPACE, V6, P392, DOI 10.1016/j.eupc.2004.04.008; Whitehead J, 1997, DESIGN ANAL SEQUENTI	31	446	464	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 8	2009	361	15					1427	1436		10.1056/NEJMoa0901889	http://dx.doi.org/10.1056/NEJMoa0901889			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503MU	19812399	Green Accepted			2022-12-28	WOS:000270540000004
J	Young, D; Patel, S				Young, D.; Patel, Sandip		ACRE Trial Collaborators	Effect of "collaborative requesting" on consent rate for organ donation: randomised controlled trial (ACRE trial)	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To determine whether collaborative requesting increases consent for organ donation from the relatives of patients declared dead by criteria for brain stem death. Design Unblinded multicentre randomised controlled trial using a sequential design. Centralised 24 hour telephone randomisation based on randomised permuted blocks of 10. Setting 79 general, neuroscience, and paediatric intensive care units in the United Kingdom. Participants 201 relatives of patients meeting criteria for brain stem death. Relatives were blind to the intervention and to the trial; all other participants were necessarily unblinded. Interventions Collaborative requesting for consent for organ donation by the potential donor's clinician and a donor transplant coordinator ( organ procurement officer) compared with routine requesting by the clinical team alone. Main outcome measure Proportion of relatives consenting to organ donation. Results 101 relatives were randomised to routine requesting and 100 to collaborative requesting. All were analysed on an intention to treat basis. In the routine requesting group, 62 relatives consented to organ donation. In the collaborative requesting group, 57 relatives consented. After correction for the ethnicity, age, and sex of the potential donors the risk adjusted ratio of the odds of consent in the collaborative requesting group relative to the routine group was 0.80 (95% confidence interval 0.43 to 1.53), with a P value of 0.49 adjusted for interim analysis and trial over-running. The conversion rate (donors with consent from whom any organs were retrieved) was 92% (57/62) in the routine requesting group and 79% (45/57) in the collaborative requesting group (P=0.043). There were 140 approaches to relatives in the per protocol analysis, leading to 60.3% (44/73) consent after routine and 67.2% (45/67) after collaborative requesting (risk adjusted odds ratio of consent 1.47, 0.67 to 3.20, P=0.33). Conclusion There is no increase in consent rates for organ donation when collaborative requesting is used in place of routine requesting by the patient's clinician. Trial registration ISRCTN01169903	[Young, D.] John Radcliffe Hosp, IntensiveCare Soc Clin Trials Grp, Kadoorie Ctr Crit Care Res & Educ, Oxford OX3 9DU, England	University of Oxford	Young, D (corresponding author), John Radcliffe Hosp, IntensiveCare Soc Clin Trials Grp, Kadoorie Ctr Crit Care Res & Educ, Oxford OX3 9DU, England.	duncan.young@nda.ox.ac.uk	Young, John D/M-9756-2016; Laha, Shondipon/AAN-9181-2020; Ostermann, Marlies/B-8777-2015	Laha, Shondipon/0000-0001-8748-9766; Peters, Tim/0000-0003-2881-4180; Young, John Duncan/0000-0002-6838-4835; Ostermann, Marlies/0000-0001-9500-9080; Woodcock, Thomas/0000-0001-5878-4379; Collett, David/0000-0003-4861-7627; Danbury, Chris/0000-0001-7807-0541	NHS Blood and Transplant	NHS Blood and Transplant	This study was funded by NHS Blood and Transplant. The study sponsor ( Oxford University) had no role in any aspect of the design or implementation of the study. The funder's role in study design was limited to the practicalities of setting up the randomisation service and linking the study data with the National Transplant database. The study funder took no part in the interpretation of data, writing the article and the decision to submit it for publication. All the researchers (TSC) had access to the data and approved the final analysis and manuscript. Competinginterests: Dave Collett and Karen Morgan are employed by the study funder, NHS Blood and Transplant. Chris Danbury and Susan Richards serve on the donor advisory group organised by NHS Blood and Transplant.	Barber K, 2006, BMJ-BRIT MED J, V332, P1124, DOI 10.1136/bmj.38804.658183.55; DeJong W, 1998, Am J Crit Care, V7, P13; Department of Health, 2008, ORG TRANSPL REP ORG; Klieger J, 1994, J TRANSPLANT COORDIN, V4, P132; MPS Research Unit, 2000, PEST 4 OP MAN; MURPHY C, 2009, POTENTIAL DONOR AUDI; *NHS BLOOD TRANSPL, 2007, B SPRING 2007; *NHS BLOOD TRANSPL, 2007, ANN BUS PLAN 2007 08; PIKE RE, 1991, S AFR MED J, V79, P264; Shafer TJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b701; Simpkin AL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b991; Whitehead J, 1997, DESIGN ANAL SEQUENTI; *WORK GROUP C MED, 1995, J ROY COLL PHYS LOND, V29, P281	13	24	24	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2009	339								b3911	10.1136/bmj.b3911	http://dx.doi.org/10.1136/bmj.b3911			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TH	19815583	Green Published, hybrid			2022-12-28	WOS:000270719300003
J	Schroth, W; Goetz, MP; Hamann, U; Fasching, PA; Schmidt, M; Winter, S; Fritz, P; Simon, W; Suman, VJ; Ames, MM; Safgren, SL; Kuffel, MJ; Ulmer, HU; Bolander, J; Strick, R; Beckmann, MW; Koelbl, H; Weinshilboum, RM; Ingle, JN; Eichelbaum, M; Schwab, M; Brauch, H				Schroth, Werner; Goetz, Matthew P.; Hamann, Ute; Fasching, Peter A.; Schmidt, Marcus; Winter, Stefan; Fritz, Peter; Simon, Wolfgang; Suman, Vera J.; Ames, Matthew M.; Safgren, Stephanie L.; Kuffel, Mary J.; Ulmer, Hans Ulrich; Bolaender, Julia; Strick, Reiner; Beckmann, Matthias W.; Koelbl, Heinz; Weinshilboum, Richard M.; Ingle, James N.; Eichelbaum, Michel; Schwab, Matthias; Brauch, Hiltrud			Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADJUVANT ENDOCRINE THERAPY; METABOLIC-ACTIVATION; POSTMENOPAUSAL WOMEN; CYTOCHROME-P450 2D6; RANDOMIZED-TRIAL; GENOTYPE; SURVIVAL; CYP2D6-ASTERISK-10; BIOTRANSFORMATION; PHARMACOKINETICS	Context The growth inhibitory effect of tamoxifen, which is used for the treatment of hormone receptor-positive breast cancer, is mediated by its metabolites, 4-hydroxytamoxifen and endoxifen. The formation of active metabolites is catalyzed by the polymorphic cytochrome P450 2D6 (CYP2D6) enzyme. Objective To determine whether CYP2D6 variation is associated with clinical outcomes in women receiving adjuvant tamoxifen. Design, Setting, and Patients Retrospective analysis of German and US cohorts of patients treated with adjuvant tamoxifen for early stage breast cancer. The 1325 patients had diagnoses between 1986 and 2005 of stage I through III breast cancer and were mainly postmenopausal (95.4%). Last follow-up was in December 2008; inclusion criteria were hormone receptor positivity, no metastatic disease at diagnosis, adjuvant tamoxifen therapy, and no chemotherapy. DNA from tumor tissue or blood was genotyped for CYP2D6 variants associated with reduced (*10, *41) or absent (*3, *4, *5) enzyme activity. Women were classified as having an extensive (n=609), heterozygous extensive/intermediate (n=637), or poor (n=79) CYP2D6 metabolism. Main Outcome Measures Time to recurrence, event-free survival, disease-free survival, and overall survival. Results Median follow-up was 6.3 years. At 9 years of follow-up, the recurrence rates were 14.9% for extensive metabolizers, 20.9% for heterozygous extensive/intermediate metabolizers, and 29.0% for poor metabolizers, and all-cause mortality rates were 16.7%, 18.0%, and 22.8%, respectively. Compared with extensive metabolizers, there was a significantly increased risk of recurrence for heterozygous extensive/intermediate metabolizers (time to recurrence adjusted hazard ratio [HR], 1.40; 95% confidence interval [CI], 1.04-1.90) and for poor metabolizers (time to recurrence HR, 1.90; 95% CI, 1.10-3.28). Compared with extensive metabolizers, those with decreased CYP2D6 activity (heterozygous extensive/intermediate and poor metabolism) had worse event-free survival (HR, 1.33; 95% CI, 1.06-1.68) and disease-free survival (HR, 1.29; 95% CI, 1.03-1.61), but there was no significant difference in overall survival (HR, 1.15; 95% CI, 0.88-1.51). Conclusion Among women with breast cancer treated with tamoxifen, there was an association between CYP2D6 variation and clinical outcomes, such that the presence of 2 functional CYP2D6 alleles was associated with better clinical outcomes and the presence of nonfunctional or reduced-function alleles with worse outcomes. JAMA. 2009; 302(13): 1429-1436	[Schroth, Werner; Winter, Stefan; Fritz, Peter; Eichelbaum, Michel; Schwab, Matthias; Brauch, Hiltrud] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Simon, Wolfgang] Robert Bosch Krankenhaus, Stuttgart, Germany; [Schroth, Werner; Winter, Stefan; Fritz, Peter; Eichelbaum, Michel; Schwab, Matthias; Brauch, Hiltrud] Univ Tubingen, Tubingen, Germany; [Schwab, Matthias] Univ Tubingen Hosp, Dept Clin Pharmacol, Tubingen, Germany; [Goetz, Matthew P.; Ingle, James N.] Mayo Clin, Dept Oncol, Rochester, MN USA; [Goetz, Matthew P.; Ames, Matthew M.; Safgren, Stephanie L.; Kuffel, Mary J.; Weinshilboum, Richard M.] Mayo Clin, Dept Mol Pharmacol & Expt Pharmaceut, Rochester, MN USA; [Suman, Vera J.] Mayo Clin, Dept Biostat, Rochester, MN USA; [Hamann, Ute] Deutsch Krebsforschungszentrum, D-6900 Heidelberg, Germany; [Fasching, Peter A.; Strick, Reiner; Beckmann, Matthias W.] Univ Hosp Erlangen, Univ Breast Ctr Franconia, Erlangen, Germany; [Fasching, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Schmidt, Marcus; Koelbl, Heinz] Johannes Gutenberg Univ Mainz, Dept Gynecol & Obstet, Mainz, Germany; [Ulmer, Hans Ulrich; Bolaender, Julia] Stadt Klinikum, Frauenklin, Karlsruhe, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Mayo Clinic; Mayo Clinic; Mayo Clinic; Helmholtz Association; German Cancer Research Center (DKFZ); University of Erlangen Nuremberg; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Johannes Gutenberg University of Mainz	Brauch, H (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, D-70376 Stuttgart, Germany.	hiltrud.brauch@ikp-stuttgart.de	Schmidt, Marcus/H-3383-2013; Fasching, Peter A/ABH-9912-2020; Goetz, Matthew P/AAH-2333-2020; Schwab, Matthias/ABH-7449-2020	Schmidt, Marcus/0000-0003-1365-2414; Fasching, Peter A/0000-0003-4885-8471; Harrington, Jon/0000-0003-1293-5201; Brauch, Hiltrud/0000-0001-7531-2736	Robert Bosch Foundation, Stuttgart, Germany; National Institutes of Health [CA 90628, CA116201, CA 15083, U-01 GM61388, CA-25224]; NATIONAL CANCER INSTITUTE [K12CA090628, P50CA116201, P30CA015083, U10CA025224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061388] Funding Source: NIH RePORTER	Robert Bosch Foundation, Stuttgart, Germany; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Robert Bosch Foundation, Stuttgart, Germany (W. S., M. S., and H. B.) and by National Institutes of Health grants CA 90628 (M. P. G.), Mayo Clinic Breast Cancer Specialized Program of Research Excellence CA116201 (J. N. I., M. P. G., V. J. S., and R. M. V.), CA 15083: U-01 GM61388 (R. M. W., M. P. G., and J. N. I.), and CA-25224 (North Central Cancer Treatment Group).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; ALLEN KE, 1980, BRIT J PHARMACOL, V71, P83, DOI 10.1111/j.1476-5381.1980.tb10912.x; Andersen P. K., 1992, STAT MODELS BASED CO; Borges S, 2006, CLIN PHARMACOL THER, V80, P61, DOI 10.1016/j.clpt.2006.03.013; Brauch H, 2008, BREAST CARE, V3, P43, DOI 10.1159/000114642; Buck MB, 2008, BREAST CANCER RES TR, V107, P15, DOI 10.1007/s10549-007-9526-7; Chapman JAW, 2008, JNCI-J NATL CANCER I, V100, P252, DOI 10.1093/jnci/djn014; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Flockhart David, 2008, Clin Adv Hematol Oncol, V6, P493; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; Goetz MP, 2005, J CLIN ONCOL, V23, P9312, DOI 10.1200/JCO.2005.03.3266; Griese EU, 1998, PHARMACOGENETICS, V8, P15, DOI 10.1097/00008571-199802000-00003; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Ingle JN, 2008, CANCER, V112, P695, DOI 10.1002/cncr.23192; Ingle JN, 2006, BREAST CANCER RES TR, V98, P217, DOI 10.1007/s10549-005-9152-1; Jordan V C, 1982, Breast Cancer Res Treat, V2, P123, DOI 10.1007/BF01806449; Jordan VC, 2008, EUR J CANCER, V44, P30, DOI 10.1016/j.ejca.2007.11.002; JORDAN VC, 1977, J ENDOCRINOL, V75, P305, DOI 10.1677/joe.0.0750305; Kiyotani K, 2008, CANCER SCI, V99, P995, DOI 10.1111/j.1349-7006.2008.00780.x; LIEN EA, 1989, CANCER RES, V49, P2175; Lim HS, 2007, J CLIN ONCOL, V25, P3837, DOI 10.1200/JCO.2007.11.4850; Lim YC, 2005, CANCER CHEMOTH PHARM, V55, P471, DOI 10.1007/s00280-004-0926-7; McCullagh P., 1989, GENERALIZED LINEAR M, DOI DOI 10.1007/978-1-4899-3242-6; Nowell SA, 2005, BREAST CANCER RES TR, V91, P249, DOI 10.1007/s10549-004-7751-x; Punglia RS, 2008, JNCI-J NATL CANCER I, V100, P642, DOI 10.1093/jnci/djn100; Raimundo S, 2004, CLIN PHARMACOL THER, V76, P128, DOI 10.1016/j.clpt.2004.04.009; ROBERTSON DW, 1982, J STEROID BIOCHEM, V16, P1, DOI 10.1016/0022-4731(82)90137-6; SCHROTH W, 2009, JOINT COLD SPRING HA; Schroth W, 2007, J CLIN ONCOL, V25, P5187, DOI 10.1200/JCO.2007.12.2705; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Wegman P, 2005, BREAST CANCER RES, V7, pR284, DOI 10.1186/bcr993; Wegman P, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1640; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Weinshilboum R, 2008, ADV EXP MED BIOL, V630, P220; Williams N, 2008, LANCET ONCOL, V9, P45, DOI 10.1016/S1470-2045(07)70385-6; Wu XL, 2009, CANCER RES, V69, P1722, DOI 10.1158/0008-5472.CAN-08-3933; Xu Y, 2008, ANN ONCOL, V19, P1423, DOI 10.1093/annonc/mdn155; Zanger UM, 2004, N-S ARCH PHARMACOL, V369, P23, DOI 10.1007/s00210-003-0832-2	40	395	409	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	2009	302	13					1429	1436		10.1001/jama.2009.1420	http://dx.doi.org/10.1001/jama.2009.1420			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503CL	19809024	Bronze, Green Accepted			2022-12-28	WOS:000270509600017
J	Kleine, H; Luscher, B				Kleine, Henning; Luescher, Bernhard			Learning How to Read ADP-Ribosylation	CELL			English	Editorial Material							POLY(ADP-RIBOSE); CHROMATIN; ACTIVATION; PROTEINS; PROTEOME	ADP-ribosylation is a posttranslational modification that is emerging as a broadly used mechanism to regulate the functions of proteins and their interactions. Recent findings by three groups (Ahel et al., 2009; Gottschalk et al., 2009; Timinszky et al., 2009) establish that proteins with macrodomains bind poly-ADP-ribose to mediate the cellular response to DNA damage.	[Kleine, Henning; Luescher, Bernhard] Rhein Westfal TH Aachen, Sch Med, Inst Biochem & Mol Biol, D-52074 Aachen, Germany	RWTH Aachen University	Luscher, B (corresponding author), Rhein Westfal TH Aachen, Sch Med, Inst Biochem & Mol Biol, Pauwelsstr 30, D-52074 Aachen, Germany.	luescher@rwth-aachen.de	Luscher, Bernhard/A-7330-2011	Luscher, Bernhard/0000-0002-9622-8709; Kleine, Henning/0000-0003-2559-6608				Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Dania N, 2009, P NATL ACAD SCI USA, V106, P4243, DOI 10.1073/pnas.0900066106; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Karras GI, 2005, EMBO J, V24, P1911, DOI 10.1038/sj.emboj.7600664; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664	10	37	38	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					17	19		10.1016/j.cell.2009.09.018	http://dx.doi.org/10.1016/j.cell.2009.09.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804746	Bronze			2022-12-28	WOS:000270388600008
J	Su, CY; Menuz, K; Carlson, JR				Su, Chih-Ying; Menuz, Karen; Carlson, John R.			Olfactory Perception: Receptors, Cells, and Circuits	CELL			English	Review							DROSOPHILA ANTENNAL LOBE; PHEROMONE-BINDING-PROTEIN; ODOR-EVOKED ACTIVITY; MOUSE SEPTAL ORGAN; CHEMOSENSORY RECEPTORS; MUSHROOM BODY; SENSORY NEURONS; PRESYNAPTIC INHIBITION; GRUENEBERG GANGLION; ANOPHELES-GAMBIAE	Remarkable advances in our understanding of olfactory perception have been made in recent years, including the discovery of new mechanisms of olfactory signaling and new principles of olfactory processing. Here, we discuss the insight that has been gained into the receptors, cells, and circuits that underlie the sense of smell.	[Su, Chih-Ying; Menuz, Karen; Carlson, John R.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu		Menuz, Karen/0000-0001-8163-0941	NIDCD NIH HHS [R01 DC004729, R01 DC002174, R01 DC004729-09, R01 DC002174-23] Funding Source: Medline; NIGMS NIH HHS [R01 GM063364, R01 GM063364-08] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004729, R01DC002174] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Balu R, 2007, J NEUROSCI, V27, P5621, DOI 10.1523/JNEUROSCI.4630-06.2007; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bhandawat V, 2005, SCIENCE, V308, P1931, DOI 10.1126/science.1109886; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; BOGNER F, 1986, J COMP PHYSIOL A, V158, P741, DOI 10.1007/BF01324818; Bradley J, 2005, CURR OPIN NEUROBIOL, V15, P343, DOI 10.1016/j.conb.2005.05.014; Brechbuhl J, 2008, SCIENCE, V321, P1092, DOI 10.1126/science.1160770; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cygnar KD, 2009, NAT NEUROSCI, V12, P454, DOI 10.1038/nn.2289; DACKS AM, 2009, J NEUROGENE IN PRESS, DOI DOI 10.1080/01677060903085722; DasGupta S, 2008, CURR BIOL, V18, P1668, DOI 10.1016/j.cub.2008.08.071; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; de Bruyne M, 2008, J CHEM ECOL, V34, P882, DOI 10.1007/s10886-008-9485-4; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Elmore T, 2003, J NEUROSCI, V23, P9906; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Fleischer J, 2007, CHEM SENSES, V32, P623, DOI 10.1093/chemse/bjm032; Fleischer J, 2006, J NEUROCHEM, V98, P543, DOI 10.1111/j.1471-4159.2006.03894.x; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Freitag J, 1998, J COMP PHYSIOL A, V183, P635, DOI 10.1007/s003590050287; Gao Y, 2009, NAT NEUROSCI, V12, P731, DOI 10.1038/nn.2319; Grosmaitre X, 2007, NAT NEUROSCI, V10, P348, DOI 10.1038/nn1856; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hashiguchi Y, 2007, MOL BIOL EVOL, V24, P2099, DOI 10.1093/molbev/msm140; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; KAISSLIN.KE, 1970, NATURWISSENSCHAFTEN, V57, P23, DOI 10.1007/BF00593550; Kaluza JF, 2004, J NEUROSCI RES, V76, P442, DOI 10.1002/jnr.20083; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Kato A, 2009, CELL MOL LIFE SCI, V66, P3743, DOI 10.1007/s00018-009-0111-6; Kazama H, 2008, NEURON, V58, P401, DOI 10.1016/j.neuron.2008.02.030; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Keller A, 2007, P NATL ACAD SCI USA, V104, P5614, DOI 10.1073/pnas.0605321104; Kepecs A, 2007, J NEUROPHYSIOL, V98, P205, DOI 10.1152/jn.00071.2007; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Kloppenburg P, 2008, ANNU REV ENTOMOL, V53, P179, DOI 10.1146/annurev.ento.53.103106.093408; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Laska M, 2007, NEUROSCIENCE, V144, P295, DOI 10.1016/j.neuroscience.2006.08.063; Laska M, 1999, CHEM SENSES, V24, P429, DOI 10.1093/chemse/24.4.429; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Li W, 2008, SCIENCE, V319, P1842, DOI 10.1126/science.1152837; Li W, 2006, NEURON, V52, P1097, DOI 10.1016/j.neuron.2006.10.026; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; Lin WH, 2004, J NEUROSCI, V24, P3703, DOI 10.1523/JNEUROSCI.0188-04.2004; Litaudon P, 2003, EUR J NEUROSCI, V17, P2457, DOI 10.1046/j.1460-9568.2003.02654.x; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; Ma MH, 2003, J NEUROSCI, V23, P317; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Maresh A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002640; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Masse NY, 2009, CURR BIOL, V19, pR700, DOI 10.1016/j.cub.2009.06.026; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Murphy GJ, 2004, J NEUROSCI, V24, P3023, DOI 10.1523/JNEUROSCI.5745-03.2004; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Niimura Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000708; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Pelosi P, 2006, CELL MOL LIFE SCI, V63, P1658, DOI 10.1007/s00018-005-5607-0; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Petzold GC, 2009, NAT NEUROSCI, V12, P784, DOI 10.1038/nn.2335; Pirez N, 2008, J NEUROSCI, V28, P6360, DOI 10.1523/JNEUROSCI.0793-08.2008; Poo C, 2009, NEURON, V62, P850, DOI 10.1016/j.neuron.2009.05.022; Rajan R, 2006, SCIENCE, V311, P666, DOI 10.1126/science.1122096; Reisert J, 2005, NEURON, V45, P553, DOI 10.1016/j.neuron.2005.01.012; Reisert J, 2009, CHEM SENSES, V34, P535, DOI 10.1093/chemse/bjp028; Rinberg D, 2006, SEMIN CELL DEV BIOL, V17, P454, DOI 10.1016/j.semcdb.2006.04.009; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Root CM, 2008, NEURON, V59, P311, DOI 10.1016/j.neuron.2008.07.003; Root CM, 2007, P NATL ACAD SCI USA, V104, P11826, DOI 10.1073/pnas.0704523104; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; SANCHEZ MGD, 2005, J COMP PHYSIOL A, V191, P189; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Shea SD, 2008, J NEUROSCI, V28, P10711, DOI 10.1523/JNEUROSCI.3853-08.2008; Shepherd GM, 2007, BRAIN RES REV, V55, P373, DOI 10.1016/j.brainresrev.2007.03.005; Shiraiwa T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002191; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Song Y, 2008, NEURON, V58, P374, DOI 10.1016/j.neuron.2008.02.029; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; SULLIVAN RM, 1992, DEV BRAIN RES, V70, P279, DOI 10.1016/0165-3806(92)90207-D; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Tian HK, 2004, J NEUROSCI, V24, P8383, DOI 10.1523/JNEUROSCI.2222-04.2004; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Verhagen JV, 2007, NAT NEUROSCI, V10, P631, DOI 10.1038/nn1892; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Wang ZS, 2006, J NEUROSCI, V26, P7375, DOI 10.1523/JNEUROSCI.1967-06.2006; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wilson DA, 2004, NEUROSCIENTIST, V10, P513, DOI 10.1177/1073858404267048; Wilson RI, 2006, ANNU REV NEUROSCI, V29, P163, DOI 10.1146/annurev.neuro.29.051605.112950; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105; Xu FQ, 2005, J COMP NEUROL, V489, P491, DOI 10.1002/cne.20652; Yan ZQ, 2008, NEURON, V58, P613, DOI 10.1016/j.neuron.2008.03.012; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005	135	328	345	15	143	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					45	59		10.1016/j.cell.2009.09.015	http://dx.doi.org/10.1016/j.cell.2009.09.015			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804753	Green Accepted, Bronze			2022-12-28	WOS:000270388600015
J	Sukkar, E				Sukkar, Elizabeth			International Aid The cost of donated drugs	BRITISH MEDICAL JOURNAL			English	Editorial Material												Elizabeth.Sukkar@informa.com						Hogerzeil HV, 1997, BRIT MED J, V314, P737, DOI 10.1136/bmj.314.7082.737; Pharmaciens Sans Frontieres, 2005, IOP C SERIES EARTH E; WHO, 1999, GUID SAF DISP UNW PH; World Health Organization, 1999, GUID DRUG DON	4	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 2	2009	339								b3830	10.1136/bmj.b3830	http://dx.doi.org/10.1136/bmj.b3830			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502LD	19801381				2022-12-28	WOS:000270460200001
J	Keith, DW				Keith, David W.			Why Capture CO2 from the Atmosphere?	SCIENCE			English	Editorial Material							CARBON-DIOXIDE; CLIMATE-CHANGE; AIR	Air capture is an industrial process for capturing CO2 from ambient air; it is one of an emerging set of technologies for CO2 removal that includes geological storage of biotic carbon and the acceleration of geochemical weathering. Although air capture will cost more than capture from power plants when both are operated under the same economic conditions, air capture allows one to apply industrial economies of scale to small and mobile emission sources and enables a partial decoupling of carbon capture from the energy infrastructure, advantages that may compensate for the intrinsic difficulty of capturing carbon from the air.	Univ Calgary, Inst Sustainable Energy Environm & Econ, Energy & Environm Syst Grp, Calgary, AB T2N 1N4, Canada	University of Calgary	Keith, DW (corresponding author), Univ Calgary, Inst Sustainable Energy Environm & Econ, Energy & Environm Syst Grp, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.		Keith, David W/E-9777-2010	Keith, David W/0000-0002-8224-3780				AINES R, 2008, ENABLING COST EFFECT; Blackstock J. J., 2009, CLIMATE ENG RESPONSE; Gray ML, 2008, INT J GREENH GAS CON, V2, P3, DOI 10.1016/S1750-5836(07)00088-6; Herzog H, 2003, LAB ENERGY ENV PUBLI; House KZ, 2007, ENVIRON SCI TECHNOL, V41, P8464, DOI 10.1021/es0701816; Jones N, 2009, NATURE, V458, P1094, DOI 10.1038/4581094a; Keith DW, 2006, CLIMATIC CHANGE, V74, P17, DOI 10.1007/s10584-005-9026-x; Keith DW, 2000, ANNU REV ENERG ENV, V25, P245, DOI 10.1146/annurev.energy.25.1.245; Mahmoudkhani M, 2009, INT J GREENH GAS CON, V3, P376, DOI 10.1016/j.ijggc.2009.02.003; Nikulshina V, 2009, CHEM ENG J, V146, P244, DOI 10.1016/j.cej.2008.06.005; Parson EA, 2006, CLIMATIC CHANGE, V74, P5, DOI 10.1007/s10584-005-9032-z; Pielke RA, 2009, ENVIRON SCI POLICY, V12, P216, DOI 10.1016/j.envsci.2009.01.002; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Stephens JC, 2008, CLIMATIC CHANGE, V90, P217, DOI 10.1007/s10584-008-9440-y; Zeman FS, 2008, PHILOS T R SOC A, V366, P3901, DOI 10.1098/rsta.2008.0143	15	478	493	23	315	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	2009	325	5948					1654	1655		10.1126/science.1175680	http://dx.doi.org/10.1126/science.1175680			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779189				2022-12-28	WOS:000270131800033
J	Conrad, DF; Pinto, D; Redon, R; Feuk, L; Gokcumen, O; Zhang, YJ; Aerts, J; Andrews, TD; Barnes, C; Campbell, P; Fitzgerald, T; Hu, M; Ihm, CH; Kristiansson, K; MacArthur, DG; MacDonald, JR; Onyiah, I; Pang, AWC; Robson, S; Stirrups, K; Valsesia, A; Walter, K; Wei, J; Tyler-Smith, C; Carter, NP; Lee, C; Scherer, SW; Hurles, ME				Conrad, Donald F.; Pinto, Dalila; Redon, Richard; Feuk, Lars; Gokcumen, Omer; Zhang, Yujun; Aerts, Jan; Andrews, T. Daniel; Barnes, Chris; Campbell, Peter; Fitzgerald, Tomas; Hu, Min; Ihm, Chun Hwa; Kristiansson, Kati; MacArthur, Daniel G.; MacDonald, Jeffrey R.; Onyiah, Ifejinelo; Pang, Andy Wing Chun; Robson, Sam; Stirrups, Kathy; Valsesia, Armand; Walter, Klaudia; Wei, John; Tyler-Smith, Chris; Carter, Nigel P.; Lee, Charles; Scherer, Stephen W.; Hurles, Matthew E.		Wellcome Trust Case Control	Origins and functional impact of copy number variation in the human genome	NATURE			English	Article							RECOMBINATION HOT-SPOTS; STRUCTURAL VARIATION; POSITIVE SELECTION; DELETION POLYMORPHISM; WIDE ASSOCIATION; GENE; REARRANGEMENTS; INSTABILITY; NUCLEOTIDE; EXPRESSION	Structural variations of DNA greater than 1 kilobase in size account for most bases that vary among human genomes, but are still relatively under-ascertained. Here we use tiling oligonucleotide microarrays, comprising 42 million probes, to generate a comprehensive map of 11,700 copy number variations (CNVs) greater than 443 base pairs, of which most (8,599) have been validated independently. For 4,978 of these CNVs, we generated reference genotypes from 450 individuals of European, African or East Asian ancestry. The predominant mutational mechanisms differ among CNV size classes. Retrotransposition has duplicated and inserted some coding and non-coding DNA segments randomly around the genome. Furthermore, by correlation with known trait-associated single nucleotide polymorphisms (SNPs), we identified 30 loci with CNVs that are candidates for influencing disease susceptibility. Despite this, having assessed the completeness of our map and the patterns of linkage disequilibrium between CNVs and SNPs, we conclude that, for complex traits, the heritability void left by genome-wide association studies will not be accounted for by common CNVs.	[Conrad, Donald F.; Redon, Richard; Zhang, Yujun; Aerts, Jan; Andrews, T. Daniel; Barnes, Chris; Campbell, Peter; Fitzgerald, Tomas; Hu, Min; Kristiansson, Kati; MacArthur, Daniel G.; Onyiah, Ifejinelo; Robson, Sam; Stirrups, Kathy; Valsesia, Armand; Walter, Klaudia; Tyler-Smith, Chris; Carter, Nigel P.; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Pinto, Dalila; Feuk, Lars; MacDonald, Jeffrey R.; Pang, Andy Wing Chun; Wei, John; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Genom, MaRS Ctr, Toronto, ON M5G 1L7, Canada; [Pinto, Dalila; Feuk, Lars; MacDonald, Jeffrey R.; Pang, Andy Wing Chun; Wei, John; Scherer, Stephen W.] Hosp Sick Children, Program Genet & Genom, MaRS Ctr, Toronto, ON M5G 1L7, Canada; [Redon, Richard] INSERM, UMR915, Inst Thorax, F-44035 Nantes, France; [Feuk, Lars] Uppsala Univ, Rudbeck Lab, Uppsala Dept Genet & Pathol, S-75185 Uppsala, Sweden; [Gokcumen, Omer; Ihm, Chun Hwa; Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Gokcumen, Omer; Ihm, Chun Hwa; Lee, Charles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Scherer, Stephen W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	Wellcome Trust Sanger Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Uppsala University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto	Hurles, ME (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	steve@genet.sickkids.on.ca; meh@sanger.ac.uk	Pinto, Dalila/C-4218-2016; Valsesia, Armand/F-1724-2010; Redon, Richard/F-3303-2014; Andrews, Dan/ABG-4815-2020; Prescott, Natalie J/F-6490-2011; Scherer, Stephen W./B-3785-2013; Aerts, Jan/AAQ-6949-2020; MacDonald, Jeffrey Robert/GLU-2255-2022; MacArthur, Daniel/E-3275-2010; Gokcumen, Omer/J-6984-2013	Pinto, Dalila/0000-0002-8769-0846; Redon, Richard/0000-0001-7751-2280; Prescott, Natalie J/0000-0002-5901-7371; Scherer, Stephen W./0000-0002-8326-1999; Aerts, Jan/0000-0002-6416-2717; Gokcumen, Omer/0000-0003-4371-679X; Andrews, Dan/0000-0003-3922-6376; Fitzgerald, Tomas/0000-0002-2370-8496; Walter, Klaudia/0000-0003-4448-0301; Kristiansson, Kati/0000-0003-4688-107X; Barnes, Chris/0000-0002-9459-1395; Valsesia, Armand/0000-0003-0746-9664; MacDonald, Jeffrey/0000-0001-5058-2393; MacArthur, Daniel/0000-0002-5771-2290	Wellcome Trust [077006/Z/05/Z]; Canada Foundation of Innovation and Ontario Innovation Trust; Canadian Institutes of Health Research (CIHR); Genome Canada/Ontario Genomics Institute; McLaughlin Centre for Molecular Medicine; Ontario Ministry of Research and Innovation; Hospital for Sick Children Foundation; Department of Pathology at Brigham and Women's Hospital; National Institutes of Health (NIH) [HG004221, GM081533]; Academy of Finland; Royal Netherlands Academy of Arts and Sciences [TMF/DA/5801]; Netherlands Organization for Scientific Research [825.06.031]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081533] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Canada Foundation of Innovation and Ontario Innovation Trust; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Genome Canada/Ontario Genomics Institute(Genome Canada); McLaughlin Centre for Molecular Medicine; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Hospital for Sick Children Foundation; Department of Pathology at Brigham and Women's Hospital; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Royal Netherlands Academy of Arts and Sciences; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank A. Boyko, J. J. Emerson, J. Pickrell, S. Kudaravalli, J. Pritchard, T. Down, S. McCarroll, J. Collins, C. Beazley, M. Dermitzakis, P. Eis, T. Richmond, M. Hogan, D. Bailey, S. Giles, G. Speight, N. Sparkes, D. Peiffer, C. Chen, K. Li, P. Oeth, D. Stetson and D. Church for advice, sharing data, sharing software and technical assistance. We are grateful for the efforts and support of our colleagues at NimbleGen, Agilent, Illumina, Applied Biosystems and Sequenom. We thank J. Barrett for comments on an earlier version of the manuscript. The Centre for Applied Genomics at the Hospital for Sick Children and Wellcome Trust Sanger Institute are acknowledged for database, technical assistance and bioinformatics support. This research was supported by the Wellcome Trust (grant no. 077006/Z/05/Z; to M. E. H., N. P. C., C. T.-S.), Canada Foundation of Innovation and Ontario Innovation Trust (to S. W. S.), Canadian Institutes of Health Research (CIHR) (to S. W. S.), Genome Canada/Ontario Genomics Institute (to S. W. S.), the McLaughlin Centre for Molecular Medicine (to S. W. S.), Ontario Ministry of Research and Innovation (to S. W. S.), the Hospital for Sick Children Foundation (to S. W. S.), the Department of Pathology at Brigham and Women's Hospital (to C. L.) and the National Institutes of Health (NIH) (grants HG004221 and GM081533; to C. L.). K. K. is supported by the Academy of Finland. D. P. is supported by fellowships from the Royal Netherlands Academy of Arts and Sciences (TMF/DA/5801) and the Netherlands Organization for Scientific Research (Rubicon 825.06.031). S. W. S. holds the GlaxoSmithKline Pathfinder Chair in Genetics and Genomics at the University of Toronto and the Hospital for Sick Children.	Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Buchanan JA, 2008, GENET MED, V10, P639, DOI [10.1097/GIM.0b013e318183f848, 10.1097GIM.0b013e318183f848]; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Cid R, 2009, NAT GENET, V41, P211, DOI 10.1038/ng.313; Down TA, 2005, NUCLEIC ACIDS RES, V33, P1445, DOI 10.1093/nar/gki282; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GONDO Y, 1993, P NATL ACAD SCI USA, V90, P297, DOI 10.1073/pnas.90.1.297; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Hurles ME, 2008, TRENDS GENET, V24, P238, DOI 10.1016/j.tig.2008.03.001; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jeffreys A, 1999, ELECTROPHORESIS, V20, P1665, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1665::AID-ELPS1665>3.0.CO;2-L; Jeffreys AJ, 2004, PHILOS T ROY SOC B, V359, P141, DOI 10.1098/rstb.2003.1372; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kim PM, 2007, P NATL ACAD SCI USA, V104, P20274, DOI 10.1073/pnas.0710183104; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lee C, 2007, NAT GENET, V39, pS48, DOI 10.1038/ng2092; Levy S, 2008, NATURE, V456, P49, DOI 10.1038/456049a; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Ng PC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000160; Nielsen R, 2009, GENOME RES, V19, P838, DOI 10.1101/gr.088336.108; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pique-Regi R, 2008, BIOINFORMATICS, V24, P309, DOI 10.1093/bioinformatics/btm601; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sen SK, 2006, AM J HUM GENET, V79, P41, DOI 10.1086/504600; Silva AM, 2010, AM J HUM BIOL, V22, P76, DOI 10.1002/ajhb.20956; Smith EE, 2009, GENOME RES, V19, P850, DOI 10.1101/gr.085647.108; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tian DC, 2008, NATURE, V455, P105, DOI 10.1038/nature07175; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang LL, 2002, AM J HUM GENET, V71, P165, DOI 10.1086/341234; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Yang TL, 2008, AM J HUM GENET, V83, P663, DOI 10.1016/j.ajhg.2008.10.006	50	1295	1350	3	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					704	712		10.1038/nature08516	http://dx.doi.org/10.1038/nature08516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	19812545	Green Accepted			2022-12-28	WOS:000276205000035
J	Dzau, VJ; Ackerly, DC; Sutton-Wallace, P; Merson, MH; Williams, RS; Krishnan, KR; Taber, RC; Califf, RM				Dzau, Victor J.; Ackerly, D. Clay; Sutton-Wallace, Pamela; Merson, Michael H.; Williams, R. Sanders; Krishnan, K. Ranga; Taber, Robert C.; Califf, Robert M.			The role of academic health science systems in the transformation of medicine	LANCET			English	Editorial Material							TRANSLATIONAL RESEARCH; QUALITY; CARE; PARTNERSHIP; INDUSTRY; CYCLE; US		[Dzau, Victor J.] Duke Univ, Med Ctr, Off Chancellor, Durham, NC 27710 USA; [Williams, R. Sanders; Krishnan, K. Ranga] Duke Natl Univ Singapore, Grad Sch Med, Singapore, Singapore	Duke University; National University of Singapore	Dzau, VJ (corresponding author), Duke Univ, Med Ctr, Off Chancellor, Box 3701, Durham, NC 27710 USA.	victor.dzau@duke.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NCRR NIH HHS [1 UL1 RR024128-01] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Balas EA, 2001, J AM MED INFORM ASSN, V8, P398, DOI 10.1136/jamia.2001.0080398; Berndt ER, 2005, NAT REV DRUG DISCOV, V4, P545, DOI 10.1038/nrd1774; Braunwald E, 2006, AM J MED, V119, P457, DOI 10.1016/j.amjmed.2005.11.025; *BUSINESSDICTIONAR, MATR ORG DEF; Califf RM, 2002, J AM COLL CARDIOL, V40, P1895, DOI 10.1016/S0735-1097(02)02537-8; Califf RM, 2007, HEALTH AFFAIR, V26, P62, DOI 10.1377/hlthaff.26.1.62; Contopoulos-Ioannidis DG, 2008, SCIENCE, V321, P1298, DOI 10.1126/science.1160622; Cooksey D., 2006, REV UK HLTH RES FUND; Creek TL, 2007, JAIDS-J ACQ IMM DEF, V45, P102, DOI 10.1097/QAI.0b013e318047df88; DUBE N, 2008, PRIMARY CARE CASE MA; Ehringhaus S., 2004, US MED SCH POLICIES; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P2789, DOI 10.1001/jama.299.23.2789; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hillestad R, 2005, HEALTH AFFAIR, V24, P1103, DOI 10.1377/hlthaff.24.5.1103; *HJ KAIS FAM FDN, 2007, HLTH CAR COSTS PRIM; Hussey P, 2008, INT J QUAL HEALTH C, V20, P53, DOI 10.1093/intqhc/mzm055; *IMP INN, 2008, ANN REP IMP INN; *KINGS HLTH PARTN, FREQ ASK QUEST; Leatherman S, 2003, HEALTH AFFAIR, V22, P17, DOI 10.1377/hlthaff.22.2.17; Lee TH, 2007, NEW ENGL J MED, V357, P1175, DOI 10.1056/NEJMp078102; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Merson M.H., 2009, DRAMATIC EXPANSION U; *NIH OFF PORTF AN, CLIN TRANSL SCI AW; *NIH OFF PORTF AN, 2008, NIH ROADM OV; Olsen L., 2007, LEARNING HEALTHCARE, DOI DOI 10.17226/; Stamler JS, 2003, AM J MED, V115, P683, DOI 10.1016/j.amjmed.2003.10.003; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; *UK DEP HLTH NEWS, 2009, NHS PAT BEN TOP FLIG; US Food and Drug Administration, 2009, CLIN TRIALS TRANSF I; Williams RS, 2008, ACAD MED, V83, P122, DOI 10.1097/ACM.0b013e318160b8bc; Yaggy SD, 2006, GERONTOLOGIST, V46, P271, DOI 10.1093/geront/46.2.271; Yeates KE, 2004, AM J KIDNEY DIS, V44, P1083, DOI 10.1053/j.ajkd.2004.08.031; Zerhouni EA, 2005, NEW ENGL J MED, V353, P1621, DOI 10.1056/NEJMsb053723; Zerhouni EA, 2005, JAMA-J AM MED ASSOC, V294, P1352, DOI 10.1001/jama.294.11.1352	35	92	94	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 13	2010	375	9718					949	953		10.1016/S0140-6736(09)61082-5	http://dx.doi.org/10.1016/S0140-6736(09)61082-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	574NA	19800111				2022-12-28	WOS:000275995300034
J	Shine, KI; Rogers, B; Goldfrank, LR				Shine, Kenneth I.; Rogers, Bonnie; Goldfrank, Lewis R.			Novel H1N1 Influenza and Respiratory Protection for Health Care Workers.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shine, Kenneth I.] Univ Texas Syst, Austin, TX USA; [Rogers, Bonnie] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA; [Goldfrank, Lewis R.] NYU, Sch Med, New York, NY USA	University of Texas System; University of Texas Austin; University of North Carolina; University of North Carolina Chapel Hill; New York University	Shine, KI (corresponding author), Univ Texas Syst, Austin, TX USA.							*CDCP, 2009, FLU SYMPT SEV INFL S; Institute of Medicine, 2008, PREP INFL PAND PERS; Institute of Medicine, 2009, RESP PROT HEALTHC WO; Oberg T, 2008, AM J INFECT CONTROL, V36, P276, DOI 10.1016/j.ajic.2007.07.008; Radonovich LJ, 2009, JAMA-J AM MED ASSOC, V301, P36, DOI 10.1001/jama.2008.894	5	34	34	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 5	2009	361	19					1823	1825		10.1056/NEJMp0908437	http://dx.doi.org/10.1056/NEJMp0908437			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	514OZ	19797278				2022-12-28	WOS:000271405800004
J	Saito, K; Inagaki, S; Mituyama, T; Kawamura, Y; Ono, Y; Sakota, E; Kotani, H; Asai, K; Siomi, H; Siomi, MC				Saito, Kuniaki; Inagaki, Sachi; Mituyama, Toutai; Kawamura, Yoshinori; Ono, Yukiteru; Sakota, Eri; Kotani, Hazuki; Asai, Kiyoshi; Siomi, Haruhiko; Siomi, Mikiko C.			A regulatory circuit for piwi by the large Maf gene traffic jam in Drosophila	NATURE			English	Article							GERMLINE STEM-CELLS; RNA PATHWAY; PIRNA; MECHANISMS; MUTATIONS; DIVISION; ENCODES; GONAD; RISC	PIWI-interacting RNAs (piRNAs) silence retrotransposons in Drosophila germ lines by associating with the PIWI proteins Argonaute 3 (AGO3), Aubergine (Aub) and Piwi(1,2). piRNAs in Drosophila are produced from intergenic repetitive genes and piRNA clusters by two systems: the primary processing pathway and the amplification loop(1-7). The amplification loop occurs in a Dicer-independent, PIWI-Slicer-dependent manner(3,4,8). However, primary piRNA processing remains elusive. Here we analysed piRNA processing in a Drosophila ovarian somatic cell line where Piwi, but not Aub or AGO3, is expressed; thus, only the primary piRNAs exist. In addition to flamenco, a Piwi-specific piRNA cluster(3), traffic jam (tj)(9), a large Maf gene, was determined as a new piRNA cluster. piRNAs arising from tj correspond to the untranslated regions of tj messenger RNA and are sense-oriented. piRNA loading on to Piwi may occur in the cytoplasm. zucchini(10), a gene encoding a putative cytoplasmic nuclease, is required for tj-derived piRNA production. In tj and piwi mutant ovaries, somatic cells fail to intermingle with germ cells and Fasciclin III is overexpressed. Loss of tj abolishes Piwi expression in gonadal somatic cells. Thus, in gonadal somatic cells, tj gives rise simultaneously to two different molecules: the TJ protein, which activates Piwi expression, and piRNAs, which define the Piwi targets for silencing.	[Saito, Kuniaki; Inagaki, Sachi; Kawamura, Yoshinori; Kotani, Hazuki; Siomi, Haruhiko; Siomi, Mikiko C.] Keio Univ, Sch Med, Tokyo 1608582, Japan; [Mituyama, Toutai; Asai, Kiyoshi] Natl Inst Adv Ind Sci & Technol, CBRC, Tokyo 1350064, Japan; [Kawamura, Yoshinori] Univ Tokushima, Inst Hlth Biosci, Tokushima 7708503, Japan; [Ono, Yukiteru] Informat & Math Sci Lab Inc, Dept Life Sci, Tokushima 1120012, Japan; [Sakota, Eri] JBIC, Tokyo 1358073, Japan; [Asai, Kiyoshi] Univ Tokyo, Grad Sch Frontier Sci, Chiba 2778583, Japan; [Siomi, Mikiko C.] CREST, JST, Kawaguchi, Saitama 3320012, Japan	Keio University; National Institute of Advanced Industrial Science & Technology (AIST); Tokushima University; University of Tokyo; Japan Science & Technology Agency (JST)	Siomi, H (corresponding author), Keio Univ, Sch Med, Tokyo 1608582, Japan.	awa403@sc.itc.keio.ac.jp; siomim@sc.itc.keio.ac.jp	Asai, Kiyoshi/AAT-8344-2020; Saito, Kuniaki/A-6967-2015; Siomi, Haruhiko/A-7020-2015; Inagaki, Sachi/P-8036-2019; Mituyama, Toutai/A-5610-2017	Asai, Kiyoshi/0000-0003-0909-4982; Saito, Kuniaki/0000-0001-8233-9283; Siomi, Haruhiko/0000-0001-8690-3822; Inagaki, Sachi/0000-0002-2365-9938; Mituyama, Toutai/0000-0002-1110-6375	MEXT; NEDO ( New Energy and Industrial Technology Development Organization); CREST; Grants-in-Aid for Scientific Research [19061001] Funding Source: KAKEN	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEDO ( New Energy and Industrial Technology Development Organization)(New Energy and Industrial Technology Development Organization (NEDO)); CREST(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Niki, D. Godt, H. Lin, E. Matunis, S. Kobayashi, Y. Kitadate, Y. Kageyama and H. Sano for providing reagents. We also thank Bloomington and Kyoto Drosophila Stock Center for the supply of Drosophila strains. We thank K. Yamada, E. Hattori, K. M. Nishida and T. N. Okada for technical assistance; S. Takahashi and K. Kataoka for discussions and suggestions; and other members of the Siomi laboratory for discussions and comments on the manuscript. We also thank K. Greer and D. McGowan for encouragement. This work was supported by MEXT grants to H. S. and NEDO ( New Energy and Industrial Technology Development Organization) grants to M. C. S., T. M. and K. A. M. C. S. is supported by CREST from JST. M. C. S. is Associate Professor of Global COE for Human Metabolomics Systems Biology by MEXT.	Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Cox DN, 2000, DEVELOPMENT, V127, P503; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Harris AN, 2001, DEVELOPMENT, V128, P2823; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Kataoka K, 2007, J BIOCHEM, V141, P775, DOI 10.1093/jb/mvm105; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kitadate Y, 2007, DEV CELL, V13, P151, DOI 10.1016/j.devcel.2007.05.001; Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Lin HF, 1997, DEVELOPMENT, V124, P2463; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mituyama T, 2009, NUCLEIC ACIDS RES, V37, pD89, DOI 10.1093/nar/gkn805; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Niki Y, 2006, P NATL ACAD SCI USA, V103, P16325, DOI 10.1073/pnas.0607435103; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Siomi H, 2009, NATURE, V457, P396, DOI 10.1038/nature07754; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wilson RJ, 2008, NUCLEIC ACIDS RES, V36, pD588, DOI 10.1093/nar/gkm930; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263	30	318	334	3	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 29	2009	461	7268					1296	U135		10.1038/nature08501	http://dx.doi.org/10.1038/nature08501			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511TF	19812547				2022-12-28	WOS:000271190800052
J	Bookman, MA				Bookman, Michael A.			Dose-dense chemotherapy in advanced ovarian cancer	LANCET			English	Editorial Material							PHASE-III TRIAL; GYNECOLOGIC-ONCOLOGY-GROUP; RANDOMIZED-TRIAL; WEEKLY PACLITAXEL; BREAST-CANCER; INTERGROUP; PLATINUM; CARBOPLATIN; CISPLATIN; INFUSION		Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA	Arizona Center Cancer Care; University of Arizona	Bookman, MA (corresponding author), Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA.	mbookman@igcs.org						Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Bookman MA, 2009, J CLIN ONCOL, V27, P1419, DOI 10.1200/JCO.2008.19.1684; du Bois A, 2005, ANN ONCOL, V16, P7, DOI 10.1093/annonc/mdi961; EISENHAUER EA, 1994, J CLIN ONCOL, V12, P2654, DOI 10.1200/JCO.1994.12.12.2654; Guminski AD, 2001, CANCER CHEMOTH PHARM, V48, P229, DOI 10.1007/s002800100279; Katsumata N, 2009, LANCET, V374, P1331, DOI 10.1016/S0140-6736(09)61157-0; Lau D, 2004, ANTI-CANCER DRUG, V15, P871, DOI 10.1097/00001813-200410000-00007; Markman M, 2006, GYNECOL ONCOL, V101, P436, DOI 10.1016/j.ygyno.2005.10.036; Omura GA, 2003, J CLIN ONCOL, V21, P2843, DOI 10.1200/JCO.2003.10.082; Seidman AD, 2008, J CLIN ONCOL, V26, P1642, DOI 10.1200/JCO.2007.11.6699; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056; Spriggs DR, 2007, J CLIN ONCOL, V25, P4466, DOI 10.1200/JCO.2006.10.3846; Vasey PA, 2004, JNCI-J NATL CANCER I, V96, P1682, DOI 10.1093/jnci/djh323; 2009, ICON7 OVERVIEW	14	12	14	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 17	2009	374	9698					1303	1305		10.1016/S0140-6736(09)61305-2	http://dx.doi.org/10.1016/S0140-6736(09)61305-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MW	19767094				2022-12-28	WOS:000271254600004
J	DuPont, HL				DuPont, Herbert L.			Bacterial Diarrhea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IRRITABLE-BOWEL-SYNDROME; NORTH-AMERICAN TRAVELERS; SINGLE-NUCLEOTIDE POLYMORPHISM; ADHERENT ESCHERICHIA-COLI; CLOSTRIDIUM-DIFFICILE; UNITED-STATES; TOXIN PRODUCTION; INFECTIOUS DIARRHEA; EVIDENCE BASE; FOLLOW-UP	A 47-year-old man reports a 1-week history of diarrhea, with grossly bloody stools for the past 5 days, a reports no history of travel, contacts with sick persons, or underlying gastrointestinal disease. How should he be evaluated and treated for an infectious cause of his illness?	[DuPont, Herbert L.] Univ Texas Houston, Sch Publ Hlth, St Lukes Episcopal Hosp, Baylor Coll Med, Houston, TX USA; [DuPont, Herbert L.] Kelsey Res Fdn, Houston, TX USA	Baylor College of Medicine; Saint Lukes Episcopal Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	DuPont, HL (corresponding author), 1200 Herman Pressler Dr,Suite 733, Houston, TX 77030 USA.	herbert.l.dupont@uth.tmc.edu	DuPont, Herbert/AAH-6776-2021		Kelsey Research Foundation; University of Texas School of Public Health; National Institutes of Health [DK 56338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	Kelsey Research Foundation; University of Texas School of Public Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by discretionary funds from the Kelsey Research Foundation and the University of Texas School of Public Health and in part by a grant from the National Institutes of Health (DK 56338) that funds the Texas Gulf Coast Digestive Diseases Center.	Ailes E, 2008, FOODBORNE PATHOG DIS, V5, P329, DOI 10.1089/fpd.2008.0090; Allos BM, 2004, CLIN INFECT DIS, V38, pS115, DOI 10.1086/381577; Appleman SS, 2009, CLIN PEDIATR, V48, P99, DOI 10.1177/0009922808321901; Bishara J, 2008, J HOSP INFECT, V68, P308, DOI 10.1016/j.jhin.2008.01.033; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; BROWN KH, 1988, J PEDIATR-US, V112, P191, DOI 10.1016/S0022-3476(88)80055-6; Chang JY, 2008, J INFECT DIS, V197, P435, DOI 10.1086/525047; Curry SR, 2009, CLIN INFECT DIS, V48, P425, DOI 10.1086/596315; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; DuPont HL, 2009, J TRAVEL MED, V16, P149, DOI 10.1111/j.1708-8305.2008.00299.x; DuPont HL, 2009, J TRAVEL MED, V16, P161, DOI 10.1111/j.1708-8305.2009.00300.x; DuPont HL, 2005, ANN INTERN MED, V143, P239, DOI 10.7326/0003-4819-143-3-200508020-00022; DuPont HL, 2005, ANN INTERN MED, V142, P805, DOI 10.7326/0003-4819-142-10-200505170-00005; DuPont HL, 1997, AM J GASTROENTEROL, V92, P1962; DUPONT HL, 1987, JAMA-J AM MED ASSOC, V257, P1347, DOI 10.1001/jama.257.10.1347; Ethelberg S, 2007, CLIN MICROBIOL INFEC, V13, P1095, DOI 10.1111/j.1469-0691.2007.01816.x; Flores J, 2008, CLIN VACCINE IMMUNOL, V15, P1194, DOI 10.1128/CVI.00070-08; Garcia-Aljaro C, 2009, APPL ENVIRON MICROB, V75, P329, DOI 10.1128/AEM.01367-08; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; Hedberg CW, 2008, EPIDEMIOL INFECT, V136, P65, DOI 10.1017/S0950268807008199; Jiang ZD, 2006, AM J GASTROENTEROL, V101, P1112, DOI 10.1111/j.1572-0241.2006.00482.x; Jiang ZD, 2003, J INFECT DIS, V188, P506, DOI 10.1086/377102; Jung IS, 2009, J CLIN GASTROENTEROL, V43, P534, DOI 10.1097/MCG.0b013e31818c87d7; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kendrick JB, 2007, CLIN INFECT DIS, V45, P217, DOI 10.1086/518990; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Meraz IM, 2008, J TRAVEL MED, V15, P412, DOI 10.1111/j.1708-8305.2008.00249.x; Mohamed JA, 2007, CLIN INFECT DIS, V44, P945, DOI 10.1086/512199; Mohamed JA, 2009, J INFECT DIS, V199, P477, DOI 10.1086/596319; Neal KR, 2002, GUT, V51, P410, DOI 10.1136/gut.51.3.410; Ochoa TJ, 2007, ANTIMICROB AGENTS CH, V51, P2837, DOI 10.1128/AAC.01397-06; Ohara T, 2002, ANTIMICROB AGENTS CH, V46, P3478, DOI 10.1128/AAC.46.11.3478-3483.2002; Okhuysen PC, 2004, AM J GASTROENTEROL, V99, P1774, DOI 10.1111/j.1572-0241.2004.30435.x; Shah N, 2009, AM J TROP MED HYG, V80, P609, DOI 10.4269/ajtmh.2009.80.609; Spano LC, 2008, J MED MICROBIOL, V57, P359, DOI 10.1099/jmm.0.47660-0; Spiller RC, 2007, J GASTROENTEROL, V42, P41, DOI 10.1007/s00535-006-1925-8; Stermer E, 2006, CLIN INFECT DIS, V43, P898, DOI 10.1086/507540; Talan DA, 2001, CLIN INFECT DIS, V32, P573, DOI 10.1086/318718; Tam CC, 2006, J INFECT DIS, V194, P95, DOI 10.1086/504294; Tarr PI, 2009, KIDNEY INT, V75, pS29, DOI 10.1038/ki.2008.615; Thielman NM, 2004, NEW ENGL J MED, V350, P38, DOI 10.1056/NEJMcp031534; Tornblom H, 2007, CLIN GASTROENTEROL H, V5, P461, DOI 10.1016/j.cgh.2007.01.007; Townes JM, 2008, ANN RHEUM DIS, V67, P1689, DOI 10.1136/ard.2007.083451; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Vugia D., 2009, Morbidity and Mortality Weekly Report, V58, P333; Willenbrock H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r267; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239; Zilberberg MD, 2008, EMERG INFECT DIS, V14, P929, DOI 10.3201/eid1406.071447	50	89	95	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2009	361	16					1560	1569		10.1056/NEJMcp0904162	http://dx.doi.org/10.1056/NEJMcp0904162			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506LT	19828533				2022-12-28	WOS:000270777000009
J	Tamura, MK; Covinsky, KE; Chertow, GM; Yaffe, K; Landefeld, CS; McCulloch, CE				Tamura, Manjula Kurella; Covinsky, Kenneth E.; Chertow, Glenn M.; Yaffe, Kristine; Landefeld, C. Seth; McCulloch, Charles E.			Functional Status of Elderly Adults before and after Initiation of Dialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPREHENSIVE GERIATRIC ASSESSMENT; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; MINIMUM DATA SET; CARDIAC REHABILITATION; HEMODIALYSIS; SURVIVAL; OCTOGENARIANS; INTERVENTION; VALIDATION	BACKGROUND It is unclear whether functional status before dialysis is maintained after the initiation of this therapy in elderly patients with end-stage renal disease (ESRD). METHODS Using a national registry of patients undergoing dialysis, which was linked to a national registry of nursing home residents, we identified all 3702 nursing home residents in the United States who were starting treatment with dialysis between June 1998 and October 2000 and for whom at least one measurement of functional status was available before the initiation of dialysis. Functional status was measured by assessing the degree of dependence in seven activities of daily living (on the Minimum Data Set-Activities of Daily Living [MDS-ADL] scale of 0 to 28 points, with higher scores indication greater functional difficulty). RESULTS The median MDS-ADL score increased from 12 during the 3 months before the initiation of dialysis to 16 during the 3 months after the initiation of dialysis. Three months after the initiation of dialysis, functional status had been maintained in 39% of nursing home residents, but by 12 months after the initiation of dialysis, 58% had died and predialysis functional status had been maintained in only 13%. In a random-effects model, the initiation of dialysis was associated with a sharp declin in functional status, indicated by an increase of 2.8 points in the MDS-ADL score (95% confidence interval [CI], 2.5 to 3.0); this decline was independent of age, sex, race, and functional-status trajectory before the initiation of dialysis. The decline in functional status associated with the initiation of dialysis remained substantial (1.7 points; 95% CI, 1.4 to 2.1), even after adjustment for the presence or absence of an accelerated functional decline during the 3-month period before the initiation of dialysis. CONCLUSIONS Among nursing home residents with ESRD, the initiation of dialysis is associated with a substantial and sustained decline in functional status.	[Tamura, Manjula Kurella; Chertow, Glenn M.] Stanford Univ, Sch Med, Div Nephrol, Dept Med, Palo Alto, CA 94304 USA; [Covinsky, Kenneth E.; Landefeld, C. Seth] Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat & Neurol, San Francisco, CA 94143 USA; [Yaffe, Kristine; McCulloch, Charles E.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Covinsky, Kenneth E.; Yaffe, Kristine; Landefeld, C. Seth] San Francisco VA Med Ctr, San Francisco, CA USA	Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Tamura, MK (corresponding author), Stanford Univ, Sch Med, Div Nephrol, Dept Med, 780 Welch Rd,Suite 106, Palo Alto, CA 94304 USA.	mktamura@stanford.edu	Tamura, Manjula Kurella/C-8284-2014	Tamura, Manjula Kurella/0000-0001-5227-2479; Chertow, Glenn/0000-0002-7599-0534	National Institute of Aging [K23AG028952]; National Center for Research Resources [KL2RR024130]; National Institute of Diabetes and Digestive and Kidney Diseases [N01DK12450]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG028952, K24AG029812] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by a Paul B. Beeson Career Development Award in Aging (K23AG028952, to Dr. Kurella Tamura) from the National Institute of Aging and grants from the National Center for Research Resources (KL2RR024130) and the National Institute of Diabetes and Digestive and Kidney Diseases (N01DK12450).	ANDERSON JE, 1993, AM J KIDNEY DIS, V21, P619, DOI 10.1016/S0272-6386(12)80034-5; Brunori G, 2007, AM J KIDNEY DIS, V49, P569, DOI 10.1053/j.ajkd.2007.02.278; Caplan GA, 2004, J AM GERIATR SOC, V52, P1417, DOI 10.1111/j.1532-5415.2004.52401.x; Carey EC, 2004, J GEN INTERN MED, V19, P1027, DOI 10.1111/j.1525-1497.2004.40016.x; Collins AJ, 2005, AM J KIDNEY DIS, V45, pV, DOI 10.1053/j.ajkd.2004.10.009; Cook WL, 2008, KIDNEY INT, V73, P1289, DOI 10.1038/ki.2008.62; DeOreo PB, 1997, AM J KIDNEY DIS, V30, P204, DOI 10.1016/S0272-6386(97)90053-6; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Gillick MR, 2000, NEW ENGL J MED, V342, P206, DOI 10.1056/NEJM200001203420312; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; HAWES C, 1995, GERONTOLOGIST, V35, P172, DOI 10.1093/geront/35.2.172; Huang YJ, 2008, KIDNEY INT, V74, P1079, DOI 10.1038/ki.2008.381; IFUDU O, 1994, JAMA-J AM MED ASSOC, V271, P29, DOI 10.1001/jama.271.1.29; Inouye SK, 1998, JAMA-J AM MED ASSOC, V279, P1187, DOI 10.1001/jama.279.15.1187; Joly D, 2003, J AM SOC NEPHROL, V14, P1012, DOI 10.1097/01.ASN.0000054493.04151.80; Kurella M, 2007, ANN INTERN MED, V146, P177, DOI 10.7326/0003-4819-146-3-200702060-00006; Kutner NG, 2006, J AM SOC NEPHROL, V17, P1175, DOI 10.1681/ASN.2005101027; Lawton MP, 1998, J AM GERIATR SOC, V46, P736, DOI 10.1111/j.1532-5415.1998.tb03809.x; Li M, 2007, AM J KIDNEY DIS, V50, P90, DOI 10.1053/j.ajkd.2007.04.011; Murtagh FEM, 2007, NEPHROL DIAL TRANSPL, V22, P1955, DOI 10.1093/ndt/gfm153; Reddy NC, 2007, NEPHROL DIAL TRANSPL, V22, P1399, DOI 10.1093/ndt/gfl809; Reuben DB, 1999, J AM GERIATR SOC, V47, P269, DOI 10.1111/j.1532-5415.1999.tb02988.x; Smith C, 2003, NEPHRON CLIN PRACT, V95, pC40, DOI 10.1159/000073708; Snowden M, 1999, J AM GERIATR SOC, V47, P1000, DOI 10.1111/j.1532-5415.1999.tb01297.x; Winkelmayer WC, 2005, AM J KIDNEY DIS, V46, P225, DOI 10.1053/j.ajkd.2005.04.029	25	666	687	2	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2009	361	16					1539	1547		10.1056/NEJMoa0904655	http://dx.doi.org/10.1056/NEJMoa0904655			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	506LT	19828531	Green Accepted			2022-12-28	WOS:000270777000007
J	Malani, PN				Malani, Preeti N.			Functional Status Assessment in the Preoperative Evaluation of Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SURGICAL SITE INFECTION; STAPHYLOCOCCUS-AUREUS; RISK-FACTOR; PREVENTION; MANAGEMENT		[Malani, Preeti N.] Ann Arbor Vet Affairs Healthcare Syst, GRECC, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48105 USA; [Malani, Preeti N.] Ann Arbor Vet Affairs Healthcare Syst, GRECC, Dept Internal Med, Div Geriatr Med, Ann Arbor, MI 48105 USA; [Malani, Preeti N.] Univ Michigan Hlth Syst, Ann Arbor, MI USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Malani, PN (corresponding author), Ann Arbor Vet Affairs Healthcare Syst, GRECC, Dept Internal Med, Div Infect Dis, 2215 Fuller Rd,111-I,8th Floor, Ann Arbor, MI 48105 USA.	pmalani@umich.edu						Anderson DJ, 2008, INFECT CONT HOSP EP, V29, P832, DOI 10.1086/590124; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Flinn DR, 2009, J AM COLL SURGEONS, V209, P261, DOI 10.1016/j.jamcollsurg.2009.03.008; High KP, 2005, CLIN INFECT DIS, V40, P114, DOI 10.1086/426082; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kaye KS, 2009, J AM GERIATR SOC, V57, P46, DOI 10.1111/j.1532-5415.2008.02053.x; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Segers P, 2006, JAMA-J AM MED ASSOC, V296, P2460, DOI 10.1001/jama.296.20.2460; Young MH, 2008, DRUG AGING, V25, P399, DOI 10.2165/00002512-200825050-00004	10	36	37	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	2009	302	14					1582	1583		10.1001/jama.2009.1453	http://dx.doi.org/10.1001/jama.2009.1453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505UA	19826029				2022-12-28	WOS:000270721800028
J	Margueron, R; Justin, N; Ohno, K; Sharpe, ML; Son, J; Drury, WJ; Voigt, P; Martin, SR; Taylor, WR; De Marco, V; Pirrotta, V; Reinberg, D; Gamblin, SJ				Margueron, Raphael; Justin, Neil; Ohno, Katsuhito; Sharpe, Miriam L.; Son, Jinsook; Drury, William J., III; Voigt, Philipp; Martin, Stephen R.; Taylor, William R.; De Marco, Valeria; Pirrotta, Vincenzo; Reinberg, Danny; Gamblin, Steven J.			Role of the polycomb protein EED in the propagation of repressive histone marks	NATURE			English	Article							METHYLTRANSFERASE ACTIVITY; STRUCTURAL BASIS; DROSOPHILA; RECOGNITION; H3; TRIMETHYLATION; ESC; METHYLATION; COMPLEXES; CHROMATIN	Polycomb group proteins have an essential role in the epigenetic maintenance of repressive chromatin states. The gene-silencing activity of the Polycomb repressive complex 2 (PRC2) depends on its ability to trimethylate lysine 27 of histone H3 (H3K27) by the catalytic SET domain of the EZH2 subunit, and at least two other subunits of the complex: SUZ12 and EED. Here we show that the carboxy-terminal domain of EED specifically binds to histone tails carrying trimethyl-lysine residues associated with repressive chromatin marks, and that this leads to the allosteric activation of the methyltransferase activity of PRC2. Mutations in EED that prevent it from recognizing repressive trimethyl-lysine marks abolish the activation of PRC2 in vitro and, in Drosophila, reduce global methylation and disrupt development. These findings suggest a model for the propagation of the H3K27me3 mark that accounts for the maintenance of repressive chromatin domains and for the transmission of a histone modification from mother to daughter cells.	[Ohno, Katsuhito; Pirrotta, Vincenzo] Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Labs, Piscataway, NJ 08854 USA; [Margueron, Raphael; Son, Jinsook; Drury, William J., III; Voigt, Philipp; Reinberg, Danny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Margueron, Raphael; Son, Jinsook; Drury, William J., III; Voigt, Philipp; Reinberg, Danny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Justin, Neil; Sharpe, Miriam L.; Martin, Stephen R.; Taylor, William R.; De Marco, Valeria; Gamblin, Steven J.] MRC Natl Inst Med Res, London NW7 1AA, England	Rutgers State University New Brunswick; Howard Hughes Medical Institute; New York University; New York University; MRC National Institute for Medical Research	Pirrotta, V (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Nelson Labs, 604 Allison Rd, Piscataway, NJ 08854 USA.	pirrotta@biology.rutgers.edu; reinbd01@med.nyu.edu; sgambli@nimr.mrc.ac.uk	Margueron, Raphael F/B-9996-2015; Justin, Neil/E-1774-2011	Margueron, Raphael F/0000-0002-9093-7977; Voigt, Philipp/0000-0003-4366-0490; Reinberg, Danny/0000-0003-4288-2016; Gamblin, Steve/0000-0001-5331-639X; Sharpe, Miriam/0000-0002-8936-1595	Deutsche Akademie der Naturforscher Leopoldina [LPDS 2009-5]; NIH [GM064844, GM37120]; HHMI; MRC; Division of Life Sciences of Rutgers University; Medical Research Council [MC_U117584222] Funding Source: researchfish; MRC [MC_U117584222] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064844, R37GM037120, R01GM037120] Funding Source: NIH RePORTER	Deutsche Akademie der Naturforscher Leopoldina; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Division of Life Sciences of Rutgers University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. McCabe for technical assistance, K. Basler for fly stocks and the pUASTattB plasmid, T. Jenuwein for antibodies and J. Muller for Drosophila PRC2 baculovirus. We thank J. Millar and A. Gould for suggestions and discussions, D. Allis for insightful discussions on histone specificity, P. Walker for technical assistance, and J. Brock for assistance with figures. This work was supported by the following grants: Fellowship from the Deutsche Akademie der Naturforscher Leopoldina (LPDS 2009-5) to P. V., NIH grants GM064844 and GM37120 and HHMI to D. R. Work in the S. J. G. laboratory is funded by the MRC. Work in the V. P. laboratory was supported by the Division of Life Sciences of Rutgers University.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Han ZF, 2007, STRUCTURE, V15, P1306, DOI 10.1016/j.str.2007.08.007; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kurzhals RL, 2008, DEV BIOL, V313, P293, DOI 10.1016/j.ydbio.2007.10.025; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Murzina NV, 2008, STRUCTURE, V16, P1077, DOI 10.1016/j.str.2008.05.006; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nekrasov M, 2005, EMBO REP, V6, P348, DOI 10.1038/sj.embor.7400376; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Ohno K, 2008, MECH DEVELOP, V125, P527, DOI 10.1016/j.mod.2008.01.002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Schiefner A, 2004, J BIOL CHEM, V279, P5588, DOI 10.1074/jbc.M309771200; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; STRUHL G, 1982, CELL, V31, P285, DOI 10.1016/0092-8674(82)90428-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tie F, 2007, MOL CELL BIOL, V27, P2014, DOI 10.1128/MCB.01822-06; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4	40	810	823	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					762	U11		10.1038/nature08398	http://dx.doi.org/10.1038/nature08398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19767730	Green Accepted			2022-12-28	WOS:000270547500029
J	Ng, PC; Venter, JC; Murray, SS; Levy, S				Ng, Pauline C.; Venter, J. Craig; Murray, Sarah S.; Levy, Samuel			An agenda for personalized medicine	NATURE			English	Editorial Material							ADVERSE DRUG-REACTIONS; CELIAC-DISEASE; RISK-FACTORS; VARIANTS; DATABASE		[Ng, Pauline C.; Venter, J. Craig] J Craig Venter Inst, San Diego, CA 92121 USA; [Murray, Sarah S.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Levy, Samuel] J Craig Venter Inst, Rockville, MD 20850 USA	J. Craig Venter Institute; Scripps Research Institute; J. Craig Venter Institute	Ng, PC (corresponding author), J Craig Venter Inst, Sci Ctr Dr, San Diego, CA 92121 USA.	png@jcvi.org						Adeyemo A, 2010, PUBLIC HEALTH GENOMI, V13, P72, DOI 10.1159/000218711; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Duncan D. E., 2009, EXPT MAN WHAT ONE MA; Easton DF, 2007, AM J HUM GENET, V81, P873, DOI 10.1086/521032; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Green PHR, 2003, LANCET, V362, P383, DOI 10.1016/S0140-6736(03)14027-5; Heshka JT, 2008, GENET MED, V10, P19, DOI 10.1097/GIM.0b013e31815f524f; Hogarth S, 2008, ANNU REV GENOM HUM G, V9, P161, DOI 10.1146/annurev.genom.9.081307.164319; HSU A, 2008, GUIDELINES VETTING; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Navigenics, 2008, APPL PREV GEN MED CL; *PERS MED COAL, 2008, PERS GEN IND STAND S; Pirmohamed M, 2004, BMJ-BRIT MED J, V329, P15, DOI 10.1136/bmj.329.7456.15; Prainsack B, 2008, NATURE, V456, P34, DOI 10.1038/456034a; Sangkuhl K, 2008, DRUG METAB REV, V40, P539, DOI 10.1080/03602530802413338 ; SINGER E, 2009, TECHNOLOGY REV MIT; Topol EJ, 2007, JAMA-J AM MED ASSOC, V298, P218, DOI 10.1001/jama.298.2.218	23	241	248	0	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					724	726		10.1038/461724a	http://dx.doi.org/10.1038/461724a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	503OR	19812653				2022-12-28	WOS:000270547500016
J	Gostin, LO				Gostin, Lawrence O.			FDA Regulation of Tobacco Politics, Law, and the Public's Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES		Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; Brandt AM, 2008, NEW ENGL J MED, V359, P445, DOI 10.1056/NEJMp0803729; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P524	3	25	25	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	2009	302	13					1459	1460		10.1001/jama.2009.1421	http://dx.doi.org/10.1001/jama.2009.1421			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503CL	19809027				2022-12-28	WOS:000270509600021
J	Hart, M; Moots, RJ				Hart, Michael; Moots, Robert J.			A Patient's Journey Behcet's syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Moots, Robert J.] Aintree Univ Hosp NHS Fdn Trust, Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England	Aintree University Hospitals NHS Foundation Trust		michaelanddawn@btinternet.com	Moots, Robert/AAM-8091-2020						0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	OCT 5	2009	339								b3876	10.1136/bmj.b3876	http://dx.doi.org/10.1136/bmj.b3876			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	505TE	19805471				2022-12-28	WOS:000270718700001
J	Boulton, SJ				Boulton, Simon J.			Condensin(g) Crossover Control to a Few Breaks	CELL			English	Editorial Material							MEIOTIC CROSSING-OVER; ELEGANS	Meiotic chromosome pairs must receive at least one crossover to ensure proper segregation at the first meiotic division. Mets and Meyer (2009) now present compelling evidence that the establishment of higher-order chromosome structure by a condensin complex regulates crossover recombination by controlling the distribution and frequency of meiotic double-strand breaks.	Canc Res UK, London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England	Cancer Research UK	Boulton, SJ (corresponding author), Canc Res UK, London Res Inst, DNA Damage Response Lab, Clare Hall, S Mimms EN6 3LD, Herts, England.	simon.boulton@cancer.org.uk						Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Csankovszki G, 2009, CURR BIOL, V19, P9, DOI 10.1016/j.cub.2008.12.006; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Kelly KO, 2000, GENETICS, V156, P617; Maloisel L, 1998, GENE DEV, V12, P1381, DOI 10.1101/gad.12.9.1381; Tsai CJ, 2008, GENE DEV, V22, P194, DOI 10.1101/gad.1618508	8	1	1	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 2	2009	139	1					21	23		10.1016/j.cell.2009.09.016	http://dx.doi.org/10.1016/j.cell.2009.09.016			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804748	Bronze			2022-12-28	WOS:000270388600010
J	Heo, I; Kim, VN				Heo, Inha; Kim, V. Narry			Regulating the Regulators: Posttranslational Modifications of RNA Silencing Factors	CELL			English	Review							ARGININE METHYLATION; TUDOR; GERM; LOCALIZATION; TRANSPOSONS; ARGONAUTE-2; STABILITY; BODIES; MICE	Every regulator should be regulated, and this holds true for small RNAs and their associated proteins. Knowledge has begun to emerge of the various mechanisms that impose specificity on the expression and function of RNA silencing factors. Recent papers, including one in this issue of Cell (Paroo et al., 2009), now reveal the posttranslational modifications that take part in the regulation of the core RNA silencing factors, Ago, Piwi, and TRBP.	[Heo, Inha; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Heo, Inha; Kim, V. Narry] Seoul Natl Univ, Natl Creat Res Initiat Ctr, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, VN (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	narrykim@snu.ac.kr			Creative Research Initiatives Program [20090063603]; National Research Foundation of Korea (NRF) [BK21]; Ministry of Education, Science and Technology of Korea	Creative Research Initiatives Program; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank D. Jee, C. Joo, and Y.-K. Kim for helpful discussions. This work was supported by the Creative Research Initiatives Program (20090063603) through the National Research Foundation of Korea (NRF) and the BK21 Research Fellowship (I.H.) from the Ministry of Education, Science and Technology of Korea.	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Hosokawa M, 2007, DEV BIOL, V301, P38, DOI 10.1016/j.ydbio.2006.10.046; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kirino Y, 2009, NAT CELL BIOL, V11, P652, DOI 10.1038/ncb1872; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Siomi MC, 2009, CURR OPIN CELL BIOL, V21, P426, DOI 10.1016/j.ceb.2009.02.003; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Thomson T, 2005, CELL RES, V15, P281, DOI 10.1038/sj.cr.7290297; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Vasileva A, 2009, CURR BIOL, V19, P630, DOI 10.1016/j.cub.2009.02.047; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599	16	49	52	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 2	2009	139	1					28	31		10.1016/j.cell.2009.09.013	http://dx.doi.org/10.1016/j.cell.2009.09.013			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804751	Bronze			2022-12-28	WOS:000270388600013
J	Suwa, G; Kono, RT; Simpson, SW; Asfaw, B; Lovejoy, CO; White, TD				Suwa, Gen; Kono, Reiko T.; Simpson, Scott W.; Asfaw, Berhane; Lovejoy, C. Owen; White, Tim D.			Paleobiological Implications of the Ardipithecus ramidus Dentition	SCIENCE			English	Article							MOLAR ENAMEL THICKNESS; PAN-TROGLODYTES; MIDDLE AWASH; TOOTH SIZE; AUSTRALOPITHECUS-AFARENSIS; DISTRIBUTION PATTERNS; CANINE DIMORPHISM; SEXUAL-DIMORPHISM; UPPER MIOCENE; EARLY HOMINID	The Middle Awash Ardipithecus ramidus sample comprises over 145 teeth, including associated maxillary and mandibular sets. These help reveal the earliest stages of human evolution. Ar. ramidus lacks the postcanine megadontia of Australopithecus. Its molars have thinner enamel and are functionally less durable than those of Australopithecus but lack the derived Pan pattern of thin occlusal enamel associated with ripe-fruit frugivory. The Ar. ramidus dental morphology and wear pattern are consistent with a partially terrestrial, omnivorous/frugivorous niche. Analyses show that the ARA-VP-6/500 skeleton is female and that Ar. ramidus was nearly monomorphic in canine size and shape. The canine/lower third premolar complex indicates a reduction of canine size and honing capacity early in hominid evolution, possibly driven by selection targeted on the male upper canine.	[Suwa, Gen] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Kono, Reiko T.] Natl Museum Nat & Sci, Dept Anthropol, Shinjuku Ku, Tokyo 1690073, Japan; [Simpson, Scott W.] Case Western Reserve Univ, Sch Med, Dept Anat, Cleveland, OH 44106 USA; [Asfaw, Berhane] Rift Valley Res Serv, Addis Ababa, Ethiopia; [Lovejoy, C. Owen] Kent State Univ, Div Biomed Sci, Dept Anthropol, Kent, OH 44240 USA; [White, Tim D.] Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA; [White, Tim D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Tokyo; National Museum of Nature and Science; Case Western Reserve University; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Suwa, G (corresponding author), Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan.	suwa@um.u-tokyo.ac.jp	, owen/N-7301-2019; Lund, Laura/H-7335-2012; Simpson, Scott/GRS-0081-2022	, owen/0000-0003-0053-4523; 	NSF [8210897, 9318698, 9512534, 9632389, 9727519, 9729060, 9910344, 0321893]; Japan Society for the Promotion of Science [11640708, 11691176, 14540657, 16405016, 16770187, 17207017, 19207019, 19770215, 21255005]	NSF(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	For funding, we thank NSF (grant nos. 8210897, 9318698, 9512534, 9632389, 9727519, 9729060, 9910344, and 0321893 HOMINID-RHOI) and the Japan Society for the Promotion of Science (grant nos. 11640708, 11691176, 14540657, 16405016, 16770187, 17207017, 19207019, 19770215, and 21255005); the Ministry of Tourism and Culture, the Authority for Research and Conservation of the Cultural Heritage, and the National Museum of Ethiopia for permissions and facilitation; the Afar Regional Government, the Afar people of the Middle Awash, and many other field workers for contributing directly to the data; the institutions and staff of National Museum of Ethiopia, National Museums of Kenya, Transvaal Museum South Africa, Cleveland Museum of Natural History, Royal Museum of Central Africa Tervuren, Naturalis Leiden, and the Department of Zoology of the National Museum of Nature and Science (Tokyo) for access to comparative materials; H. Gilbert for graphics work on Fig. 1; D. DeGusta and L. Hlusko for editorial assistance; R. Bernor, L. de Bonis, M. Brunet, M. C. Dean, B. Engesser, F. Guy, E. Heizmann, W. Liu, S. Moya-Sola, M. Plavcan, D. Reid, S. Semaw, and J. F. Thackeray for cooperation with comparative data and fossils; and T. Tanijiri, M. Chubachi, D. Kubo, S. Matsukawa, M. Ozaki, H. Fukase, S. Mizushima, and A. Saso for analytical and graphics assistance.	Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Campbell CJ, 2008, CAM S BIO EVOL ANTHR, V55, P1, DOI 10.1017/CBO9780511721915; CONROY GC, 1991, AM J PHYS ANTHROPOL, V86, P243, DOI 10.1002/ajpa.1330860212; Cope Dana A., 1993, P211; Dean MC, 2001, AM J PHYS ANTHROPOL, V116, P209, DOI 10.1002/ajpa.1116; DEAN MC, 2001, DENT MORPHOLOGY, P135; Di Fiore A, 2005, INT J PRIMATOL, V26, P1137, DOI 10.1007/s10764-005-6462-4; GINGERICH PD, 1979, AM J PHYS ANTHROPOL, V51, P457, DOI 10.1002/ajpa.1330510318; Grine FE, 2006, J HUM EVOL, V51, P297, DOI 10.1016/j.jhevol.2006.04.004; Haile-Selassie Y, 2004, SCIENCE, V303, P1503, DOI 10.1126/science.1092978; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Haile-Selassie Yohannes, 2009, P159; Hamada Y, 2002, AM J PHYS ANTHROPOL, V118, P268, DOI 10.1002/ajpa.10078; Hamada Y, 1999, PRIMATES, V40, P439, DOI 10.1007/BF02557580; JOHANSON DC, 1974, THESIS U CHICAGO; KELLEY J, 1995, AM J PHYS ANTHROPOL, V96, P365, DOI 10.1002/ajpa.1330960405; Kinzey W.G., 1984, P65; Kono Reiko T., 2008, Bulletin of the National Science Museum Series D (Anthropology), V34, P1; Kono RT, 2004, ANTHROPOL SCI, V112, P121, DOI 10.1537/ase.03106; Kuykendall KL, 1996, AM J PHYS ANTHROPOL, V99, P135, DOI 10.1002/(SICI)1096-8644(199601)99:1<135::AID-AJPA8>3.0.CO;2-#; Leigh SR, 2005, AM J PHYS ANTHROPOL, V127, P296, DOI 10.1002/ajpa.20096; Leigh SR, 1996, AM J PHYS ANTHROPOL, V101, P455, DOI 10.1002/(SICI)1096-8644(199612)101:4<455::AID-AJPA2>3.0.CO;2-V; Leigh SR, 1996, AM J PHYS ANTHROPOL, V99, P43, DOI 10.1002/(SICI)1096-8644(199601)99:1<43::AID-AJPA3>3.0.CO;2-0; Leigh SR, 2008, J HUM EVOL, V55, P75, DOI 10.1016/j.jhevol.2008.01.001; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; Lucas PW, 2008, J ANAT, V212, P486, DOI 10.1111/j.1469-7580.2008.00877.x; MALENKY RK, 1994, AM J PRIMATOL, V32, P1, DOI 10.1002/ajp.1350320102; MCHENRY HM, 1986, J HUM EVOL, V15, P177, DOI 10.1016/S0047-2484(86)80044-6; MCHENRY HM, 1984, AM J PHYS ANTHROPOL, V64, P297, DOI 10.1002/ajpa.1330640312; Pickford M, 2005, ANTHROPOL SCI, V113, P95, DOI 10.1537/ase.04S014; Plavcan J.M., 1990, THESIS DUKE U; Reno PL, 2003, P NATL ACAD SCI USA, V100, P9404, DOI 10.1073/pnas.1133180100; Schwartz GT, 2001, AM J PHYS ANTHROPOL, V115, P269, DOI 10.1002/ajpa.1081; Semaw S, 2005, NATURE, V433, P301, DOI 10.1038/nature03177; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Shields ED, 2005, AM J PHYS ANTHROPOL, V128, P299, DOI 10.1002/ajpa.20110; SIMPSON SW, 1992, AM J PHYS ANTHROPOL, V87, P29, DOI 10.1002/ajpa.1330870104; Smith B. Holly, 1994, Yearbook of Physical Anthropology, V37, P177; Sponheimer M, 2006, J HUM EVOL, V51, P128, DOI 10.1016/j.jhevol.2006.02.002; Suwa G, 2009, SCIENCE, V326, DOI 10.1126/science.1175825; Vinyard CJ, 2005, J HUM EVOL, V49, P241, DOI 10.1016/j.jhevol.2005.04.002; Vogel ER, 2008, J HUM EVOL, V55, P60, DOI 10.1016/j.jhevol.2007.12.005; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; White TD, 2000, AM J PHYS ANTHROPOL, V111, P45, DOI 10.1002/(SICI)1096-8644(200001)111:1<45::AID-AJPA4>3.0.CO;2-I; White TD, 2009, SCIENCE, V326, P87, DOI 10.1126/science.1175822; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802	48	130	135	6	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					94	99		10.1126/science.1175824	http://dx.doi.org/10.1126/science.1175824			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501CA	19810195	Green Published			2022-12-28	WOS:000270355600042
J	Miller, DH; Leary, SM				Miller, David H.; Leary, Siobhan M.			Treatment of clinically isolated syndrome: to be PreClSe	LANCET			English	Editorial Material							MULTIPLE-SCLEROSIS; GLATIRAMER ACETATE; INTERFERON BETA-1B; MS; DEMYELINATION; MULTICENTER; CONVERSION; DEFINITE; TRIAL; RISK		[Miller, David H.] UCL, Inst Neurol, Dept Neuroinflammat, London WC1N 3BG, England; [Leary, Siobhan M.] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Miller, DH (corresponding author), UCL, Inst Neurol, Dept Neuroinflammat, London WC1N 3BG, England.	d.miller@ion.ucl.ac.uk						Beck RW, 2003, ARCH OPHTHALMOL-CHIC, V121, P944; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Comi G, 2009, LANCET, V374, P1503, DOI 10.1016/S0140-6736(09)61259-9; Comi G, 2001, LANCET, V357, P1576, DOI 10.1016/S0140-6736(00)04725-5; DeLuca GC, 2006, BRAIN, V129, P1507, DOI 10.1093/brain/awl074; Ellis R, 2009, MULT SCLER J, V15, P505, DOI 10.1177/1352458508100967; Fisniku LK, 2008, BRAIN, V131, P808, DOI 10.1093/brain/awm329; Jacobs LD, 2000, NEW ENGL J MED, V343, P898, DOI 10.1056/NEJM200009283431301; Kappos L, 2006, NEUROLOGY, V67, P1242, DOI 10.1212/01.wnl.0000237641.33768.8d; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Mikol DD, 2008, LANCET NEUROL, V7, P903, DOI 10.1016/S1474-4422(08)70200-X; Panitch H, 2004, NEUROLOGY, V63, P1788; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Wolinsky JS, 2007, ANN NEUROL, V61, P14, DOI 10.1002/ana.21079; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693	15	6	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT-NOV	2009	374	9700					1475	1476		10.1016/S0140-6736(09)61453-7	http://dx.doi.org/10.1016/S0140-6736(09)61453-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517CS	19815269				2022-12-28	WOS:000271591300004
J	Nabulsi, M				Nabulsi, Mona			Uncertainties Page Is combining or alternating antipyretic therapy more beneficial than monotherapy for febrile children?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; ANTIINFLAMMATORY DRUG-USE; IBUPROFEN; FEVER; ACETAMINOPHEN; PARACETAMOL		Amer Univ Beirut, Fac Med, Dept Paediat & Adolescent Med, Div Gen Paediat, Beirut, Lebanon	American University of Beirut	Nabulsi, M (corresponding author), Amer Univ Beirut, Fac Med, Dept Paediat & Adolescent Med, Div Gen Paediat, POB 113-6044-C8, Beirut, Lebanon.	mn04@aub.edu.lb						Coca SG, 2008, CLIN J AM SOC NEPHRO, V3, P481, DOI 10.2215/CJN.03520807; Diez Domingo J, 2001, An Esp Pediatr, V55, P503; Eguia L, 1997, PHARMACOTHERAPY, V17, P363; Erlewyn-Lajeunesse MDS, 2006, ARCH DIS CHILD, V91, P414, DOI 10.1136/adc.2005.087874; Hay AD, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1302; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kramer LC, 2008, CLIN PEDIATR, V47, P907, DOI 10.1177/0009922808319967; Lesko SM, 2001, PEDIATRICS, V107, P1108, DOI 10.1542/peds.107.5.1108; Mayoral CE, 2000, PEDIATRICS, V105, P1009, DOI 10.1542/peds.105.5.1009; MCINTIRE SC, 1993, PEDIATRICS, V92, P459; Nabulsi MM, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-4; *NAT I HLTH CLIN E, 2007, FEV ILLN CHILDR ASS; Sarrell EM, 2006, ARCH PEDIAT ADOL MED, V160, P197, DOI 10.1001/archpedi.160.2.197; Wright AD, 2007, CLIN PEDIATR, V46, P146, DOI 10.1177/0009922806293922	14	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 1	2009	339								b3540	10.1136/bmj.b3540	http://dx.doi.org/10.1136/bmj.b3540			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502LB	19797346				2022-12-28	WOS:000270460000001
J	Murray, SA; Kendall, M; Carduff, E; Worth, A; Harris, FM; Lloyd, A; Cavers, D; Grant, L; Sheikh, A				Murray, Scott A.; Kendall, Marilyn; Carduff, Emma; Worth, Allison; Harris, Fiona M.; Lloyd, Anna; Cavers, Debbie; Grant, Liz; Sheikh, Aziz			Use of serial qualitative interviews to understand patients' evolving experiences and needs	BRITISH MEDICAL JOURNAL			English	Article							LUNG-CANCER; LIFE; CARE; SCOTLAND; FAILURE; ILLNESS; END		[Murray, Scott A.; Grant, Liz; Sheikh, Aziz] Univ Edinburgh, Primary Palliat Care Res Grp, Ctr Populat Hlth Sci, Gen Practice Sect, Edinburgh EH8 9DX, Midlothian, Scotland	University of Edinburgh	Murray, SA (corresponding author), Univ Edinburgh, Primary Palliat Care Res Grp, Ctr Populat Hlth Sci, Gen Practice Sect, Edinburgh EH8 9DX, Midlothian, Scotland.	scott.murray@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; Harris, Fiona/0000-0003-3258-5624	Department of Health Funding Source: Medline; Chief Scientist Office Funding Source: Medline	Department of Health; Chief Scientist Office		Back AL, 2002, ARCH INTERN MED, V162, P1257, DOI 10.1001/archinte.162.11.1257; Baker F, 1999, CANCER PRACT, V7, P190, DOI 10.1046/j.1523-5394.1999.74005.x; Buseh AG, 2006, WOMEN HEALTH, V44, P1, DOI 10.1300/J013v44n03_01; Corden A, 2007, SOC POLICY SOC, V6, P583, DOI 10.1017/S1474746407003910; Cornwell Jocelyn, 1984, HARD EARNED LIVES AC; Gilligan Carol, 1993, DIFFERENT VOICE PSYC; Grant Elizabeth, 2004, Palliat Support Care, V2, P371; Harris FM, 2008, EUR J CANCER CARE, V17, P377, DOI 10.1111/j.1365-2354.2007.00880.x; Holland J., 2006, QUALITATIVE LONGITUD; Kemper R.V., 2002, CHRONICLING CULTURES; Kendall M, 2007, BMJ-BRIT MED J, V334, P521, DOI 10.1136/bmj.39097.582639.55; Lawton J, 2005, SOC SCI MED, V60, P1423, DOI 10.1016/j.socscimed.2004.08.013; Lawton J, 2001, QUAL HEALTH RES, V11, P693, DOI 10.1177/104973201129119389; Lawton J, 2008, SOC SCI MED, V67, P47, DOI 10.1016/j.socscimed.2008.03.028; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lowes L, 2006, J ADV NURS, V55, P587, DOI 10.1111/j.1365-2648.2006.03950.x; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Murray Sa, 2007, PATIENTS CARERS PROF; Murray SA, 2007, J PAIN SYMPTOM MANAG, V34, P393, DOI 10.1016/j.jpainsymman.2006.12.009; Murray SA, 2006, LANCET, V368, P901, DOI 10.1016/S0140-6736(06)69350-1; Peterson JW, 2009, J PEDIATR HEALTH CAR, V23, P93, DOI 10.1016/j.pedhc.2007.10.002; Riley J, 2005, LANCET, V365, P735; Smith DJ, 2003, BRIT J CRIMINOL, V43, P169, DOI 10.1093/bjc/43.1.169; SMITH N, 2004, UNDERSTANDING RES SO; Steinhauser KE, 2006, PALLIATIVE MED, V20, P745, DOI 10.1177/0269216306073112; White RT, 2005, RES SCI EDUC, V35, P137, DOI 10.1007/s11165-004-3437-y; Whitehead L, 2006, INT J NURS STUD, V43, P1023, DOI 10.1016/j.ijnurstu.2006.01.003; Wideheim AK, 2002, CANCER NURS, V25, P236, DOI 10.1097/00002820-200206000-00012; Woodgate RL, 2004, J ADV NURS, V46, P358, DOI 10.1111/j.1365-2648.2004.03002.x; Worth A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b183; Yates P, 1999, Oncol Nurs Forum, V26, P113	32	174	174	0	20	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 28	2009	339								b3702	10.1136/bmj.b3702	http://dx.doi.org/10.1136/bmj.b3702			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	502KW	19786485	Green Submitted			2022-12-28	WOS:000270459400001
J	Merlin, C; Gegear, RJ; Reppert, SM				Merlin, Christine; Gegear, Robert J.; Reppert, Steven M.			Antennal Circadian Clocks Coordinate Sun Compass Orientation in Migratory Monarch Butterflies	SCIENCE			English	Article							POLARIZED SKYLIGHT; DROSOPHILA BRAIN; NEURONS; RHYTHMS; INSECT; MODEL	During their fall migration, Eastern North American monarch butterflies (Danaus plexippus) use a time-compensated Sun compass to aid navigation to their overwintering grounds in central Mexico. It has been assumed that the circadian clock that provides time compensation resides in the brain, although this assumption has never been examined directly. Here, we show that the antennae are necessary for proper time-compensated Sun compass orientation in migratory monarch butterflies, that antennal clocks exist in monarchs, and that they likely provide the primary timing mechanism for Sun compass orientation. These unexpected findings pose a novel function for the antennae and open a new line of investigation into clock-compass connections that may extend widely to other insects that use this orientation mechanism.	[Merlin, Christine; Gegear, Robert J.; Reppert, Steven M.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	Steven.Reppert@umassmed.edu		Gegear, Robert/0000-0001-9886-1324	NIH [R01 GM086794]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Foley and A. Casselman for assistance; F. Gagnon, C. Cullar, and O. Taylor for supplying monarch butterflies; and D. Weaver, Q. Yuan, and members of the Reppert laboratory for their inputs and comments. Supported by NIH grant R01 GM086794.	Brower Lincoln P., 1995, Journal of the Lepidopterists' Society, V49, P304; Calvert William H., 2001, Journal of the Lepidopterists' Society, V55, P162; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Froy O, 2003, SCIENCE, V300, P1303, DOI 10.1126/science.1084874; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Heinze S, 2007, SCIENCE, V315, P995, DOI 10.1126/science.1135531; Kamikouchi A, 2009, NATURE, V458, P165, DOI 10.1038/nature07810; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Merlin C, 2006, INSECT MOL BIOL, V15, P137, DOI 10.1111/j.1365-2583.2006.00617.x; Merlin C, 2007, J BIOL RHYTHM, V22, P502, DOI 10.1177/0748730407307737; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Perez SM, 1997, NATURE, V387, P29, DOI 10.1038/387029a0; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Reppert SM, 2006, CELL, V124, P233, DOI 10.1016/j.cell.2006.01.009; Reppert SM, 2004, CURR BIOL, V14, P155, DOI 10.1016/j.cub.2003.12.034; Saifullah ASM, 2009, J BIOL RHYTHM, V24, P144, DOI 10.1177/0748730408331166; Sakura M, 2008, J NEUROPHYSIOL, V99, P667, DOI 10.1152/jn.00784.2007; Sane SP, 2007, SCIENCE, V315, P863, DOI 10.1126/science.1133598; Sauman I, 2005, NEURON, V46, P457, DOI 10.1016/j.neuron.2005.03.014; Schuckel J, 2007, CELL TISSUE RES, V330, P271, DOI 10.1007/s00441-007-0471-x; Stalleicken J, 2005, J EXP BIOL, V208, P2399, DOI 10.1242/jeb.01613; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; TRUMAN JW, 1970, SCIENCE, V167, P1624, DOI 10.1126/science.167.3925.1624; Urquhart FA., 1960, MONARCH BUTTERFLY; Yorozu S, 2009, NATURE, V458, P201, DOI 10.1038/nature07843; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004; Zhu HS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-14; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	29	117	126	1	122	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1700	1704		10.1126/science.1176221	http://dx.doi.org/10.1126/science.1176221			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779201	Green Submitted, Green Accepted			2022-12-28	WOS:000270131800049
J	Peng, Y; Ellis, BD; Wang, XP; Fettinger, JC; Power, PP				Peng, Yang; Ellis, Bobby D.; Wang, Xinping; Fettinger, James C.; Power, Philip P.			Reversible Reactions of Ethylene with Distannynes Under Ambient Conditions	SCIENCE			English	Article							ELEMENT ALKYNE ANALOGS; DISILYNE RSISIR R; GERMANIUM ANALOG; STABLE COMPOUND; REACTIVITY; AR; COMPLEXES; CHEMISTRY; BONDS; SN	Ethylene's cycloadditions to unsaturated hydrocarbons occupy well-established ground in classical organic chemistry. In contrast, its reactivity toward alkene and alkyne analogs of carbon's heavier-element congeners silicon, germanium, tin, or lead has been little explored. We show here that treatment of the distannynes (ArSnSnAriPr4)-Sn-iPr4 [Ar-iPr4 = C6H3-2,6(C6H3-2,6-Pr-i(2))(2), 1] or (ArSnSnAriPr8)-Sn-iPr8 [Ar-iPr8 = C6H-2,6(C6H2-2,4,6-Pr-i(3))(2)-3,5-Pr-i(2), 2] with ethylene under ambient conditions affords the cycloadducts (ArSn)-Sn-iPr4(mu(2):eta(1):eta(1)-C2H4)(2)SnAriPr4 (3) or (ArSn)-Sn-iPr8(mu(2):eta(1):eta(1)-C2H4)(2)SnAriPr8 (4) that were structurally and spectroscopically characterized. Ethylene incorporation in 3 and 4 involves tin-carbon sigma bonding and is shown to be fully reversible under ambient conditions; hydrocarbon solutions of 3 or 4 revert to the distannynes 1 or 2 with ethylene elimination under reduced pressure or upon standing at similar to 25 degrees C. Variable-temperature proton nuclear magnetic resonance studies showed that the enthalpies of reaction were near -48 (3) and -27 (4) kilojoules per mole.	[Peng, Yang; Ellis, Bobby D.; Wang, Xinping; Fettinger, James C.; Power, Philip P.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis	Power, PP (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	pppower@ucdavis.edu	Peng, Yang/A-3924-2011; Ellis, Bobby/D-3306-2011	Peng, Yang/0000-0002-6780-2468; Fettinger, James/0000-0002-6428-4909	NSF [CHE- 0641020]	NSF(National Science Foundation (NSF))	We are grateful to NSF (grant CHE- 0641020) for financial support. Metrical data for the crystal structures of compounds 3, 4, 6, and 7 are available from the Cambridge Crystallographic Data Centre (CCDC) under reference numbers CCDC 739244, 739245, 741040, and 741039, respectively.	COTTON JD, 1976, J CHEM SOC DALTON, P2275, DOI 10.1039/dt9760002275; Cui CM, 2005, J AM CHEM SOC, V127, P17530, DOI 10.1021/ja055372s; DAVIS MAF, 1973, BIOCHIM BIOPHYS ACTA, V317, P214, DOI 10.1016/0005-2795(73)90216-X; Hardman NJ, 2003, J AM CHEM SOC, V125, P2667, DOI 10.1021/ja028579j; Hinchley SL, 2001, J AM CHEM SOC, V123, P9045, DOI 10.1021/ja010615b; JURKSCHAT K, 1982, J ORGANOMET CHEM, V236, P69, DOI 10.1016/S0022-328X(00)86750-9; Kinjo R, 2007, J AM CHEM SOC, V129, P7766, DOI 10.1021/ja072759h; KLINKHAMMER KW, 2002, CHEM ORGANIC GERMA 1, V2, P273; KREBS A, 1989, ANGEW CHEM INT EDIT, V28, P603, DOI 10.1002/anie.198906031; KYUSHIN S, 1994, CHEM LETT, P997, DOI 10.1246/cl.1994.997; Ma S., 2009, HDB CYCLIZATION REAC, V1; MA S, 2009, HDB CYCLIZATION REAC, V2; MATSUMOTO H, 1988, CHEM LETT, P629, DOI 10.1246/cl.1988.629; NAGELBERG SB, 1982, ORGANOMETALLICS, V1, P851, DOI 10.1021/om00066a016; OHGAKI H, 1995, ORGANOMETALLICS, V14, P2139, DOI 10.1021/om00005a005; Ohtaki T, 1996, ORGANOMETALLICS, V15, P3103, DOI 10.1021/om9600147; Phillips AD, 2002, J AM CHEM SOC, V124, P5930, DOI 10.1021/ja0257164; Power PP, 2007, ORGANOMETALLICS, V26, P4362, DOI 10.1021/om700365p; Radzewich CE, 1998, J AM CHEM SOC, V120, P9384, DOI 10.1021/ja9818405; Sekiguchi A, 2004, SCIENCE, V305, P1755, DOI 10.1126/science.1102209; SITA LR, 1989, J AM CHEM SOC, V111, P3769, DOI 10.1021/ja00192a056; SITA LR, 1990, ORGANOMETALLICS, V9, P1644, DOI 10.1021/om00119a041; SITA LR, 1988, J AM CHEM SOC, V110, P5208, DOI 10.1021/ja00223a059; Stender M, 2002, ANGEW CHEM INT EDIT, V41, P1785, DOI 10.1002/1521-3773(20020517)41:10<1785::AID-ANIE1785>3.0.CO;2-6; Stender M, 2002, CHEM COMMUN, P1312, DOI 10.1039/b203403d; Sugiyama Y, 2006, J AM CHEM SOC, V128, P1023, DOI 10.1021/ja057205y; WELLS AF, 1984, STRUCTURAL INORGANIC, P1175; WEST R, 1981, SCIENCE, V214, P1343, DOI 10.1126/science.214.4527.1343; Wiberg N, 2004, Z ANORG ALLG CHEM, V630, P1823, DOI 10.1002/zaac.200400177; Woodward R. B., 1970, CONSERVATION ORBITAL; Wrackmeyer B, 1999, ANN R NMR S, V38, P203, DOI 10.1016/S0066-4103(08)60038-1	31	147	147	3	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1668	1670		10.1126/science.1176443	http://dx.doi.org/10.1126/science.1176443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	498II	19779193				2022-12-28	WOS:000270131800039
J	Elsig, J; Schmitt, J; Leuenberger, D; Schneider, R; Eyer, M; Leuenberger, M; Joos, F; Fischer, H; Stocker, TF				Elsig, Joachim; Schmitt, Jochen; Leuenberger, Daiana; Schneider, Robert; Eyer, Marc; Leuenberger, Markus; Joos, Fortunat; Fischer, Hubertus; Stocker, Thomas F.			Stable isotope constraints on Holocene carbon cycle changes from an Antarctic ice core	NATURE			English	Article							ATMOSPHERIC CO2; TERRESTRIAL; DYNAMICS; RECORD; AGE; VARIABILITY; PEATLANDS; DIOXIDE; CLIMATE; SINK	Reconstructions of atmospheric CO2 concentrations based on Antarctic ice cores(1,2) reveal significant changes during the Holocene epoch, but the processes responsible for these changes in CO2 concentrations have not been unambiguously identified. Distinct characteristics in the carbon isotope signatures of the major carbon reservoirs (ocean, biosphere, sediments and atmosphere) constrain variations in the CO2 fluxes between those reservoirs. Here we present a highly resolved atmospheric delta C-13 record for the past 11,000 years from measurements on atmospheric CO2 trapped in an Antarctic ice core. From mass-balance inverse model calculations(3,4) performed with a simplified carbon cycle model, we show that the decrease in atmospheric CO2 of about 5 parts per million by volume (p.p.m.v.). The increase in delta C-13 of about 0.25 parts per thousand during the early Holocene is most probably the result of a combination of carbon uptake of about 290 gigatonnes of carbon by the land biosphere and carbon release from the ocean in response to carbonate compensation of the terrestrial uptake during the termination of the last ice age. The 20 p.p.m.v. increase of atmospheric CO2 and the small decrease in delta C-13 of about 0.05 parts per thousand during the later Holocene can mostly be explained by contributions from carbonate compensation of earlier land-biosphere uptake and coral reef formation, with only a minor contribution from a small decrease of the land-biosphere carbon inventory.	[Elsig, Joachim; Schmitt, Jochen; Leuenberger, Daiana; Schneider, Robert; Eyer, Marc; Leuenberger, Markus; Joos, Fortunat; Fischer, Hubertus; Stocker, Thomas F.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Elsig, Joachim; Schmitt, Jochen; Leuenberger, Daiana; Schneider, Robert; Eyer, Marc; Leuenberger, Markus; Joos, Fortunat; Fischer, Hubertus; Stocker, Thomas F.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Schmitt, Jochen; Fischer, Hubertus] Alfred Wegener Inst Polar & Marine Res AWI, D-27568 Bremerhaven, Germany	University of Bern; University of Bern; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Stocker, TF (corresponding author), Univ Bern, Inst Phys, Sidlerstr 5, CH-3012 Bern, Switzerland.	stocker@climate.unibe.ch	Schmitt, Jochen/B-7893-2009; Joos, Fortunat/B-4118-2018; Leuenberger, Markus C/K-9655-2016; Stocker, Thomas/B-1273-2013; Fischer, Hubertus/A-1211-2014	Schmitt, Jochen/0000-0003-4695-3029; Joos, Fortunat/0000-0002-9483-6030; Leuenberger, Markus C/0000-0003-4299-6793; Fischer, Hubertus/0000-0002-2787-4221	EU (EPICA-MIS); national contributions from Belgium, Denmark, France, Germany, Italy, the Netherlands, Norway, Sweden, Switzerland and the United Kingdom; Swiss NSF; DFG priority programme INTERDYNAMIK; German climate programme DEKLIM	EU (EPICA-MIS)(European Commission); national contributions from Belgium, Denmark, France, Germany, Italy, the Netherlands, Norway, Sweden, Switzerland and the United Kingdom(Netherlands Government); Swiss NSF(Swiss National Science Foundation (SNSF)); DFG priority programme INTERDYNAMIK(German Research Foundation (DFG)); German climate programme DEKLIM	This work is a contribution to the European Project for Ice Coring in Antarctica (EPICA), a joint European Science Foundation/European Commission scientific programme, funded by the EU (EPICA-MIS) and by national contributions from Belgium, Denmark, France, Germany, Italy, the Netherlands, Norway, Sweden, Switzerland and the United Kingdom. The main logistic support was provided by IPEV and PNRA ( at Dome C) and AWI ( at Dronning Maud Land). We thank A. Landais, D. Rodriguez, E. Capron and G. Dreyfus for the contribution of delta<SUP>15</SUP>N data as well as P. Nyfeler and K. Grossenbacher for their technical support, T. Tschumi for sharing his Bern3D results, and J. Chappellaz for comments. We acknowledge financial support by the Swiss NSF, the DFG priority programme INTERDYNAMIK and the German climate programme DEKLIM. This is EPICA publication no. 227.	Beilman DW, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2007GB003112; BERGER WH, 1982, NATURWISSENSCHAFTEN, V69, P87, DOI 10.1007/BF00441228; Broecker W, 2001, GEOCHEM GEOPHY GEOSY, V2, part. no.; Brovkin V, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001662; Brovkin V, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002885; Bruno M, 1997, GLOBAL BIOGEOCHEM CY, V11, P111, DOI 10.1029/96GB03611; CROWLEY TJ, 1995, GLOBAL BIOGEOCHEM CY, V9, P377, DOI 10.1029/95GB01107; Duplessy JC, 1988, PALEOCEANOGRAPHY, V3, P343, DOI 10.1029/PA003i003p00343; EYER M, 2004, THESIS U BERN, P1; Fluckiger J, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001417; Francey RJ, 1999, TELLUS B, V51, P170, DOI 10.1034/j.1600-0889.1999.t01-1-00005.x; Indermuhle A, 1999, NATURE, V398, P121, DOI 10.1038/18158; Joos F, 1998, GLOBAL BIOGEOCHEM CY, V12, P277, DOI 10.1029/98GB00746; Joos F, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002156; Kim JH, 2004, QUATERNARY SCI REV, V23, P2141, DOI 10.1016/j.quascirev.2004.08.010; LEUENBERGER M, 1992, NATURE, V357, P488, DOI 10.1038/357488a0; Loulergue L, 2007, CLIM PAST, V3, P527, DOI 10.5194/cp-3-527-2007; Lourantou A., 2008, THESIS U J FOURIER; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; MacDonald GM, 2006, SCIENCE, V314, P285, DOI 10.1126/science.1131722; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Ridgwell AJ, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000893; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Schurgers G, 2006, CLIM PAST, V2, P205, DOI 10.5194/cp-2-205-2006; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Smith HJ, 1999, NATURE, V400, P248, DOI 10.1038/22291; Smith LC, 2004, SCIENCE, V303, P353, DOI 10.1126/science.1090553; Strassmann KM, 2008, TELLUS B, V60, P583, DOI 10.1111/j.1600-0889.2008.00340.x; Vecsei A, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002147; Wang Y, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002484	30	152	153	4	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					507	510		10.1038/nature08393	http://dx.doi.org/10.1038/nature08393			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19779448	Green Published			2022-12-28	WOS:000270082900036
J	Hubert, C; Loy, A; Nickel, M; Arnosti, C; Baranyi, C; Bruchert, V; Ferdelman, T; Finster, K; Christensen, FM; de Rezende, JR; Vandieken, V; Jorgensen, BB				Hubert, Casey; Loy, Alexander; Nickel, Maren; Arnosti, Carol; Baranyi, Christian; Bruechert, Volker; Ferdelman, Timothy; Finster, Kai; Christensen, Flemming Monsted; de Rezende, Julia Rosa; Vandieken, Verona; Jorgensen, Bo Barker			A Constant Flux of Diverse Thermophilic Bacteria into the Cold Arctic Seabed	SCIENCE			English	Article							SULFATE-REDUCING BACTERIA; SP NOV.; MICROBIAL DIVERSITY; GEN. NOV.; TEMPERATURE; REDUCTION; SEDIMENTS; BIOSPHERE; SVALBARD	Microorganisms have been repeatedly discovered in environments that do not support their metabolic activity. Identifying and quantifying these misplaced organisms can reveal dispersal mechanisms that shape natural microbial diversity. Using endospore germination experiments, we estimated a stable supply of thermophilic bacteria into permanently cold Arctic marine sediment at a rate exceeding 10(8) spores per square meter per year. These metabolically and phylogenetically diverse Firmicutes show no detectable activity at cold in situ temperatures but rapidly mineralize organic matter by hydrolysis, fermentation, and sulfate reduction upon induction at 50 degrees C. The closest relatives to these bacteria come from warm subsurface petroleum reservoir and ocean crust ecosystems, suggesting that seabed fluid flow from these environments is delivering thermophiles to the cold ocean. These transport pathways may broadly influence microbial community composition in the marine environment.	[Hubert, Casey; Nickel, Maren; Bruechert, Volker; Ferdelman, Timothy; de Rezende, Julia Rosa; Vandieken, Verona; Jorgensen, Bo Barker] Max Planck Inst Marine Microbiol, Biogeochem Grp, D-28359 Bremen, Germany; [Loy, Alexander; Baranyi, Christian] Univ Vienna, Dept Microbial Ecol, A-1090 Vienna, Austria; [Arnosti, Carol] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27599 USA; [Finster, Kai; Christensen, Flemming Monsted] Aarhus Univ, Dept Biol Sci, Microbiol Sect, DK-8000 Aarhus C, Denmark; [Christensen, Flemming Monsted; de Rezende, Julia Rosa; Jorgensen, Bo Barker] Aarhus Univ, Dept Biol Sci, Ctr Geomicrobiol, DK-8000 Aarhus C, Denmark	Max Planck Society; University of Vienna; University of North Carolina; University of North Carolina Chapel Hill; Aarhus University; Aarhus University	Hubert, C (corresponding author), Max Planck Inst Marine Microbiol, Biogeochem Grp, Celsiusstr 1, D-28359 Bremen, Germany.	chubert@mpi-bremen.de	Ferdelman, Timothy G/A-3758-2013; baranyi, christian/AAZ-3471-2020; de Rezende, Julia/G-3670-2012; Loy, Alexander/A-8182-2008; Jorgensen, Bo B/C-2214-2013; Finster, Kai W/I-7475-2013	Ferdelman, Timothy G/0000-0002-9701-3793; baranyi, christian/0000-0003-3118-2145; de Rezende, Julia/0000-0001-7750-4344; Loy, Alexander/0000-0001-8923-5882; Jorgensen, Bo B/0000-0001-9398-8027; Finster, Kai W/0000-0002-9132-5542; Hubert, Casey/0000-0002-8691-8116; Bruchert, Volker/0000-0002-8956-3840	Natural Sciences and Engineering Research Council of Canada; Austrian Science Fund [P20185-B17]; U.S. National Science Foundation [OCE-0323975, OCE-0848703]; Max Planck Society; Austrian Science Fund (FWF) [P 20185] Funding Source: researchfish	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Austrian Science Fund(Austrian Science Fund (FWF)); U.S. National Science Foundation(National Science Foundation (NSF)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank S. Henningsen, J. Mortensen, K. Barker, and A. Steen for assistance aboard R/V Farm and the Alfred Wegener Institute for kindly providing laboratory space in Ny Alesund, Svalbard ( project KOP56; RIS ID: 3298). We are grateful to K. Imhoff, M. Meyer, and A. Schipper for technical assistance and to A. Judd, M. Holtappels, N. Finke, and W. Bach for valuable discussions. This work was supported by the Natural Sciences and Engineering Research Council of Canada ( C. H.), the Austrian Science Fund (P20185-B17; A. L.), the U.S. National Science Foundation (OCE-0323975 and OCE-0848703; C. A.), and the Max Planck Society. Nucleotide sequences have been deposited in the European Molecular Biology Laboratory database under accession numbers FN396615 to FN396795.	Alain K, 2002, INT J SYST EVOL MICR, V52, P1621, DOI 10.1099/00207713-52-5-1621; Arnosti C, 2006, GEOMICROBIOL J, V23, P551, DOI 10.1080/01490450600897336; Baas Becking LGM, 1934, GEOBIOLOGIE INLEIDIN; BARTHOLO.JW, 1966, J BACTERIOL, V92, P635, DOI 10.1128/JB.92.3.635-638.1966; Cowen JP, 2004, RES MICROBIOL, V155, P497, DOI 10.1016/j.resmic.2004.03.008; Damm E, 2005, CONT SHELF RES, V25, P1453, DOI 10.1016/j.csr.2005.03.003; Detmers J, 2001, APPL ENVIRON MICROB, V67, P888, DOI 10.1128/AEM.67.2.888-894.2001; Egorova AA, 1938, CR ACAD SCI URSS, V19, P649; Finke N, 2008, ISME J, V2, P815, DOI [10.1038/ismej.2008.20, 10.1038/ISMEJ.2008.20]; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; Huber JA, 2006, ENVIRON MICROBIOL, V8, P88, DOI 10.1111/j.1462-2920.2005.00872.x; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Hutnak M, 2008, NAT GEOSCI, V1, P611, DOI 10.1038/ngeo264; ISAKSEN MF, 1994, FEMS MICROBIOL ECOL, V14, P1; Judd A., 2007, SEABED FLUID FLOW IM, DOI 10.1017/CBO9780511535918; Knoblauch C, 1999, ENVIRON MICROBIOL, V1, P457, DOI 10.1046/j.1462-2920.1999.00061.x; Lee YJ, 2005, EXTREMOPHILES, V9, P375, DOI 10.1007/s00792-005-0453-4; MCBEE RH, 1956, J BACTERIOL, V71, P182, DOI 10.1128/JB.71.2.182-185.1956; Parkes RJ, 2007, ORG GEOCHEM, V38, P845, DOI 10.1016/j.orggeochem.2006.12.011; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Ravenschlag K, 2001, APPL ENVIRON MICROB, V67, P387, DOI 10.1128/AEM.67.1.387-395.2001; Sagemann J, 1998, GEOMICROBIOL J, V15, P85, DOI 10.1080/01490459809378067; Sahm K, 1999, ENVIRON MICROBIOL, V1, P65, DOI 10.1046/j.1462-2920.1999.00007.x; Setlow P, 2003, CURR OPIN MICROBIOL, V6, P550, DOI 10.1016/j.mib.2003.10.001; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STETTER KO, 1993, NATURE, V365, P743, DOI 10.1038/365743a0; Vandieken V, 2006, INT J SYST EVOL MICR, V56, P687, DOI 10.1099/ijs.0.64058-0	27	145	150	1	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1541	1544		10.1126/science.1174012	http://dx.doi.org/10.1126/science.1174012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762643	Green Published			2022-12-28	WOS:000269887900040
J	Dominguez-Cherit, G; Lapinsky, SE; Macias, AE; Pinto, R; Espinosa-Perez, L; de la Torre, A; Poblano-Morales, M; Baltazar-Torres, JA; Bautista, E; Martinez, A; Martinez, MA; Rivero, E; Valdez, R; Ruiz-Palacios, G; Hernandez, M; Stewart, TE; Fowler, RA				Dominguez-Cherit, Guillermo; Lapinsky, Stephen E.; Macias, Alejandro E.; Pinto, Ruxandra; Espinosa-Perez, Lourdes; de la Torre, Alethse; Poblano-Morales, Manuel; Baltazar-Torres, Jose A.; Bautista, Edgar; Martinez, Abril; Martinez, Marco A.; Rivero, Eduardo; Valdez, Rafael; Ruiz-Palacios, Guillermo; Hernandez, Martin; Stewart, Thomas E.; Fowler, Robert A.			Critically Ill Patients With 2009 Influenza A(H1N1) in Mexico	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							H5N1; MORTALITY; DISEASE	Context In March 2009, novel 2009 influenza A(H1N1) was first reported in the southwestern United States and Mexico. The population and health care system in Mexico City experienced the first and greatest early burden of critical illness. Objective To describe baseline characteristics, treatment, and outcomes of consecutive critically ill patients in Mexico hospitals that treated the majority of such patients with confirmed, probable, or suspected 2009 influenza A(H1N1). Design, Setting, and Patients Observational study of 58 critically ill patients with 2009 influenza A(H1N1) at 6 hospitals between March 24 and June 1, 2009. Demographic data, symptoms, comorbid conditions, illness progression, treatments, and clinical outcomes were collected using a piloted case report form. Main Outcome Measures The primary outcome measure was mortality. Secondary outcomes included rate of 2009 influenza (A) H1N1-related critical illness and mechanical ventilation as well as intensive care unit (ICU) and hospital length of stay. Results Critical illness occurred in 58 of 899 patients (6.5%) admitted to the hospital with confirmed, probable, or suspected 2009 influenza (A) H1N1. Patients were young (median, 44.0 [range, 10-83] years); all presented with fever and all but 1 with respiratory symptoms. Few patients had comorbid respiratory disorders, but 21 (36%) were obese. Time from hospital to ICU admission was short (median, 1 day [inter-quartile range {IQR}, 0-3 days]), and all patients but 2 received mechanical ventilation for severe acute respiratory distress syndrome and refractory hypoxemia (median day 1 ratio of PaO2 to fraction of inspired oxygen, 83 [IQR, 59-145] mm Hg). By 60 days, 24 patients had died (41.4%; 95% confidence interval, 28.9%-55.0%). Patients who died had greater initial severity of illness, worse hypoxemia, higher creatine kinase levels, higher creatinine levels, and ongoing organ dysfunction. After adjusting for a reduced opportunity of patients dying early to receive neuraminidase inhibitors, neuraminidase inhibitor treatment (vs no treatment) was associated with improved survival (odds ratio, 8.5; 95% confidence interval, 1.2-62.8). Conclusion Critical illness from 2009 influenza A(H1N1) in Mexico occurred in young individuals, was associated with severe acute respiratory distress syndrome and shock, and had a high case-fatality rate. JAMA. 2009;302(17):1880-1887	[Pinto, Ruxandra; Fowler, Robert A.] Sunnybrook Hlth Sci Ctr, Toronto, ON M5N 3M5, Canada; [Dominguez-Cherit, Guillermo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Div Pulm & Crit Care, Mexico City, DF, Mexico; [Macias, Alejandro E.; de la Torre, Alethse] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Hosp Epidemiol Dept, Mexico City, DF, Mexico; [Ruiz-Palacios, Guillermo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infect Dis, Mexico City, DF, Mexico; [Rivero, Eduardo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Crit Care Med, Mexico City, DF, Mexico; [Lapinsky, Stephen E.; Pinto, Ruxandra] Univ Toronto, Dept Med, Toronto, ON, Canada; [Lapinsky, Stephen E.; Pinto, Ruxandra; Stewart, Thomas E.; Fowler, Robert A.] Univ Toronto, Interdepartmental Div Crit Care Med, Toronto, ON, Canada; [Espinosa-Perez, Lourdes] Inst Tecnol Estud Super Monterrey, Sch Med, Monterrey, Mexico; Univ Trondheim, Toronto, ON, Canada; [Poblano-Morales, Manuel] Hosp Juarez Mexico, Mexico City, DF, Mexico; [Baltazar-Torres, Jose A.] IMSS, Hosp Especialidades Ctr Med La Raza, Mexico City, DF, Mexico; [Bautista, Edgar] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Martinez, Abril; Martinez, Marco A.] Hosp Gen Dr Manuel Gea Gonzalez, Dept Internal Med, Mexico City, DF, Mexico; [Valdez, Rafael] Hosp Gen Dr Manuel Gea Gonzalez, Infect Dis Hosp, Mexico City, DF, Mexico; [Hernandez, Martin] Hosp San Jose Tec Monterrey, Monterrey, Mexico; [Stewart, Thomas E.] Univ Toronto, Mt Sinai Hosp, Univ Hlth Network, Dept Med & Anaesthesia, Toronto, ON M5G 1X5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; University of Toronto; University of Toronto; Tecnologico de Monterrey; Instituto Mexicano del Seguro Social; Tecnologico de Monterrey; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto	Fowler, RA (corresponding author), Sunnybrook Hlth Sci Ctr, 2075 Bayview Ave D478, Toronto, ON M5N 3M5, Canada.	rob.fowler@sunnybrook.ca	Macías, Alejandro Molina/HHS-2363-2022; Lapinsky, Stephen/C-4624-2015; Ruiz-Palacios, Guillermo/GYQ-5462-2022	Lapinsky, Stephen/0000-0002-6930-0306; Dominguez-Cherit, Guillermo/0000-0003-1403-4415; BALTAZAR-TORRES, JOSE ANGEL/0000-0002-2360-7986; Macias, Alejandro/0000-0002-6573-4350				Abe M, 2006, CLIN NEPHROL, V66, P166; *AM THOR SOC, 2009, AM THOR SOC 2009 INT; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; Arabi Y, 2007, CRIT CARE MED, V35, P1397, DOI 10.1097/01.CCM.0000262940.34596.4B; *CAN CRIT CAR TRIA, INFL REL RES IN; *CAN CRIT CAR TRIA, SOC CRIT CAR MED H1N; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; *CDCP, INT GUID CAS DEF BE; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Central Intelligence Agency, WORLD FACTB FIELD LI; Christian MD, 2006, CAN MED ASSOC J, V175, P1377, DOI 10.1503/cmaj.060911; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Fowler RA, 2003, JAMA-J AM MED ASSOC, V290, P367, DOI 10.1001/jama.290.3.367; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Gruber PC, 2006, INTENS CARE MED, V32, P823, DOI 10.1007/s00134-006-0148-z; Kerr JR, 2009, J CLIN PATHOL, V62, P577, DOI 10.1136/jcp.2009.067710; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Li FCK, 2008, J EPIDEMIOL COMMUN H, V62, P555, DOI 10.1136/jech.2007.064030; Martinez Guerra M L, 1973, Prensa Med Mex, V38, P1; *MEX SCR SAL, GRAF DEF DESCR PREL; *MEX SECR SAL, SIT ACT EP; Morens DM, 2007, J INFECT DIS, V195, P1018, DOI 10.1086/511989; O'Brien JM, 2006, CRIT CARE MED, V34, P738, DOI 10.1097/01.CCM.0000202207.87891.FC; Oliveira Eduardo C, 2003, J Intensive Care Med, V18, P80, DOI 10.1177/0885066602250368; Phua J, 2009, AM J RESP CRIT CARE, V179, P220, DOI 10.1164/rccm.200805-722OC; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Public Health Agency of Canada, CAS DEF NAT SURV H1N; SIMON NM, 1970, J AMER MED ASSOC, V212, P1704, DOI 10.1001/jama.212.10.1704; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; *WHO, 2009, GLOB AL RESP GAR PAN; *WHO, 2009, INFL A H1N1 UPD 32; WHO (World Health Organization), 2011, GLOB AL RESP GAR INF; World Health Organization, WHO GLOB INF BMI OV; World Health Organization. Global alert and response (GAR), GLOB AL RESP GAR PAN	35	660	707	0	56	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 4	2009	302	17					1880	1887		10.1001/jama.2009.1536	http://dx.doi.org/10.1001/jama.2009.1536			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514DU	19822626	Bronze			2022-12-28	WOS:000271375300019
J	Zwischenberger, JB; Lynch, JE				Zwischenberger, Joseph B.; Lynch, James E.			Will CESAR answer the adult ECMO debate?	LANCET			English	Editorial Material							RESPIRATORY-DISTRESS-SYNDROME; VENTILATION		[Zwischenberger, Joseph B.] Univ Kentucky, Coll Med, Dept Surg, Lexington, KY 40536 USA; [Lynch, James E.] Univ Texas Med Branch, Galveston, TX USA	University of Kentucky; University of Texas System; University of Texas Medical Branch Galveston	Zwischenberger, JB (corresponding author), Univ Kentucky, Coll Med, Dept Surg, Lexington, KY 40536 USA.	jzwis2@uky.edu						Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Florchinger B, 2008, ANN THORAC SURG, V86, P410, DOI 10.1016/j.athoracsur.2008.04.045; MORRIS AH, 1994, AM J RESP CRIT CARE, V149, P295, DOI 10.1164/ajrccm.149.2.8306022; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; ZAPOL WM, 1979, JAMA-J AM MED ASSOC, V242, P2193, DOI 10.1001/jama.242.20.2193	5	47	49	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2009	374	9698					1307	1308		10.1016/S0140-6736(09)61630-5	http://dx.doi.org/10.1016/S0140-6736(09)61630-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MW	19762074				2022-12-28	WOS:000271254600006
J	Calonge, N; Petitti, DB; DeWitt, TG; Gregory, KD; Harris, R; Isham, G; LeFevre, ML; Loveland-Cherry, C; Marion, LN; Moyer, VA; Ockene, JK; Sawaya, GF; Siu, AL; Teutsch, SM; Yawn, BP				Calonge, Ned; Petitti, Diana B.; DeWitt, Thomas G.; Gregory, Kimberly D.; Harris, Russell; Isham, George; LeFevre, Michael L.; Loveland-Cherry, Carol; Marion, Lucy N.; Moyer, Virginia A.; Ockene, Judith K.; Sawaya, George F.; Siu, Albert L.; Teutsch, Steven M.; Yawn, Barbara P.		US Preventive Serv Task Force	Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							BEAM COMPUTED-TOMOGRAPHY; C-REACTIVE PROTEIN; ARTERY CALCIUM SCORE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; PRIMARY-CARE; EVENTS; PREDICTION; RATIONALE	Description: New recommendation from the U.S. Preventive Services Task Force (USPSTF) on the use of nontraditional, or novel, risk factors in assessing the coronary heart disease (CHD) risk of asymptomatic persons. Methods: Systematic reviews were conducted of literature since 1996 on 9 proposed nontraditional markers of CHD risk: high-sensitivity C-reactive protein, ankle-brachial index, leukocyte count, fasting blood glucose, periodontal disease, carotid intima-media thickness, coronary artery calcification score on electron-beam computed tomography, homocysteine, and lipoprotein(a). The reviews followed a hierarchical approach aimed at determining which factors could practically and definitively reassign persons assessed as intermediate-risk according to their Framingham score to either a high-risk or low-risk strata, and thereby improve outcomes by means of aggressive risk-factor modification in those newly assigned to the high-risk stratum. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of using the nontraditional risk factors studied to screen asymptomatic men and women with no history of CHD to prevent CHD events. (I statement).	[US Preventive Serv Task Force] US Prevent Serv Task Force, Agcy Healthcare Res & Qual, Rockville, MD USA; [Calonge, Ned] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Petitti, Diana B.] Arizona State Univ, Phoenix, AZ USA; [DeWitt, Thomas G.] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA; [Gregory, Kimberly D.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Harris, Russell] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Isham, George] HealthPartners, Minneapolis, MN USA; [LeFevre, Michael L.] Univ Missouri, Sch Med, Columbia, MO USA; [Loveland-Cherry, Carol] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Marion, Lucy N.] Med Coll Georgia, Augusta, GA 30912 USA; [Moyer, Virginia A.] Baylor Coll Med, Houston, TX 77030 USA; [Ockene, Judith K.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Sawaya, George F.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Siu, Albert L.] Mt Sinai Med Ctr, New York, NY 10029 USA; [Teutsch, Steven M.] Merck & Co Inc, West Point, PA USA; [Yawn, Barbara P.] Olmsted Med Ctr, Rochester, MN USA	Agency for Healthcare Research & Quality; Colorado Department of Public Health & Environment; Arizona State University; Arizona State University-Downtown Phoenix; Cincinnati Children's Hospital Medical Center; Cedars Sinai Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Missouri System; University of Missouri Columbia; University of Michigan System; University of Michigan; University System of Georgia; Augusta University; Baylor College of Medicine; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Merck & Company; Olmsted Medical Center								Achenbach S, 2002, CIRCULATION, V106, P1077, DOI 10.1161/01.CIR.0000027567.49283.FF; Arad Y, 2005, J AM COLL CARDIOL, V46, P166, DOI 10.1016/j.jacc.2005.02.089; Arad Y, 2000, J AM COLL CARDIOL, V36, P1253, DOI 10.1016/S0735-1097(00)00872-X; Bassuk SS, 2004, J WOMENS HEALTH, V13, P99, DOI 10.1089/154099904322836519; Berg AO, 2003, ANN INTERN MED, V139, P930, DOI 10.7326/0003-4819-139-11-200312020-00012; Berg AO, 2002, ANN INTERN MED, V137, P205, DOI 10.7326/0003-4819-137-3-200208060-00014; Berg AO, 2003, AM J PREV MED, V24, P93; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Calonge N, 2007, ANN INTERN MED, V147, P783, DOI 10.7326/0003-4819-147-11-200712040-00009; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Chambless LE, 2003, J CLIN EPIDEMIOL, V56, P880, DOI 10.1016/S0895-4356(03)00055-6; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; HELFAND M, 2009, EVIDENCE SYNTHESIS, V73; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Humphrey LL, 2008, MAYO CLIN PROC, V83, P1203, DOI 10.4065/83.11.1203; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; LaMonte MJ, 2005, AM J EPIDEMIOL, V162, P421, DOI 10.1093/aje/kwi228; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; MacMahon M, 2000, NUTR METAB CARDIOVAS, V10, P195; *MED COLL WI, 2009, COR HEART DIS RISK C; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; MININO AM, 2007, NATL VITAL STAT REPO, V55; National Heart Lung and Blood Institute, 2002, 3 NAT HEART LUNG BLO; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Qiao Q, 2002, EUR HEART J, V23, P1267, DOI 10.1053/euhj.2001.3113; Raggi P, 2001, AM HEART J, V141, P375, DOI 10.1067/mhj.2001.113220; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2003, CIRCULATION, V108, P2292, DOI 10.1161/01.CIR.0000100688.17280.E6; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Taylor AJ, 2005, J AM COLL CARDIOL, V46, P807, DOI 10.1016/j.jacc.2005.05.049; U.S. Preventive Services Task Force Agency for Healthcare Research and Quality, 2008, SCREEN LIP DIS AD US; van der Meer IM, 2004, CIRCULATION, V109, P1089, DOI 10.1161/01.CIR.0000120708.59903.1B; Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIONAHA.104.488916; Wong ND, 2000, AM J CARDIOL, V86, P495, DOI 10.1016/S0002-9149(00)01000-6	39	134	137	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 6	2009	151	7					474	W160		10.7326/0003-4819-151-7-200910060-00008	http://dx.doi.org/10.7326/0003-4819-151-7-200910060-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502OT	19805770				2022-12-28	WOS:000270470500005
J	Kaeberlein, M; Kapahi, P				Kaeberlein, Matt; Kapahi, Pankaj			Aging Is RSKy Business	SCIENCE			English	Editorial Material							EXTENDS LIFE-SPAN; TRANSLATION; LONGEVITY; MICE		[Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Kapahi, Pankaj] Buck Inst Age Res, Novato, CA 94945 USA	University of Washington; University of Washington Seattle; Buck Institute for Research on Aging	Kaeberlein, M (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kaeber@u.washington.edu; pkapahi@buckinstitute.org			NATIONAL INSTITUTE ON AGING [R01AG031108] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG031108] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006; Anisimov VN, 2003, BIOGERONTOLOGY, V4, P297, DOI 10.1023/A:1026299318315; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Greer EL, 2009, ANN NY ACAD SCI, V1170, P688, DOI 10.1111/j.1749-6632.2009.04019.x; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Kaeberlein M, 2009, NATURE, V460, P331, DOI 10.1038/460331a; Kaeberlein M, 2008, AGING CELL, V7, P777, DOI 10.1111/j.1474-9726.2008.00439.x; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Ruvinsky I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005618; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037	13	28	30	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 2	2009	326	5949					55	56		10.1126/science.1181034	http://dx.doi.org/10.1126/science.1181034			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797648				2022-12-28	WOS:000270355600029
J	Maxmen, A				Maxmen, Amy			Taking Risks to Transform Science	CELL			English	Editorial Material																			0	4	4	1	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 2	2009	139	1					13	15		10.1016/j.cell.2009.09.019	http://dx.doi.org/10.1016/j.cell.2009.09.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804745	Bronze			2022-12-28	WOS:000270388600007
J	Aponte, JJ; Schellenberg, D; Egan, A; Breckenridge, A; Carneiro, I; Critchley, J; Danquah, I; Dodoo, A; Kobbe, R; Lell, B; May, J; Premji, Z; Sanz, S; Sevene, E; Soulaymani-Becheikh, R; Winstanley, P; Adjei, S; Anemana, S; Chandramohan, D; Issifou, S; Mockenhaupt, F; Owusu-Agyei, S; Greenwood, B; Grobusch, MP; Kremsner, PG; Macete, E; Mshinda, H; Newman, RD; Slutsker, L; Tanner, M; Alonso, P; Menendez, C				Aponte, John J.; Schellenberg, David; Egan, Andrea; Breckenridge, Alasdair; Carneiro, Ilona; Critchley, Julia; Danquah, Ina; Dodoo, Alexander; Kobbe, Robin; Lell, Bertrand; May, Juergen; Premji, Zul; Sanz, Sergi; Sevene, Esperanza; Soulaymani-Becheikh, Rachida; Winstanley, Peter; Adjei, Samuel; Anemana, Sylvester; Chandramohan, Daniel; Issifou, Saadou; Mockenhaupt, Frank; Owusu-Agyei, Seth; Greenwood, Brian; Grobusch, Martin P.; Kremsner, Peter G.; Macete, Eusebio; Mshinda, Hassan; Newman, Robert D.; Slutsker, Laurence; Tanner, Marcel; Alonso, Pedro; Menendez, Clara			Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials	LANCET			English	Article							PLASMODIUM-FALCIPARUM; DOUBLE-BLIND; TANZANIAN INFANTS; ANTIMALARIAL TREATMENT; IRON SUPPLEMENTATION; ROUTINE VACCINATIONS; ANEMIA CONTROL; CHILDREN; HEALTH; RESISTANCE	Background Intermittent preventive treatment (IPT) is a promising strategy for malaria control in infants. We undertook a pooled analysis of the safety and efficacy of IPT in infants (IPTi) with sulfadoxine-pyrimethamine in Africa. Methods We pooled data from six double-blind, randomised, placebo-controlled trials (undertaken one each in Tanzania, Mozambique, and Gabon, and three in Ghana) that assessed the efficacy of IPTi with sulfadoxine-pyrimethamine. In all trials, IPTi or placebo was given to infants at the time of routine vaccinations delivered by WHO's Expanded Program on Immunization. Data from the trials for incidence of clinical malaria, risk of anaemia (packed-cell volume <25% or haemoglobin <80 g/L), and incidence of hospital admissions and adverse events in infants up to 12 months of age were reanalysed by use of standard outcome definitions and time periods. Analysis was by modified intention to treat, including all infants who received at least one dose of IPTi or placebo. Findings The six trials provided data for 7930 infants (IPTi, n=3958; placebo, n=3972). IPTi had a protective efficacy of 30.3% (95% CI 19.8-39.4, p<0.0001) against clinical malaria, 21.3% (8.2-32.5, p=0.002) against the risk of anaemia, 38.1% (12.5-56.2, p=0.007) against hospital admissions associated with malaria parasitaemia, and 22.9% (10.0-34.0, p=0.001) against all-cause hospital admissions. There were 56 deaths in the IPTi group compared with 53 in the placebo group (rate ratio 1.05, 95% Cl 0.72-1.54, p=0.79). One death, judged as possibly related to IPTi because it occurred 19 days after a treatment dose, was subsequently attributed to probable sepsis. Four of 676 non-fatal hospital admissions in the IPTi group were deemed related to study treatment compared with five of 860 in the placebo group. None of three serious dermatological adverse events in the IPTi group were judged related to study treatment compared with one of 13 in the placebo group. Interpretation IPTi with sulfadoxine-pyrimethamine was safe and efficacious across a range of malaria transmission settings, suggesting that this intervention is a useful contribution to malaria control.	[Tanner, Marcel] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Aponte, John J.; Egan, Andrea; Sanz, Sergi; Alonso, Pedro; Menendez, Clara] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Schellenberg, David; Carneiro, Ilona; Chandramohan, Daniel; Greenwood, Brian] London Sch Hyg & Trop Med, London WC1, England; [Breckenridge, Alasdair] Med & Healthcare Prod Regulatory Agcy, London, England; [Critchley, Julia] Newcastle Univ, Inst Hlth & Soc, Adv Res Chron Dis Epidemiol ARCHEPI Programme, Sch Populat & Hlth Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Danquah, Ina; Mockenhaupt, Frank] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany; [Dodoo, Alexander] Univ Ghana, Sch Med, Korle Bu Teaching Hosp, Ctr Trop Clin Pharmacol & Therapeut, Accra, Ghana; [Kobbe, Robin; May, Juergen] Bernhard Nocht Inst Trop Med, Res Grp Infect Dis Epidemiol, Hamburg, Germany; [Lell, Bertrand; Issifou, Saadou; Kremsner, Peter G.] Univ Tubingen, Dept Parasitol, Inst Trop Med, Tubingen, Germany; [Lell, Bertrand; Issifou, Saadou; Grobusch, Martin P.; Kremsner, Peter G.] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; [Premji, Zul] Muhimbili Univ, Coll Hlth Sci, Dept Parasitol Med Entomol, Sch Publ Hlth & Social Sci, Dar Es Salaam, Tanzania; [Sevene, Esperanza] Eduardo Mondlane Univ, Fac Med, Dept Pharmacol, Maputo, Mozambique; [Soulaymani-Becheikh, Rachida] Ctr Antipoisons & Pharmacovigilance Maroc, Rabat, Morocco; [Winstanley, Peter] Univ Liverpool, Sch Clin Sci, Liverpool L69 3BX, Merseyside, England; [Adjei, Samuel] Minist Hlth, Ghana Hlth Serv, Agona, Ashanti Region, Ghana; [Anemana, Sylvester] Minist Hlth, Ghana Hlth Serv, Secondi Takoradi, Western Region, Ghana; [Owusu-Agyei, Seth] Minist Hlth, Ghana Hlth Serv, Kintampo Hlth Res Ctr, Kintampo, Ghana; [Grobusch, Martin P.] Univ Witwatersrand, Infect Dis Unit, Div Clin Microbiol & Infect Dis, NHLS, Johannesburg, South Africa; [Grobusch, Martin P.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Macete, Eusebio; Alonso, Pedro] Ctr Invest Saude Manhica, Manhica, Mozambique; [Mshinda, Hassan] Ifakara Hlth Res Dev Ctr, Ifakara, Tanzania; [Newman, Robert D.; Slutsker, Laurence] Ctr Dis Control & Prevent, Atlanta, GA USA	University of Basel; Swiss Tropical & Public Health Institute; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of London; London School of Hygiene & Tropical Medicine; The Medicines & Healthcare Products Regulatory Agency; Newcastle University - UK; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Ghana; Bernhard Nocht Institut fur Tropenmedizin; Eberhard Karls University of Tubingen; Eduardo Mondlane University; University of Liverpool; Ghana Health Service; Ghana Health Service; Ghana Health Service; Kintampo Health Research Centre; National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; Centro de Investigacao em Saude de Manhica; Ifakara Health Institute; Centers for Disease Control & Prevention - USA	Tanner, M (corresponding author), Swiss Trop Inst, Socinstr 57,POB 4002, CH-4002 Basel, Switzerland.	marcel.tanner@unibas.ch	May, Jürgen/E-7857-2011; Alonso, Pedro L/AAZ-3645-2020; Mockenhaupt, Frank P/U-9824-2017; Menéndez, Clara/Q-3446-2016; Sanz, Sergi/AAY-7211-2020	Alonso, Pedro L/0000-0003-3292-3443; Mockenhaupt, Frank P/0000-0002-8117-5421; Menéndez, Clara/0000-0002-2641-6907; Schellenberg, David/0000-0001-8222-0186; Sanz Bravo, Sergi/0000-0001-5010-4527; Owusu-Agyei, Seth/0000-0002-0807-1781; Critchley, Julia/0000-0002-5248-4188; Danquah, Ina/0000-0003-3222-3498; May, Jurgen/0000-0001-7831-8420	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding Bill & Melinda Gates Foundation.	Alexander N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-9; Aponte JJ, 2007, PLOS MED, V4, P1259, DOI 10.1371/journal.pmed.0040242; Breman JG, 2005, J INFECT DIS, V192, P1869, DOI 10.1086/497702; Cairns M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002227; Chandramohan D, 2005, BMJ-BRIT MED J, V331, P727, DOI 10.1136/bmj.331.7519.727; Chandramohan D, 2007, TROP MED INT HEALTH, V12, P743, DOI 10.1111/j.1365-3156.2007.01844.x; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; Desai MR, 2003, J INFECT DIS, V187, P658, DOI 10.1086/367986; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Egan A, 2005, TROP MED INT HEALTH, V10, P815, DOI 10.1111/j.1365-3156.2005.01474.x; Greenwood BM, 1995, T ROY SOC TROP MED H, V89, P629, DOI 10.1016/0035-9203(95)90419-0; Grobusch MP, 2007, CURR OPIN INFECT DIS, V20, P613, DOI 10.1097/QCO.0b013e3282f1ae3b; Grobusch MP, 2007, J INFECT DIS, V196, P1595, DOI 10.1086/522160; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hutton G, 2009, B WORLD HEALTH ORGAN, V87, P123, DOI 10.2471/BLT.08.051961; Institute of Medicine, 2008, ASS ROL INT PREV TRE; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Kruger C, 2004, LANCET, V363, P2000, DOI 10.1016/S0140-6736(04)16424-6; Macete E, 2006, J INFECT DIS, V194, P276, DOI 10.1086/505431; Manzi F, 2009, T ROY SOC TROP MED H, V103, P79, DOI 10.1016/j.trstmh.2008.08.014; Marks F, 2005, J INFECT DIS, V192, P1962, DOI 10.1086/497698; Massaga JJ, 2003, LANCET, V361, P1853, DOI 10.1016/S0140-6736(03)13504-0; May J, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-198; Mayor A, 2008, J INFECT DIS, V197, P1737, DOI 10.1086/588144; Menendez C, 1997, LANCET, V350, P844, DOI 10.1016/S0140-6736(97)04229-3; Menendez C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-132; MENON A, 1990, T ROY SOC TROP MED H, V84, P768, DOI 10.1016/0035-9203(90)90071-L; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; Munday S, 2007, J PAEDIATR CHILD H, V43, P424, DOI 10.1111/j.1440-1754.2007.01105.x; O'Meara Wendy Prudhomme, 2005, Malar J, V4, P33, DOI 10.1186/1475-2875-4-33; OTOO LN, 1989, T ROY SOC TROP MED H, V83, P778, DOI 10.1016/0035-9203(89)90324-6; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; Pool R, 2006, TROP MED INT HEALTH, V11, P1670, DOI 10.1111/j.1365-3156.2006.01725.x; *ROCH LAB INC, 2009, FANS SUF PYR PROD IN; Rosen JB, 2004, LANCET, V363, P1386, DOI 10.1016/S0140-6736(04)16052-2; Schellenberg D, 2006, CURR MOL MED, V6, P253, DOI 10.2174/156652406776055168; Schellenberg D, 2005, LANCET, V365, P1481, DOI 10.1016/S0140-6736(05)66418-5; Schellenberg D, 2002, AM J TROP MED HYG, V67, P17, DOI 10.4269/ajtmh.2002.67.17; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Schellenberg D, 2006, TRENDS PARASITOL, V22, P296, DOI 10.1016/j.pt.2006.05.006; SMITH T, 1994, STAT MED, V13, P2345, DOI 10.1002/sim.4780132206; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; ter Kuile FO, 2006, J INFECT DIS, V194, P269, DOI 10.1086/505434; Uppsala Monitoring Centre World Health Organization., 2000, SAF MON MED PROD GUI; Verhoef H, 2002, LANCET, V360, P908, DOI 10.1016/S0140-6736(02)11027-0; *WHO, 2004, AFRMAL0401 WHO DEM R; *WHO EXP COMM MAL, 2000, 20 WHO EXP COMM MAL; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	50	155	156	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2009	374	9700					1533	1542		10.1016/S0140-6736(09)61258-7	http://dx.doi.org/10.1016/S0140-6736(09)61258-7			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517CS	19765816	Green Submitted			2022-12-28	WOS:000271591300032
J	Roland, M; Elliott, M; Lyratzopoulos, G; Barbiere, J; Parker, RA; Smith, P; Bower, P; Campbell, J				Roland, Martin; Elliott, Marc; Lyratzopoulos, Georgios; Barbiere, Josephine; Parker, Richard A.; Smith, Patten; Bower, Peter; Campbell, John			Reliability of patient responses in pay for performance schemes: analysis of national General Practitioner Patient Survey data in England	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEASURING PATIENTS EXPERIENCES; NONRESPONSE RATES; PRIMARY-CARE; HEALTH-CARE; QUALITY; PHYSICIANS; BIAS; CAHPS(R); IMPACT	Objective To assess the robustness of patient responses to a new national survey of patient experience as a basis for providing financial incentives to doctors. Design Analysis of the representativeness of the respondents to the GP Patient Survey compared with those who were sampled (5.5 million patients registered with 8273 general practices in England in January 2009) and with the general population. Analysis of non-response bias looked at the relation between practice response rates and scores on the survey. Analysis of the reliability of the survey estimated the proportion of the variance of practice scores attributable to true differences between practices. Results The overall response rate was 38.2% (2.2 million responses), which is comparable to that in surveys using similar methodology in the UK. Men, young adults, and people living in deprived areas were under-represented among respondents. However, for questions related to pay for performance, there was no systematic association between response rates and questionnaire scores. Two questions which triggered payments to general practitioners were reliable measures of practice performance, with average practice-level reliability coefficients of 93.2% and 95.0%. Less than 3% and 0.5% of practices had fewer than the number of responses required to achieve conventional reliability levels of 90% and 70%. A change to the payment formula in 2009 resulted in an increase in the average impact of random variation in patient scores on payments to general practitioners compared with payments made in 2007 and 2008. Conclusions There is little evidence to support the concern of some general practitioners that low response rates and selective non-response bias have led to systematic unfairness in payments attached to questionnaire scores. The study raises issues relating to the validity and reliability of payments based on patient surveys and provides lessons for the UK and for other countries considering the use of patient experience as part of pay for performance schemes.	[Roland, Martin; Lyratzopoulos, Georgios; Barbiere, Josephine; Parker, Richard A.] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England; [Elliott, Marc] RAND Corp, Santa Monica, CA 90401 USA; [Campbell, John] Peninsula Med Sch, Exeter EX1 2LU, Devon, England; [Bower, Peter] Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; [Smith, Patten] Ipsos MORI, London SE1 1FY, England	University of Cambridge; RAND Corporation; University of Exeter; University of Manchester	Roland, M (corresponding author), Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England.	mr108@cam.ac.uk	Bower, Peter/A-1508-2011; Campbell, John/A-5792-2011; Lyratzopoulos, Georgios/O-8260-2019; Lyratzopoulos, Georgios/B-6301-2012	Bower, Peter/0000-0001-9558-3349; Campbell, John/0000-0002-6752-3493; Lyratzopoulos, Georgios/0000-0002-2873-7421; Roland, Martin/0000-0002-8533-3060	Department of Health	Department of Health	The study was funded with a grant from the Department of Health. The opinions expressed are those of the authors and not of the department. All authors had full access to the data and take responsibility for the accuracy of the data analysis. The Department of Health was not involved in the analysis of the data.	Angus VC, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-21; [Anonymous], [No title captured]; Benavent Jaume, 2009, Qual Prim Care, V17, P123; Bower P, 2003, BRIT J GEN PRACT, V53, P126; CAMPBELL J, 2009, DEV NATL GP PATIENT; Campbell SA, 2008, ANN FAM MED, V6, P228, DOI 10.1370/afm.844; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Chapple A, 2002, SOC SCI MED, V54, P1215, DOI 10.1016/S0277-9536(01)00091-0; Checkland K, 2008, SOCIOL HEALTH ILL, V30, P788, DOI 10.1111/j.1467-9566.2008.01081.x; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Elliott MN, 2009, HEALTH SERV RES, V44, P501, DOI 10.1111/j.1475-6773.2008.00914.x; Elliott MN, 2005, HEALTH SERV RES, V40, P2096, DOI 10.1111/j.1475-6773.2005.00476.x; GIORDANO LA, 2009, MED CARE RES REV; GLORDANO LA, 2009, MED CARE RES REV, DOI DOI 10.1177/1077558709341065; Goldstein E, 2001, HEALTH CARE FINANC R, V22, P101; Greco M, 2001, Aust Fam Physician, V30, P1096; GROVES R, 2004, WILEY SERIES SURVEY; Groves RM, 2008, PUBLIC OPIN QUART, V72, P167, DOI 10.1093/poq/nfn011; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; HAYS RD, 1999, CONSUMER ASSESSME S3, V37, pMS22; *IPS MORI, GP PAT SURV ACC SUMM; *IPS MORI, NAT GP PAT SURV ACC; *IPS MORI, GP PAT SURV 2009 TEC; Kahn KL, 2003, HEALTH SERV RES, V38, P1579, DOI 10.1111/j.1475-6773.2003.00194.x; Mead N, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-13; Mead N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3450; Richards SH, 2003, HEALTH SOC CARE COMM, V11, P510, DOI 10.1046/j.1365-2524.2003.00457.x; Robinson JC, 2009, INQUIRY-J HEALTH CAR, V46, P172, DOI 10.5034/inquiryjrnl_46.02.172; Rodriguez HP, 2009, MED CARE, V47, P835, DOI 10.1097/MLR.0b013e318197b1e1; Rodriguez HP, 2009, AM J MED QUAL, V24, P35, DOI 10.1177/1062860608326418; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Rosenthal MB, 2004, HEALTH AFFAIR, V23, P127, DOI 10.1377/hlthaff.23.2.127; Rosenthal MB, 2006, NEW ENGL J MED, V355, P1895, DOI 10.1056/NEJMsa063682; Safran DG, 2001, J FAM PRACTICE, V50, P130; Safran DG, 2006, J GEN INTERN MED, V21, P13, DOI 10.1111/j.1525-1497.2005.00311.x; Scott IA, 2007, MED J AUSTRALIA, V187, P31, DOI 10.5694/j.1326-5377.2007.tb01111.x; Wensing M, 2004, HEALTH POLICY, V68, P353, DOI 10.1016/j.healthpol.2003.10.010; Wensing M, 2008, HEALTH EXPECT, V11, P384, DOI 10.1111/j.1369-7625.2008.00507.x; Williams B, 1998, SOC SCI MED, V47, P1351, DOI 10.1016/S0277-9536(98)00213-5	40	104	106	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 29	2009	339								b3851	10.1136/bmj.b3851	http://dx.doi.org/10.1136/bmj.b3851			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	502KX	19808811	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000270459600003
J	Byrne, S; Dundas, CM; Kennedy, MR; Mellon, MT; McEwen, AS; Cull, SC; Daubar, IJ; Shean, DE; Seelos, KD; Murchie, SL; Cantor, BA; Arvidson, RE; Edgett, KS; Reufer, A; Thomas, N; Harrison, TN; Posiolova, LV; Seelos, FP				Byrne, Shane; Dundas, Colin M.; Kennedy, Megan R.; Mellon, Michael T.; McEwen, Alfred S.; Cull, Selby C.; Daubar, Ingrid J.; Shean, David E.; Seelos, Kimberly D.; Murchie, Scott L.; Cantor, Bruce A.; Arvidson, Raymond E.; Edgett, Kenneth S.; Reufer, Andreas; Thomas, Nicolas; Harrison, Tanya N.; Posiolova, Liliya V.; Seelos, Frank P.			Distribution of Mid-Latitude Ground Ice on Mars from New Impact Craters	SCIENCE			English	Article							NEAR-SURFACE; STABILITY; DYNAMICS; HYDROGEN; BEHAVIOR; ODYSSEY; WATER; DUST; H2O	New impact craters at five sites in the martian mid-latitudes excavated material from depths of decimeters that has a brightness and color indicative of water ice. Near-infrared spectra of the largest example confirm this composition, and repeated imaging showed fading over several months, as expected for sublimating ice. Thermal models of one site show that millimeters of sublimation occurred during this fading period, indicating clean ice rather than ice in soil pores. Our derived ice-table depths are consistent with models using higher long-term average atmospheric water vapor content than present values. Craters at most of these sites may have excavated completely through this clean ice, probing the ice table to previously unsampled depths of meters and revealing substantial heterogeneity in the vertical distribution of the ice itself.	[Byrne, Shane; Dundas, Colin M.; McEwen, Alfred S.; Daubar, Ingrid J.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Kennedy, Megan R.; Shean, David E.; Cantor, Bruce A.; Edgett, Kenneth S.; Harrison, Tanya N.; Posiolova, Liliya V.] Malin Space Sci Syst, San Diego, CA 92191 USA; [Mellon, Michael T.] Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80303 USA; [Cull, Selby C.; Arvidson, Raymond E.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Seelos, Kimberly D.; Murchie, Scott L.; Seelos, Frank P.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Reufer, Andreas; Thomas, Nicolas] Univ Bern, Inst Phys, Bern, Switzerland	University of Arizona; University of Colorado System; University of Colorado Boulder; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Bern	Byrne, S (corresponding author), Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA.	shane@lpl.arizona.edu	Byrne, Shane/B-8104-2012; Mellon, Michael/C-3456-2016; Seelos, Frank/C-7875-2016; Seelos, Kimberly D/F-4647-2015; Murchie, Scott L/E-8030-2015; Daubar, Ingrid/N-1408-2013; Harrison, Tanya N./AAH-4918-2020; Thomas, Nicolas/G-4693-2015	Seelos, Frank/0000-0001-9721-941X; Seelos, Kimberly D/0000-0001-7236-0580; Murchie, Scott L/0000-0002-1616-8751; Edgett, Kenneth/0000-0001-7197-5751; Dundas, Colin/0000-0003-2343-7224; Shean, David/0000-0003-3840-3860; Daubar, Ingrid/0000-0001-9790-2972; Thomas, Nicolas/0000-0002-0146-0071	NASA Mars Reconnaissance Orbiter (MRO) project	NASA Mars Reconnaissance Orbiter (MRO) project	Funding for this work was provided by the NASA Mars Reconnaissance Orbiter (MRO) project. We thank the CTX, HiRISE, CRISM, and MRO-operations teams for the (time-critical) acquisition of these data and three reviewers for their helpful comments.	Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Cantor BA, 2007, ICARUS, V186, P60, DOI 10.1016/j.icarus.2006.08.019; Chamberlain MA, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002801; Diez B, 2008, ICARUS, V196, P409, DOI 10.1016/j.icarus.2008.02.006; Feldman WC, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002160; FELDMAN WC, 1993, J GEOPHYS RES-PLANET, V98, P20855, DOI 10.1029/93JE02325; Feldman WC, 2002, SCIENCE, V297, P75, DOI 10.1126/science.1073541; FISCHER EM, 1993, ICARUS, V102, P185, DOI 10.1006/icar.1993.1043; Fisher DA, 2005, ICARUS, V179, P387, DOI 10.1016/j.icarus.2005.07.024; Fouchet T, 2007, ICARUS, V190, P32, DOI 10.1016/j.icarus.2007.03.003; Holt JW, 2008, SCIENCE, V322, P1235, DOI 10.1126/science.1164246; KIEFFER HH, 1990, J GEOPHYS RES-SOLID, V95, P1481, DOI 10.1029/JB095iB02p01481; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Malin MC, 2006, SCIENCE, V314, P1573, DOI 10.1126/science.1135156; Malin MC, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002808; MCEWEN AS, 2007, J GEOPHYS RES-PLANET, V112, DOI DOI 10.1029/2005JE002605; MELLON MT, 1995, J GEOPHYS RES-PLANET, V100, P11781, DOI 10.1029/95JE01027; Mellon MT, 2004, ICARUS, V169, P324, DOI 10.1016/j.icarus.2003.10.022; MELLON MT, 1993, J GEOPHYS RES-PLANET, V98, P3345, DOI 10.1029/92JE02355; MELLON MT, 2009, LUNAR PLANET SCI C, V40, P1904; Miller RD, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001873; Mitrofanov I, 2002, SCIENCE, V297, P78, DOI 10.1126/science.1073616; MOORE HJ, 1979, J GEOPHYS RES, V84, P8365, DOI 10.1029/JB084iB14p08365; Murchie S, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002682; Mustard JF, 2001, NATURE, V412, P411, DOI 10.1038/35086515; PAIGE DA, 1992, NATURE, V356, P43, DOI 10.1038/356043a0; Plaut JJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036379; Rempel AW, 2004, J FLUID MECH, V498, P227, DOI 10.1017/S0022112003006761; Schorghofer N, 2007, NATURE, V449, P192, DOI 10.1038/nature06082; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Smith PH, 2009, SCIENCE, V325, P58, DOI 10.1126/science.1172339; SQUYRES SW, 1986, SCIENCE, V231, P249, DOI 10.1126/science.231.4735.249	32	227	229	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1674	1676		10.1126/science.1175307	http://dx.doi.org/10.1126/science.1175307			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779195				2022-12-28	WOS:000270131800041
J	Du, X; Skachko, I; Duerr, F; Luican, A; Andrei, EY				Du, Xu; Skachko, Ivan; Duerr, Fabian; Luican, Adina; Andrei, Eva Y.			Fractional quantum Hall effect and insulating phase of Dirac electrons in graphene	NATURE			English	Article							MAGNETIC-FIELDS	In graphene, which is an atomic layer of crystalline carbon, two of the distinguishing properties of the material are the charge carriers' two-dimensional and relativistic character. The first experimental evidence of the two-dimensional nature of graphene came from the observation of a sequence of plateaus in measurements of its transport properties in the presence of an applied magnetic field(1,2). These are signatures of the so-called integer quantum Hall effect. However, as a consequence of the relativistic character of the charge carriers, the integer quantum Hall effect observed in graphene is qualitatively different from its semiconductor analogue(3). As a third distinguishing feature of graphene, it has been conjectured that interactions and correlations should be important in this material, but surprisingly, evidence of collective behaviour in graphene is lacking. In particular, the quintessential collective quantum behaviour in two dimensions, the fractional quantum Hall effect (FQHE), has so far resisted observation in graphene despite intense efforts and theoretical predictions of its existence(4-9). Here we report the observation of the FQHE in graphene. Our observations are made possible by using suspended graphene devices probed by two-terminal charge transport measurements(10). This allows us to isolate the sample from substrate-induced perturbations that usually obscure the effects of interactions in this system and to avoid effects of finite geometry. At low carrier density, we find a field-induced transition to an insulator that competes with the FQHE, allowing its observation only in the highest quality samples. We believe that these results will open the door to the physics of FQHE and other collective behaviour in graphene.	[Du, Xu; Skachko, Ivan; Duerr, Fabian; Luican, Adina; Andrei, Eva Y.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick	Andrei, EY (corresponding author), Rutgers State Univ, Dept Phys & Astron, POB 849, Piscataway, NJ 08855 USA.	eandrei@physics.rutgers.edu	Luican-Mayer, Adina/AAO-1111-2020	Luican-Mayer, Adina/0000-0001-9537-4600	 [DE-FG02-99ER45742];  [NSF-DMR-045673]	; 	Work was supported by DE-FG02-99ER45742 and partially supported by NSF-DMR-045673. We thank J. Jain, D. Abanin, L. Levitov, A. Akhmerov, V. Falko and H. Fertig, for discussions.	Abanin DA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.196806; Abanin DA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035416; Alicea J, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075422; BOEBINGER GS, 1987, PHYS REV B, V36, P7919, DOI 10.1103/PhysRevB.36.7919; Bolotin KI, 2008, SOLID STATE COMMUN, V146, P351, DOI 10.1016/j.ssc.2008.02.024; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Checkelsky JG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.206801; Du X, 2008, NAT NANOTECHNOL, V3, P491, DOI 10.1038/nnano.2008.199; Goerbig MO, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.241405; Gorbar EV, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085437; JAIN JK, 1989, PHYS REV LETT, V63, P199, DOI 10.1103/PhysRevLett.63.199; Khveshchenko DV, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.153405; Li GH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.176804; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Peres NMR, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125411; POPLAVSKYY O, 2009, LOCAL DENSITY STATES; Shibata N, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235426; Shimshoni E, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.206408; Toke C, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.235417; WAKABAYASHI JI, 1978, J PHYS SOC JPN, V44, P1839, DOI 10.1143/JPSJ.44.1839; XIN W, 2005, PHYS REV B, V72, P5325; Yang K, 2007, SOLID STATE COMMUN, V143, P27, DOI 10.1016/j.ssc.2007.03.051; Yang K, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.075423; Zhang Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.136806; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235	28	704	721	10	343	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 12	2009	462	7270					192	195		10.1038/nature08522	http://dx.doi.org/10.1038/nature08522			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	517YM	19829294	Green Submitted			2022-12-28	WOS:000271655100037
J	Roy, R; Kozlov, AG; Lohman, TM; Ha, T				Roy, Rahul; Kozlov, Alexander G.; Lohman, Timothy M.; Ha, Taekjip			SSB protein diffusion on single-stranded DNA stimulates RecA filament formation	NATURE			English	Article							ESCHERICHIA-COLI; BINDING-PROTEIN; HOMOLOGOUS RECOMBINATION; GENETIC-RECOMBINATION; MOLECULE FRET; COMPLEXES; REPAIR; MECHANISM; SSDNA; MODES	Single-stranded DNA generated in the cell during DNA metabolism is stabilized and protected by binding of ssDNA-binding (SSB) proteins. Escherichia coli SSB, a representative homotetrameric SSB, binds to ssDNA by wrapping the DNA using its four subunits. However, such a tightly wrapped, high-affinity protein-DNA complex still needs to be removed or repositioned quickly for unhindered action of other proteins. Here we show, using single-molecule two- and three-colour fluorescence resonance energy transfer, that tetrameric SSB can spontaneously migrate along ssDNA. Diffusional migration of SSB helps in the local displacement of SSB by an elongating RecA filament. SSB diffusion also melts short DNA hairpins transiently and stimulates RecA filament elongation on DNA with secondary structure. This observation of diffusional movement of a protein on ssDNA introduces a new model for how an SSB protein can be redistributed, while remaining tightly bound to ssDNA during recombination and repair processes.	[Roy, Rahul; Ha, Taekjip] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Roy, Rahul; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Roy, Rahul; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Kozlov, Alexander G.; Lohman, Timothy M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Washington University (WUSTL); Howard Hughes Medical Institute	Ha, T (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	tjha@illinois.edu	Roy, Rahul/D-5329-2009; Ha, Taekjip/B-9506-2009; Roy, Rahul/Y-5878-2019	Roy, Rahul/0000-0003-3329-8803; Ha, Taekjip/0000-0003-2195-6258; Roy, Rahul/0000-0003-3329-8803	National Institutes of Health; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065367, R01GM030498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Joo, S. A. McKinney, I. Rasnik, S. Hohng and S. Myong for experimental help and discussion; C. Murphy, M. Nahas and K. Raghunathan for discussion; T. Ho and A. Niedziela- Majka for help with DNA and protein preparation, respectively; and R. Porter for the SSB expression plasmid. T. H. is an employee of the Howard Hughes Medical Institute. These studies were supported by grants from the National Institutes of Health and the National Science Foundation.	Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; BUJALOWSKI W, 1987, J MOL BIOL, V195, P897, DOI 10.1016/0022-2836(87)90493-1; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; CLENDENNING JB, 1994, BIOPHYS CHEM, V52, P227, DOI 10.1016/0301-4622(94)00036-J; Eggington JM, 2006, BIOCHEMISTRY-US, V45, P14490, DOI 10.1021/bi061178m; ENNIS DG, 1987, GENETICS, V115, P11; GLASSBERG J, 1979, J BACTERIOL, V140, P14, DOI 10.1128/JB.140.1.14-19.1979; GLIKIN GC, 1983, NATURE, V303, P770, DOI 10.1038/303770a0; GOLUB EI, 1983, P NATL ACAD SCI-BIOL, V80, P1401, DOI 10.1073/pnas.80.5.1401; GRIFFITH JD, 1984, COLD SPRING HARB SYM, V49, P553, DOI 10.1101/SQB.1984.049.01.062; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Hohng S, 2004, BIOPHYS J, V87, P1328, DOI 10.1529/biophysj.104.043935; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kozlov AG, 2002, BIOCHEMISTRY-US, V41, P11611, DOI 10.1021/bi020361m; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Kuznetsov SV, 2006, J MOL BIOL, V359, P55, DOI 10.1016/j.jmb.2006.02.070; Lecointe F, 2007, EMBO J, V26, P4239, DOI 10.1038/sj.emboj.7601848; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; MEYER RR, 1990, MICROBIOL REV, V54, P342, DOI 10.1128/MMBR.54.4.342-380.1990; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; MUNIYAPPA K, 1984, P NATL ACAD SCI-BIOL, V81, P2757, DOI 10.1073/pnas.81.9.2757; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Richard DJ, 2008, NATURE, V453, P677, DOI 10.1038/nature06883; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; ROMER R, 1984, BIOCHEMISTRY-US, V23, P6132; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Roy R, 2007, J MOL BIOL, V369, P1244, DOI 10.1016/j.jmb.2007.03.079; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Sun WL, 1998, J MOL BIOL, V276, P689, DOI 10.1006/jmbi.1997.1471; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875	41	200	202	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1092	1097		10.1038/nature08442	http://dx.doi.org/10.1038/nature08442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19820696	Green Accepted			2022-12-28	WOS:000270987600037
J	Verbiscer, AJ; Skrutskie, MF; Hamilton, DP				Verbiscer, Anne J.; Skrutskie, Michael F.; Hamilton, Douglas P.			Saturn's largest ring	NATURE			English	Article							DARK SIDE; IAPETUS; PHOEBE; SATELLITES; HYPERION; LAPETUS; DUST	Most planetary rings in the Solar System lie within a few radii of their host body, because at these distances gravitational accelerations inhibit satellite formation. The best known exceptions are Jupiter's gossamer rings(1) and Saturn's E ring, broad sheets of dust that extend outward until they fade from view at five to ten planetary radii. Source satellites continuously supply the dust, which is subsequently lost in collisions or by radial transport. Here we report that Saturn has an enormous ring associated with its outer moon Phoebe, extending from at least 128R(S) to 207R(S) ( Saturn's radius R(S) is 60,330 km). The ring's vertical thickness of 40R(S) matches the range of vertical motion of Phoebe along its orbit. Dynamical considerations argue that these ring particles span the Saturnian system from the main rings to the edges of interplanetary space. The ring's normal optical depth of similar to 2 x 10(-8) is comparable to that of Jupiter's faintest gossamer ring, although its particle number density is several hundred times smaller. Repeated impacts on Phoebe, from both interplanetary and circumplanetary particle populations, probably keep the ring populated with material. Ring particles smaller than centimetres in size slowly migrate inward(2,3) and many of them ultimately strike the dark leading face of Iapetus.	[Verbiscer, Anne J.; Skrutskie, Michael F.] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Hamilton, Douglas P.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	University of Virginia; University System of Maryland; University of Maryland College Park	Verbiscer, AJ (corresponding author), Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA.	verbiscer@virginia.edu			NASA through an award issued by JPL/Caltech	NASA through an award issued by JPL/Caltech	This work is based on observations made with the Spitzer Space Telescope, which is operated by the Jet Propulsion Laboratory, California Institute of Technology under a contract with NASA. Support for this work was provided by NASA through an award issued by JPL/Caltech.	BURATTI BJ, 1995, ICARUS, V115, P219, DOI 10.1006/icar.1995.1093; Buratti BJ, 2005, ICARUS, V175, P490, DOI 10.1016/j.icarus.2004.11.024; Buratti BJ, 2002, ICARUS, V155, P375, DOI 10.1006/icar.2001.6730; Burns JA, 1999, SCIENCE, V284, P1146, DOI 10.1126/science.284.5417.1146; Burns JA, 1996, ASTR SOC P, V104, P179; Clark RN, 2005, NATURE, V435, P66, DOI 10.1038/nature03558; Cruikshank DP, 2008, ICARUS, V193, P334, DOI 10.1016/j.icarus.2007.04.036; CRUIKSHANK DP, 1983, ICARUS, V53, P90, DOI 10.1016/0019-1035(83)90023-4; Hamilton DP, 2008, NATURE, V453, P72, DOI 10.1038/nature06886; Hamilton DP, 1996, ICARUS, V119, P153, DOI 10.1006/icar.1996.0008; HAMILTON DP, 1993, ICARUS, V101, P244, DOI 10.1006/icar.1993.1022; Jarvis KS, 2000, ICARUS, V146, P125, DOI 10.1006/icar.2000.6311; Nesvorny D, 2003, ASTRON J, V126, P398, DOI 10.1086/375461; Porco CC, 2005, SCIENCE, V307, P1237, DOI 10.1126/science.1107981; Soter S., 1974, IAU C, V28; Vilas F, 1996, ICARUS, V124, P262, DOI 10.1006/icar.1996.0202	16	93	95	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 22	2009	461	7267					1098	1100		10.1038/nature08515	http://dx.doi.org/10.1038/nature08515			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19812546				2022-12-28	WOS:000270987600038
J	Sereno, PC; Tan, L; Brusatte, SL; Kriegstein, HJ; Zhao, XJ; Cloward, K				Sereno, Paul C.; Tan, Lin; Brusatte, Stephen L.; Kriegstein, Henry J.; Zhao, Xijin; Cloward, Karen			Tyrannosaurid Skeletal Design First Evolved at Small Body Size	SCIENCE			English	Article							THEROPOD DINOSAURS; CRANIAL ANATOMY; NORTH-AMERICA; MECHANICS; POSITION; ENGLAND; LENGTH; CHINA	Nearly all of the large-bodied predators (>2.5 tons) on northern continents during the Late Cretaceous were tyrannosaurid dinosaurs. We show that their most conspicuous functional specializations-a proportionately large skull, incisiform premaxillary teeth, expanded jaw-closing musculature, diminutive forelimbs, and hindlimbs with cursorial proportions-were present in a new, small-bodied, basal tyrannosauroid from Lower Cretaceous rocks in northeastern China. These specializations, which were later scaled up in Late Cretaceous tyrannosaurids with body masses approaching 100 times greater, drove the most dominant radiation of macropredators of the Mesozoic.	[Sereno, Paul C.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Tan, Lin] Bur Land & Resources, Long Hao Inst Geol & Paleontol, Hohhot 010010, Peoples R China; [Brusatte, Stephen L.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Zhao, Xijin] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; [Cloward, Karen] Western Paleontol Labs, Lehi, UT 84043 USA	University of Chicago; American Museum of Natural History (AMNH); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Sereno, PC (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	dinosaur@uchicago.edu	Brusatte, Stephen/O-9663-2014	Brusatte, Stephen/0000-0001-7525-7319	Whitten-Newman Foundation; National Geographic Society	Whitten-Newman Foundation; National Geographic Society(National Geographic Society)	For final drafts of all figures, we thank C. Abraczinskas. For preparation of fossil material, we thank personnel of the Western Paleontological Laboratories and the Fossil Lab at the University of Chicago. For assistance with computed tomography imaging, we thank C. Straus and C. Wietholt; for preparation of paleohistologic sections, we thank E. Lamm and D. Varricchio. For examination of fossil material in their care, we thank X. Xu, M. Norell, and S. Hutt. Supported by the Whitten-Newman Foundation and the National Geographic Society (to P. C. S.). This is Publication 3 of the Chinese-American Dinosaur Expeditions.	Benson RBJ, 2008, J VERTEBR PALEONTOL, V28, P732, DOI 10.1671/0272-4634(2008)28[732:NIOSAT]2.0.CO;2; Brochu C., 2002, J VERTEBRATE PALEO S, V7, P1, DOI DOI 10.1671/0272-4634(2002)022[0001:ARAOPA]2.0.CO;2; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Franzosa J.W., 2004, THESIS U TEXAS AUSTI; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; Hopson J.A., 1979, P39; Hurum JH, 2003, ACTA PALAEONTOL POL, V48, P161; Hutt S, 2001, CRETACEOUS RES, V22, P227, DOI 10.1006/cres.2001.0252; Larsson HCE, 2000, J VERTEBR PALEONTOL, V20, P615, DOI 10.1671/0272-4634(2000)020[0615:FEANTD]2.0.CO;2; Li DQ, 2010, P ROY SOC B-BIOL SCI, V277, P183, DOI 10.1098/rspb.2009.0249; Matthew WD, 1923, AM MUS NOVIT, V89, P1, DOI [10.5281/zenodo.4715537, DOI 10.5281/ZENODO.4715537]; Middleton KM, 2000, ZOOL J LINN SOC-LOND, V128, P149; Rauhut O, 2008, J VERTEBR PALEONTOL, V28, p130A; Rauhut OWM, 2003, PALAEONTOLOGY, V46, P903, DOI 10.1111/1475-4983.00325; Rayfield EJ, 2005, ZOOL J LINN SOC-LOND, V144, P309, DOI 10.1111/j.1096-3642.2005.00176.x; Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2; SERENO PC, 2005, PHYLOINFORMATICS, V8, P1, DOI DOI 10.5281/ZENODO.59797; Smith A. G., 1994, ATLAS MESOZOIC CENOZ, P1; Snively E, 2006, ACTA PALAEONTOL POL, V51, P435; Stokstad E, 2004, SCIENCE, V306, P211; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; Zelenitsky DK, 2009, P ROY SOC B-BIOL SCI, V276, P667, DOI 10.1098/rspb.2008.1075	27	70	76	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					418	422		10.1126/science.1177428	http://dx.doi.org/10.1126/science.1177428			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19762599				2022-12-28	WOS:000270818600051
J	Swaminathan, MS				Swaminathan, M. S.			Norman E. Borlaug (1914-2009) OBITUARY	NATURE			English	Biographical-Item									[Swaminathan, M. S.] Int Rice Res Inst, Manila 1099, Philippines	CGIAR; International Rice Research Institute (IRRI)	Swaminathan, MS (corresponding author), MS Swaminathan Res Fdn, 3rd Cross St,Taramani Inst Area, Madras 600113, Tamil Nadu, India.	chairman@mssrf.res.in							0	13	13	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					894	894		10.1038/461894a	http://dx.doi.org/10.1038/461894a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19829366				2022-12-28	WOS:000270817700031
J	Wang, YL; Juranek, S; Li, HT; Sheng, G; Wardle, GS; Tuschl, T; Patel, DJ				Wang, Yanli; Juranek, Stefan; Li, Haitao; Sheng, Gang; Wardle, Greg S.; Tuschl, Thomas; Patel, Dinshaw J.			Nucleation, propagation and cleavage of target RNAs in Ago silencing complexes	NATURE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; RECOGNITION; ARGONAUTE; DNA; MESSENGER; RISC; MECHANISMS; SLICER; INTERFERENCE	The slicer activity of the RNA-induced silencing complex resides within its Argonaute (Ago) component, in which the PIWI domain provides the catalytic residues governing guide-strand mediated site-specific cleavage of target RNA. Here we report on structures of ternary complexes of Thermus thermophilus Ago catalytic mutants with 5'-phosphorylated 21-nucleotide guide DNA and complementary target RNAs of 12, 15 and 19 nucleotides in length, which define the molecular basis for Mg2+-facilitated site-specific cleavage of the target. We observe pivot-like domain movements within the Ago scaffold on proceeding from nucleation to propagation steps of guide-target duplex formation, with duplex zippering beyond one turn of the helix requiring the release of the 3'-end of the guide from the PAZ pocket. Cleavage assays on targets of various lengths supported this model, and sugar-phosphate-backbone-modified target strands showed the importance of structural and catalytic divalent metal ions observed in the crystal structures.	[Wang, Yanli; Li, Haitao; Sheng, Gang; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Juranek, Stefan; Wardle, Greg S.; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Rockefeller University	Patel, DJ (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	ttuschl@mail.rockefeller.edu; pateld@mskcc.org	Li, Haitao/B-2668-2012; wang, yanli/G-3306-2010	Li, Haitao/0000-0001-6741-293X; Wang, Yanli/0000-0002-5969-1745	National Institutes of Health (NIH); Starr Foundation; Howard Hughes Medical Institute (HHMI); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068476] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was supported by funds from the National Institutes of Health (NIH) and the Starr Foundation to D. J. P., and from the NIH, Starr Foundation and the Howard Hughes Medical Institute (HHMI) to T. T. We would like to thank the staff of NE-CAT beam lines at the Advanced Photon Source (APS), Argonne National Laboratory, and the X-29 beamline at the Brookhaven National Laboratory, supported by the US Department of Energy, for assistance with data collection. We thank Z. Wang for assistance with X-ray data collection at the APS.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGERS PMJ, 1978, P NATL ACAD SCI USA, V75, P4798, DOI 10.1073/pnas.75.10.4798; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; de Fougerolles A, 2007, NAT REV DRUG DISCOV, V6, P443, DOI 10.1038/nrd2310; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Freier SM, 1997, NUCLEIC ACIDS RES, V25, P4429, DOI 10.1093/nar/25.22.4429; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Parker JS, 2009, MOL CELL, V33, P204, DOI 10.1016/j.molcel.2008.12.012; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488; Patel DJ, 2006, COLD SPRING HARB SYM, V71, P81, DOI 10.1101/sqb.2006.71.053; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Thorogood H, 1996, J BIOL CHEM, V271, P8855, DOI 10.1074/jbc.271.15.8855; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tonelli M, 2003, BIOPHYS J, V85, P2525, DOI 10.1016/S0006-3495(03)74675-X; Turner DH, 1996, CURR OPIN STRUC BIOL, V6, P299, DOI 10.1016/S0959-440X(96)80047-9; Verma S, 1998, ANNU REV BIOCHEM, V67, P99, DOI 10.1146/annurev.biochem.67.1.99; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	48	371	414	3	87	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					754	U3		10.1038/nature08434	http://dx.doi.org/10.1038/nature08434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19812667	Green Accepted			2022-12-28	WOS:000270547500028
J	Aathavan, K; Politzer, AT; Kaplan, A; Moffitt, JR; Chemla, YR; Grimes, S; Jardine, PJ; Anderson, DL; Bustamante, C				Aathavan, K.; Politzer, Adam T.; Kaplan, Ariel; Moffitt, Jeffrey R.; Chemla, Yann R.; Grimes, Shelley; Jardine, Paul J.; Anderson, Dwight L.; Bustamante, Carlos			Substrate interactions and promiscuity in a viral DNA packaging motor	NATURE			English	Article							ATP HYDROLYSIS; PORTAL MOTOR; TRANSLOCATION; HELICASE; MECHANISM; BACKBONE; TRACKING	The ASCE (additional strand, conserved E) superfamily of proteins consists of structurally similar ATPases associated with diverse cellular activities involving metabolism and transport of proteins and nucleic acids in all forms of life(1). A subset of these enzymes consists of multimeric ringed pumps responsible for DNA transport in processes including genome packaging in adenoviruses, herpesviruses, poxviruses and tailed bacteriophages(2). Although their mechanism of mechanochemical conversion is beginning to be understood(3), little is known about how these motors engage their nucleic acid substrates. Questions remain as to whether the motors contact a single DNA element, such as a phosphate or a base, or whether contacts are distributed over several parts of the DNA. Furthermore, the role of these contacts in the mechanochemical cycle is unknown. Here we use the genome packaging motor of the Bacillus subtilis bacteriophage phi 29 (ref. 4) to address these questions. The full mechanochemical cycle of the motor, in which the ATPase is a pentameric-ring(5) of gene product 16 (gp16), involves two phases-an ATP-loading dwell followed by a translocation burst of four 2.5-base-pair (bp) steps(6) triggered by hydrolysis product release(7). By challenging the motor with a variety of modified DNA substrates, we show that during the dwell phase important contacts are made with adjacent phosphates every 10-bp on the 5'-3' strand in the direction of packaging. As well as providing stable, long-lived contacts, these phosphate interactions also regulate the chemical cycle. In contrast, during the burst phase, we find that DNA translocation is driven against large forces by extensive contacts, some of which are not specific to the chemical moieties of DNA. Such promiscuous, nonspecific contacts may reflect common translocase-substrate interactions for both the nucleic acid and protein translocases of the ASCE superfamily(1).	[Aathavan, K.; Politzer, Adam T.; Bustamante, Carlos] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA; [Aathavan, K.; Politzer, Adam T.; Kaplan, Ariel; Moffitt, Jeffrey R.; Chemla, Yann R.; Bustamante, Carlos] Univ Calif Berkeley, Jason L Choy Lab Single Mol Biophys, Berkeley, CA 94720 USA; [Kaplan, Ariel; Bustamante, Carlos] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Kaplan, Ariel; Moffitt, Jeffrey R.; Chemla, Yann R.; Bustamante, Carlos] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Grimes, Shelley; Jardine, Paul J.; Anderson, Dwight L.] Univ Minnesota, Dept Diagnost & Biol Sci, Minneapolis, MN 55455 USA; [Grimes, Shelley; Jardine, Paul J.; Anderson, Dwight L.] Univ Minnesota, Inst Mol Virol, Minneapolis, MN 55455 USA; [Anderson, Dwight L.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Bustamante, Carlos] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Bustamante, Carlos] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu	Kaplan, Ariel/F-3657-2010	Kaplan, Ariel/0000-0002-9731-6962; Jardine, Paul/0000-0002-1090-0550; Chemla, Yann/0000-0001-9167-0234; Bustamante, Carlos/0000-0002-2970-0073	Burroughs Wellcome Fund; NIH Molecular Biophysics Training Grant; Human Frontier Science Program Cross-Disciplinary Fellowship; NSF Graduate Research Fellowship; Burroughs Wellcome Fund Career Award; National Institutes of Health ( NIH) [GM-071552, DE-003606, GM-059604]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE003606, R37DE003606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059604, R01GM071552] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH Molecular Biophysics Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program Cross-Disciplinary Fellowship(Human Frontier Science Program); NSF Graduate Research Fellowship(National Science Foundation (NSF)); Burroughs Wellcome Fund Career Award(Burroughs Wellcome Fund); National Institutes of Health ( NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. L. Hetherington, M. Kopaczynska, A. Spakowitz and J. M. Berger for critical discussions, and D. Reid, M. T. Couvillon and N. L. S. Chavez for preliminary work leading to this publication. K. A. acknowledges the PMMB fellowship through the Burroughs Wellcome Fund, A. T. P. the NIH Molecular Biophysics Training Grant, A. K. the Human Frontier Science Program Cross-Disciplinary Fellowship, J. R. M. the NSF Graduate Research Fellowship, and Y. R. C. the Burroughs Wellcome Fund Career Award at the Scientific Interface for funding. This research was supported in part by the National Institutes of Health ( NIH) grants GM-071552, DE-003606 and GM-059604. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; AGRESTI A, 2003, CATEGORICAL DATA ANA, pCH5; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; BURROUGHS AM, 2007, COMP GENOMICS EVOLUT, P48; Chemla YR, 2005, CELL, V122, P683, DOI 10.1016/j.cell.2005.06.024; Dillingham MS, 1999, NUCLEIC ACIDS RES, V27, P3310, DOI 10.1093/nar/27.16.3310; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Eoff RL, 2005, BIOCHEMISTRY-US, V44, P666, DOI 10.1021/bi0484926; Grimes S, 2002, ADV VIRUS RES, V58, P255, DOI 10.1016/S0065-3527(02)58007-6; Hopfner KP, 2007, CURR OPIN STRUC BIOL, V17, P87, DOI 10.1016/j.sbi.2006.11.003; HOWARD J, 2001, MECH MOTOR PROTEINS, P62; Iyer LM, 2004, NUCLEIC ACIDS RES, V32, P5260, DOI 10.1093/nar/gkh828; Kawaoka J, 2004, NAT STRUCT MOL BIOL, V11, P526, DOI 10.1038/nsmb771; Lewis JR, 2006, J USABILITY STUD, V1, P136; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; Moffitt JR, 2006, P NATL ACAD SCI USA, V103, P9006, DOI 10.1073/pnas.0603342103; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Moll WD, 2005, J MOL BIOL, V351, P100, DOI 10.1016/j.jmb.2005.05.038; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Oram M, 2008, J MOL BIOL, V381, P61, DOI 10.1016/j.jmb.2008.05.074; PEARSON RK, 1988, GENETICS, V118, P5; Rickgauer JP, 2008, BIOPHYS J, V94, P159, DOI 10.1529/biophysj.107.104612; SENGUPTA DJ, 1992, SCIENCE, V256, P1656, DOI 10.1126/science.256.5064.1656; Shen JP, 2005, P NATL ACAD SCI USA, V102, P11248, DOI 10.1073/pnas.0409646102; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Smith SB, 2003, METHOD ENZYMOL, V361, P134; Stanley LK, 2006, EMBO J, V25, P2230, DOI 10.1038/sj.emboj.7601104; STRAUSS JK, 1994, SCIENCE, V266, P1829, DOI 10.1126/science.7997878; Thiviyanathan V, 2002, BIOCHEMISTRY-US, V41, P827, DOI 10.1021/bi011551k	30	88	88	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					669	U118		10.1038/nature08443	http://dx.doi.org/10.1038/nature08443			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794496	Green Accepted			2022-12-28	WOS:000270302600044
J	Gentile, G; Famaey, B; Zhao, HS; Salucci, P				Gentile, Gianfranco; Famaey, Benoit; Zhao, HongSheng; Salucci, Paolo			Universality of galactic surface densities within one dark halo scale-length	NATURE			English	Article							TULLY-FISHER RELATION; SPIRAL GALAXIES; ROTATION CURVE; MATTER DISTRIBUTION; MASS; MOND	It was recently discovered that the mean dark matter surface density within one dark halo scale-length (the radius within which the volume density profile of dark matter remains approximately flat) is constant across a wide range of galaxies(1). This scaling relation holds for galaxies spanning a luminosity range of 14 magnitudes and the whole Hubble sequence(1-3). Here we report that the luminous matter surface density is also constant within one scale-length of the dark halo. This means that the gravitational acceleration generated by the luminous component in galaxies is always the same at this radius. Although the total luminous-to-dark matter ratio is not constant, within one halo scale-length it is constant. Our finding can be interpreted as a close correlation between the enclosed surface densities of luminous and dark matter in galaxies(4).	[Gentile, Gianfranco] Univ Ghent, Sterrenkundig Observatorium, B-9000 Ghent, Belgium; [Gentile, Gianfranco; Famaey, Benoit] Univ Libre Bruxelles, Inst Astron & Astrophys, B-1050 Brussels, Belgium; [Famaey, Benoit] Univ Strasbourg, CNRS, UMR 7550, Astron Observ, F-67000 Strasbourg, France; [Famaey, Benoit] Univ Bonn, AIfA, D-53121 Bonn, Germany; [Zhao, HongSheng] Univ St Andrews, Sch Phys & Astron, SUPA, St Andrews KY16 9SS, Fife, Scotland; [Zhao, HongSheng] Leiden Univ, Sterrewacht & Inst Lorentz, NL-2333 CA Leiden, Netherlands; [Salucci, Paolo] SISSA, Int Sch Adv Studies, I-34151 Trieste, Italy	Ghent University; Universite Libre de Bruxelles; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Bonn; University of St Andrews; Leiden University; Leiden University - Excl LUMC; International School for Advanced Studies (SISSA)	Gentile, G (corresponding author), Univ Ghent, Sterrenkundig Observatorium, Krijgslaan 281, B-9000 Ghent, Belgium.	gianfranco.gentile@ugent.be		Famaey, Benoit/0000-0003-3180-9825; Zhao, Hongsheng/0000-0001-9715-8688	FWO-Vlaanderen (Belgium); Alexander von Humboldt foundation (Germany); FNRS (Belgium),; CNRS (France); STFC [PP/D000890/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D000890/1] Funding Source: researchfish	FWO-Vlaanderen (Belgium)(FWO); Alexander von Humboldt foundation (Germany)(Alexander von Humboldt Foundation); FNRS (Belgium),(Fonds de la Recherche Scientifique - FNRS); CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	G. G. was supported by the FWO-Vlaanderen ( Belgium), and B. F. was supported in part by the Alexander von Humboldt foundation ( Germany), the FNRS (Belgium), and the CNRS (France). We thank A. Jorissen and L. Hill for their comments on the manuscript.	BURKERT A, 1995, ASTROPHYS J, V447, pL25, DOI 10.1086/309560; de Blok WJG, 2008, ASTRON J, V136, P2648, DOI 10.1088/0004-6256/136/6/2648; Donato F, 2009, MON NOT R ASTRON SOC, V397, P1169, DOI 10.1111/j.1365-2966.2009.15004.x; Famaey B, 2007, PHYS REV D, V75, DOI 10.1103/PhysRevD.75.063002; Gentile G, 2005, ASTROPHYS J, V634, pL145, DOI 10.1086/498939; Gentile G, 2008, ASTROPHYS J, V684, P1018, DOI 10.1086/590048; Gentile G, 2007, MON NOT R ASTRON SOC, V375, P199, DOI 10.1111/j.1365-2966.2006.11283.x; Kormendy J., 2004, IAU S, V220, P377; McGaugh SS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.171302; McGaugh SS, 2004, ASTROPHYS J, V609, P652, DOI 10.1086/421338; Milgrom M, 2005, MON NOT R ASTRON SOC, V357, P45, DOI 10.1111/j.1365-2966.2004.08578.x; MILGROM M, 1983, ASTROPHYS J, V270, P365, DOI 10.1086/161130; Persic M, 1996, MON NOT R ASTRON SOC, V281, P27, DOI 10.1093/mnras/278.1.27; Spano M, 2008, MON NOT R ASTRON SOC, V383, P297, DOI 10.1111/j.1365-2966.2007.12545.x; Yegorova IA, 2007, MON NOT R ASTRON SOC, V377, P507, DOI 10.1111/j.1365-2966.2007.11637.x; ZWAAN MA, 1995, MON NOT R ASTRON SOC, V273, pL35, DOI 10.1093/mnras/273.1.L35	16	115	118	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 1	2009	461	7264					627	628		10.1038/nature08437	http://dx.doi.org/10.1038/nature08437			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794488	Green Submitted			2022-12-28	WOS:000270302600034
J	Ellis, O				Ellis, Oliver			Patient Safety Risky business	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Ellis, O (corresponding author), BMJ, London WC1H 9JR, England.	oellis@bmj.com							0	0	0	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 30	2009	339								b3964	10.1136/bmj.b3964	http://dx.doi.org/10.1136/bmj.b3964			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	502KZ	19793780				2022-12-28	WOS:000270459800003
J	Tilley, A; Khanafer, A; Chakrabarty, A; Balasubramaniam, R; Waterland, P; Fox, T				Tilley, Anna; Khanafer, Adib; Chakrabarty, Abhijoy; Balasubramaniam, Ravivarma; Waterland, Peter; Fox, Tony			Picture quiz An elderly woman with obstruction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SMALL-BOWEL OBSTRUCTION; OBTURATOR HERNIA; ETIOLOGY		[Tilley, Anna; Khanafer, Adib; Chakrabarty, Abhijoy; Balasubramaniam, Ravivarma; Waterland, Peter; Fox, Tony] Royal Shrewsbury Hosp, Shrewsbury SY3 8XQ, Salop, England		Tilley, A (corresponding author), Royal Shrewsbury Hosp, Shrewsbury SY3 8XQ, Salop, England.	anna.tilley@imperial.ac.uk						Berstein JM, 1996, SURGERY, V119, P133, DOI 10.1016/S0039-6060(96)80159-0; BLACK J, 2005, BROWSES INTRO SYMPTO; Habib E, 2003, ANN CHIR, V128, P94, DOI 10.1016/S0003-3944(02)00037-8; HANNINGTONKIFF JG, 1980, LANCET, V1, P180; KOZLOWSKI JM, 1977, ARCH SURG-CHICAGO, V112, P1001; LO CY, 1994, AM J SURG, V167, P396, DOI 10.1016/0002-9610(94)90123-6; Markogiannakis H, 2007, WORLD J GASTROENTERO, V13, P432, DOI 10.3748/wjg.v13.i3.432; Morris PJ, 2000, OXFORD TXB SURG; Omori H, 2006, INT SURG, V91, P188; Salameh JR, 2008, SURG CLIN N AM, V88, P45, DOI 10.1016/j.suc.2007.10.004	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2009	339								b3641	10.1136/bmj.b3641	http://dx.doi.org/10.1136/bmj.b3641			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OF	19776104				2022-12-28	WOS:000270231700004
J	Norman, G; Barraclough, K; Dolovich, L; Price, D				Norman, Geoff; Barraclough, Kevin; Dolovich, Lisa; Price, David			Diagnosis in General Practice Iterative diagnosis	BRITISH MEDICAL JOURNAL			English	Article							REASONING STRATEGIES; EXPERIENCE		[Norman, Geoff] McMaster Univ, Fac Hlth Sci, Program Educ Res & Dev, Dept Family Med,MDCL, Hamilton, ON L8N 3Z5, Canada	McMaster University	Norman, G (corresponding author), McMaster Univ, Fac Hlth Sci, Program Educ Res & Dev, Dept Family Med,MDCL, Room 3510,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	norman@mcmaster.ca		Dolovich, Lisa/0000-0002-0061-6783				Almond SC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1878; Ark TK, 2007, MED EDUC, V41, P281, DOI 10.1111/j.1365-2929.2007.02688.x; Barraclough K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3493; BARROWS HS, 1982, CLIN INVEST MED, V5, P49; Croskerry P, 2000, ACAD EMERG MED, V7, P1223, DOI 10.1111/j.1553-2712.2000.tb00467.x; Elstein AS, 2002, BRIT MED J, V324, P729, DOI 10.1136/bmj.324.7339.729; Eva KW, 2007, MED EDUC, V41, P1152, DOI 10.1111/j.1365-2923.2007.02923.x; Eva KW, 2006, J CONTIN EDUC HEALTH, V26, P192, DOI 10.1002/chp.69; Graber ML, 2005, ARCH INTERN MED, V165, P1493, DOI 10.1001/archinte.165.13.1493; Groves M, 2003, MED TEACH, V25, P308, DOI 10.1080/0142159031000100427; Norman G., 1994, TEACH LEARN MED, V6, P114, DOI [DOI 10.1080/10401339409539657, 10.1080/10401339409539657]; Norman G, 2007, MED EDUC, V41, P1140, DOI 10.1111/j.1365-2923.2007.02914.x	12	28	28	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 22	2009	339								b3490	10.1136/bmj.b3490	http://dx.doi.org/10.1136/bmj.b3490			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OE	19773326				2022-12-28	WOS:000270231500003
J	Lam, H; Oh, DC; Cava, F; Takacs, CN; Clardy, J; de Pedro, MA; Waldor, MK				Lam, Hubert; Oh, Dong-Chan; Cava, Felipe; Takacs, Constantin N.; Clardy, Jon; de Pedro, Miguel A.; Waldor, Matthew K.			D-Amino Acids Govern Stationary Phase Cell Wall Remodeling in Bacteria	SCIENCE			English	Article							ESCHERICHIA-COLI; BACILLUS-SUBTILIS; PEPTIDOGLYCAN; GROWTH	In all known organisms, amino acids are predominantly thought to be synthesized and used as their L-enantiomers. Here, we found that bacteria produce diverse D-amino acids as well, which accumulate at millimolar concentrations in supernatants of stationary phase cultures. In Vibrio cholerae, a dedicated racemase produced D-Met and D-Leu, whereas Bacillus subtilis generated D-Tyr and D-Phe. These unusual D-amino acids appear to modulate synthesis of peptidoglycan, a strong and elastic polymer that serves as the stress-bearing component of the bacterial cell wall. D-Amino acids influenced peptidoglycan composition, amount, and strength, both by means of their incorporation into the polymer and by regulating enzymes that synthesize and modify it. Thus, synthesis of D-amino acids may be a common strategy for bacteria to adapt to changing environmental conditions.	[Lam, Hubert; Cava, Felipe; Takacs, Constantin N.; Waldor, Matthew K.] Harvard Univ, Brigham & Womens Hosp, Channing Lab, Sch Med, Boston, MA 02115 USA; [Lam, Hubert; Cava, Felipe; Takacs, Constantin N.; Waldor, Matthew K.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Oh, Dong-Chan; Clardy, Jon] Harvard Univ, Dept Biol Chem & Mol Pharmacol, Sch Med, Boston, MA 02115 USA; [de Pedro, Miguel A.] Cient Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa Consejo Super Invest, Fac Ciencias, Madrid 28049, Spain	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Waldor, MK (corresponding author), Harvard Univ, Brigham & Womens Hosp, Channing Lab, Sch Med, Boston, MA 02115 USA.	mwaldor@rics.bwh.harvard.edu	Cava, Felipe/L-2082-2017	Cava, Felipe/0000-0001-5995-718X; Waldor, Matthew/0000-0003-1843-7000	Howard Hughes Medical Institute (HHMI); NIH [AI-R37-42347, CA24487, GM086258]; Ministry of Education and Science, Spain (MEC) [BFU2006-04574]; Fundacion Ramon Areces; Jane Coffin Childs Fellowship; MEC Fellowship; HHMI Exceptional Research Opportunities (EXROP); NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086258] Funding Source: NIH RePORTER	Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education and Science, Spain (MEC)(Spanish Government); Fundacion Ramon Areces; Jane Coffin Childs Fellowship; MEC Fellowship(German Research Foundation (DFG)); HHMI Exceptional Research Opportunities (EXROP)(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Davis, C. Jacobs-Wagner, and D. Rudner for insightful comments on the manuscript. This work was supported by Howard Hughes Medical Institute (HHMI); NIH AI-R37-42347 ( M. K. W.) and CA24487 and GM086258 ( J. C.); Ministry of Education and Science, Spain (MEC) BFU2006-04574 and Fundacion Ramon Areces (M. A. P.); Jane Coffin Childs Fellowship ( H. L.); MEC Fellowship ( F. C.); and HHMI Exceptional Research Opportunities (EXROP) ( C.N.T.).	Anfora AT, 2007, INFECT IMMUN, V75, P5298, DOI 10.1128/IAI.00652-07; CAPARROS M, 1992, J BACTERIOL, V174, P5549; CHAMPNEY WS, 1970, J BACTERIOL, V104, P107, DOI 10.1128/JB.104.1.107-116.1970; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; LARK C, 1959, CAN J MICROBIOL, V5, P369, DOI 10.1139/m59-046; OConnor KA, 1997, MOL MICROBIOL, V24, P839, DOI 10.1046/j.1365-2958.1997.3931757.x; Tiyanont K, 2006, P NATL ACAD SCI USA, V103, P11033, DOI 10.1073/pnas.0600829103; TSURUOKA T, 1985, EUR J BIOCHEM, V151, P209, DOI 10.1111/j.1432-1033.1985.tb09089.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Yoshimura T, 2003, J BIOSCI BIOENG, V96, P103, DOI 10.1016/S1389-1723(03)90111-3	10	404	417	6	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 18	2009	325	5947					1552	1555		10.1126/science.1178123	http://dx.doi.org/10.1126/science.1178123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762646	Green Accepted			2022-12-28	WOS:000269887900043
J	Fasano, A				Fasano, Alessio			Should we screen for coeliac disease? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							POPULATION; DIAGNOSIS		[Fasano, Alessio] Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA; [Fasano, Alessio] Univ Maryland, Sch Med, Ctr Celiac Res, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Fasano, A (corresponding author), Univ Maryland, Sch Med, Mucosal Biol Res Ctr, Baltimore, MD 21201 USA.	afasano@mbrc.umaryland.edu	Fasano, Alessio/K-5486-2016	Fasano, Alessio/0000-0002-2134-0261				Anderson LA, 2007, WORLD J GASTROENTERO, V13, P146, DOI 10.3748/wjg.v13.i1.146; Caicedo R. A., 2008, Frontiers in celiac disease, P107, DOI 10.1159/000128665; Catassi C., 2008, Frontiers in celiac disease, P23, DOI 10.1159/000128610; Catassi C, 2008, CURR OPIN GASTROEN, V24, P687, DOI 10.1097/MOG.0b013e32830edc1e; Catassi C, 2007, AM J GASTROENTEROL, V102, P1454, DOI 10.1111/j.1572-0241.2007.01173.x; *EUR OBS HLTH SYST, 2006, POL BRIEF SCREEN EUR; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; Gasbarrini G, 2008, DIGEST DIS, V26, P121, DOI 10.1159/000116769; Green Peter H R, 2008, J Insur Med, V40, P218; Green PHR, 2001, AM J GASTROENTEROL, V96, P126, DOI 10.1111/j.1572-0241.2001.03462.x; Guandalini S, 2008, CURR OPIN GASTROEN, V24, P707, DOI 10.1097/MOG.0b013e32830f4527; Mearin ML, 2005, BEST PRACT RES CL GA, V19, P441, DOI 10.1016/j.bpg.2005.02.004; Shamir R, 2006, MED DECIS MAKING, V26, P282, DOI 10.1177/0272989X06289012; Sollid LM, 2009, MUCOSAL IMMUNOL, V2, P3, DOI 10.1038/mi.2008.74; Stern M., 2008, Frontiers in celiac disease, P114, DOI 10.1159/000128671	15	28	28	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 17	2009	339								b3592	10.1136/bmj.b3592	http://dx.doi.org/10.1136/bmj.b3592			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RU	19762413				2022-12-28	WOS:000269994900005
J	Walsh, MR; Koh, CA; Sloan, ED; Sum, AK; Wu, DT				Walsh, Matthew R.; Koh, Carolyn A.; Sloan, E. Dendy; Sum, Amadeu K.; Wu, David T.			Microsecond Simulations of Spontaneous Methane Hydrate Nucleation and Growth	SCIENCE			English	Article							MOLECULAR-DYNAMICS SIMULATION; CLATHRATE HYDRATE; CARBON-DIOXIDE; HYDROGEN CLUSTERS; CRYSTAL-GROWTH; GAS; WATER; CRYSTALLIZATION; INTERFACE; PRESSURE	Despite the industrial implications and worldwide abundance of gas hydrates, the formation mechanism of these compounds remains poorly understood. We report direct molecular dynamics simulations of the spontaneous nucleation and growth of methane hydrate. The multiple-microsecond trajectories offer detailed insight into the process of hydrate nucleation. Cooperative organization is observed to lead to methane adsorption onto planar faces of water and the fluctuating formation and dissociation of early hydrate cages. The early cages are mostly face-sharing partial small cages, favoring structure II; however, larger cages subsequently appear as a result of steric constraints and thermodynamic preference for the structure I phase. The resulting structure after nucleation and growth is a combination of the two dominant types of hydrate crystals (structure I and structure II), which are linked by uncommon 5(12)6(3) cages that facilitate structure coexistence without an energetically unfavorable interface.	[Walsh, Matthew R.; Koh, Carolyn A.; Sloan, E. Dendy; Sum, Amadeu K.; Wu, David T.] Colorado Sch Mines, Dept Chem Engn, Ctr Hydrate Res, Golden, CO 80401 USA; [Wu, David T.] Colorado Sch Mines, Dept Chem, Golden, CO 80401 USA	Colorado School of Mines; Colorado School of Mines	Sum, AK (corresponding author), Colorado Sch Mines, Dept Chem Engn, Ctr Hydrate Res, Golden, CO 80401 USA.	asum@mines.edu; dwu@mines.edu	Wu, David/AAS-8175-2021; Sum, Amadeu K/B-1103-2009	Sum, Amadeu K/0000-0003-1903-4537	NSF Materials Research Science and Engineering Center [DMR0820518]; U. S. Department of Energy-Basic Energy Sciences [DE-FG02-05ER46242]; CSM Hydrate Consortium; BP; Champion Technologies; Chevron; ConocoPhillips; ExxonMobil; Halliburton; Multi-Chem Group; Nalco; Petrobras; Schlumberger; Shell; SPT Group; StatoilHydro; Total; NSF [CBET-0933856]; National Renewable Energy Laboratory	NSF Materials Research Science and Engineering Center(National Science Foundation (NSF)); U. S. Department of Energy-Basic Energy Sciences(United States Department of Energy (DOE)); CSM Hydrate Consortium; BP; Champion Technologies; Chevron; ConocoPhillips; ExxonMobil(Exxon Mobil Corporation); Halliburton; Multi-Chem Group; Nalco; Petrobras(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras); Schlumberger(Schlumberger); Shell(Royal Dutch Shell); SPT Group; StatoilHydro; Total(Total SA); NSF(National Science Foundation (NSF)); National Renewable Energy Laboratory(United States Department of Energy (DOE))	Supported by the NSF Materials Research Science and Engineering Center (NSF-MRSEC award DMR0820518), the U. S. Department of Energy-Basic Energy Sciences (DOE-BES award DE-FG02-05ER46242), and the CSM Hydrate Consortium (which is currently sponsored by BP, Champion Technologies, Chevron, ConocoPhillips, ExxonMobil, Halliburton, Multi-Chem Group, Nalco, Petrobras, Schlumberger, Shell, SPT Group, StatoilHydro, and Total). A. K. S. and D. T. W. were supported by NSF grant CBET-0933856. The simulations were carried out on facilities at the Golden Energy Computing Organization at the Colorado School of Mines, using resources acquired with financial assistance from NSF and the National Renewable Energy Laboratory. All graphics were prepared with VMD (S8). We thank T. Kaiser, M. Robbert, P. Rensing, T. Strobel, P. Prasad, Z. Aman, and L. Zerpa for support in computing efforts, and L. Jacobson, W. Hujo, and V. Molinero for generously sharing their cage recognition code.	Attard P, 2002, PHYSICA A, V314, P696, DOI 10.1016/S0378-4371(02)01191-3; BAEZ LA, 1994, ANN NY ACAD SCI, V715, P177, DOI 10.1111/j.1749-6632.1994.tb38833.x; Boswell R, 2009, SCIENCE, V325, P957, DOI 10.1126/science.1175074; Fisher CR, 2000, NATURWISSENSCHAFTEN, V87, P184, DOI 10.1007/s001140050700; FLEYFEL F, 1991, J PHYS CHEM-US, V95, P3811, DOI 10.1021/j100162a068; Florusse LJ, 2004, SCIENCE, V306, P469, DOI 10.1126/science.1102076; Guo GJ, 2007, J PHYS CHEM C, V111, P2595, DOI 10.1021/jp064271t; Jacobson LC, 2009, J PHYS CHEM B, V113, P10298, DOI 10.1021/jp903439a; Kaiho K, 1996, PALEOCEANOGRAPHY, V11, P447, DOI 10.1029/96PA01021; Koh CA, 2000, J CHEM PHYS, V113, P6390, DOI 10.1063/1.1288818; Koh CA, 1996, J PHYS CHEM-US, V100, P6412, DOI 10.1021/jp960094s; Mao WL, 2002, SCIENCE, V297, P2247, DOI 10.1126/science.1075394; Mastny EA, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2925680; Matsumoto M, 2002, NATURE, V416, P409, DOI 10.1038/416409a; MILTON DJ, 1974, SCIENCE, V183, P654, DOI 10.1126/science.183.4125.654; Moon C, 2007, FARADAY DISCUSS, V136, P367, DOI 10.1039/b618194p; Moon C, 2003, J AM CHEM SOC, V125, P4706, DOI 10.1021/ja028537v; Nada H, 2006, J PHYS CHEM B, V110, P16526, DOI 10.1021/jp062182a; Ogawa T, 2006, APPL THERM ENG, V26, P2157, DOI 10.1016/j.applthermaleng.2006.04.003; Park Y, 2006, P NATL ACAD SCI USA, V103, P12690, DOI 10.1073/pnas.0602251103; Rodger PM, 1996, FLUID PHASE EQUILIBR, V116, P326, DOI 10.1016/0378-3812(95)02903-6; Schicks JM, 2004, ANGEW CHEM INT EDIT, V43, P3310, DOI 10.1002/anie.200453898; Sloan ED, 2008, CHEM IND-SER, V119, pXIX; Sloan ED, 2003, NATURE, V426, P353, DOI 10.1038/nature02135; Staykova DK, 2003, J PHYS CHEM B, V107, P10299, DOI 10.1021/jp027787v; Vatamanu J, 2006, J AM CHEM SOC, V128, P15588, DOI 10.1021/ja066515t; Vatamanu J, 2006, J PHYS CHEM B, V110, P15896, DOI 10.1021/jp061684l; Vorotyntsev VM, 2001, THEOR FOUND CHEM ENG, V35, P513, DOI 10.1023/A:1012390423740; WALSH MR, 2009, J ENERGY EC, V31, P815; Zhang JF, 2008, J PHYS CHEM B, V112, P10608, DOI 10.1021/jp076904p	30	525	540	12	437	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 20	2009	326	5956					1095	1098		10.1126/science.1174010	http://dx.doi.org/10.1126/science.1174010			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	521UW	19815725				2022-12-28	WOS:000271951000038
J	Sridhar, S				Sridhar, Saranya			An affordable cholera vaccine: an important step forward	LANCET			English	Editorial Material							WHOLE-CELL; FIELD TRIAL; BANGLADESH; EFFICACY		Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Sridhar, S (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA.	saranya.sridhar@gmail.com		Sridhar, Saranya/0000-0002-4267-3102				Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; Anh DD, 2007, VACCINE, V25, P1149, DOI 10.1016/j.vaccine.2006.09.049; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P273; Emch M, 2007, HEALTH PLACE, V13, P238, DOI 10.1016/j.healthplace.2006.01.005; SANCHEZ JL, 1994, LANCET, V344, P1273, DOI 10.1016/S0140-6736(94)90755-2; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; Thiem VD, 2006, VACCINE, V24, P4297, DOI 10.1016/j.vaccine.2006.03.008; Trach DD, 1997, LANCET, V349, P231, DOI 10.1016/S0140-6736(96)06107-7; vanLoon FPL, 1996, VACCINE, V14, P162, DOI 10.1016/0264-410X(95)00122-H; *WHO, 2009, CHOL ZIMB UPD 4	10	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 14	2009	374	9702					1658	1660		10.1016/S0140-6736(09)61418-5	http://dx.doi.org/10.1016/S0140-6736(09)61418-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	522LP	19819005				2022-12-28	WOS:000271999700006
J	Rogaev, EI; Grigorenko, AP; Faskhutdinova, G; Kittler, ELW; Moliaka, YK				Rogaev, Evgeny I.; Grigorenko, Anastasia P.; Faskhutdinova, Gulnaz; Kittler, Ellen L. W.; Moliaka, Yuri K.			Genotype Analysis Identifies the Cause of the "Royal Disease"	SCIENCE			English	Article							HEMOPHILIA; FAMILY		[Rogaev, Evgeny I.; Grigorenko, Anastasia P.; Faskhutdinova, Gulnaz; Kittler, Ellen L. W.; Moliaka, Yuri K.] Univ Massachusetts, Sch Med, Worcester, MA 01604 USA; [Rogaev, Evgeny I.; Grigorenko, Anastasia P.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow 119991, Russia; [Rogaev, Evgeny I.; Grigorenko, Anastasia P.] Russian Acad Med Sci, Mental Hlth Res Ctr, Moscow 113152, Russia; [Rogaev, Evgeny I.] Moscow MV Lomonosov State Univ, Fac Bioengn & Bioinformat, Moscow 119992, Russia	University of Massachusetts System; University of Massachusetts Worcester; Russian Academy of Sciences; Vavilov Institute of General Genetics; Russian Academy of Medical Sciences; Lomonosov Moscow State University	Rogaev, EI (corresponding author), Univ Massachusetts, Sch Med, 303 Belmont St, Worcester, MA 01604 USA.	Evgeny.Rogaev@umassmed.edu	Grigorenko, Anastasia/AAN-8226-2020; Rogaev, Evgeny/AAN-7662-2020					Ojeda-Thies C, 2003, HAEMOPHILIA, V9, P153, DOI 10.1046/j.1365-2516.2003.00732.x; Rogaev EI, 2009, P NATL ACAD SCI USA, V106, P5258, DOI 10.1073/pnas.0811190106; Stevens RF, 1999, BRIT J HAEMATOL, V105, P25, DOI 10.1111/j.1365-2141.1999.01327.x; White GC, 2001, THROMB HAEMOSTASIS, V85, P560, DOI 10.1055/s-0037-1615621	4	65	68	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 6	2009	326	5954					817	817		10.1126/science.1180660	http://dx.doi.org/10.1126/science.1180660			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	515KG	19815722				2022-12-28	WOS:000271468000033
J	Kitano, J; Ross, JA; Mori, S; Kume, M; Jones, FC; Chan, YF; Absher, DM; Grimwood, J; Schmutz, J; Myers, RM; Kingsley, DM; Peichel, CL				Kitano, Jun; Ross, Joseph A.; Mori, Seiichi; Kume, Manabu; Jones, Felicity C.; Chan, Yingguang F.; Absher, Devin M.; Grimwood, Jane; Schmutz, Jeremy; Myers, Richard M.; Kingsley, David M.; Peichel, Catherine L.			A role for a neo-sex chromosome in stickleback speciation	NATURE			English	Article							REPRODUCTIVE ISOLATION; CICHLID FISH; THREESPINE STICKLEBACKS; SEGREGATION DISTORTION; SYMPATRIC SPECIATION; Y-CHROMOSOME; EVOLUTION; DROSOPHILA; SELECTION; GASTEROSTEUS	Sexual antagonism, or conflict between the sexes, has been proposed as a driving force in both sex-chromosome turnover and speciation. Although closely related species often have different sex-chromosome systems, it is unknown whether sex-chromosome turnover contributes to the evolution of reproductive isolation between species. Here we show that a newly evolved sex chromosome contains genes that contribute to speciation in threespine stickleback fish (Gasterosteus aculeatus). We first identified a neo-sex chromosome system found only in one member of a sympatric species pair in Japan. We then performed genetic linkage mapping of male-specific traits important for reproductive isolation between the Japanese species pair. The neo-X chromosome contains loci for male courtship display traits that contribute to behavioural isolation, whereas the ancestral X chromosome contains loci for both behavioural isolation and hybrid male sterility. Our work not only provides strong evidence for a large X-effect on reproductive isolation in a vertebrate system, but also provides direct evidence that a young neo-X chromosome contributes to reproductive isolation between closely related species. Our data indicate that sex-chromosome turnover might have a greater role in speciation than was previously appreciated.	[Kitano, Jun; Ross, Joseph A.; Peichel, Catherine L.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; [Ross, Joseph A.] Univ Washington, Grad Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Mori, Seiichi] Gifu Keizai Univ, Biol Lab, Gifu 5038550, Japan; [Kume, Manabu] Publ Works Res Inst, Aqua Restorat Res Ctr, Gifu 5016021, Japan; [Jones, Felicity C.; Chan, Yingguang F.; Kingsley, David M.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Jones, Felicity C.; Chan, Yingguang F.; Kingsley, David M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Absher, Devin M.; Grimwood, Jane; Schmutz, Jeremy; Myers, Richard M.] Stanford Univ, Dept Genet, Stanford, CA 94304 USA; [Absher, Devin M.; Grimwood, Jane; Schmutz, Jeremy; Myers, Richard M.] Stanford Univ, Stanford Human Genome Ctr, Stanford, CA 94304 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; PWRI: Public Works Research Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Peichel, CL (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, 1100 Fairview Ave N, Seattle, WA 98109 USA.	cpeichel@fhcrc.org	Grimwood, Jane/ABD-5737-2021; Chan, Yingguang Frank/ABG-9852-2020; Chan, Yingguang/A-7654-2011; Kume, Manabu/AAI-7926-2020; Jones, Felicity C/AAY-3523-2021; Schmutz, Jeremy/N-3173-2013; Ross, Joseph/D-1574-2012; Kume, Manabu/Y-5237-2018	Chan, Yingguang Frank/0000-0001-6292-9681; Chan, Yingguang/0000-0001-6292-9681; Kume, Manabu/0000-0001-7287-029X; Jones, Felicity C/0000-0002-5027-1031; Schmutz, Jeremy/0000-0001-8062-9172; Kume, Manabu/0000-0001-7287-029X; Ross, Joseph/0000-0001-6553-2591	Uehara Memorial Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Water and People Project of Research Institute for Humanity and Nature; Akkeshi Town Grants-in-Aid for Scientific Research in the Lake Akkeshi-Bekanbeushi Wetland; Burroughs Wellcome Fund Career Award in the Biomedical Sciences; National Institutes of Health [T32 GM07270, R01 GM071854, P50 HG02568]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071854, T32GM007270] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Water and People Project of Research Institute for Humanity and Nature; Akkeshi Town Grants-in-Aid for Scientific Research in the Lake Akkeshi-Bekanbeushi Wetland; Burroughs Wellcome Fund Career Award in the Biomedical Sciences(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Nishitani, J. Kitajima, M. Nishida, S. Takeyama, T. Andoh, T. Kuwahara, C. Torii, Akkeshi Fisheries Cooperative Association, Akkeshi Waterfowl Center, S. Brady, A. Southwick, all members of the Peichel laboratory, and many field assistants for technical help and discussion. We thank J. Boughman, T. Bradshaw, H. Malik, J. McKinnon, N. Phadnis and D. Schluter for comments on the manuscript. We also thank the Broad Institute for the public release of an initial stickleback genome assembly. This research was supported by the Uehara Memorial Foundation ( J. K.), a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and Water and People Project of Research Institute for Humanity and Nature ( S. M.), Akkeshi Town Grants-in-Aid for Scientific Research in the Lake Akkeshi-Bekanbeushi Wetland ( M. K.), a Burroughs Wellcome Fund Career Award in the Biomedical Sciences ( C. L. P.), and National Institutes of Health grants T32 GM07270 ( J. A. R.), R01 GM071854 ( C. L. P.) and P50 HG02568 ( R. M. M., D. M. K. and C. L. P.).	Arnqvist Goran, 2005, pUnpaginated; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CHARLESWORTH B, 1987, AM NAT, V130, P113, DOI 10.1086/284701; CHARLESWORTH D, 1980, GENET RES, V35, P205, DOI 10.1017/S0016672300014051; Ezaz T, 2006, CURR BIOL, V16, pR736, DOI 10.1016/j.cub.2006.08.021; Foster Susan A., 1994, P381; Gavrilets S, 2004, FITNESS LANDSCAPES O; Higuchi M, 1996, ENVIRON BIOL FISH, V47, P1, DOI 10.1007/BF00002375; Kingsley David M., 2007, P41; Kitano J, 2007, COPEIA, P336, DOI 10.1643/0045-8511(2007)7[336:SDITEM]2.0.CO;2; Kitano J, 2007, BIOL J LINN SOC, V91, P671, DOI 10.1111/j.1095-8312.2007.00824.x; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kyoichi S, 2004, GENETICS, V166, P789, DOI 10.1534/genetics.166.2.789; Lande R, 2001, GENETICA, V112, P435, DOI 10.1023/A:1013379521338; Mank JE, 2006, BIOL J LINN SOC, V87, P83, DOI 10.1111/j.1095-8312.2006.00558.x; Orr HA, 2001, GENETICS, V158, P1089; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Phadnis N, 2009, SCIENCE, V323, P376, DOI 10.1126/science.1163934; Presgraves DC, 2008, TRENDS GENET, V24, P336, DOI 10.1016/j.tig.2008.04.007; Qvarnstrom A, 2009, HEREDITY, V102, P4, DOI 10.1038/hdy.2008.93; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; RICE WR, 1987, GENETICS, V116, P161; RICE WR, 1987, EVOLUTION, V41, P911, DOI 10.1111/j.1558-5646.1987.tb05864.x; Ross JA, 2008, GENETICS, V179, P2173, DOI 10.1534/genetics.108.088559; Ross JA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000391; Seehausen O, 1999, ECOL LETT, V2, P367; Tanaka K, 2007, GENETICS, V177, P2075, DOI 10.1534/genetics.107.075598; Tao Y, 2001, P NATL ACAD SCI USA, V98, P13183, DOI 10.1073/pnas.231478798; van Doorn GS, 2007, NATURE, V449, P909, DOI 10.1038/nature06178; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; van Ooijen JW, 2002, MAPQTL 4 0 SOFTWARE; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; Wootton R. J., 1984, FUNCTIONAL BIOL STIC; Woram RA, 2003, GENOME RES, V13, P272, DOI 10.1101/gr.578503; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534	35	255	265	6	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1079	1083		10.1038/nature08441	http://dx.doi.org/10.1038/nature08441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19783981	Green Accepted			2022-12-28	WOS:000270987600035
J	Chain, PSG; Grafham, DV; Fulton, RS; FitzGerald, MG; Hostetler, J; Muzny, D; Ali, J; Birren, B; Bruce, DC; Buhay, C; Cole, JR; Ding, Y; Dugan, S; Field, D; Garrity, GM; Gibbs, R; Graves, T; Han, CS; Harrison, SH; Highlander, S; Hugenholtz, P; Khouri, HM; Kodira, CD; Kolker, E; Kyrpides, NC; Lang, D; Lapidus, A; Malfatti, SA; Markowitz, V; Metha, T; Nelson, KE; Parkhill, J; Pitluck, S; Qin, X; Read, TD; Schmutz, J; Sozhamannan, S; Sterk, P; Strausberg, RL; Sutton, G; Thomson, NR; Tiedje, JM; Weinstock, G; Wollam, A; Detter, JC				Chain, P. S. G.; Grafham, D. V.; Fulton, R. S.; FitzGerald, M. G.; Hostetler, J.; Muzny, D.; Ali, J.; Birren, B.; Bruce, D. C.; Buhay, C.; Cole, J. R.; Ding, Y.; Dugan, S.; Field, D.; Garrity, G. M.; Gibbs, R.; Graves, T.; Han, C. S.; Harrison, S. H.; Highlander, S.; Hugenholtz, P.; Khouri, H. M.; Kodira, C. D.; Kolker, E.; Kyrpides, N. C.; Lang, D.; Lapidus, A.; Malfatti, S. A.; Markowitz, V.; Metha, T.; Nelson, K. E.; Parkhill, J.; Pitluck, S.; Qin, X.; Read, T. D.; Schmutz, J.; Sozhamannan, S.; Sterk, P.; Strausberg, R. L.; Sutton, G.; Thomson, N. R.; Tiedje, J. M.; Weinstock, G.; Wollam, A.; Detter, J. C.		Genomic Stand Consortium; Human Microbiome Project Jumpstart	Genome Project Standards in a New Era of Sequencing	SCIENCE			English	Editorial Material									[Chain, P. S. G.] Lawrence Livermore Natl Lab, Livermore, CA USA; [Chain, P. S. G.; Cole, J. R.; Garrity, G. M.; Harrison, S. H.; Tiedje, J. M.] Michigan State Univ, E Lansing, MI 48824 USA; [Fulton, R. S.; Graves, T.; Weinstock, G.; Wollam, A.] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Muzny, D.; Buhay, C.; Ding, Y.; Dugan, S.; Gibbs, R.; Highlander, S.; Qin, X.] Baylor Coll Med, Houston, TX 77030 USA; [Bruce, D. C.; Detter, J. C.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Kolker, E.] Seattle Childrens Hosp & Res Inst, Seattle, WA USA; [Kolker, E.] Univ Washington, Sch Med, Seattle, WA 98195 USA; [Markowitz, V.] Lawrence Berkeley Natl Lab, Berkeley, CA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Michigan State University; Washington University (WUSTL); Baylor College of Medicine; United States Department of Energy (DOE); Los Alamos National Laboratory; Seattle Children's Hospital; University of Washington; University of Washington Seattle; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory		pchain@lanl.gov; dg1@sanger.ac.uk	Parkhill, Julian/G-4703-2011; Chain, Patrick/O-4140-2019; Read, Timothy/E-6240-2011; Schmutz, Jeremy/N-3173-2013; chain, patrick/B-9777-2013; Kyrpides, Nikos C./A-6305-2014; Lapidus, Alla L/I-4348-2013; Garrity, George M/I-8452-2019; Garrity, George/F-7551-2013; Sozhamannan, Shanmuga/AAN-7809-2020; Sozhamannan, Shanmuga/AGF-2410-2022; Hugenholtz, Philip/AAD-9138-2019; Kolker, Eugene/C-6711-2008; Weinstock, George M/C-6314-2013; Field, Dawn/C-1653-2010; Thomson, Nicholas/P-5988-2014	Parkhill, Julian/0000-0002-7069-5958; Chain, Patrick/0000-0003-3949-3634; Schmutz, Jeremy/0000-0001-8062-9172; Kyrpides, Nikos C./0000-0002-6131-0462; Lapidus, Alla L/0000-0003-0427-8731; Garrity, George M/0000-0002-4465-7034; Garrity, George/0000-0002-4465-7034; Sozhamannan, Shanmuga/0000-0002-6762-7874; Hugenholtz, Philip/0000-0001-5386-7925; Weinstock, George M/0000-0002-2997-4592; Read, Timothy/0000-0001-8966-9680; Thomson, Nicholas/0000-0002-4432-8505; Sterk, Peter/0000-0003-1668-7778; Han, Cliff/0000-0003-1972-0692; Malfatti, Stephanie/0000-0003-4225-9857	NERC [NE/D01252X/1] Funding Source: UKRI; Natural Environment Research Council [NE/D01252X/1] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968, U54HG004973] Funding Source: NIH RePORTER; NHGRI NIH HHS [U54 HG004968, U54 HG004973] Funding Source: Medline	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Blakesley RW, 2004, GENOME RES, V14, P2235, DOI 10.1101/gr.2648404; Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; *INT STAND SEQ FID, 2 INT STRAT M HUM GE; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884	5	282	285	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					236	237		10.1126/science.1180614	http://dx.doi.org/10.1126/science.1180614			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	504EX	19815760	Green Submitted, Green Accepted			2022-12-28	WOS:000270599500024
J	Xu, XD; Graeff, R; Xie, QG; Gamble, KL; Mori, T; Johnson, CH				Xu, Xiaodong; Graeff, Richard; Xie, Qiguang; Gamble, Karen L.; Mori, Tetsuya; Johnson, Carl Hirschie			Comment on "The Arabidopsis Circadian Clock Incorporates a cADPR-Based Feedback Loop"	SCIENCE			English	Editorial Material							CYCLIC ADP-RIBOSE; CALCIUM; OSCILLATIONS; PLANTS; CA2+	Dodd et al. (Reports, 14 December 2007, p. 1789) reported that the Arabidopsis circadian clock incorporates the signaling molecule cyclic adenosine diphosphate ribose (cADPR). In contrast, we found that there is no rhythm of cADPR levels nor are there any significant effects on the rhythm by cADPR overexpression, thus raising questions about the conclusions of Dodd et al.	[Xu, Xiaodong; Xie, Qiguang; Gamble, Karen L.; Mori, Tetsuya; Johnson, Carl Hirschie] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Graeff, Richard] Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA	Vanderbilt University; University of Minnesota System; University of Minnesota Twin Cities	Johnson, CH (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	carl.h.johnson@vanderbilt.edu	Johnson, Carl H/I-4655-2014; Gamble, Karen/A-1753-2010; Xu, Xiaodong/HGD-8082-2022	Mori, Tetsuya/0000-0001-6036-5261; Gamble, Karen/0000-0003-3813-8577; Xu, Xiaodong/0000-0002-8795-7651	NIGMS NIH HHS [K99 GM086683-01, GM061568, R01 GM061568, K99 GM086683] Funding Source: Medline; NIMH NIH HHS [R01 MH043836, MH043836] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K99GM086683, R01GM061568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043836, R29MH043836] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLEN GJ, 1995, SCIENCE, V268, P735, DOI 10.1126/science.7732384; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Lee HC, 2001, ANNU REV PHARMACOL, V41, P317, DOI 10.1146/annurev.pharmtox.41.1.317; Love J, 2004, PLANT CELL, V16, P956, DOI 10.1105/tpc.020214; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Sanchez JP, 2004, PLANT J, V38, P381, DOI 10.1111/j.1365-313X.2004.02055.x; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126	11	7	7	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950								10.1126/science.1169503	http://dx.doi.org/10.1126/science.1169503			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815758	Green Accepted			2022-12-28	WOS:000270599500019
J	Artal-Sanz, M; Tavernarakis, N				Artal-Sanz, Marta; Tavernarakis, Nektarios			Prohibitin couples diapause signalling to mitochondrial metabolism during ageing in C-elegans	NATURE			English	Article							CAENORHABDITIS-ELEGANS; LIFE-SPAN; TRANSCRIPTION FACTOR; REGULATES LONGEVITY; OXIDATIVE STRESS; PROTEINS; KINASE; GENE; SENESCENCE; NUTRITION	Marked alterations in cellular energy metabolism are a universal hallmark of the ageing process(1). The biogenesis and function of mitochondria, the energy-generating organelles in eukaryotic cells, are primary longevity determinants. Genetic or pharmacological manipulations of mitochondrial activity profoundly affect the life-span of diverse organisms(2). However, the molecular mechanisms regulating mitochondrial biogenesis and energy metabolism during ageing are poorly understood. Prohibitins are ubiquitous, evolutionarily conserved proteins, which form a ring-like, high-molecular-mass complex at the inner membrane of mitochondria(3). Here, we show that the mitochondrial prohibitin complex promotes longevity by modulating mitochondrial function and fat metabolism in the nematode Caenorhabditis elegans. We found that prohibitin deficiency shortens the lifespan of otherwise wild-type animals. Notably, knockdown of prohibitin promotes longevity in diapause mutants or under conditions of dietary restriction. In addition, prohibitin deficiency extends the lifespan of animals with compromised mitochondrial function or fat metabolism. Depletion of prohibitin influences ATP levels, animal fat content and mitochondrial proliferation in a genetic-background- and age-specific manner. Together, these findings reveal a novel mechanism regulating mitochondrial biogenesis and function, with opposing effects on energy metabolism, fat utilization and ageing in C. elegans. Prohibitin may have a similar key role in modulating energy metabolism during ageing in mammals.	[Artal-Sanz, Marta; Tavernarakis, Nektarios] Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece		Tavernarakis, N (corresponding author), Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion 71110, Crete, Greece.	martal@ibv.csic.es; tavernarakis@imbb.forth.gr	Artal-Sanz, Marta/J-6186-2012; Tavernarakis, Nektarios/B-9684-2013	Artal-Sanz, Marta/0000-0003-1126-0492; Tavernarakis, Nektarios/0000-0002-5253-1466	EMBO; European Research Council ( ERC); Marie Curie Fellowships; European Commission [LSHM-CT-2005-19063]	EMBO(European Molecular Biology Organization (EMBO)); European Research Council ( ERC)(European Research Council (ERC)European Commission); Marie Curie Fellowships(European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank A. Pasparaki for technical support with experiments. Some nematode strains used in this work were provided by the C. elegans Gene Knockout Project at OMRF (http://www.mutantfactory.ouhsc.edu/), which is part of the International C. elegans Gene Knockout Consortium, the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources ( NCRR), and S. Mitani ( National Bioresource Project) in Japan. We thank A. Fire for plasmid vectors and J. Berden for antibodies. This work was funded by grants from EMBO, the European Research Council ( ERC), the Marie Curie Fellowships Programme and the European Commission Coordination Action ENINET ( contract number LSHM-CT-2005-19063).	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; Coates PJ, 2001, EXP CELL RES, V265, P262, DOI 10.1006/excr.2001.5166; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; ESTEVEZ M, 1993, NATURE, V365, P644, DOI 10.1038/365644a0; FRANCIS R, 1995, GENETICS, V139, P579; Gaskova D, 2007, BIOCHEM BIOPH RES CO, V354, P814, DOI 10.1016/j.bbrc.2007.01.073; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kampkotter A, 2007, ARCH TOXICOL, V81, P849, DOI 10.1007/s00204-007-0215-4; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Mishra S, 2005, TRENDS MOL MED, V11, P192, DOI 10.1016/j.molmed.2005.02.004; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Rea S, 2003, DEV CELL, V5, P197, DOI 10.1016/S1534-5807(03)00242-9; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Roberts SB, 2006, PHYSIOL REV, V86, P651, DOI 10.1152/physrev.00019.2005; Sanz MA, 2003, J BIOL CHEM, V278, P32091, DOI 10.1074/jbc.M304877200; Schleicher M, 2008, J CELL BIOL, V180, P101, DOI 10.1083/jcb.200706072; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053	34	141	149	3	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					793	U47		10.1038/nature08466	http://dx.doi.org/10.1038/nature08466			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19812672				2022-12-28	WOS:000270547500036
J	Kim, JJ; Goldie, SJ				Kim, Jane J.; Goldie, Sue J.			Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CANCER-SOCIETY GUIDELINE; CERVICAL-CANCER; ECONOMIC-IMPACT; HPV VACCINE; PARTICLE VACCINE; HEALTH-CARE; INFECTION; WOMEN; PREVALENCE; EFFICACY	Objective To assess the cost effectiveness of including preadolescent boys in a routine human papillomavirus (HPV) vaccination programme for preadolescent girls. Design Cost effectiveness analysis from the societal perspective Setting United States. Population Girls and boys aged 12 years. Interventions HPV vaccination of girls alone and of girls and boys in the context of screening for cervical cancer. Main outcome measure Incremental cost effectiveness ratios, expressed as cost per quality adjusted life year (QALY) gained. Results With 75% vaccination coverage and an assumption of complete, lifelong vaccine efficacy, routine HPV vaccination of 12 year old girls was consistently less than $ 50 000 per QALY gained compared with screening alone. Including preadolescent boys in a routine vaccination programme for preadolescent girls resulted in higher costs and benefits and generally had cost effectiveness ratios that exceeded $ 100 000 per QALY across a range of HPV related outcomes, scenarios for cervical cancer screening, and assumptions of vaccine efficacy and duration. Vaccinating both girls and boys fell below a willingness to pay threshold of $ 100 000 per QALY only under scenarios of high, lifelong vaccine efficacy against all HPV related diseases (including other non-cervical cancers and genital warts), or scenarios of lower efficacy with lower coverage or lower vaccine costs. Conclusions Given currently available information, including boys in an HPV vaccination programme generally exceeds conventional thresholds of good value for money, even under favourable conditions of vaccine protection and health benefits. Uncertainty still exists in many areas that can either strengthen or attenuate our findings. As new information emerges, assumptions and analyses will need to be iteratively revised to continue to inform policies for HPV vaccination.	[Kim, Jane J.; Goldie, Sue J.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Kim, JJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Ctr Hlth Decis Sci, 718 Huntington Ave, Boston, MA 02115 USA.	jkim@hsph.harvard.edu			National Cancer Institute [R01 CA93435]; Centers for Disease Control and Prevention; American Cancer Society; Bill and Melinda Gates Foundation [30505]; NATIONAL CANCER INSTITUTE [R01CA093435] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); American Cancer Society(American Cancer Society); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are supported by grants from the National Cancer Institute (R01 CA93435), the Centers for Disease Control and Prevention, and the American Cancer Society, and by the Bill and Melinda Gates Foundation (30505) for related work in developing countries. The authors' work was independent of the funders, and the funding sources had no involvement in the study design; collection, analysis, or interpretation of data; writing of the report; or the decision to submit the paper for publication.	American College of Obstetricians and Gynecologists, 2003, Int J Gynaecol Obstet, V83, P237; [Anonymous], [No title captured]; Barnaby N, 2007, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2007/07/017; Barnett D, 2009, HEALTH AFFAIR, V28, P600, DOI 10.1377/hlthaff.28.2.600; Bishai D, 2000, ARCH OTOLARYNGOL, V126, P935, DOI 10.1001/archotol.126.8.935; Boot HJ, 2007, VACCINE, V25, P6245, DOI 10.1016/j.vaccine.2007.05.061; Brisson M, 2007, VACCINE, V25, P5399, DOI 10.1016/j.vaccine.2007.04.086; Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026; Clifford GM, 2003, BRIT J CANCER, V89, P101, DOI 10.1038/sj.bjc.6601024; Clifford GM, 2003, BRIT J CANCER, V88, P63, DOI 10.1038/sj.bjc.6600688; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Dasbach EJ, 2006, EPIDEMIOL REV, V28, P88, DOI 10.1093/epirev/mxj006; DERKAY CS, 1995, ARCH OTOLARYNGOL, V121, P1386; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Eltoum IA, 2007, CANCER CYTOPATHOL, V111, P34, DOI 10.1002/cncr.22487; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Franceschi S, 2002, BRIT J CANCER, V86, P705, DOI 10.1038/sj.bjc.6600194; Franco EL, 2006, VACCINE, V24, P171, DOI 10.1016/j.vaccine.2006.05.061; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; GIULIANO AR, 2008, EFFICACY QUADRIVALEN; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Gold MR, 1996, COST EFFECTIVENESS H; Goldhaber-Fiebert JD, 2008, JNCI-J NATL CANCER I, V100, P308, DOI 10.1093/jnci/djn019; Goldie SJ, 2004, OBSTET GYNECOL, V103, P619, DOI 10.1097/01.AOG.0000120143.50098.c7; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Goldie SJ, 2007, VACCINE, V25, P6257, DOI 10.1016/j.vaccine.2007.05.058; Hamilton Brady E, 2006, Natl Vital Stat Rep, V55, P1; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Haug C, 2009, JAMA-J AM MED ASSOC, V302, P795, DOI 10.1001/jama.2009.1215; Hu D, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.064; Insinga RP, 2004, CANCER EPIDEM BIOMAR, V13, P355; Insinga RP, 2003, CLIN INFECT DIS, V36, P1397, DOI 10.1086/375074; *INT UN CANC, 1966, CANC NIC 5 CONT, V1; Iskedjian M, 2004, VACCINE, V22, P4215, DOI 10.1016/j.vaccine.2004.04.025; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kim JJ, 2007, BRIT J CANCER, V97, P1322, DOI 10.1038/sj.bjc.6604023; Kim JJ, 2008, VACCINE, V26, pK76, DOI 10.1016/j.vaccine.2008.06.009; Kim JJ, 2008, NEW ENGL J MED, V359, P821, DOI 10.1056/NEJMsa0707052; Kim JJ, 2007, AM J EPIDEMIOL, V166, P137, DOI 10.1093/aje/kwm086; Kulasingam SL, 2003, JAMA-J AM MED ASSOC, V290, P781, DOI 10.1001/jama.290.6.781; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; Marra F, 2009, PHARMACOECONOMICS, V27, P127, DOI 10.2165/00019053-200927020-00004; Mennini FS, 2009, GYNECOL ONCOL, V112, P370, DOI 10.1016/j.ygyno.2008.09.031; MITKA M, 2008, JAMA, V300, P1290; Mosher William D, 2005, Adv Data, P1; *NAT CANC I, 2005, SURV EP END RES SEER; Newall AT, 2007, LANCET INFECT DIS, V7, P289, DOI 10.1016/S1473-3099(07)70083-X; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; PALEFSKY J, 2008, EFFICACY QUADRIVALEN; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Rowhani-Rahbar A, 2009, VACCINE, V27, P5612, DOI 10.1016/j.vaccine.2009.07.027; Sanders GD, 2003, EMERG INFECT DIS, V9, P37; Saslow D, 2002, CA-CANCER J CLIN, V52, P342, DOI 10.3322/canjclin.52.6.342; Saslow D, 2007, CA-CANCER J CLIN, V57, P7, DOI 10.3322/canjclin.57.1.7; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Slade BA, 2009, JAMA-J AM MED ASSOC, V302, P750, DOI 10.1001/jama.2009.1201; Steinbrook R, 2009, NEW ENGL J MED, V360, P1057, DOI 10.1056/NEJMp0900665; Taira AV, 2004, EMERG INFECT DIS, V10, P1915, DOI 10.3201/eid1011.040222; *US CDCP, 1999, HIV COUNS TEST SYST; *US CDCP, 2007, MMWR-MORBID MORTAL W, V56, P885; *US CDCP, 2008, MMWR-MORBID MORTAL W, V57, P1100; *US CDCP, 2009, HPV VACC INF YOUNG W; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wallace LA, 2005, VACCINE, V23, P5624, DOI 10.1016/j.vaccine.2005.06.034; Watson M, 2008, CANCER-AM CANCER SOC, V113, P2841, DOI 10.1002/cncr.23758; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047	71	158	161	2	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2009	339								b3884	10.1136/bmj.b3884	http://dx.doi.org/10.1136/bmj.b3884			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TH	19815582	Green Published, hybrid			2022-12-28	WOS:000270719300002
J	Lahn, BT; Ebenstein, L				Lahn, Bruce T.; Ebenstein, Lanny			Let's celebrate human genetic diversity	NATURE			English	Editorial Material							SELECTION; GENOME		[Lahn, Bruce T.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ebenstein, Lanny] Univ Calif Santa Barbara, Dept Econ, Santa Barbara, CA 93106 USA	University of Chicago; University of California System; University of California Santa Barbara	Lahn, BT (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	blahn@bsd.uchicago.edu						de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; KAMIN LJ, 1984, NOT OUR GENES BIOL I; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Peregrine Peter N., 2009, ANCIENT HUMAN MIGRAT; Phan VH, 2009, EXPERT OPIN DRUG MET, V5, P243, DOI [10.1517/17425250902800153, 10.1517/17425250902800153 ]; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rose S, 2009, NATURE, V457, P786, DOI 10.1038/457786a; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Zhu XF, 2008, ADV GENET, V60, P547, DOI 10.1016/S0065-2660(07)00419-1	15	15	15	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 8	2009	461	7265					726	728		10.1038/461726a	http://dx.doi.org/10.1038/461726a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	503OR	19812654				2022-12-28	WOS:000270547500017
J	Ozsolak, F; Platt, AR; Jones, DR; Reifenberger, JG; Sass, LE; McInerney, P; Thompson, JF; Bowers, J; Jarosz, M; Milos, PM				Ozsolak, Fatih; Platt, Adam R.; Jones, Dan R.; Reifenberger, Jeffrey G.; Sass, Lauryn E.; McInerney, Peter; Thompson, John F.; Bowers, Jayson; Jarosz, Mirna; Milos, Patrice M.			Direct RNA sequencing	NATURE			English	Article							2ND-STRAND CDNA SYNTHESIS; DNA; TRANSCRIPTOME; POLYADENYLATION; EXPRESSION; SNORNA	Our understanding of human biology and disease is ultimately dependent on a complete understanding of the genome and its functions. The recent application of microarray and sequencing technologies to transcriptomics has changed the simplistic view of transcriptomes to a more complicated view of genome-wide transcription where a large fraction of transcripts emanates from unannotated parts of genomes(1-7), and underlined our limited knowledge of the dynamic state of transcription. Most of this broad body of knowledge was obtained indirectly because current transcriptome analysis methods typically require RNA to be converted to complementary DNA ( cDNA) before measurements, even though the cDNA synthesis step introduces multiple biases and artefacts that interfere with both the proper characterization and quantification of transcripts(8-18). Furthermore, cDNA synthesis is not particularly suitable for the analysis of short, degraded and/or small quantity RNA samples. Here we report direct single molecule RNA sequencing without prior conversion of RNA to cDNA. We applied this technology to sequence femtomole quantities of poly(A)(+) Saccharomyces cerevisiae RNA using a surface coated with poly(dT) oligonucleotides to capture the RNAs at their natural poly(A) tails and initiate sequencing by synthesis. We observed transcript 3' end heterogeneity and polyadenylated small nucleolar RNAs. This study provides a path to high-throughput and low-cost direct RNA sequencing and achieving the ultimate goal of a comprehensive and bias-free understanding of transcriptomes.	[Ozsolak, Fatih; Platt, Adam R.; Jones, Dan R.; Reifenberger, Jeffrey G.; Sass, Lauryn E.; McInerney, Peter; Thompson, John F.; Bowers, Jayson; Jarosz, Mirna; Milos, Patrice M.] Helicos BioSci Corp, Cambridge, MA 02139 USA		Ozsolak, F (corresponding author), Helicos BioSci Corp, 1 Kendall Sq, Cambridge, MA 02139 USA.	fatihozsolak@gmail.com; pmilos@helicosbio.com		Thompson, John/0000-0001-8568-3311; Jones, Daniel/0000-0001-8108-0169	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005230] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG005230] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Braslavsky I, 2003, P NATL ACAD SCI USA, V100, P3960, DOI 10.1073/pnas.0230489100; Cocquet J, 2006, GENOMICS, V88, P127, DOI 10.1016/j.ygeno.2005.12.013; Denoeud F, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r175; Grzechnik P, 2008, MOL CELL, V32, P247, DOI 10.1016/j.molcel.2008.10.003; GUBLER U, 1987, METHOD ENZYMOL, V152, P330; GUBLER U, 1987, METHOD ENZYMOL, V152, P325; Haddad F, 2006, AM J PHYSIOL-HEART C, V290, pH2351, DOI 10.1152/ajpheart.01111.2005; Haddad F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-21; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; KARKAS JD, 1972, P NATL ACAD SCI USA, V69, P398, DOI 10.1073/pnas.69.2.398; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Lipson D, 2009, NAT BIOTECHNOL, V27, P652, DOI 10.1038/nbt.1551; Mader RM, 2001, J LAB CLIN MED, V137, P422, DOI 10.1067/mlc.2001.115452; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; QianWu J, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-1-r3, 10.1186/gb-2008-9-5-220]; ROBERTS JD, 1989, MOL CELL BIOL, V9, P469, DOI 10.1128/MCB.9.2.469; Roy SW, 2008, BIOESSAYS, V30, P601, DOI 10.1002/bies.20749; Roy SW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-208; RUTTIMANN C, 1985, EUR J BIOCHEM, V149, P41, DOI 10.1111/j.1432-1033.1985.tb08890.x; Slomovic S, 2006, NUCLEIC ACIDS RES, V34, P2966, DOI 10.1093/nar/gkl357; SPIEGELMAN S, 1970, NATURE, V227, P1029, DOI 10.1038/2271029a0; STENESH J, 1968, BIOCHIM BIOPHYS ACTA, V161, P442, DOI 10.1016/0005-2787(68)90121-4; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; VARADARAJ K, 1994, GENE, V140, P1, DOI 10.1016/0378-1119(94)90723-4; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002	30	289	329	9	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					814	U73		10.1038/nature08390	http://dx.doi.org/10.1038/nature08390			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19776739				2022-12-28	WOS:000270547500040
J	Nabel, GJ				Nabel, Gary J.			The Coordinates of Truth	SCIENCE			English	Editorial Material							DEPENDENT DNA POLYMERASE; RNA; VIRIONS; SCIENCE		NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gnabel@nih.gov						BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; BERGET SM, 1977, P NATL ACAD SCI USA, V74, P3171, DOI 10.1073/pnas.74.8.3171; Esparza J, 2007, J EXP MED, V204, P701, DOI 10.1084/jem.20070073; GELINAS RE, 1977, CELL, V11, P533, DOI 10.1016/0092-8674(77)90071-X; Kell DB, 2004, BIOESSAYS, V26, P99, DOI 10.1002/bies.10385; Kuhn Thomas S., 1962, STRUCTURE SCI REVOLU, P144; POPPER KR, 1959, LOGIC SCI DISCOVERY, P144; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0	8	25	25	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 2	2009	326	5949					53	54		10.1126/science.1177637	http://dx.doi.org/10.1126/science.1177637			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501CA	19797647				2022-12-28	WOS:000270355600028
J	Nishida, Y; Arakawa, S; Fujitani, K; Yamaguchi, H; Mizuta, T; Kanaseki, T; Komatsu, M; Otsu, K; Tsujimoto, Y; Shimizu, S				Nishida, Yuya; Arakawa, Satoko; Fujitani, Kenji; Yamaguchi, Hirofumi; Mizuta, Takeshi; Kanaseki, Toku; Komatsu, Masaaki; Otsu, Kinya; Tsujimoto, Yoshihide; Shimizu, Shigeomi			Discovery of Atg5/Atg7-independent alternative macroautophagy	NATURE			English	Article							AUTOPHAGOSOME FORMATION; STARVATION; PROTEIN; DEGRADATION; ENDOSOMES; BECLIN-1; DISEASE; LC3	Macroautophagy is a process that leads to the bulk degradation of subcellular constituents by producing autophagosomes/autolysosomes(1-3). It is believed that Atg5 (ref. 4) and Atg7 (ref. 5) are essential genes for mammalian macroautophagy. Here we show, however, that mouse cells lacking Atg5 or Atg7 can still form autophagosomes/autolysosomes and perform autophagy-mediated protein degradation when subjected to certain stressors. Although lipidation of the microtubule-associated protein light chain 3 (LC3, also known as Map1lc3a) to form LC3-II is generally considered to be a good indicator of macroautophagy(6), it did not occur during the Atg5/Atg7-independent alternative process of macroautophagy. We also found that this alternative process of macroautophagy was regulated by several autophagic proteins, including Unc-51-like kinase 1 (Ulk1) and beclin 1. Unlike conventional macroautophagy, autophagosomes seemed to be generated in aRab9-dependent manner by the fusion of isolation membranes with vesicles derived from the trans-Golgi and late endosomes. In vivo, Atg5-independent alternative macroautophagy was detected in several embryonic tissues. It also had a function in clearing mitochondria during erythroid maturation. These results indicate that mammalian macroautophagy can occur through at least two different pathways: an Atg5/Atg7-dependent conventional pathway and an Atg5/Atg7-independent alternative pathway.	[Nishida, Yuya; Arakawa, Satoko; Fujitani, Kenji; Yamaguchi, Hirofumi; Mizuta, Takeshi; Kanaseki, Toku; Shimizu, Shigeomi] Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Cell Biol, Bunkyo Ku, Tokyo 1138510, Japan; [Otsu, Kinya] Osaka Univ, Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Nishida, Yuya; Tsujimoto, Yoshihide] Osaka Univ, Sch Med, Dept Med Genet, Suita, Osaka 5650871, Japan; [Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Lab Frontier Sci, Bunkyo Ku, Tokyo 1138613, Japan	Tokyo Medical & Dental University (TMDU); Osaka University; Osaka University; Tokyo Metropolitan Institute of Medical Science	Shimizu, S (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Pathol Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	shimizu.pcb@mri.tmd.ac.jp	Komatsu, Masaaki/B-8321-2011; Yamaguchi, Hirofumi/ABC-4940-2020; Arakawa, Satoko/AAM-9638-2020	Komatsu, Masaaki/0000-0001-7672-7722; Arakawa, Satoko/0000-0002-4375-1643	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Creative Scientific Research; Japanese Ministry of Education, Science, Sports and Culture; Japanese Ministry of Health, Labor and Welfare; Japan Science and Technology Corporation; Uehara Memorial Foundation; Sagawa Foundation for Promotion of Cancer Research; YASUDA Medical Foundation; Astellas foundation for research on metabolic disorders; Foundation for Promotion of Cancer Research	Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Creative Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Uehara Memorial Foundation(Uehara Memorial Foundation); Sagawa Foundation for Promotion of Cancer Research; YASUDA Medical Foundation; Astellas foundation for research on metabolic disorders; Foundation for Promotion of Cancer Research	We thank M. Narita and A. R. J. Young for critical reading of the manuscript; N. Mizushima for providing Atg5<SUP>+/-</SUP> mice and the expression plasmid of GFP-LC3; T. Yoshimori for the human beclin 1 expression plasmid; and T. Kitamura for providing Plat-E cells. This study was supported in part by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), a grant for Creative Scientific Research, a grant for the 21st Century COE Program from the Japanese Ministry of Education, Science, Sports and Culture, a grant for Comprehensive Research on Aging and Health from the Japanese Ministry of Health, Labor and Welfare, and a grant for Solution-Oriented Research for Science and Technology (SORST) from the Japan Science and Technology Corporation. This study was also supported by grants from the Uehara Memorial Foundation, the Sagawa Foundation for Promotion of Cancer Research, the YASUDA Medical Foundation, the Astellas foundation for research on metabolic disorders, and the Foundation for Promotion of Cancer Research.	Bursch W, 2001, CELL DEATH DIFFER, V8, P569, DOI 10.1038/sj.cdd.4400852; Cuervo AM, 2004, MOL CELL BIOCHEM, V263, P55, DOI 10.1023/B:MCBI.0000041848.57020.57; Fader CM, 2006, AUTOPHAGY, V2, P122, DOI 10.4161/auto.2.2.2350; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; Matsui M, 2006, BIOCHEM BIOPH RES CO, V339, P485, DOI 10.1016/j.bbrc.2005.11.044; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; OgierDenis E, 1996, J BIOL CHEM, V271, P28593, DOI 10.1074/jbc.271.45.28593; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Rosenbluth JM, 2009, AUTOPHAGY, V5, P114, DOI 10.4161/auto.5.1.7294; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Young ARJ, 2006, J CELL SCI, V119, P3888, DOI 10.1242/jcs.03172; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100	28	819	843	4	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					654	U99		10.1038/nature08455	http://dx.doi.org/10.1038/nature08455			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19794493				2022-12-28	WOS:000270302600041
J	McKnight, R; Boughton, N				McKnight, Rebecca; Boughton, Nicky			A patient's journey Anorexia nervosa	BRITISH MEDICAL JOURNAL			English	Editorial Material									[McKnight, Rebecca] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Boughton, Nicky] Warneford Hosp, Cotswold House Specialist Eating Disorders Serv, Oxford, England	University of Oxford	McKnight, R (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	rebecca.mcknight@psych.ox.ac.uk							0	30	30	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 24	2009	339								b3800	10.1136/bmj.b3800	http://dx.doi.org/10.1136/bmj.b3800			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	499OG	19778976				2022-12-28	WOS:000270231800007
J	Asch, DA; Nicholson, S; Srinivas, S; Herrin, J; Epstein, AJ				Asch, David A.; Nicholson, Sean; Srinivas, Sindhu; Herrin, Jeph; Epstein, Andrew J.			Evaluating Obstetrical Residency Programs Using Patient Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRAINING-PROGRAMS; PROVIDER VOLUME; MORTALITY; HOSPITALS; SURGEONS; QUALITY	Context Patient outcomes have been used to assess the performance of hospitals and physicians; in contrast, residency programs have been compared based on non-clinical measures. Objective To assess whether obstetrics and gynecology residency programs can be evaluated by the quality of care their alumni deliver. Design, Setting, and Patients A retrospective analysis of all Florida and New York obstetrical hospital discharges between 1992 and 2007, representing 4 906 169 deliveries performed by 4124 obstetricians from 107 US residency programs. Main Outcome Measures Nine measures of maternal complications from vaginal and cesarean births reflecting laceration, hemorrhage, and all other complications after vaginal delivery; hemorrhage, infection, and all other complications after cesarean delivery; and composites for vaginal and cesarean deliveries and for all deliveries regardless of mode. Results Obstetricians' residency program was associated with substantial variation in maternal complication rates. Women treated by obstetricians trained in residency programs in the bottom quintile for risk-standardized major maternal complication rates had an adjusted complication rate of 13.6%, approximately one-third higher than the 10.3% adjusted rate for women treated by obstetricians from programs in the top quintile (absolute difference, 3.3%; 95% confidence interval, 2.8%-3.8%). The rankings of residency programs based on each of the 9 measures were similar. Adjustment for medical licensure examination scores did not substantially alter the program ranking. Conclusions Obstetrics and gynecology training programs can be ranked by the maternal complication rates of their graduates' patients. These rankings are stable across individual types of complications and are not associated with residents' licensing examination scores. JAMA. 2009;302(12):1277-1283	[Asch, David A.; Nicholson, Sean; Srinivas, Sindhu; Epstein, Andrew J.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Asch, David A.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Srinivas, Sindhu] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Nicholson, Sean] Cornell Univ, Ithaca, NY USA; [Herrin, Jeph; Epstein, Andrew J.] Yale Univ, New Haven, CT USA	University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Cornell University; Yale University	Asch, DA (corresponding author), Univ Penn, Leonard Davis Inst Hlth Econ, 3641 Locust Walk, Philadelphia, PA 19104 USA.	asch@wharton.upenn.edu	Sandall, Jane/D-4146-2009	Sandall, Jane/0000-0003-2000-743X; Epstein, Andrew/0000-0001-5078-6564; Asch, David/0000-0002-7970-286X	National Board of Medical Examiners	National Board of Medical Examiners	This work was supported by a grant from the Stemmler Fund of the National Board of Medical Examiners (Drs Asch, Nicholson, and Epstein).	Asch DA, 2007, JAMA-J AM MED ASSOC, V298, P1049, DOI 10.1001/jama.298.9.1049; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Bryk A. S., 1992, HIERARCHICAL LINEAR; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Gregory KD, 2002, HEALTH SERV RES, V37, P1387, DOI 10.1111/1475-6773.10762; Hannan EL, 2003, CIRCULATION, V108, P795, DOI 10.1161/01.CIR.0000084551.52010.3B; Hannan EL, 1997, JAMA-J AM MED ASSOC, V277, P892, DOI 10.1001/jama.277.11.892; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hartz AJ, 1999, MED CARE, V37, P93, DOI 10.1097/00005650-199901000-00013; HOERGER TJ, 1995, MED CARE, V33, P332, DOI 10.1097/00005650-199504000-00002; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; Luft HS, 2003, MED CARE, V41, P1118, DOI 10.1097/01.MLR.0000088086.81977.F1; Normand SLT, 2007, STAT SCI, V22, P206, DOI 10.1214/088342307000000096; Shahian DM, 2005, ANN THORAC SURG, V80, P2106, DOI 10.1016/j.athoracsur.2005.06.078; Sheikh K, 2003, MED CARE, V41, P1111, DOI 10.1097/01.MLR.0000088085.61714.AE; Sheikh K, 2001, AM J MED, V111, P712, DOI 10.1016/S0002-9343(01)00924-X; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Snijders TAB, 2000, MULTILEVEL ANAL INTR; BIRTHS PRELIMINARY D	19	211	211	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1277	1283		10.1001/jama.2009.1356	http://dx.doi.org/10.1001/jama.2009.1356			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497AR	19773562	Bronze			2022-12-28	WOS:000270026000009
J	West, CP; Tan, AD; Habermann, TM; Sloan, JA; Shanafelt, TD				West, Colin P.; Tan, Angelina D.; Habermann, Thomas M.; Sloan, Jeff A.; Shanafelt, Tait D.			Association of Resident Fatigue and Distress With Perceived Medical Errors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EPWORTH SLEEPINESS SCALE; ADVERSE EVENTS; DAYTIME SLEEPINESS; INTENSIVE-CARE; WORK HOURS; BURNOUT; MISTAKES; INTERNS; EMPATHY; CANCER	Context Fatigue and distress have been separately shown to be associated with medical errors. The contribution of each factor when assessed simultaneously is unknown. Objective To determine the association of fatigue and distress with self-perceived major medical errors among resident physicians using validated metrics. Design, Setting, and Participants Prospective longitudinal cohort study of categorical and preliminary internal medicine residents at Mayo Clinic, Rochester, Minnesota. Data were provided by 380 of 430 eligible residents (88.3%). Participants began training from 2003 to 2008 and completed surveys quarterly through February 2009. Surveys included self-assessment of medical errors, linear analog self-assessment of overall quality of life (QOL) and fatigue, the Maslach Burnout Inventory, the PRIME-MD depression screening instrument, and the Epworth Sleepiness Scale. Main Outcome Measures Frequency of self-perceived, self-defined major medical errors was recorded. Associations of fatigue, QOL, burnout, and symptoms of depression with a subsequently reported major medical error were determined using generalized estimating equations for repeated measures. Results The mean response rate to individual surveys was 67.5%. Of the 356 participants providing error data (93.7%), 139 (39%) reported making at least 1 major medical error during the study period. In univariate analyses, there was an association of subsequent self-reported error with the Epworth Sleepiness Scale score (odds ratio [OR], 1.10 per unit increase; 95% confidence interval [CI], 1.03-1.16; P = .002) and fatigue score (OR, 1.14 per unit increase; 95% CI, 1.08-1.21; P < .001). Subsequent error was also associated with burnout (ORs per 1-unit change: depersonalization OR, 1.09; 95% CI, 1.05-1.12; P < .001; emotional exhaustion OR, 1.06; 95% CI, 1.04-1.08; P < .001; lower personal accomplishment OR, 0.94; 95% CI, 0.92-0.97; P < .001), a positive depression screen (OR, 2.56; 95% CI, 1.76-3.72; P < .001), and overall QOL (OR, 0.84 per unit increase; 95% CI, 0.79-0.91; P < .001). Fatigue and distress variables remained statistically significant when modeled together with little change in the point estimates of effect. Sleepiness and distress, when modeled together, showed little change in point estimates of effect, but sleepiness no longer had a statistically significant association with errors when adjusted for burnout or depression. Conclusion Among internal medicine residents, higher levels of fatigue and distress are independently associated with self-perceived medical errors. JAMA. 2009;302(12):1294-1300	[West, Colin P.] Mayo Clin, Div Gen Internal Med, Rochester, MN 55905 USA; [West, Colin P.; Tan, Angelina D.; Sloan, Jeff A.] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN 55905 USA; [West, Colin P.; Habermann, Thomas M.; Shanafelt, Tait D.] Mayo Clin, Dept Med, Rochester, MN 55905 USA; [Habermann, Thomas M.; Shanafelt, Tait D.] Mayo Clin, Div Hematol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	West, CP (corresponding author), Mayo Clin, Div Gen Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	west.colin@mayo.edu			Mayo Clinic Department of Medicine Program on Physician Well-being	Mayo Clinic Department of Medicine Program on Physician Well-being	This work was supported by the Mayo Clinic Department of Medicine Program on Physician Well-being.	Agency for Healthcare Research and Quality, MAK HLTH CAR SAF CRI; Baker GR, 2004, CAN MED ASSOC J, V170, P1678, DOI 10.1503/cmaj.1040498; Barger LK, 2006, PLOS MED, V3, P2440, DOI 10.1371/journal.pmed.0030487; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Diggle PJ, 1994, ANAL LONGITUDINAL DA; Fahrenkopf AM, 2008, BRIT MED J, V336, P488, DOI 10.1136/bmj.39469.763218.BE; Gaba DM, 2002, NEW ENGL J MED, V347, P1249, DOI 10.1056/NEJMsa020846; Gander P, 2007, OCCUP ENVIRON MED, V64, P733, DOI 10.1136/oem.2006.030916; Gopal R, 2005, ARCH INTERN MED, V165, P2595, DOI 10.1001/archinte.165.22.2595; Gudex C, 1996, QUAL LIFE RES, V5, P521, DOI 10.1007/BF00439226; Handel DA, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-136; Institute of Medicine, 2008, RES DUT HOURS ENH SL; Jagsi R, 2005, ARCH INTERN MED, V165, P2607, DOI 10.1001/archinte.165.22.2607; JOHNS MW, 1992, SLEEP, V15, P376, DOI 10.1093/sleep/15.4.376; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; LIANG KY, 1986, BIOMETRIKA, V73, P1; Lockley SW, 2007, JT COMM J QUAL PATIE, V33, P7, DOI 10.1016/S1553-7250(07)33109-7; MIZRAHI T, 1984, SOC SCI MED, V19, P135, DOI 10.1016/0277-9536(84)90280-6; Nuckols TK, 2009, NEW ENGL J MED, V360, P2202, DOI 10.1056/NEJMsa0810251; ONEIL AC, 1993, ANN INTERN MED, V119, P370, DOI 10.7326/0003-4819-119-5-199309010-00004; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Pigeon WR, 2003, J PSYCHOSOM RES, V54, P61, DOI 10.1016/S0022-3999(02)00542-1; Rosen IM, 2006, ACAD MED, V81, P82, DOI 10.1097/00001888-200601000-00020; Rothschild JM, 2005, CRIT CARE MED, V33, P1694, DOI 10.1097/01.CCM.0000171609.91035.BD; Rummans TA, 2006, J CLIN ONCOL, V24, P635, DOI 10.1200/JCO.2006.06.209; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, V3rd, P22; Shanafelt TD, 2005, ONCOLOGY-BASEL, V68, P23, DOI 10.1159/000084519; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Shen JH, 2006, SLEEP MED REV, V10, P63, DOI 10.1016/j.smrv.2005.05.004; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Thomas NK, 2004, JAMA-J AM MED ASSOC, V292, P2880, DOI 10.1001/jama.292.23.2880; Weingart SN, 2001, J GEN INTERN MED, V16, P809, DOI 10.1046/j.1525-1497.2001.10231.x; West CP, 2006, JAMA-J AM MED ASSOC, V296, P1071, DOI 10.1001/jama.296.9.1071; Whooley MA, 1997, J GEN INTERN MED, V12, P439, DOI 10.1046/j.1525-1497.1997.00076.x; Williams JW, 2002, JAMA-J AM MED ASSOC, V287, P1160, DOI 10.1001/jama.287.9.1160; WU AW, 1991, JAMA-J AM MED ASSOC, V265, P2089, DOI 10.1001/jama.265.16.2089; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	40	589	600	1	42	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1294	1300		10.1001/jama.2009.1389	http://dx.doi.org/10.1001/jama.2009.1389			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497AR	19773564	Bronze			2022-12-28	WOS:000270026000011
J	Leff, DR; Heath, D				Leff, Daniel Richard; Heath, Dugal			Surgery for obesity in adulthood	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LONG-TERM MORTALITY; BARIATRIC SURGERY; GASTRIC BYPASS; COST-EFFECTIVENESS; WEIGHT-LOSS; FOLLOW-UP; METAANALYSIS; IMPACT		[Heath, Dugal] Whittington Hosp NHS Trust, Dept Surg, NLOSS, London N19 5NF, England; [Leff, Daniel Richard] St Marys Hosp, Dept BioSurg & Surg Technol, London W2 1NY, England	Imperial College London	Heath, D (corresponding author), Whittington Hosp NHS Trust, Dept Surg, NLOSS, London N19 5NF, England.	Dugal.Heath@whittington.nhs.uk						Ackroyd R, 2006, OBES SURG, V16, P1488, DOI 10.1381/096089206778870067; Adams TD, 2007, NEW ENGL J MED, V357, P753, DOI 10.1056/NEJMoa066603; [Anonymous], 2006, OB PREV ID ASS MAN O; Biagini J, 2008, OBES SURG, V18, P573, DOI 10.1007/s11695-008-9470-6; Buchwald H, 2007, SURGERY, V142, P621, DOI 10.1016/j.surg.2007.07.018; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; Christou NV, 2004, ANN SURG, V240, P416, DOI 10.1097/01.sla.0000137343.63376.19; Colquitt JL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003641.pub3; Cremieux PY, 2008, AM J MANAG CARE, V14, P589; Hawkins SC, 2007, OBES SURG, V17, P434, DOI 10.1007/s11695-007-9073-7; Higa KD, 2001, J LAPAROENDOSC ADV A, V11, P377, DOI 10.1089/10926420152761905; Himpens J, 2006, OBES SURG, V16, P1450, DOI 10.1381/096089206778869933; House of Commons Health Committee, 2004, OB 3 REP SESS 2003 2, V1; *INF CTR, 2006, STAT OB PHYS ACT DIE; Mark AL, 2008, HYPERTENSION, V51, P1426, DOI 10.1161/HYPERTENSIONAHA.106.085944; Mechanick JI, 2009, OBESITY, V17, pS1, DOI 10.1038/oby.2009.28; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; O'Brien PE, 2006, OBES SURG, V16, P1032, DOI 10.1381/096089206778026316; Perez N, 2005, OBES SURG, V15, P1061, DOI 10.1381/0960892054621143; Rosenbaum M, 1997, NEW ENGL J MED, V337, P396, DOI 10.1056/NEJM199708073370606; Salem L, 2008, SURG OBES RELAT DIS, V4, P26, DOI 10.1016/j.soard.2007.09.009; Sanchez-Santos R, 2009, OBES SURG, V19, P1203, DOI 10.1007/s11695-009-9892-9; Sjostrom L, 2004, NEW ENGL J MED, V351, P2683, DOI 10.1056/NEJMoa035622; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Stroh C, 2009, OBES SURG, V19, P105, DOI 10.1007/s11695-008-9736-z; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wolnerhanssen BK, 2008, SURG OBES RELAT DIS, V4, P500, DOI 10.1016/j.soard.2008.03.252; Yermilov I, 2009, OBESITY, V17, P1521, DOI 10.1038/oby.2009.78	28	30	31	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2009	339								b3402	10.1136/bmj.b3402	http://dx.doi.org/10.1136/bmj.b3402			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	499OE	19773325				2022-12-28	WOS:000270231500002
J	Halic, M; Moazed, D				Halic, Mario; Moazed, Danesh			Transposon Silencing by piRNAs	CELL			English	Editorial Material							DOMAIN PROTEIN; DROSOPHILA; RHINO; PIWI	In animal cells, small RNA molecules, called piRNAs, defend the genome against selfish DNA elements such as transposons. In this issue, Klattenhoff et al. (2009) report that an HP1 family protein, Rhino, is required for piRNA generation and transposon silencing in Drosophila germline cells. The results provide a link between heterochromatin and piRNA-mediated genome defense.	[Halic, Mario; Moazed, Danesh] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Halic, Mario; Moazed, Danesh] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Moazed, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu	Halic, Mario/X-2163-2018		Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM072805-07, R01 GM072805] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072805] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Vermaak D, 2005, PLOS GENET, V1, P96, DOI 10.1371/journal.pgen.0010009; Volpe AM, 2001, GENETICS, V159, P1117; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	9	44	45	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 18	2009	138	6					1058	1060		10.1016/j.cell.2009.08.030	http://dx.doi.org/10.1016/j.cell.2009.08.030			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766558	Bronze, Green Accepted			2022-12-28	WOS:000269923200005
J	Sohmen, D; Harms, JM; Schlunzen, F; Wilson, DN				Sohmen, Daniel; Harms, Joerg M.; Schluenzen, Frank; Wilson, Daniel N.			SnapShot: Antibiotic Inhibition of Protein Synthesis I	CELL			English	Editorial Material							RIBOSOME		[Sohmen, Daniel; Wilson, Daniel N.] Univ Munich, D-80539 Munich, Germany; [Harms, Joerg M.] Univ Hamburg, MPSD, Hamburg, Germany; [Schluenzen, Frank] DESY, D-2000 Hamburg, Germany; [Wilson, Daniel N.] CiPS M, Munich, Germany	University of Munich; University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Sohmen, D (corresponding author), Univ Munich, Marchioninistr 15, D-80539 Munich, Germany.		Schluenzen, Frank/P-9177-2019; Schluenzen, Frank/H-6274-2014; Harms, Joerg/K-8786-2012; Wilson, Daniel/AAE-8504-2019	Schluenzen, Frank/0000-0003-2849-0542; Schluenzen, Frank/0000-0003-2849-0542; Harms, Joerg/0000-0002-9442-8264; Wilson, Daniel/0000-0003-3816-3828				Moore PB, 2003, ANNU REV BIOCHEM, V72, P813, DOI 10.1146/annurev.biochem.72.110601.135450; Polacek N, 2005, CRIT REV BIOCHEM MOL, V40, P285, DOI 10.1080/10409230500326334; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/s001090050044; Sutcliffe JA, 2005, CURR OPIN MICROBIOL, V8, P534, DOI 10.1016/j.mib.2005.08.004; Tenson T, 2006, MOL MICROBIOL, V59, P1664, DOI 10.1111/j.1365-2958.2006.05063.x; Wilson D. N., 2004, PROTEIN SYNTHESIS RI, P449; Yonath A, 2005, ANNU REV BIOCHEM, V74, P649, DOI 10.1146/annurev.biochem.74.082803.133130	7	25	25	3	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 18	2009	138	6					1248	A1248		10.1016/j.cell.2009.08.001	http://dx.doi.org/10.1016/j.cell.2009.08.001			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766574	Bronze			2022-12-28	WOS:000269923200024
J	Chaudhry, A; Rudra, D; Treuting, P; Samstein, RM; Liang, YQ; Kas, A; Rudensky, AY				Chaudhry, Ashutosh; Rudra, Dipayan; Treuting, Piper; Samstein, Robert M.; Liang, Yuqiong; Kas, Arnold; Rudensky, Alexander Y.			CD4(+) Regulatory T Cells Control T(H)17 Responses in a Stat3-Dependent Manner	SCIENCE			English	Article							ROR-GAMMA; TGF-BETA; DIFFERENTIATION; INFLAMMATION; IL-23; FOXP3; HOMEOSTASIS; INDUCTION; PATHWAYS; PROGRAMS	Distinct classes of protective immunity are guided by activation of STAT transcription factor family members in response to environmental cues. CD4(+) regulatory T cells (T-regs) suppress excessive immune responses, and their deficiency results in a lethal, multi-organ autoimmune syndrome characterized by T helper 1 (T(H)1) and T helper 2 (T(H)2) CD4(+) T cell-dominated lesions. Here we show that pathogenic T(H)17 responses in mice are also restrained by T-regs. This suppression was lost upon T-reg-specific ablation of Stat3, a transcription factor critical for T(H)17 differentiation, and resulted in the development of a fatal intestinal inflammation. These findings suggest that T-regs adapt to their environment by engaging distinct effector response-specific suppression modalities upon activation of STAT proteins that direct the corresponding class of the immune response.	[Chaudhry, Ashutosh; Rudra, Dipayan; Samstein, Robert M.; Liang, Yuqiong; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Chaudhry, Ashutosh; Rudra, Dipayan; Samstein, Robert M.; Liang, Yuqiong; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Chaudhry, Ashutosh; Rudra, Dipayan; Kas, Arnold; Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Treuting, Piper] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.	rudenska@mskcc.org	Treuting, Piper M./AAB-2721-2019; Rudra, Dipayan/B-6660-2012; Rudra, Dipayan/AAZ-5426-2020	Treuting, Piper M./0000-0002-1812-1519; Rudra, Dipayan/0000-0002-9667-5891; Chaudhry, Ashutosh/0000-0003-3379-5236; Samstein, Robert/0000-0001-6860-2401	NIH [AI-061816, AI-034206]; Cancer Research Institute; Arthritis Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI034206, R37AI034206, R01AI061816, R01AI034206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Arthritis Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Forbush, T. Chu, L. Karpik, and A. Bravo for assistance with the mouse colony management; S. Akira for Stat3fl/fl mice; and J. Renauld for antibody to IL-22. This work was supported by NIH grants AI-061816 and AI-034206. A. C. is supported by the Cancer Research Institute, and D. R. is supported by the Arthritis Foundation. A. Y. R. is an investigator with the Howard Hughes Medical Institute. Gene expression microarray data have been deposited in the NCBI Gene Expression Omnibus repository with the accession code GSE17962.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Maloy KJ, 2008, MUCOSAL IMMUNOL, V1, P339, DOI 10.1038/mi.2008.28; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Yadav M, 2008, J IMMUNOL, V180, P2772, DOI 10.4049/jimmunol.180.5.2772; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	26	733	760	0	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 13	2009	326	5955					986	991		10.1126/science.1172702	http://dx.doi.org/10.1126/science.1172702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19797626	Green Accepted			2022-12-28	WOS:000271712300038
J	Wartman, SA; Hillhouse, EW; Gunning-Schepers, L; Wong, JEL				Wartman, Steven A.; Hillhouse, Edward W.; Gunning-Schepers, Louise; Wong, John E. L.			An international association of academic health centres	LANCET			English	Editorial Material									[Hillhouse, Edward W.] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England; [Wartman, Steven A.] Assoc Acad Hlth Ctr, Washington, DC USA; [Gunning-Schepers, Louise] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Wong, John E. L.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore; [Wong, John E. L.] Natl Univ Hlth Syst, Singapore, Singapore	University of Leeds; University of Amsterdam; Academic Medical Center Amsterdam; National University of Singapore; National University of Singapore	Hillhouse, EW (corresponding author), Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England.	e.w.hillhouse@leeds.ac.uk	Wong, John, Eu-Li/C-2947-2009					Davies SM, 2008, ACAD MED, V83, P535, DOI 10.1097/ACM.0b013e3181723033; Dzau VJ, 2010, LANCET, V375, P949, DOI 10.1016/S0140-6736(09)61082-5; Gracey M, 2009, LANCET, V374, P65, DOI 10.1016/S0140-6736(09)60914-4; Martin DR, 2006, ACAD MED, V81, P189, DOI 10.1097/00001888-200602000-00021; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Wartman SA, 2008, ACAD MED, V83, P797, DOI 10.1097/ACM.0b013e318181cf8c	6	6	6	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2009	374	9699					1402	1403		10.1016/S0140-6736(09)61594-4	http://dx.doi.org/10.1016/S0140-6736(09)61594-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	512MZ	19800112				2022-12-28	WOS:000271255000008
J	Hotchkiss, RS; Strasser, A; McDunn, JE; Swanson, PE				Hotchkiss, Richard S.; Strasser, Andreas; McDunn, Jonathan E.; Swanson, Paul E.			MECHANISMS OF DISEASE Cell Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BH3-ONLY PROTEINS PUMA; TUMOR NECROSIS FACTOR; INDUCED APOPTOSIS; CANCER-THERAPY; CYTOCHROME-C; PHARMACOLOGICAL MANIPULATION; MEMBRANE PERMEABILIZATION; AUTOREACTIVE THYMOCYTES; CEREBRAL-ISCHEMIA; ADOPTIVE TRANSFER		[Hotchkiss, Richard S.; McDunn, Jonathan E.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Strasser, Andreas] Walter & Eliza Hall Inst Med Res, Dept Mol Genet Canc, Melbourne, Vic 3050, Australia; [Swanson, Paul E.] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Walter & Eliza Hall Institute; University of Washington; University of Washington Seattle	Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, 660 S Euclid, St Louis, MO 63110 USA.	hotch@wustl.edu	Strasser, Andreas/C-7581-2013	Strasser, Andreas/0000-0002-5020-4891; Swanson, Paul/0000-0001-5557-7403; McDunn, Jonathan/0000-0001-8792-828X	National Institutes of Health [GM44118, GM55194]; Leukemia and Lymphoma Society of America; National Health and Medical Research Council of Australia; Alan A. and Edith L. Wolff Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044118, R01GM055194, R37GM044118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Alan A. and Edith L. Wolff Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants (GM44118 and GM55194) from the National Institutes of Health and by the Leukemia and Lymphoma Society of America, the National Health and Medical Research Council of Australia, and the Alan A. and Edith L. Wolff Foundation.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Ahn CH, 2007, APMIS, V115, P1344, DOI 10.1111/j.1600-0463.2007.00858.x; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; ASHFORD TP, 1962, J CELL BIOL, V12, P198, DOI 10.1083/jcb.12.1.198; Ayala A, 2008, CURR PHARM DESIGN, V14, P1853, DOI 10.2174/138161208784980617; Barinaga M, 2000, SCIENCE, V287, P947, DOI 10.1126/science.287.5455.947; Bossy B, 2008, CURR NEUROPHARMACOL, V6, P97, DOI 10.2174/157015908784533897; Bouchier-Hayes L, 2005, J CLIN INVEST, V115, P2640, DOI 10.1172/JCI26274; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cauwels A, 2003, NAT IMMUNOL, V4, P387, DOI 10.1038/ni914; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Conus S, 2008, J EXP MED, V205, P685, DOI 10.1084/jem.20072152; Conus S, 2008, BIOCHEM PHARMACOL, V76, P1374, DOI 10.1016/j.bcp.2008.07.041; Cragg MS, 2009, NAT REV CANCER, V9, P321, DOI 10.1038/nrc2615; Cudkowicz ME, 2008, MUSCLE NERVE, V38, P837, DOI 10.1002/mus.21059; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Foulis Alan K, 2008, Novartis Found Symp, V292, P2; Freire-de-Lima CG, 2000, NATURE, V404, P904, DOI 10.1038/35009154; Freire-de-Lima CG, 2000, NATURE, V403, P199, DOI 10.1038/35003208; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Goldstein JC, 2005, CELL DEATH DIFFER, V12, P453, DOI 10.1038/sj.cdd.4401596; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Green DR, 2005, J CLIN INVEST, V115, P2610, DOI 10.1172/JCI26321; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2000, CRIT CARE MED, V28, P3207, DOI 10.1097/00003246-200009000-00016; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2003, P NATL ACAD SCI USA, V100, P6724, DOI 10.1073/pnas.1031788100; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jiang SX, 2005, J BIOL CHEM, V280, P33811, DOI 10.1074/jbc.M503113200; Johnson GB, 2003, CRIT REV IMMUNOL, V23, P15, DOI 10.1615/CritRevImmunol.v23.i12.20; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Koenig A, 2008, CELL DEATH DIFFER, V15, P1701, DOI 10.1038/cdd.2008.100; Koumura A, 2008, NEUROSCIENCE, V157, P309, DOI 10.1016/j.neuroscience.2008.09.007; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; KUMAR V, 2005, ROBBINS COTRAN PATHO, P4; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P16614, DOI 10.1073/pnas.0606176103; Kuroda J, 2006, P NATL ACAD SCI USA, V103, P14907, DOI 10.1073/pnas.0606176103; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Lampl Y, 2007, NEUROLOGY, V69, P1404, DOI 10.1212/01.wnl.0000277487.04281.db; LASTER SM, 1988, J IMMUNOL, V141, P2629; Lee CC, 2008, ANNU REV MED, V59, P177, DOI 10.1146/annurev.med.59.061506.110403; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Lemasters JJ, 2005, GASTROENTEROLOGY, V129, P351, DOI 10.1053/j.gastro.2005.06.006; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Liu XL, 2004, ANNU REV PHARMACOL, V44, P349, DOI 10.1146/annurev.pharmtox.44.101802.121804; Loepke AW, 2009, ANESTH ANALG, V108, P90, DOI 10.1213/ane.0b013e31818cdb29; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Maclean KH, 2008, J CLIN INVEST, V118, P1584, DOI 10.1172/JCI33700C1; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; MAJNO G, 1995, AM J PATHOL, V146, P3; Malhi H, 2006, HEPATOLOGY, V43, pS31, DOI 10.1002/hep.21062; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Marx J, 2006, SCIENCE, V312, P1160, DOI 10.1126/science.312.5777.1160; McKenzie MD, 2008, DIABETES, V57, P1284, DOI 10.2337/db07-1692; Melino G, 2001, NATURE, V412, P23, DOI 10.1038/35083653; Miller JB, 2006, TRENDS MOL MED, V12, P279, DOI 10.1016/j.molmed.2006.04.003; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Narula Jagat, 2001, Cardiology Clinics, V19, P113, DOI 10.1016/S0733-8651(05)70198-3; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Nishimura Y, 2001, CELL DEATH DIFFER, V8, P850, DOI 10.1038/sj.cdd.4400877; Oliveira JB, 2008, J CLIN IMMUNOL, V28, pS20, DOI 10.1007/s10875-007-9161-4; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Plummer R, 2007, CLIN CANCER RES, V13, P6187, DOI 10.1158/1078-0432.CCR-07-0950; Pockros PJ, 2007, HEPATOLOGY, V46, P324, DOI 10.1002/hep.21664; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reed JC, 2006, NAT CLIN PRACT ONCOL, V3, P388, DOI 10.1038/ncponc0538; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Sarkar S, 2008, MOL BIOSYST, V4, P895, DOI 10.1039/b804606a; Sato T, 2008, J IMMUNOL, V181, P197, DOI 10.4049/jimmunol.181.1.197; SCHNEIDER MD, 2005, SCI STKE, pPE26; Schwulst SJ, 2007, BIOCHEM BIOPH RES CO, V353, P780, DOI 10.1016/j.bbrc.2006.12.098; Sheridan C, 2008, TRENDS CELL BIOL, V18, P353, DOI 10.1016/j.tcb.2008.06.002; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Tolcher AW, 2008, J CLIN ONCOL, V26, P5198, DOI 10.1200/JCO.2008.17.2064; Turk B, 2007, FEBS LETT, V581, P2761, DOI 10.1016/j.febslet.2007.05.038; VANDENABEELE P, 2006, SCI STKE, pPE44; Vanlangenakker N, 2008, CURR MOL MED, V8, P207, DOI 10.2174/156652408784221306; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Watanabe E, 2009, LAB INVEST, V89, P549, DOI 10.1038/labinvest.2009.8; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wu H, 2007, CELL, V131, P655, DOI 10.1016/j.cell.2007.10.042; Yamamoto S, 2008, J CARDIOTHOR VASC AN, V22, P548, DOI 10.1053/j.jvca.2008.02.011; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu JW, 2008, ONCOGENE, V27, P6216, DOI 10.1038/onc.2008.299; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	128	826	869	2	87	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2009	361	16					1570	1583		10.1056/NEJMra0901217	http://dx.doi.org/10.1056/NEJMra0901217			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506LT	19828534	Green Accepted			2022-12-28	WOS:000270777000010
J	Haller, G; Myles, PS; Taffe, P; Perneger, TV; Wu, CL				Haller, Guy; Myles, Paul S.; Taffe, Patrick; Perneger, Thomas V.; Wu, Christopher L.			Rate of undesirable events at beginning of academic year: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CREW RESOURCE-MANAGEMENT; INTENSIVE-CARE-UNIT; LENGTH-OF-STAY; ADVERSE EVENTS; JULY PHENOMENON; PATIENT SAFETY; ERRORS; QUALITY; ANESTHESIA; RESIDENTS	Objective To determine whether an increase in the rate of undesirable events occurs after care provided by trainees at the beginning of the academic year. Design Retrospective cohort study using administrative and patient record data. Setting University affiliated hospital in Melbourne, Australia. Participants 19 560 patients having an anaesthetic procedure carried out by first to fifth year trainees starting work for the first time at the hospital over a period of five years (1995-2000). Main outcome measures Absolute event rates, absolute rate reduction, and rate ratios of undesirable events. Results The rate of undesirable events was higher at the beginning of the academic year compared with the rest of the year (absolute event rate 137 v 107 per 1000 patient hours, relative rate reduction 28%, P<0.001). The overall adjusted rate ratio for undesirable events was 1.40, 95% confidence interval 1.24 to 1.58. This excess risk was seen for all residents, regardless of their level of seniority. The excess risk decreased progressively after the first month, and the trend disappeared fully after the fourth month of the year (rate ratio for fourth month 1.21, 0.93 to 1.57). The most important decreases were for central and peripheral nerve injuries (relative difference 82%), inadequate oxygenation of the patient (66%), vomiting/aspiration in theatre (53%), and technical failures of tracheal tube placement (49%). Conclusions The rate of undesirable events was greater among trainees at the beginning of the academic year regardless of their level of clinical experience. This suggests that several additional factors, such as knowledge of the working environment, teamwork, and communication, may contribute to the increase.	[Haller, Guy] Univ Geneva, Univ Hosp Geneva, Dept Anaesthesia Pharmacol & Intens Care, CH-1211 Geneva, Switzerland; [Myles, Paul S.] Monash Univ, Dept Anaesthesia & Perioperat Med, Alfred Hosp, Prahran, Vic 3181, Australia; [Taffe, Patrick] Univ Lausanne, Inst Social & Prevent Med, CH-1005 Lausanne, Switzerland; [Perneger, Thomas V.] Univ Hosp Geneva, Div Clin Epidemiol, Geneva, Switzerland; [Wu, Christopher L.] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	University of Geneva; Florey Institute of Neuroscience & Mental Health; Monash University; University of Lausanne; University of Geneva; Johns Hopkins University	Haller, G (corresponding author), Univ Geneva, Univ Hosp Geneva, Dept Anaesthesia Pharmacol & Intens Care, CH-1211 Geneva, Switzerland.	Guy.Haller@hcuge.ch	Myles, Paul/AAU-9524-2020; Taffé, Patrick/AAW-2701-2020; Wu, Christopher/AAH-5389-2020	Myles, Paul/0000-0002-3324-5456; Taffe, Patrick/0000-0002-2049-6651; Wu, Christopher/0000-0002-4484-0787; haller, guy/0000-0001-7367-7029	University of Geneva (Switzerland)	University of Geneva (Switzerland)	This research was supported by a University of Geneva (Switzerland) postgraduate research scholarship awarded to GH. The sponsor had no role in study design; data collection, analysis, and interpretation; or publication of results. The researchers were all independent from the funder.	Abeysekera A, 2005, ANAESTHESIA, V60, P220, DOI 10.1111/j.1365-2044.2005.04123.x; *AM SOC AN, 2008, ASA STAND GUID STAT; Andrews LB, 1997, LANCET, V349, P309, DOI 10.1016/S0140-6736(96)08268-2; *ANZCA, 2006, PROF STAND ANZCA, V6; AYLIN P, 1994, BRIT MED J, V309, P1690, DOI 10.1136/bmj.309.6970.1690; Baldwin DC, 2008, J INTERPROF CARE, V22, P573, DOI 10.1080/13561820802364740; Barry WA, 2003, J GEN INTERN MED, V18, P639, DOI 10.1046/j.1525-1497.2003.20605.x; Barzansky B, 2008, JAMA-J AM MED ASSOC, V300, P1221, DOI 10.1001/jama.300.10.1221; BELL BM, 1993, JAMA-J AM MED ASSOC, V269, P403, DOI 10.1001/jama.269.3.403; Booth JG, 2003, STAT MODEL, V3, P179, DOI 10.1191/1471082X03st058oa; BUCHWALD D, 1989, ARCH INTERN MED, V149, P765, DOI 10.1001/archinte.149.4.765; Claridge JA, 2001, SURGERY, V130, P346, DOI 10.1067/msy.2001.116670; Cosgrove CM, 2002, ANN ROY COLL SURG, V84, P344, DOI 10.1308/003588402760452691; Cruess SR, 2004, TEACH LEARN MED, V16, P74, DOI 10.1207/s15328015tlm1601_15; Dhaliwal AS, 2008, AM J SURG, V196, P720, DOI 10.1016/j.amjsurg.2008.07.005; Dunn EJ, 2007, JT COMM J QUAL PATIE, V33, P317, DOI 10.1016/S1553-7250(07)33036-5; Englesbe MJ, 2007, ANN SURG, V246, P456, DOI 10.1097/SLA.0b013e31814855f2; Epstein RM, 2002, JAMA-J AM MED ASSOC, V287, P226, DOI 10.1001/jama.287.2.226; Finkielman JD, 2004, CRIT CARE MED, V32, P1161, DOI 10.1097/01.CCM.0000126151.56590.99; Ford AA, 2007, J PERINATOL, V27, P73, DOI 10.1038/sj.jp.7211635; FRESS EW, 2004, LONGITUDINAL PANEL D; Gawande A., 2002, COMPLICATIONS SURG N; Haller G, 2005, ANESTHESIOLOGY, V103, P1121, DOI 10.1097/00000542-200512010-00004; Haller G, 2008, INT J QUAL HEALTH C, V20, P254, DOI 10.1093/intqhc/mzn018; Haller G, 2007, J AM MED INFORM ASSN, V14, P175, DOI 10.1197/jamia.M2196; Helmreich RL, 2000, BRIT MED J, V320, P781, DOI 10.1136/bmj.320.7237.781; Institute of Medicine, 2004, PATIENT SAFETY ACHIE; Issenberg SB, 1999, JAMA-J AM MED ASSOC, V282, P861, DOI 10.1001/jama.282.9.861; Jagsi R, 2005, ARCH INTERN MED, V165, P2607, DOI 10.1001/archinte.165.22.2607; Kluger MT, 1999, ANAESTHESIA, V54, P19, DOI 10.1046/j.1365-2044.1999.00642.x; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Kopacz DJ, 2002, REGION ANESTH PAIN M, V27, P9, DOI 10.1053/rapm.2002.29715; Lesar TS, 1997, JAMA-J AM MED ASSOC, V277, P312, DOI 10.1001/jama.277.4.312; MARSHALL JB, 1995, GASTROINTEST ENDOSC, V42, P287, DOI 10.1016/S0016-5107(95)70123-0; Mellin-Olsen J, 2007, EUR J ANAESTH, V24, P479, DOI 10.1017/S0265021507000324; Michel P, 2004, BRIT MED J, V328, P199, DOI 10.1136/bmj.328.7433.199; Norman J, 1996, J CLIN MONITOR, V12, P91; *ORG EC COOP DEV, OECD HLTH DAT 2008; Parke B, 2008, INT J AVIAT PSYCHOL, V18, P72, DOI 10.1080/10508410701749464; PETERSEN LA, 1994, ANN INTERN MED, V121, P866, DOI 10.7326/0003-4819-121-11-199412010-00008; Prystowsky JB, 2002, SURGERY, V132, P663, DOI 10.1067/msy.2002.127550; RICH EC, 1990, JAMA-J AM MED ASSOC, V263, P953; Rogers SO, 2006, SURGERY, V140, P25, DOI 10.1016/j.surg.2006.01.008; RUNCIMAN WB, 1993, ANAESTH INTENS CARE, V21, P506, DOI 10.1177/0310057X9302100506; SEE WA, 1993, JAMA-J AM MED ASSOC, V270, P2689, DOI 10.1001/jama.270.22.2689; SHNIDER SM, 1963, ANESTHESIOLOGY, V24, P11, DOI 10.1097/00000542-196301000-00002; Shulkin D J, 1995, Am J Med Qual, V10, P14, DOI 10.1177/0885713X9501000104; Smith ER, 2006, J NEUROSURG, V105, P169, DOI 10.3171/ped.2006.105.3.169; Volpp KGM, 2003, NEW ENGL J MED, V348, P851, DOI 10.1056/NEJMsb021667; *WHO, 2000, ICD 10 AM INT STAT C	50	83	84	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 13	2009	339								b3974	10.1136/bmj.b3974	http://dx.doi.org/10.1136/bmj.b3974			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	508DO	19826176	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000270908100003
J	Chaudhury, S; Smith, A; Anderson, BE; Ghose, S; Jessen, PS				Chaudhury, S.; Smith, A.; Anderson, B. E.; Ghose, S.; Jessen, P. S.			Quantum signatures of chaos in a kicked top	NATURE			English	Article							DECOHERENCE	Chaotic behaviour is ubiquitous and plays an important part in most fields of science. In classical physics, chaos is characterized by hypersensitivity of the time evolution of a system to initial conditions. Quantum mechanics does not permit a similar definition owing in part to the uncertainty principle, and in part to the Schrodinger equation, which preserves the overlap between quantum states. This fundamental disconnect poses a challenge to quantum-classical correspondence(1), and has motivated a long-standing search for quantum signatures of classical chaos(2,3). Here we present the experimental realization of a common paradigm for quantum chaos-the quantum kicked top(2,4)- and the observation directly in quantum phase space of dynamics that have a chaotic classical counterpart. Our system is based on the combined electronic and nuclear spin of a single atom and is therefore deep in the quantum regime; nevertheless, we find good correspondence between the quantum dynamics and classical phase space structures. Because chaos is inherently a dynamical phenomenon, special significance attaches to dynamical signatures such as sensitivity to perturbation(1,5) or the generation of entropy(6) and entanglement(7,8), for which only indirect evidence has been available(9- 11). We observe clear differences in the sensitivity to perturbation in chaotic versus regular, non-chaotic regimes, and present experimental evidence for dynamical entanglement as a signature of chaos.	[Chaudhury, S.; Smith, A.; Anderson, B. E.; Jessen, P. S.] Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA; [Ghose, S.] Wilfrid Laurier Univ, Dept Phys & Comp Sci, Waterloo, ON N2L 3C5, Canada	University of Arizona; Wilfrid Laurier University	Jessen, PS (corresponding author), Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA.	poul.jessen@optics.arizona.edu	Jessen, Poul S/A-5433-2009		National Science Foundation [0653631]; Office of Naval Research [N00014-05-1-420]; NSERC Discovery	National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); NSERC Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC))	We thank I. H. Deutsch and P. Jacquod for discussions. This work was supported by the National Science Foundation ( grant no. 0653631) and the Office of Naval Research ( grant no. N00014-05-1-420). S. G. was supported by an NSERC Discovery grant.	AGARWAL GS, 1981, PHYS REV A, V24, P2889, DOI 10.1103/PhysRevA.24.2889; Alhassid Y, 2000, REV MOD PHYS, V72, P895, DOI 10.1103/RevModPhys.72.895; Ballentine A.P., 1995, AM J PHYS, V63, P285; Bhattacharya T, 2000, PHYS REV LETT, V85, P4852, DOI 10.1103/PhysRevLett.85.4852; BLUMEL R, 1997, CHAOS ATOMIC PHYS; Chaudhury S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.163002; Furuya K, 1998, PHYS REV LETT, V80, P5524, DOI 10.1103/PhysRevLett.80.5524; Ghose S, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.042318; Haake F., 1987, Zeitschrift fur Physik B (Condensed Matter), V65, P381, DOI 10.1007/BF01303727; Haake F., 2018, SPRINGER SERIES SYNE, DOI 10.1007/978-3-319-97580-1; Habib S, 1998, PHYS REV LETT, V80, P4361, DOI 10.1103/PhysRevLett.80.4361; Hensinger WK, 2001, NATURE, V412, P52, DOI 10.1038/35083510; Jacquod P, 2009, ADV PHYS, V58, P67, DOI 10.1080/00018730902831009; Jalabert RA, 2001, PHYS REV LETT, V86, P2490, DOI 10.1103/PhysRevLett.86.2490; LEE HW, 1995, PHYS REP, V259, P147, DOI 10.1016/0370-1573(95)00007-4; Merkel ST, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.023404; Micheli A, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.013607; PERES A, 1984, PHYS REV A, V30, P1610, DOI 10.1103/PhysRevA.30.1610; Prosen T, 2007, J PHYS A-MATH THEOR, V40, P7881, DOI 10.1088/1751-8113/40/28/S02; Ryan CA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.250502; Silberfarb A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.030402; Smith GA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.180403; Steck DA, 2001, SCIENCE, V293, P274, DOI 10.1126/science.1061569; Stockmann H. J., 1999, QUANTUM CHAOS INTRO; Takeuchi M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.023003; Trail CM, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046211; Weidenmuller HA, 2009, REV MOD PHYS, V81, P539, DOI 10.1103/RevModPhys.81.539; Weinstein YS, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.157902; ZUREK WH, 1994, PHYS REV LETT, V72, P2508, DOI 10.1103/PhysRevLett.72.2508	30	181	182	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					768	771		10.1038/nature08396	http://dx.doi.org/10.1038/nature08396			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19812668				2022-12-28	WOS:000270547500030
J	Ishikawa, H; Ma, Z; Barber, GN				Ishikawa, Hiroki; Ma, Zhe; Barber, Glen N.			STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity	NATURE			English	Article							HEPATITIS-C VIRUS; RIG-I; ADAPTER PROTEIN; CYTOPLASMIC DNA; CYTOSOLIC DNA; KAPPA-B; RECOGNITION; RNA; INFLAMMASOME; ACTIVATION	The innate immune system is critical for the early detection of invading pathogens and for initiating cellular host defence countermeasures, which include the production of type I interferon (IFN) 1-3. However, little is known about how the innate immune system is galvanized to respond to DNA-based microbes. Here we show that STING (stimulator of interferon genes) is critical for the induction of IFN by non-CpG intracellular DNA species produced by various DNA pathogens after infection(4). Murine embryonic fibroblasts, as well as antigen presenting cells such as macrophages and dendritic cells (exposed to intracellular B-form DNA, the DNA virus herpes simplex virus 1 (HSV-1) or bacteria Listeria monocytogenes), were found to require STING to initiate effective IFN production. Accordingly, Sting-knockout mice were susceptible to lethal infection after exposure to HSV-1. The importance of STING in facilitating DNA-mediated innate immune responses was further evident because cytotoxic T-cell responses induced by plasmid DNA vaccination were reduced in Sting-deficient animals. In the presence of intracellular DNA, STING relocalized with TANK-binding kinase 1 (TBK1) from the endoplasmic reticulum to perinuclear vesicles containing the exocystcomponent Sec5 (also known as EXOC2). Collectively, our studies indicate that STING is essential for host defence against DNA pathogens such as HSV-1 and facilitates the adjuvant activity of DNA-based vaccines.	[Barber, Glen N.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	University of Miami; University of Miami	Barber, GN (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.	gbarber@med.miami.edu	Ma, Zhe/N-9467-2017; Li, Chia Cheng/D-9906-2015	Ma, Zhe/0000-0002-7222-2556; 	NIH [AI079336]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI079336, R01AI079336] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Yewdell for VV-OVA, B. Jacobs for VVDE3L, K. Frueh for HCMV, M. Kobayashi for baculovirus, H. Horiuchi for the Sec5 antibody, Y. C. Weh for Tbk1-knockout MEFs, and S. Nagata, T. Maniatis, J. Hiscott and N. Reich for plasmid constructs. This work was supported by NIH grant AI079336.	ABLASSER A, 2009, NATURE          0716, DOI DOI 10.1038/NI.1779; Bauer S, 2008, IMMUNOBIOLOGY, V213, P315, DOI 10.1016/j.imbio.2007.10.010; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Mavinakere MS, 2006, J VIROL, V80, P6771, DOI 10.1128/JVI.00492-06; Menetret JF, 2008, STRUCTURE, V16, P1126, DOI 10.1016/j.str.2008.05.003; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Spiczka KS, 2008, J CELL SCI, V121, P2880, DOI 10.1242/jcs.031641; Spies B, 2003, J IMMUNOL, V171, P5908, DOI 10.4049/jimmunol.171.11.5908; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	30	1577	1653	16	280	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					788	U40		10.1038/nature08476	http://dx.doi.org/10.1038/nature08476			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19776740	Green Accepted			2022-12-28	WOS:000270547500035
J	Smith, LFP; Ewings, PD; Quinlan, C				Smith, Lindsay F. P.; Ewings, Paul D.; Quinlan, Catherine			Incidence of pregnancy after expectant, medical, or surgical management of spontaneous first trimester miscarriage: long term follow-up of miscarriage treatment (MIST) randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SPONTANEOUS-ABORTION; MISSED ABORTION; FERTILITY	Objectives To compare fertility rates after the three methods of managing early miscarriage in women recruited to the MIST (miscarriage treatment) randomised controlled trial. Setting Early pregnancy clinics of acute hospitals in the south west region of England. Participants 1199 women who had had an early miscarriage (<13 weeks) confirmed by scan. Intervention Expectant, medical, or surgical management. Main outcome measures Self reported pregnancy rates and live birth rates. Results Of 1199 women recruited to the trial, 1128 consented to follow-up. Of these, 762 women replied giving pregnancy details (68% response rate). Respondents were representative of the trial participants. The live birth rate five years after the index miscarriage was similar in the three management groups: 177/224 (79%, 95% confidence interval 73% to 84%) in the expectant management group, 181/230 ( 79%, 73% to 84%) in the medical group, and 192/235 (82%, 76% to 86%) in the surgical group. There was also no significant difference according to previous birth history. Older women and those with previous miscarriages were significantly less likely to subsequently give birth. Conclusion Method of miscarriage management does not affect subsequent pregnancy rates with around four in five women giving birth within five years of the index miscarriage. Women can be reassured that long term fertility concerns need not affect their choice of miscarriage management. Trial registration National Research Register N0467011677/N0467073587.	[Smith, Lindsay F. P.; Quinlan, Catherine] E Somerset Res Consortium, W Coker BA22 9AH, Somerset, England; [Ewings, Paul D.] Taunton & Somerset Hosp, Res & Dev Support Unit, Taunton TA1 5DA, Somerset, England		Smith, LFP (corresponding author), E Somerset Res Consortium, W Coker BA22 9AH, Somerset, England.	research@esrec.nhs.uk			BMA Claire Wand Fund	BMA Claire Wand Fund	This study was funded by the BMA Claire Wand Fund. All authors are independent from the body providing funding for this research. Sponsorship and research governance management for this study was provided by East Somerset Research Consortium.	ANKUM WM, 1995, LANCET, V345, P1179, DOI 10.1016/S0140-6736(95)91010-7; Blohm F, 1997, LANCET, V349, P995, DOI 10.1016/S0140-6736(97)24014-6; Chipchase J, 1997, BRIT J OBSTET GYNAEC, V104, P840, DOI 10.1111/j.1471-0528.1997.tb12030.x; Chung TKH, 1999, FERTIL STERIL, V71, P1054, DOI 10.1016/S0015-0282(99)00128-4; CLAYTON SG, 1989, GYNAECOLOGY 10 TEACH; DAVID TJ, 1980, BRIT MED J, V280, P447, DOI 10.1136/bmj.280.6212.447-a; DICKEY RP, 1993, BRIT MED J, V307, P259, DOI 10.1136/bmj.307.6898.259-b; ELREFAEY H, 1992, BRIT MED J, V305, P1399, DOI 10.1136/bmj.305.6866.1399; FORBES K, 1995, BRIT MED J, V310, P1426, DOI 10.1136/bmj.310.6992.1426; Geyman J P, 1999, J Am Board Fam Pract, V12, P55; HENSHAW R, 1993, BRIT MED J, V306, P8944; Johnson N, 1997, EUR J OBSTET GYN R B, V72, P213, DOI 10.1016/S0301-2115(96)02668-1; Kaplan B, 1996, HUM REPROD, V11, P92; LEVIN S, 1979, ACTA OBSTET GYN SCAN, V58, P371, DOI 10.3109/00016347909154598; Nielsen S, 1999, BRIT J OBSTET GYNAEC, V106, P804, DOI 10.1111/j.1471-0528.1999.tb08401.x; NIELSEN S, 1995, LANCET, V345, P84, DOI 10.1016/S0140-6736(95)90060-8; Petrou S, 2006, BJOG-INT J OBSTET GY, V113, P879, DOI 10.1111/j.1471-0528.2006.00998.x; *ROYAL COLL OBST G, 2003, GREEN TOP GUID ROYAL, V17; Smith LF, 2006, BRIT J GEN PRACT, V56, P198; SMITH LFP, 1993, BRIT MED J, V306, P1540, DOI 10.1136/bmj.306.6891.1540-c; Trinder J, 2006, BMJ-BRIT MED J, V332, P1235, DOI 10.1136/bmj.38828.593125.55	21	39	39	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 8	2009	339								b3827	10.1136/bmj.b3827	http://dx.doi.org/10.1136/bmj.b3827			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TH	19815581	Green Published, hybrid			2022-12-28	WOS:000270719300001
J	Bland, JM				Bland, John Martin			The tyranny of power: is there a better way to calculate sample size?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED-TRIALS; NEED		Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of York - UK	Bland, JM (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	mb55@york.ac.uk						[Anonymous], 1986, Lancet, V2, P57; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bland M, 1987, INTRO MED STAT; Brown MM, 2001, LANCET, V357, P1729; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Featherstone RL, 2004, CEREBROVASC DIS, V18, P69, DOI 10.1159/000078753; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Petherick E S, 2006, BMC Med Res Methodol, V6, P43, DOI 10.1186/1471-2288-6-43; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; PETO R, 1981, THROMB HAEMOSTASIS, V46, P325; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421	14	55	55	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 6	2009	339								b3985	10.1136/bmj.b3985	http://dx.doi.org/10.1136/bmj.b3985			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505TF	19808754				2022-12-28	WOS:000270719100008
J	Blandin, SA; Wang-Sattler, R; Lamacchia, M; Gagneur, J; Lycett, G; Ning, Y; Levashina, EA; Steinmetz, LM				Blandin, Stephanie A.; Wang-Sattler, Rui; Lamacchia, Marina; Gagneur, Julien; Lycett, Gareth; Ning, Ye; Levashina, Elena A.; Steinmetz, Lars M.			Dissecting the Genetic Basis of Resistance to Malaria Parasites in Anopheles gambiae	SCIENCE			English	Article							COMPLEMENT-LIKE PROTEIN; QUANTITATIVE TRAIT LOCI; MELANIZATION RESPONSE; PLASMODIUM-BERGHEI; MOSQUITO; TEP1	The ability of Anopheles gambiae mosquitoes to transmit Plasmodium parasites is highly variable between individuals. However, the genetic basis of this variability has remained unknown. We combined genome-wide mapping and reciprocal allele-specific RNA interference (rasRNAi) to identify the genomic locus that confers resistance to malaria parasites and demonstrated that polymorphisms in a single gene encoding the antiparasitic thioester-containing protein 1 (TEP1) explain a substantial part of the variability in parasite killing. The link between TEP1 alleles and resistance to malaria may offer new tools for controlling malaria transmission. The successful application of rasRNAi in Anopheles suggests that it could also be applied to other organisms where RNAi is feasible to dissect complex phenotypes to the level of individual quantitative trait alleles.	[Blandin, Stephanie A.; Wang-Sattler, Rui; Gagneur, Julien; Lycett, Gareth; Ning, Ye; Steinmetz, Lars M.] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Blandin, Stephanie A.; Lamacchia, Marina; Levashina, Elena A.] INSERM, CNRS, UPR9022, U963, F-67084 Strasbourg, France; [Wang-Sattler, Rui] Helmholtz Zentrum Munchen, Inst Epidemiol, D-85764 Munich, Germany	European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Steinmetz, LM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	larsms@embl.de	Wang-Sattler, Rui/B-5354-2014; Blandin, Stephanie/I-2786-2016; Blandin, Stephanie/ABH-2267-2021	Wang-Sattler, Rui/0000-0002-8794-8229; Blandin, Stephanie/0000-0003-4566-1200; Blandin, Stephanie/0000-0003-4566-1200; Levashina, Elena/0000-0003-4605-906X; Lycett, Gareth/0000-0002-2422-053X; Steinmetz, Lars/0000-0002-3962-2865; Gagneur, Julien/0000-0002-8924-8365	NIH; Deutsche Forschungsgemeinschaft; CNRS; INSERM; European Molecular Biology Organization (EMBO) Young Investigators Program; European Commission Network of Excellence "BioMalPar"; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068717] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); European Molecular Biology Organization (EMBO) Young Investigators Program(European Molecular Biology Organization (EMBO)); European Commission Network of Excellence "BioMalPar"; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Cohuet for sharing sequencing information, R. Carmouche and J. Luis from the EMBL Genecore facility for support with genotyping, R. Bourgon for advice on statistical analyses, A. Budd for suggestions on the phylogenetic analysis, D. Doherty and J. Soichot for help with breeding mosquitoes, and E. Marois and C. Ramakrishnan for comments on the manuscript. We acknowledge the support of F. Kafatos, in whose laboratory this work was initially carried out. This work was supported by grants from NIH and the Deutsche Forschungsgemeinschaft ( L. M. S.), CNRS and INSERM ( E. A. L. and S. A. B), the European Molecular Biology Organization (EMBO) Young Investigators Program ( E. A. L.), and the European Commission Network of Excellence "BioMalPar" ( E. A. L.). S. A. B. received a postdoctoral fellowship from EMBO. E. A. L. is an international Howard Hughes Medical Institute research scholar. EMBL Nucleotide Sequence Database accession numbers for TEP1 alleles sequenced in this report are as follows: FN431782 to FN431785.	Baxter RHG, 2007, P NATL ACAD SCI USA, V104, P11615, DOI 10.1073/pnas.0704967104; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin SA, 2008, CELL HOST MICROBE, V3, P364, DOI 10.1016/j.chom.2008.05.007; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gorman MJ, 1997, AM J TROP MED HYG, V56, P446, DOI 10.4269/ajtmh.1997.56.446; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Niare O, 2002, SCIENCE, V298, P213, DOI 10.1126/science.1073420; Obbard DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-274; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Riehle MM, 2006, SCIENCE, V312, P577, DOI 10.1126/science.1124153; Shiao SH, 2006, PLOS PATHOG, V2, P1152, DOI 10.1371/journal.ppat.0020133; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; VERNICK KD, 1995, EXP PARASITOL, V80, P583, DOI 10.1006/expr.1995.1074; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Zheng LB, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-16; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	21	80	84	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					147	150		10.1126/science.1175241	http://dx.doi.org/10.1126/science.1175241			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797663	Green Accepted			2022-12-28	WOS:000270355600057
J	Goldston, D				Goldston, David			Innovation strategy	NATURE			English	Editorial Material									Nat Resources Def Council, Washington, DC USA		Goldston, D (corresponding author), Nat Resources Def Council, Washington, DC USA.	partyofonecolumn@gmail.com							0	1	1	2	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					585	585		10.1038/461585a	http://dx.doi.org/10.1038/461585a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	500LH	19794469	Bronze			2022-12-28	WOS:000270302600011
J	O'Brien, PC; Seymour, JF				O'Brien, Peter C.; Seymour, John F.			Progress in primary CNS lymphoma	LANCET			English	Editorial Material							NERVOUS-SYSTEM LYMPHOMA; HIGH-DOSE METHOTREXATE; RADIOTHERAPY; CHEMOTHERAPY; TRIAL; MULTICENTER; SURVIVAL; BRAIN		[O'Brien, Peter C.] Calvary Mater Newcastle, Dept Radiat Oncol, Newcastle, NSW 2310, Australia	Calvary Mater Newcastle Hospital	O'Brien, PC (corresponding author), Calvary Mater Newcastle, Dept Radiat Oncol, Newcastle, NSW 2310, Australia.	peter.obrien@mater.health.nsw.gov.au	Seymour, John/K-7326-2019	Seymour, John/0000-0003-2188-6835				Abrey LE, 2005, J CLIN ONCOL, V23, P5034, DOI 10.1200/JCO.2005.13.524; Abrey LE, 1998, J CLIN ONCOL, V16, P859, DOI 10.1200/JCO.1998.16.3.859; Batchelor T, 2003, J CLIN ONCOL, V21, P1044, DOI 10.1200/JCO.2003.03.036; ERVIN T, 1980, CANCER, V45, P1556, DOI 10.1002/1097-0142(19800401)45:7<1556::AID-CNCR2820450707>3.0.CO;2-B; Ferreri AJM, 2002, NEUROLOGY, V58, P1513, DOI 10.1212/WNL.58.10.1513; Ferreri AJM, 2009, LANCET, V374, P1512, DOI 10.1016/S0140-6736(09)61416-1; Herrlinger U, 2002, ANN NEUROL, V51, P247, DOI 10.1002/ana.10102; Mead GM, 2000, CANCER, V89, P1359, DOI 10.1002/1097-0142(20000915)89:6<1359::AID-CNCR21>3.0.CO;2-9; NELSON DF, 1992, INT J RADIAT ONCOL, V23, P9, DOI 10.1016/0360-3016(92)90538-S; OTT RJ, 1991, EUR J CANCER, V27, P1356, DOI 10.1016/0277-5379(91)90009-3; Poortmans PMP, 2003, J CLIN ONCOL, V21, P4483, DOI 10.1200/JCO.2003.03.108; Reni M, 2004, J CLIN ONCOL, V22, P1165, DOI 10.1200/JCO.2004.99.259; Shenkier TN, 2005, CANCER, V103, P1008, DOI 10.1002/cncr.20868; Steensma DP, 2009, J CLIN ONCOL, V27, P1737, DOI 10.1200/JCO.2008.20.6292	14	12	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT-NOV	2009	374	9700					1477	1478		10.1016/S0140-6736(09)61488-4	http://dx.doi.org/10.1016/S0140-6736(09)61488-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517CS	19767091				2022-12-28	WOS:000271591300005
J	Rockstrom, J; Steffen, W; Noone, K; Persson, A; Chapin, FS; Lambin, EF; Lenton, TM; Scheffer, M; Folke, C; Schellnhuber, HJ; Nykvist, B; de Wit, CA; Hughes, T; van der Leeuw, S; Rodhe, H; Sorlin, S; Snyder, PK; Costanza, R; Svedin, U; Falkenmark, M; Karlberg, L; Corell, RW; Fabry, VJ; Hansen, J; Walker, B; Liverman, D; Richardson, K; Crutzen, P; Foley, JA				Rockstrom, Johan; Steffen, Will; Noone, Kevin; Persson, Asa; Chapin, F. Stuart, III; Lambin, Eric F.; Lenton, Timothy M.; Scheffer, Marten; Folke, Carl; Schellnhuber, Hans Joachim; Nykvist, Bjorn; de Wit, Cynthia A.; Hughes, Terry; van der Leeuw, Sander; Rodhe, Henning; Sorlin, Sverker; Snyder, Peter K.; Costanza, Robert; Svedin, Uno; Falkenmark, Malin; Karlberg, Louise; Corell, Robert W.; Fabry, Victoria J.; Hansen, James; Walker, Brian; Liverman, Diana; Richardson, Katherine; Crutzen, Paul; Foley, Jonathan A.			A safe operating space for humanity	NATURE			English	Article							CLIMATE; RESILIENCE; BIODIVERSITY; CONSEQUENCES; PERSPECTIVE; PHOSPHORUS; SHIFTS; SEA		[Rockstrom, Johan; Steffen, Will; Noone, Kevin; Persson, Asa; Folke, Carl; Nykvist, Bjorn; Sorlin, Sverker; Costanza, Robert; Svedin, Uno; Falkenmark, Malin; Karlberg, Louise; Walker, Brian] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Rockstrom, Johan; Persson, Asa; Nykvist, Bjorn; Karlberg, Louise] Stockholm Environm Inst, S-10691 Stockholm, Sweden; [Steffen, Will] Australian Natl Univ, ANU Climate Change Inst, Canberra, ACT 0200, Australia; [Noone, Kevin; de Wit, Cynthia A.] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden; [Chapin, F. Stuart, III] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Lambin, Eric F.] Catholic Univ Louvain, Dept Geog, B-1348 Louvain, Belgium; [Lenton, Timothy M.] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Scheffer, Marten] Wageningen Univ, Aquat Ecol & Water Qual Management Grp, NL-6700 HB Wageningen, Netherlands; [Folke, Carl] Royal Swedish Acad Sci, Beijer Inst Ecol Econ, S-10405 Stockholm, Sweden; [Schellnhuber, Hans Joachim] Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany; [Schellnhuber, Hans Joachim] Univ Oxford, Tyndall Ctr, Oxford OX1 3QY, England; [Schellnhuber, Hans Joachim; Liverman, Diana] Univ Oxford, Environm Change Inst, Oxford OX1 3QY, England; [Hughes, Terry] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [van der Leeuw, Sander] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Rodhe, Henning] Stockholm Univ, Dept Meteorol, S-10691 Stockholm, Sweden; [Sorlin, Sverker] Royal Inst Technol, Div Hist Sci & Technol, S-10044 Stockholm, Sweden; [Snyder, Peter K.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Costanza, Robert] Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05405 USA; [Falkenmark, Malin] Stockholm Int Water Inst, S-11151 Stockholm, Sweden; [Corell, Robert W.] H John Heinz III Ctr Sci Econ & Environm, Washington, DC 20006 USA; [Fabry, Victoria J.] Calif State Univ San Marcos, Dept Biol Sci, San Marcos, CA 92096 USA; [Hansen, James] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Walker, Brian] Commonwealth Sci & Ind Org, Sustainable Ecosyst, Canberra, ACT 2601, Australia; [Liverman, Diana] Univ Arizona, Inst Environm, Tucson, AZ 85721 USA; [Richardson, Katherine] Fac Nat Sci, DK-2200 Copenhagen N, Denmark; [Crutzen, Paul] Max Planck Inst Chem, D-55020 Mainz, Germany; [Foley, Jonathan A.] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA	Stockholm University; Stockholm Environment Institute; Australian National University; Stockholm University; University of Alaska System; University of Alaska Fairbanks; Universite Catholique Louvain; University of East Anglia; Wageningen University & Research; Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics; Potsdam Institut fur Klimafolgenforschung; University of Oxford; University of Oxford; James Cook University; Arizona State University; Arizona State University-Tempe; Stockholm University; Royal Institute of Technology; University of Minnesota System; University of Minnesota Twin Cities; University of Vermont; California State University System; California State University San Marcos; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Arizona; Max Planck Society; University of Minnesota System; University of Minnesota Twin Cities	Rockstrom, J (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, Kraftriket 2B, S-10691 Stockholm, Sweden.		Walker, Brian H/F-2386-2011; Chapin, F Stuart/AAZ-3931-2020; Costanza, Robert/A-4912-2008; Steffen, Will/C-7651-2011; Crutzen, Paul J/F-6044-2012; Quinn, Patrick/B-5489-2010; de Wit, Cynthia A/J-8063-2012; Snyder, Peter/H-3063-2013; Richardson, Katherine/D-7592-2014; Scheffer, Marten/C-1852-2012; Foley, Jonathan A/GRS-5522-2022; Lenton, Tim M/X-1893-2018; Johannesdottir, Solveig L/U-2219-2017; Hughes, Terry P/L-4721-2013; Persson, Åsa/ABD-8096-2021; van der Leeuw, Sander/AAF-7850-2019; Folke, Carl/Z-1545-2019; Schellnhuber, Hans Joachim/B-2607-2012; Schellnhuber, Hans Joachim/O-3873-2019; Costanza, Robert/AAJ-3546-2021	Chapin, F Stuart/0000-0002-2558-9910; Costanza, Robert/0000-0001-6348-8734; de Wit, Cynthia A/0000-0001-8497-2699; Richardson, Katherine/0000-0003-3785-2787; Lenton, Tim M/0000-0002-6725-7498; Johannesdottir, Solveig L/0000-0002-4402-6830; Hughes, Terry P/0000-0002-5257-5063; Schellnhuber, Hans Joachim/0000-0001-7453-4935; Schellnhuber, Hans Joachim/0000-0001-7453-4935; Persson, Asa/0000-0002-8886-5046; Lambin, Eric/0000-0002-0673-5257; Folke, Carl/0000-0002-4050-3281; Rockstrom, Johan/0000-0001-8988-2983; Noone, Kevin/0000-0001-7095-7412	Natural Environment Research Council [tynd10001] Funding Source: researchfish; NERC [tynd10001] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		[Anonymous], 1996, HIDDEN ORDER ADAPTAT; ARROW K, 1995, SCIENCE, V268, P520, DOI 10.1126/science.268.5210.520; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Berger A, 2002, SCIENCE, V297, P1287, DOI 10.1126/science.1076120; Boulding K., 1966, 6 RES FUT FOR ENV QU, DOI DOI 10.4324/9781315064147; BRETHERTON FP, 1988, EARTH SYSTEM SCI CLO; Carpenter S. R., 2003, EXCELLENCE ECOLOGY S, V15; Cazenave A, 2006, SCIENCE, V314, P1250, DOI 10.1126/science.1133325; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Church JA, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024826; Clark WC, 2003, P NATL ACAD SCI USA, V100, P8059, DOI 10.1073/pnas.1231333100; Costanza R., 1991, STRUCT CHANGE ECON D, V2, P335, DOI [10.1016/S0954-349X(05)80007-4, DOI 10.1016/S0954-349X(05)80007-4]; Crutzen PJ, 2002, NATURE, V415, P23, DOI 10.1038/415023a; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Gruber N, 2008, NATURE, V451, P293, DOI 10.1038/nature06592; Handoh IC, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002039; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Hassan R., 2005, ECOSYSTEMS HUMAN WEL, V1, P297, DOI DOI 10.1021/JF020083Y; Holling C.S., 1986, SUSTAINABLE DEV BIOS, P292, DOI DOI 10.1371/JOURNAL.PONE.0134639; Johannessen OM, 2008, ATMOS OCEAN SCI LETT, V1, P51, DOI 10.1080/16742834.2008.11446766; Kaufmann SA, 1993, ORIGINS ORDER; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Levin S., 1999, FRAGILE DOMINION; Lovelock James, 1979, GAIA NEW LOOK LIFE E; Mace G. M., 2005, ECOSYSTEMS HUMAN WEL, P79; Mackenzie FT, 2002, CHEM GEOL, V190, P13, DOI 10.1016/S0009-2541(02)00108-0; Odum E.P., 1989, ECOLOGY OUR ENDANGER; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Rioual P, 2001, NATURE, V413, P293, DOI 10.1038/35095037; ROCKSTROM J, ECOL SOC IN PRESS; Sahney S, 2008, P ROY SOC B-BIOL SCI, V275, P759, DOI 10.1098/rspb.2007.1370; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schellnhuber H.J., 2004, GLOBAL CHANGE EARTH; Schellnhuber HJ, 1999, NATURE, V402, pC19, DOI 10.1038/35011515; Snyder PK, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004462; Solomon S., 2007, PHYS SCI BASIS WORKI; Steffen W, 2007, AMBIO, V36, P614, DOI 10.1579/0044-7447(2007)36[614:TAAHNO]2.0.CO;2; Turner B., 1990, EARTH TRANSFORMED HU; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walker B, 2004, ECOL SOC, V9; Zillen L, 2008, EARTH-SCI REV, V91, P77, DOI 10.1016/j.earscirev.2008.10.001	46	7273	7482	158	3139	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					472	475		10.1038/461472a	http://dx.doi.org/10.1038/461472a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19779433	Bronze			2022-12-28	WOS:000270082900020
J	Kogan, JR; Holmboe, ES; Hauer, KE				Kogan, Jennifer R.; Holmboe, Eric S.; Hauer, Karen E.			Tools for Direct Observation and Assessment of Clinical Skills of Medical Trainees A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							EXERCISE MINI-CEX; COMMUNICATION-SKILLS; RESIDENT PERFORMANCE; PROFESSIONAL COMPETENCE; FORMATIVE ASSESSMENT; ENCOUNTER CARDS; RELIABILITY; VALIDITY; STUDENTS; EDUCATION	Context Direct observation of medical trainees with actual patients is important for performance-based clinical skills assessment. Multiple tools for direct observation are available, but their characteristics and outcomes have not been compared systematically. Objectives To identify observation tools used to assess medical trainees' clinical skills with actual patients and to summarize the evidence of their validity and outcomes. Data Sources Electronic literature search of PubMed, ERIC, CINAHL, and Web of Science for English-language articles published between 1965 and March 2009 and review of references from article bibliographies. Study Selection Included studies described a tool designed for direct observation of medical trainees' clinical skills with actual patients by educational supervisors. Tools used only in simulated settings or assessing surgical/procedural skills were excluded. Of 10 672 citations, 199 articles were reviewed and 85 met inclusion criteria. Data Extraction Two authors independently abstracted studies using a modified Best Evidence Medical Education coding form to inform judgment of key psychometric characteristics. Differences were reconciled by consensus. Results A total of 55 tools were identified. Twenty-one tools were studied with students and 32 with residents or fellows. Two were used across the educational continuum. Most (n = 32) were developed for formative assessment. Rater training was described for 26 tools. Only 11 tools had validity evidence based on internal structure and relationship to other variables. Trainee or observer attitudes about the tool were the most commonly measured outcomes. Self-assessed changes in trainee knowledge, skills, or attitudes (n = 9) or objectively measured change in knowledge or skills (n = 5) were infrequently reported. The strongest validity evidence has been established for the Mini Clinical Evaluation Exercise (Mini-CEX). Conclusion Although many tools are available for the direct observation of clinical skills, validity evidence and description of educational outcomes are scarce. JAMA. 2009;302(12):1316-1326	[Kogan, Jennifer R.] Univ Penn Hlth Syst, Dept Med, Philadelphia, PA 19104 USA; [Holmboe, Eric S.] Amer Board Internal Med, Philadelphia, PA USA; [Hauer, Karen E.] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Pennsylvania; American Board of Internal Medicine; University of California System; University of California San Francisco	Kogan, JR (corresponding author), Univ Penn Hlth Syst, Dept Med, 3701 Market St,Ste 640, Philadelphia, PA 19104 USA.	jennifer.kogan@uphs.upenn.edu			American Board of Internal Medicine	American Board of Internal Medicine	This study was funded by a grant from the American Board of Internal Medicine.	*ACCR COUNC GRAD M, ACGME PROGR REQ RES; ALOIA JF, 1976, J MED EDUC, V51, P410; Anderson CI, 2005, AM J SURG, V189, P288, DOI 10.1016/j.amjsurg.2005.01.001; BECKMAN H, 1990, J GEN INTERN MED, V5, P42, DOI 10.1007/BF02602308; Beckman TJ, 2007, MED TEACH, V29, P210, DOI 10.1080/01421590701291469; Benenson RS, 2003, ACAD EMERG MED, V10, P219, DOI 10.1111/j.1553-2712.2003.tb01994.x; *BEST EV MED ED, APP 3A PROT BEME COD; Boulet JR, 2002, ADV HEALTH SCI EDUC, V7, P85, DOI 10.1023/A:1015750009235; Brennan BG, 1997, ACAD MED, V72, pS43, DOI 10.1097/00001888-199710001-00015; Burch VC, 2006, SAMJ S AFR MED J, V96, P430; BURDICK WP, 1995, ACAD EMERG MED, V2, P909, DOI 10.1111/j.1553-2712.1995.tb03108.x; Callahan E J, 1991, Fam Med, V23, P19; CAMPBELL LM, 1993, BRIT J GEN PRACT, V43, P430; CASSATA DM, 1977, J FAM PRACTICE, V4, P673; Chaudhry SI, 2008, J GEN INTERN MED, V23, P1010, DOI 10.1007/s11606-008-0578-0; Chen FM, 2004, ACAD MED, V79, P955, DOI 10.1097/00001888-200410000-00010; Clay AS, 2007, CRIT CARE MED, V35, P738, DOI 10.1097/01.CCM.0000257329.22025.18; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Cook David A, 2006, Am J Med, V119; Cook DA, 2009, ADV HEALTH SCI EDUC, V14, P655, DOI 10.1007/s10459-008-9147-x; Cook DA, 2009, J GEN INTERN MED, V24, P74, DOI 10.1007/s11606-008-0842-3; Crossley J, 2002, MED EDUC, V36, P800, DOI 10.1046/j.1365-2923.2002.01294.x; Cydulka RK, 1996, ACAD EMERG MED, V3, P345, DOI 10.1111/j.1553-2712.1996.tb03448.x; Daelmans HEM, 2004, MED EDUC, V38, P1270, DOI 10.1111/j.1365-2929.2004.02019.x; Dawson D J, 1983, Proc Annu Conf Res Med Educ, V22, P186; de Haes JCJM, 2001, PATIENT EDUC COUNS, V45, P35, DOI 10.1016/S0738-3991(01)00141-0; de Lima AA, 2005, MED TEACH, V27, P46, DOI 10.1080/01421590400013529; De Lima AA, 2007, MED TEACH, V29, P785, DOI 10.1080/01421590701352261; Donato AA, 2008, MED EDUC, V42, P1234, DOI 10.1111/j.1365-2923.2008.03230.x; Downing SM, 2004, MED EDUC, V38, P1006, DOI 10.1111/j.1365-2929.2004.01932.x; Downing SM, 2003, MED EDUC, V37, P830, DOI 10.1046/j.1365-2923.2003.01594.x; Duffy FD, 2004, ACAD MED, V79, P495, DOI 10.1097/00001888-200406000-00002; DUNNINGTON G, 1990, AM J SURG, V159, P423, DOI 10.1016/S0002-9610(05)81289-9; DUNNINGTON GL, 1994, AM J SURG, V167, P604, DOI 10.1016/0002-9610(94)90107-4; Durning SJ, 2002, ACAD MED, V77, P900, DOI 10.1097/00001888-200209000-00020; Durning SJ, 2009, ACAD MED, V84, P545, DOI 10.1097/ACM.0b013e31819f8031; Dyrbye LN, 2007, ACAD MED, V82, P654, DOI 10.1097/ACM.0b013e318065be1e; Edwards FD, 2007, FAM MED, V39, P116; Epstein RM, 2007, NEW ENGL J MED, V356, P387, DOI 10.1056/NEJMra054784; Ericsson KA, 2004, ACAD MED, V79, pS70, DOI 10.1097/00001888-200410001-00022; Fernando N, 2008, MED EDUC, V42, P89, DOI 10.1111/j.1365-2923.2007.02939.x; Golnik KC, 2005, OPHTHALMOLOGY, V112, P1649, DOI 10.1016/j.ophtha.2005.06.006; Golnik KC, 2004, OPHTHALMOLOGY, V111, P1271, DOI 10.1016/j.ophtha.2004.04.014; Hamdy H, 2003, MED EDUC, V37, P205, DOI 10.1046/j.1365-2923.2003.01438.x; Han PKJ, 2005, ACAD MED, V80, P669, DOI 10.1097/00001888-200507000-00009; Hastings AM, 2006, MED EDUC, V40, P437, DOI 10.1111/j.1365-2929.2006.02445.x; Hastings AM, 2000, MED EDUC, V34, P101; Hatala R, 1999, ACAD MED, V74, pS118, DOI 10.1097/00001888-199910000-00059; Hatala R, 2006, MED EDUC, V40, P950, DOI 10.1111/j.1365-2929.2006.02566.x; Hauer K E, 2000, Acad Med, V75, P524, DOI 10.1097/00001888-200005000-00046; HAYS RB, 1990, MED EDUC, V24, P110, DOI 10.1111/j.1365-2923.1990.tb02508.x; HERBERS JE, 1989, J GEN INTERN MED, V4, P202, DOI 10.1007/BF02599524; Holmboe ES, 2004, J GEN INTERN MED, V19, P558, DOI 10.1111/j.1525-1497.2004.30134.x; Holmboe ES, 2004, ANN INTERN MED, V140, P874, DOI 10.7326/0003-4819-140-11-200406010-00008; Holmboe ES, 2003, ACAD MED, V78, P826, DOI 10.1097/00001888-200308000-00018; Hulley SB, 2007, DESIGNING CLIN RES; Jouriles NJ, 2002, ACAD EMERG MED, V9, P1338, DOI 10.1111/j.1553-2712.2002.tb01598.x; Kane M., 2005, EDUC MEAS-ISSUES PRA, V18, P5, DOI [DOI 10.1111/J.1745-3992.1999.TB00010.X, 10.1111/j.1745-3992.1999.tb00010.x]; Kirkpatrick D. L., 1967, TRAINING DEV HDB; Kogan JR, 2006, J GEN INTERN MED, V21, P501, DOI 10.1111/j.1525-1497.2006.00436.x; Kogan Jennifer R, 2002, Acad Med, V77, P1156, DOI 10.1097/00001888-200211000-00021; Kogan JR, 2003, ACAD MED, V78, pS33, DOI 10.1097/00001888-200310001-00011; Kramer AWM, 2004, MED EDUC, V38, P158, DOI 10.1111/j.1365-2923.2004.01747.x; KROBOTH FJ, 1985, ARCH INTERN MED, V145, P1121, DOI 10.1001/archinte.145.6.1121; Kroboth FJ, 1996, J GEN INTERN MED, V11, P551, DOI 10.1007/BF02599606; KROBOTH FJ, 1992, J GEN INTERN MED, V7, P174, DOI 10.1007/BF02598008; Lagerkvist B, 1976, Med Educ, V10, P176; Lane JL, 2000, PEDIATRICS, V105, P973; Liaison Committee on Medical Education, FUNCT STRUCT MED SCH; LINKS PS, 1984, MED EDUC, V18, P46, DOI 10.1111/j.1365-2923.1984.tb01476.x; Malhotra S, 2008, MED TEACH, V30, P414, DOI 10.1080/01421590801946962; MCCORMICK DP, 1993, PEDIATRICS, V92, P116; McKinley RK, 2000, MED EDUC, V34, P573, DOI 10.1046/j.1365-2923.2000.00490.x; Messick S., 1995, EDUC MEAS-ISSUES PRA, V14, P5, DOI [10.1111/j.1745-3992.1995.tb00881.x, DOI 10.1111/J.1745-3992.1995.TB00881.X]; MEULEMAN JR, 1989, ACAD MED, V64, P277, DOI 10.1097/00001888-198905000-00018; MIR MA, 1989, MED EDUC, V23, P276, DOI 10.1111/j.1365-2923.1989.tb01545.x; Morris A, 2006, POSTGRAD MED J, V82, P285, DOI 10.1136/pgmj.2005.040477; Nair BR, 2008, MED J AUSTRALIA, V189, P159, DOI 10.5694/j.1326-5377.2008.tb01951.x; Nasca TJ, 2009, ACAD MED, V84, P293, DOI 10.1097/ACM.0b013e3181971fae; NEWBLE DI, 1991, MED EDUC, V25, P369, DOI 10.1111/j.1365-2923.1991.tb00083.x; NOEL GL, 1992, ANN INTERN MED, V117, P757, DOI 10.7326/0003-4819-117-9-757; Norcini JJ, 2003, ANN INTERN MED, V138, P476, DOI 10.7326/0003-4819-138-6-200303180-00012; NORCINI JJ, 1995, ANN INTERN MED, V123, P795, DOI 10.7326/0003-4819-123-10-199511150-00008; Norgaard K, 2004, MED EDUC, V38, P700, DOI 10.1111/j.1365-2929.2004.01840.x; Nuovo J, 2006, MED EDUC, V40, P630, DOI 10.1111/j.1365-2929.2006.02506.x; Paukert JL, 2002, AM J SURG, V183, P300, DOI 10.1016/S0002-9610(02)00786-9; PRICE J, 1994, MED EDUC, V28, P120, DOI 10.1111/j.1365-2923.1994.tb02530.x; Reed D, 2005, ANN INTERN MED, V142, P1080, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00008; Reed DA, 2005, JAMA-J AM MED ASSOC, V294, P1052, DOI 10.1001/jama.294.9.1052; REISNER E, 1991, AM J SURG, V162, P271, DOI 10.1016/0002-9610(91)90086-S; RHOTON MF, 1990, MED EDUC, V24, P280, DOI 10.1111/j.1365-2923.1990.tb00013.x; Richards ML, 2007, J SURG RES, V140, P139, DOI 10.1016/j.jss.2006.11.002; Rosenzweig S, 1999, J EMERG MED, V17, P355, DOI 10.1016/S0736-4679(98)00181-4; Ross R, 2002, ACAD MED, V77, P268, DOI 10.1097/00001888-200203000-00021; Roth C S, 1996, Acad Med, V71, P558, DOI 10.1097/00001888-199605000-00087; SCHEIDT PC, 1986, J MED EDUC, V61, P585; SHAPIRO J, 1991, FAM PRACT, V8, P10, DOI 10.1093/fampra/8.1.10; Shayne P, 2002, ACAD EMERG MED, V9, P1342, DOI 10.1197/aemj.9.11.1342; Shayne P, 2006, ACAD EMERG MED, V13, P727, DOI 10.1197/j.aem.2006.01.030; Shumway JM, 2003, MED TEACH, V25, P569, DOI 10.1080/0142159032000151907; STONE H, 1989, MED TEACH, V11, P75, DOI 10.3109/01421598909146278; Swanson D B, 1981, Annu Conf Res Med Educ, V20, P3; Torre DM, 2007, TEACH LEARN MED, V19, P271, DOI 10.1080/10401330701366622; Torre DM, 2005, MED TEACH, V27, P559, DOI 10.1080/01421590500237895; ULMER C, 2008, COMMITTEE OPTIMIZING; Van der Vleuten CPM, 1996, ADV HEALTH SCI EDUC, V1, P41, DOI 10.1007/BF00596229; van der Vleuten CPM, 2005, MED EDUC, V39, P309, DOI 10.1111/j.1365-2929.2005.02094.x; Wendling AL, 2004, FAM MED, V36, P178; WIENER SL, 1976, NEW YORK STATE J MED, V76, P610; Wood J, 2004, ACAD RADIOL, V11, P931, DOI 10.1016/j.acra.2004.04.015; WOOLLISCROFT JO, 1984, J MED EDUC, V59, P19; WOOLLISCROFT JO, 1984, J MED EDUC, V59, P799; Zimmer KP, 2008, PEDIATRICS, V121, pE1633, DOI 10.1542/peds.2007-2637; 2008 AAMC GRADUATION	114	362	378	1	83	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 23	2009	302	12					1316	1326		10.1001/jama.2009.1365	http://dx.doi.org/10.1001/jama.2009.1365			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497AR	19773567				2022-12-28	WOS:000270026000014
J	Sinha, M; Watanabe, S; Johnson, A; Moazed, D; Peterson, CL				Sinha, Manisha; Watanabe, Shinya; Johnson, Aaron; Moazed, Danesh; Peterson, Craig L.			Recombinational Repair within Heterochromatin Requires ATP-Dependent Chromatin Remodeling	CELL			English	Article							DOUBLE-STRAND BREAK; POSITION-EFFECT VARIEGATION; SACCHAROMYCES-CEREVISIAE; SILENT CHROMATIN; DNA-DAMAGE; TELOMERIC HETEROCHROMATIN; NUCLEOSOME COMPLEX; FISSION YEAST; HISTONE H3; IN-VITRO	Heterochromatin plays a key role in protection of chromosome integrity by suppressing homologous recombination. In Saccharomyces cerevisiae, Sir2p, Sir3p, and Sir4p are structural components of heterochromatin found at telomeres and the silent mating-type loci. Here we have investigated whether incorporation of Sir proteins into minichromosomes regulates early steps of recombinational repair in vitro. We find that addition of Sir3p to a nucleosomal substrate is sufficient to eliminate yRad51p-catalyzed formation of joints, and that this repression is enhanced by Sir2p/Sir4p. Importantly, Sir-mediated repression requires histone residues that are critical for silencing in vivo. Moreover, we demonstrate that the SWI/SNF chromatin-remodeling enzyme facilitates joint formation by evicting Sir3p, thereby promoting subsequent Rad54p-dependent formation of a strand invasion product. These results suggest that recombinational repair in the context of heterochromatin presents additional constraints that can be overcome by ATP-dependent chromatin-remodeling enzymes.	[Sinha, Manisha; Watanabe, Shinya; Peterson, Craig L.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Sinha, Manisha] Univ Massachusetts, Sch Med, Interdisciplinary Grad Program, Worcester, MA 01605 USA; [Johnson, Aaron; Moazed, Danesh] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Moazed, Danesh] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Peterson, CL (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	craig.peterson@umassmed.edu			National Institutes of Health [GM54096, GM061641]; a Ruth L. Kirschstein National Research Service Award; National Institute of General Medical Sciences [F32 GM078799]; Howard Hughes Medical Institute investigator; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054096, F32GM078799, R37GM049650, R01GM061641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); a Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute investigator(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Anthony Imbalzano (UMMS) for antibody to the FLAG epitope and Blaine Bartholomew ( University of. S. Illinois) for providing the strain harboring the RSC2-TAP allele. We apologize to those colleagues whose work we were unable to cite due to space restrictions. This work was supported by grants from the National Institutes of Health to C. L. P. (GM54096) and to D. M. (GM061641) and by a Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship through the National Institute of General Medical Sciences to A. J. (F32 GM078799). D. M. is a Howard Hughes Medical Institute investigator.	ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Barton AB, 2008, GENETICS, V179, P1221, DOI 10.1534/genetics.107.083493; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Buchberger JR, 2008, MOL CELL BIOL, V28, P6903, DOI 10.1128/MCB.01210-08; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Chai B, 2005, GENE DEV, V19, P1656, DOI 10.1101/gad.1273105; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; Georgel PT, 2001, P NATL ACAD SCI USA, V98, P8584, DOI 10.1073/pnas.151258798; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jaco I, 2008, J CELL BIOL, V181, P885, DOI 10.1083/jcb.200803042; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Liou GG, 2005, CELL, V121, P515, DOI 10.1016/j.cell.2005.03.035; Logie C, 1999, METHOD ENZYMOL, V304, P726; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOO S, 1994, SCIENCE, V264, P1768, DOI 10.1126/science.8209257; Luger K, 1999, METH MOL B, V119, P1; Martino F, 2009, MOL CELL, V33, P323, DOI 10.1016/j.molcel.2009.01.009; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Osley MA, 2007, MUTAT RES-FUND MOL M, V618, P65, DOI 10.1016/j.mrfmmm.2006.07.011; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; PASSARGE E, 1979, AM J HUM GENET, V31, P106; Peng JC, 2008, CURR OPIN GENET DEV, V18, P204, DOI 10.1016/j.gde.2008.01.021; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; RIDDLES PW, 1985, J BIOL CHEM, V260, P165; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Savitsky M, 2002, MOL CELL BIOL, V22, P3204, DOI 10.1128/MCB.22.9.3204-3218.2002; Schmuckli-Maurer J, 1999, MOL GEN GENET, V260, P551, DOI 10.1007/s004380050928; Sinha M, 2008, MOL CELL, V30, P803, DOI 10.1016/j.molcel.2008.04.015; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Solinger JA, 2001, J MOL BIOL, V307, P1207, DOI 10.1006/jmbi.2001.4555; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; Tsukuda T, 2009, DNA REPAIR, V8, P360, DOI 10.1016/j.dnarep.2008.11.014; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Westphal T, 2002, GENETICS, V160, P609; White SA, 2008, CURR TOP MICROBIOL, V320, P157; Wolner B, 2005, J BIOL CHEM, V280, P10855, DOI 10.1074/jbc.M414388200; Zaitseva EM, 1999, J BIOL CHEM, V274, P2907, DOI 10.1074/jbc.274.5.2907; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zou S, 1996, GENE DEV, V10, P634, DOI 10.1101/gad.10.5.634	54	61	61	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1109	1121		10.1016/j.cell.2009.07.013	http://dx.doi.org/10.1016/j.cell.2009.07.013			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766565	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000269923200012
J	Barkun, JS; Aronson, JK; Feldman, LS; Maddern, GJ; Strasberg, SM				Barkun, Jeffrey S.; Aronson, Jeffrey K.; Feldman, Liane S.; Maddern, Guy J.; Strasberg, Steven M.		Balliol Collaboration	Surgical Innovation and Evaluation 1 Evaluation and stages of surgical innovations	LANCET			English	Article							RANDOMIZED CONTROLLED-TRIALS; MEASURING POSTOPERATIVE COMPLICATIONS; VOLUME REDUCTION SURGERY; OUTCOMES-BASED-STRATEGY; GENERAL-SURGERY; ENDOSCOPIC SURGERY; MORTALITY ROUNDS; CLINICAL-TRIALS; EMPHYSEMA; TECHNOLOGIES	Surgical innovation is an important part of surgical practice. Its assessment is complex because of idiosyncrasies related to surgical practice, but necessary so that introduction and adoption of surgical innovations can derive from evidence-based principles rather than trial and error. A regulatory framework is also desirable to protect patients against the potential harms of any novel procedure. In this first of three Series papers on surgical innovation and evaluation, we propose a five-stage paradigm to describe the development of innovative surgical procedures.	[Barkun, Jeffrey S.; Feldman, Liane S.] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A1, Canada; [Aronson, Jeffrey K.] Univ Dept Primary Hlth Care, Oxford, England; [Maddern, Guy J.] Univ Adelaide, Discipline Surg, Queen Elizabeth Hosp, Adelaide, SA 5005, Australia; [Strasberg, Steven M.] Washington Univ, St Louis, MO USA	McGill University; University of Oxford; University of Adelaide; Washington University (WUSTL)	Barkun, JS (corresponding author), McGill Univ, Ctr Hlth, 687 Pine Ave W, Montreal, PQ H3A 1A1, Canada.	jeffrey.barkun@muhc.mcgill.ca	Cook, Jonathan/D-3648-2015; Blazeby, Jane/H-6703-2019; Burton, Martin/F-8579-2012	Cook, Jonathan/0000-0002-4156-6989; Blazeby, Jane/0000-0002-3354-3330; Boutron, Isabelle/0000-0002-5263-6241; Burton, Martin/0000-0002-1261-5876; Maddern, Guy/0000-0003-2064-181X; Campbell, Marion/0000-0001-5386-4097	Ethicon UK; National Institute of Health Research Health Technology Assessment Programme; Nuffield Department of Surgery at the University of Oxford; Department of Surgery at McGill University; Medical Research Council [G0800808] Funding Source: researchfish; Chief Scientist Office [HSRU1] Funding Source: researchfish; MRC [G0800808] Funding Source: UKRI	Ethicon UK; National Institute of Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Nuffield Department of Surgery at the University of Oxford; Department of Surgery at McGill University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Balliol Colloquium has been supported by Ethicon UK with unrestricted educational grants and by the National Institute of Health Research Health Technology Assessment Programme. The Balliol Colloquium was administratively and financially supported by the Nuffield Department of Surgery at the University of Oxford and the Department of Surgery at McGill University.	Aronson JK, 2006, BMJ-BRIT MED J, V333, P1267, DOI 10.1136/bmj.39036.666389.94; Balasubramanian SP, 2006, ANN SURG, V244, P663, DOI 10.1097/01.sla.0000217640.11224.05; Barker CF, 2004, J AM COLL SURGEONS, V198, P1, DOI 10.1016/j.jamcollsurg.2003.08.021; Bath FJ, 1998, STROKE, V29, P2203, DOI 10.1161/01.STR.29.10.2203; BENNETT PN, 1988, HUM TOXICOL, V7, P465, DOI 10.1177/096032718800700514; Berger RL, 2001, ANN THORAC SURG, V72, P649, DOI 10.1016/S0003-4975(01)02636-4; Bergman S, 2006, SURG CLIN N AM, V86, P129, DOI 10.1016/j.suc.2005.10.007; Bernstein M, 2004, J NEUROSURG, V100, P2, DOI 10.3171/jns.2004.100.1.0002; Biffl WL, 2008, J AM COLL SURGEONS, V206, P1204, DOI 10.1016/j.jamcollsurg.2008.02.011; Borchers AT, 2007, CLIN THER, V29, P1, DOI 10.1016/j.clinthera.2007.01.006; BUNKER JP, 1978, SCIENCE, V200, P937, DOI 10.1126/science.347581; BUTLER VP, 1974, CIRCULATION, V49, P399; Buxton MJ, 1987, EC APPRAISAL HLTH TE, P103; Campbell DA, 1997, SURGERY, V122, P719; Casler JD, 2003, ARCH OTOLARYNGOL, V129, P674, DOI 10.1001/archotol.129.6.674; Chang DC, 2006, J AM COLL SURGEONS, V203, P827, DOI 10.1016/j.jamcollsurg.2006.08.013; Cook JA, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-9; Cooper JD, 1996, AM J RESP CRIT CARE, V153, P1201, DOI 10.1164/ajrccm.153.4.8616541; Cooper JD, 1999, LANCET, V353, pSL26; Cronin DC, 2001, NEW ENGL J MED, V344, P1633, DOI 10.1056/NEJM200105243442112; Drazen JM, 2003, NEW ENGL J MED, V348, P2134, DOI 10.1056/NEJMe030058; Ergina PL, 2009, LANCET, V374, P1097, DOI 10.1016/S0140-6736(09)61086-2; Feldman L, 1997, SURGERY, V122, P711, DOI 10.1016/S0039-6060(97)90078-7; Gladwell M., 2006, TIPPING POINT LITTLE; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Greene AK, 2007, PLAST RECONSTR SURG, V119, P1606, DOI 10.1097/01.prs.0000258529.62886.c1; Jacquier I, 2006, ANN SURG, V244, P677, DOI 10.1097/01.sla.0000242707.44007.80; Johnson AP, 2009, INT J TECHNOL ASSESS, V25, P141, DOI 10.1017/S0266462309090199; Krummel Thomas M, 2006, Semin Pediatr Surg, V15, P237, DOI 10.1053/j.sempedsurg.2006.07.002; Lane WA, 1913, BMJ-BRIT MED J, V1913, P546, DOI 10.1136/bmj.1.2724.546; Littlejohns P, 2009, LANCET ONCOL, V10, P417, DOI 10.1016/S1470-2045(09)70077-4; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; McKneally MF, 2003, WORLD J SURG, V27, P930, DOI 10.1007/s00268-003-7096-3; McLeod RS, 2007, WORLD J SURG, V31, P1551, DOI 10.1007/s00268-007-9133-0; McLeod RS, 1996, SURGERY, V119, P483, DOI 10.1016/S0039-6060(96)80254-6; Meakins JL, 2002, AM J SURG, V183, P399, DOI 10.1016/S0002-9610(02)00825-5; *MED HEALTHC PROD, INV ADV INC CLIN TRI; Miller DC, 2006, JAMA-J AM MED ASSOC, V295, P2480, DOI 10.1001/jama.295.21.2480; Mutsaerts ELAR, 2003, EUR J SURG ONCOL, V29, P731, DOI 10.1016/S0748-7983(03)00146-X; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1978, BELM REP ETH PRINC G; Piggott M, 2004, PALLIATIVE MED, V18, P32, DOI 10.1191/0269216304pm857oa; Plumb J, 2009, INT J TECHNOL ASSESS, V25, P124, DOI 10.1017/S0266462309090175; Rattner D, 2006, SURG ENDOSC, V20, P329, DOI 10.1007/s00464-005-3006-0; Reitsma AM, 2002, J AM COLL SURGEONS, V194, P792, DOI 10.1016/S1072-7515(02)01153-5; Riskin DJ, 2006, ANN SURG, V244, P686, DOI 10.1097/01.sla.0000242706.91771.ce; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; Seiler CA, 2006, CONTEMP CLIN TRIALS, V27, P211, DOI 10.1016/j.cct.2005.10.004; Shikata S, 2006, ANN SURG, V244, P668, DOI 10.1097/01.sla.0000225356.04304.bc; Shuhaiber JH, 2004, ARCH SURG-CHICAGO, V139, P170, DOI 10.1001/archsurg.139.2.170; Sjostrom Hanning, 1972, THALIDOMIDE POWER DR; Solomon MJ, 1998, MED J AUSTRALIA, V169, P380, DOI 10.5694/j.1326-5377.1998.tb126809.x; SOLOMON MJ, 1993, DIS COLON RECTUM, V36, P43, DOI 10.1007/BF02050300; Strasberg SM, 2003, J AM COLL SURGEONS, V196, P938, DOI 10.1016/S1072-7515(03)00112-1; Strippoli GFM, 2004, J AM SOC NEPHROL, V15, P411, DOI 10.1097/01.ASN.0000100125.21491.46; Tooher R, 2004, ANZ J SURG, V74, P961, DOI 10.1111/j.1445-1433.2004.03217.x; Troidl H, 1999, WORLD J SURG, V23, P743, DOI 10.1007/s002689900575; Urbach DR, 2005, CAN MED ASSOC J, V172, P1015, DOI 10.1503/cmaj.1041363; Wald NJ, 2003, BRIT MED J, V327, P616, DOI 10.1136/bmj.327.7415.616; Ware JH, 2003, NEW ENGL J MED, V348, P2055, DOI 10.1056/NEJMp030068; Wente MN, 2003, DIGEST SURG, V20, P263, DOI 10.1159/000071183; Wilson CB, 2006, BMJ-BRIT MED J, V332, P112, DOI 10.1136/bmj.332.7533.112	61	388	395	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2009	374	9695					1089	1096		10.1016/S0140-6736(09)61083-7	http://dx.doi.org/10.1016/S0140-6736(09)61083-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501HA	19782874				2022-12-28	WOS:000270370900031
J	Kuo, CH; Kamalasena, D; Htun, NM; Singarayar, S; Bailey, B				Kuo, Chih-Hung; Kamalasena, Dilan; Htun, Nay Min; Singarayar, Suresh; Bailey, Brian			Serious postoperative syncope	LANCET			English	Editorial Material									[Kuo, Chih-Hung] Univ Sydney, Royal Prince Alfred Hosp, Cent Clin Sch, Sydney, NSW 2050, Australia; [Singarayar, Suresh; Bailey, Brian] Royal Prince Alfred Hosp, Dept Cardiol, Sydney, NSW, Australia; [Kamalasena, Dilan] Bankstown Hosp, Dept Cardiol, Sydney, NSW, Australia; [Htun, Nay Min] Alfred Hosp, Dept Cardiol, Melbourne, Vic, Australia	University of Sydney; University of Sydney; Florey Institute of Neuroscience & Mental Health	Kuo, CH (corresponding author), Univ Sydney, Royal Prince Alfred Hosp, Cent Clin Sch, Missenden Rd, Sydney, NSW 2050, Australia.	chkuo@med.usyd.edu.au						Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Badner NH, 1998, ANESTHESIOLOGY, V88, P572, DOI 10.1097/00000542-199803000-00005; Meine TJ, 2005, AM HEART J, V149, P1043, DOI 10.1016/j.ahj.2005.02.010; SECHZER PH, 1971, ANESTH ANAL CURR RES, V50, P1	4	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2009	374	9695					1118	1118		10.1016/S0140-6736(09)61084-9	http://dx.doi.org/10.1016/S0140-6736(09)61084-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501HA	19782878				2022-12-28	WOS:000270370900035
J	Meakins, JL				Meakins, Jonathan L.			Surgical research: act 3, answers	LANCET			English	Editorial Material							RANDOMIZED CLINICAL-TRIALS; EVIDENCE-BASED SURGERY; CHOLECYSTECTOMY; OPERATIONS; NEEDS		[Meakins, Jonathan L.] McGill Univ, Dept Surg, Montreal, PQ H3A 1A1, Canada; [Meakins, Jonathan L.] Univ Oxford, Nuffield Dept Surg, Oxford OX3 9DU, England	McGill University; University of Oxford	Meakins, JL (corresponding author), McGill Univ, Dept Surg, Montreal, PQ H3A 1A1, Canada.	jonathan.meakins@muhc.mcgill.ca						BARKUN JS, 1992, LANCET, V340, P1116, DOI 10.1016/0140-6736(92)93148-G; Berger RL, 2001, ANN THORAC SURG, V72, P649, DOI 10.1016/S0003-4975(01)02636-4; BUNKER JP, 1977, COSTS RISKS BENEFITS; CHALMERS TC, 1976, CONTROVERSY SURGERY, P3; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Hall JC, 1998, SURGERY, V124, P22, DOI 10.1067/msy.1998.87813; Horton R, 1996, LANCET, V347, P984, DOI 10.1016/S0140-6736(96)90137-3; Jacquier I, 2006, ANN SURG, V244, P677, DOI 10.1097/01.sla.0000242707.44007.80; Maier RV, 2006, ARCH SURG-CHICAGO, V141, P317, DOI 10.1001/archsurg.141.3.317; Majeed AW, 1996, LANCET, V347, P989, DOI 10.1016/S0140-6736(96)90143-9; McLeod R, 2006, ANN SURG, V244, P684, DOI 10.1097/01.sla.0000243593.93571.98; RUSSELL I, 1995, BRIT MED J, V311, P1243, DOI 10.1136/bmj.311.7015.1243; SPODICK DH, 1975, JAMA-J AM MED ASSOC, V232, P31; Stirrat GM, 2004, J MED ETHICS, V30, P160, DOI 10.1136/jme.2003.007054; Young JM, 2003, ANZ J SURG, V73, P507, DOI 10.1046/j.1445-1433.2003.02662.x	15	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP-OCT	2009	374	9695					1039	1040		10.1016/S0140-6736(09)61681-0	http://dx.doi.org/10.1016/S0140-6736(09)61681-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501HA	19782853				2022-12-28	WOS:000270370900004
J	Burresi, M; van Oosten, D; Kampfrath, T; Schoenmaker, H; Heideman, R; Leinse, A; Kuipers, L				Burresi, M.; van Oosten, D.; Kampfrath, T.; Schoenmaker, H.; Heideman, R.; Leinse, A.; Kuipers, L.			Probing the Magnetic Field of Light at Optical Frequencies	SCIENCE			English	Article							NEGATIVE REFRACTIVE-INDEX; METAMATERIAL; SPACE	Light is an electromagnetic wave composed of oscillating electric and magnetic fields, the one never occurring without the other. In light-matter interactions at optical frequencies, the magnetic component of light generally plays a negligible role. When we "see" or detect light, only its electric field is perceived; we are practically blind to its magnetic component. We used concepts from the field of metamaterials to probe the magnetic field of light with an engineered near-field aperture probe. We visualized with subwavelength resolution the magnetic- and electric-field distribution of propagating light.	[Burresi, M.; van Oosten, D.; Kampfrath, T.; Schoenmaker, H.] FOM Inst Atom & Mol Phys AMOLF, Stichting Fundamenteel Onderzoek Mat FOM Inst, Ctr Nanophoton, NL-1098 XG Amsterdam, Netherlands; [Heideman, R.; Leinse, A.; Kuipers, L.] Univ Twente, LioniX BV, NL-7500 AH Enschede, Netherlands	AMOLF; Lionix BV; University of Twente	Burresi, M (corresponding author), FOM Inst Atom & Mol Phys AMOLF, Stichting Fundamenteel Onderzoek Mat FOM Inst, Ctr Nanophoton, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands.	burresi@amolf.nl	Kuipers, Laurens/A-9378-2014; Burresi, Matteo/B-4174-2009; van Oosten, Dries/H-9287-2016		Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO); NWO (Vici grant); Dutch Ministry of Economic Affairs	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO (Vici grant)(Netherlands Organization for Scientific Research (NWO)); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	We gratefully thank M. Hammer and A. Ivanova for providing useful calculations, and J. C. Prangsma and M. Spasenovic for support and discussions. The authors gratefully acknowledge the support of the Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science. This work is part of the research program of FOM, which is financially supported by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO). Support by the NWO (Vici grant) is gratefully acknowledged. This work is also supported by NanoNed, a nanotechnology program of the Dutch Ministry of Economic Affairs. The authors declare to have no competing financial interests.	Balistreri MLM, 2001, SCIENCE, V294, P1080, DOI 10.1126/science.1065163; Bitzer A, 2009, OPT EXPRESS, V17, P3826, DOI 10.1364/OE.17.003826; Burresi M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.033902; Devaux E, 2000, PHYS REV B, V62, P10504, DOI 10.1103/PhysRevB.62.10504; Dolling G, 2006, SCIENCE, V312, P892, DOI 10.1126/science.1126021; Engelen RJP, 2007, NAT PHYS, V3, P401, DOI 10.1038/nphys576; Enkrich C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.203901; Jackson J. D, 1998, CLASSICAL ELECTRODYN, VThird; Landau LD., 1984, ELECTRODYNAMICS CONT; Liu N, 2009, NAT PHOTONICS, V3, P157, DOI 10.1038/NPHOTON.2009.4; Marques R, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144440; Meyrath TP, 2008, APPL PHYS B-LASERS O, V93, P107, DOI 10.1007/s00340-008-3207-z; NOECKER MC, 1988, PHYS REV LETT, V61, P310, DOI 10.1103/PhysRevLett.61.310; Novotny L., 2012, PRINCIPLES NANOOPTIC; Papasimakis N, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.253903; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Pukhov A, 1996, PHYS REV LETT, V76, P3975, DOI 10.1103/PhysRevLett.76.3975; Schurig D, 2006, SCIENCE, V314, P977, DOI 10.1126/science.1133628; Seo MA, 2007, OPT EXPRESS, V15, P11781, DOI 10.1364/OE.15.011781; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Smith DR, 2004, SCIENCE, V305, P788, DOI 10.1126/science.1096796; Snyder A.W., 1983, OPTICAL WAVEGUIDE TH; Soukoulis CM, 2007, SCIENCE, V315, P47, DOI 10.1126/science.1136481; Tatarakis M, 2002, NATURE, V415, P280, DOI 10.1038/415280a; Valentine J, 2008, NATURE, V455, P376, DOI 10.1038/nature07247; Veerman JA, 1998, APPL PHYS LETT, V72, P3115, DOI 10.1063/1.121564; Verhagen E, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.203904	28	196	200	5	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 23	2009	326	5952					550	553		10.1126/science.1177096	http://dx.doi.org/10.1126/science.1177096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19797622				2022-12-28	WOS:000271019400034
J	Pieters, CM; Goswami, JN; Clark, RN; Annadurai, M; Boardman, J; Buratti, B; Combe, JP; Dyar, MD; Green, R; Head, JW; Hibbitts, C; Hicks, M; Isaacson, P; Klima, R; Kramer, G; Kumar, S; Livo, E; Lundeen, S; Malaret, E; McCord, T; Mustard, J; Nettles, J; Petro, N; Runyon, C; Staid, M; Sunshine, J; Taylor, LA; Tompkins, S; Varanasi, P				Pieters, C. M.; Goswami, J. N.; Clark, R. N.; Annadurai, M.; Boardman, J.; Buratti, B.; Combe, J. -P.; Dyar, M. D.; Green, R.; Head, J. W.; Hibbitts, C.; Hicks, M.; Isaacson, P.; Klima, R.; Kramer, G.; Kumar, S.; Livo, E.; Lundeen, S.; Malaret, E.; McCord, T.; Mustard, J.; Nettles, J.; Petro, N.; Runyon, C.; Staid, M.; Sunshine, J.; Taylor, L. A.; Tompkins, S.; Varanasi, P.			Character and Spatial Distribution of OH/H2O on the Surface of the Moon Seen by M-3 on Chandrayaan-1	SCIENCE			English	Article							WATER ICE; EPITHERMAL NEUTRONS; OPTICAL-CONSTANTS; LUNAR PROSPECTOR; HYDROGEN; POLES	The search for water on the surface of the anhydrous Moon had remained an unfulfilled quest for 40 years. However, the Moon Mineralogy Mapper (M-3) on Chandrayaan-1 has recently detected absorption features near 2.8 to 3.0 micrometers on the surface of the Moon. For silicate bodies, such features are typically attributed to hydroxyl- and/or water-bearing materials. On the Moon, the feature is seen as a widely distributed absorption that appears strongest at cooler high latitudes and at several fresh feldspathic craters. The general lack of correlation of this feature in sunlit M-3 data with neutron spectrometer hydrogen abundance data suggests that the formation and retention of hydroxyl and water are ongoing surficial processes. Hydroxyl/water production processes may feed polar cold traps and make the lunar regolith a candidate source of volatiles for human exploration.	[Pieters, C. M.; Head, J. W.; Isaacson, P.; Klima, R.; Mustard, J.; Nettles, J.] Brown Univ, Providence, RI 02912 USA; [Goswami, J. N.] Phys Res Lab, Ahmadabad 380009, Gujarat, India; [Goswami, J. N.; Annadurai, M.] Indian Space Res Org, Bangalore 562140, Karnataka, India; [Clark, R. N.; Livo, E.] US Geol Survey, Denver, CO 80225 USA; [Boardman, J.] Analyt Imaging & Geophys, Boulder, CO 80303 USA; [Buratti, B.; Green, R.; Hicks, M.; Lundeen, S.; Varanasi, P.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Combe, J. -P.; Kramer, G.; McCord, T.] Bear Fight Ctr, Winthrop, WA 98862 USA; [Dyar, M. D.] Mt Holyoke Coll, S Hadley, MA 01075 USA; [Hibbitts, C.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Kumar, S.] Natl Remote Sensing Agcy, Hyderabad, Andhra Pradesh, India; [Malaret, E.] Appl Coherent Technol Corp, Herndon, VA 22070 USA; [Petro, N.] NASA Goddard, Greenbelt, MD 20771 USA; [Runyon, C.] Coll Charleston, Charleston, SC 29424 USA; [Staid, M.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Sunshine, J.] Univ Maryland, College Pk, MD 20742 USA; [Taylor, L. A.] Univ Tennessee, Knoxville, TN 37996 USA; [Tompkins, S.] Def Adv Res Projects Agcy, Arlington, VA 22203 USA	Brown University; Department of Space (DoS), Government of India; Physical Research Laboratory - India; Department of Space (DoS), Government of India; Indian Space Research Organisation (ISRO); United States Department of the Interior; United States Geological Survey; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Mount Holyoke College; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Department of Space (DoS), Government of India; Indian Space Research Organisation (ISRO); National Remote Sensing Centre (NRSC); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; College of Charleston; University System of Maryland; University of Maryland College Park; University of Tennessee System; University of Tennessee Knoxville; United States Department of Defense; Defense Advanced Research Projects Agency (DARPA)	Pieters, CM (corresponding author), Brown Univ, Providence, RI 02912 USA.	carle_pieters@brown.edu	Hibbitts, Charles/B-7787-2016; Petro, Noah E/F-5340-2013	Hibbitts, Charles/0000-0001-9089-4391; Petro, Noah/0000-0003-4676-077X; Sunshine, Jessica/0000-0002-9413-8785; Ahmed, Syed/0000-0001-7001-6030	NASA's Discovery program [NNM05AB26C, NNG06GJ31G]	NASA's Discovery program(National Aeronautics & Space Administration (NASA))	M<SUP>3</SUP> is funded as a Mission of Opportunity under NASA's Discovery program contract NNM05AB26C to Brown University. Lunar reflectance spectra were acquired using the NASA/Keck Reflectance Experiment Laboratory, a multiuser facility supported by NASA grant NNG06GJ31G. A portion of this research was carried out at the JPL, California Institute of Technology, under a contract with NASA. We thank the team of engineers at JPL who designed and built M3 ( led by T. Glavich and M. White) and the Chandrayaan-1 mission operations team ( led by N. S. Hegde, with M3 implementation largely by S. Gomathi), whose mission support has made M3 data possible. The M3 team is honored to be a guest instrument on India's first mission to the Moon.	ARNOLD JR, 1979, J GEOPHYS RES, V84, P5659, DOI 10.1029/JB084iB10p05659; BOARDMAN JW, 2009, 6 EARSEL SIG IS WORK; Burns R. G, 1993, MINERALOGICAL APPL C; CLARK RN, 1979, ICARUS, V40, P94, DOI 10.1016/0019-1035(79)90056-3; Clark RN, 2009, SCIENCE, V326, P562, DOI 10.1126/science.1178105; Crider DH, 2002, ADV SPACE RES, V30, P1869, DOI 10.1016/S0273-1177(02)00493-3; Feldman WC, 1998, SCIENCE, V281, P1496, DOI 10.1126/science.281.5382.1496; Feldman WC, 2001, J GEOPHYS RES-PLANET, V106, P23231, DOI 10.1029/2000JE001444; GREEN RO, 2009, 40 LUN PLAN SCI C HO; Johnson JR, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001430; Keller LP, 1997, GEOCHIM COSMOCHIM AC, V61, P2331, DOI 10.1016/S0016-7037(97)00085-9; Lawrence DJ, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002637; Maurice S, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002208; Noble SK, 2007, ICARUS, V192, P629, DOI 10.1016/j.icarus.2007.07.021; Pieters CM, 2000, METEORIT PLANET SCI, V35, P1101, DOI 10.1111/j.1945-5100.2000.tb01496.x; Seaman SJ, 2006, AM MINERAL, V91, P12, DOI 10.2138/am.2006.1765; Starukhina LV, 2000, ICARUS, V147, P585, DOI 10.1006/icar.2000.6476; Sunshine JM, 2009, SCIENCE, V326, P565, DOI 10.1126/science.1179788; Taylor LA, 2001, J GEOPHYS RES-PLANET, V106, P27985, DOI 10.1029/2000JE001402; Urey H.C., 1952, PLANETS THEIR ORIGIN, DOI [10.1063/1.3067687, DOI 10.1063/1.3067687]; WARREN SG, 1984, APPL OPTICS, V23, P1206, DOI 10.1364/AO.23.001206; WATSON K, 1961, J GEOPHYS RES, V66, P3033, DOI 10.1029/JZ066i009p03033; WIELICZKA DM, 1989, APPL OPTICS, V28, P1714, DOI 10.1364/AO.28.001714	23	458	485	7	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					568	572		10.1126/science.1178658	http://dx.doi.org/10.1126/science.1178658			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19779151				2022-12-28	WOS:000271019400040
J	Tager, AM; Sharma, A; Mark, EJ				Tager, Andrew M.; Sharma, Amita; Mark, Eugene J.			A Man with Progressive Dyspnea The Hermansky-Pudlak syndrome, with interstitial pulmonary fibrosis and respiratory failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LUNG; PNEUMONIA; MUTATIONS; TYPE-2; FORM		[Tager, Andrew M.] Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA; [Tager, Andrew M.] Massachusetts Gen Hosp, Dept Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02114 USA; [Sharma, Amita] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Mark, Eugene J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Tager, Andrew M.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Sharma, Amita] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Mark, Eugene J.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Tager, AM (corresponding author), Massachusetts Gen Hosp, Pulm & Crit Care Unit, Boston, MA 02114 USA.							*AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00; American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Borrero PJS, 2006, J INVEST DERMATOL, V126, P85, DOI 10.1038/sj.jid.5700034; Brantly M, 2000, CHEST, V117, P129, DOI 10.1378/chest.117.1.129; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Cordova A, 2005, PEDIATR BLOOD CANCER, V44, P51, DOI 10.1002/pbc.20210; Fischer A, 2006, CHEST, V130, P976, DOI 10.1378/chest.130.4.976; Gahl WA, 1998, NEW ENGL J MED, V338, P1258, DOI 10.1056/NEJM199804303381803; Gahl WA, 2002, MOL GENET METAB, V76, P234, DOI 10.1016/S1096-7192(02)00044-6; GARAY SM, 1979, AM J MED, V66, P737, DOI 10.1016/0002-9343(79)91111-2; Gotway MB, 2007, THORAX, V62, P546, DOI 10.1136/thx.2004.040022; Huizing M, 2002, Curr Mol Med, V2, P451, DOI 10.2174/1566524023362357; Hunninghake GW, 1999, SARCOIDOSIS VASC DIF, V16, P149; Lederer DJ, 2005, J HEART LUNG TRANSPL, V24, P1697, DOI 10.1016/j.healun.2004.11.015; Nakatani Y, 2000, VIRCHOWS ARCH, V437, P304, DOI 10.1007/s004280000241; Nathan SD, 2007, AM J RESP CRIT CARE, V175, P875, DOI 10.1164/rccm.200608-1153CC; Pierson DM, 2006, RESPIRATION, V73, P382, DOI 10.1159/000091609; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Rossi SE, 2000, RADIOGRAPHICS, V20, P1245, DOI 10.1148/radiographics.20.5.g00se081245; Ryu JH, 2005, CHEST, V127, P178, DOI 10.1378/chest.127.1.178; Sato T, 2006, RHEUMATOL INT, V26, P551, DOI 10.1007/s00296-005-0028-9; SCHINELLA RA, 1985, HUM PATHOL, V16, P366, DOI 10.1016/S0046-8177(85)80230-6; Steele MP, 2005, AM J RESP CRIT CARE, V172, P1146, DOI 10.1164/rccm.200408-1104OC; Takahashi K, 2004, INTERNAL MED, V43, P972, DOI 10.2169/internalmedicine.43.972; Travis WD, 2008, AM J RESP CRIT CARE, V177, P1338, DOI 10.1164/rccm.200611-1685OC; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; WITKOP CJ, 1987, AM J HEMATOL, V26, P305, DOI 10.1002/ajh.2830260403; Woodhead F, 2008, CLIN CHEST MED, V29, P149, DOI 10.1016/j.ccm.2007.11.009	30	4	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2009	361	16					1585	1593		10.1056/NEJMcpc0905544	http://dx.doi.org/10.1056/NEJMcpc0905544			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	506LT	19828536				2022-12-28	WOS:000270777000014
J	Lee, CN; Ko, CY				Lee, Clara N.; Ko, Clifford Y.			Beyond Outcomes-The Appropriateness of Surgical Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RACIAL DISPARITIES; CANCER		[Lee, Clara N.] Univ N Carolina, Sch Med, Div Plast & Reconstruct Surg, Chapel Hill, NC 27599 USA; [Lee, Clara N.] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA; [Ko, Clifford Y.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Ko, Clifford Y.] Amer Coll Surg, Chicago, IL USA; [Ko, Clifford Y.] RAND Corp, Santa Monica, CA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; American College of Surgeons; RAND Corporation	Lee, CN (corresponding author), Univ N Carolina, Sch Med, Div Plast & Reconstruct Surg, CB 7195, Chapel Hill, NC 27599 USA.	cnlee@med.unc.edu						Bach PB, 1999, NEW ENGL J MED, V341, P1198, DOI 10.1056/NEJM199910143411606; Ball JK, 1996, MED CARE, V34, P970, DOI 10.1097/00005650-199609000-00008; Bickell NA, 2008, JNCI-J NATL CANCER I, V100, P1717, DOI 10.1093/jnci/djn387; Bridges CR, 2003, ANN THORAC SURG, V76, pS1356, DOI 10.1016/S0003-4975(03)01203-7; Hall BL, 2009, ANN SURG, V250, P363, DOI 10.1097/SLA.0b013e3181b4148f; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Joslyn SA, 2005, PLAST RECONSTR SURG, V115, P1289, DOI 10.1097/01.PRS.0000156974.69184.5E; Moylan CA, 2008, JAMA-J AM MED ASSOC, V300, P2371, DOI 10.1001/jama.2008.720; OCONNOR AM, 2004, HLTH AFF MILLWOOD S, pVAR63, DOI DOI 10.1377/HLTHAFF.VAR.63; Regenbogen SE, 2009, ANN SURG, V250, P424, DOI 10.1097/SLA.0b013e3181b41d53	10	27	29	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 14	2009	302	14					1580	1581		10.1001/jama.2009.1465	http://dx.doi.org/10.1001/jama.2009.1465			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505UA	19826028				2022-12-28	WOS:000270721800027
J	Kuroda, DG; Singh, CP; Peng, ZH; Kleiman, VD				Kuroda, Daniel G.; Singh, C. P.; Peng, Zhonghua; Kleiman, Valeria D.			Mapping Excited-State Dynamics by Coherent Control of a Dendrimer's Photoemission Efficiency	SCIENCE			English	Article							FEMTOSECOND QUANTUM CONTROL; GENERAL-METHOD; WAVE-PACKET; EXCITATION	Adaptive laser pulse shaping has enabled impressive control over photophysical processes in complex molecules. However, the optimal pulse shape that emerges rarely offers straightforward insight into the excited-state properties being manipulated. We have shown that the emission quantum yield of a donor-acceptor macromolecule (a phenylene ethynylene dendrimer tethered to perylene) can be enhanced by 15% through iterative phase modulation of the excitation pulse. Furthermore, by analyzing the pulse optimization process and optimal pulse features, we successfully isolated the dominant elements underlying the control mechanism. We demonstrated that a step function in the spectral phase directs the postexcitation dynamics of the donor moiety, thus characterizing the coherent nature of the donor excited state. An accompanying pump-probe experiment implicates a 2+1 photon control pathway, in which the optimal pulse promotes a delayed excitation to a second excited state through favorable quantum interference.	[Kuroda, Daniel G.; Singh, C. P.; Kleiman, Valeria D.] Univ Florida, Dept Chem, Ctr Chem Phys, Gainesville, FL 32611 USA; [Peng, Zhonghua] Univ Missouri, Dept Chem, Kansas City, MO 64110 USA	State University System of Florida; University of Florida; University of Missouri System; University of Missouri Kansas City	Kleiman, VD (corresponding author), Univ Florida, Dept Chem, Ctr Chem Phys, Gainesville, FL 32611 USA.	kleiman@chem.ufl.edu	Kleiman, Valeria/H-7818-2013	Kleiman, Valeria/0000-0002-9975-6558; Singh, C. P./0000-0002-3845-9074; Peng, Zhonghua/0000-0002-5597-7324	NSF [CHE-0239120]	NSF(National Science Foundation (NSF))	This work was supported by the NSF, CHE-0239120.	Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; Atas E, 2005, J PHYS CHEM B, V109, P13553, DOI 10.1021/jp051488z; Bartels RA, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.043404; Branderhorst MPA, 2008, SCIENCE, V320, P638, DOI 10.1126/science.1154576; Brixner T, 2003, J CHEM PHYS, V118, P3692, DOI 10.1063/1.1538239; Brixner T, 2001, NATURE, V414, P57, DOI 10.1038/35102037; Cardoza D, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1867334; Daniel C, 2003, SCIENCE, V299, P536, DOI 10.1126/science.1078517; Herek JL, 2002, NATURE, V417, P533, DOI 10.1038/417533a; JUDSON RS, 1992, PHYS REV LETT, V68, P1500, DOI 10.1103/PhysRevLett.68.1500; Kleiman VD, 1998, CHEM PHYS, V233, P207, DOI 10.1016/S0301-0104(97)00367-4; Levis RJ, 2001, SCIENCE, V292, P709, DOI 10.1126/science.1059133; Meshulach D, 1997, OPT COMMUN, V138, P345, DOI 10.1016/S0030-4018(97)00090-4; Meshulach D, 1999, PHYS REV A, V60, P1287, DOI 10.1103/PhysRevA.60.1287; Meshulach D, 1998, NATURE, V396, P239, DOI 10.1038/24329; Montgomery MA, 2007, J PHYS CHEM A, V111, P5126, DOI 10.1021/jp073132o; Montgomery MA, 2007, J PHYS CHEM A, V111, P1426, DOI 10.1021/jp065962s; Montgomery MA, 2006, J PHYS CHEM A, V110, P6391, DOI 10.1021/jp061160l; Ogilvie JP, 2005, OPT LETT, V30, P911, DOI 10.1364/OL.30.8.000911; Ohmori K, 2009, ANNU REV PHYS CHEM, V60, P487, DOI 10.1146/annurev.physchem.59.032607.093818; Otake I, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2139999; Peng ZH, 2000, J AM CHEM SOC, V122, P6619, DOI 10.1021/ja0006907; Peng ZH, 2006, PHOTOSYNTH RES, V87, P115, DOI 10.1007/s11120-005-8534-x; Prokhorenko VI, 2006, SCIENCE, V313, P1257, DOI 10.1126/science.1130747; Prokhorenko VI, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1886750; Rego LGC, 2009, ANNU REV PHYS CHEM, V60, P293, DOI 10.1146/annurev.physchem.040808.090409; RICE SA, 1992, SCIENCE, V258, P412, DOI 10.1126/science.258.5081.412; Savolainen J, 2008, P NATL ACAD SCI USA, V105, P7641, DOI 10.1073/pnas.0711927105; SCHMIDT MHB, LAB2 A VIRTUAL FEMTO; Swallen SF, 1999, J MOL STRUCT, V485, P585, DOI 10.1016/S0022-2860(99)00188-X; TANNOR DJ, 1988, ADV CHEM PHYS, V70, P441, DOI 10.1002/9780470141199.ch10; TANNOR DJ, 1985, J CHEM PHYS, V83, P5013, DOI 10.1063/1.449767; WARREN WS, 1993, SCIENCE, V259, P1581, DOI 10.1126/science.259.5101.1581; White JL, 2004, J PHYS B-AT MOL OPT, V37, pL399, DOI 10.1088/0953-4075/37/24/L02	34	81	82	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					263	267		10.1126/science.1176524	http://dx.doi.org/10.1126/science.1176524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19815771				2022-12-28	WOS:000270599500036
J	Harutyunyan, AR; Chen, GG; Paronyan, TM; Pigos, EM; Kuznetsov, OA; Hewaparakrama, K; Kim, SM; Zakharov, D; Stach, EA; Sumanasekera, GU				Harutyunyan, Avetik R.; Chen, Gugang; Paronyan, Tereza M.; Pigos, Elena M.; Kuznetsov, Oleg A.; Hewaparakrama, Kapila; Kim, Seung Min; Zakharov, Dmitri; Stach, Eric A.; Sumanasekera, Gamini U.			Preferential Growth of Single-Walled Carbon Nanotubes with Metallic Conductivity	SCIENCE			English	Article							WATER; NANOCRYSTALS; ELECTRONICS; TRANSITION; SURFACE; ROUTE	Single-walled carbon nanotubes can be classified as either metallic or semiconducting, depending on their conductivity, which is determined by their chirality. Existing synthesis methods cannot controllably grow nanotubes with a specific type of conductivity. By varying the noble gas ambient during thermal annealing of the catalyst, and in combination with oxidative and reductive species, we altered the fraction of tubes with metallic conductivity from one-third of the population to a maximum of 91%. In situ transmission electron microscopy studies reveal that this variation leads to differences in both morphology and coarsening behavior of the nanoparticles that we used to nucleate nanotubes. These catalyst rearrangements demonstrate that there are correlations between catalyst morphology and resulting nanotube electronic structure and indicate that chiral-selective growth may be possible.	[Harutyunyan, Avetik R.; Chen, Gugang; Pigos, Elena M.; Kuznetsov, Oleg A.] Honda Res Inst USA, Columbus, OH 43212 USA; [Paronyan, Tereza M.; Hewaparakrama, Kapila; Sumanasekera, Gamini U.] Univ Louisville, Dept Phys & Astron, Louisville, KY 40292 USA; [Kim, Seung Min; Stach, Eric A.] Purdue Univ, Sch Mat Engn, W Lafayette, IN 47907 USA; [Kim, Seung Min; Zakharov, Dmitri; Stach, Eric A.] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA	Honda Motor Company; University of Louisville; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Harutyunyan, AR (corresponding author), Honda Res Inst USA, 1381 Kinnear Rd, Columbus, OH 43212 USA.	aharutyunyan@honda-ri.com	Kuznetsov, Oleg/ABA-4555-2021; Stach, Eric Andrew/M-6455-2019; Stach, Eric A/D-8545-2011; Zakharov, Dmitri N/F-4493-2014	Kuznetsov, Oleg/0000-0002-4808-1597; Stach, Eric Andrew/0000-0002-3366-2153; Stach, Eric A/0000-0002-3366-2153; 	Honda Research Institute USA	Honda Research Institute USA	We thank M. S. Dresselhaus and J. Kong for help in Raman measurements, B. Weisman and A. Naumov for photoluminescence measurements, B. I. Yakobson for discussions, and B. Maruyama for assistance. A patent related to this work has been submitted (U. S. patent application no. 12/511,047). This research was supported by the Honda Research Institute USA.	Amama PB, 2009, NANO LETT, V9, P44, DOI 10.1021/nl801876h; Arnold MS, 2006, NAT NANOTECHNOL, V1, P60, DOI 10.1038/nnano.2006.52; Avouris P, 2002, ACCOUNTS CHEM RES, V35, P1026, DOI 10.1021/ar010152e; Bachilo SM, 2003, J AM CHEM SOC, V125, P11186, DOI 10.1021/ja036622c; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Collins PC, 2001, SCIENCE, V292, P706, DOI 10.1126/science.1058782; GJOSTEIN NA, 1963, ACTA METALL MATER, V11, P957, DOI 10.1016/0001-6160(63)90065-8; Hansen PL, 2002, SCIENCE, V295, P2053, DOI 10.1126/science.1069325; Harutyunyan AR, 2002, NANO LETT, V2, P525, DOI 10.1021/nl0255101; Hata K, 2004, SCIENCE, V306, P1362, DOI 10.1126/science.1104962; Izard N, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2939560; Kataura H, 1999, SYNTHETIC MET, V103, P2555, DOI 10.1016/S0379-6779(98)00278-1; Krupke R, 2003, SCIENCE, V301, P344, DOI 10.1126/science.1086534; Li YM, 2004, NANO LETT, V4, P317, DOI 10.1021/nl035097c; Maultzsch J, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205438; Medeiros-Ribeiro G, 1998, SCIENCE, V279, P353, DOI 10.1126/science.279.5349.353; Miyata Y, 2006, J PHYS CHEM B, V110, P25, DOI 10.1021/jp055692y; Mora E, 2008, J AM CHEM SOC, V130, P11840, DOI 10.1021/ja8035724; Qu LT, 2008, NANO LETT, V8, P2682, DOI 10.1021/nl800967n; Rao AM, 1997, NATURE, V388, P257, DOI 10.1038/40827; Rinzler AG, 2006, NAT NANOTECHNOL, V1, P17, DOI 10.1038/nnano.2006.76; SAITO R, 1998, PHYS PROPERTIES CARB, P144; Samsonidze GG, 2004, APPL PHYS LETT, V85, P5703, DOI 10.1063/1.1829160; Smalley RE, 2006, J AM CHEM SOC, V128, P15824, DOI 10.1021/ja065767r; Strano MS, 2003, SCIENCE, V301, P1519, DOI 10.1126/science.1087691; Wang YH, 2005, NANO LETT, V5, P997, DOI 10.1021/nl047851f; Yamada T, 2008, NANO LETT, V8, P4288, DOI 10.1021/nl801981m; Zhang GY, 2006, J AM CHEM SOC, V128, P6026, DOI 10.1021/ja061324b; Zheng M, 2003, SCIENCE, V302, P1545, DOI 10.1126/science.1091911; [No title captured]	30	348	353	8	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 2	2009	326	5949					116	120		10.1126/science.1177599	http://dx.doi.org/10.1126/science.1177599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19797656				2022-12-28	WOS:000270355600047
J	Sohmen, D; Harms, JM; Schlunzen, F; Wilson, DN				Sohmen, Daniel; Harms, Joerg M.; Schluenzen, Frank; Wilson, Daniel N.			SnapShot: Antibiotic Inhibition of Protein Synthesis II	CELL			English	Editorial Material							RIBOSOME		[Sohmen, Daniel; Wilson, Daniel N.] Univ Munich, D-80539 Munich, Germany; [Harms, Joerg M.] Univ Hamburg, MPSD, Hamburg, Germany; [Schluenzen, Frank] DESY, D-2000 Hamburg, Germany; [Wilson, Daniel N.] CiPS M, Munich, Germany	University of Munich; University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Sohmen, D (corresponding author), Univ Munich, D-80539 Munich, Germany.		Harms, Joerg/K-8786-2012; Schluenzen, Frank/H-6274-2014; Schluenzen, Frank/P-9177-2019; Wilson, Daniel/AAE-8504-2019	Harms, Joerg/0000-0002-9442-8264; Schluenzen, Frank/0000-0003-2849-0542; Schluenzen, Frank/0000-0003-2849-0542; Wilson, Daniel/0000-0003-3816-3828				Moore PB, 2003, ANNU REV BIOCHEM, V72, P813, DOI 10.1146/annurev.biochem.72.110601.135450; Polacek N, 2005, CRIT REV BIOCHEM MOL, V40, P285, DOI 10.1080/10409230500326334; Spahn CMT, 1996, J MOL MED, V74, P423, DOI 10.1007/s001090050044; Sutcliffe JA, 2005, CURR OPIN MICROBIOL, V8, P534, DOI 10.1016/j.mib.2005.08.004; Tenson T, 2006, MOL MICROBIOL, V59, P1664, DOI 10.1111/j.1365-2958.2006.05063.x; Wilson D. N., 2004, PROTEIN SYNTHESIS RI, P449; Yonath A, 2005, ANNU REV BIOCHEM, V74, P649, DOI 10.1146/annurev.biochem.74.082803.133130	7	18	19	2	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	OCT 2	2009	139	1							212.e1	10.1016/j.cell.2009.08.009	http://dx.doi.org/10.1016/j.cell.2009.08.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	501NM	19804764	Bronze			2022-12-28	WOS:000270388600029
J	White, TD; Asfaw, B; Beyene, Y; Haile-Selassie, Y; Lovejoy, CO; Suwa, G; WoldeGabriel, G				White, Tim D.; Asfaw, Berhane; Beyene, Yonas; Haile-Selassie, Yohannes; Lovejoy, C. Owen; Suwa, Gen; WoldeGabriel, Giday			Ardipithecus ramidus and the Paleobiology of Early Hominids	SCIENCE			English	Article							EARLY PLIOCENE HOMINIDS; AUSTRALOPITHECUS-AFARENSIS; FOSSIL RECORD; MIDDLE AWASH; NATURAL-HISTORY; UPPER MIOCENE; HUMAN GAIT; ETHIOPIA; EVOLUTION; ORIGINS	Hominid fossils predating the emergence of Australopithecus have been sparse and fragmentary. The evolution of our lineage after the last common ancestor we shared with chimpanzees has therefore remained unclear. Ardipithecus ramidus, recovered in ecologically and temporally resolved contexts in Ethiopia's Afar Rift, now illuminates earlier hominid paleobiology and aspects of extant African ape evolution. More than 110 specimens recovered from 4.4-million-year-old sediments include a partial skeleton with much of the skull, hands, feet, limbs, and pelvis. This hominid combined arboreal palmigrade clambering and careful climbing with a form of terrestrial bipedality more primitive than that of Australopithecus. Ar. ramidus had a reduced canine/premolar complex and a little-derived cranial morphology and consumed a predominantly C-3 plant-based diet (plants using the C-3 photosynthetic pathway). Its ecological habitat appears to have been largely woodland-focused. Ar. ramidus lacks any characters typical of suspension, vertical climbing, or knuckle-walking. Ar. ramidus indicates that despite the genetic similarities of living humans and chimpanzees, the ancestor we last shared probably differed substantially from any extant African ape. Hominids and extant African apes have each become highly specialized through very different evolutionary pathways. This evidence also illuminates the origins of orthogrady, bipedality, ecology, diet, and social behavior in earliest Hominidae and helps to define the basal hominid adaptation, thereby accentuating the derived nature of Australopithecus.	[White, Tim D.] Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA; [White, Tim D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Asfaw, Berhane] Rift Valley Res Serv, Addis Ababa, Ethiopia; [Beyene, Yonas] Minist Youth Sports & Culture, Dept Anthropol & Archaeol, Author Res & Conservat Cultural Heritage, Addis Ababa, Ethiopia; [Haile-Selassie, Yohannes] Cleveland Museum Nat Hist, Dept Phys Anthropol, Cleveland, OH 44106 USA; [Lovejoy, C. Owen] Kent State Univ, Sch Biomed Sci, Dept Anthropol, Kent, OH 44240 USA; [Suwa, Gen] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Cleveland Museum of Natural History; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University of Tokyo	White, TD (corresponding author), Univ Calif Berkeley, Human Evolut Res Ctr, 3101 Valley Life Sci Bldg, Berkeley, CA 94720 USA.	timwhite@berkeley.edu	, owen/N-7301-2019	, owen/0000-0003-0053-4523	NSF [8210897, 9318698, 9512534, 9632389, 9729060, 9727519, 9910344, 0321893]; Institute of Geophysics and Planetary Physics of the University of California at Los Alamos National Laboratory (LANL); Japan Society for the Promotion of Science	NSF(National Science Foundation (NSF)); Institute of Geophysics and Planetary Physics of the University of California at Los Alamos National Laboratory (LANL)(United States Department of Energy (DOE)Los Alamos National Laboratory); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	For funding, we thank NSF (this material is based on work supported by grants 8210897, 9318698, 9512534, 9632389, 9729060, 9727519, 9910344, and 0321893 HOMINID-RHOI), the Institute of Geophysics and Planetary Physics of the University of California at Los Alamos National Laboratory (LANL), and the Japan Society for the Promotion of Science. D. Clark and C. Howell inspired this effort and conducted laboratory and field research. We thank the coauthors of the companion papers (22-30), with special thanks to the ARA-VP-6/500 and -7/2 excavation teams, including A. Amzaye, the Alisera Afar Clan, Lu Baka, A. Bears, D. Brill, J. M. Carretero, S. Cornero, D. DeGusta, A. Defleur, A. Dessie, G. Fule, A. Getty, H. Gilbert, E. Gulec, G. Kadir, B. Latimer, D. Pennington, A. Sevim, S. Simpson, D. Trachewsky, and S. Yoseph. G. Curtis, J. DeHeinzelin, and G. Heiken provided field geological support. D. Helgren, D. DeGusta, L. Hlusko, and H. Gilbert provided insightful suggestions and advice. We thank H. Gilbert, K. Brudvik, L. Bach, D. Paul, B. Daniels, and D. Brill for illustrations; G. Richards and A. Mleczko for imaging; the Ministry of Tourism and Culture, the Authority for Research and Conservation of the Cultural Heritage, and the National Museum of Ethiopia for permissions and facilitation; and the Afar Regional Government, the Afar people of the Middle Awash, and many other field workers who contributed directly to the research efforts and results.	Allard P, 2001, NEUROPSYCHOBIOLOGY, V44, P70, DOI 10.1159/000054918; Begun DR, 2005, ANTHROPOL SCI, V113, P53, DOI 10.1537/ase.04S008; BEHRENSMEYER AK, 1982, PALEOBIOLOGY, V8, P211, DOI 10.1017/S0094837300006941; Britten RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/pnas.172510699; Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Darwin C., 1871, P475; De Bonis Louis, 1994, Evolutionary Anthropology, V3, P75, DOI 10.1002/evan.1360030303; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; Elton S, 2008, J ANAT, V212, P377, DOI 10.1111/j.1469-7580.2008.00872.x; Fedorov AV, 2006, SCIENCE, V312, P1485, DOI 10.1126/science.1122666; Gee Henry, 1999, DEEP TIME CLADISTICS; GILBERT H, 2008, HOMOERECTUS PLEISTOC; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Haile-Selassie Y, 2004, SCIENCE, V303, P1503, DOI 10.1126/science.1092978; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Haile-Selassie Yohannes, 2009, P159; HILL A, 1987, YEARB PHYS ANTHROPOL, V31, P49; Hlusko LJ, 2004, AM J PHYS ANTHROPOL, V124, P223, DOI 10.1002/ajpa.10353; Huxley T., 1863, EVIDENCE MANS PLACE; HUXLEY TH, 1860, WESTMINSTER REV, V73, P541; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P373, DOI 10.1002/ajpa.1330570402; KAPPELMAN J, 1995, NATURE, V376, P558, DOI 10.1038/376558b0; Kidwell SM, 1996, ANNU REV EARTH PL SC, V24, P433, DOI 10.1146/annurev.earth.24.1.433; Kimbel WH, 2006, J HUM EVOL, V51, P134, DOI 10.1016/j.jhevol.2006.02.003; Latimer B., 1991, P169; LEAKEY MD, 1976, NATURE, V262, P460, DOI 10.1038/262460a0; LEAKEY MG, LOTHAGAM DAWN HUMANI; Louchart A, 2009, SCIENCE, V326, DOI 10.1126/science.1175823; Lovejoy CO, 2007, GAIT POSTURE, V25, P325, DOI 10.1016/j.gaitpost.2006.05.001; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175834; Lovejoy CO, 2009, SCIENCE, V326, P100, DOI 10.1126/science.1175833; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175827; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175831; Lovejoy CO, 1999, P NATL ACAD SCI USA, V96, P13247, DOI 10.1073/pnas.96.23.13247; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Lovejoy CO, 2005, GAIT POSTURE, V21, P113, DOI 10.1016/j.gaitpost.2004.06.010; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; MCCOLLUM MA, J EXP ZOOL PART B, V312, DOI DOI 10.1002/JEZ.B.21316; Moore Jim, 1996, P275, DOI 10.1017/CBO9780511752414.022; Palfy J, 2007, EARTH PLANET SC LETT, V258, P160, DOI 10.1016/j.epsl.2007.03.029; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pik R, 2003, EARTH PLANET SC LETT, V215, P73, DOI 10.1016/S0012-821X(03)00457-6; Pilbeam D, 2004, CR PALEVOL, V3, P305, DOI 10.1016/j.crpv.2004.01.006; Pulquerio MJF, 2007, TRENDS ECOL EVOL, V22, P180, DOI 10.1016/j.tree.2006.11.013; Renne PR, 1999, GEOL SOC AM BULL, V111, P869, DOI 10.1130/0016-7606(1999)111<0869:COTMPS>2.3.CO;2; Reno PL, 2003, P NATL ACAD SCI USA, V100, P9404, DOI 10.1073/pnas.1133180100; SARICH VM, 1967, P NATL ACAD SCI USA, V58, P142, DOI 10.1073/pnas.58.1.142; Semaw S, 2005, NATURE, V433, P301, DOI 10.1038/nature03177; Senut B, 2004, CR PALEVOL, V3, P265, DOI 10.1016/j.crpv.2003.12.005; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Shubin N, 2009, NATURE, V457, P818, DOI 10.1038/nature07891; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Stern JT, 2000, EVOL ANTHROPOL, V9, P113, DOI 10.1002/1520-6505(2000)9:3<113::AID-EVAN2>3.0.CO;2-W; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; Suwa G, 2007, NATURE, V448, P921, DOI 10.1038/nature06113; Suwa G, 2009, SCIENCE, V326, P94, DOI 10.1126/science.1175824; Suwa G, 2009, SCIENCE, V326, DOI 10.1126/science.1175825; TRINKAUS E, 1990, AM J PHYS ANTHROPOL, V83, P1, DOI 10.1002/ajpa.1330830102; Ward C, 1999, EVOL ANTHROPOL, V7, P197, DOI 10.1002/(SICI)1520-6505(1999)7:6<197::AID-EVAN4>3.0.CO;2-T; Wesselman H.B., 2009, ARDIPITHECUS KADDABA; Western D, 2009, SCIENCE, V324, P1061, DOI 10.1126/science.1171155; White TD, 2006, NATURE, V440, P883, DOI 10.1038/nature04629; WHITE TD, 1995, NATURE, V375, P88, DOI 10.1038/375088a0; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0; WHITE TD, PRIMATE FOSSIL RECOR, P407; WHITE TD, 2009, PALEOBIOLOGICAL REVO, P121; White TD, 2009, SCIENCE, V326, P87, DOI 10.1126/science.1175822; WOLDEGABRIEL G, 1994, NATURE, V371, P330, DOI 10.1038/371330a0; WoldeGabriel G, 2009, SCIENCE, V326, DOI 10.1126/science.1175817; Wood B, 2002, NATURE, V418, P133, DOI 10.1038/418133a; Wrangham R, 2001, DEV PRIMATOL-PROG PR, P5	76	406	422	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					75	86		10.1126/science.1175802	http://dx.doi.org/10.1126/science.1175802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501CA	19810190				2022-12-28	WOS:000270355600040
J	McGready, R				McGready, Rose			Intermittent preventive treatment of malaria in infancy	LANCET			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; PLASMODIUM-FALCIPARUM MALARIA; SULFADOXINE-PYRIMETHAMINE; DOUBLE-BLIND; EFFICACY; CHILDREN; CHLOROQUINE; COMBINATION; AMODIAQUINE; ARTESUNATE		Shoklo Malaria Res Unit, Mae Sot 63110, Tak, Thailand	Mahidol University	McGready, R (corresponding author), Shoklo Malaria Res Unit, Mae Sot 63110, Tak, Thailand.	rose@shoklo-unit.com	McGready, Rose/A-3290-2014	McGready, Rose/0000-0003-1621-3257				Abacassamo F, 2004, TROP MED INT HEALTH, V9, P200, DOI 10.1046/j.1365-3156.2003.01182.x; Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Bousema JT, 2003, TROP MED INT HEALTH, V8, P427, DOI 10.1046/j.1365-3156.2003.01047.x; Checchi F, 2004, TROP MED INT HEALTH, V9, P445, DOI 10.1111/j.1365-3156.2004.01217.x; Djaman Joseph, 2004, Sante, V14, P205; Evans SJW, 1997, BRIT J CLIN PHARMACO, V43, P665; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; LUXEMBURGER C, 1996, ANN TROP PAEDIATR, V16, P2818; Priotto G, 2003, T ROY SOC TROP MED H, V97, P325, DOI 10.1016/S0035-9203(03)90161-1; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; SLUTSKER LM, 1990, B WORLD HEALTH ORGAN, V68, P53; White WT, 2005, CYBIUM, V29, P33	12	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT-NOV	2009	374	9700					1478	1480		10.1016/S0140-6736(09)61629-9	http://dx.doi.org/10.1016/S0140-6736(09)61629-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	517CS	19765814				2022-12-28	WOS:000271591300006
J	Holt, LJ; Tuch, BB; Villen, J; Johnson, AD; Gygi, SP; Morgan, DO				Holt, Liam J.; Tuch, Brian B.; Villen, Judit; Johnson, Alexander D.; Gygi, Steven P.; Morgan, David O.			Global Analysis of Cdk1 Substrate Phosphorylation Sites Provides Insights into Evolution	SCIENCE			English	Article							CYCLIN-DEPENDENT KINASE; YEAST; MECHANISM; TARGETS; DOMAINS	To explore the mechanisms and evolution of cell-cycle control, we analyzed the position and conservation of large numbers of phosphorylation sites for the cyclin-dependent kinase Cdk1 in the budding yeast Saccharomyces cerevisiae. We combined specific chemical inhibition of Cdk1 with quantitative mass spectrometry to identify the positions of 547 phosphorylation sites on 308 Cdk1 substrates in vivo. Comparisons of these substrates with orthologs throughout the ascomycete lineage revealed that the position of most phosphorylation sites is not conserved in evolution; instead, clusters of sites shift position in rapidly evolving disordered regions. We propose that the regulation of protein function by phosphorylation often depends on simple nonspecific mechanisms that disrupt or enhance protein-protein interactions. The gain or loss of phosphorylation sites in rapidly evolving regions could facilitate the evolution of kinase-signaling circuits.	[Villen, Judit; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Holt, Liam J.; Morgan, David O.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Holt, Liam J.; Morgan, David O.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Tuch, Brian B.; Johnson, Alexander D.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA	Harvard University; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gygi, SP (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	steven_gygi@hms.harvard.edu; david.morgan@ucsf.edu		Villen, Judit/0000-0002-1005-1739; Holt, Liam/0000-0002-4002-0861; Morgan, David/0000-0001-8753-4416	NIH [GM50684, HG3456, GM037049]; NSF; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037049, R01GM069901] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Feldman, R. Fletterick, M. Jacobson, H. Li, M. Matyskiela, P. O'Farrell, M. Sullivan, and S. Naylor for helpful comments; A. K. Dunker, E. Garner, C. Oldfield, K. Shimizu, and T. Ishida for disorder prediction algorithms; the Broad Institute, Sanger Center, Genolevures, and the Joint Genome Institute for genome sequence data; and O. Jensen, C. Zhang, and K. Shokat for reagents. This work was supported by grants from NIH (GM50684 to D. O. M., HG3456 to S. P. G., and GM037049 to A. D. J.) and fellowships from NSF (to L. J. H. and B. B. T.).	Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Drury LS, 2009, CURR BIOL, V19, P530, DOI 10.1016/j.cub.2009.02.034; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Holt LJ, 2007, MOL CELL, V25, P689, DOI 10.1016/j.molcel.2007.02.012; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Moses AM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r23; Moses AM, 2007, P NATL ACAD SCI USA, V104, P17713, DOI 10.1073/pnas.0700997104; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Serber Z, 2007, CELL, V128, P441, DOI 10.1016/j.cell.2007.01.018; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yaffe MB, 2001, CURR OPIN CELL BIOL, V13, P131, DOI 10.1016/S0955-0674(00)00189-7	20	643	2391	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 25	2009	325	5948					1682	1686		10.1126/science.1172867	http://dx.doi.org/10.1126/science.1172867			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779198	Green Accepted			2022-12-28	WOS:000270131800044
J	Sita, LR				Sita, Lawrence R.			Tin Takes Ethylene On-and Off	SCIENCE			English	Editorial Material							MOLECULES		Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Sita, LR (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	lsita@umd.edu	Sita, Lawrence/F-6853-2010					Albright T. A., 1985, ORBITAL INTERACTIONS; Bader RFW, 2007, J COMPUT CHEM, V28, P4, DOI 10.1002/jcc.20528; Cotton F. A., 1990, CHEM APPL GROUP THEO, V3rd; Hoffmann R, 2008, ANGEW CHEM INT EDIT, V47, P7164, DOI 10.1002/anie.200801206; Hoffmann R, 2008, ANGEW CHEM INT EDIT, V47, P4474, DOI 10.1002/anie.200705775; Minkin V. I., 1987, NONCLASSICAL STRUCTU; Peng Y, 2009, SCIENCE, V325, P1668, DOI 10.1126/science.1176443; SITA LR, 1994, ACCOUNTS CHEM RES, V27, P191, DOI 10.1021/ar00043a002; Wiberg KB, 1996, ACCOUNTS CHEM RES, V29, P229, DOI 10.1021/ar950207a; WIBERG KB, 1984, ACCOUNTS CHEM RES, V17, P379, DOI 10.1021/ar00107a001; Woodward R. B., 1970, CONSERVATION ORBITAL	11	0	0	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	2009	325	5948					1631	1632		10.1126/science.1179881	http://dx.doi.org/10.1126/science.1179881			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	498II	19779179				2022-12-28	WOS:000270131800023
J	Spencer, JP; Dineva, E; Smith, LB				Spencer, John P.; Dineva, Evelina; Smith, Linda B.			Comment on "Infants' Perseverative Search Errors Are Induced by Pragmatic Misinterpretation"	SCIENCE			English	Editorial Material							FIELD-THEORY; INTENTIONS; DYNAMICS; MEMORY		[Spencer, John P.; Dineva, Evelina] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Spencer, John P.; Dineva, Evelina] Univ Iowa, Delta Ctr, Iowa City, IA 52242 USA; [Smith, Linda B.] Indiana Univ, Dept Brain & Psychol Sci, Bloomington, IN 47405 USA	University of Iowa; University of Iowa; Indiana University System; Indiana University Bloomington	Spencer, JP (corresponding author), Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA.	john-spencer@uiowa.edu	Dineva, Evelina/AAE-8796-2021	Spencer, John/0000-0002-7320-144X	NIMH NIH HHS [R01 MH062480-06, R01 MH062480, R01 MH062480-05A2, R01-MH062480] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062480] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Behne T, 2005, DEVELOPMENTAL SCI, V8, P492, DOI 10.1111/j.1467-7687.2005.00440.x; Clearfield MW, 2009, DEVELOPMENTAL SCI, V12, P26, DOI 10.1111/j.1467-7687.2008.00769.x; Csibra G, 2006, ATTENTION PERFORM, P249; Gergely G, 2007, DEVELOPMENTAL SCI, V10, P139, DOI 10.1111/j.1467-7687.2007.00576.x; Moore C., 2006, HUMAN BODY PERCEPTIO, P427; Moore C, 2007, INFANCY, V11, P215, DOI 10.1111/j.1532-7078.2007.tb00224.x; Piaget, 1954, CONSTR REALITY CHILD; Samuelson LK, 1998, CHILD DEV, V69, P94, DOI 10.1111/j.1467-8624.1998.tb06136.x; Smith LB, 1999, PSYCHOL REV, V106, P235, DOI 10.1037/0033-295X.106.2.235; Thelen E, 2001, BEHAV BRAIN SCI, V24, P1, DOI 10.1017/S0140525X01003910; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Topal J, 2008, SCIENCE, V321, P1831, DOI 10.1126/science.1161437; Yoon JMD, 2008, P NATL ACAD SCI USA, V105, P13690, DOI 10.1073/pnas.0804388105	13	10	10	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 25	2009	325	5948								10.1126/science.1172759	http://dx.doi.org/10.1126/science.1172759			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	498II	19779175	Green Accepted			2022-12-28	WOS:000270131800016
J	Sipkins, DA				Sipkins, Dorothy A.			Rendering the Leukemia Cell Susceptible to Attack	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STEM-CELLS		Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Chicago	Sipkins, DA (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA.							Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Rousselot P, 2007, BLOOD, V109, P58, DOI 10.1182/blood-2006-03-011239; Selleri C, 1996, BLOOD, V87, P4149, DOI 10.1182/blood.V87.10.4149.bloodjournal87104149; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227	5	11	12	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2009	361	13					1307	1309		10.1056/NEJMcibr0904291	http://dx.doi.org/10.1056/NEJMcibr0904291			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	497RN	19776414				2022-12-28	WOS:000270078700015
J	Patel, A; Buszewicz, M; Beecham, J; Griffin, M; Rait, G; Nazareth, I; Atkinson, A; Barlow, J; Haines, A				Patel, Anita; Buszewicz, Marta; Beecham, Jennifer; Griffin, Mark; Rait, Greta; Nazareth, Irwin; Atkinson, Angela; Barlow, Julie; Haines, Andy			Economic evaluation of arthritis self management in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COST-EFFECTIVENESS; CHRONIC DISEASE; HEALTH-STATUS; PROGRAM; TRIAL	Objective To assess the cost effectiveness of a self management programme plus education booklet for arthritis in primary care. Design Cost effectiveness and cost utility analysis from health and social care and societal perspectives alongside a randomised controlled trial. Setting 74 general practices in the United Kingdom. Participants 812 patients aged 50 or more with osteoarthritis of the hips or knees, or both, and pain or disability, or both. Interventions Randomisation to either six sessions of an arthritis self management programme plus an education booklet (intervention group) or the education booklet alone (standard care control group). Main outcome measures Total health and social care costs and total societal costs at 12 months; cost effectiveness (incremental cost effectiveness ratios and cost effectiveness acceptability curves) on basis of quality of life (SF-36, primary outcome measure), EuroQol visual analogue scale, and quality adjusted life years (QALYs). Results At 12 months health and social care costs in the intervention group were 101 pound higher (95% confidence interval 3 pound to 176) pound than those in the control group because the additional costs of the arthritis self management programme did not seem to be fully offset by savings elsewhere. There were no significant differences in societal costs (which were up to 13 times the size of health and social care costs) or any of the outcomes. From the health and social care perspective the intervention was dominated by the control on the basis of QALYs (which were non-significantly lower in the intervention group) and had incremental cost effectiveness ratios between 279 pound and 13 pound 473 for the other outcomes. From the societal perspective the intervention seemed superior to the control owing to non-significantly lower costs and non-significantly better outcomes on all measures except QALYs. Probabilities of the arthritis self management programme's cost effectiveness ranged between 12% and 97% (for thresholds ranging 0 pound to 1000) pound based on one point improvements in SF-36 outcomes, but the clinical significance of this is debatable. Probabilities of cost effectiveness on the basis of the visual analogue scale and QALYs were low. Conclusions Cost effectiveness of an arthritis self management programme is not suggested on the basis of current National Institute for Health and Clinical Excellence cost perspectives and QALY thresholds. The probability of cost effectiveness is greater when broader costs and other quality of life outcomes are considered. These results suggest that the cost effectiveness of the Department of Health's expert patients programme cannot be assumed across all clinical conditions and that further rigorous evaluations for other conditions may be needed.	[Patel, Anita] Kings Coll London, Inst Psychiat, Ctr Econ Mental Hlth, London SE5 8AF, England; [Buszewicz, Marta; Griffin, Mark; Rait, Greta; Nazareth, Irwin] UCL, Sch Life & Med Sci, Res Dept Primary Care & Populat Hlth, London WC1E 6BT, England; [Beecham, Jennifer] Univ Kent, Personal Social Serv Res Unit, Canterbury, Kent, England; [Rait, Greta; Nazareth, Irwin] MRC Gen Practice Res Framework, London, England; [Atkinson, Angela] James Cook Univ Hosp, NE Stroke Res Network, Middlesbrough, Cleveland, England; [Barlow, Julie] Coventry Univ, Fac Hlth & Life Sci, Appl Res Ctr Hlth & Lifestyle Intervent, Self Management Programme, Coventry, W Midlands, England; [Haines, Andy] London Sch Hyg & Trop Med, London, England	University of London; King's College London; University of London; University College London; University of Kent; James Cook University Hospital; Coventry University; University of London; London School of Hygiene & Tropical Medicine	Patel, A (corresponding author), Kings Coll London, Inst Psychiat, Ctr Econ Mental Hlth, London SE5 8AF, England.	anita.patel@iop.kcl.ac.uk	Patel, Anita/F-9832-2010; Beecham, Jennifer K/E-7836-2010; Griffin, Mark/C-1827-2008	Beecham, Jennifer K/0000-0001-5147-3383; Rait, Greta/0000-0002-7216-7294; Haines, Andy/0000-0002-8053-4605; Nazareth, Irwin/0000-0003-2146-9628; Patel, Anita/0000-0003-0769-1732	UK Medical Research Council [G9900306]; MRC [MC_U122797163, MC_U122797165] Funding Source: UKRI; Medical Research Council [MC_U122797163, MC_U122797165] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This trial was funded by the UK Medical Research Council (grant No G9900306). The trial was initially funded to run for three years, from 1 June 2000 to 31 May 2003. A supplement and extension extended the trial completion date to 31 May 2004. The UK Medical Research Council funded the trial, peer reviewed the protocol, and was represented on the trial steering committee. The funders had no role in the study design or management, data collection, analysis and interpretation, writing of the report, or preparation of the manuscript.	*ARTHR CAR, 2007, ARTHR CAR FACT SHEET; Beecham J., 2001, MEASURING MENTAL HLT; BEECHAM J, 2002, MEASURING MENTAL HLT; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Buszewicz M, 2006, BMJ-BRIT MED J, V333, P879, DOI 10.1136/bmj.38965.375718.80; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Curtis, 2003, UNIT COSTS HLTH SOCI; Department of Health (UK), 1999, CAR CAR NAT STRAT CA; DOLAN P, 1995, 138 U YORK; Drummond MJ, 2008, BMJ-BRIT MED J, V337, P770; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Griffiths C, 2007, BMJ-BRIT MED J, V334, P1254, DOI 10.1136/bmj.39227.698785.47; Kennedy A, 2007, J EPIDEMIOL COMMUN H, V61, P254, DOI 10.1136/jech.2006.053538; Kruger JMS, 1998, ARCH INTERN MED, V158, P1245, DOI 10.1001/archinte.158.11.1245; LORIG K, 1993, HEALTH EDUC QUART, V20, P17, DOI 10.1177/109019819302000104; Lorig K R, 2001, Eff Clin Pract, V4, P256; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; RAFTERY J, 1995, EC EVALUATION MENTAL; Richardson G, 2008, J EPIDEMIOL COMMUN H, V62, P361, DOI 10.1136/jech.2006.057430; Richardson G, 2005, INT J TECHNOL ASSESS, V21, P423, DOI 10.1017/S0266462305050592; RICHARDSON J, 2001, 126 MON U; Solomon DH, 2002, J RHEUMATOL, V29, P362; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	26	29	30	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 22	2009	339								b3532	10.1136/bmj.b3532	http://dx.doi.org/10.1136/bmj.b3532			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	499OE	19773329	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000270231500006
J	Blanke, SR				Blanke, Steven R.			Expanding Functionality Within the Looking-Glass Universe	SCIENCE			English	Editorial Material							BACILLUS-ANTHRACIS		[Blanke, Steven R.] Univ Illinois, Dept Microbiol, Urbana, IL 61810 USA; [Blanke, Steven R.] Univ Illinois, Inst Genom Biol, Urbana, IL 61810 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Blanke, SR (corresponding author), Univ Illinois, Dept Microbiol, Urbana, IL 61810 USA.	sblanke@illinois.edu			NIAID NIH HHS [AI045928, AI076830] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076830, R01AI045928] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CAROLL L, 1871, LOOKING GLASS; Ezzell JW, 1999, J APPL MICROBIOL, V87, P250, DOI 10.1046/j.1365-2672.1999.00881.x; Grunewald J, 2006, MICROBIOL MOL BIOL R, V70, P121, DOI 10.1128/MMBR.70.1.121-146.2006; Huang AS, 2006, J NEUROSCI, V26, P2814, DOI 10.1523/JNEUROSCI.5060-05.2006; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Lamzin VS, 1995, CURR OPIN STRUC BIOL, V5, P830, DOI 10.1016/0959-440X(95)80018-2; MASON SF, 1984, NATURE, V311, P19, DOI 10.1038/311019a0; McKevitt MT, 2007, INFECT IMMUN, V75, P5726, DOI 10.1128/IAI.00727-07; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; PRELOG V, 1976, SCIENCE, V193, P17, DOI 10.1126/science.935852	10	4	4	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 18	2009	325	5947					1505	1506		10.1126/science.1180332	http://dx.doi.org/10.1126/science.1180332			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	495JS	19762631				2022-12-28	WOS:000269887900024
J	Johnston, CA; Hirono, K; Prehoda, KE; Doe, CQ				Johnston, Christopher A.; Hirono, Keiko; Prehoda, Kenneth E.; Doe, Chris Q.			Identification of an Aurora-A/Pins(LINKER)/Dlg Spindle Orientation Pathway using Induced Cell Polarity in S2 Cells	CELL			English	Article							DROSOPHILA AURORA-A; NEURAL STEM-CELLS; G-ALPHA-I; CORTICAL POLARITY; SELF-RENEWAL; CAENORHABDITIS-ELEGANS; ASYMMETRIC DIVISIONS; TUMOR-SUPPRESSOR; PROTEIN COMPLEX; NEUROBLASTS	Asymmetric cell division is intensely studied because it can generate cellular diversity as well as maintain stem cell populations. Asymmetric cell division requires mitotic spindle alignment with intrinsic or extrinsic polarity cues, but mechanistic detail of this process is lacking. Here, we develop a method to construct cortical polarity in a normally unpolarized cell line and use this method to characterize Partner of Inscuteable ( Pins; LGN/AGS3 in mammals) -dependent spindle orientation. We identify a previously unrecognized evolutionarily conserved Pins domain ( Pins LINKER) that requires Aurora-A phosphorylation to recruit Discs large (Dlg; PSD-95/hDlg in mammals) and promote partial spindle orientation. The well-characterized Pins TPR domain has no function alone, but placing the Pins TPR in cis to the Pins LINKER gives dynein-dependent precise spindle orientation. This "induced cortical polarity'' assay is suitable for rapid identification of the proteins, domains, and amino acids regulating spindle orientation or cell polarity.	[Johnston, Christopher A.; Hirono, Keiko; Prehoda, Kenneth E.; Doe, Chris Q.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Johnston, Christopher A.; Hirono, Keiko; Doe, Chris Q.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Johnston, Christopher A.; Hirono, Keiko; Doe, Chris Q.] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97403 USA	University of Oregon; University of Oregon; Howard Hughes Medical Institute; University of Oregon	Prehoda, KE (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	prehoda@uoregon.edu; cdoe@uoregon.edu		Prehoda, Ken/0000-0003-4214-6158	Damon Runyon postdoctoral fellowship; National Institutes of Health [GM068032]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087457, R01GM068032] Funding Source: NIH RePORTER	Damon Runyon postdoctoral fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Cabernard for Figure 6M; T. Gillies for Figures 6N and 6K; S. Liu, R. Vale, K. Siller, S. Spencer, T. Kaufman, J. Raff, J. Knoblich, and the Bloomington Stock Center for providing fly, DNA, and antibody reagents; B. Wee for technical assistance; and B. Bowerman, C. Cabernard, S. O'Rourke, S. Rogers, and S. Atwood for comments. This work was funded by a Damon Runyon postdoctoral fellowship ( C. A. J.), the National Institutes of Health GM068032 ( K. E. P.), and the Howard Hughes Medical Institute ( C. Q. D.).	Bai JM, 2001, DEVELOPMENT, V128, P591; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Couwenbergs C, 2007, J CELL BIOL, V179, P15, DOI 10.1083/jcb.200707085; Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Echard A, 2004, CURR BIOL, V14, P1685, DOI 10.1016/j.cub.2004.08.063; Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Hutterer A, 2006, DEV CELL, V11, P147, DOI 10.1016/j.devcel.2006.06.002; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Knoblich JA, 1999, CURR BIOL, V9, P155, DOI 10.1016/S0960-9822(99)80070-0; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lorson MA, 2000, J CELL BIOL, V148, P73, DOI 10.1083/jcb.148.1.73; Megraw TL, 1999, DEVELOPMENT, V126, P2829; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649; Nipper RW, 2007, P NATL ACAD SCI USA, V104, P14306, DOI 10.1073/pnas.0701812104; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siller KH, 2008, DEV BIOL, V319, P1, DOI 10.1016/j.ydbio.2008.03.018; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174	40	164	165	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 18	2009	138	6					1150	1163		10.1016/j.cell.2009.07.041	http://dx.doi.org/10.1016/j.cell.2009.07.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766567	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000269923200015
J	Thompson, CB				Thompson, Craig B.			Attacking Cancer at Its Root	CELL			English	Editorial Material							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE; PHILADELPHIA-CHROMOSOME; IMATINIB-RESISTANT; CHRONIC-PHASE; BLAST CRISIS; INHIBITOR; DASATINIB; EFFICACY	This year the Lasker DeBakey Clinical Research Award will be shared by Brian Druker, Nicholas Lydon, and Charles Sawyers for their development of a targeted molecular therapy for treating chronic myeloid leukemia. Their work demonstrated the ability of drugs directed against cancer-causing oncogenes to turn a rapidly fatal malignancy into a manageable chronic disease.	Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Thompson, CB (corresponding author), Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.	craig@mail.med.upenn.edu						Buchdunger E, 1996, CANCER RES, V56, P100; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; Cortes J, 2008, LEUKEMIA, V22, P2176, DOI 10.1038/leu.2008.221; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; DRUKER BJ, 2001, NEW ENGL J MED, V344, P1037; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; ODA T, 1994, J BIOL CHEM, V269, P22925; Sawyers CL, 2002, BLOOD, V99, P3530, DOI 10.1182/blood.V99.10.3530; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Zimmermann J, 1997, BIOORG MED CHEM LETT, V7, P187, DOI 10.1016/S0960-894X(96)00601-4	14	22	22	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 18	2009	138	6					1051	1054		10.1016/j.cell.2009.09.002	http://dx.doi.org/10.1016/j.cell.2009.09.002			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19766556	Bronze			2022-12-28	WOS:000269923200003
J	Jay, M; Marmot, MG				Jay, M.; Marmot, M. G.			Health and climate change	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jay, M.] House Lords, London SW1A 0PW, England; [Marmot, M. G.] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of London; University College London	Jay, M (corresponding author), House Lords, London SW1A 0PW, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G0100222, G8802774, G19/35] Funding Source: Medline; Medical Research Council [G0100222, G19/35, G8802774] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], CLIMATE CHANGE HUMAN; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; *GROUP 8 LEAD, 2009, RESP LEAD SUST FUT; Intergovernmental Panel on Climate Change, 4 IPCC; McMichael AJ, 2008, BRIT MED J, V336, P191, DOI 10.1136/bmj.39392.473727.AD; *OPT POP TRUST, 2009, POP GROWTH CLIM CHAN; Stern Nicholas, 2006, STERN REV EC CLIMATE	8	12	13	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2009	339								b3669	10.1136/bmj.b3669	http://dx.doi.org/10.1136/bmj.b3669			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	496RR	19762077				2022-12-28	WOS:000269994600011
J	Jay, M; Marmot, MG				Jay, M.; Marmot, M. G.			Health and climate change	LANCET			English	Editorial Material									[Marmot, M. G.] UCL, Int Inst Soc & Hlth, London WC1E 6BT, England; [Jay, M.] Merlin, London, England	University of London; University College London	Marmot, MG (corresponding author), UCL, Int Inst Soc & Hlth, London WC1E 6BT, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419	British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G0100222, G8802774, G19/35] Funding Source: Medline; Medical Research Council [G0100222, G19/35, G8802774] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Intergovernmental Panel on Climate Change, 2007, CLIM CHANG 2007 SYNT; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; McMichael AJ, 2008, BRIT MED J, V336, P191, DOI 10.1136/bmj.39392.473727.AD; *OPT POP TRUST, 2009, POP GROWTH CLIM CHAN; Stern Nicholas, 2007, EC CLIMATE CHANGE; *WHO, SEA LEV RIS; [No title captured]	8	12	13	2	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2009	374	9694					961	962		10.1016/S0140-6736(09)61603-2	http://dx.doi.org/10.1016/S0140-6736(09)61603-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	498PK	19762077				2022-12-28	WOS:000270154100010
J	Jefferson, T; Foxlee, R; Del Mar, C; Dooley, L; Ferroni, E; Hewak, B; Prabhala, A; Nair, S; Rivetti, A				Jefferson, Tom; Foxlee, Ruth; Del Mar, Chris; Dooley, Liz; Ferroni, Eliana; Hewak, Bill; Prabhala, Adi; Nair, Sree; Rivetti, Alex			Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HEALTH-CARE WORKERS; VIRUCIDAL PAPER HANDKERCHIEFS; PERSONAL PROTECTIVE EQUIPMENT; INFECTION-CONTROL STRATEGY; ALCOHOL HAND SANITIZER; SYNCYTIAL VIRUS; HONG-KONG; NOSOCOMIAL TRANSMISSION; INFLUENZA VACCINES; CONTROLLED-TRIAL	Objective To systematically review evidence for the effectiveness of physical interventions to interrupt or reduce the spread of respiratory viruses. Data extraction Search strategy of the Cochrane Library, Medline, OldMedline, Embase, and CINAHL, without language restriction, for any intervention to prevent transmission of respiratory viruses (isolation, quarantine, social distancing, barriers, personal protection, and hygiene). Study designs were randomised trials, cohort studies, case-controt studies, and controlled before and after studies. Data synthesis Of 2300 titles scanned 138 full papers were retrieved, including 49 papers of 51 studies. Study quality was poor for the three randomised controlled trials and most of the cluster randomised controlled trials; the observational studies were of mixed quality. Heterogeneity precluded meta-analysis of most data except that from six case-control studies. The highest quality cluster randomised trials suggest that the spread of respiratory viruses into the community can be prevented by intervening with hygienic measures aimed at younger children. Meta-analysis of six case-control studies suggests that physical measures are highly effective in preventing the spread of SARS: handwashing more than 10 times daily (odds ratio 0.45, 95% confidence interval 0.36 to 0.57; number needed to treat=4, 95% confidence interval 3.65 to 5.52); wearing masks (0.32, 0.25 to 0.40; NNT=6, 4.54 to 8.03); wearing N95 masks (0.09, 0.03 to 0.30; NNT=3, 2.37 to 4.06); wearing gloves (0.43,0.29 to 0.65; NNT=5,4.15 to 15.41); wearing gowns (0.23, 0.14 to 0.37; NNT=5, 3.37 to 7.12); and handwashing, masks, gloves, and gowns combined, (0.09, 0.02 to 0.35; NNT=3, 2.66 to 4.97). The incremental effect of adding virucidals or antiseptics to normal handwashing to decrease the spread of respiratory disease remains uncertain. The lack of proper evaluation of global measures such as screening at entry ports and social distancing prevent firm conclusions being drawn. Conclusion Routine long term implementation of some physical measures to interrupt or reduce the spread of respiratory viruses might be difficult but many simple and low cost interventions could be useful in reducing the spread.	[Del Mar, Chris; Dooley, Liz; Hewak, Bill; Prabhala, Adi] Bond Univ, Fac Hlth Sci & Med, Cochrane Acute Resp Infect Grp, Gold Coast, Qld 4229, Australia; [Jefferson, Tom; Rivetti, Alex] Manipal Acad Higher Educ, Dept Stat, Manipal, Karnataka, India; [Foxlee, Ruth] Publ Hlth Agcy Lazio Reg, Rome, Italy; [Ferroni, Eliana] Univ York, Dept Hlth Sci, Cochrane Wounds Grp, York YO10 5DD, N Yorkshire, England; [Nair, Sree] Cochrane Vaccines Field, Alessandria, Italy	Bond University; Manipal Academy of Higher Education (MAHE); University of York - UK	Del Mar, C (corresponding author), Bond Univ, Fac Hlth Sci & Med, Cochrane Acute Resp Infect Grp, Gold Coast, Qld 4229, Australia.	cdelmar@bond.edu.au	FERRONI, ELIANA/ABB-3304-2021; Del Mar, Chris B/B-1136-2008	Del Mar, Chris B/0000-0003-3821-8163; FERRONI, ELIANA/0000-0003-4803-2004; Al-Ansary, Lubna/0000-0001-7127-914X				Abou El Hassan MAI, 2004, J VIROL, V78, P12243, DOI 10.1128/JVI.78.22.12243-12251.2004; AGAH R, 1987, AM J DIS CHILD, V141, P695, DOI 10.1001/archpedi.1987.04460060111049; Amirav I, 2005, J PEDIATR-US, V147, P627, DOI 10.1016/j.jpeds.2005.05.035; Anderson RM, 2004, PHILOS T R SOC B, V359, P1091, DOI 10.1098/rstb.2004.1490; [Anonymous], 2005, Child Health Alert, V23, P1; [Anonymous], 2005, MED LETT DRUGS THER, V47, P3; [Anonymous], 2002, CLIN INFECT DIS, V34, pii; [Anonymous], 2003, MMWR-MORBID MORTAL W, V52, P29; Aragon D, 2005, AACN ADV CRIT CARE, V16, P121, DOI 10.1097/00044067-200504000-00002; Barros AJD, 1999, ACTA PAEDIATR, V88, P1113, DOI 10.1080/08035259950168180; Bell DM, 2004, EMERG INFECT DIS, V10, P1900, DOI 10.3201/eid1011.040729; Ben-Abraham R, 2002, J CRIT CARE, V17, P176, DOI 10.1053/jcrc.2002.35809; BLACK RE, 1981, AM J EPIDEMIOL, V113, P445, DOI 10.1093/oxfordjournals.aje.a113112; Breugelmans JG, 2004, EMERG INFECT DIS, V10, P1502, DOI 10.3201/eid1008.040093; Carabin H, 1999, EPIDEMIOLOGY, V10, P219, DOI 10.1097/00001648-199905000-00005; Carter JM, 2002, J NATL MED ASSOC, V94, pA11; Castillo-Chavez C, 2003, JAMA-J AM MED ASSOC, V290, P2876, DOI 10.1001/jama.290.21.2876; Cava MA, 2005, J NURS SCHOLARSHIP, V37, P343, DOI 10.1111/j.1547-5069.2005.00059.x; Cava MA, 2005, PUBLIC HEALTH NURS, V22, P398, DOI 10.1111/j.0737-1209.2005.220504.x; *CDC, 2003, MMWR-MORBID MORTAL W, V52, P433; *CDCP, 2007, INF CONTR GUID PREV; Centers for Disease Control and Prevention, 2005, 2004 2005 INT GUID U; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1037; Chai LYA, 2005, CLIN INFECT DIS, V40, P632, DOI 10.1086/427150; Chaovavanich Achara, 2004, Journal of the Medical Association of Thailand, V87, P1182; Chau PH, 2003, J EPIDEMIOL COMMUN H, V57, P766, DOI 10.1136/jech.57.10.766; Chia SE, 2005, OCCUP ENVIRON MED, V62, P473, DOI 10.1136/oem.2004.015024; DAVIES KJ, 1994, BRIT DENT J, V176, P262, DOI 10.1038/sj.bdj.4808430; Day R A, 1993, Clin Nurs Res, V2, P24, DOI 10.1177/105477389300200104; Day T, 2006, AM J EPIDEMIOL, V163, P479, DOI 10.1093/aje/kwj056; Dell'Omodarme M, 2005, STAT MED, V24, P2669, DOI 10.1002/sim.2131; Derrick JL, 2005, J HOSP INFECT, V59, P365, DOI 10.1016/j.jhin.2004.10.013; Desenclos JC, 2004, EMERG INFECT DIS, V10, P195, DOI 10.3201/eid1002.030351; DICK EC, 1986, J INFECT DIS, V153, P352, DOI 10.1093/infdis/153.2.352; DiGiovanni C, 2004, BIOSECUR BIOTERROR, V2, P265, DOI 10.1089/bsp.2004.2.265; DOEBBELING BN, 1992, NEW ENGL J MED, V327, P88, DOI 10.1056/NEJM199207093270205; Doherty JA, 1998, J HOSP INFECT, V38, P203, DOI 10.1016/S0195-6701(98)90275-4; Dwosh HA, 2003, CAN MED ASSOC J, V168, P1415; Dyer DL, 2000, FAM MED, V32, P633; EGGER M, 2007, COCHRANE METHODOLOGY; Falsey AR, 1999, INFECT CONT HOSP EP, V20, P200, DOI 10.1086/501612; FARR BM, 1988, AM J EPIDEMIOL, V128, P1162; Fendler EJ, 2002, AM J INFECT CONTROL, V30, P226, DOI 10.1067/mic.2002.120129; Flint J, 2003, Can Commun Dis Rep, V29, P105; Fung CP, 2004, INFECT CONT HOSP EP, V25, P1026, DOI 10.1086/502339; GALA CL, 1986, JAMA-J AM MED ASSOC, V256, P2706; Gaydos JC, 2001, AM J PREV MED, V21, P150, DOI 10.1016/S0749-3797(01)00332-4; Gensini GF, 2004, J INFECTION, V49, P257, DOI 10.1016/j.jinf.2004.03.002; Girou E, 2002, BRIT MED J, V325, P362, DOI 10.1136/bmj.325.7360.362; Glass K, 2006, EPIDEMIOL INFECT, V134, P1092, DOI 10.1017/S0950268806005863; Gore J, 2001, J Fam Pract, V50, P64; Gostin LO, 2003, JAMA-J AM MED ASSOC, V290, P3229, DOI 10.1001/jama.290.24.3229; Guinan M, 2002, AM J INFECT CONTROL, V30, P217, DOI 10.1067/mic.2002.120366; Gupta AG, 2005, J INFECTION, V50, P386, DOI 10.1016/j.jinf.2004.08.006; GWALTNEY JM, 1982, AM J EPIDEMIOL, V116, P828, DOI 10.1093/oxfordjournals.aje.a113473; GWALTNEY JM, 1980, J INFECT DIS, V142, P811, DOI 10.1093/infdis/142.6.811; HALL CB, 1981, AM J DIS CHILD, V135, P512, DOI 10.1001/archpedi.1981.02130300012006; HALL CB, 1981, J PEDIATR-US, V99, P100, DOI 10.1016/S0022-3476(81)80969-9; Han Hongbin, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35 Suppl, P86; HAYDEN GF, 1985, J INFECT DIS, V152, P403, DOI 10.1093/infdis/152.2.403; HENDLEY JO, 1988, EPIDEMIOL REV, V10, P242, DOI 10.1093/oxfordjournals.epirev.a036024; Heymann A, 2004, PEDIATR INFECT DIS J, V23, P675, DOI 10.1097/01.inf.0000128778.54105.06; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hilburn J, 2003, AM J INFECT CONTROL, V31, P109, DOI 10.1067/mic.2003.15; Ho AS, 2003, ANN INTERN MED, V139, P564, DOI 10.7326/0003-4819-139-7-200310070-00008; ISAACS D, 1991, ARCH DIS CHILD, V66, P227, DOI 10.1136/adc.66.2.227; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson T, 2005, LANCET, V366, P803, DOI 10.1016/S0140-6736(05)67204-2; Jefferson T, 2005, LANCET, V366, P1165, DOI 10.1016/S0140-6736(05)67339-4; Jefferson T, 2005, LANCET, V365, P773, DOI 10.1016/S0140-6736(05)17984-7; Jiang Shan-ping, 2003, Zhonghua Jiehe He Huxi Zazhi, V26, P594; Jiang SP, 2003, CHINESE MED J-PEKING, V116, P1293; Jones EW, 2005, CAN BULL MED HIST, V22, P57, DOI 10.3138/cbmh.22.1.57; Kaydos-Daniels SC, 2004, EMERG INFECT DIS, V10, P373, DOI 10.3201/eid1002.030748; Khan SK, 2000, UNDERTAKING SYSTEMAT; Kimel L S, 1996, J Sch Nurs, V12, P14, DOI 10.1177/105984059601200204; Kimel LS, 1996, J SCH NURS, V12, p[14, 8]; Kosugi Yoriko, 2004, Kansenshogaku Zasshi, V78, P995; KOTCH JB, 1994, PEDIATRICS, V94, P991; KRASINSKI K, 1990, J PEDIATR-US, V116, P894, DOI 10.1016/S0022-3476(05)80646-8; Krilov LR, 1996, AM J INFECT CONTROL, V24, P167, DOI 10.1016/S0196-6553(96)90008-5; Ladegaard M B, 1999, Ugeskr Laeger, V161, P4396; Lam BCC, 2004, PEDIATRICS, V114, pE565, DOI 10.1542/peds.2004-1107; Lange JH, 2004, J EPIDEMIOL COMMUN H, V58, P434; Larson EL, 2004, ANN INTERN MED, V140, P321, DOI 10.7326/0003-4819-140-5-200403020-00007; Lau JTF, 2005, J ALTERN COMPLEM MED, V11, P49, DOI 10.1089/acm.2005.11.49; Lau JTF, 2004, J EPIDEMIOL COMMUN H, V58, P988, DOI 10.1136/jech.2003.017483; Lau JTF, 2004, EMERG INFECT DIS, V10, P587, DOI 10.3201/eid1004.030628; LECLAIR JM, 1987, NEW ENGL J MED, V317, P329, DOI 10.1056/NEJM198708063170601; Lee GM, 2005, PEDIATRICS, V115, P852, DOI 10.1542/peds.2004-0856; Leung TF, 2004, J HOSP INFECT, V56, P215, DOI 10.1016/j.jhin.2003.11.004; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; LONGINI IM, 1988, AM J EPIDEMIOL, V128, P639, DOI 10.1093/oxfordjournals.aje.a115011; Luby SP, 2005, LANCET, V366, P225, DOI 10.1016/S0140-6736(05)66912-7; Luckingham B, 1984, J Ariz Hist, V25, P191; Ma Huai-jian, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P741; Macartney KK, 2000, PEDIATRICS, V106, P520, DOI 10.1542/peds.106.3.520; MADGE P, 1992, LANCET, V340, P1079, DOI 10.1016/0140-6736(92)93088-5; Makris AT, 2000, AM J INFECT CONTROL, V28, P3, DOI 10.1016/S0196-6553(00)90004-X; MARIN J, 1991, ZBL HYG UMWELTMED, V191, P516; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Master D, 1997, Fam Med, V29, P336; MONSMA M, 1992, J SCHOOL HEALTH, V62, P109, DOI 10.1111/j.1746-1561.1992.tb06031.x; Morton Jennifer L, 2004, J Sch Nurs, V20, P161; MURPHY D, 1981, J PEDIATR-US, V99, P746, DOI 10.1016/S0022-3476(81)80401-5; Niffenegger J P, 1997, J Pediatr Health Care, V11, P26, DOI 10.1016/S0891-5245(97)90141-3; Nishiura H, 2005, AM J TROP MED HYG, V73, P17, DOI 10.4269/ajtmh.2005.73.17; OCALLAGHAN CA, 1993, LANCET, V341, P182, DOI 10.1016/0140-6736(93)90049-M; Olsen SJ, 2003, NEW ENGL J MED, V349, P2416, DOI 10.1056/NEJMoa031349; Ooi PL, 2005, AM J INFECT CONTROL, V33, P252, DOI 10.1016/j.ajic.2004.08.007; Ou Jian-ming, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P1093; Pang XH, 2003, JAMA-J AM MED ASSOC, V290, P3215, DOI 10.1001/jama.290.24.3215; Pang Xing-Huo, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P674; PELKE S, 1994, ARCH PEDIAT ADOL MED, V148, P1016, DOI 10.1001/archpedi.1994.02170100014004; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Prasad GVR, 2004, TRANSPLANTATION, V77, P1917, DOI 10.1097/01.TP.0000131946.36777.06; Rabenau HF, 2005, J HOSP INFECT, V61, P107, DOI 10.1016/j.jhin.2004.12.023; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Roberts L, 2000, PEDIATRICS, V105, P738, DOI 10.1542/peds.105.4.738; Rosenthal VD, 2005, AM J INFECT CONTROL, V33, P392, DOI 10.1016/j.ajic.2004.08.009; Ryan MAK, 2001, AM J PREV MED, V21, P79, DOI 10.1016/S0749-3797(01)00323-3; SAFIULIN A A, 1972, Gigiena i Sanitariya, V37, P99; Sandora TJ, 2005, PEDIATRICS, V116, P587, DOI 10.1542/peds.2005-0199; Sattar SA, 2000, INFECT CONT HOSP EP, V21, P516, DOI 10.1086/501796; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; Simon A, 2006, INT J HYG ENVIR HEAL, V209, P317, DOI 10.1016/j.ijheh.2006.02.003; Sizun J, 1996, ARCH PEDIATRIE, V3, P723, DOI 10.1016/0929-693X(96)87097-7; SNYDMAN DR, 1988, INFECT CONT HOSP EP, V9, P105, DOI 10.1086/645804; Somogyi R, 2004, CHEST, V125, P1155, DOI 10.1378/chest.125.3.1155; Svoboda T, 2004, NEW ENGL J MED, V350, P2352, DOI 10.1056/NEJMoa032111; Teleman MD, 2004, EPIDEMIOL INFECT, V132, P797, DOI [10.1017/S0950268804002766, 10.1017/s0950268804002766]; Turner RB, 2004, ANTIMICROB AGENTS CH, V48, P2595, DOI 10.1128/AAC.48.7.2595-2598.2004; UENJO T, 1990, NIPPON GANKA GAKKAI, V94, P44; Wang Hong-wei, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P574; Wang JP, 2003, CHEM J CHINESE U, V24, P565; Weber JT, 2004, ANN INTERN MED, V140, P397, DOI 10.7326/0003-4819-140-5-200403020-00016; Wells G., 2005, NEWCASTLE OTTAWA SCA; White C, 2005, J AM COLL HEALTH, V53, P175, DOI 10.3200/JACH.53.4.175-181; White C, 2003, AM J INFECT CONTROL, V31, P364, DOI 10.1016/S0196-6553(03)00041-5; White C G, 2001, J Sch Nurs, V17, P258; Wilczynski Jan, 1997, Medycyna Doswiadczalna i Mikrobiologia, V49, P199; Wilder-Smith A, 2003, TROP MED INT HEALTH, V8, P1035, DOI 10.1046/j.1360-2276.2003.01133.x; Wilder-Smith Annelies, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P481; Wong TW, 2005, AM J INFECT CONTROL, V33, P580, DOI 10.1016/j.ajic.2005.05.025; Wu J, 2004, EMERG INFECT DIS, V10, P210, DOI 10.3201/eid1002.030730; Yen MY, 2006, J HOSP INFECT, V62, P195, DOI 10.1016/j.jhin.2005.02.011; Yin Wen-wu, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P18; Yu ITS, 2004, NEW ENGL J MED, V350, P1731, DOI 10.1056/NEJMoa032867; Zamora JE, 2006, CAN MED ASSOC J, V175, P249, DOI 10.1503/cmaj.060094; Zhao Z, 2003, J MED MICROBIOL, V52, P715, DOI 10.1099/jmm.0.05320-0; 2004, CONSUM REP, V69, P56; 2005, J HOPKINS MED LETT H, V17, P8	153	251	258	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2008	336	7635					77	80		10.1136/bmj.39393.510347.BE	http://dx.doi.org/10.1136/bmj.39393.510347.BE			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	253BX	19773323	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000252494800028
